data_2afj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2afj _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.577 ' O ' ' N ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 121.107 0.479 . . . . 0.0 110.025 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.462 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 1.7 tt0 -45.02 -34.72 2.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.053 -1.029 . . . . 0.0 108.988 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.37 -24.05 64.78 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.385 -0.822 . . . . 0.0 108.787 178.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.577 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -83.42 -32.3 26.18 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.603 ' C ' ' CD1' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -81.52 -38.19 26.65 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.891 0.853 . . . . 0.0 109.284 179.165 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.558 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 0.9 OUTLIER -46.8 -30.72 2.59 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.625 0.726 . . . . 0.0 109.88 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.68 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . . . -72.58 -169.99 0.15 Allowed Pre-proline 0 C--N 1.298 -1.652 0 O-C-N 121.497 -0.752 . . . . 0.0 109.364 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.68 ' HD2' ' CB ' ' A' ' 35' ' ' ALA . 42.0 Cg_endo -69.48 106.18 1.57 Allowed 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.6 1.316 . . . . 0.0 109.765 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.616 ' HD3' ' O ' ' A' ' 35' ' ' ALA . 50.5 Cg_endo -88.67 108.59 0.51 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.13 1.595 . . . . 0.0 111.166 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.77 ' O ' ' N ' ' A' ' 40' ' ' LEU . 49.4 Cg_endo -76.81 150.55 30.74 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.925 1.487 . . . . 0.0 109.998 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.723 ' O ' ' CG ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER 3.3 61.39 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 122.617 1.199 . . . . 0.0 110.455 -178.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.77 ' N ' ' O ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -149.66 -45.47 0.13 Allowed 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 178.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.612 HG21 ' CD1' ' A' ' 40' ' ' LEU . 2.2 t -86.38 -35.64 9.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' A' ' 46' ' ' HIS . . . -89.21 -43.23 11.15 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.38 0.61 . . . . 0.0 110.089 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.557 ' HG3' ' CD ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -68.66 -25.17 64.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.461 -0.774 . . . . 0.0 110.416 -179.685 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.653 ' HA ' HG12 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -79.05 -50.84 10.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.146 -0.971 . . . . 0.0 108.999 179.475 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.656 ' HA ' ' CB ' ' A' ' 49' ' ' ASN . 9.3 m170 -63.8 -16.16 60.53 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 42' ' ' ALA . 3.7 t-160 -96.36 -28.75 14.33 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.44 -119.21 0.05 OUTLIER Glycine 0 N--CA 1.477 1.403 0 N-CA-C 107.838 -2.105 . . . . 0.0 107.838 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.856 ' HB3' ' CD1' ' A' ' 214' ' ' ILE . 0.8 OUTLIER -103.52 70.56 1.04 Allowed 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.011 -1.287 . . . . 0.0 110.478 179.143 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.656 ' CB ' ' HA ' ' A' ' 45' ' ' HIS . 0.3 OUTLIER -109.24 111.97 59.76 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 121.1 -1.0 . . . . 0.0 111.721 179.578 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.846 ' HG2' ' HB2' ' A' ' 53' ' ' CYS . 48.5 Cg_endo -80.57 -59.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.302 -1.902 0 O-C-N 123.78 1.411 . . . . 0.0 108.847 177.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.698 ' HG2' ' O ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER 179.81 -95.73 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.602 -0.686 . . . . 0.0 110.191 178.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.594 ' C ' ' HA2' ' A' ' 80' ' ' GLY 0.26 54.1 m-20 -68.97 33.97 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.178 0.989 . . . . 0.0 109.175 178.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.846 ' HB2' ' HG2' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -101.07 -176.92 3.3 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.843 -177.38 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.671 ' CB ' HG12 ' A' ' 78' ' ' VAL . 0.3 OUTLIER -50.6 101.73 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.689 -0.804 . . . . 0.0 111.662 -177.17 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.511 ' HG3' ' N ' ' A' ' 56' ' ' ASN . 9.4 pt-20 -102.07 -32.78 9.97 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.826 0.822 . . . . 0.0 109.522 177.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.511 ' N ' ' HG3' ' A' ' 55' ' ' GLU . 21.6 m-80 -70.01 -7.98 45.42 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.76 -0.587 . . . . 0.0 111.811 -178.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.57 HD11 ' CD1' ' A' ' 66' ' ' PHE . 1.2 pt -112.69 166.17 6.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 120.844 -1.16 . . . . 0.0 109.988 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.637 ' O ' ' CB ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -108.98 126.86 53.55 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.371 -0.831 . . . . 0.0 110.563 -179.13 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 44' ' ' ARG . 9.6 p -130.42 130.76 65.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 O-C-N 121.46 -0.775 . . . . 0.0 109.275 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.557 ' CD ' ' HG3' ' A' ' 43' ' ' GLN . 19.7 tttm -135.61 153.25 51.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.069 -1.019 . . . . 0.0 110.689 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.512 ' HA ' ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -66.21 -121.8 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.401 -0.812 . . . . 0.0 110.269 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 44.51 26.54 1.06 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.699 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 124.38 61.01 0.18 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.699 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER 0.61 88.76 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.796 -0.826 . . . . 0.0 110.758 -179.658 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 42.4 t -127.64 114.73 17.74 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.289 -0.882 . . . . 0.0 111.396 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.617 ' CD1' HG22 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -84.37 134.31 34.49 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.526 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.637 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 2.4 tt0 -126.66 131.03 51.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.74 -1.225 . . . . 0.0 110.847 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.522 ' NH1' ' OD2' ' A' ' 76' ' ' ASP . 0.0 OUTLIER -136.06 156.07 49.27 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.414 -0.804 . . . . 0.0 109.539 179.602 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.671 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -85.37 -69.92 0.13 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.071 -1.018 . . . . 0.0 111.243 -179.105 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.671 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 55.8 Cg_endo -72.16 -113.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.55 1.289 . . . . 0.0 110.324 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.48 ' O ' ' N ' ' A' ' 73' ' ' GLN . 4.7 t -140.38 164.83 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.454 -1.404 . . . . 0.0 110.369 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.543 ' CB ' ' NE1' ' A' ' 207' ' ' TRP . . . -41.62 -24.45 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.306 -0.872 . . . . 0.0 110.377 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.495 ' C ' ' O ' ' A' ' 72' ' ' ALA . 1.6 pt20 -36.11 -34.33 0.05 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.263 -0.898 . . . . 0.0 110.577 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 72' ' ' ALA . 69.0 p -149.54 -36.52 0.16 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 110.317 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.587 ' O ' ' OG ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -72.15 -55.1 7.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.189 -0.945 . . . . 0.0 110.134 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.522 ' OD2' ' NH1' ' A' ' 68' ' ' ARG . 4.7 t0 -99.24 155.36 17.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.225 -0.922 . . . . 0.0 109.741 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.63 74.12 1.26 Allowed Glycine 0 N--CA 1.487 2.068 0 N-CA-C 107.23 -2.348 . . . . 0.0 107.23 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.673 HG22 ' HA ' ' A' ' 53' ' ' CYS . 1.4 p -158.08 162.67 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 O-C-N 121.806 -0.82 . . . . 0.0 109.406 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.667 ' CG ' ' O ' ' A' ' 203' ' ' VAL . 0.0 OUTLIER -145.52 137.35 25.36 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.072 -1.051 . . . . 0.0 113.008 -178.419 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.594 ' HA2' ' C ' ' A' ' 52' ' ' ASP . . . -74.73 154.05 46.51 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 107.729 -2.148 . . . . 0.0 107.729 176.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.511 ' HG2' ' N ' ' A' ' 82' ' ' ARG . 1.3 ttmp? -126.18 -97.55 0.42 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.796 -1.414 . . . . 0.0 112.374 -178.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.88 ' HD3' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -43.33 -87.41 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.208 -0.933 . . . . 0.0 111.666 -178.102 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.88 ' N ' ' HD3' ' A' ' 82' ' ' ARG . . . 60.39 76.9 0.2 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.564 ' CE1' ' SD ' ' A' ' 173' ' ' MET . 10.1 t80 -94.42 132.08 39.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.356 -1.085 . . . . 0.0 110.842 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.468 ' O ' ' SD ' ' A' ' 173' ' ' MET . 7.3 t -140.01 161.34 37.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.39 -0.819 . . . . 0.0 109.911 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.488 ' HA ' ' HG2' ' A' ' 173' ' ' MET . 4.1 mtt180 -111.26 160.22 17.19 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.066 -1.022 . . . . 0.0 109.776 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.77 158.29 34.19 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 172' ' ' ASP . 2.5 tt -87.61 123.52 32.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.306 -1.114 . . . . 0.0 110.163 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.567 ' CD2' ' O ' ' A' ' 171' ' ' LEU . 0.6 OUTLIER -147.36 173.36 12.68 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 110.134 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.454 ' HB3' ' HA ' ' A' ' 170' ' ' VAL . . . -149.58 155.4 40.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.351 -0.843 . . . . 0.0 110.037 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.78 ' HB3' ' CD2' ' A' ' 216' ' ' TYR . 0.0 OUTLIER -134.72 170.67 15.48 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.116 -0.99 . . . . 0.0 110.352 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.663 ' N ' ' O ' ' A' ' 215' ' ' ARG . 1.0 OUTLIER -129.1 147.89 51.0 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.889 -0.725 . . . . 0.0 110.797 -179.471 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.552 ' CG2' ' OH ' ' A' ' 180' ' ' TYR . 0.6 OUTLIER -144.3 145.48 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.53 -0.731 . . . . 0.0 109.933 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.545 ' O ' ' CG2' ' A' ' 212' ' ' VAL . 0.0 OUTLIER -145.02 144.32 30.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.173 -0.955 . . . . 0.0 110.204 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.608 ' CD1' HG22 ' A' ' 212' ' ' VAL . 41.7 m95 -117.99 107.6 43.71 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.239 -0.913 . . . . 0.0 110.473 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.566 ' HG3' ' CZ ' ' A' ' 213' ' ' ARG . 49.8 Cg_endo -75.04 109.79 2.99 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.875 1.46 . . . . 0.0 109.899 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.508 ' O ' HD12 ' A' ' 97' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.114 -0.991 . . . . 0.0 110.225 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.855 HG22 ' O ' ' A' ' 204' ' ' SER . 17.4 m . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 121.681 0.753 . . . . 0.0 110.612 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.532 HG11 ' N ' ' A' ' 107' ' ' GLY . 89.8 t -150.63 170.09 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.623 -0.673 . . . . 0.0 109.341 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.618 ' CA ' ' HA3' ' A' ' 132' ' ' GLY . . . 165.6 167.3 25.99 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.34 -1.409 . . . . 0.0 110.479 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.533 ' CG1' ' HB2' ' A' ' 199' ' ' LEU . 1.7 t -112.55 141.73 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.551 -0.97 . . . . 0.0 109.507 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 130' ' ' SER . . . -114.53 142.61 46.19 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.081 -1.012 . . . . 0.0 110.655 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.568 HG23 ' CG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -118.77 131.99 56.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.277 -0.889 . . . . 0.0 110.357 179.718 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.97 -26.79 17.4 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.399 -0.813 . . . . 0.0 109.286 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.485 ' O ' ' C ' ' A' ' 113' ' ' ALA . 4.1 pp -83.83 -12.17 55.97 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.558 -0.714 . . . . 0.0 109.448 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.572 ' CB ' ' CB ' ' A' ' 129' ' ' GLU . . . . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.587 -0.695 . . . . 0.0 110.441 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.251 0.548 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.572 ' CB ' ' CB ' ' A' ' 113' ' ' ALA . 3.9 tt0 -150.03 129.64 13.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.313 -0.867 . . . . 0.0 109.997 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 32.3 t -120.43 119.68 33.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.189 -0.944 . . . . 0.0 110.409 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.28 131.62 40.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.349 -0.845 . . . . 0.0 109.841 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.618 ' HA3' ' CA ' ' A' ' 107' ' ' GLY . . . -165.05 -144.67 4.13 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.696 ' CE3' ' CD2' ' A' ' 180' ' ' TYR . 31.5 m0 -116.67 114.45 24.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.343 -1.092 . . . . 0.0 110.556 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -118.13 143.42 46.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.527 -0.733 . . . . 0.0 110.033 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.557 HD13 ' N ' ' A' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.732 0 O-C-N 121.23 -0.919 . . . . 0.0 110.335 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.531 ' CG2' HD21 ' A' ' 167' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.69 71.8 3.21 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.976 1.514 . . . . 0.0 110.617 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.419 ' O ' ' HB3' ' A' ' 94' ' ' SER . 1.4 mt-10 -172.29 -81.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.355 -0.841 . . . . 0.0 110.118 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.516 ' HG2' ' N ' ' A' ' 167' ' ' LEU . 0.8 OUTLIER -151.55 154.92 37.42 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.322 -0.861 . . . . 0.0 109.739 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.597 ' HG ' ' CE1' ' A' ' 180' ' ' TYR . 0.0 OUTLIER -152.77 139.9 19.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.091 -1.005 . . . . 0.0 110.483 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' A' ' 181' ' ' SER . 17.0 tp -114.3 112.76 23.6 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.226 -0.921 . . . . 0.0 109.748 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.657 ' CG2' ' CE1' ' A' ' 180' ' ' TYR . 4.2 t -97.1 131.63 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.039 -1.038 . . . . 0.0 110.808 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.454 ' HA ' ' HB3' ' A' ' 90' ' ' ALA . 4.3 t -106.65 122.96 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.482 -0.761 . . . . 0.0 109.491 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.567 ' O ' ' CD2' ' A' ' 89' ' ' HIS . 4.6 tp -133.21 115.28 14.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.069 -1.02 . . . . 0.0 110.554 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.501 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 32.1 t0 -120.3 135.15 55.1 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.296 -0.877 . . . . 0.0 110.199 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.564 ' SD ' ' CE1' ' A' ' 84' ' ' TYR . 0.0 OUTLIER -94.58 -39.13 10.53 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.635 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 173' ' ' MET . 5.8 mm-40 -42.65 -27.7 0.19 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.219 -0.926 . . . . 0.0 108.828 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.589 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.1 OUTLIER -112.62 -27.07 8.34 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.235 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 82.57 24.23 54.21 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.589 ' OG1' ' HB3' ' A' ' 175' ' ' GLU . 0.2 OUTLIER -121.14 128.68 52.76 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.248 -1.148 . . . . 0.0 111.141 -179.458 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.572 ' N ' ' CD2' ' A' ' 178' ' ' LEU . 0.2 OUTLIER -139.99 153.69 46.93 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.459 -0.776 . . . . 0.0 109.588 179.338 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.421 ' O ' HG11 ' A' ' 169' ' ' VAL . . . -153.1 174.04 31.89 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.696 ' CD2' ' CE3' ' A' ' 133' ' ' TRP . 0.7 OUTLIER -118.94 118.67 32.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.351 -1.087 . . . . 0.0 110.119 -179.946 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.536 ' O ' ' CD1' ' A' ' 167' ' ' LEU . 39.3 t -144.76 165.23 28.67 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.177 -0.952 . . . . 0.0 109.96 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.609 HD13 ' CD2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -102.64 116.88 47.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 121.452 -0.78 . . . . 0.0 109.674 179.541 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 66.56 8.31 45.5 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 87.05 35.95 9.4 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' THR . . . . . 0.419 ' N ' ' OG ' ' A' ' 181' ' ' SER . 33.0 m -84.89 -74.55 0.39 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.293 -1.122 . . . . 0.0 110.563 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.609 ' CD2' HD13 ' A' ' 182' ' ' ILE . 18.7 m-85 -81.01 88.04 5.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.109 -0.995 . . . . 0.0 110.662 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.602 ' O ' ' CE2' ' A' ' 191' ' ' PHE . 2.3 tp -177.84 28.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.595 -0.691 . . . . 0.0 109.5 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.427 ' H ' ' HD2' ' A' ' 189' ' ' PRO . . . -104.15 -68.27 0.75 Allowed Glycine 0 N--CA 1.491 2.336 0 C-N-CA 120.059 -1.067 . . . . 0.0 110.514 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.427 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 44.4 Cg_endo -71.1 -30.05 16.79 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.843 1.444 . . . . 0.0 111.17 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -73.12 12.29 0.58 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.175 -0.953 . . . . 0.0 111.17 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.602 ' CE2' ' O ' ' A' ' 187' ' ' LEU . 0.3 OUTLIER -90.13 -13.15 36.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.08 -1.012 . . . . 0.0 109.741 179.255 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.47 -20.37 31.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.436 -0.79 . . . . 0.0 110.718 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -108.97 -24.7 5.92 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.821 -1.711 . . . . 0.0 108.821 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.621 ' HA ' ' HD2' ' A' ' 197' ' ' ARG . 6.6 tt -61.99 -32.71 73.2 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.611 -0.935 . . . . 0.0 109.016 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.542 ' HA ' ' CG2' ' A' ' 177' ' ' THR . 0.1 OUTLIER -47.16 -29.18 2.14 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.434 -0.791 . . . . 0.0 109.409 179.422 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -114.42 -19.38 6.24 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.664 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.91 -8.36 49.59 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.493 -1.004 . . . . 0.0 110.049 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' THR . . . . . 0.54 ' O ' ' CG2' ' A' ' 110' ' ' THR . 0.1 OUTLIER -43.52 143.16 1.0 Allowed 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.91 0.862 . . . . 0.0 111.587 -178.152 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' A' ' 197' ' ' ARG . 0.0 OUTLIER -140.41 172.26 12.98 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 22.3 m-85 -83.15 129.82 59.52 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.953 -1.092 . . . . 0.0 109.34 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.533 ' HD3' ' CD1' ' A' ' 178' ' ' LEU . 48.1 Cg_endo -74.18 129.6 13.28 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.054 1.555 . . . . 0.0 111.73 -178.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.485 ' O ' HG13 ' A' ' 106' ' ' VAL . 8.3 m -133.42 151.58 51.82 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.584 -0.697 . . . . 0.0 109.405 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.671 ' CG1' ' HG3' ' A' ' 50' ' ' PRO . 1.6 p -135.79 139.49 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.033 -1.042 . . . . 0.0 110.431 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' SER . . . . . 0.855 ' O ' HG22 ' A' ' 105' ' ' VAL . 74.7 m -119.7 126.88 52.18 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.756 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.589 ' HA ' ' CH2' ' A' ' 95' ' ' TRP . . . -109.79 138.3 46.35 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.772 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.568 ' CG1' ' N ' ' A' ' 207' ' ' TRP . 0.3 OUTLIER -91.62 -159.68 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.506 -0.746 . . . . 0.0 110.542 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.568 ' N ' ' CG1' ' A' ' 206' ' ' VAL . 0.8 OUTLIER -47.07 176.39 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 110.265 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.422 ' N ' ' OD2' ' A' ' 76' ' ' ASP . . . -82.1 -0.12 89.28 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -72.87 -33.68 66.24 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.616 -0.932 . . . . 0.0 110.155 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . 0.668 ' O ' ' C ' ' A' ' 211' ' ' GLN . 11.4 t -97.08 -0.25 47.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.346 -0.846 . . . . 0.0 110.149 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.668 ' C ' ' O ' ' A' ' 210' ' ' CYS . 0.6 OUTLIER 0.49 106.39 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.787 0.803 . . . . 0.0 111.42 -179.804 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.608 HG22 ' CD1' ' A' ' 95' ' ' TRP . 1.9 p -87.85 145.02 8.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.708 -0.62 . . . . 0.0 109.545 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . 0.609 ' HG3' ' HG ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -87.27 156.45 19.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.17 -0.956 . . . . 0.0 110.466 -178.686 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.856 ' CD1' ' HB3' ' A' ' 48' ' ' TRP . 0.2 OUTLIER -143.86 130.24 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.453 -0.779 . . . . 0.0 110.657 -179.323 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.663 ' O ' ' N ' ' A' ' 92' ' ' GLU . 6.8 mtt180 -130.81 108.86 10.16 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . 0.78 ' CD2' ' HB3' ' A' ' 91' ' ' TRP . 1.6 t80 -113.84 139.92 48.76 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 120.976 -1.077 . . . . 0.0 111.693 -177.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' MET . . . . . 0.45 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 0.3 OUTLIER -136.87 125.85 24.32 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.19 0.519 . . . . 0.0 109.89 179.548 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 120.47 -21.8 8.5 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.586 ' HB2' ' CE1' ' A' ' 216' ' ' TYR . 5.9 tm-20 . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.152 -1.205 . . . . 0.0 110.362 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.541 ' CD2' ' HG3' ' A' ' 55' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 121.184 0.516 . . . . 0.0 110.048 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.535 ' HA ' HD23 ' A' ' 33' ' ' LEU . 2.1 pp20? -47.54 -43.05 24.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.917 . . . . 0.0 109.745 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.436 ' N ' ' CD ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -57.75 -21.19 39.85 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.201 179.269 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.54 ' O ' ' HB2' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -83.4 -35.2 25.25 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.563 ' C ' ' CD1' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -67.8 -35.63 78.98 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 122.059 0.933 . . . . 0.0 109.087 179.15 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.557 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 1.0 OUTLIER -82.65 -6.8 59.56 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.301 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.643 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . . . -45.82 -67.31 0.39 Allowed Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.226 -0.921 . . . . 0.0 111.068 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.698 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 46.1 Cg_endo -70.42 142.49 45.17 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.674 1.355 . . . . 0.0 110.288 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.692 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 53.3 Cg_endo -96.79 20.62 0.44 Allowed 'Trans proline' 0 CA--C 1.552 1.385 0 C-N-CA 121.724 1.616 . . . . 0.0 113.828 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.698 ' CD ' ' HB2' ' A' ' 36' ' ' PRO . 50.6 Cg_endo -79.58 151.01 22.11 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 122.609 0.794 . . . . 0.0 110.625 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.722 ' CG ' ' OE1' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -15.33 -54.7 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.755 -0.59 . . . . 0.0 111.835 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.681 ' CD2' ' C ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -44.56 -51.48 8.92 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 120.455 -1.403 . . . . 0.0 109.701 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.66 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 23.4 t -87.26 -30.47 5.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.146 -0.971 . . . . 0.0 110.614 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.67 -36.8 15.04 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.974 -1.079 . . . . 0.0 111.587 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.753 ' CD ' ' HB2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -82.24 -19.53 39.46 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.252 -0.905 . . . . 0.0 110.01 -179.188 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.604 ' N ' ' NE2' ' A' ' 43' ' ' GLN . 2.1 ttt180 -83.23 -42.68 16.95 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.304 -0.872 . . . . 0.0 109.952 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.678 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 14.7 m170 -60.4 -18.07 48.17 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.609 -0.682 . . . . 0.0 110.703 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -96.29 -34.71 11.5 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.032 -1.067 . . . . 0.0 109.556 178.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.522 ' HA3' ' HB2' ' A' ' 61' ' ' GLU . . . -92.42 -101.87 1.44 Allowed Glycine 0 N--CA 1.487 2.056 0 N-CA-C 106.929 -2.468 . . . . 0.0 106.929 178.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.713 ' CH2' ' HB ' ' A' ' 212' ' ' VAL . 93.8 m95 -81.27 73.81 8.29 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.05 -1.265 . . . . 0.0 108.044 177.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.678 ' HA ' ' HA ' ' A' ' 45' ' ' HIS . 0.1 OUTLIER -43.69 147.02 0.88 Allowed Pre-proline 0 C--N 1.297 -1.714 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.087 -179.362 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.665 ' HD3' ' CD2' ' A' ' 45' ' ' HIS . 40.5 Cg_endo -68.48 -33.04 23.83 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 124.498 1.788 . . . . 0.0 110.142 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.834 ' CE ' ' N ' ' A' ' 51' ' ' LYS . 0.2 OUTLIER -63.58 -16.64 61.4 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.612 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.878 ' O ' ' N ' ' A' ' 79' ' ' ARG . 4.2 m-20 -104.83 0.56 28.2 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 177.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 21.7 t -167.57 137.31 2.75 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 120.149 -0.621 . . . . 0.0 110.025 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.732 ' CB ' HD22 ' A' ' 56' ' ' ASN . 0.0 OUTLIER -100.77 161.33 13.67 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.209 179.159 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.541 ' HG3' ' CD2' ' A' ' 29' ' ' LEU . 24.3 pm0 -38.12 -20.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.326 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.732 HD22 ' CB ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -41.81 -29.61 0.21 Allowed 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 118.495 -1.282 . . . . 0.0 108.204 -179.762 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.54 ' CD1' ' O ' ' A' ' 207' ' ' TRP . 1.2 mt -131.13 166.11 29.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-O 121.63 0.729 . . . . 0.0 111.056 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.52 ' N ' ' CG2' ' A' ' 57' ' ' ILE . 2.8 t70 -128.11 105.67 8.53 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.695 HG12 ' HA ' ' A' ' 66' ' ' PHE . 10.7 m -128.44 135.52 62.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.327 -0.858 . . . . 0.0 110.955 -178.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.753 ' HB2' ' CD ' ' A' ' 43' ' ' GLN . 2.5 tttm -124.02 155.32 38.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.365 -0.835 . . . . 0.0 110.574 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.522 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . 4.2 tt0 -83.98 -131.25 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.387 -0.821 . . . . 0.0 110.142 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 43.24 52.44 6.0 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 108.389 -1.885 . . . . 0.0 108.389 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.667 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 108.88 61.66 0.54 Allowed Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.667 ' C ' ' O ' ' A' ' 63' ' ' GLY . 1.5 mm? 0.49 80.06 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.92 -0.753 . . . . 0.0 111.421 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 63' ' ' GLY . 1.6 m -99.51 114.37 27.31 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.266 -0.896 . . . . 0.0 109.599 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.695 ' HA ' HG12 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -104.89 124.74 49.99 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.311 -0.868 . . . . 0.0 110.079 -179.683 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.511 ' O ' ' O ' ' A' ' 58' ' ' ASP . 29.2 tt0 -144.62 145.56 31.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 109.862 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.557 ' HG2' ' O ' ' A' ' 207' ' ' TRP . 0.0 OUTLIER -132.68 118.12 18.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 110.207 -179.791 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.688 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 9.9 mmm-85 -84.73 -71.65 0.1 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.284 -0.885 . . . . 0.0 110.302 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.688 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 56.4 Cg_endo -72.18 -145.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.569 1.3 . . . . 0.0 109.155 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.484 ' O ' ' HG2' ' A' ' 73' ' ' GLN . 3.2 t -140.09 163.77 23.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 O-C-N 121.406 -0.809 . . . . 0.0 109.738 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 71' ' ' VAL . . . -43.19 103.3 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.067 -1.021 . . . . 0.0 109.891 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 3.8 pt20 -128.28 -113.27 0.27 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.211 -0.93 . . . . 0.0 110.593 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.462 ' C ' ' O ' ' A' ' 73' ' ' GLN . 22.0 p -36.06 -52.08 0.76 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.319 -0.863 . . . . 0.0 110.809 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.48 ' CB ' ' HB3' ' A' ' 54' ' ' SER . 0.2 OUTLIER -118.41 -137.39 0.35 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.131 -0.98 . . . . 0.0 109.993 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.701 ' O ' ' C ' ' A' ' 77' ' ' GLY . 1.3 t0 -140.66 154.84 46.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.893 . . . . 0.0 110.387 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.701 ' C ' ' O ' ' A' ' 76' ' ' ASP . . . -12.23 -98.32 0.0 OUTLIER Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.587 ' CG2' ' CB ' ' A' ' 205' ' ' ALA . 3.7 m -128.06 121.64 56.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.038 -1.272 . . . . 0.0 110.003 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.878 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -145.53 133.76 21.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.415 -0.803 . . . . 0.0 110.907 -179.756 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.727 ' HA3' ' HA ' ' A' ' 52' ' ' ASP . . . -163.7 145.23 10.24 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.546 ' HA ' ' CB ' ' A' ' 202' ' ' SER . 1.5 tttm -138.73 80.84 1.81 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -1.133 . . . . 0.0 110.04 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.48 -92.79 0.28 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.128 -0.983 . . . . 0.0 110.213 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 53.95 69.59 1.19 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -120.78 111.41 17.55 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.195 -1.179 . . . . 0.0 110.308 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.601 ' HB3' ' CE1' ' A' ' 89' ' ' HIS . 0.8 OUTLIER -140.02 173.65 11.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.936 . . . . 0.0 110.165 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.595 ' N ' ' CD ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -118.47 138.16 52.68 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.225 -0.922 . . . . 0.0 110.119 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.489 ' HA2' ' CG ' ' A' ' 174' ' ' GLU . . . 98.05 -116.52 5.56 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.495 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 0.9 OUTLIER -128.6 135.33 49.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.407 -1.055 . . . . 0.0 110.295 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.601 ' CE1' ' HB3' ' A' ' 85' ' ' SER . 9.0 m-70 -147.08 161.14 41.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.154 -0.966 . . . . 0.0 109.811 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.556 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -158.02 147.12 19.45 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.042 -1.036 . . . . 0.0 110.517 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.746 ' CD1' ' CZ ' ' A' ' 216' ' ' TYR . 1.3 m0 -134.75 170.23 16.14 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.374 -0.829 . . . . 0.0 109.097 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.645 ' N ' ' O ' ' A' ' 215' ' ' ARG . 3.2 mt-10 -136.47 138.96 41.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.118 -0.989 . . . . 0.0 111.23 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.526 ' CD1' ' O ' ' A' ' 92' ' ' GLU . 8.3 mm -142.93 126.4 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.58 -0.7 . . . . 0.0 109.361 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.553 ' OG ' ' CZ ' ' A' ' 213' ' ' ARG . 1.4 m -143.62 143.51 31.5 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.166 -0.959 . . . . 0.0 110.325 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.585 ' HH2' ' CB ' ' A' ' 205' ' ' ALA . 47.9 m95 -114.4 88.46 15.64 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.322 -0.861 . . . . 0.0 110.282 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 94' ' ' SER . 50.9 Cg_endo -91.92 109.86 0.27 Allowed 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 123.909 1.479 . . . . 0.0 110.255 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.541 ' O ' ' CD1' ' A' ' 97' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 O-C-N 120.809 -1.182 . . . . 0.0 110.492 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.619 ' CG2' ' C ' ' A' ' 204' ' ' SER . 27.0 m . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 121.396 0.617 . . . . 0.0 110.366 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.522 ' CG2' HG21 ' A' ' 203' ' ' VAL . 8.4 t -150.69 170.04 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.464 -0.773 . . . . 0.0 109.631 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.631 ' CA ' ' HA3' ' A' ' 132' ' ' GLY . . . 164.02 164.05 18.33 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.504 -1.331 . . . . 0.0 110.689 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.576 ' CG1' ' HB2' ' A' ' 199' ' ' LEU . 2.5 t -114.3 155.7 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.639 -0.919 . . . . 0.0 109.072 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.495 ' HB1' ' CE ' ' A' ' 81' ' ' LYS . . . -142.93 144.75 32.52 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.863 -1.148 . . . . 0.0 111.129 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.568 HG23 ' CG ' ' A' ' 199' ' ' LEU . 0.8 OUTLIER -103.47 125.12 49.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.397 -0.815 . . . . 0.0 110.0 179.544 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.85 -28.39 16.55 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.459 -0.775 . . . . 0.0 109.9 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.673 ' O ' ' C ' ' A' ' 113' ' ' ALA . 0.5 OUTLIER -81.22 -12.45 59.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.321 -0.862 . . . . 0.0 109.719 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.673 ' C ' ' O ' ' A' ' 112' ' ' LEU . . . . . . . . 0 N--CA 1.5 2.046 0 O-C-N 121.967 -0.458 . . . . 0.0 111.408 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.232 0.539 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -150.11 128.52 12.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 110.083 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 24.0 t -120.43 119.75 33.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 110.276 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -133.35 130.17 38.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -0.902 . . . . 0.0 109.852 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.631 ' HA3' ' CA ' ' A' ' 107' ' ' GLY . . . -169.41 -146.56 5.1 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.705 ' CZ3' ' CG ' ' A' ' 180' ' ' TYR . 47.4 m0 -121.54 113.74 20.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -1.138 . . . . 0.0 110.501 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.527 ' O ' ' CG2' ' A' ' 135' ' ' ILE . 3.9 t70 -118.14 122.9 44.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.554 -0.716 . . . . 0.0 110.164 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.527 ' CG2' ' O ' ' A' ' 134' ' ' ASP . 17.6 pt . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 110.172 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.651 ' HB ' ' HD3' ' A' ' 164' ' ' PRO . 2.7 t . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.651 ' HD3' ' HB ' ' A' ' 163' ' ' VAL . 54.7 Cg_endo -78.89 154.44 26.13 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.457 1.24 . . . . 0.0 109.912 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -58.53 -30.61 67.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.043 -1.036 . . . . 0.0 109.374 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.466 ' HG3' ' OG ' ' A' ' 94' ' ' SER . 1.4 ttt180 -151.82 155.83 38.98 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.631 -0.668 . . . . 0.0 109.321 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.528 HD23 ' CG ' ' A' ' 164' ' ' PRO . 1.2 mp -126.86 138.63 53.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.965 -1.084 . . . . 0.0 110.461 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.479 ' CD1' ' CD ' ' A' ' 92' ' ' GLU . 1.0 OUTLIER -120.76 126.71 50.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.337 -0.852 . . . . 0.0 109.969 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.542 HG13 ' CE3' ' A' ' 91' ' ' TRP . 46.0 t -89.93 136.04 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 109.99 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.451 HG23 ' CD2' ' A' ' 168' ' ' LEU . 3.5 t -124.16 126.47 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.205 -0.934 . . . . 0.0 109.971 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.595 HD22 ' CZ2' ' A' ' 91' ' ' TRP . 0.0 OUTLIER -133.04 120.39 21.28 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.116 -0.99 . . . . 0.0 109.843 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 173' ' ' MET . 46.1 t0 -117.92 135.28 54.22 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.33 -0.856 . . . . 0.0 109.928 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.465 ' O ' ' C ' ' A' ' 174' ' ' GLU . 0.0 OUTLIER -98.62 -42.44 7.26 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.796 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.489 ' CG ' ' HA2' ' A' ' 87' ' ' GLY . 1.1 mm-40 -43.62 -26.87 0.26 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.223 -0.923 . . . . 0.0 108.72 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.552 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 2.7 tp10 -112.49 -28.32 7.9 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.717 0.77 . . . . 0.0 108.977 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 85.95 22.53 48.89 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 108.684 -1.766 . . . . 0.0 108.684 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.585 ' HA ' ' CD2' ' A' ' 194' ' ' LEU . 0.3 OUTLIER -113.77 123.5 49.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.222 -1.163 . . . . 0.0 111.087 -179.513 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.571 ' N ' ' CD2' ' A' ' 178' ' ' LEU . 0.2 OUTLIER -143.89 154.19 43.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.424 -0.797 . . . . 0.0 109.805 179.458 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -177.86 -161.06 25.43 Favored Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.506 -1.331 . . . . 0.0 110.273 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.705 ' CG ' ' CZ3' ' A' ' 133' ' ' TRP . 0.5 OUTLIER -118.7 123.52 45.09 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.493 -1.004 . . . . 0.0 109.724 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.515 ' HB2' ' CD2' ' A' ' 187' ' ' LEU . 5.7 t -130.15 125.68 35.64 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.417 -0.802 . . . . 0.0 110.356 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.619 HD12 ' CH2' ' A' ' 133' ' ' TRP . 0.1 OUTLIER -110.02 116.9 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.216 -0.928 . . . . 0.0 109.911 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 47.93 23.57 2.64 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 69.14 40.17 82.81 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' THR . . . . . 0.632 ' CG2' ' CE2' ' A' ' 186' ' ' TYR . 92.4 m -71.36 -76.27 0.11 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.277 -1.131 . . . . 0.0 110.642 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.632 ' CE2' ' CG2' ' A' ' 185' ' ' THR . 25.7 m-85 -126.5 89.28 2.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.172 -0.955 . . . . 0.0 110.641 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -176.54 26.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.404 -0.81 . . . . 0.0 109.765 179.641 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.487 ' H ' ' HD2' ' A' ' 189' ' ' PRO . . . -95.52 -61.46 1.01 Allowed Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.97 -1.11 . . . . 0.0 110.568 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.487 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 45.0 Cg_endo -71.94 -29.52 15.02 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.951 1.5 . . . . 0.0 111.001 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -74.65 15.78 0.34 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.197 -0.94 . . . . 0.0 111.03 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -90.35 -12.91 36.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.086 -1.009 . . . . 0.0 110.099 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.09 -15.31 34.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.0 110.187 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -109.99 -18.83 8.5 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.614 ' HA ' ' HD2' ' A' ' 197' ' ' ARG . 6.3 tt -61.82 -32.25 72.55 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.727 -0.867 . . . . 0.0 108.82 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.529 ' HA ' HG21 ' A' ' 177' ' ' THR . 0.0 OUTLIER -47.2 -29.64 2.48 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.576 -0.702 . . . . 0.0 109.422 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -114.19 -19.33 6.35 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.645 ' C ' ' CD ' ' A' ' 197' ' ' ARG . 0.0 OUTLIER -90.88 -4.87 56.22 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.507 -0.996 . . . . 0.0 109.774 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' THR . . . . . 0.534 ' O ' ' CG2' ' A' ' 110' ' ' THR . 0.1 OUTLIER -43.38 145.59 0.57 Allowed 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.913 0.863 . . . . 0.0 111.396 -178.269 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 197' ' ' ARG . 0.0 OUTLIER -140.11 172.27 12.99 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.487 ' O ' HG13 ' A' ' 108' ' ' VAL . 1.7 m-85 -82.85 129.62 61.12 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 120.887 -1.133 . . . . 0.0 109.274 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.548 ' HD3' HD12 ' A' ' 178' ' ' LEU . 49.8 Cg_endo -78.07 125.92 7.53 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.079 1.568 . . . . 0.0 111.388 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.546 ' CB ' ' HA ' ' A' ' 81' ' ' LYS . 9.3 p -133.59 138.39 45.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.476 -0.765 . . . . 0.0 109.891 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.522 HG21 ' CG2' ' A' ' 106' ' ' VAL . 7.1 p -119.31 159.54 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.142 -0.974 . . . . 0.0 109.402 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' SER . . . . . 0.619 ' C ' ' CG2' ' A' ' 105' ' ' VAL . 22.3 m -160.15 162.67 33.98 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.129 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.587 ' CB ' ' CG2' ' A' ' 78' ' ' VAL . . . -150.14 160.13 43.9 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.424 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.484 ' O ' ' O ' ' A' ' 205' ' ' ALA . 0.4 OUTLIER -49.42 -176.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.635 -0.666 . . . . 0.0 110.329 179.618 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.628 ' CG ' ' N ' ' A' ' 208' ' ' GLY . 22.7 p-90 -92.4 -44.44 8.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.929 . . . . 0.0 110.05 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.628 ' N ' ' CG ' ' A' ' 207' ' ' TRP . . . -164.33 128.28 1.79 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -173.89 -39.8 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.239 -1.153 . . . . 0.0 110.432 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . 0.509 ' O ' ' HG3' ' A' ' 211' ' ' GLN . 1.2 m -155.75 -93.48 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.404 -0.81 . . . . 0.0 110.551 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.509 ' HG3' ' O ' ' A' ' 210' ' ' CYS . 2.1 mt-30 179.53 159.82 0.74 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.067 -1.021 . . . . 0.0 110.161 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.713 ' HB ' ' CH2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -127.5 144.05 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.165 -0.959 . . . . 0.0 110.784 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . 0.65 ' NE ' ' O ' ' A' ' 213' ' ' ARG . 0.0 OUTLIER -101.46 110.79 22.85 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.256 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.592 ' HB ' ' CH2' ' A' ' 48' ' ' TRP . 1.4 tt -118.12 132.84 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.906 -1.121 . . . . 0.0 111.319 -178.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.645 ' O ' ' N ' ' A' ' 92' ' ' GLU . 1.6 mtt180 -130.09 109.41 10.82 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . 0.746 ' CZ ' ' CD1' ' A' ' 91' ' ' TRP . 27.3 t80 -113.49 145.49 41.12 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.274 -0.891 . . . . 0.0 111.115 -178.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' MET . . . . . 0.476 ' HA ' ' CE ' ' A' ' 217' ' ' MET . 3.8 tpt -136.56 108.59 7.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.536 -0.727 . . . . 0.0 109.877 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 132.97 7.09 2.67 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.566 ' HB2' ' CD1' ' A' ' 216' ' ' TYR . 22.2 tt0 . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.132 -1.216 . . . . 0.0 110.123 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.629 ' O ' ' N ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 121.137 0.494 . . . . 0.0 110.075 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.563 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 10.8 pt-20 -44.49 -45.95 9.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.146 -0.971 . . . . 0.0 109.225 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.22 -20.79 7.53 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.639 -0.824 . . . . 0.0 108.777 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.629 ' N ' ' O ' ' A' ' 29' ' ' LEU . 4.1 tp -83.83 -33.62 24.85 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.65 HD22 ' CB ' ' A' ' 55' ' ' GLU . 0.4 OUTLIER -73.66 -36.12 65.33 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 122.012 0.911 . . . . 0.0 109.179 179.367 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.571 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 7.3 m -85.0 -6.76 59.33 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.324 0.583 . . . . 0.0 109.775 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.645 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . . . -49.45 -67.61 0.42 Allowed Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.307 -0.871 . . . . 0.0 110.879 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.658 ' C ' ' HD3' ' A' ' 38' ' ' PRO . 46.5 Cg_endo -72.14 157.68 53.61 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.655 1.345 . . . . 0.0 110.366 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 36' ' ' PRO . 53.9 Cg_endo -99.14 55.3 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 121.94 1.76 . . . . 0.0 112.006 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.658 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 49.4 Cg_endo -73.7 150.7 45.38 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.064 1.034 . . . . 0.0 110.108 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.742 ' O ' ' HB3' ' A' ' 43' ' ' GLN . 0.5 OUTLIER -41.86 -21.87 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.199 -0.938 . . . . 0.0 109.873 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.878 ' O ' ' HB3' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -61.2 -50.45 73.07 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.014 -1.053 . . . . 0.0 109.184 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.895 ' O ' ' CD2' ' A' ' 45' ' ' HIS . 2.9 t -67.27 -39.84 83.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 C-N-CA 118.481 -1.287 . . . . 0.0 110.845 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.36 -39.9 12.41 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.784 -1.197 . . . . 0.0 112.797 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.799 ' OE1' ' HA ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -82.2 -20.54 37.58 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 118.406 -1.318 . . . . 0.0 109.536 -179.414 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.878 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 5.0 ttp180 -68.68 -52.29 32.64 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.895 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 40.6 m-70 -45.62 -23.57 0.26 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.471 ' N ' ' C ' ' A' ' 44' ' ' ARG . 3.3 t-160 -95.96 -33.01 12.32 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.033 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 49' ' ' ASN . . . -87.72 -115.63 1.16 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 107.065 -2.414 . . . . 0.0 107.065 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.734 ' CD1' ' CG1' ' A' ' 59' ' ' VAL . 93.7 m95 -67.48 74.47 0.16 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.749 -1.442 . . . . 0.0 108.33 177.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.671 ' OD1' ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -44.11 111.62 1.2 Allowed Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.63 -0.669 . . . . 0.0 110.614 -179.29 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.777 ' O ' ' O ' ' A' ' 53' ' ' CYS . 55.4 Cg_endo -79.49 1.65 9.02 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.166 1.91 . . . . 0.0 111.692 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.699 ' CE ' ' CA ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -50.59 -75.6 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.387 -1.446 . . . . 0.0 108.459 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.795 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 0.6 OUTLIER -64.79 3.43 0.54 Allowed 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.777 ' O ' ' O ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -124.67 170.45 10.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.423 -0.798 . . . . 0.0 110.797 -178.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.581 ' N ' ' SG ' ' A' ' 53' ' ' CYS . 4.4 t -100.51 165.8 11.24 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.015 -1.053 . . . . 0.0 108.906 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.695 ' O ' ' N ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -94.32 1.13 55.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.93 -1.106 . . . . 0.0 110.547 -179.045 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.638 ' ND2' ' N ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -22.17 -42.01 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 122.401 1.096 . . . . 0.0 109.937 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.695 ' N ' ' O ' ' A' ' 55' ' ' GLU . 11.3 pt -126.03 169.61 17.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.555 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.648 ' O ' ' HB3' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -105.69 118.04 35.57 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.324 -0.86 . . . . 0.0 109.299 -178.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.734 ' CG1' ' CD1' ' A' ' 48' ' ' TRP . 90.1 t -124.44 136.05 61.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.273 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.799 ' HA ' ' OE1' ' A' ' 43' ' ' GLN . 1.7 ttmt -135.21 155.14 51.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.714 -1.241 . . . . 0.0 111.043 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.552 ' N ' ' OE1' ' A' ' 43' ' ' GLN . 23.2 tt0 -67.47 -109.26 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.453 -0.779 . . . . 0.0 110.226 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.546 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 37.26 35.17 0.15 Allowed Glycine 0 N--CA 1.494 2.558 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.68 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 114.56 56.85 0.38 Allowed Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 -178.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.68 ' C ' ' O ' ' A' ' 63' ' ' GLY . 2.0 mm? 0.83 84.98 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.962 -0.728 . . . . 0.0 110.92 -178.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 63' ' ' GLY . 1.7 m -128.43 130.61 47.86 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.383 -0.823 . . . . 0.0 110.708 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.679 ' CE2' ' HB ' ' A' ' 212' ' ' VAL . 5.3 m-30 -83.61 152.4 24.84 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.648 ' HB3' ' O ' ' A' ' 58' ' ' ASP . 1.1 tp10 -147.65 121.4 9.25 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.228 -0.92 . . . . 0.0 109.755 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.57 ' HG2' ' CD1' ' A' ' 207' ' ' TRP . 1.0 OUTLIER -118.99 156.32 29.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.419 -0.801 . . . . 0.0 109.416 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.55 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -168.15 -56.94 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 120.98 -1.075 . . . . 0.0 111.043 -179.559 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 69' ' ' ARG . 41.0 Cg_endo -67.29 -47.14 2.4 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.804 1.423 . . . . 0.0 110.729 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.565 HG13 ' CG2' ' A' ' 57' ' ' ILE . 2.0 p -78.31 165.38 3.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.879 0.847 . . . . 0.0 111.048 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.548 ' N ' ' CG2' ' A' ' 71' ' ' VAL . . . -156.59 -40.01 0.08 Allowed 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.049 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 75' ' ' THR . 1.8 mt-30 -74.73 151.56 39.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.906 . . . . 0.0 110.125 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.9 91.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.335 -0.853 . . . . 0.0 110.21 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.51 ' N ' ' O ' ' A' ' 73' ' ' GLN . 2.6 m -97.03 -130.38 0.18 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.32 -0.862 . . . . 0.0 110.061 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.513 ' O ' ' O ' ' A' ' 77' ' ' GLY . 0.2 OUTLIER -120.75 113.8 20.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.186 -0.946 . . . . 0.0 110.452 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.559 ' HA2' ' CE3' ' A' ' 207' ' ' TRP . . . -57.14 -114.24 0.01 OUTLIER Glycine 0 N--CA 1.485 1.925 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.53 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -148.42 123.17 2.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.944 -1.327 . . . . 0.0 110.979 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.795 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -104.47 175.08 5.61 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.549 -0.72 . . . . 0.0 109.489 179.313 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.576 ' N ' ' CG ' ' A' ' 79' ' ' ARG . . . -157.42 58.29 0.36 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.539 ' HG3' ' CB ' ' A' ' 202' ' ' SER . 0.7 OUTLIER -89.9 75.02 7.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.075 -1.25 . . . . 0.0 110.122 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.805 ' HD3' ' H ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -141.94 -95.29 0.13 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.316 -0.865 . . . . 0.0 110.292 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.805 ' H ' ' HD3' ' A' ' 82' ' ' ARG . . . 56.54 62.23 6.59 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -105.71 95.7 5.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.177 -1.19 . . . . 0.0 110.261 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.584 ' OG ' ' CD2' ' A' ' 89' ' ' HIS . 0.4 OUTLIER -140.01 171.51 14.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 110.018 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.64 ' O ' ' CD2' ' A' ' 89' ' ' HIS . 30.1 mtm180 -123.38 175.79 6.52 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.164 -0.96 . . . . 0.0 110.237 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.513 ' N ' ' HB3' ' A' ' 173' ' ' MET . . . 62.52 -116.45 9.39 Favored Glycine 0 N--CA 1.482 1.722 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.433 HD11 ' HB2' ' A' ' 172' ' ' ASP . 11.6 tp -129.37 127.76 41.69 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.559 -0.966 . . . . 0.0 110.995 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.64 ' CD2' ' O ' ' A' ' 86' ' ' ARG . 93.3 m-70 -147.26 173.16 12.82 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.269 -0.895 . . . . 0.0 109.95 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.544 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -163.81 164.11 23.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.261 -0.899 . . . . 0.0 110.133 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.722 ' CD1' ' CZ ' ' A' ' 216' ' ' TYR . 1.1 m0 -134.86 145.89 48.73 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.301 -0.874 . . . . 0.0 109.54 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.644 ' O ' ' N ' ' A' ' 215' ' ' ARG . 2.1 tt0 -109.97 118.9 37.67 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.431 -0.907 . . . . 0.0 109.883 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.524 ' O ' ' CD1' ' A' ' 167' ' ' LEU . 17.3 mm -118.08 130.05 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.019 -1.051 . . . . 0.0 111.028 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.533 ' CB ' ' HB3' ' A' ' 213' ' ' ARG . 0.0 OUTLIER -118.53 126.38 51.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.404 -0.81 . . . . 0.0 109.428 179.319 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.579 ' CH2' ' HA ' ' A' ' 205' ' ' ALA . 7.1 t-105 -117.3 88.19 27.03 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.119 -0.988 . . . . 0.0 110.217 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.529 ' O ' ' O ' ' A' ' 211' ' ' GLN . 50.0 Cg_endo -96.21 112.21 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 121.968 1.779 . . . . 0.0 110.673 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.689 0 O-C-N 120.824 -1.173 . . . . 0.0 110.184 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.712 ' CG2' ' CB ' ' A' ' 204' ' ' SER . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.111 0 CA-C-O 121.818 0.818 . . . . 0.0 109.197 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.574 ' CG1' ' O ' ' A' ' 202' ' ' SER . 22.2 t -152.04 159.8 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.277 -0.889 . . . . 0.0 109.574 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.583 ' HA2' ' HA3' ' A' ' 132' ' ' GLY . . . -175.57 136.77 3.48 Favored Glycine 0 N--CA 1.487 2.078 0 C-N-CA 118.826 -1.654 . . . . 0.0 110.859 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.558 HG13 ' N ' ' A' ' 201' ' ' PRO . 2.8 t -104.42 141.71 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.601 -0.941 . . . . 0.0 108.999 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.579 ' HB2' ' CE1' ' A' ' 200' ' ' TYR . . . -130.54 152.39 49.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.883 -1.136 . . . . 0.0 111.126 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.534 ' CG2' ' HB3' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -121.13 130.87 53.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.481 -0.762 . . . . 0.0 110.055 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -89.44 -25.96 21.22 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.291 -0.881 . . . . 0.0 109.343 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.4 pp -83.35 -12.49 56.51 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.489 -0.757 . . . . 0.0 109.398 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.47 -0.769 . . . . 0.0 110.246 179.944 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.5 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.347 0.594 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.578 ' OE2' ' CG ' ' A' ' 131' ' ' TRP . 4.6 tm-20 -145.03 126.84 15.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.902 . . . . 0.0 109.892 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.48 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -122.09 119.45 31.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.946 . . . . 0.0 110.666 -179.727 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . 0.578 ' CG ' ' OE2' ' A' ' 129' ' ' GLU . 16.7 m0 -133.25 133.27 42.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.47 -0.768 . . . . 0.0 109.519 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.583 ' HA3' ' HA2' ' A' ' 107' ' ' GLY . . . -177.23 -140.94 3.84 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.442 -1.361 . . . . 0.0 110.207 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.595 ' CH2' HD11 ' A' ' 182' ' ' ILE . 52.0 m0 -117.17 112.95 21.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.207 -1.172 . . . . 0.0 110.75 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.33 148.27 43.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.761 -0.587 . . . . 0.0 110.269 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.559 ' CD1' ' CG1' ' A' ' 105' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.204 -0.935 . . . . 0.0 109.955 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.85 0.357 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.18 65.16 4.31 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.903 1.475 . . . . 0.0 110.75 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 27.2 tp10 -167.83 -84.14 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.398 -0.814 . . . . 0.0 110.101 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -152.31 155.86 38.49 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.4 -0.812 . . . . 0.0 110.344 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 93' ' ' ILE . 2.9 mp -135.74 137.02 41.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 109.793 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.53 114.21 15.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.066 -1.021 . . . . 0.0 110.571 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.649 ' CG2' ' CE1' ' A' ' 180' ' ' TYR . 18.4 t -89.92 136.04 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.852 . . . . 0.0 109.784 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.425 ' HB ' ' CD1' ' A' ' 187' ' ' LEU . 7.5 t -113.06 111.18 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.089 -1.007 . . . . 0.0 110.519 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.626 ' CB ' ' CZ2' ' A' ' 91' ' ' TRP . 0.0 OUTLIER -119.68 105.6 11.33 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.292 -0.88 . . . . 0.0 109.311 179.607 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.433 ' HB2' HD11 ' A' ' 88' ' ' LEU . 5.5 t0 -120.33 135.3 55.06 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.577 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.529 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 0.3 OUTLIER -95.9 -40.68 9.18 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.414 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -44.73 -26.39 0.38 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.299 -0.876 . . . . 0.0 108.99 179.205 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.612 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.0 OUTLIER -110.78 -26.79 9.18 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.282 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.573 ' O ' ' CG2' ' A' ' 198' ' ' THR . . . 81.53 25.46 53.9 Favored Glycine 0 N--CA 1.482 1.73 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.634 ' HA ' HG22 ' A' ' 198' ' ' THR . 0.0 OUTLIER -118.56 112.08 19.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.196 -1.179 . . . . 0.0 111.381 -179.484 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.592 ' CD1' ' CG2' ' A' ' 198' ' ' THR . 4.0 mp -118.76 153.85 33.77 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.481 -0.762 . . . . 0.0 109.256 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.403 ' O ' HG12 ' A' ' 169' ' ' VAL . . . 177.39 -174.47 46.99 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.07 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.649 ' CE1' ' CG2' ' A' ' 169' ' ' VAL . 0.3 OUTLIER -123.99 125.62 44.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.341 -1.094 . . . . 0.0 109.949 179.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 35.5 t -136.69 132.77 35.37 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.268 -0.895 . . . . 0.0 110.194 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.595 HD11 ' CH2' ' A' ' 133' ' ' TRP . 0.0 OUTLIER -103.67 116.81 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.309 -0.87 . . . . 0.0 109.756 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 88.76 -10.41 72.44 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 80.61 46.82 7.1 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 79.8 m -129.41 -2.5 4.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.255 -1.144 . . . . 0.0 110.441 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.498 ' CD2' HD13 ' A' ' 182' ' ' ILE . 0.2 OUTLIER -99.77 -54.96 2.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.207 -0.933 . . . . 0.0 110.264 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.634 ' O ' ' CE2' ' A' ' 191' ' ' PHE . 5.3 mt -77.48 44.54 0.44 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.225 -0.922 . . . . 0.0 109.785 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -80.91 -96.78 0.39 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.47 ' C ' ' H ' ' A' ' 191' ' ' PHE . 46.9 Cg_endo -72.9 -25.1 16.97 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 124.229 1.647 . . . . 0.0 111.017 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.529 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -68.62 21.42 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.506 -0.746 . . . . 0.0 111.76 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.634 ' CE2' ' O ' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -90.23 -13.83 34.63 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.707 -1.246 . . . . 0.0 110.349 179.467 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.05 -14.72 33.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.105 -0.997 . . . . 0.0 110.597 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -112.63 -11.16 15.3 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.607 ' O ' ' N ' ' A' ' 198' ' ' THR . 7.5 tt -74.69 -28.58 60.88 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.474 -1.015 . . . . 0.0 109.108 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.488 ' O ' ' OG1' ' A' ' 198' ' ' THR . 0.0 OUTLIER -54.08 -33.82 58.54 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.385 -0.822 . . . . 0.0 109.714 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -94.23 -26.88 12.98 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.783 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.46 -6.08 55.29 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.68 -0.894 . . . . 0.0 109.943 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' THR . . . . . 0.634 HG22 ' HA ' ' A' ' 177' ' ' THR . 0.2 OUTLIER -44.59 131.86 6.5 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.877 0.846 . . . . 0.0 112.532 -178.114 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.783 ' HG ' ' O ' ' A' ' 197' ' ' ARG . 0.0 OUTLIER -140.74 170.75 15.18 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.571 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.589 ' O ' ' CD1' ' A' ' 200' ' ' TYR . 25.6 p90 -84.6 128.72 60.1 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 120.775 -1.203 . . . . 0.0 109.548 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.558 ' N ' HG13 ' A' ' 108' ' ' VAL . 51.0 Cg_endo -84.49 143.78 9.96 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.138 1.599 . . . . 0.0 111.393 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.574 ' O ' ' CG1' ' A' ' 106' ' ' VAL . 0.9 OUTLIER -133.54 138.54 46.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.51 -0.744 . . . . 0.0 109.908 179.401 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.46 HG12 ' HA3' ' A' ' 80' ' ' GLY . 14.6 p -119.64 157.93 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.161 -0.962 . . . . 0.0 110.108 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' SER . . . . . 0.712 ' CB ' ' CG2' ' A' ' 105' ' ' VAL . 0.4 OUTLIER -160.18 145.87 15.28 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.391 -0.818 . . . . 0.0 110.688 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.579 ' HA ' ' CH2' ' A' ' 95' ' ' TRP . . . -146.21 166.44 26.23 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.56 0.695 . . . . 0.0 110.573 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 207' ' ' TRP . 1.2 t -110.24 176.17 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 CA-C-O 121.456 0.646 . . . . 0.0 110.608 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.57 ' CD1' ' HG2' ' A' ' 68' ' ' ARG . 4.4 p90 -124.97 175.52 7.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.349 -0.844 . . . . 0.0 110.016 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 113.38 -165.57 12.05 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . 0.452 ' O ' ' O ' ' A' ' 210' ' ' CYS . 0.0 OUTLIER -44.52 -29.39 0.71 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.393 -1.063 . . . . 0.0 110.3 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 211' ' ' GLN . 27.0 p -58.03 -154.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.318 -0.864 . . . . 0.0 110.236 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.529 ' O ' ' O ' ' A' ' 96' ' ' PRO . 0.9 OUTLIER 179.59 125.34 0.07 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.248 -0.908 . . . . 0.0 110.377 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.679 ' HB ' ' CE2' ' A' ' 66' ' ' PHE . 8.3 t -128.6 144.32 38.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 121.671 -0.643 . . . . 0.0 109.941 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . 0.537 ' CZ ' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -122.41 124.35 43.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.247 -0.908 . . . . 0.0 109.996 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.712 ' HB ' ' CZ3' ' A' ' 48' ' ' TRP . 2.3 tt -119.22 128.06 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.013 -1.054 . . . . 0.0 111.183 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.644 ' N ' ' O ' ' A' ' 92' ' ' GLU . 1.1 mtt180 -130.14 136.9 49.8 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.407 -0.808 . . . . 0.0 109.259 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . 0.722 ' CZ ' ' CD1' ' A' ' 91' ' ' TRP . 14.0 t80 -118.9 150.17 40.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.04 -1.038 . . . . 0.0 110.908 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' MET . . . . . 0.505 ' CB ' ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -124.57 107.68 11.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.944 . . . . 0.0 110.05 179.371 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 95.71 74.02 1.2 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.527 ' HB2' ' CD1' ' A' ' 216' ' ' TYR . 3.6 tp10 . . . . . 0 N--CA 1.493 1.718 0 O-C-N 121.187 -1.184 . . . . 0.0 110.125 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.542 ' O ' ' CD1' ' A' ' 29' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.356 0.598 . . . . 0.0 109.657 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.533 ' HA ' ' CD2' ' A' ' 33' ' ' LEU . 16.8 pt-20 -49.42 -28.42 5.15 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.255 -0.903 . . . . 0.0 109.167 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.43 ' N ' ' HG3' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -68.24 -23.3 64.78 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.513 -0.875 . . . . 0.0 108.687 179.011 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.469 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 0.6 OUTLIER -83.37 -36.84 24.03 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.697 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.613 ' HG ' ' N ' ' A' ' 34' ' ' SER . 0.3 OUTLIER -69.75 -35.79 75.25 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 122.022 0.915 . . . . 0.0 109.365 179.165 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.613 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 1.5 m -78.99 -7.51 58.13 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.804 -0.56 . . . . 0.0 110.346 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.644 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . . . -38.63 -66.54 0.31 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.249 -0.907 . . . . 0.0 110.307 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.703 ' C ' ' HD3' ' A' ' 38' ' ' PRO . 49.0 Cg_endo -74.5 151.88 42.75 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.645 1.34 . . . . 0.0 109.938 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 36' ' ' PRO . 54.1 Cg_endo -99.06 53.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.856 1.704 . . . . 0.0 112.235 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.703 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 52.7 Cg_endo -76.7 150.12 30.74 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 122.906 0.95 . . . . 0.0 110.384 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.681 ' C ' ' NE2' ' A' ' 43' ' ' GLN . 1.6 t0 -40.78 -30.39 0.12 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 108.624 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.668 ' O ' ' CB ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -40.95 -44.54 2.36 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.414 0.626 . . . . 0.0 109.449 179.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.709 ' O ' ' CD2' ' A' ' 45' ' ' HIS . 6.1 t -65.66 -27.25 40.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.797 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 39' ' ' ASP . . . -88.85 -43.57 11.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.91 -1.119 . . . . 0.0 111.587 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.681 ' NE2' ' C ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -81.32 -20.32 41.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.845 -1.16 . . . . 0.0 109.671 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.668 ' CB ' ' O ' ' A' ' 40' ' ' LEU . 4.1 ttp85 -71.87 -55.03 8.28 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.709 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 21.1 m-70 -54.26 -27.56 35.77 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.367 0.603 . . . . 0.0 109.573 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -95.54 -30.62 13.73 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.324 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 43' ' ' GLN . . . -84.41 -103.73 0.6 Allowed Glycine 0 N--CA 1.487 2.056 0 N-CA-C 107.429 -2.269 . . . . 0.0 107.429 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.738 ' CD2' ' CE1' ' A' ' 66' ' ' PHE . 91.8 m95 -76.88 74.42 3.49 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.206 -1.173 . . . . 0.0 109.184 178.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.698 ' OD1' ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -44.19 110.9 1.07 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.718 -0.614 . . . . 0.0 110.675 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.628 ' CD ' ' HE2' ' A' ' 51' ' ' LYS . 47.1 Cg_endo -72.08 0.93 6.51 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.202 1.935 . . . . 0.0 112.134 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.713 ' CE ' ' N ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -71.79 -33.1 68.29 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 178.36 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.728 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 8.9 m-20 -117.29 -12.59 10.49 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 113.913 -1.494 . . . . 0.0 107.363 177.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.704 ' HA ' ' HB ' ' A' ' 78' ' ' VAL . 9.0 t -105.81 147.15 28.97 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.175 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.476 ' H ' ' CB ' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -77.6 105.29 8.66 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.244 -0.91 . . . . 0.0 109.426 179.059 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.499 ' HB3' ' HB3' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -70.2 4.04 2.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.448 -0.782 . . . . 0.0 110.4 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.58 HD21 ' N ' ' A' ' 56' ' ' ASN . 1.4 m120 -41.4 -29.52 0.15 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.752 0.787 . . . . 0.0 109.446 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.583 ' CG2' ' NE1' ' A' ' 207' ' ' TRP . 25.2 pt -112.94 168.88 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.58 ' O ' ' HB3' ' A' ' 67' ' ' GLU . 10.2 t0 -105.85 103.48 12.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.894 -1.129 . . . . 0.0 109.925 -178.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.625 ' CG2' ' HB2' ' A' ' 48' ' ' TRP . 3.6 m -118.24 135.81 57.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.804 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.681 ' HG3' ' CD ' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -124.92 143.3 50.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.011 -1.055 . . . . 0.0 110.844 -179.423 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.535 ' O ' ' C ' ' A' ' 62' ' ' GLY . 46.1 tt0 -63.61 -124.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.452 -0.78 . . . . 0.0 109.954 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.535 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 37.7 50.61 1.93 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.674 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 109.33 46.89 0.9 Allowed Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.106 -1.997 . . . . 0.0 108.106 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.674 ' C ' ' O ' ' A' ' 63' ' ' GLY . 2.2 mm? 0.76 86.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.541 0.686 . . . . 0.0 111.252 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.0 t -120.29 117.55 28.12 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.521 -0.737 . . . . 0.0 110.507 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.738 ' CE1' ' CD2' ' A' ' 48' ' ' TRP . 1.8 m-85 -82.51 130.65 35.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.388 -0.82 . . . . 0.0 109.186 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.58 ' HB3' ' O ' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -132.9 121.81 23.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.902 -1.124 . . . . 0.0 110.528 179.626 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.522 ' O ' ' HD3' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -125.31 156.26 38.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.492 -0.755 . . . . 0.0 109.229 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.534 ' HB3' ' CD ' ' A' ' 70' ' ' PRO . 11.5 tpp180 -174.68 -56.92 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 120.773 -1.204 . . . . 0.0 111.183 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.534 ' CD ' ' HB3' ' A' ' 69' ' ' ARG . 41.2 Cg_endo -67.01 -50.39 1.08 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.651 1.343 . . . . 0.0 110.542 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.623 HG22 ' HB ' ' A' ' 75' ' ' THR . 1.3 p -78.57 165.23 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 121.739 0.78 . . . . 0.0 110.852 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.534 ' N ' ' CG2' ' A' ' 71' ' ' VAL . . . -163.83 -43.1 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.257 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 75' ' ' THR . 16.8 mt-30 -56.1 -172.85 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.156 -0.965 . . . . 0.0 110.246 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.74 85.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.916 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.623 ' HB ' HG22 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -136.96 5.36 2.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -0.868 . . . . 0.0 110.312 -179.619 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.585 ' CB ' ' NE1' ' A' ' 207' ' ' TRP . 1.8 p30 -99.16 155.07 17.66 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.217 -0.927 . . . . 0.0 109.962 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 114.65 104.36 2.55 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 106.848 -2.501 . . . . 0.0 106.848 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.764 ' O ' ' HA ' ' A' ' 204' ' ' SER . 2.0 m -116.95 163.0 14.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.161 -1.2 . . . . 0.0 110.322 -178.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.728 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 3.9 ttp180 -120.16 169.34 10.33 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.643 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.562 ' HA2' ' CB ' ' A' ' 52' ' ' ASP . . . -164.22 83.46 0.11 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.481 ' CG ' ' O ' ' A' ' 81' ' ' LYS . 3.7 ttpm? -116.88 16.11 15.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.389 -1.065 . . . . 0.0 110.421 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.456 ' O ' ' C ' ' A' ' 83' ' ' GLY . 1.1 ptt180 -76.16 -101.98 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.106 -0.996 . . . . 0.0 110.228 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 82' ' ' ARG . . . 41.58 46.22 4.62 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.45 ' CE1' ' NH1' ' A' ' 86' ' ' ARG . 0.6 OUTLIER -98.58 103.88 15.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.228 -1.16 . . . . 0.0 110.174 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.57 ' HB3' ' CE1' ' A' ' 89' ' ' HIS . 11.5 t -139.9 173.36 11.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 110.362 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.551 ' N ' ' CD ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -118.53 139.33 51.62 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.372 -0.83 . . . . 0.0 109.827 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 103.36 -112.25 4.17 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.581 ' O ' ' CD2' ' A' ' 89' ' ' HIS . 7.5 tt -128.18 134.53 49.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -1.128 . . . . 0.0 110.362 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.581 ' CD2' ' O ' ' A' ' 88' ' ' LEU . 7.7 m80 -146.86 161.7 40.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.329 -0.857 . . . . 0.0 109.688 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.06 146.59 10.86 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.082 -1.011 . . . . 0.0 110.508 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.678 ' HB2' ' CD2' ' A' ' 216' ' ' TYR . 1.7 p90 -135.13 171.3 14.63 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.305 -0.872 . . . . 0.0 109.473 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 215' ' ' ARG . 15.6 tt0 -137.71 140.12 40.55 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.265 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.596 HG13 ' CD1' ' A' ' 91' ' ' TRP . 4.4 mt -140.03 154.22 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.642 ' HB3' ' HA ' ' A' ' 166' ' ' ARG . 0.4 OUTLIER -147.24 122.12 9.98 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.03 -1.068 . . . . 0.0 111.651 -179.005 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.837 ' HH2' ' O ' ' A' ' 204' ' ' SER . 37.0 m95 -111.63 88.45 9.45 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 94' ' ' SER . 52.5 Cg_endo -83.61 108.95 1.51 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.695 1.366 . . . . 0.0 111.524 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.534 ' O ' HD11 ' A' ' 97' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.253 -0.904 . . . . 0.0 109.622 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 204' ' ' SER 0.264 3.6 m . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.751 HG22 ' CE2' ' A' ' 95' ' ' TRP . 1.0 OUTLIER -152.27 122.47 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.399 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 202' ' ' SER . . . 168.76 -161.64 35.36 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 118.832 -1.651 . . . . 0.0 110.898 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.629 HG23 ' CD1' ' A' ' 199' ' ' LEU . 1.4 p -141.49 150.67 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.596 -0.943 . . . . 0.0 109.835 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.563 ' N ' HG22 ' A' ' 108' ' ' VAL . . . -128.57 152.78 47.92 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.059 -1.026 . . . . 0.0 110.724 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.623 ' N ' ' HB3' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -101.24 126.35 47.97 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.264 -0.898 . . . . 0.0 110.296 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.58 -30.22 15.09 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.591 0.71 . . . . 0.0 109.726 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.579 ' O ' ' C ' ' A' ' 113' ' ' ALA . 0.8 OUTLIER -80.96 -11.83 59.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.458 -0.776 . . . . 0.0 109.926 179.819 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.579 ' C ' ' O ' ' A' ' 112' ' ' LEU . . . . . . . . 0 N--CA 1.499 1.977 0 O-C-N 121.829 -0.544 . . . . 0.0 111.222 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.257 0.551 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 110' ' ' THR . 1.7 tt0 -150.02 130.06 13.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.298 -0.876 . . . . 0.0 110.087 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.51 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 47.9 t -120.46 119.92 34.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 110.211 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . 0.527 ' O ' ' O ' ' A' ' 108' ' ' VAL . 0.6 OUTLIER -128.1 124.57 37.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -0.939 . . . . 0.0 110.138 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.455 ' HA3' ' HA3' ' A' ' 107' ' ' GLY . . . 170.82 -133.95 2.96 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.521 ' CE3' ' CD2' ' A' ' 180' ' ' TYR . 47.3 m0 -121.36 112.84 19.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.09 -1.241 . . . . 0.0 110.404 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.48 ' O ' HG23 ' A' ' 135' ' ' ILE . 32.2 t0 -119.22 111.46 18.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.643 -0.661 . . . . 0.0 110.448 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.48 HG23 ' O ' ' A' ' 134' ' ' ASP . 22.2 pt . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.1 -1.0 . . . . 0.0 110.229 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.539 ' CG2' HD21 ' A' ' 167' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.51 64.42 2.94 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.067 1.562 . . . . 0.0 110.379 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -168.48 -83.85 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.487 -0.758 . . . . 0.0 109.805 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.642 ' HA ' ' HB3' ' A' ' 94' ' ' SER . 2.2 ttp180 -152.12 150.43 29.88 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.432 -0.793 . . . . 0.0 110.348 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.594 ' N ' ' CD1' ' A' ' 167' ' ' LEU . 1.7 mp -144.92 131.04 19.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 110.274 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.482 ' C ' ' CD1' ' A' ' 168' ' ' LEU . 2.6 tm? -103.79 124.54 49.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.351 -0.843 . . . . 0.0 109.595 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.676 ' CG2' ' CE1' ' A' ' 180' ' ' TYR . 2.4 t -107.18 135.53 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.943 . . . . 0.0 110.63 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.501 HG12 ' CD1' ' A' ' 187' ' ' LEU . 9.7 p -112.48 133.32 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.507 -0.746 . . . . 0.0 109.836 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.556 ' CD1' ' HB3' ' A' ' 178' ' ' LEU . 11.5 tp -133.03 105.87 7.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.151 -0.968 . . . . 0.0 110.228 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 173' ' ' MET . 49.1 t0 -103.83 136.02 44.28 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.24 -0.912 . . . . 0.0 109.943 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.514 ' O ' ' N ' ' A' ' 175' ' ' GLU . 5.5 tpt -96.91 -41.81 8.24 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.747 -0.595 . . . . 0.0 110.231 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.505 ' C ' ' O ' ' A' ' 173' ' ' MET . 2.7 tm-20 -40.26 -28.66 0.06 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.893 . . . . 0.0 108.666 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.669 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.2 OUTLIER -114.84 -26.64 7.72 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.485 ' O ' HG21 ' A' ' 198' ' ' THR . . . 81.2 25.35 55.29 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.491 -1.844 . . . . 0.0 108.491 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.669 ' OG1' ' HB3' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -113.42 127.82 56.25 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.335 -1.097 . . . . 0.0 111.436 -179.335 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.556 ' HB3' ' CD1' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -134.74 153.71 51.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.473 -0.767 . . . . 0.0 109.378 178.794 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.506 ' O ' HG12 ' A' ' 169' ' ' VAL . . . -155.52 172.74 33.67 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.52 -1.324 . . . . 0.0 109.984 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.676 ' CE1' ' CG2' ' A' ' 169' ' ' VAL . 0.4 OUTLIER -118.77 122.89 43.49 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.47 -1.018 . . . . 0.0 109.895 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 186' ' ' TYR . 16.7 t -142.79 139.26 30.91 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.31 -0.869 . . . . 0.0 110.051 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.487 HG22 ' HG ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -98.56 116.76 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.341 -0.849 . . . . 0.0 109.923 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 81.63 -7.26 62.4 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 86.31 42.35 6.63 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.26 -35.94 8.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.31 -1.112 . . . . 0.0 110.415 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.476 ' O ' ' HB2' ' A' ' 181' ' ' SER . 24.6 m-85 -109.12 90.22 3.23 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.187 -0.946 . . . . 0.0 110.312 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.597 ' O ' ' CE2' ' A' ' 191' ' ' PHE . 0.7 OUTLIER -176.7 28.32 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.471 -0.768 . . . . 0.0 109.671 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -110.51 -71.67 0.66 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.842 -1.171 . . . . 0.0 110.403 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.4 ' C ' ' H ' ' A' ' 191' ' ' PHE . 44.9 Cg_endo -70.87 -28.84 19.41 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.952 1.501 . . . . 0.0 111.026 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.523 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -74.17 15.44 0.32 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.299 -0.876 . . . . 0.0 111.142 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.597 ' CE2' ' O ' ' A' ' 187' ' ' LEU . 0.3 OUTLIER -90.52 -16.3 29.12 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.004 -1.06 . . . . 0.0 110.408 179.652 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . 0.466 ' HA ' ' NE ' ' A' ' 192' ' ' ARG . 0.0 OUTLIER -90.03 -13.97 34.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.319 -0.863 . . . . 0.0 110.75 -179.616 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -112.47 -8.8 20.68 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 108.786 -1.725 . . . . 0.0 108.786 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.622 HD22 ' CG2' ' A' ' 177' ' ' THR . 7.7 tt -78.19 -31.66 49.6 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.617 -0.931 . . . . 0.0 109.213 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.546 ' CA ' HG22 ' A' ' 198' ' ' THR . 0.0 OUTLIER -53.56 -39.73 64.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.438 -0.789 . . . . 0.0 109.707 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -86.04 -24.61 40.41 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.699 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -91.09 -4.59 56.13 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.644 -0.916 . . . . 0.0 110.09 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' THR . . . . . 0.587 ' O ' ' CG2' ' A' ' 110' ' ' THR . 26.0 p -43.06 116.44 0.9 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.496 -0.753 . . . . 0.0 110.986 -178.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.699 ' HG ' ' O ' ' A' ' 197' ' ' ARG . 0.0 OUTLIER -128.69 171.82 11.83 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.564 -0.71 . . . . 0.0 109.955 179.654 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.564 ' O ' HG22 ' A' ' 108' ' ' VAL . 14.9 m-30 -83.49 134.72 44.66 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.196 -0.94 . . . . 0.0 109.952 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.652 ' HB3' ' CH2' ' A' ' 91' ' ' TRP . 43.9 Cg_endo -68.35 118.58 5.73 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.089 1.573 . . . . 0.0 111.614 -178.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.517 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.2 OUTLIER -134.01 148.62 51.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.469 -0.769 . . . . 0.0 110.49 179.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.49 HG21 ' O ' ' A' ' 105' ' ' VAL . 8.2 p -149.84 159.13 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.125 -0.984 . . . . 0.0 110.311 179.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' SER . . . . . 0.837 ' O ' ' HH2' ' A' ' 95' ' ' TRP . 0.3 OUTLIER -144.88 125.67 14.29 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.178 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.545 ' HA ' ' CH2' ' A' ' 95' ' ' TRP . . . -115.72 166.55 11.81 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.438 0.637 . . . . 0.0 110.854 -178.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.579 ' CG1' ' HB3' ' A' ' 210' ' ' CYS . 1.1 p -136.88 165.57 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.343 -0.848 . . . . 0.0 109.952 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.585 ' NE1' ' CB ' ' A' ' 76' ' ' ASP . 40.7 p-90 -132.91 -2.68 3.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.092 -1.005 . . . . 0.0 110.175 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -74.62 -0.83 59.94 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -175.99 -41.69 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.449 -1.03 . . . . 0.0 110.724 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . 0.579 ' HB3' ' CG1' ' A' ' 206' ' ' VAL . 0.0 OUTLIER -98.96 146.3 26.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.429 -0.795 . . . . 0.0 110.802 -179.542 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -135.01 102.6 5.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.531 -0.731 . . . . 0.0 109.545 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.714 ' O ' ' CZ2' ' A' ' 48' ' ' TRP . 7.2 p -104.42 143.84 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.439 -0.788 . . . . 0.0 110.38 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . 0.553 ' CD ' ' HB2' ' A' ' 94' ' ' SER . 2.9 ptp180 -95.61 131.64 41.61 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.324 -0.86 . . . . 0.0 109.619 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.677 HG22 ' CE3' ' A' ' 48' ' ' TRP . 1.2 tt -118.84 113.95 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.061 -1.024 . . . . 0.0 111.561 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.612 ' O ' ' N ' ' A' ' 92' ' ' GLU . 7.6 ttm180 -112.99 108.81 17.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.073 -1.017 . . . . 0.0 108.896 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . 0.678 ' CD2' ' HB2' ' A' ' 91' ' ' TRP . 1.6 t80 -104.44 149.65 25.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.93 . . . . 0.0 111.179 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.24 107.92 7.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.579 -0.7 . . . . 0.0 109.917 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 141.5 -22.02 2.55 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.172 -1.193 . . . . 0.0 110.194 -179.932 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.531 ' O ' ' CD1' ' A' ' 29' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.21 0.529 . . . . 0.0 109.888 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.503 ' HG2' ' CG ' ' A' ' 55' ' ' GLU . 0.9 OUTLIER -45.97 -42.8 13.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.307 -0.87 . . . . 0.0 109.783 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -56.92 -23.27 43.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.4 -0.813 . . . . 0.0 109.302 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.495 ' O ' ' HB2' ' A' ' 35' ' ' ALA . 16.7 tp -83.22 -34.5 25.86 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.615 ' CD2' ' CG ' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -72.92 -36.34 67.23 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.917 0.865 . . . . 0.0 109.116 179.124 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.606 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 1.4 m -69.17 -14.29 62.9 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.252 0.549 . . . . 0.0 110.465 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.604 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . . . -51.72 -61.85 3.75 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.164 -0.96 . . . . 0.0 110.201 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.69 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 43.3 Cg_endo -69.86 110.31 2.54 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.988 1.52 . . . . 0.0 110.77 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.742 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 49.1 Cg_endo -74.92 -24.81 12.64 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 124.146 1.603 . . . . 0.0 112.84 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.742 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 42.3 Cg_endo -68.3 152.4 75.74 Favored 'Trans proline' 0 C--N 1.315 -1.214 0 O-C-N 122.892 0.943 . . . . 0.0 112.38 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.611 ' O ' ' CG ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER 4.79 80.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 123.561 1.648 . . . . 0.0 110.887 -178.694 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.699 ' CD2' ' C ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER 179.97 -51.7 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 113.655 -1.611 . . . . 0.0 107.705 178.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.649 ' CG2' HD11 ' A' ' 40' ' ' LEU . 1.8 t -87.36 -20.17 7.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 118.933 -1.107 . . . . 0.0 109.661 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.27 -46.49 8.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.154 -0.966 . . . . 0.0 111.954 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.59 ' O ' ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -79.39 -20.89 46.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.662 -1.274 . . . . 0.0 109.411 -179.464 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.714 ' NE ' ' O ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -72.47 -36.22 68.41 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.491 -0.884 . . . . 0.0 108.767 179.283 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.675 ' N ' ' CD2' ' A' ' 45' ' ' HIS . 7.2 m170 -81.73 -26.07 34.88 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.866 -0.521 . . . . 0.0 110.272 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -96.38 -28.7 14.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.129 -0.982 . . . . 0.0 110.104 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.83 -111.09 1.02 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.767 ' CZ2' ' O ' ' A' ' 212' ' ' VAL . 88.6 m95 -91.63 73.97 5.88 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.09 -1.241 . . . . 0.0 109.436 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.77 ' OD1' ' HG3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -52.4 150.09 9.35 Favored Pre-proline 0 N--CA 1.489 1.495 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.151 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.713 ' O ' ' N ' ' A' ' 53' ' ' CYS . 54.2 Cg_endo -91.81 -0.01 4.39 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 122.273 1.982 . . . . 0.0 113.221 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.77 ' HG3' ' OD1' ' A' ' 49' ' ' ASN . 0.0 OUTLIER 0.69 -98.69 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.639 0 CA-C-O 122.646 1.212 . . . . 0.0 111.192 -178.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.811 ' HB3' ' NE ' ' A' ' 79' ' ' ARG 0.259 0.5 OUTLIER -62.19 -28.08 69.42 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.568 -179.707 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.859 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . 0.7 OUTLIER -104.82 -177.02 3.24 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.323 1.059 . . . . 0.0 112.481 -178.096 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.563 ' O ' ' HB3' ' A' ' 50' ' ' PRO . 2.0 m -87.38 165.21 15.76 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.897 0.856 . . . . 0.0 111.257 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.837 ' O ' ' N ' ' A' ' 57' ' ' ILE . 2.5 pm0 -94.21 9.71 36.88 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.045 0.926 . . . . 0.0 108.748 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.575 ' O ' HG11 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -16.27 -38.26 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.263 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.837 ' N ' ' O ' ' A' ' 55' ' ' GLU . 6.6 pt -130.12 167.43 25.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.128 -178.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.588 ' HB2' HD22 ' A' ' 40' ' ' LEU . 6.0 t0 -107.76 141.39 39.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.401 -0.812 . . . . 0.0 110.11 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.741 HG23 ' HB2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -130.42 136.03 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.337 -0.852 . . . . 0.0 110.509 -179.166 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.537 ' NZ ' ' HB2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -135.27 155.05 51.28 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.977 -1.077 . . . . 0.0 110.755 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 62' ' ' GLY . 5.3 mt-10 -78.24 -129.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.515 -0.741 . . . . 0.0 110.115 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 42.15 42.98 4.39 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.666 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 116.11 48.1 0.49 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.666 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.5 OUTLIER 0.42 90.5 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.847 -0.796 . . . . 0.0 111.084 -179.438 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -124.96 123.2 39.38 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.493 -0.754 . . . . 0.0 111.194 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.625 ' CD1' ' CG1' ' A' ' 59' ' ' VAL . 18.2 m-85 -83.39 127.1 33.4 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.596 ' O ' ' HB ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -110.38 121.15 44.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.007 -1.058 . . . . 0.0 110.557 -179.495 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.568 ' HD3' ' N ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -136.11 155.98 49.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.491 -0.755 . . . . 0.0 109.365 179.471 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.575 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -173.18 -55.98 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 120.929 -1.107 . . . . 0.0 111.065 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 69' ' ' ARG . 40.9 Cg_endo -67.24 -47.66 2.16 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.756 1.398 . . . . 0.0 110.645 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.575 HG11 ' O ' ' A' ' 56' ' ' ASN . 1.6 p -78.49 165.29 3.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-O 121.937 0.875 . . . . 0.0 110.983 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.547 ' N ' ' CG2' ' A' ' 71' ' ' VAL . . . -159.22 -36.52 0.06 Allowed 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.312 0.577 . . . . 0.0 110.026 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -141.99 13.48 2.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.36 -0.838 . . . . 0.0 110.127 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 75' ' ' THR . 0.6 OUTLIER -63.36 -158.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 110.195 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.555 HG23 ' HB2' ' A' ' 54' ' ' SER . 0.6 OUTLIER -54.42 -107.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.164 -0.96 . . . . 0.0 110.27 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.529 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 2.4 m-20 -140.32 150.09 43.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.906 -1.121 . . . . 0.0 110.935 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.529 ' O ' ' ND2' ' A' ' 56' ' ' ASN . . . -40.39 -86.49 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.575 ' CG2' ' O ' ' A' ' 49' ' ' ASN . 0.2 OUTLIER -138.05 145.48 28.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.135 -1.214 . . . . 0.0 109.721 178.523 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.859 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 4.2 tmm_? -148.44 133.83 18.55 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.494 ' HA2' ' HB2' ' A' ' 52' ' ' ASP . . . -126.2 143.34 14.33 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.538 ' HE3' ' CB ' ' A' ' 202' ' ' SER . 0.3 OUTLIER -165.47 9.93 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.067 -1.255 . . . . 0.0 111.451 -179.66 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.733 ' HD2' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -135.27 -9.76 2.23 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.676 -1.265 . . . . 0.0 110.83 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.733 ' N ' ' HD2' ' A' ' 82' ' ' ARG . . . -74.81 38.1 1.07 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.476 ' CE1' HD11 ' A' ' 171' ' ' LEU . 15.8 t80 -94.17 119.37 32.89 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.435 -1.038 . . . . 0.0 110.087 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.7 p -99.92 177.48 5.1 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.302 -0.874 . . . . 0.0 110.395 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.554 ' HA ' ' CB ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -108.04 167.38 10.04 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.307 -0.871 . . . . 0.0 109.933 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.471 ' N ' ' HB3' ' A' ' 173' ' ' MET . . . 100.77 -124.71 8.34 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.497 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 1.3 tp -129.06 130.12 46.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.463 -1.022 . . . . 0.0 110.398 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.552 ' NE2' ' O ' ' A' ' 86' ' ' ARG . 8.4 m-70 -147.29 158.64 44.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.129 -0.982 . . . . 0.0 109.968 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.545 ' O ' ' O ' ' A' ' 217' ' ' MET . . . -161.6 135.22 6.54 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.129 -0.982 . . . . 0.0 109.58 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.695 ' CZ3' ' CG1' ' A' ' 169' ' ' VAL . 0.0 OUTLIER -134.09 156.28 48.54 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.917 -1.114 . . . . 0.0 109.846 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.665 ' O ' ' N ' ' A' ' 215' ' ' ARG . 0.8 OUTLIER -109.53 124.07 50.47 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.705 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.521 ' CG2' ' OH ' ' A' ' 180' ' ' TYR . 0.8 OUTLIER -141.85 154.12 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.953 -1.092 . . . . 0.0 110.62 -179.325 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.508 ' HB3' ' HA ' ' A' ' 166' ' ' ARG . 0.6 OUTLIER -134.17 123.09 23.78 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.5 -0.75 . . . . 0.0 109.093 179.425 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.759 ' HH2' ' O ' ' A' ' 204' ' ' SER . 2.1 t90 -127.6 88.21 54.16 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.067 -1.021 . . . . 0.0 110.817 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -95.43 109.08 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 124.154 1.608 . . . . 0.0 110.166 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.535 ' HB2' ' CG2' ' A' ' 135' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 O-C-N 120.843 -1.16 . . . . 0.0 110.315 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.65 HG11 ' O ' ' A' ' 204' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 121.498 0.666 . . . . 0.0 112.015 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.664 ' O ' ' HB2' ' A' ' 133' ' ' TRP . 0.2 OUTLIER -151.24 112.91 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.687 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 132' ' ' GLY . . . 179.55 -147.31 7.51 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 118.621 -1.752 . . . . 0.0 111.223 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.623 ' CG1' ' HB2' ' A' ' 199' ' ' LEU . 1.4 t -139.66 170.27 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.554 -0.968 . . . . 0.0 109.618 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' A' ' 200' ' ' TYR . . . -121.17 139.88 52.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.998 -1.064 . . . . 0.0 110.766 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.535 HG21 ' CB ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -136.47 133.73 36.88 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.32 -0.862 . . . . 0.0 110.461 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.16 -26.08 17.57 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.308 -0.87 . . . . 0.0 109.266 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.448 ' O ' ' C ' ' A' ' 113' ' ' ALA . 1.0 OUTLIER -85.37 -12.19 52.74 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.545 -0.722 . . . . 0.0 109.445 179.416 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.473 ' HB3' ' HB3' ' A' ' 129' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.552 -0.718 . . . . 0.0 110.646 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.194 0.521 . . . . 0.0 110.092 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.473 ' HB3' ' HB3' ' A' ' 113' ' ' ALA . 5.9 tp10 -150.21 141.44 23.17 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.271 -0.893 . . . . 0.0 109.692 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 13.4 t -119.86 120.05 35.33 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.592 -0.692 . . . . 0.0 109.978 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -133.36 136.38 45.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.378 -0.827 . . . . 0.0 109.619 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.606 ' O ' ' CD1' ' A' ' 133' ' ' TRP . . . -178.0 -107.56 0.22 Allowed Glycine 0 N--CA 1.487 2.093 0 C-N-CA 119.545 -1.312 . . . . 0.0 109.924 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.694 ' CH2' ' HB2' ' A' ' 180' ' ' TYR . 5.2 m-90 -141.0 128.91 21.8 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.26 -1.141 . . . . 0.0 111.568 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -118.74 148.04 43.22 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.723 -0.611 . . . . 0.0 109.743 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.535 ' CG2' ' HB2' ' A' ' 97' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.344 -0.848 . . . . 0.0 109.921 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.635 ' CG1' ' HD2' ' A' ' 164' ' ' PRO . 15.2 t . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.635 ' HD2' ' CG1' ' A' ' 163' ' ' VAL . 38.2 Cg_endo -64.57 -177.89 0.6 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.693 1.365 . . . . 0.0 110.758 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' A' ' 94' ' ' SER . 0.3 OUTLIER -48.57 -58.2 5.05 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.43 -0.794 . . . . 0.0 110.389 -179.402 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.508 ' HA ' ' HB3' ' A' ' 94' ' ' SER . 1.3 ttp180 -151.94 155.96 39.1 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.498 -0.751 . . . . 0.0 110.578 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.647 ' HB2' ' CE1' ' A' ' 180' ' ' TYR . 0.9 OUTLIER -137.68 157.74 45.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.483 -0.761 . . . . 0.0 109.782 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.522 HD11 ' CG ' ' A' ' 92' ' ' GLU . 3.4 tt -103.11 126.72 50.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.93 . . . . 0.0 109.799 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.695 ' CG1' ' CZ3' ' A' ' 91' ' ' TRP . 57.9 t -90.04 138.3 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.349 -0.844 . . . . 0.0 110.829 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 85.9 t -116.14 111.51 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.545 -0.722 . . . . 0.0 109.265 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.531 HD12 ' CB ' ' A' ' 178' ' ' LEU . 14.4 tp -118.94 105.51 11.54 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.966 -1.084 . . . . 0.0 110.251 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -120.58 133.79 55.34 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.339 -0.851 . . . . 0.0 110.209 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.554 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 1.6 tpt -99.7 -37.96 8.9 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.25 -24.15 1.67 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.474 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.1 OUTLIER -107.04 -26.28 11.22 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.202 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.574 ' O ' ' CG2' ' A' ' 198' ' ' THR . . . 82.17 24.47 54.62 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 108.604 -1.798 . . . . 0.0 108.604 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.616 ' HA ' ' CD2' ' A' ' 194' ' ' LEU . 0.6 OUTLIER -130.07 122.91 29.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.093 -1.239 . . . . 0.0 111.486 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.549 ' CD2' ' CG2' ' A' ' 198' ' ' THR . 0.1 OUTLIER -140.52 153.58 46.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.454 -0.779 . . . . 0.0 109.611 179.168 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.497 ' O ' HG12 ' A' ' 169' ' ' VAL . . . 179.98 -152.2 10.65 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.633 -1.27 . . . . 0.0 110.212 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.694 ' HB2' ' CH2' ' A' ' 133' ' ' TRP . 0.1 OUTLIER -123.0 142.21 51.09 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.331 -1.099 . . . . 0.0 109.332 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.492 ' HA ' ' HB3' ' A' ' 186' ' ' TYR . 15.3 t -140.76 124.78 17.3 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.422 -0.799 . . . . 0.0 110.154 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.61 HD12 ' CD2' ' A' ' 186' ' ' TYR . 0.1 OUTLIER -107.26 116.64 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.215 -0.928 . . . . 0.0 109.276 179.502 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 79.81 -47.19 3.25 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 137.62 36.39 0.17 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' THR . . . . . 0.435 ' O ' ' C ' ' A' ' 186' ' ' TYR . 73.0 m -122.89 -51.47 1.91 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.242 -1.152 . . . . 0.0 110.859 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.61 ' CD2' HD12 ' A' ' 182' ' ' ILE . 0.1 OUTLIER -40.98 -74.34 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.079 -1.013 . . . . 0.0 110.613 -179.415 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.619 ' CD2' ' CZ ' ' A' ' 191' ' ' PHE . 1.1 mp -71.25 43.85 0.08 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.001 -1.062 . . . . 0.0 109.886 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 186' ' ' TYR . . . -75.67 -99.28 0.13 Allowed Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.51 ' C ' ' H ' ' A' ' 191' ' ' PHE . 49.6 Cg_endo -74.13 -24.17 15.05 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.207 1.635 . . . . 0.0 110.946 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -65.86 16.81 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.487 -0.758 . . . . 0.0 111.724 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.619 ' CZ ' ' CD2' ' A' ' 187' ' ' LEU . 0.3 OUTLIER -90.45 -16.68 28.53 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.828 -1.17 . . . . 0.0 110.394 179.56 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . 0.468 ' NE ' ' HA ' ' A' ' 192' ' ' ARG . 0.0 OUTLIER -90.2 -15.12 32.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.282 -0.886 . . . . 0.0 110.902 -179.452 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -110.82 -16.95 9.42 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.658 HD21 ' C ' ' A' ' 194' ' ' LEU . 7.5 tt -67.86 -36.31 80.08 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.617 -0.931 . . . . 0.0 108.87 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.516 ' HA ' HG23 ' A' ' 177' ' ' THR . 0.0 OUTLIER -44.69 -34.88 2.4 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.403 -0.811 . . . . 0.0 109.825 179.562 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.451 ' N ' ' HD2' ' A' ' 195' ' ' LYS . . . -94.11 -27.31 12.43 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.64 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.94 -4.69 56.3 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.603 -0.94 . . . . 0.0 110.108 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' THR . . . . . 0.611 ' N ' ' O ' ' A' ' 194' ' ' LEU . 0.7 OUTLIER -44.06 143.49 1.14 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.825 0.821 . . . . 0.0 111.649 -178.327 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' A' ' 197' ' ' ARG . 0.0 OUTLIER -140.28 171.74 13.73 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.509 ' C ' HG11 ' A' ' 108' ' ' VAL . 2.8 m-30 -84.18 129.81 56.87 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 120.925 -1.11 . . . . 0.0 109.782 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.499 ' HD3' ' CD1' ' A' ' 178' ' ' LEU . 41.6 Cg_endo -67.51 115.75 3.87 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.888 1.468 . . . . 0.0 111.035 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.538 ' CB ' ' HE3' ' A' ' 81' ' ' LYS . 1.6 p -133.14 154.06 50.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.43 -0.794 . . . . 0.0 110.229 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 105' ' ' VAL . 2.0 p -158.1 164.11 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.32 -0.863 . . . . 0.0 110.217 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' SER . . . . . 0.759 ' O ' ' HH2' ' A' ' 95' ' ' TRP . 0.1 OUTLIER -157.94 126.56 5.57 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.397 -0.815 . . . . 0.0 109.981 179.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.482 ' HB2' ' CZ ' ' A' ' 66' ' ' PHE . . . -119.23 161.63 20.06 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.312 -0.868 . . . . 0.0 110.831 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.559 ' CG1' ' N ' ' A' ' 207' ' ' TRP . 1.1 t -124.33 176.14 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 CA-C-O 121.251 0.548 . . . . 0.0 110.063 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.568 ' CE2' ' HG3' ' A' ' 68' ' ' ARG . 44.2 p90 -103.31 155.0 18.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -0.883 . . . . 0.0 110.056 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 135.18 -152.84 20.95 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . 0.466 ' O ' ' O ' ' A' ' 210' ' ' CYS . 5.1 tm0? -66.89 -29.04 68.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.324 -1.103 . . . . 0.0 110.258 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 209' ' ' GLN . 9.2 t -46.74 175.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.304 -0.872 . . . . 0.0 109.985 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.422 ' HG2' ' C ' ' A' ' 210' ' ' CYS . 0.8 OUTLIER -170.11 111.29 0.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 110.588 -179.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.767 ' O ' ' CZ2' ' A' ' 48' ' ' TRP . 27.4 m -115.42 145.39 21.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.527 -0.733 . . . . 0.0 109.783 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . 0.848 ' HE ' ' HA ' ' A' ' 213' ' ' ARG . 0.7 OUTLIER -108.48 128.54 54.89 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.204 179.728 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.709 ' HB ' ' CZ3' ' A' ' 48' ' ' TRP . 5.6 tt -123.51 119.62 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.026 -1.047 . . . . 0.0 111.933 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.665 ' N ' ' O ' ' A' ' 92' ' ' GLU . 23.3 ttt180 -130.33 135.07 47.69 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . 0.656 ' CZ ' ' CD1' ' A' ' 91' ' ' TRP . 1.8 t80 -119.07 151.02 39.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.651 -1.281 . . . . 0.0 112.265 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' MET . . . . . 0.545 ' O ' ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -131.11 107.77 9.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.686 -0.634 . . . . 0.0 109.612 179.061 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 79.23 61.87 2.28 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.578 ' HB2' ' CD1' ' A' ' 216' ' ' TYR . 16.9 tt0 . . . . . 0 N--CA 1.493 1.722 0 O-C-N 121.138 -1.213 . . . . 0.0 110.237 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 121.126 0.488 . . . . 0.0 110.092 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.571 ' HA ' ' CD2' ' A' ' 33' ' ' LEU . 16.1 pt-20 -45.74 -37.82 6.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 109.719 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.455 ' N ' ' HG3' ' A' ' 30' ' ' GLU . 1.7 tm-20 -72.4 -23.21 61.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.376 -0.828 . . . . 0.0 109.167 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.578 ' O ' ' HD2' ' A' ' 36' ' ' PRO . 15.3 tp -83.81 -30.49 26.5 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.598 ' HG ' ' N ' ' A' ' 34' ' ' SER . 0.3 OUTLIER -71.0 -34.35 71.26 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 122.081 0.943 . . . . 0.0 108.968 179.304 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.598 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -83.81 -6.93 59.54 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.072 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.624 ' CB ' ' HD3' ' A' ' 36' ' ' PRO . . . -71.5 -65.73 0.84 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.313 -0.867 . . . . 0.0 111.11 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.69 ' C ' ' HD3' ' A' ' 38' ' ' PRO . 49.6 Cg_endo -75.45 143.97 28.3 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.607 1.32 . . . . 0.0 110.441 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 36' ' ' PRO . 53.9 Cg_endo -99.02 54.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.947 1.764 . . . . 0.0 112.251 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.69 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 51.8 Cg_endo -75.52 150.91 36.63 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 122.958 0.978 . . . . 0.0 109.845 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.645 ' O ' ' HB3' ' A' ' 43' ' ' GLN . 0.9 OUTLIER -34.04 -34.52 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.187 -0.946 . . . . 0.0 109.662 179.895 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 1.225 ' O ' ' HB3' ' A' ' 44' ' ' ARG . 1.8 tp -62.79 -43.91 97.57 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 110.34 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.688 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 46.6 t -86.68 -36.8 10.65 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 C-N-CA 118.389 -1.324 . . . . 0.0 110.029 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.13 -40.12 11.21 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.436 -0.906 . . . . 0.0 112.696 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.645 ' HB3' ' O ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -87.88 -19.15 27.76 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 120.899 -1.126 . . . . 0.0 110.164 -178.645 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 1.225 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 5.3 ttt180 -84.66 -52.62 5.95 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.795 1.284 . . . . 0.0 109.778 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.688 ' CG ' ' O ' ' A' ' 41' ' ' VAL . 13.7 m170 -52.35 -15.03 0.54 Allowed 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.26 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 20.4 t-160 -82.84 -38.59 22.81 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 118.147 -1.421 . . . . 0.0 110.136 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.736 ' O ' ' N ' ' A' ' 49' ' ' ASN . . . -94.39 -109.93 2.2 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 106.234 -2.746 . . . . 0.0 106.234 177.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.804 ' CD2' ' N ' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -58.39 71.42 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 177.062 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.736 ' N ' ' O ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -57.66 109.95 2.14 Favored Pre-proline 0 C--N 1.289 -2.052 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.192 -178.615 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.588 ' CD ' ' HA ' ' A' ' 45' ' ' HIS . 51.5 Cg_endo -92.54 -0.03 3.92 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.171 1.914 . . . . 0.0 110.448 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.687 ' CE ' ' CA ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -44.97 -77.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.147 -0.97 . . . . 0.0 110.425 -179.518 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.622 ' HB3' ' HE ' ' A' ' 79' ' ' ARG . 0.2 OUTLIER -40.57 -19.29 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.708 0.766 . . . . 0.0 109.192 178.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.638 ' N ' ' O ' ' A' ' 51' ' ' LYS . 3.1 t -114.69 -178.52 3.39 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.653 0.74 . . . . 0.0 110.776 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.579 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 0.3 OUTLIER -89.0 166.6 13.79 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.84 0.828 . . . . 0.0 110.595 -179.736 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.797 ' O ' ' N ' ' A' ' 57' ' ' ILE . 3.2 pp20? -81.93 8.75 9.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.713 -0.617 . . . . 0.0 110.039 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.579 ' ND2' ' O ' ' A' ' 54' ' ' SER . 0.1 OUTLIER -24.51 -33.1 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.675 0.75 . . . . 0.0 110.134 -179.534 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.797 ' N ' ' O ' ' A' ' 55' ' ' GLU . 6.1 pt -141.73 165.18 18.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.798 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 67' ' ' GLU . 9.2 t0 -114.91 126.79 55.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.463 -0.773 . . . . 0.0 109.967 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.715 HG13 ' CD1' ' A' ' 48' ' ' TRP . 57.7 t -130.04 127.01 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.115 -0.991 . . . . 0.0 109.907 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.625 ' HA ' ' CH2' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -136.37 157.1 47.6 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.986 -1.071 . . . . 0.0 111.585 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.67 ' N ' ' CH2' ' A' ' 48' ' ' TRP . 1.3 tt0 -52.5 -110.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.694 -0.629 . . . . 0.0 111.076 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 44.54 37.57 5.0 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 107.661 -2.176 . . . . 0.0 107.661 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.73 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 94.35 78.32 1.41 Allowed Glycine 0 N--CA 1.486 1.973 0 N-CA-C 107.809 -2.117 . . . . 0.0 107.809 -178.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.73 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.4 OUTLIER 1.26 88.21 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.661 -0.905 . . . . 0.0 110.126 -178.711 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 46.4 t -122.35 114.64 21.05 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.425 -0.797 . . . . 0.0 111.677 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.66 ' CD1' HG13 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -84.41 135.36 34.3 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.501 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.556 ' O ' ' N ' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -138.39 131.62 30.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.851 -1.156 . . . . 0.0 111.15 -179.535 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.543 ' HG2' ' CA ' ' A' ' 208' ' ' GLY . 0.0 OUTLIER -130.71 141.81 50.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.53 -0.732 . . . . 0.0 109.043 179.133 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.605 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 2.4 ttp180 -110.46 -68.2 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.783 -1.198 . . . . 0.0 111.325 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.605 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 56.3 Cg_endo -71.61 -124.1 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.5 0 O-C-N 123.394 1.207 . . . . 0.0 109.586 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.55 ' O ' ' N ' ' A' ' 73' ' ' GLN . 3.6 t -140.1 164.18 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.441 -1.412 . . . . 0.0 109.874 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.573 ' HB1' ' CE3' ' A' ' 207' ' ' TRP . . . -46.66 91.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.169 -0.957 . . . . 0.0 109.892 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.55 ' N ' ' O ' ' A' ' 71' ' ' VAL . 9.8 mt-30 -50.08 -176.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.932 . . . . 0.0 110.313 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.0 m -51.76 -18.84 1.37 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 0.0 110.127 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 1.3 m -96.87 -131.88 0.2 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.215 -0.928 . . . . 0.0 110.081 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.579 ' O ' ' C ' ' A' ' 77' ' ' GLY . 80.5 m-20 -140.4 154.83 46.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.187 -0.946 . . . . 0.0 110.172 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.579 ' C ' ' O ' ' A' ' 76' ' ' ASP . . . -31.88 -77.78 0.03 OUTLIER Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.557 HG21 ' N ' ' A' ' 79' ' ' ARG . 0.4 OUTLIER -149.18 153.29 11.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.345 -1.091 . . . . 0.0 109.783 179.024 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.631 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 0.2 OUTLIER -145.7 174.63 11.03 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.712 -0.617 . . . . 0.0 110.071 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.576 ' N ' ' CG ' ' A' ' 79' ' ' ARG . . . -157.48 152.55 23.83 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.521 ' HB2' ' CB ' ' A' ' 202' ' ' SER . 0.1 OUTLIER 179.85 -27.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.206 -1.173 . . . . 0.0 110.661 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.48 ' HG2' ' OD1' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -72.92 -100.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.137 -0.977 . . . . 0.0 110.334 -179.794 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 82' ' ' ARG . . . 43.0 59.61 3.28 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.526 ' CD2' ' O ' ' A' ' 84' ' ' TYR . 28.2 t80 -95.33 95.68 8.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.18 -1.188 . . . . 0.0 110.185 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.465 ' O ' ' HG2' ' A' ' 173' ' ' MET . 0.1 OUTLIER -140.11 173.67 11.28 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 110.252 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.496 ' HA ' ' CB ' ' A' ' 173' ' ' MET . 2.3 mmt85 -101.42 -174.36 2.58 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.177 -0.952 . . . . 0.0 109.676 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.96 158.35 15.98 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 172' ' ' ASP . 1.8 tt -87.47 127.41 35.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -1.11 . . . . 0.0 109.98 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.421 ' NE2' ' O ' ' A' ' 86' ' ' ARG . 40.9 m-70 -133.25 173.1 11.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 110.162 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -156.76 151.31 25.56 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.07 -1.019 . . . . 0.0 110.389 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.714 ' CB ' ' CD2' ' A' ' 216' ' ' TYR . 4.1 p90 -146.2 171.06 15.5 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.246 -0.909 . . . . 0.0 109.936 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.584 ' N ' ' O ' ' A' ' 215' ' ' ARG . 0.7 OUTLIER -138.28 152.14 48.26 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.351 -0.939 . . . . 0.0 111.45 -178.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.59 ' CG2' ' CD1' ' A' ' 167' ' ' LEU . 3.7 tt -144.18 151.58 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.545 -0.722 . . . . 0.0 109.674 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.524 ' HB2' ' CG ' ' A' ' 213' ' ' ARG . 0.1 OUTLIER -142.65 135.85 28.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.092 -1.005 . . . . 0.0 110.672 -179.572 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.607 ' CH2' ' HA ' ' A' ' 205' ' ' ALA . 88.3 m95 -104.47 96.25 9.83 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.775 -0.578 . . . . 0.0 110.204 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.62 ' HD2' ' O ' ' A' ' 211' ' ' GLN . 45.9 Cg_endo -72.29 152.37 55.45 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 121.959 1.772 . . . . 0.0 111.214 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.824 ' CD2' ' C ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.795 0 O-C-N 121.533 -0.729 . . . . 0.0 111.158 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.67 HG22 ' CB ' ' A' ' 204' ' ' SER . 34.9 m . . . . . 0 N--CA 1.485 1.29 0 CA-C-O 121.779 0.8 . . . . 0.0 110.471 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 203' ' ' VAL . 9.0 p -152.31 166.91 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.396 -0.815 . . . . 0.0 109.121 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.638 ' CA ' ' HA3' ' A' ' 132' ' ' GLY . . . 176.28 167.99 35.8 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 118.987 -1.578 . . . . 0.0 110.941 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.65 ' CG1' ' CD1' ' A' ' 199' ' ' LEU . 2.2 t -123.91 155.61 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.712 -0.876 . . . . 0.0 109.017 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.574 ' HB2' ' CE2' ' A' ' 200' ' ' TYR . . . -142.96 150.78 40.15 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.805 -1.185 . . . . 0.0 111.365 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.586 ' CG2' ' HB3' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -131.45 134.95 46.71 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.513 -0.742 . . . . 0.0 110.087 179.505 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.96 -24.77 18.28 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.343 -0.848 . . . . 0.0 109.337 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.6 pp -86.69 -12.11 49.29 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.583 -0.698 . . . . 0.0 109.255 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.487 ' CB ' ' HB2' ' A' ' 129' ' ' GLU . . . . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.465 -0.772 . . . . 0.0 110.44 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 32.0 t . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.243 0.544 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.487 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . 0.2 OUTLIER -133.5 119.64 19.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 110.051 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 3.1 t -120.58 119.99 34.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 110.334 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -123.68 124.91 43.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.851 . . . . 0.0 109.693 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.638 ' HA3' ' CA ' ' A' ' 107' ' ' GLY . . . -164.53 -164.36 19.64 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.607 ' CH2' ' O ' ' A' ' 180' ' ' TYR . 36.4 m0 -114.64 113.17 24.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -1.103 . . . . 0.0 110.462 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -119.63 107.77 13.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.709 -0.62 . . . . 0.0 109.488 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.441 ' CG2' ' O ' ' A' ' 135' ' ' ILE . 15.7 tt . . . . . 0 C--N 1.298 -1.643 0 O-C-N 121.156 -0.965 . . . . 0.0 110.394 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.753 ' N ' ' CD ' ' A' ' 164' ' ' PRO . 8.4 p . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 119.917 -0.087 . . . . 0.0 111.134 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.753 ' CD ' ' N ' ' A' ' 163' ' ' VAL . 48.3 Cg_endo -79.3 52.51 4.31 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 O-C-N 123.068 1.036 . . . . 0.0 109.792 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 95' ' ' TRP . 0.9 OUTLIER 178.77 -72.4 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.693 0.759 . . . . 0.0 109.371 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.459 ' HA ' ' HB3' ' A' ' 94' ' ' SER . 1.4 tpp180 -140.85 144.0 35.08 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.642 HD12 ' CE2' ' A' ' 180' ' ' TYR . 0.6 OUTLIER -164.36 157.08 17.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.041 -1.037 . . . . 0.0 110.745 -179.604 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.5 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . 7.7 tt -123.31 137.14 54.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.286 -0.884 . . . . 0.0 110.082 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.622 ' CG2' ' CE1' ' A' ' 180' ' ' TYR . 19.0 t -121.4 147.94 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 110.082 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.519 ' CG2' HD22 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -127.89 128.87 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.181 -0.95 . . . . 0.0 110.438 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.548 ' CD1' ' HB3' ' A' ' 178' ' ' LEU . 4.7 tp -133.14 105.91 7.3 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.225 -0.922 . . . . 0.0 109.678 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 54.3 t0 -114.88 136.64 52.88 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 110.648 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.496 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -93.26 -39.6 10.9 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.799 -0.563 . . . . 0.0 109.689 179.678 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 173' ' ' MET . 3.5 tt0 -42.51 -28.07 0.2 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.323 -0.861 . . . . 0.0 108.894 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.587 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 3.0 tt0 -111.86 -26.22 9.04 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.52 ' O ' ' HB ' ' A' ' 198' ' ' THR . . . 80.0 25.07 58.58 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.644 ' CG2' HD23 ' A' ' 194' ' ' LEU . 0.2 OUTLIER -121.81 136.7 54.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.191 -1.182 . . . . 0.0 111.252 -179.431 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.567 ' O ' ' CD1' ' A' ' 194' ' ' LEU . 0.3 OUTLIER -144.66 153.76 42.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.56 -0.713 . . . . 0.0 109.514 179.302 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.512 ' O ' HG11 ' A' ' 169' ' ' VAL . . . -154.03 167.6 32.28 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.588 -1.292 . . . . 0.0 110.197 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.642 ' CE2' HD12 ' A' ' 167' ' ' LEU . 0.9 OUTLIER -118.74 125.26 49.23 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.594 -0.945 . . . . 0.0 108.906 179.64 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.52 ' CB ' ' HB2' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -144.41 165.07 28.96 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.069 -1.019 . . . . 0.0 110.646 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.609 HD11 ' CD2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -120.81 116.65 50.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 O-C-N 121.667 -0.646 . . . . 0.0 109.38 179.402 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 62.78 11.67 37.8 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 86.92 34.52 10.93 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' THR . . . . . 0.635 ' CG2' ' CE1' ' A' ' 186' ' ' TYR . 31.8 m -87.43 -79.41 0.28 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -1.161 . . . . 0.0 110.545 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.635 ' CE1' ' CG2' ' A' ' 185' ' ' THR . 2.0 m-85 -83.66 89.47 7.13 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.971 -1.081 . . . . 0.0 110.389 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.621 ' HG ' ' CE1' ' A' ' 191' ' ' PHE . 12.3 tp 179.9 29.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.589 -0.694 . . . . 0.0 109.504 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -106.73 -72.06 0.8 Allowed Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.754 -1.212 . . . . 0.0 110.984 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.424 ' C ' ' H ' ' A' ' 191' ' ' PHE . 44.8 Cg_endo -70.48 -30.84 18.35 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.899 1.473 . . . . 0.0 111.727 -178.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.637 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -72.42 17.21 0.11 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.125 -0.984 . . . . 0.0 111.519 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.621 ' CE1' ' HG ' ' A' ' 187' ' ' LEU . 1.1 m-30 -90.83 -22.14 21.13 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.962 -1.086 . . . . 0.0 110.981 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . 0.477 ' HG2' ' NH1' ' A' ' 192' ' ' ARG . 0.1 OUTLIER -90.02 -14.66 33.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.033 -1.042 . . . . 0.0 110.659 -179.391 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -106.62 -17.36 12.27 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.516 -1.834 . . . . 0.0 108.516 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.644 HD23 ' CG2' ' A' ' 177' ' ' THR . 7.2 tt -65.99 -41.44 91.1 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.699 -0.883 . . . . 0.0 109.525 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.598 ' C ' HG22 ' A' ' 198' ' ' THR . 0.0 OUTLIER -47.07 -31.12 3.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.455 -0.778 . . . . 0.0 110.415 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.551 ' N ' ' HE3' ' A' ' 195' ' ' LYS . . . -99.61 -22.91 11.57 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 1.002 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -91.22 -3.66 56.74 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.942 -0.74 . . . . 0.0 110.164 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' THR . . . . . 0.605 ' CG2' ' O ' ' A' ' 194' ' ' LEU . 33.9 p -42.6 123.17 2.53 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.781 0.801 . . . . 0.0 111.785 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 1.002 ' HG ' ' O ' ' A' ' 197' ' ' ARG . 0.0 OUTLIER -140.72 172.9 12.05 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.495 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.58 ' O ' ' CD1' ' A' ' 200' ' ' TYR . 41.0 p90 -83.13 131.26 54.13 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 120.934 -1.104 . . . . 0.0 109.625 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.548 ' HD3' HD12 ' A' ' 178' ' ' LEU . 52.2 Cg_endo -81.74 132.43 7.65 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 124.01 1.532 . . . . 0.0 111.935 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.521 ' CB ' ' HB2' ' A' ' 81' ' ' LYS . 20.0 p -133.44 127.31 33.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.61 -0.681 . . . . 0.0 109.346 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 11.8 p -119.66 156.33 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.01 -1.056 . . . . 0.0 110.589 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' SER . . . . . 0.67 ' CB ' HG22 ' A' ' 105' ' ' VAL . 1.4 m -134.18 129.27 35.55 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.527 -0.733 . . . . 0.0 110.726 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.607 ' HA ' ' CH2' ' A' ' 95' ' ' TRP . . . -123.14 131.22 53.6 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.285 0.564 . . . . 0.0 110.202 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.569 ' CG1' ' N ' ' A' ' 207' ' ' TRP . 1.2 t -47.35 176.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.46 -0.775 . . . . 0.0 110.419 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.69 ' CG ' ' N ' ' A' ' 208' ' ' GLY . 0.2 OUTLIER -101.3 -50.44 3.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.201 -0.937 . . . . 0.0 111.072 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.69 ' N ' ' CG ' ' A' ' 207' ' ' TRP . . . -144.36 -1.19 0.93 Allowed Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.596 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . 0.545 ' OE1' ' CH2' ' A' ' 207' ' ' TRP . 4.0 tp60 -66.9 -23.43 65.99 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.424 -1.045 . . . . 0.0 109.646 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . 0.549 ' SG ' ' CG1' ' A' ' 206' ' ' VAL . 20.7 p -143.98 -121.98 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.625 0.726 . . . . 0.0 110.018 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.62 ' O ' ' HD2' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -173.53 139.55 0.75 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.634 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.623 ' HB ' ' CZ ' ' A' ' 66' ' ' PHE . 2.3 t -127.24 140.6 48.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 120.607 -1.308 . . . . 0.0 111.321 -178.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . 0.573 ' CD ' ' HD3' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -128.39 109.28 11.28 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.153 178.73 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.563 ' O ' HD11 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -123.54 150.79 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.425 -0.797 . . . . 0.0 110.913 -179.024 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.584 ' O ' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -130.0 108.89 10.44 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . 0.714 ' CD2' ' CB ' ' A' ' 91' ' ' TRP . 1.5 t80 -115.8 140.28 49.37 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.187 -0.945 . . . . 0.0 111.048 -178.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' MET . . . . . 0.421 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 0.0 OUTLIER -136.71 123.99 21.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.648 -0.657 . . . . 0.0 110.142 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 145.8 -37.54 1.26 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.274 -1.133 . . . . 0.0 110.224 -179.949 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.595 ' HG ' ' N ' ' A' ' 30' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.153 0.502 . . . . 0.0 110.218 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.595 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 10.6 pt-20 -48.57 -29.26 4.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.119 -0.988 . . . . 0.0 108.819 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -66.75 -23.52 66.1 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 29' ' ' LEU . 15.1 tp -83.22 -35.85 25.08 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.606 ' C ' ' CD1' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -73.25 -38.01 66.14 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.903 0.858 . . . . 0.0 109.027 178.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.566 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 23.0 t -58.56 -22.71 56.62 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.444 0.64 . . . . 0.0 110.062 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.708 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . -57.95 -173.71 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.454 -0.779 . . . . 0.0 109.555 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.628 ' HD2' ' CB ' ' A' ' 35' ' ' ALA . 42.5 Cg_endo -69.16 102.28 0.91 Allowed 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.875 1.461 . . . . 0.0 110.099 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.708 ' HD3' ' O ' ' A' ' 35' ' ' ALA . 49.1 Cg_endo -94.23 121.21 0.35 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.19 1.627 . . . . 0.0 111.215 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.904 ' O ' ' N ' ' A' ' 40' ' ' LEU . 51.6 Cg_endo -83.84 149.58 12.51 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.925 1.487 . . . . 0.0 110.524 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.634 ' C ' ' O ' ' A' ' 38' ' ' PRO . 0.6 OUTLIER 3.02 51.98 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 122.126 0.965 . . . . 0.0 111.358 -179.649 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.904 ' N ' ' O ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -139.63 -48.89 0.47 Allowed 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 178.154 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.652 ' HB ' ' HB2' ' A' ' 37' ' ' PRO . 2.7 t -88.52 -32.76 6.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 119.327 -0.949 . . . . 0.0 108.554 177.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.46 -43.97 10.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.638 -0.664 . . . . 0.0 112.049 -178.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.699 ' OE1' ' HA ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -81.41 -19.99 41.37 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.056 -1.058 . . . . 0.0 109.972 -178.78 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.653 ' CB ' ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -71.85 -51.63 21.42 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.613 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.628 ' CE1' ' O ' ' A' ' 41' ' ' VAL . 29.6 m170 -56.38 -16.35 5.54 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.638 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -95.04 -33.19 12.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.263 -0.898 . . . . 0.0 109.383 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.645 ' C ' ' CE3' ' A' ' 48' ' ' TRP . . . -83.77 -101.93 0.56 Allowed Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.157 -1.977 . . . . 0.0 108.157 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.786 ' CD2' ' N ' ' A' ' 48' ' ' TRP . 0.3 OUTLIER -86.86 73.06 10.03 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 122.963 1.363 . . . . 0.0 108.479 179.492 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 49' ' ' ASN . 0.1 OUTLIER -46.21 111.67 1.53 Allowed Pre-proline 0 C--N 1.287 -2.148 0 CA-C-N 114.218 -1.356 . . . . 0.0 112.333 -178.295 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.708 ' O ' ' N ' ' A' ' 52' ' ' ASP . 55.4 Cg_endo -91.9 2.09 4.2 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.496 2.131 . . . . 0.0 110.277 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.801 ' HA ' ' CE ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -52.34 71.29 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.909 1.338 . . . . 0.0 111.655 -177.783 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.708 ' N ' ' O ' ' A' ' 50' ' ' PRO . 1.6 m-20 178.03 0.16 0.0 OUTLIER 'General case' 0 C--N 1.262 -3.213 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.2 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.828 ' HB2' ' CB ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -166.01 -175.69 3.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.389 -0.819 . . . . 0.0 111.259 -178.187 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.638 ' OG ' ' O ' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -51.78 124.5 12.63 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.955 0.883 . . . . 0.0 110.709 -179.016 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.739 ' C ' ' H ' ' A' ' 57' ' ' ILE . 1.6 pt-20 -99.67 8.41 44.37 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.591 0.71 . . . . 0.0 110.956 -179.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.636 ' ND2' ' OG ' ' A' ' 54' ' ' SER . 0.4 OUTLIER -58.84 22.94 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.666 0.746 . . . . 0.0 110.199 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.739 ' H ' ' C ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -112.99 166.13 7.15 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 CA-C-O 121.679 0.752 . . . . 0.0 110.342 -179.7 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.658 ' HA ' ' CD2' ' A' ' 40' ' ' LEU . 10.1 t0 -134.72 96.32 3.53 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 121.868 0.842 . . . . 0.0 109.737 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.731 ' HA ' ' O ' ' A' ' 65' ' ' CYS . 1.4 m -121.7 121.33 64.11 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 CA-C-O 121.27 0.557 . . . . 0.0 110.186 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.699 ' HA ' ' OE1' ' A' ' 43' ' ' GLN . 7.9 ttmt -135.75 153.42 51.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 110.658 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.552 ' N ' ' HG2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -55.27 -123.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.431 -0.793 . . . . 0.0 110.724 -179.457 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 44.0 32.37 2.34 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.698 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 110.9 65.47 0.53 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.698 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.2 OUTLIER 0.63 90.23 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.835 -0.803 . . . . 0.0 110.832 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.731 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 1.0 OUTLIER -116.88 114.4 23.83 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.528 -0.733 . . . . 0.0 109.786 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.61 ' CE2' HG11 ' A' ' 59' ' ' VAL . 13.4 t80 -116.25 123.56 48.02 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.461 -0.774 . . . . 0.0 109.541 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -151.82 149.03 28.54 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.909 -1.119 . . . . 0.0 110.886 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.562 ' HD2' ' CB ' ' A' ' 207' ' ' TRP . 17.4 ttt85 -122.51 152.87 39.9 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.253 -0.904 . . . . 0.0 109.71 179.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.68 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 2.7 mtt180 -85.8 -69.02 0.13 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.084 -1.01 . . . . 0.0 110.398 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.68 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 56.1 Cg_endo -71.34 -145.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.706 1.371 . . . . 0.0 109.382 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.484 ' O ' ' HG2' ' A' ' 73' ' ' GLN . 4.8 t -140.01 164.45 22.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 O-C-N 121.378 -0.826 . . . . 0.0 109.954 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.638 ' CB ' ' CZ3' ' A' ' 207' ' ' TRP . . . -63.06 111.38 2.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.208 -0.932 . . . . 0.0 110.105 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.489 ' O ' ' N ' ' A' ' 75' ' ' THR . 0.9 OUTLIER -140.65 -103.81 0.15 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.238 -0.914 . . . . 0.0 110.393 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.482 ' C ' ' O ' ' A' ' 73' ' ' GLN . 8.4 t -38.26 -29.95 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.166 -0.958 . . . . 0.0 110.39 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.537 ' CG2' ' HB2' ' A' ' 54' ' ' SER . 2.7 t -137.49 -134.69 0.14 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.254 -0.904 . . . . 0.0 110.049 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.627 ' O ' ' C ' ' A' ' 77' ' ' GLY . 2.3 t0 -140.11 154.6 47.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 109.905 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.638 ' O ' ' OG ' ' A' ' 54' ' ' SER . . . -25.01 -94.0 0.01 OUTLIER Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.644 ' CG1' HG13 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -158.24 163.13 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.098 -1.236 . . . . 0.0 109.521 179.728 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.828 ' CB ' ' HB2' ' A' ' 53' ' ' CYS . 3.1 tmm_? -141.08 134.66 30.05 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.4 -0.813 . . . . 0.0 110.776 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.822 ' O ' ' O ' ' A' ' 81' ' ' LYS . . . -116.17 -152.34 9.86 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.001 -2.039 . . . . 0.0 108.001 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.837 ' C ' ' HA ' ' A' ' 202' ' ' SER . 0.0 OUTLIER 2.02 123.33 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.414 -1.05 . . . . 0.0 110.986 179.357 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.532 ' NH2' ' OD2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -126.46 -19.83 4.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.267 -0.896 . . . . 0.0 110.549 -179.444 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.526 ' N ' ' HD2' ' A' ' 82' ' ' ARG . . . 133.53 37.73 0.23 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.485 ' HB2' ' HD3' ' A' ' 82' ' ' ARG . 7.9 t80 -134.8 95.86 3.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.06 -1.259 . . . . 0.0 110.286 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 173' ' ' MET . 0.7 OUTLIER -140.16 140.68 35.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.169 -0.957 . . . . 0.0 110.538 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.555 ' HA ' ' CB ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -131.42 145.44 51.81 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -0.902 . . . . 0.0 109.597 179.654 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.442 ' N ' ' HB3' ' A' ' 173' ' ' MET . . . 81.18 165.71 34.79 Favored Glycine 0 N--CA 1.481 1.693 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 172' ' ' ASP . 4.9 tt -87.23 117.86 26.27 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.34 -1.094 . . . . 0.0 110.047 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.454 ' NE2' ' O ' ' A' ' 86' ' ' ARG . 91.4 m-70 -135.39 173.28 11.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -0.882 . . . . 0.0 109.881 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.36 136.58 23.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.14 -0.975 . . . . 0.0 110.107 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.69 ' CB ' ' CD2' ' A' ' 216' ' ' TYR . 0.5 OUTLIER -135.07 171.0 15.05 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.156 -0.965 . . . . 0.0 110.632 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 215' ' ' ARG . 2.6 mt-10 -133.41 151.19 51.79 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.745 -0.597 . . . . 0.0 110.004 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.585 ' O ' HD22 ' A' ' 167' ' ' LEU . 11.5 mt -144.6 154.85 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.237 -0.915 . . . . 0.0 110.799 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.665 ' HB3' ' HB2' ' A' ' 213' ' ' ARG . 14.5 t -141.3 151.43 43.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 109.642 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.706 ' CE2' HG21 ' A' ' 106' ' ' VAL . 14.4 m95 -137.39 90.92 14.7 Favored Pre-proline 0 C--N 1.296 -1.721 0 O-C-N 121.526 -0.734 . . . . 0.0 110.565 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.518 ' HD2' ' HA ' ' A' ' 212' ' ' VAL . 49.4 Cg_endo -78.93 125.41 6.6 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.977 1.514 . . . . 0.0 110.149 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.519 ' CD2' HD12 ' A' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.184 -0.947 . . . . 0.0 110.229 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.748 HG11 ' HA ' ' A' ' 134' ' ' ASP . 1.5 t . . . . . 0 N--CA 1.499 2.002 0 CA-C-O 120.982 0.42 . . . . 0.0 111.023 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.706 HG21 ' CE2' ' A' ' 95' ' ' TRP . 5.5 t -132.84 148.58 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.021 -1.049 . . . . 0.0 109.253 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.594 ' HA3' ' HA2' ' A' ' 132' ' ' GLY . . . 175.62 -156.89 22.83 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 118.916 -1.611 . . . . 0.0 111.658 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.569 HG13 ' CD1' ' A' ' 199' ' ' LEU . 2.4 t -135.8 150.48 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.727 -0.866 . . . . 0.0 109.494 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.545 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -120.36 152.94 37.18 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.066 -1.021 . . . . 0.0 110.933 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.544 ' CG2' ' HB3' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -125.76 130.08 50.76 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.277 -0.889 . . . . 0.0 110.491 179.828 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.39 -27.79 16.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.53 -0.731 . . . . 0.0 109.539 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.458 HD13 ' O ' ' A' ' 196' ' ' GLY . 2.0 pp -83.4 -12.1 56.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.527 -0.733 . . . . 0.0 109.558 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.557 ' HB3' ' CB ' ' A' ' 129' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.512 -0.742 . . . . 0.0 110.462 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.277 0.56 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.557 ' CB ' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -137.98 123.3 19.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.194 -0.941 . . . . 0.0 109.974 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.445 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 8.4 t -142.29 139.52 31.9 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.279 -0.888 . . . . 0.0 110.112 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 8.4 m0 -124.62 128.51 48.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 108.929 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.594 ' HA2' ' HA3' ' A' ' 107' ' ' GLY . . . -127.05 -162.44 11.18 Favored Glycine 0 N--CA 1.484 1.846 0 C-N-CA 118.821 -1.657 . . . . 0.0 111.266 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.716 ' CZ3' ' CD1' ' A' ' 180' ' ' TYR . 6.4 m0 -126.14 118.12 24.58 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.766 -0.843 . . . . 0.0 110.723 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.748 ' HA ' HG11 ' A' ' 105' ' ' VAL . 13.5 t70 -118.68 111.57 18.69 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.599 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.593 HD13 ' N ' ' A' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.747 0 O-C-N 121.156 -0.965 . . . . 0.0 110.315 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.75 ' CG1' ' HD2' ' A' ' 164' ' ' PRO . 1.3 t . . . . . 0 N--CA 1.493 1.717 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.75 ' HD2' ' CG1' ' A' ' 163' ' ' VAL . 39.2 Cg_endo -65.12 -177.54 0.63 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.557 1.293 . . . . 0.0 111.481 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.566 ' O ' ' OG ' ' A' ' 94' ' ' SER . 0.3 OUTLIER -40.49 -41.6 1.46 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.737 -0.602 . . . . 0.0 111.068 -179.086 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.49 ' C ' ' CD1' ' A' ' 167' ' ' LEU . 8.3 ttt-85 -146.83 155.99 42.77 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.231 -0.918 . . . . 0.0 110.767 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.678 ' N ' ' CD1' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -157.56 158.42 35.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.459 -0.775 . . . . 0.0 110.658 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.548 ' O ' ' O ' ' A' ' 181' ' ' SER . 0.6 OUTLIER -102.99 141.15 36.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.144 -0.972 . . . . 0.0 109.673 -179.758 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.652 ' CG2' ' CE1' ' A' ' 180' ' ' TYR . 9.3 t -119.25 139.52 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.078 -1.014 . . . . 0.0 111.107 -179.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 12.7 t -114.13 109.27 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.419 -0.8 . . . . 0.0 109.241 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.578 ' CD1' ' CD2' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -121.56 108.84 14.07 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.134 -0.979 . . . . 0.0 110.476 -179.225 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 36.9 t0 -120.21 132.69 55.46 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.799 0.809 . . . . 0.0 110.018 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.555 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 7.0 tpt -94.79 -37.72 11.11 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.847 -0.533 . . . . 0.0 109.642 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 173' ' ' MET . 3.9 mt-10 -43.65 -27.19 0.29 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.522 -0.871 . . . . 0.0 108.805 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.555 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.0 OUTLIER -112.25 -26.53 8.73 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.036 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.506 ' O ' HG23 ' A' ' 198' ' ' THR . . . 82.49 23.49 56.29 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.564 ' CG2' ' CD2' ' A' ' 194' ' ' LEU . 0.1 OUTLIER -120.26 124.14 44.92 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.139 -1.213 . . . . 0.0 111.189 -179.559 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.645 ' N ' ' CD1' ' A' ' 178' ' ' LEU . 2.3 mp -135.24 152.45 51.55 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.55 -0.719 . . . . 0.0 109.568 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.534 ' CA ' HD11 ' A' ' 187' ' ' LEU . . . -155.52 177.84 32.46 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.48 -1.343 . . . . 0.0 110.262 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.716 ' CD1' ' CZ3' ' A' ' 133' ' ' TRP . 0.5 OUTLIER -118.77 125.62 50.02 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.499 -1.0 . . . . 0.0 108.836 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.548 ' O ' ' O ' ' A' ' 168' ' ' LEU . 43.5 t -144.18 140.85 29.58 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.084 -1.01 . . . . 0.0 111.135 -179.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.514 HG23 ' HB3' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -95.66 116.33 37.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.478 -0.763 . . . . 0.0 109.319 179.056 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 87.97 -35.07 3.59 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 116.1 39.6 0.87 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 54.9 m -127.28 -5.42 6.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.21 -1.17 . . . . 0.0 110.725 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.531 ' CB ' ' HA ' ' A' ' 181' ' ' SER . 0.3 OUTLIER -85.05 -46.83 10.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.99 -1.069 . . . . 0.0 110.372 -179.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.601 ' O ' ' CE2' ' A' ' 191' ' ' PHE . 2.4 mt -82.09 41.98 0.7 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.181 -0.95 . . . . 0.0 110.024 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -79.89 -91.17 0.44 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.469 ' C ' ' H ' ' A' ' 191' ' ' PHE . 47.6 Cg_endo -73.56 -24.82 15.69 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.012 1.532 . . . . 0.0 110.772 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.525 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -69.07 21.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.48 -0.763 . . . . 0.0 111.7 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.601 ' CE2' ' O ' ' A' ' 187' ' ' LEU . 0.3 OUTLIER -90.27 -38.0 13.71 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.788 -1.195 . . . . 0.0 110.372 179.57 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.67 -13.57 60.64 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.145 -0.972 . . . . 0.0 110.495 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -107.81 -7.69 31.12 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.791 -1.723 . . . . 0.0 108.791 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.649 ' O ' ' N ' ' A' ' 198' ' ' THR . 10.5 tt -78.14 -36.52 47.63 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.584 ' CA ' HG21 ' A' ' 198' ' ' THR . 1.0 OUTLIER -44.07 -44.02 7.22 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.679 -0.638 . . . . 0.0 109.933 179.126 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.458 ' O ' HD13 ' A' ' 112' ' ' LEU . . . -83.29 -26.24 44.62 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.72 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.75 -3.69 57.24 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.699 -0.883 . . . . 0.0 109.934 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' THR . . . . . 0.649 ' N ' ' O ' ' A' ' 194' ' ' LEU . 11.2 p -42.73 135.12 3.02 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.825 0.821 . . . . 0.0 111.722 -177.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.72 ' HG ' ' O ' ' A' ' 197' ' ' ARG . 0.0 OUTLIER -140.15 171.0 14.8 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.68 -0.638 . . . . 0.0 109.381 179.454 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.516 ' HB3' ' HA3' ' A' ' 83' ' ' GLY . 25.1 m-85 -84.56 129.29 57.92 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 120.997 -1.064 . . . . 0.0 110.123 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.562 ' O ' ' CG ' ' A' ' 81' ' ' LYS . 52.8 Cg_endo -83.38 111.52 1.83 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.954 1.502 . . . . 0.0 110.78 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.837 ' HA ' ' C ' ' A' ' 81' ' ' LYS . 12.2 p -133.94 160.61 37.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 109.864 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.626 ' CG1' ' CA ' ' A' ' 80' ' ' GLY . 14.4 p -122.87 157.11 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.731 -1.23 . . . . 0.0 110.924 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 105' ' ' VAL . 0.3 OUTLIER -138.57 127.2 23.41 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.496 -0.752 . . . . 0.0 109.094 178.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -128.15 157.85 39.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.954 -1.091 . . . . 0.0 110.481 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.595 HG21 ' CE3' ' A' ' 207' ' ' TRP . 5.9 p -90.13 -137.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.193 -0.942 . . . . 0.0 110.103 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.638 ' CZ3' ' CB ' ' A' ' 72' ' ' ALA . 10.1 p90 -126.21 58.47 1.36 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.975 -1.078 . . . . 0.0 110.493 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 83.27 -1.54 88.54 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . 0.54 ' CB ' HG11 ' A' ' 206' ' ' VAL . 3.0 tp60 -75.47 -33.21 60.81 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.486 -1.008 . . . . 0.0 110.257 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . 0.659 ' O ' ' C ' ' A' ' 211' ' ' GLN . 48.8 t -124.92 17.24 8.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.337 -0.852 . . . . 0.0 110.259 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.659 ' C ' ' O ' ' A' ' 210' ' ' CYS . 3.2 pt20 0.35 114.46 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.592 0.71 . . . . 0.0 111.859 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.592 HG22 ' CD1' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -118.99 145.19 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.441 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . 0.665 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 20.1 mtm180 -88.61 151.51 22.43 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.094 -1.004 . . . . 0.0 110.144 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.629 ' HB ' ' CE3' ' A' ' 48' ' ' TRP . 0.8 OUTLIER -136.36 123.59 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.315 -0.865 . . . . 0.0 111.231 -179.023 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 92' ' ' GLU . 75.2 ttt180 -131.01 108.63 9.93 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . 0.69 ' CD2' ' CB ' ' A' ' 91' ' ' TRP . 3.2 t80 -118.45 148.94 42.06 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.001 -1.062 . . . . 0.0 111.454 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' MET . . . . . 0.551 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 0.0 OUTLIER -125.25 107.78 11.07 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.522 -0.736 . . . . 0.0 109.706 179.315 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 134.85 -1.61 3.9 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 . . . . . 0 N--CA 1.493 1.676 0 O-C-N 121.062 -1.258 . . . . 0.0 110.116 179.9 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.518 ' HG ' ' N ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 121.127 0.489 . . . . 0.0 109.852 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.538 ' HG3' ' CB ' ' A' ' 73' ' ' GLN . 26.6 mt-10 -49.06 -47.83 44.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.119 -0.988 . . . . 0.0 109.304 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -61.07 -27.5 68.39 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 29' ' ' LEU . 5.9 tp -83.67 -29.36 27.68 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.666 ' C ' ' CD1' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -88.09 -36.52 16.87 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.722 0.772 . . . . 0.0 109.47 179.585 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.499 ' N ' HD11 ' A' ' 33' ' ' LEU . 11.6 p -45.84 -31.17 1.97 Allowed 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.683 0.754 . . . . 0.0 109.748 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.827 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . -91.46 167.21 16.16 Favored Pre-proline 0 C--N 1.298 -1.644 0 O-C-N 121.572 -0.705 . . . . 0.0 109.354 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.44 ' HD2' ' HB2' ' A' ' 35' ' ' ALA . 43.5 Cg_endo -70.18 99.01 0.76 Allowed 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.063 1.56 . . . . 0.0 110.431 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.827 ' HD3' ' O ' ' A' ' 35' ' ' ALA . 47.5 Cg_endo -96.6 -175.45 0.28 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 121.999 1.799 . . . . 0.0 110.397 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 1.017 ' O ' ' N ' ' A' ' 40' ' ' LEU . 39.6 Cg_endo -65.54 153.31 78.79 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.041 1.548 . . . . 0.0 110.043 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.67 ' O ' ' N ' ' A' ' 43' ' ' GLN . 1.9 t0 -15.29 -34.14 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.375 0.607 . . . . 0.0 110.143 -178.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 1.017 ' N ' ' O ' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -29.4 -46.78 0.06 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.435 -0.791 . . . . 0.0 109.551 178.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.632 ' HB ' ' HG2' ' A' ' 37' ' ' PRO . 0.9 OUTLIER -85.05 -31.5 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 118.657 -1.217 . . . . 0.0 109.94 179.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.628 ' N ' ' O ' ' A' ' 39' ' ' ASP . . . -89.89 -43.29 10.7 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.078 -1.014 . . . . 0.0 110.784 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.792 ' HG2' ' HA ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -72.23 -21.12 61.44 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.449 -0.782 . . . . 0.0 110.653 -179.13 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.743 ' HG2' ' HA ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -76.47 -55.31 5.65 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.627 ' CE1' ' O ' ' A' ' 41' ' ' VAL . 16.8 m170 -58.89 -18.21 31.06 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -97.82 -25.33 15.08 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.718 0.77 . . . . 0.0 109.259 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.458 ' HA3' HG21 ' A' ' 59' ' ' VAL . . . -63.85 -114.57 0.01 OUTLIER Glycine 0 N--CA 1.479 1.528 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.76 ' CE2' ' CD1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -103.26 70.88 1.08 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.492 -1.283 . . . . 0.0 111.052 179.208 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.571 ' ND2' ' HB3' ' A' ' 53' ' ' CYS . 1.0 OUTLIER -109.23 116.65 54.79 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.025 -1.047 . . . . 0.0 110.152 178.37 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.829 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 40.7 Cg_endo -69.07 -64.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 N-CA-C 109.432 -1.026 . . . . 0.0 109.432 178.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 1.046 ' HA ' ' CE ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER 175.49 35.22 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 O-C-N 120.976 -1.077 . . . . 0.0 112.02 177.752 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.853 ' HB2' ' HA2' ' A' ' 80' ' ' GLY 0.25 2.2 m-20 -168.58 20.78 0.02 OUTLIER 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.62 -179.451 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.694 ' SG ' ' NH1' ' A' ' 44' ' ' ARG . 1.7 t -102.23 144.57 30.59 Favored 'General case' 0 C--N 1.289 -2.03 0 C-N-CA 118.866 -1.134 . . . . 0.0 111.657 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.646 ' HB3' ' CG2' ' A' ' 75' ' ' THR . 0.0 OUTLIER -103.0 167.43 9.84 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.624 0.726 . . . . 0.0 109.954 179.306 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.743 ' HA ' ' HG2' ' A' ' 44' ' ' ARG . 0.9 OUTLIER -71.35 8.26 1.09 Allowed 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.592 -0.693 . . . . 0.0 111.211 -179.306 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.61 ' ND2' ' O ' ' A' ' 54' ' ' SER . 0.4 OUTLIER -29.02 -32.29 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.923 0.868 . . . . 0.0 109.474 179.414 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.728 ' N ' ' O ' ' A' ' 55' ' ' GLU . 3.7 pt -135.29 167.21 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.797 -0.565 . . . . 0.0 110.107 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.572 ' O ' ' CB ' ' A' ' 67' ' ' GLU . 3.4 t0 -109.01 113.04 25.57 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.038 -1.039 . . . . 0.0 110.61 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.732 ' HB ' ' CE2' ' A' ' 48' ' ' TRP . 1.2 m -129.78 135.8 60.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 O-C-N 121.49 -0.756 . . . . 0.0 109.086 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.792 ' HA ' ' HG2' ' A' ' 43' ' ' GLN . 9.0 tttm -128.68 155.31 45.24 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 118.826 -1.15 . . . . 0.0 112.29 -178.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.545 ' O ' ' C ' ' A' ' 62' ' ' GLY . 1.1 tt0 -71.54 -126.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.616 -0.677 . . . . 0.0 110.476 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.545 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 38.85 52.39 2.55 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 107.808 -2.117 . . . . 0.0 107.808 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.662 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 97.86 49.56 1.76 Allowed Glycine 0 N--CA 1.485 1.924 0 N-CA-C 107.113 -2.395 . . . . 0.0 107.113 -177.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.662 ' C ' ' O ' ' A' ' 63' ' ' GLY . 2.8 tt 1.54 93.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.719 0.771 . . . . 0.0 111.232 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 35.0 t -105.32 113.87 27.71 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.602 0.715 . . . . 0.0 110.364 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.76 ' CD1' ' CE2' ' A' ' 48' ' ' TRP . 3.2 m-85 -82.63 130.33 35.1 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.511 -0.743 . . . . 0.0 109.908 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.572 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 2.4 tm-20 -145.75 121.3 10.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.801 -1.187 . . . . 0.0 109.94 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.532 ' CB ' ' HB2' ' A' ' 207' ' ' TRP . 0.5 OUTLIER -126.03 155.3 41.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.371 -0.831 . . . . 0.0 109.404 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.694 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.8 OUTLIER -130.1 -72.52 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 120.89 -1.131 . . . . 0.0 110.875 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.694 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 57.1 Cg_endo -72.98 -126.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.434 1.228 . . . . 0.0 109.266 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.444 ' O ' ' OE1' ' A' ' 73' ' ' GLN . 2.4 t -140.31 164.24 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.574 -1.329 . . . . 0.0 109.962 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.516 ' CB ' ' HA ' ' A' ' 76' ' ' ASP . . . -59.84 94.24 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.17 -0.956 . . . . 0.0 110.266 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.538 ' CB ' ' HG3' ' A' ' 30' ' ' GLU . 1.2 mp0 -76.08 -90.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.18 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.49 ' OG ' ' N ' ' A' ' 75' ' ' THR . 1.5 t -44.04 -94.64 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.144 -0.972 . . . . 0.0 109.623 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.646 ' CG2' ' HB3' ' A' ' 54' ' ' SER . 7.6 t -88.57 -124.37 0.05 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.148 -0.97 . . . . 0.0 109.189 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.733 ' O ' ' C ' ' A' ' 77' ' ' GLY . 13.2 p30 -140.55 154.63 46.59 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.836 -1.165 . . . . 0.0 110.413 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.733 ' C ' ' O ' ' A' ' 76' ' ' ASP . . . 2.95 -78.2 0.0 OUTLIER Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.664 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 0.1 OUTLIER -158.16 137.42 3.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.507 -0.996 . . . . 0.0 110.389 179.185 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.848 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 0.7 OUTLIER -144.33 150.68 38.2 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.401 0.62 . . . . 0.0 109.779 179.711 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.853 ' HA2' ' HB2' ' A' ' 52' ' ' ASP . . . -165.32 116.23 0.68 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.572 -1.811 . . . . 0.0 108.572 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.597 ' O ' ' C ' ' A' ' 82' ' ' ARG . 4.7 ttpm? -124.59 -75.08 0.6 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.113 -1.227 . . . . 0.0 111.549 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.64 ' HG2' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -25.1 -47.38 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.504 -0.747 . . . . 0.0 111.11 -178.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.64 ' N ' ' HG2' ' A' ' 82' ' ' ARG . . . 34.24 58.95 0.65 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -93.85 108.25 20.05 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.426 -1.043 . . . . 0.0 110.645 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.508 ' CB ' ' HE3' ' A' ' 173' ' ' MET . 0.8 OUTLIER -140.0 162.87 34.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.432 -0.792 . . . . 0.0 110.002 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -118.67 137.91 52.98 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.233 -0.917 . . . . 0.0 109.931 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.511 ' O ' ' HB2' ' A' ' 173' ' ' MET . . . 111.2 158.59 15.32 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.541 HD13 ' CB ' ' A' ' 172' ' ' ASP . 18.6 tp -87.6 133.27 33.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -1.152 . . . . 0.0 110.19 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.493 ' ND1' ' O ' ' A' ' 88' ' ' LEU . 66.3 m-70 -147.11 173.08 12.82 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.135 -0.978 . . . . 0.0 110.064 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.553 ' O ' ' CB ' ' A' ' 217' ' ' MET . . . -154.03 139.99 18.26 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.203 -0.936 . . . . 0.0 109.64 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.554 ' HB3' ' HA ' ' A' ' 216' ' ' TYR . 0.0 OUTLIER -134.74 166.43 22.97 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.968 -1.083 . . . . 0.0 110.442 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.629 ' N ' ' O ' ' A' ' 215' ' ' ARG . 22.5 tt0 -115.16 138.63 50.69 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.545 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.524 ' O ' ' CB ' ' A' ' 167' ' ' LEU . 0.2 OUTLIER -144.02 134.99 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 120.625 -1.297 . . . . 0.0 110.765 -179.662 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.709 ' HB3' ' HA ' ' A' ' 166' ' ' ARG . 0.9 OUTLIER -118.68 126.38 51.79 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.477 -0.764 . . . . 0.0 109.537 179.421 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.746 ' CE3' ' CG1' ' A' ' 106' ' ' VAL . 2.8 t90 -129.9 87.62 51.37 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.179 -0.95 . . . . 0.0 109.93 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.495 ' HA ' ' HA ' ' A' ' 164' ' ' PRO . 51.6 Cg_endo -95.7 109.15 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.776 1.651 . . . . 0.0 110.742 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.7 tt . . . . . 0 N--CA 1.49 1.567 0 O-C-N 120.968 -1.083 . . . . 0.0 110.285 179.311 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.644 ' CG2' ' HA ' ' A' ' 134' ' ' ASP . 0.6 OUTLIER . . . . . 0 N--CA 1.501 2.076 0 CA-C-O 121.04 0.448 . . . . 0.0 111.912 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.746 ' CG1' ' CE3' ' A' ' 95' ' ' TRP . 1.3 p -132.52 141.71 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.935 -1.103 . . . . 0.0 109.999 177.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.554 ' HA3' ' HA3' ' A' ' 132' ' ' GLY . . . 160.93 -149.1 17.89 Favored Glycine 0 N--CA 1.487 2.061 0 C-N-CA 119.628 -1.273 . . . . 0.0 109.959 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 200' ' ' TYR . 1.6 p -148.73 161.3 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.385 -1.068 . . . . 0.0 110.157 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.512 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -133.75 152.24 51.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.129 -0.982 . . . . 0.0 110.714 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.627 ' CG2' ' HB3' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -105.98 128.62 53.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.846 . . . . 0.0 109.862 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.74 -27.2 17.37 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.541 -0.725 . . . . 0.0 109.71 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.501 ' O ' ' C ' ' A' ' 113' ' ' ALA . 3.8 pp -83.95 -12.1 55.87 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.512 -0.742 . . . . 0.0 109.538 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 112' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.719 0 O-C-N 121.72 -0.612 . . . . 0.0 110.625 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 57.7 m . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.416 0.627 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 110' ' ' THR . 6.5 tm-20 -150.07 129.42 12.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.916 . . . . 0.0 110.051 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.476 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 6.9 t -121.14 120.71 36.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.259 -0.901 . . . . 0.0 110.203 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . 0.493 ' O ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -128.86 124.74 36.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.288 -0.883 . . . . 0.0 109.915 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.554 ' HA3' ' HA3' ' A' ' 107' ' ' GLY . . . -172.35 -160.01 20.01 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.591 ' CZ3' HD11 ' A' ' 167' ' ' LEU . 33.9 m0 -109.27 115.09 29.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.214 -1.168 . . . . 0.0 110.192 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.644 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 4.1 t70 -118.31 148.08 42.83 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.416 0.627 . . . . 0.0 110.536 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.495 HG21 HD12 ' A' ' 135' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.504 -0.748 . . . . 0.0 109.404 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.535 ' CG2' HD23 ' A' ' 167' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.495 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 45.4 Cg_endo -72.26 65.97 3.53 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.086 1.571 . . . . 0.0 110.852 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 164' ' ' PRO . 3.6 mt-10 -167.26 -85.74 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.319 -0.863 . . . . 0.0 109.854 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.709 ' HA ' ' HB3' ' A' ' 94' ' ' SER . 23.6 ttp180 -152.65 156.22 38.82 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.367 -0.833 . . . . 0.0 110.29 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.591 HD11 ' CZ3' ' A' ' 133' ' ' TRP . 0.2 OUTLIER -139.8 133.91 31.03 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.272 -0.892 . . . . 0.0 110.7 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.411 ' O ' ' O ' ' A' ' 181' ' ' SER . 0.4 OUTLIER -103.83 130.78 51.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.329 -0.857 . . . . 0.0 109.228 179.285 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.651 ' CG2' ' CE1' ' A' ' 180' ' ' TYR . 2.7 t -124.57 144.47 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.966 -1.084 . . . . 0.0 111.087 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.472 HG23 ' CD2' ' A' ' 187' ' ' LEU . 2.3 t -119.84 129.31 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.555 -0.716 . . . . 0.0 109.079 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.517 ' CD1' ' HB3' ' A' ' 178' ' ' LEU . 12.4 tp -133.09 109.82 9.77 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.93 -1.106 . . . . 0.0 110.808 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.541 ' CB ' HD13 ' A' ' 88' ' ' LEU . 5.2 t0 -99.51 139.08 35.7 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.393 -0.817 . . . . 0.0 109.203 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.511 ' HB2' ' O ' ' A' ' 87' ' ' GLY . 23.9 mmt -98.95 -44.62 6.26 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.227 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.522 ' HG2' ' N ' ' A' ' 175' ' ' GLU . 3.8 pt-20 -43.48 -24.96 0.12 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.12 -0.987 . . . . 0.0 108.565 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.522 ' N ' ' HG2' ' A' ' 174' ' ' GLU . 3.5 tp10 -115.12 -26.28 7.75 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.506 ' O ' ' OG1' ' A' ' 198' ' ' THR . . . 78.06 27.24 58.56 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.58 HG23 ' HB ' ' A' ' 198' ' ' THR . 1.4 p -113.09 139.94 48.29 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.414 -1.051 . . . . 0.0 111.313 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.545 ' CD1' HG22 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -146.62 154.05 41.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.533 -0.729 . . . . 0.0 109.73 179.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.463 ' CA ' HD22 ' A' ' 187' ' ' LEU . . . -141.52 163.69 26.79 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.651 ' CE1' ' CG2' ' A' ' 169' ' ' VAL . 0.9 OUTLIER -118.63 118.31 31.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -1.146 . . . . 0.0 109.484 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.538 ' CB ' ' HB2' ' A' ' 186' ' ' TYR . 2.7 t -144.64 159.05 43.45 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.33 -0.856 . . . . 0.0 110.085 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.581 HD13 ' CD2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -96.08 116.4 37.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.443 -0.785 . . . . 0.0 109.316 179.191 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 72.76 5.71 65.15 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.86 43.31 18.08 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' THR . . . . . 0.494 ' N ' ' OG ' ' A' ' 181' ' ' SER . 95.4 m -116.18 -1.38 12.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.199 -1.177 . . . . 0.0 110.561 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.581 ' CD2' HD13 ' A' ' 182' ' ' ILE . 0.1 OUTLIER -111.22 -25.08 9.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.153 -0.967 . . . . 0.0 110.359 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.602 ' O ' ' CE2' ' A' ' 191' ' ' PHE . 4.0 mp -84.46 48.29 1.49 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.252 -0.905 . . . . 0.0 110.105 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -106.86 -73.51 0.85 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.6 -29.31 13.29 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.979 1.515 . . . . 0.0 111.167 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.645 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -73.42 12.27 0.63 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.267 -0.896 . . . . 0.0 111.429 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.602 ' CE2' ' O ' ' A' ' 187' ' ' LEU . 0.3 OUTLIER -90.17 -10.68 43.58 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.141 -0.974 . . . . 0.0 109.802 179.132 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.74 -20.22 27.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.381 -0.824 . . . . 0.0 110.908 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.534 ' O ' ' HB3' ' A' ' 197' ' ' ARG . . . -111.15 -13.32 13.67 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.645 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 3.7 tt -74.56 -19.99 60.12 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.496 ' O ' HG23 ' A' ' 198' ' ' THR . 0.0 OUTLIER -59.64 -32.08 70.11 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.715 -0.615 . . . . 0.0 109.53 179.119 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -106.83 -25.36 6.24 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.592 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -82.93 -3.3 56.88 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.855 0.836 . . . . 0.0 109.944 179.653 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' THR . . . . . 0.58 ' HB ' HG23 ' A' ' 177' ' ' THR . 0.4 OUTLIER -41.0 136.85 1.38 Allowed 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 122.096 0.951 . . . . 0.0 111.24 -178.1 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.665 ' CD1' ' CG2' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -141.85 171.31 14.23 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.372 -179.653 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.725 ' O ' HG23 ' A' ' 108' ' ' VAL . 97.1 m-85 -86.84 129.7 51.39 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.15 -0.969 . . . . 0.0 109.523 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.52 ' HA ' ' HB ' ' A' ' 108' ' ' VAL . 42.0 Cg_endo -68.24 121.12 8.08 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.863 1.454 . . . . 0.0 111.19 -179.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.577 ' CB ' ' HA ' ' A' ' 81' ' ' LYS . 97.0 p -133.81 142.06 47.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.342 -0.849 . . . . 0.0 110.939 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.644 HG23 ' CG2' ' A' ' 106' ' ' VAL . 1.1 p -146.4 160.51 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.391 -0.818 . . . . 0.0 109.391 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' SER . . . . . 0.51 ' O ' ' HH2' ' A' ' 95' ' ' TRP . 0.3 OUTLIER -160.35 127.19 4.3 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.415 -0.803 . . . . 0.0 109.645 179.683 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.462 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -114.13 162.1 16.92 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.834 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.585 ' CG1' ' N ' ' A' ' 207' ' ' TRP . 1.1 t -105.69 -179.13 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.587 -0.696 . . . . 0.0 110.47 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.585 ' N ' ' CG1' ' A' ' 206' ' ' VAL . 23.0 p90 -94.14 -33.07 13.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.332 -0.855 . . . . 0.0 110.593 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 207' ' ' TRP . . . -44.21 171.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 211' ' ' GLN . 0.0 OUTLIER -40.58 -49.24 2.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.35 -1.088 . . . . 0.0 110.572 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . 0.518 ' SG ' ' CG1' ' A' ' 206' ' ' VAL . 6.9 p -36.83 93.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.461 -0.774 . . . . 0.0 110.436 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.526 ' N ' ' O ' ' A' ' 209' ' ' GLN . 2.1 pt20 -115.41 123.69 49.29 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.233 -0.917 . . . . 0.0 110.107 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.647 ' O ' ' CZ ' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -101.53 144.52 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.599 -0.688 . . . . 0.0 109.701 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . 0.662 ' HB2' ' HB2' ' A' ' 94' ' ' SER . 0.0 OUTLIER -87.64 159.57 18.49 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.194 -0.941 . . . . 0.0 110.279 -179.078 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.673 HD12 ' CA ' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -138.33 124.65 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -0.944 . . . . 0.0 111.362 -178.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.629 ' O ' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -130.94 137.49 49.31 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . 0.554 ' HA ' ' HB3' ' A' ' 91' ' ' TRP . 5.5 t80 -119.35 150.64 39.82 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.792 -1.192 . . . . 0.0 111.121 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' MET . . . . . 0.553 ' CB ' ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -131.05 107.95 9.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.354 -0.841 . . . . 0.0 110.044 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 72.47 85.18 0.22 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.514 ' HG3' ' CZ ' ' A' ' 216' ' ' TYR . 31.4 tt0 . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.285 -1.127 . . . . 0.0 110.14 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.514 HD21 ' NE2' ' A' ' 73' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.176 0.512 . . . . 0.0 109.771 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.546 ' HA ' ' CD2' ' A' ' 33' ' ' LEU . 6.4 tm-20 -47.61 -35.47 9.31 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.294 -0.879 . . . . 0.0 109.356 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -60.49 -24.99 65.73 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.277 -0.889 . . . . 0.0 108.856 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -83.35 -33.87 25.74 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.594 ' CD2' ' HG3' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -78.72 -36.65 43.01 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.861 0.839 . . . . 0.0 109.311 179.274 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.574 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 1.2 t -80.74 -7.39 59.35 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 121.171 0.51 . . . . 0.0 109.937 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.635 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . . . -37.96 -65.32 0.37 Allowed Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.44 -0.787 . . . . 0.0 110.538 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.722 ' C ' ' HD3' ' A' ' 38' ' ' PRO . 47.8 Cg_endo -73.25 143.05 34.78 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.773 1.407 . . . . 0.0 109.928 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -98.58 53.32 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 121.813 1.675 . . . . 0.0 112.568 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.722 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 52.5 Cg_endo -77.1 150.3 29.35 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 122.89 0.942 . . . . 0.0 109.845 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.664 ' C ' ' NE2' ' A' ' 43' ' ' GLN . 2.1 t0 -39.71 -32.56 0.15 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.056 -1.028 . . . . 0.0 108.81 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.725 ' O ' ' CB ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -40.95 -45.22 2.52 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.314 0.578 . . . . 0.0 109.628 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.643 ' N ' ' CD1' ' A' ' 40' ' ' LEU . 10.0 t -68.01 -26.82 35.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.017 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 39' ' ' ASP . . . -89.41 -43.94 10.53 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.018 -1.051 . . . . 0.0 111.703 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.665 ' O ' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -80.59 -24.77 38.93 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.24 -1.384 . . . . 0.0 108.929 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.725 ' CB ' ' O ' ' A' ' 40' ' ' LEU . 21.4 ttt-85 -64.28 -57.71 8.64 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.222 1.011 . . . . 0.0 108.739 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.68 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 54.3 m170 -53.57 -17.26 1.97 Allowed 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.703 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -95.9 -31.75 12.97 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.132 -1.427 . . . . 0.0 111.155 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.61 -60.26 0.51 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 106.845 -2.502 . . . . 0.0 106.845 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 1.07 ' CD1' HG22 ' A' ' 59' ' ' VAL 0.267 0.3 OUTLIER -98.37 71.27 2.04 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.171 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.795 ' O ' ' HB3' ' A' ' 53' ' ' CYS . 0.0 OUTLIER -61.91 168.31 3.77 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.701 -0.624 . . . . 0.0 112.104 -178.874 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.693 ' O ' ' O ' ' A' ' 53' ' ' CYS . 37.4 Cg_endo -61.38 -61.37 0.17 Allowed 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 121.572 1.515 . . . . 0.0 113.17 -178.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.771 ' HE2' ' OD1' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -67.67 -74.35 0.12 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.045 -1.659 . . . . 0.0 108.323 179.745 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.719 ' N ' ' HA3' ' A' ' 80' ' ' GLY . 0.9 OUTLIER -38.12 -27.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.203 -0.936 . . . . 0.0 109.529 179.15 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.795 ' HB3' ' O ' ' A' ' 49' ' ' ASN . 0.2 OUTLIER -138.48 129.99 27.6 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 118.736 -1.186 . . . . 0.0 111.951 -179.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.92 ' H ' ' HA ' ' A' ' 78' ' ' VAL . 0.9 OUTLIER -58.28 123.5 16.28 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.2 179.278 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.594 ' HG3' ' CD2' ' A' ' 33' ' ' LEU . 3.6 pt-20 -69.78 -24.48 63.51 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.439 -0.788 . . . . 0.0 109.693 179.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.737 ' ND2' ' HB3' ' A' ' 54' ' ' SER . 3.7 m-80 -28.96 -36.03 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.683 0.754 . . . . 0.0 110.874 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.586 ' N ' ' O ' ' A' ' 55' ' ' GLU . 2.6 pt -116.66 166.69 10.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 O-C-N 121.705 -0.622 . . . . 0.0 110.773 -178.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.521 ' OD1' ' CG ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -107.59 116.16 31.44 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 1.07 HG22 ' CD1' ' A' ' 48' ' ' TRP . 6.3 p -130.01 128.72 65.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 CA-C-O 121.409 0.623 . . . . 0.0 111.55 -178.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.692 ' HG2' ' N ' ' A' ' 61' ' ' GLU . 5.2 tttm -136.96 157.92 45.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.342 -0.849 . . . . 0.0 110.715 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.788 ' N ' ' CH2' ' A' ' 48' ' ' TRP . 19.0 tp10 -42.54 -111.65 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.678 -0.639 . . . . 0.0 111.238 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.56 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 36.67 45.78 1.05 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.669 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 93.14 55.58 1.58 Allowed Glycine 0 N--CA 1.487 2.058 0 N-CA-C 107.369 -2.292 . . . . 0.0 107.369 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.669 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.2 OUTLIER 1.11 92.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.792 0.806 . . . . 0.0 111.182 -178.216 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.508 ' C ' HG23 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -140.66 134.88 31.06 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.542 -179.787 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.819 ' CE2' ' HD1' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -102.18 142.79 32.87 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.142 178.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.555 ' O ' ' HB ' ' A' ' 57' ' ' ILE . 67.9 tt0 -114.38 121.32 43.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 110.174 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.496 ' HB2' HG23 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -121.23 149.8 42.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.477 -0.764 . . . . 0.0 109.966 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.678 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -127.89 -71.37 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.063 -1.023 . . . . 0.0 110.797 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.678 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 55.8 Cg_endo -73.86 -108.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.35 1.184 . . . . 0.0 110.177 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.9 t -140.48 164.35 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.638 -1.289 . . . . 0.0 110.27 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.407 ' HA ' ' HB3' ' A' ' 56' ' ' ASN . . . -99.63 87.58 3.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -0.867 . . . . 0.0 109.931 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.551 ' CG ' ' N ' ' A' ' 74' ' ' SER . 2.5 pt20 -70.39 -44.58 67.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.258 -0.901 . . . . 0.0 110.642 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.551 ' N ' ' CG ' ' A' ' 73' ' ' GLN . 0.4 OUTLIER -55.84 -74.8 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.161 -0.962 . . . . 0.0 109.969 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.704 HG23 ' HB3' ' A' ' 54' ' ' SER . 0.3 OUTLIER -129.61 -140.37 0.23 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.308 -0.87 . . . . 0.0 109.405 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.666 ' O ' ' N ' ' A' ' 78' ' ' VAL . 22.7 p-10 -141.1 154.75 46.07 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.976 -1.077 . . . . 0.0 110.788 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.631 ' O ' ' CG1' ' A' ' 78' ' ' VAL . . . 34.78 -95.16 0.01 OUTLIER Glycine 0 N--CA 1.487 2.055 0 N-CA-C 106.715 -2.554 . . . . 0.0 106.715 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.92 ' HA ' ' H ' ' A' ' 54' ' ' SER . 31.0 m -158.2 119.42 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 O-C-N 121.872 -0.781 . . . . 0.0 109.823 176.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.69 ' O ' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -147.32 133.87 19.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.361 -0.837 . . . . 0.0 110.982 -179.147 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.719 ' HA3' ' N ' ' A' ' 52' ' ' ASP . . . -143.36 166.14 26.88 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 178.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 0.7 OUTLIER -140.2 75.62 1.52 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.345 -1.091 . . . . 0.0 110.078 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.531 ' CZ ' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -145.53 -108.73 0.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.312 -0.867 . . . . 0.0 110.128 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.531 ' N ' ' CZ ' ' A' ' 82' ' ' ARG . . . 70.42 80.78 0.28 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -134.24 104.38 6.15 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.285 -1.127 . . . . 0.0 110.21 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.577 ' HB2' ' CE1' ' A' ' 89' ' ' HIS . 11.4 p -140.03 164.87 28.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.153 -0.967 . . . . 0.0 110.255 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.451 ' HA ' ' CG ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -119.75 135.93 54.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.295 -0.878 . . . . 0.0 109.972 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.34 -119.94 5.15 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.488 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 7.8 tp -128.33 138.1 52.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -1.147 . . . . 0.0 110.327 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.577 ' CE1' ' HB2' ' A' ' 85' ' ' SER . 43.2 m-70 -147.06 164.81 31.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.273 -0.892 . . . . 0.0 109.992 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.607 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -163.13 152.95 15.55 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.191 -0.943 . . . . 0.0 110.302 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.715 ' CD1' ' CZ ' ' A' ' 216' ' ' TYR . 0.0 OUTLIER -134.62 170.34 15.94 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.079 -1.013 . . . . 0.0 109.891 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.659 ' N ' ' O ' ' A' ' 215' ' ' ARG . 0.6 OUTLIER -140.62 147.54 39.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.368 -0.832 . . . . 0.0 110.672 -179.505 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.554 ' CD1' HG13 ' A' ' 214' ' ' ILE . 2.2 mm -144.68 154.25 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.34 -0.85 . . . . 0.0 110.024 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.72 ' O ' ' HD3' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -151.2 124.38 8.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.338 -0.851 . . . . 0.0 109.614 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.602 ' CB ' ' CD1' ' A' ' 135' ' ' ILE . 34.6 m95 -106.84 89.42 4.32 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.267 -0.896 . . . . 0.0 110.561 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.72 ' HD3' ' O ' ' A' ' 94' ' ' SER . 52.7 Cg_endo -91.92 124.37 0.76 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.496 1.464 . . . . 0.0 111.013 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.503 ' O ' HD12 ' A' ' 97' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.756 0 O-C-N 121.277 -0.889 . . . . 0.0 109.599 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.817 ' CG1' ' HA ' ' A' ' 134' ' ' ASP . 0.6 OUTLIER . . . . . 0 N--CA 1.499 2.021 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.615 HG12 ' CZ ' ' A' ' 180' ' ' TYR . 4.9 p -145.85 167.5 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 120.416 -1.428 . . . . 0.0 111.905 -178.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.666 ' CA ' ' HA3' ' A' ' 132' ' ' GLY . . . 164.57 146.63 4.83 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.602 ' CG2' ' HB2' ' A' ' 199' ' ' LEU . 7.8 p -94.82 155.19 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.116 -1.226 . . . . 0.0 109.691 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.665 ' C ' ' HB3' ' A' ' 199' ' ' LEU . . . -132.6 149.02 52.37 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.679 -0.809 . . . . 0.0 111.006 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.573 HG22 ' CB ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -106.28 131.05 53.98 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.399 -0.813 . . . . 0.0 109.946 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -84.97 -26.4 27.17 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.444 -0.785 . . . . 0.0 109.418 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.47 -12.14 54.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.419 -0.8 . . . . 0.0 109.352 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.474 ' HB2' ' HG3' ' A' ' 129' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.378 -0.827 . . . . 0.0 110.444 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.282 0.563 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.517 ' O ' ' CA ' ' A' ' 109' ' ' ALA . 5.5 mt-10 -140.58 123.9 16.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.892 . . . . 0.0 110.111 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.528 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 1.9 t -121.06 121.17 37.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.474 -0.766 . . . . 0.0 110.354 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . 0.437 ' CD1' ' O ' ' A' ' 130' ' ' SER . 33.3 m0 -130.94 131.8 44.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.172 -0.955 . . . . 0.0 110.243 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.666 ' HA3' ' CA ' ' A' ' 107' ' ' GLY . . . -172.73 -152.47 8.68 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.619 ' CZ3' HD21 ' A' ' 167' ' ' LEU . 43.5 m0 -112.79 113.27 25.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.161 -1.199 . . . . 0.0 111.11 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.817 ' HA ' ' CG1' ' A' ' 105' ' ' VAL . 18.9 m-20 -120.96 148.12 44.53 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.735 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.602 ' CD1' ' CB ' ' A' ' 95' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.049 -1.032 . . . . 0.0 110.454 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.785 ' N ' ' CD ' ' A' ' 164' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 119.647 -0.216 . . . . 0.0 111.076 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.785 ' CD ' ' N ' ' A' ' 163' ' ' VAL . 43.4 Cg_endo -72.12 59.3 2.99 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 N-CA-C 109.574 -0.971 . . . . 0.0 109.574 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.513 ' O ' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER 179.91 -76.33 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.361 0.601 . . . . 0.0 109.454 -179.732 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.528 ' HB2' ' NH1' ' A' ' 166' ' ' ARG . 3.0 ttm105 -152.0 156.17 39.45 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.477 -0.765 . . . . 0.0 110.233 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.658 HD13 ' CZ ' ' A' ' 180' ' ' TYR . 0.0 OUTLIER -159.05 138.63 11.65 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.181 -0.949 . . . . 0.0 110.261 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.651 ' N ' ' CD2' ' A' ' 167' ' ' LEU . 2.9 tt -112.86 121.38 44.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 109.829 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.659 ' CG2' ' CE1' ' A' ' 180' ' ' TYR . 3.6 t -101.43 146.72 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.956 -1.09 . . . . 0.0 110.759 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.5 t -134.26 108.56 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.502 -0.749 . . . . 0.0 109.667 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.638 ' CB ' ' CZ2' ' A' ' 91' ' ' TRP . 0.0 OUTLIER -118.29 121.16 39.74 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.044 -1.035 . . . . 0.0 110.006 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 173' ' ' MET . 46.1 t0 -111.44 137.29 49.42 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.278 -0.889 . . . . 0.0 109.896 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.509 ' N ' ' OD1' ' A' ' 172' ' ' ASP . 2.0 tmt? -95.23 -40.21 9.68 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.6 -0.687 . . . . 0.0 109.931 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.474 ' C ' ' O ' ' A' ' 173' ' ' MET . 0.3 OUTLIER -41.77 -27.81 0.13 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.189 -0.945 . . . . 0.0 108.858 179.209 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.637 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.6 OUTLIER -114.42 -27.32 7.6 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.202 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.501 ' O ' HG23 ' A' ' 198' ' ' THR . . . 83.83 23.88 51.28 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 108.559 -1.816 . . . . 0.0 108.559 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.637 ' OG1' ' HB3' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -113.17 121.71 45.32 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.311 -1.111 . . . . 0.0 111.243 -179.444 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.583 ' N ' ' CD2' ' A' ' 178' ' ' LEU . 0.2 OUTLIER -124.87 151.28 45.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.401 -0.812 . . . . 0.0 109.671 179.03 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.468 ' O ' HG11 ' A' ' 169' ' ' VAL . . . -149.31 166.89 29.59 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.659 ' CE1' ' CG2' ' A' ' 169' ' ' VAL . 0.7 OUTLIER -123.58 117.86 26.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.408 -1.054 . . . . 0.0 108.439 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.563 ' O ' ' CD2' ' A' ' 167' ' ' LEU . 35.2 t -145.66 155.63 43.13 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.971 -1.081 . . . . 0.0 110.724 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.584 HG23 ' CZ3' ' A' ' 133' ' ' TRP . 0.0 OUTLIER -95.7 116.3 37.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.453 -0.779 . . . . 0.0 108.941 178.554 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 64.42 9.65 38.26 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.26 42.97 33.56 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 3.5 m -121.99 -2.43 9.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.17 -1.194 . . . . 0.0 110.705 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.607 ' CD2' ' CZ2' ' A' ' 133' ' ' TRP . 0.1 OUTLIER -101.28 -71.12 0.72 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.193 -0.942 . . . . 0.0 110.413 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.601 ' O ' ' CD2' ' A' ' 191' ' ' PHE . 3.9 mm? -67.0 47.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 110.258 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 186' ' ' TYR . . . -71.23 -73.4 0.8 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.461 ' C ' ' H ' ' A' ' 191' ' ' PHE . 49.7 Cg_endo -75.29 -25.48 11.39 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.922 1.486 . . . . 0.0 111.145 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.531 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -68.31 23.79 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.448 -0.783 . . . . 0.0 112.2 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.601 ' CD2' ' O ' ' A' ' 187' ' ' LEU . 2.1 m-85 -90.43 -38.68 13.12 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.66 -1.275 . . . . 0.0 110.536 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -13.61 61.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.198 -0.938 . . . . 0.0 110.162 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -106.43 -8.95 32.22 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.104 -1.999 . . . . 0.0 108.104 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.631 HD23 ' CG2' ' A' ' 177' ' ' THR . 8.7 tt -73.1 -42.59 62.8 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.892 -0.77 . . . . 0.0 109.071 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.543 ' CA ' HG21 ' A' ' 198' ' ' THR . 0.0 OUTLIER -45.27 -42.48 9.63 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.472 -0.767 . . . . 0.0 110.012 179.755 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.468 ' N ' ' HD2' ' A' ' 195' ' ' LYS . . . -85.06 -23.75 47.56 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.798 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -91.04 -4.47 56.33 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.693 -0.886 . . . . 0.0 110.082 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' THR . . . . . 0.598 ' N ' ' O ' ' A' ' 194' ' ' LEU . 24.5 p -44.56 129.49 6.78 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 121.471 0.653 . . . . 0.0 111.742 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.798 ' HG ' ' O ' ' A' ' 197' ' ' ARG . 0.0 OUTLIER -140.39 171.82 13.61 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.482 -0.761 . . . . 0.0 109.849 179.49 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.504 ' C ' ' CG2' ' A' ' 108' ' ' VAL . 3.8 m-85 -83.9 129.55 58.6 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.012 -1.055 . . . . 0.0 109.963 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.588 ' HB3' ' CH2' ' A' ' 91' ' ' TRP . 49.6 Cg_endo -76.18 124.86 8.15 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 124.055 1.555 . . . . 0.0 111.787 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 80' ' ' GLY . 52.1 m -133.68 160.42 37.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.443 -0.786 . . . . 0.0 109.282 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.513 ' CG1' ' O ' ' A' ' 52' ' ' ASP . 1.1 t -119.42 162.41 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.835 -1.166 . . . . 0.0 110.608 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' SER . . . . . 0.645 ' O ' ' N ' ' A' ' 105' ' ' VAL . 1.6 m -160.68 138.44 9.55 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.696 ' HB2' HG22 ' A' ' 78' ' ' VAL . . . -144.77 129.13 17.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.753 -1.217 . . . . 0.0 111.582 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.47 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 1.0 OUTLIER -38.56 160.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-O 121.178 0.514 . . . . 0.0 110.135 178.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.449 ' N ' HG11 ' A' ' 206' ' ' VAL . 0.9 OUTLIER -50.68 -43.73 57.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.172 -0.955 . . . . 0.0 109.584 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 170.73 134.75 1.8 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -164.61 -63.28 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -1.133 . . . . 0.0 110.559 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . 0.544 ' O ' ' C ' ' A' ' 211' ' ' GLN . 0.5 OUTLIER -136.29 85.55 2.16 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.339 -0.851 . . . . 0.0 110.623 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.544 ' C ' ' O ' ' A' ' 210' ' ' CYS . 1.0 OUTLIER -26.59 126.54 0.06 Allowed 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 122.233 1.016 . . . . 0.0 111.608 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.657 ' CG2' ' O ' ' A' ' 94' ' ' SER . 0.7 OUTLIER -113.16 143.78 22.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.064 179.119 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . 0.618 ' HA ' HD21 ' A' ' 64' ' ' LEU . 40.5 mtm180 -88.65 144.4 26.32 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.024 -1.048 . . . . 0.0 111.104 -178.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.572 HG21 ' CD2' ' A' ' 64' ' ' LEU . 4.2 tt -144.59 139.51 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.507 -0.745 . . . . 0.0 110.446 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.659 ' O ' ' N ' ' A' ' 92' ' ' GLU . 4.2 mtt180 -130.41 109.18 10.53 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . 0.715 ' CZ ' ' CD1' ' A' ' 91' ' ' TRP . 4.3 t80 -117.33 140.37 49.65 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.945 -1.097 . . . . 0.0 111.588 -178.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -136.68 114.98 11.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.818 -0.551 . . . . 0.0 109.996 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 123.38 17.98 3.14 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.505 ' HG3' ' NH1' ' A' ' 82' ' ' ARG . 4.9 tt0 . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.236 -1.155 . . . . 0.0 110.142 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.486 ' HG ' ' N ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.313 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.486 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 3.5 tt0 -55.02 -43.86 74.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.223 -0.923 . . . . 0.0 109.117 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -52.35 -24.46 7.64 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.431 ' O ' HD11 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -83.11 -32.23 26.83 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.838 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.733 ' C ' ' CD1' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -85.44 -38.55 18.53 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.759 0.79 . . . . 0.0 109.313 179.211 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.559 ' N ' HD13 ' A' ' 33' ' ' LEU . 37.6 t -45.85 -25.51 0.53 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.449 0.642 . . . . 0.0 109.817 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.662 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . -80.68 -164.54 0.05 OUTLIER Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 121.634 -0.666 . . . . 0.0 109.623 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.643 ' CD ' ' CB ' ' A' ' 35' ' ' ALA . 53.2 Cg_endo -95.95 74.61 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.679 1.586 . . . . 0.0 110.96 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.662 ' HD3' ' O ' ' A' ' 35' ' ' ALA . 44.4 Cg_endo -69.29 157.28 61.88 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.458 1.241 . . . . 0.0 110.323 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.735 ' O ' ' N ' ' A' ' 40' ' ' LEU . 50.0 Cg_endo -79.92 152.33 21.88 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 124.103 1.58 . . . . 0.0 111.716 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.719 ' O ' ' CG ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER 4.13 60.35 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 122.845 1.307 . . . . 0.0 110.792 -179.288 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.735 ' N ' ' O ' ' A' ' 38' ' ' PRO . 0.2 OUTLIER -144.63 -45.3 0.24 Allowed 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.144 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.663 ' O ' ' CD2' ' A' ' 45' ' ' HIS . 2.1 t -86.85 -35.1 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 119.076 -1.049 . . . . 0.0 108.575 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.527 ' O ' ' CB ' ' A' ' 46' ' ' HIS . . . -88.55 -36.53 16.32 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.462 -0.774 . . . . 0.0 110.183 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.669 ' HG2' ' HA ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -76.42 -22.98 53.99 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.414 -0.804 . . . . 0.0 110.469 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.621 ' NH2' ' HB ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -84.45 -47.58 10.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.233 -0.917 . . . . 0.0 109.965 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.663 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 40.6 m-70 -73.35 -16.43 61.35 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.535 -0.728 . . . . 0.0 109.424 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.527 ' CB ' ' O ' ' A' ' 42' ' ' ALA . 3.2 t60 -96.7 -31.02 12.89 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.639 0.733 . . . . 0.0 109.085 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 46' ' ' HIS . . . -61.08 -115.47 0.01 OUTLIER Glycine 0 N--CA 1.479 1.534 0 N-CA-C 108.114 -1.995 . . . . 0.0 108.114 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.866 ' HB2' HD12 ' A' ' 214' ' ' ILE . 6.4 p-90 -103.31 71.3 1.1 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.573 -1.251 . . . . 0.0 111.194 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.593 ' ND2' ' HB3' ' A' ' 53' ' ' CYS . 0.9 OUTLIER -108.93 114.57 58.24 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 120.873 -1.142 . . . . 0.0 110.183 178.397 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.6 ' HG2' ' CA ' ' A' ' 80' ' ' GLY . 39.1 Cg_endo -67.35 -63.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.767 0 N-CA-C 109.323 -1.068 . . . . 0.0 109.323 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.983 ' HA ' ' CE ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER 176.02 31.48 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.781 -1.2 . . . . 0.0 112.912 177.423 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.874 ' HB3' ' HG2' ' A' ' 79' ' ' ARG 0.256 0.2 OUTLIER -162.22 19.72 0.1 Allowed 'General case' 0 C--N 1.265 -3.087 0 CA-C-O 122.16 0.981 . . . . 0.0 109.134 -179.207 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.593 ' HB3' ' ND2' ' A' ' 49' ' ' ASN . 18.9 t -102.29 128.64 48.76 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-O 122.336 1.065 . . . . 0.0 111.203 -177.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.602 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 0.1 OUTLIER -91.86 166.72 12.59 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.894 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.706 ' O ' ' N ' ' A' ' 57' ' ' ILE . 1.7 pm0 -75.98 6.25 5.46 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.619 -0.675 . . . . 0.0 110.846 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.623 ' ND2' ' O ' ' A' ' 76' ' ' ASP . 0.1 OUTLIER -28.33 -33.37 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.182 0 CA-C-O 122.065 0.936 . . . . 0.0 109.882 179.256 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.711 ' HB ' ' HG2' ' A' ' 68' ' ' ARG . 0.4 OUTLIER -134.64 169.02 22.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.863 -0.523 . . . . 0.0 109.724 -178.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.547 ' O ' ' CB ' ' A' ' 67' ' ' GLU . 3.4 t70 -107.53 106.93 17.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.821 -1.174 . . . . 0.0 111.034 -178.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.614 HG12 ' CZ2' ' A' ' 48' ' ' TRP . 2.1 m -122.62 135.54 62.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.669 ' HA ' ' HG2' ' A' ' 43' ' ' GLN . 11.1 ttpp -127.42 155.41 43.7 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.632 -1.293 . . . . 0.0 112.09 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.52 ' HA ' HD11 ' A' ' 64' ' ' LEU . 19.0 tt0 -65.17 -128.89 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.741 -0.599 . . . . 0.0 110.397 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 41.05 47.02 4.21 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.679 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 102.76 50.59 1.08 Allowed Glycine 0 N--CA 1.486 2.017 0 N-CA-C 107.904 -2.078 . . . . 0.0 107.904 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.679 ' C ' ' O ' ' A' ' 63' ' ' GLY . 2.3 mm? 1.14 81.35 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.763 0.792 . . . . 0.0 110.806 -178.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.413 ' N ' ' O ' ' A' ' 63' ' ' GLY . 6.3 t -99.29 114.96 28.08 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.686 -0.634 . . . . 0.0 109.976 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.864 ' CE1' ' CE2' ' A' ' 48' ' ' TRP . 1.9 m-85 -82.83 129.9 35.06 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.461 -0.774 . . . . 0.0 109.539 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.547 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 1.2 tm-20 -137.37 121.58 18.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.868 -1.145 . . . . 0.0 110.339 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.711 ' HG2' ' HB ' ' A' ' 57' ' ' ILE . 9.2 mtp180 -115.57 154.76 28.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 0.0 109.55 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.655 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 16.5 ttt85 -95.72 -69.08 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 120.956 -1.09 . . . . 0.0 109.859 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.655 ' HD3' ' HB3' ' A' ' 69' ' ' ARG . 57.6 Cg_endo -77.48 -123.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 N-CA-C 108.713 -1.303 . . . . 0.0 108.713 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 73' ' ' GLN . 2.6 t -140.07 164.33 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.52 -1.363 . . . . 0.0 109.589 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.64 ' CB ' ' CZ3' ' A' ' 207' ' ' TRP . . . -41.66 92.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.176 -0.953 . . . . 0.0 110.314 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.552 ' N ' ' O ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -179.97 -31.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.221 -0.924 . . . . 0.0 110.294 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.463 ' C ' ' O ' ' A' ' 73' ' ' GLN . 10.4 p -40.12 -50.61 2.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.343 -0.848 . . . . 0.0 110.228 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.541 HG21 ' N ' ' A' ' 76' ' ' ASP . 7.5 m -169.03 -84.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.269 -0.894 . . . . 0.0 110.031 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.623 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 66.2 t0 -140.13 113.19 8.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.221 -0.924 . . . . 0.0 110.36 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.533 ' O ' ' O ' ' A' ' 76' ' ' ASP . . . -42.59 -91.41 0.01 OUTLIER Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.046 -2.022 . . . . 0.0 108.046 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.621 ' HB ' ' NH2' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -144.15 139.39 24.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.123 -1.222 . . . . 0.0 109.88 179.302 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.874 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 29.3 ttp180 -145.65 148.08 32.69 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.844 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.691 ' HA2' ' HB2' ' A' ' 52' ' ' ASP . . . -136.99 124.6 3.15 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.491 ' HB3' ' OD1' ' A' ' 52' ' ' ASP . 6.1 ttpm? -134.26 -71.38 0.5 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.855 -1.379 . . . . 0.0 111.74 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.559 ' CZ ' ' NZ ' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -58.32 -93.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.19 -0.944 . . . . 0.0 110.799 -178.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 51.13 70.04 0.97 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.679 -1.769 . . . . 0.0 108.679 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.575 ' C ' ' CD1' ' A' ' 84' ' ' TYR . 1.0 OUTLIER -94.57 142.16 27.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.341 -1.094 . . . . 0.0 110.495 -179.308 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.577 ' HB3' ' CE1' ' A' ' 89' ' ' HIS . 1.4 m -135.87 174.34 10.73 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.548 -0.72 . . . . 0.0 109.886 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.579 ' O ' ' CE1' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -126.62 138.51 53.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.18 -0.95 . . . . 0.0 110.7 -179.746 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 173' ' ' MET . . . 92.15 -119.46 5.8 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.497 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 4.5 tt -128.74 139.63 52.11 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.676 -0.896 . . . . 0.0 110.123 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.579 ' CE1' ' O ' ' A' ' 86' ' ' ARG . 18.3 m-70 -147.23 162.38 39.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.162 -0.961 . . . . 0.0 110.186 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 217' ' ' MET . . . -160.65 138.66 9.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.219 -0.926 . . . . 0.0 109.949 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.663 ' CZ2' ' CG1' ' A' ' 169' ' ' VAL . 1.3 p90 -134.89 170.75 15.39 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.242 -0.911 . . . . 0.0 110.36 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.608 ' N ' ' O ' ' A' ' 215' ' ' ARG . 38.1 mt-10 -141.82 152.58 43.82 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.637 -0.664 . . . . 0.0 110.497 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.535 HG23 ' N ' ' A' ' 94' ' ' SER . 10.1 mt -144.48 154.2 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.902 . . . . 0.0 110.57 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.55 ' OG ' ' HB2' ' A' ' 213' ' ' ARG . 1.2 m -119.35 133.5 55.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.354 -0.841 . . . . 0.0 109.469 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.737 ' CD1' ' HB2' ' A' ' 164' ' ' PRO 0.261 2.3 t-105 -136.52 88.12 20.46 Favored Pre-proline 0 C--N 1.297 -1.697 0 O-C-N 121.441 -0.787 . . . . 0.0 110.332 -178.759 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.54 ' HD2' ' O ' ' A' ' 211' ' ' GLN . 51.7 Cg_endo -91.99 107.02 0.24 Allowed 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.095 1.05 . . . . 0.0 110.682 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.566 ' HB2' ' HG2' ' A' ' 164' ' ' PRO . 5.6 tt . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.09 -1.006 . . . . 0.0 109.934 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.727 HG21 ' O ' ' A' ' 105' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.623 ' CG2' ' CG2' ' A' ' 203' ' ' VAL . 34.3 t -148.76 169.15 2.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.156 -0.965 . . . . 0.0 110.267 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.676 ' HA2' ' HA3' ' A' ' 132' ' ' GLY . . . -175.35 131.41 1.93 Allowed Glycine 0 N--CA 1.483 1.797 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.682 ' CG1' HD13 ' A' ' 199' ' ' LEU . 0.3 OUTLIER -102.41 143.41 14.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.618 -0.93 . . . . 0.0 109.628 -179.569 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.534 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -109.79 129.76 55.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.128 -0.982 . . . . 0.0 110.704 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.548 ' CG2' ' O ' ' A' ' 197' ' ' ARG . 0.0 OUTLIER -110.55 131.74 54.79 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.309 -0.869 . . . . 0.0 110.065 179.65 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -91.25 -27.13 18.64 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.502 0.668 . . . . 0.0 109.238 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.426 ' CD2' ' O ' ' A' ' 196' ' ' GLY . 1.8 pp -82.15 -12.59 58.08 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.505 -0.747 . . . . 0.0 109.492 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.477 ' CB ' ' HB3' ' A' ' 129' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.404 -0.81 . . . . 0.0 110.091 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.1 p . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.29 0.567 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.477 ' HB3' ' CB ' ' A' ' 113' ' ' ALA . 21.6 tt0 -150.11 131.08 14.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.225 -0.922 . . . . 0.0 109.874 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.4 t -120.41 119.6 33.54 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.195 -0.941 . . . . 0.0 110.503 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -133.47 141.99 48.06 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.471 -0.768 . . . . 0.0 109.192 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.676 ' HA3' ' HA2' ' A' ' 107' ' ' GLY . . . -173.27 -138.92 2.74 Favored Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.336 -1.411 . . . . 0.0 110.652 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.731 ' CZ3' ' CG ' ' A' ' 180' ' ' TYR . 45.9 m0 -113.11 118.18 34.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.392 -1.063 . . . . 0.0 110.611 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.53 ' O ' ' CG2' ' A' ' 135' ' ' ILE . 4.2 p30 -118.06 126.5 52.41 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.359 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.53 ' CG2' ' O ' ' A' ' 134' ' ' ASP . 7.3 pt . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.338 -0.851 . . . . 0.0 110.055 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.864 ' N ' ' HD3' ' A' ' 164' ' ' PRO . 4.0 p . . . . . 0 N--CA 1.485 1.302 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.864 ' HD3' ' N ' ' A' ' 163' ' ' VAL . 55.2 Cg_endo -93.78 152.08 2.28 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.609 1.32 . . . . 0.0 111.22 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 94' ' ' SER . 5.7 tp10 178.83 -70.33 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.412 -0.805 . . . . 0.0 109.663 178.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -147.88 141.47 25.49 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.579 -0.7 . . . . 0.0 109.378 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.575 HD22 ' CZ ' ' A' ' 180' ' ' TYR . 0.5 OUTLIER -162.52 157.14 21.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.128 -0.982 . . . . 0.0 110.455 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.504 ' C ' ' CD2' ' A' ' 168' ' ' LEU . 6.5 tt -120.68 134.8 55.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.332 -0.855 . . . . 0.0 110.15 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.671 ' CG2' ' CE1' ' A' ' 180' ' ' TYR . 94.1 t -109.97 128.62 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.272 -0.893 . . . . 0.0 110.412 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 4.7 t -103.75 110.47 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.343 -0.848 . . . . 0.0 109.815 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.53 ' CD1' ' HB3' ' A' ' 178' ' ' LEU . 13.7 tp -121.5 106.06 11.05 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.18 -0.95 . . . . 0.0 109.983 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -111.43 136.8 50.06 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.283 -0.885 . . . . 0.0 110.477 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.538 ' CE ' ' CE2' ' A' ' 84' ' ' TYR . 12.5 tpp -92.3 -40.07 11.14 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 120.412 -0.515 . . . . 0.0 109.702 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 173' ' ' MET . 15.2 tt0 -41.95 -28.89 0.19 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.279 -0.888 . . . . 0.0 108.91 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.508 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.0 OUTLIER -109.4 -25.83 10.32 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.539 ' O ' ' OG1' ' A' ' 198' ' ' THR . . . 78.96 24.63 61.48 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.643 HG22 ' CD2' ' A' ' 194' ' ' LEU . 1.1 p -125.38 148.74 48.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.206 -1.173 . . . . 0.0 111.112 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.541 ' CD1' ' HG3' ' A' ' 201' ' ' PRO . 0.4 OUTLIER -148.1 154.33 40.06 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.525 -0.734 . . . . 0.0 109.952 179.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -149.25 164.68 29.34 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.731 ' CG ' ' CZ3' ' A' ' 133' ' ' TRP . 0.4 OUTLIER -118.86 121.88 41.03 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.14 -1.212 . . . . 0.0 109.859 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.511 ' HB2' ' CB ' ' A' ' 187' ' ' LEU . 11.4 t -113.01 124.5 52.78 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.371 -0.83 . . . . 0.0 110.078 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.58 HD13 ' CH2' ' A' ' 133' ' ' TRP . 0.0 OUTLIER -104.21 116.82 48.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.594 -0.691 . . . . 0.0 109.715 179.756 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 72.93 4.59 62.84 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.174 -1.571 . . . . 0.0 109.174 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 68.65 47.49 55.97 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' THR . . . . . 0.506 HG23 ' CE1' ' A' ' 186' ' ' TYR . 46.3 m -137.07 -27.09 1.0 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -1.173 . . . . 0.0 110.802 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.506 ' CE1' HG23 ' A' ' 185' ' ' THR . 21.8 m-85 -116.8 76.55 1.04 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.949 -1.095 . . . . 0.0 110.676 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.562 ' HG ' ' CE1' ' A' ' 191' ' ' PHE . 0.6 OUTLIER 179.7 29.41 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.529 0.68 . . . . 0.0 109.196 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.54 ' H ' ' HD2' ' A' ' 189' ' ' PRO . . . -105.48 -62.01 0.63 Allowed Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.915 -1.136 . . . . 0.0 111.447 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.54 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 43.5 Cg_endo -70.24 -31.6 18.12 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.685 1.361 . . . . 0.0 111.791 -178.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.604 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -71.83 9.2 0.95 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.077 -1.014 . . . . 0.0 111.367 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.562 ' CE1' ' HG ' ' A' ' 187' ' ' LEU . 1.4 m-85 -90.53 -10.78 42.28 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.278 -0.889 . . . . 0.0 110.161 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . 0.503 ' HA ' ' NE ' ' A' ' 192' ' ' ARG . 0.2 OUTLIER -90.12 -15.21 32.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.353 -0.842 . . . . 0.0 110.191 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 197' ' ' ARG . . . -112.07 -17.01 8.62 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.018 -2.033 . . . . 0.0 108.018 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.708 ' HA ' ' CD ' ' A' ' 197' ' ' ARG . 3.8 tt -65.52 -26.31 67.84 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.831 -0.805 . . . . 0.0 109.134 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.546 ' HA ' HG23 ' A' ' 177' ' ' THR . 0.0 OUTLIER -54.51 -26.25 30.51 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.599 -0.688 . . . . 0.0 109.773 179.242 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.426 ' O ' ' CD2' ' A' ' 112' ' ' LEU . . . -118.87 -17.62 5.0 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.748 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.32 -3.96 57.43 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.459 -1.024 . . . . 0.0 110.322 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' THR . . . . . 0.589 ' HB ' HG22 ' A' ' 177' ' ' THR . 0.5 OUTLIER -42.1 132.3 3.28 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 122.325 1.059 . . . . 0.0 112.052 -178.094 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.748 ' HG ' ' O ' ' A' ' 197' ' ' ARG . 0.1 OUTLIER -142.61 171.32 14.21 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.431 178.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.579 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 2.6 m-85 -84.89 128.43 60.6 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 120.814 -1.179 . . . . 0.0 109.817 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.601 ' CA ' HG13 ' A' ' 108' ' ' VAL . 55.7 Cg_endo -87.43 142.33 6.04 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 124.022 1.538 . . . . 0.0 112.4 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.56 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 43.1 m -133.91 134.92 43.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.677 -0.639 . . . . 0.0 109.5 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.623 ' CG2' ' CG2' ' A' ' 106' ' ' VAL . 4.0 p -119.5 161.31 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.811 -1.181 . . . . 0.0 110.335 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' SER . . . . . 0.659 ' O ' HG21 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -160.51 161.48 32.77 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.971 0.891 . . . . 0.0 110.822 179.687 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.498 ' O ' HG12 ' A' ' 78' ' ' VAL . . . -150.65 165.92 31.93 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 121.956 0.884 . . . . 0.0 110.868 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.651 ' CG2' ' CE3' ' A' ' 207' ' ' TRP . 0.3 OUTLIER -98.79 -152.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.037 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.681 ' HB3' ' HD3' ' A' ' 68' ' ' ARG . 48.7 p90 -91.07 -140.66 0.17 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.123 -0.986 . . . . 0.0 110.415 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.526 ' O ' ' NE2' ' A' ' 211' ' ' GLN . . . -65.91 0.29 6.06 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . 0.627 ' HB2' ' CE2' ' A' ' 207' ' ' TRP . 0.0 OUTLIER -66.09 -28.26 68.69 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.287 -1.125 . . . . 0.0 110.407 -179.818 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . 0.671 ' O ' ' C ' ' A' ' 211' ' ' GLN . 22.9 p -145.52 14.9 1.43 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 110.853 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.671 ' C ' ' O ' ' A' ' 210' ' ' CYS . 0.0 OUTLIER -6.04 117.74 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.655 0.741 . . . . 0.0 111.466 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.678 HG12 ' CZ ' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -121.88 144.77 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.76 -0.588 . . . . 0.0 109.985 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . 0.55 ' HB2' ' OG ' ' A' ' 94' ' ' SER . 0.8 OUTLIER -88.07 171.8 10.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.217 -0.927 . . . . 0.0 110.229 -179.482 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.866 HD12 ' HB2' ' A' ' 48' ' ' TRP . 0.7 OUTLIER -143.36 118.53 4.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-O 122.013 0.911 . . . . 0.0 111.805 -178.346 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.608 ' O ' ' N ' ' A' ' 92' ' ' GLU . 66.4 mtt-85 -130.62 108.91 10.26 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . 0.627 ' CE2' ' HB3' ' A' ' 91' ' ' TRP . 3.2 t80 -105.82 149.3 26.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.094 -1.004 . . . . 0.0 111.094 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' MET . . . . . 0.465 ' O ' ' O ' ' A' ' 90' ' ' ALA . 1.0 OUTLIER -131.5 121.05 23.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.48 -0.762 . . . . 0.0 110.154 179.745 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 132.58 -32.82 2.74 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.236 -1.155 . . . . 0.0 110.226 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.091 0.472 . . . . 0.0 110.08 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.472 ' HA ' HD22 ' A' ' 33' ' ' LEU . 24.8 pt-20 -47.06 -35.12 6.51 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.304 -0.872 . . . . 0.0 109.579 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.469 ' N ' ' HG3' ' A' ' 30' ' ' GLU . 1.1 tm-20 -63.91 -23.51 67.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.446 -0.784 . . . . 0.0 108.992 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.5 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -83.29 -33.88 25.86 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.645 ' HG ' ' N ' ' A' ' 34' ' ' SER . 0.3 OUTLIER -73.55 -35.98 65.59 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 122.058 0.933 . . . . 0.0 108.917 179.293 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.645 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 23.5 t -71.24 -12.57 61.53 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.605 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.634 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . . . -45.31 -64.97 0.72 Allowed Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.19 -0.944 . . . . 0.0 110.268 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.738 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 50.0 Cg_endo -72.8 147.8 45.15 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.75 1.395 . . . . 0.0 110.15 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.494 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 54.7 Cg_endo -99.3 42.84 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.001 1.801 . . . . 0.0 112.912 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.738 ' HD3' ' HB2' ' A' ' 36' ' ' PRO . 50.8 Cg_endo -76.23 151.13 33.83 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 122.908 0.951 . . . . 0.0 110.303 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.71 ' O ' ' HB3' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -28.62 -36.08 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.587 -0.696 . . . . 0.0 110.659 179.676 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.684 ' O ' ' HB3' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -49.91 -48.52 51.6 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.786 -1.197 . . . . 0.0 110.501 -179.605 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.626 ' O ' ' CD2' ' A' ' 45' ' ' HIS . 41.1 t -83.93 -32.55 8.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 121.161 -0.962 . . . . 0.0 110.296 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 46' ' ' HIS . . . -89.72 -41.13 12.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.092 -1.005 . . . . 0.0 111.731 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.71 ' HB3' ' O ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -78.46 -20.54 50.73 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.095 -1.003 . . . . 0.0 110.39 -179.215 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.684 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 7.6 tpt180 -76.42 -55.02 5.93 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.626 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 38.3 m-70 -65.73 -17.19 64.44 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.519 ' HB2' ' O ' ' A' ' 42' ' ' ALA . 74.1 t60 -96.77 -17.15 20.44 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.697 0.76 . . . . 0.0 109.355 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.97 -112.3 0.12 Allowed Glycine 0 N--CA 1.477 1.367 0 N-CA-C 108.156 -1.977 . . . . 0.0 108.156 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.806 ' HB3' ' CD1' ' A' ' 214' ' ' ILE . 4.6 m95 -102.97 70.93 1.11 Allowed 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.849 -1.14 . . . . 0.0 110.844 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.638 ' ND2' ' HB3' ' A' ' 53' ' ' CYS . 0.9 OUTLIER -108.41 111.97 61.22 Favored Pre-proline 0 C--N 1.302 -1.491 0 O-C-N 121.139 -0.976 . . . . 0.0 109.694 178.017 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.832 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 40.9 Cg_endo -68.03 -63.68 0.05 OUTLIER 'Trans proline' 0 C--N 1.301 -1.949 0 O-C-N 123.291 1.153 . . . . 0.0 109.764 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 1.105 ' HA ' ' CE ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER 176.07 36.98 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 122.502 1.144 . . . . 0.0 111.561 178.059 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.77 ' HB3' ' HG2' ' A' ' 79' ' ' ARG 0.255 0.7 OUTLIER -169.8 23.23 0.02 OUTLIER 'General case' 0 C--N 1.269 -2.921 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.331 -179.385 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.638 ' HB3' ' ND2' ' A' ' 49' ' ' ASN . 8.3 t -101.27 127.42 47.88 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-O 122.523 1.154 . . . . 0.0 111.337 -177.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.553 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 0.6 OUTLIER -90.11 166.23 13.52 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.337 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.644 ' HG3' ' CD1' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -74.45 1.97 10.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.693 -0.629 . . . . 0.0 110.981 -179.146 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.591 ' ND2' ' O ' ' A' ' 76' ' ' ASP . 0.0 OUTLIER -31.64 -32.63 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.642 0.734 . . . . 0.0 109.833 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.632 ' N ' ' O ' ' A' ' 55' ' ' GLU . 4.6 pt -136.34 166.39 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.562 -0.711 . . . . 0.0 110.41 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.576 ' O ' ' CB ' ' A' ' 67' ' ' GLU . 1.0 OUTLIER -109.21 121.59 45.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 110.458 -179.263 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.617 HG13 ' CD1' ' A' ' 66' ' ' PHE . 58.4 t -130.32 132.69 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.287 -0.883 . . . . 0.0 110.21 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.668 ' HB2' ' HG3' ' A' ' 43' ' ' GLN . 3.1 ttpt -135.26 155.07 51.25 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.218 -0.926 . . . . 0.0 110.397 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 63' ' ' GLY . 4.2 tt0 -74.87 -118.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.351 -0.843 . . . . 0.0 110.203 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 42.08 28.81 0.53 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.674 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 129.65 60.55 0.1 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.682 ' CD2' ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER 0.44 84.83 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.751 -0.852 . . . . 0.0 111.172 -179.716 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 31.5 t -126.65 114.82 18.54 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.162 -0.961 . . . . 0.0 111.005 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.617 ' CD1' HG13 ' A' ' 59' ' ' VAL . 3.6 m-85 -90.23 124.72 35.1 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.576 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 3.4 tt0 -125.37 147.53 49.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.737 -1.227 . . . . 0.0 110.516 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.563 ' HB3' ' CG2' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -136.09 115.68 12.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.434 -0.791 . . . . 0.0 109.777 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.65 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -68.94 -65.99 1.12 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.024 -1.048 . . . . 0.0 110.255 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.65 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 56.1 Cg_endo -70.49 -143.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.924 1.487 . . . . 0.0 109.354 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.484 ' O ' ' N ' ' A' ' 73' ' ' GLN . 3.5 t -139.6 164.11 24.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 O-C-N 121.319 -0.863 . . . . 0.0 109.965 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.539 ' HB1' ' CD1' ' A' ' 207' ' ' TRP . . . -66.92 59.25 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 0.0 110.113 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.484 ' N ' ' O ' ' A' ' 71' ' ' VAL . 4.7 mt-30 -53.38 -92.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.181 -0.949 . . . . 0.0 110.378 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.71 27.86 1.48 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.93 . . . . 0.0 110.367 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.462 ' CG2' ' OE1' ' A' ' 30' ' ' GLU . 1.4 m -103.5 -134.19 0.32 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.19 -0.944 . . . . 0.0 109.761 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.591 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 22.8 t70 -140.67 113.14 8.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 110.363 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.554 ' O ' ' ND2' ' A' ' 56' ' ' ASN . . . -51.44 -90.96 0.01 OUTLIER Glycine 0 N--CA 1.488 2.105 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 178.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.553 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 0.1 OUTLIER -132.29 134.68 59.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.296 -1.12 . . . . 0.0 109.181 178.405 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.77 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 45.1 ttp180 -146.13 161.99 38.95 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.813 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.745 ' HA2' ' HB2' ' A' ' 52' ' ' ASP . . . -152.94 117.04 0.78 Allowed Glycine 0 N--CA 1.495 2.62 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.488 ' HG3' ' HB3' ' A' ' 202' ' ' SER . 2.5 ttmp? -155.75 -117.26 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.959 -1.318 . . . . 0.0 111.262 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.654 ' HD3' ' H ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -48.53 -17.19 0.14 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.336 -0.853 . . . . 0.0 111.481 -179.131 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.654 ' H ' ' HD3' ' A' ' 82' ' ' ARG . . . -77.5 36.24 1.58 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.589 ' CE1' HD23 ' A' ' 171' ' ' LEU . 0.6 OUTLIER -111.49 156.61 21.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.105 -1.233 . . . . 0.0 110.405 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.29 177.83 5.08 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.443 -0.786 . . . . 0.0 110.667 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.533 ' HA ' ' CB ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -99.45 -173.47 2.48 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.394 -0.816 . . . . 0.0 110.024 -179.669 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.414 ' H ' ' CB ' ' A' ' 173' ' ' MET . . . 100.48 160.65 28.04 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.8 tt -87.66 114.22 24.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.172 -1.193 . . . . 0.0 110.479 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -147.41 173.22 12.84 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.378 -0.826 . . . . 0.0 109.935 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.562 ' O ' ' O ' ' A' ' 217' ' ' MET . . . -151.63 148.85 28.46 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.149 -0.969 . . . . 0.0 109.79 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.636 ' CZ3' ' CG1' ' A' ' 169' ' ' VAL . 0.0 OUTLIER -134.75 161.33 35.48 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.846 -1.159 . . . . 0.0 110.216 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.59 ' N ' ' O ' ' A' ' 215' ' ' ARG . 0.0 OUTLIER -109.47 124.84 51.72 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.515 179.642 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.546 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 1.6 mp -126.14 154.31 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.14 -0.975 . . . . 0.0 110.385 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.551 ' CA ' ' O ' ' A' ' 165' ' ' GLU . 0.0 OUTLIER -135.52 119.85 17.89 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.541 -0.724 . . . . 0.0 109.415 179.667 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.7 ' HH2' ' O ' ' A' ' 204' ' ' SER . 2.3 t-105 -128.61 89.14 50.21 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.106 -0.997 . . . . 0.0 110.87 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.565 ' HB3' ' CB ' ' A' ' 165' ' ' GLU . 50.5 Cg_endo -88.06 115.09 0.91 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.097 1.578 . . . . 0.0 110.277 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.471 ' O ' HD13 ' A' ' 97' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.049 -1.032 . . . . 0.0 110.311 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 204' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 121.447 0.641 . . . . 0.0 111.88 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.69 HG23 ' CG ' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -151.53 118.82 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.555 -0.715 . . . . 0.0 109.521 178.286 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.516 ' HA3' ' HA3' ' A' ' 132' ' ' GLY . . . 161.62 -154.34 25.3 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 118.887 -1.625 . . . . 0.0 110.725 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.575 ' HB ' ' CD1' ' A' ' 199' ' ' LEU . 58.2 t -138.77 157.92 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.687 -0.89 . . . . 0.0 109.785 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.564 ' CB ' ' HA ' ' A' ' 130' ' ' SER . . . -133.93 153.38 51.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.043 -1.036 . . . . 0.0 110.436 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.606 ' CG2' ' HB3' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -101.08 128.28 47.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.234 -0.917 . . . . 0.0 109.817 179.618 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.21 -27.76 17.46 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.509 -0.744 . . . . 0.0 109.588 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.444 ' O ' ' C ' ' A' ' 113' ' ' ALA . 0.8 OUTLIER -81.7 -12.54 58.6 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.411 -0.806 . . . . 0.0 109.57 179.312 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.537 ' CB ' ' HB2' ' A' ' 129' ' ' GLU . . . . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.515 -0.741 . . . . 0.0 110.263 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.26 0.553 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.537 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . 0.3 OUTLIER -150.0 129.9 13.38 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 110.107 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.564 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 47.8 t -120.36 119.94 34.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.332 -0.855 . . . . 0.0 110.181 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . 0.48 ' O ' ' O ' ' A' ' 108' ' ' VAL . 0.8 OUTLIER -129.69 124.74 34.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.374 -0.829 . . . . 0.0 109.906 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.516 ' HA3' ' HA3' ' A' ' 107' ' ' GLY . . . 174.92 -133.23 2.4 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.611 ' CD2' HG21 ' A' ' 163' ' ' VAL . 54.8 m0 -110.68 113.65 26.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.122 -1.223 . . . . 0.0 110.694 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.408 ' C ' HD13 ' A' ' 135' ' ' ILE . 6.0 t0 -117.97 134.84 54.58 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.741 -0.599 . . . . 0.0 110.263 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.588 ' CD1' ' N ' ' A' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.275 -0.891 . . . . 0.0 110.308 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.674 ' CG1' ' HD2' ' A' ' 164' ' ' PRO . 53.8 t . . . . . 0 N--CA 1.494 1.743 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.674 ' HD2' ' CG1' ' A' ' 163' ' ' VAL . 38.1 Cg_endo -64.48 134.15 40.25 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.808 1.425 . . . . 0.0 110.771 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.565 ' CB ' ' HB3' ' A' ' 96' ' ' PRO . 24.4 pt-20 -41.23 -25.22 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.604 -0.685 . . . . 0.0 111.317 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 164' ' ' PRO . 0.0 OUTLIER -116.08 138.38 51.29 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.944 -1.097 . . . . 0.0 110.698 -179.388 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 93' ' ' ILE . 2.5 pp -158.9 154.64 26.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.615 -0.678 . . . . 0.0 109.924 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' A' ' 181' ' ' SER . 18.0 tp -112.78 141.08 47.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.116 -0.99 . . . . 0.0 110.128 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.664 ' CG2' ' CE2' ' A' ' 180' ' ' TYR . 6.5 t -124.06 136.3 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.147 -0.97 . . . . 0.0 110.486 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.503 ' O ' ' CG1' ' A' ' 170' ' ' VAL . 9.8 p -115.3 121.4 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.449 -0.782 . . . . 0.0 109.377 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.589 HD23 ' CE1' ' A' ' 84' ' ' TYR . 0.0 OUTLIER -127.16 107.82 10.36 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.042 -1.036 . . . . 0.0 110.104 -179.512 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -120.01 129.49 54.28 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.876 0.846 . . . . 0.0 109.903 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.533 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -98.77 -39.46 8.62 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.576 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 173' ' ' MET . 0.1 OUTLIER -46.37 -26.47 0.84 Allowed 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.439 -0.905 . . . . 0.0 108.698 178.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.535 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 3.3 tt0 -110.16 -27.43 9.14 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 198' ' ' THR . . . 84.15 23.36 52.11 Favored Glycine 0 N--CA 1.483 1.77 0 N-CA-C 108.756 -1.738 . . . . 0.0 108.756 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.61 ' HA ' ' CD2' ' A' ' 194' ' ' LEU . 0.1 OUTLIER -118.46 116.96 27.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.166 -1.197 . . . . 0.0 111.402 -179.55 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.571 ' N ' ' CD1' ' A' ' 178' ' ' LEU . 3.3 mp -130.6 153.71 48.62 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.421 -0.799 . . . . 0.0 109.501 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.49 ' C ' ' CD2' ' A' ' 187' ' ' LEU . . . -161.93 166.96 36.45 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.14 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.664 ' CE2' ' CG2' ' A' ' 169' ' ' VAL . 1.1 t80 -125.01 118.28 25.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.439 -1.036 . . . . 0.0 109.85 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.525 ' OG ' ' N ' ' A' ' 186' ' ' TYR . 0.6 OUTLIER -145.15 165.25 28.86 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.334 -0.854 . . . . 0.0 110.072 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.575 HD12 ' CE2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -110.18 116.6 52.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 O-C-N 121.501 -0.749 . . . . 0.0 109.543 179.195 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 79.6 -1.72 76.27 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 87.9 39.99 6.82 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' ' 186' ' ' TYR . 32.1 m -94.38 -86.84 0.27 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.214 -1.168 . . . . 0.0 110.65 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.575 ' CE2' HD12 ' A' ' 182' ' ' ILE . 22.5 m-85 -40.15 -40.74 1.15 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.263 -0.898 . . . . 0.0 110.78 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.509 ' N ' HD12 ' A' ' 187' ' ' LEU . 5.8 mp -80.56 47.2 0.92 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.08 -1.013 . . . . 0.0 109.948 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -108.72 -82.15 1.38 Allowed Glycine 0 N--CA 1.491 2.3 0 C-N-CA 119.853 -1.165 . . . . 0.0 110.326 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.429 ' C ' ' H ' ' A' ' 191' ' ' PHE . 46.0 Cg_endo -71.98 -28.39 16.28 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.926 1.488 . . . . 0.0 111.081 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.594 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -72.67 20.71 0.07 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.27 -0.894 . . . . 0.0 111.363 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.429 ' H ' ' C ' ' A' ' 189' ' ' PRO . 1.6 m-85 -90.2 -13.55 35.29 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.928 -1.107 . . . . 0.0 110.325 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . 0.519 ' HA ' ' NE ' ' A' ' 192' ' ' ARG . 0.1 OUTLIER -90.28 -14.69 32.74 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.317 -0.865 . . . . 0.0 110.563 -179.76 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' A' ' 197' ' ' ARG . . . -111.28 -18.91 7.84 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.706 ' HA ' ' HD2' ' A' ' 197' ' ' ARG . 6.2 tt -61.95 -33.72 74.81 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.799 -0.824 . . . . 0.0 108.818 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.518 ' HA ' ' CG2' ' A' ' 177' ' ' THR . 0.0 OUTLIER -45.59 -29.84 1.32 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.553 -0.717 . . . . 0.0 109.529 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -115.59 -21.16 5.18 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.706 ' HD2' ' HA ' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -90.99 -9.24 46.72 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.661 -0.905 . . . . 0.0 109.666 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' THR . . . . . 0.549 ' CB ' ' O ' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -43.5 148.95 0.29 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.015 0.912 . . . . 0.0 111.961 -177.785 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.606 ' HB3' ' CG2' ' A' ' 110' ' ' THR . 0.1 OUTLIER -140.59 169.81 16.96 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.511 179.519 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.547 ' N ' ' O ' ' A' ' 109' ' ' ALA . 19.0 m-85 -84.75 129.92 54.96 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.017 -1.052 . . . . 0.0 109.499 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.573 ' HG3' ' CD1' ' A' ' 171' ' ' LEU . 41.4 Cg_endo -67.87 125.13 12.71 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.805 1.424 . . . . 0.0 110.407 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 57.5 p -133.29 152.27 51.92 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.253 -0.904 . . . . 0.0 111.195 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.561 ' CG1' ' HG3' ' A' ' 50' ' ' PRO . 4.0 p -158.93 160.6 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.648 -0.657 . . . . 0.0 109.532 179.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' SER . . . . . 0.7 ' O ' ' HH2' ' A' ' 95' ' ' TRP . 0.3 OUTLIER -160.38 130.32 5.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.307 -0.87 . . . . 0.0 110.319 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.544 ' CB ' HG12 ' A' ' 78' ' ' VAL . . . -108.74 150.53 27.46 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.031 -1.043 . . . . 0.0 110.398 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.508 HG13 ' N ' ' A' ' 207' ' ' TRP . 1.2 t -91.19 159.97 2.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.542 0.687 . . . . 0.0 110.712 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.539 ' CD1' ' HB1' ' A' ' 72' ' ' ALA . 16.7 p-90 -82.54 46.61 1.08 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.286 -0.884 . . . . 0.0 109.646 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -108.88 -128.95 5.8 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . 0.791 ' O ' ' O ' ' A' ' 210' ' ' CYS . 1.0 OUTLIER -127.51 -22.59 3.62 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.357 -1.084 . . . . 0.0 110.548 -179.538 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . 0.791 ' O ' ' O ' ' A' ' 209' ' ' GLN . 31.4 p 1.6 -133.42 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.032 0.444 . . . . 0.0 111.875 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.552 ' HB3' ' HG2' ' A' ' 96' ' ' PRO . 0.0 OUTLIER 178.88 33.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.847 -1.158 . . . . 0.0 110.808 -179.595 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.543 HG22 ' CE3' ' A' ' 95' ' ' TRP . 2.5 p -86.63 124.96 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.032 -1.042 . . . . 0.0 110.267 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . 0.542 ' HG2' HD23 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -96.97 170.51 9.1 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.624 -0.672 . . . . 0.0 110.868 -179.3 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.806 ' CD1' ' HB3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -132.25 122.37 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.244 -0.91 . . . . 0.0 110.612 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.59 ' O ' ' N ' ' A' ' 92' ' ' GLU . 0.5 OUTLIER -130.63 140.15 50.4 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.563 -0.711 . . . . 0.0 109.96 179.464 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . 0.577 ' HA ' ' HB3' ' A' ' 91' ' ' TRP . 8.2 t80 -118.93 150.92 39.08 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.257 -0.902 . . . . 0.0 110.924 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' MET . . . . . 0.562 ' O ' ' O ' ' A' ' 90' ' ' ALA . 9.0 tpp -134.99 108.01 7.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.933 . . . . 0.0 110.244 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 128.44 -9.48 6.53 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.486 ' HB2' ' CD1' ' A' ' 216' ' ' TYR . 3.9 mm-40 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.203 -1.175 . . . . 0.0 110.044 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.578 ' HG ' ' N ' ' A' ' 30' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.019 0.438 . . . . 0.0 110.122 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.578 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 19.1 pt-20 -47.99 -29.78 3.75 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.095 -1.003 . . . . 0.0 108.538 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -64.59 -23.95 67.43 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.543 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -82.68 -37.25 25.07 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.826 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.603 ' CD2' ' HG2' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -71.39 -38.28 71.49 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.823 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.672 ' O ' ' O ' ' A' ' 35' ' ' ALA . 1.8 m -78.45 -7.08 57.01 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.252 0.548 . . . . 0.0 110.007 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.85 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . . . -49.43 -153.73 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.689 -0.632 . . . . 0.0 110.645 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.85 ' HD2' ' CB ' ' A' ' 35' ' ' ALA . 38.1 Cg_endo -65.3 -170.74 0.17 Allowed 'Trans proline' 0 N--CA 1.488 1.177 0 O-C-N 122.734 0.86 . . . . 0.0 110.349 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.624 ' CD ' ' HB2' ' A' ' 36' ' ' PRO . 52.0 Cg_endo -97.17 50.2 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.525 1.483 . . . . 0.0 113.413 -178.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.743 ' HD2' ' O ' ' A' ' 36' ' ' PRO . 46.7 Cg_endo -73.07 150.67 48.66 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 N-CA-C 108.671 -1.319 . . . . 0.0 108.671 178.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.644 ' C ' ' O ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -21.32 -52.93 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.108 -0.995 . . . . 0.0 111.23 -179.171 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.717 ' O ' ' HB3' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -54.38 -45.97 72.95 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 120.786 -1.196 . . . . 0.0 110.096 -179.344 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.719 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 6.2 t -86.99 -33.6 7.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 O-C-N 121.021 -1.049 . . . . 0.0 110.29 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 37' ' ' PRO . . . -90.91 -39.54 12.23 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.003 -1.06 . . . . 0.0 112.435 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.773 ' OE1' ' HA ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -83.0 -20.07 35.79 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.936 -1.102 . . . . 0.0 109.988 -178.832 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.717 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -80.45 -46.67 15.53 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.242 -0.911 . . . . 0.0 109.371 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.719 ' CG ' ' O ' ' A' ' 41' ' ' VAL . 14.7 m170 -54.86 -16.9 2.99 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.645 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.57 ' CG ' ' OE1' ' A' ' 61' ' ' GLU . 6.0 t60 -95.46 -35.06 11.85 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.079 -1.048 . . . . 0.0 109.271 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.465 ' HA2' ' OE2' ' A' ' 61' ' ' GLU . . . -93.53 -107.01 1.85 Allowed Glycine 0 N--CA 1.488 2.128 0 N-CA-C 107.116 -2.394 . . . . 0.0 107.116 178.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.76 ' CD1' ' CG1' ' A' ' 59' ' ' VAL . 98.9 m95 -79.83 73.57 6.58 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.001 -1.293 . . . . 0.0 108.271 177.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.606 ' HA ' ' HA ' ' A' ' 45' ' ' HIS . 0.1 OUTLIER -46.95 138.81 7.15 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.503 -0.748 . . . . 0.0 111.262 -179.357 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.649 ' HG2' ' HE3' ' A' ' 51' ' ' LYS . 39.8 Cg_endo -69.55 -27.01 27.98 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 124.387 1.73 . . . . 0.0 110.862 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.853 ' CE ' ' N ' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -63.16 -17.9 62.88 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 178.293 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.808 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 7.4 m-20 -121.12 3.25 10.43 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.223 177.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.664 ' HA ' ' CB ' ' A' ' 78' ' ' VAL . 2.4 t -138.56 128.29 25.01 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.949 0.88 . . . . 0.0 111.045 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.735 ' H ' ' HA ' ' A' ' 78' ' ' VAL . 0.7 OUTLIER -70.12 118.07 12.49 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.634 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.661 ' O ' ' N ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -51.38 -27.93 11.26 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.079 -1.013 . . . . 0.0 111.211 -179.258 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.728 ' ND2' ' CB ' ' A' ' 54' ' ' SER . 1.4 m-80 -28.29 -34.5 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.747 0.784 . . . . 0.0 110.279 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.661 ' N ' ' O ' ' A' ' 55' ' ' GLU . 15.9 pt -112.29 166.62 6.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.585 -0.697 . . . . 0.0 109.444 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.547 ' N ' ' O ' ' A' ' 67' ' ' GLU . 13.7 t70 -108.51 109.75 21.07 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.13 -0.981 . . . . 0.0 109.788 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.76 ' CG1' ' CD1' ' A' ' 48' ' ' TRP . 95.7 t -130.56 135.16 61.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 O-C-N 121.78 -0.575 . . . . 0.0 110.462 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.773 ' HA ' ' OE1' ' A' ' 43' ' ' GLN . 2.8 tttt -136.3 155.41 50.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.88 -1.138 . . . . 0.0 111.227 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.57 ' OE1' ' CG ' ' A' ' 46' ' ' HIS . 3.1 tt0 -69.07 -120.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.47 -0.769 . . . . 0.0 110.265 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.518 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 38.48 48.99 2.33 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 108.346 -1.901 . . . . 0.0 108.346 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.688 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 102.07 58.65 0.78 Allowed Glycine 0 N--CA 1.487 2.047 0 N-CA-C 107.932 -2.067 . . . . 0.0 107.932 -178.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.689 HD13 ' NE1' ' A' ' 48' ' ' TRP . 2.0 mm? 0.91 82.98 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.886 -0.773 . . . . 0.0 111.105 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.422 ' O ' HG12 ' A' ' 59' ' ' VAL . 3.7 t -99.76 114.65 27.92 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.514 -0.741 . . . . 0.0 109.885 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.61 ' CE1' ' CD2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -97.21 124.89 41.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.414 -0.804 . . . . 0.0 109.538 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 58' ' ' ASP . 8.3 tt0 -145.88 122.01 10.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.826 -1.171 . . . . 0.0 110.23 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.555 ' CD ' ' O ' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -122.81 142.66 50.51 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.332 -0.855 . . . . 0.0 109.674 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.675 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 44.7 mtt180 -112.91 -71.44 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.033 -1.042 . . . . 0.0 110.591 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.675 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 56.6 Cg_endo -73.6 -122.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.502 1.264 . . . . 0.0 109.184 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 t -140.05 164.09 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.5 -1.375 . . . . 0.0 109.96 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.571 ' CB ' ' HA ' ' A' ' 76' ' ' ASP . . . -62.46 88.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.226 -0.921 . . . . 0.0 110.192 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.558 ' N ' ' OD1' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -66.79 -77.5 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.171 -0.956 . . . . 0.0 110.368 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 73' ' ' GLN . 1.9 p -50.86 -101.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.112 -0.992 . . . . 0.0 110.03 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.543 ' CG2' ' OG ' ' A' ' 54' ' ' SER . 7.1 t -82.93 -129.25 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.929 -1.107 . . . . 0.0 109.203 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.689 ' O ' ' N ' ' A' ' 78' ' ' VAL . 0.9 OUTLIER -140.9 154.39 46.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.966 -1.084 . . . . 0.0 110.802 179.555 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.579 ' C ' ' O ' ' A' ' 76' ' ' ASP . . . 29.88 -89.87 0.01 OUTLIER Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.429 -1.868 . . . . 0.0 108.429 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.735 ' HA ' ' H ' ' A' ' 54' ' ' SER . 17.1 m -155.26 138.73 7.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 O-C-N 121.736 -0.861 . . . . 0.0 109.999 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.721 ' C ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -144.95 133.22 21.66 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.239 -0.913 . . . . 0.0 112.047 -178.454 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.808 ' CA ' ' HA ' ' A' ' 52' ' ' ASP . . . -115.43 162.68 12.41 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.236 -1.545 . . . . 0.0 109.236 178.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.474 ' HA ' ' HB2' ' A' ' 202' ' ' SER . 13.0 ttpp -160.57 -28.21 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.134 -1.215 . . . . 0.0 110.452 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.541 ' CD ' ' HB3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -82.18 -73.51 0.39 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.978 -1.076 . . . . 0.0 109.872 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.47 ' C ' ' O ' ' A' ' 82' ' ' ARG . . . 36.49 53.15 1.37 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.423 ' CD1' ' C ' ' A' ' 84' ' ' TYR . 2.1 t80 -94.55 125.29 39.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -1.137 . . . . 0.0 110.603 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.574 ' HB3' ' CD2' ' A' ' 89' ' ' HIS . 30.7 m -139.9 166.68 23.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.163 -0.961 . . . . 0.0 110.022 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.537 ' O ' ' NE2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -116.87 133.77 55.6 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.059 -1.026 . . . . 0.0 110.201 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 101.03 -114.92 5.15 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.524 ' O ' ' CD2' ' A' ' 89' ' ' HIS . 17.7 tp -128.49 132.18 48.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.359 -1.083 . . . . 0.0 110.248 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.574 ' CD2' ' HB3' ' A' ' 85' ' ' SER . 2.9 m80 -147.16 156.78 43.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.12 -0.987 . . . . 0.0 109.915 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.546 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -163.04 155.45 18.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.939 . . . . 0.0 110.074 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.715 ' CD1' ' CZ ' ' A' ' 216' ' ' TYR . 0.0 OUTLIER -134.67 158.86 43.0 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.275 -0.891 . . . . 0.0 109.238 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.589 ' CB ' ' O ' ' A' ' 215' ' ' ARG . 3.0 tt0 -109.81 134.11 52.4 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.876 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.543 ' CB ' ' OH ' ' A' ' 180' ' ' TYR . 8.3 mm -129.18 132.25 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.421 -0.8 . . . . 0.0 109.657 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.667 ' HB3' ' HA ' ' A' ' 166' ' ' ARG . 13.3 p -155.22 154.31 32.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.188 -0.945 . . . . 0.0 110.271 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.669 ' CD1' ' N ' ' A' ' 95' ' ' TRP . 14.4 m95 -123.32 86.41 51.86 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.09 -1.006 . . . . 0.0 109.8 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.568 ' CD ' ' HB2' ' A' ' 213' ' ' ARG . 52.2 Cg_endo -99.06 109.0 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 121.978 1.785 . . . . 0.0 110.634 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 210' ' ' CYS . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 O-C-N 120.883 -1.136 . . . . 0.0 109.764 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.761 HG22 ' O ' ' A' ' 204' ' ' SER . 18.4 m . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.648 HG11 ' N ' ' A' ' 107' ' ' GLY . 36.9 t -149.23 156.26 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.14 -0.975 . . . . 0.0 110.757 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.648 ' N ' HG11 ' A' ' 106' ' ' VAL . . . -149.96 150.23 22.26 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.659 HG11 ' HB2' ' A' ' 199' ' ' LEU . 2.9 t -122.38 141.88 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -1.098 . . . . 0.0 109.666 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.551 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -124.25 156.67 36.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.095 -1.003 . . . . 0.0 110.77 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.549 ' CG2' ' HB3' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -120.52 133.63 55.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.35 -0.844 . . . . 0.0 110.207 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -88.9 -25.03 22.33 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.344 -0.848 . . . . 0.0 109.335 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.6 pp -86.67 -11.96 49.77 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.516 -0.74 . . . . 0.0 109.251 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.434 ' HB2' ' OE1' ' A' ' 129' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.535 -0.728 . . . . 0.0 110.378 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.246 0.546 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.434 ' OE1' ' HB2' ' A' ' 113' ' ' ALA . 0.6 OUTLIER -149.98 128.97 12.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.355 -0.841 . . . . 0.0 110.076 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 39.1 t -120.55 120.13 34.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.292 -0.88 . . . . 0.0 110.224 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . 0.465 ' O ' ' O ' ' A' ' 108' ' ' VAL . 1.5 m95 -132.82 124.87 28.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.91 . . . . 0.0 109.99 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.53 ' HA3' ' CA ' ' A' ' 107' ' ' GLY . . . -155.18 -172.13 22.52 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.626 ' O ' ' CD1' ' A' ' 133' ' ' TRP . 3.5 p90 -145.26 140.4 27.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.368 -1.077 . . . . 0.0 110.902 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.413 ' OD2' HG11 ' A' ' 105' ' ' VAL . 0.7 OUTLIER -120.45 149.05 43.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.778 -0.576 . . . . 0.0 109.709 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.528 ' CD1' HG13 ' A' ' 105' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 O-C-N 120.966 -1.084 . . . . 0.0 110.361 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.585 ' CG1' ' HB2' ' A' ' 167' ' ' LEU . 48.0 t . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.583 ' HD2' ' CG1' ' A' ' 163' ' ' VAL . 38.0 Cg_endo -64.05 176.09 2.74 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.718 1.378 . . . . 0.0 110.572 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 164' ' ' PRO . 12.9 mt-10 -35.75 -32.18 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.503 -0.748 . . . . 0.0 110.681 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.667 ' HA ' ' HB3' ' A' ' 94' ' ' SER . 21.2 ttm180 -152.26 156.71 40.22 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.269 -0.894 . . . . 0.0 111.087 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.585 ' HB2' ' CG1' ' A' ' 163' ' ' VAL . 7.2 tt -126.21 157.1 39.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.584 -0.697 . . . . 0.0 109.719 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.569 ' O ' ' O ' ' A' ' 181' ' ' SER . 24.9 tp -123.6 116.61 23.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.087 -1.008 . . . . 0.0 110.739 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.699 ' CG1' ' CZ3' ' A' ' 91' ' ' TRP . 10.6 t -91.93 141.91 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.101 -0.999 . . . . 0.0 109.61 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 178' ' ' LEU . 11.4 t -118.93 124.71 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.917 . . . . 0.0 111.133 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.436 HD12 ' HB3' ' A' ' 178' ' ' LEU . 13.0 tp -133.4 105.68 7.07 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.384 -0.822 . . . . 0.0 109.346 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -115.47 139.32 50.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 110.544 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.517 ' O ' ' C ' ' A' ' 174' ' ' GLU . 0.0 OUTLIER -93.43 -41.0 10.05 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 120.174 -0.611 . . . . 0.0 109.996 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.517 ' C ' ' O ' ' A' ' 173' ' ' MET . 15.9 tt0 -39.11 -30.93 0.06 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 0.0 108.497 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 173' ' ' MET . 4.7 tt0 -113.2 -24.97 9.11 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.619 ' O ' ' HB ' ' A' ' 198' ' ' THR . . . 76.81 25.97 63.65 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 -179.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.669 ' CG2' ' HG ' ' A' ' 194' ' ' LEU . 2.2 p -113.14 144.45 42.64 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.346 -1.091 . . . . 0.0 110.77 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.582 HD12 ' CG ' ' A' ' 201' ' ' PRO . 0.1 OUTLIER -153.03 154.04 34.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.405 -0.809 . . . . 0.0 110.169 -179.545 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.538 ' HA3' ' CD1' ' A' ' 187' ' ' LEU . . . -166.05 -173.17 34.23 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.662 ' CE1' ' CG2' ' A' ' 169' ' ' VAL . 0.7 OUTLIER -118.05 122.48 43.27 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.363 -1.08 . . . . 0.0 109.431 -179.75 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.612 ' HA ' ' CD2' ' A' ' 186' ' ' TYR . 41.9 t -144.24 142.5 30.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.288 -0.883 . . . . 0.0 110.822 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.534 ' CG2' ' HD2' ' A' ' 164' ' ' PRO . 0.0 OUTLIER -90.75 116.34 31.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.405 -0.809 . . . . 0.0 109.321 179.046 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 94.96 -26.03 20.83 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.501 ' CA ' HD21 ' A' ' 168' ' ' LEU . . . 102.54 42.18 2.21 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 187' ' ' LEU . 4.7 m -137.53 -54.84 0.68 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.158 -1.201 . . . . 0.0 110.444 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.723 ' CG ' ' O ' ' A' ' 186' ' ' TYR . 0.1 OUTLIER -62.0 77.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.129 0.966 . . . . 0.0 109.962 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.622 ' HG ' ' CE1' ' A' ' 191' ' ' PHE . 1.7 tt 179.87 24.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.48 0.657 . . . . 0.0 109.793 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.763 ' N ' ' CD ' ' A' ' 189' ' ' PRO . . . -104.94 -21.3 9.11 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.892 -1.147 . . . . 0.0 112.074 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.763 ' CD ' ' N ' ' A' ' 188' ' ' GLY . 47.5 Cg_endo -74.21 -42.76 0.64 Allowed 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 122.812 0.901 . . . . 0.0 111.386 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -90.18 10.43 24.55 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.996 -1.065 . . . . 0.0 111.004 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.647 ' CE1' ' CD2' ' A' ' 194' ' ' LEU . 1.5 m-85 -89.98 -13.3 36.42 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.13 -0.981 . . . . 0.0 109.786 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . 0.507 ' HA ' ' NE ' ' A' ' 192' ' ' ARG . 0.0 OUTLIER -70.19 -29.23 66.05 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.158 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.52 ' O ' ' HB3' ' A' ' 197' ' ' ARG . . . -102.41 -18.76 15.61 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.111 -1.996 . . . . 0.0 108.111 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.721 ' HA ' ' HD2' ' A' ' 197' ' ' ARG . 0.9 OUTLIER -61.61 -20.32 63.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.792 -0.828 . . . . 0.0 109.454 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 195' ' ' LYS . 0.1 OUTLIER -64.32 -22.25 66.89 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.441 -0.787 . . . . 0.0 109.367 179.257 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.44 ' N ' ' HE3' ' A' ' 195' ' ' LYS . . . -125.43 -20.23 2.21 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.721 ' HD2' ' HA ' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -90.45 -4.19 57.15 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.479 -1.012 . . . . 0.0 109.267 179.661 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' THR . . . . . 0.619 ' HB ' ' O ' ' A' ' 176' ' ' GLY . 0.1 OUTLIER -43.19 138.54 2.18 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 122.401 1.096 . . . . 0.0 112.43 -177.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.659 ' HB2' HG11 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -141.39 172.93 12.01 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.772 179.399 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.508 ' C ' HG13 ' A' ' 108' ' ' VAL . 8.5 m-85 -82.3 128.66 66.57 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.619 -1.301 . . . . 0.0 109.502 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.582 ' CG ' HD12 ' A' ' 178' ' ' LEU . 53.2 Cg_endo -78.44 144.79 20.53 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 124.045 1.55 . . . . 0.0 112.556 -178.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.575 ' O ' ' CG1' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -133.58 147.56 51.54 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.247 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.617 ' CG1' ' HB3' ' A' ' 52' ' ' ASP . 8.4 p -119.14 163.5 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.722 -1.236 . . . . 0.0 110.388 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' SER . . . . . 0.761 ' O ' HG22 ' A' ' 105' ' ' VAL . 0.4 OUTLIER -155.07 134.65 12.66 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.013 0.911 . . . . 0.0 110.466 179.606 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.605 ' CB ' ' CG2' ' A' ' 78' ' ' VAL . . . -138.91 147.42 42.3 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.792 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.488 ' CG1' ' HB3' ' A' ' 211' ' ' GLN . 2.5 p -66.25 173.41 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.405 -0.81 . . . . 0.0 110.54 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.585 ' O ' ' CG ' ' A' ' 207' ' ' TRP . 33.0 p-90 -107.02 114.26 28.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.281 -0.887 . . . . 0.0 110.257 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 66' ' ' PHE . . . 172.32 174.18 39.5 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -78.38 -73.53 0.32 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -1.157 . . . . 0.0 110.436 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . 0.456 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 89.1 m -86.29 86.24 7.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.356 -0.84 . . . . 0.0 110.292 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.488 ' HB3' ' CG1' ' A' ' 206' ' ' VAL . 25.1 mm-40 -154.3 -49.92 0.09 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.211 -0.931 . . . . 0.0 110.365 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.578 HG23 ' CZ3' ' A' ' 95' ' ' TRP . 47.9 t -127.81 143.73 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.119 -0.988 . . . . 0.0 112.033 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . 0.568 ' HB2' ' CD ' ' A' ' 96' ' ' PRO . 15.6 tpp85 -128.9 137.79 51.63 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.601 HG21 ' CE2' ' A' ' 48' ' ' TRP . 3.1 tt -142.36 136.32 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.643 -1.286 . . . . 0.0 112.289 -178.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.589 ' O ' ' CB ' ' A' ' 92' ' ' GLU . 12.7 tpt180 -130.11 109.43 10.82 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . 0.715 ' CZ ' ' CD1' ' A' ' 91' ' ' TRP . 2.1 t80 -89.0 149.59 23.19 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.055 -1.028 . . . . 0.0 111.531 -178.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 44.2 tpp -132.79 107.92 8.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.671 -0.643 . . . . 0.0 109.632 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 93.39 87.46 1.6 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.257 -1.143 . . . . 0.0 110.406 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.601 ' O ' ' N ' ' A' ' 32' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.321 0.581 . . . . 0.0 109.796 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.567 ' CG ' ' CG ' ' A' ' 55' ' ' GLU . 1.6 tt0 -46.64 -26.86 1.0 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.408 -0.808 . . . . 0.0 109.159 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -74.85 -22.58 58.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.463 -0.773 . . . . 0.0 108.933 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.601 ' N ' ' O ' ' A' ' 29' ' ' LEU . 1.1 mm? -83.84 -32.17 25.4 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.643 ' HG ' ' N ' ' A' ' 34' ' ' SER . 0.3 OUTLIER -71.11 -35.93 71.98 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 122.064 0.935 . . . . 0.0 109.139 179.299 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.643 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 3.7 t -79.71 -7.62 58.72 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.323 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.671 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . . . -70.42 -70.96 0.29 Allowed Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.122 -0.986 . . . . 0.0 110.899 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.671 ' CD ' ' CB ' ' A' ' 35' ' ' ALA . 51.6 Cg_endo -75.39 160.92 38.37 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.495 1.261 . . . . 0.0 110.483 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -99.81 52.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.123 1.882 . . . . 0.0 112.113 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.645 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 48.6 Cg_endo -72.89 151.04 50.35 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.125 1.066 . . . . 0.0 110.703 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.672 ' OD2' ' HD3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -15.2 -65.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.757 -0.59 . . . . 0.0 111.786 179.282 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.739 ' CD2' ' C ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -45.28 -43.71 10.79 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.413 -0.804 . . . . 0.0 110.412 -179.434 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.667 ' CG1' ' CE1' ' A' ' 45' ' ' HIS . 3.8 t -85.08 -19.33 8.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 O-C-N 121.168 -0.958 . . . . 0.0 111.185 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.52 -44.12 10.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.89 -1.132 . . . . 0.0 112.339 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.697 ' NE2' ' HG2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -85.39 -19.48 31.32 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 118.385 -1.326 . . . . 0.0 109.425 -179.737 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.651 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -69.31 -41.81 76.22 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 122.165 0.983 . . . . 0.0 108.472 179.218 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.667 ' CE1' ' CG1' ' A' ' 41' ' ' VAL . 20.3 m170 -63.74 -28.82 70.15 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.748 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -96.35 -29.64 13.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.874 -1.141 . . . . 0.0 109.608 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.09 -89.83 1.47 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 107.339 -2.304 . . . . 0.0 107.339 178.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.686 ' CD1' ' CG1' ' A' ' 59' ' ' VAL . 97.4 m95 -90.77 74.37 6.59 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.58 ' ND2' ' N ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -43.26 137.94 2.74 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.527 -0.733 . . . . 0.0 111.428 -179.045 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.652 ' HG2' ' HE3' ' A' ' 51' ' ' LYS . 40.0 Cg_endo -67.67 -23.31 42.65 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 124.435 1.755 . . . . 0.0 111.168 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.835 ' CE ' ' N ' ' A' ' 51' ' ' LYS . 0.6 OUTLIER -65.29 -15.58 62.66 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 178.326 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 1.08 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 11.2 m-20 -121.97 3.15 9.95 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.162 177.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.746 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 9.5 t -148.0 138.08 22.7 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.507 0.67 . . . . 0.0 110.292 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.753 ' HB2' ' O ' ' A' ' 76' ' ' ASP . 1.5 m -80.29 130.68 35.37 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.175 -0.953 . . . . 0.0 109.835 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.584 ' HA ' ' NH2' ' A' ' 44' ' ' ARG . 4.3 pm0 -44.63 -24.36 0.19 Allowed 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.632 ' ND2' ' HB2' ' A' ' 54' ' ' SER . 0.1 OUTLIER -55.5 -4.58 0.1 Allowed 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.575 -1.328 . . . . 0.0 109.866 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.555 HD11 ' HA ' ' A' ' 207' ' ' TRP . 22.8 mm -111.96 157.75 12.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.477 -0.765 . . . . 0.0 110.518 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.551 ' O ' ' CB ' ' A' ' 67' ' ' GLU . 35.9 t0 -118.87 105.4 11.46 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.709 0.766 . . . . 0.0 109.534 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.7 ' CG1' ' CD1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -131.08 136.12 58.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 O-C-N 121.628 -0.67 . . . . 0.0 110.919 -178.942 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.697 ' HG2' ' NE2' ' A' ' 43' ' ' GLN . 28.7 mttp -135.53 155.28 50.75 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.282 -0.886 . . . . 0.0 110.535 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.499 ' HG3' ' N ' ' A' ' 62' ' ' GLY . 7.8 pt-20 -75.82 -130.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.227 -0.921 . . . . 0.0 110.408 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.499 ' N ' ' HG3' ' A' ' 61' ' ' GLU . . . 45.73 45.12 12.99 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.661 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 108.9 60.55 0.53 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.661 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.3 OUTLIER -0.32 78.98 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.878 -0.778 . . . . 0.0 111.27 -179.283 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.499 ' O ' ' SG ' ' A' ' 65' ' ' CYS . 31.9 p -99.58 114.33 27.29 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.13 -0.981 . . . . 0.0 109.647 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.7 ' CD1' ' CG1' ' A' ' 59' ' ' VAL . 1.2 t80 -90.55 124.84 35.35 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.479 -0.763 . . . . 0.0 110.211 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 4.9 tt0 -139.99 152.89 46.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.172 -0.955 . . . . 0.0 109.674 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.546 ' HG3' ' HB3' ' A' ' 207' ' ' TRP . 0.1 OUTLIER -135.93 140.25 43.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.022 -1.049 . . . . 0.0 110.83 -179.578 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.615 ' CB ' ' HD2' ' A' ' 70' ' ' PRO . 1.4 mtp85 -61.13 -173.94 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.386 -0.821 . . . . 0.0 109.208 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.615 ' HD2' ' CB ' ' A' ' 69' ' ' ARG . 50.9 Cg_endo -66.28 -138.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.591 1.311 . . . . 0.0 108.958 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.404 ' H ' ' HB2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -139.72 152.61 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.966 -1.083 . . . . 0.0 110.015 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.6 -39.95 0.13 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.161 -0.962 . . . . 0.0 110.188 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.549 ' O ' ' N ' ' A' ' 75' ' ' THR . 0.2 OUTLIER -170.14 147.12 3.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.286 -0.884 . . . . 0.0 110.145 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 73' ' ' GLN . 9.2 t -43.74 91.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 110.353 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.549 ' N ' ' O ' ' A' ' 73' ' ' GLN . 1.5 m -99.17 -129.4 0.2 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.296 -0.877 . . . . 0.0 110.053 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.753 ' O ' ' HB2' ' A' ' 54' ' ' SER . 72.5 m-20 -137.73 113.91 10.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.195 -0.94 . . . . 0.0 110.486 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.558 ' O ' HG11 ' A' ' 78' ' ' VAL . . . -50.73 -96.16 0.01 OUTLIER Glycine 0 N--CA 1.484 1.837 0 N-CA-C 107.759 -2.136 . . . . 0.0 107.759 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.746 ' HA ' ' HA ' ' A' ' 53' ' ' CYS . 6.9 m -143.05 126.93 14.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.215 -1.168 . . . . 0.0 110.237 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.604 ' C ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -145.57 134.16 22.11 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.131 -0.981 . . . . 0.0 112.536 -178.615 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 1.08 ' CA ' ' HA ' ' A' ' 52' ' ' ASP . . . -133.13 161.56 24.17 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 178.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.513 ' HA ' ' CB ' ' A' ' 202' ' ' SER . 0.4 OUTLIER -169.96 24.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.237 -1.155 . . . . 0.0 110.345 -179.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.469 ' O ' ' CD2' ' A' ' 200' ' ' TYR . 1.1 ptt180 -91.36 -102.44 0.11 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.075 -1.016 . . . . 0.0 110.428 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.444 ' HA3' ' HD2' ' A' ' 201' ' ' PRO . . . 81.03 66.6 1.61 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -121.77 95.8 4.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -1.166 . . . . 0.0 110.361 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 173' ' ' MET . 69.7 m -140.09 155.6 46.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.207 -0.933 . . . . 0.0 110.286 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.518 ' C ' ' NE2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -118.2 135.42 54.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.207 -0.933 . . . . 0.0 109.809 179.832 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 106.45 -118.32 5.64 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.476 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 51.3 tp -128.79 123.09 31.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.408 -1.054 . . . . 0.0 110.904 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.518 ' NE2' ' C ' ' A' ' 86' ' ' ARG . 4.2 m-70 -147.2 153.17 39.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.205 -0.934 . . . . 0.0 109.758 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.54 ' C ' ' CE3' ' A' ' 91' ' ' TRP . . . -163.71 156.85 18.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.025 -1.047 . . . . 0.0 110.201 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.731 ' CE3' ' CE2' ' A' ' 216' ' ' TYR . 0.0 OUTLIER -134.98 154.69 51.63 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.184 -0.948 . . . . 0.0 110.108 179.484 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.648 ' O ' ' N ' ' A' ' 215' ' ' ARG . 0.5 OUTLIER -109.56 118.93 37.89 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.318 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.538 ' CG2' HG13 ' A' ' 214' ' ' ILE . 0.1 OUTLIER -132.95 133.86 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.819 -1.176 . . . . 0.0 111.491 -178.659 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.541 ' O ' ' HD3' ' A' ' 96' ' ' PRO . 0.1 OUTLIER -116.84 120.08 37.39 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.441 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.896 ' HH2' ' O ' ' A' ' 204' ' ' SER . 6.3 t-105 -116.13 87.39 19.25 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.106 -0.997 . . . . 0.0 110.332 -178.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.577 ' HG2' ' O ' ' A' ' 211' ' ' GLN . 49.9 Cg_endo -99.24 138.66 0.32 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.257 1.972 . . . . 0.0 110.319 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.534 ' C ' ' CD1' ' A' ' 97' ' ' LEU . 1.9 tm? . . . . . 0 N--CA 1.492 1.641 0 O-C-N 120.866 -1.146 . . . . 0.0 109.405 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.742 HG11 ' O ' ' A' ' 204' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 121.496 0.665 . . . . 0.0 112.657 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.683 ' CG2' ' CD2' ' A' ' 95' ' ' TRP . 1.0 OUTLIER -152.16 122.82 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.62 -0.675 . . . . 0.0 109.431 177.413 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.515 ' HA3' ' HA3' ' A' ' 132' ' ' GLY . . . 160.44 -158.56 30.0 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 118.711 -1.709 . . . . 0.0 111.097 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.527 ' CG1' ' HB2' ' A' ' 199' ' ' LEU . 2.3 t -120.78 169.34 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.725 -0.867 . . . . 0.0 109.717 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 130' ' ' SER . . . -146.19 132.66 19.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.996 -1.065 . . . . 0.0 110.263 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.564 HG23 ' CD2' ' A' ' 199' ' ' LEU . 9.7 p -89.43 120.85 31.12 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.146 -0.971 . . . . 0.0 110.304 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.17 -31.55 14.74 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.638 -0.664 . . . . 0.0 109.817 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.412 ' HG ' ' N ' ' A' ' 113' ' ' ALA . 0.6 OUTLIER -76.91 -12.47 59.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.401 -0.812 . . . . 0.0 110.01 179.807 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.444 ' O ' ' OE1' ' A' ' 129' ' ' GLU . . . . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.376 -0.828 . . . . 0.0 110.261 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.341 0.591 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.444 ' OE1' ' O ' ' A' ' 113' ' ' ALA . 0.9 OUTLIER -150.4 138.1 19.89 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.224 -0.923 . . . . 0.0 109.766 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 8.9 t -120.06 120.71 37.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.386 -0.821 . . . . 0.0 110.006 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . 0.465 ' O ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -132.2 133.36 44.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.882 . . . . 0.0 110.255 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.515 ' HA3' ' HA3' ' A' ' 107' ' ' GLY . . . 165.72 -120.38 0.92 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.662 ' CZ3' ' CD2' ' A' ' 180' ' ' TYR . 47.0 m0 -119.48 112.81 19.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.043 -1.269 . . . . 0.0 110.025 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.458 ' C ' HD13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -118.92 148.22 43.17 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.397 0.618 . . . . 0.0 110.685 -179.545 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.629 ' CD1' ' N ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.946 . . . . 0.0 110.116 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.584 ' H ' ' HD2' ' A' ' 164' ' ' PRO . 1.3 t . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.584 ' HD2' ' H ' ' A' ' 163' ' ' VAL . 45.6 Cg_endo -73.29 68.6 4.19 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.74 1.389 . . . . 0.0 110.705 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.433 ' C ' HD23 ' A' ' 167' ' ' LEU . 94.5 mt-10 -80.72 -81.27 0.13 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.304 -0.873 . . . . 0.0 109.116 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.599 ' O ' ' CD1' ' A' ' 167' ' ' LEU . 9.7 ttp180 -119.09 115.53 24.48 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.394 -0.816 . . . . 0.0 108.961 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.682 ' N ' ' CD2' ' A' ' 167' ' ' LEU . 0.3 OUTLIER -132.14 157.46 44.2 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 121.424 0.631 . . . . 0.0 110.474 -179.015 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.471 ' CD1' ' OE1' ' A' ' 92' ' ' GLU . 0.7 OUTLIER -107.42 125.82 51.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.371 -0.831 . . . . 0.0 109.736 179.401 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.642 ' CG1' ' CD1' ' A' ' 91' ' ' TRP . 19.3 t -89.53 132.37 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.139 -0.975 . . . . 0.0 110.062 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.469 HG13 HD23 ' A' ' 168' ' ' LEU . 0.1 OUTLIER -125.3 111.48 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.398 -0.814 . . . . 0.0 110.186 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.66 ' HB3' ' CZ2' ' A' ' 91' ' ' TRP . 2.0 tp -107.41 114.04 27.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.339 -0.851 . . . . 0.0 110.022 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.492 ' N ' HD13 ' A' ' 171' ' ' LEU . 53.1 t0 -116.22 129.85 56.5 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.268 -0.895 . . . . 0.0 110.067 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.474 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 12.4 tpp -100.85 -42.02 6.62 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 173' ' ' MET . 0.7 OUTLIER -45.87 -25.62 0.56 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.078 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.541 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.0 OUTLIER -111.59 -28.07 8.3 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.751 0.786 . . . . 0.0 108.895 179.29 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.533 ' O ' ' CG2' ' A' ' 198' ' ' THR . . . 85.37 22.66 50.65 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.579 ' HA ' ' CD2' ' A' ' 194' ' ' LEU . 0.2 OUTLIER -119.73 111.43 18.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.258 -1.142 . . . . 0.0 111.081 -179.631 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.598 ' N ' HD21 ' A' ' 194' ' ' LEU . 0.3 OUTLIER -136.01 154.34 51.1 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.251 -0.906 . . . . 0.0 110.225 179.345 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.454 ' HA2' HG22 ' A' ' 108' ' ' VAL . . . 172.49 -153.21 18.46 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.662 ' CD2' ' CZ3' ' A' ' 133' ' ' TRP . 0.1 OUTLIER -118.79 125.21 49.09 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.192 -1.181 . . . . 0.0 109.768 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.466 ' HB2' HD21 ' A' ' 187' ' ' LEU . 17.0 t -116.72 124.88 50.76 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.381 -0.825 . . . . 0.0 110.171 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.604 HG23 ' CD1' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -103.7 116.71 47.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.495 -0.753 . . . . 0.0 109.645 179.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 49.66 22.49 4.12 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 57.26 48.43 80.27 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' THR . . . . . 0.564 HG22 ' CE1' ' A' ' 186' ' ' TYR . 69.1 m -110.48 -86.53 0.54 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.326 -1.102 . . . . 0.0 110.892 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.568 ' CD1' ' N ' ' A' ' 186' ' ' TYR . 8.9 m-30 -59.67 -56.57 20.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.26 -0.9 . . . . 0.0 110.809 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.517 HD22 ' N ' ' A' ' 180' ' ' TYR . 0.6 OUTLIER -76.25 43.94 0.31 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.002 -1.061 . . . . 0.0 110.12 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -105.32 -70.47 0.78 Allowed Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.913 -1.137 . . . . 0.0 110.269 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.442 ' C ' ' H ' ' A' ' 191' ' ' PHE . 45.3 Cg_endo -71.5 -29.71 16.1 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.899 1.473 . . . . 0.0 111.151 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -72.74 34.17 0.07 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.339 -0.851 . . . . 0.0 111.267 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.442 ' H ' ' C ' ' A' ' 189' ' ' PRO . 0.4 OUTLIER -90.51 -43.94 9.91 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.982 -1.074 . . . . 0.0 109.884 179.351 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -16.65 61.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.32 -0.863 . . . . 0.0 110.107 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -106.23 -13.38 23.16 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.622 ' O ' ' N ' ' A' ' 198' ' ' THR . 7.2 tt -70.94 -29.92 66.08 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.589 -0.948 . . . . 0.0 109.433 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.554 ' HE3' ' N ' ' A' ' 196' ' ' GLY . 0.1 OUTLIER -53.92 -32.61 54.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.224 -0.922 . . . . 0.0 109.493 179.745 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.554 ' N ' ' HE3' ' A' ' 195' ' ' LYS . . . -94.93 -25.97 13.66 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.714 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.67 -4.76 56.53 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.764 -0.845 . . . . 0.0 109.632 179.499 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' THR . . . . . 0.622 ' N ' ' O ' ' A' ' 194' ' ' LEU . 0.2 OUTLIER -44.01 136.96 3.51 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.76 0.79 . . . . 0.0 111.747 -178.243 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.714 ' HG ' ' O ' ' A' ' 197' ' ' ARG . 0.0 OUTLIER -140.37 170.81 15.12 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.381 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.52 ' O ' HG12 ' A' ' 108' ' ' VAL . 3.1 m-30 -84.76 139.03 37.54 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.934 . . . . 0.0 109.752 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.444 ' HD2' ' HA3' ' A' ' 83' ' ' GLY . 40.6 Cg_endo -67.8 113.74 3.09 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.871 1.458 . . . . 0.0 110.203 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.513 ' CB ' ' HA ' ' A' ' 81' ' ' LYS . 25.1 p -133.11 152.95 51.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.296 -0.877 . . . . 0.0 110.81 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 79' ' ' ARG . 6.1 p -160.2 149.91 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.524 -0.735 . . . . 0.0 110.049 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' SER . . . . . 0.896 ' O ' ' HH2' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -139.86 126.53 20.51 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.303 -0.873 . . . . 0.0 109.134 178.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -127.81 163.5 24.25 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.746 -1.221 . . . . 0.0 111.678 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.532 ' CG1' ' N ' ' A' ' 207' ' ' TRP . 1.2 t -50.2 174.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.752 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.555 ' HA ' HD11 ' A' ' 57' ' ' ILE . 79.0 m95 -51.29 -74.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.375 -0.828 . . . . 0.0 109.259 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.606 ' HA2' ' CD2' ' A' ' 66' ' ' PHE . . . 177.03 103.86 0.17 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . 0.494 ' HB2' ' O ' ' A' ' 208' ' ' GLY . 18.6 tt0 179.68 -49.11 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.767 -0.843 . . . . 0.0 110.195 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . 0.521 ' O ' ' CG ' ' A' ' 211' ' ' GLN . 1.7 m -43.0 -96.78 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.62 -0.675 . . . . 0.0 110.658 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.577 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 0.0 OUTLIER 179.53 45.23 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.24 -0.912 . . . . 0.0 109.523 -179.603 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.484 ' HA ' ' HD2' ' A' ' 96' ' ' PRO . 29.2 t -86.08 138.22 19.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-O 121.558 0.694 . . . . 0.0 110.758 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . 0.415 ' HA ' ' HZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -125.71 143.7 50.93 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.48 -0.763 . . . . 0.0 110.139 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.593 ' HB ' ' CZ3' ' A' ' 48' ' ' TRP . 1.5 tt -140.12 127.59 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.086 -1.009 . . . . 0.0 110.488 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -129.96 144.23 51.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.306 -0.871 . . . . 0.0 109.596 179.519 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . 0.731 ' CE2' ' CE3' ' A' ' 91' ' ' TRP . 1.2 t80 -118.62 151.37 38.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.248 -0.908 . . . . 0.0 111.318 -178.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' MET . . . . . 0.468 ' HB3' ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -127.79 107.83 10.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.469 -0.77 . . . . 0.0 109.658 179.332 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 71.75 76.51 0.59 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.575 ' HB2' ' CD2' ' A' ' 216' ' ' TYR . 32.1 tt0 . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.22 -1.164 . . . . 0.0 110.296 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.493 ' CD1' ' C ' ' A' ' 29' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.203 0.525 . . . . 0.0 109.918 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 34' ' ' SER . 1.4 pp20? -46.17 -37.37 6.94 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.135 -0.978 . . . . 0.0 109.165 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -57.44 -25.56 59.84 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.381 -0.825 . . . . 0.0 108.823 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 29' ' ' LEU . 5.9 tp -83.12 -32.21 26.82 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.6 ' C ' ' CD1' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -84.94 -38.42 19.36 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 121.82 0.819 . . . . 0.0 109.237 179.164 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.565 ' O ' ' O ' ' A' ' 35' ' ' ALA . 1.1 t -49.23 -20.63 0.65 Allowed 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.388 0.613 . . . . 0.0 110.189 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.775 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . . . -52.34 -161.37 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.516 -0.74 . . . . 0.0 109.692 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.775 ' HD2' ' CB ' ' A' ' 35' ' ' ALA . 39.2 Cg_endo -66.61 121.85 9.16 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 O-C-N 123.001 1.0 . . . . 0.0 109.754 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.569 ' CB ' ' CG2' ' A' ' 41' ' ' VAL . 44.0 Cg_endo -70.08 109.27 2.33 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.154 1.607 . . . . 0.0 111.732 -178.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.774 ' O ' ' N ' ' A' ' 40' ' ' LEU . 52.0 Cg_endo -79.74 151.62 22.01 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.238 1.652 . . . . 0.0 109.239 178.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.705 ' CG ' ' OE1' ' A' ' 43' ' ' GLN . 0.9 OUTLIER -12.83 -51.23 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 122.167 0.984 . . . . 0.0 110.062 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 1.008 ' O ' ' HB3' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -34.78 -43.23 0.17 Allowed 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.934 -179.346 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.618 HG21 ' CD1' ' A' ' 40' ' ' LEU . 2.9 t -70.87 -24.81 25.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 O-C-N 121.168 -0.957 . . . . 0.0 110.678 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.607 ' N ' ' O ' ' A' ' 39' ' ' ASP . . . -90.69 -41.54 11.24 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 118.981 -1.087 . . . . 0.0 113.104 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.705 ' OE1' ' CG ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -87.37 -19.37 28.24 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.862 -1.149 . . . . 0.0 109.829 -179.1 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 1.008 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 7.5 ttm-85 -72.44 -53.98 10.64 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.735 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 66.3 m170 -55.49 -27.98 51.76 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.556 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -96.07 -30.43 13.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.02 -1.05 . . . . 0.0 109.586 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.87 -74.11 1.27 Allowed Glycine 0 N--CA 1.488 2.131 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.736 ' CD2' ' CE1' ' A' ' 66' ' ' PHE . 99.2 m95 -100.36 74.09 1.71 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.564 HD21 ' HB2' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -43.65 145.71 1.11 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.5 -0.75 . . . . 0.0 110.984 -179.419 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.735 ' HD3' ' HA ' ' A' ' 45' ' ' HIS . 42.8 Cg_endo -70.88 -31.07 16.16 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 124.297 1.682 . . . . 0.0 110.681 -178.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.913 ' O ' ' HA2' ' A' ' 80' ' ' GLY . 0.3 OUTLIER -64.17 -16.15 61.32 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.225 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.988 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 4.8 m-20 -118.72 0.28 11.43 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.638 177.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.612 ' HA ' ' CA ' ' A' ' 78' ' ' VAL . 16.0 t -150.04 132.9 16.04 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.21 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.649 ' CB ' ' ND2' ' A' ' 56' ' ' ASN . 0.5 OUTLIER -75.23 117.65 17.29 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.593 0.711 . . . . 0.0 109.688 179.186 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.646 ' O ' ' N ' ' A' ' 57' ' ' ILE . 6.7 pt-20 -42.54 -28.67 0.23 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.595 -0.69 . . . . 0.0 112.801 -178.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.672 ' H ' ' ND2' ' A' ' 56' ' ' ASN . 0.1 OUTLIER -40.34 -16.0 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.298 0 O-C-N 120.96 -1.087 . . . . 0.0 111.04 -179.114 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.646 ' N ' ' O ' ' A' ' 55' ' ' GLU . 1.2 mt -111.55 165.6 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 120.998 -1.064 . . . . 0.0 110.329 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 67' ' ' GLU . 4.2 t70 -117.54 104.27 10.9 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.76 0.791 . . . . 0.0 110.455 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.708 ' HB ' ' CD1' ' A' ' 48' ' ' TRP . 34.8 m -130.38 135.42 60.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 121.73 -0.606 . . . . 0.0 110.034 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.742 ' HG2' ' HA ' ' A' ' 40' ' ' LEU . 24.7 mttt -133.04 141.31 48.18 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.763 -1.211 . . . . 0.0 111.377 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.555 ' CG ' ' HB3' ' A' ' 43' ' ' GLN . 0.4 OUTLIER -59.95 -129.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.495 -0.753 . . . . 0.0 110.508 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 44.53 51.11 8.01 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 107.978 -2.049 . . . . 0.0 107.978 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.663 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 103.01 61.58 0.71 Allowed Glycine 0 N--CA 1.486 2.005 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 -178.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.663 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.2 OUTLIER 0.83 80.81 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.0 -0.706 . . . . 0.0 111.215 -178.737 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.426 ' N ' ' O ' ' A' ' 63' ' ' GLY . 0.5 OUTLIER -99.96 113.89 26.78 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.44 -0.788 . . . . 0.0 110.241 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.736 ' CE1' ' CD2' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -103.22 124.62 48.96 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.555 -0.716 . . . . 0.0 109.422 179.455 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.571 ' O ' HG22 ' A' ' 57' ' ' ILE . 1.1 tp10 -150.73 149.72 30.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.015 -1.053 . . . . 0.0 110.465 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.602 ' HG2' ' CE2' ' A' ' 207' ' ' TRP . 0.0 OUTLIER -119.54 151.74 38.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.309 -0.87 . . . . 0.0 109.969 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.627 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -94.85 -67.05 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 110.577 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.627 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 55.9 Cg_endo -73.53 -119.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.584 1.307 . . . . 0.0 109.583 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.0 t -139.97 164.23 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.317 -1.489 . . . . 0.0 110.21 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.578 ' HB3' ' CD2' ' A' ' 207' ' ' TRP . . . -70.48 69.94 0.42 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 0.0 110.108 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -87.29 -160.26 0.58 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.276 -0.89 . . . . 0.0 110.39 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.2 m -73.25 1.22 9.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.928 . . . . 0.0 110.313 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.468 HG22 ' OD1' ' A' ' 56' ' ' ASN . 3.7 m -116.43 0.41 12.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.923 . . . . 0.0 110.104 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.515 ' CB ' ' HA ' ' A' ' 72' ' ' ALA . 0.4 OUTLIER -99.81 154.8 18.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 110.149 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 54' ' ' SER . . . 132.47 145.87 5.55 Favored Glycine 0 N--CA 1.483 1.771 0 N-CA-C 108.07 -2.012 . . . . 0.0 108.07 -179.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.612 ' CA ' ' HA ' ' A' ' 53' ' ' CYS . 4.4 m -117.27 128.61 74.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 O-C-N 121.16 -1.2 . . . . 0.0 109.846 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.596 ' C ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -145.11 134.61 23.2 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.966 -0.693 . . . . 0.0 112.521 -177.674 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.988 ' CA ' ' HA ' ' A' ' 52' ' ' ASP . . . -123.09 165.58 15.69 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 178.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 201' ' ' PRO . 0.1 OUTLIER -177.52 68.18 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.409 -1.054 . . . . 0.0 110.23 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.932 ' HD3' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -163.38 -91.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.139 -0.975 . . . . 0.0 110.783 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.932 ' N ' ' HD3' ' A' ' 82' ' ' ARG . . . 83.64 87.5 0.81 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -115.59 97.19 6.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.264 -1.139 . . . . 0.0 110.437 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.535 ' O ' ' CG ' ' A' ' 173' ' ' MET . 1.5 m -139.97 160.31 40.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.33 -0.856 . . . . 0.0 110.059 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.515 ' C ' ' NE2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -118.6 134.27 55.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.078 -1.014 . . . . 0.0 110.211 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 101.56 -115.58 5.3 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.506 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 13.2 tp -128.52 130.48 47.52 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.391 -1.064 . . . . 0.0 110.565 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.515 ' NE2' ' C ' ' A' ' 86' ' ' ARG . 4.1 m-70 -147.23 158.5 43.97 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.26 -0.9 . . . . 0.0 109.962 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -162.95 156.43 19.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.134 -0.979 . . . . 0.0 110.354 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.65 ' CB ' ' CD2' ' A' ' 216' ' ' TYR . 5.4 p90 -143.76 170.82 15.16 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.353 -0.842 . . . . 0.0 110.01 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 215' ' ' ARG . 3.6 tt0 -145.86 157.52 43.9 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.429 -0.794 . . . . 0.0 110.932 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.562 ' N ' ' HG3' ' A' ' 92' ' ' GLU . 7.0 tp -143.15 154.37 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.545 -0.722 . . . . 0.0 109.848 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.669 ' O ' ' HD3' ' A' ' 96' ' ' PRO . 0.1 OUTLIER -149.88 137.09 19.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.321 -0.862 . . . . 0.0 110.3 -179.63 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.715 ' CG ' HG22 ' A' ' 212' ' ' VAL . 49.7 m95 -108.93 88.3 5.37 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 121.258 -0.901 . . . . 0.0 110.655 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.669 ' HD3' ' O ' ' A' ' 94' ' ' SER . 52.3 Cg_endo -97.26 108.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.348 1.365 . . . . 0.0 110.215 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.719 0 O-C-N 120.781 -1.2 . . . . 0.0 110.187 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.705 HG21 ' CB ' ' A' ' 204' ' ' SER . 34.2 m . . . . . 0 N--CA 1.482 1.135 0 CA-C-O 121.891 0.853 . . . . 0.0 110.357 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.519 HG12 ' N ' ' A' ' 107' ' ' GLY . 76.5 t -151.15 170.21 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.648 ' CA ' ' HA3' ' A' ' 132' ' ' GLY . . . 168.75 169.22 31.89 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 118.798 -1.667 . . . . 0.0 111.251 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.644 ' CG1' ' CD1' ' A' ' 199' ' ' LEU . 2.2 t -121.74 159.82 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.694 -0.886 . . . . 0.0 109.321 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.557 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -140.07 143.8 36.5 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.977 -1.077 . . . . 0.0 111.401 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.58 ' CG2' ' HB3' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -126.07 135.52 51.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.522 -0.736 . . . . 0.0 110.161 179.473 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.15 -25.35 17.9 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.445 -0.784 . . . . 0.0 109.173 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.48 ' O ' ' C ' ' A' ' 113' ' ' ALA . 2.7 pp -85.54 -12.22 52.18 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.581 -0.7 . . . . 0.0 109.356 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.48 ' C ' ' O ' ' A' ' 112' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.57 -0.706 . . . . 0.0 110.352 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 24.5 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.175 0.512 . . . . 0.0 110.234 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.18 134.33 17.08 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.217 -0.927 . . . . 0.0 109.821 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 14.1 t -151.4 118.61 5.94 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.301 -0.874 . . . . 0.0 110.391 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . 0.52 ' CD1' ' N ' ' A' ' 131' ' ' TRP . 2.7 p-90 -135.59 166.23 23.69 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.648 ' HA3' ' CA ' ' A' ' 107' ' ' GLY . . . 177.67 -138.26 3.75 Favored Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.773 -1.203 . . . . 0.0 110.431 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.612 ' CH2' ' HB3' ' A' ' 180' ' ' TYR . 53.5 m0 -104.8 113.4 26.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.365 -1.08 . . . . 0.0 110.657 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.52 ' O ' ' CG2' ' A' ' 135' ' ' ILE . 1.9 p30 -118.74 113.31 20.95 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.45 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.531 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 3.5 pt . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.171 -0.956 . . . . 0.0 110.027 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.685 ' O ' HD22 ' A' ' 167' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.631 ' CD ' ' N ' ' A' ' 163' ' ' VAL . 48.8 Cg_endo -82.8 62.41 7.76 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.548 1.288 . . . . 0.0 109.118 178.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.644 ' O ' ' CB ' ' A' ' 94' ' ' SER . 11.0 tp10 -173.75 -78.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.64 -0.662 . . . . 0.0 109.61 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.592 ' C ' ' CD2' ' A' ' 167' ' ' LEU . 7.7 ttt180 -151.6 132.96 14.59 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.537 -0.727 . . . . 0.0 109.645 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.685 HD22 ' O ' ' A' ' 163' ' ' VAL . 3.0 mm? -140.33 153.61 46.49 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.366 -0.834 . . . . 0.0 110.8 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.42 ' N ' ' HE1' ' A' ' 180' ' ' TYR . 6.2 tp -129.07 130.24 46.28 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.567 -0.708 . . . . 0.0 109.259 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.803 ' HB ' ' HA ' ' A' ' 180' ' ' TYR . 0.2 OUTLIER -127.25 144.1 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.955 -1.091 . . . . 0.0 110.262 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.489 ' N ' HG23 ' A' ' 169' ' ' VAL . 4.3 p -102.53 133.19 46.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.815 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.602 ' CD1' ' CD2' ' A' ' 178' ' ' LEU . 2.7 tp -124.76 105.89 9.64 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.433 -0.792 . . . . 0.0 109.824 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.514 ' OD1' ' CG ' ' A' ' 174' ' ' GLU . 5.1 t70 -119.97 134.44 55.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 110.488 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.535 ' CG ' ' O ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -98.8 -42.23 7.29 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.278 0.561 . . . . 0.0 109.63 179.491 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.514 ' CG ' ' OD1' ' A' ' 172' ' ' ASP . 7.9 pt-20 -45.01 -24.91 0.26 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.246 -0.908 . . . . 0.0 108.828 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.611 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.2 OUTLIER -112.25 -27.01 8.5 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.16 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.524 ' O ' HG22 ' A' ' 198' ' ' THR . . . 80.88 25.73 55.24 Favored Glycine 0 N--CA 1.483 1.787 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.624 ' CG2' ' CD2' ' A' ' 194' ' ' LEU . 0.1 OUTLIER -112.7 124.05 51.69 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.096 -1.238 . . . . 0.0 111.093 -179.434 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.632 ' N ' ' CD1' ' A' ' 178' ' ' LEU . 2.6 mp -129.08 153.47 47.61 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.51 -0.744 . . . . 0.0 109.434 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.542 ' O ' ' CG2' ' A' ' 169' ' ' VAL . . . -178.9 163.67 31.5 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.2 -1.476 . . . . 0.0 110.633 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.803 ' HA ' ' HB ' ' A' ' 169' ' ' VAL . 0.1 OUTLIER -118.28 128.17 54.42 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.455 -1.026 . . . . 0.0 109.492 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.597 ' OG ' ' N ' ' A' ' 186' ' ' TYR . 5.7 t -132.34 165.15 24.86 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.662 0.744 . . . . 0.0 110.186 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.601 HG22 ' CD1' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -105.46 116.7 49.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 O-C-N 121.792 -0.568 . . . . 0.0 109.556 179.356 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 64.4 8.86 33.79 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 86.81 35.18 10.31 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' THR . . . . . 0.477 ' O ' ' C ' ' A' ' 186' ' ' TYR . 37.3 m -106.77 -65.93 1.05 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.117 -1.225 . . . . 0.0 110.71 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.597 ' N ' ' OG ' ' A' ' 181' ' ' SER . 0.1 OUTLIER -35.98 -74.3 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.315 -0.866 . . . . 0.0 110.761 -179.618 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.578 ' HB2' ' HB2' ' A' ' 181' ' ' SER . 2.7 mm? -67.69 46.19 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.037 -1.039 . . . . 0.0 110.081 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 186' ' ' TYR . . . -73.51 -99.05 0.08 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.572 ' C ' ' H ' ' A' ' 191' ' ' PHE . 49.2 Cg_endo -73.65 -23.99 16.34 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.109 1.583 . . . . 0.0 111.242 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -62.39 29.39 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.39 -0.819 . . . . 0.0 111.797 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.572 ' H ' ' C ' ' A' ' 189' ' ' PRO . 1.0 OUTLIER -90.54 -22.33 21.35 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.782 -1.199 . . . . 0.0 110.461 179.391 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . 0.507 ' N ' ' HD2' ' A' ' 192' ' ' ARG . 0.0 OUTLIER -87.82 -13.02 43.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.178 -0.951 . . . . 0.0 110.443 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -108.77 -10.46 24.78 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.334 -1.906 . . . . 0.0 108.334 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.647 ' O ' ' N ' ' A' ' 198' ' ' THR . 7.8 tt -72.86 -41.56 64.63 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.731 -0.864 . . . . 0.0 108.808 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.576 ' CA ' HG23 ' A' ' 198' ' ' THR . 0.0 OUTLIER -43.92 -42.14 5.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.486 -0.759 . . . . 0.0 109.975 179.61 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.511 ' N ' ' HD2' ' A' ' 195' ' ' LYS . . . -85.32 -25.64 39.12 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.867 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.66 -3.74 57.28 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.789 -0.83 . . . . 0.0 109.911 179.835 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' THR . . . . . 0.647 ' N ' ' O ' ' A' ' 194' ' ' LEU . 15.9 p -42.75 125.59 3.44 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.811 0.815 . . . . 0.0 111.85 -177.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.867 ' HG ' ' O ' ' A' ' 197' ' ' ARG . 0.1 OUTLIER -140.39 171.44 14.15 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.136 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.519 ' C ' HG13 ' A' ' 108' ' ' VAL . 3.2 m-85 -84.2 129.16 59.36 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.949 -1.094 . . . . 0.0 109.97 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.518 ' O ' ' HA ' ' A' ' 81' ' ' LYS . 50.7 Cg_endo -76.92 136.01 16.21 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 124.014 1.534 . . . . 0.0 111.012 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.507 ' HB2' ' CB ' ' A' ' 81' ' ' LYS . 4.7 t -133.18 140.21 47.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.449 -0.782 . . . . 0.0 109.945 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 79' ' ' ARG . 6.0 p -120.3 153.5 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.237 -0.914 . . . . 0.0 110.153 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' SER . . . . . 0.705 ' CB ' HG21 ' A' ' 105' ' ' VAL . 6.3 t -142.39 127.39 18.41 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.27 -0.894 . . . . 0.0 110.051 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.617 ' HA ' ' CH2' ' A' ' 95' ' ' TRP . . . -124.88 140.36 53.0 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.455 0.645 . . . . 0.0 110.415 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.578 ' CG1' ' N ' ' A' ' 207' ' ' TRP . 0.3 OUTLIER -64.56 -158.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.552 -0.718 . . . . 0.0 110.672 -179.527 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.602 ' CE2' ' HG2' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -121.1 154.98 35.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.409 -0.807 . . . . 0.0 109.932 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.458 ' O ' ' OE1' ' A' ' 211' ' ' GLN . . . 134.23 -175.18 20.55 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . 0.533 ' CG ' ' OE1' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -98.21 -30.04 12.86 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.207 -1.172 . . . . 0.0 110.401 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 1.6 t -116.36 81.25 1.59 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.334 -0.854 . . . . 0.0 110.468 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.458 ' OE1' ' O ' ' A' ' 208' ' ' GLY . 0.0 OUTLIER -123.68 -90.49 0.57 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.165 -0.96 . . . . 0.0 110.241 179.683 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.715 HG22 ' CG ' ' A' ' 95' ' ' TRP . 4.2 p -127.5 143.26 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.085 -1.009 . . . . 0.0 111.276 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . 0.553 ' CD ' ' HB3' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -102.18 145.59 29.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.469 -0.769 . . . . 0.0 108.953 178.64 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.585 ' HB ' ' CZ3' ' A' ' 48' ' ' TRP . 4.8 tt -115.97 140.44 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.954 -1.091 . . . . 0.0 111.266 -178.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.606 ' O ' ' N ' ' A' ' 92' ' ' GLU . 7.9 ttm180 -130.6 109.32 10.57 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . 0.65 ' CD2' ' CB ' ' A' ' 91' ' ' TRP . 3.2 t80 -118.13 146.99 43.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.035 -1.041 . . . . 0.0 111.248 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' MET . . . . . 0.505 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 2.6 mmt -136.39 115.84 12.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.564 -0.71 . . . . 0.0 110.0 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 126.69 -4.45 7.54 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.577 ' HB2' ' CE1' ' A' ' 216' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.248 -1.148 . . . . 0.0 110.229 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.631 ' O ' ' N ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 120.928 0.394 . . . . 0.0 110.459 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.517 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 42.9 mt-10 -43.87 -35.59 2.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.157 -0.964 . . . . 0.0 108.973 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -58.9 -24.26 62.09 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.631 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -83.46 -32.96 25.74 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.777 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.582 ' C ' ' CD1' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -82.2 -37.18 26.44 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.696 0.76 . . . . 0.0 109.488 179.389 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.546 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 14.9 m -61.61 -11.38 11.18 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.279 0.561 . . . . 0.0 110.264 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.728 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . . . -51.95 -168.04 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.431 -0.793 . . . . 0.0 110.272 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.728 ' HD2' ' CB ' ' A' ' 35' ' ' ALA . 40.7 Cg_endo -67.91 -169.81 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.55 1.289 . . . . 0.0 110.059 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.644 ' CD ' ' HB2' ' A' ' 36' ' ' PRO . 51.6 Cg_endo -96.77 63.55 0.13 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.528 1.486 . . . . 0.0 112.269 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.692 ' CD ' ' O ' ' A' ' 36' ' ' PRO . 51.2 Cg_endo -73.54 151.56 47.47 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.275 1.144 . . . . 0.0 109.583 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.59 ' O ' ' HB3' ' A' ' 43' ' ' GLN . 1.3 t0 -33.67 -30.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.3 -0.875 . . . . 0.0 109.833 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.953 ' O ' ' HB3' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -57.2 -44.88 84.08 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.279 -0.888 . . . . 0.0 110.72 -179.354 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.635 ' O ' ' ND1' ' A' ' 45' ' ' HIS . 22.3 t -85.74 -34.4 8.4 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 C-N-CA 118.54 -1.264 . . . . 0.0 110.327 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.62 -39.08 12.07 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.134 -0.979 . . . . 0.0 113.114 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.652 ' NE2' ' HB3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -87.13 -18.75 29.7 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 120.82 -1.175 . . . . 0.0 109.885 -178.741 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.953 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 3.0 ttp85 -76.84 -55.36 5.55 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.28 -0.887 . . . . 0.0 108.918 178.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.635 ' ND1' ' O ' ' A' ' 41' ' ' VAL . 65.9 m170 -45.4 -23.58 0.22 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.407 ' N ' ' O ' ' A' ' 44' ' ' ARG . 7.0 t60 -84.5 -39.67 18.58 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.489 ' CA ' ' HG3' ' A' ' 61' ' ' GLU . . . -83.52 -80.57 1.01 Allowed Glycine 0 N--CA 1.487 2.054 0 N-CA-C 106.679 -2.568 . . . . 0.0 106.679 177.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.693 ' CE2' ' CD1' ' A' ' 66' ' ' PHE . 99.5 m95 -90.42 73.5 6.95 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.299 -1.118 . . . . 0.0 108.87 177.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.721 ' O ' ' HB3' ' A' ' 53' ' ' CYS . 0.0 OUTLIER -44.88 163.1 0.2 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.721 -0.612 . . . . 0.0 110.997 179.835 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.764 ' O ' ' O ' ' A' ' 53' ' ' CYS . 41.0 Cg_endo -67.66 -60.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.818 1.431 . . . . 0.0 110.887 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.741 ' O ' ' O ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -40.17 -84.82 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.661 -1.274 . . . . 0.0 109.121 179.385 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.713 ' HA ' ' N ' ' A' ' 80' ' ' GLY . 2.0 m-20 -47.92 0.89 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.337 -0.852 . . . . 0.0 111.548 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.764 ' O ' ' O ' ' A' ' 50' ' ' PRO . 1.3 t -166.07 129.95 2.16 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.631 -1.293 . . . . 0.0 112.199 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.888 ' H ' ' HA ' ' A' ' 78' ' ' VAL . 1.8 m -81.85 124.1 29.39 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.437 -0.789 . . . . 0.0 109.753 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.65 ' HB3' ' NH2' ' A' ' 44' ' ' ARG . 3.2 pt-20 -51.6 -2.03 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.377 -0.827 . . . . 0.0 110.746 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.64 ' ND2' ' N ' ' A' ' 56' ' ' ASN . 0.3 OUTLIER -49.46 -21.5 0.95 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.835 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.535 ' CG2' ' CG1' ' A' ' 59' ' ' VAL . 0.9 OUTLIER -112.04 166.73 6.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.676 -0.64 . . . . 0.0 109.916 -179.705 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.514 ' N ' ' CG2' ' A' ' 57' ' ' ILE . 2.0 t70 -109.12 96.11 6.09 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.006 0.908 . . . . 0.0 110.054 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.649 HG13 ' CD1' ' A' ' 66' ' ' PHE . 33.3 m -128.35 135.45 62.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.711 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.652 ' HB3' ' NE2' ' A' ' 43' ' ' GLN . 13.1 mtpt -125.62 155.41 40.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.006 -1.058 . . . . 0.0 111.558 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.492 ' O ' ' C ' ' A' ' 62' ' ' GLY . 1.4 tt0 -80.24 -130.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.384 -0.823 . . . . 0.0 110.06 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.492 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 39.92 53.87 3.08 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.676 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 105.84 66.05 0.66 Allowed Glycine 0 N--CA 1.486 2.009 0 N-CA-C 107.785 -2.126 . . . . 0.0 107.785 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.68 HD12 ' CZ2' ' A' ' 48' ' ' TRP . 0.2 OUTLIER 0.77 86.31 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 122.026 -0.691 . . . . 0.0 111.454 -178.522 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -99.66 113.93 26.68 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.703 179.564 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.693 ' CD1' ' CE2' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -114.38 124.67 52.53 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.569 -0.707 . . . . 0.0 109.193 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.519 ' O ' HG22 ' A' ' 57' ' ' ILE . 3.7 tm-20 -150.36 130.32 13.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.982 -1.074 . . . . 0.0 110.921 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.529 ' HG2' ' N ' ' A' ' 208' ' ' GLY . 0.6 OUTLIER -110.85 156.15 21.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.372 -0.83 . . . . 0.0 109.449 179.209 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.589 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 2.3 tpt180 -173.94 -52.95 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 120.982 -1.074 . . . . 0.0 111.687 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 69' ' ' ARG . 40.0 Cg_endo -66.09 -52.79 0.8 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.508 1.268 . . . . 0.0 111.298 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.624 HG22 ' CB ' ' A' ' 56' ' ' ASN . 25.4 t -78.55 164.97 3.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.244 -0.91 . . . . 0.0 110.867 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.489 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -179.47 -30.49 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.445 0.64 . . . . 0.0 109.429 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -73.93 -116.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.373 -0.829 . . . . 0.0 110.202 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.9 t -124.48 50.07 1.74 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.019 -1.051 . . . . 0.0 110.397 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.502 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 4.2 m -83.41 -125.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 0.0 110.054 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.549 ' CB ' ' OD1' ' A' ' 56' ' ' ASN . 0.4 OUTLIER -136.6 112.69 9.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.089 -1.007 . . . . 0.0 110.71 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.534 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -57.23 -92.89 0.01 OUTLIER Glycine 0 N--CA 1.482 1.765 0 N-CA-C 105.359 -3.096 . . . . 0.0 105.359 177.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.888 ' HA ' ' H ' ' A' ' 54' ' ' SER . 32.7 m -152.9 119.5 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.229 -1.16 . . . . 0.0 110.047 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.741 ' O ' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -146.87 134.09 20.55 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.602 -0.686 . . . . 0.0 111.224 -179.299 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.713 ' N ' ' HA ' ' A' ' 52' ' ' ASP . . . -132.2 -179.64 16.4 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.567 ' HB2' ' CB ' ' A' ' 202' ' ' SER . 0.0 OUTLIER 179.98 26.5 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.432 -1.04 . . . . 0.0 110.28 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.73 ' CD ' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -69.77 -18.59 63.5 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.164 -0.96 . . . . 0.0 110.722 -179.674 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.73 ' N ' ' CD ' ' A' ' 82' ' ' ARG . . . 27.8 44.37 0.04 OUTLIER Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.503 ' N ' ' O ' ' A' ' 82' ' ' ARG . 1.2 t80 -103.63 95.56 6.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.218 -1.166 . . . . 0.0 110.482 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.519 ' OG ' ' CD2' ' A' ' 171' ' ' LEU . 3.6 p -140.47 166.58 24.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.311 -0.868 . . . . 0.0 110.172 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.549 ' HD2' ' NE2' ' A' ' 89' ' ' HIS . 0.5 OUTLIER -136.31 156.52 48.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 109.928 179.584 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.566 ' N ' ' HB3' ' A' ' 173' ' ' MET . . . 62.31 -114.45 6.83 Favored Glycine 0 N--CA 1.483 1.816 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.19 131.26 47.09 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.513 -0.992 . . . . 0.0 110.968 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.549 ' NE2' ' HD2' ' A' ' 86' ' ' ARG . 74.1 m-70 -147.25 173.38 12.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.199 -0.938 . . . . 0.0 109.997 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.6 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -163.59 154.36 16.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.362 -0.836 . . . . 0.0 110.583 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.736 ' CD1' ' CZ ' ' A' ' 216' ' ' TYR . 0.1 OUTLIER -134.66 170.79 15.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.171 -0.955 . . . . 0.0 109.3 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.606 ' HB3' ' HB3' ' A' ' 215' ' ' ARG . 0.9 OUTLIER -146.8 152.66 39.12 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.699 -179.511 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.554 ' CD1' HG13 ' A' ' 214' ' ' ILE . 7.8 mm -142.71 153.66 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.675 -0.641 . . . . 0.0 109.433 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.536 ' HB3' ' HB2' ' A' ' 166' ' ' ARG . 0.0 OUTLIER -155.35 127.56 7.71 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.788 -1.195 . . . . 0.0 111.511 -179.564 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.643 ' CD1' ' N ' ' A' ' 95' ' ' TRP . 5.8 m95 -114.21 87.9 14.16 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.221 -0.924 . . . . 0.0 109.922 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.53 ' O ' ' NE2' ' A' ' 211' ' ' GLN . 51.7 Cg_endo -95.14 107.13 0.12 Allowed 'Trans proline' 0 C--N 1.302 -1.891 0 O-C-N 123.399 1.21 . . . . 0.0 110.333 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.414 ' HA ' HD11 ' A' ' 97' ' ' LEU . 23.5 tp . . . . . 0 N--CA 1.49 1.56 0 O-C-N 120.9 -1.125 . . . . 0.0 109.091 178.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.661 ' CG2' ' O ' ' A' ' 204' ' ' SER . 3.7 m . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.704 ' CG2' ' O ' ' A' ' 202' ' ' SER . 0.7 OUTLIER -150.33 149.61 14.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.459 -0.776 . . . . 0.0 110.584 -178.302 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.565 ' HA2' ' HA3' ' A' ' 132' ' ' GLY . . . -153.91 142.79 9.44 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.643 ' HA ' ' O ' ' A' ' 200' ' ' TYR . 2.8 m -98.46 155.17 3.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.251 -1.146 . . . . 0.0 110.299 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.529 ' C ' ' HB3' ' A' ' 199' ' ' LEU . . . -124.47 141.32 52.17 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.356 -0.84 . . . . 0.0 110.614 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.565 HG22 ' CB ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -121.07 131.62 54.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.397 -0.815 . . . . 0.0 110.127 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.95 -26.4 17.58 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.346 -0.846 . . . . 0.0 109.358 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.0 pp -83.91 -12.31 55.63 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.572 -0.705 . . . . 0.0 109.329 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.542 -0.724 . . . . 0.0 110.245 -179.98 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 66.7 p . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.276 0.56 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -145.12 125.66 14.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.302 -0.874 . . . . 0.0 109.977 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 1.1 t -121.59 119.73 32.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 110.484 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . 0.565 ' O ' HG22 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -133.37 135.16 44.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.882 . . . . 0.0 109.781 179.679 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.565 ' HA3' ' HA2' ' A' ' 107' ' ' GLY . . . -175.66 -137.76 2.64 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.028 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.641 ' CH2' ' CD1' ' A' ' 182' ' ' ILE . 42.4 m0 -118.79 113.63 21.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.419 -1.048 . . . . 0.0 110.843 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.424 ' C ' HG12 ' A' ' 135' ' ' ILE . 45.5 t0 -118.63 147.64 43.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.512 -0.742 . . . . 0.0 109.895 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.5 HD13 HG21 ' A' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.116 -0.99 . . . . 0.0 110.239 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.745 ' CG1' ' CD ' ' A' ' 164' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.863 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.745 ' CD ' ' CG1' ' A' ' 163' ' ' VAL . 43.8 Cg_endo -72.29 178.76 5.7 Favored 'Trans proline' 0 C--N 1.318 -1.03 0 O-C-N 122.481 0.727 . . . . 0.0 110.999 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.515 ' O ' ' HB3' ' A' ' 94' ' ' SER . 2.2 mt-10 -46.51 -32.2 3.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.428 -0.795 . . . . 0.0 111.232 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.536 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 18.2 ttp180 -151.83 156.17 39.64 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.981 -1.075 . . . . 0.0 111.13 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.552 HD21 ' CB ' ' A' ' 163' ' ' VAL . 1.7 mp -126.85 157.31 39.65 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.543 -0.723 . . . . 0.0 109.436 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 181' ' ' SER . 1.1 tt -117.44 121.41 40.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.065 -1.022 . . . . 0.0 110.728 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.631 ' CG1' ' CE3' ' A' ' 91' ' ' TRP . 16.4 t -89.65 128.78 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.3 -0.875 . . . . 0.0 109.494 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.463 HG21 ' CD2' ' A' ' 168' ' ' LEU . 19.2 t -109.99 115.62 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.004 -1.06 . . . . 0.0 110.675 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.574 HD13 ' CD2' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -129.27 123.12 31.1 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.285 -0.884 . . . . 0.0 109.491 179.505 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 173' ' ' MET . 47.3 t0 -120.13 137.96 53.86 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.177 -0.952 . . . . 0.0 110.021 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.566 ' HB3' ' N ' ' A' ' 87' ' ' GLY . 0.0 OUTLIER -98.56 -40.68 8.11 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.56 179.676 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -50.85 -22.61 2.27 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.318 -0.864 . . . . 0.0 109.073 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.574 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.3 OUTLIER -109.26 -27.97 9.25 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.803 0.811 . . . . 0.0 108.924 179.473 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.583 ' O ' ' CB ' ' A' ' 198' ' ' THR . . . 86.84 22.34 46.48 Favored Glycine 0 N--CA 1.482 1.709 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.647 HG23 HD22 ' A' ' 194' ' ' LEU . 0.0 OUTLIER -112.52 133.45 54.57 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.099 -1.236 . . . . 0.0 111.466 -179.389 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.644 ' N ' ' CD1' ' A' ' 178' ' ' LEU . 2.6 mp -130.52 153.59 48.68 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.654 -0.654 . . . . 0.0 109.472 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.472 ' O ' HG13 ' A' ' 169' ' ' VAL . . . 176.16 -175.29 47.39 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.231 -1.461 . . . . 0.0 110.538 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.629 ' CE2' HG22 ' A' ' 169' ' ' VAL . 0.2 OUTLIER -127.18 131.51 50.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.67 -0.9 . . . . 0.0 109.173 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 168' ' ' LEU . 3.4 t -136.7 131.22 33.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.122 -0.986 . . . . 0.0 110.536 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.641 ' CD1' ' CH2' ' A' ' 133' ' ' TRP . 0.0 OUTLIER -102.27 116.84 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.372 -0.83 . . . . 0.0 109.393 179.212 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 83.45 -11.87 53.85 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 81.43 47.05 6.59 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 32.4 m -136.13 -36.46 0.74 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.135 -1.215 . . . . 0.0 110.775 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.593 ' CD2' HD13 ' A' ' 182' ' ' ILE . 5.1 m-30 -67.0 -77.23 0.07 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.005 -1.06 . . . . 0.0 110.506 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.602 ' O ' ' CE2' ' A' ' 191' ' ' PHE . 2.4 mm? -68.46 44.28 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.906 -1.121 . . . . 0.0 109.88 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.463 ' H ' ' C ' ' A' ' 186' ' ' TYR . . . -94.95 -63.89 1.0 Allowed Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.99 -1.1 . . . . 0.0 110.611 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.457 ' HD2' ' O ' ' A' ' 186' ' ' TYR . 45.1 Cg_endo -72.01 -30.99 13.0 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.802 1.422 . . . . 0.0 111.3 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.739 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -74.58 16.59 0.26 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.239 -0.913 . . . . 0.0 111.418 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.602 ' CE2' ' O ' ' A' ' 187' ' ' LEU . 0.3 OUTLIER -89.57 -8.34 52.88 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.063 -1.023 . . . . 0.0 109.982 179.204 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.06 -15.3 32.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.568 -0.707 . . . . 0.0 110.126 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -115.71 -11.17 10.54 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 107.483 -2.247 . . . . 0.0 107.483 179.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.859 ' HA ' ' HD2' ' A' ' 197' ' ' ARG . 0.4 OUTLIER -70.56 -22.17 62.62 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.796 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.571 ' HA ' HG22 ' A' ' 177' ' ' THR . 0.0 OUTLIER -57.29 -26.55 61.04 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.355 -0.84 . . . . 0.0 109.378 179.038 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.531 ' N ' ' HE3' ' A' ' 195' ' ' LYS . . . -106.08 -37.74 2.45 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.859 ' HD2' ' HA ' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -79.62 -4.52 51.98 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.448 -1.031 . . . . 0.0 110.567 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' THR . . . . . 0.583 ' CB ' ' O ' ' A' ' 176' ' ' GLY . 0.2 OUTLIER -43.37 133.82 4.08 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-O 122.194 0.997 . . . . 0.0 112.174 -177.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.835 ' HG ' ' O ' ' A' ' 197' ' ' ARG . 0.0 OUTLIER -141.73 171.06 14.57 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.218 179.19 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.643 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 46.5 m-85 -90.21 126.79 55.68 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.827 -1.171 . . . . 0.0 109.373 178.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.582 ' HG2' ' CH2' ' A' ' 91' ' ' TRP . 53.2 Cg_endo -82.16 150.36 15.64 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 124.196 1.629 . . . . 0.0 112.489 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.704 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 73.6 p -133.69 149.84 51.52 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.567 ' HA ' ' HB ' ' A' ' 106' ' ' VAL . 14.5 p -118.62 168.17 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.406 -1.434 . . . . 0.0 110.623 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' SER . . . . . 0.661 ' O ' ' CG2' ' A' ' 105' ' ' VAL . 0.4 OUTLIER -156.0 145.16 20.64 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.425 0.631 . . . . 0.0 109.923 179.681 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.669 ' CB ' ' CG2' ' A' ' 78' ' ' VAL . . . -145.47 135.96 24.18 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.74 -0.6 . . . . 0.0 109.705 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.572 ' CG1' ' N ' ' A' ' 207' ' ' TRP . 1.5 t -76.57 172.06 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.459 -0.776 . . . . 0.0 110.512 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.609 ' CD1' ' O ' ' A' ' 207' ' ' TRP . 14.2 p90 -121.91 128.51 51.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.307 -0.871 . . . . 0.0 110.089 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.529 ' N ' ' HG2' ' A' ' 68' ' ' ARG . . . 154.4 -167.12 32.39 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . 0.449 ' C ' ' O ' ' A' ' 208' ' ' GLY . 0.0 OUTLIER -40.21 -28.74 0.06 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.381 -1.07 . . . . 0.0 110.142 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . 0.494 ' C ' ' HG3' ' A' ' 211' ' ' GLN . 9.7 t -64.26 164.29 11.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.321 -0.862 . . . . 0.0 110.219 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.53 ' NE2' ' O ' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -164.24 109.55 1.01 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.358 -0.839 . . . . 0.0 109.655 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.645 ' O ' ' CH2' ' A' ' 48' ' ' TRP . 5.7 p -102.65 143.77 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.437 -0.79 . . . . 0.0 110.308 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . 0.439 ' HB2' ' OG ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -93.93 156.2 16.75 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.364 -0.835 . . . . 0.0 109.41 179.361 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.612 ' HB ' ' CZ3' ' A' ' 48' ' ' TRP . 4.9 tt -139.06 131.54 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.046 -1.034 . . . . 0.0 110.812 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.606 ' HB3' ' HB3' ' A' ' 92' ' ' GLU . 12.6 ttt180 -130.1 108.29 9.96 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . 0.736 ' CZ ' ' CD1' ' A' ' 91' ' ' TRP . 4.2 t80 -118.92 142.94 47.32 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.385 -0.822 . . . . 0.0 111.15 -177.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.58 115.57 12.34 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.558 -0.713 . . . . 0.0 110.102 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 133.85 53.85 0.07 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.265 -1.138 . . . . 0.0 110.114 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.566 ' HG ' ' N ' ' A' ' 30' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.184 0.516 . . . . 0.0 110.285 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.566 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 1.3 mt-10 -47.69 -35.12 9.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.101 -0.999 . . . . 0.0 109.192 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -62.27 -24.07 67.07 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.309 -0.87 . . . . 0.0 108.841 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.545 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.7 OUTLIER -83.44 -34.06 25.54 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.596 ' HG ' ' N ' ' A' ' 34' ' ' SER . 0.3 OUTLIER -76.17 -36.06 58.88 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.877 0.846 . . . . 0.0 109.42 179.323 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.596 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -80.46 -7.37 59.13 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.161 179.878 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.636 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . . . -54.87 -66.81 0.82 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.213 -0.929 . . . . 0.0 110.488 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.69 ' C ' ' HD3' ' A' ' 38' ' ' PRO . 48.9 Cg_endo -73.65 143.22 33.62 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.692 1.364 . . . . 0.0 110.316 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 36' ' ' PRO . 53.8 Cg_endo -98.88 56.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 121.898 1.732 . . . . 0.0 112.034 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.69 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 52.8 Cg_endo -75.82 150.91 35.35 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 122.979 0.989 . . . . 0.0 110.118 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.606 ' O ' ' HB3' ' A' ' 43' ' ' GLN . 1.0 OUTLIER -34.26 -33.52 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.313 -0.867 . . . . 0.0 109.457 179.557 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 1.063 ' O ' ' HB3' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -57.41 -46.88 83.02 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.242 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.57 ' CG2' HD12 ' A' ' 40' ' ' LEU . 54.4 t -86.6 -33.7 7.32 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 O-C-N 120.647 -1.283 . . . . 0.0 110.415 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.21 -39.17 12.25 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.401 -0.812 . . . . 0.0 113.058 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.606 ' HB3' ' O ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -86.67 -19.65 28.93 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 120.726 -1.234 . . . . 0.0 109.455 -178.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 1.063 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -79.36 -51.09 9.87 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 122.078 0.942 . . . . 0.0 109.528 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.732 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 59.5 m170 -51.52 -17.57 0.85 Allowed 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.632 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.402 ' CD2' ' C ' ' A' ' 46' ' ' HIS . 4.0 t60 -84.46 -39.21 19.21 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.443 -1.303 . . . . 0.0 110.029 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.566 ' O ' ' CD1' ' A' ' 214' ' ' ILE . . . -97.98 -68.19 0.93 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 106.597 -2.601 . . . . 0.0 106.597 177.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.838 ' CD1' ' CG2' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -89.26 72.61 8.13 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 177.229 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.714 ' HA ' ' HA ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER -55.22 151.45 18.15 Favored Pre-proline 0 N--CA 1.494 1.754 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.412 -178.514 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.732 ' HD3' ' HA ' ' A' ' 45' ' ' HIS . 45.0 Cg_endo -78.49 -25.86 6.43 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 124.522 1.801 . . . . 0.0 110.563 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.847 ' CE ' ' N ' ' A' ' 51' ' ' LYS . 0.4 OUTLIER -64.48 -14.3 56.4 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.145 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 1.073 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 9.8 m-20 -122.75 2.16 9.45 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.644 178.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.783 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 10.1 t -151.73 132.94 14.45 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.877 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.714 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 0.8 OUTLIER -71.81 118.49 14.73 Favored 'General case' 0 C--N 1.292 -1.926 0 O-C-N 121.548 -0.72 . . . . 0.0 110.34 179.434 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.626 ' C ' ' H ' ' A' ' 57' ' ' ILE . 0.7 OUTLIER -40.25 -20.49 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.503 -0.748 . . . . 0.0 111.786 -179.641 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.714 ' ND2' ' HB2' ' A' ' 54' ' ' SER . 0.0 OUTLIER -54.45 -1.9 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.762 -1.211 . . . . 0.0 109.638 179.755 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.626 ' H ' ' C ' ' A' ' 55' ' ' GLU . 26.9 mm -111.68 155.35 13.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.923 0.868 . . . . 0.0 111.323 -177.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.93 ' HA ' HD22 ' A' ' 40' ' ' LEU . 1.4 t70 -118.14 95.36 4.86 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.718 0.77 . . . . 0.0 109.266 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.838 ' CG2' ' CD1' ' A' ' 48' ' ' TRP . 1.1 p -131.56 118.99 41.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 O-C-N 121.808 -0.557 . . . . 0.0 111.397 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.607 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -136.76 157.57 46.44 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.066 -1.021 . . . . 0.0 111.265 179.551 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.771 ' N ' ' CH2' ' A' ' 48' ' ' TRP . 1.0 OUTLIER -39.27 -112.98 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.717 -0.614 . . . . 0.0 112.029 -179.157 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.514 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 42.11 44.57 4.82 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 107.291 -2.324 . . . . 0.0 107.291 -177.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.743 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 84.64 87.08 0.89 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 106.881 -2.488 . . . . 0.0 106.881 -177.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.743 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.2 OUTLIER 1.48 82.88 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.632 -0.922 . . . . 0.0 109.901 -177.875 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.447 ' N ' ' O ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -101.57 114.15 27.93 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.879 -0.728 . . . . 0.0 110.48 -178.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.639 ' CB ' ' HA ' ' A' ' 211' ' ' GLN . 4.5 t80 -114.42 123.39 49.33 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.582 ' O ' ' N ' ' A' ' 58' ' ' ASP . 1.3 tm-20 -151.7 163.05 39.96 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.16 -0.963 . . . . 0.0 110.497 -179.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.611 ' CG ' ' HB2' ' A' ' 207' ' ' TRP . 0.2 OUTLIER -111.42 153.37 26.19 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.222 -0.923 . . . . 0.0 109.841 179.223 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.704 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 34.8 mtp180 -85.2 -73.87 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 120.978 -1.076 . . . . 0.0 109.665 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.704 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 57.5 Cg_endo -76.23 -124.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 N-CA-C 108.384 -1.429 . . . . 0.0 108.384 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.6 t -140.44 164.51 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.455 -1.403 . . . . 0.0 109.947 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.576 ' HB2' ' CD1' ' A' ' 207' ' ' TRP . . . -80.04 33.45 0.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.178 -0.951 . . . . 0.0 110.357 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -45.98 -47.47 16.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.258 -0.901 . . . . 0.0 110.361 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.9 p -172.67 30.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.27 -0.894 . . . . 0.0 110.154 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.9 t -97.87 -132.06 0.22 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.883 . . . . 0.0 109.992 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.595 ' O ' ' HB2' ' A' ' 54' ' ' SER . 12.5 m-20 -140.41 114.05 8.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.157 -0.964 . . . . 0.0 110.572 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 76' ' ' ASP . . . -55.83 -106.52 0.01 OUTLIER Glycine 0 N--CA 1.486 1.986 0 N-CA-C 107.942 -2.063 . . . . 0.0 107.942 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.783 ' HA ' ' HA ' ' A' ' 53' ' ' CYS . 4.4 m -138.16 123.91 24.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 120.998 -1.295 . . . . 0.0 110.078 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.662 ' NE ' ' O ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -145.42 133.83 21.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.18 -0.95 . . . . 0.0 112.161 -178.616 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 1.073 ' CA ' ' HA ' ' A' ' 52' ' ' ASP . . . -131.79 163.84 23.72 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 178.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.532 ' CB ' ' HB3' ' A' ' 202' ' ' SER . 2.5 ttpm? -171.01 87.28 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.494 -1.003 . . . . 0.0 109.513 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.809 ' HD3' ' H ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -152.31 -91.18 0.05 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.227 -0.92 . . . . 0.0 110.542 -179.366 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.809 ' H ' ' HD3' ' A' ' 82' ' ' ARG . . . 45.75 42.78 11.2 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -97.21 106.2 18.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -1.11 . . . . 0.0 110.217 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.594 ' HB2' ' CE1' ' A' ' 89' ' ' HIS . 75.5 p -138.28 167.17 22.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 0.0 110.071 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.516 ' O ' ' NE2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -120.14 135.44 54.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.216 -0.927 . . . . 0.0 110.285 -179.824 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 172' ' ' ASP . . . 102.83 -116.64 5.54 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.476 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 2.5 tp -128.36 130.27 47.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.321 -1.105 . . . . 0.0 110.282 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.594 ' CE1' ' HB2' ' A' ' 85' ' ' SER . 33.4 m-70 -146.33 166.2 27.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.099 -1.001 . . . . 0.0 109.997 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.539 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -158.99 153.71 24.63 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.054 -1.029 . . . . 0.0 109.92 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.717 ' CD1' ' CE2' ' A' ' 216' ' ' TYR . 1.4 m0 -134.81 148.57 50.22 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.298 -0.876 . . . . 0.0 109.911 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.653 ' O ' ' N ' ' A' ' 215' ' ' ARG . 7.8 mt-10 -109.56 118.42 36.55 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.52 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.509 ' O ' ' HB2' ' A' ' 167' ' ' LEU . 1.2 mp -133.69 154.52 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.054 -1.029 . . . . 0.0 110.877 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.566 ' HA ' ' HG ' ' A' ' 167' ' ' LEU . 0.3 OUTLIER -140.88 119.94 12.8 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.16 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.774 ' CE3' ' CG2' ' A' ' 106' ' ' VAL . 3.0 t-105 -117.41 89.5 31.91 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.072 -1.018 . . . . 0.0 110.657 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -89.18 109.53 0.47 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.085 1.571 . . . . 0.0 110.153 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.507 ' HG ' HG13 ' A' ' 135' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.758 0 O-C-N 121.128 -0.982 . . . . 0.0 110.399 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.647 ' N ' ' CH2' ' A' ' 95' ' ' TRP . 4.9 p . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 121.244 0.545 . . . . 0.0 112.405 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.774 ' CG2' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -122.31 115.93 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 177.114 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.575 ' CA ' ' HA3' ' A' ' 132' ' ' GLY . . . -160.54 -164.96 16.43 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 118.648 -1.739 . . . . 0.0 111.227 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.532 ' CG1' ' HB2' ' A' ' 199' ' ' LEU . 0.7 OUTLIER -120.54 156.23 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.617 -0.931 . . . . 0.0 109.515 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 130' ' ' SER . . . -128.13 143.09 51.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.861 -1.149 . . . . 0.0 110.686 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.553 HG23 ' CG ' ' A' ' 199' ' ' LEU . 0.7 OUTLIER -115.38 123.13 47.9 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.196 -0.94 . . . . 0.0 110.455 179.74 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.91 -31.03 14.47 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.465 -0.772 . . . . 0.0 109.712 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.695 ' O ' ' C ' ' A' ' 113' ' ' ALA . 1.7 pp -79.22 -11.87 59.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.507 -0.745 . . . . 0.0 110.115 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.695 ' C ' ' O ' ' A' ' 112' ' ' LEU . . . . . . . . 0 N--CA 1.499 2.01 0 O-C-N 121.872 -0.518 . . . . 0.0 111.128 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.17 0.51 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -149.84 128.91 12.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.268 -0.895 . . . . 0.0 109.964 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 2.9 t -120.41 119.35 32.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.16 -0.963 . . . . 0.0 110.501 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -133.94 136.19 44.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.501 -0.749 . . . . 0.0 109.305 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.588 ' O ' ' CD1' ' A' ' 133' ' ' TRP . . . -165.39 -111.34 0.24 Allowed Glycine 0 N--CA 1.486 2.001 0 C-N-CA 119.042 -1.552 . . . . 0.0 110.796 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.735 ' CH2' ' CB ' ' A' ' 180' ' ' TYR . 5.3 m-90 -140.3 122.77 16.1 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 121.168 -1.195 . . . . 0.0 111.634 -178.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.551 ' OD1' ' CG2' ' A' ' 105' ' ' VAL . 0.9 OUTLIER -118.89 148.62 42.72 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.394 -179.638 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.507 HG13 ' HG ' ' A' ' 97' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.79 0 O-C-N 121.348 -0.845 . . . . 0.0 110.313 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.672 ' N ' ' HD3' ' A' ' 164' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.457 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.672 ' HD3' ' N ' ' A' ' 163' ' ' VAL . 53.7 Cg_endo -79.76 81.91 2.64 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.785 1.413 . . . . 0.0 110.872 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -167.25 -84.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.05 -1.031 . . . . 0.0 110.106 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.535 ' O ' ' CD2' ' A' ' 167' ' ' LEU . 20.3 ttp180 -151.9 155.84 38.9 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.461 -0.775 . . . . 0.0 109.988 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.605 ' HB3' HG21 ' A' ' 182' ' ' ILE . 9.9 mt -138.15 128.85 26.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.192 -0.943 . . . . 0.0 110.525 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 17.7 tp -103.63 141.34 36.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.259 -0.9 . . . . 0.0 109.167 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.682 ' CG2' ' CE2' ' A' ' 180' ' ' TYR . 6.8 t -125.55 132.22 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.799 -1.188 . . . . 0.0 111.58 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.485 ' O ' ' CG1' ' A' ' 170' ' ' VAL . 11.4 p -138.02 104.93 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.546 ' CD1' ' HB3' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -118.41 141.13 48.85 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.134 -0.979 . . . . 0.0 110.417 -179.083 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 173' ' ' MET . 40.4 t0 -120.2 138.68 53.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.29 -0.881 . . . . 0.0 110.19 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.55 ' CG ' ' O ' ' A' ' 85' ' ' SER . 4.1 tpt -89.97 -39.15 13.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.624 -0.673 . . . . 0.0 109.849 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 173' ' ' MET . 1.4 tt0 -42.09 -27.78 0.15 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.892 . . . . 0.0 109.191 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.505 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 3.0 tt0 -106.99 -27.76 10.46 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.702 0.763 . . . . 0.0 108.97 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 86.11 21.98 50.37 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.596 ' HA ' ' CD2' ' A' ' 194' ' ' LEU . 0.8 OUTLIER -121.76 150.54 41.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.342 -1.093 . . . . 0.0 110.642 -179.651 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.546 ' HB3' ' CD1' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -117.44 153.52 32.95 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.439 -0.788 . . . . 0.0 109.895 179.815 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -134.09 122.03 2.88 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.735 ' CB ' ' CH2' ' A' ' 133' ' ' TRP . 2.4 t80 -119.77 124.8 47.06 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.26 -1.141 . . . . 0.0 109.508 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.452 ' HA ' HG21 ' A' ' 185' ' ' THR . 12.5 t -103.66 122.21 44.55 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 122.135 0.969 . . . . 0.0 109.456 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.817 ' O ' ' N ' ' A' ' 185' ' ' THR . 0.0 OUTLIER -129.42 158.54 42.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.819 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.612 ' C ' ' O ' ' A' ' 182' ' ' ILE . . . -33.63 -34.77 0.03 OUTLIER Glycine 0 N--CA 1.493 2.446 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.686 ' O ' ' CD1' ' A' ' 186' ' ' TYR . . . -105.5 32.66 7.2 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.549 -1.82 . . . . 0.0 108.549 178.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' THR . . . . . 0.817 ' N ' ' O ' ' A' ' 182' ' ' ILE . 53.3 m -37.77 -26.59 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.494 -1.004 . . . . 0.0 110.871 -179.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.7 ' O ' ' CD2' ' A' ' 186' ' ' TYR . 16.9 p90 -41.38 91.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 122.202 1.001 . . . . 0.0 109.316 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.649 ' N ' ' O ' ' A' ' 185' ' ' THR . 0.1 OUTLIER 179.81 31.2 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.542 -0.724 . . . . 0.0 109.221 -178.79 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.865 ' N ' ' CD ' ' A' ' 189' ' ' PRO . . . -105.67 2.08 39.22 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.403 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.865 ' CD ' ' N ' ' A' ' 188' ' ' GLY . 48.7 Cg_endo -75.79 -27.12 9.06 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 N-CA-C 109.426 -1.028 . . . . 0.0 109.426 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -81.43 21.97 0.73 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.631 -0.668 . . . . 0.0 110.476 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -73.2 -48.67 33.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.11 -0.994 . . . . 0.0 109.945 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 9.5 mtm180 -52.87 -19.25 2.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.187 -0.946 . . . . 0.0 109.766 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -107.32 -17.93 10.91 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.166 -1.973 . . . . 0.0 108.166 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.652 HD23 ' C ' ' A' ' 194' ' ' LEU . 6.9 tt -62.2 -31.32 71.83 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.692 -0.887 . . . . 0.0 109.205 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.543 ' HE3' ' N ' ' A' ' 196' ' ' GLY . 0.0 OUTLIER -49.52 -27.83 4.8 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.443 -0.786 . . . . 0.0 109.407 179.534 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.543 ' N ' ' HE3' ' A' ' 195' ' ' LYS . . . -112.29 -21.59 6.17 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.633 ' C ' ' CD ' ' A' ' 197' ' ' ARG . 0.0 OUTLIER -90.77 -10.42 42.95 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.65 -0.912 . . . . 0.0 109.749 179.745 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 194' ' ' LEU . 0.1 OUTLIER -43.83 145.25 0.71 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.907 0.86 . . . . 0.0 111.427 -178.559 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' A' ' 197' ' ' ARG . 0.0 OUTLIER -140.43 171.45 14.12 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.24 0.543 . . . . 0.0 109.725 179.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.468 ' O ' HG11 ' A' ' 108' ' ' VAL . 15.8 m-30 -84.33 136.98 39.75 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.178 -0.951 . . . . 0.0 109.218 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.578 ' HG3' ' CH2' ' A' ' 91' ' ' TRP . 40.8 Cg_endo -67.03 109.82 1.81 Allowed 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 123.862 1.454 . . . . 0.0 110.814 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.532 ' HB3' ' CB ' ' A' ' 81' ' ' LYS . 57.4 p -133.47 137.2 45.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.507 -0.746 . . . . 0.0 109.595 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.565 ' CG2' HG11 ' A' ' 106' ' ' VAL . 4.9 p -128.9 146.55 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.994 -1.066 . . . . 0.0 111.187 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 26.7 m -128.75 127.19 41.54 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.577 ' CB ' ' CG2' ' A' ' 78' ' ' VAL . . . -126.28 166.14 17.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 0.0 110.716 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.583 ' CG1' ' N ' ' A' ' 207' ' ' TRP . 0.9 OUTLIER -101.63 174.66 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 121.363 0.602 . . . . 0.0 110.233 -179.533 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.611 ' HB2' ' CG ' ' A' ' 68' ' ' ARG . 63.9 p-90 -99.01 128.43 45.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.89 . . . . 0.0 110.264 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 144.04 -147.48 18.78 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 211' ' ' GLN . 0.0 OUTLIER -66.18 -25.25 66.85 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.345 -1.091 . . . . 0.0 110.239 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . 0.678 ' O ' ' C ' ' A' ' 211' ' ' GLN . 4.9 t -37.12 -30.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.593 -0.692 . . . . 0.0 110.621 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.678 ' C ' ' O ' ' A' ' 210' ' ' CYS . 10.4 mt-30 0.07 114.59 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 121.65 0.738 . . . . 0.0 111.427 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 210' ' ' CYS . 0.8 OUTLIER -115.62 144.09 24.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.642 -0.661 . . . . 0.0 110.668 -179.164 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . 0.558 ' HG3' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -88.54 121.96 31.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.281 -0.887 . . . . 0.0 109.566 179.758 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.623 ' CD1' ' O ' ' A' ' 214' ' ' ILE . 0.0 OUTLIER -123.5 121.59 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 110.896 -179.241 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.653 ' N ' ' O ' ' A' ' 92' ' ' GLU . 0.2 OUTLIER -130.87 139.61 50.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.513 -0.742 . . . . 0.0 109.665 179.495 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . 0.717 ' CE2' ' CD1' ' A' ' 91' ' ' TRP . 0.9 OUTLIER -118.7 150.76 39.21 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.965 -1.085 . . . . 0.0 110.728 -179.439 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' MET . . . . . 0.494 ' CB ' ' O ' ' A' ' 90' ' ' ALA . 2.0 ttm -125.08 107.82 11.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.305 -0.872 . . . . 0.0 110.039 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 116.54 21.59 4.67 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.108 -1.23 . . . . 0.0 110.23 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.052 0.453 . . . . 0.0 109.982 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.526 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 3.0 pt-20 -48.42 -35.71 13.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.052 -1.03 . . . . 0.0 108.691 179.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -59.13 -26.09 64.42 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -77.73 -36.01 51.35 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.457 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.644 ' C ' ' CD1' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -76.3 -38.85 55.49 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.663 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.551 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -45.92 -26.62 0.73 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.454 0.645 . . . . 0.0 109.925 179.891 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.696 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . . . -52.16 -168.47 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.567 -0.708 . . . . 0.0 109.376 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.696 ' HD2' ' CB ' ' A' ' 35' ' ' ALA . 39.7 Cg_endo -67.07 104.53 0.86 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.448 1.236 . . . . 0.0 109.704 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.689 ' HB2' ' CG2' ' A' ' 41' ' ' VAL . 51.1 Cg_endo -90.84 115.24 0.46 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.284 1.676 . . . . 0.0 111.49 -178.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.902 ' O ' ' N ' ' A' ' 40' ' ' LEU . 50.6 Cg_endo -86.13 152.59 9.57 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 124.087 1.572 . . . . 0.0 110.493 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.676 ' C ' ' O ' ' A' ' 38' ' ' PRO . 0.4 OUTLIER 4.26 53.68 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 122.313 1.054 . . . . 0.0 110.185 -178.258 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.902 ' N ' ' O ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -129.64 -39.62 1.44 Allowed 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.934 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.78 ' O ' ' CD2' ' A' ' 45' ' ' HIS . 1.6 t -78.38 -36.4 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 118.751 -1.179 . . . . 0.0 111.69 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.418 ' HB1' ' OE1' ' A' ' 43' ' ' GLN . . . -74.71 -37.79 62.5 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.585 -1.322 . . . . 0.0 111.681 -178.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.884 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -87.35 -20.27 26.99 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.414 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.798 ' CB ' ' O ' ' A' ' 40' ' ' LEU . 6.6 ttm180 -65.88 -50.6 63.92 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 122.511 1.148 . . . . 0.0 108.085 178.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.78 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 43.2 m-70 -68.68 -17.79 64.14 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.707 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -96.6 -33.19 11.88 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.335 -0.853 . . . . 0.0 109.526 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 43' ' ' GLN . . . -87.3 -113.59 1.0 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.905 ' CD1' ' CG1' ' A' ' 59' ' ' VAL . 11.9 m95 -86.29 74.31 10.02 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.027 -1.278 . . . . 0.0 108.61 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.631 ' OD1' ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -51.29 127.43 29.96 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.507 -0.746 . . . . 0.0 111.104 -178.92 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.629 ' C ' ' H ' ' A' ' 52' ' ' ASP . 50.3 Cg_endo -86.64 2.48 7.16 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.339 2.026 . . . . 0.0 111.884 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 1.012 ' HE2' ' HA ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -57.06 -2.19 0.08 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.651 -1.281 . . . . 0.0 109.365 -179.256 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.649 ' O ' ' NE ' ' A' ' 79' ' ' ARG . 0.3 OUTLIER -117.83 -9.46 10.66 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.668 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.591 ' CB ' ' HB3' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -155.65 -178.6 7.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.422 -0.799 . . . . 0.0 110.705 -179.474 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.557 ' CB ' HD22 ' A' ' 56' ' ' ASN . 5.0 p -68.51 143.09 55.08 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.235 -0.916 . . . . 0.0 109.767 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.654 ' O ' ' N ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -98.78 7.71 45.76 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.654 -0.654 . . . . 0.0 111.199 -178.796 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 76' ' ' ASP . 0.0 OUTLIER -27.16 -38.12 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 122.031 0.919 . . . . 0.0 109.42 -179.751 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.654 ' N ' ' O ' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -140.0 145.81 25.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.704 ' OD1' ' HA ' ' A' ' 44' ' ' ARG . 0.8 OUTLIER -149.99 158.63 44.36 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 118.789 -1.164 . . . . 0.0 110.867 -179.873 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.953 ' HB ' ' C ' ' A' ' 65' ' ' CYS . 1.5 m -114.02 138.45 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.791 0.805 . . . . 0.0 111.92 -177.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.686 ' HA ' ' HB3' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -102.37 152.65 20.84 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.912 179.177 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.459 ' O ' ' O ' ' A' ' 60' ' ' LYS . 1.8 tt0 -60.81 -132.84 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.26 -0.9 . . . . 0.0 110.309 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 44.48 27.71 1.33 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.68 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 131.44 39.73 0.24 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 -179.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.68 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.3 OUTLIER 0.6 87.4 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.897 -0.766 . . . . 0.0 111.026 -179.456 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.953 ' C ' ' HB ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -140.3 134.88 31.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.433 -0.792 . . . . 0.0 110.973 -179.487 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.845 ' CD2' ' CG1' ' A' ' 59' ' ' VAL . 46.1 m-85 -80.14 148.58 30.88 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.599 0.714 . . . . 0.0 110.054 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -128.67 121.63 28.98 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.603 -0.685 . . . . 0.0 109.653 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.573 ' HG3' ' CG2' ' A' ' 57' ' ' ILE . 6.3 ttt-85 -119.06 130.67 55.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.923 . . . . 0.0 110.214 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.699 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 9.0 mtm-85 -69.81 -74.0 0.17 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.926 . . . . 0.0 110.376 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.699 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 57.0 Cg_endo -75.82 -112.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.246 1.13 . . . . 0.0 109.544 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.545 ' O ' ' NH1' ' A' ' 68' ' ' ARG . 1.9 t -140.68 158.14 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.551 -1.343 . . . . 0.0 110.087 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.614 ' HB2' ' CE3' ' A' ' 207' ' ' TRP . . . -97.03 109.94 22.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.135 -0.978 . . . . 0.0 109.823 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.88 53.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.141 -0.975 . . . . 0.0 110.712 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 179.81 -61.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.054 -1.029 . . . . 0.0 110.636 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.9 m -81.9 -127.56 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.189 -0.944 . . . . 0.0 110.27 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.613 ' O ' ' O ' ' A' ' 77' ' ' GLY . 0.6 OUTLIER -140.01 116.03 10.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.142 -0.974 . . . . 0.0 109.885 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.613 ' O ' ' O ' ' A' ' 76' ' ' ASP . . . -37.98 -100.03 0.01 OUTLIER Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.508 HG21 ' N ' ' A' ' 79' ' ' ARG . 0.2 OUTLIER -158.87 150.05 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.067 -1.255 . . . . 0.0 110.255 179.379 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.649 ' NE ' ' O ' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -143.56 171.01 14.76 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.666 -0.646 . . . . 0.0 109.82 179.856 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.53 ' N ' ' CG ' ' A' ' 79' ' ' ARG . . . -150.26 133.12 4.22 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.565 ' HB2' ' HA ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -155.07 55.06 0.65 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.297 -1.12 . . . . 0.0 110.245 179.837 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.473 ' O ' ' C ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -125.43 -88.31 0.59 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.915 . . . . 0.0 110.069 179.88 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.473 ' C ' ' O ' ' A' ' 82' ' ' ARG . . . 40.63 58.42 2.57 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -94.45 95.93 9.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.353 -1.087 . . . . 0.0 110.376 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 173' ' ' MET . 38.3 m -136.88 168.07 20.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -0.851 . . . . 0.0 109.948 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.436 ' HA ' ' HG2' ' A' ' 173' ' ' MET . 0.0 OUTLIER -112.47 143.99 42.68 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.22 -0.925 . . . . 0.0 109.835 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.67 -120.34 5.23 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.486 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 13.9 tp -128.36 135.63 49.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.318 -1.107 . . . . 0.0 110.395 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.486 ' CG ' ' C ' ' A' ' 88' ' ' LEU . 8.0 m-70 -147.08 156.34 42.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.207 -0.933 . . . . 0.0 109.569 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.23 138.09 6.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.069 -1.02 . . . . 0.0 110.875 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.721 ' CB ' ' CD2' ' A' ' 216' ' ' TYR . 3.7 p90 -135.27 171.12 14.89 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.404 -0.81 . . . . 0.0 109.456 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 215' ' ' ARG . 23.7 tt0 -135.63 156.82 48.24 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.474 -0.89 . . . . 0.0 111.352 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.579 ' O ' ' OH ' ' A' ' 180' ' ' TYR . 27.9 mm -143.59 141.89 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.555 -0.716 . . . . 0.0 109.637 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.565 ' HB3' ' HA ' ' A' ' 166' ' ' ARG . 2.9 p -155.84 146.36 21.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.886 -1.134 . . . . 0.0 110.777 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.583 ' CZ3' HG22 ' A' ' 212' ' ' VAL . 39.4 m95 -116.81 87.46 21.98 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.321 -0.862 . . . . 0.0 109.269 178.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.505 ' HG2' ' HG3' ' A' ' 213' ' ' ARG . 51.9 Cg_endo -95.72 108.42 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.719 1.378 . . . . 0.0 111.015 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.627 HD22 ' O ' ' A' ' 210' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 O-C-N 120.973 -1.079 . . . . 0.0 109.586 178.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.692 HG21 ' CB ' ' A' ' 204' ' ' SER . 35.1 m . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 121.587 0.708 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 202' ' ' SER . 2.7 p -150.8 149.72 14.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 O-C-N 121.518 -0.739 . . . . 0.0 109.399 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.583 ' HA2' ' HA3' ' A' ' 132' ' ' GLY . . . -162.7 148.89 16.22 Favored Glycine 0 N--CA 1.485 1.952 0 C-N-CA 118.984 -1.579 . . . . 0.0 110.985 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.611 HG13 ' CG ' ' A' ' 199' ' ' LEU . 11.8 t -105.78 156.97 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.707 -0.878 . . . . 0.0 108.947 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.531 ' N ' HD12 ' A' ' 199' ' ' LEU . . . -150.11 146.69 27.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.728 -1.233 . . . . 0.0 111.501 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.654 ' CG2' ' HB3' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -114.18 138.33 50.59 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.561 0.696 . . . . 0.0 109.65 179.268 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.87 -24.45 18.47 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.532 -0.73 . . . . 0.0 109.064 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.672 ' O ' ' C ' ' A' ' 113' ' ' ALA . 0.7 OUTLIER -86.68 -12.21 49.01 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.555 -0.716 . . . . 0.0 109.268 179.08 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.672 ' C ' ' O ' ' A' ' 112' ' ' LEU . . . . . . . . 0 N--CA 1.499 2.021 0 O-C-N 122.04 -0.412 . . . . 0.0 111.192 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.6 m . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.161 0.505 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 14.7 tm-20 -126.41 115.99 20.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.18 -0.95 . . . . 0.0 109.949 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 48.5 t -120.21 119.37 33.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 110.458 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . 0.445 ' HB2' ' OE2' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -133.55 125.34 28.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.468 -0.77 . . . . 0.0 109.764 179.634 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.583 ' HA3' ' HA2' ' A' ' 107' ' ' GLY . . . -170.18 -143.33 3.89 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.718 ' CZ3' ' CD2' ' A' ' 180' ' ' TYR . 53.7 m0 -115.95 113.48 23.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -1.169 . . . . 0.0 110.317 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.548 ' O ' ' CG2' ' A' ' 135' ' ' ILE . 3.9 p30 -118.25 131.29 56.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.649 -0.657 . . . . 0.0 110.391 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.548 ' CG2' ' O ' ' A' ' 134' ' ' ASP . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.278 -0.889 . . . . 0.0 110.248 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.609 ' H ' ' HD2' ' A' ' 164' ' ' PRO . 1.3 t . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.609 ' HD2' ' H ' ' A' ' 163' ' ' VAL . 48.6 Cg_endo -77.28 55.22 4.99 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.714 1.376 . . . . 0.0 110.839 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -64.0 -58.67 6.0 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.617 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 2.1 ttp180 -151.59 115.44 4.92 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.691 HD13 ' N ' ' A' ' 167' ' ' LEU . 0.7 OUTLIER -150.25 158.27 43.97 Favored 'General case' 0 C--N 1.287 -2.131 0 O-C-N 121.676 -0.64 . . . . 0.0 110.735 -178.711 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.457 ' HA ' ' HG3' ' A' ' 92' ' ' GLU . 1.7 tp -103.86 139.73 38.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.425 -0.797 . . . . 0.0 109.36 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.689 HG22 ' CE1' ' A' ' 180' ' ' TYR . 1.8 t -105.78 130.25 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.091 -1.006 . . . . 0.0 110.439 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.0 t -100.14 125.76 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.524 -0.735 . . . . 0.0 110.058 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.566 ' HB2' ' CZ3' ' A' ' 91' ' ' TRP . 13.3 tp -133.27 106.24 7.44 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.141 -0.975 . . . . 0.0 110.127 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 173' ' ' MET . 50.4 t0 -119.71 137.81 53.69 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.188 -0.945 . . . . 0.0 110.095 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.473 ' HB2' ' O ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -93.48 -40.48 10.31 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.654 -0.654 . . . . 0.0 109.857 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 173' ' ' MET . 37.5 tt0 -43.13 -26.34 0.15 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.272 -0.893 . . . . 0.0 109.11 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.729 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.2 OUTLIER -113.88 -25.75 8.47 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.832 0.825 . . . . 0.0 108.894 179.33 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.521 ' O ' ' CG2' ' A' ' 198' ' ' THR . . . 78.83 27.89 55.73 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 108.139 -1.984 . . . . 0.0 108.139 -178.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.729 ' OG1' ' HB3' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -112.64 143.17 44.29 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.28 -1.129 . . . . 0.0 111.608 -179.182 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.535 HD13 ' CD ' ' A' ' 201' ' ' PRO . 0.5 OUTLIER -148.66 154.2 39.33 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.671 -0.643 . . . . 0.0 109.615 179.377 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.521 ' HA3' ' CD2' ' A' ' 187' ' ' LEU . . . -174.13 166.2 38.15 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.718 ' CD2' ' CZ3' ' A' ' 133' ' ' TRP . 1.7 t80 -118.95 117.52 29.04 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.368 -1.077 . . . . 0.0 109.73 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 186' ' ' TYR . 6.9 t -146.01 165.18 29.8 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.167 -0.958 . . . . 0.0 110.197 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.567 HG23 ' CD2' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -100.12 116.47 43.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.734 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 71.04 6.92 61.43 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.99 43.1 18.07 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 1.7 m -101.18 -69.52 0.77 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.241 -1.152 . . . . 0.0 110.957 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.512 ' N ' ' OG ' ' A' ' 181' ' ' SER . 6.7 m-30 -45.1 -83.52 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.14 -0.975 . . . . 0.0 110.907 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.544 ' O ' ' CE1' ' A' ' 191' ' ' PHE . 0.1 OUTLIER -66.98 43.95 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.87 -1.144 . . . . 0.0 110.202 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 186' ' ' TYR . . . -91.46 -63.4 1.18 Allowed Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.927 -1.13 . . . . 0.0 110.581 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.452 ' HD2' ' O ' ' A' ' 186' ' ' TYR . 46.6 Cg_endo -72.54 -30.25 12.4 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.859 1.452 . . . . 0.0 111.476 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.578 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -74.1 29.4 0.08 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.232 -0.918 . . . . 0.0 111.572 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.544 ' CE1' ' O ' ' A' ' 187' ' ' LEU . 1.2 m-30 -90.53 -14.85 31.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.769 -1.207 . . . . 0.0 110.409 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . 0.522 ' N ' ' HD2' ' A' ' 192' ' ' ARG . 0.0 OUTLIER -90.09 -13.66 35.35 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.328 -0.858 . . . . 0.0 110.283 -179.701 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -110.91 -12.57 15.75 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 107.707 -2.157 . . . . 0.0 107.707 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.7 ' HG ' ' NE ' ' A' ' 197' ' ' ARG . 5.4 tt -67.28 -37.62 83.74 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.56 ' CA ' HG21 ' A' ' 198' ' ' THR . 0.0 OUTLIER -44.66 -37.27 3.56 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.561 -0.712 . . . . 0.0 109.787 179.51 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.91 -27.83 30.47 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.7 ' NE ' ' HG ' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -90.26 -3.34 57.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.707 -0.878 . . . . 0.0 109.942 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' THR . . . . . 0.589 ' N ' ' O ' ' A' ' 194' ' ' LEU . 15.8 p -41.1 114.52 0.5 Allowed 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.996 0.903 . . . . 0.0 110.042 -178.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.654 ' HB3' ' CG2' ' A' ' 110' ' ' THR . 2.6 pt? -139.42 171.63 13.98 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.05 -178.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.437 ' N ' ' CD1' ' A' ' 200' ' ' TYR . 5.9 m-85 -84.46 129.44 57.57 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.911 -1.118 . . . . 0.0 110.189 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.549 ' O ' ' CG ' ' A' ' 81' ' ' LYS . 52.8 Cg_endo -84.88 135.98 5.86 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 124.12 1.59 . . . . 0.0 111.164 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.565 ' HA ' ' HB2' ' A' ' 81' ' ' LYS . 3.7 p -133.39 136.99 45.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.292 -0.88 . . . . 0.0 109.993 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.518 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . 3.9 p -122.44 155.39 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -0.961 . . . . 0.0 109.938 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' SER . . . . . 0.692 ' CB ' HG21 ' A' ' 105' ' ' VAL . 2.7 t -130.81 127.5 38.79 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.168 -0.957 . . . . 0.0 110.684 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.61 ' HB3' ' CZ ' ' A' ' 66' ' ' PHE . . . -119.06 154.28 33.4 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.01 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.526 ' CG1' ' OE1' ' A' ' 211' ' ' GLN . 2.9 p -115.11 -172.49 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 110.284 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.614 ' CE3' ' HB2' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -82.77 165.36 19.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.293 -0.879 . . . . 0.0 110.182 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 132.18 131.72 3.25 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . 0.404 ' HG2' ' N ' ' A' ' 210' ' ' CYS . 7.9 tt0 -62.36 -87.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -1.15 . . . . 0.0 110.303 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . 0.627 ' O ' HD22 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -81.18 83.39 6.82 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.323 -0.861 . . . . 0.0 110.541 -179.83 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.528 ' HG3' ' CD2' ' A' ' 97' ' ' LEU . 2.5 tt0 -155.6 -42.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.187 -0.946 . . . . 0.0 110.659 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.643 HG11 ' CH2' ' A' ' 48' ' ' TRP . 88.3 t -127.27 132.68 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.986 -1.071 . . . . 0.0 111.194 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . 0.505 ' HG3' ' HG2' ' A' ' 96' ' ' PRO . 0.4 OUTLIER -139.86 149.16 43.08 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.42 -0.8 . . . . 0.0 109.811 179.559 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.694 ' HB ' ' CH2' ' A' ' 48' ' ' TRP . 5.9 tt -144.31 143.89 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.086 -1.009 . . . . 0.0 111.436 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.564 ' O ' ' N ' ' A' ' 92' ' ' GLU . 15.1 mtt180 -130.21 108.72 10.25 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . 0.721 ' CD2' ' CB ' ' A' ' 91' ' ' TRP . 2.4 t80 -116.29 146.76 42.15 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.031 -1.043 . . . . 0.0 111.435 -177.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' MET . . . . . 0.519 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 5.6 tmm? -136.41 107.93 6.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.561 -0.712 . . . . 0.0 109.706 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 149.81 -40.26 0.86 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.165 -1.197 . . . . 0.0 110.205 -179.89 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.486 ' CD1' ' C ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.204 0.526 . . . . 0.0 109.822 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.507 ' HA ' HD22 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -48.81 -34.26 12.04 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.16 -0.963 . . . . 0.0 109.279 179.625 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.77 -21.96 66.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.438 -0.789 . . . . 0.0 109.077 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.464 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -83.37 -35.73 24.9 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.783 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.634 ' HG ' ' N ' ' A' ' 34' ' ' SER . 0.3 OUTLIER -68.56 -37.08 79.62 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 122.071 0.939 . . . . 0.0 109.002 178.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.634 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 3.5 m -76.84 -7.88 56.3 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.387 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.559 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . . . -36.63 -59.61 0.86 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.421 -0.8 . . . . 0.0 110.034 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.676 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 48.2 Cg_endo -74.36 108.42 2.67 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.146 1.603 . . . . 0.0 110.337 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.728 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 48.5 Cg_endo -74.36 -25.2 13.51 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.987 1.519 . . . . 0.0 112.7 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.728 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 43.8 Cg_endo -69.18 152.0 72.32 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 122.944 0.971 . . . . 0.0 112.163 -178.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.689 ' O ' ' CG ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER 3.56 66.83 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 123.121 1.439 . . . . 0.0 111.092 -179.072 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.694 ' C ' ' OE1' ' A' ' 43' ' ' GLN . 0.2 OUTLIER -156.66 -44.97 0.07 Allowed 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 177.863 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.619 ' CG2' HD12 ' A' ' 40' ' ' LEU . 2.8 t -87.71 -31.1 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.785 177.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.54 -44.3 10.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.323 -0.861 . . . . 0.0 111.573 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.862 ' HB2' ' HA ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -74.78 -19.32 60.26 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.178 -0.951 . . . . 0.0 110.523 -179.28 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.757 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 2.8 ttp85 -82.29 -41.6 19.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.869 . . . . 0.0 110.066 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.62 ' N ' ' CD2' ' A' ' 45' ' ' HIS . 19.7 m170 -68.81 -17.03 63.95 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.717 -0.614 . . . . 0.0 111.353 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.416 ' O ' ' O ' ' A' ' 47' ' ' GLY . 6.0 t60 -95.21 -32.96 12.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.752 -1.218 . . . . 0.0 110.102 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.669 ' HA3' ' CG2' ' A' ' 59' ' ' VAL . . . -62.45 -99.43 0.01 OUTLIER Glycine 0 N--CA 1.488 2.164 0 N-CA-C 106.447 -2.661 . . . . 0.0 106.447 178.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.899 ' CE2' ' HB ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -100.14 95.44 6.83 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 175.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.803 ' O ' ' HB3' ' A' ' 53' ' ' CYS . 0.0 OUTLIER -42.33 111.36 0.94 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.644 -0.66 . . . . 0.0 111.679 -178.202 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.605 ' HA ' ' CB ' ' A' ' 53' ' ' CYS . 47.7 Cg_endo -73.49 0.69 7.73 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 122.625 2.217 . . . . 0.0 112.172 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.694 ' CE ' ' N ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -65.02 -31.68 73.04 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 177.928 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.706 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 3.2 m-20 -116.12 -12.58 11.23 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 113.46 -1.7 . . . . 0.0 106.668 176.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.803 ' HB3' ' O ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -108.22 157.82 18.0 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.656 0.741 . . . . 0.0 110.913 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.502 ' HB2' ' O ' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -75.78 142.61 42.29 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.552 0.692 . . . . 0.0 110.008 179.345 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.552 ' HG3' ' CD2' ' A' ' 33' ' ' LEU . 1.1 pm0 -99.33 -4.35 31.92 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.562 -0.711 . . . . 0.0 110.459 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.606 ' ND2' ' O ' ' A' ' 75' ' ' THR . 9.4 m-80 -50.39 -12.67 0.1 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.629 -0.669 . . . . 0.0 110.805 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.61 HG13 ' CZ3' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -124.7 169.0 16.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.288 -0.882 . . . . 0.0 109.242 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.598 ' O ' ' CB ' ' A' ' 67' ' ' GLU . 49.3 t0 -107.2 133.78 51.27 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.899 -1.126 . . . . 0.0 111.087 -177.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.899 ' HB ' ' CE2' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -130.95 137.15 56.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.675 -179.532 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.862 ' HA ' ' HB2' ' A' ' 43' ' ' GLN . 60.0 mttp -123.86 151.58 43.29 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 118.581 -1.248 . . . . 0.0 111.119 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.461 ' O ' ' C ' ' A' ' 62' ' ' GLY . 0.7 OUTLIER -77.6 -128.72 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.474 -0.766 . . . . 0.0 110.274 -179.787 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 41.3 42.28 3.23 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.556 -1.818 . . . . 0.0 108.556 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.683 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 108.82 67.67 0.61 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.683 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER 0.84 88.09 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.847 -0.796 . . . . 0.0 110.983 -179.076 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 1.2 t -99.88 114.33 27.47 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.45 -0.781 . . . . 0.0 111.049 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.807 ' CD1' ' NE1' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -83.56 128.51 34.57 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.136 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.598 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 1.6 tt0 -138.79 121.82 16.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.567 -1.333 . . . . 0.0 110.502 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.661 ' CZ ' ' CZ3' ' A' ' 207' ' ' TRP . 0.0 OUTLIER -130.85 142.85 50.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.38 -0.825 . . . . 0.0 109.406 179.767 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.683 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -130.96 -70.69 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.055 -1.028 . . . . 0.0 110.954 -179.464 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.683 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 55.5 Cg_endo -69.89 -145.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.552 1.291 . . . . 0.0 109.492 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.577 ' HA ' ' CH2' ' A' ' 207' ' ' TRP . 3.9 t -140.02 164.27 23.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 O-C-N 121.417 -0.802 . . . . 0.0 110.175 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.554 ' CB ' ' HB3' ' A' ' 76' ' ' ASP . . . -130.44 94.11 3.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 110.021 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.484 ' O ' ' O ' ' A' ' 72' ' ' ALA . 67.3 mt-30 -48.12 -99.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.281 -0.887 . . . . 0.0 110.106 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.5 p -88.61 39.24 0.91 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.084 -1.01 . . . . 0.0 109.605 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.606 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 3.0 m -144.6 15.73 1.62 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.317 -0.864 . . . . 0.0 110.198 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.617 ' HB2' ' CD1' ' A' ' 207' ' ' TRP . 19.1 p-10 -98.47 155.16 17.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.296 -0.878 . . . . 0.0 109.928 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 54' ' ' SER . . . 106.78 127.73 5.86 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 106.781 -2.528 . . . . 0.0 106.781 -178.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.63 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 1.2 m -117.51 131.67 69.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 120.814 -1.403 . . . . 0.0 111.131 -178.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.706 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 2.5 ttp180 -104.12 175.08 5.6 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.657 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.628 ' HA2' ' CB ' ' A' ' 52' ' ' ASP . . . -167.4 80.7 0.1 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -125.63 130.48 51.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -1.153 . . . . 0.0 110.311 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.531 ' HG2' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -140.41 -31.21 0.64 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -0.89 . . . . 0.0 110.551 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.531 ' N ' ' HG2' ' A' ' 82' ' ' ARG . . . 37.82 40.6 0.78 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.431 ' H ' ' HG2' ' A' ' 82' ' ' ARG . 1.7 t80 -134.71 95.57 3.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.155 -1.203 . . . . 0.0 110.001 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.476 ' CB ' HD22 ' A' ' 171' ' ' LEU . 0.6 OUTLIER -140.27 163.72 32.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.883 . . . . 0.0 110.415 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.604 ' O ' ' CD2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -131.08 158.82 39.37 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.327 -0.858 . . . . 0.0 110.095 179.661 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.521 ' N ' ' HB3' ' A' ' 173' ' ' MET . . . 51.72 -111.59 1.5 Allowed Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 21.2 tp -128.97 134.39 48.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.516 -0.99 . . . . 0.0 111.134 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.604 ' CD2' ' O ' ' A' ' 86' ' ' ARG . 88.6 m-70 -147.31 173.66 12.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.262 -0.899 . . . . 0.0 109.786 179.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.561 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -163.38 158.96 21.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.179 -0.95 . . . . 0.0 110.586 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.726 ' CD1' ' CZ ' ' A' ' 216' ' ' TYR . 1.0 OUTLIER -134.61 170.63 15.51 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.281 -0.887 . . . . 0.0 109.29 179.557 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.666 ' N ' ' O ' ' A' ' 215' ' ' ARG . 6.7 mt-10 -147.82 145.27 28.67 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.178 -0.951 . . . . 0.0 110.748 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.515 ' CD1' HG22 ' A' ' 203' ' ' VAL . 6.3 mt -144.74 153.97 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.283 -0.885 . . . . 0.0 110.879 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.599 ' HB2' ' CB ' ' A' ' 213' ' ' ARG . 2.2 m -135.18 140.95 45.75 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.803 ' HZ2' ' N ' ' A' ' 105' ' ' VAL . 4.9 m95 -99.61 125.58 40.26 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.096 -1.003 . . . . 0.0 111.873 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.719 ' HB3' ' O ' ' A' ' 211' ' ' GLN . 49.4 Cg_endo -79.63 153.24 23.2 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.388 2.059 . . . . 0.0 111.569 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.593 ' CD2' ' C ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.481 0.658 . . . . 0.0 110.236 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.803 ' N ' ' HZ2' ' A' ' 95' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.538 HG22 ' CG2' ' A' ' 203' ' ' VAL . 2.2 t -127.79 170.16 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.929 -1.107 . . . . 0.0 111.368 -176.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.648 ' CA ' ' HA3' ' A' ' 132' ' ' GLY . . . -179.92 156.83 18.99 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 109.986 -1.245 . . . . 0.0 109.986 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.599 HG11 HD12 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -108.6 140.72 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.41 -1.053 . . . . 0.0 109.538 179.855 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.484 ' O ' ' HB3' ' A' ' 199' ' ' LEU . . . -109.85 140.39 43.85 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.227 -0.921 . . . . 0.0 110.738 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.514 HG23 ' CD2' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -119.46 130.41 55.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.453 -0.78 . . . . 0.0 110.324 179.809 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.73 -27.47 17.22 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.501 -0.749 . . . . 0.0 109.295 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.458 ' O ' ' C ' ' A' ' 113' ' ' ALA . 0.9 OUTLIER -81.69 -12.3 58.71 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.535 -0.728 . . . . 0.0 109.587 179.474 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.534 ' CB ' ' HB2' ' A' ' 129' ' ' GLU . . . . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.553 -0.717 . . . . 0.0 110.235 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.426 ' HB3' ' O ' ' A' ' 110' ' ' THR . 14.7 m . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.26 0.552 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.534 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . 4.9 mm-40 -150.25 133.82 16.58 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.323 -0.861 . . . . 0.0 109.861 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.5 t -120.18 119.73 34.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 110.559 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -133.25 136.32 45.48 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.367 -0.833 . . . . 0.0 109.411 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.648 ' HA3' ' CA ' ' A' ' 107' ' ' GLY . . . -158.83 -163.47 13.04 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.436 -1.364 . . . . 0.0 110.309 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.677 ' CE3' ' CG ' ' A' ' 180' ' ' TYR . 24.6 m0 -115.77 113.12 23.01 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.477 -1.013 . . . . 0.0 110.197 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.687 ' HA ' ' CG1' ' A' ' 105' ' ' VAL . 2.1 p-10 -119.48 142.96 47.81 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.717 -0.614 . . . . 0.0 110.154 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.611 HG13 ' CD1' ' A' ' 95' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 109.634 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.62 ' CG1' ' HB2' ' A' ' 167' ' ' LEU . 1.5 t . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.491 ' HD2' ' CG2' ' A' ' 182' ' ' ILE . 43.1 Cg_endo -70.56 178.52 4.98 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.859 1.452 . . . . 0.0 110.913 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.506 ' O ' ' HB3' ' A' ' 94' ' ' SER . 11.1 pt-20 -50.07 -18.34 0.54 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.477 -0.764 . . . . 0.0 110.826 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.48 ' NH1' ' HG2' ' A' ' 166' ' ' ARG . 7.9 tpt180 -133.67 154.97 50.53 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.102 -0.999 . . . . 0.0 109.929 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.684 ' CD2' ' N ' ' A' ' 168' ' ' LEU . 0.0 OUTLIER -164.04 146.78 9.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.28 -0.888 . . . . 0.0 109.789 -179.802 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.684 ' N ' ' CD2' ' A' ' 167' ' ' LEU . 1.2 tt -125.77 131.19 52.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.142 -0.974 . . . . 0.0 110.611 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.647 ' CG1' ' CE3' ' A' ' 91' ' ' TRP . 97.2 t -89.52 156.92 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.395 -0.815 . . . . 0.0 109.805 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.449 ' CG2' HD11 ' A' ' 187' ' ' LEU . 22.4 t -134.55 112.1 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.165 -0.959 . . . . 0.0 110.155 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -132.39 122.48 25.07 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.287 -0.883 . . . . 0.0 109.791 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -120.15 139.13 53.08 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.244 -0.91 . . . . 0.0 109.942 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.521 ' HB3' ' N ' ' A' ' 87' ' ' GLY . 0.3 OUTLIER -93.05 -38.25 11.73 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.553 -0.717 . . . . 0.0 109.778 179.768 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 173' ' ' MET . 0.8 OUTLIER -43.11 -27.28 0.2 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 108.7 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.598 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.7 OUTLIER -114.59 -27.38 7.52 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.78 0.8 . . . . 0.0 108.876 179.157 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.483 ' O ' HG21 ' A' ' 198' ' ' THR . . . 84.68 22.54 53.15 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 108.706 -1.757 . . . . 0.0 108.706 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.598 ' OG1' ' HB3' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -115.53 133.72 55.76 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.288 -1.125 . . . . 0.0 111.376 -179.476 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -143.85 152.63 41.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.569 -0.707 . . . . 0.0 109.423 178.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.523 ' O ' HG11 ' A' ' 169' ' ' VAL . . . -161.67 -156.1 8.21 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.677 ' CG ' ' CE3' ' A' ' 133' ' ' TRP . 0.1 OUTLIER -125.65 138.34 53.9 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.27 -1.135 . . . . 0.0 108.904 -179.905 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.481 ' HB2' ' HB2' ' A' ' 187' ' ' LEU . 9.2 t -144.0 141.59 30.23 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.143 -0.973 . . . . 0.0 110.624 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.593 HD13 ' CD2' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -127.12 116.76 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.655 -0.653 . . . . 0.0 109.563 179.629 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 65.55 10.09 47.5 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 77.0 41.01 23.71 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' THR . . . . . 0.429 HG22 ' CZ ' ' A' ' 186' ' ' TYR . 17.4 m -97.31 -47.56 5.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -1.142 . . . . 0.0 110.643 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.593 ' CD2' HD13 ' A' ' 182' ' ' ILE . 8.6 m-85 -112.08 85.55 2.17 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.097 -1.002 . . . . 0.0 110.683 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.614 ' HG ' ' CE1' ' A' ' 191' ' ' PHE . 0.9 OUTLIER -179.79 28.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.686 -0.634 . . . . 0.0 109.647 179.54 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -94.88 -89.52 1.72 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.491 ' C ' ' H ' ' A' ' 191' ' ' PHE . 49.6 Cg_endo -74.24 -21.02 18.17 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 124.18 1.621 . . . . 0.0 111.21 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.558 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -66.31 15.2 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.527 -0.733 . . . . 0.0 111.877 -178.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.614 ' CE1' ' HG ' ' A' ' 187' ' ' LEU . 1.1 m-30 -90.51 -28.07 18.78 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.854 -1.154 . . . . 0.0 111.146 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . 0.564 ' HA ' ' NE ' ' A' ' 192' ' ' ARG . 0.1 OUTLIER -86.52 -13.13 46.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.949 -1.094 . . . . 0.0 110.744 -179.5 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -107.48 -13.04 21.77 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.659 ' O ' ' N ' ' A' ' 198' ' ' THR . 9.2 tt -72.17 -40.54 67.89 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.572 -0.958 . . . . 0.0 109.012 179.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.52 ' HD2' ' N ' ' A' ' 196' ' ' GLY . 0.0 OUTLIER -44.12 -40.25 4.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.215 -0.928 . . . . 0.0 109.869 179.583 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.52 ' N ' ' HD2' ' A' ' 195' ' ' LYS . . . -86.27 -26.82 32.4 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.854 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.62 -4.38 56.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.686 -0.891 . . . . 0.0 109.905 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' THR . . . . . 0.659 ' N ' ' O ' ' A' ' 194' ' ' LEU . 0.8 OUTLIER -43.85 132.08 5.32 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.739 0.78 . . . . 0.0 111.732 -178.441 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.854 ' HG ' ' O ' ' A' ' 197' ' ' ARG . 0.0 OUTLIER -140.68 171.01 14.7 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.656 -0.652 . . . . 0.0 109.444 179.254 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.487 ' CZ ' ' HA3' ' A' ' 83' ' ' GLY . 0.1 OUTLIER -85.98 128.93 56.12 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 120.909 -1.119 . . . . 0.0 109.84 179.358 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.546 ' CA ' HG12 ' A' ' 108' ' ' VAL . 51.0 Cg_endo -85.91 129.16 3.4 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.995 1.524 . . . . 0.0 111.396 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.494 ' O ' HG11 ' A' ' 106' ' ' VAL . 24.5 t -133.46 142.87 48.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.297 -0.877 . . . . 0.0 109.585 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.538 ' CG2' HG22 ' A' ' 106' ' ' VAL . 7.4 p -122.35 153.96 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.825 -1.172 . . . . 0.0 111.43 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 15.1 p -149.58 145.39 26.78 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -150.26 167.36 27.19 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.765 -1.209 . . . . 0.0 112.059 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.48 -176.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 121.639 0.733 . . . . 0.0 111.31 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.661 ' CZ3' ' CZ ' ' A' ' 68' ' ' ARG . 22.7 p-90 -129.78 -5.12 4.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.672 -0.642 . . . . 0.0 109.823 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 207' ' ' TRP . . . -51.72 -168.97 0.01 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . 0.764 ' O ' ' O ' ' A' ' 210' ' ' CYS . 0.5 OUTLIER -79.67 -51.61 9.02 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.467 -1.02 . . . . 0.0 110.864 -179.562 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . 0.764 ' O ' ' O ' ' A' ' 209' ' ' GLN . 26.4 p 0.99 -129.18 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 121.07 0.462 . . . . 0.0 111.422 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.719 ' O ' ' HB3' ' A' ' 96' ' ' PRO . 0.0 OUTLIER 178.64 93.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.766 -1.209 . . . . 0.0 111.054 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.644 ' HB ' ' CZ ' ' A' ' 66' ' ' PHE . 3.1 t -87.05 123.09 39.67 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 O-C-N 121.381 -0.825 . . . . 0.0 108.84 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . 0.599 ' CB ' ' HB2' ' A' ' 94' ' ' SER . 2.0 tpp85 -89.85 147.36 23.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.097 -1.002 . . . . 0.0 110.52 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.583 ' O ' HD23 ' A' ' 64' ' ' LEU . 1.1 mt -144.33 128.46 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 110.474 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.666 ' O ' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -130.59 108.22 9.77 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.297 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . 0.726 ' CZ ' ' CD1' ' A' ' 91' ' ' TRP . 3.6 t80 -119.02 144.98 46.23 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.249 -0.907 . . . . 0.0 111.233 -178.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' MET . . . . . 0.46 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 1.2 ttp -136.59 108.45 7.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.561 -0.712 . . . . 0.0 110.05 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 130.74 70.34 0.11 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.261 -1.141 . . . . 0.0 110.199 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.602 ' HG ' ' N ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.244 0.545 . . . . 0.0 110.026 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.602 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 8.7 mt-10 -52.18 -35.9 50.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.066 -1.021 . . . . 0.0 108.997 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.65 -25.42 60.17 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.444 ' O ' ' HB3' ' A' ' 35' ' ' ALA . 0.5 OUTLIER -82.03 -35.74 28.48 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.707 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.62 ' C ' ' CD1' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -77.87 -38.92 44.86 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.91 0.862 . . . . 0.0 108.873 178.884 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.564 ' O ' ' O ' ' A' ' 35' ' ' ALA . 23.2 t -57.58 -14.31 5.1 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.318 0.58 . . . . 0.0 110.25 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.786 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . . . -52.61 -161.26 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.402 -0.811 . . . . 0.0 109.942 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.786 ' HD2' ' CB ' ' A' ' 35' ' ' ALA . 38.6 Cg_endo -65.8 118.37 5.43 Favored 'Trans proline' 0 C--N 1.315 -1.214 0 O-C-N 123.008 1.004 . . . . 0.0 109.647 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.567 ' CB ' HG23 ' A' ' 41' ' ' VAL . 45.7 Cg_endo -71.35 108.44 2.37 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.28 1.674 . . . . 0.0 112.162 -178.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.761 ' O ' ' N ' ' A' ' 40' ' ' LEU . 50.7 Cg_endo -81.98 151.97 16.49 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.23 1.648 . . . . 0.0 108.676 178.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.662 ' C ' ' O ' ' A' ' 38' ' ' PRO . 3.1 t0 -21.49 -41.89 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.311 -0.868 . . . . 0.0 109.806 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.761 ' N ' ' O ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -37.84 -50.06 1.24 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 122.012 -0.43 . . . . 0.0 109.875 179.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.656 ' N ' ' CD1' ' A' ' 40' ' ' LEU . 13.8 t -62.03 -26.92 41.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.683 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.611 ' N ' ' O ' ' A' ' 39' ' ' ASP . . . -89.06 -44.79 10.11 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.166 -0.958 . . . . 0.0 111.073 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.658 ' NE2' ' C ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -79.05 -25.28 43.17 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 118.405 -1.318 . . . . 0.0 108.648 179.389 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.741 ' CB ' ' O ' ' A' ' 40' ' ' LEU . 9.1 ttp180 -61.39 -52.87 62.81 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 122.343 1.068 . . . . 0.0 108.198 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.591 ' CE1' ' O ' ' A' ' 41' ' ' VAL . 26.0 m170 -60.93 -18.0 54.4 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.989 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -96.87 -30.07 13.35 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 118.207 -1.397 . . . . 0.0 111.648 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.48 ' O ' HD12 ' A' ' 214' ' ' ILE . . . -109.2 -67.12 0.58 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 107.605 -2.198 . . . . 0.0 107.605 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.784 ' CH2' ' N ' ' A' ' 61' ' ' GLU 0.265 0.1 OUTLIER -96.2 71.02 2.81 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.316 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.703 ' OD1' ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -60.26 112.53 5.62 Favored Pre-proline 0 N--CA 1.491 1.616 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.487 -178.809 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.663 ' CD ' ' HE3' ' A' ' 51' ' ' LYS . 44.5 Cg_endo -74.74 0.38 8.84 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 124.535 1.808 . . . . 0.0 112.024 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.913 ' CE ' ' N ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -64.57 -19.72 65.81 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 178.703 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.757 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 8.6 m-20 -133.34 -2.29 3.12 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 114.149 -1.387 . . . . 0.0 107.856 178.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.605 ' HB3' ' HA ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -113.34 152.11 30.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.571 -0.706 . . . . 0.0 110.058 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.492 ' CB ' HD21 ' A' ' 56' ' ' ASN . 0.0 OUTLIER -68.06 104.42 1.76 Allowed 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.13 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.56 ' O ' ' N ' ' A' ' 57' ' ' ILE . 26.1 pt-20 -67.81 -17.01 64.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.105 -0.997 . . . . 0.0 109.064 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.537 ' H ' ' ND2' ' A' ' 56' ' ' ASN . 11.8 m-80 -33.36 -32.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.678 0.752 . . . . 0.0 110.346 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.694 ' HB ' ' O ' ' A' ' 67' ' ' GLU . 9.0 pt -112.92 166.96 6.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.616 -0.677 . . . . 0.0 110.01 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.577 ' O ' ' N ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -107.13 117.11 33.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.247 -0.908 . . . . 0.0 109.372 -179.362 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.765 HG21 ' CD1' ' A' ' 66' ' ' PHE . 2.6 p -124.52 120.36 58.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 O-C-N 121.445 -0.785 . . . . 0.0 111.463 -178.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.685 ' HG2' ' N ' ' A' ' 61' ' ' GLU . 6.6 tttt -137.4 159.54 41.66 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.534 -0.729 . . . . 0.0 110.27 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.784 ' N ' ' CH2' ' A' ' 48' ' ' TRP . 1.2 tt0 -45.45 -106.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.596 -0.69 . . . . 0.0 110.535 -179.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.569 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 35.7 33.76 0.06 OUTLIER Glycine 0 N--CA 1.493 2.487 0 N-CA-C 108.141 -1.984 . . . . 0.0 108.141 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.69 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 107.8 62.83 0.56 Allowed Glycine 0 N--CA 1.485 1.927 0 N-CA-C 108.01 -2.036 . . . . 0.0 108.01 -178.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.69 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.4 OUTLIER 1.18 80.64 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.899 -0.765 . . . . 0.0 110.724 -179.324 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.429 ' N ' ' O ' ' A' ' 63' ' ' GLY . 17.3 p -141.17 136.92 32.3 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 118.418 -1.313 . . . . 0.0 112.176 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.765 ' CD1' HG21 ' A' ' 59' ' ' VAL . 17.9 m-85 -89.34 165.32 14.45 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.694 ' O ' ' HB ' ' A' ' 57' ' ' ILE . 5.5 tm-20 -136.94 121.01 17.76 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.91 -1.119 . . . . 0.0 109.944 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.561 ' CD ' ' O ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -126.32 148.71 49.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.237 -0.915 . . . . 0.0 109.977 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.75 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 1.7 mtm180 -104.93 -78.93 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.024 -1.048 . . . . 0.0 110.454 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.75 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 57.6 Cg_endo -75.08 -152.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.163 1.086 . . . . 0.0 109.368 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.42 ' H ' ' HB2' ' A' ' 70' ' ' PRO . 2.4 t -140.76 162.55 22.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.543 ' CB ' ' HB ' ' A' ' 75' ' ' THR . . . 179.85 175.87 0.75 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.932 -1.105 . . . . 0.0 110.621 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.464 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 2.5 pt20 -66.19 -115.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.385 -0.822 . . . . 0.0 110.31 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 73' ' ' GLN . 11.5 p -41.78 -27.1 0.1 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.195 -0.941 . . . . 0.0 110.225 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.543 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 22.6 m -44.29 -28.51 0.54 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.879 . . . . 0.0 110.028 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.651 ' CB ' ' CD1' ' A' ' 207' ' ' TRP . 12.4 p30 -112.68 155.46 24.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.887 . . . . 0.0 109.992 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 205' ' ' ALA . . . 79.86 123.93 0.47 Allowed Glycine 0 N--CA 1.484 1.899 0 N-CA-C 106.886 -2.485 . . . . 0.0 106.886 -178.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.562 ' HB ' ' CB ' ' A' ' 53' ' ' CYS . 1.2 m -117.74 161.85 16.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 120.851 -1.382 . . . . 0.0 110.939 -178.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.757 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -119.5 173.5 6.95 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.015 179.128 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.665 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -149.47 48.44 0.6 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.555 ' HA ' ' CB ' ' A' ' 202' ' ' SER . 22.7 ttpp -81.95 76.28 8.85 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -1.101 . . . . 0.0 109.985 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.502 ' CG ' ' OD2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -141.47 -91.03 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.381 -0.825 . . . . 0.0 110.064 -179.921 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.415 ' H ' ' CD ' ' A' ' 82' ' ' ARG . . . 49.11 62.69 4.47 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.487 ' CD2' ' O ' ' A' ' 84' ' ' TYR . 52.3 t80 -94.46 96.06 9.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -1.148 . . . . 0.0 109.995 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.572 ' OG ' ' CD2' ' A' ' 89' ' ' HIS . 0.1 OUTLIER -132.13 153.91 50.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.888 . . . . 0.0 110.263 -179.853 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.614 ' O ' ' CD2' ' A' ' 89' ' ' HIS . 46.5 ttp180 -114.72 176.43 5.05 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.321 -0.862 . . . . 0.0 109.779 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.563 ' N ' ' CG ' ' A' ' 86' ' ' ARG . . . 46.78 -111.22 0.66 Allowed Glycine 0 N--CA 1.485 1.959 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.525 ' O ' ' ND1' ' A' ' 89' ' ' HIS . 5.9 tt -129.08 126.83 40.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.478 -1.013 . . . . 0.0 110.751 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.614 ' CD2' ' O ' ' A' ' 86' ' ' ARG . 52.1 m-70 -147.41 173.69 12.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.792 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.51 155.31 17.29 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.347 -0.846 . . . . 0.0 110.263 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.703 ' CZ2' ' CG1' ' A' ' 169' ' ' VAL . 1.2 p90 -135.05 171.12 14.87 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.199 -0.938 . . . . 0.0 110.064 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.571 ' N ' ' O ' ' A' ' 215' ' ' ARG . 2.9 tp10 -132.93 142.63 48.99 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.538 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.534 ' CG2' ' OH ' ' A' ' 180' ' ' TYR . 0.3 OUTLIER -144.78 138.36 22.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.215 -0.928 . . . . 0.0 110.961 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.577 ' HB2' ' CB ' ' A' ' 213' ' ' ARG . 0.7 OUTLIER -117.75 137.3 52.8 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.724 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.574 ' HH2' ' O ' ' A' ' 204' ' ' SER . 46.9 t-105 -116.0 87.89 20.21 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.046 -1.034 . . . . 0.0 111.631 -178.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 94' ' ' SER . 52.4 Cg_endo -98.16 109.35 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 121.862 1.708 . . . . 0.0 110.046 178.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 O-C-N 120.662 -1.274 . . . . 0.0 110.417 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.791 HG22 ' O ' ' A' ' 105' ' ' VAL . 1.2 m . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 121.674 0.75 . . . . 0.0 109.27 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.572 ' CG1' ' O ' ' A' ' 202' ' ' SER . 78.3 t -135.71 152.26 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 120.999 -1.063 . . . . 0.0 109.926 -178.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.561 ' N ' HG12 ' A' ' 106' ' ' VAL . . . -141.52 135.52 6.86 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.646 ' CG1' HD11 ' A' ' 199' ' ' LEU . 1.3 t -125.79 131.62 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.435 -1.038 . . . . 0.0 108.319 179.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.556 ' CB ' ' HA ' ' A' ' 130' ' ' SER . . . -150.12 149.49 30.33 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.073 -1.017 . . . . 0.0 111.52 -178.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.729 ' OG1' ' N ' ' A' ' 129' ' ' GLU . 0.6 OUTLIER -89.47 112.08 23.14 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 122.209 1.004 . . . . 0.0 109.897 178.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 110' ' ' THR 0.294 . . -32.77 -53.42 0.34 Allowed 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.976 179.161 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.767 ' HB2' ' HB3' ' A' ' 128' ' ' SER . 0.0 OUTLIER -43.7 -26.31 0.23 Allowed 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.448 -178.72 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.655 ' N ' ' O ' ' A' ' 110' ' ' THR . . . . . . . . 0 N--CA 1.494 1.769 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.288 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.767 ' HB3' ' HB2' ' A' ' 112' ' ' LEU . 2.4 p . . . . . 0 N--CA 1.501 2.079 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.729 ' N ' ' OG1' ' A' ' 110' ' ' THR . 2.6 tt0 -152.22 160.71 43.32 Favored 'General case' 0 C--N 1.308 -1.229 0 O-C-N 120.323 -1.485 . . . . 0.0 111.213 -178.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.556 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 2.5 t -134.25 126.39 29.72 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.876 -0.515 . . . . 0.0 109.76 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . 0.479 ' CB ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -133.14 155.16 49.8 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 120.929 -1.107 . . . . 0.0 109.855 -179.873 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.512 ' HA2' ' HA2' ' A' ' 107' ' ' GLY . . . -141.58 133.67 5.87 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.58 ' CZ3' HG23 ' A' ' 108' ' ' VAL . 3.8 m0 -104.9 113.53 27.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -1.166 . . . . 0.0 109.689 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.534 ' O ' ' CG2' ' A' ' 135' ' ' ILE . 0.3 OUTLIER -118.48 148.19 42.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.133 -0.979 . . . . 0.0 110.428 -179.843 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.534 ' CG2' ' O ' ' A' ' 134' ' ' ASP . 3.7 pt . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.316 -0.865 . . . . 0.0 110.11 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.608 ' CG1' ' HD2' ' A' ' 164' ' ' PRO . 42.4 t . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.608 ' HD2' ' CG1' ' A' ' 163' ' ' VAL . 40.0 Cg_endo -67.01 125.43 13.61 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.656 1.345 . . . . 0.0 110.495 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 94' ' ' SER . 1.4 tt0 -41.05 -24.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.423 -0.798 . . . . 0.0 110.642 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' ' 164' ' ' PRO . 9.7 ttt85 -111.27 137.58 48.82 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.173 -0.954 . . . . 0.0 109.783 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.537 HD21 ' CG1' ' A' ' 163' ' ' VAL . 3.0 mp -138.47 146.31 41.9 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.463 -0.773 . . . . 0.0 110.411 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.93 124.51 49.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.495 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.703 ' CG1' ' CZ2' ' A' ' 91' ' ' TRP . 2.5 t -114.92 139.76 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.073 -1.017 . . . . 0.0 110.683 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.425 ' O ' ' CG1' ' A' ' 170' ' ' VAL . 9.3 p -118.32 124.93 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.578 -0.701 . . . . 0.0 110.062 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.561 ' CD1' ' HB3' ' A' ' 178' ' ' LEU . 9.3 tp -133.37 111.29 10.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.135 -0.978 . . . . 0.0 110.154 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.524 ' OD2' ' CB ' ' A' ' 88' ' ' LEU . 6.5 t70 -116.27 138.31 51.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.296 -0.877 . . . . 0.0 110.14 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.533 ' N ' ' O ' ' A' ' 87' ' ' GLY . 0.0 OUTLIER -94.64 -44.38 7.85 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.71 -0.619 . . . . 0.0 110.041 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.491 ' C ' ' O ' ' A' ' 173' ' ' MET . 2.7 mt-10 -40.19 -28.52 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.115 -0.99 . . . . 0.0 108.791 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.641 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.4 OUTLIER -111.56 -25.15 9.71 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.901 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.597 ' O ' ' CG2' ' A' ' 198' ' ' THR . . . 77.18 24.94 64.97 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.641 ' OG1' ' HB3' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -113.14 134.91 54.33 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.293 -1.122 . . . . 0.0 111.12 -179.429 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.561 ' HB3' ' CD1' ' A' ' 171' ' ' LEU . 0.6 OUTLIER -142.54 154.13 44.19 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.655 -0.653 . . . . 0.0 109.815 179.265 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.495 ' O ' HG12 ' A' ' 169' ' ' VAL . . . -162.11 162.17 34.0 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.654 ' CE1' ' CG2' ' A' ' 169' ' ' VAL . 1.1 t80 -118.68 121.77 40.92 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.459 -1.024 . . . . 0.0 109.657 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.438 ' CB ' HD22 ' A' ' 187' ' ' LEU . 0.3 OUTLIER -144.26 139.7 28.79 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.267 -0.895 . . . . 0.0 110.349 -179.67 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.545 HD13 ' CE2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -102.78 116.72 47.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.37 -0.831 . . . . 0.0 109.666 179.553 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 88.69 -9.13 77.33 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.526 ' HA2' ' CD2' ' A' ' 187' ' ' LEU . . . 86.21 43.61 6.21 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 70.2 m -114.35 -25.32 8.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.287 -1.125 . . . . 0.0 110.618 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.545 ' CE2' HD13 ' A' ' 182' ' ' ILE . 21.2 m-85 -107.97 69.1 0.72 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.172 -0.955 . . . . 0.0 110.42 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.578 ' HB2' ' CE1' ' A' ' 191' ' ' PHE . 0.9 OUTLIER -173.5 26.21 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.748 0.785 . . . . 0.0 109.497 179.719 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -94.64 -81.62 1.54 Allowed Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.033 -1.08 . . . . 0.0 110.7 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.15 -30.05 16.65 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.997 1.525 . . . . 0.0 111.307 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.567 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -74.06 13.78 0.5 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.312 -0.868 . . . . 0.0 111.234 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.578 ' CE1' ' HB2' ' A' ' 187' ' ' LEU . 1.2 m-30 -90.73 -26.79 19.35 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.018 -1.051 . . . . 0.0 110.416 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.62 -13.27 49.2 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.303 -0.873 . . . . 0.0 110.253 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 197' ' ' ARG . . . -108.17 -6.15 32.05 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.166 -1.974 . . . . 0.0 108.166 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.684 ' O ' ' N ' ' A' ' 198' ' ' THR . 7.6 tt -77.64 -41.44 38.38 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.584 ' CA ' HG22 ' A' ' 198' ' ' THR . 1.6 ttmt -43.79 -45.89 7.47 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.761 -0.587 . . . . 0.0 110.163 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -83.54 -24.51 50.19 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.695 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -91.12 -3.8 56.77 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.658 -0.907 . . . . 0.0 110.035 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' THR . . . . . 0.684 ' N ' ' O ' ' A' ' 194' ' ' LEU . 21.8 p -42.98 112.81 0.4 Allowed 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.641 0.734 . . . . 0.0 111.86 -177.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.695 ' HG ' ' O ' ' A' ' 197' ' ' ARG . 0.0 OUTLIER -140.44 171.0 14.76 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.713 -0.617 . . . . 0.0 109.647 178.738 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 11.0 m-85 -84.7 129.23 57.79 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.07 -1.019 . . . . 0.0 110.741 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.6 ' CA ' HG12 ' A' ' 108' ' ' VAL . 51.4 Cg_endo -88.62 146.4 5.9 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 124.179 1.62 . . . . 0.0 110.985 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 11.8 p -133.86 157.08 46.86 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.232 -0.918 . . . . 0.0 110.606 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.665 ' O ' ' N ' ' A' ' 80' ' ' GLY . 7.4 p -119.46 157.1 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.076 -1.015 . . . . 0.0 109.693 178.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' SER . . . . . 0.714 ' O ' HG22 ' A' ' 105' ' ' VAL . 0.9 OUTLIER -160.3 156.06 25.75 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 120.922 -1.112 . . . . 0.0 110.623 179.47 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.477 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -150.39 164.74 35.08 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.729 0.776 . . . . 0.0 111.02 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.602 ' CG1' ' N ' ' A' ' 207' ' ' TRP . 1.2 t -60.06 -179.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 121.344 0.592 . . . . 0.0 111.32 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.651 ' CD1' ' CB ' ' A' ' 76' ' ' ASP . 4.3 t90 -26.19 -55.91 0.07 Allowed 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.288 0.566 . . . . 0.0 110.919 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 209' ' ' GLN . . . 138.73 -1.74 2.64 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' ' 208' ' ' GLY . 1.6 tt0 -42.84 -29.92 0.36 Allowed 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.419 -1.048 . . . . 0.0 109.698 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . 0.506 ' C ' ' CG ' ' A' ' 211' ' ' GLN . 28.9 p -94.91 -131.79 0.16 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.433 -0.792 . . . . 0.0 109.855 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.506 ' CG ' ' C ' ' A' ' 210' ' ' CYS . 0.0 OUTLIER -178.59 112.67 0.06 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.933 . . . . 0.0 110.2 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.571 ' O ' ' CD1' ' A' ' 64' ' ' LEU . 33.9 m -89.63 139.55 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.277 -0.89 . . . . 0.0 109.765 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . 0.6 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -88.9 135.6 33.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.124 -0.985 . . . . 0.0 109.213 179.676 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.48 HD12 ' O ' ' A' ' 47' ' ' GLY . 0.8 OUTLIER -144.51 112.43 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 120.99 -1.069 . . . . 0.0 111.559 -178.707 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.571 ' O ' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -118.02 108.42 15.22 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.061 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . 0.678 ' CD2' ' CB ' ' A' ' 91' ' ' TRP . 2.1 t80 -106.11 149.14 27.03 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.188 -0.945 . . . . 0.0 111.648 -177.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' MET . . . . . 0.422 ' N ' ' HD1' ' A' ' 216' ' ' TYR . 36.1 ttp -129.72 107.63 9.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.72 -0.613 . . . . 0.0 109.56 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . 0.466 ' O ' ' OG ' ' A' ' 85' ' ' SER . . . 108.7 63.73 0.55 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 . . . . . 0 N--CA 1.494 1.759 0 O-C-N 121.195 -1.18 . . . . 0.0 110.012 179.881 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.612 ' O ' ' N ' ' A' ' 32' ' ' LEU . 1.1 pt? . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.182 0.515 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.56 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 59.9 mt-10 -46.66 -26.86 1.0 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.053 -1.03 . . . . 0.0 108.704 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -70.99 -22.21 62.2 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.612 ' N ' ' O ' ' A' ' 29' ' ' LEU . 14.7 tp -83.57 -34.86 25.09 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.611 HD21 ' CG ' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -70.41 -36.56 74.1 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.884 0.849 . . . . 0.0 109.057 179.122 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.584 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 2.9 t -70.48 -14.24 62.45 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.423 0.63 . . . . 0.0 109.945 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.799 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . . . -54.45 -160.73 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.511 -0.743 . . . . 0.0 109.967 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.799 ' HD2' ' CB ' ' A' ' 35' ' ' ALA . 38.2 Cg_endo -65.55 -166.55 0.1 OUTLIER 'Trans proline' 0 N--CA 1.489 1.22 0 O-C-N 123.188 1.099 . . . . 0.0 110.022 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.711 ' CD ' ' HB2' ' A' ' 36' ' ' PRO . 51.2 Cg_endo -96.67 54.42 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 121.394 1.396 . . . . 0.0 113.183 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.704 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 51.7 Cg_endo -76.46 151.06 32.75 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 122.93 0.963 . . . . 0.0 109.761 178.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.706 ' OD1' ' N ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -13.89 -54.41 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.53 -0.731 . . . . 0.0 112.072 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.919 ' O ' ' HB3' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -51.86 -46.56 64.49 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.933 -1.104 . . . . 0.0 110.959 -179.502 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.658 ' CG1' ' CE1' ' A' ' 45' ' ' HIS . 11.9 t -86.11 -19.14 8.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 O-C-N 121.52 -0.738 . . . . 0.0 111.639 -177.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 46' ' ' HIS . . . -88.95 -41.49 12.36 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.667 -1.271 . . . . 0.0 111.197 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.684 ' HB2' ' HA ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -87.65 -19.43 27.72 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 118.848 -1.141 . . . . 0.0 109.426 179.832 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.919 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -77.73 -38.02 48.07 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.113 0.959 . . . . 0.0 108.865 179.276 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.658 ' CE1' ' CG1' ' A' ' 41' ' ' VAL . 6.5 m170 -80.81 -18.2 48.32 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.429 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 42' ' ' ALA . 1.0 OUTLIER -97.42 -34.18 11.13 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.194 -0.941 . . . . 0.0 109.465 178.625 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.617 ' O ' ' CD1' ' A' ' 214' ' ' ILE . . . -68.18 -114.94 0.02 OUTLIER Glycine 0 N--CA 1.489 2.198 0 N-CA-C 107.299 -2.32 . . . . 0.0 107.299 178.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 1.066 ' CZ2' ' HA ' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -85.63 87.86 7.46 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 176.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.552 ' ND2' ' N ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -42.72 153.17 0.33 Allowed Pre-proline 0 N--CA 1.492 1.652 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -177.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.68 ' C ' ' H ' ' A' ' 52' ' ' ASP . 43.7 Cg_endo -70.38 -31.05 18.47 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 O-C-N 124.773 1.933 . . . . 0.0 110.952 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.849 ' N ' ' HE3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -62.37 0.13 0.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.36 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.68 ' H ' ' C ' ' A' ' 50' ' ' PRO . 12.9 m-20 -141.87 2.92 1.59 Allowed 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.112 178.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.811 ' HA ' ' N ' ' A' ' 79' ' ' ARG . 1.6 t -150.69 147.74 27.72 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.377 -0.827 . . . . 0.0 111.545 -179.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.934 ' H ' ' HA ' ' A' ' 78' ' ' VAL . 0.7 OUTLIER -86.92 121.78 29.86 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 120.903 -1.123 . . . . 0.0 109.824 178.648 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.765 ' O ' ' N ' ' A' ' 57' ' ' ILE . 1.1 pt-20 -44.77 -35.27 2.63 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.489 -0.757 . . . . 0.0 112.976 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.752 ' H ' ' ND2' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -32.48 -20.52 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.54 0 O-C-N 121.29 -0.882 . . . . 0.0 111.379 -179.217 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.765 ' N ' ' O ' ' A' ' 55' ' ' GLU . 1.6 mt -111.18 167.18 5.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.307 -0.87 . . . . 0.0 110.131 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.507 ' N ' ' CG2' ' A' ' 57' ' ' ILE . 36.0 t70 -108.54 128.55 54.91 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.376 -0.828 . . . . 0.0 110.357 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 1.003 ' HB ' ' CE2' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -131.28 132.03 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.577 -0.702 . . . . 0.0 111.099 -179.075 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.684 ' HA ' ' HB2' ' A' ' 43' ' ' GLN . 24.6 tttt -136.58 130.7 32.74 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.804 -1.185 . . . . 0.0 110.101 178.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.591 ' H ' ' HB3' ' A' ' 43' ' ' GLN . 1.6 pt-20 -52.58 -117.25 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.442 -0.786 . . . . 0.0 111.079 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 45.69 41.39 9.72 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 107.998 -2.041 . . . . 0.0 107.998 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.698 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 98.81 74.09 1.13 Allowed Glycine 0 N--CA 1.487 2.07 0 N-CA-C 108.293 -1.923 . . . . 0.0 108.293 -178.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.698 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER 0.84 75.38 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.758 -0.848 . . . . 0.0 110.887 -178.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.546 ' N ' ' O ' ' A' ' 63' ' ' GLY . 53.7 t -101.61 114.64 28.86 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.312 -0.868 . . . . 0.0 110.491 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 1.066 ' HA ' ' CZ2' ' A' ' 48' ' ' TRP . 1.6 m-85 -82.68 138.03 34.26 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.395 -0.816 . . . . 0.0 110.268 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.494 ' O ' ' O ' ' A' ' 58' ' ' ASP . 1.8 tt0 -138.2 121.77 17.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.16 -0.962 . . . . 0.0 109.913 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.484 ' HG3' ' HB2' ' A' ' 207' ' ' TRP . 0.6 OUTLIER -131.17 145.74 52.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.181 -0.95 . . . . 0.0 110.343 -179.87 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.64 ' HB3' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -125.1 -67.52 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.361 -0.837 . . . . 0.0 110.317 179.789 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.64 ' CD ' ' HB3' ' A' ' 69' ' ' ARG . 55.9 Cg_endo -69.7 -141.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.385 1.203 . . . . 0.0 109.133 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 t -139.74 164.0 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.053 -1.029 . . . . 0.0 110.045 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.6 119.35 6.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.129 -0.982 . . . . 0.0 110.136 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -84.99 -93.62 0.08 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.178 -0.951 . . . . 0.0 110.267 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.9 p -104.19 23.38 13.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.145 -0.972 . . . . 0.0 110.133 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.553 HG21 ' CB ' ' A' ' 54' ' ' SER . 3.4 t -141.5 -134.84 0.1 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.307 -0.871 . . . . 0.0 110.088 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.733 ' O ' ' C ' ' A' ' 77' ' ' GLY . 4.9 m-20 -140.55 153.62 46.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 110.868 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.733 ' C ' ' O ' ' A' ' 76' ' ' ASP . . . -26.48 -62.28 0.08 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 106.067 -2.813 . . . . 0.0 106.067 179.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.934 ' HA ' ' H ' ' A' ' 54' ' ' SER . 29.0 m -148.92 118.75 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 122.108 -0.643 . . . . 0.0 109.327 176.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.811 ' N ' ' HA ' ' A' ' 53' ' ' CYS . 0.0 OUTLIER -146.6 137.01 23.81 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.687 -0.633 . . . . 0.0 110.681 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.814 ' HA3' ' C ' ' A' ' 51' ' ' LYS . . . -163.38 156.03 27.65 Favored Glycine 0 N--CA 1.481 1.636 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 178.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 201' ' ' PRO . 0.2 OUTLIER -143.66 128.55 18.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.345 -1.091 . . . . 0.0 110.152 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.793 ' HD3' ' H ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -150.35 -95.64 0.07 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.194 -0.941 . . . . 0.0 110.226 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.793 ' H ' ' HD3' ' A' ' 82' ' ' ARG . . . 47.84 63.98 3.22 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -119.16 95.49 4.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.134 -1.216 . . . . 0.0 110.255 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.574 ' HB3' ' CD2' ' A' ' 89' ' ' HIS . 1.0 OUTLIER -140.3 169.37 17.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.249 -0.907 . . . . 0.0 110.098 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.561 ' O ' ' NE2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -117.37 133.48 55.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 110.128 179.792 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 103.76 -117.19 5.63 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.516 ' C ' ' CD2' ' A' ' 89' ' ' HIS . 7.6 tt -128.64 127.0 41.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.398 -1.06 . . . . 0.0 110.39 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.574 ' CD2' ' HB3' ' A' ' 85' ' ' SER . 8.5 m-70 -147.05 161.43 40.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.165 -0.959 . . . . 0.0 110.215 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 169' ' ' VAL . . . -163.52 157.87 20.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.22 -0.925 . . . . 0.0 109.857 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.643 ' CZ2' ' CG1' ' A' ' 169' ' ' VAL . 3.0 p90 -134.79 160.25 38.8 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.065 -1.022 . . . . 0.0 110.403 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.643 ' N ' ' O ' ' A' ' 215' ' ' ARG . 31.3 mt-10 -119.11 121.17 39.18 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.339 0.59 . . . . 0.0 110.648 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.499 HG12 ' HA ' ' A' ' 214' ' ' ILE . 5.3 mt -135.01 149.33 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.215 -0.928 . . . . 0.0 110.168 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.584 ' OG ' ' NH2' ' A' ' 213' ' ' ARG . 0.0 OUTLIER -121.17 135.84 55.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 109.654 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.885 ' HH2' ' O ' ' A' ' 204' ' ' SER . 6.1 t-105 -115.72 87.88 19.01 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.246 -0.909 . . . . 0.0 110.303 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 94' ' ' SER . 51.0 Cg_endo -97.47 114.06 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.156 1.904 . . . . 0.0 110.967 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.462 HD23 ' HB2' ' A' ' 210' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 O-C-N 120.895 -1.128 . . . . 0.0 109.523 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.834 HG13 ' O ' ' A' ' 204' ' ' SER . 0.5 OUTLIER . . . . . 0 N--CA 1.477 0.893 0 CA-C-O 121.482 0.658 . . . . 0.0 109.981 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.639 HG21 ' CZ3' ' A' ' 95' ' ' TRP . 9.7 t -152.49 136.94 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.476 -0.765 . . . . 0.0 109.698 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.485 ' HA3' ' HA3' ' A' ' 132' ' ' GLY . . . 154.07 -146.12 14.04 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 118.895 -1.621 . . . . 0.0 110.559 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.605 HG23 ' CD1' ' A' ' 199' ' ' LEU . 2.7 p -149.76 156.93 6.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.689 -0.889 . . . . 0.0 109.597 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.557 ' CB ' ' HA ' ' A' ' 130' ' ' SER . . . -146.41 153.34 40.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.059 -1.025 . . . . 0.0 111.104 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.609 ' CG2' ' HB3' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -110.72 128.61 55.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.468 -0.77 . . . . 0.0 109.738 179.529 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.6 -26.22 17.97 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.31 -0.869 . . . . 0.0 109.726 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.422 ' C ' ' CD1' ' A' ' 112' ' ' LEU . 4.1 pp -84.88 -11.94 54.55 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.417 -0.802 . . . . 0.0 109.481 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.397 -0.814 . . . . 0.0 110.548 -179.78 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.315 0.578 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -130.45 117.28 19.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 110.147 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.557 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 1.0 OUTLIER -123.96 122.05 36.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -0.914 . . . . 0.0 110.257 -179.876 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 3.2 m0 -125.54 129.53 49.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.245 -0.91 . . . . 0.0 109.958 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.485 ' HA3' ' HA3' ' A' ' 107' ' ' GLY . . . 173.87 -114.8 0.53 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . 0.692 ' CH2' ' CG ' ' A' ' 180' ' ' TYR . 34.3 m0 -129.16 122.96 30.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -1.162 . . . . 0.0 110.303 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.461 ' O ' HG12 ' A' ' 135' ' ' ILE . 0.8 OUTLIER -118.03 107.93 14.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.286 -0.883 . . . . 0.0 110.13 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 134' ' ' ASP . 1.3 mt . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.296 -0.878 . . . . 0.0 109.949 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.847 ' HB ' ' HD3' ' A' ' 164' ' ' PRO . 2.4 t . . . . . 0 N--CA 1.497 1.897 0 CA-C-O 119.678 -0.201 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.847 ' HD3' ' HB ' ' A' ' 163' ' ' VAL . 52.9 Cg_endo -95.84 179.21 0.59 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.104 1.055 . . . . 0.0 111.203 -178.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.8 -37.38 5.89 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.529 ' O ' ' CD1' ' A' ' 167' ' ' LEU . 0.3 OUTLIER -142.71 142.19 31.94 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.106 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.628 ' N ' ' CD2' ' A' ' 167' ' ' LEU . 0.3 OUTLIER -126.79 154.75 43.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.003 -1.06 . . . . 0.0 110.971 -179.24 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.7 tt -123.64 135.08 53.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.496 -0.753 . . . . 0.0 109.653 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.643 ' CG1' ' CZ2' ' A' ' 91' ' ' TRP . 42.3 t -106.41 141.71 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.122 -0.986 . . . . 0.0 110.73 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.444 ' N ' HG11 ' A' ' 169' ' ' VAL . 53.4 t -122.25 114.81 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.357 -0.839 . . . . 0.0 109.742 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.525 ' CD1' ' HB3' ' A' ' 178' ' ' LEU . 0.4 OUTLIER -128.09 124.08 36.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.18 -0.95 . . . . 0.0 110.423 -179.649 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.447 ' N ' HD12 ' A' ' 171' ' ' LEU . 5.5 t70 -116.32 138.36 51.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.312 -0.868 . . . . 0.0 109.914 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.502 ' O ' ' N ' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -93.34 -41.09 10.03 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.05 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.488 ' C ' ' O ' ' A' ' 173' ' ' MET . 0.6 OUTLIER -41.0 -27.84 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.195 -0.94 . . . . 0.0 108.987 179.399 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.557 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 1.8 tp10 -113.45 -27.63 7.84 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.518 ' O ' ' CG2' ' A' ' 198' ' ' THR . . . 83.62 23.74 52.45 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.603 ' CG2' ' CD2' ' A' ' 194' ' ' LEU . 0.7 OUTLIER -116.59 135.52 53.74 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.344 -1.092 . . . . 0.0 111.029 -179.515 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.574 ' N ' ' CD2' ' A' ' 178' ' ' LEU . 0.2 OUTLIER -136.29 150.65 49.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.45 -0.781 . . . . 0.0 109.594 179.361 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -148.15 -175.17 20.58 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.691 -1.242 . . . . 0.0 110.08 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.692 ' CG ' ' CH2' ' A' ' 133' ' ' TRP . 0.2 OUTLIER -138.98 127.2 22.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.4 -1.059 . . . . 0.0 110.082 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 21.2 t -117.99 124.44 48.19 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.174 -0.954 . . . . 0.0 109.881 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.647 ' CD1' ' CZ2' ' A' ' 133' ' ' TRP . 0.1 OUTLIER -116.15 116.48 52.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.506 -0.746 . . . . 0.0 109.777 179.814 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.511 ' C ' ' O ' ' A' ' 182' ' ' ILE . . . 38.51 28.94 0.06 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 182' ' ' ILE . . . 62.32 43.2 99.41 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' THR . . . . . 0.548 ' CB ' HG12 ' A' ' 182' ' ' ILE . 25.2 m -72.24 -78.86 0.08 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.201 -1.176 . . . . 0.0 110.468 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.702 ' CG ' ' O ' ' A' ' 186' ' ' TYR . 8.6 p90 -175.11 104.47 0.09 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.855 -1.153 . . . . 0.0 111.051 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.475 HD21 ' O ' ' A' ' 180' ' ' TYR . 4.8 tp 179.6 23.2 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.366 -0.834 . . . . 0.0 110.778 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.835 ' N ' ' CD ' ' A' ' 189' ' ' PRO . . . -109.65 -5.77 29.31 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.752 -1.213 . . . . 0.0 112.088 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.835 ' CD ' ' N ' ' A' ' 188' ' ' GLY . 50.5 Cg_endo -75.59 -33.03 4.31 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 O-C-N 122.718 0.851 . . . . 0.0 110.97 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.573 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -83.04 41.36 0.75 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.221 -0.924 . . . . 0.0 110.976 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -90.53 -46.22 8.45 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.204 -0.935 . . . . 0.0 110.455 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . 0.548 ' HA ' ' NE ' ' A' ' 192' ' ' ARG . 0.5 OUTLIER -68.11 -14.91 63.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.16 -0.963 . . . . 0.0 110.001 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 197' ' ' ARG . . . -103.47 -10.92 34.69 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.703 ' O ' ' N ' ' A' ' 198' ' ' THR . 9.2 tt -70.35 -43.36 70.35 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.851 -0.793 . . . . 0.0 109.142 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.568 ' CA ' HG22 ' A' ' 198' ' ' THR . 0.1 OUTLIER -43.91 -41.16 5.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.485 -0.759 . . . . 0.0 110.005 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.551 ' N ' ' HE3' ' A' ' 195' ' ' LYS . . . -88.09 -24.87 33.24 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' ARG . . . . . 0.706 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -91.07 -2.84 57.56 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.838 -0.801 . . . . 0.0 109.737 179.659 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' THR . . . . . 0.703 ' N ' ' O ' ' A' ' 194' ' ' LEU . 13.4 p -41.42 125.94 2.72 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.829 0.823 . . . . 0.0 111.212 -177.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.706 ' HG ' ' O ' ' A' ' 197' ' ' ARG . 0.0 OUTLIER -138.11 172.77 12.43 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -179.571 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.518 ' C ' ' CG2' ' A' ' 108' ' ' VAL . 4.2 m-30 -83.76 129.84 57.85 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 120.958 -1.089 . . . . 0.0 109.659 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.571 ' HA ' ' HB ' ' A' ' 108' ' ' VAL . 46.6 Cg_endo -72.49 129.17 14.39 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 124.047 1.551 . . . . 0.0 111.851 -178.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.41 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 1.8 p -133.62 160.27 38.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.486 -0.759 . . . . 0.0 110.101 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 79' ' ' ARG . 14.9 p -137.1 156.51 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.256 -0.903 . . . . 0.0 110.556 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' SER . . . . . 0.885 ' O ' ' HH2' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -160.11 127.93 4.66 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.442 -0.787 . . . . 0.0 109.217 179.052 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.476 ' CB ' ' CG2' ' A' ' 78' ' ' VAL . . . -127.93 159.95 33.37 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.5 -0.75 . . . . 0.0 110.738 -178.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.568 ' CG1' ' N ' ' A' ' 207' ' ' TRP . 1.0 OUTLIER -60.45 175.61 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 CA-C-O 121.334 0.588 . . . . 0.0 110.655 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.568 ' N ' ' CG1' ' A' ' 206' ' ' VAL . 39.7 p90 -120.84 57.71 0.97 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.439 -0.788 . . . . 0.0 110.207 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -134.53 -144.37 5.03 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . 0.411 ' O ' ' C ' ' A' ' 210' ' ' CYS . 2.2 tp60 -67.2 -31.67 72.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.353 -1.086 . . . . 0.0 110.481 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . 0.463 ' SG ' HG12 ' A' ' 206' ' ' VAL . 17.2 p -43.58 153.35 0.12 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.289 -0.882 . . . . 0.0 109.917 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.676 ' HA ' ' CD1' ' A' ' 66' ' ' PHE . 8.2 pt20 -156.56 123.67 5.28 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.103 -0.998 . . . . 0.0 110.628 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.431 ' HA ' ' CD ' ' A' ' 96' ' ' PRO . 1.5 m -101.61 140.32 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.336 -0.852 . . . . 0.0 110.114 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . 0.584 ' NH2' ' OG ' ' A' ' 94' ' ' SER . 0.5 OUTLIER -89.43 127.1 35.8 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.237 -0.914 . . . . 0.0 108.999 179.399 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.645 HG12 ' O ' ' A' ' 214' ' ' ILE . 0.1 OUTLIER -103.59 113.5 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-O 121.939 0.876 . . . . 0.0 111.248 -178.621 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' ARG . . . . . 0.643 ' O ' ' N ' ' A' ' 92' ' ' GLU . 4.0 ttt180 -130.61 126.89 37.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.407 -0.808 . . . . 0.0 108.863 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . 0.59 ' CD2' ' HB3' ' A' ' 91' ' ' TRP . 4.0 t80 -119.27 150.39 40.19 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.921 -1.112 . . . . 0.0 111.017 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' MET . . . . . 0.457 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 6.2 ttp -126.98 107.87 10.45 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.298 -0.876 . . . . 0.0 109.677 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 89.24 59.18 1.58 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.244 -1.15 . . . . 0.0 110.179 179.942 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.16 44.66 1.33 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -1.162 . . . . 0.0 110.18 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.8 m -93.04 -19.76 21.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.204 -0.935 . . . . 0.0 110.257 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.93 -179.64 3.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -0.936 . . . . 0.0 110.154 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' A' ' 11' ' ' GLN . 1.2 tpt180 -89.67 -71.93 0.58 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.261 -0.899 . . . . 0.0 110.235 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.4 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 11.7 tt0 -47.49 116.6 1.49 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.214 -0.929 . . . . 0.0 110.249 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 88.1 p -127.79 -153.39 0.57 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 110.281 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 13' ' ' THR . 1.9 t -147.4 126.11 6.23 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.24 -0.912 . . . . 0.0 110.151 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.16 110.98 3.17 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.957 1.504 . . . . 0.0 110.387 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.48 68.43 0.71 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -0.901 . . . . 0.0 110.17 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -133.31 118.42 18.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.3 -0.875 . . . . 0.0 110.275 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -139.26 75.54 1.52 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 110.15 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.28 101.45 0.08 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.263 -0.898 . . . . 0.0 110.145 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 179.85 -155.08 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.201 -0.937 . . . . 0.0 110.201 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.46 ' CG ' ' N ' ' A' ' 21' ' ' SER . 25.3 t80 -91.79 -102.38 0.11 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.29 -0.881 . . . . 0.0 110.22 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.46 ' N ' ' CG ' ' A' ' 20' ' ' TYR . 2.0 t -150.21 140.41 22.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.133 -0.979 . . . . 0.0 110.176 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 1.8 p30 -167.72 66.91 0.08 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.207 -0.933 . . . . 0.0 110.267 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.443 ' CG ' ' N ' ' A' ' 24' ' ' SER . 13.7 t80 -76.7 -104.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 110.017 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.443 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 2.8 m -123.4 104.86 34.07 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.552 -0.717 . . . . 0.0 110.111 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -78.11 164.32 27.19 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.018 1.536 . . . . 0.0 110.446 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.97 158.03 50.34 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.002 1.527 . . . . 0.0 110.539 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 179.68 45.11 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.476 -0.765 . . . . 0.0 110.12 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 168.99 -19.94 0.08 OUTLIER Glycine 0 N--CA 1.49 2.299 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.378 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.577 ' O ' ' N ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -71.97 -49.69 35.18 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.064 -1.256 . . . . 0.0 110.025 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.462 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 1.7 tt0 -45.02 -34.72 2.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.053 -1.029 . . . . 0.0 108.988 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.37 -24.05 64.78 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.385 -0.822 . . . . 0.0 108.787 178.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.577 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -83.42 -32.3 26.18 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.603 ' C ' ' CD1' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -81.52 -38.19 26.65 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.891 0.853 . . . . 0.0 109.284 179.165 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.558 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 0.9 OUTLIER -46.8 -30.72 2.59 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.625 0.726 . . . . 0.0 109.88 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.68 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . . . -72.58 -169.99 0.15 Allowed Pre-proline 0 C--N 1.298 -1.652 0 O-C-N 121.497 -0.752 . . . . 0.0 109.364 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.68 ' HD2' ' CB ' ' A' ' 35' ' ' ALA . 42.0 Cg_endo -69.48 106.18 1.57 Allowed 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.6 1.316 . . . . 0.0 109.765 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.616 ' HD3' ' O ' ' A' ' 35' ' ' ALA . 50.5 Cg_endo -88.67 108.59 0.51 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.13 1.595 . . . . 0.0 111.166 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.77 ' O ' ' N ' ' A' ' 40' ' ' LEU . 49.4 Cg_endo -76.81 150.55 30.74 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.925 1.487 . . . . 0.0 109.998 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.723 ' O ' ' CG ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER 3.3 61.39 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 122.617 1.199 . . . . 0.0 110.455 -178.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.77 ' N ' ' O ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -149.66 -45.47 0.13 Allowed 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 178.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.612 HG21 ' CD1' ' A' ' 40' ' ' LEU . 2.2 t -86.38 -35.64 9.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' A' ' 46' ' ' HIS . . . -89.21 -43.23 11.15 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.38 0.61 . . . . 0.0 110.089 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.557 ' HG3' ' CD ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -68.66 -25.17 64.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.461 -0.774 . . . . 0.0 110.416 -179.685 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.653 ' HA ' HG12 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -79.05 -50.84 10.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.146 -0.971 . . . . 0.0 108.999 179.475 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.656 ' HA ' ' CB ' ' A' ' 49' ' ' ASN . 9.3 m170 -63.8 -16.16 60.53 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 42' ' ' ALA . 3.7 t-160 -96.36 -28.75 14.33 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.44 -119.21 0.05 OUTLIER Glycine 0 N--CA 1.477 1.403 0 N-CA-C 107.838 -2.105 . . . . 0.0 107.838 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.856 ' HB3' ' CD1' ' A' ' 214' ' ' ILE . 0.8 OUTLIER -103.52 70.56 1.04 Allowed 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.011 -1.287 . . . . 0.0 110.478 179.143 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.656 ' CB ' ' HA ' ' A' ' 45' ' ' HIS . 0.3 OUTLIER -109.24 111.97 59.76 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 121.1 -1.0 . . . . 0.0 111.721 179.578 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.846 ' HG2' ' HB2' ' A' ' 53' ' ' CYS . 48.5 Cg_endo -80.57 -59.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.302 -1.902 0 O-C-N 123.78 1.411 . . . . 0.0 108.847 177.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.698 ' HG2' ' O ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER 179.81 -95.73 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.602 -0.686 . . . . 0.0 110.191 178.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.594 ' C ' ' HA2' ' A' ' 80' ' ' GLY 0.26 54.1 m-20 -68.97 33.97 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.178 0.989 . . . . 0.0 109.175 178.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.846 ' HB2' ' HG2' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -101.07 -176.92 3.3 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.843 -177.38 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.671 ' CB ' HG12 ' A' ' 78' ' ' VAL . 0.3 OUTLIER -50.6 101.73 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.689 -0.804 . . . . 0.0 111.662 -177.17 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.511 ' HG3' ' N ' ' A' ' 56' ' ' ASN . 9.4 pt-20 -102.07 -32.78 9.97 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.826 0.822 . . . . 0.0 109.522 177.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.511 ' N ' ' HG3' ' A' ' 55' ' ' GLU . 21.6 m-80 -70.01 -7.98 45.42 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.76 -0.587 . . . . 0.0 111.811 -178.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.57 HD11 ' CD1' ' A' ' 66' ' ' PHE . 1.2 pt -112.69 166.17 6.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 120.844 -1.16 . . . . 0.0 109.988 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.637 ' O ' ' CB ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -108.98 126.86 53.55 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.371 -0.831 . . . . 0.0 110.563 -179.13 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 44' ' ' ARG . 9.6 p -130.42 130.76 65.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 O-C-N 121.46 -0.775 . . . . 0.0 109.275 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.557 ' CD ' ' HG3' ' A' ' 43' ' ' GLN . 19.7 tttm -135.61 153.25 51.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.069 -1.019 . . . . 0.0 110.689 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.512 ' HA ' ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -66.21 -121.8 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.401 -0.812 . . . . 0.0 110.269 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 44.51 26.54 1.06 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.699 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 124.38 61.01 0.18 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.699 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER 0.61 88.76 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.796 -0.826 . . . . 0.0 110.758 -179.658 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 42.4 t -127.64 114.73 17.74 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.289 -0.882 . . . . 0.0 111.396 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.617 ' CD1' HG22 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -84.37 134.31 34.49 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.526 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.637 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 2.4 tt0 -126.66 131.03 51.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.74 -1.225 . . . . 0.0 110.847 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.522 ' NH1' ' OD2' ' A' ' 76' ' ' ASP . 0.0 OUTLIER -136.06 156.07 49.27 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.414 -0.804 . . . . 0.0 109.539 179.602 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.671 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -85.37 -69.92 0.13 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.071 -1.018 . . . . 0.0 111.243 -179.105 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.671 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 55.8 Cg_endo -72.16 -113.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.55 1.289 . . . . 0.0 110.324 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.48 ' O ' ' N ' ' A' ' 73' ' ' GLN . 4.7 t -140.38 164.83 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.454 -1.404 . . . . 0.0 110.369 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.543 ' CB ' ' NE1' ' A' ' 207' ' ' TRP . . . -41.62 -24.45 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.306 -0.872 . . . . 0.0 110.377 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.495 ' C ' ' O ' ' A' ' 72' ' ' ALA . 1.6 pt20 -36.11 -34.33 0.05 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.263 -0.898 . . . . 0.0 110.577 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 72' ' ' ALA . 69.0 p -149.54 -36.52 0.16 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 110.317 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.587 ' O ' ' OG ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -72.15 -55.1 7.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.189 -0.945 . . . . 0.0 110.134 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.522 ' OD2' ' NH1' ' A' ' 68' ' ' ARG . 4.7 t0 -99.24 155.36 17.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.225 -0.922 . . . . 0.0 109.741 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.63 74.12 1.26 Allowed Glycine 0 N--CA 1.487 2.068 0 N-CA-C 107.23 -2.348 . . . . 0.0 107.23 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.673 HG22 ' HA ' ' A' ' 53' ' ' CYS . 1.4 p -158.08 162.67 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 O-C-N 121.806 -0.82 . . . . 0.0 109.406 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.667 ' CG ' ' O ' ' A' ' 203' ' ' VAL . 0.0 OUTLIER -145.52 137.35 25.36 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.072 -1.051 . . . . 0.0 113.008 -178.419 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.594 ' HA2' ' C ' ' A' ' 52' ' ' ASP . . . -74.73 154.05 46.51 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 107.729 -2.148 . . . . 0.0 107.729 176.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.511 ' HG2' ' N ' ' A' ' 82' ' ' ARG . 1.3 ttmp? -126.18 -97.55 0.42 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.796 -1.414 . . . . 0.0 112.374 -178.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.88 ' HD3' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -43.33 -87.41 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.208 -0.933 . . . . 0.0 111.666 -178.102 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.88 ' N ' ' HD3' ' A' ' 82' ' ' ARG . . . 60.39 76.9 0.2 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.564 ' CE1' ' SD ' ' A' ' 173' ' ' MET . 10.1 t80 -94.42 132.08 39.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.356 -1.085 . . . . 0.0 110.842 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.468 ' O ' ' SD ' ' A' ' 173' ' ' MET . 7.3 t -140.01 161.34 37.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.39 -0.819 . . . . 0.0 109.911 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.488 ' HA ' ' HG2' ' A' ' 173' ' ' MET . 4.1 mtt180 -111.26 160.22 17.19 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.066 -1.022 . . . . 0.0 109.776 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.77 158.29 34.19 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 172' ' ' ASP . 2.5 tt -87.61 123.52 32.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.306 -1.114 . . . . 0.0 110.163 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.567 ' CD2' ' O ' ' A' ' 171' ' ' LEU . 0.6 OUTLIER -147.36 173.36 12.68 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 110.134 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.454 ' HB3' ' HA ' ' A' ' 170' ' ' VAL . . . -149.58 155.4 40.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.351 -0.843 . . . . 0.0 110.037 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.78 ' HB3' ' CD2' ' A' ' 216' ' ' TYR . 0.0 OUTLIER -134.72 170.67 15.48 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.116 -0.99 . . . . 0.0 110.352 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.663 ' N ' ' O ' ' A' ' 215' ' ' ARG . 1.0 OUTLIER -129.1 147.89 51.0 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.889 -0.725 . . . . 0.0 110.797 -179.471 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.552 ' CG2' ' OH ' ' A' ' 180' ' ' TYR . 0.6 OUTLIER -144.3 145.48 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.53 -0.731 . . . . 0.0 109.933 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.545 ' O ' ' CG2' ' A' ' 212' ' ' VAL . 0.0 OUTLIER -145.02 144.32 30.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.173 -0.955 . . . . 0.0 110.204 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.799 ' CE3' ' HA ' ' A' ' 104' ' ' ALA . 41.7 m95 -117.99 107.6 43.71 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.239 -0.913 . . . . 0.0 110.473 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.566 ' HG3' ' CZ ' ' A' ' 213' ' ' ARG . 49.8 Cg_endo -75.04 109.79 2.99 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.875 1.46 . . . . 0.0 109.899 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.517 ' CD2' ' OG1' ' A' ' 102' ' ' THR . 0.0 OUTLIER -95.44 -12.03 26.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.114 -0.991 . . . . 0.0 110.225 -179.725 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 97' ' ' LEU . 2.8 tm-20 -40.44 -33.32 0.25 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.239 -0.913 . . . . 0.0 110.577 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 209' ' ' GLN . 1.0 OUTLIER -42.61 -83.71 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.258 -0.901 . . . . 0.0 110.607 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.497 ' HB2' ' NH1' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -167.67 -59.75 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.418 -0.801 . . . . 0.0 110.304 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.522 ' O ' ' CG2' ' A' ' 102' ' ' THR . . . -149.34 126.0 2.13 Favored Glycine 0 N--CA 1.485 1.903 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.597 ' O ' ' CG ' ' A' ' 103' ' ' HIS . 75.5 p -156.21 -150.55 0.29 Allowed 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.305 -1.115 . . . . 0.0 110.014 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.597 ' CG ' ' O ' ' A' ' 102' ' ' THR . 0.5 OUTLIER -179.68 113.05 0.05 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.055 -1.028 . . . . 0.0 110.873 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.799 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . . . -76.19 131.91 39.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.27 -0.894 . . . . 0.0 109.377 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.855 HG22 ' O ' ' A' ' 204' ' ' SER . 17.4 m -132.2 116.48 29.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 C-N-CA 117.961 -1.496 . . . . 0.0 110.612 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.532 HG11 ' N ' ' A' ' 107' ' ' GLY . 89.8 t -150.63 170.09 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.623 -0.673 . . . . 0.0 109.341 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.618 ' CA ' ' HA3' ' A' ' 132' ' ' GLY . . . 165.6 167.3 25.99 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.34 -1.409 . . . . 0.0 110.479 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.533 ' CG1' ' HB2' ' A' ' 199' ' ' LEU . 1.7 t -112.55 141.73 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.551 -0.97 . . . . 0.0 109.507 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 130' ' ' SER . . . -114.53 142.61 46.19 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.081 -1.012 . . . . 0.0 110.655 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.568 HG23 ' CG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -118.77 131.99 56.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.277 -0.889 . . . . 0.0 110.357 179.718 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.97 -26.79 17.4 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.399 -0.813 . . . . 0.0 109.286 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.485 ' O ' ' C ' ' A' ' 113' ' ' ALA . 4.1 pp -83.83 -12.17 55.97 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.558 -0.714 . . . . 0.0 109.448 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.572 ' CB ' ' CB ' ' A' ' 129' ' ' GLU . . . -36.02 109.99 0.43 Allowed Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.587 -0.695 . . . . 0.0 110.441 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.81 -156.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.024 1.539 . . . . 0.0 110.431 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.422 ' CD1' ' HA3' ' A' ' 125' ' ' GLY . 0.3 OUTLIER -171.87 59.21 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.176 -0.953 . . . . 0.0 110.306 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -102.07 -70.99 0.73 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.384 -0.822 . . . . 0.0 110.241 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.515 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -114.59 56.61 0.72 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 110.255 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.515 ' C ' ' O ' ' A' ' 117' ' ' ALA . 8.2 t70 -32.06 146.65 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.512 -0.743 . . . . 0.0 110.66 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -44.96 -37.54 4.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.307 -0.87 . . . . 0.0 110.223 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.434 ' O ' ' CB ' ' A' ' 121' ' ' ALA . 1.6 m-30 -63.86 -56.4 15.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.33 -0.856 . . . . 0.0 110.21 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' A' ' 120' ' ' TYR . . . 173.48 -67.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.149 -0.969 . . . . 0.0 110.161 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 178.65 88.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.257 -0.902 . . . . 0.0 110.22 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 17.2 mt -98.88 -66.52 0.9 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.239 -0.913 . . . . 0.0 110.191 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 177.27 -153.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -0.887 . . . . 0.0 110.212 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.422 ' HA3' ' CD1' ' A' ' 115' ' ' LEU . . . -156.75 158.04 28.46 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.462 ' OG ' ' N ' ' A' ' 127' ' ' ASN . 4.7 t -123.91 -101.04 0.4 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.274 -1.133 . . . . 0.0 110.043 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.462 ' N ' ' OG ' ' A' ' 126' ' ' SER . 0.5 OUTLIER -126.66 -27.55 3.1 Favored 'General case' 0 C--N 1.286 -2.152 0 CA-C-O 121.222 0.534 . . . . 0.0 110.193 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.1 m -160.49 -166.42 1.65 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 110.315 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.572 ' CB ' ' CB ' ' A' ' 113' ' ' ALA . 3.9 tt0 -150.03 129.64 13.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.313 -0.867 . . . . 0.0 109.997 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 32.3 t -120.43 119.68 33.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.189 -0.944 . . . . 0.0 110.409 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.28 131.62 40.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.349 -0.845 . . . . 0.0 109.841 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.618 ' HA3' ' CA ' ' A' ' 107' ' ' GLY . . . -165.05 -144.67 4.13 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.696 ' CE3' ' CD2' ' A' ' 180' ' ' TYR . 31.5 m0 -116.67 114.45 24.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.343 -1.092 . . . . 0.0 110.556 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -118.13 143.42 46.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.527 -0.733 . . . . 0.0 110.033 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.588 HG12 ' CG ' ' A' ' 103' ' ' HIS . 0.1 OUTLIER -77.64 2.35 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.23 -0.919 . . . . 0.0 110.335 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.497 ' N ' HD13 ' A' ' 135' ' ' ILE . . . -66.01 -9.84 48.91 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.78 4.39 44.5 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.279 -1.13 . . . . 0.0 109.286 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 139' ' ' LYS . . . -125.6 -7.08 5.84 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.484 ' O ' ' O ' ' A' ' 138' ' ' GLY . 48.1 mtpt -54.21 -164.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.416 -1.05 . . . . 0.0 110.177 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.5 mt -86.38 4.61 38.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.207 -0.933 . . . . 0.0 110.151 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.57 ' HB3' ' CD2' ' A' ' 142' ' ' HIS . 0.1 OUTLIER -85.04 3.44 38.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 110.243 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.57 ' CD2' ' HB3' ' A' ' 141' ' ' TYR . 91.5 m-70 -150.18 85.81 1.41 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.163 -0.961 . . . . 0.0 110.25 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -142.07 -69.85 0.35 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.228 -0.92 . . . . 0.0 110.212 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 78.9 p -45.14 -41.66 8.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.296 -0.878 . . . . 0.0 110.221 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -99.33 84.61 3.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.259 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -138.5 126.58 3.5 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.05 10.7 7.49 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.233 -1.157 . . . . 0.0 110.209 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.417 ' O ' ' HD3' ' A' ' 150' ' ' PRO . 2.6 mt-10 -63.31 173.72 1.45 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.32 -0.863 . . . . 0.0 110.262 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -56.31 109.83 1.93 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 110.175 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 44.9 Cg_endo -72.87 -10.89 25.32 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.95 1.5 . . . . 0.0 110.487 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -83.31 -62.91 1.46 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.226 -0.921 . . . . 0.0 110.258 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.456 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 84.7 m-85 -119.27 165.77 16.31 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.337 -0.852 . . . . 0.0 110.136 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 152' ' ' TYR . 45.7 Cg_endo -72.66 110.92 3.12 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.037 1.546 . . . . 0.0 110.453 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -173.13 159.43 3.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 110.215 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 179.31 110.51 0.28 Allowed Glycine 0 N--CA 1.48 1.614 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.86 -43.82 0.75 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.876 1.461 . . . . 0.0 110.374 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.461 ' OE1' ' HG2' ' A' ' 160' ' ' GLN . 27.4 mm-40 -68.94 -2.09 8.94 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.309 -0.87 . . . . 0.0 110.469 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.19 -24.06 77.0 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.435 ' HG2' HG11 ' A' ' 163' ' ' VAL . 0.5 OUTLIER -83.18 6.63 18.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.146 -1.208 . . . . 0.0 110.272 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.524 ' O ' ' CD1' ' A' ' 161' ' ' LEU . 1.0 OUTLIER -68.94 -16.48 63.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.273 -0.892 . . . . 0.0 109.437 179.551 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.543 ' HG ' ' CD1' ' A' ' 133' ' ' TRP . 1.0 OUTLIER -161.24 22.52 0.13 Allowed 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.802 0.811 . . . . 0.0 109.488 179.338 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.533 ' CG1' ' O ' ' A' ' 162' ' ' VAL . 2.4 t -161.46 88.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.652 -0.655 . . . . 0.0 109.875 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.531 ' CG2' HD21 ' A' ' 167' ' ' LEU . 0.2 OUTLIER -113.06 83.84 6.52 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 0.0 109.961 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.69 71.8 3.21 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.976 1.514 . . . . 0.0 110.617 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.419 ' O ' ' HB3' ' A' ' 94' ' ' SER . 1.4 mt-10 -172.29 -81.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.355 -0.841 . . . . 0.0 110.118 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.516 ' HG2' ' N ' ' A' ' 167' ' ' LEU . 0.8 OUTLIER -151.55 154.92 37.42 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.322 -0.861 . . . . 0.0 109.739 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.597 ' HG ' ' CE1' ' A' ' 180' ' ' TYR . 0.0 OUTLIER -152.77 139.9 19.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.091 -1.005 . . . . 0.0 110.483 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' A' ' 181' ' ' SER . 17.0 tp -114.3 112.76 23.6 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.226 -0.921 . . . . 0.0 109.748 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.657 ' CG2' ' CE1' ' A' ' 180' ' ' TYR . 4.2 t -97.1 131.63 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.039 -1.038 . . . . 0.0 110.808 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.454 ' HA ' ' HB3' ' A' ' 90' ' ' ALA . 4.3 t -106.65 122.96 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.482 -0.761 . . . . 0.0 109.491 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.567 ' O ' ' CD2' ' A' ' 89' ' ' HIS . 4.6 tp -133.21 115.28 14.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.069 -1.02 . . . . 0.0 110.554 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.501 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 32.1 t0 -120.3 135.15 55.1 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.296 -0.877 . . . . 0.0 110.199 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.564 ' SD ' ' CE1' ' A' ' 84' ' ' TYR . 0.0 OUTLIER -94.58 -39.13 10.53 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.635 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 173' ' ' MET . 5.8 mm-40 -42.65 -27.7 0.19 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.219 -0.926 . . . . 0.0 108.828 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.589 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.1 OUTLIER -112.62 -27.07 8.34 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.235 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 82.57 24.23 54.21 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.589 ' OG1' ' HB3' ' A' ' 175' ' ' GLU . 0.2 OUTLIER -121.14 128.68 52.76 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.248 -1.148 . . . . 0.0 111.141 -179.458 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.572 ' N ' ' CD2' ' A' ' 178' ' ' LEU . 0.2 OUTLIER -139.99 153.69 46.93 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.459 -0.776 . . . . 0.0 109.588 179.338 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.421 ' O ' HG11 ' A' ' 169' ' ' VAL . . . -153.1 174.04 31.89 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.696 ' CD2' ' CE3' ' A' ' 133' ' ' TRP . 0.7 OUTLIER -118.94 118.67 32.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.351 -1.087 . . . . 0.0 110.119 -179.946 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.536 ' O ' ' CD1' ' A' ' 167' ' ' LEU . 39.3 t -144.76 165.23 28.67 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.177 -0.952 . . . . 0.0 109.96 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.609 HD13 ' CD2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -102.64 116.88 47.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 121.452 -0.78 . . . . 0.0 109.674 179.541 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 66.56 8.31 45.5 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 87.05 35.95 9.4 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' THR . . . . . 0.419 ' N ' ' OG ' ' A' ' 181' ' ' SER . 33.0 m -84.89 -74.55 0.39 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.293 -1.122 . . . . 0.0 110.563 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.609 ' CD2' HD13 ' A' ' 182' ' ' ILE . 18.7 m-85 -81.01 88.04 5.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.109 -0.995 . . . . 0.0 110.662 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.602 ' O ' ' CE2' ' A' ' 191' ' ' PHE . 2.3 tp -177.84 28.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.595 -0.691 . . . . 0.0 109.5 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.427 ' H ' ' HD2' ' A' ' 189' ' ' PRO . . . -104.15 -68.27 0.75 Allowed Glycine 0 N--CA 1.491 2.336 0 C-N-CA 120.059 -1.067 . . . . 0.0 110.514 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.427 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 44.4 Cg_endo -71.1 -30.05 16.79 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.843 1.444 . . . . 0.0 111.17 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -73.12 12.29 0.58 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.175 -0.953 . . . . 0.0 111.17 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.602 ' CE2' ' O ' ' A' ' 187' ' ' LEU . 0.3 OUTLIER -90.13 -13.15 36.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.08 -1.012 . . . . 0.0 109.741 179.255 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.47 -20.37 31.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.436 -0.79 . . . . 0.0 110.718 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -108.97 -24.7 5.92 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.821 -1.711 . . . . 0.0 108.821 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.621 ' HA ' ' HD2' ' A' ' 197' ' ' ARG . 6.6 tt -61.99 -32.71 73.2 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.611 -0.935 . . . . 0.0 109.016 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.542 ' HA ' ' CG2' ' A' ' 177' ' ' THR . 0.1 OUTLIER -47.16 -29.18 2.14 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.434 -0.791 . . . . 0.0 109.409 179.422 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -114.42 -19.38 6.24 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.664 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.91 -8.36 49.59 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.493 -1.004 . . . . 0.0 110.049 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.54 ' O ' ' CG2' ' A' ' 110' ' ' THR . 0.1 OUTLIER -43.52 143.16 1.0 Allowed 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.91 0.862 . . . . 0.0 111.587 -178.152 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' A' ' 197' ' ' ARG . 0.0 OUTLIER -140.41 172.26 12.98 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 22.3 m-85 -83.15 129.82 59.52 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.953 -1.092 . . . . 0.0 109.34 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.533 ' HD3' ' CD1' ' A' ' 178' ' ' LEU . 48.1 Cg_endo -74.18 129.6 13.28 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.054 1.555 . . . . 0.0 111.73 -178.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.485 ' O ' HG13 ' A' ' 106' ' ' VAL . 8.3 m -133.42 151.58 51.82 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.584 -0.697 . . . . 0.0 109.405 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.671 ' CG1' ' HG3' ' A' ' 50' ' ' PRO . 1.6 p -135.79 139.49 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.033 -1.042 . . . . 0.0 110.431 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' SER . . . . . 0.855 ' O ' HG22 ' A' ' 105' ' ' VAL . 74.7 m -119.7 126.88 52.18 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.756 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.589 ' HA ' ' CH2' ' A' ' 95' ' ' TRP . . . -109.79 138.3 46.35 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.772 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.568 ' CG1' ' N ' ' A' ' 207' ' ' TRP . 0.3 OUTLIER -91.62 -159.68 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.506 -0.746 . . . . 0.0 110.542 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.568 ' N ' ' CG1' ' A' ' 206' ' ' VAL . 0.8 OUTLIER -47.07 176.39 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 110.265 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.422 ' N ' ' OD2' ' A' ' 76' ' ' ASP . . . -82.1 -0.12 89.28 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.483 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 0.5 OUTLIER -72.87 -33.68 66.24 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.616 -0.932 . . . . 0.0 110.155 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . 0.668 ' O ' ' C ' ' A' ' 211' ' ' GLN . 11.4 t -97.08 -0.25 47.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.346 -0.846 . . . . 0.0 110.149 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.668 ' C ' ' O ' ' A' ' 210' ' ' CYS . 0.6 OUTLIER 0.49 106.39 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.787 0.803 . . . . 0.0 111.42 -179.804 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.608 HG22 ' CD1' ' A' ' 95' ' ' TRP . 1.9 p -87.85 145.02 8.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.708 -0.62 . . . . 0.0 109.545 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 0.609 ' HG3' ' HG ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -87.27 156.45 19.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.17 -0.956 . . . . 0.0 110.466 -178.686 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.856 ' CD1' ' HB3' ' A' ' 48' ' ' TRP . 0.2 OUTLIER -143.86 130.24 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.453 -0.779 . . . . 0.0 110.657 -179.323 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.663 ' O ' ' N ' ' A' ' 92' ' ' GLU . 6.8 mtt180 -130.81 108.86 10.16 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . 0.78 ' CD2' ' HB3' ' A' ' 91' ' ' TRP . 1.6 t80 -113.84 139.92 48.76 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 120.976 -1.077 . . . . 0.0 111.693 -177.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' MET . . . . . 0.45 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 0.3 OUTLIER -136.87 125.85 24.32 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.19 0.519 . . . . 0.0 109.89 179.548 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 120.47 -21.8 8.5 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.586 ' HB2' ' CE1' ' A' ' 216' ' ' TYR . 5.9 tm-20 -95.72 150.21 20.63 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.152 -1.205 . . . . 0.0 110.362 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . 0.408 ' O ' ' OE2' ' A' ' 219' ' ' GLU . 6.4 mtm180 -136.32 -141.09 0.16 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.297 -0.877 . . . . 0.0 110.142 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . 0.521 ' O ' ' C ' ' A' ' 222' ' ' VAL . 8.0 ttp180 -159.13 82.55 0.78 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.248 -0.907 . . . . 0.0 110.087 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.521 ' C ' ' O ' ' A' ' 221' ' ' ARG . 13.6 p -33.67 151.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.642 -0.661 . . . . 0.0 110.673 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 222' ' ' VAL . 5.4 tp10 -179.02 -51.32 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.275 -0.89 . . . . 0.0 110.147 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 225' ' ' THR . 18.9 tp10 179.2 -29.89 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.217 -0.927 . . . . 0.0 110.304 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.431 ' C ' ' O ' ' A' ' 224' ' ' GLU . 2.5 t -41.72 142.78 0.59 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.254 -0.904 . . . . 0.0 110.307 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.39 109.3 3.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.256 -0.903 . . . . 0.0 110.24 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.57 -170.45 1.86 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.314 -0.866 . . . . 0.0 110.23 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 98.4 mt -77.91 135.02 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.91 . . . . 0.0 110.203 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.424 ' O ' ' CD ' ' A' ' 230' ' ' ARG . 38.6 t-80 -135.45 79.04 1.76 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.226 -0.921 . . . . 0.0 110.258 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . 0.676 ' O ' ' C ' ' A' ' 231' ' ' ASP . 0.9 OUTLIER 179.86 33.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.314 -0.866 . . . . 0.0 110.215 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.676 ' C ' ' O ' ' A' ' 230' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 117.979 -1.01 . . . . 0.0 111.421 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.21 161.21 13.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -1.158 . . . . 0.0 110.235 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.424 ' O ' ' HB1' ' A' ' 9' ' ' ALA . 0.4 OUTLIER -116.0 132.22 56.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.209 -0.932 . . . . 0.0 110.209 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.424 ' HB1' ' O ' ' A' ' 8' ' ' SER . . . -177.04 -157.9 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.255 -0.903 . . . . 0.0 110.152 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.84 143.92 48.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.258 -0.901 . . . . 0.0 110.283 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -97.58 28.09 3.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.209 -0.932 . . . . 0.0 110.2 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.8 t -129.73 -1.49 4.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.198 -0.939 . . . . 0.0 110.212 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.8 m -124.33 132.18 24.27 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.245 -0.909 . . . . 0.0 110.129 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.29 75.34 2.9 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.006 1.529 . . . . 0.0 110.342 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 15' ' ' THR . 7.0 t -62.26 105.38 0.6 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -0.872 . . . . 0.0 110.225 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.418 ' O ' ' CG ' ' A' ' 17' ' ' GLN . 1.1 m -103.43 -174.28 2.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.882 . . . . 0.0 110.198 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.418 ' CG ' ' O ' ' A' ' 16' ' ' SER . 0.5 OUTLIER -161.52 -64.14 0.06 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.904 . . . . 0.0 110.184 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -171.63 165.97 6.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.223 -0.923 . . . . 0.0 110.218 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.44 -160.9 0.11 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 110.263 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.7 -78.57 0.6 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.282 -0.886 . . . . 0.0 110.301 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.21 -155.24 0.56 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.528 -0.733 . . . . 0.0 110.21 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 2.8 p-10 -121.85 -110.82 0.33 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.249 -0.907 . . . . 0.0 109.912 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.32 -58.45 0.79 Allowed 'General case' 0 C--N 1.284 -2.276 0 CA-C-O 121.433 0.635 . . . . 0.0 110.241 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.8 m -74.34 164.35 61.9 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.463 -0.773 . . . . 0.0 110.306 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.15 143.28 35.53 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.984 1.518 . . . . 0.0 110.559 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.66 ' O ' ' C ' ' A' ' 27' ' ' GLU . 46.1 Cg_endo -73.41 -167.66 0.38 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.999 1.526 . . . . 0.0 110.503 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.66 ' C ' ' O ' ' A' ' 26' ' ' PRO . 3.1 mm-40 1.33 68.43 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.541 0.686 . . . . 0.0 111.183 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 26' ' ' PRO . . . 179.15 -26.41 0.05 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.541 ' CD2' ' HG3' ' A' ' 55' ' ' GLU . 0.6 OUTLIER -76.89 -30.03 56.02 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.276 -1.132 . . . . 0.0 110.048 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.535 ' HA ' HD23 ' A' ' 33' ' ' LEU . 2.1 pp20? -47.54 -43.05 24.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.917 . . . . 0.0 109.745 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.436 ' N ' ' CD ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -57.75 -21.19 39.85 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.201 179.269 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.54 ' O ' ' HB2' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -83.4 -35.2 25.25 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.563 ' C ' ' CD1' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -67.8 -35.63 78.98 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 122.059 0.933 . . . . 0.0 109.087 179.15 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.557 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 1.0 OUTLIER -82.65 -6.8 59.56 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.301 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.643 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . . . -45.82 -67.31 0.39 Allowed Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.226 -0.921 . . . . 0.0 111.068 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.698 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . 46.1 Cg_endo -70.42 142.49 45.17 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.674 1.355 . . . . 0.0 110.288 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.692 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 53.3 Cg_endo -96.79 20.62 0.44 Allowed 'Trans proline' 0 CA--C 1.552 1.385 0 C-N-CA 121.724 1.616 . . . . 0.0 113.828 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.698 ' CD ' ' HB2' ' A' ' 36' ' ' PRO . 50.6 Cg_endo -79.58 151.01 22.11 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 122.609 0.794 . . . . 0.0 110.625 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.722 ' CG ' ' OE1' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -15.33 -54.7 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.755 -0.59 . . . . 0.0 111.835 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.681 ' CD2' ' C ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -44.56 -51.48 8.92 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 120.455 -1.403 . . . . 0.0 109.701 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.66 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 23.4 t -87.26 -30.47 5.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.146 -0.971 . . . . 0.0 110.614 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.67 -36.8 15.04 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.974 -1.079 . . . . 0.0 111.587 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.753 ' CD ' ' HB2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -82.24 -19.53 39.46 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.252 -0.905 . . . . 0.0 110.01 -179.188 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.604 ' N ' ' NE2' ' A' ' 43' ' ' GLN . 2.1 ttt180 -83.23 -42.68 16.95 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.304 -0.872 . . . . 0.0 109.952 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.678 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 14.7 m170 -60.4 -18.07 48.17 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.609 -0.682 . . . . 0.0 110.703 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -96.29 -34.71 11.5 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.032 -1.067 . . . . 0.0 109.556 178.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.522 ' HA3' ' HB2' ' A' ' 61' ' ' GLU . . . -92.42 -101.87 1.44 Allowed Glycine 0 N--CA 1.487 2.056 0 N-CA-C 106.929 -2.468 . . . . 0.0 106.929 178.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.713 ' CH2' ' HB ' ' A' ' 212' ' ' VAL . 93.8 m95 -81.27 73.81 8.29 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.05 -1.265 . . . . 0.0 108.044 177.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.678 ' HA ' ' HA ' ' A' ' 45' ' ' HIS . 0.1 OUTLIER -43.69 147.02 0.88 Allowed Pre-proline 0 C--N 1.297 -1.714 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.087 -179.362 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.665 ' HD3' ' CD2' ' A' ' 45' ' ' HIS . 40.5 Cg_endo -68.48 -33.04 23.83 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 124.498 1.788 . . . . 0.0 110.142 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.834 ' CE ' ' N ' ' A' ' 51' ' ' LYS . 0.2 OUTLIER -63.58 -16.64 61.4 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.612 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.878 ' O ' ' N ' ' A' ' 79' ' ' ARG . 4.2 m-20 -104.83 0.56 28.2 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 177.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 21.7 t -167.57 137.31 2.75 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 120.149 -0.621 . . . . 0.0 110.025 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.732 ' CB ' HD22 ' A' ' 56' ' ' ASN . 0.0 OUTLIER -100.77 161.33 13.67 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.209 179.159 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.541 ' HG3' ' CD2' ' A' ' 29' ' ' LEU . 24.3 pm0 -38.12 -20.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.326 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.732 HD22 ' CB ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -41.81 -29.61 0.21 Allowed 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 118.495 -1.282 . . . . 0.0 108.204 -179.762 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.54 ' CD1' ' O ' ' A' ' 207' ' ' TRP . 1.2 mt -131.13 166.11 29.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-O 121.63 0.729 . . . . 0.0 111.056 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.52 ' N ' ' CG2' ' A' ' 57' ' ' ILE . 2.8 t70 -128.11 105.67 8.53 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.695 HG12 ' HA ' ' A' ' 66' ' ' PHE . 10.7 m -128.44 135.52 62.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.327 -0.858 . . . . 0.0 110.955 -178.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.753 ' HB2' ' CD ' ' A' ' 43' ' ' GLN . 2.5 tttm -124.02 155.32 38.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.365 -0.835 . . . . 0.0 110.574 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.522 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . 4.2 tt0 -83.98 -131.25 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.387 -0.821 . . . . 0.0 110.142 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 43.24 52.44 6.0 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 108.389 -1.885 . . . . 0.0 108.389 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.667 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 108.88 61.66 0.54 Allowed Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.667 ' C ' ' O ' ' A' ' 63' ' ' GLY . 1.5 mm? 0.49 80.06 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.92 -0.753 . . . . 0.0 111.421 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 63' ' ' GLY . 1.6 m -99.51 114.37 27.31 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.266 -0.896 . . . . 0.0 109.599 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.695 ' HA ' HG12 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -104.89 124.74 49.99 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.311 -0.868 . . . . 0.0 110.079 -179.683 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.511 ' O ' ' O ' ' A' ' 58' ' ' ASP . 29.2 tt0 -144.62 145.56 31.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 109.862 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.557 ' HG2' ' O ' ' A' ' 207' ' ' TRP . 0.0 OUTLIER -132.68 118.12 18.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 110.207 -179.791 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.688 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 9.9 mmm-85 -84.73 -71.65 0.1 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.284 -0.885 . . . . 0.0 110.302 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.688 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 56.4 Cg_endo -72.18 -145.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.569 1.3 . . . . 0.0 109.155 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.484 ' O ' ' HG2' ' A' ' 73' ' ' GLN . 3.2 t -140.09 163.77 23.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 O-C-N 121.406 -0.809 . . . . 0.0 109.738 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 71' ' ' VAL . . . -43.19 103.3 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.067 -1.021 . . . . 0.0 109.891 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 3.8 pt20 -128.28 -113.27 0.27 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.211 -0.93 . . . . 0.0 110.593 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.551 ' CB ' ' HA ' ' A' ' 26' ' ' PRO . 22.0 p -36.06 -52.08 0.76 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.319 -0.863 . . . . 0.0 110.809 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.48 ' CB ' ' HB3' ' A' ' 54' ' ' SER . 0.2 OUTLIER -118.41 -137.39 0.35 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.131 -0.98 . . . . 0.0 109.993 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.701 ' O ' ' C ' ' A' ' 77' ' ' GLY . 1.3 t0 -140.66 154.84 46.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.893 . . . . 0.0 110.387 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.701 ' C ' ' O ' ' A' ' 76' ' ' ASP . . . -12.23 -98.32 0.0 OUTLIER Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.587 ' CG2' ' CB ' ' A' ' 205' ' ' ALA . 3.7 m -128.06 121.64 56.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.038 -1.272 . . . . 0.0 110.003 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.878 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -145.53 133.76 21.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.415 -0.803 . . . . 0.0 110.907 -179.756 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.727 ' HA3' ' HA ' ' A' ' 52' ' ' ASP . . . -163.7 145.23 10.24 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.546 ' HA ' ' CB ' ' A' ' 202' ' ' SER . 1.5 tttm -138.73 80.84 1.81 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -1.133 . . . . 0.0 110.04 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.48 -92.79 0.28 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.128 -0.983 . . . . 0.0 110.213 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 53.95 69.59 1.19 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -120.78 111.41 17.55 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.195 -1.179 . . . . 0.0 110.308 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.601 ' HB3' ' CE1' ' A' ' 89' ' ' HIS . 0.8 OUTLIER -140.02 173.65 11.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.936 . . . . 0.0 110.165 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.595 ' N ' ' CD ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -118.47 138.16 52.68 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.225 -0.922 . . . . 0.0 110.119 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.489 ' HA2' ' CG ' ' A' ' 174' ' ' GLU . . . 98.05 -116.52 5.56 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.495 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 0.9 OUTLIER -128.6 135.33 49.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.407 -1.055 . . . . 0.0 110.295 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.601 ' CE1' ' HB3' ' A' ' 85' ' ' SER . 9.0 m-70 -147.08 161.14 41.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.154 -0.966 . . . . 0.0 109.811 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.556 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -158.02 147.12 19.45 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.042 -1.036 . . . . 0.0 110.517 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.746 ' CD1' ' CZ ' ' A' ' 216' ' ' TYR . 1.3 m0 -134.75 170.23 16.14 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.374 -0.829 . . . . 0.0 109.097 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.645 ' N ' ' O ' ' A' ' 215' ' ' ARG . 3.2 mt-10 -136.47 138.96 41.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.118 -0.989 . . . . 0.0 111.23 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.526 ' CD1' ' O ' ' A' ' 92' ' ' GLU . 8.3 mm -142.93 126.4 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.58 -0.7 . . . . 0.0 109.361 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.553 ' OG ' ' CZ ' ' A' ' 213' ' ' ARG . 1.4 m -143.62 143.51 31.5 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.166 -0.959 . . . . 0.0 110.325 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.722 ' CD2' ' HA ' ' A' ' 104' ' ' ALA . 47.9 m95 -114.4 88.46 15.64 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.322 -0.861 . . . . 0.0 110.282 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.568 ' O ' ' N ' ' A' ' 101' ' ' GLY . 50.9 Cg_endo -91.92 109.86 0.27 Allowed 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 123.909 1.479 . . . . 0.0 110.255 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.658 ' HA ' ' O ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -88.86 -12.91 40.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.809 -1.182 . . . . 0.0 110.492 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 97' ' ' LEU . 13.9 tp10 -42.87 -32.58 0.64 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.091 -1.005 . . . . 0.0 109.262 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.521 ' CB ' ' HD3' ' A' ' 100' ' ' ARG . 4.2 mt-30 -147.81 12.42 1.0 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.589 -0.694 . . . . 0.0 109.47 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.658 ' O ' ' HA ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -179.21 -108.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.472 -0.768 . . . . 0.0 109.768 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.638 ' O ' ' CB ' ' A' ' 210' ' ' CYS . . . 47.28 172.29 0.01 OUTLIER Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.552 HG21 ' CE3' ' A' ' 95' ' ' TRP . 8.9 t 179.59 -177.11 0.32 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.098 -1.236 . . . . 0.0 110.097 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.562 ' CE1' ' O ' ' A' ' 136' ' ' GLY . 0.0 OUTLIER -42.32 95.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.228 -0.92 . . . . 0.0 109.52 179.609 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.722 ' HA ' ' CD2' ' A' ' 95' ' ' TRP . . . -74.32 119.71 18.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 110.971 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.619 ' CG2' ' C ' ' A' ' 204' ' ' SER . 27.0 m -136.19 115.97 16.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 118.91 -1.116 . . . . 0.0 110.366 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.522 ' CG2' HG21 ' A' ' 203' ' ' VAL . 8.4 t -150.69 170.04 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.464 -0.773 . . . . 0.0 109.631 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.631 ' CA ' ' HA3' ' A' ' 132' ' ' GLY . . . 164.02 164.05 18.33 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.504 -1.331 . . . . 0.0 110.689 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.576 ' CG1' ' HB2' ' A' ' 199' ' ' LEU . 2.5 t -114.3 155.7 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.639 -0.919 . . . . 0.0 109.072 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.495 ' HB1' ' CE ' ' A' ' 81' ' ' LYS . . . -142.93 144.75 32.52 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.863 -1.148 . . . . 0.0 111.129 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.568 HG23 ' CG ' ' A' ' 199' ' ' LEU . 0.8 OUTLIER -103.47 125.12 49.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.397 -0.815 . . . . 0.0 110.0 179.544 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.85 -28.39 16.55 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.459 -0.775 . . . . 0.0 109.9 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.673 ' O ' ' C ' ' A' ' 113' ' ' ALA . 0.5 OUTLIER -81.22 -12.45 59.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.321 -0.862 . . . . 0.0 109.719 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.673 ' C ' ' O ' ' A' ' 112' ' ' LEU . . . -1.58 76.53 0.04 OUTLIER Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.967 -0.458 . . . . 0.0 111.408 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.546 ' N ' ' O ' ' A' ' 112' ' ' LEU . 45.1 Cg_endo -74.41 -61.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.967 1.509 . . . . 0.0 110.385 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 115' ' ' LEU . 1.2 pp 179.9 50.77 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 0.0 110.125 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 118' ' ' ASP . 0.8 OUTLIER -41.68 -68.06 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 110.294 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.537 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -61.3 75.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.298 -0.876 . . . . 0.0 110.206 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.537 ' C ' ' O ' ' A' ' 117' ' ' ALA . 7.5 t0 -31.64 -68.44 0.09 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.544 -0.723 . . . . 0.0 110.669 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.424 ' O ' ' O ' ' A' ' 117' ' ' ALA . 1.1 p-80 -69.96 -158.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 110.14 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.515 ' CD2' ' O ' ' A' ' 120' ' ' TYR . 34.5 p90 -123.28 59.22 1.09 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.322 -0.861 . . . . 0.0 110.163 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -47.19 -66.47 0.4 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 110.265 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -168.26 -43.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 110.222 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.1 mt -73.31 102.12 3.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.949 . . . . 0.0 110.186 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.26 174.7 10.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.295 -0.878 . . . . 0.0 110.147 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 179.84 138.73 3.46 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.419 ' O ' ' OD1' ' A' ' 127' ' ' ASN . 94.0 p -161.89 28.8 0.12 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.314 -1.109 . . . . 0.0 110.204 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 126' ' ' SER . 1.5 m-20 -163.72 -44.95 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.372 -0.83 . . . . 0.0 110.209 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -167.16 161.74 14.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.33 -0.856 . . . . 0.0 110.193 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -150.11 128.52 12.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 110.083 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 24.0 t -120.43 119.75 33.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 110.276 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -133.35 130.17 38.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -0.902 . . . . 0.0 109.852 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.631 ' HA3' ' CA ' ' A' ' 107' ' ' GLY . . . -169.41 -146.56 5.1 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.705 ' CZ3' ' CG ' ' A' ' 180' ' ' TYR . 47.4 m0 -121.54 113.74 20.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -1.138 . . . . 0.0 110.501 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.527 ' O ' ' CG2' ' A' ' 135' ' ' ILE . 3.9 t70 -118.14 122.9 44.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.554 -0.716 . . . . 0.0 110.164 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.543 ' CG1' ' HA ' ' A' ' 161' ' ' LEU . 17.6 pt -156.84 36.21 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 110.172 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.562 ' O ' ' CE1' ' A' ' 103' ' ' HIS . . . -87.21 -71.91 1.29 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.436 ' HB3' ' CG ' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -81.35 7.98 10.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -1.164 . . . . 0.0 110.229 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 56.43 43.14 90.28 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.681 ' O ' ' C ' ' A' ' 140' ' ' LEU . 19.6 mtpt -86.38 -178.0 6.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -1.119 . . . . 0.0 110.182 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.681 ' C ' ' O ' ' A' ' 139' ' ' LYS . 3.2 tp 0.29 74.05 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.401 0.62 . . . . 0.0 111.334 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.559 ' N ' ' O ' ' A' ' 139' ' ' LYS . 31.7 p90 -106.07 32.37 4.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.927 . . . . 0.0 110.213 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -98.99 60.04 1.2 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 110.262 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -119.66 -74.5 0.61 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.221 -0.924 . . . . 0.0 110.195 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.28 162.73 0.12 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 110.274 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.496 ' HG3' ' N ' ' A' ' 146' ' ' GLY . 44.3 pttt -167.79 -143.1 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.255 -0.903 . . . . 0.0 110.256 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.496 ' N ' ' HG3' ' A' ' 145' ' ' LYS . . . 78.41 -129.07 9.08 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.45 39.25 3.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.198 -1.178 . . . . 0.0 110.218 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -44.47 164.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.153 -0.967 . . . . 0.0 110.287 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -174.24 165.26 2.61 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.353 -0.842 . . . . 0.0 110.218 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.533 ' HA ' ' N ' ' A' ' 155' ' ' GLY . 46.9 Cg_endo -74.37 1.82 6.94 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.027 1.54 . . . . 0.0 110.461 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.81 -94.72 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.256 -0.903 . . . . 0.0 110.292 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.542 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 3.0 m-85 -79.68 -58.73 0.62 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.113 -0.992 . . . . 0.0 110.412 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.542 ' CD ' ' CB ' ' A' ' 152' ' ' TYR . 45.2 Cg_endo -72.64 164.89 34.27 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.918 1.483 . . . . 0.0 110.49 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.478 ' O ' ' O ' ' A' ' 155' ' ' GLY . . . -67.78 112.94 5.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.329 -0.857 . . . . 0.0 110.316 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.533 ' N ' ' HA ' ' A' ' 150' ' ' PRO . . . -48.76 178.54 0.01 OUTLIER Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.91 -27.13 14.72 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.988 1.52 . . . . 0.0 110.397 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.32 -6.98 11.32 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.318 -0.864 . . . . 0.0 110.456 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -125.77 -10.9 4.2 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 159' ' ' GLU . 1.2 tm-20 -80.51 7.11 10.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.254 -1.145 . . . . 0.0 110.338 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.478 ' O ' ' HB3' ' A' ' 161' ' ' LEU . 26.3 mm100 -45.88 -25.2 0.49 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.307 -0.871 . . . . 0.0 109.753 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.562 ' CD2' ' N ' ' A' ' 161' ' ' LEU . 2.4 pt? -178.86 27.1 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.393 0.616 . . . . 0.0 110.307 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.541 ' CG2' ' HB2' ' A' ' 95' ' ' TRP . 2.3 t -166.43 96.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.473 -0.767 . . . . 0.0 110.156 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.651 ' HB ' ' HD3' ' A' ' 164' ' ' PRO . 2.7 t -78.15 -67.92 0.25 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.102 -0.998 . . . . 0.0 109.722 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.651 ' HD3' ' HB ' ' A' ' 163' ' ' VAL . 54.7 Cg_endo -78.89 154.44 26.13 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.457 1.24 . . . . 0.0 109.912 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -58.53 -30.61 67.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.043 -1.036 . . . . 0.0 109.374 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.466 ' HG3' ' OG ' ' A' ' 94' ' ' SER . 1.4 ttt180 -151.82 155.83 38.98 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.631 -0.668 . . . . 0.0 109.321 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.528 HD23 ' CG ' ' A' ' 164' ' ' PRO . 1.2 mp -126.86 138.63 53.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.965 -1.084 . . . . 0.0 110.461 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.479 ' CD1' ' CD ' ' A' ' 92' ' ' GLU . 1.0 OUTLIER -120.76 126.71 50.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.337 -0.852 . . . . 0.0 109.969 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.542 HG13 ' CE3' ' A' ' 91' ' ' TRP . 46.0 t -89.93 136.04 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 109.99 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.451 HG23 ' CD2' ' A' ' 168' ' ' LEU . 3.5 t -124.16 126.47 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.205 -0.934 . . . . 0.0 109.971 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.595 HD22 ' CZ2' ' A' ' 91' ' ' TRP . 0.0 OUTLIER -133.04 120.39 21.28 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.116 -0.99 . . . . 0.0 109.843 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 173' ' ' MET . 46.1 t0 -117.92 135.28 54.22 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.33 -0.856 . . . . 0.0 109.928 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.465 ' O ' ' C ' ' A' ' 174' ' ' GLU . 0.0 OUTLIER -98.62 -42.44 7.26 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.796 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.489 ' CG ' ' HA2' ' A' ' 87' ' ' GLY . 1.1 mm-40 -43.62 -26.87 0.26 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.223 -0.923 . . . . 0.0 108.72 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.552 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 2.7 tp10 -112.49 -28.32 7.9 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.717 0.77 . . . . 0.0 108.977 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 85.95 22.53 48.89 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 108.684 -1.766 . . . . 0.0 108.684 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.585 ' HA ' ' CD2' ' A' ' 194' ' ' LEU . 0.3 OUTLIER -113.77 123.5 49.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.222 -1.163 . . . . 0.0 111.087 -179.513 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.571 ' N ' ' CD2' ' A' ' 178' ' ' LEU . 0.2 OUTLIER -143.89 154.19 43.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.424 -0.797 . . . . 0.0 109.805 179.458 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -177.86 -161.06 25.43 Favored Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.506 -1.331 . . . . 0.0 110.273 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.705 ' CG ' ' CZ3' ' A' ' 133' ' ' TRP . 0.5 OUTLIER -118.7 123.52 45.09 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.493 -1.004 . . . . 0.0 109.724 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.515 ' HB2' ' CD2' ' A' ' 187' ' ' LEU . 5.7 t -130.15 125.68 35.64 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.417 -0.802 . . . . 0.0 110.356 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.619 HD12 ' CH2' ' A' ' 133' ' ' TRP . 0.1 OUTLIER -110.02 116.9 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.216 -0.928 . . . . 0.0 109.911 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 47.93 23.57 2.64 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 69.14 40.17 82.81 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' THR . . . . . 0.632 ' CG2' ' CE2' ' A' ' 186' ' ' TYR . 92.4 m -71.36 -76.27 0.11 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.277 -1.131 . . . . 0.0 110.642 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.632 ' CE2' ' CG2' ' A' ' 185' ' ' THR . 25.7 m-85 -126.5 89.28 2.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.172 -0.955 . . . . 0.0 110.641 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -176.54 26.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.404 -0.81 . . . . 0.0 109.765 179.641 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.487 ' H ' ' HD2' ' A' ' 189' ' ' PRO . . . -95.52 -61.46 1.01 Allowed Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.97 -1.11 . . . . 0.0 110.568 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.487 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 45.0 Cg_endo -71.94 -29.52 15.02 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.951 1.5 . . . . 0.0 111.001 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -74.65 15.78 0.34 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.197 -0.94 . . . . 0.0 111.03 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -90.35 -12.91 36.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.086 -1.009 . . . . 0.0 110.099 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.09 -15.31 34.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.0 110.187 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -109.99 -18.83 8.5 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.614 ' HA ' ' HD2' ' A' ' 197' ' ' ARG . 6.3 tt -61.82 -32.25 72.55 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.727 -0.867 . . . . 0.0 108.82 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.529 ' HA ' HG21 ' A' ' 177' ' ' THR . 0.0 OUTLIER -47.2 -29.64 2.48 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.576 -0.702 . . . . 0.0 109.422 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -114.19 -19.33 6.35 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.645 ' C ' ' CD ' ' A' ' 197' ' ' ARG . 0.0 OUTLIER -90.88 -4.87 56.22 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.507 -0.996 . . . . 0.0 109.774 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.534 ' O ' ' CG2' ' A' ' 110' ' ' THR . 0.1 OUTLIER -43.38 145.59 0.57 Allowed 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.913 0.863 . . . . 0.0 111.396 -178.269 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 197' ' ' ARG . 0.0 OUTLIER -140.11 172.27 12.99 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.487 ' O ' HG13 ' A' ' 108' ' ' VAL . 1.7 m-85 -82.85 129.62 61.12 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 120.887 -1.133 . . . . 0.0 109.274 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.548 ' HD3' HD12 ' A' ' 178' ' ' LEU . 49.8 Cg_endo -78.07 125.92 7.53 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.079 1.568 . . . . 0.0 111.388 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.546 ' CB ' ' HA ' ' A' ' 81' ' ' LYS . 9.3 p -133.59 138.39 45.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.476 -0.765 . . . . 0.0 109.891 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.522 HG21 ' CG2' ' A' ' 106' ' ' VAL . 7.1 p -119.31 159.54 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.142 -0.974 . . . . 0.0 109.402 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' SER . . . . . 0.619 ' C ' ' CG2' ' A' ' 105' ' ' VAL . 22.3 m -160.15 162.67 33.98 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.129 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.587 ' CB ' ' CG2' ' A' ' 78' ' ' VAL . . . -150.14 160.13 43.9 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.424 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.546 ' CG2' ' HB2' ' A' ' 103' ' ' HIS . 0.4 OUTLIER -49.42 -176.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.635 -0.666 . . . . 0.0 110.329 179.618 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.628 ' CG ' ' N ' ' A' ' 208' ' ' GLY . 22.7 p-90 -92.4 -44.44 8.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.929 . . . . 0.0 110.05 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.628 ' N ' ' CG ' ' A' ' 207' ' ' TRP . . . -164.33 128.28 1.79 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -173.89 -39.8 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.239 -1.153 . . . . 0.0 110.432 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . 0.638 ' CB ' ' O ' ' A' ' 101' ' ' GLY . 1.2 m -155.75 -93.48 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.404 -0.81 . . . . 0.0 110.551 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.575 ' CB ' ' HB2' ' A' ' 100' ' ' ARG . 2.1 mt-30 179.53 159.82 0.74 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.067 -1.021 . . . . 0.0 110.161 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.713 ' HB ' ' CH2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -127.5 144.05 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.165 -0.959 . . . . 0.0 110.784 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 0.65 ' NE ' ' O ' ' A' ' 213' ' ' ARG . 0.0 OUTLIER -101.46 110.79 22.85 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.256 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.592 ' HB ' ' CH2' ' A' ' 48' ' ' TRP . 1.4 tt -118.12 132.84 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.906 -1.121 . . . . 0.0 111.319 -178.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.645 ' O ' ' N ' ' A' ' 92' ' ' GLU . 1.6 mtt180 -130.09 109.41 10.82 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . 0.746 ' CZ ' ' CD1' ' A' ' 91' ' ' TRP . 27.3 t80 -113.49 145.49 41.12 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.274 -0.891 . . . . 0.0 111.115 -178.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' MET . . . . . 0.476 ' HA ' ' CE ' ' A' ' 217' ' ' MET . 3.8 tpt -136.56 108.59 7.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.536 -0.727 . . . . 0.0 109.877 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 132.97 7.09 2.67 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.566 ' HB2' ' CD1' ' A' ' 216' ' ' TYR . 22.2 tt0 -95.34 157.66 15.8 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.132 -1.216 . . . . 0.0 110.123 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.08 -162.66 0.96 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.931 . . . . 0.0 110.308 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . 0.546 ' O ' ' C ' ' A' ' 222' ' ' VAL . 0.0 OUTLIER -160.88 108.05 1.5 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.283 -0.886 . . . . 0.0 110.075 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.546 ' C ' ' O ' ' A' ' 221' ' ' ARG . 2.0 p -29.77 111.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.52 -0.738 . . . . 0.0 110.854 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.538 ' O ' ' C ' ' A' ' 224' ' ' GLU . 0.8 OUTLIER -74.45 53.18 0.52 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.233 -0.917 . . . . 0.0 110.192 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.538 ' C ' ' O ' ' A' ' 223' ' ' GLU . 11.0 pt-20 -29.46 -41.1 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.561 -0.712 . . . . 0.0 110.818 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.513 ' N ' ' O ' ' A' ' 223' ' ' GLU . 7.0 t -50.24 115.69 1.54 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -0.961 . . . . 0.0 110.211 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.18 57.51 4.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.27 -0.894 . . . . 0.0 110.275 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -157.5 -168.98 2.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.205 -0.934 . . . . 0.0 110.251 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.433 ' O ' ' C ' ' A' ' 229' ' ' HIS . 25.4 mt -111.67 101.76 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.327 -0.858 . . . . 0.0 110.197 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.53 ' O ' ' N ' ' A' ' 231' ' ' ASP . 26.0 t-80 -42.71 -76.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.284 -0.885 . . . . 0.0 110.228 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . 0.684 ' O ' ' C ' ' A' ' 231' ' ' ASP . 0.9 OUTLIER -56.57 82.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.325 -0.859 . . . . 0.0 110.231 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.684 ' C ' ' O ' ' A' ' 230' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.951 -1.023 . . . . 0.0 111.48 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.8 m -99.74 -56.33 2.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.168 -1.195 . . . . 0.0 110.191 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 t -143.99 -54.18 0.35 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 110.314 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -167.49 -167.04 0.83 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.327 -0.858 . . . . 0.0 110.168 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -83.12 50.4 1.73 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.21 -0.931 . . . . 0.0 110.179 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.25 124.12 9.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.254 -0.904 . . . . 0.0 110.231 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.3 110.1 8.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.915 . . . . 0.0 110.205 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.12 143.85 98.54 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.277 -0.889 . . . . 0.0 110.156 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.94 85.87 1.14 Allowed 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 124.001 1.527 . . . . 0.0 110.453 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.1 t -70.38 171.49 9.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.257 -0.902 . . . . 0.0 110.155 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 18' ' ' ALA . 8.5 t -84.9 -171.96 3.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.198 -0.939 . . . . 0.0 110.058 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -43.5 93.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.921 . . . . 0.0 110.23 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 16' ' ' SER . . . -55.48 -173.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.305 -0.872 . . . . 0.0 110.263 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 18' ' ' ALA . 4.3 mt -55.28 -161.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 110.336 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -63.36 -10.6 17.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 110.35 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.439 ' OG ' ' N ' ' A' ' 22' ' ' ASP . 8.9 t -178.62 -173.42 0.32 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 0.0 110.228 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.439 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.4 OUTLIER -177.41 30.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 110.219 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -145.6 -71.27 0.26 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.304 -0.873 . . . . 0.0 110.265 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -131.63 105.46 14.31 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.292 -0.88 . . . . 0.0 110.199 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.479 ' HB2' ' HD2' ' A' ' 26' ' ' PRO . 45.9 Cg_endo -73.26 175.13 10.98 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.069 1.563 . . . . 0.0 110.314 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 25' ' ' PRO . 43.3 Cg_endo -71.9 160.37 47.93 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.872 1.459 . . . . 0.0 110.473 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -83.46 43.03 0.86 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.383 -0.823 . . . . 0.0 109.867 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.65 27.14 69.35 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.629 ' O ' ' N ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -70.78 -51.9 24.05 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.46 -1.023 . . . . 0.0 110.075 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.563 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 10.8 pt-20 -44.49 -45.95 9.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.146 -0.971 . . . . 0.0 109.225 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.22 -20.79 7.53 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.639 -0.824 . . . . 0.0 108.777 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.629 ' N ' ' O ' ' A' ' 29' ' ' LEU . 4.1 tp -83.83 -33.62 24.85 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.65 HD22 ' CB ' ' A' ' 55' ' ' GLU . 0.4 OUTLIER -73.66 -36.12 65.33 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 122.012 0.911 . . . . 0.0 109.179 179.367 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.571 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 7.3 m -85.0 -6.76 59.33 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.324 0.583 . . . . 0.0 109.775 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.645 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . . . -49.45 -67.61 0.42 Allowed Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.307 -0.871 . . . . 0.0 110.879 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.658 ' C ' ' HD3' ' A' ' 38' ' ' PRO . 46.5 Cg_endo -72.14 157.68 53.61 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.655 1.345 . . . . 0.0 110.366 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 36' ' ' PRO . 53.9 Cg_endo -99.14 55.3 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 121.94 1.76 . . . . 0.0 112.006 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.658 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 49.4 Cg_endo -73.7 150.7 45.38 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.064 1.034 . . . . 0.0 110.108 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.742 ' O ' ' HB3' ' A' ' 43' ' ' GLN . 0.5 OUTLIER -41.86 -21.87 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.199 -0.938 . . . . 0.0 109.873 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.878 ' O ' ' HB3' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -61.2 -50.45 73.07 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.014 -1.053 . . . . 0.0 109.184 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.895 ' O ' ' CD2' ' A' ' 45' ' ' HIS . 2.9 t -67.27 -39.84 83.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 C-N-CA 118.481 -1.287 . . . . 0.0 110.845 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.36 -39.9 12.41 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.784 -1.197 . . . . 0.0 112.797 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.799 ' OE1' ' HA ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -82.2 -20.54 37.58 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 118.406 -1.318 . . . . 0.0 109.536 -179.414 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.878 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 5.0 ttp180 -68.68 -52.29 32.64 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.895 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 40.6 m-70 -45.62 -23.57 0.26 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.471 ' N ' ' C ' ' A' ' 44' ' ' ARG . 3.3 t-160 -95.96 -33.01 12.32 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.033 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 49' ' ' ASN . . . -87.72 -115.63 1.16 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 107.065 -2.414 . . . . 0.0 107.065 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.734 ' CD1' ' CG1' ' A' ' 59' ' ' VAL . 93.7 m95 -67.48 74.47 0.16 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.749 -1.442 . . . . 0.0 108.33 177.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.671 ' OD1' ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -44.11 111.62 1.2 Allowed Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.63 -0.669 . . . . 0.0 110.614 -179.29 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.777 ' O ' ' O ' ' A' ' 53' ' ' CYS . 55.4 Cg_endo -79.49 1.65 9.02 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.166 1.91 . . . . 0.0 111.692 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.699 ' CE ' ' CA ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -50.59 -75.6 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.387 -1.446 . . . . 0.0 108.459 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.795 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 0.6 OUTLIER -64.79 3.43 0.54 Allowed 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.777 ' O ' ' O ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -124.67 170.45 10.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.423 -0.798 . . . . 0.0 110.797 -178.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.581 ' N ' ' SG ' ' A' ' 53' ' ' CYS . 4.4 t -100.51 165.8 11.24 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.015 -1.053 . . . . 0.0 108.906 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.695 ' O ' ' N ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -94.32 1.13 55.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.93 -1.106 . . . . 0.0 110.547 -179.045 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.638 ' ND2' ' N ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -22.17 -42.01 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 122.401 1.096 . . . . 0.0 109.937 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.695 ' N ' ' O ' ' A' ' 55' ' ' GLU . 11.3 pt -126.03 169.61 17.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.555 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.648 ' O ' ' HB3' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -105.69 118.04 35.57 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.324 -0.86 . . . . 0.0 109.299 -178.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.734 ' CG1' ' CD1' ' A' ' 48' ' ' TRP . 90.1 t -124.44 136.05 61.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.273 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.799 ' HA ' ' OE1' ' A' ' 43' ' ' GLN . 1.7 ttmt -135.21 155.14 51.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.714 -1.241 . . . . 0.0 111.043 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.552 ' N ' ' OE1' ' A' ' 43' ' ' GLN . 23.2 tt0 -67.47 -109.26 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.453 -0.779 . . . . 0.0 110.226 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.546 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 37.26 35.17 0.15 Allowed Glycine 0 N--CA 1.494 2.558 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.68 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 114.56 56.85 0.38 Allowed Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 -178.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.68 ' C ' ' O ' ' A' ' 63' ' ' GLY . 2.0 mm? 0.83 84.98 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.962 -0.728 . . . . 0.0 110.92 -178.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 63' ' ' GLY . 1.7 m -128.43 130.61 47.86 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.383 -0.823 . . . . 0.0 110.708 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.679 ' CE2' ' HB ' ' A' ' 212' ' ' VAL . 5.3 m-30 -83.61 152.4 24.84 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.648 ' HB3' ' O ' ' A' ' 58' ' ' ASP . 1.1 tp10 -147.65 121.4 9.25 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.228 -0.92 . . . . 0.0 109.755 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.57 ' HG2' ' CD1' ' A' ' 207' ' ' TRP . 1.0 OUTLIER -118.99 156.32 29.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.419 -0.801 . . . . 0.0 109.416 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.55 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -168.15 -56.94 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 120.98 -1.075 . . . . 0.0 111.043 -179.559 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 69' ' ' ARG . 41.0 Cg_endo -67.29 -47.14 2.4 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.804 1.423 . . . . 0.0 110.729 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.565 HG13 ' CG2' ' A' ' 57' ' ' ILE . 2.0 p -78.31 165.38 3.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.879 0.847 . . . . 0.0 111.048 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.548 ' N ' ' CG2' ' A' ' 71' ' ' VAL . . . -156.59 -40.01 0.08 Allowed 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.049 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 75' ' ' THR . 1.8 mt-30 -74.73 151.56 39.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.906 . . . . 0.0 110.125 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.9 91.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.335 -0.853 . . . . 0.0 110.21 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.51 ' N ' ' O ' ' A' ' 73' ' ' GLN . 2.6 m -97.03 -130.38 0.18 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.32 -0.862 . . . . 0.0 110.061 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.513 ' O ' ' O ' ' A' ' 77' ' ' GLY . 0.2 OUTLIER -120.75 113.8 20.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.186 -0.946 . . . . 0.0 110.452 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.559 ' HA2' ' CE3' ' A' ' 207' ' ' TRP . . . -57.14 -114.24 0.01 OUTLIER Glycine 0 N--CA 1.485 1.925 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.53 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 0.5 OUTLIER -148.42 123.17 2.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.944 -1.327 . . . . 0.0 110.979 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.795 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -104.47 175.08 5.61 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.549 -0.72 . . . . 0.0 109.489 179.313 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.576 ' N ' ' CG ' ' A' ' 79' ' ' ARG . . . -157.42 58.29 0.36 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.539 ' HG3' ' CB ' ' A' ' 202' ' ' SER . 0.7 OUTLIER -89.9 75.02 7.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.075 -1.25 . . . . 0.0 110.122 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.805 ' HD3' ' H ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -141.94 -95.29 0.13 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.316 -0.865 . . . . 0.0 110.292 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.805 ' H ' ' HD3' ' A' ' 82' ' ' ARG . . . 56.54 62.23 6.59 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -105.71 95.7 5.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.177 -1.19 . . . . 0.0 110.261 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.584 ' OG ' ' CD2' ' A' ' 89' ' ' HIS . 0.4 OUTLIER -140.01 171.51 14.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 110.018 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.64 ' O ' ' CD2' ' A' ' 89' ' ' HIS . 30.1 mtm180 -123.38 175.79 6.52 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.164 -0.96 . . . . 0.0 110.237 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.513 ' N ' ' HB3' ' A' ' 173' ' ' MET . . . 62.52 -116.45 9.39 Favored Glycine 0 N--CA 1.482 1.722 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.433 HD11 ' HB2' ' A' ' 172' ' ' ASP . 11.6 tp -129.37 127.76 41.69 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.559 -0.966 . . . . 0.0 110.995 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.64 ' CD2' ' O ' ' A' ' 86' ' ' ARG . 93.3 m-70 -147.26 173.16 12.82 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.269 -0.895 . . . . 0.0 109.95 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.544 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -163.81 164.11 23.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.261 -0.899 . . . . 0.0 110.133 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.722 ' CD1' ' CZ ' ' A' ' 216' ' ' TYR . 1.1 m0 -134.86 145.89 48.73 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.301 -0.874 . . . . 0.0 109.54 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.644 ' O ' ' N ' ' A' ' 215' ' ' ARG . 2.1 tt0 -109.97 118.9 37.67 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.431 -0.907 . . . . 0.0 109.883 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.524 ' O ' ' CD1' ' A' ' 167' ' ' LEU . 17.3 mm -118.08 130.05 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.019 -1.051 . . . . 0.0 111.028 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.533 ' CB ' ' HB3' ' A' ' 213' ' ' ARG . 0.0 OUTLIER -118.53 126.38 51.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.404 -0.81 . . . . 0.0 109.428 179.319 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.791 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 7.1 t-105 -117.3 88.19 27.03 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.119 -0.988 . . . . 0.0 110.217 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.529 ' O ' ' O ' ' A' ' 211' ' ' GLN . 50.0 Cg_endo -96.21 112.21 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 121.968 1.779 . . . . 0.0 110.673 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.532 ' CD1' ' HB ' ' A' ' 102' ' ' THR . 0.5 OUTLIER -95.07 -67.41 0.85 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.824 -1.173 . . . . 0.0 110.184 179.641 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.477 ' CB ' ' OE1' ' A' ' 99' ' ' GLN . 3.3 mt-10 -98.0 -24.81 15.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 0.0 109.808 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.477 ' OE1' ' CB ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER 179.96 -29.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.643 0.735 . . . . 0.0 109.614 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.428 ' HG2' ' CG ' ' A' ' 99' ' ' GLN . 5.6 mmt180 -119.58 -50.62 2.31 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.529 -0.732 . . . . 0.0 109.649 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.643 ' HA2' ' O ' ' A' ' 95' ' ' TRP . . . 170.15 -164.86 38.21 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.588 ' O ' ' CG ' ' A' ' 103' ' ' HIS . 2.8 m -170.62 -55.39 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.235 -1.156 . . . . 0.0 110.523 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.638 ' CE1' ' CG2' ' A' ' 162' ' ' VAL . 7.1 m-70 -167.32 103.37 0.52 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.094 -1.003 . . . . 0.0 111.103 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.791 ' HA ' ' CE2' ' A' ' 95' ' ' TRP . . . -88.62 146.78 24.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.222 -0.924 . . . . 0.0 109.165 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.712 ' CG2' ' CB ' ' A' ' 204' ' ' SER . 0.7 OUTLIER -110.61 114.57 47.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 C-N-CA 117.778 -1.569 . . . . 0.0 109.197 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.574 ' CG1' ' O ' ' A' ' 202' ' ' SER . 22.2 t -152.04 159.8 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.277 -0.889 . . . . 0.0 109.574 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.583 ' HA2' ' HA3' ' A' ' 132' ' ' GLY . . . -175.57 136.77 3.48 Favored Glycine 0 N--CA 1.487 2.078 0 C-N-CA 118.826 -1.654 . . . . 0.0 110.859 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.558 HG13 ' N ' ' A' ' 201' ' ' PRO . 2.8 t -104.42 141.71 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.601 -0.941 . . . . 0.0 108.999 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.579 ' HB2' ' CE1' ' A' ' 200' ' ' TYR . . . -130.54 152.39 49.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.883 -1.136 . . . . 0.0 111.126 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.534 ' CG2' ' HB3' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -121.13 130.87 53.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.481 -0.762 . . . . 0.0 110.055 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -89.44 -25.96 21.22 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.291 -0.881 . . . . 0.0 109.343 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.47 ' O ' ' HD3' ' A' ' 114' ' ' PRO . 1.4 pp -83.35 -12.49 56.51 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.489 -0.757 . . . . 0.0 109.398 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -107.65 85.12 2.19 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.47 -0.769 . . . . 0.0 110.246 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 112' ' ' LEU . 46.4 Cg_endo -73.14 104.78 1.84 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.922 1.485 . . . . 0.0 110.5 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.46 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 0.2 OUTLIER 179.95 60.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.277 -0.889 . . . . 0.0 110.162 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -66.92 -40.98 87.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.942 . . . . 0.0 110.33 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.534 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . 179.87 -72.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.246 -0.909 . . . . 0.0 110.181 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.534 ' C ' ' O ' ' A' ' 117' ' ' ALA . 11.2 t0 -31.28 126.83 0.19 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.511 -0.743 . . . . 0.0 110.769 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -93.83 -75.55 0.5 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.293 -0.879 . . . . 0.0 110.177 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -118.45 8.65 12.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.929 . . . . 0.0 110.198 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.449 ' CB ' ' OD1' ' A' ' 118' ' ' ASP . . . -70.39 -22.29 62.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.186 -0.946 . . . . 0.0 110.217 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -152.55 25.97 0.58 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.934 . . . . 0.0 110.224 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.495 ' C ' ' CD1' ' A' ' 124' ' ' LEU . 25.2 mt 47.52 -147.39 0.2 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.322 -0.861 . . . . 0.0 110.212 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.658 ' CD1' ' N ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -160.49 -171.96 3.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.34 -0.85 . . . . 0.0 110.41 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 121.22 -3.84 11.33 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.1 m -152.59 47.97 0.74 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.243 -1.151 . . . . 0.0 110.199 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -157.61 160.08 37.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.365 -0.834 . . . . 0.0 110.117 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.5 p -114.67 -160.37 0.73 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.907 . . . . 0.0 110.131 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.578 ' OE2' ' CG ' ' A' ' 131' ' ' TRP . 4.6 tm-20 -145.03 126.84 15.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.902 . . . . 0.0 109.892 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.48 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -122.09 119.45 31.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.946 . . . . 0.0 110.666 -179.727 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . 0.578 ' CG ' ' OE2' ' A' ' 129' ' ' GLU . 16.7 m0 -133.25 133.27 42.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.47 -0.768 . . . . 0.0 109.519 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.583 ' HA3' ' HA2' ' A' ' 107' ' ' GLY . . . -177.23 -140.94 3.84 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.442 -1.361 . . . . 0.0 110.207 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.595 ' CH2' HD11 ' A' ' 182' ' ' ILE . 52.0 m0 -117.17 112.95 21.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.207 -1.172 . . . . 0.0 110.75 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.537 ' O ' ' CD2' ' A' ' 161' ' ' LEU . 0.3 OUTLIER -119.33 148.27 43.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.761 -0.587 . . . . 0.0 110.269 179.608 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.559 ' CD1' ' CG1' ' A' ' 105' ' ' VAL . 0.1 OUTLIER -101.86 -11.2 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.204 -0.935 . . . . 0.0 109.955 179.574 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.78 -8.49 52.98 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.426 ' HB2' HD21 ' A' ' 161' ' ' LEU . 1.1 mtm-85 -83.75 0.49 47.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.401 -1.058 . . . . 0.0 109.312 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.744 ' O ' ' O ' ' A' ' 139' ' ' LYS . . . -116.22 -16.74 6.52 Favored Glycine 0 N--CA 1.485 1.908 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.744 ' O ' ' O ' ' A' ' 138' ' ' GLY . 0.1 OUTLIER 0.98 -131.1 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 CA-C-O 121.771 0.796 . . . . 0.0 112.283 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.454 ' C ' ' O ' ' A' ' 139' ' ' LYS . 38.9 mt -37.66 -67.5 0.19 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.574 -0.704 . . . . 0.0 110.443 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -139.34 -104.8 0.17 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.209 -0.932 . . . . 0.0 110.282 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -148.26 72.75 1.22 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.215 -0.928 . . . . 0.0 110.219 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.488 ' CG ' ' N ' ' A' ' 144' ' ' SER . 10.5 pt20 -45.31 -40.61 7.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.314 -0.866 . . . . 0.0 110.195 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.488 ' N ' ' CG ' ' A' ' 143' ' ' GLN . 58.4 m -68.97 102.88 1.69 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.188 -0.945 . . . . 0.0 110.33 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.04 98.88 11.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.183 -0.948 . . . . 0.0 110.122 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.4 -105.63 0.99 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 148' ' ' GLU . 0.5 OUTLIER -159.02 86.01 0.82 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.291 -1.123 . . . . 0.0 110.187 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 147' ' ' LEU . 0.7 OUTLIER -44.59 115.49 0.87 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.213 -0.929 . . . . 0.0 110.141 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.547 ' N ' ' CD ' ' A' ' 150' ' ' PRO . . . -130.02 49.39 4.66 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.343 -0.848 . . . . 0.0 110.132 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.547 ' CD ' ' N ' ' A' ' 149' ' ' ALA . 46.1 Cg_endo -73.23 -1.02 9.97 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.989 1.52 . . . . 0.0 110.404 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.93 -91.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.159 -0.963 . . . . 0.0 110.265 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.563 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 0.5 OUTLIER -77.5 -59.73 0.81 Allowed Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.191 -0.943 . . . . 0.0 110.247 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.563 ' CD ' ' CB ' ' A' ' 152' ' ' TYR . 45.8 Cg_endo -72.98 152.59 51.82 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.026 1.54 . . . . 0.0 110.397 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 155' ' ' GLY . . . -91.28 127.1 36.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.146 -0.971 . . . . 0.0 110.238 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 154' ' ' ALA . . . -42.1 110.59 0.25 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.42 -20.8 23.55 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.967 1.509 . . . . 0.0 110.369 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.474 ' HA ' ' HB2' ' A' ' 160' ' ' GLN . 0.0 OUTLIER -68.62 -1.51 6.97 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.334 -0.854 . . . . 0.0 110.601 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.431 ' O ' ' HB ' ' A' ' 162' ' ' VAL . . . -61.86 -61.75 6.42 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -92.33 4.84 52.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.209 -1.171 . . . . 0.0 110.213 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.537 ' O ' ' CD1' ' A' ' 161' ' ' LEU . 15.4 tt0 -73.53 -18.43 61.09 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.329 -0.857 . . . . 0.0 109.222 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.537 ' CD2' ' O ' ' A' ' 134' ' ' ASP . 0.2 OUTLIER -159.73 21.62 0.17 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.864 0.84 . . . . 0.0 109.444 179.414 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.638 ' CG2' ' CE1' ' A' ' 103' ' ' HIS . 2.5 t -163.14 95.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.716 -0.615 . . . . 0.0 109.937 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 1.7 t -108.47 76.32 0.65 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.15 -0.969 . . . . 0.0 110.149 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.491 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 46.8 Cg_endo -73.18 65.16 4.31 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.903 1.475 . . . . 0.0 110.75 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 27.2 tp10 -167.83 -84.14 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.398 -0.814 . . . . 0.0 110.101 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -152.31 155.86 38.49 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.4 -0.812 . . . . 0.0 110.344 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 93' ' ' ILE . 2.9 mp -135.74 137.02 41.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 109.793 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.53 114.21 15.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.066 -1.021 . . . . 0.0 110.571 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.649 ' CG2' ' CE1' ' A' ' 180' ' ' TYR . 18.4 t -89.92 136.04 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.852 . . . . 0.0 109.784 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.425 ' HB ' ' CD1' ' A' ' 187' ' ' LEU . 7.5 t -113.06 111.18 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.089 -1.007 . . . . 0.0 110.519 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.626 ' CB ' ' CZ2' ' A' ' 91' ' ' TRP . 0.0 OUTLIER -119.68 105.6 11.33 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.292 -0.88 . . . . 0.0 109.311 179.607 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.433 ' HB2' HD11 ' A' ' 88' ' ' LEU . 5.5 t0 -120.33 135.3 55.06 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.577 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.529 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 0.3 OUTLIER -95.9 -40.68 9.18 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.414 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -44.73 -26.39 0.38 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.299 -0.876 . . . . 0.0 108.99 179.205 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.612 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.0 OUTLIER -110.78 -26.79 9.18 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.282 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.573 ' O ' ' CG2' ' A' ' 198' ' ' THR . . . 81.53 25.46 53.9 Favored Glycine 0 N--CA 1.482 1.73 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.634 ' HA ' HG22 ' A' ' 198' ' ' THR . 0.0 OUTLIER -118.56 112.08 19.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.196 -1.179 . . . . 0.0 111.381 -179.484 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.592 ' CD1' ' CG2' ' A' ' 198' ' ' THR . 4.0 mp -118.76 153.85 33.77 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.481 -0.762 . . . . 0.0 109.256 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.403 ' O ' HG12 ' A' ' 169' ' ' VAL . . . 177.39 -174.47 46.99 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.07 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.649 ' CE1' ' CG2' ' A' ' 169' ' ' VAL . 0.3 OUTLIER -123.99 125.62 44.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.341 -1.094 . . . . 0.0 109.949 179.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 35.5 t -136.69 132.77 35.37 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.268 -0.895 . . . . 0.0 110.194 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.595 HD11 ' CH2' ' A' ' 133' ' ' TRP . 0.0 OUTLIER -103.67 116.81 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.309 -0.87 . . . . 0.0 109.756 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 88.76 -10.41 72.44 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 80.61 46.82 7.1 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 79.8 m -129.41 -2.5 4.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.255 -1.144 . . . . 0.0 110.441 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.498 ' CD2' HD13 ' A' ' 182' ' ' ILE . 0.2 OUTLIER -99.77 -54.96 2.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.207 -0.933 . . . . 0.0 110.264 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.634 ' O ' ' CE2' ' A' ' 191' ' ' PHE . 5.3 mt -77.48 44.54 0.44 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.225 -0.922 . . . . 0.0 109.785 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -80.91 -96.78 0.39 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.47 ' C ' ' H ' ' A' ' 191' ' ' PHE . 46.9 Cg_endo -72.9 -25.1 16.97 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 124.229 1.647 . . . . 0.0 111.017 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.529 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -68.62 21.42 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.506 -0.746 . . . . 0.0 111.76 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.634 ' CE2' ' O ' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -90.23 -13.83 34.63 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.707 -1.246 . . . . 0.0 110.349 179.467 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.05 -14.72 33.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.105 -0.997 . . . . 0.0 110.597 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -112.63 -11.16 15.3 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.607 ' O ' ' N ' ' A' ' 198' ' ' THR . 7.5 tt -74.69 -28.58 60.88 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.474 -1.015 . . . . 0.0 109.108 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.488 ' O ' ' OG1' ' A' ' 198' ' ' THR . 0.0 OUTLIER -54.08 -33.82 58.54 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.385 -0.822 . . . . 0.0 109.714 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -94.23 -26.88 12.98 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.783 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.46 -6.08 55.29 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.68 -0.894 . . . . 0.0 109.943 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.634 HG22 ' HA ' ' A' ' 177' ' ' THR . 0.2 OUTLIER -44.59 131.86 6.5 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.877 0.846 . . . . 0.0 112.532 -178.114 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.783 ' HG ' ' O ' ' A' ' 197' ' ' ARG . 0.0 OUTLIER -140.74 170.75 15.18 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.571 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.589 ' O ' ' CD1' ' A' ' 200' ' ' TYR . 25.6 p90 -84.6 128.72 60.1 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 120.775 -1.203 . . . . 0.0 109.548 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.558 ' N ' HG13 ' A' ' 108' ' ' VAL . 51.0 Cg_endo -84.49 143.78 9.96 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.138 1.599 . . . . 0.0 111.393 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.574 ' O ' ' CG1' ' A' ' 106' ' ' VAL . 0.9 OUTLIER -133.54 138.54 46.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.51 -0.744 . . . . 0.0 109.908 179.401 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.46 HG12 ' HA3' ' A' ' 80' ' ' GLY . 14.6 p -119.64 157.93 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.161 -0.962 . . . . 0.0 110.108 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' SER . . . . . 0.712 ' CB ' ' CG2' ' A' ' 105' ' ' VAL . 0.4 OUTLIER -160.18 145.87 15.28 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.391 -0.818 . . . . 0.0 110.688 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.579 ' HA ' ' CH2' ' A' ' 95' ' ' TRP . . . -146.21 166.44 26.23 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.56 0.695 . . . . 0.0 110.573 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 207' ' ' TRP . 1.2 t -110.24 176.17 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 CA-C-O 121.456 0.646 . . . . 0.0 110.608 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.57 ' CD1' ' HG2' ' A' ' 68' ' ' ARG . 4.4 p90 -124.97 175.52 7.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.349 -0.844 . . . . 0.0 110.016 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 113.38 -165.57 12.05 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.452 ' O ' ' O ' ' A' ' 210' ' ' CYS . 0.0 OUTLIER -44.52 -29.39 0.71 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.393 -1.063 . . . . 0.0 110.3 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 211' ' ' GLN . 27.0 p -58.03 -154.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.318 -0.864 . . . . 0.0 110.236 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.529 ' O ' ' O ' ' A' ' 96' ' ' PRO . 0.9 OUTLIER 179.59 125.34 0.07 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.248 -0.908 . . . . 0.0 110.377 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.679 ' HB ' ' CE2' ' A' ' 66' ' ' PHE . 8.3 t -128.6 144.32 38.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 121.671 -0.643 . . . . 0.0 109.941 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 0.537 ' CZ ' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -122.41 124.35 43.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.247 -0.908 . . . . 0.0 109.996 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.712 ' HB ' ' CZ3' ' A' ' 48' ' ' TRP . 2.3 tt -119.22 128.06 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.013 -1.054 . . . . 0.0 111.183 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.644 ' N ' ' O ' ' A' ' 92' ' ' GLU . 1.1 mtt180 -130.14 136.9 49.8 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.407 -0.808 . . . . 0.0 109.259 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . 0.722 ' CZ ' ' CD1' ' A' ' 91' ' ' TRP . 14.0 t80 -118.9 150.17 40.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.04 -1.038 . . . . 0.0 110.908 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' MET . . . . . 0.505 ' CB ' ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -124.57 107.68 11.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.944 . . . . 0.0 110.05 179.371 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 95.71 74.02 1.2 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.527 ' HB2' ' CD1' ' A' ' 216' ' ' TYR . 3.6 tp10 -135.52 130.58 34.83 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.187 -1.184 . . . . 0.0 110.125 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . 0.492 ' O ' ' CG ' ' A' ' 220' ' ' ARG . 0.0 OUTLIER -126.58 109.52 12.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.122 -0.986 . . . . 0.0 110.341 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 220' ' ' ARG . 2.5 tpm_? -178.78 100.62 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.255 -0.903 . . . . 0.0 110.224 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -169.22 127.12 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.115 -0.991 . . . . 0.0 110.333 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.531 ' O ' ' C ' ' A' ' 224' ' ' GLU . 0.1 OUTLIER 179.83 -31.1 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.192 -0.943 . . . . 0.0 110.227 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.531 ' C ' ' O ' ' A' ' 223' ' ' GLU . 2.1 mt-10 -32.4 -44.19 0.09 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.349 -0.844 . . . . 0.0 110.725 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.419 HG22 ' O ' ' A' ' 227' ' ' ARG . 27.0 m -47.07 135.73 9.4 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.19 -0.944 . . . . 0.0 110.202 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.43 18.45 7.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.902 . . . . 0.0 110.218 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.419 ' O ' HG22 ' A' ' 225' ' ' THR . 7.3 ptm180 -160.56 -170.54 2.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.277 -0.89 . . . . 0.0 110.174 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.433 HG22 ' O ' ' A' ' 228' ' ' ILE . 3.8 tp -162.91 117.58 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 110.212 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 23.4 p80 -117.44 -0.01 12.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 110.167 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . 0.682 ' O ' ' C ' ' A' ' 231' ' ' ASP . 0.0 OUTLIER -50.33 110.06 0.36 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.235 -0.915 . . . . 0.0 110.191 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.682 ' C ' ' O ' ' A' ' 230' ' ' ARG . 8.9 t0 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.971 -1.014 . . . . 0.0 111.432 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.3 p -49.14 -24.67 1.76 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.272 -1.134 . . . . 0.0 110.183 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.24 -47.96 0.27 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.296 -0.877 . . . . 0.0 110.185 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.38 166.41 23.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.223 -0.923 . . . . 0.0 110.186 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.446 ' O ' ' O ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -99.81 -28.12 13.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.314 -0.866 . . . . 0.0 110.197 -179.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.446 ' O ' ' O ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -47.22 175.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.199 -0.938 . . . . 0.0 110.186 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.78 74.95 1.68 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.912 . . . . 0.0 110.172 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.533 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -47.24 -55.73 14.86 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 110.241 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 13' ' ' THR . 46.5 Cg_endo -72.75 121.58 7.48 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.124 1.592 . . . . 0.0 110.556 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.448 ' O ' ' HB3' ' A' ' 16' ' ' SER . 0.1 OUTLIER -92.5 64.58 4.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 110.233 -179.912 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 15' ' ' THR . 10.6 p -178.3 63.91 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.309 -0.869 . . . . 0.0 110.2 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -104.18 96.21 6.49 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.249 -0.907 . . . . 0.0 110.245 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.75 134.51 41.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.116 -0.99 . . . . 0.0 110.269 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.92 -5.24 58.11 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.328 1.061 . . . . 0.0 110.301 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -170.92 -141.01 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.233 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.7 m -103.01 33.77 3.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.181 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -83.15 44.23 0.93 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.168 -0.958 . . . . 0.0 110.312 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.23 -41.87 16.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 110.159 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.36 105.36 56.51 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.333 -0.854 . . . . 0.0 110.063 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.2 133.89 20.22 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.017 1.535 . . . . 0.0 110.583 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.706 ' O ' ' N ' ' A' ' 28' ' ' GLY . 46.1 Cg_endo -72.79 -161.09 0.1 Allowed 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.052 1.554 . . . . 0.0 110.512 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.674 ' C ' ' O ' ' A' ' 26' ' ' PRO . 28.9 mm-40 1.71 64.78 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.615 0.721 . . . . 0.0 111.125 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.706 ' N ' ' O ' ' A' ' 26' ' ' PRO . . . 160.8 27.9 0.02 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.542 ' O ' ' CD1' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -60.23 -19.91 56.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.268 -1.137 . . . . 0.0 109.657 179.743 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.533 ' HA ' ' CD2' ' A' ' 33' ' ' LEU . 16.8 pt-20 -49.42 -28.42 5.15 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.255 -0.903 . . . . 0.0 109.167 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.43 ' N ' ' HG3' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -68.24 -23.3 64.78 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.513 -0.875 . . . . 0.0 108.687 179.011 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.469 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 0.6 OUTLIER -83.37 -36.84 24.03 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.697 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.613 ' HG ' ' N ' ' A' ' 34' ' ' SER . 0.3 OUTLIER -69.75 -35.79 75.25 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 122.022 0.915 . . . . 0.0 109.365 179.165 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.613 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 1.5 m -78.99 -7.51 58.13 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.804 -0.56 . . . . 0.0 110.346 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.644 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . . . -38.63 -66.54 0.31 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.249 -0.907 . . . . 0.0 110.307 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.703 ' C ' ' HD3' ' A' ' 38' ' ' PRO . 49.0 Cg_endo -74.5 151.88 42.75 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.645 1.34 . . . . 0.0 109.938 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 36' ' ' PRO . 54.1 Cg_endo -99.06 53.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.856 1.704 . . . . 0.0 112.235 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.703 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 52.7 Cg_endo -76.7 150.12 30.74 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 122.906 0.95 . . . . 0.0 110.384 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.681 ' C ' ' NE2' ' A' ' 43' ' ' GLN . 1.6 t0 -40.78 -30.39 0.12 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 108.624 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.668 ' O ' ' CB ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -40.95 -44.54 2.36 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.414 0.626 . . . . 0.0 109.449 179.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.709 ' O ' ' CD2' ' A' ' 45' ' ' HIS . 6.1 t -65.66 -27.25 40.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.797 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 39' ' ' ASP . . . -88.85 -43.57 11.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.91 -1.119 . . . . 0.0 111.587 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.681 ' NE2' ' C ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -81.32 -20.32 41.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.845 -1.16 . . . . 0.0 109.671 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.668 ' CB ' ' O ' ' A' ' 40' ' ' LEU . 4.1 ttp85 -71.87 -55.03 8.28 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.709 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 21.1 m-70 -54.26 -27.56 35.77 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.367 0.603 . . . . 0.0 109.573 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.567 ' CE1' ' HG2' ' A' ' 220' ' ' ARG . 0.9 OUTLIER -95.54 -30.62 13.73 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.324 179.083 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 43' ' ' GLN . . . -84.41 -103.73 0.6 Allowed Glycine 0 N--CA 1.487 2.056 0 N-CA-C 107.429 -2.269 . . . . 0.0 107.429 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.738 ' CD2' ' CE1' ' A' ' 66' ' ' PHE . 91.8 m95 -76.88 74.42 3.49 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.206 -1.173 . . . . 0.0 109.184 178.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.698 ' OD1' ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -44.19 110.9 1.07 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.718 -0.614 . . . . 0.0 110.675 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.628 ' CD ' ' HE2' ' A' ' 51' ' ' LYS . 47.1 Cg_endo -72.08 0.93 6.51 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.202 1.935 . . . . 0.0 112.134 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.713 ' CE ' ' N ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -71.79 -33.1 68.29 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 178.36 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.728 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 8.9 m-20 -117.29 -12.59 10.49 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 113.913 -1.494 . . . . 0.0 107.363 177.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.704 ' HA ' ' HB ' ' A' ' 78' ' ' VAL . 9.0 t -105.81 147.15 28.97 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.175 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.476 ' H ' ' CB ' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -77.6 105.29 8.66 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.244 -0.91 . . . . 0.0 109.426 179.059 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.499 ' HB3' ' HB3' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -70.2 4.04 2.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.448 -0.782 . . . . 0.0 110.4 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.58 HD21 ' N ' ' A' ' 56' ' ' ASN . 1.4 m120 -41.4 -29.52 0.15 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.752 0.787 . . . . 0.0 109.446 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.583 ' CG2' ' NE1' ' A' ' 207' ' ' TRP . 25.2 pt -112.94 168.88 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.58 ' O ' ' HB3' ' A' ' 67' ' ' GLU . 10.2 t0 -105.85 103.48 12.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.894 -1.129 . . . . 0.0 109.925 -178.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.625 ' CG2' ' HB2' ' A' ' 48' ' ' TRP . 3.6 m -118.24 135.81 57.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.804 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.681 ' HG3' ' CD ' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -124.92 143.3 50.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.011 -1.055 . . . . 0.0 110.844 -179.423 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.535 ' O ' ' C ' ' A' ' 62' ' ' GLY . 46.1 tt0 -63.61 -124.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.452 -0.78 . . . . 0.0 109.954 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.535 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 37.7 50.61 1.93 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.674 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 109.33 46.89 0.9 Allowed Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.106 -1.997 . . . . 0.0 108.106 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.674 ' C ' ' O ' ' A' ' 63' ' ' GLY . 2.2 mm? 0.76 86.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.541 0.686 . . . . 0.0 111.252 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.0 t -120.29 117.55 28.12 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.521 -0.737 . . . . 0.0 110.507 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.738 ' CE1' ' CD2' ' A' ' 48' ' ' TRP . 1.8 m-85 -82.51 130.65 35.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.388 -0.82 . . . . 0.0 109.186 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.58 ' HB3' ' O ' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -132.9 121.81 23.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.902 -1.124 . . . . 0.0 110.528 179.626 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.522 ' O ' ' HD3' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -125.31 156.26 38.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.492 -0.755 . . . . 0.0 109.229 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.534 ' HB3' ' CD ' ' A' ' 70' ' ' PRO . 11.5 tpp180 -174.68 -56.92 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 120.773 -1.204 . . . . 0.0 111.183 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.534 ' CD ' ' HB3' ' A' ' 69' ' ' ARG . 41.2 Cg_endo -67.01 -50.39 1.08 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.651 1.343 . . . . 0.0 110.542 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.623 HG22 ' HB ' ' A' ' 75' ' ' THR . 1.3 p -78.57 165.23 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 121.739 0.78 . . . . 0.0 110.852 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.534 ' N ' ' CG2' ' A' ' 71' ' ' VAL . . . -163.83 -43.1 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.257 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 75' ' ' THR . 16.8 mt-30 -56.1 -172.85 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.156 -0.965 . . . . 0.0 110.246 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.74 85.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.916 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.623 ' HB ' HG22 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -136.96 5.36 2.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -0.868 . . . . 0.0 110.312 -179.619 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.585 ' CB ' ' NE1' ' A' ' 207' ' ' TRP . 1.8 p30 -99.16 155.07 17.66 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.217 -0.927 . . . . 0.0 109.962 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 114.65 104.36 2.55 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 106.848 -2.501 . . . . 0.0 106.848 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.764 ' O ' ' HA ' ' A' ' 204' ' ' SER . 2.0 m -116.95 163.0 14.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.161 -1.2 . . . . 0.0 110.322 -178.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.728 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 3.9 ttp180 -120.16 169.34 10.33 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.643 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.562 ' HA2' ' CB ' ' A' ' 52' ' ' ASP . . . -164.22 83.46 0.11 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.481 ' CG ' ' O ' ' A' ' 81' ' ' LYS . 3.7 ttpm? -116.88 16.11 15.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.389 -1.065 . . . . 0.0 110.421 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.456 ' O ' ' C ' ' A' ' 83' ' ' GLY . 1.1 ptt180 -76.16 -101.98 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.106 -0.996 . . . . 0.0 110.228 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 82' ' ' ARG . . . 41.58 46.22 4.62 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.45 ' CE1' ' NH1' ' A' ' 86' ' ' ARG . 0.6 OUTLIER -98.58 103.88 15.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.228 -1.16 . . . . 0.0 110.174 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.57 ' HB3' ' CE1' ' A' ' 89' ' ' HIS . 11.5 t -139.9 173.36 11.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 110.362 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.551 ' N ' ' CD ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -118.53 139.33 51.62 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.372 -0.83 . . . . 0.0 109.827 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 103.36 -112.25 4.17 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.581 ' O ' ' CD2' ' A' ' 89' ' ' HIS . 7.5 tt -128.18 134.53 49.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -1.128 . . . . 0.0 110.362 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.581 ' CD2' ' O ' ' A' ' 88' ' ' LEU . 7.7 m80 -146.86 161.7 40.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.329 -0.857 . . . . 0.0 109.688 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.06 146.59 10.86 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.082 -1.011 . . . . 0.0 110.508 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.678 ' HB2' ' CD2' ' A' ' 216' ' ' TYR . 1.7 p90 -135.13 171.3 14.63 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.305 -0.872 . . . . 0.0 109.473 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 215' ' ' ARG . 15.6 tt0 -137.71 140.12 40.55 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.265 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.596 HG13 ' CD1' ' A' ' 91' ' ' TRP . 4.4 mt -140.03 154.22 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.642 ' HB3' ' HA ' ' A' ' 166' ' ' ARG . 0.4 OUTLIER -147.24 122.12 9.98 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.03 -1.068 . . . . 0.0 111.651 -179.005 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.837 ' HH2' ' O ' ' A' ' 204' ' ' SER . 37.0 m95 -111.63 88.45 9.45 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 94' ' ' SER . 52.5 Cg_endo -83.61 108.95 1.51 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.695 1.366 . . . . 0.0 111.524 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.575 ' CD1' ' HA ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -96.86 -26.69 15.0 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.253 -0.904 . . . . 0.0 109.622 178.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -37.36 -45.39 0.68 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.468 -0.77 . . . . 0.0 110.808 -179.196 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.77 -95.99 0.15 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.077 -1.014 . . . . 0.0 109.682 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.497 ' O ' ' O ' ' A' ' 101' ' ' GLY . 2.2 ptp180 -121.41 -141.63 0.33 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.405 -0.809 . . . . 0.0 109.571 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.523 ' C ' ' HA ' ' A' ' 210' ' ' CYS . . . 37.29 94.07 0.01 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.289 -1.125 . . . . 0.0 110.289 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.69 ' N ' ' HA ' ' A' ' 210' ' ' CYS . 0.0 OUTLIER -54.94 -160.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -1.144 . . . . 0.0 110.294 179.457 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.662 ' CD2' ' N ' ' A' ' 104' ' ' ALA . 10.1 t60 -127.44 165.73 19.25 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.305 -0.872 . . . . 0.0 109.742 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.665 ' HB2' ' CZ3' ' A' ' 95' ' ' TRP . . . -146.8 -92.77 0.09 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.824 -1.172 . . . . 0.0 111.744 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 204' ' ' SER 0.264 3.6 m -136.9 138.91 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 117.506 -1.678 . . . . 0.0 114.964 -175.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.751 HG22 ' CE2' ' A' ' 95' ' ' TRP . 1.0 OUTLIER -152.27 122.47 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.399 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 202' ' ' SER . . . 168.76 -161.64 35.36 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 118.832 -1.651 . . . . 0.0 110.898 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.629 HG23 ' CD1' ' A' ' 199' ' ' LEU . 1.4 p -141.49 150.67 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.596 -0.943 . . . . 0.0 109.835 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.563 ' N ' HG22 ' A' ' 108' ' ' VAL . . . -128.57 152.78 47.92 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.059 -1.026 . . . . 0.0 110.724 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.623 ' N ' ' HB3' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -101.24 126.35 47.97 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.264 -0.898 . . . . 0.0 110.296 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.58 -30.22 15.09 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.591 0.71 . . . . 0.0 109.726 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.609 ' O ' ' N ' ' A' ' 114' ' ' PRO . 0.8 OUTLIER -80.96 -11.83 59.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.458 -0.776 . . . . 0.0 109.926 179.819 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.579 ' C ' ' O ' ' A' ' 112' ' ' LEU . . . -23.59 87.19 0.04 OUTLIER Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 121.829 -0.544 . . . . 0.0 111.222 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.609 ' N ' ' O ' ' A' ' 112' ' ' LEU . 50.1 Cg_endo -77.05 49.89 2.94 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 124.115 1.587 . . . . 0.0 110.493 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 179.87 53.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -0.951 . . . . 0.0 110.273 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.484 ' NE2' ' O ' ' A' ' 128' ' ' SER . 4.1 tp60 -75.6 -90.01 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 110.171 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.511 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . 179.98 -163.2 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 110.29 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.511 ' C ' ' O ' ' A' ' 117' ' ' ALA . 28.8 t0 -31.64 100.77 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.58 -0.7 . . . . 0.0 110.721 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.514 ' CG ' ' O ' ' A' ' 119' ' ' HIS . 18.5 t-80 -89.73 5.86 44.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 110.3 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -55.55 -40.45 71.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.898 . . . . 0.0 110.174 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -51.14 -86.48 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.9 . . . . 0.0 110.212 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 50.96 91.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.0 110.289 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 tt -173.01 -43.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.289 -0.882 . . . . 0.0 110.12 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.494 ' C ' ' CD1' ' A' ' 124' ' ' LEU . 1.0 OUTLIER -131.1 40.84 3.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 110.261 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 81.72 115.79 0.42 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -172.32 34.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -1.165 . . . . 0.0 110.263 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -144.23 41.19 1.37 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.169 -0.957 . . . . 0.0 110.272 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.484 ' O ' ' NE2' ' A' ' 116' ' ' GLN . 13.4 t -127.18 -176.24 3.67 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.261 -0.899 . . . . 0.0 110.164 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 110' ' ' THR . 1.7 tt0 -150.02 130.06 13.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.298 -0.876 . . . . 0.0 110.087 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.51 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 47.9 t -120.46 119.92 34.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 110.211 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . 0.527 ' O ' ' O ' ' A' ' 108' ' ' VAL . 0.6 OUTLIER -128.1 124.57 37.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -0.939 . . . . 0.0 110.138 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.455 ' HA3' ' HA3' ' A' ' 107' ' ' GLY . . . 170.82 -133.95 2.96 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.616 ' CD1' ' HA ' ' A' ' 161' ' ' LEU . 47.3 m0 -121.36 112.84 19.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.09 -1.241 . . . . 0.0 110.404 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.48 ' O ' HG23 ' A' ' 135' ' ' ILE . 32.2 t0 -119.22 111.46 18.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.643 -0.661 . . . . 0.0 110.448 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.642 ' CG1' ' CD2' ' A' ' 103' ' ' HIS . 22.2 pt -139.97 26.74 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.1 -1.0 . . . . 0.0 110.229 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -101.6 -27.95 6.91 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.85 8.27 17.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.29 -1.123 . . . . 0.0 109.986 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.71 51.06 4.7 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -57.57 -18.83 21.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.261 -1.141 . . . . 0.0 110.299 -179.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -42.86 -40.63 2.98 Favored 'General case' 0 C--N 1.277 -2.561 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.142 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -131.9 36.51 3.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.303 -0.873 . . . . 0.0 110.15 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.431 ' CG ' ' N ' ' A' ' 143' ' ' GLN . 5.2 p80 -51.0 -35.12 32.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.28 -0.888 . . . . 0.0 110.228 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.431 ' N ' ' CG ' ' A' ' 142' ' ' HIS . 3.4 tp-100 -132.49 -85.78 0.47 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.183 -0.948 . . . . 0.0 110.307 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 35.1 m -121.53 141.79 50.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.206 -0.934 . . . . 0.0 110.249 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.26 104.33 16.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.893 . . . . 0.0 110.185 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -67.85 -116.24 0.02 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.23 13.66 2.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.239 -1.154 . . . . 0.0 110.184 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -47.6 161.25 0.09 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.306 -0.871 . . . . 0.0 110.17 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -51.48 126.52 29.84 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 110.213 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.98 -2.69 12.39 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.971 1.511 . . . . 0.0 110.445 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.57 ' O ' ' CD2' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -62.6 -72.72 0.12 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.276 -0.89 . . . . 0.0 110.25 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.584 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 0.3 OUTLIER -176.03 -60.58 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.301 -0.874 . . . . 0.0 110.229 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.584 ' CD ' ' CB ' ' A' ' 152' ' ' TYR . 46.1 Cg_endo -72.79 126.57 11.48 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.912 1.48 . . . . 0.0 110.445 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 155' ' ' GLY . . . -59.71 144.25 48.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.208 -0.932 . . . . 0.0 110.174 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 154' ' ' ALA . . . 42.26 -157.39 0.07 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -73.23 -62.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.016 1.535 . . . . 0.0 110.422 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.417 ' OE1' ' OH ' ' A' ' 186' ' ' TYR . 0.8 OUTLIER -56.42 -60.87 2.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.169 -0.957 . . . . 0.0 110.299 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 68.66 6.23 49.16 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -93.53 6.51 47.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.289 -1.124 . . . . 0.0 110.257 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 160' ' ' GLN . 2.8 tp-100 -58.42 -17.48 20.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.265 -0.897 . . . . 0.0 109.338 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.616 ' HA ' ' CD1' ' A' ' 133' ' ' TRP . 0.7 OUTLIER -173.25 26.87 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.647 0.737 . . . . 0.0 109.548 179.511 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.535 ' CG1' ' O ' ' A' ' 162' ' ' VAL . 2.4 t -159.34 88.1 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.599 -0.688 . . . . 0.0 109.863 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.539 ' CG2' HD21 ' A' ' 167' ' ' LEU . 0.9 OUTLIER -109.96 90.37 9.32 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.333 -0.854 . . . . 0.0 109.915 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.51 64.42 2.94 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.067 1.562 . . . . 0.0 110.379 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -168.48 -83.85 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.487 -0.758 . . . . 0.0 109.805 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.642 ' HA ' ' HB3' ' A' ' 94' ' ' SER . 2.2 ttp180 -152.12 150.43 29.88 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.432 -0.793 . . . . 0.0 110.348 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.594 ' N ' ' CD1' ' A' ' 167' ' ' LEU . 1.7 mp -144.92 131.04 19.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 110.274 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.482 ' C ' ' CD1' ' A' ' 168' ' ' LEU . 2.6 tm? -103.79 124.54 49.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.351 -0.843 . . . . 0.0 109.595 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.676 ' CG2' ' CE1' ' A' ' 180' ' ' TYR . 2.4 t -107.18 135.53 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.943 . . . . 0.0 110.63 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.501 HG12 ' CD1' ' A' ' 187' ' ' LEU . 9.7 p -112.48 133.32 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.507 -0.746 . . . . 0.0 109.836 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.556 ' CD1' ' HB3' ' A' ' 178' ' ' LEU . 11.5 tp -133.03 105.87 7.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.151 -0.968 . . . . 0.0 110.228 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 173' ' ' MET . 49.1 t0 -103.83 136.02 44.28 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.24 -0.912 . . . . 0.0 109.943 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.514 ' O ' ' N ' ' A' ' 175' ' ' GLU . 5.5 tpt -96.91 -41.81 8.24 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.747 -0.595 . . . . 0.0 110.231 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.505 ' C ' ' O ' ' A' ' 173' ' ' MET . 2.7 tm-20 -40.26 -28.66 0.06 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.893 . . . . 0.0 108.666 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.669 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.2 OUTLIER -114.84 -26.64 7.72 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.485 ' O ' HG21 ' A' ' 198' ' ' THR . . . 81.2 25.35 55.29 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.491 -1.844 . . . . 0.0 108.491 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.669 ' OG1' ' HB3' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -113.42 127.82 56.25 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.335 -1.097 . . . . 0.0 111.436 -179.335 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.556 ' HB3' ' CD1' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -134.74 153.71 51.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.473 -0.767 . . . . 0.0 109.378 178.794 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.506 ' O ' HG12 ' A' ' 169' ' ' VAL . . . -155.52 172.74 33.67 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.52 -1.324 . . . . 0.0 109.984 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.676 ' CE1' ' CG2' ' A' ' 169' ' ' VAL . 0.4 OUTLIER -118.77 122.89 43.49 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.47 -1.018 . . . . 0.0 109.895 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 186' ' ' TYR . 16.7 t -142.79 139.26 30.91 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.31 -0.869 . . . . 0.0 110.051 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.487 HG22 ' HG ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -98.56 116.76 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.341 -0.849 . . . . 0.0 109.923 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 81.63 -7.26 62.4 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 86.31 42.35 6.63 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.26 -35.94 8.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.31 -1.112 . . . . 0.0 110.415 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.476 ' O ' ' HB2' ' A' ' 181' ' ' SER . 24.6 m-85 -109.12 90.22 3.23 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.187 -0.946 . . . . 0.0 110.312 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.597 ' O ' ' CE2' ' A' ' 191' ' ' PHE . 0.7 OUTLIER -176.7 28.32 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.471 -0.768 . . . . 0.0 109.671 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -110.51 -71.67 0.66 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.842 -1.171 . . . . 0.0 110.403 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.4 ' C ' ' H ' ' A' ' 191' ' ' PHE . 44.9 Cg_endo -70.87 -28.84 19.41 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.952 1.501 . . . . 0.0 111.026 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.523 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -74.17 15.44 0.32 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.299 -0.876 . . . . 0.0 111.142 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.597 ' CE2' ' O ' ' A' ' 187' ' ' LEU . 0.3 OUTLIER -90.52 -16.3 29.12 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.004 -1.06 . . . . 0.0 110.408 179.652 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.466 ' HA ' ' NE ' ' A' ' 192' ' ' ARG . 0.0 OUTLIER -90.03 -13.97 34.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.319 -0.863 . . . . 0.0 110.75 -179.616 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -112.47 -8.8 20.68 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 108.786 -1.725 . . . . 0.0 108.786 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.622 HD22 ' CG2' ' A' ' 177' ' ' THR . 7.7 tt -78.19 -31.66 49.6 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.617 -0.931 . . . . 0.0 109.213 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.546 ' CA ' HG22 ' A' ' 198' ' ' THR . 0.0 OUTLIER -53.56 -39.73 64.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.438 -0.789 . . . . 0.0 109.707 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -86.04 -24.61 40.41 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.699 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -91.09 -4.59 56.13 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.644 -0.916 . . . . 0.0 110.09 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.587 ' O ' ' CG2' ' A' ' 110' ' ' THR . 26.0 p -43.06 116.44 0.9 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.496 -0.753 . . . . 0.0 110.986 -178.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.699 ' HG ' ' O ' ' A' ' 197' ' ' ARG . 0.0 OUTLIER -128.69 171.82 11.83 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.564 -0.71 . . . . 0.0 109.955 179.654 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.564 ' O ' HG22 ' A' ' 108' ' ' VAL . 14.9 m-30 -83.49 134.72 44.66 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.196 -0.94 . . . . 0.0 109.952 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.652 ' HB3' ' CH2' ' A' ' 91' ' ' TRP . 43.9 Cg_endo -68.35 118.58 5.73 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.089 1.573 . . . . 0.0 111.614 -178.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.517 ' O ' ' O ' ' A' ' 107' ' ' GLY . 0.2 OUTLIER -134.01 148.62 51.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.469 -0.769 . . . . 0.0 110.49 179.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.49 HG21 ' O ' ' A' ' 105' ' ' VAL . 8.2 p -149.84 159.13 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.125 -0.984 . . . . 0.0 110.311 179.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' SER . . . . . 0.837 ' O ' ' HH2' ' A' ' 95' ' ' TRP . 0.3 OUTLIER -144.88 125.67 14.29 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.178 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.545 ' HA ' ' CH2' ' A' ' 95' ' ' TRP . . . -115.72 166.55 11.81 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.438 0.637 . . . . 0.0 110.854 -178.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.579 ' CG1' ' HB3' ' A' ' 210' ' ' CYS . 1.1 p -136.88 165.57 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.343 -0.848 . . . . 0.0 109.952 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.585 ' NE1' ' CB ' ' A' ' 76' ' ' ASP . 40.7 p-90 -132.91 -2.68 3.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.092 -1.005 . . . . 0.0 110.175 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -74.62 -0.83 59.94 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.485 ' O ' ' HA2' ' A' ' 101' ' ' GLY . 4.7 tt0 -175.99 -41.69 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.449 -1.03 . . . . 0.0 110.724 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . 0.69 ' HA ' ' N ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -98.96 146.3 26.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.429 -0.795 . . . . 0.0 110.802 -179.542 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.5 ' HG3' ' CA ' ' A' ' 101' ' ' GLY . 3.6 mt-30 -135.01 102.6 5.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.531 -0.731 . . . . 0.0 109.545 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.714 ' O ' ' CZ2' ' A' ' 48' ' ' TRP . 7.2 p -104.42 143.84 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.439 -0.788 . . . . 0.0 110.38 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 0.553 ' CD ' ' HB2' ' A' ' 94' ' ' SER . 2.9 ptp180 -95.61 131.64 41.61 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.324 -0.86 . . . . 0.0 109.619 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.677 HG22 ' CE3' ' A' ' 48' ' ' TRP . 1.2 tt -118.84 113.95 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.061 -1.024 . . . . 0.0 111.561 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.612 ' O ' ' N ' ' A' ' 92' ' ' GLU . 7.6 ttm180 -112.99 108.81 17.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.073 -1.017 . . . . 0.0 108.896 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . 0.678 ' CD2' ' HB2' ' A' ' 91' ' ' TRP . 1.6 t80 -104.44 149.65 25.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.93 . . . . 0.0 111.179 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.24 107.92 7.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.579 -0.7 . . . . 0.0 109.917 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 141.5 -22.02 2.55 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -95.37 144.89 25.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.172 -1.193 . . . . 0.0 110.194 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . 0.567 ' HG2' ' CE1' ' A' ' 46' ' ' HIS . 0.1 OUTLIER -178.02 132.13 0.15 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.133 -0.98 . . . . 0.0 110.274 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . 0.483 ' O ' ' C ' ' A' ' 222' ' ' VAL . 0.0 OUTLIER -129.54 80.16 1.95 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 110.153 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.483 ' C ' ' O ' ' A' ' 221' ' ' ARG . 3.3 p -36.27 115.94 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.6 -0.688 . . . . 0.0 110.577 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.512 ' O ' ' C ' ' A' ' 224' ' ' GLU . 9.6 tm-20 -178.77 -71.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.321 -0.862 . . . . 0.0 110.149 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.512 ' C ' ' O ' ' A' ' 223' ' ' GLU . 6.7 mt-10 -34.06 -46.14 0.23 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.406 -0.809 . . . . 0.0 110.613 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.416 ' C ' ' O ' ' A' ' 224' ' ' GLU . 0.1 OUTLIER -42.61 161.7 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.281 -0.887 . . . . 0.0 110.235 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.23 32.46 0.76 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 110.23 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.39 120.93 1.87 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 0.0 110.21 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 24.6 pt -77.79 1.69 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.33 -0.856 . . . . 0.0 110.225 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.4 127.71 33.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.243 -0.911 . . . . 0.0 110.149 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . 0.431 ' O ' ' HB3' ' A' ' 231' ' ' ASP . 5.0 tpp180 -46.72 -28.24 1.44 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.126 -0.984 . . . . 0.0 110.162 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.431 ' HB3' ' O ' ' A' ' 230' ' ' ARG . 1.1 p30 . . . . . 0 C--N 1.304 -1.377 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.263 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.0 t -144.86 14.09 1.51 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.16 -1.2 . . . . 0.0 110.213 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.57 63.99 7.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.153 -0.967 . . . . 0.0 110.188 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -162.3 33.8 0.11 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 110.251 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.509 ' O ' ' CG ' ' A' ' 10' ' ' ARG . 0.1 OUTLIER -96.99 66.72 2.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.279 -0.888 . . . . 0.0 110.202 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -156.1 141.12 17.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.162 -0.962 . . . . 0.0 110.204 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.8 t -87.55 110.04 20.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -0.894 . . . . 0.0 110.228 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.3 113.13 19.77 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 110.258 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.89 171.01 18.31 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.979 1.515 . . . . 0.0 110.401 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.3 p -92.11 83.73 5.17 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.316 -0.865 . . . . 0.0 110.211 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.35 -143.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -0.922 . . . . 0.0 110.201 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -101.71 -155.29 0.51 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.107 -0.995 . . . . 0.0 110.265 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.43 135.14 45.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 110.188 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.89 -160.61 0.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.255 -0.903 . . . . 0.0 110.203 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.7 -158.21 0.64 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.304 -0.872 . . . . 0.0 110.121 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.63 161.02 28.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.368 -0.832 . . . . 0.0 110.168 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -174.29 32.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.252 -0.905 . . . . 0.0 110.257 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.38 -78.01 0.44 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.888 . . . . 0.0 110.211 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.483 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.9 OUTLIER -102.88 155.03 37.08 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.222 -0.924 . . . . 0.0 110.147 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.36 110.3 3.03 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.971 1.511 . . . . 0.0 110.559 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.671 ' O ' ' N ' ' A' ' 28' ' ' GLY . 48.0 Cg_endo -74.36 -164.64 0.23 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.086 1.572 . . . . 0.0 110.497 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.663 ' C ' ' O ' ' A' ' 26' ' ' PRO . 1.5 tt0 1.46 66.22 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.589 0.709 . . . . 0.0 111.192 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.671 ' N ' ' O ' ' A' ' 26' ' ' PRO . . . -153.61 -34.4 0.03 OUTLIER Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.531 ' O ' ' CD1' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -73.77 -32.56 63.86 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.449 -1.03 . . . . 0.0 109.888 179.731 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.503 ' HG2' ' CG ' ' A' ' 55' ' ' GLU . 0.9 OUTLIER -45.97 -42.8 13.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.307 -0.87 . . . . 0.0 109.783 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -56.92 -23.27 43.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.4 -0.813 . . . . 0.0 109.302 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.495 ' O ' ' HB2' ' A' ' 35' ' ' ALA . 16.7 tp -83.22 -34.5 25.86 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.615 ' CD2' ' CG ' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -72.92 -36.34 67.23 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.917 0.865 . . . . 0.0 109.116 179.124 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.606 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 1.4 m -69.17 -14.29 62.9 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.252 0.549 . . . . 0.0 110.465 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.604 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . . . -51.72 -61.85 3.75 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.164 -0.96 . . . . 0.0 110.201 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.69 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 43.3 Cg_endo -69.86 110.31 2.54 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.988 1.52 . . . . 0.0 110.77 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.742 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 49.1 Cg_endo -74.92 -24.81 12.64 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 124.146 1.603 . . . . 0.0 112.84 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.742 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 42.3 Cg_endo -68.3 152.4 75.74 Favored 'Trans proline' 0 C--N 1.315 -1.214 0 O-C-N 122.892 0.943 . . . . 0.0 112.38 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.611 ' O ' ' CG ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER 4.79 80.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 123.561 1.648 . . . . 0.0 110.887 -178.694 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.699 ' CD2' ' C ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER 179.97 -51.7 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 113.655 -1.611 . . . . 0.0 107.705 178.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.649 ' CG2' HD11 ' A' ' 40' ' ' LEU . 1.8 t -87.36 -20.17 7.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 118.933 -1.107 . . . . 0.0 109.661 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.27 -46.49 8.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.154 -0.966 . . . . 0.0 111.954 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.59 ' O ' ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -79.39 -20.89 46.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.662 -1.274 . . . . 0.0 109.411 -179.464 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.714 ' NE ' ' O ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -72.47 -36.22 68.41 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.491 -0.884 . . . . 0.0 108.767 179.283 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.675 ' N ' ' CD2' ' A' ' 45' ' ' HIS . 7.2 m170 -81.73 -26.07 34.88 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.866 -0.521 . . . . 0.0 110.272 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -96.38 -28.7 14.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.129 -0.982 . . . . 0.0 110.104 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.83 -111.09 1.02 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.767 ' CZ2' ' O ' ' A' ' 212' ' ' VAL . 88.6 m95 -91.63 73.97 5.88 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.09 -1.241 . . . . 0.0 109.436 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.77 ' OD1' ' HG3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -52.4 150.09 9.35 Favored Pre-proline 0 N--CA 1.489 1.495 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.151 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.713 ' O ' ' N ' ' A' ' 53' ' ' CYS . 54.2 Cg_endo -91.81 -0.01 4.39 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 122.273 1.982 . . . . 0.0 113.221 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.77 ' HG3' ' OD1' ' A' ' 49' ' ' ASN . 0.0 OUTLIER 0.69 -98.69 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.639 0 CA-C-O 122.646 1.212 . . . . 0.0 111.192 -178.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.811 ' HB3' ' NE ' ' A' ' 79' ' ' ARG 0.259 0.5 OUTLIER -62.19 -28.08 69.42 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.568 -179.707 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.859 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . 0.7 OUTLIER -104.82 -177.02 3.24 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.323 1.059 . . . . 0.0 112.481 -178.096 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.563 ' O ' ' HB3' ' A' ' 50' ' ' PRO . 2.0 m -87.38 165.21 15.76 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.897 0.856 . . . . 0.0 111.257 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.837 ' O ' ' N ' ' A' ' 57' ' ' ILE . 2.5 pm0 -94.21 9.71 36.88 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.045 0.926 . . . . 0.0 108.748 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.575 ' O ' HG11 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -16.27 -38.26 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.263 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.837 ' N ' ' O ' ' A' ' 55' ' ' GLU . 6.6 pt -130.12 167.43 25.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.128 -178.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.588 ' HB2' HD22 ' A' ' 40' ' ' LEU . 6.0 t0 -107.76 141.39 39.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.401 -0.812 . . . . 0.0 110.11 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.741 HG23 ' HB2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -130.42 136.03 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.337 -0.852 . . . . 0.0 110.509 -179.166 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.537 ' NZ ' ' HB2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -135.27 155.05 51.28 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.977 -1.077 . . . . 0.0 110.755 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 62' ' ' GLY . 5.3 mt-10 -78.24 -129.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.515 -0.741 . . . . 0.0 110.115 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 42.15 42.98 4.39 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.666 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 116.11 48.1 0.49 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.666 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.5 OUTLIER 0.42 90.5 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.847 -0.796 . . . . 0.0 111.084 -179.438 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -124.96 123.2 39.38 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.493 -0.754 . . . . 0.0 111.194 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.625 ' CD1' ' CG1' ' A' ' 59' ' ' VAL . 18.2 m-85 -83.39 127.1 33.4 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.596 ' O ' ' HB ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -110.38 121.15 44.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.007 -1.058 . . . . 0.0 110.557 -179.495 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.568 ' HD3' ' N ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -136.11 155.98 49.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.491 -0.755 . . . . 0.0 109.365 179.471 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.575 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -173.18 -55.98 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 120.929 -1.107 . . . . 0.0 111.065 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 69' ' ' ARG . 40.9 Cg_endo -67.24 -47.66 2.16 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.756 1.398 . . . . 0.0 110.645 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.575 HG11 ' O ' ' A' ' 56' ' ' ASN . 1.6 p -78.49 165.29 3.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-O 121.937 0.875 . . . . 0.0 110.983 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.547 ' N ' ' CG2' ' A' ' 71' ' ' VAL . . . -159.22 -36.52 0.06 Allowed 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.312 0.577 . . . . 0.0 110.026 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.458 ' OE1' ' OG ' ' A' ' 24' ' ' SER . 7.0 pt20 -141.99 13.48 2.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.36 -0.838 . . . . 0.0 110.127 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 75' ' ' THR . 0.6 OUTLIER -63.36 -158.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 110.195 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.555 HG23 ' HB2' ' A' ' 54' ' ' SER . 0.6 OUTLIER -54.42 -107.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.164 -0.96 . . . . 0.0 110.27 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.529 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 2.4 m-20 -140.32 150.09 43.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.906 -1.121 . . . . 0.0 110.935 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.529 ' O ' ' ND2' ' A' ' 56' ' ' ASN . . . -40.39 -86.49 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.575 ' CG2' ' O ' ' A' ' 49' ' ' ASN . 0.2 OUTLIER -138.05 145.48 28.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.135 -1.214 . . . . 0.0 109.721 178.523 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.859 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 4.2 tmm_? -148.44 133.83 18.55 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.494 ' HA2' ' HB2' ' A' ' 52' ' ' ASP . . . -126.2 143.34 14.33 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.538 ' HE3' ' CB ' ' A' ' 202' ' ' SER . 0.3 OUTLIER -165.47 9.93 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.067 -1.255 . . . . 0.0 111.451 -179.66 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.733 ' HD2' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -135.27 -9.76 2.23 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.676 -1.265 . . . . 0.0 110.83 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.733 ' N ' ' HD2' ' A' ' 82' ' ' ARG . . . -74.81 38.1 1.07 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.476 ' CE1' HD11 ' A' ' 171' ' ' LEU . 15.8 t80 -94.17 119.37 32.89 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.435 -1.038 . . . . 0.0 110.087 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.7 p -99.92 177.48 5.1 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.302 -0.874 . . . . 0.0 110.395 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.554 ' HA ' ' CB ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -108.04 167.38 10.04 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.307 -0.871 . . . . 0.0 109.933 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.471 ' N ' ' HB3' ' A' ' 173' ' ' MET . . . 100.77 -124.71 8.34 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.497 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 1.3 tp -129.06 130.12 46.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.463 -1.022 . . . . 0.0 110.398 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.552 ' NE2' ' O ' ' A' ' 86' ' ' ARG . 8.4 m-70 -147.29 158.64 44.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.129 -0.982 . . . . 0.0 109.968 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.545 ' O ' ' O ' ' A' ' 217' ' ' MET . . . -161.6 135.22 6.54 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.129 -0.982 . . . . 0.0 109.58 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.695 ' CZ3' ' CG1' ' A' ' 169' ' ' VAL . 0.0 OUTLIER -134.09 156.28 48.54 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.917 -1.114 . . . . 0.0 109.846 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.665 ' O ' ' N ' ' A' ' 215' ' ' ARG . 0.8 OUTLIER -109.53 124.07 50.47 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.705 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.521 ' CG2' ' OH ' ' A' ' 180' ' ' TYR . 0.8 OUTLIER -141.85 154.12 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.953 -1.092 . . . . 0.0 110.62 -179.325 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.508 ' HB3' ' HA ' ' A' ' 166' ' ' ARG . 0.6 OUTLIER -134.17 123.09 23.78 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.5 -0.75 . . . . 0.0 109.093 179.425 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.759 ' HH2' ' O ' ' A' ' 204' ' ' SER . 2.1 t90 -127.6 88.21 54.16 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.067 -1.021 . . . . 0.0 110.817 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -95.43 109.08 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 124.154 1.608 . . . . 0.0 110.166 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.535 ' HB2' ' CG2' ' A' ' 135' ' ' ILE . 0.2 OUTLIER -96.06 -7.41 36.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.843 -1.16 . . . . 0.0 110.315 179.701 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.456 ' OE2' ' HG3' ' A' ' 99' ' ' GLN . 0.9 OUTLIER -55.55 -15.44 2.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.288 -0.882 . . . . 0.0 110.384 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.496 ' O ' ' HD2' ' A' ' 100' ' ' ARG . 2.7 mt-30 -76.22 -29.41 57.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.111 -0.993 . . . . 0.0 110.426 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.496 ' HD2' ' O ' ' A' ' 99' ' ' GLN . 31.5 mmm180 -150.06 -136.35 0.07 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.444 -0.785 . . . . 0.0 110.206 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.533 ' HA2' ' CD1' ' A' ' 97' ' ' LEU . . . -178.85 127.08 1.11 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.482 ' O ' ' HA3' ' A' ' 136' ' ' GLY . 2.4 m -166.4 -132.25 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.252 -1.146 . . . . 0.0 110.164 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -108.78 23.78 14.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.178 -0.951 . . . . 0.0 110.221 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.533 ' CB ' HD23 ' A' ' 97' ' ' LEU . . . -48.07 138.9 8.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.222 -0.924 . . . . 0.0 110.033 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.65 HG11 ' O ' ' A' ' 204' ' ' SER . 0.1 OUTLIER -135.33 136.98 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.961 -1.087 . . . . 0.0 112.015 -178.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.664 ' O ' ' HB2' ' A' ' 133' ' ' TRP . 0.2 OUTLIER -151.24 112.91 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.687 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 132' ' ' GLY . . . 179.55 -147.31 7.51 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 118.621 -1.752 . . . . 0.0 111.223 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.623 ' CG1' ' HB2' ' A' ' 199' ' ' LEU . 1.4 t -139.66 170.27 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.554 -0.968 . . . . 0.0 109.618 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' A' ' 200' ' ' TYR . . . -121.17 139.88 52.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.998 -1.064 . . . . 0.0 110.766 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.535 HG21 ' CB ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -136.47 133.73 36.88 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.32 -0.862 . . . . 0.0 110.461 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.16 -26.08 17.57 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.308 -0.87 . . . . 0.0 109.266 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.448 ' O ' ' C ' ' A' ' 113' ' ' ALA . 1.0 OUTLIER -85.37 -12.19 52.74 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.545 -0.722 . . . . 0.0 109.445 179.416 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.558 ' N ' ' HD2' ' A' ' 114' ' ' PRO . . . -39.42 -53.98 3.9 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.552 -0.718 . . . . 0.0 110.646 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 113' ' ' ALA . 46.4 Cg_endo -72.93 102.97 1.51 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.879 1.463 . . . . 0.0 110.497 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.446 ' CD2' ' O ' ' A' ' 114' ' ' PRO . 0.0 OUTLIER 179.89 48.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.338 -0.851 . . . . 0.0 110.221 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -128.54 -33.72 2.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.913 . . . . 0.0 110.24 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.523 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -177.14 150.62 0.75 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 110.24 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.523 ' C ' ' O ' ' A' ' 117' ' ' ALA . 22.7 t0 -31.83 109.47 0.06 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.565 -0.709 . . . . 0.0 110.724 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -81.13 157.17 25.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.319 -0.863 . . . . 0.0 110.263 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.443 ' O ' ' N ' ' A' ' 122' ' ' ALA . 8.3 t80 -127.36 138.95 53.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.287 -0.883 . . . . 0.0 110.226 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 120' ' ' TYR . . . 56.64 -88.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.921 . . . . 0.0 110.164 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.477 ' O ' ' CB ' ' A' ' 123' ' ' LEU . . . 47.43 26.17 0.72 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.27 -0.894 . . . . 0.0 110.224 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.477 ' CB ' ' O ' ' A' ' 122' ' ' ALA . 0.2 OUTLIER 66.66 103.13 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.259 -0.901 . . . . 0.0 110.234 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 125' ' ' GLY . 0.4 OUTLIER 55.25 -156.25 0.25 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.243 -0.91 . . . . 0.0 110.31 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 124' ' ' LEU . . . -60.46 -145.64 0.01 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 36.9 p -148.7 20.76 1.02 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -1.121 . . . . 0.0 110.207 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -44.66 -89.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.228 -0.92 . . . . 0.0 110.141 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.65 170.57 14.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.289 -0.882 . . . . 0.0 110.092 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.473 ' HB3' ' HB3' ' A' ' 113' ' ' ALA . 5.9 tp10 -150.21 141.44 23.17 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.271 -0.893 . . . . 0.0 109.692 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 13.4 t -119.86 120.05 35.33 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.592 -0.692 . . . . 0.0 109.978 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -133.36 136.38 45.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.378 -0.827 . . . . 0.0 109.619 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.606 ' O ' ' CD1' ' A' ' 133' ' ' TRP . . . -178.0 -107.56 0.22 Allowed Glycine 0 N--CA 1.487 2.093 0 C-N-CA 119.545 -1.312 . . . . 0.0 109.924 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.694 ' CH2' ' HB2' ' A' ' 180' ' ' TYR . 5.2 m-90 -141.0 128.91 21.8 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.26 -1.141 . . . . 0.0 111.568 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -118.74 148.04 43.22 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.723 -0.611 . . . . 0.0 109.743 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.535 ' CG2' ' HB2' ' A' ' 97' ' ' LEU . 0.1 OUTLIER -131.89 -29.28 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.344 -0.848 . . . . 0.0 109.921 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 102' ' ' THR . . . -63.41 -27.81 71.37 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.409 ' HB3' ' HG2' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -85.35 8.19 19.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -1.12 . . . . 0.0 109.925 179.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 139' ' ' LYS . . . 44.13 41.56 6.32 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.477 ' O ' ' O ' ' A' ' 138' ' ' GLY . 6.6 mmmt -52.8 -169.94 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -1.165 . . . . 0.0 110.151 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.514 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 1.4 pp -160.41 104.3 1.43 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.172 -0.955 . . . . 0.0 110.317 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -152.27 24.51 0.62 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.301 -0.874 . . . . 0.0 110.165 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.574 ' CD2' HD13 ' A' ' 161' ' ' LEU . 2.4 p80 -93.83 33.46 1.31 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -0.924 . . . . 0.0 110.263 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -72.43 -41.07 66.59 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.277 -0.889 . . . . 0.0 110.252 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 78.1 p -58.39 -161.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.245 -0.91 . . . . 0.0 110.223 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -55.53 167.19 0.54 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.886 . . . . 0.0 110.234 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 147' ' ' LEU . . . 103.58 84.11 1.76 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 146' ' ' GLY . 0.1 OUTLIER -179.88 56.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.2 -1.177 . . . . 0.0 110.144 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.432 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 0.5 OUTLIER 179.81 71.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.885 . . . . 0.0 110.343 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.589 ' N ' ' CD ' ' A' ' 150' ' ' PRO . . . -147.54 47.23 0.54 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.216 -0.928 . . . . 0.0 110.356 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 149' ' ' ALA . 48.0 Cg_endo -74.06 1.78 6.8 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.991 1.522 . . . . 0.0 110.551 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 150' ' ' PRO . 2.9 mp0 -44.6 -96.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 110.44 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.551 ' CD2' ' HD3' ' A' ' 153' ' ' PRO . 0.3 OUTLIER -84.08 -59.26 0.36 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.181 -0.949 . . . . 0.0 110.535 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.551 ' HD3' ' CD2' ' A' ' 152' ' ' TYR . 46.6 Cg_endo -72.56 162.84 40.24 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.873 1.459 . . . . 0.0 110.632 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.48 ' O ' ' O ' ' A' ' 155' ' ' GLY . . . -68.58 112.47 5.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 0.0 110.318 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 154' ' ' ALA . . . -54.05 -106.98 0.01 OUTLIER Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.83 -9.36 22.34 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.966 1.508 . . . . 0.0 110.565 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.453 ' HB2' ' HB2' ' A' ' 154' ' ' ALA . 2.4 mm100 -65.85 -4.37 6.66 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.16 -0.962 . . . . 0.0 110.563 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -150.72 -37.09 0.03 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -79.22 7.02 8.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.337 -1.096 . . . . 0.0 110.282 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.502 ' O ' ' HB2' ' A' ' 161' ' ' LEU . 2.7 tt0 -52.37 -18.32 1.56 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.283 -0.886 . . . . 0.0 110.386 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.574 HD13 ' CD2' ' A' ' 142' ' ' HIS . 13.5 tp -179.39 30.34 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.444 -0.785 . . . . 0.0 110.286 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.491 ' CG1' ' CG2' ' A' ' 135' ' ' ILE . 14.7 t -138.49 -124.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.355 -0.84 . . . . 0.0 110.103 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.635 ' CG1' ' HD2' ' A' ' 164' ' ' PRO . 15.2 t -130.23 155.05 81.43 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.178 -0.951 . . . . 0.0 109.436 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.635 ' HD2' ' CG1' ' A' ' 163' ' ' VAL . 38.2 Cg_endo -64.57 -177.89 0.6 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.693 1.365 . . . . 0.0 110.758 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.483 ' HB2' ' HB3' ' A' ' 153' ' ' PRO . 0.3 OUTLIER -48.57 -58.2 5.05 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.43 -0.794 . . . . 0.0 110.389 -179.402 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.508 ' HA ' ' HB3' ' A' ' 94' ' ' SER . 1.3 ttp180 -151.94 155.96 39.1 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.498 -0.751 . . . . 0.0 110.578 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.647 ' HB2' ' CE1' ' A' ' 180' ' ' TYR . 0.9 OUTLIER -137.68 157.74 45.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.483 -0.761 . . . . 0.0 109.782 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.522 HD11 ' CG ' ' A' ' 92' ' ' GLU . 3.4 tt -103.11 126.72 50.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.93 . . . . 0.0 109.799 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.695 ' CG1' ' CZ3' ' A' ' 91' ' ' TRP . 57.9 t -90.04 138.3 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.349 -0.844 . . . . 0.0 110.829 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 85.9 t -116.14 111.51 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.545 -0.722 . . . . 0.0 109.265 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.531 HD12 ' CB ' ' A' ' 178' ' ' LEU . 14.4 tp -118.94 105.51 11.54 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.966 -1.084 . . . . 0.0 110.251 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -120.58 133.79 55.34 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.339 -0.851 . . . . 0.0 110.209 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.554 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 1.6 tpt -99.7 -37.96 8.9 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.25 -24.15 1.67 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.474 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.1 OUTLIER -107.04 -26.28 11.22 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.202 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.574 ' O ' ' CG2' ' A' ' 198' ' ' THR . . . 82.17 24.47 54.62 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 108.604 -1.798 . . . . 0.0 108.604 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.616 ' HA ' ' CD2' ' A' ' 194' ' ' LEU . 0.6 OUTLIER -130.07 122.91 29.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.093 -1.239 . . . . 0.0 111.486 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.549 ' CD2' ' CG2' ' A' ' 198' ' ' THR . 0.1 OUTLIER -140.52 153.58 46.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.454 -0.779 . . . . 0.0 109.611 179.168 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.497 ' O ' HG12 ' A' ' 169' ' ' VAL . . . 179.98 -152.2 10.65 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.633 -1.27 . . . . 0.0 110.212 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.694 ' HB2' ' CH2' ' A' ' 133' ' ' TRP . 0.1 OUTLIER -123.0 142.21 51.09 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.331 -1.099 . . . . 0.0 109.332 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.492 ' HA ' ' HB3' ' A' ' 186' ' ' TYR . 15.3 t -140.76 124.78 17.3 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.422 -0.799 . . . . 0.0 110.154 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.61 HD12 ' CD2' ' A' ' 186' ' ' TYR . 0.1 OUTLIER -107.26 116.64 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.215 -0.928 . . . . 0.0 109.276 179.502 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 79.81 -47.19 3.25 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 137.62 36.39 0.17 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' THR . . . . . 0.435 ' O ' ' C ' ' A' ' 186' ' ' TYR . 73.0 m -122.89 -51.47 1.91 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.242 -1.152 . . . . 0.0 110.859 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.61 ' CD2' HD12 ' A' ' 182' ' ' ILE . 0.1 OUTLIER -40.98 -74.34 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.079 -1.013 . . . . 0.0 110.613 -179.415 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.619 ' CD2' ' CZ ' ' A' ' 191' ' ' PHE . 1.1 mp -71.25 43.85 0.08 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.001 -1.062 . . . . 0.0 109.886 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 186' ' ' TYR . . . -75.67 -99.28 0.13 Allowed Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.51 ' C ' ' H ' ' A' ' 191' ' ' PHE . 49.6 Cg_endo -74.13 -24.17 15.05 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.207 1.635 . . . . 0.0 110.946 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -65.86 16.81 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.487 -0.758 . . . . 0.0 111.724 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.619 ' CZ ' ' CD2' ' A' ' 187' ' ' LEU . 0.3 OUTLIER -90.45 -16.68 28.53 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.828 -1.17 . . . . 0.0 110.394 179.56 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.468 ' NE ' ' HA ' ' A' ' 192' ' ' ARG . 0.0 OUTLIER -90.2 -15.12 32.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.282 -0.886 . . . . 0.0 110.902 -179.452 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -110.82 -16.95 9.42 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.658 HD21 ' C ' ' A' ' 194' ' ' LEU . 7.5 tt -67.86 -36.31 80.08 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.617 -0.931 . . . . 0.0 108.87 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.516 ' HA ' HG23 ' A' ' 177' ' ' THR . 0.0 OUTLIER -44.69 -34.88 2.4 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.403 -0.811 . . . . 0.0 109.825 179.562 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.451 ' N ' ' HD2' ' A' ' 195' ' ' LYS . . . -94.11 -27.31 12.43 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.64 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.94 -4.69 56.3 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.603 -0.94 . . . . 0.0 110.108 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.611 ' N ' ' O ' ' A' ' 194' ' ' LEU . 0.7 OUTLIER -44.06 143.49 1.14 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.825 0.821 . . . . 0.0 111.649 -178.327 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' A' ' 197' ' ' ARG . 0.0 OUTLIER -140.28 171.74 13.73 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.509 ' C ' HG11 ' A' ' 108' ' ' VAL . 2.8 m-30 -84.18 129.81 56.87 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 120.925 -1.11 . . . . 0.0 109.782 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.499 ' HD3' ' CD1' ' A' ' 178' ' ' LEU . 41.6 Cg_endo -67.51 115.75 3.87 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.888 1.468 . . . . 0.0 111.035 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.538 ' CB ' ' HE3' ' A' ' 81' ' ' LYS . 1.6 p -133.14 154.06 50.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.43 -0.794 . . . . 0.0 110.229 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 105' ' ' VAL . 2.0 p -158.1 164.11 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.32 -0.863 . . . . 0.0 110.217 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' SER . . . . . 0.759 ' O ' ' HH2' ' A' ' 95' ' ' TRP . 0.1 OUTLIER -157.94 126.56 5.57 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.397 -0.815 . . . . 0.0 109.981 179.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.482 ' HB2' ' CZ ' ' A' ' 66' ' ' PHE . . . -119.23 161.63 20.06 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.312 -0.868 . . . . 0.0 110.831 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.559 ' CG1' ' N ' ' A' ' 207' ' ' TRP . 1.1 t -124.33 176.14 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 CA-C-O 121.251 0.548 . . . . 0.0 110.063 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.568 ' CE2' ' HG3' ' A' ' 68' ' ' ARG . 44.2 p90 -103.31 155.0 18.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -0.883 . . . . 0.0 110.056 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 135.18 -152.84 20.95 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.476 ' OE1' ' CG ' ' A' ' 100' ' ' ARG . 5.1 tm0? -66.89 -29.04 68.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.324 -1.103 . . . . 0.0 110.258 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 209' ' ' GLN . 9.2 t -46.74 175.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.304 -0.872 . . . . 0.0 109.985 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.422 ' HG2' ' C ' ' A' ' 210' ' ' CYS . 0.8 OUTLIER -170.11 111.29 0.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 110.588 -179.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.767 ' O ' ' CZ2' ' A' ' 48' ' ' TRP . 27.4 m -115.42 145.39 21.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.527 -0.733 . . . . 0.0 109.783 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 0.848 ' HE ' ' HA ' ' A' ' 213' ' ' ARG . 0.7 OUTLIER -108.48 128.54 54.89 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.204 179.728 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.709 ' HB ' ' CZ3' ' A' ' 48' ' ' TRP . 5.6 tt -123.51 119.62 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.026 -1.047 . . . . 0.0 111.933 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.665 ' N ' ' O ' ' A' ' 92' ' ' GLU . 23.3 ttt180 -130.33 135.07 47.69 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . 0.656 ' CZ ' ' CD1' ' A' ' 91' ' ' TRP . 1.8 t80 -119.07 151.02 39.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.651 -1.281 . . . . 0.0 112.265 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' MET . . . . . 0.545 ' O ' ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -131.11 107.77 9.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.686 -0.634 . . . . 0.0 109.612 179.061 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 79.23 61.87 2.28 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.578 ' HB2' ' CD1' ' A' ' 216' ' ' TYR . 16.9 tt0 -95.4 150.44 20.28 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.138 -1.213 . . . . 0.0 110.237 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . 0.459 ' N ' ' HG2' ' A' ' 219' ' ' GLU . 0.0 OUTLIER -43.24 136.42 2.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.236 -0.915 . . . . 0.0 110.266 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . 0.504 ' O ' ' C ' ' A' ' 222' ' ' VAL . 4.8 mtt85 -119.28 85.58 2.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 110.316 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.504 ' C ' ' O ' ' A' ' 221' ' ' ARG . 2.6 p -33.54 118.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.504 -0.748 . . . . 0.0 110.582 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.508 ' O ' ' C ' ' A' ' 224' ' ' GLU . 1.9 tt0 179.85 -74.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.254 -0.904 . . . . 0.0 110.251 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.508 ' C ' ' O ' ' A' ' 223' ' ' GLU . 7.7 tt0 -33.89 -89.1 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.466 -0.771 . . . . 0.0 110.638 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.54 111.18 0.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.261 -0.899 . . . . 0.0 110.326 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.78 133.83 53.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.285 -0.885 . . . . 0.0 110.058 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.64 -38.1 5.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.343 -0.848 . . . . 0.0 110.267 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.431 ' O ' HG13 ' A' ' 228' ' ' ILE . 17.1 pt -130.16 133.46 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.217 -0.927 . . . . 0.0 110.295 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.406 ' O ' ' C ' ' A' ' 230' ' ' ARG . 16.8 m170 -97.95 -35.9 10.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.283 -0.886 . . . . 0.0 110.158 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . 0.67 ' O ' ' C ' ' A' ' 231' ' ' ASP . 0.0 OUTLIER -44.12 153.69 0.13 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.209 -0.932 . . . . 0.0 110.178 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.67 ' C ' ' O ' ' A' ' 230' ' ' ARG . 38.9 m-20 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.986 -1.007 . . . . 0.0 111.421 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.98 96.07 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -1.154 . . . . 0.0 110.145 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 51.59 66.66 1.13 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.27 -0.894 . . . . 0.0 110.217 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.63 60.75 6.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.893 . . . . 0.0 110.17 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.89 34.37 0.15 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 110.285 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -77.03 118.52 19.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.212 -0.93 . . . . 0.0 110.198 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.1 m -82.1 96.42 7.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.217 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 37.1 p -137.94 143.57 40.36 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.201 -0.937 . . . . 0.0 110.199 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -73.08 -36.25 4.47 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.001 1.527 . . . . 0.0 110.387 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 90.6 m -97.45 149.81 21.74 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.27 -0.894 . . . . 0.0 110.194 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.2 m -103.91 154.78 19.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -0.88 . . . . 0.0 110.224 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.92 48.67 0.96 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -0.847 . . . . 0.0 110.297 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.38 143.6 57.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.265 -0.897 . . . . 0.0 110.219 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.48 HD23 ' N ' ' A' ' 19' ' ' LEU . 4.3 mt -52.02 173.95 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.922 . . . . 0.0 110.231 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -60.71 -172.38 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.208 -0.932 . . . . 0.0 110.445 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.5 t -94.65 -164.04 1.12 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.285 -0.884 . . . . 0.0 110.347 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -164.55 37.01 0.07 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.906 . . . . 0.0 110.302 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.42 -74.49 0.46 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 0.0 110.209 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.6 109.0 42.27 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.346 -0.847 . . . . 0.0 110.053 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.91 163.89 37.1 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.914 1.481 . . . . 0.0 110.616 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.457 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 47.4 Cg_endo -73.24 165.32 32.93 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.06 1.558 . . . . 0.0 110.443 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 1.2 tt0 -179.28 39.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.328 -0.858 . . . . 0.0 110.156 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.18 22.3 57.35 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -63.82 -33.23 75.22 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.35 -1.088 . . . . 0.0 110.092 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.571 ' HA ' ' CD2' ' A' ' 33' ' ' LEU . 16.1 pt-20 -45.74 -37.82 6.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 109.719 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.455 ' N ' ' HG3' ' A' ' 30' ' ' GLU . 1.7 tm-20 -72.4 -23.21 61.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.376 -0.828 . . . . 0.0 109.167 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.578 ' O ' ' HD2' ' A' ' 36' ' ' PRO . 15.3 tp -83.81 -30.49 26.5 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.598 ' HG ' ' N ' ' A' ' 34' ' ' SER . 0.3 OUTLIER -71.0 -34.35 71.26 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 122.081 0.943 . . . . 0.0 108.968 179.304 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.598 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -83.81 -6.93 59.54 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.072 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.624 ' CB ' ' HD3' ' A' ' 36' ' ' PRO . . . -71.5 -65.73 0.84 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.313 -0.867 . . . . 0.0 111.11 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.69 ' C ' ' HD3' ' A' ' 38' ' ' PRO . 49.6 Cg_endo -75.45 143.97 28.3 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.607 1.32 . . . . 0.0 110.441 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 36' ' ' PRO . 53.9 Cg_endo -99.02 54.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.947 1.764 . . . . 0.0 112.251 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.69 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 51.8 Cg_endo -75.52 150.91 36.63 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 122.958 0.978 . . . . 0.0 109.845 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.645 ' O ' ' HB3' ' A' ' 43' ' ' GLN . 0.9 OUTLIER -34.04 -34.52 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.187 -0.946 . . . . 0.0 109.662 179.895 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 1.225 ' O ' ' HB3' ' A' ' 44' ' ' ARG . 1.8 tp -62.79 -43.91 97.57 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 110.34 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.688 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 46.6 t -86.68 -36.8 10.65 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 C-N-CA 118.389 -1.324 . . . . 0.0 110.029 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.13 -40.12 11.21 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.436 -0.906 . . . . 0.0 112.696 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.645 ' HB3' ' O ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -87.88 -19.15 27.76 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 120.899 -1.126 . . . . 0.0 110.164 -178.645 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 1.225 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 5.3 ttt180 -84.66 -52.62 5.95 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.795 1.284 . . . . 0.0 109.778 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.688 ' CG ' ' O ' ' A' ' 41' ' ' VAL . 13.7 m170 -52.35 -15.03 0.54 Allowed 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.26 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 20.4 t-160 -82.84 -38.59 22.81 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 118.147 -1.421 . . . . 0.0 110.136 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.736 ' O ' ' N ' ' A' ' 49' ' ' ASN . . . -94.39 -109.93 2.2 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 106.234 -2.746 . . . . 0.0 106.234 177.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.804 ' CD2' ' N ' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -58.39 71.42 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 177.062 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.736 ' N ' ' O ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -57.66 109.95 2.14 Favored Pre-proline 0 C--N 1.289 -2.052 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.192 -178.615 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.588 ' CD ' ' HA ' ' A' ' 45' ' ' HIS . 51.5 Cg_endo -92.54 -0.03 3.92 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.171 1.914 . . . . 0.0 110.448 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.687 ' CE ' ' CA ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -44.97 -77.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.147 -0.97 . . . . 0.0 110.425 -179.518 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.622 ' HB3' ' HE ' ' A' ' 79' ' ' ARG . 0.2 OUTLIER -40.57 -19.29 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.708 0.766 . . . . 0.0 109.192 178.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.638 ' N ' ' O ' ' A' ' 51' ' ' LYS . 3.1 t -114.69 -178.52 3.39 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.653 0.74 . . . . 0.0 110.776 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.579 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 0.3 OUTLIER -89.0 166.6 13.79 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.84 0.828 . . . . 0.0 110.595 -179.736 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.797 ' O ' ' N ' ' A' ' 57' ' ' ILE . 3.2 pp20? -81.93 8.75 9.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.713 -0.617 . . . . 0.0 110.039 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.579 ' ND2' ' O ' ' A' ' 54' ' ' SER . 0.1 OUTLIER -24.51 -33.1 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.675 0.75 . . . . 0.0 110.134 -179.534 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.797 ' N ' ' O ' ' A' ' 55' ' ' GLU . 6.1 pt -141.73 165.18 18.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.798 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 67' ' ' GLU . 9.2 t0 -114.91 126.79 55.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.463 -0.773 . . . . 0.0 109.967 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.715 HG13 ' CD1' ' A' ' 48' ' ' TRP . 57.7 t -130.04 127.01 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.115 -0.991 . . . . 0.0 109.907 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.625 ' HA ' ' CH2' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -136.37 157.1 47.6 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.986 -1.071 . . . . 0.0 111.585 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.67 ' N ' ' CH2' ' A' ' 48' ' ' TRP . 1.3 tt0 -52.5 -110.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.694 -0.629 . . . . 0.0 111.076 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 44.54 37.57 5.0 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 107.661 -2.176 . . . . 0.0 107.661 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.73 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 94.35 78.32 1.41 Allowed Glycine 0 N--CA 1.486 1.973 0 N-CA-C 107.809 -2.117 . . . . 0.0 107.809 -178.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.73 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.4 OUTLIER 1.26 88.21 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.661 -0.905 . . . . 0.0 110.126 -178.711 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 46.4 t -122.35 114.64 21.05 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.425 -0.797 . . . . 0.0 111.677 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.66 ' CD1' HG13 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -84.41 135.36 34.3 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.501 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.556 ' O ' ' N ' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -138.39 131.62 30.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.851 -1.156 . . . . 0.0 111.15 -179.535 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.543 ' HG2' ' CA ' ' A' ' 208' ' ' GLY . 0.0 OUTLIER -130.71 141.81 50.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.53 -0.732 . . . . 0.0 109.043 179.133 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.605 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 2.4 ttp180 -110.46 -68.2 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.783 -1.198 . . . . 0.0 111.325 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.605 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 56.3 Cg_endo -71.61 -124.1 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.5 0 O-C-N 123.394 1.207 . . . . 0.0 109.586 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.55 ' O ' ' N ' ' A' ' 73' ' ' GLN . 3.6 t -140.1 164.18 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.441 -1.412 . . . . 0.0 109.874 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.573 ' HB1' ' CE3' ' A' ' 207' ' ' TRP . . . -46.66 91.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.169 -0.957 . . . . 0.0 109.892 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.55 ' N ' ' O ' ' A' ' 71' ' ' VAL . 9.8 mt-30 -50.08 -176.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.932 . . . . 0.0 110.313 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.0 m -51.76 -18.84 1.37 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 0.0 110.127 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 1.3 m -96.87 -131.88 0.2 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.215 -0.928 . . . . 0.0 110.081 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.579 ' O ' ' C ' ' A' ' 77' ' ' GLY . 80.5 m-20 -140.4 154.83 46.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.187 -0.946 . . . . 0.0 110.172 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.579 ' C ' ' O ' ' A' ' 76' ' ' ASP . . . -31.88 -77.78 0.03 OUTLIER Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.557 HG21 ' N ' ' A' ' 79' ' ' ARG . 0.4 OUTLIER -149.18 153.29 11.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.345 -1.091 . . . . 0.0 109.783 179.024 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.631 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 0.2 OUTLIER -145.7 174.63 11.03 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.712 -0.617 . . . . 0.0 110.071 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.576 ' N ' ' CG ' ' A' ' 79' ' ' ARG . . . -157.48 152.55 23.83 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.521 ' HB2' ' CB ' ' A' ' 202' ' ' SER . 0.1 OUTLIER 179.85 -27.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.206 -1.173 . . . . 0.0 110.661 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.48 ' HG2' ' OD1' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -72.92 -100.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.137 -0.977 . . . . 0.0 110.334 -179.794 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 82' ' ' ARG . . . 43.0 59.61 3.28 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.526 ' CD2' ' O ' ' A' ' 84' ' ' TYR . 28.2 t80 -95.33 95.68 8.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.18 -1.188 . . . . 0.0 110.185 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.465 ' O ' ' HG2' ' A' ' 173' ' ' MET . 0.1 OUTLIER -140.11 173.67 11.28 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 110.252 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.496 ' HA ' ' CB ' ' A' ' 173' ' ' MET . 2.3 mmt85 -101.42 -174.36 2.58 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.177 -0.952 . . . . 0.0 109.676 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.96 158.35 15.98 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 172' ' ' ASP . 1.8 tt -87.47 127.41 35.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -1.11 . . . . 0.0 109.98 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.421 ' NE2' ' O ' ' A' ' 86' ' ' ARG . 40.9 m-70 -133.25 173.1 11.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 110.162 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -156.76 151.31 25.56 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.07 -1.019 . . . . 0.0 110.389 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.714 ' CB ' ' CD2' ' A' ' 216' ' ' TYR . 4.1 p90 -146.2 171.06 15.5 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.246 -0.909 . . . . 0.0 109.936 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.584 ' N ' ' O ' ' A' ' 215' ' ' ARG . 0.7 OUTLIER -138.28 152.14 48.26 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.351 -0.939 . . . . 0.0 111.45 -178.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.59 ' CG2' ' CD1' ' A' ' 167' ' ' LEU . 3.7 tt -144.18 151.58 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.545 -0.722 . . . . 0.0 109.674 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.524 ' HB2' ' CG ' ' A' ' 213' ' ' ARG . 0.1 OUTLIER -142.65 135.85 28.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.092 -1.005 . . . . 0.0 110.672 -179.572 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.759 ' CH2' ' HA ' ' A' ' 104' ' ' ALA . 88.3 m95 -104.47 96.25 9.83 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.775 -0.578 . . . . 0.0 110.204 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.62 ' HD2' ' O ' ' A' ' 211' ' ' GLN . 45.9 Cg_endo -72.29 152.37 55.45 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 121.959 1.772 . . . . 0.0 111.214 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.824 ' CD2' ' C ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -32.87 -42.69 0.08 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.533 -0.729 . . . . 0.0 111.158 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.706 ' C ' ' CB ' ' A' ' 210' ' ' CYS . 3.1 mt-10 -35.71 -28.33 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.687 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.738 ' HA ' ' HB3' ' A' ' 210' ' ' CYS . 7.3 pt20 -67.16 50.41 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.247 -0.908 . . . . 0.0 110.304 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.476 ' NH1' HD23 ' A' ' 97' ' ' LEU . 1.9 mtt-85 -56.03 -99.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.173 -0.955 . . . . 0.0 110.233 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.589 ' O ' ' CD2' ' A' ' 103' ' ' HIS . . . -44.88 -93.13 0.01 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.2 p -59.45 136.81 58.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.249 -1.148 . . . . 0.0 110.071 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.589 ' CD2' ' O ' ' A' ' 101' ' ' GLY . 8.8 m-70 -98.95 -135.49 0.28 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -0.888 . . . . 0.0 110.212 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.759 ' HA ' ' CH2' ' A' ' 95' ' ' TRP . . . -94.88 131.51 40.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.184 -0.948 . . . . 0.0 110.352 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.67 HG22 ' CB ' ' A' ' 204' ' ' SER . 34.9 m -128.01 114.12 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 118.003 -1.479 . . . . 0.0 110.471 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 203' ' ' VAL . 9.0 p -152.31 166.91 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.396 -0.815 . . . . 0.0 109.121 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.638 ' CA ' ' HA3' ' A' ' 132' ' ' GLY . . . 176.28 167.99 35.8 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 118.987 -1.578 . . . . 0.0 110.941 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.65 ' CG1' ' CD1' ' A' ' 199' ' ' LEU . 2.2 t -123.91 155.61 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.712 -0.876 . . . . 0.0 109.017 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.574 ' HB2' ' CE2' ' A' ' 200' ' ' TYR . . . -142.96 150.78 40.15 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.805 -1.185 . . . . 0.0 111.365 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.586 ' CG2' ' HB3' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -131.45 134.95 46.71 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.513 -0.742 . . . . 0.0 110.087 179.505 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.96 -24.77 18.28 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.343 -0.848 . . . . 0.0 109.337 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.6 pp -86.69 -12.11 49.29 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.583 -0.698 . . . . 0.0 109.255 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.529 ' CB ' ' CD ' ' A' ' 114' ' ' PRO . . . -41.82 -57.61 3.91 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.465 -0.772 . . . . 0.0 110.44 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.529 ' CD ' ' CB ' ' A' ' 113' ' ' ALA . 46.6 Cg_endo -73.84 149.95 43.44 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.956 1.503 . . . . 0.0 110.505 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.478 ' HB3' ' O ' ' A' ' 114' ' ' PRO . 0.7 OUTLIER -178.39 47.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 110.016 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -91.73 -86.75 0.22 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.329 -0.857 . . . . 0.0 110.257 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.533 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -150.74 67.17 0.94 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.152 -0.968 . . . . 0.0 110.156 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 120' ' ' TYR . 43.0 t0 -30.68 -53.14 0.18 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.464 -0.772 . . . . 0.0 110.778 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.475 ' HB3' ' O ' ' A' ' 118' ' ' ASP . 9.2 t-80 62.42 -71.37 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.357 -0.839 . . . . 0.0 110.239 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.54 ' N ' ' O ' ' A' ' 118' ' ' ASP . 0.4 OUTLIER -149.32 -51.07 0.15 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 110.165 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 120' ' ' TYR . . . 176.97 -52.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.959 . . . . 0.0 110.172 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 59.83 167.69 0.07 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.236 -0.915 . . . . 0.0 110.202 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.443 ' O ' ' CD1' ' A' ' 124' ' ' LEU . 34.0 tp -81.05 -19.22 44.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.16 -0.963 . . . . 0.0 110.237 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.443 ' CD1' ' O ' ' A' ' 123' ' ' LEU . 1.3 tp -148.25 44.27 1.05 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.254 -0.903 . . . . 0.0 110.193 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -65.61 -119.47 0.01 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.98 58.47 1.54 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.203 -1.175 . . . . 0.0 110.212 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.3 m-20 -47.1 -69.38 0.13 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.256 -0.902 . . . . 0.0 110.166 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.486 ' HA ' ' HG3' ' A' ' 114' ' ' PRO . 32.0 t -156.65 175.8 13.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.252 -0.905 . . . . 0.0 110.211 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.487 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . 0.2 OUTLIER -133.5 119.64 19.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 110.051 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 3.1 t -120.58 119.99 34.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 110.334 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -123.68 124.91 43.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.851 . . . . 0.0 109.693 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.638 ' HA3' ' CA ' ' A' ' 107' ' ' GLY . . . -164.53 -164.36 19.64 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.607 ' CH2' ' O ' ' A' ' 180' ' ' TYR . 36.4 m0 -114.64 113.17 24.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -1.103 . . . . 0.0 110.462 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.417 ' O ' HD11 ' A' ' 140' ' ' LEU . 34.5 m-20 -119.63 107.77 13.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.709 -0.62 . . . . 0.0 109.488 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.471 ' O ' ' HB2' ' A' ' 103' ' ' HIS . 15.7 tt -144.26 48.15 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.156 -0.965 . . . . 0.0 110.394 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.489 ' HA2' ' HB2' ' A' ' 103' ' ' HIS . . . -91.9 -23.65 27.27 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.94 4.25 23.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -1.175 . . . . 0.0 109.989 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.472 ' O ' ' HG2' ' A' ' 139' ' ' LYS . . . 79.32 -11.67 29.7 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.189 -1.165 . . . . 0.0 110.189 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 138' ' ' GLY . 7.8 mmtt -145.31 -164.1 1.86 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.047 -1.267 . . . . 0.0 110.459 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 139' ' ' LYS . 0.6 OUTLIER -178.44 61.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.414 -0.804 . . . . 0.0 110.178 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.427 ' CG ' ' O ' ' A' ' 141' ' ' TYR . 40.8 t80 -72.7 68.06 0.82 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.189 -0.944 . . . . 0.0 110.333 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 5.6 m170 -71.67 -71.47 0.27 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 110.311 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.55 -80.89 0.41 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.249 -0.907 . . . . 0.0 110.169 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.31 -162.21 1.48 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.325 -0.859 . . . . 0.0 110.184 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.39 96.17 0.08 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.201 -0.937 . . . . 0.0 110.182 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -146.14 23.16 1.75 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 148' ' ' GLU . 0.5 OUTLIER -172.07 49.65 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.187 -1.184 . . . . 0.0 110.159 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 147' ' ' LEU . 7.3 tp10 179.93 94.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 110.036 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -122.67 98.59 43.01 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.229 -0.92 . . . . 0.0 110.2 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.98 53.45 2.88 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.973 1.512 . . . . 0.0 110.504 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.5 ' NE2' ' N ' ' A' ' 151' ' ' GLN . 0.2 OUTLIER -77.79 -91.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 0.0 110.184 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.634 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 5.0 m-85 -107.34 -66.44 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.272 -0.893 . . . . 0.0 110.505 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.634 ' CD ' ' CB ' ' A' ' 152' ' ' TYR . 47.3 Cg_endo -73.03 142.91 35.33 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.574 1.302 . . . . 0.0 110.383 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.507 ' O ' ' O ' ' A' ' 155' ' ' GLY . . . -66.48 132.46 48.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 110.117 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.507 ' O ' ' O ' ' A' ' 154' ' ' ALA . . . 58.75 125.53 0.01 OUTLIER Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.07 -49.67 0.29 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.842 1.443 . . . . 0.0 110.494 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -61.96 -10.2 9.06 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.265 -0.897 . . . . 0.0 110.413 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.55 ' O ' ' CG2' ' A' ' 162' ' ' VAL . . . 59.74 62.1 6.48 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.481 ' HA ' HG21 ' A' ' 162' ' ' VAL . 3.2 pp20? -69.5 6.47 1.07 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.405 -1.056 . . . . 0.0 110.682 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.425 ' H ' ' C ' ' A' ' 158' ' ' GLY . 3.0 pt20 -76.52 0.13 21.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.891 . . . . 0.0 109.957 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.448 ' HA ' ' OE1' ' A' ' 165' ' ' GLU . 0.6 OUTLIER -167.42 35.43 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.312 -0.868 . . . . 0.0 110.008 179.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.55 ' CG2' ' O ' ' A' ' 158' ' ' GLY . 24.1 t -106.79 -115.3 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.275 -0.89 . . . . 0.0 110.422 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.753 ' N ' ' CD ' ' A' ' 164' ' ' PRO . 8.4 p -87.17 -25.91 0.34 Allowed Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.188 -0.945 . . . . 0.0 111.134 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.753 ' CD ' ' N ' ' A' ' 163' ' ' VAL . 48.3 Cg_endo -79.3 52.51 4.31 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 O-C-N 123.068 1.036 . . . . 0.0 109.792 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 95' ' ' TRP . 0.9 OUTLIER 178.77 -72.4 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.693 0.759 . . . . 0.0 109.371 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.459 ' HA ' ' HB3' ' A' ' 94' ' ' SER . 1.4 tpp180 -140.85 144.0 35.08 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.642 HD12 ' CE2' ' A' ' 180' ' ' TYR . 0.6 OUTLIER -164.36 157.08 17.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.041 -1.037 . . . . 0.0 110.745 -179.604 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.5 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . 7.7 tt -123.31 137.14 54.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.286 -0.884 . . . . 0.0 110.082 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.622 ' CG2' ' CE1' ' A' ' 180' ' ' TYR . 19.0 t -121.4 147.94 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 110.082 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.519 ' CG2' HD22 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -127.89 128.87 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.181 -0.95 . . . . 0.0 110.438 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.548 ' CD1' ' HB3' ' A' ' 178' ' ' LEU . 4.7 tp -133.14 105.91 7.3 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.225 -0.922 . . . . 0.0 109.678 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 54.3 t0 -114.88 136.64 52.88 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 110.648 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.496 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -93.26 -39.6 10.9 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.799 -0.563 . . . . 0.0 109.689 179.678 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 173' ' ' MET . 3.5 tt0 -42.51 -28.07 0.2 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.323 -0.861 . . . . 0.0 108.894 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.587 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 3.0 tt0 -111.86 -26.22 9.04 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.52 ' O ' ' HB ' ' A' ' 198' ' ' THR . . . 80.0 25.07 58.58 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.644 ' CG2' HD23 ' A' ' 194' ' ' LEU . 0.2 OUTLIER -121.81 136.7 54.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.191 -1.182 . . . . 0.0 111.252 -179.431 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.567 ' O ' ' CD1' ' A' ' 194' ' ' LEU . 0.3 OUTLIER -144.66 153.76 42.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.56 -0.713 . . . . 0.0 109.514 179.302 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.512 ' O ' HG11 ' A' ' 169' ' ' VAL . . . -154.03 167.6 32.28 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.588 -1.292 . . . . 0.0 110.197 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.642 ' CE2' HD12 ' A' ' 167' ' ' LEU . 0.9 OUTLIER -118.74 125.26 49.23 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.594 -0.945 . . . . 0.0 108.906 179.64 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.52 ' CB ' ' HB2' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -144.41 165.07 28.96 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.069 -1.019 . . . . 0.0 110.646 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.609 HD11 ' CD2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -120.81 116.65 50.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 O-C-N 121.667 -0.646 . . . . 0.0 109.38 179.402 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 62.78 11.67 37.8 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 86.92 34.52 10.93 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' THR . . . . . 0.635 ' CG2' ' CE1' ' A' ' 186' ' ' TYR . 31.8 m -87.43 -79.41 0.28 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -1.161 . . . . 0.0 110.545 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.635 ' CE1' ' CG2' ' A' ' 185' ' ' THR . 2.0 m-85 -83.66 89.47 7.13 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.971 -1.081 . . . . 0.0 110.389 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.621 ' HG ' ' CE1' ' A' ' 191' ' ' PHE . 12.3 tp 179.9 29.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.589 -0.694 . . . . 0.0 109.504 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -106.73 -72.06 0.8 Allowed Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.754 -1.212 . . . . 0.0 110.984 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.424 ' C ' ' H ' ' A' ' 191' ' ' PHE . 44.8 Cg_endo -70.48 -30.84 18.35 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.899 1.473 . . . . 0.0 111.727 -178.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.637 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -72.42 17.21 0.11 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.125 -0.984 . . . . 0.0 111.519 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.621 ' CE1' ' HG ' ' A' ' 187' ' ' LEU . 1.1 m-30 -90.83 -22.14 21.13 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.962 -1.086 . . . . 0.0 110.981 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.477 ' HG2' ' NH1' ' A' ' 192' ' ' ARG . 0.1 OUTLIER -90.02 -14.66 33.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.033 -1.042 . . . . 0.0 110.659 -179.391 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -106.62 -17.36 12.27 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.516 -1.834 . . . . 0.0 108.516 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.644 HD23 ' CG2' ' A' ' 177' ' ' THR . 7.2 tt -65.99 -41.44 91.1 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.699 -0.883 . . . . 0.0 109.525 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.598 ' C ' HG22 ' A' ' 198' ' ' THR . 0.0 OUTLIER -47.07 -31.12 3.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.455 -0.778 . . . . 0.0 110.415 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.551 ' N ' ' HE3' ' A' ' 195' ' ' LYS . . . -99.61 -22.91 11.57 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 1.002 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -91.22 -3.66 56.74 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.942 -0.74 . . . . 0.0 110.164 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.605 ' CG2' ' O ' ' A' ' 194' ' ' LEU . 33.9 p -42.6 123.17 2.53 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.781 0.801 . . . . 0.0 111.785 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 1.002 ' HG ' ' O ' ' A' ' 197' ' ' ARG . 0.0 OUTLIER -140.72 172.9 12.05 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.495 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.58 ' O ' ' CD1' ' A' ' 200' ' ' TYR . 41.0 p90 -83.13 131.26 54.13 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 120.934 -1.104 . . . . 0.0 109.625 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.548 ' HD3' HD12 ' A' ' 178' ' ' LEU . 52.2 Cg_endo -81.74 132.43 7.65 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 124.01 1.532 . . . . 0.0 111.935 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.521 ' CB ' ' HB2' ' A' ' 81' ' ' LYS . 20.0 p -133.44 127.31 33.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.61 -0.681 . . . . 0.0 109.346 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 11.8 p -119.66 156.33 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.01 -1.056 . . . . 0.0 110.589 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' SER . . . . . 0.67 ' CB ' HG22 ' A' ' 105' ' ' VAL . 1.4 m -134.18 129.27 35.55 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.527 -0.733 . . . . 0.0 110.726 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.607 ' HA ' ' CH2' ' A' ' 95' ' ' TRP . . . -123.14 131.22 53.6 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.285 0.564 . . . . 0.0 110.202 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.569 ' CG1' ' N ' ' A' ' 207' ' ' TRP . 1.2 t -47.35 176.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.46 -0.775 . . . . 0.0 110.419 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.69 ' CG ' ' N ' ' A' ' 208' ' ' GLY . 0.2 OUTLIER -101.3 -50.44 3.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.201 -0.937 . . . . 0.0 111.072 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.69 ' N ' ' CG ' ' A' ' 207' ' ' TRP . . . -144.36 -1.19 0.93 Allowed Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.596 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.545 ' OE1' ' CH2' ' A' ' 207' ' ' TRP . 4.0 tp60 -66.9 -23.43 65.99 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.424 -1.045 . . . . 0.0 109.646 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . 0.738 ' HB3' ' HA ' ' A' ' 99' ' ' GLN . 20.7 p -143.98 -121.98 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.625 0.726 . . . . 0.0 110.018 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.62 ' O ' ' HD2' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -173.53 139.55 0.75 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.634 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.623 ' HB ' ' CZ ' ' A' ' 66' ' ' PHE . 2.3 t -127.24 140.6 48.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 120.607 -1.308 . . . . 0.0 111.321 -178.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 0.573 ' CD ' ' HD3' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -128.39 109.28 11.28 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.153 178.73 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.563 ' O ' HD11 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -123.54 150.79 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.425 -0.797 . . . . 0.0 110.913 -179.024 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.584 ' O ' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -130.0 108.89 10.44 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . 0.714 ' CD2' ' CB ' ' A' ' 91' ' ' TRP . 1.5 t80 -115.8 140.28 49.37 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.187 -0.945 . . . . 0.0 111.048 -178.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' MET . . . . . 0.421 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 0.0 OUTLIER -136.71 123.99 21.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.648 -0.657 . . . . 0.0 110.142 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 145.8 -37.54 1.26 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -95.5 142.47 27.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.274 -1.133 . . . . 0.0 110.224 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . 0.475 ' HG3' ' N ' ' A' ' 221' ' ' ARG . 2.8 ptp180 -161.75 -139.48 0.05 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.906 . . . . 0.0 110.221 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . 0.488 ' O ' ' C ' ' A' ' 222' ' ' VAL . 6.0 ttm180 -102.13 79.18 1.84 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.199 -0.938 . . . . 0.0 110.162 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.488 ' C ' ' O ' ' A' ' 221' ' ' ARG . 9.3 p -35.03 116.16 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.552 -0.717 . . . . 0.0 110.559 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.505 ' O ' ' C ' ' A' ' 224' ' ' GLU . 49.8 mt-10 -83.81 34.41 0.49 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.176 -0.953 . . . . 0.0 110.53 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.505 ' C ' ' O ' ' A' ' 223' ' ' GLU . 4.7 tp10 -33.73 -70.72 0.07 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.425 -0.797 . . . . 0.0 110.715 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.4 ' C ' ' O ' ' A' ' 224' ' ' GLU . 5.1 t -42.78 109.83 0.15 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.235 -0.915 . . . . 0.0 110.159 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.51 137.63 23.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.339 -0.851 . . . . 0.0 110.139 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 11.0 ptt85 -103.1 28.85 5.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 110.238 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 5.9 tp -131.13 24.99 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.915 . . . . 0.0 110.232 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.427 ' O ' ' CG ' ' A' ' 231' ' ' ASP . 4.2 m170 -88.14 2.59 51.73 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.217 -0.927 . . . . 0.0 110.149 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . 0.465 ' O ' ' HB3' ' A' ' 231' ' ' ASP . 0.0 OUTLIER -51.54 107.78 0.22 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.214 -0.929 . . . . 0.0 110.221 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.465 ' HB3' ' O ' ' A' ' 230' ' ' ARG . 3.6 p30 . . . . . 0 C--N 1.307 -1.279 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.306 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.408 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -55.4 161.56 1.87 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -1.171 . . . . 0.0 110.137 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -159.96 69.25 0.41 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.266 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.74 45.48 1.19 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.288 -0.882 . . . . 0.0 110.115 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.67 75.17 5.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.178 -0.951 . . . . 0.0 110.275 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -48.71 146.36 3.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.926 . . . . 0.0 110.219 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.6 m -161.18 -81.8 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.304 -0.873 . . . . 0.0 110.176 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.4 m -160.32 123.73 1.95 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 0.0 110.121 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.17 -170.69 0.67 Allowed 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.921 1.485 . . . . 0.0 110.439 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.38 -163.34 1.58 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.921 . . . . 0.0 110.179 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.407 ' O ' ' OG ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -95.43 14.63 21.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.266 -0.896 . . . . 0.0 110.159 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.425 ' HA ' ' OE1' ' A' ' 17' ' ' GLN . 4.1 mm100 -72.6 141.29 48.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.209 -0.932 . . . . 0.0 110.208 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.62 177.1 0.97 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.281 -0.887 . . . . 0.0 110.269 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.02 -154.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.889 . . . . 0.0 110.258 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.507 ' O ' ' O ' ' A' ' 21' ' ' SER . 1.0 OUTLIER -76.71 -155.83 0.07 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 110.023 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.507 ' O ' ' O ' ' A' ' 20' ' ' TYR . 0.7 OUTLIER -52.05 -167.94 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.234 -0.916 . . . . 0.0 110.404 -179.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.58 40.89 0.25 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.901 . . . . 0.0 110.326 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -56.29 -57.43 12.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 110.152 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.489 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -134.27 130.59 20.25 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.352 -0.843 . . . . 0.0 110.111 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.4 110.09 2.99 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.035 1.545 . . . . 0.0 110.494 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 24' ' ' SER . 47.6 Cg_endo -74.2 164.98 32.98 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.127 1.593 . . . . 0.0 110.304 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 2.3 tt0 -175.94 37.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.883 . . . . 0.0 110.057 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.465 ' O ' ' HG2' ' A' ' 30' ' ' GLU . . . 48.41 25.89 4.68 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.595 ' HG ' ' N ' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -41.83 -25.64 0.06 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.429 -1.042 . . . . 0.0 110.218 -179.676 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.595 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 10.6 pt-20 -48.57 -29.26 4.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.119 -0.988 . . . . 0.0 108.819 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -66.75 -23.52 66.1 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 29' ' ' LEU . 15.1 tp -83.22 -35.85 25.08 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.606 ' C ' ' CD1' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -73.25 -38.01 66.14 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.903 0.858 . . . . 0.0 109.027 178.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.566 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 23.0 t -58.56 -22.71 56.62 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.444 0.64 . . . . 0.0 110.062 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.708 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . -57.95 -173.71 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.454 -0.779 . . . . 0.0 109.555 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.628 ' HD2' ' CB ' ' A' ' 35' ' ' ALA . 42.5 Cg_endo -69.16 102.28 0.91 Allowed 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.875 1.461 . . . . 0.0 110.099 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.708 ' HD3' ' O ' ' A' ' 35' ' ' ALA . 49.1 Cg_endo -94.23 121.21 0.35 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.19 1.627 . . . . 0.0 111.215 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.904 ' O ' ' N ' ' A' ' 40' ' ' LEU . 51.6 Cg_endo -83.84 149.58 12.51 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.925 1.487 . . . . 0.0 110.524 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.634 ' C ' ' O ' ' A' ' 38' ' ' PRO . 0.6 OUTLIER 3.02 51.98 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 122.126 0.965 . . . . 0.0 111.358 -179.649 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.904 ' N ' ' O ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -139.63 -48.89 0.47 Allowed 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 178.154 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.652 ' HB ' ' HB2' ' A' ' 37' ' ' PRO . 2.7 t -88.52 -32.76 6.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 119.327 -0.949 . . . . 0.0 108.554 177.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.46 -43.97 10.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.638 -0.664 . . . . 0.0 112.049 -178.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.699 ' OE1' ' HA ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -81.41 -19.99 41.37 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.056 -1.058 . . . . 0.0 109.972 -178.78 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.653 ' CB ' ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -71.85 -51.63 21.42 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.613 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.628 ' CE1' ' O ' ' A' ' 41' ' ' VAL . 29.6 m170 -56.38 -16.35 5.54 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.638 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -95.04 -33.19 12.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.263 -0.898 . . . . 0.0 109.383 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.645 ' C ' ' CE3' ' A' ' 48' ' ' TRP . . . -83.77 -101.93 0.56 Allowed Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.157 -1.977 . . . . 0.0 108.157 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.786 ' CD2' ' N ' ' A' ' 48' ' ' TRP . 0.3 OUTLIER -86.86 73.06 10.03 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 122.963 1.363 . . . . 0.0 108.479 179.492 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 49' ' ' ASN . 0.1 OUTLIER -46.21 111.67 1.53 Allowed Pre-proline 0 C--N 1.287 -2.148 0 CA-C-N 114.218 -1.356 . . . . 0.0 112.333 -178.295 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.708 ' O ' ' N ' ' A' ' 52' ' ' ASP . 55.4 Cg_endo -91.9 2.09 4.2 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.496 2.131 . . . . 0.0 110.277 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.801 ' HA ' ' CE ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -52.34 71.29 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.909 1.338 . . . . 0.0 111.655 -177.783 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.708 ' N ' ' O ' ' A' ' 50' ' ' PRO . 1.6 m-20 178.03 0.16 0.0 OUTLIER 'General case' 0 C--N 1.262 -3.213 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.2 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.828 ' HB2' ' CB ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -166.01 -175.69 3.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.389 -0.819 . . . . 0.0 111.259 -178.187 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.638 ' OG ' ' O ' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -51.78 124.5 12.63 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.955 0.883 . . . . 0.0 110.709 -179.016 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.739 ' C ' ' H ' ' A' ' 57' ' ' ILE . 1.6 pt-20 -99.67 8.41 44.37 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.591 0.71 . . . . 0.0 110.956 -179.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.636 ' ND2' ' OG ' ' A' ' 54' ' ' SER . 0.4 OUTLIER -58.84 22.94 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.666 0.746 . . . . 0.0 110.199 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.739 ' H ' ' C ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -112.99 166.13 7.15 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 CA-C-O 121.679 0.752 . . . . 0.0 110.342 -179.7 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.658 ' HA ' ' CD2' ' A' ' 40' ' ' LEU . 10.1 t0 -134.72 96.32 3.53 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 121.868 0.842 . . . . 0.0 109.737 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.731 ' HA ' ' O ' ' A' ' 65' ' ' CYS . 1.4 m -121.7 121.33 64.11 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 CA-C-O 121.27 0.557 . . . . 0.0 110.186 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.699 ' HA ' ' OE1' ' A' ' 43' ' ' GLN . 7.9 ttmt -135.75 153.42 51.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 110.658 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.552 ' N ' ' HG2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -55.27 -123.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.431 -0.793 . . . . 0.0 110.724 -179.457 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 44.0 32.37 2.34 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.698 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 110.9 65.47 0.53 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.698 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.2 OUTLIER 0.63 90.23 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.835 -0.803 . . . . 0.0 110.832 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.731 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 1.0 OUTLIER -116.88 114.4 23.83 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.528 -0.733 . . . . 0.0 109.786 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.61 ' CE2' HG11 ' A' ' 59' ' ' VAL . 13.4 t80 -116.25 123.56 48.02 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.461 -0.774 . . . . 0.0 109.541 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -151.82 149.03 28.54 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.909 -1.119 . . . . 0.0 110.886 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.562 ' HD2' ' CB ' ' A' ' 207' ' ' TRP . 17.4 ttt85 -122.51 152.87 39.9 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.253 -0.904 . . . . 0.0 109.71 179.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.68 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 2.7 mtt180 -85.8 -69.02 0.13 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.084 -1.01 . . . . 0.0 110.398 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.68 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 56.1 Cg_endo -71.34 -145.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.706 1.371 . . . . 0.0 109.382 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.484 ' O ' ' HG2' ' A' ' 73' ' ' GLN . 4.8 t -140.01 164.45 22.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 O-C-N 121.378 -0.826 . . . . 0.0 109.954 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.638 ' CB ' ' CZ3' ' A' ' 207' ' ' TRP . . . -63.06 111.38 2.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.208 -0.932 . . . . 0.0 110.105 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.489 ' O ' ' N ' ' A' ' 75' ' ' THR . 0.9 OUTLIER -140.65 -103.81 0.15 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.238 -0.914 . . . . 0.0 110.393 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.482 ' C ' ' O ' ' A' ' 73' ' ' GLN . 8.4 t -38.26 -29.95 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.166 -0.958 . . . . 0.0 110.39 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.537 ' CG2' ' HB2' ' A' ' 54' ' ' SER . 2.7 t -137.49 -134.69 0.14 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.254 -0.904 . . . . 0.0 110.049 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.627 ' O ' ' C ' ' A' ' 77' ' ' GLY . 2.3 t0 -140.11 154.6 47.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 109.905 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.638 ' O ' ' OG ' ' A' ' 54' ' ' SER . . . -25.01 -94.0 0.01 OUTLIER Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.644 ' CG1' HG13 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -158.24 163.13 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.098 -1.236 . . . . 0.0 109.521 179.728 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.828 ' CB ' ' HB2' ' A' ' 53' ' ' CYS . 3.1 tmm_? -141.08 134.66 30.05 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.4 -0.813 . . . . 0.0 110.776 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.822 ' O ' ' O ' ' A' ' 81' ' ' LYS . . . -116.17 -152.34 9.86 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.001 -2.039 . . . . 0.0 108.001 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.837 ' C ' ' HA ' ' A' ' 202' ' ' SER . 0.0 OUTLIER 2.02 123.33 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.414 -1.05 . . . . 0.0 110.986 179.357 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.532 ' NH2' ' OD2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -126.46 -19.83 4.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.267 -0.896 . . . . 0.0 110.549 -179.444 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.526 ' N ' ' HD2' ' A' ' 82' ' ' ARG . . . 133.53 37.73 0.23 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.485 ' HB2' ' HD3' ' A' ' 82' ' ' ARG . 7.9 t80 -134.8 95.86 3.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.06 -1.259 . . . . 0.0 110.286 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 173' ' ' MET . 0.7 OUTLIER -140.16 140.68 35.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.169 -0.957 . . . . 0.0 110.538 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.555 ' HA ' ' CB ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -131.42 145.44 51.81 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -0.902 . . . . 0.0 109.597 179.654 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.442 ' N ' ' HB3' ' A' ' 173' ' ' MET . . . 81.18 165.71 34.79 Favored Glycine 0 N--CA 1.481 1.693 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 172' ' ' ASP . 4.9 tt -87.23 117.86 26.27 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.34 -1.094 . . . . 0.0 110.047 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.454 ' NE2' ' O ' ' A' ' 86' ' ' ARG . 91.4 m-70 -135.39 173.28 11.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -0.882 . . . . 0.0 109.881 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.36 136.58 23.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.14 -0.975 . . . . 0.0 110.107 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.69 ' CB ' ' CD2' ' A' ' 216' ' ' TYR . 0.5 OUTLIER -135.07 171.0 15.05 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.156 -0.965 . . . . 0.0 110.632 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 215' ' ' ARG . 2.6 mt-10 -133.41 151.19 51.79 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.745 -0.597 . . . . 0.0 110.004 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.585 ' O ' HD22 ' A' ' 167' ' ' LEU . 11.5 mt -144.6 154.85 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.237 -0.915 . . . . 0.0 110.799 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.665 ' HB3' ' HB2' ' A' ' 213' ' ' ARG . 14.5 t -141.3 151.43 43.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 109.642 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.742 ' CZ3' ' O ' ' A' ' 104' ' ' ALA . 14.4 m95 -137.39 90.92 14.7 Favored Pre-proline 0 C--N 1.296 -1.721 0 O-C-N 121.526 -0.734 . . . . 0.0 110.565 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.518 ' HD2' ' HA ' ' A' ' 212' ' ' VAL . 49.4 Cg_endo -78.93 125.41 6.6 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.977 1.514 . . . . 0.0 110.149 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.523 ' HG ' ' CA ' ' A' ' 138' ' ' GLY . 0.0 OUTLIER -95.09 -6.44 42.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.184 -0.947 . . . . 0.0 110.229 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.443 ' HG3' ' OE1' ' A' ' 99' ' ' GLN . 11.6 pt-20 -43.65 -31.21 0.72 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.891 . . . . 0.0 110.449 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.472 ' OE1' ' NE2' ' A' ' 211' ' ' GLN . 0.9 OUTLIER -74.67 -86.79 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.162 -0.961 . . . . 0.0 110.457 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.48 ' O ' HD13 ' A' ' 97' ' ' LEU . 45.3 mmm-85 -139.96 -53.77 0.53 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.377 -0.827 . . . . 0.0 110.244 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.463 ' O ' HG23 ' A' ' 102' ' ' THR . . . 61.26 138.39 0.01 OUTLIER Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 101' ' ' GLY . 0.0 OUTLIER 179.79 -45.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.242 -1.152 . . . . 0.0 110.183 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.638 ' O ' ' C ' ' A' ' 104' ' ' ALA . 2.2 m80 -123.43 -91.75 0.54 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.244 -0.91 . . . . 0.0 110.157 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.816 ' HB1' ' HB ' ' A' ' 206' ' ' VAL . . . 0.64 115.59 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 121.38 0.61 . . . . 0.0 112.084 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.748 HG11 ' HA ' ' A' ' 134' ' ' ASP . 1.5 t -139.29 158.71 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.126 -0.984 . . . . 0.0 111.023 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.706 HG21 ' CE2' ' A' ' 95' ' ' TRP . 5.5 t -132.84 148.58 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.021 -1.049 . . . . 0.0 109.253 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.594 ' HA3' ' HA2' ' A' ' 132' ' ' GLY . . . 175.62 -156.89 22.83 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 118.916 -1.611 . . . . 0.0 111.658 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.569 HG13 ' CD1' ' A' ' 199' ' ' LEU . 2.4 t -135.8 150.48 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.727 -0.866 . . . . 0.0 109.494 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.545 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -120.36 152.94 37.18 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.066 -1.021 . . . . 0.0 110.933 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.544 ' CG2' ' HB3' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -125.76 130.08 50.76 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.277 -0.889 . . . . 0.0 110.491 179.828 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.465 ' O ' ' HD2' ' A' ' 114' ' ' PRO . . . -93.39 -27.79 16.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.53 -0.731 . . . . 0.0 109.539 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.458 HD13 ' O ' ' A' ' 196' ' ' GLY . 2.0 pp -83.4 -12.1 56.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.527 -0.733 . . . . 0.0 109.558 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.597 ' N ' ' HD2' ' A' ' 114' ' ' PRO . . . -47.12 -51.43 41.15 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.512 -0.742 . . . . 0.0 110.462 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 113' ' ' ALA . 45.3 Cg_endo -72.91 106.84 2.22 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.858 1.452 . . . . 0.0 110.469 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.581 HD23 ' CE1' ' A' ' 120' ' ' TYR . 2.2 tp 179.82 61.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.285 -0.884 . . . . 0.0 110.241 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -105.79 -29.93 9.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.281 -0.887 . . . . 0.0 110.2 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.519 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -65.64 168.27 7.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.357 -0.84 . . . . 0.0 110.227 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.519 ' C ' ' O ' ' A' ' 117' ' ' ALA . 32.3 t70 -33.39 151.76 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.449 -0.782 . . . . 0.0 110.697 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.44 ' C ' ' O ' ' A' ' 118' ' ' ASP . 16.1 m80 -41.85 131.48 3.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.342 -0.849 . . . . 0.0 110.173 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.581 ' CE1' HD23 ' A' ' 115' ' ' LEU . 33.3 p90 -82.13 133.26 35.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.363 -0.836 . . . . 0.0 110.274 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.425 ' O ' ' CB ' ' A' ' 122' ' ' ALA . . . -130.12 103.66 6.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.183 -0.948 . . . . 0.0 110.235 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.425 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . 64.15 16.33 9.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.252 -0.905 . . . . 0.0 110.187 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 125' ' ' GLY . 13.0 tp -103.1 -19.94 14.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.291 -0.881 . . . . 0.0 110.299 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.46 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 7.7 mt 56.89 -84.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.121 -0.987 . . . . 0.0 110.218 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 123' ' ' LEU . . . 132.33 135.62 3.7 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 38.4 p -95.61 27.81 3.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.298 -1.119 . . . . 0.0 110.206 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -129.01 178.67 6.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.924 . . . . 0.0 110.259 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.482 ' HA ' ' HG3' ' A' ' 114' ' ' PRO . 1.1 p -161.5 161.77 30.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.923 . . . . 0.0 110.148 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.557 ' CB ' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -137.98 123.3 19.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.194 -0.941 . . . . 0.0 109.974 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.445 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 8.4 t -142.29 139.52 31.9 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.279 -0.888 . . . . 0.0 110.112 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 8.4 m0 -124.62 128.51 48.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 108.929 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.594 ' HA2' ' HA3' ' A' ' 107' ' ' GLY . . . -127.05 -162.44 11.18 Favored Glycine 0 N--CA 1.484 1.846 0 C-N-CA 118.821 -1.657 . . . . 0.0 111.266 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.716 ' CZ3' ' CD1' ' A' ' 180' ' ' TYR . 6.4 m0 -126.14 118.12 24.58 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.766 -0.843 . . . . 0.0 110.723 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.748 ' HA ' HG11 ' A' ' 105' ' ' VAL . 13.5 t70 -118.68 111.57 18.69 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.599 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.593 HD13 ' N ' ' A' ' 135' ' ' ILE . 0.1 OUTLIER -79.3 4.92 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.156 -0.965 . . . . 0.0 110.315 179.41 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.542 ' N ' HD13 ' A' ' 135' ' ' ILE . . . -41.61 -25.54 0.2 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.501 ' O ' ' N ' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -79.97 4.88 15.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.982 -1.305 . . . . 0.0 110.284 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.544 ' O ' ' CG ' ' A' ' 139' ' ' LYS . . . 40.11 26.39 0.1 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.544 ' CG ' ' O ' ' A' ' 138' ' ' GLY . 12.8 mttp -166.39 -159.03 0.35 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.272 -1.134 . . . . 0.0 110.236 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.471 ' HA ' HG11 ' A' ' 162' ' ' VAL . 1.2 mp -133.87 -51.86 0.85 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.263 -0.898 . . . . 0.0 110.055 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.574 ' O ' ' CD2' ' A' ' 141' ' ' TYR . 33.1 p90 -166.18 107.66 0.72 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.315 -0.866 . . . . 0.0 110.036 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -90.85 38.82 0.96 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.306 -0.871 . . . . 0.0 110.298 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -101.71 -82.12 0.48 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 110.185 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.45 -172.91 3.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -0.89 . . . . 0.0 110.197 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -113.4 -162.05 0.79 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.195 -0.94 . . . . 0.0 110.202 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 113.75 149.18 10.17 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 148' ' ' GLU . 0.7 OUTLIER -96.33 22.38 7.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -1.161 . . . . 0.0 110.253 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 147' ' ' LEU . 31.5 tp10 179.94 122.8 0.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 110.208 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -50.96 107.92 0.93 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.174 -0.954 . . . . 0.0 110.126 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 46.2 Cg_endo -73.13 -12.92 25.91 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.982 1.517 . . . . 0.0 110.358 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -86.85 -85.55 0.16 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.317 -0.864 . . . . 0.0 110.185 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.567 ' CG ' ' HD2' ' A' ' 153' ' ' PRO . 0.1 OUTLIER -115.78 -178.62 0.53 Allowed Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 0.0 110.065 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.567 ' HD2' ' CG ' ' A' ' 152' ' ' TYR . 45.2 Cg_endo -72.8 111.16 3.19 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.877 1.462 . . . . 0.0 110.476 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.426 ' O ' ' C ' ' A' ' 155' ' ' GLY . . . -178.91 111.49 0.05 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.268 -0.895 . . . . 0.0 110.133 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 154' ' ' ALA . . . -42.75 132.28 5.01 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.46 -34.53 5.72 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.957 1.504 . . . . 0.0 110.49 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.505 ' HG2' ' CG ' ' A' ' 159' ' ' GLU . 0.1 OUTLIER -64.91 -6.79 9.15 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.235 -0.916 . . . . 0.0 110.404 -179.73 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 54.99 44.54 82.93 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.505 ' CG ' ' HG2' ' A' ' 157' ' ' GLN . 8.1 mt-10 -80.9 5.23 16.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.208 -1.172 . . . . 0.0 109.981 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.89 -16.6 30.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.353 -0.842 . . . . 0.0 109.3 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 133' ' ' TRP . 0.6 OUTLIER -172.68 26.89 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.706 0.765 . . . . 0.0 109.482 179.579 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.532 HG22 ' O ' ' A' ' 134' ' ' ASP . 2.4 t -161.23 91.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.585 -0.697 . . . . 0.0 110.141 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.75 ' CG1' ' HD2' ' A' ' 164' ' ' PRO . 1.3 t -85.81 155.9 58.5 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.339 -0.851 . . . . 0.0 109.069 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.75 ' HD2' ' CG1' ' A' ' 163' ' ' VAL . 39.2 Cg_endo -65.12 -177.54 0.63 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.557 1.293 . . . . 0.0 111.481 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.566 ' O ' ' OG ' ' A' ' 94' ' ' SER . 0.3 OUTLIER -40.49 -41.6 1.46 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.737 -0.602 . . . . 0.0 111.068 -179.086 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.49 ' C ' ' CD1' ' A' ' 167' ' ' LEU . 8.3 ttt-85 -146.83 155.99 42.77 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.231 -0.918 . . . . 0.0 110.767 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.678 ' N ' ' CD1' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -157.56 158.42 35.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.459 -0.775 . . . . 0.0 110.658 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.548 ' O ' ' O ' ' A' ' 181' ' ' SER . 0.6 OUTLIER -102.99 141.15 36.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.144 -0.972 . . . . 0.0 109.673 -179.758 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.652 ' CG2' ' CE1' ' A' ' 180' ' ' TYR . 9.3 t -119.25 139.52 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.078 -1.014 . . . . 0.0 111.107 -179.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 12.7 t -114.13 109.27 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.419 -0.8 . . . . 0.0 109.241 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.578 ' CD1' ' CD2' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -121.56 108.84 14.07 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.134 -0.979 . . . . 0.0 110.476 -179.225 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 36.9 t0 -120.21 132.69 55.46 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.799 0.809 . . . . 0.0 110.018 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.555 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 7.0 tpt -94.79 -37.72 11.11 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.847 -0.533 . . . . 0.0 109.642 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 173' ' ' MET . 3.9 mt-10 -43.65 -27.19 0.29 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.522 -0.871 . . . . 0.0 108.805 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.555 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.0 OUTLIER -112.25 -26.53 8.73 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.036 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.506 ' O ' HG23 ' A' ' 198' ' ' THR . . . 82.49 23.49 56.29 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.564 ' CG2' ' CD2' ' A' ' 194' ' ' LEU . 0.1 OUTLIER -120.26 124.14 44.92 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.139 -1.213 . . . . 0.0 111.189 -179.559 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.645 ' N ' ' CD1' ' A' ' 178' ' ' LEU . 2.3 mp -135.24 152.45 51.55 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.55 -0.719 . . . . 0.0 109.568 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.534 ' CA ' HD11 ' A' ' 187' ' ' LEU . . . -155.52 177.84 32.46 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.48 -1.343 . . . . 0.0 110.262 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.716 ' CD1' ' CZ3' ' A' ' 133' ' ' TRP . 0.5 OUTLIER -118.77 125.62 50.02 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.499 -1.0 . . . . 0.0 108.836 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.548 ' O ' ' O ' ' A' ' 168' ' ' LEU . 43.5 t -144.18 140.85 29.58 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.084 -1.01 . . . . 0.0 111.135 -179.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.514 HG23 ' HB3' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -95.66 116.33 37.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.478 -0.763 . . . . 0.0 109.319 179.056 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 87.97 -35.07 3.59 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 116.1 39.6 0.87 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 54.9 m -127.28 -5.42 6.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.21 -1.17 . . . . 0.0 110.725 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.531 ' CB ' ' HA ' ' A' ' 181' ' ' SER . 0.3 OUTLIER -85.05 -46.83 10.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.99 -1.069 . . . . 0.0 110.372 -179.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.601 ' O ' ' CE2' ' A' ' 191' ' ' PHE . 2.4 mt -82.09 41.98 0.7 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.181 -0.95 . . . . 0.0 110.024 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -79.89 -91.17 0.44 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.469 ' C ' ' H ' ' A' ' 191' ' ' PHE . 47.6 Cg_endo -73.56 -24.82 15.69 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.012 1.532 . . . . 0.0 110.772 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.525 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -69.07 21.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.48 -0.763 . . . . 0.0 111.7 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.601 ' CE2' ' O ' ' A' ' 187' ' ' LEU . 0.3 OUTLIER -90.27 -38.0 13.71 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.788 -1.195 . . . . 0.0 110.372 179.57 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.67 -13.57 60.64 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.145 -0.972 . . . . 0.0 110.495 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -107.81 -7.69 31.12 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.791 -1.723 . . . . 0.0 108.791 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.649 ' O ' ' N ' ' A' ' 198' ' ' THR . 10.5 tt -78.14 -36.52 47.63 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.584 ' CA ' HG21 ' A' ' 198' ' ' THR . 1.0 OUTLIER -44.07 -44.02 7.22 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.679 -0.638 . . . . 0.0 109.933 179.126 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.458 ' O ' HD13 ' A' ' 112' ' ' LEU . . . -83.29 -26.24 44.62 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.72 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.75 -3.69 57.24 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.699 -0.883 . . . . 0.0 109.934 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.649 ' N ' ' O ' ' A' ' 194' ' ' LEU . 11.2 p -42.73 135.12 3.02 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.825 0.821 . . . . 0.0 111.722 -177.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.72 ' HG ' ' O ' ' A' ' 197' ' ' ARG . 0.0 OUTLIER -140.15 171.0 14.8 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.68 -0.638 . . . . 0.0 109.381 179.454 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.516 ' HB3' ' HA3' ' A' ' 83' ' ' GLY . 25.1 m-85 -84.56 129.29 57.92 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 120.997 -1.064 . . . . 0.0 110.123 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.562 ' O ' ' CG ' ' A' ' 81' ' ' LYS . 52.8 Cg_endo -83.38 111.52 1.83 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.954 1.502 . . . . 0.0 110.78 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.837 ' HA ' ' C ' ' A' ' 81' ' ' LYS . 12.2 p -133.94 160.61 37.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 109.864 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.626 ' CG1' ' CA ' ' A' ' 80' ' ' GLY . 14.4 p -122.87 157.11 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.731 -1.23 . . . . 0.0 110.924 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 105' ' ' VAL . 0.3 OUTLIER -138.57 127.2 23.41 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.496 -0.752 . . . . 0.0 109.094 178.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.51 ' HA ' ' HB2' ' A' ' 104' ' ' ALA . . . -128.15 157.85 39.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.954 -1.091 . . . . 0.0 110.481 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.816 ' HB ' ' HB1' ' A' ' 104' ' ' ALA . 5.9 p -90.13 -137.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.193 -0.942 . . . . 0.0 110.103 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.638 ' CZ3' ' CB ' ' A' ' 72' ' ' ALA . 10.1 p90 -126.21 58.47 1.36 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.975 -1.078 . . . . 0.0 110.493 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 83.27 -1.54 88.54 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.54 ' CB ' HG11 ' A' ' 206' ' ' VAL . 3.0 tp60 -75.47 -33.21 60.81 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.486 -1.008 . . . . 0.0 110.257 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . 0.659 ' O ' ' C ' ' A' ' 211' ' ' GLN . 48.8 t -124.92 17.24 8.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.337 -0.852 . . . . 0.0 110.259 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.659 ' C ' ' O ' ' A' ' 210' ' ' CYS . 3.2 pt20 0.35 114.46 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.592 0.71 . . . . 0.0 111.859 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.592 HG22 ' CD1' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -118.99 145.19 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.441 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 0.665 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 20.1 mtm180 -88.61 151.51 22.43 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.094 -1.004 . . . . 0.0 110.144 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.629 ' HB ' ' CE3' ' A' ' 48' ' ' TRP . 0.8 OUTLIER -136.36 123.59 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.315 -0.865 . . . . 0.0 111.231 -179.023 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 92' ' ' GLU . 75.2 ttt180 -131.01 108.63 9.93 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . 0.69 ' CD2' ' CB ' ' A' ' 91' ' ' TRP . 3.2 t80 -118.45 148.94 42.06 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.001 -1.062 . . . . 0.0 111.454 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' MET . . . . . 0.551 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 0.0 OUTLIER -125.25 107.78 11.07 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.522 -0.736 . . . . 0.0 109.706 179.315 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 134.85 -1.61 3.9 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.463 ' OE1' ' O ' ' A' ' 220' ' ' ARG . 9.1 tm-20 -95.28 153.58 17.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.062 -1.258 . . . . 0.0 110.116 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . 0.463 ' O ' ' OE1' ' A' ' 219' ' ' GLU . 26.9 mmt180 -42.25 128.4 3.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.241 -0.912 . . . . 0.0 110.416 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . 0.522 ' O ' ' C ' ' A' ' 222' ' ' VAL . 36.7 ttt-85 -172.65 112.32 0.25 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 110.103 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.522 ' C ' ' O ' ' A' ' 221' ' ' ARG . 5.2 p -33.89 105.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.441 -0.787 . . . . 0.0 110.588 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.434 ' O ' ' HB3' ' A' ' 224' ' ' GLU . 29.9 tp10 -62.99 -9.94 11.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.307 -0.871 . . . . 0.0 110.344 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.453 ' O ' ' HB ' ' A' ' 225' ' ' THR . 2.6 pt-20 179.29 -30.18 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.185 -0.947 . . . . 0.0 110.296 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.453 ' HB ' ' O ' ' A' ' 224' ' ' GLU . 3.3 t 179.9 136.18 0.11 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.189 -0.944 . . . . 0.0 110.219 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.11 -153.4 0.07 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.277 -0.889 . . . . 0.0 110.2 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.99 -58.61 2.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -0.877 . . . . 0.0 110.258 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.51 ' O ' ' N ' ' A' ' 230' ' ' ARG . 33.1 mm -80.77 -57.74 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.219 -0.926 . . . . 0.0 110.237 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -60.73 77.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.222 -0.924 . . . . 0.0 110.137 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . 0.671 ' O ' ' C ' ' A' ' 231' ' ' ASP . 0.0 OUTLIER -49.74 159.52 0.37 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.342 -0.848 . . . . 0.0 110.262 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.671 ' C ' ' O ' ' A' ' 230' ' ' ARG . 3.3 m-20 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.952 -1.023 . . . . 0.0 111.479 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.43 164.28 12.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.192 -1.181 . . . . 0.0 110.144 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.37 32.02 4.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 0.0 110.198 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.35 132.88 44.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.881 . . . . 0.0 110.202 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.2 99.65 0.95 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.206 -0.933 . . . . 0.0 110.262 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -129.3 118.24 21.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.251 -0.906 . . . . 0.0 110.257 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.402 ' C ' ' OG1' ' A' ' 13' ' ' THR . 0.1 OUTLIER -78.33 116.23 18.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.314 -0.866 . . . . 0.0 110.23 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.575 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -178.06 -60.0 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.315 -0.865 . . . . 0.0 110.189 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.575 ' CD ' ' CB ' ' A' ' 13' ' ' THR . 45.6 Cg_endo -72.5 -44.03 0.84 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.051 1.553 . . . . 0.0 110.393 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 71.8 p -129.67 112.07 13.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.187 -0.946 . . . . 0.0 110.195 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.1 t -147.74 -178.77 6.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.901 . . . . 0.0 110.225 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.439 ' O ' ' HB1' ' A' ' 18' ' ' ALA . 1.7 tp60 -77.69 -71.01 0.44 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.352 -0.842 . . . . 0.0 110.246 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 17' ' ' GLN . . . -176.51 105.52 0.07 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.176 -0.953 . . . . 0.0 110.244 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.55 -154.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.179 -0.95 . . . . 0.0 110.271 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.446 ' CG ' ' N ' ' A' ' 21' ' ' SER . 25.1 t80 -108.8 -105.53 0.35 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.301 -0.875 . . . . 0.0 110.243 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.446 ' N ' ' CG ' ' A' ' 20' ' ' TYR . 0.7 OUTLIER -117.81 153.57 33.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.061 -1.025 . . . . 0.0 110.175 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 5.4 p-10 -174.38 40.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.284 -0.885 . . . . 0.0 110.29 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -46.58 -73.1 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.271 -0.893 . . . . 0.0 110.1 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.476 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 50.6 p -103.49 105.07 45.29 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.208 -0.932 . . . . 0.0 109.943 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.03 110.06 3.01 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.031 1.543 . . . . 0.0 110.649 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 24' ' ' SER . 46.0 Cg_endo -74.1 160.19 43.1 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.992 1.522 . . . . 0.0 110.489 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.461 ' O ' ' CG ' ' A' ' 27' ' ' GLU . 0.4 OUTLIER -124.3 35.08 4.89 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.458 -0.776 . . . . 0.0 109.707 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 32' ' ' LEU . . . 63.65 22.25 65.85 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.518 ' HG ' ' N ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -80.97 -54.32 5.67 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.428 -1.042 . . . . 0.0 109.852 -179.819 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.538 ' HG3' ' CB ' ' A' ' 73' ' ' GLN . 26.6 mt-10 -49.06 -47.83 44.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.119 -0.988 . . . . 0.0 109.304 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -61.07 -27.5 68.39 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 29' ' ' LEU . 5.9 tp -83.67 -29.36 27.68 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.666 ' C ' ' CD1' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -88.09 -36.52 16.87 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.722 0.772 . . . . 0.0 109.47 179.585 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.499 ' N ' HD11 ' A' ' 33' ' ' LEU . 11.6 p -45.84 -31.17 1.97 Allowed 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.683 0.754 . . . . 0.0 109.748 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.827 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . -91.46 167.21 16.16 Favored Pre-proline 0 C--N 1.298 -1.644 0 O-C-N 121.572 -0.705 . . . . 0.0 109.354 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.44 ' HD2' ' HB2' ' A' ' 35' ' ' ALA . 43.5 Cg_endo -70.18 99.01 0.76 Allowed 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.063 1.56 . . . . 0.0 110.431 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.827 ' HD3' ' O ' ' A' ' 35' ' ' ALA . 47.5 Cg_endo -96.6 -175.45 0.28 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 121.999 1.799 . . . . 0.0 110.397 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 1.017 ' O ' ' N ' ' A' ' 40' ' ' LEU . 39.6 Cg_endo -65.54 153.31 78.79 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.041 1.548 . . . . 0.0 110.043 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.67 ' O ' ' N ' ' A' ' 43' ' ' GLN . 1.9 t0 -15.29 -34.14 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.375 0.607 . . . . 0.0 110.143 -178.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 1.017 ' N ' ' O ' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -29.4 -46.78 0.06 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.435 -0.791 . . . . 0.0 109.551 178.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.632 ' HB ' ' HG2' ' A' ' 37' ' ' PRO . 0.9 OUTLIER -85.05 -31.5 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 118.657 -1.217 . . . . 0.0 109.94 179.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.628 ' N ' ' O ' ' A' ' 39' ' ' ASP . . . -89.89 -43.29 10.7 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.078 -1.014 . . . . 0.0 110.784 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.792 ' HG2' ' HA ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -72.23 -21.12 61.44 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.449 -0.782 . . . . 0.0 110.653 -179.13 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.743 ' HG2' ' HA ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -76.47 -55.31 5.65 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.627 ' CE1' ' O ' ' A' ' 41' ' ' VAL . 16.8 m170 -58.89 -18.21 31.06 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -97.82 -25.33 15.08 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.718 0.77 . . . . 0.0 109.259 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.458 ' HA3' HG21 ' A' ' 59' ' ' VAL . . . -63.85 -114.57 0.01 OUTLIER Glycine 0 N--CA 1.479 1.528 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.76 ' CE2' ' CD1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -103.26 70.88 1.08 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.492 -1.283 . . . . 0.0 111.052 179.208 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.571 ' ND2' ' HB3' ' A' ' 53' ' ' CYS . 1.0 OUTLIER -109.23 116.65 54.79 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.025 -1.047 . . . . 0.0 110.152 178.37 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.829 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 40.7 Cg_endo -69.07 -64.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 N-CA-C 109.432 -1.026 . . . . 0.0 109.432 178.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 1.046 ' HA ' ' CE ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER 175.49 35.22 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 O-C-N 120.976 -1.077 . . . . 0.0 112.02 177.752 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.853 ' HB2' ' HA2' ' A' ' 80' ' ' GLY 0.25 2.2 m-20 -168.58 20.78 0.02 OUTLIER 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.62 -179.451 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.694 ' SG ' ' NH1' ' A' ' 44' ' ' ARG . 1.7 t -102.23 144.57 30.59 Favored 'General case' 0 C--N 1.289 -2.03 0 C-N-CA 118.866 -1.134 . . . . 0.0 111.657 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.646 ' HB3' ' CG2' ' A' ' 75' ' ' THR . 0.0 OUTLIER -103.0 167.43 9.84 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.624 0.726 . . . . 0.0 109.954 179.306 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.743 ' HA ' ' HG2' ' A' ' 44' ' ' ARG . 0.9 OUTLIER -71.35 8.26 1.09 Allowed 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.592 -0.693 . . . . 0.0 111.211 -179.306 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.61 ' ND2' ' O ' ' A' ' 54' ' ' SER . 0.4 OUTLIER -29.02 -32.29 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.923 0.868 . . . . 0.0 109.474 179.414 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.728 ' N ' ' O ' ' A' ' 55' ' ' GLU . 3.7 pt -135.29 167.21 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.797 -0.565 . . . . 0.0 110.107 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.572 ' O ' ' CB ' ' A' ' 67' ' ' GLU . 3.4 t0 -109.01 113.04 25.57 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.038 -1.039 . . . . 0.0 110.61 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.732 ' HB ' ' CE2' ' A' ' 48' ' ' TRP . 1.2 m -129.78 135.8 60.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 O-C-N 121.49 -0.756 . . . . 0.0 109.086 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.792 ' HA ' ' HG2' ' A' ' 43' ' ' GLN . 9.0 tttm -128.68 155.31 45.24 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 118.826 -1.15 . . . . 0.0 112.29 -178.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.545 ' O ' ' C ' ' A' ' 62' ' ' GLY . 1.1 tt0 -71.54 -126.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.616 -0.677 . . . . 0.0 110.476 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.545 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 38.85 52.39 2.55 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 107.808 -2.117 . . . . 0.0 107.808 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.662 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 97.86 49.56 1.76 Allowed Glycine 0 N--CA 1.485 1.924 0 N-CA-C 107.113 -2.395 . . . . 0.0 107.113 -177.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.662 ' C ' ' O ' ' A' ' 63' ' ' GLY . 2.8 tt 1.54 93.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.719 0.771 . . . . 0.0 111.232 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 35.0 t -105.32 113.87 27.71 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.602 0.715 . . . . 0.0 110.364 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.76 ' CD1' ' CE2' ' A' ' 48' ' ' TRP . 3.2 m-85 -82.63 130.33 35.1 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.511 -0.743 . . . . 0.0 109.908 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.572 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 2.4 tm-20 -145.75 121.3 10.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.801 -1.187 . . . . 0.0 109.94 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.532 ' CB ' ' HB2' ' A' ' 207' ' ' TRP . 0.5 OUTLIER -126.03 155.3 41.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.371 -0.831 . . . . 0.0 109.404 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.694 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.8 OUTLIER -130.1 -72.52 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 120.89 -1.131 . . . . 0.0 110.875 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.694 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 57.1 Cg_endo -72.98 -126.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.434 1.228 . . . . 0.0 109.266 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.444 ' O ' ' OE1' ' A' ' 73' ' ' GLN . 2.4 t -140.31 164.24 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.574 -1.329 . . . . 0.0 109.962 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.516 ' CB ' ' HA ' ' A' ' 76' ' ' ASP . . . -59.84 94.24 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.17 -0.956 . . . . 0.0 110.266 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.538 ' CB ' ' HG3' ' A' ' 30' ' ' GLU . 1.2 mp0 -76.08 -90.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.18 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.49 ' OG ' ' N ' ' A' ' 75' ' ' THR . 1.5 t -44.04 -94.64 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.144 -0.972 . . . . 0.0 109.623 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.646 ' CG2' ' HB3' ' A' ' 54' ' ' SER . 7.6 t -88.57 -124.37 0.05 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.148 -0.97 . . . . 0.0 109.189 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.733 ' O ' ' C ' ' A' ' 77' ' ' GLY . 13.2 p30 -140.55 154.63 46.59 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.836 -1.165 . . . . 0.0 110.413 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.733 ' C ' ' O ' ' A' ' 76' ' ' ASP . . . 2.95 -78.2 0.0 OUTLIER Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.664 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 0.1 OUTLIER -158.16 137.42 3.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.507 -0.996 . . . . 0.0 110.389 179.185 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.848 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 0.7 OUTLIER -144.33 150.68 38.2 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.401 0.62 . . . . 0.0 109.779 179.711 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.853 ' HA2' ' HB2' ' A' ' 52' ' ' ASP . . . -165.32 116.23 0.68 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.572 -1.811 . . . . 0.0 108.572 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.597 ' O ' ' C ' ' A' ' 82' ' ' ARG . 4.7 ttpm? -124.59 -75.08 0.6 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.113 -1.227 . . . . 0.0 111.549 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.64 ' HG2' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -25.1 -47.38 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.504 -0.747 . . . . 0.0 111.11 -178.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.64 ' N ' ' HG2' ' A' ' 82' ' ' ARG . . . 34.24 58.95 0.65 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -93.85 108.25 20.05 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.426 -1.043 . . . . 0.0 110.645 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.508 ' CB ' ' HE3' ' A' ' 173' ' ' MET . 0.8 OUTLIER -140.0 162.87 34.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.432 -0.792 . . . . 0.0 110.002 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -118.67 137.91 52.98 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.233 -0.917 . . . . 0.0 109.931 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.511 ' O ' ' HB2' ' A' ' 173' ' ' MET . . . 111.2 158.59 15.32 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.541 HD13 ' CB ' ' A' ' 172' ' ' ASP . 18.6 tp -87.6 133.27 33.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -1.152 . . . . 0.0 110.19 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.493 ' ND1' ' O ' ' A' ' 88' ' ' LEU . 66.3 m-70 -147.11 173.08 12.82 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.135 -0.978 . . . . 0.0 110.064 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.553 ' O ' ' CB ' ' A' ' 217' ' ' MET . . . -154.03 139.99 18.26 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.203 -0.936 . . . . 0.0 109.64 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.554 ' HB3' ' HA ' ' A' ' 216' ' ' TYR . 0.0 OUTLIER -134.74 166.43 22.97 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.968 -1.083 . . . . 0.0 110.442 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.629 ' N ' ' O ' ' A' ' 215' ' ' ARG . 22.5 tt0 -115.16 138.63 50.69 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.545 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.524 ' O ' ' CB ' ' A' ' 167' ' ' LEU . 0.2 OUTLIER -144.02 134.99 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 120.625 -1.297 . . . . 0.0 110.765 -179.662 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.709 ' HB3' ' HA ' ' A' ' 166' ' ' ARG . 0.9 OUTLIER -118.68 126.38 51.79 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.477 -0.764 . . . . 0.0 109.537 179.421 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.746 ' CE3' ' CG1' ' A' ' 106' ' ' VAL . 2.8 t90 -129.9 87.62 51.37 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.179 -0.95 . . . . 0.0 109.93 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.495 ' HA ' ' HA ' ' A' ' 164' ' ' PRO . 51.6 Cg_endo -95.7 109.15 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.776 1.651 . . . . 0.0 110.742 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.559 HD21 ' N ' ' A' ' 101' ' ' GLY . 5.7 tt -96.15 -22.03 17.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.968 -1.083 . . . . 0.0 110.285 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -44.88 -30.07 0.92 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.348 -0.845 . . . . 0.0 110.686 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.499 ' O ' ' NE ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -94.99 7.06 47.28 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.094 -1.004 . . . . 0.0 110.451 -179.816 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.607 ' CB ' ' HA ' ' A' ' 210' ' ' CYS . 0.9 OUTLIER -134.94 -115.02 0.19 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.145 -0.972 . . . . 0.0 110.322 -179.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.559 ' N ' HD21 ' A' ' 97' ' ' LEU . . . -166.77 156.81 28.93 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.554 ' CB ' ' HA2' ' A' ' 136' ' ' GLY . 0.7 OUTLIER -38.69 139.94 0.39 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.429 -1.042 . . . . 0.0 110.366 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.692 ' CG ' ' N ' ' A' ' 104' ' ' ALA . 0.5 OUTLIER -178.28 -146.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.072 -1.018 . . . . 0.0 111.376 179.817 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.926 ' CB ' ' HA ' ' A' ' 205' ' ' ALA . . . -38.85 168.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.797 0.808 . . . . 0.0 112.503 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.644 ' CG2' ' HA ' ' A' ' 134' ' ' ASP . 0.6 OUTLIER -137.93 159.6 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.665 -0.647 . . . . 0.0 111.912 -178.346 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.746 ' CG1' ' CE3' ' A' ' 95' ' ' TRP . 1.3 p -132.52 141.71 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.935 -1.103 . . . . 0.0 109.999 177.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.554 ' HA3' ' HA3' ' A' ' 132' ' ' GLY . . . 160.93 -149.1 17.89 Favored Glycine 0 N--CA 1.487 2.061 0 C-N-CA 119.628 -1.273 . . . . 0.0 109.959 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 200' ' ' TYR . 1.6 p -148.73 161.3 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.385 -1.068 . . . . 0.0 110.157 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.512 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -133.75 152.24 51.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.129 -0.982 . . . . 0.0 110.714 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.627 ' CG2' ' HB3' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -105.98 128.62 53.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.846 . . . . 0.0 109.862 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.74 -27.2 17.37 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.541 -0.725 . . . . 0.0 109.71 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.521 ' O ' ' HD3' ' A' ' 114' ' ' PRO . 3.8 pp -83.95 -12.1 55.87 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.512 -0.742 . . . . 0.0 109.538 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 112' ' ' LEU . . . -35.29 95.34 0.09 OUTLIER Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.72 -0.612 . . . . 0.0 110.625 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 112' ' ' LEU . 50.9 Cg_endo -77.92 -96.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.077 1.567 . . . . 0.0 110.329 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 114' ' ' PRO . 3.8 tp 179.71 49.3 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.118 -0.989 . . . . 0.0 110.108 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' A' ' 118' ' ' ASP . 6.0 tt0 -64.04 -37.17 86.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.177 -0.952 . . . . 0.0 110.202 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.542 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -60.91 79.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.346 -0.846 . . . . 0.0 110.202 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.542 ' C ' ' O ' ' A' ' 117' ' ' ALA . 13.5 t70 -31.67 -63.01 0.18 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.46 -0.775 . . . . 0.0 110.743 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.0 OUTLIER 60.79 135.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.291 -0.88 . . . . 0.0 110.203 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -81.54 -77.99 0.2 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -0.922 . . . . 0.0 110.19 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.5 84.61 0.1 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.227 -0.92 . . . . 0.0 110.185 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.31 136.04 6.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.193 -0.942 . . . . 0.0 110.19 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.3 mp -87.39 -154.45 0.25 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 110.185 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 33.3 mt -106.51 158.53 16.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 110.254 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -158.96 156.9 27.95 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.14 23.16 1.35 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.174 -1.192 . . . . 0.0 110.233 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -85.94 -138.07 0.08 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.218 -0.926 . . . . 0.0 110.145 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 57.7 m -116.7 -165.42 1.06 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.113 -0.992 . . . . 0.0 110.218 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 110' ' ' THR . 6.5 tm-20 -150.07 129.42 12.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.916 . . . . 0.0 110.051 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.476 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 6.9 t -121.14 120.71 36.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.259 -0.901 . . . . 0.0 110.203 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . 0.493 ' O ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -128.86 124.74 36.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.288 -0.883 . . . . 0.0 109.915 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.554 ' HA3' ' HA3' ' A' ' 107' ' ' GLY . . . -172.35 -160.01 20.01 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.591 ' CZ3' HD11 ' A' ' 167' ' ' LEU . 33.9 m0 -109.27 115.09 29.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.214 -1.168 . . . . 0.0 110.192 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.644 ' HA ' ' CG2' ' A' ' 105' ' ' VAL . 4.1 t70 -118.31 148.08 42.83 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.416 0.627 . . . . 0.0 110.536 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.522 ' CG2' HG22 ' A' ' 162' ' ' VAL . 0.3 OUTLIER -143.52 17.59 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.504 -0.748 . . . . 0.0 109.404 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.554 ' HA2' ' CB ' ' A' ' 102' ' ' THR . . . -115.53 -40.54 0.85 Allowed Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.451 ' O ' ' C ' ' A' ' 138' ' ' GLY . 0.0 OUTLIER -90.7 8.03 36.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.076 -1.249 . . . . 0.0 110.02 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.531 ' O ' ' O ' ' A' ' 139' ' ' LYS . . . 41.4 45.87 4.35 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.531 ' O ' ' O ' ' A' ' 138' ' ' GLY . 2.2 mmmp? -52.23 -164.24 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.506 -0.997 . . . . 0.0 110.593 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.98 64.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 110.386 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.554 ' HA ' ' CD2' ' A' ' 161' ' ' LEU . 29.6 p90 -80.2 8.3 7.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.916 . . . . 0.0 110.284 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.558 ' O ' ' CG ' ' A' ' 142' ' ' HIS . 13.9 p80 -137.88 79.16 1.73 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.93 . . . . 0.0 110.151 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -64.32 -57.45 9.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.979 . . . . 0.0 110.297 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.67 165.33 14.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 110.265 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.08 8.52 44.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.163 -0.961 . . . . 0.0 110.205 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.23 -130.72 3.11 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.485 ' O ' ' HD2' ' A' ' 150' ' ' PRO . 0.3 OUTLIER -174.0 80.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.19 -1.183 . . . . 0.0 110.145 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.46 ' OE1' ' HB2' ' A' ' 157' ' ' GLN . 3.0 mt-10 -62.62 108.99 1.26 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.301 -0.874 . . . . 0.0 110.369 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.583 ' CB ' ' CD ' ' A' ' 150' ' ' PRO . . . 179.91 -60.88 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.218 -0.926 . . . . 0.0 110.327 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 149' ' ' ALA . 47.5 Cg_endo -73.04 -10.53 24.66 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 124.016 1.535 . . . . 0.0 110.605 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.431 ' O ' ' CD2' ' A' ' 152' ' ' TYR . 2.8 mp0 -55.03 -62.87 1.38 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.163 -0.961 . . . . 0.0 110.176 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.516 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 0.2 OUTLIER 179.84 -57.67 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 110.081 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.516 ' CD ' ' CB ' ' A' ' 152' ' ' TYR . 46.8 Cg_endo -73.21 144.62 37.58 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.949 1.5 . . . . 0.0 110.199 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 155' ' ' GLY . . . -41.6 127.03 3.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.221 -0.924 . . . . 0.0 110.081 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.463 ' C ' ' O ' ' A' ' 154' ' ' ALA . . . -40.36 107.5 0.08 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' A' ' 148' ' ' GLU . 45.2 Cg_endo -71.72 -41.36 2.25 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.925 1.487 . . . . 0.0 110.47 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.465 ' HA ' ' HG3' ' A' ' 160' ' ' GLN . 1.2 tp60 -67.27 -3.55 8.25 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.282 -0.886 . . . . 0.0 110.392 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.415 ' O ' ' HB ' ' A' ' 162' ' ' VAL . . . -81.43 -55.3 3.26 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -82.61 6.52 17.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -1.163 . . . . 0.0 110.253 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.465 ' HG3' ' HA ' ' A' ' 157' ' ' GLN . 3.1 mm-40 -68.3 -17.39 64.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.897 . . . . 0.0 109.269 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.554 ' CD2' ' HA ' ' A' ' 141' ' ' TYR . 1.0 OUTLIER -166.78 24.94 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.704 0.764 . . . . 0.0 109.363 179.454 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.55 ' CG1' ' O ' ' A' ' 162' ' ' VAL . 2.4 t -158.8 85.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.401 0.619 . . . . 0.0 109.825 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.535 ' CG2' HD23 ' A' ' 167' ' ' LEU . 0.2 OUTLIER -117.97 86.96 26.7 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.429 -0.794 . . . . 0.0 109.671 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.495 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 45.4 Cg_endo -72.26 65.97 3.53 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.086 1.571 . . . . 0.0 110.852 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 164' ' ' PRO . 3.6 mt-10 -167.26 -85.74 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.319 -0.863 . . . . 0.0 109.854 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.709 ' HA ' ' HB3' ' A' ' 94' ' ' SER . 23.6 ttp180 -152.65 156.22 38.82 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.367 -0.833 . . . . 0.0 110.29 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.591 HD11 ' CZ3' ' A' ' 133' ' ' TRP . 0.2 OUTLIER -139.8 133.91 31.03 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.272 -0.892 . . . . 0.0 110.7 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.411 ' O ' ' O ' ' A' ' 181' ' ' SER . 0.4 OUTLIER -103.83 130.78 51.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.329 -0.857 . . . . 0.0 109.228 179.285 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.651 ' CG2' ' CE1' ' A' ' 180' ' ' TYR . 2.7 t -124.57 144.47 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.966 -1.084 . . . . 0.0 111.087 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.472 HG23 ' CD2' ' A' ' 187' ' ' LEU . 2.3 t -119.84 129.31 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.555 -0.716 . . . . 0.0 109.079 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.517 ' CD1' ' HB3' ' A' ' 178' ' ' LEU . 12.4 tp -133.09 109.82 9.77 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.93 -1.106 . . . . 0.0 110.808 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.541 ' CB ' HD13 ' A' ' 88' ' ' LEU . 5.2 t0 -99.51 139.08 35.7 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.393 -0.817 . . . . 0.0 109.203 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.511 ' HB2' ' O ' ' A' ' 87' ' ' GLY . 23.9 mmt -98.95 -44.62 6.26 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.227 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.522 ' HG2' ' N ' ' A' ' 175' ' ' GLU . 3.8 pt-20 -43.48 -24.96 0.12 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.12 -0.987 . . . . 0.0 108.565 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.522 ' N ' ' HG2' ' A' ' 174' ' ' GLU . 3.5 tp10 -115.12 -26.28 7.75 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.506 ' O ' ' OG1' ' A' ' 198' ' ' THR . . . 78.06 27.24 58.56 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.58 HG23 ' HB ' ' A' ' 198' ' ' THR . 1.4 p -113.09 139.94 48.29 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.414 -1.051 . . . . 0.0 111.313 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.545 ' CD1' HG22 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -146.62 154.05 41.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.533 -0.729 . . . . 0.0 109.73 179.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.463 ' CA ' HD22 ' A' ' 187' ' ' LEU . . . -141.52 163.69 26.79 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.651 ' CE1' ' CG2' ' A' ' 169' ' ' VAL . 0.9 OUTLIER -118.63 118.31 31.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -1.146 . . . . 0.0 109.484 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.538 ' CB ' ' HB2' ' A' ' 186' ' ' TYR . 2.7 t -144.64 159.05 43.45 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.33 -0.856 . . . . 0.0 110.085 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.581 HD13 ' CD2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -96.08 116.4 37.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.443 -0.785 . . . . 0.0 109.316 179.191 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 72.76 5.71 65.15 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.86 43.31 18.08 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' THR . . . . . 0.494 ' N ' ' OG ' ' A' ' 181' ' ' SER . 95.4 m -116.18 -1.38 12.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.199 -1.177 . . . . 0.0 110.561 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.581 ' CD2' HD13 ' A' ' 182' ' ' ILE . 0.1 OUTLIER -111.22 -25.08 9.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.153 -0.967 . . . . 0.0 110.359 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.602 ' O ' ' CE2' ' A' ' 191' ' ' PHE . 4.0 mp -84.46 48.29 1.49 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.252 -0.905 . . . . 0.0 110.105 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -106.86 -73.51 0.85 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.6 -29.31 13.29 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.979 1.515 . . . . 0.0 111.167 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.645 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -73.42 12.27 0.63 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.267 -0.896 . . . . 0.0 111.429 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.602 ' CE2' ' O ' ' A' ' 187' ' ' LEU . 0.3 OUTLIER -90.17 -10.68 43.58 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.141 -0.974 . . . . 0.0 109.802 179.132 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.74 -20.22 27.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.381 -0.824 . . . . 0.0 110.908 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.534 ' O ' ' HB3' ' A' ' 197' ' ' ARG . . . -111.15 -13.32 13.67 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.645 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 3.7 tt -74.56 -19.99 60.12 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.496 ' O ' HG23 ' A' ' 198' ' ' THR . 0.0 OUTLIER -59.64 -32.08 70.11 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.715 -0.615 . . . . 0.0 109.53 179.119 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -106.83 -25.36 6.24 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.592 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -82.93 -3.3 56.88 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.855 0.836 . . . . 0.0 109.944 179.653 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.58 ' HB ' HG23 ' A' ' 177' ' ' THR . 0.4 OUTLIER -41.0 136.85 1.38 Allowed 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 122.096 0.951 . . . . 0.0 111.24 -178.1 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.665 ' CD1' ' CG2' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -141.85 171.31 14.23 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.372 -179.653 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.725 ' O ' HG23 ' A' ' 108' ' ' VAL . 97.1 m-85 -86.84 129.7 51.39 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.15 -0.969 . . . . 0.0 109.523 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.52 ' HA ' ' HB ' ' A' ' 108' ' ' VAL . 42.0 Cg_endo -68.24 121.12 8.08 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.863 1.454 . . . . 0.0 111.19 -179.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.577 ' CB ' ' HA ' ' A' ' 81' ' ' LYS . 97.0 p -133.81 142.06 47.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.342 -0.849 . . . . 0.0 110.939 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.644 HG23 ' CG2' ' A' ' 106' ' ' VAL . 1.1 p -146.4 160.51 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.391 -0.818 . . . . 0.0 109.391 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' SER . . . . . 0.535 ' O ' ' CB ' ' A' ' 104' ' ' ALA . 0.3 OUTLIER -160.35 127.19 4.3 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.415 -0.803 . . . . 0.0 109.645 179.683 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.926 ' HA ' ' CB ' ' A' ' 104' ' ' ALA . . . -114.13 162.1 16.92 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.834 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.585 ' CG1' ' N ' ' A' ' 207' ' ' TRP . 1.1 t -105.69 -179.13 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.587 -0.696 . . . . 0.0 110.47 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.585 ' N ' ' CG1' ' A' ' 206' ' ' VAL . 23.0 p90 -94.14 -33.07 13.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.332 -0.855 . . . . 0.0 110.593 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 207' ' ' TRP . . . -44.21 171.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 211' ' ' GLN . 0.0 OUTLIER -40.58 -49.24 2.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.35 -1.088 . . . . 0.0 110.572 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . 0.651 ' HB2' ' CG ' ' A' ' 103' ' ' HIS . 6.9 p -36.83 93.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.461 -0.774 . . . . 0.0 110.436 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.526 ' N ' ' O ' ' A' ' 209' ' ' GLN . 2.1 pt20 -115.41 123.69 49.29 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.233 -0.917 . . . . 0.0 110.107 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.647 ' O ' ' CZ ' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -101.53 144.52 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.599 -0.688 . . . . 0.0 109.701 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 0.662 ' HB2' ' HB2' ' A' ' 94' ' ' SER . 0.0 OUTLIER -87.64 159.57 18.49 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.194 -0.941 . . . . 0.0 110.279 -179.078 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.673 HD12 ' CA ' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -138.33 124.65 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -0.944 . . . . 0.0 111.362 -178.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.629 ' O ' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -130.94 137.49 49.31 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . 0.554 ' HA ' ' HB3' ' A' ' 91' ' ' TRP . 5.5 t80 -119.35 150.64 39.82 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.792 -1.192 . . . . 0.0 111.121 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' MET . . . . . 0.553 ' CB ' ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -131.05 107.95 9.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.354 -0.841 . . . . 0.0 110.044 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 72.47 85.18 0.22 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.514 ' HG3' ' CZ ' ' A' ' 216' ' ' TYR . 31.4 tt0 -111.74 157.81 20.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.285 -1.127 . . . . 0.0 110.14 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . 0.484 ' HG3' ' N ' ' A' ' 221' ' ' ARG . 0.1 OUTLIER -114.21 148.94 36.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.915 . . . . 0.0 110.342 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . 0.55 ' O ' ' N ' ' A' ' 223' ' ' GLU . 1.4 mpp_? -136.23 82.84 1.97 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.335 -0.853 . . . . 0.0 110.091 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.47 ' C ' ' O ' ' A' ' 221' ' ' ARG . 5.3 p -34.72 92.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.515 -0.741 . . . . 0.0 110.816 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 221' ' ' ARG . 1.5 mm-40 -78.96 -81.54 0.11 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.244 -0.91 . . . . 0.0 110.22 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.52 ' HB2' ' O ' ' A' ' 223' ' ' GLU . 0.8 OUTLIER 179.36 41.49 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.304 -0.872 . . . . 0.0 110.168 179.549 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.434 ' O ' ' CG ' ' A' ' 226' ' ' ARG . 0.0 OUTLIER -42.74 107.31 0.08 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.322 -0.861 . . . . 0.0 110.332 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.434 ' CG ' ' O ' ' A' ' 225' ' ' THR . 0.0 OUTLIER -179.97 85.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.21 -0.931 . . . . 0.0 110.21 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -165.53 -62.85 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.384 -0.822 . . . . 0.0 110.213 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 27.9 mm -104.1 85.52 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.355 -0.841 . . . . 0.0 110.292 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -110.36 168.48 9.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.328 -0.857 . . . . 0.0 110.105 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . 0.671 ' O ' ' C ' ' A' ' 231' ' ' ASP . 4.3 mtp180 -45.21 -46.07 12.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.363 -0.836 . . . . 0.0 110.236 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.671 ' C ' ' O ' ' A' ' 230' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.974 -1.012 . . . . 0.0 111.494 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.447 ' OG ' ' N ' ' A' ' 8' ' ' SER . 54.3 p -79.82 -59.65 2.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.213 -1.169 . . . . 0.0 110.204 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.447 ' N ' ' OG ' ' A' ' 7' ' ' SER . 23.9 p -77.58 55.46 1.31 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 110.235 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.81 -150.12 0.46 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.173 -0.954 . . . . 0.0 110.215 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -143.14 160.37 40.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.917 . . . . 0.0 110.163 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -103.38 76.57 1.44 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.195 -0.941 . . . . 0.0 110.221 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.75 123.06 18.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 110.211 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.515 ' O ' ' CG2' ' A' ' 13' ' ' THR . 14.9 t -95.35 116.08 66.0 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.21 -0.931 . . . . 0.0 110.186 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.03 147.99 44.18 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.98 1.516 . . . . 0.0 110.47 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.1 p -151.06 139.96 20.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 110.201 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.85 171.13 13.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.375 -0.828 . . . . 0.0 110.274 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -133.78 126.65 31.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.0 110.206 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.9 152.8 41.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.239 -0.913 . . . . 0.0 110.2 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.8 -159.54 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.257 -0.902 . . . . 0.0 110.197 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.79 -146.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 110.128 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.2 t -119.13 50.07 1.26 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.229 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -82.31 44.37 0.87 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.354 -0.841 . . . . 0.0 110.376 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.474 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -111.62 -66.89 1.04 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.09 -1.006 . . . . 0.0 110.126 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.02 110.06 27.72 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.464 -0.773 . . . . 0.0 110.162 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 23' ' ' PHE . 46.6 Cg_endo -72.97 174.47 11.9 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.957 1.504 . . . . 0.0 110.439 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 25' ' ' PRO . 46.6 Cg_endo -73.32 166.43 29.94 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.019 1.536 . . . . 0.0 110.362 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.7 mp0 -128.67 35.6 4.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.242 -0.911 . . . . 0.0 110.246 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.459 ' O ' ' HG2' ' A' ' 31' ' ' GLU . . . 78.21 19.1 75.21 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.514 HD21 ' NE2' ' A' ' 73' ' ' GLN . 0.1 OUTLIER -49.56 -32.54 12.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.284 -1.127 . . . . 0.0 109.771 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.546 ' HA ' ' CD2' ' A' ' 33' ' ' LEU . 6.4 tm-20 -47.61 -35.47 9.31 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.294 -0.879 . . . . 0.0 109.356 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 28' ' ' GLY . 16.5 pt-20 -60.49 -24.99 65.73 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.277 -0.889 . . . . 0.0 108.856 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -83.35 -33.87 25.74 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.594 ' CD2' ' HG3' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -78.72 -36.65 43.01 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.861 0.839 . . . . 0.0 109.311 179.274 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.574 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 1.2 t -80.74 -7.39 59.35 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 121.171 0.51 . . . . 0.0 109.937 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.635 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . . . -37.96 -65.32 0.37 Allowed Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.44 -0.787 . . . . 0.0 110.538 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.722 ' C ' ' HD3' ' A' ' 38' ' ' PRO . 47.8 Cg_endo -73.25 143.05 34.78 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.773 1.407 . . . . 0.0 109.928 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -98.58 53.32 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 121.813 1.675 . . . . 0.0 112.568 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.722 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 52.5 Cg_endo -77.1 150.3 29.35 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 122.89 0.942 . . . . 0.0 109.845 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.664 ' C ' ' NE2' ' A' ' 43' ' ' GLN . 2.1 t0 -39.71 -32.56 0.15 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.056 -1.028 . . . . 0.0 108.81 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.725 ' O ' ' CB ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -40.95 -45.22 2.52 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.314 0.578 . . . . 0.0 109.628 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.643 ' N ' ' CD1' ' A' ' 40' ' ' LEU . 10.0 t -68.01 -26.82 35.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.017 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 39' ' ' ASP . . . -89.41 -43.94 10.53 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.018 -1.051 . . . . 0.0 111.703 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.665 ' O ' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -80.59 -24.77 38.93 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.24 -1.384 . . . . 0.0 108.929 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.725 ' CB ' ' O ' ' A' ' 40' ' ' LEU . 21.4 ttt-85 -64.28 -57.71 8.64 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.222 1.011 . . . . 0.0 108.739 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.68 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 54.3 m170 -53.57 -17.26 1.97 Allowed 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.703 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -95.9 -31.75 12.97 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.132 -1.427 . . . . 0.0 111.155 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.61 -60.26 0.51 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 106.845 -2.502 . . . . 0.0 106.845 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 1.07 ' CD1' HG22 ' A' ' 59' ' ' VAL 0.267 0.3 OUTLIER -98.37 71.27 2.04 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.171 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.795 ' O ' ' HB3' ' A' ' 53' ' ' CYS . 0.0 OUTLIER -61.91 168.31 3.77 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.701 -0.624 . . . . 0.0 112.104 -178.874 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.693 ' O ' ' O ' ' A' ' 53' ' ' CYS . 37.4 Cg_endo -61.38 -61.37 0.17 Allowed 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 121.572 1.515 . . . . 0.0 113.17 -178.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.771 ' HE2' ' OD1' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -67.67 -74.35 0.12 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.045 -1.659 . . . . 0.0 108.323 179.745 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.719 ' N ' ' HA3' ' A' ' 80' ' ' GLY . 0.9 OUTLIER -38.12 -27.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.203 -0.936 . . . . 0.0 109.529 179.15 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.795 ' HB3' ' O ' ' A' ' 49' ' ' ASN . 0.2 OUTLIER -138.48 129.99 27.6 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 118.736 -1.186 . . . . 0.0 111.951 -179.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.92 ' H ' ' HA ' ' A' ' 78' ' ' VAL . 0.9 OUTLIER -58.28 123.5 16.28 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.2 179.278 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.594 ' HG3' ' CD2' ' A' ' 33' ' ' LEU . 3.6 pt-20 -69.78 -24.48 63.51 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.439 -0.788 . . . . 0.0 109.693 179.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.737 ' ND2' ' HB3' ' A' ' 54' ' ' SER . 3.7 m-80 -28.96 -36.03 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.683 0.754 . . . . 0.0 110.874 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.586 ' N ' ' O ' ' A' ' 55' ' ' GLU . 2.6 pt -116.66 166.69 10.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 O-C-N 121.705 -0.622 . . . . 0.0 110.773 -178.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.521 ' OD1' ' CG ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -107.59 116.16 31.44 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 1.07 HG22 ' CD1' ' A' ' 48' ' ' TRP . 6.3 p -130.01 128.72 65.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 CA-C-O 121.409 0.623 . . . . 0.0 111.55 -178.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.692 ' HG2' ' N ' ' A' ' 61' ' ' GLU . 5.2 tttm -136.96 157.92 45.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.342 -0.849 . . . . 0.0 110.715 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.788 ' N ' ' CH2' ' A' ' 48' ' ' TRP . 19.0 tp10 -42.54 -111.65 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.678 -0.639 . . . . 0.0 111.238 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.56 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 36.67 45.78 1.05 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.669 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 93.14 55.58 1.58 Allowed Glycine 0 N--CA 1.487 2.058 0 N-CA-C 107.369 -2.292 . . . . 0.0 107.369 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.669 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.2 OUTLIER 1.11 92.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.792 0.806 . . . . 0.0 111.182 -178.216 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.508 ' C ' HG23 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -140.66 134.88 31.06 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.542 -179.787 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.819 ' CE2' ' HD1' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -102.18 142.79 32.87 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.142 178.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.555 ' O ' ' HB ' ' A' ' 57' ' ' ILE . 67.9 tt0 -114.38 121.32 43.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 110.174 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.496 ' HB2' HG23 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -121.23 149.8 42.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.477 -0.764 . . . . 0.0 109.966 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.678 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -127.89 -71.37 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.063 -1.023 . . . . 0.0 110.797 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.678 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 55.8 Cg_endo -73.86 -108.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.35 1.184 . . . . 0.0 110.177 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.9 t -140.48 164.35 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.638 -1.289 . . . . 0.0 110.27 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.407 ' HA ' ' HB3' ' A' ' 56' ' ' ASN . . . -99.63 87.58 3.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -0.867 . . . . 0.0 109.931 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.551 ' CG ' ' N ' ' A' ' 74' ' ' SER . 2.5 pt20 -70.39 -44.58 67.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.258 -0.901 . . . . 0.0 110.642 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.551 ' N ' ' CG ' ' A' ' 73' ' ' GLN . 0.4 OUTLIER -55.84 -74.8 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.161 -0.962 . . . . 0.0 109.969 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.704 HG23 ' HB3' ' A' ' 54' ' ' SER . 0.3 OUTLIER -129.61 -140.37 0.23 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.308 -0.87 . . . . 0.0 109.405 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.666 ' O ' ' N ' ' A' ' 78' ' ' VAL . 22.7 p-10 -141.1 154.75 46.07 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.976 -1.077 . . . . 0.0 110.788 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.631 ' O ' ' CG1' ' A' ' 78' ' ' VAL . . . 34.78 -95.16 0.01 OUTLIER Glycine 0 N--CA 1.487 2.055 0 N-CA-C 106.715 -2.554 . . . . 0.0 106.715 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.92 ' HA ' ' H ' ' A' ' 54' ' ' SER . 31.0 m -158.2 119.42 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 O-C-N 121.872 -0.781 . . . . 0.0 109.823 176.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.69 ' O ' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -147.32 133.87 19.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.361 -0.837 . . . . 0.0 110.982 -179.147 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.719 ' HA3' ' N ' ' A' ' 52' ' ' ASP . . . -143.36 166.14 26.88 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 178.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 0.7 OUTLIER -140.2 75.62 1.52 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.345 -1.091 . . . . 0.0 110.078 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.531 ' CZ ' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -145.53 -108.73 0.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.312 -0.867 . . . . 0.0 110.128 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.531 ' N ' ' CZ ' ' A' ' 82' ' ' ARG . . . 70.42 80.78 0.28 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -134.24 104.38 6.15 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.285 -1.127 . . . . 0.0 110.21 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.577 ' HB2' ' CE1' ' A' ' 89' ' ' HIS . 11.4 p -140.03 164.87 28.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.153 -0.967 . . . . 0.0 110.255 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.451 ' HA ' ' CG ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -119.75 135.93 54.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.295 -0.878 . . . . 0.0 109.972 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.34 -119.94 5.15 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.488 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 7.8 tp -128.33 138.1 52.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -1.147 . . . . 0.0 110.327 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.577 ' CE1' ' HB2' ' A' ' 85' ' ' SER . 43.2 m-70 -147.06 164.81 31.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.273 -0.892 . . . . 0.0 109.992 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.607 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -163.13 152.95 15.55 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.191 -0.943 . . . . 0.0 110.302 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.715 ' CD1' ' CZ ' ' A' ' 216' ' ' TYR . 0.0 OUTLIER -134.62 170.34 15.94 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.079 -1.013 . . . . 0.0 109.891 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.659 ' N ' ' O ' ' A' ' 215' ' ' ARG . 0.6 OUTLIER -140.62 147.54 39.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.368 -0.832 . . . . 0.0 110.672 -179.505 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.554 ' CD1' HG13 ' A' ' 214' ' ' ILE . 2.2 mm -144.68 154.25 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.34 -0.85 . . . . 0.0 110.024 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.72 ' O ' ' HD3' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -151.2 124.38 8.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.338 -0.851 . . . . 0.0 109.614 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.666 ' CZ3' ' CE1' ' A' ' 103' ' ' HIS . 34.6 m95 -106.84 89.42 4.32 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.267 -0.896 . . . . 0.0 110.561 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.72 ' HD3' ' O ' ' A' ' 94' ' ' SER . 52.7 Cg_endo -91.92 124.37 0.76 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.496 1.464 . . . . 0.0 111.013 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.503 ' O ' HD12 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -95.45 -5.98 41.8 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.277 -0.889 . . . . 0.0 109.599 179.198 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 97' ' ' LEU . 2.7 tp10 -37.35 -45.36 0.68 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.347 -0.845 . . . . 0.0 111.963 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.537 ' C ' ' HG2' ' A' ' 100' ' ' ARG . 33.2 tt0 -125.58 -114.1 0.29 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.657 -1.277 . . . . 0.0 110.848 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.554 ' O ' ' N ' ' A' ' 211' ' ' GLN . 13.0 mmt85 -152.11 -134.3 0.05 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.27 -0.894 . . . . 0.0 110.226 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.498 ' HA3' ' HB2' ' A' ' 211' ' ' GLN . . . 95.69 173.82 36.6 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.707 ' HB ' ' CD1' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -60.19 -143.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.017 -1.284 . . . . 0.0 109.907 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.666 ' CE1' ' CZ3' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -154.92 -166.08 2.21 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.768 -1.208 . . . . 0.0 111.575 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.781 ' HA ' ' CB ' ' A' ' 205' ' ' ALA . . . -177.1 90.64 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.63 -0.669 . . . . 0.0 110.001 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.817 ' CG1' ' HA ' ' A' ' 134' ' ' ASP . 0.6 OUTLIER -94.01 152.09 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.615 HG12 ' CZ ' ' A' ' 180' ' ' TYR . 4.9 p -145.85 167.5 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 120.416 -1.428 . . . . 0.0 111.905 -178.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.666 ' CA ' ' HA3' ' A' ' 132' ' ' GLY . . . 164.57 146.63 4.83 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.602 ' CG2' ' HB2' ' A' ' 199' ' ' LEU . 7.8 p -94.82 155.19 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.116 -1.226 . . . . 0.0 109.691 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.665 ' C ' ' HB3' ' A' ' 199' ' ' LEU . . . -132.6 149.02 52.37 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.679 -0.809 . . . . 0.0 111.006 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.573 HG22 ' CB ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -106.28 131.05 53.98 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.399 -0.813 . . . . 0.0 109.946 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -84.97 -26.4 27.17 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.444 -0.785 . . . . 0.0 109.418 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.47 -12.14 54.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.419 -0.8 . . . . 0.0 109.352 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.564 ' N ' ' HD2' ' A' ' 114' ' ' PRO . . . -43.87 -54.06 11.66 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.378 -0.827 . . . . 0.0 110.444 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 113' ' ' ALA . 46.3 Cg_endo -72.54 143.0 37.46 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.875 1.461 . . . . 0.0 110.599 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 114' ' ' PRO . 16.3 tp -178.83 58.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 110.136 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -49.61 -85.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 110.255 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.525 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -125.68 137.46 53.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.287 -0.883 . . . . 0.0 110.293 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.525 ' C ' ' O ' ' A' ' 117' ' ' ALA . 8.0 t70 -32.05 110.03 0.07 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.534 -0.729 . . . . 0.0 110.745 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.466 ' O ' ' O ' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -126.04 -72.02 0.67 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.889 . . . . 0.0 110.142 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.466 ' O ' ' O ' ' A' ' 119' ' ' HIS . 13.1 t80 58.03 116.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.222 -0.923 . . . . 0.0 110.254 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 124' ' ' LEU . . . -170.13 72.27 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.184 -0.948 . . . . 0.0 110.125 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 54.36 -142.99 0.76 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.251 -0.906 . . . . 0.0 110.177 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.34 50.07 1.14 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.258 -0.901 . . . . 0.0 110.237 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 121' ' ' ALA . 0.8 OUTLIER -78.8 78.78 5.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.292 -0.88 . . . . 0.0 110.129 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 105.36 146.77 14.93 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.19 21.05 7.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.187 -1.184 . . . . 0.0 110.183 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' A' ' 127' ' ' ASN . 7.9 m-20 -56.63 132.81 52.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.349 -0.844 . . . . 0.0 110.141 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.471 ' HA ' ' HG3' ' A' ' 114' ' ' PRO . 2.0 p -146.38 -156.34 0.7 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.306 -0.871 . . . . 0.0 110.179 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.517 ' O ' ' CA ' ' A' ' 109' ' ' ALA . 5.5 mt-10 -140.58 123.9 16.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.892 . . . . 0.0 110.111 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.528 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 1.9 t -121.06 121.17 37.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.474 -0.766 . . . . 0.0 110.354 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . 0.437 ' CD1' ' O ' ' A' ' 130' ' ' SER . 33.3 m0 -130.94 131.8 44.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.172 -0.955 . . . . 0.0 110.243 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.666 ' HA3' ' CA ' ' A' ' 107' ' ' GLY . . . -172.73 -152.47 8.68 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.619 ' CZ3' HD21 ' A' ' 167' ' ' LEU . 43.5 m0 -112.79 113.27 25.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.161 -1.199 . . . . 0.0 111.11 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.817 ' HA ' ' CG1' ' A' ' 105' ' ' VAL . 18.9 m-20 -120.96 148.12 44.53 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.735 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.602 ' CD1' ' CB ' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -139.96 -26.82 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.049 -1.032 . . . . 0.0 110.454 179.387 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.38 -55.82 6.61 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.526 ' HG3' ' N ' ' A' ' 138' ' ' GLY . 2.1 ptt180 -79.96 -21.12 44.11 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.389 1.09 . . . . 0.0 109.412 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.526 ' N ' ' HG3' ' A' ' 137' ' ' ARG . . . -90.5 3.21 81.58 Favored Glycine 0 C--N 1.288 -2.135 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 141' ' ' TYR . 13.0 tttt -58.53 -140.24 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.379 -1.071 . . . . 0.0 110.449 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.9 tp -65.61 64.13 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.636 -0.665 . . . . 0.0 110.282 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.726 ' O ' ' N ' ' A' ' 143' ' ' GLN . 22.8 t80 -149.81 77.74 1.34 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.296 -0.878 . . . . 0.0 110.192 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.652 ' C ' ' O ' ' A' ' 141' ' ' TYR . 68.3 m-70 1.56 63.05 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.635 0.731 . . . . 0.0 111.37 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.726 ' N ' ' O ' ' A' ' 141' ' ' TYR . 0.1 OUTLIER -80.73 -69.91 0.57 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.621 -0.674 . . . . 0.0 110.299 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.9 m -44.96 154.49 0.14 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.191 -0.943 . . . . 0.0 110.28 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -80.25 -56.83 3.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.281 -0.887 . . . . 0.0 110.184 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 136.45 108.94 0.93 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.7 tp -175.07 95.01 0.07 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.198 -1.178 . . . . 0.0 110.29 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -58.22 115.87 3.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.13 -0.981 . . . . 0.0 110.257 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -117.07 70.79 5.49 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.253 -0.905 . . . . 0.0 110.165 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 151' ' ' GLN . 46.8 Cg_endo -72.85 -1.12 9.96 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.066 1.561 . . . . 0.0 110.584 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.454 ' O ' ' O ' ' A' ' 150' ' ' PRO . 2.6 mp0 -47.96 -97.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.892 . . . . 0.0 110.202 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.624 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 0.6 OUTLIER -98.62 -65.14 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.243 -0.911 . . . . 0.0 110.423 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.624 ' CD ' ' CB ' ' A' ' 152' ' ' TYR . 46.4 Cg_endo -72.85 155.69 53.3 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.621 1.327 . . . . 0.0 110.444 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 155' ' ' GLY . . . -66.21 149.17 50.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.151 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.504 ' O ' ' O ' ' A' ' 154' ' ' ALA . . . -58.32 -146.79 0.01 OUTLIER Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.71 -31.34 10.68 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.935 1.492 . . . . 0.0 110.411 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.8 -2.23 8.97 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.346 -0.846 . . . . 0.0 110.508 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.54 ' O ' ' CG2' ' A' ' 162' ' ' VAL . . . -79.31 3.89 65.26 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.512 ' HA ' HG21 ' A' ' 162' ' ' VAL . 0.0 OUTLIER -76.59 6.58 5.64 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.25 -1.147 . . . . 0.0 110.429 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -73.89 -2.14 22.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.328 -0.858 . . . . 0.0 110.326 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.485 ' C ' ' CD1' ' A' ' 161' ' ' LEU . 2.5 pp -172.09 36.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.217 -0.927 . . . . 0.0 110.329 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.602 ' CG1' HG21 ' A' ' 163' ' ' VAL . 70.5 t -92.29 -88.56 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.353 -0.842 . . . . 0.0 110.47 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.785 ' N ' ' CD ' ' A' ' 164' ' ' PRO . 0.1 OUTLIER -91.98 -19.89 0.24 Allowed Pre-proline 0 C--N 1.29 -1.983 0 O-C-N 121.823 -0.548 . . . . 0.0 111.076 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.785 ' CD ' ' N ' ' A' ' 163' ' ' VAL . 43.4 Cg_endo -72.12 59.3 2.99 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 N-CA-C 109.574 -0.971 . . . . 0.0 109.574 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.513 ' O ' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER 179.91 -76.33 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.361 0.601 . . . . 0.0 109.454 -179.732 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.528 ' HB2' ' NH1' ' A' ' 166' ' ' ARG . 3.0 ttm105 -152.0 156.17 39.45 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.477 -0.765 . . . . 0.0 110.233 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.658 HD13 ' CZ ' ' A' ' 180' ' ' TYR . 0.0 OUTLIER -159.05 138.63 11.65 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.181 -0.949 . . . . 0.0 110.261 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.651 ' N ' ' CD2' ' A' ' 167' ' ' LEU . 2.9 tt -112.86 121.38 44.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 109.829 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.659 ' CG2' ' CE1' ' A' ' 180' ' ' TYR . 3.6 t -101.43 146.72 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.956 -1.09 . . . . 0.0 110.759 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.5 t -134.26 108.56 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.502 -0.749 . . . . 0.0 109.667 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.638 ' CB ' ' CZ2' ' A' ' 91' ' ' TRP . 0.0 OUTLIER -118.29 121.16 39.74 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.044 -1.035 . . . . 0.0 110.006 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 173' ' ' MET . 46.1 t0 -111.44 137.29 49.42 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.278 -0.889 . . . . 0.0 109.896 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.509 ' N ' ' OD1' ' A' ' 172' ' ' ASP . 2.0 tmt? -95.23 -40.21 9.68 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.6 -0.687 . . . . 0.0 109.931 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.474 ' C ' ' O ' ' A' ' 173' ' ' MET . 0.3 OUTLIER -41.77 -27.81 0.13 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.189 -0.945 . . . . 0.0 108.858 179.209 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.637 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.6 OUTLIER -114.42 -27.32 7.6 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.202 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.501 ' O ' HG23 ' A' ' 198' ' ' THR . . . 83.83 23.88 51.28 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 108.559 -1.816 . . . . 0.0 108.559 -179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.637 ' OG1' ' HB3' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -113.17 121.71 45.32 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.311 -1.111 . . . . 0.0 111.243 -179.444 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.583 ' N ' ' CD2' ' A' ' 178' ' ' LEU . 0.2 OUTLIER -124.87 151.28 45.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.401 -0.812 . . . . 0.0 109.671 179.03 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.468 ' O ' HG11 ' A' ' 169' ' ' VAL . . . -149.31 166.89 29.59 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.659 ' CE1' ' CG2' ' A' ' 169' ' ' VAL . 0.7 OUTLIER -123.58 117.86 26.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.408 -1.054 . . . . 0.0 108.439 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.563 ' O ' ' CD2' ' A' ' 167' ' ' LEU . 35.2 t -145.66 155.63 43.13 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.971 -1.081 . . . . 0.0 110.724 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.584 HG23 ' CZ3' ' A' ' 133' ' ' TRP . 0.0 OUTLIER -95.7 116.3 37.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.453 -0.779 . . . . 0.0 108.941 178.554 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 64.42 9.65 38.26 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.26 42.97 33.56 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 3.5 m -121.99 -2.43 9.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.17 -1.194 . . . . 0.0 110.705 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.607 ' CD2' ' CZ2' ' A' ' 133' ' ' TRP . 0.1 OUTLIER -101.28 -71.12 0.72 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.193 -0.942 . . . . 0.0 110.413 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.601 ' O ' ' CD2' ' A' ' 191' ' ' PHE . 3.9 mm? -67.0 47.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 110.258 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 186' ' ' TYR . . . -71.23 -73.4 0.8 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.461 ' C ' ' H ' ' A' ' 191' ' ' PHE . 49.7 Cg_endo -75.29 -25.48 11.39 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.922 1.486 . . . . 0.0 111.145 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.531 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -68.31 23.79 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.448 -0.783 . . . . 0.0 112.2 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.601 ' CD2' ' O ' ' A' ' 187' ' ' LEU . 2.1 m-85 -90.43 -38.68 13.12 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.66 -1.275 . . . . 0.0 110.536 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -13.61 61.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.198 -0.938 . . . . 0.0 110.162 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -106.43 -8.95 32.22 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.104 -1.999 . . . . 0.0 108.104 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.631 HD23 ' CG2' ' A' ' 177' ' ' THR . 8.7 tt -73.1 -42.59 62.8 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.892 -0.77 . . . . 0.0 109.071 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.543 ' CA ' HG21 ' A' ' 198' ' ' THR . 0.0 OUTLIER -45.27 -42.48 9.63 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.472 -0.767 . . . . 0.0 110.012 179.755 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.468 ' N ' ' HD2' ' A' ' 195' ' ' LYS . . . -85.06 -23.75 47.56 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.798 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -91.04 -4.47 56.33 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.693 -0.886 . . . . 0.0 110.082 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.598 ' N ' ' O ' ' A' ' 194' ' ' LEU . 24.5 p -44.56 129.49 6.78 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 121.471 0.653 . . . . 0.0 111.742 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.798 ' HG ' ' O ' ' A' ' 197' ' ' ARG . 0.0 OUTLIER -140.39 171.82 13.61 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.482 -0.761 . . . . 0.0 109.849 179.49 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.504 ' C ' ' CG2' ' A' ' 108' ' ' VAL . 3.8 m-85 -83.9 129.55 58.6 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.012 -1.055 . . . . 0.0 109.963 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.588 ' HB3' ' CH2' ' A' ' 91' ' ' TRP . 49.6 Cg_endo -76.18 124.86 8.15 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 124.055 1.555 . . . . 0.0 111.787 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 80' ' ' GLY . 52.1 m -133.68 160.42 37.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.443 -0.786 . . . . 0.0 109.282 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.513 ' CG1' ' O ' ' A' ' 52' ' ' ASP . 1.1 t -119.42 162.41 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.835 -1.166 . . . . 0.0 110.608 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' SER . . . . . 0.645 ' O ' ' N ' ' A' ' 105' ' ' VAL . 1.6 m -160.68 138.44 9.55 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.781 ' CB ' ' HA ' ' A' ' 104' ' ' ALA . . . -144.77 129.13 17.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.753 -1.217 . . . . 0.0 111.582 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.47 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 1.0 OUTLIER -38.56 160.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-O 121.178 0.514 . . . . 0.0 110.135 178.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.449 ' N ' HG11 ' A' ' 206' ' ' VAL . 0.9 OUTLIER -50.68 -43.73 57.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.172 -0.955 . . . . 0.0 109.584 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.679 ' HA2' ' HA ' ' A' ' 102' ' ' THR . . . 170.73 134.75 1.8 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.604 ' HB3' ' CD2' ' A' ' 103' ' ' HIS . 0.2 OUTLIER -164.61 -63.28 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -1.133 . . . . 0.0 110.559 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . 0.641 ' CB ' ' CE1' ' A' ' 103' ' ' HIS . 0.5 OUTLIER -136.29 85.55 2.16 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.339 -0.851 . . . . 0.0 110.623 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.554 ' N ' ' O ' ' A' ' 100' ' ' ARG . 1.0 OUTLIER -26.59 126.54 0.06 Allowed 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 122.233 1.016 . . . . 0.0 111.608 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.736 HG13 ' N ' ' A' ' 104' ' ' ALA . 0.7 OUTLIER -113.16 143.78 22.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.064 179.119 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 0.618 ' HA ' HD21 ' A' ' 64' ' ' LEU . 40.5 mtm180 -88.65 144.4 26.32 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.024 -1.048 . . . . 0.0 111.104 -178.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.572 HG21 ' CD2' ' A' ' 64' ' ' LEU . 4.2 tt -144.59 139.51 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.507 -0.745 . . . . 0.0 110.446 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.659 ' O ' ' N ' ' A' ' 92' ' ' GLU . 4.2 mtt180 -130.41 109.18 10.53 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . 0.715 ' CZ ' ' CD1' ' A' ' 91' ' ' TRP . 4.3 t80 -117.33 140.37 49.65 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.945 -1.097 . . . . 0.0 111.588 -178.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -136.68 114.98 11.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.818 -0.551 . . . . 0.0 109.996 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 123.38 17.98 3.14 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.505 ' HG3' ' NH1' ' A' ' 82' ' ' ARG . 4.9 tt0 -97.0 117.81 31.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.236 -1.155 . . . . 0.0 110.142 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.74 -168.48 1.99 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.253 -0.904 . . . . 0.0 110.154 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . 0.51 ' O ' ' C ' ' A' ' 222' ' ' VAL . 0.0 OUTLIER -158.45 95.06 1.31 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.339 -0.851 . . . . 0.0 110.252 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.51 ' C ' ' O ' ' A' ' 221' ' ' ARG . 2.6 p -34.55 136.89 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.454 -0.778 . . . . 0.0 110.588 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.508 ' O ' ' C ' ' A' ' 224' ' ' GLU . 0.4 OUTLIER 179.91 52.63 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.188 -0.945 . . . . 0.0 110.292 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.508 ' C ' ' O ' ' A' ' 223' ' ' GLU . 0.8 OUTLIER -33.36 -77.04 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.44 -0.787 . . . . 0.0 110.676 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.45 HG22 HG21 ' A' ' 228' ' ' ILE . 7.0 t -52.46 132.15 34.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 110.158 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.464 ' HD2' ' O ' ' A' ' 226' ' ' ARG . 0.0 OUTLIER -111.12 -3.6 15.38 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.386 -0.821 . . . . 0.0 110.221 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -64.59 -30.17 71.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.269 -0.895 . . . . 0.0 110.211 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.45 HG21 HG22 ' A' ' 225' ' ' THR . 5.6 tt -86.08 136.48 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.182 -0.949 . . . . 0.0 110.138 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -178.95 -42.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.288 -0.883 . . . . 0.0 110.259 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . 0.671 ' O ' ' C ' ' A' ' 231' ' ' ASP . 0.2 OUTLIER -50.54 167.27 0.07 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 110.255 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.671 ' C ' ' O ' ' A' ' 230' ' ' ARG . 17.0 t70 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.008 -0.996 . . . . 0.0 111.489 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.01 -155.98 0.33 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -1.138 . . . . 0.0 110.264 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 8' ' ' SER . 6.7 t -166.85 43.62 0.05 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.262 -0.899 . . . . 0.0 110.278 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -130.44 -38.03 1.37 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.311 -0.868 . . . . 0.0 110.264 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.0 mtm-85 -106.66 130.23 54.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.343 -0.848 . . . . 0.0 110.185 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -159.86 -39.45 0.05 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.306 -0.872 . . . . 0.0 110.153 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.65 177.46 10.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.285 -0.884 . . . . 0.0 110.201 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.46 105.6 3.3 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.299 -0.876 . . . . 0.0 110.189 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.98 -40.7 1.65 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.014 1.534 . . . . 0.0 110.495 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.448 ' O ' ' HB3' ' A' ' 16' ' ' SER . 0.1 OUTLIER -126.65 120.31 29.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.341 -0.849 . . . . 0.0 110.134 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 15' ' ' THR . 89.0 p -178.32 -65.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.906 . . . . 0.0 110.29 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -77.98 107.13 10.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.323 -0.861 . . . . 0.0 110.283 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.465 ' C ' ' CD1' ' A' ' 19' ' ' LEU . . . -62.59 -171.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 110.239 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.629 ' CD1' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -163.21 -171.34 2.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.354 -0.841 . . . . 0.0 110.426 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -166.32 -144.56 0.07 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.159 -0.963 . . . . 0.0 110.301 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.847 ' O ' ' N ' ' A' ' 23' ' ' PHE . 21.3 p -103.77 -145.28 0.37 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.252 -0.905 . . . . 0.0 110.313 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.646 ' C ' ' O ' ' A' ' 21' ' ' SER . 1.1 m-20 2.44 55.88 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.847 0.832 . . . . 0.0 111.114 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.847 ' N ' ' O ' ' A' ' 21' ' ' SER . 0.1 OUTLIER -38.48 -70.85 0.09 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.343 0.592 . . . . 0.0 110.219 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.83 112.71 21.41 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.475 -0.765 . . . . 0.0 110.073 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 23' ' ' PHE . 46.6 Cg_endo -72.66 172.04 16.02 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.01 1.531 . . . . 0.0 110.486 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.532 ' HG3' ' CB ' ' A' ' 30' ' ' GLU . 45.7 Cg_endo -72.51 -179.3 3.97 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.186 1.624 . . . . 0.0 110.347 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -84.28 36.42 0.58 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 110.003 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.93 12.32 60.54 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.486 ' HG ' ' N ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -81.44 -54.64 5.28 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.153 -1.204 . . . . 0.0 109.737 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.532 ' CB ' ' HG3' ' A' ' 26' ' ' PRO . 3.5 tt0 -55.02 -43.86 74.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.223 -0.923 . . . . 0.0 109.117 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -52.35 -24.46 7.64 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.431 ' O ' HD11 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -83.11 -32.23 26.83 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.838 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.733 ' C ' ' CD1' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -85.44 -38.55 18.53 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.759 0.79 . . . . 0.0 109.313 179.211 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.559 ' N ' HD13 ' A' ' 33' ' ' LEU . 37.6 t -45.85 -25.51 0.53 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.449 0.642 . . . . 0.0 109.817 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.662 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . -80.68 -164.54 0.05 OUTLIER Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 121.634 -0.666 . . . . 0.0 109.623 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.643 ' CD ' ' CB ' ' A' ' 35' ' ' ALA . 53.2 Cg_endo -95.95 74.61 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.679 1.586 . . . . 0.0 110.96 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.662 ' HD3' ' O ' ' A' ' 35' ' ' ALA . 44.4 Cg_endo -69.29 157.28 61.88 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.458 1.241 . . . . 0.0 110.323 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.735 ' O ' ' N ' ' A' ' 40' ' ' LEU . 50.0 Cg_endo -79.92 152.33 21.88 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 124.103 1.58 . . . . 0.0 111.716 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.719 ' O ' ' CG ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER 4.13 60.35 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 122.845 1.307 . . . . 0.0 110.792 -179.288 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.735 ' N ' ' O ' ' A' ' 38' ' ' PRO . 0.2 OUTLIER -144.63 -45.3 0.24 Allowed 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.144 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.663 ' O ' ' CD2' ' A' ' 45' ' ' HIS . 2.1 t -86.85 -35.1 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 119.076 -1.049 . . . . 0.0 108.575 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.527 ' O ' ' CB ' ' A' ' 46' ' ' HIS . . . -88.55 -36.53 16.32 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.462 -0.774 . . . . 0.0 110.183 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.669 ' HG2' ' HA ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -76.42 -22.98 53.99 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.414 -0.804 . . . . 0.0 110.469 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.621 ' NH2' ' HB ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -84.45 -47.58 10.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.233 -0.917 . . . . 0.0 109.965 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.663 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 40.6 m-70 -73.35 -16.43 61.35 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.535 -0.728 . . . . 0.0 109.424 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.527 ' CB ' ' O ' ' A' ' 42' ' ' ALA . 3.2 t60 -96.7 -31.02 12.89 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.639 0.733 . . . . 0.0 109.085 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 46' ' ' HIS . . . -61.08 -115.47 0.01 OUTLIER Glycine 0 N--CA 1.479 1.534 0 N-CA-C 108.114 -1.995 . . . . 0.0 108.114 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.866 ' HB2' HD12 ' A' ' 214' ' ' ILE . 6.4 p-90 -103.31 71.3 1.1 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.573 -1.251 . . . . 0.0 111.194 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.593 ' ND2' ' HB3' ' A' ' 53' ' ' CYS . 0.9 OUTLIER -108.93 114.57 58.24 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 120.873 -1.142 . . . . 0.0 110.183 178.397 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.6 ' HG2' ' CA ' ' A' ' 80' ' ' GLY . 39.1 Cg_endo -67.35 -63.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.767 0 N-CA-C 109.323 -1.068 . . . . 0.0 109.323 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.983 ' HA ' ' CE ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER 176.02 31.48 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.781 -1.2 . . . . 0.0 112.912 177.423 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.874 ' HB3' ' HG2' ' A' ' 79' ' ' ARG 0.256 0.2 OUTLIER -162.22 19.72 0.1 Allowed 'General case' 0 C--N 1.265 -3.087 0 CA-C-O 122.16 0.981 . . . . 0.0 109.134 -179.207 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.593 ' HB3' ' ND2' ' A' ' 49' ' ' ASN . 18.9 t -102.29 128.64 48.76 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-O 122.336 1.065 . . . . 0.0 111.203 -177.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.602 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 0.1 OUTLIER -91.86 166.72 12.59 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.894 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.706 ' O ' ' N ' ' A' ' 57' ' ' ILE . 1.7 pm0 -75.98 6.25 5.46 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.619 -0.675 . . . . 0.0 110.846 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.623 ' ND2' ' O ' ' A' ' 76' ' ' ASP . 0.1 OUTLIER -28.33 -33.37 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.182 0 CA-C-O 122.065 0.936 . . . . 0.0 109.882 179.256 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.711 ' HB ' ' HG2' ' A' ' 68' ' ' ARG . 0.4 OUTLIER -134.64 169.02 22.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.863 -0.523 . . . . 0.0 109.724 -178.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.547 ' O ' ' CB ' ' A' ' 67' ' ' GLU . 3.4 t70 -107.53 106.93 17.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.821 -1.174 . . . . 0.0 111.034 -178.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.614 HG12 ' CZ2' ' A' ' 48' ' ' TRP . 2.1 m -122.62 135.54 62.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.669 ' HA ' ' HG2' ' A' ' 43' ' ' GLN . 11.1 ttpp -127.42 155.41 43.7 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.632 -1.293 . . . . 0.0 112.09 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.52 ' HA ' HD11 ' A' ' 64' ' ' LEU . 19.0 tt0 -65.17 -128.89 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.741 -0.599 . . . . 0.0 110.397 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 41.05 47.02 4.21 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.679 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 102.76 50.59 1.08 Allowed Glycine 0 N--CA 1.486 2.017 0 N-CA-C 107.904 -2.078 . . . . 0.0 107.904 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.679 ' C ' ' O ' ' A' ' 63' ' ' GLY . 2.3 mm? 1.14 81.35 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.763 0.792 . . . . 0.0 110.806 -178.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.413 ' N ' ' O ' ' A' ' 63' ' ' GLY . 6.3 t -99.29 114.96 28.08 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.686 -0.634 . . . . 0.0 109.976 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.864 ' CE1' ' CE2' ' A' ' 48' ' ' TRP . 1.9 m-85 -82.83 129.9 35.06 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.461 -0.774 . . . . 0.0 109.539 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.547 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 1.2 tm-20 -137.37 121.58 18.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.868 -1.145 . . . . 0.0 110.339 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.711 ' HG2' ' HB ' ' A' ' 57' ' ' ILE . 9.2 mtp180 -115.57 154.76 28.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 0.0 109.55 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.655 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 16.5 ttt85 -95.72 -69.08 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 120.956 -1.09 . . . . 0.0 109.859 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.655 ' HD3' ' HB3' ' A' ' 69' ' ' ARG . 57.6 Cg_endo -77.48 -123.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 N-CA-C 108.713 -1.303 . . . . 0.0 108.713 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 73' ' ' GLN . 2.6 t -140.07 164.33 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.52 -1.363 . . . . 0.0 109.589 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.64 ' CB ' ' CZ3' ' A' ' 207' ' ' TRP . . . -41.66 92.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.176 -0.953 . . . . 0.0 110.314 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.552 ' N ' ' O ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -179.97 -31.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.221 -0.924 . . . . 0.0 110.294 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.463 ' C ' ' O ' ' A' ' 73' ' ' GLN . 10.4 p -40.12 -50.61 2.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.343 -0.848 . . . . 0.0 110.228 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.541 HG21 ' N ' ' A' ' 76' ' ' ASP . 7.5 m -169.03 -84.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.269 -0.894 . . . . 0.0 110.031 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.623 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 66.2 t0 -140.13 113.19 8.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.221 -0.924 . . . . 0.0 110.36 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.533 ' O ' ' O ' ' A' ' 76' ' ' ASP . . . -42.59 -91.41 0.01 OUTLIER Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.046 -2.022 . . . . 0.0 108.046 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.621 ' HB ' ' NH2' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -144.15 139.39 24.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.123 -1.222 . . . . 0.0 109.88 179.302 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.874 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 29.3 ttp180 -145.65 148.08 32.69 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.844 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.691 ' HA2' ' HB2' ' A' ' 52' ' ' ASP . . . -136.99 124.6 3.15 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.491 ' HB3' ' OD1' ' A' ' 52' ' ' ASP . 6.1 ttpm? -134.26 -71.38 0.5 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.855 -1.379 . . . . 0.0 111.74 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.559 ' CZ ' ' NZ ' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -58.32 -93.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.19 -0.944 . . . . 0.0 110.799 -178.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 51.13 70.04 0.97 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.679 -1.769 . . . . 0.0 108.679 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.575 ' C ' ' CD1' ' A' ' 84' ' ' TYR . 1.0 OUTLIER -94.57 142.16 27.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.341 -1.094 . . . . 0.0 110.495 -179.308 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.577 ' HB3' ' CE1' ' A' ' 89' ' ' HIS . 1.4 m -135.87 174.34 10.73 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.548 -0.72 . . . . 0.0 109.886 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.579 ' O ' ' CE1' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -126.62 138.51 53.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.18 -0.95 . . . . 0.0 110.7 -179.746 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 173' ' ' MET . . . 92.15 -119.46 5.8 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.497 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 4.5 tt -128.74 139.63 52.11 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.676 -0.896 . . . . 0.0 110.123 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.579 ' CE1' ' O ' ' A' ' 86' ' ' ARG . 18.3 m-70 -147.23 162.38 39.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.162 -0.961 . . . . 0.0 110.186 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 217' ' ' MET . . . -160.65 138.66 9.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.219 -0.926 . . . . 0.0 109.949 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.663 ' CZ2' ' CG1' ' A' ' 169' ' ' VAL . 1.3 p90 -134.89 170.75 15.39 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.242 -0.911 . . . . 0.0 110.36 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.608 ' N ' ' O ' ' A' ' 215' ' ' ARG . 38.1 mt-10 -141.82 152.58 43.82 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.637 -0.664 . . . . 0.0 110.497 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.535 HG23 ' N ' ' A' ' 94' ' ' SER . 10.1 mt -144.48 154.2 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.902 . . . . 0.0 110.57 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.55 ' OG ' ' HB2' ' A' ' 213' ' ' ARG . 1.2 m -119.35 133.5 55.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.354 -0.841 . . . . 0.0 109.469 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.737 ' CD1' ' HB2' ' A' ' 164' ' ' PRO 0.261 2.3 t-105 -136.52 88.12 20.46 Favored Pre-proline 0 C--N 1.297 -1.697 0 O-C-N 121.441 -0.787 . . . . 0.0 110.332 -178.759 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.54 ' HD2' ' O ' ' A' ' 211' ' ' GLN . 51.7 Cg_endo -91.99 107.02 0.24 Allowed 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.095 1.05 . . . . 0.0 110.682 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.566 ' HB2' ' HG2' ' A' ' 164' ' ' PRO . 5.6 tt -97.84 -68.2 0.81 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.09 -1.006 . . . . 0.0 109.934 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.505 ' CG ' HD23 ' A' ' 97' ' ' LEU . 12.9 mt-10 -99.02 -45.43 5.94 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.508 -0.745 . . . . 0.0 110.261 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.508 ' HG2' ' N ' ' A' ' 100' ' ' ARG . 64.9 tt0 -152.74 -99.31 0.05 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.31 -0.869 . . . . 0.0 110.491 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.538 ' C ' ' HB2' ' A' ' 165' ' ' GLU . 1.4 mmt180 -113.36 -140.75 0.38 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.08 -1.012 . . . . 0.0 110.656 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.71 ' O ' ' HB3' ' A' ' 165' ' ' GLU . . . 103.42 -141.34 15.2 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.579 ' N ' ' O ' ' A' ' 163' ' ' VAL . 0.0 OUTLIER 178.47 109.62 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.165 -1.197 . . . . 0.0 110.153 179.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.703 ' N ' ' HA ' ' A' ' 164' ' ' PRO . 0.2 OUTLIER 179.67 -176.22 0.3 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.677 -1.264 . . . . 0.0 112.222 -179.818 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.706 ' CB ' ' CE3' ' A' ' 95' ' ' TRP . . . 179.81 -178.32 0.4 Allowed 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.727 HG21 ' O ' ' A' ' 105' ' ' VAL . 0.9 OUTLIER -94.56 115.16 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 116.675 -2.01 . . . . 0.0 107.763 178.487 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.623 ' CG2' ' CG2' ' A' ' 203' ' ' VAL . 34.3 t -148.76 169.15 2.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.156 -0.965 . . . . 0.0 110.267 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.676 ' HA2' ' HA3' ' A' ' 132' ' ' GLY . . . -175.35 131.41 1.93 Allowed Glycine 0 N--CA 1.483 1.797 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.682 ' CG1' HD13 ' A' ' 199' ' ' LEU . 0.3 OUTLIER -102.41 143.41 14.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.618 -0.93 . . . . 0.0 109.628 -179.569 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.534 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -109.79 129.76 55.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.128 -0.982 . . . . 0.0 110.704 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.548 ' CG2' ' O ' ' A' ' 197' ' ' ARG . 0.0 OUTLIER -110.55 131.74 54.79 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.309 -0.869 . . . . 0.0 110.065 179.65 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -91.25 -27.13 18.64 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.502 0.668 . . . . 0.0 109.238 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.426 ' CD2' ' O ' ' A' ' 196' ' ' GLY . 1.8 pp -82.15 -12.59 58.08 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.505 -0.747 . . . . 0.0 109.492 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.477 ' CB ' ' HB3' ' A' ' 129' ' ' GLU . . . -52.26 143.86 24.29 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.404 -0.81 . . . . 0.0 110.091 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.459 ' O ' ' HB2' ' A' ' 115' ' ' LEU . 46.2 Cg_endo -72.5 165.04 33.83 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.922 1.485 . . . . 0.0 110.411 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.477 ' CD1' ' O ' ' A' ' 128' ' ' SER . 1.2 tt -179.97 62.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 110.249 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -85.08 -39.19 18.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.163 -0.96 . . . . 0.0 110.208 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.524 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -131.15 74.84 1.62 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.317 -0.864 . . . . 0.0 110.161 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.524 ' C ' ' O ' ' A' ' 117' ' ' ALA . 12.1 t70 -31.55 146.08 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.413 -0.805 . . . . 0.0 110.771 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -98.32 -44.69 6.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.145 -0.972 . . . . 0.0 110.213 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.453 ' O ' ' OD2' ' A' ' 118' ' ' ASP . 0.3 OUTLIER -128.02 178.08 6.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.251 -0.906 . . . . 0.0 110.152 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 120' ' ' TYR . . . -42.87 130.98 4.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -0.934 . . . . 0.0 110.132 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.13 -167.16 0.83 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.912 . . . . 0.0 110.304 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 tp -114.27 -170.87 1.81 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.939 . . . . 0.0 110.202 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -50.63 -26.53 5.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.299 -0.876 . . . . 0.0 110.144 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -105.52 132.15 10.98 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 13.5 m -100.0 26.15 6.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.213 -1.169 . . . . 0.0 110.247 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.422 ' O ' ' HB3' ' A' ' 128' ' ' SER . 0.9 OUTLIER -146.06 52.69 1.14 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 110.305 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.477 ' O ' ' CD1' ' A' ' 115' ' ' LEU . 17.1 p -179.64 -171.32 0.18 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 110.345 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.477 ' HB3' ' CB ' ' A' ' 113' ' ' ALA . 21.6 tt0 -150.11 131.08 14.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.225 -0.922 . . . . 0.0 109.874 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.4 t -120.41 119.6 33.54 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.195 -0.941 . . . . 0.0 110.503 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -133.47 141.99 48.06 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.471 -0.768 . . . . 0.0 109.192 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.676 ' HA3' ' HA2' ' A' ' 107' ' ' GLY . . . -173.27 -138.92 2.74 Favored Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.336 -1.411 . . . . 0.0 110.652 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.731 ' CZ3' ' CG ' ' A' ' 180' ' ' TYR . 45.9 m0 -113.11 118.18 34.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.392 -1.063 . . . . 0.0 110.611 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.53 ' O ' ' CG2' ' A' ' 135' ' ' ILE . 4.2 p30 -118.06 126.5 52.41 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.359 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.53 ' CG2' ' O ' ' A' ' 134' ' ' ASP . 7.3 pt -160.34 37.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.338 -0.851 . . . . 0.0 110.055 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.46 -58.36 8.72 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 139' ' ' LYS . 3.5 mpt_? -86.46 5.63 34.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.108 -1.23 . . . . 0.0 110.403 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.454 ' HA2' ' HB3' ' A' ' 161' ' ' LEU . . . 38.86 28.74 0.07 OUTLIER Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.539 ' N ' HD21 ' A' ' 161' ' ' LEU . 0.4 OUTLIER -65.45 -162.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.124 -1.221 . . . . 0.0 110.363 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.663 ' O ' ' C ' ' A' ' 141' ' ' TYR . 1.5 pp -160.31 100.89 1.37 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.331 -0.856 . . . . 0.0 110.192 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.663 ' C ' ' O ' ' A' ' 140' ' ' LEU . 1.8 m-85 0.17 75.95 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.694 -0.629 . . . . 0.0 111.308 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.521 ' N ' ' O ' ' A' ' 140' ' ' LEU . 6.3 m170 -55.49 -36.85 67.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.295 -0.878 . . . . 0.0 110.283 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.3 -44.95 96.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.896 . . . . 0.0 110.287 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.0 p -57.32 -168.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 110.26 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 145' ' ' LYS . 14.6 mmtt -114.68 -55.23 2.51 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.277 -0.889 . . . . 0.0 110.195 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 121.08 170.25 13.98 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -172.24 39.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.198 -1.178 . . . . 0.0 110.336 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -45.87 157.87 0.1 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.282 -0.886 . . . . 0.0 110.231 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -179.99 102.74 0.17 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.181 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.426 ' HA ' ' HG3' ' A' ' 156' ' ' PRO . 46.6 Cg_endo -73.66 53.01 2.62 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.994 1.523 . . . . 0.0 110.406 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.49 -50.24 7.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.916 . . . . 0.0 110.32 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.541 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 0.1 OUTLIER -177.37 -58.77 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.32 -0.862 . . . . 0.0 110.249 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.541 ' CD ' ' CB ' ' A' ' 152' ' ' TYR . 46.1 Cg_endo -72.58 171.08 17.9 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.043 1.549 . . . . 0.0 110.422 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 153' ' ' PRO . . . -40.65 144.23 0.27 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 0.0 110.425 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -179.08 -83.9 0.06 OUTLIER Glycine 0 N--CA 1.481 1.641 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.426 ' HG3' ' HA ' ' A' ' 150' ' ' PRO . 45.7 Cg_endo -73.43 -2.59 12.34 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.065 1.56 . . . . 0.0 110.489 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 158' ' ' GLY . 1.9 mp0 -64.63 -6.75 8.35 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.259 -0.901 . . . . 0.0 110.496 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 157' ' ' GLN . . . 42.18 28.88 0.56 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.512 ' O ' ' CG ' ' A' ' 159' ' ' GLU . 22.6 tt0 -79.36 6.43 10.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.237 -1.155 . . . . 0.0 110.184 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.467 ' O ' ' CG ' ' A' ' 161' ' ' LEU . 0.5 OUTLIER -59.48 -15.92 20.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.344 -0.848 . . . . 0.0 109.516 179.601 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.539 HD21 ' N ' ' A' ' 139' ' ' LYS . 0.2 OUTLIER -174.98 27.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.585 0.707 . . . . 0.0 109.791 179.487 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.58 ' CG1' ' O ' ' A' ' 162' ' ' VAL . 2.5 t -157.14 81.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-O 121.686 0.755 . . . . 0.0 109.717 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.864 ' N ' ' HD3' ' A' ' 164' ' ' PRO . 4.0 p -150.17 41.83 0.23 Allowed Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 121.407 -0.808 . . . . 0.0 110.376 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.864 ' HD3' ' N ' ' A' ' 163' ' ' VAL . 55.2 Cg_endo -93.78 152.08 2.28 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.609 1.32 . . . . 0.0 111.22 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.71 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 5.7 tp10 178.83 -70.33 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.412 -0.805 . . . . 0.0 109.663 178.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.47 ' O ' ' HB ' ' A' ' 102' ' ' THR . 3.0 ttp180 -147.88 141.47 25.49 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.579 -0.7 . . . . 0.0 109.378 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.575 HD22 ' CZ ' ' A' ' 180' ' ' TYR . 0.5 OUTLIER -162.52 157.14 21.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.128 -0.982 . . . . 0.0 110.455 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.504 ' C ' ' CD2' ' A' ' 168' ' ' LEU . 6.5 tt -120.68 134.8 55.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.332 -0.855 . . . . 0.0 110.15 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.671 ' CG2' ' CE1' ' A' ' 180' ' ' TYR . 94.1 t -109.97 128.62 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.272 -0.893 . . . . 0.0 110.412 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 4.7 t -103.75 110.47 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.343 -0.848 . . . . 0.0 109.815 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.53 ' CD1' ' HB3' ' A' ' 178' ' ' LEU . 13.7 tp -121.5 106.06 11.05 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.18 -0.95 . . . . 0.0 109.983 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -111.43 136.8 50.06 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.283 -0.885 . . . . 0.0 110.477 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.538 ' CE ' ' CE2' ' A' ' 84' ' ' TYR . 12.5 tpp -92.3 -40.07 11.14 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 120.412 -0.515 . . . . 0.0 109.702 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 173' ' ' MET . 15.2 tt0 -41.95 -28.89 0.19 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.279 -0.888 . . . . 0.0 108.91 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.508 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.0 OUTLIER -109.4 -25.83 10.32 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.539 ' O ' ' OG1' ' A' ' 198' ' ' THR . . . 78.96 24.63 61.48 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.643 HG22 ' CD2' ' A' ' 194' ' ' LEU . 1.1 p -125.38 148.74 48.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.206 -1.173 . . . . 0.0 111.112 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.541 ' CD1' ' HG3' ' A' ' 201' ' ' PRO . 0.4 OUTLIER -148.1 154.33 40.06 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.525 -0.734 . . . . 0.0 109.952 179.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -149.25 164.68 29.34 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.731 ' CG ' ' CZ3' ' A' ' 133' ' ' TRP . 0.4 OUTLIER -118.86 121.88 41.03 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.14 -1.212 . . . . 0.0 109.859 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.511 ' HB2' ' CB ' ' A' ' 187' ' ' LEU . 11.4 t -113.01 124.5 52.78 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.371 -0.83 . . . . 0.0 110.078 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.58 HD13 ' CH2' ' A' ' 133' ' ' TRP . 0.0 OUTLIER -104.21 116.82 48.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.594 -0.691 . . . . 0.0 109.715 179.756 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 72.93 4.59 62.84 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.174 -1.571 . . . . 0.0 109.174 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 68.65 47.49 55.97 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' THR . . . . . 0.506 HG23 ' CE1' ' A' ' 186' ' ' TYR . 46.3 m -137.07 -27.09 1.0 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -1.173 . . . . 0.0 110.802 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.506 ' CE1' HG23 ' A' ' 185' ' ' THR . 21.8 m-85 -116.8 76.55 1.04 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.949 -1.095 . . . . 0.0 110.676 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.562 ' HG ' ' CE1' ' A' ' 191' ' ' PHE . 0.6 OUTLIER 179.7 29.41 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.529 0.68 . . . . 0.0 109.196 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.54 ' H ' ' HD2' ' A' ' 189' ' ' PRO . . . -105.48 -62.01 0.63 Allowed Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.915 -1.136 . . . . 0.0 111.447 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.54 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 43.5 Cg_endo -70.24 -31.6 18.12 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.685 1.361 . . . . 0.0 111.791 -178.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.604 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -71.83 9.2 0.95 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.077 -1.014 . . . . 0.0 111.367 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.562 ' CE1' ' HG ' ' A' ' 187' ' ' LEU . 1.4 m-85 -90.53 -10.78 42.28 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.278 -0.889 . . . . 0.0 110.161 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.503 ' HA ' ' NE ' ' A' ' 192' ' ' ARG . 0.2 OUTLIER -90.12 -15.21 32.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.353 -0.842 . . . . 0.0 110.191 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 197' ' ' ARG . . . -112.07 -17.01 8.62 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.018 -2.033 . . . . 0.0 108.018 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.708 ' HA ' ' CD ' ' A' ' 197' ' ' ARG . 3.8 tt -65.52 -26.31 67.84 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.831 -0.805 . . . . 0.0 109.134 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.546 ' HA ' HG23 ' A' ' 177' ' ' THR . 0.0 OUTLIER -54.51 -26.25 30.51 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.599 -0.688 . . . . 0.0 109.773 179.242 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.426 ' O ' ' CD2' ' A' ' 112' ' ' LEU . . . -118.87 -17.62 5.0 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.748 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.32 -3.96 57.43 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.459 -1.024 . . . . 0.0 110.322 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.589 ' HB ' HG22 ' A' ' 177' ' ' THR . 0.5 OUTLIER -42.1 132.3 3.28 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 122.325 1.059 . . . . 0.0 112.052 -178.094 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.748 ' HG ' ' O ' ' A' ' 197' ' ' ARG . 0.1 OUTLIER -142.61 171.32 14.21 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.431 178.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.579 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 2.6 m-85 -84.89 128.43 60.6 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 120.814 -1.179 . . . . 0.0 109.817 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.601 ' CA ' HG13 ' A' ' 108' ' ' VAL . 55.7 Cg_endo -87.43 142.33 6.04 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 124.022 1.538 . . . . 0.0 112.4 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.56 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 43.1 m -133.91 134.92 43.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.677 -0.639 . . . . 0.0 109.5 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.623 ' CG2' ' CG2' ' A' ' 106' ' ' VAL . 4.0 p -119.5 161.31 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.811 -1.181 . . . . 0.0 110.335 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' SER . . . . . 0.659 ' O ' HG21 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -160.51 161.48 32.77 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.971 0.891 . . . . 0.0 110.822 179.687 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.498 ' O ' HG12 ' A' ' 78' ' ' VAL . . . -150.65 165.92 31.93 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 121.956 0.884 . . . . 0.0 110.868 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.651 ' CG2' ' CE3' ' A' ' 207' ' ' TRP . 0.3 OUTLIER -98.79 -152.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.037 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.681 ' HB3' ' HD3' ' A' ' 68' ' ' ARG . 48.7 p90 -91.07 -140.66 0.17 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.123 -0.986 . . . . 0.0 110.415 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.526 ' O ' ' NE2' ' A' ' 211' ' ' GLN . . . -65.91 0.29 6.06 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.627 ' HB2' ' CE2' ' A' ' 207' ' ' TRP . 0.0 OUTLIER -66.09 -28.26 68.69 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.287 -1.125 . . . . 0.0 110.407 -179.818 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . 0.671 ' O ' ' C ' ' A' ' 211' ' ' GLN . 22.9 p -145.52 14.9 1.43 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 110.853 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.671 ' C ' ' O ' ' A' ' 210' ' ' CYS . 0.0 OUTLIER -6.04 117.74 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.655 0.741 . . . . 0.0 111.466 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.678 HG12 ' CZ ' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -121.88 144.77 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.76 -0.588 . . . . 0.0 109.985 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 0.55 ' HB2' ' OG ' ' A' ' 94' ' ' SER . 0.8 OUTLIER -88.07 171.8 10.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.217 -0.927 . . . . 0.0 110.229 -179.482 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.866 HD12 ' HB2' ' A' ' 48' ' ' TRP . 0.7 OUTLIER -143.36 118.53 4.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-O 122.013 0.911 . . . . 0.0 111.805 -178.346 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.608 ' O ' ' N ' ' A' ' 92' ' ' GLU . 66.4 mtt-85 -130.62 108.91 10.26 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . 0.627 ' CE2' ' HB3' ' A' ' 91' ' ' TRP . 3.2 t80 -105.82 149.3 26.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.094 -1.004 . . . . 0.0 111.094 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' MET . . . . . 0.465 ' O ' ' O ' ' A' ' 90' ' ' ALA . 1.0 OUTLIER -131.5 121.05 23.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.48 -0.762 . . . . 0.0 110.154 179.745 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 132.58 -32.82 2.74 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 220' ' ' ARG . 0.9 OUTLIER -95.57 136.36 36.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.236 -1.155 . . . . 0.0 110.226 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . 0.69 ' O ' ' C ' ' A' ' 221' ' ' ARG . 18.9 mtm180 -150.41 120.26 7.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 0.0 110.271 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . 0.69 ' C ' ' O ' ' A' ' 220' ' ' ARG . 3.9 mtp180 0.03 78.48 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.431 0.634 . . . . 0.0 111.265 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.49 ' C ' ' O ' ' A' ' 221' ' ' ARG . 2.6 p -35.68 156.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.649 -0.657 . . . . 0.0 110.532 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.518 ' O ' ' C ' ' A' ' 224' ' ' GLU . 11.4 tt0 179.94 70.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.198 -0.939 . . . . 0.0 110.287 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.518 ' C ' ' O ' ' A' ' 223' ' ' GLU . 4.6 mt-10 -33.17 -37.11 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.483 -0.761 . . . . 0.0 110.728 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 223' ' ' GLU . 86.1 m -41.81 112.17 0.3 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.332 -0.855 . . . . 0.0 110.209 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' A' ' 225' ' ' THR . 13.7 mmm180 -141.7 19.87 2.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 110.272 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 226' ' ' ARG . 0.0 OUTLIER -179.99 -31.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.217 -0.927 . . . . 0.0 110.306 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.424 HG22 HD13 ' A' ' 228' ' ' ILE . 2.8 mt -95.8 -132.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.32 -0.863 . . . . 0.0 110.016 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.479 ' O ' ' HB2' ' A' ' 230' ' ' ARG . 1.0 OUTLIER -170.34 -146.66 0.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.11 -0.994 . . . . 0.0 110.284 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . 0.682 ' O ' ' C ' ' A' ' 231' ' ' ASP . 1.4 tpt180 -179.57 142.05 0.17 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.392 -0.818 . . . . 0.0 110.056 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.682 ' C ' ' O ' ' A' ' 230' ' ' ARG . 1.2 m-20 . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 117.989 -1.005 . . . . 0.0 111.422 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 8' ' ' SER . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.6 p -59.47 87.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.201 -1.176 . . . . 0.0 110.228 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 6' ' ' GLY . 34.3 t -171.13 143.18 1.89 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.204 -0.935 . . . . 0.0 110.163 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.401 ' O ' ' O ' ' A' ' 10' ' ' ARG . . . -100.09 147.83 25.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.101 -0.999 . . . . 0.0 110.239 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.401 ' O ' ' O ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -46.72 170.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.893 . . . . 0.0 110.243 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.56 131.92 47.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.174 -0.954 . . . . 0.0 110.199 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.4 m -124.87 14.83 8.6 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.905 . . . . 0.0 110.212 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.413 ' HB ' ' HD2' ' A' ' 14' ' ' PRO . 6.3 p -80.39 165.39 46.67 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.336 -0.853 . . . . 0.0 110.131 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.413 ' HD2' ' HB ' ' A' ' 13' ' ' THR . 46.1 Cg_endo -73.15 86.7 1.1 Allowed 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.047 1.551 . . . . 0.0 110.434 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.67 -169.79 0.93 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.264 -0.897 . . . . 0.0 110.278 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.5 p -162.81 -149.47 0.15 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.912 . . . . 0.0 110.192 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.97 4.47 25.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 110.161 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.26 139.02 55.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.136 -0.977 . . . . 0.0 110.266 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.08 -164.43 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.357 -0.84 . . . . 0.0 110.235 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -122.51 -158.23 0.77 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 0.0 110.207 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 52.6 p -148.02 131.12 16.34 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.219 -0.926 . . . . 0.0 110.166 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.41 79.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.203 -0.936 . . . . 0.0 110.259 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.44 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -96.7 -71.36 0.68 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.235 -0.915 . . . . 0.0 110.174 179.926 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.47 105.29 24.8 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.3 -0.875 . . . . 0.0 110.1 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 23' ' ' PHE . 47.0 Cg_endo -73.35 168.65 24.22 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.936 1.493 . . . . 0.0 110.444 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.462 ' HB3' ' HB3' ' A' ' 74' ' ' SER . 45.7 Cg_endo -72.94 165.23 33.36 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.035 1.545 . . . . 0.0 110.364 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.97 37.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.202 -0.936 . . . . 0.0 110.324 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.05 23.19 31.05 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -51.89 -32.98 34.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.434 -1.039 . . . . 0.0 110.08 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.472 ' HA ' HD22 ' A' ' 33' ' ' LEU . 24.8 pt-20 -47.06 -35.12 6.51 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.304 -0.872 . . . . 0.0 109.579 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.469 ' N ' ' HG3' ' A' ' 30' ' ' GLU . 1.1 tm-20 -63.91 -23.51 67.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.446 -0.784 . . . . 0.0 108.992 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.5 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -83.29 -33.88 25.86 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.645 ' HG ' ' N ' ' A' ' 34' ' ' SER . 0.3 OUTLIER -73.55 -35.98 65.59 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 122.058 0.933 . . . . 0.0 108.917 179.293 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.645 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 23.5 t -71.24 -12.57 61.53 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.605 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.634 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . . . -45.31 -64.97 0.72 Allowed Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.19 -0.944 . . . . 0.0 110.268 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.738 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 50.0 Cg_endo -72.8 147.8 45.15 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.75 1.395 . . . . 0.0 110.15 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.494 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 54.7 Cg_endo -99.3 42.84 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.001 1.801 . . . . 0.0 112.912 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.738 ' HD3' ' HB2' ' A' ' 36' ' ' PRO . 50.8 Cg_endo -76.23 151.13 33.83 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 122.908 0.951 . . . . 0.0 110.303 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.71 ' O ' ' HB3' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -28.62 -36.08 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.587 -0.696 . . . . 0.0 110.659 179.676 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.684 ' O ' ' HB3' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -49.91 -48.52 51.6 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.786 -1.197 . . . . 0.0 110.501 -179.605 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.626 ' O ' ' CD2' ' A' ' 45' ' ' HIS . 41.1 t -83.93 -32.55 8.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 121.161 -0.962 . . . . 0.0 110.296 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 46' ' ' HIS . . . -89.72 -41.13 12.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.092 -1.005 . . . . 0.0 111.731 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.71 ' HB3' ' O ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -78.46 -20.54 50.73 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.095 -1.003 . . . . 0.0 110.39 -179.215 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.684 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 7.6 tpt180 -76.42 -55.02 5.93 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.626 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 38.3 m-70 -65.73 -17.19 64.44 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.519 ' HB2' ' O ' ' A' ' 42' ' ' ALA . 74.1 t60 -96.77 -17.15 20.44 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.697 0.76 . . . . 0.0 109.355 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.97 -112.3 0.12 Allowed Glycine 0 N--CA 1.477 1.367 0 N-CA-C 108.156 -1.977 . . . . 0.0 108.156 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.806 ' HB3' ' CD1' ' A' ' 214' ' ' ILE . 4.6 m95 -102.97 70.93 1.11 Allowed 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.849 -1.14 . . . . 0.0 110.844 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.638 ' ND2' ' HB3' ' A' ' 53' ' ' CYS . 0.9 OUTLIER -108.41 111.97 61.22 Favored Pre-proline 0 C--N 1.302 -1.491 0 O-C-N 121.139 -0.976 . . . . 0.0 109.694 178.017 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.832 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 40.9 Cg_endo -68.03 -63.68 0.05 OUTLIER 'Trans proline' 0 C--N 1.301 -1.949 0 O-C-N 123.291 1.153 . . . . 0.0 109.764 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 1.105 ' HA ' ' CE ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER 176.07 36.98 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 122.502 1.144 . . . . 0.0 111.561 178.059 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.77 ' HB3' ' HG2' ' A' ' 79' ' ' ARG 0.255 0.7 OUTLIER -169.8 23.23 0.02 OUTLIER 'General case' 0 C--N 1.269 -2.921 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.331 -179.385 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.638 ' HB3' ' ND2' ' A' ' 49' ' ' ASN . 8.3 t -101.27 127.42 47.88 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-O 122.523 1.154 . . . . 0.0 111.337 -177.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.553 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 0.6 OUTLIER -90.11 166.23 13.52 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.337 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.644 ' HG3' ' CD1' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -74.45 1.97 10.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.693 -0.629 . . . . 0.0 110.981 -179.146 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.591 ' ND2' ' O ' ' A' ' 76' ' ' ASP . 0.0 OUTLIER -31.64 -32.63 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.642 0.734 . . . . 0.0 109.833 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.632 ' N ' ' O ' ' A' ' 55' ' ' GLU . 4.6 pt -136.34 166.39 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.562 -0.711 . . . . 0.0 110.41 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.576 ' O ' ' CB ' ' A' ' 67' ' ' GLU . 1.0 OUTLIER -109.21 121.59 45.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 110.458 -179.263 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.617 HG13 ' CD1' ' A' ' 66' ' ' PHE . 58.4 t -130.32 132.69 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.287 -0.883 . . . . 0.0 110.21 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.668 ' HB2' ' HG3' ' A' ' 43' ' ' GLN . 3.1 ttpt -135.26 155.07 51.25 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.218 -0.926 . . . . 0.0 110.397 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 63' ' ' GLY . 4.2 tt0 -74.87 -118.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.351 -0.843 . . . . 0.0 110.203 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 42.08 28.81 0.53 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.674 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 129.65 60.55 0.1 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.682 ' CD2' ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER 0.44 84.83 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.751 -0.852 . . . . 0.0 111.172 -179.716 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 31.5 t -126.65 114.82 18.54 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.162 -0.961 . . . . 0.0 111.005 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.617 ' CD1' HG13 ' A' ' 59' ' ' VAL . 3.6 m-85 -90.23 124.72 35.1 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.576 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 3.4 tt0 -125.37 147.53 49.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.737 -1.227 . . . . 0.0 110.516 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.563 ' HB3' ' CG2' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -136.09 115.68 12.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.434 -0.791 . . . . 0.0 109.777 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.65 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -68.94 -65.99 1.12 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.024 -1.048 . . . . 0.0 110.255 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.65 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 56.1 Cg_endo -70.49 -143.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.924 1.487 . . . . 0.0 109.354 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.484 ' O ' ' N ' ' A' ' 73' ' ' GLN . 3.5 t -139.6 164.11 24.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 O-C-N 121.319 -0.863 . . . . 0.0 109.965 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.539 ' HB1' ' CD1' ' A' ' 207' ' ' TRP . . . -66.92 59.25 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 0.0 110.113 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.484 ' N ' ' O ' ' A' ' 71' ' ' VAL . 4.7 mt-30 -53.38 -92.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.181 -0.949 . . . . 0.0 110.378 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.462 ' HB3' ' HB3' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -143.71 27.86 1.48 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.93 . . . . 0.0 110.367 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.462 ' CG2' ' OE1' ' A' ' 30' ' ' GLU . 1.4 m -103.5 -134.19 0.32 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.19 -0.944 . . . . 0.0 109.761 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.591 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 22.8 t70 -140.67 113.14 8.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 110.363 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.554 ' O ' ' ND2' ' A' ' 56' ' ' ASN . . . -51.44 -90.96 0.01 OUTLIER Glycine 0 N--CA 1.488 2.105 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 178.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.553 ' HA ' ' SG ' ' A' ' 53' ' ' CYS . 0.1 OUTLIER -132.29 134.68 59.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.296 -1.12 . . . . 0.0 109.181 178.405 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.77 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 45.1 ttp180 -146.13 161.99 38.95 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.813 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.745 ' HA2' ' HB2' ' A' ' 52' ' ' ASP . . . -152.94 117.04 0.78 Allowed Glycine 0 N--CA 1.495 2.62 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.488 ' HG3' ' HB3' ' A' ' 202' ' ' SER . 2.5 ttmp? -155.75 -117.26 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.959 -1.318 . . . . 0.0 111.262 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.654 ' HD3' ' H ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -48.53 -17.19 0.14 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.336 -0.853 . . . . 0.0 111.481 -179.131 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.654 ' H ' ' HD3' ' A' ' 82' ' ' ARG . . . -77.5 36.24 1.58 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.589 ' CE1' HD23 ' A' ' 171' ' ' LEU . 0.6 OUTLIER -111.49 156.61 21.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.105 -1.233 . . . . 0.0 110.405 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.29 177.83 5.08 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.443 -0.786 . . . . 0.0 110.667 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.533 ' HA ' ' CB ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -99.45 -173.47 2.48 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.394 -0.816 . . . . 0.0 110.024 -179.669 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.414 ' H ' ' CB ' ' A' ' 173' ' ' MET . . . 100.48 160.65 28.04 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.8 tt -87.66 114.22 24.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.172 -1.193 . . . . 0.0 110.479 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -147.41 173.22 12.84 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.378 -0.826 . . . . 0.0 109.935 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.562 ' O ' ' O ' ' A' ' 217' ' ' MET . . . -151.63 148.85 28.46 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.149 -0.969 . . . . 0.0 109.79 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.636 ' CZ3' ' CG1' ' A' ' 169' ' ' VAL . 0.0 OUTLIER -134.75 161.33 35.48 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.846 -1.159 . . . . 0.0 110.216 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.59 ' N ' ' O ' ' A' ' 215' ' ' ARG . 0.0 OUTLIER -109.47 124.84 51.72 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.515 179.642 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.546 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 1.6 mp -126.14 154.31 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.14 -0.975 . . . . 0.0 110.385 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.551 ' CA ' ' O ' ' A' ' 165' ' ' GLU . 0.0 OUTLIER -135.52 119.85 17.89 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.541 -0.724 . . . . 0.0 109.415 179.667 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.7 ' HH2' ' O ' ' A' ' 204' ' ' SER . 2.3 t-105 -128.61 89.14 50.21 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.106 -0.997 . . . . 0.0 110.87 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.565 ' HB3' ' CB ' ' A' ' 165' ' ' GLU . 50.5 Cg_endo -88.06 115.09 0.91 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.097 1.578 . . . . 0.0 110.277 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.515 HD22 ' CB ' ' A' ' 104' ' ' ALA . 0.1 OUTLIER -95.08 -6.48 41.93 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.049 -1.032 . . . . 0.0 110.311 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -65.78 -8.75 23.09 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.152 -0.968 . . . . 0.0 110.24 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.433 ' C ' ' HG2' ' A' ' 100' ' ' ARG . 18.5 mm-40 -87.93 -102.7 0.08 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -0.886 . . . . 0.0 110.259 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.433 ' HG2' ' C ' ' A' ' 99' ' ' GLN . 17.7 mmm180 -134.83 -126.76 0.16 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.065 -1.022 . . . . 0.0 110.172 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.465 ' HA3' ' HB3' ' A' ' 210' ' ' CYS . . . 65.24 112.59 0.01 OUTLIER Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.85 -62.7 1.61 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.312 -1.111 . . . . 0.0 110.223 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.532 ' HB2' ' CG2' ' A' ' 206' ' ' VAL . 10.4 m170 -98.32 173.71 6.85 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.308 -0.87 . . . . 0.0 110.439 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.515 ' CB ' HD22 ' A' ' 97' ' ' LEU . . . 179.85 133.32 0.1 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.318 -0.864 . . . . 0.0 110.035 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 204' ' ' SER . 0.1 OUTLIER -135.19 134.91 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.962 -1.086 . . . . 0.0 111.88 -179.125 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.69 HG23 ' CG ' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -151.53 118.82 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.555 -0.715 . . . . 0.0 109.521 178.286 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.516 ' HA3' ' HA3' ' A' ' 132' ' ' GLY . . . 161.62 -154.34 25.3 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 118.887 -1.625 . . . . 0.0 110.725 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.575 ' HB ' ' CD1' ' A' ' 199' ' ' LEU . 58.2 t -138.77 157.92 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.687 -0.89 . . . . 0.0 109.785 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.564 ' CB ' ' HA ' ' A' ' 130' ' ' SER . . . -133.93 153.38 51.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.043 -1.036 . . . . 0.0 110.436 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.606 ' CG2' ' HB3' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -101.08 128.28 47.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.234 -0.917 . . . . 0.0 109.817 179.618 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.21 -27.76 17.46 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.509 -0.744 . . . . 0.0 109.588 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.444 ' O ' ' C ' ' A' ' 113' ' ' ALA . 0.8 OUTLIER -81.7 -12.54 58.6 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.411 -0.806 . . . . 0.0 109.57 179.312 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.537 ' CB ' ' HB2' ' A' ' 129' ' ' GLU . . . -40.87 150.44 0.29 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.515 -0.741 . . . . 0.0 110.263 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -73.17 -81.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.003 1.528 . . . . 0.0 110.593 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.468 ' HG ' ' HA ' ' A' ' 127' ' ' ASN . 0.4 OUTLIER 179.82 63.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.161 -0.962 . . . . 0.0 110.15 179.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 115' ' ' LEU . 28.3 tp60 -39.14 -39.25 0.57 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.307 -0.87 . . . . 0.0 110.266 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.552 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -41.8 160.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.367 -0.833 . . . . 0.0 110.128 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.552 ' C ' ' O ' ' A' ' 117' ' ' ALA . 21.9 t70 -30.53 -89.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.474 -0.766 . . . . 0.0 110.774 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -168.79 -52.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.212 -0.93 . . . . 0.0 110.169 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.5 93.75 2.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.313 -0.867 . . . . 0.0 110.2 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -130.85 67.52 1.5 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.155 -0.966 . . . . 0.0 110.197 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 123' ' ' LEU . . . -100.22 135.52 41.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 0.0 110.213 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER 60.87 102.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.25 -0.906 . . . . 0.0 110.216 179.919 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 62.66 47.83 4.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.311 -0.868 . . . . 0.0 110.26 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -100.52 -124.88 5.41 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.1 m -148.38 62.72 1.09 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -1.164 . . . . 0.0 110.193 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.468 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 2.4 t-20 -77.33 -6.52 53.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -0.895 . . . . 0.0 110.169 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 33.3 t -102.72 171.02 7.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.303 -0.873 . . . . 0.0 110.228 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.537 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . 0.3 OUTLIER -150.0 129.9 13.38 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 110.107 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.564 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 47.8 t -120.36 119.94 34.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.332 -0.855 . . . . 0.0 110.181 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . 0.48 ' O ' ' O ' ' A' ' 108' ' ' VAL . 0.8 OUTLIER -129.69 124.74 34.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.374 -0.829 . . . . 0.0 109.906 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.516 ' HA3' ' HA3' ' A' ' 107' ' ' GLY . . . 174.92 -133.23 2.4 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.611 ' CD2' HG21 ' A' ' 163' ' ' VAL . 54.8 m0 -110.68 113.65 26.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.122 -1.223 . . . . 0.0 110.694 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.408 ' C ' HD13 ' A' ' 135' ' ' ILE . 6.0 t0 -117.97 134.84 54.58 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.741 -0.599 . . . . 0.0 110.263 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.588 ' CD1' ' N ' ' A' ' 135' ' ' ILE . 0.1 OUTLIER -141.64 7.5 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.275 -0.891 . . . . 0.0 110.308 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -101.23 -48.37 1.45 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.74 6.31 36.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.355 -1.085 . . . . 0.0 109.67 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -118.08 -12.98 7.32 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.673 ' O ' ' C ' ' A' ' 140' ' ' LEU . 7.1 tptm -67.29 -140.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -1.103 . . . . 0.0 110.512 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.673 ' C ' ' O ' ' A' ' 139' ' ' LYS . 0.7 OUTLIER 0.39 74.03 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.328 0.585 . . . . 0.0 111.306 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.543 ' N ' ' O ' ' A' ' 139' ' ' LYS . 20.8 t80 -154.64 101.22 2.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.358 -0.838 . . . . 0.0 110.144 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -153.38 86.35 1.22 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.168 -0.957 . . . . 0.0 110.22 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -104.38 -67.4 0.9 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.269 -0.894 . . . . 0.0 110.241 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.97 124.53 49.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.18 -0.95 . . . . 0.0 110.177 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.28 -173.76 4.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.936 . . . . 0.0 110.235 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 75.38 49.86 8.88 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.9 tt -151.76 83.41 1.28 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -1.104 . . . . 0.0 110.22 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 149' ' ' ALA . 36.1 tt0 179.83 140.34 0.13 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.28 -0.887 . . . . 0.0 110.178 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 148' ' ' GLU . . . -177.08 79.29 0.25 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.197 -0.939 . . . . 0.0 110.421 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.427 ' HB3' ' HA3' ' A' ' 155' ' ' GLY . 47.4 Cg_endo -74.57 52.51 2.9 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.027 1.541 . . . . 0.0 110.46 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.48 -90.37 0.08 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.232 -0.917 . . . . 0.0 110.26 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.568 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 3.1 m-85 -76.68 -60.26 0.88 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.247 -0.908 . . . . 0.0 110.259 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.568 ' CD ' ' CB ' ' A' ' 152' ' ' TYR . 46.7 Cg_endo -72.67 169.92 20.75 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.983 1.518 . . . . 0.0 110.41 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 155' ' ' GLY . . . -80.54 104.75 11.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.26 -0.9 . . . . 0.0 110.295 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 154' ' ' ALA . . . -43.61 136.6 4.73 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.426 ' HG2' ' OE1' ' A' ' 157' ' ' GLN . 47.1 Cg_endo -73.54 -17.59 23.4 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.909 1.478 . . . . 0.0 110.344 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.461 ' HA ' ' HB2' ' A' ' 160' ' ' GLN . 3.2 mp0 -68.6 -0.76 5.54 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.256 -0.903 . . . . 0.0 110.685 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -46.06 -43.94 13.64 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -89.34 6.54 40.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -1.15 . . . . 0.0 110.207 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.461 ' HB2' ' HA ' ' A' ' 157' ' ' GLN . 0.0 OUTLIER -89.85 0.56 56.97 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.428 -0.795 . . . . 0.0 110.144 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.692 ' O ' ' C ' ' A' ' 162' ' ' VAL . 1.1 mt -127.31 71.41 1.33 Allowed 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.209 -0.932 . . . . 0.0 110.086 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.692 ' C ' ' O ' ' A' ' 161' ' ' LEU . 2.5 t 1.0 92.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 121.557 0.694 . . . . 0.0 110.926 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.674 ' CG1' ' HD2' ' A' ' 164' ' ' PRO . 53.8 t -35.52 153.0 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.904 -0.498 . . . . 0.0 110.081 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.674 ' HD2' ' CG1' ' A' ' 163' ' ' VAL . 38.1 Cg_endo -64.48 134.15 40.25 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.808 1.425 . . . . 0.0 110.771 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.565 ' CB ' ' HB3' ' A' ' 96' ' ' PRO . 24.4 pt-20 -41.23 -25.22 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.604 -0.685 . . . . 0.0 111.317 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 164' ' ' PRO . 0.0 OUTLIER -116.08 138.38 51.29 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.944 -1.097 . . . . 0.0 110.698 -179.388 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 93' ' ' ILE . 2.5 pp -158.9 154.64 26.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.615 -0.678 . . . . 0.0 109.924 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' A' ' 181' ' ' SER . 18.0 tp -112.78 141.08 47.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.116 -0.99 . . . . 0.0 110.128 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.664 ' CG2' ' CE2' ' A' ' 180' ' ' TYR . 6.5 t -124.06 136.3 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.147 -0.97 . . . . 0.0 110.486 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.503 ' O ' ' CG1' ' A' ' 170' ' ' VAL . 9.8 p -115.3 121.4 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.449 -0.782 . . . . 0.0 109.377 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.589 HD23 ' CE1' ' A' ' 84' ' ' TYR . 0.0 OUTLIER -127.16 107.82 10.36 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.042 -1.036 . . . . 0.0 110.104 -179.512 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -120.01 129.49 54.28 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.876 0.846 . . . . 0.0 109.903 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.533 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -98.77 -39.46 8.62 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.576 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 173' ' ' MET . 0.1 OUTLIER -46.37 -26.47 0.84 Allowed 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.439 -0.905 . . . . 0.0 108.698 178.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.535 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 3.3 tt0 -110.16 -27.43 9.14 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 198' ' ' THR . . . 84.15 23.36 52.11 Favored Glycine 0 N--CA 1.483 1.77 0 N-CA-C 108.756 -1.738 . . . . 0.0 108.756 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.61 ' HA ' ' CD2' ' A' ' 194' ' ' LEU . 0.1 OUTLIER -118.46 116.96 27.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.166 -1.197 . . . . 0.0 111.402 -179.55 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.571 ' N ' ' CD1' ' A' ' 178' ' ' LEU . 3.3 mp -130.6 153.71 48.62 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.421 -0.799 . . . . 0.0 109.501 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.49 ' C ' ' CD2' ' A' ' 187' ' ' LEU . . . -161.93 166.96 36.45 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.14 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.664 ' CE2' ' CG2' ' A' ' 169' ' ' VAL . 1.1 t80 -125.01 118.28 25.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.439 -1.036 . . . . 0.0 109.85 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.525 ' OG ' ' N ' ' A' ' 186' ' ' TYR . 0.6 OUTLIER -145.15 165.25 28.86 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.334 -0.854 . . . . 0.0 110.072 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.575 HD12 ' CE2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -110.18 116.6 52.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 O-C-N 121.501 -0.749 . . . . 0.0 109.543 179.195 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 79.6 -1.72 76.27 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 87.9 39.99 6.82 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' ' 186' ' ' TYR . 32.1 m -94.38 -86.84 0.27 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.214 -1.168 . . . . 0.0 110.65 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.575 ' CE2' HD12 ' A' ' 182' ' ' ILE . 22.5 m-85 -40.15 -40.74 1.15 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.263 -0.898 . . . . 0.0 110.78 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.509 ' N ' HD12 ' A' ' 187' ' ' LEU . 5.8 mp -80.56 47.2 0.92 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.08 -1.013 . . . . 0.0 109.948 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -108.72 -82.15 1.38 Allowed Glycine 0 N--CA 1.491 2.3 0 C-N-CA 119.853 -1.165 . . . . 0.0 110.326 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.429 ' C ' ' H ' ' A' ' 191' ' ' PHE . 46.0 Cg_endo -71.98 -28.39 16.28 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.926 1.488 . . . . 0.0 111.081 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.594 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -72.67 20.71 0.07 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.27 -0.894 . . . . 0.0 111.363 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.429 ' H ' ' C ' ' A' ' 189' ' ' PRO . 1.6 m-85 -90.2 -13.55 35.29 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.928 -1.107 . . . . 0.0 110.325 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.519 ' HA ' ' NE ' ' A' ' 192' ' ' ARG . 0.1 OUTLIER -90.28 -14.69 32.74 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.317 -0.865 . . . . 0.0 110.563 -179.76 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' A' ' 197' ' ' ARG . . . -111.28 -18.91 7.84 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.706 ' HA ' ' HD2' ' A' ' 197' ' ' ARG . 6.2 tt -61.95 -33.72 74.81 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.799 -0.824 . . . . 0.0 108.818 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.518 ' HA ' ' CG2' ' A' ' 177' ' ' THR . 0.0 OUTLIER -45.59 -29.84 1.32 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.553 -0.717 . . . . 0.0 109.529 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -115.59 -21.16 5.18 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.706 ' HD2' ' HA ' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -90.99 -9.24 46.72 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.661 -0.905 . . . . 0.0 109.666 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.549 ' CB ' ' O ' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -43.5 148.95 0.29 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.015 0.912 . . . . 0.0 111.961 -177.785 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.606 ' HB3' ' CG2' ' A' ' 110' ' ' THR . 0.1 OUTLIER -140.59 169.81 16.96 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.511 179.519 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.547 ' N ' ' O ' ' A' ' 109' ' ' ALA . 19.0 m-85 -84.75 129.92 54.96 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.017 -1.052 . . . . 0.0 109.499 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.573 ' HG3' ' CD1' ' A' ' 171' ' ' LEU . 41.4 Cg_endo -67.87 125.13 12.71 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.805 1.424 . . . . 0.0 110.407 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 57.5 p -133.29 152.27 51.92 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.253 -0.904 . . . . 0.0 111.195 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.561 ' CG1' ' HG3' ' A' ' 50' ' ' PRO . 4.0 p -158.93 160.6 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.648 -0.657 . . . . 0.0 109.532 179.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' SER . . . . . 0.7 ' O ' ' HH2' ' A' ' 95' ' ' TRP . 0.3 OUTLIER -160.38 130.32 5.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.307 -0.87 . . . . 0.0 110.319 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.544 ' CB ' HG12 ' A' ' 78' ' ' VAL . . . -108.74 150.53 27.46 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.031 -1.043 . . . . 0.0 110.398 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.532 ' CG2' ' HB2' ' A' ' 103' ' ' HIS . 1.2 t -91.19 159.97 2.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.542 0.687 . . . . 0.0 110.712 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.539 ' CD1' ' HB1' ' A' ' 72' ' ' ALA . 16.7 p-90 -82.54 46.61 1.08 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.286 -0.884 . . . . 0.0 109.646 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -108.88 -128.95 5.8 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.791 ' O ' ' O ' ' A' ' 210' ' ' CYS . 1.0 OUTLIER -127.51 -22.59 3.62 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.357 -1.084 . . . . 0.0 110.548 -179.538 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . 0.791 ' O ' ' O ' ' A' ' 209' ' ' GLN . 31.4 p 1.6 -133.42 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.032 0.444 . . . . 0.0 111.875 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.552 ' HB3' ' HG2' ' A' ' 96' ' ' PRO . 0.0 OUTLIER 178.88 33.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.847 -1.158 . . . . 0.0 110.808 -179.595 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.543 HG22 ' CE3' ' A' ' 95' ' ' TRP . 2.5 p -86.63 124.96 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.032 -1.042 . . . . 0.0 110.267 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 0.542 ' HG2' HD23 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -96.97 170.51 9.1 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.624 -0.672 . . . . 0.0 110.868 -179.3 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.806 ' CD1' ' HB3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -132.25 122.37 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.244 -0.91 . . . . 0.0 110.612 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.59 ' O ' ' N ' ' A' ' 92' ' ' GLU . 0.5 OUTLIER -130.63 140.15 50.4 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.563 -0.711 . . . . 0.0 109.96 179.464 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . 0.577 ' HA ' ' HB3' ' A' ' 91' ' ' TRP . 8.2 t80 -118.93 150.92 39.08 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.257 -0.902 . . . . 0.0 110.924 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' MET . . . . . 0.562 ' O ' ' O ' ' A' ' 90' ' ' ALA . 9.0 tpp -134.99 108.01 7.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.933 . . . . 0.0 110.244 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 128.44 -9.48 6.53 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.486 ' HB2' ' CD1' ' A' ' 216' ' ' TYR . 3.9 mm-40 -95.49 117.76 30.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.203 -1.175 . . . . 0.0 110.044 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -105.04 176.74 5.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.29 -0.881 . . . . 0.0 110.312 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . 0.518 ' O ' ' C ' ' A' ' 222' ' ' VAL . 0.0 OUTLIER -123.85 83.28 2.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 0.0 110.054 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.518 ' C ' ' O ' ' A' ' 221' ' ' ARG . 8.5 p -33.21 144.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.493 -0.755 . . . . 0.0 110.593 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.657 ' O ' ' C ' ' A' ' 224' ' ' GLU . 30.6 mm-40 -73.24 52.42 0.35 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.195 -0.941 . . . . 0.0 110.333 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.657 ' C ' ' O ' ' A' ' 223' ' ' GLU . 1.1 tt0 0.77 70.35 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.329 0.585 . . . . 0.0 111.395 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.61 ' N ' ' O ' ' A' ' 223' ' ' GLU . 15.6 m -170.11 96.94 0.28 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.548 -0.72 . . . . 0.0 110.097 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.45 ' O ' ' O ' ' A' ' 225' ' ' THR . 3.1 tpp180 -43.7 167.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.32 -0.863 . . . . 0.0 110.118 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -43.08 138.09 2.25 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.16 -0.962 . . . . 0.0 110.199 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.494 HD12 ' CG2' ' A' ' 225' ' ' THR . 4.9 pt -142.13 129.34 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 110.166 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -66.35 -25.45 66.81 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.267 -0.896 . . . . 0.0 110.202 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . 0.676 ' O ' ' C ' ' A' ' 231' ' ' ASP . 0.0 OUTLIER 179.8 -35.01 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.161 -0.962 . . . . 0.0 110.184 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.676 ' C ' ' O ' ' A' ' 230' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 117.961 -1.019 . . . . 0.0 111.437 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 50.06 -175.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.254 -1.145 . . . . 0.0 110.207 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.2 m -105.68 -147.29 0.4 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.912 . . . . 0.0 110.163 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -164.58 128.05 2.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.229 -0.919 . . . . 0.0 110.235 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.462 ' O ' ' CG ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -97.54 72.61 2.35 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.904 . . . . 0.0 110.201 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -148.6 -152.43 0.44 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.331 -0.855 . . . . 0.0 110.236 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.49 30.28 1.03 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.372 -0.83 . . . . 0.0 110.179 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.544 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -63.34 -54.87 40.75 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.0 110.27 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 13' ' ' THR . 46.1 Cg_endo -73.04 -158.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.981 1.516 . . . . 0.0 110.452 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.438 HG21 ' O ' ' A' ' 15' ' ' THR . 15.0 t -41.03 151.18 0.07 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.292 -0.88 . . . . 0.0 110.292 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.13 170.79 0.06 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -0.922 . . . . 0.0 110.299 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -106.5 -45.84 4.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 0.0 110.324 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -170.83 105.03 0.25 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 0.0 110.383 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.91 -162.58 0.87 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.209 -0.932 . . . . 0.0 110.287 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.1 m-30 -77.29 -160.43 0.17 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.161 -0.962 . . . . 0.0 110.138 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.0 t -149.03 155.4 40.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 0.0 110.252 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -176.14 40.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.89 . . . . 0.0 110.176 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -104.84 -73.38 0.68 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -0.891 . . . . 0.0 110.245 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -125.13 164.53 31.24 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.335 -0.853 . . . . 0.0 110.228 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.99 113.29 3.73 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.01 1.532 . . . . 0.0 110.429 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.681 ' O ' ' C ' ' A' ' 27' ' ' GLU . 46.5 Cg_endo -72.95 -168.95 0.45 Allowed 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 124.01 1.532 . . . . 0.0 110.348 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.681 ' C ' ' O ' ' A' ' 26' ' ' PRO . 27.9 tt0 1.23 68.49 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.585 0.707 . . . . 0.0 111.062 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.642 ' N ' ' O ' ' A' ' 26' ' ' PRO . . . 169.04 -21.26 0.08 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.578 ' HG ' ' N ' ' A' ' 30' ' ' GLU . 0.9 OUTLIER -42.48 -24.86 0.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.16 -1.2 . . . . 0.0 110.122 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.578 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 19.1 pt-20 -47.99 -29.78 3.75 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.095 -1.003 . . . . 0.0 108.538 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -64.59 -23.95 67.43 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.543 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -82.68 -37.25 25.07 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.826 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.603 ' CD2' ' HG2' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -71.39 -38.28 71.49 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.823 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.672 ' O ' ' O ' ' A' ' 35' ' ' ALA . 1.8 m -78.45 -7.08 57.01 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.252 0.548 . . . . 0.0 110.007 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.85 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . . . -49.43 -153.73 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.689 -0.632 . . . . 0.0 110.645 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.85 ' HD2' ' CB ' ' A' ' 35' ' ' ALA . 38.1 Cg_endo -65.3 -170.74 0.17 Allowed 'Trans proline' 0 N--CA 1.488 1.177 0 O-C-N 122.734 0.86 . . . . 0.0 110.349 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.624 ' CD ' ' HB2' ' A' ' 36' ' ' PRO . 52.0 Cg_endo -97.17 50.2 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.525 1.483 . . . . 0.0 113.413 -178.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.743 ' HD2' ' O ' ' A' ' 36' ' ' PRO . 46.7 Cg_endo -73.07 150.67 48.66 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 N-CA-C 108.671 -1.319 . . . . 0.0 108.671 178.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.644 ' C ' ' O ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -21.32 -52.93 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.108 -0.995 . . . . 0.0 111.23 -179.171 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.717 ' O ' ' HB3' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -54.38 -45.97 72.95 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 120.786 -1.196 . . . . 0.0 110.096 -179.344 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.719 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 6.2 t -86.99 -33.6 7.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 O-C-N 121.021 -1.049 . . . . 0.0 110.29 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 37' ' ' PRO . . . -90.91 -39.54 12.23 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.003 -1.06 . . . . 0.0 112.435 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.773 ' OE1' ' HA ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -83.0 -20.07 35.79 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.936 -1.102 . . . . 0.0 109.988 -178.832 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.717 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -80.45 -46.67 15.53 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.242 -0.911 . . . . 0.0 109.371 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.719 ' CG ' ' O ' ' A' ' 41' ' ' VAL . 14.7 m170 -54.86 -16.9 2.99 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.645 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.57 ' CG ' ' OE1' ' A' ' 61' ' ' GLU . 6.0 t60 -95.46 -35.06 11.85 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.079 -1.048 . . . . 0.0 109.271 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.465 ' HA2' ' OE2' ' A' ' 61' ' ' GLU . . . -93.53 -107.01 1.85 Allowed Glycine 0 N--CA 1.488 2.128 0 N-CA-C 107.116 -2.394 . . . . 0.0 107.116 178.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.76 ' CD1' ' CG1' ' A' ' 59' ' ' VAL . 98.9 m95 -79.83 73.57 6.58 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.001 -1.293 . . . . 0.0 108.271 177.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.606 ' HA ' ' HA ' ' A' ' 45' ' ' HIS . 0.1 OUTLIER -46.95 138.81 7.15 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.503 -0.748 . . . . 0.0 111.262 -179.357 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.649 ' HG2' ' HE3' ' A' ' 51' ' ' LYS . 39.8 Cg_endo -69.55 -27.01 27.98 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 124.387 1.73 . . . . 0.0 110.862 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.853 ' CE ' ' N ' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -63.16 -17.9 62.88 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 178.293 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.808 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 7.4 m-20 -121.12 3.25 10.43 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.223 177.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.664 ' HA ' ' CB ' ' A' ' 78' ' ' VAL . 2.4 t -138.56 128.29 25.01 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.949 0.88 . . . . 0.0 111.045 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.735 ' H ' ' HA ' ' A' ' 78' ' ' VAL . 0.7 OUTLIER -70.12 118.07 12.49 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.634 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.661 ' O ' ' N ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -51.38 -27.93 11.26 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.079 -1.013 . . . . 0.0 111.211 -179.258 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.728 ' ND2' ' CB ' ' A' ' 54' ' ' SER . 1.4 m-80 -28.29 -34.5 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.747 0.784 . . . . 0.0 110.279 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.661 ' N ' ' O ' ' A' ' 55' ' ' GLU . 15.9 pt -112.29 166.62 6.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.585 -0.697 . . . . 0.0 109.444 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.547 ' N ' ' O ' ' A' ' 67' ' ' GLU . 13.7 t70 -108.51 109.75 21.07 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.13 -0.981 . . . . 0.0 109.788 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.76 ' CG1' ' CD1' ' A' ' 48' ' ' TRP . 95.7 t -130.56 135.16 61.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 O-C-N 121.78 -0.575 . . . . 0.0 110.462 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.773 ' HA ' ' OE1' ' A' ' 43' ' ' GLN . 2.8 tttt -136.3 155.41 50.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.88 -1.138 . . . . 0.0 111.227 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.57 ' OE1' ' CG ' ' A' ' 46' ' ' HIS . 3.1 tt0 -69.07 -120.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.47 -0.769 . . . . 0.0 110.265 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.518 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 38.48 48.99 2.33 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 108.346 -1.901 . . . . 0.0 108.346 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.688 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 102.07 58.65 0.78 Allowed Glycine 0 N--CA 1.487 2.047 0 N-CA-C 107.932 -2.067 . . . . 0.0 107.932 -178.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.689 HD13 ' NE1' ' A' ' 48' ' ' TRP . 2.0 mm? 0.91 82.98 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.886 -0.773 . . . . 0.0 111.105 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.422 ' O ' HG12 ' A' ' 59' ' ' VAL . 3.7 t -99.76 114.65 27.92 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.514 -0.741 . . . . 0.0 109.885 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.61 ' CE1' ' CD2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -97.21 124.89 41.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.414 -0.804 . . . . 0.0 109.538 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 58' ' ' ASP . 8.3 tt0 -145.88 122.01 10.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.826 -1.171 . . . . 0.0 110.23 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.555 ' CD ' ' O ' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -122.81 142.66 50.51 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.332 -0.855 . . . . 0.0 109.674 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.675 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 44.7 mtt180 -112.91 -71.44 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.033 -1.042 . . . . 0.0 110.591 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.675 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 56.6 Cg_endo -73.6 -122.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.502 1.264 . . . . 0.0 109.184 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 t -140.05 164.09 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.5 -1.375 . . . . 0.0 109.96 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.571 ' CB ' ' HA ' ' A' ' 76' ' ' ASP . . . -62.46 88.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.226 -0.921 . . . . 0.0 110.192 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.558 ' N ' ' OD1' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -66.79 -77.5 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.171 -0.956 . . . . 0.0 110.368 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 73' ' ' GLN . 1.9 p -50.86 -101.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.112 -0.992 . . . . 0.0 110.03 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.543 ' CG2' ' OG ' ' A' ' 54' ' ' SER . 7.1 t -82.93 -129.25 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.929 -1.107 . . . . 0.0 109.203 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.689 ' O ' ' N ' ' A' ' 78' ' ' VAL . 0.9 OUTLIER -140.9 154.39 46.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.966 -1.084 . . . . 0.0 110.802 179.555 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.579 ' C ' ' O ' ' A' ' 76' ' ' ASP . . . 29.88 -89.87 0.01 OUTLIER Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.429 -1.868 . . . . 0.0 108.429 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.735 ' HA ' ' H ' ' A' ' 54' ' ' SER . 17.1 m -155.26 138.73 7.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 O-C-N 121.736 -0.861 . . . . 0.0 109.999 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.721 ' C ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -144.95 133.22 21.66 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.239 -0.913 . . . . 0.0 112.047 -178.454 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.808 ' CA ' ' HA ' ' A' ' 52' ' ' ASP . . . -115.43 162.68 12.41 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.236 -1.545 . . . . 0.0 109.236 178.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.474 ' HA ' ' HB2' ' A' ' 202' ' ' SER . 13.0 ttpp -160.57 -28.21 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.134 -1.215 . . . . 0.0 110.452 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.541 ' CD ' ' HB3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -82.18 -73.51 0.39 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.978 -1.076 . . . . 0.0 109.872 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.47 ' C ' ' O ' ' A' ' 82' ' ' ARG . . . 36.49 53.15 1.37 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.423 ' CD1' ' C ' ' A' ' 84' ' ' TYR . 2.1 t80 -94.55 125.29 39.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -1.137 . . . . 0.0 110.603 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.574 ' HB3' ' CD2' ' A' ' 89' ' ' HIS . 30.7 m -139.9 166.68 23.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.163 -0.961 . . . . 0.0 110.022 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.537 ' O ' ' NE2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -116.87 133.77 55.6 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.059 -1.026 . . . . 0.0 110.201 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 101.03 -114.92 5.15 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.524 ' O ' ' CD2' ' A' ' 89' ' ' HIS . 17.7 tp -128.49 132.18 48.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.359 -1.083 . . . . 0.0 110.248 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.574 ' CD2' ' HB3' ' A' ' 85' ' ' SER . 2.9 m80 -147.16 156.78 43.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.12 -0.987 . . . . 0.0 109.915 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.546 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -163.04 155.45 18.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.939 . . . . 0.0 110.074 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.715 ' CD1' ' CZ ' ' A' ' 216' ' ' TYR . 0.0 OUTLIER -134.67 158.86 43.0 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.275 -0.891 . . . . 0.0 109.238 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.589 ' CB ' ' O ' ' A' ' 215' ' ' ARG . 3.0 tt0 -109.81 134.11 52.4 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.876 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.543 ' CB ' ' OH ' ' A' ' 180' ' ' TYR . 8.3 mm -129.18 132.25 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.421 -0.8 . . . . 0.0 109.657 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.667 ' HB3' ' HA ' ' A' ' 166' ' ' ARG . 13.3 p -155.22 154.31 32.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.188 -0.945 . . . . 0.0 110.271 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.962 ' CZ2' ' HA ' ' A' ' 104' ' ' ALA . 14.4 m95 -123.32 86.41 51.86 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.09 -1.006 . . . . 0.0 109.8 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.568 ' CD ' ' HB2' ' A' ' 213' ' ' ARG . 52.2 Cg_endo -99.06 109.0 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 121.978 1.785 . . . . 0.0 110.634 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 210' ' ' CYS . 0.2 OUTLIER -96.03 -66.05 0.93 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.883 -1.136 . . . . 0.0 109.764 179.125 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -97.63 -45.09 6.52 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.24 -0.913 . . . . 0.0 110.001 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.467 ' O ' ' HG2' ' A' ' 100' ' ' ARG . 0.5 OUTLIER 179.93 46.83 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.243 -0.911 . . . . 0.0 110.102 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 99' ' ' GLN . 1.8 mtt180 -149.71 -135.1 0.07 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.169 -0.957 . . . . 0.0 110.319 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 95' ' ' TRP . . . -165.36 178.64 40.21 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.572 ' O ' ' CD1' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -164.69 164.42 21.36 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.186 -1.185 . . . . 0.0 110.238 179.782 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.604 ' HA ' ' CG2' ' A' ' 163' ' ' VAL . 3.7 t-80 -66.46 161.08 23.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.311 -0.868 . . . . 0.0 110.426 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.962 ' HA ' ' CZ2' ' A' ' 95' ' ' TRP . . . -111.79 165.44 12.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 110.205 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.761 HG22 ' O ' ' A' ' 204' ' ' SER . 18.4 m -101.85 116.56 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 118.459 -1.296 . . . . 0.0 107.64 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.648 HG11 ' N ' ' A' ' 107' ' ' GLY . 36.9 t -149.23 156.26 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.14 -0.975 . . . . 0.0 110.757 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.648 ' N ' HG11 ' A' ' 106' ' ' VAL . . . -149.96 150.23 22.26 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.659 HG11 ' HB2' ' A' ' 199' ' ' LEU . 2.9 t -122.38 141.88 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -1.098 . . . . 0.0 109.666 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.551 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -124.25 156.67 36.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.095 -1.003 . . . . 0.0 110.77 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.549 ' CG2' ' HB3' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -120.52 133.63 55.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.35 -0.844 . . . . 0.0 110.207 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -88.9 -25.03 22.33 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.344 -0.848 . . . . 0.0 109.335 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.6 pp -86.67 -11.96 49.77 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.516 -0.74 . . . . 0.0 109.251 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.434 ' HB2' ' OE1' ' A' ' 129' ' ' GLU . . . -48.72 109.03 1.06 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.535 -0.728 . . . . 0.0 110.378 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.423 ' O ' ' CD1' ' A' ' 115' ' ' LEU . 46.1 Cg_endo -73.45 -155.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.032 1.543 . . . . 0.0 110.196 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.48 HD22 ' CB ' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -161.57 54.25 0.26 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.093 -1.004 . . . . 0.0 110.14 179.877 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.409 ' O ' ' O ' ' A' ' 117' ' ' ALA . 2.4 tt0 -101.66 -28.48 12.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.225 -0.922 . . . . 0.0 110.107 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.529 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -61.17 -148.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -0.915 . . . . 0.0 110.231 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.529 ' C ' ' O ' ' A' ' 117' ' ' ALA . 43.4 t0 -31.53 124.11 0.25 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.502 -0.749 . . . . 0.0 110.772 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.501 ' O ' ' N ' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -112.67 -79.95 0.59 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.885 . . . . 0.0 110.231 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.468 ' CB ' ' O ' ' A' ' 119' ' ' HIS . 0.1 OUTLIER 66.22 -63.95 0.23 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.352 -0.843 . . . . 0.0 110.142 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 119' ' ' HIS . . . -91.18 -158.04 0.53 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.217 -0.927 . . . . 0.0 110.183 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -167.07 29.99 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.274 -0.891 . . . . 0.0 110.184 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.08 -44.4 16.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 0.0 110.297 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.48 ' CB ' HD22 ' A' ' 115' ' ' LEU . 5.3 mt -89.49 -96.84 0.1 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.328 -0.858 . . . . 0.0 110.186 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 70.01 4.54 49.19 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.94 43.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.159 -1.2 . . . . 0.0 110.21 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.451 ' CB ' HD22 ' A' ' 124' ' ' LEU . 6.0 m-20 -128.99 -165.4 1.5 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 0.0 110.285 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.4 p -86.84 -174.32 4.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.302 -0.874 . . . . 0.0 110.171 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.434 ' OE1' ' HB2' ' A' ' 113' ' ' ALA . 0.6 OUTLIER -149.98 128.97 12.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.355 -0.841 . . . . 0.0 110.076 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 39.1 t -120.55 120.13 34.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.292 -0.88 . . . . 0.0 110.224 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . 0.465 ' O ' ' O ' ' A' ' 108' ' ' VAL . 1.5 m95 -132.82 124.87 28.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.91 . . . . 0.0 109.99 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.53 ' HA3' ' CA ' ' A' ' 107' ' ' GLY . . . -155.18 -172.13 22.52 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.626 ' O ' ' CD1' ' A' ' 133' ' ' TRP . 3.5 p90 -145.26 140.4 27.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.368 -1.077 . . . . 0.0 110.902 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 136' ' ' GLY . 0.7 OUTLIER -120.45 149.05 43.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.778 -0.576 . . . . 0.0 109.709 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.591 ' CD1' ' C ' ' A' ' 104' ' ' ALA . 0.2 OUTLIER -109.7 -6.75 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.966 -1.084 . . . . 0.0 110.361 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.521 ' N ' ' OD1' ' A' ' 134' ' ' ASP . . . -85.76 -40.78 7.51 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.71 4.57 49.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.279 -1.13 . . . . 0.0 109.454 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 139' ' ' LYS . . . -119.61 -5.36 11.19 Favored Glycine 0 N--CA 1.484 1.855 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.488 ' O ' ' CD2' ' A' ' 142' ' ' HIS . 1.2 tttt -59.02 -140.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.428 -1.042 . . . . 0.0 110.475 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.534 ' CD1' ' O ' ' A' ' 140' ' ' LEU . 1.0 OUTLIER -65.67 61.54 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.538 -0.726 . . . . 0.0 110.367 -179.872 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.473 ' CD1' ' O ' ' A' ' 141' ' ' TYR . 8.1 t80 -128.29 -6.65 5.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.212 -0.93 . . . . 0.0 110.255 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.488 ' CD2' ' O ' ' A' ' 139' ' ' LYS . 12.8 p80 -111.88 43.32 1.58 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.192 -0.942 . . . . 0.0 110.256 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.61 -40.1 50.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.284 -0.885 . . . . 0.0 110.203 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 15.0 m -61.7 -152.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.29 -0.881 . . . . 0.0 110.283 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -102.98 61.59 0.79 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.276 -0.89 . . . . 0.0 110.223 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.428 ' O ' HD21 ' A' ' 147' ' ' LEU . . . -71.46 -95.26 0.07 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.428 HD21 ' O ' ' A' ' 146' ' ' GLY . 0.1 OUTLIER -172.26 60.83 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.185 -1.185 . . . . 0.0 110.268 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -56.93 177.04 0.09 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.215 -0.928 . . . . 0.0 110.22 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.471 ' O ' ' HG2' ' A' ' 153' ' ' PRO . . . -176.9 60.1 0.17 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.285 -0.884 . . . . 0.0 110.23 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.522 ' HA ' ' CA ' ' A' ' 155' ' ' GLY . 48.1 Cg_endo -73.86 1.44 7.05 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.007 1.53 . . . . 0.0 110.526 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -63.93 -92.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.171 -0.956 . . . . 0.0 110.302 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.512 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 0.4 OUTLIER -78.2 -57.4 0.92 Allowed Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.307 -0.871 . . . . 0.0 110.494 -179.789 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.512 ' CD ' ' CB ' ' A' ' 152' ' ' TYR . 46.3 Cg_endo -72.71 131.65 17.53 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.946 1.498 . . . . 0.0 110.569 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.491 ' O ' ' O ' ' A' ' 155' ' ' GLY . . . -45.2 104.45 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.362 -0.836 . . . . 0.0 110.359 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.522 ' CA ' ' HA ' ' A' ' 150' ' ' PRO . . . -59.96 -139.99 0.01 OUTLIER Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.474 ' O ' ' OE2' ' A' ' 159' ' ' GLU . 45.2 Cg_endo -73.14 -6.48 19.02 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.926 1.487 . . . . 0.0 110.312 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.46 -3.09 10.21 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.325 -0.86 . . . . 0.0 110.544 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -61.25 -55.04 31.55 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.577 ' HB3' ' CG2' ' A' ' 135' ' ' ILE . 0.4 OUTLIER -108.24 5.05 25.34 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.238 -1.154 . . . . 0.0 110.098 179.777 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.45 ' HB2' ' O ' ' A' ' 156' ' ' PRO . 0.0 OUTLIER -67.06 -9.87 43.81 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.444 -0.785 . . . . 0.0 109.154 179.2 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.704 ' O ' ' C ' ' A' ' 162' ' ' VAL . 0.2 OUTLIER -114.83 39.37 2.88 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.579 -0.701 . . . . 0.0 110.162 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.704 ' C ' ' O ' ' A' ' 161' ' ' LEU . 2.3 t 1.2 99.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-O 121.597 0.713 . . . . 0.0 110.402 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.604 ' CG2' ' HA ' ' A' ' 103' ' ' HIS . 48.0 t -33.72 151.08 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.882 -0.511 . . . . 0.0 109.927 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.583 ' HD2' ' CG1' ' A' ' 163' ' ' VAL . 38.0 Cg_endo -64.05 176.09 2.74 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.718 1.378 . . . . 0.0 110.572 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 164' ' ' PRO . 12.9 mt-10 -35.75 -32.18 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.503 -0.748 . . . . 0.0 110.681 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.667 ' HA ' ' HB3' ' A' ' 94' ' ' SER . 21.2 ttm180 -152.26 156.71 40.22 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.269 -0.894 . . . . 0.0 111.087 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.585 ' HB2' ' CG1' ' A' ' 163' ' ' VAL . 7.2 tt -126.21 157.1 39.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.584 -0.697 . . . . 0.0 109.719 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.569 ' O ' ' O ' ' A' ' 181' ' ' SER . 24.9 tp -123.6 116.61 23.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.087 -1.008 . . . . 0.0 110.739 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.699 ' CG1' ' CZ3' ' A' ' 91' ' ' TRP . 10.6 t -91.93 141.91 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.101 -0.999 . . . . 0.0 109.61 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 178' ' ' LEU . 11.4 t -118.93 124.71 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.917 . . . . 0.0 111.133 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.436 HD12 ' HB3' ' A' ' 178' ' ' LEU . 13.0 tp -133.4 105.68 7.07 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.384 -0.822 . . . . 0.0 109.346 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -115.47 139.32 50.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 110.544 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.517 ' O ' ' C ' ' A' ' 174' ' ' GLU . 0.0 OUTLIER -93.43 -41.0 10.05 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 120.174 -0.611 . . . . 0.0 109.996 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.517 ' C ' ' O ' ' A' ' 173' ' ' MET . 15.9 tt0 -39.11 -30.93 0.06 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 0.0 108.497 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 173' ' ' MET . 4.7 tt0 -113.2 -24.97 9.11 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.619 ' O ' ' HB ' ' A' ' 198' ' ' THR . . . 76.81 25.97 63.65 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 -179.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.669 ' CG2' ' HG ' ' A' ' 194' ' ' LEU . 2.2 p -113.14 144.45 42.64 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.346 -1.091 . . . . 0.0 110.77 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.582 HD12 ' CG ' ' A' ' 201' ' ' PRO . 0.1 OUTLIER -153.03 154.04 34.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.405 -0.809 . . . . 0.0 110.169 -179.545 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.538 ' HA3' ' CD1' ' A' ' 187' ' ' LEU . . . -166.05 -173.17 34.23 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.662 ' CE1' ' CG2' ' A' ' 169' ' ' VAL . 0.7 OUTLIER -118.05 122.48 43.27 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.363 -1.08 . . . . 0.0 109.431 -179.75 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.612 ' HA ' ' CD2' ' A' ' 186' ' ' TYR . 41.9 t -144.24 142.5 30.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.288 -0.883 . . . . 0.0 110.822 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.534 ' CG2' ' HD2' ' A' ' 164' ' ' PRO . 0.0 OUTLIER -90.75 116.34 31.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.405 -0.809 . . . . 0.0 109.321 179.046 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 94.96 -26.03 20.83 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.501 ' CA ' HD21 ' A' ' 168' ' ' LEU . . . 102.54 42.18 2.21 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 187' ' ' LEU . 4.7 m -137.53 -54.84 0.68 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.158 -1.201 . . . . 0.0 110.444 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.723 ' CG ' ' O ' ' A' ' 186' ' ' TYR . 0.1 OUTLIER -62.0 77.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.129 0.966 . . . . 0.0 109.962 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.622 ' HG ' ' CE1' ' A' ' 191' ' ' PHE . 1.7 tt 179.87 24.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.48 0.657 . . . . 0.0 109.793 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.763 ' N ' ' CD ' ' A' ' 189' ' ' PRO . . . -104.94 -21.3 9.11 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.892 -1.147 . . . . 0.0 112.074 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.763 ' CD ' ' N ' ' A' ' 188' ' ' GLY . 47.5 Cg_endo -74.21 -42.76 0.64 Allowed 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 122.812 0.901 . . . . 0.0 111.386 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -90.18 10.43 24.55 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.996 -1.065 . . . . 0.0 111.004 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.647 ' CE1' ' CD2' ' A' ' 194' ' ' LEU . 1.5 m-85 -89.98 -13.3 36.42 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.13 -0.981 . . . . 0.0 109.786 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.507 ' HA ' ' NE ' ' A' ' 192' ' ' ARG . 0.0 OUTLIER -70.19 -29.23 66.05 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.158 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.52 ' O ' ' HB3' ' A' ' 197' ' ' ARG . . . -102.41 -18.76 15.61 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.111 -1.996 . . . . 0.0 108.111 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.721 ' HA ' ' HD2' ' A' ' 197' ' ' ARG . 0.9 OUTLIER -61.61 -20.32 63.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.792 -0.828 . . . . 0.0 109.454 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 195' ' ' LYS . 0.1 OUTLIER -64.32 -22.25 66.89 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.441 -0.787 . . . . 0.0 109.367 179.257 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.44 ' N ' ' HE3' ' A' ' 195' ' ' LYS . . . -125.43 -20.23 2.21 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.721 ' HD2' ' HA ' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -90.45 -4.19 57.15 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.479 -1.012 . . . . 0.0 109.267 179.661 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.619 ' HB ' ' O ' ' A' ' 176' ' ' GLY . 0.1 OUTLIER -43.19 138.54 2.18 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 122.401 1.096 . . . . 0.0 112.43 -177.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.659 ' HB2' HG11 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -141.39 172.93 12.01 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.772 179.399 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.508 ' C ' HG13 ' A' ' 108' ' ' VAL . 8.5 m-85 -82.3 128.66 66.57 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.619 -1.301 . . . . 0.0 109.502 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.582 ' CG ' HD12 ' A' ' 178' ' ' LEU . 53.2 Cg_endo -78.44 144.79 20.53 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 124.045 1.55 . . . . 0.0 112.556 -178.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.575 ' O ' ' CG1' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -133.58 147.56 51.54 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.247 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.617 ' CG1' ' HB3' ' A' ' 52' ' ' ASP . 8.4 p -119.14 163.5 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.722 -1.236 . . . . 0.0 110.388 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' SER . . . . . 0.761 ' O ' HG22 ' A' ' 105' ' ' VAL . 0.4 OUTLIER -155.07 134.65 12.66 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.013 0.911 . . . . 0.0 110.466 179.606 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.605 ' CB ' ' CG2' ' A' ' 78' ' ' VAL . . . -138.91 147.42 42.3 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.792 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.488 ' CG1' ' HB3' ' A' ' 211' ' ' GLN . 2.5 p -66.25 173.41 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.405 -0.81 . . . . 0.0 110.54 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.585 ' O ' ' CG ' ' A' ' 207' ' ' TRP . 33.0 p-90 -107.02 114.26 28.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.281 -0.887 . . . . 0.0 110.257 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 66' ' ' PHE . . . 172.32 174.18 39.5 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -78.38 -73.53 0.32 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -1.157 . . . . 0.0 110.436 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . 0.456 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 89.1 m -86.29 86.24 7.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.356 -0.84 . . . . 0.0 110.292 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.488 ' HB3' ' CG1' ' A' ' 206' ' ' VAL . 25.1 mm-40 -154.3 -49.92 0.09 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.211 -0.931 . . . . 0.0 110.365 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.578 HG23 ' CZ3' ' A' ' 95' ' ' TRP . 47.9 t -127.81 143.73 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.119 -0.988 . . . . 0.0 112.033 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 0.568 ' HB2' ' CD ' ' A' ' 96' ' ' PRO . 15.6 tpp85 -128.9 137.79 51.63 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.601 HG21 ' CE2' ' A' ' 48' ' ' TRP . 3.1 tt -142.36 136.32 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.643 -1.286 . . . . 0.0 112.289 -178.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.589 ' O ' ' CB ' ' A' ' 92' ' ' GLU . 12.7 tpt180 -130.11 109.43 10.82 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . 0.715 ' CZ ' ' CD1' ' A' ' 91' ' ' TRP . 2.1 t80 -89.0 149.59 23.19 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.055 -1.028 . . . . 0.0 111.531 -178.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 44.2 tpp -132.79 107.92 8.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.671 -0.643 . . . . 0.0 109.632 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 93.39 87.46 1.6 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 221' ' ' ARG . 0.3 OUTLIER -95.33 157.88 15.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.257 -1.143 . . . . 0.0 110.406 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 221' ' ' ARG . 27.6 ttt85 -41.27 96.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.375 -0.828 . . . . 0.0 110.245 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . 0.535 ' O ' ' C ' ' A' ' 222' ' ' VAL . 0.0 OUTLIER -177.74 115.11 0.08 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.247 -0.908 . . . . 0.0 109.985 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.535 ' C ' ' O ' ' A' ' 221' ' ' ARG . 0.5 OUTLIER -30.31 121.47 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.428 -0.795 . . . . 0.0 110.614 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.662 ' O ' ' C ' ' A' ' 224' ' ' GLU . 1.4 mt-10 -57.64 -75.68 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.228 -0.92 . . . . 0.0 110.33 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.662 ' C ' ' O ' ' A' ' 223' ' ' GLU . 19.5 mt-10 0.75 70.26 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.347 0.594 . . . . 0.0 111.317 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.614 ' N ' ' O ' ' A' ' 223' ' ' GLU . 68.6 p -45.25 93.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.52 -0.737 . . . . 0.0 110.15 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 224' ' ' GLU . 0.1 OUTLIER -146.57 -164.72 2.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -0.88 . . . . 0.0 110.331 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.426 ' O ' ' HG3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -155.55 61.03 0.61 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.927 . . . . 0.0 110.2 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.486 ' CD1' ' C ' ' A' ' 228' ' ' ILE . 2.2 pp -135.02 41.78 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.153 -0.967 . . . . 0.0 110.308 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.427 ' C ' ' O ' ' A' ' 228' ' ' ILE . 94.9 m-70 -42.68 -47.98 5.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.293 -0.88 . . . . 0.0 110.249 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . 0.676 ' O ' ' C ' ' A' ' 231' ' ' ASP . 6.9 ttp180 -47.88 131.57 15.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 110.273 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.676 ' C ' ' O ' ' A' ' 230' ' ' ARG . 5.9 m-20 . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 117.988 -1.006 . . . . 0.0 111.413 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 7' ' ' SER . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 6' ' ' GLY . 8.0 t 59.05 120.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -1.156 . . . . 0.0 110.211 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.39 -42.7 64.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -0.868 . . . . 0.0 110.194 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -177.15 105.94 0.06 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.351 -0.843 . . . . 0.0 110.148 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.59 85.89 2.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.315 -0.866 . . . . 0.0 110.178 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.33 115.4 3.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -0.897 . . . . 0.0 110.223 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.0 t -53.75 -88.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.193 -0.942 . . . . 0.0 110.071 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.477 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 3.0 t -170.27 53.4 0.21 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.93 . . . . 0.0 110.216 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 13' ' ' THR . 45.4 Cg_endo -72.96 149.88 47.9 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.016 1.535 . . . . 0.0 110.38 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.417 ' O ' ' CG2' ' A' ' 15' ' ' THR . 7.5 t -109.37 48.12 0.89 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.307 -0.871 . . . . 0.0 110.219 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.11 -20.59 60.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.315 -0.866 . . . . 0.0 110.166 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -97.4 -147.75 0.31 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.288 -0.883 . . . . 0.0 110.205 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -44.07 153.11 0.15 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.202 -0.936 . . . . 0.0 110.28 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.46 -149.36 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.257 -0.902 . . . . 0.0 110.164 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.34 -158.78 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.295 -0.878 . . . . 0.0 110.055 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.8 p -69.59 105.84 2.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.198 -0.939 . . . . 0.0 110.022 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -80.31 43.79 0.65 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 110.394 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.86 -48.16 83.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.892 . . . . 0.0 110.201 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.6 147.24 45.99 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.454 -0.779 . . . . 0.0 110.114 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.421 ' HD2' HD21 ' A' ' 32' ' ' LEU . 46.3 Cg_endo -73.0 135.5 23.26 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.007 1.53 . . . . 0.0 110.512 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.694 ' O ' ' N ' ' A' ' 28' ' ' GLY . 45.9 Cg_endo -72.44 -161.01 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 124.089 1.573 . . . . 0.0 110.456 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.656 ' C ' ' O ' ' A' ' 26' ' ' PRO . 16.1 mm-40 1.72 65.55 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.586 0.708 . . . . 0.0 110.988 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.694 ' N ' ' O ' ' A' ' 26' ' ' PRO . . . 156.16 31.24 0.03 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.601 ' O ' ' N ' ' A' ' 32' ' ' LEU . 1.0 OUTLIER -74.02 -13.85 60.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -1.139 . . . . 0.0 109.796 179.826 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.567 ' CG ' ' CG ' ' A' ' 55' ' ' GLU . 1.6 tt0 -46.64 -26.86 1.0 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.408 -0.808 . . . . 0.0 109.159 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -74.85 -22.58 58.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.463 -0.773 . . . . 0.0 108.933 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.601 ' N ' ' O ' ' A' ' 29' ' ' LEU . 1.1 mm? -83.84 -32.17 25.4 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.643 ' HG ' ' N ' ' A' ' 34' ' ' SER . 0.3 OUTLIER -71.11 -35.93 71.98 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 122.064 0.935 . . . . 0.0 109.139 179.299 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.643 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 3.7 t -79.71 -7.62 58.72 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.323 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.671 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . . . -70.42 -70.96 0.29 Allowed Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.122 -0.986 . . . . 0.0 110.899 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.671 ' CD ' ' CB ' ' A' ' 35' ' ' ALA . 51.6 Cg_endo -75.39 160.92 38.37 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.495 1.261 . . . . 0.0 110.483 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -99.81 52.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.123 1.882 . . . . 0.0 112.113 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.645 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 48.6 Cg_endo -72.89 151.04 50.35 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.125 1.066 . . . . 0.0 110.703 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.672 ' OD2' ' HD3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -15.2 -65.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.757 -0.59 . . . . 0.0 111.786 179.282 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.739 ' CD2' ' C ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -45.28 -43.71 10.79 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.413 -0.804 . . . . 0.0 110.412 -179.434 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.667 ' CG1' ' CE1' ' A' ' 45' ' ' HIS . 3.8 t -85.08 -19.33 8.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 O-C-N 121.168 -0.958 . . . . 0.0 111.185 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.52 -44.12 10.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.89 -1.132 . . . . 0.0 112.339 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.697 ' NE2' ' HG2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -85.39 -19.48 31.32 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 118.385 -1.326 . . . . 0.0 109.425 -179.737 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.651 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -69.31 -41.81 76.22 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 122.165 0.983 . . . . 0.0 108.472 179.218 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.667 ' CE1' ' CG1' ' A' ' 41' ' ' VAL . 20.3 m170 -63.74 -28.82 70.15 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.748 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -96.35 -29.64 13.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.874 -1.141 . . . . 0.0 109.608 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.09 -89.83 1.47 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 107.339 -2.304 . . . . 0.0 107.339 178.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.686 ' CD1' ' CG1' ' A' ' 59' ' ' VAL . 97.4 m95 -90.77 74.37 6.59 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.58 ' ND2' ' N ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -43.26 137.94 2.74 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.527 -0.733 . . . . 0.0 111.428 -179.045 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.652 ' HG2' ' HE3' ' A' ' 51' ' ' LYS . 40.0 Cg_endo -67.67 -23.31 42.65 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 124.435 1.755 . . . . 0.0 111.168 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.835 ' CE ' ' N ' ' A' ' 51' ' ' LYS . 0.6 OUTLIER -65.29 -15.58 62.66 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 178.326 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 1.08 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 11.2 m-20 -121.97 3.15 9.95 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.162 177.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.746 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 9.5 t -148.0 138.08 22.7 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.507 0.67 . . . . 0.0 110.292 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.753 ' HB2' ' O ' ' A' ' 76' ' ' ASP . 1.5 m -80.29 130.68 35.37 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.175 -0.953 . . . . 0.0 109.835 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.584 ' HA ' ' NH2' ' A' ' 44' ' ' ARG . 4.3 pm0 -44.63 -24.36 0.19 Allowed 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.632 ' ND2' ' HB2' ' A' ' 54' ' ' SER . 0.1 OUTLIER -55.5 -4.58 0.1 Allowed 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.575 -1.328 . . . . 0.0 109.866 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.555 HD11 ' HA ' ' A' ' 207' ' ' TRP . 22.8 mm -111.96 157.75 12.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.477 -0.765 . . . . 0.0 110.518 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.551 ' O ' ' CB ' ' A' ' 67' ' ' GLU . 35.9 t0 -118.87 105.4 11.46 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.709 0.766 . . . . 0.0 109.534 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.7 ' CG1' ' CD1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -131.08 136.12 58.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 O-C-N 121.628 -0.67 . . . . 0.0 110.919 -178.942 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.697 ' HG2' ' NE2' ' A' ' 43' ' ' GLN . 28.7 mttp -135.53 155.28 50.75 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.282 -0.886 . . . . 0.0 110.535 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.499 ' HG3' ' N ' ' A' ' 62' ' ' GLY . 7.8 pt-20 -75.82 -130.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.227 -0.921 . . . . 0.0 110.408 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.499 ' N ' ' HG3' ' A' ' 61' ' ' GLU . . . 45.73 45.12 12.99 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.661 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 108.9 60.55 0.53 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.661 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.3 OUTLIER -0.32 78.98 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.878 -0.778 . . . . 0.0 111.27 -179.283 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.499 ' O ' ' SG ' ' A' ' 65' ' ' CYS . 31.9 p -99.58 114.33 27.29 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.13 -0.981 . . . . 0.0 109.647 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.7 ' CD1' ' CG1' ' A' ' 59' ' ' VAL . 1.2 t80 -90.55 124.84 35.35 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.479 -0.763 . . . . 0.0 110.211 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 4.9 tt0 -139.99 152.89 46.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.172 -0.955 . . . . 0.0 109.674 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.546 ' HG3' ' HB3' ' A' ' 207' ' ' TRP . 0.1 OUTLIER -135.93 140.25 43.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.022 -1.049 . . . . 0.0 110.83 -179.578 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.615 ' CB ' ' HD2' ' A' ' 70' ' ' PRO . 1.4 mtp85 -61.13 -173.94 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.386 -0.821 . . . . 0.0 109.208 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.615 ' HD2' ' CB ' ' A' ' 69' ' ' ARG . 50.9 Cg_endo -66.28 -138.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.591 1.311 . . . . 0.0 108.958 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.404 ' H ' ' HB2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -139.72 152.61 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.966 -1.083 . . . . 0.0 110.015 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.6 -39.95 0.13 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.161 -0.962 . . . . 0.0 110.188 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.549 ' O ' ' N ' ' A' ' 75' ' ' THR . 0.2 OUTLIER -170.14 147.12 3.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.286 -0.884 . . . . 0.0 110.145 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 73' ' ' GLN . 9.2 t -43.74 91.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 110.353 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.549 ' N ' ' O ' ' A' ' 73' ' ' GLN . 1.5 m -99.17 -129.4 0.2 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.296 -0.877 . . . . 0.0 110.053 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.753 ' O ' ' HB2' ' A' ' 54' ' ' SER . 72.5 m-20 -137.73 113.91 10.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.195 -0.94 . . . . 0.0 110.486 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.558 ' O ' HG11 ' A' ' 78' ' ' VAL . . . -50.73 -96.16 0.01 OUTLIER Glycine 0 N--CA 1.484 1.837 0 N-CA-C 107.759 -2.136 . . . . 0.0 107.759 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.746 ' HA ' ' HA ' ' A' ' 53' ' ' CYS . 6.9 m -143.05 126.93 14.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.215 -1.168 . . . . 0.0 110.237 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.604 ' C ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -145.57 134.16 22.11 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.131 -0.981 . . . . 0.0 112.536 -178.615 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 1.08 ' CA ' ' HA ' ' A' ' 52' ' ' ASP . . . -133.13 161.56 24.17 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 178.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.513 ' HA ' ' CB ' ' A' ' 202' ' ' SER . 0.4 OUTLIER -169.96 24.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.237 -1.155 . . . . 0.0 110.345 -179.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.469 ' O ' ' CD2' ' A' ' 200' ' ' TYR . 1.1 ptt180 -91.36 -102.44 0.11 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.075 -1.016 . . . . 0.0 110.428 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.444 ' HA3' ' HD2' ' A' ' 201' ' ' PRO . . . 81.03 66.6 1.61 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -121.77 95.8 4.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -1.166 . . . . 0.0 110.361 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 173' ' ' MET . 69.7 m -140.09 155.6 46.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.207 -0.933 . . . . 0.0 110.286 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.518 ' C ' ' NE2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -118.2 135.42 54.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.207 -0.933 . . . . 0.0 109.809 179.832 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 106.45 -118.32 5.64 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.476 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 51.3 tp -128.79 123.09 31.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.408 -1.054 . . . . 0.0 110.904 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.518 ' NE2' ' C ' ' A' ' 86' ' ' ARG . 4.2 m-70 -147.2 153.17 39.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.205 -0.934 . . . . 0.0 109.758 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.54 ' C ' ' CE3' ' A' ' 91' ' ' TRP . . . -163.71 156.85 18.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.025 -1.047 . . . . 0.0 110.201 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.731 ' CE3' ' CE2' ' A' ' 216' ' ' TYR . 0.0 OUTLIER -134.98 154.69 51.63 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.184 -0.948 . . . . 0.0 110.108 179.484 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.648 ' O ' ' N ' ' A' ' 215' ' ' ARG . 0.5 OUTLIER -109.56 118.93 37.89 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.318 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.538 ' CG2' HG13 ' A' ' 214' ' ' ILE . 0.1 OUTLIER -132.95 133.86 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.819 -1.176 . . . . 0.0 111.491 -178.659 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.541 ' O ' ' HD3' ' A' ' 96' ' ' PRO . 0.1 OUTLIER -116.84 120.08 37.39 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.441 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.896 ' HH2' ' O ' ' A' ' 204' ' ' SER . 6.3 t-105 -116.13 87.39 19.25 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.106 -0.997 . . . . 0.0 110.332 -178.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.577 ' HG2' ' O ' ' A' ' 211' ' ' GLN . 49.9 Cg_endo -99.24 138.66 0.32 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.257 1.972 . . . . 0.0 110.319 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.597 ' CD2' ' CB ' ' A' ' 103' ' ' HIS . 1.9 tm? -95.03 -67.05 0.87 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.866 -1.146 . . . . 0.0 109.405 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.484 ' N ' HD12 ' A' ' 97' ' ' LEU . 4.3 mt-10 -96.68 -14.57 21.99 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.437 -0.79 . . . . 0.0 109.203 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.52 ' C ' ' CG ' ' A' ' 100' ' ' ARG . 0.1 OUTLIER 179.99 -32.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.538 0.685 . . . . 0.0 109.893 179.772 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.52 ' CG ' ' C ' ' A' ' 99' ' ' GLN . 3.1 mtt180 -152.23 -43.99 0.1 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.51 -0.744 . . . . 0.0 110.469 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' A' ' 97' ' ' LEU . . . -55.34 -175.04 0.13 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.56 ' OG1' ' NE1' ' A' ' 95' ' ' TRP . 0.9 OUTLIER -121.9 -154.9 0.61 Allowed 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.434 -1.039 . . . . 0.0 110.1 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.597 ' CB ' ' CD2' ' A' ' 97' ' ' LEU . 13.7 t-80 179.74 -50.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.199 -0.938 . . . . 0.0 110.701 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.621 ' CB ' ' HZ2' ' A' ' 95' ' ' TRP . . . -85.45 -109.52 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 0.0 110.859 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.742 HG11 ' O ' ' A' ' 204' ' ' SER . 0.1 OUTLIER -136.23 138.59 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.414 -1.429 . . . . 0.0 112.657 -178.286 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.683 ' CG2' ' CD2' ' A' ' 95' ' ' TRP . 1.0 OUTLIER -152.16 122.82 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.62 -0.675 . . . . 0.0 109.431 177.413 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.515 ' HA3' ' HA3' ' A' ' 132' ' ' GLY . . . 160.44 -158.56 30.0 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 118.711 -1.709 . . . . 0.0 111.097 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.527 ' CG1' ' HB2' ' A' ' 199' ' ' LEU . 2.3 t -120.78 169.34 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.725 -0.867 . . . . 0.0 109.717 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 130' ' ' SER . . . -146.19 132.66 19.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.996 -1.065 . . . . 0.0 110.263 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.564 HG23 ' CD2' ' A' ' 199' ' ' LEU . 9.7 p -89.43 120.85 31.12 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.146 -0.971 . . . . 0.0 110.304 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.17 -31.55 14.74 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.638 -0.664 . . . . 0.0 109.817 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.461 ' C ' ' HD3' ' A' ' 114' ' ' PRO . 0.6 OUTLIER -76.91 -12.47 59.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.401 -0.812 . . . . 0.0 110.01 179.807 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.444 ' O ' ' OE1' ' A' ' 129' ' ' GLU . . . -112.83 68.46 1.05 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.376 -0.828 . . . . 0.0 110.261 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.461 ' HD3' ' C ' ' A' ' 112' ' ' LEU . 46.5 Cg_endo -72.7 -44.55 0.66 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.917 1.482 . . . . 0.0 110.362 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.456 ' HB3' ' O ' ' A' ' 114' ' ' PRO . 1.2 pp -179.88 53.14 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.247 -0.908 . . . . 0.0 110.222 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -56.06 -77.28 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.205 -0.935 . . . . 0.0 110.214 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.524 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -43.58 -45.16 6.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.402 -0.811 . . . . 0.0 110.225 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.524 ' C ' ' O ' ' A' ' 117' ' ' ALA . 2.7 t70 -31.75 142.45 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.454 -0.779 . . . . 0.0 110.823 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.415 ' CD2' ' C ' ' A' ' 119' ' ' HIS . 0.8 OUTLIER -145.21 35.07 1.09 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.395 -0.816 . . . . 0.0 110.177 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.469 ' O ' ' CG ' ' A' ' 120' ' ' TYR . 1.9 p90 -167.28 131.23 1.85 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 110.203 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.435 ' O ' ' CB ' ' A' ' 122' ' ' ALA . . . 42.53 -162.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.884 . . . . 0.0 110.149 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . 64.06 77.62 0.31 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -0.87 . . . . 0.0 110.255 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.49 ' CG ' ' O ' ' A' ' 123' ' ' LEU . 0.9 OUTLIER -175.53 71.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.0 110.185 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.56 -69.58 0.1 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.158 -0.963 . . . . 0.0 110.276 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -132.56 2.96 5.01 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.95 49.29 0.87 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.105 -1.232 . . . . 0.0 110.27 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.428 ' ND2' ' HB3' ' A' ' 114' ' ' PRO . 6.9 t30 -95.2 78.54 3.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.898 . . . . 0.0 110.251 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -175.74 172.58 2.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 110.218 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.444 ' OE1' ' O ' ' A' ' 113' ' ' ALA . 0.9 OUTLIER -150.4 138.1 19.89 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.224 -0.923 . . . . 0.0 109.766 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 8.9 t -120.06 120.71 37.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.386 -0.821 . . . . 0.0 110.006 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . 0.465 ' O ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -132.2 133.36 44.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.882 . . . . 0.0 110.255 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.515 ' HA3' ' HA3' ' A' ' 107' ' ' GLY . . . 165.72 -120.38 0.92 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.662 ' CZ3' ' CD2' ' A' ' 180' ' ' TYR . 47.0 m0 -119.48 112.81 19.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.043 -1.269 . . . . 0.0 110.025 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.458 ' C ' HD13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -118.92 148.22 43.17 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.397 0.618 . . . . 0.0 110.685 -179.545 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.629 ' CD1' ' N ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER -139.34 3.45 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.946 . . . . 0.0 110.116 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.94 -14.79 61.61 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -85.0 3.05 40.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -1.132 . . . . 0.0 109.413 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.786 ' O ' ' O ' ' A' ' 139' ' ' LYS . . . -148.57 13.25 1.19 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.786 ' O ' ' O ' ' A' ' 138' ' ' GLY . 0.4 OUTLIER 1.12 -133.51 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 121.795 0.807 . . . . 0.0 112.196 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.77 -72.12 0.09 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.449 -0.782 . . . . 0.0 110.127 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.455 ' CE2' HD21 ' A' ' 161' ' ' LEU . 0.1 OUTLIER 179.87 106.54 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 110.308 179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -93.58 -2.05 54.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 0.0 110.244 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -100.59 -75.11 0.59 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.36 -0.837 . . . . 0.0 110.323 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.24 156.53 39.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.18 -0.95 . . . . 0.0 110.242 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 145' ' ' LYS . 0.1 OUTLIER -77.98 80.93 4.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.892 . . . . 0.0 110.336 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -160.64 142.52 8.2 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' A' ' 148' ' ' GLU . 1.8 tp -89.88 13.51 14.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.199 -1.177 . . . . 0.0 110.131 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.49 ' O ' ' HD3' ' A' ' 150' ' ' PRO . 0.8 OUTLIER -179.75 100.18 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.233 -0.917 . . . . 0.0 110.09 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.46 ' CB ' ' HB2' ' A' ' 154' ' ' ALA . . . -41.6 101.18 0.24 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.208 -0.933 . . . . 0.0 110.109 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 47.1 Cg_endo -74.71 -14.86 21.77 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.019 1.536 . . . . 0.0 110.42 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -91.61 -99.69 0.12 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.335 -0.853 . . . . 0.0 110.179 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.574 ' CG ' ' HD2' ' A' ' 153' ' ' PRO . 0.1 OUTLIER -73.31 -178.56 0.72 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.156 -0.965 . . . . 0.0 109.991 179.861 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.574 ' HD2' ' CG ' ' A' ' 152' ' ' TYR . 45.5 Cg_endo -72.76 110.98 3.14 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.978 1.515 . . . . 0.0 110.335 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.46 ' HB2' ' CB ' ' A' ' 149' ' ' ALA . . . -174.98 163.48 3.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.189 -0.944 . . . . 0.0 110.228 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.576 ' N ' ' CD ' ' A' ' 156' ' ' PRO . . . 49.03 47.03 32.95 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 155' ' ' GLY . 46.9 Cg_endo -74.08 -63.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.801 1.421 . . . . 0.0 110.565 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.473 ' HB3' ' HG2' ' A' ' 159' ' ' GLU . 3.3 mp0 -75.93 -0.89 23.06 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.216 -0.928 . . . . 0.0 110.425 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.484 ' O ' ' HB ' ' A' ' 162' ' ' VAL . . . 43.89 26.68 0.84 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.553 ' CB ' HG22 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -92.11 4.06 53.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -1.142 . . . . 0.0 110.277 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.19 -16.99 23.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -0.88 . . . . 0.0 108.929 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.528 ' CD1' HG23 ' A' ' 162' ' ' VAL . 0.9 OUTLIER -173.96 27.7 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.562 0.696 . . . . 0.0 109.403 179.47 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.567 ' CG1' ' O ' ' A' ' 162' ' ' VAL . 2.4 t -155.02 84.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.587 -0.696 . . . . 0.0 110.355 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.584 ' H ' ' HD2' ' A' ' 164' ' ' PRO . 1.3 t -154.29 -58.43 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.388 -0.82 . . . . 0.0 110.272 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.584 ' HD2' ' H ' ' A' ' 163' ' ' VAL . 45.6 Cg_endo -73.29 68.6 4.19 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.74 1.389 . . . . 0.0 110.705 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.488 ' HG2' ' CB ' ' A' ' 100' ' ' ARG . 94.5 mt-10 -80.72 -81.27 0.13 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.304 -0.873 . . . . 0.0 109.116 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.599 ' O ' ' CD1' ' A' ' 167' ' ' LEU . 9.7 ttp180 -119.09 115.53 24.48 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.394 -0.816 . . . . 0.0 108.961 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.682 ' N ' ' CD2' ' A' ' 167' ' ' LEU . 0.3 OUTLIER -132.14 157.46 44.2 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 121.424 0.631 . . . . 0.0 110.474 -179.015 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.471 ' CD1' ' OE1' ' A' ' 92' ' ' GLU . 0.7 OUTLIER -107.42 125.82 51.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.371 -0.831 . . . . 0.0 109.736 179.401 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.642 ' CG1' ' CD1' ' A' ' 91' ' ' TRP . 19.3 t -89.53 132.37 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.139 -0.975 . . . . 0.0 110.062 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.469 HG13 HD23 ' A' ' 168' ' ' LEU . 0.1 OUTLIER -125.3 111.48 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.398 -0.814 . . . . 0.0 110.186 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.66 ' HB3' ' CZ2' ' A' ' 91' ' ' TRP . 2.0 tp -107.41 114.04 27.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.339 -0.851 . . . . 0.0 110.022 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.492 ' N ' HD13 ' A' ' 171' ' ' LEU . 53.1 t0 -116.22 129.85 56.5 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.268 -0.895 . . . . 0.0 110.067 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.474 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 12.4 tpp -100.85 -42.02 6.62 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 173' ' ' MET . 0.7 OUTLIER -45.87 -25.62 0.56 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.078 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.541 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.0 OUTLIER -111.59 -28.07 8.3 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.751 0.786 . . . . 0.0 108.895 179.29 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.533 ' O ' ' CG2' ' A' ' 198' ' ' THR . . . 85.37 22.66 50.65 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.579 ' HA ' ' CD2' ' A' ' 194' ' ' LEU . 0.2 OUTLIER -119.73 111.43 18.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.258 -1.142 . . . . 0.0 111.081 -179.631 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.598 ' N ' HD21 ' A' ' 194' ' ' LEU . 0.3 OUTLIER -136.01 154.34 51.1 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.251 -0.906 . . . . 0.0 110.225 179.345 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.454 ' HA2' HG22 ' A' ' 108' ' ' VAL . . . 172.49 -153.21 18.46 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.662 ' CD2' ' CZ3' ' A' ' 133' ' ' TRP . 0.1 OUTLIER -118.79 125.21 49.09 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.192 -1.181 . . . . 0.0 109.768 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.466 ' HB2' HD21 ' A' ' 187' ' ' LEU . 17.0 t -116.72 124.88 50.76 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.381 -0.825 . . . . 0.0 110.171 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.604 HG23 ' CD1' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -103.7 116.71 47.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.495 -0.753 . . . . 0.0 109.645 179.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 49.66 22.49 4.12 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 57.26 48.43 80.27 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' THR . . . . . 0.564 HG22 ' CE1' ' A' ' 186' ' ' TYR . 69.1 m -110.48 -86.53 0.54 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.326 -1.102 . . . . 0.0 110.892 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.568 ' CD1' ' N ' ' A' ' 186' ' ' TYR . 8.9 m-30 -59.67 -56.57 20.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.26 -0.9 . . . . 0.0 110.809 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.517 HD22 ' N ' ' A' ' 180' ' ' TYR . 0.6 OUTLIER -76.25 43.94 0.31 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.002 -1.061 . . . . 0.0 110.12 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -105.32 -70.47 0.78 Allowed Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.913 -1.137 . . . . 0.0 110.269 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.442 ' C ' ' H ' ' A' ' 191' ' ' PHE . 45.3 Cg_endo -71.5 -29.71 16.1 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.899 1.473 . . . . 0.0 111.151 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -72.74 34.17 0.07 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.339 -0.851 . . . . 0.0 111.267 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.442 ' H ' ' C ' ' A' ' 189' ' ' PRO . 0.4 OUTLIER -90.51 -43.94 9.91 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.982 -1.074 . . . . 0.0 109.884 179.351 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -16.65 61.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.32 -0.863 . . . . 0.0 110.107 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -106.23 -13.38 23.16 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.622 ' O ' ' N ' ' A' ' 198' ' ' THR . 7.2 tt -70.94 -29.92 66.08 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.589 -0.948 . . . . 0.0 109.433 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.554 ' HE3' ' N ' ' A' ' 196' ' ' GLY . 0.1 OUTLIER -53.92 -32.61 54.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.224 -0.922 . . . . 0.0 109.493 179.745 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.554 ' N ' ' HE3' ' A' ' 195' ' ' LYS . . . -94.93 -25.97 13.66 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.714 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.67 -4.76 56.53 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.764 -0.845 . . . . 0.0 109.632 179.499 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.622 ' N ' ' O ' ' A' ' 194' ' ' LEU . 0.2 OUTLIER -44.01 136.96 3.51 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.76 0.79 . . . . 0.0 111.747 -178.243 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.714 ' HG ' ' O ' ' A' ' 197' ' ' ARG . 0.0 OUTLIER -140.37 170.81 15.12 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.381 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.52 ' O ' HG12 ' A' ' 108' ' ' VAL . 3.1 m-30 -84.76 139.03 37.54 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.934 . . . . 0.0 109.752 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.444 ' HD2' ' HA3' ' A' ' 83' ' ' GLY . 40.6 Cg_endo -67.8 113.74 3.09 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.871 1.458 . . . . 0.0 110.203 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.513 ' CB ' ' HA ' ' A' ' 81' ' ' LYS . 25.1 p -133.11 152.95 51.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.296 -0.877 . . . . 0.0 110.81 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 79' ' ' ARG . 6.1 p -160.2 149.91 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.524 -0.735 . . . . 0.0 110.049 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' SER . . . . . 0.896 ' O ' ' HH2' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -139.86 126.53 20.51 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.303 -0.873 . . . . 0.0 109.134 178.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -127.81 163.5 24.25 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.746 -1.221 . . . . 0.0 111.678 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.532 ' CG1' ' N ' ' A' ' 207' ' ' TRP . 1.2 t -50.2 174.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.752 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.555 ' HA ' HD11 ' A' ' 57' ' ' ILE . 79.0 m95 -51.29 -74.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.375 -0.828 . . . . 0.0 109.259 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.606 ' HA2' ' CD2' ' A' ' 66' ' ' PHE . . . 177.03 103.86 0.17 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.494 ' HB2' ' O ' ' A' ' 208' ' ' GLY . 18.6 tt0 179.68 -49.11 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.767 -0.843 . . . . 0.0 110.195 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . 0.521 ' O ' ' CG ' ' A' ' 211' ' ' GLN . 1.7 m -43.0 -96.78 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.62 -0.675 . . . . 0.0 110.658 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.577 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 0.0 OUTLIER 179.53 45.23 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.24 -0.912 . . . . 0.0 109.523 -179.603 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.484 ' HA ' ' HD2' ' A' ' 96' ' ' PRO . 29.2 t -86.08 138.22 19.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-O 121.558 0.694 . . . . 0.0 110.758 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 0.415 ' HA ' ' HZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -125.71 143.7 50.93 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.48 -0.763 . . . . 0.0 110.139 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.593 ' HB ' ' CZ3' ' A' ' 48' ' ' TRP . 1.5 tt -140.12 127.59 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.086 -1.009 . . . . 0.0 110.488 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -129.96 144.23 51.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.306 -0.871 . . . . 0.0 109.596 179.519 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . 0.731 ' CE2' ' CE3' ' A' ' 91' ' ' TRP . 1.2 t80 -118.62 151.37 38.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.248 -0.908 . . . . 0.0 111.318 -178.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' MET . . . . . 0.468 ' HB3' ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -127.79 107.83 10.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.469 -0.77 . . . . 0.0 109.658 179.332 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 71.75 76.51 0.59 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.575 ' HB2' ' CD2' ' A' ' 216' ' ' TYR . 32.1 tt0 -95.39 156.87 16.14 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.22 -1.164 . . . . 0.0 110.296 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . 0.487 ' NE ' ' HA ' ' A' ' 220' ' ' ARG . 0.2 OUTLIER -110.19 -141.15 0.38 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 0.0 110.123 179.781 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . 0.483 ' O ' ' O ' ' A' ' 222' ' ' VAL . 4.1 tpp180 -178.18 97.75 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 110.346 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 221' ' ' ARG . 14.2 p -38.66 161.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.302 -0.874 . . . . 0.0 110.467 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.516 ' O ' ' C ' ' A' ' 224' ' ' GLU . 0.1 OUTLIER -173.4 78.49 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 110.218 179.812 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.516 ' C ' ' O ' ' A' ' 223' ' ' GLU . 1.7 mp0 -32.87 -68.12 0.11 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.49 -0.756 . . . . 0.0 110.683 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 224' ' ' GLU . 22.8 p -42.8 149.28 0.2 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 0.0 110.244 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.4 ' HD2' ' O ' ' A' ' 224' ' ' GLU . 0.0 OUTLIER -162.87 89.83 0.67 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.287 -0.883 . . . . 0.0 110.228 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -47.21 -63.09 1.13 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 110.278 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.5 mt -54.52 141.87 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.282 -0.886 . . . . 0.0 110.337 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.445 ' O ' ' C ' ' A' ' 230' ' ' ARG . 0.2 OUTLIER -115.97 123.76 48.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.921 . . . . 0.0 110.016 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . 0.445 ' C ' ' O ' ' A' ' 229' ' ' HIS . 11.3 mtp180 -41.44 -80.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 110.223 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 230' ' ' ARG . 6.7 t70 . . . . . 0 C--N 1.306 -1.314 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.314 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.97 -158.62 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.162 -1.199 . . . . 0.0 110.244 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.1 m 53.63 80.24 0.11 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 110.156 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 11' ' ' GLN . . . -119.21 -161.44 0.85 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.88 . . . . 0.0 110.208 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -53.56 89.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 110.307 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -179.86 102.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.337 -0.852 . . . . 0.0 110.256 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.47 101.97 1.7 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 110.179 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 11' ' ' GLN . 20.4 p -136.75 76.19 47.87 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.131 -0.981 . . . . 0.0 110.174 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.42 ' O ' ' N ' ' A' ' 16' ' ' SER . 46.4 Cg_endo -73.14 148.21 44.02 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.942 1.496 . . . . 0.0 110.456 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.1 t -68.64 63.81 0.11 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.201 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.42 ' N ' ' O ' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -153.02 167.39 29.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.143 -0.973 . . . . 0.0 110.181 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.6 pm0 -55.72 128.77 36.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.135 -0.978 . . . . 0.0 110.234 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -177.52 156.42 1.17 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.201 -0.937 . . . . 0.0 110.178 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -69.81 -163.67 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 0.0 110.223 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.55 -155.08 0.59 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.353 -0.842 . . . . 0.0 110.109 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 p -83.46 103.66 12.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.251 -0.905 . . . . 0.0 110.054 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -81.8 41.22 0.64 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.912 . . . . 0.0 110.334 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.83 -73.76 0.53 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 109.973 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.8 m -78.98 115.16 50.26 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.455 -0.778 . . . . 0.0 110.133 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.72 118.36 5.54 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.963 1.507 . . . . 0.0 110.495 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.681 ' O ' ' N ' ' A' ' 28' ' ' GLY . 46.3 Cg_endo -73.14 -165.11 0.22 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.998 1.526 . . . . 0.0 110.498 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.668 ' C ' ' O ' ' A' ' 26' ' ' PRO . 10.0 mm-40 1.33 66.09 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.49 0.662 . . . . 0.0 111.059 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.681 ' N ' ' O ' ' A' ' 26' ' ' PRO . . . -153.01 -35.0 0.03 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.493 ' CD1' ' C ' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -74.43 -40.18 62.13 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.437 -1.037 . . . . 0.0 109.918 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 34' ' ' SER . 1.4 pp20? -46.17 -37.37 6.94 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.135 -0.978 . . . . 0.0 109.165 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -57.44 -25.56 59.84 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.381 -0.825 . . . . 0.0 108.823 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 29' ' ' LEU . 5.9 tp -83.12 -32.21 26.82 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.6 ' C ' ' CD1' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -84.94 -38.42 19.36 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 121.82 0.819 . . . . 0.0 109.237 179.164 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.565 ' O ' ' O ' ' A' ' 35' ' ' ALA . 1.1 t -49.23 -20.63 0.65 Allowed 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.388 0.613 . . . . 0.0 110.189 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.775 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . . . -52.34 -161.37 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.516 -0.74 . . . . 0.0 109.692 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.775 ' HD2' ' CB ' ' A' ' 35' ' ' ALA . 39.2 Cg_endo -66.61 121.85 9.16 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 O-C-N 123.001 1.0 . . . . 0.0 109.754 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.569 ' CB ' ' CG2' ' A' ' 41' ' ' VAL . 44.0 Cg_endo -70.08 109.27 2.33 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.154 1.607 . . . . 0.0 111.732 -178.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.774 ' O ' ' N ' ' A' ' 40' ' ' LEU . 52.0 Cg_endo -79.74 151.62 22.01 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.238 1.652 . . . . 0.0 109.239 178.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.705 ' CG ' ' OE1' ' A' ' 43' ' ' GLN . 0.9 OUTLIER -12.83 -51.23 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 122.167 0.984 . . . . 0.0 110.062 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 1.008 ' O ' ' HB3' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -34.78 -43.23 0.17 Allowed 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.934 -179.346 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.618 HG21 ' CD1' ' A' ' 40' ' ' LEU . 2.9 t -70.87 -24.81 25.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 O-C-N 121.168 -0.957 . . . . 0.0 110.678 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.607 ' N ' ' O ' ' A' ' 39' ' ' ASP . . . -90.69 -41.54 11.24 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 118.981 -1.087 . . . . 0.0 113.104 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.705 ' OE1' ' CG ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -87.37 -19.37 28.24 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.862 -1.149 . . . . 0.0 109.829 -179.1 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 1.008 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 7.5 ttm-85 -72.44 -53.98 10.64 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.735 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 66.3 m170 -55.49 -27.98 51.76 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.556 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -96.07 -30.43 13.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.02 -1.05 . . . . 0.0 109.586 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.87 -74.11 1.27 Allowed Glycine 0 N--CA 1.488 2.131 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.736 ' CD2' ' CE1' ' A' ' 66' ' ' PHE . 99.2 m95 -100.36 74.09 1.71 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.564 HD21 ' HB2' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -43.65 145.71 1.11 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.5 -0.75 . . . . 0.0 110.984 -179.419 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.735 ' HD3' ' HA ' ' A' ' 45' ' ' HIS . 42.8 Cg_endo -70.88 -31.07 16.16 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 124.297 1.682 . . . . 0.0 110.681 -178.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.913 ' O ' ' HA2' ' A' ' 80' ' ' GLY . 0.3 OUTLIER -64.17 -16.15 61.32 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.225 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.988 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 4.8 m-20 -118.72 0.28 11.43 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.638 177.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.612 ' HA ' ' CA ' ' A' ' 78' ' ' VAL . 16.0 t -150.04 132.9 16.04 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.21 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.649 ' CB ' ' ND2' ' A' ' 56' ' ' ASN . 0.5 OUTLIER -75.23 117.65 17.29 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.593 0.711 . . . . 0.0 109.688 179.186 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.646 ' O ' ' N ' ' A' ' 57' ' ' ILE . 6.7 pt-20 -42.54 -28.67 0.23 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.595 -0.69 . . . . 0.0 112.801 -178.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.672 ' H ' ' ND2' ' A' ' 56' ' ' ASN . 0.1 OUTLIER -40.34 -16.0 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.298 0 O-C-N 120.96 -1.087 . . . . 0.0 111.04 -179.114 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.646 ' N ' ' O ' ' A' ' 55' ' ' GLU . 1.2 mt -111.55 165.6 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 120.998 -1.064 . . . . 0.0 110.329 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 67' ' ' GLU . 4.2 t70 -117.54 104.27 10.9 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.76 0.791 . . . . 0.0 110.455 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.708 ' HB ' ' CD1' ' A' ' 48' ' ' TRP . 34.8 m -130.38 135.42 60.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 121.73 -0.606 . . . . 0.0 110.034 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.742 ' HG2' ' HA ' ' A' ' 40' ' ' LEU . 24.7 mttt -133.04 141.31 48.18 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.763 -1.211 . . . . 0.0 111.377 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.555 ' CG ' ' HB3' ' A' ' 43' ' ' GLN . 0.4 OUTLIER -59.95 -129.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.495 -0.753 . . . . 0.0 110.508 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 44.53 51.11 8.01 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 107.978 -2.049 . . . . 0.0 107.978 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.663 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 103.01 61.58 0.71 Allowed Glycine 0 N--CA 1.486 2.005 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 -178.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.663 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.2 OUTLIER 0.83 80.81 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.0 -0.706 . . . . 0.0 111.215 -178.737 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.426 ' N ' ' O ' ' A' ' 63' ' ' GLY . 0.5 OUTLIER -99.96 113.89 26.78 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.44 -0.788 . . . . 0.0 110.241 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.736 ' CE1' ' CD2' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -103.22 124.62 48.96 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.555 -0.716 . . . . 0.0 109.422 179.455 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.571 ' O ' HG22 ' A' ' 57' ' ' ILE . 1.1 tp10 -150.73 149.72 30.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.015 -1.053 . . . . 0.0 110.465 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.602 ' HG2' ' CE2' ' A' ' 207' ' ' TRP . 0.0 OUTLIER -119.54 151.74 38.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.309 -0.87 . . . . 0.0 109.969 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.627 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -94.85 -67.05 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 110.577 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.627 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 55.9 Cg_endo -73.53 -119.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.584 1.307 . . . . 0.0 109.583 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.0 t -139.97 164.23 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.317 -1.489 . . . . 0.0 110.21 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.578 ' HB3' ' CD2' ' A' ' 207' ' ' TRP . . . -70.48 69.94 0.42 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 0.0 110.108 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -87.29 -160.26 0.58 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.276 -0.89 . . . . 0.0 110.39 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.2 m -73.25 1.22 9.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.928 . . . . 0.0 110.313 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.468 HG22 ' OD1' ' A' ' 56' ' ' ASN . 3.7 m -116.43 0.41 12.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.923 . . . . 0.0 110.104 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.515 ' CB ' ' HA ' ' A' ' 72' ' ' ALA . 0.4 OUTLIER -99.81 154.8 18.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 110.149 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 54' ' ' SER . . . 132.47 145.87 5.55 Favored Glycine 0 N--CA 1.483 1.771 0 N-CA-C 108.07 -2.012 . . . . 0.0 108.07 -179.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.612 ' CA ' ' HA ' ' A' ' 53' ' ' CYS . 4.4 m -117.27 128.61 74.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 O-C-N 121.16 -1.2 . . . . 0.0 109.846 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.596 ' C ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -145.11 134.61 23.2 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.966 -0.693 . . . . 0.0 112.521 -177.674 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.988 ' CA ' ' HA ' ' A' ' 52' ' ' ASP . . . -123.09 165.58 15.69 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 178.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 201' ' ' PRO . 0.1 OUTLIER -177.52 68.18 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.409 -1.054 . . . . 0.0 110.23 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.932 ' HD3' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -163.38 -91.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.139 -0.975 . . . . 0.0 110.783 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.932 ' N ' ' HD3' ' A' ' 82' ' ' ARG . . . 83.64 87.5 0.81 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -115.59 97.19 6.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.264 -1.139 . . . . 0.0 110.437 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.535 ' O ' ' CG ' ' A' ' 173' ' ' MET . 1.5 m -139.97 160.31 40.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.33 -0.856 . . . . 0.0 110.059 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.515 ' C ' ' NE2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -118.6 134.27 55.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.078 -1.014 . . . . 0.0 110.211 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 101.56 -115.58 5.3 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.506 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 13.2 tp -128.52 130.48 47.52 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.391 -1.064 . . . . 0.0 110.565 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.515 ' NE2' ' C ' ' A' ' 86' ' ' ARG . 4.1 m-70 -147.23 158.5 43.97 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.26 -0.9 . . . . 0.0 109.962 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -162.95 156.43 19.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.134 -0.979 . . . . 0.0 110.354 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.65 ' CB ' ' CD2' ' A' ' 216' ' ' TYR . 5.4 p90 -143.76 170.82 15.16 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.353 -0.842 . . . . 0.0 110.01 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 215' ' ' ARG . 3.6 tt0 -145.86 157.52 43.9 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.429 -0.794 . . . . 0.0 110.932 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.562 ' N ' ' HG3' ' A' ' 92' ' ' GLU . 7.0 tp -143.15 154.37 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.545 -0.722 . . . . 0.0 109.848 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.669 ' O ' ' HD3' ' A' ' 96' ' ' PRO . 0.1 OUTLIER -149.88 137.09 19.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.321 -0.862 . . . . 0.0 110.3 -179.63 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.775 ' CH2' ' HA ' ' A' ' 104' ' ' ALA . 49.7 m95 -108.93 88.3 5.37 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 121.258 -0.901 . . . . 0.0 110.655 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.669 ' HD3' ' O ' ' A' ' 94' ' ' SER . 52.3 Cg_endo -97.26 108.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.348 1.365 . . . . 0.0 110.215 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.29 -67.99 0.82 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.781 -1.2 . . . . 0.0 110.187 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.47 -27.79 13.9 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.271 -0.893 . . . . 0.0 109.637 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -179.96 -29.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.625 0.726 . . . . 0.0 109.652 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.456 ' NH1' ' HG3' ' A' ' 100' ' ' ARG . 2.5 mtt85 -115.92 -67.91 0.96 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.464 -0.773 . . . . 0.0 109.787 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.555 ' HA2' ' O ' ' A' ' 95' ' ' TRP . . . 167.52 -162.95 36.74 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.463 ' HB ' ' O ' ' A' ' 101' ' ' GLY . 8.5 t -178.63 -29.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.201 -1.176 . . . . 0.0 110.721 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.563 ' O ' ' CE3' ' A' ' 95' ' ' TRP . 0.6 OUTLIER -155.56 166.31 33.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.073 -1.017 . . . . 0.0 110.867 -179.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.775 ' HA ' ' CH2' ' A' ' 95' ' ' TRP . . . 179.87 137.46 0.11 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.406 -0.809 . . . . 0.0 109.754 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.705 HG21 ' CB ' ' A' ' 204' ' ' SER . 34.2 m -131.95 115.67 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 O-C-N 120.245 -1.534 . . . . 0.0 110.357 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.519 HG12 ' N ' ' A' ' 107' ' ' GLY . 76.5 t -151.15 170.21 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.648 ' CA ' ' HA3' ' A' ' 132' ' ' GLY . . . 168.75 169.22 31.89 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 118.798 -1.667 . . . . 0.0 111.251 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.644 ' CG1' ' CD1' ' A' ' 199' ' ' LEU . 2.2 t -121.74 159.82 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.694 -0.886 . . . . 0.0 109.321 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.557 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -140.07 143.8 36.5 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.977 -1.077 . . . . 0.0 111.401 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.58 ' CG2' ' HB3' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -126.07 135.52 51.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.522 -0.736 . . . . 0.0 110.161 179.473 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.15 -25.35 17.9 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.445 -0.784 . . . . 0.0 109.173 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.48 ' O ' ' C ' ' A' ' 113' ' ' ALA . 2.7 pp -85.54 -12.22 52.18 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.581 -0.7 . . . . 0.0 109.356 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.48 ' C ' ' O ' ' A' ' 112' ' ' LEU . . . -37.4 98.35 0.16 Allowed Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.57 -0.706 . . . . 0.0 110.352 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.479 ' N ' ' O ' ' A' ' 112' ' ' LEU . 46.5 Cg_endo -73.62 -168.64 0.46 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.936 1.493 . . . . 0.0 110.516 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -179.99 48.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.32 -0.862 . . . . 0.0 110.162 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.441 ' HA ' ' OE1' ' A' ' 116' ' ' GLN . 1.5 tp-100 -129.39 -70.11 0.67 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.893 . . . . 0.0 110.223 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.525 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -179.99 115.48 0.05 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.415 -0.803 . . . . 0.0 110.17 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.525 ' C ' ' O ' ' A' ' 117' ' ' ALA . 19.0 t70 -31.72 -56.94 0.28 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.543 -0.723 . . . . 0.0 110.84 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.86 -57.53 4.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.879 . . . . 0.0 110.196 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.24 96.67 1.13 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.186 -0.946 . . . . 0.0 110.155 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -111.86 87.85 2.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.308 -0.87 . . . . 0.0 110.11 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.475 ' O ' ' CB ' ' A' ' 123' ' ' LEU . . . -80.75 4.93 17.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.242 -0.911 . . . . 0.0 110.216 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.475 ' CB ' ' O ' ' A' ' 122' ' ' ALA . 0.1 OUTLIER 66.75 -68.84 0.13 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.293 -0.879 . . . . 0.0 110.251 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 122' ' ' ALA . 0.6 OUTLIER 51.42 -161.09 0.08 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.299 -0.875 . . . . 0.0 110.267 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -73.63 -161.35 6.97 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 127' ' ' ASN . 5.1 t -144.89 67.14 1.25 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.273 -1.134 . . . . 0.0 110.237 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.417 ' O ' ' O ' ' A' ' 126' ' ' SER . 0.2 OUTLIER -53.9 -171.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 110.182 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 24.5 p -123.07 160.14 26.98 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 110.234 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.18 134.33 17.08 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.217 -0.927 . . . . 0.0 109.821 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 14.1 t -151.4 118.61 5.94 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.301 -0.874 . . . . 0.0 110.391 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . 0.52 ' CD1' ' N ' ' A' ' 131' ' ' TRP . 2.7 p-90 -135.59 166.23 23.69 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.648 ' HA3' ' CA ' ' A' ' 107' ' ' GLY . . . 177.67 -138.26 3.75 Favored Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.773 -1.203 . . . . 0.0 110.431 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.612 ' CH2' ' HB3' ' A' ' 180' ' ' TYR . 53.5 m0 -104.8 113.4 26.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.365 -1.08 . . . . 0.0 110.657 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.52 ' O ' ' CG2' ' A' ' 135' ' ' ILE . 1.9 p30 -118.74 113.31 20.95 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.45 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.531 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 3.5 pt -159.74 42.51 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.171 -0.956 . . . . 0.0 110.027 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 103' ' ' HIS . . . -49.88 -59.19 7.64 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 139' ' ' LYS . 0.5 OUTLIER -100.4 5.51 44.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.213 -1.169 . . . . 0.0 110.338 -179.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.492 ' C ' ' O ' ' A' ' 137' ' ' ARG . . . 37.06 30.36 0.04 OUTLIER Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 137' ' ' ARG . 0.1 OUTLIER -177.12 -139.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.121 -1.223 . . . . 0.0 110.553 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.678 ' O ' ' C ' ' A' ' 141' ' ' TYR . 5.9 tp -156.07 95.68 1.64 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.719 -0.613 . . . . 0.0 110.223 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.721 ' O ' ' N ' ' A' ' 143' ' ' GLN . 2.9 t80 0.31 78.0 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.807 -0.558 . . . . 0.0 111.297 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.66 ' C ' ' O ' ' A' ' 141' ' ' TYR . 17.6 p80 1.73 63.3 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.748 0.785 . . . . 0.0 111.36 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.721 ' N ' ' O ' ' A' ' 141' ' ' TYR . 31.6 tp60 -56.5 -54.84 41.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.685 -0.635 . . . . 0.0 110.29 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 143' ' ' GLN . 30.3 t -179.98 -78.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 0.0 110.208 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -134.41 94.13 3.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.275 -0.891 . . . . 0.0 110.295 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 176.08 102.3 0.15 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.7 mp -109.44 38.62 2.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -1.141 . . . . 0.0 110.124 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.91 134.34 0.1 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.273 -0.892 . . . . 0.0 110.089 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.473 ' O ' ' HD3' ' A' ' 156' ' ' PRO . . . -155.65 89.7 2.91 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.137 -0.977 . . . . 0.0 110.335 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.537 ' HA ' ' CG ' ' A' ' 156' ' ' PRO . 46.2 Cg_endo -72.8 73.63 2.96 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.935 1.492 . . . . 0.0 110.311 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -129.4 -45.44 1.22 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.242 -0.911 . . . . 0.0 110.687 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.503 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 0.1 OUTLIER -175.36 -57.07 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.192 -0.943 . . . . 0.0 110.632 -179.732 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.54 ' O ' ' C ' ' A' ' 154' ' ' ALA . 45.0 Cg_endo -72.22 171.32 17.11 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.917 1.483 . . . . 0.0 110.633 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.54 ' C ' ' O ' ' A' ' 153' ' ' PRO . . . -31.14 115.98 0.15 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.559 -0.713 . . . . 0.0 110.751 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 176.23 -80.63 0.07 OUTLIER Glycine 0 N--CA 1.48 1.571 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.537 ' CG ' ' HA ' ' A' ' 150' ' ' PRO . 49.8 Cg_endo -76.92 -3.45 13.79 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.028 1.541 . . . . 0.0 110.309 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' A' ' 134' ' ' ASP . 0.3 OUTLIER -48.05 -61.06 2.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.309 -0.869 . . . . 0.0 110.575 -179.699 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.407 ' C ' ' H ' ' A' ' 160' ' ' GLN . . . 103.8 85.37 1.86 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.91 5.33 1.59 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.284 -1.127 . . . . 0.0 110.771 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.407 ' H ' ' C ' ' A' ' 158' ' ' GLY . 0.0 OUTLIER -66.23 -12.3 55.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.163 -0.961 . . . . 0.0 109.507 179.53 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.648 ' O ' ' C ' ' A' ' 162' ' ' VAL . 6.3 mt -98.58 49.4 0.98 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.501 -0.75 . . . . 0.0 109.509 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.648 ' C ' ' O ' ' A' ' 161' ' ' LEU . 6.3 p 0.65 86.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.645 0.736 . . . . 0.0 111.914 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.685 ' O ' HD22 ' A' ' 167' ' ' LEU . 0.2 OUTLIER -96.2 -42.38 0.27 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.345 -0.847 . . . . 0.0 109.0 178.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.631 ' CD ' ' N ' ' A' ' 163' ' ' VAL . 48.8 Cg_endo -82.8 62.41 7.76 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.548 1.288 . . . . 0.0 109.118 178.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.644 ' O ' ' CB ' ' A' ' 94' ' ' SER . 11.0 tp10 -173.75 -78.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.64 -0.662 . . . . 0.0 109.61 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.592 ' C ' ' CD2' ' A' ' 167' ' ' LEU . 7.7 ttt180 -151.6 132.96 14.59 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.537 -0.727 . . . . 0.0 109.645 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.685 HD22 ' O ' ' A' ' 163' ' ' VAL . 3.0 mm? -140.33 153.61 46.49 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.366 -0.834 . . . . 0.0 110.8 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.42 ' N ' ' HE1' ' A' ' 180' ' ' TYR . 6.2 tp -129.07 130.24 46.28 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.567 -0.708 . . . . 0.0 109.259 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.803 ' HB ' ' HA ' ' A' ' 180' ' ' TYR . 0.2 OUTLIER -127.25 144.1 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.955 -1.091 . . . . 0.0 110.262 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.489 ' N ' HG23 ' A' ' 169' ' ' VAL . 4.3 p -102.53 133.19 46.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.815 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.602 ' CD1' ' CD2' ' A' ' 178' ' ' LEU . 2.7 tp -124.76 105.89 9.64 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.433 -0.792 . . . . 0.0 109.824 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.514 ' OD1' ' CG ' ' A' ' 174' ' ' GLU . 5.1 t70 -119.97 134.44 55.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 110.488 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.535 ' CG ' ' O ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -98.8 -42.23 7.29 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.278 0.561 . . . . 0.0 109.63 179.491 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.514 ' CG ' ' OD1' ' A' ' 172' ' ' ASP . 7.9 pt-20 -45.01 -24.91 0.26 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.246 -0.908 . . . . 0.0 108.828 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.611 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.2 OUTLIER -112.25 -27.01 8.5 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.16 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.524 ' O ' HG22 ' A' ' 198' ' ' THR . . . 80.88 25.73 55.24 Favored Glycine 0 N--CA 1.483 1.787 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.624 ' CG2' ' CD2' ' A' ' 194' ' ' LEU . 0.1 OUTLIER -112.7 124.05 51.69 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.096 -1.238 . . . . 0.0 111.093 -179.434 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.632 ' N ' ' CD1' ' A' ' 178' ' ' LEU . 2.6 mp -129.08 153.47 47.61 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.51 -0.744 . . . . 0.0 109.434 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.542 ' O ' ' CG2' ' A' ' 169' ' ' VAL . . . -178.9 163.67 31.5 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.2 -1.476 . . . . 0.0 110.633 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.803 ' HA ' ' HB ' ' A' ' 169' ' ' VAL . 0.1 OUTLIER -118.28 128.17 54.42 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.455 -1.026 . . . . 0.0 109.492 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.597 ' OG ' ' N ' ' A' ' 186' ' ' TYR . 5.7 t -132.34 165.15 24.86 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.662 0.744 . . . . 0.0 110.186 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.601 HG22 ' CD1' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -105.46 116.7 49.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 O-C-N 121.792 -0.568 . . . . 0.0 109.556 179.356 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 64.4 8.86 33.79 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 86.81 35.18 10.31 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' THR . . . . . 0.477 ' O ' ' C ' ' A' ' 186' ' ' TYR . 37.3 m -106.77 -65.93 1.05 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.117 -1.225 . . . . 0.0 110.71 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.62 ' CE2' HD23 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -35.98 -74.3 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.315 -0.866 . . . . 0.0 110.761 -179.618 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.578 ' HB2' ' HB2' ' A' ' 181' ' ' SER . 2.7 mm? -67.69 46.19 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.037 -1.039 . . . . 0.0 110.081 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 186' ' ' TYR . . . -73.51 -99.05 0.08 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.572 ' C ' ' H ' ' A' ' 191' ' ' PHE . 49.2 Cg_endo -73.65 -23.99 16.34 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.109 1.583 . . . . 0.0 111.242 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -62.39 29.39 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.39 -0.819 . . . . 0.0 111.797 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.572 ' H ' ' C ' ' A' ' 189' ' ' PRO . 1.0 OUTLIER -90.54 -22.33 21.35 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.782 -1.199 . . . . 0.0 110.461 179.391 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.507 ' N ' ' HD2' ' A' ' 192' ' ' ARG . 0.0 OUTLIER -87.82 -13.02 43.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.178 -0.951 . . . . 0.0 110.443 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -108.77 -10.46 24.78 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.334 -1.906 . . . . 0.0 108.334 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.647 ' O ' ' N ' ' A' ' 198' ' ' THR . 7.8 tt -72.86 -41.56 64.63 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.731 -0.864 . . . . 0.0 108.808 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.576 ' CA ' HG23 ' A' ' 198' ' ' THR . 0.0 OUTLIER -43.92 -42.14 5.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.486 -0.759 . . . . 0.0 109.975 179.61 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.511 ' N ' ' HD2' ' A' ' 195' ' ' LYS . . . -85.32 -25.64 39.12 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.867 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.66 -3.74 57.28 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.789 -0.83 . . . . 0.0 109.911 179.835 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.647 ' N ' ' O ' ' A' ' 194' ' ' LEU . 15.9 p -42.75 125.59 3.44 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.811 0.815 . . . . 0.0 111.85 -177.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.867 ' HG ' ' O ' ' A' ' 197' ' ' ARG . 0.1 OUTLIER -140.39 171.44 14.15 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.136 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.519 ' C ' HG13 ' A' ' 108' ' ' VAL . 3.2 m-85 -84.2 129.16 59.36 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.949 -1.094 . . . . 0.0 109.97 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.518 ' O ' ' HA ' ' A' ' 81' ' ' LYS . 50.7 Cg_endo -76.92 136.01 16.21 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 124.014 1.534 . . . . 0.0 111.012 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.507 ' HB2' ' CB ' ' A' ' 81' ' ' LYS . 4.7 t -133.18 140.21 47.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.449 -0.782 . . . . 0.0 109.945 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 79' ' ' ARG . 6.0 p -120.3 153.5 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.237 -0.914 . . . . 0.0 110.153 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' SER . . . . . 0.705 ' CB ' HG21 ' A' ' 105' ' ' VAL . 6.3 t -142.39 127.39 18.41 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.27 -0.894 . . . . 0.0 110.051 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.617 ' HA ' ' CH2' ' A' ' 95' ' ' TRP . . . -124.88 140.36 53.0 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.455 0.645 . . . . 0.0 110.415 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.578 ' CG1' ' N ' ' A' ' 207' ' ' TRP . 0.3 OUTLIER -64.56 -158.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.552 -0.718 . . . . 0.0 110.672 -179.527 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.602 ' CE2' ' HG2' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -121.1 154.98 35.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.409 -0.807 . . . . 0.0 109.932 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.458 ' O ' ' OE1' ' A' ' 211' ' ' GLN . . . 134.23 -175.18 20.55 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.533 ' CG ' ' OE1' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -98.21 -30.04 12.86 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.207 -1.172 . . . . 0.0 110.401 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 1.6 t -116.36 81.25 1.59 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.334 -0.854 . . . . 0.0 110.468 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.458 ' OE1' ' O ' ' A' ' 208' ' ' GLY . 0.0 OUTLIER -123.68 -90.49 0.57 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.165 -0.96 . . . . 0.0 110.241 179.683 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.715 HG22 ' CG ' ' A' ' 95' ' ' TRP . 4.2 p -127.5 143.26 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.085 -1.009 . . . . 0.0 111.276 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 0.553 ' CD ' ' HB3' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -102.18 145.59 29.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.469 -0.769 . . . . 0.0 108.953 178.64 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.585 ' HB ' ' CZ3' ' A' ' 48' ' ' TRP . 4.8 tt -115.97 140.44 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.954 -1.091 . . . . 0.0 111.266 -178.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.606 ' O ' ' N ' ' A' ' 92' ' ' GLU . 7.9 ttm180 -130.6 109.32 10.57 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . 0.65 ' CD2' ' CB ' ' A' ' 91' ' ' TRP . 3.2 t80 -118.13 146.99 43.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.035 -1.041 . . . . 0.0 111.248 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' MET . . . . . 0.505 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 2.6 mmt -136.39 115.84 12.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.564 -0.71 . . . . 0.0 110.0 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 126.69 -4.45 7.54 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.577 ' HB2' ' CE1' ' A' ' 216' ' ' TYR . 0.4 OUTLIER -106.44 136.62 45.88 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.248 -1.148 . . . . 0.0 110.229 -179.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . 0.434 ' N ' ' CD ' ' A' ' 219' ' ' GLU . 0.0 OUTLIER 179.95 -81.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 110.168 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . 0.482 ' O ' ' C ' ' A' ' 222' ' ' VAL . 24.0 ttt85 -166.87 81.34 0.23 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.306 -0.871 . . . . 0.0 110.259 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.482 ' C ' ' O ' ' A' ' 221' ' ' ARG . 12.7 p -35.96 124.56 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.494 -0.754 . . . . 0.0 110.616 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.529 ' O ' ' C ' ' A' ' 224' ' ' GLU . 1.8 tt0 179.93 -89.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.285 -0.884 . . . . 0.0 110.256 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.529 ' C ' ' O ' ' A' ' 223' ' ' GLU . 20.2 mm-40 -32.14 -64.05 0.18 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.555 -0.716 . . . . 0.0 110.722 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.38 134.91 22.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.296 -0.877 . . . . 0.0 110.197 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -158.34 112.97 2.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 0.0 110.13 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.505 ' O ' ' CG ' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -42.72 107.4 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.329 -0.857 . . . . 0.0 110.276 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.0 tt -113.77 -1.19 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.305 -0.872 . . . . 0.0 110.226 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.491 ' O ' ' CG ' ' A' ' 230' ' ' ARG . 0.7 OUTLIER -106.53 -159.03 0.68 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.162 -0.961 . . . . 0.0 110.242 179.917 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . 0.677 ' O ' ' C ' ' A' ' 231' ' ' ASP . 0.1 OUTLIER 179.78 122.3 0.06 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.273 -0.892 . . . . 0.0 110.21 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.677 ' C ' ' O ' ' A' ' 230' ' ' ARG . 9.3 p-10 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.057 -0.973 . . . . 0.0 111.472 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 37.7 p -49.89 115.0 1.21 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -1.14 . . . . 0.0 110.21 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.64 -31.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.288 -0.882 . . . . 0.0 110.227 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.16 -177.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.222 -0.924 . . . . 0.0 110.25 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.6 mtt180 -113.97 21.29 14.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.241 -0.912 . . . . 0.0 110.225 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -105.44 1.36 27.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 110.171 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 94.4 p -97.19 59.73 1.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.252 -0.905 . . . . 0.0 110.106 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.2 m -50.85 109.19 1.24 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 0.0 110.267 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.433 ' C ' ' OG1' ' A' ' 15' ' ' THR . 46.0 Cg_endo -73.42 54.2 2.8 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.993 1.523 . . . . 0.0 110.383 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.452 ' O ' ' HB2' ' A' ' 16' ' ' SER . 0.1 OUTLIER -167.97 25.92 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.199 -0.938 . . . . 0.0 110.144 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 17' ' ' GLN . 34.9 t -177.79 -170.94 0.28 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.0 110.184 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 16' ' ' SER . 2.5 tt0 -179.55 -61.05 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.303 -0.873 . . . . 0.0 110.163 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.52 136.86 42.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 110.267 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -72.24 -159.93 0.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 110.254 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -108.14 -146.11 0.4 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.189 -0.944 . . . . 0.0 110.272 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.98 152.28 24.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -0.903 . . . . 0.0 110.358 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -83.41 44.66 0.98 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.323 -0.861 . . . . 0.0 110.32 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.19 -57.06 4.05 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.328 -0.857 . . . . 0.0 110.146 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.23 160.23 76.16 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.457 -0.777 . . . . 0.0 110.215 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.429 ' HB3' ' CD ' ' A' ' 30' ' ' GLU . 46.5 Cg_endo -72.83 167.1 28.16 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.991 1.521 . . . . 0.0 110.435 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.739 ' O ' ' N ' ' A' ' 28' ' ' GLY . 43.9 Cg_endo -72.3 157.69 53.04 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.024 1.539 . . . . 0.0 110.709 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.627 ' C ' ' O ' ' A' ' 26' ' ' PRO . 1.8 mp0 0.88 61.11 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 121.131 0.491 . . . . 0.0 111.793 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.739 ' N ' ' O ' ' A' ' 26' ' ' PRO . . . 36.89 30.74 0.04 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.631 ' O ' ' N ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -73.41 -53.71 10.05 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.455 -1.027 . . . . 0.0 110.459 -179.619 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.517 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 42.9 mt-10 -43.87 -35.59 2.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.157 -0.964 . . . . 0.0 108.973 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -58.9 -24.26 62.09 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.631 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -83.46 -32.96 25.74 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.777 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.582 ' C ' ' CD1' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -82.2 -37.18 26.44 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.696 0.76 . . . . 0.0 109.488 179.389 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.546 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 14.9 m -61.61 -11.38 11.18 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.279 0.561 . . . . 0.0 110.264 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.728 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . . . -51.95 -168.04 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.431 -0.793 . . . . 0.0 110.272 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.728 ' HD2' ' CB ' ' A' ' 35' ' ' ALA . 40.7 Cg_endo -67.91 -169.81 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.55 1.289 . . . . 0.0 110.059 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.644 ' CD ' ' HB2' ' A' ' 36' ' ' PRO . 51.6 Cg_endo -96.77 63.55 0.13 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.528 1.486 . . . . 0.0 112.269 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.692 ' CD ' ' O ' ' A' ' 36' ' ' PRO . 51.2 Cg_endo -73.54 151.56 47.47 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.275 1.144 . . . . 0.0 109.583 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.59 ' O ' ' HB3' ' A' ' 43' ' ' GLN . 1.3 t0 -33.67 -30.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.3 -0.875 . . . . 0.0 109.833 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.953 ' O ' ' HB3' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -57.2 -44.88 84.08 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.279 -0.888 . . . . 0.0 110.72 -179.354 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.635 ' O ' ' ND1' ' A' ' 45' ' ' HIS . 22.3 t -85.74 -34.4 8.4 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 C-N-CA 118.54 -1.264 . . . . 0.0 110.327 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.62 -39.08 12.07 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.134 -0.979 . . . . 0.0 113.114 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.652 ' NE2' ' HB3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -87.13 -18.75 29.7 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 120.82 -1.175 . . . . 0.0 109.885 -178.741 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.953 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 3.0 ttp85 -76.84 -55.36 5.55 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.28 -0.887 . . . . 0.0 108.918 178.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.635 ' ND1' ' O ' ' A' ' 41' ' ' VAL . 65.9 m170 -45.4 -23.58 0.22 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.407 ' N ' ' O ' ' A' ' 44' ' ' ARG . 7.0 t60 -84.5 -39.67 18.58 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.489 ' CA ' ' HG3' ' A' ' 61' ' ' GLU . . . -83.52 -80.57 1.01 Allowed Glycine 0 N--CA 1.487 2.054 0 N-CA-C 106.679 -2.568 . . . . 0.0 106.679 177.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.693 ' CE2' ' CD1' ' A' ' 66' ' ' PHE . 99.5 m95 -90.42 73.5 6.95 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.299 -1.118 . . . . 0.0 108.87 177.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.721 ' O ' ' HB3' ' A' ' 53' ' ' CYS . 0.0 OUTLIER -44.88 163.1 0.2 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.721 -0.612 . . . . 0.0 110.997 179.835 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.764 ' O ' ' O ' ' A' ' 53' ' ' CYS . 41.0 Cg_endo -67.66 -60.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.818 1.431 . . . . 0.0 110.887 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.741 ' O ' ' O ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -40.17 -84.82 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.661 -1.274 . . . . 0.0 109.121 179.385 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.713 ' HA ' ' N ' ' A' ' 80' ' ' GLY . 2.0 m-20 -47.92 0.89 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.337 -0.852 . . . . 0.0 111.548 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.764 ' O ' ' O ' ' A' ' 50' ' ' PRO . 1.3 t -166.07 129.95 2.16 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.631 -1.293 . . . . 0.0 112.199 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.888 ' H ' ' HA ' ' A' ' 78' ' ' VAL . 1.8 m -81.85 124.1 29.39 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.437 -0.789 . . . . 0.0 109.753 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.65 ' HB3' ' NH2' ' A' ' 44' ' ' ARG . 3.2 pt-20 -51.6 -2.03 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.377 -0.827 . . . . 0.0 110.746 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.64 ' ND2' ' N ' ' A' ' 56' ' ' ASN . 0.3 OUTLIER -49.46 -21.5 0.95 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.835 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.535 ' CG2' ' CG1' ' A' ' 59' ' ' VAL . 0.9 OUTLIER -112.04 166.73 6.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.676 -0.64 . . . . 0.0 109.916 -179.705 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.514 ' N ' ' CG2' ' A' ' 57' ' ' ILE . 2.0 t70 -109.12 96.11 6.09 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.006 0.908 . . . . 0.0 110.054 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.649 HG13 ' CD1' ' A' ' 66' ' ' PHE . 33.3 m -128.35 135.45 62.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.711 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.652 ' HB3' ' NE2' ' A' ' 43' ' ' GLN . 13.1 mtpt -125.62 155.41 40.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.006 -1.058 . . . . 0.0 111.558 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.492 ' O ' ' C ' ' A' ' 62' ' ' GLY . 1.4 tt0 -80.24 -130.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.384 -0.823 . . . . 0.0 110.06 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.492 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 39.92 53.87 3.08 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.676 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 105.84 66.05 0.66 Allowed Glycine 0 N--CA 1.486 2.009 0 N-CA-C 107.785 -2.126 . . . . 0.0 107.785 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.68 HD12 ' CZ2' ' A' ' 48' ' ' TRP . 0.2 OUTLIER 0.77 86.31 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 122.026 -0.691 . . . . 0.0 111.454 -178.522 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -99.66 113.93 26.68 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.703 179.564 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.693 ' CD1' ' CE2' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -114.38 124.67 52.53 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.569 -0.707 . . . . 0.0 109.193 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.519 ' O ' HG22 ' A' ' 57' ' ' ILE . 3.7 tm-20 -150.36 130.32 13.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.982 -1.074 . . . . 0.0 110.921 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.529 ' HG2' ' N ' ' A' ' 208' ' ' GLY . 0.6 OUTLIER -110.85 156.15 21.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.372 -0.83 . . . . 0.0 109.449 179.209 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.589 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 2.3 tpt180 -173.94 -52.95 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 120.982 -1.074 . . . . 0.0 111.687 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 69' ' ' ARG . 40.0 Cg_endo -66.09 -52.79 0.8 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.508 1.268 . . . . 0.0 111.298 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.624 HG22 ' CB ' ' A' ' 56' ' ' ASN . 25.4 t -78.55 164.97 3.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.244 -0.91 . . . . 0.0 110.867 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.489 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -179.47 -30.49 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.445 0.64 . . . . 0.0 109.429 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -73.93 -116.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.373 -0.829 . . . . 0.0 110.202 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.9 t -124.48 50.07 1.74 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.019 -1.051 . . . . 0.0 110.397 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.502 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 4.2 m -83.41 -125.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 0.0 110.054 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.549 ' CB ' ' OD1' ' A' ' 56' ' ' ASN . 0.4 OUTLIER -136.6 112.69 9.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.089 -1.007 . . . . 0.0 110.71 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.534 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -57.23 -92.89 0.01 OUTLIER Glycine 0 N--CA 1.482 1.765 0 N-CA-C 105.359 -3.096 . . . . 0.0 105.359 177.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.888 ' HA ' ' H ' ' A' ' 54' ' ' SER . 32.7 m -152.9 119.5 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.229 -1.16 . . . . 0.0 110.047 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.741 ' O ' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -146.87 134.09 20.55 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.602 -0.686 . . . . 0.0 111.224 -179.299 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.713 ' N ' ' HA ' ' A' ' 52' ' ' ASP . . . -132.2 -179.64 16.4 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.567 ' HB2' ' CB ' ' A' ' 202' ' ' SER . 0.0 OUTLIER 179.98 26.5 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.432 -1.04 . . . . 0.0 110.28 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.73 ' CD ' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -69.77 -18.59 63.5 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.164 -0.96 . . . . 0.0 110.722 -179.674 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.73 ' N ' ' CD ' ' A' ' 82' ' ' ARG . . . 27.8 44.37 0.04 OUTLIER Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.503 ' N ' ' O ' ' A' ' 82' ' ' ARG . 1.2 t80 -103.63 95.56 6.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.218 -1.166 . . . . 0.0 110.482 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.519 ' OG ' ' CD2' ' A' ' 171' ' ' LEU . 3.6 p -140.47 166.58 24.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.311 -0.868 . . . . 0.0 110.172 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.549 ' HD2' ' NE2' ' A' ' 89' ' ' HIS . 0.5 OUTLIER -136.31 156.52 48.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 109.928 179.584 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.566 ' N ' ' HB3' ' A' ' 173' ' ' MET . . . 62.31 -114.45 6.83 Favored Glycine 0 N--CA 1.483 1.816 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.19 131.26 47.09 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.513 -0.992 . . . . 0.0 110.968 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.549 ' NE2' ' HD2' ' A' ' 86' ' ' ARG . 74.1 m-70 -147.25 173.38 12.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.199 -0.938 . . . . 0.0 109.997 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.6 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -163.59 154.36 16.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.362 -0.836 . . . . 0.0 110.583 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.736 ' CD1' ' CZ ' ' A' ' 216' ' ' TYR . 0.1 OUTLIER -134.66 170.79 15.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.171 -0.955 . . . . 0.0 109.3 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.606 ' HB3' ' HB3' ' A' ' 215' ' ' ARG . 0.9 OUTLIER -146.8 152.66 39.12 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.699 -179.511 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.554 ' CD1' HG13 ' A' ' 214' ' ' ILE . 7.8 mm -142.71 153.66 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.675 -0.641 . . . . 0.0 109.433 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.536 ' HB3' ' HB2' ' A' ' 166' ' ' ARG . 0.0 OUTLIER -155.35 127.56 7.71 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.788 -1.195 . . . . 0.0 111.511 -179.564 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.811 ' CZ2' ' HA ' ' A' ' 104' ' ' ALA . 5.8 m95 -114.21 87.9 14.16 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.221 -0.924 . . . . 0.0 109.922 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.53 ' O ' ' NE2' ' A' ' 211' ' ' GLN . 51.7 Cg_endo -95.14 107.13 0.12 Allowed 'Trans proline' 0 C--N 1.302 -1.891 0 O-C-N 123.399 1.21 . . . . 0.0 110.333 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.414 ' HA ' HD11 ' A' ' 97' ' ' LEU . 23.5 tp -96.94 -69.45 0.76 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.9 -1.125 . . . . 0.0 109.091 178.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 99' ' ' GLN . 10.0 mt-10 -100.31 -45.72 5.5 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.826 0.822 . . . . 0.0 108.996 178.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.514 ' O ' ' O ' ' A' ' 100' ' ' ARG . 1.3 tm0? 178.87 -26.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.226 0.536 . . . . 0.0 110.03 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.514 ' O ' ' O ' ' A' ' 99' ' ' GLN . 10.7 mpt_? -28.97 -99.06 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.822 -0.549 . . . . 0.0 111.548 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 163' ' ' VAL . . . -163.24 -96.97 0.11 Allowed Glycine 0 N--CA 1.487 2.059 0 C-N-CA 119.668 -1.254 . . . . 0.0 110.28 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.623 ' CG2' ' HB ' ' A' ' 163' ' ' VAL . 3.4 t -139.04 -160.05 1.02 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.934 -1.333 . . . . 0.0 111.962 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.595 ' NE2' ' CG2' ' A' ' 135' ' ' ILE . 3.2 t-80 179.33 29.59 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.764 -0.585 . . . . 0.0 109.88 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.811 ' HA ' ' CZ2' ' A' ' 95' ' ' TRP . . . -54.7 123.53 13.54 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.407 -0.808 . . . . 0.0 111.396 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.661 ' CG2' ' O ' ' A' ' 204' ' ' SER . 3.7 m -97.99 114.27 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 118.147 -1.421 . . . . 0.0 108.358 178.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.704 ' CG2' ' O ' ' A' ' 202' ' ' SER . 0.7 OUTLIER -150.33 149.61 14.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.459 -0.776 . . . . 0.0 110.584 -178.302 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.565 ' HA2' ' HA3' ' A' ' 132' ' ' GLY . . . -153.91 142.79 9.44 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.643 ' HA ' ' O ' ' A' ' 200' ' ' TYR . 2.8 m -98.46 155.17 3.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.251 -1.146 . . . . 0.0 110.299 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.529 ' C ' ' HB3' ' A' ' 199' ' ' LEU . . . -124.47 141.32 52.17 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.356 -0.84 . . . . 0.0 110.614 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.565 HG22 ' CB ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -121.07 131.62 54.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.397 -0.815 . . . . 0.0 110.127 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.95 -26.4 17.58 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.346 -0.846 . . . . 0.0 109.358 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.425 ' C ' ' HD3' ' A' ' 114' ' ' PRO . 2.0 pp -83.91 -12.31 55.63 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.572 -0.705 . . . . 0.0 109.329 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -111.14 73.05 0.9 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.542 -0.724 . . . . 0.0 110.245 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.441 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 46.8 Cg_endo -73.23 -26.54 14.59 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.064 1.56 . . . . 0.0 110.364 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.441 ' HB3' ' O ' ' A' ' 114' ' ' PRO . 0.6 OUTLIER 179.93 53.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.304 -0.872 . . . . 0.0 110.102 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -85.45 -70.14 0.61 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.88 . . . . 0.0 110.359 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.519 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -74.42 -39.09 62.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.374 -0.829 . . . . 0.0 110.225 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.519 ' C ' ' O ' ' A' ' 117' ' ' ALA . 17.6 t70 -31.76 97.01 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.47 -0.768 . . . . 0.0 110.74 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.471 ' N ' ' O ' ' A' ' 117' ' ' ALA . 3.8 m-70 -92.33 -21.64 20.16 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.345 -0.847 . . . . 0.0 110.176 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.406 ' O ' ' C ' ' A' ' 121' ' ' ALA . 23.1 m-85 -88.48 116.13 26.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.199 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 122' ' ' ALA . . . -43.22 -76.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -0.919 . . . . 0.0 110.141 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 121' ' ' ALA . . . 62.57 -165.09 0.24 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.106 -0.997 . . . . 0.0 110.161 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.47 46.74 1.99 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.189 -0.944 . . . . 0.0 110.176 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.51 71.82 1.47 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.333 -0.854 . . . . 0.0 110.136 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -134.41 4.48 4.45 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 21.5 p -100.88 36.34 1.97 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -1.152 . . . . 0.0 110.204 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.41 ' O ' ' O ' ' A' ' 128' ' ' SER . 3.1 t-20 179.93 -176.12 0.32 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.225 -0.922 . . . . 0.0 110.274 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.41 ' O ' ' O ' ' A' ' 127' ' ' ASN . 66.7 p -60.42 -150.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.943 . . . . 0.0 110.256 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -145.12 125.66 14.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.302 -0.874 . . . . 0.0 109.977 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 1.1 t -121.59 119.73 32.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 110.484 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . 0.565 ' O ' HG22 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -133.37 135.16 44.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.882 . . . . 0.0 109.781 179.679 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.565 ' HA3' ' HA2' ' A' ' 107' ' ' GLY . . . -175.66 -137.76 2.64 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.028 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.641 ' CH2' ' CD1' ' A' ' 182' ' ' ILE . 42.4 m0 -118.79 113.63 21.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.419 -1.048 . . . . 0.0 110.843 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.424 ' C ' HG12 ' A' ' 135' ' ' ILE . 45.5 t0 -118.63 147.64 43.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.512 -0.742 . . . . 0.0 109.895 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.595 ' CG2' ' NE2' ' A' ' 103' ' ' HIS . 0.1 OUTLIER -149.02 14.17 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.116 -0.99 . . . . 0.0 110.239 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -113.46 -51.56 0.5 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.42 8.18 25.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.326 -1.102 . . . . 0.0 109.577 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 139' ' ' LYS . . . -134.68 8.27 4.57 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.51 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -58.16 -147.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.282 -1.128 . . . . 0.0 110.326 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.68 ' O ' ' C ' ' A' ' 141' ' ' TYR . 5.9 tt 179.87 94.63 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.522 -0.737 . . . . 0.0 110.25 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.68 ' C ' ' O ' ' A' ' 140' ' ' LEU . 43.2 m-85 0.13 76.81 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.803 -0.561 . . . . 0.0 111.095 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.523 ' N ' ' O ' ' A' ' 140' ' ' LEU . 9.1 p80 -74.64 51.79 0.48 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.374 -0.829 . . . . 0.0 110.385 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.428 ' O ' ' C ' ' A' ' 144' ' ' SER . 24.1 tp60 -71.07 -50.04 38.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.184 -0.947 . . . . 0.0 110.241 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 143' ' ' GLN . 1.9 p -42.27 162.81 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.28 -0.887 . . . . 0.0 110.222 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.8 -171.31 2.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.336 -0.853 . . . . 0.0 110.219 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.75 -148.5 19.95 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.436 ' O ' ' HB3' ' A' ' 148' ' ' GLU . 0.1 OUTLIER -130.56 45.2 2.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -1.163 . . . . 0.0 110.161 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.436 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 0.2 OUTLIER 179.9 144.04 0.18 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.897 . . . . 0.0 110.122 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.531 ' HB3' ' CB ' ' A' ' 154' ' ' ALA . . . -49.1 176.53 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.282 -0.886 . . . . 0.0 110.225 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.459 ' HD2' ' HB1' ' A' ' 149' ' ' ALA . 45.8 Cg_endo -72.64 -12.78 27.02 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.99 1.521 . . . . 0.0 110.545 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.74 -159.29 0.73 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.291 -0.881 . . . . 0.0 110.198 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.638 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 1.8 m-30 -94.92 -66.17 0.1 OUTLIER Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.229 -0.92 . . . . 0.0 110.326 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.638 ' CD ' ' CB ' ' A' ' 152' ' ' TYR . 49.3 Cg_endo -74.19 110.57 3.12 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.574 1.302 . . . . 0.0 110.299 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.531 ' CB ' ' HB3' ' A' ' 149' ' ' ALA . . . 179.61 161.67 0.87 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.211 -0.931 . . . . 0.0 110.338 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.489 ' N ' ' CD ' ' A' ' 156' ' ' PRO . . . -173.19 53.17 0.16 Allowed Glycine 0 N--CA 1.48 1.585 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 155' ' ' GLY . 48.6 Cg_endo -75.01 -5.39 16.72 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.975 1.513 . . . . 0.0 110.298 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.445 ' O ' ' HG3' ' A' ' 157' ' ' GLN . 32.7 tp60 -68.85 -0.5 5.56 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.305 -0.872 . . . . 0.0 110.864 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.476 ' O ' HG23 ' A' ' 163' ' ' VAL . . . -86.93 -79.08 1.23 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.626 ' HG2' ' CD2' ' A' ' 133' ' ' TRP . 1.0 OUTLIER -109.76 -2.97 17.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.298 -1.119 . . . . 0.0 110.014 -179.793 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.448 ' HB3' ' HB2' ' A' ' 156' ' ' PRO . 0.1 OUTLIER -97.59 2.18 49.66 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.638 0.732 . . . . 0.0 109.23 179.344 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.667 ' O ' ' C ' ' A' ' 162' ' ' VAL . 1.3 mt -158.34 98.6 1.57 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.667 ' C ' ' O ' ' A' ' 161' ' ' LEU . 2.2 t 4.47 109.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-O 122.244 1.021 . . . . 0.0 110.568 -178.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.745 ' CG1' ' CD ' ' A' ' 164' ' ' PRO . 0.2 OUTLIER -67.46 -155.4 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.314 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.745 ' CD ' ' CG1' ' A' ' 163' ' ' VAL . 43.8 Cg_endo -72.29 178.76 5.7 Favored 'Trans proline' 0 C--N 1.318 -1.03 0 O-C-N 122.481 0.727 . . . . 0.0 110.999 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.515 ' O ' ' HB3' ' A' ' 94' ' ' SER . 2.2 mt-10 -46.51 -32.2 3.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.428 -0.795 . . . . 0.0 111.232 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.536 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 18.2 ttp180 -151.83 156.17 39.64 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.981 -1.075 . . . . 0.0 111.13 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.589 ' CD1' ' CG2' ' A' ' 102' ' ' THR . 1.7 mp -126.85 157.31 39.65 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.543 -0.723 . . . . 0.0 109.436 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 181' ' ' SER . 1.1 tt -117.44 121.41 40.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.065 -1.022 . . . . 0.0 110.728 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.631 ' CG1' ' CE3' ' A' ' 91' ' ' TRP . 16.4 t -89.65 128.78 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.3 -0.875 . . . . 0.0 109.494 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.463 HG21 ' CD2' ' A' ' 168' ' ' LEU . 19.2 t -109.99 115.62 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.004 -1.06 . . . . 0.0 110.675 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.574 HD13 ' CD2' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -129.27 123.12 31.1 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.285 -0.884 . . . . 0.0 109.491 179.505 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 173' ' ' MET . 47.3 t0 -120.13 137.96 53.86 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.177 -0.952 . . . . 0.0 110.021 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.566 ' HB3' ' N ' ' A' ' 87' ' ' GLY . 0.0 OUTLIER -98.56 -40.68 8.11 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.56 179.676 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -50.85 -22.61 2.27 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.318 -0.864 . . . . 0.0 109.073 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.574 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.3 OUTLIER -109.26 -27.97 9.25 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.803 0.811 . . . . 0.0 108.924 179.473 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.583 ' O ' ' CB ' ' A' ' 198' ' ' THR . . . 86.84 22.34 46.48 Favored Glycine 0 N--CA 1.482 1.709 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.647 HG23 HD22 ' A' ' 194' ' ' LEU . 0.0 OUTLIER -112.52 133.45 54.57 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.099 -1.236 . . . . 0.0 111.466 -179.389 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.644 ' N ' ' CD1' ' A' ' 178' ' ' LEU . 2.6 mp -130.52 153.59 48.68 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.654 -0.654 . . . . 0.0 109.472 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.472 ' O ' HG13 ' A' ' 169' ' ' VAL . . . 176.16 -175.29 47.39 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.231 -1.461 . . . . 0.0 110.538 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.629 ' CE2' HG22 ' A' ' 169' ' ' VAL . 0.2 OUTLIER -127.18 131.51 50.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.67 -0.9 . . . . 0.0 109.173 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 168' ' ' LEU . 3.4 t -136.7 131.22 33.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.122 -0.986 . . . . 0.0 110.536 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.641 ' CD1' ' CH2' ' A' ' 133' ' ' TRP . 0.0 OUTLIER -102.27 116.84 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.372 -0.83 . . . . 0.0 109.393 179.212 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 83.45 -11.87 53.85 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 81.43 47.05 6.59 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 32.4 m -136.13 -36.46 0.74 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.135 -1.215 . . . . 0.0 110.775 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.593 ' CD2' HD13 ' A' ' 182' ' ' ILE . 5.1 m-30 -67.0 -77.23 0.07 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.005 -1.06 . . . . 0.0 110.506 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.602 ' O ' ' CE2' ' A' ' 191' ' ' PHE . 2.4 mm? -68.46 44.28 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.906 -1.121 . . . . 0.0 109.88 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.463 ' H ' ' C ' ' A' ' 186' ' ' TYR . . . -94.95 -63.89 1.0 Allowed Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.99 -1.1 . . . . 0.0 110.611 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.457 ' HD2' ' O ' ' A' ' 186' ' ' TYR . 45.1 Cg_endo -72.01 -30.99 13.0 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.802 1.422 . . . . 0.0 111.3 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.739 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -74.58 16.59 0.26 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.239 -0.913 . . . . 0.0 111.418 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.602 ' CE2' ' O ' ' A' ' 187' ' ' LEU . 0.3 OUTLIER -89.57 -8.34 52.88 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.063 -1.023 . . . . 0.0 109.982 179.204 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.06 -15.3 32.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.568 -0.707 . . . . 0.0 110.126 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -115.71 -11.17 10.54 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 107.483 -2.247 . . . . 0.0 107.483 179.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.859 ' HA ' ' HD2' ' A' ' 197' ' ' ARG . 0.4 OUTLIER -70.56 -22.17 62.62 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.796 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.571 ' HA ' HG22 ' A' ' 177' ' ' THR . 0.0 OUTLIER -57.29 -26.55 61.04 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.355 -0.84 . . . . 0.0 109.378 179.038 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.531 ' N ' ' HE3' ' A' ' 195' ' ' LYS . . . -106.08 -37.74 2.45 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.859 ' HD2' ' HA ' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -79.62 -4.52 51.98 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.448 -1.031 . . . . 0.0 110.567 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.583 ' CB ' ' O ' ' A' ' 176' ' ' GLY . 0.2 OUTLIER -43.37 133.82 4.08 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-O 122.194 0.997 . . . . 0.0 112.174 -177.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.835 ' HG ' ' O ' ' A' ' 197' ' ' ARG . 0.0 OUTLIER -141.73 171.06 14.57 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.218 179.19 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.643 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 46.5 m-85 -90.21 126.79 55.68 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.827 -1.171 . . . . 0.0 109.373 178.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.582 ' HG2' ' CH2' ' A' ' 91' ' ' TRP . 53.2 Cg_endo -82.16 150.36 15.64 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 124.196 1.629 . . . . 0.0 112.489 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.704 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 73.6 p -133.69 149.84 51.52 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.567 ' HA ' ' HB ' ' A' ' 106' ' ' VAL . 14.5 p -118.62 168.17 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.406 -1.434 . . . . 0.0 110.623 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' SER . . . . . 0.661 ' O ' ' CG2' ' A' ' 105' ' ' VAL . 0.4 OUTLIER -156.0 145.16 20.64 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.425 0.631 . . . . 0.0 109.923 179.681 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.669 ' CB ' ' CG2' ' A' ' 78' ' ' VAL . . . -145.47 135.96 24.18 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.74 -0.6 . . . . 0.0 109.705 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.572 ' CG1' ' N ' ' A' ' 207' ' ' TRP . 1.5 t -76.57 172.06 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.459 -0.776 . . . . 0.0 110.512 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.609 ' CD1' ' O ' ' A' ' 207' ' ' TRP . 14.2 p90 -121.91 128.51 51.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.307 -0.871 . . . . 0.0 110.089 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.529 ' N ' ' HG2' ' A' ' 68' ' ' ARG . . . 154.4 -167.12 32.39 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.449 ' C ' ' O ' ' A' ' 208' ' ' GLY . 0.0 OUTLIER -40.21 -28.74 0.06 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.381 -1.07 . . . . 0.0 110.142 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . 0.494 ' C ' ' HG3' ' A' ' 211' ' ' GLN . 9.7 t -64.26 164.29 11.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.321 -0.862 . . . . 0.0 110.219 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.53 ' NE2' ' O ' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -164.24 109.55 1.01 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.358 -0.839 . . . . 0.0 109.655 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.645 ' O ' ' CH2' ' A' ' 48' ' ' TRP . 5.7 p -102.65 143.77 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.437 -0.79 . . . . 0.0 110.308 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 0.439 ' HB2' ' OG ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -93.93 156.2 16.75 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.364 -0.835 . . . . 0.0 109.41 179.361 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.612 ' HB ' ' CZ3' ' A' ' 48' ' ' TRP . 4.9 tt -139.06 131.54 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.046 -1.034 . . . . 0.0 110.812 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.606 ' HB3' ' HB3' ' A' ' 92' ' ' GLU . 12.6 ttt180 -130.1 108.29 9.96 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . 0.736 ' CZ ' ' CD1' ' A' ' 91' ' ' TRP . 4.2 t80 -118.92 142.94 47.32 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.385 -0.822 . . . . 0.0 111.15 -177.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.58 115.57 12.34 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.558 -0.713 . . . . 0.0 110.102 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 133.85 53.85 0.07 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -133.63 138.66 46.05 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.265 -1.138 . . . . 0.0 110.114 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . 0.427 ' C ' ' HG3' ' A' ' 221' ' ' ARG . 5.0 ptm180 -78.22 155.98 30.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.242 -0.911 . . . . 0.0 110.381 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . 0.495 ' O ' ' C ' ' A' ' 222' ' ' VAL . 0.1 OUTLIER -134.62 93.73 3.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.242 -0.911 . . . . 0.0 110.124 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.495 ' C ' ' O ' ' A' ' 221' ' ' ARG . 7.3 p -34.57 96.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.368 -0.833 . . . . 0.0 110.742 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.665 ' O ' ' C ' ' A' ' 224' ' ' GLU . 1.0 OUTLIER 179.86 86.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.333 -0.854 . . . . 0.0 110.168 179.856 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.665 ' C ' ' O ' ' A' ' 223' ' ' GLU . 3.4 pt-20 0.73 68.67 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.379 0.609 . . . . 0.0 111.517 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.63 ' N ' ' O ' ' A' ' 223' ' ' GLU . 13.1 t -68.72 161.63 27.89 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.323 -0.86 . . . . 0.0 110.312 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.12 89.31 7.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 110.186 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.45 ' NH1' ' HG3' ' A' ' 227' ' ' ARG . 2.8 ptm180 -124.28 -174.59 3.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.19 -0.944 . . . . 0.0 110.249 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 229' ' ' HIS . 1.2 tt -166.28 158.52 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.209 -0.932 . . . . 0.0 110.158 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.43 ' O ' ' C ' ' A' ' 230' ' ' ARG . 58.4 t60 -179.97 -30.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.237 -0.915 . . . . 0.0 110.285 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . 0.68 ' O ' ' C ' ' A' ' 231' ' ' ASP . 36.9 mmm-85 -42.14 126.47 3.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 110.246 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.68 ' C ' ' O ' ' A' ' 230' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 117.984 -1.008 . . . . 0.0 111.541 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 t -110.9 -46.97 3.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.336 -1.097 . . . . 0.0 110.14 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.23 -81.74 0.06 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.261 -0.9 . . . . 0.0 110.129 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -145.55 94.03 2.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.247 -0.908 . . . . 0.0 110.186 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.3 mtp180 -132.92 171.63 13.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.269 -0.895 . . . . 0.0 110.214 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -154.36 80.79 1.11 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.917 . . . . 0.0 110.166 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -79.88 -51.73 8.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 110.336 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.466 ' O ' HG23 ' A' ' 13' ' ' THR . 1.4 t -121.17 117.92 30.38 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 0.0 110.159 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.4 151.48 48.11 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.014 1.534 . . . . 0.0 110.383 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.5 m -105.34 92.19 4.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.309 -0.869 . . . . 0.0 110.219 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.7 t -141.84 25.91 1.93 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.294 -0.879 . . . . 0.0 110.197 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -153.31 -79.14 0.1 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 110.298 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.51 164.93 24.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.296 -0.878 . . . . 0.0 110.198 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -173.88 -145.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.257 -0.902 . . . . 0.0 110.194 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.51 -5.43 7.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.192 -0.943 . . . . 0.0 110.232 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 22' ' ' ASP . 79.9 p -140.04 -149.63 0.29 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 110.218 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 21' ' ' SER . 25.2 t70 -176.22 89.02 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.193 -0.942 . . . . 0.0 110.146 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.41 -76.52 0.1 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.937 . . . . 0.0 110.15 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.6 m -78.8 116.11 57.25 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.343 -0.848 . . . . 0.0 110.135 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.03 159.07 48.6 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.042 1.549 . . . . 0.0 110.439 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.654 ' O ' ' N ' ' A' ' 28' ' ' GLY . 46.3 Cg_endo -72.79 -171.39 0.75 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.008 1.53 . . . . 0.0 110.505 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.654 ' C ' ' O ' ' A' ' 26' ' ' PRO . 20.1 mt-10 1.25 67.18 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.533 0.683 . . . . 0.0 111.31 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.654 ' N ' ' O ' ' A' ' 26' ' ' PRO . . . -160.74 -32.2 0.02 OUTLIER Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.566 ' HG ' ' N ' ' A' ' 30' ' ' GLU . 0.7 OUTLIER -76.45 -22.54 54.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -1.147 . . . . 0.0 110.285 -179.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.566 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 1.3 mt-10 -47.69 -35.12 9.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.101 -0.999 . . . . 0.0 109.192 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -62.27 -24.07 67.07 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.309 -0.87 . . . . 0.0 108.841 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.545 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.7 OUTLIER -83.44 -34.06 25.54 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.596 ' HG ' ' N ' ' A' ' 34' ' ' SER . 0.3 OUTLIER -76.17 -36.06 58.88 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.877 0.846 . . . . 0.0 109.42 179.323 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.596 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -80.46 -7.37 59.13 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.161 179.878 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.636 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . . . -54.87 -66.81 0.82 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.213 -0.929 . . . . 0.0 110.488 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.69 ' C ' ' HD3' ' A' ' 38' ' ' PRO . 48.9 Cg_endo -73.65 143.22 33.62 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.692 1.364 . . . . 0.0 110.316 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 36' ' ' PRO . 53.8 Cg_endo -98.88 56.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 121.898 1.732 . . . . 0.0 112.034 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.69 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 52.8 Cg_endo -75.82 150.91 35.35 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 122.979 0.989 . . . . 0.0 110.118 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.606 ' O ' ' HB3' ' A' ' 43' ' ' GLN . 1.0 OUTLIER -34.26 -33.52 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.313 -0.867 . . . . 0.0 109.457 179.557 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 1.063 ' O ' ' HB3' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -57.41 -46.88 83.02 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.242 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.57 ' CG2' HD12 ' A' ' 40' ' ' LEU . 54.4 t -86.6 -33.7 7.32 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 O-C-N 120.647 -1.283 . . . . 0.0 110.415 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.21 -39.17 12.25 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.401 -0.812 . . . . 0.0 113.058 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.606 ' HB3' ' O ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -86.67 -19.65 28.93 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 120.726 -1.234 . . . . 0.0 109.455 -178.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 1.063 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -79.36 -51.09 9.87 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 122.078 0.942 . . . . 0.0 109.528 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.732 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 59.5 m170 -51.52 -17.57 0.85 Allowed 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.632 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.402 ' CD2' ' C ' ' A' ' 46' ' ' HIS . 4.0 t60 -84.46 -39.21 19.21 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.443 -1.303 . . . . 0.0 110.029 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.566 ' O ' ' CD1' ' A' ' 214' ' ' ILE . . . -97.98 -68.19 0.93 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 106.597 -2.601 . . . . 0.0 106.597 177.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.838 ' CD1' ' CG2' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -89.26 72.61 8.13 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 177.229 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.714 ' HA ' ' HA ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER -55.22 151.45 18.15 Favored Pre-proline 0 N--CA 1.494 1.754 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.412 -178.514 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.732 ' HD3' ' HA ' ' A' ' 45' ' ' HIS . 45.0 Cg_endo -78.49 -25.86 6.43 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 124.522 1.801 . . . . 0.0 110.563 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.847 ' CE ' ' N ' ' A' ' 51' ' ' LYS . 0.4 OUTLIER -64.48 -14.3 56.4 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.145 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 1.073 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 9.8 m-20 -122.75 2.16 9.45 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.644 178.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.783 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 10.1 t -151.73 132.94 14.45 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.877 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.714 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 0.8 OUTLIER -71.81 118.49 14.73 Favored 'General case' 0 C--N 1.292 -1.926 0 O-C-N 121.548 -0.72 . . . . 0.0 110.34 179.434 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.626 ' C ' ' H ' ' A' ' 57' ' ' ILE . 0.7 OUTLIER -40.25 -20.49 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.503 -0.748 . . . . 0.0 111.786 -179.641 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.714 ' ND2' ' HB2' ' A' ' 54' ' ' SER . 0.0 OUTLIER -54.45 -1.9 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.762 -1.211 . . . . 0.0 109.638 179.755 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.626 ' H ' ' C ' ' A' ' 55' ' ' GLU . 26.9 mm -111.68 155.35 13.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.923 0.868 . . . . 0.0 111.323 -177.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.93 ' HA ' HD22 ' A' ' 40' ' ' LEU . 1.4 t70 -118.14 95.36 4.86 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.718 0.77 . . . . 0.0 109.266 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.838 ' CG2' ' CD1' ' A' ' 48' ' ' TRP . 1.1 p -131.56 118.99 41.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 O-C-N 121.808 -0.557 . . . . 0.0 111.397 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.607 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -136.76 157.57 46.44 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.066 -1.021 . . . . 0.0 111.265 179.551 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.771 ' N ' ' CH2' ' A' ' 48' ' ' TRP . 1.0 OUTLIER -39.27 -112.98 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.717 -0.614 . . . . 0.0 112.029 -179.157 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.514 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 42.11 44.57 4.82 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 107.291 -2.324 . . . . 0.0 107.291 -177.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.743 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 84.64 87.08 0.89 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 106.881 -2.488 . . . . 0.0 106.881 -177.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.743 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.2 OUTLIER 1.48 82.88 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.632 -0.922 . . . . 0.0 109.901 -177.875 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.447 ' N ' ' O ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -101.57 114.15 27.93 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.879 -0.728 . . . . 0.0 110.48 -178.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.639 ' CB ' ' HA ' ' A' ' 211' ' ' GLN . 4.5 t80 -114.42 123.39 49.33 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.582 ' O ' ' N ' ' A' ' 58' ' ' ASP . 1.3 tm-20 -151.7 163.05 39.96 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.16 -0.963 . . . . 0.0 110.497 -179.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.611 ' CG ' ' HB2' ' A' ' 207' ' ' TRP . 0.2 OUTLIER -111.42 153.37 26.19 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.222 -0.923 . . . . 0.0 109.841 179.223 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.704 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 34.8 mtp180 -85.2 -73.87 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 120.978 -1.076 . . . . 0.0 109.665 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.704 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 57.5 Cg_endo -76.23 -124.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 N-CA-C 108.384 -1.429 . . . . 0.0 108.384 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.6 t -140.44 164.51 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.455 -1.403 . . . . 0.0 109.947 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.576 ' HB2' ' CD1' ' A' ' 207' ' ' TRP . . . -80.04 33.45 0.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.178 -0.951 . . . . 0.0 110.357 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -45.98 -47.47 16.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.258 -0.901 . . . . 0.0 110.361 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.9 p -172.67 30.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.27 -0.894 . . . . 0.0 110.154 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.9 t -97.87 -132.06 0.22 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.883 . . . . 0.0 109.992 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.595 ' O ' ' HB2' ' A' ' 54' ' ' SER . 12.5 m-20 -140.41 114.05 8.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.157 -0.964 . . . . 0.0 110.572 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 76' ' ' ASP . . . -55.83 -106.52 0.01 OUTLIER Glycine 0 N--CA 1.486 1.986 0 N-CA-C 107.942 -2.063 . . . . 0.0 107.942 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.783 ' HA ' ' HA ' ' A' ' 53' ' ' CYS . 4.4 m -138.16 123.91 24.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 120.998 -1.295 . . . . 0.0 110.078 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.662 ' NE ' ' O ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -145.42 133.83 21.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.18 -0.95 . . . . 0.0 112.161 -178.616 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 1.073 ' CA ' ' HA ' ' A' ' 52' ' ' ASP . . . -131.79 163.84 23.72 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 178.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.532 ' CB ' ' HB3' ' A' ' 202' ' ' SER . 2.5 ttpm? -171.01 87.28 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.494 -1.003 . . . . 0.0 109.513 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.809 ' HD3' ' H ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -152.31 -91.18 0.05 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.227 -0.92 . . . . 0.0 110.542 -179.366 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.809 ' H ' ' HD3' ' A' ' 82' ' ' ARG . . . 45.75 42.78 11.2 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -97.21 106.2 18.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -1.11 . . . . 0.0 110.217 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.594 ' HB2' ' CE1' ' A' ' 89' ' ' HIS . 75.5 p -138.28 167.17 22.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 0.0 110.071 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.516 ' O ' ' NE2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -120.14 135.44 54.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.216 -0.927 . . . . 0.0 110.285 -179.824 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 172' ' ' ASP . . . 102.83 -116.64 5.54 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.476 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 2.5 tp -128.36 130.27 47.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.321 -1.105 . . . . 0.0 110.282 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.594 ' CE1' ' HB2' ' A' ' 85' ' ' SER . 33.4 m-70 -146.33 166.2 27.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.099 -1.001 . . . . 0.0 109.997 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.539 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -158.99 153.71 24.63 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.054 -1.029 . . . . 0.0 109.92 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.717 ' CD1' ' CE2' ' A' ' 216' ' ' TYR . 1.4 m0 -134.81 148.57 50.22 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.298 -0.876 . . . . 0.0 109.911 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.653 ' O ' ' N ' ' A' ' 215' ' ' ARG . 7.8 mt-10 -109.56 118.42 36.55 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.52 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.509 ' O ' ' HB2' ' A' ' 167' ' ' LEU . 1.2 mp -133.69 154.52 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.054 -1.029 . . . . 0.0 110.877 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.566 ' HA ' ' HG ' ' A' ' 167' ' ' LEU . 0.3 OUTLIER -140.88 119.94 12.8 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.16 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.774 ' CE3' ' CG2' ' A' ' 106' ' ' VAL . 3.0 t-105 -117.41 89.5 31.91 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.072 -1.018 . . . . 0.0 110.657 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -89.18 109.53 0.47 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.085 1.571 . . . . 0.0 110.153 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.535 ' CD1' ' O ' ' A' ' 100' ' ' ARG . 0.3 OUTLIER -95.59 -6.35 40.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.128 -0.982 . . . . 0.0 110.399 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.522 ' HG3' ' N ' ' A' ' 99' ' ' GLN . 0.4 OUTLIER -40.25 -25.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.256 -0.902 . . . . 0.0 110.308 -179.858 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.522 ' N ' ' HG3' ' A' ' 98' ' ' GLU . 5.8 mt-30 -73.51 -99.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 110.195 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.535 ' O ' ' CD1' ' A' ' 97' ' ' LEU . 2.5 mmm180 -136.21 -84.52 0.37 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.109 -0.994 . . . . 0.0 110.261 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.516 ' O ' ' CG2' ' A' ' 102' ' ' THR . . . 57.81 -157.11 16.57 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.516 ' CG2' ' O ' ' A' ' 101' ' ' GLY . 0.1 OUTLIER -179.69 -90.87 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -1.144 . . . . 0.0 110.128 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.462 ' O ' ' C ' ' A' ' 104' ' ' ALA . 8.0 t-160 -85.61 -19.72 30.58 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.255 -0.903 . . . . 0.0 110.004 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.692 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -39.43 122.46 1.32 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.372 -0.83 . . . . 0.0 110.147 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.647 ' N ' ' CH2' ' A' ' 95' ' ' TRP . 4.9 p -137.72 159.81 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.198 -0.939 . . . . 0.0 112.405 -178.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.774 ' CG2' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -122.31 115.93 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 177.114 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.575 ' CA ' ' HA3' ' A' ' 132' ' ' GLY . . . -160.54 -164.96 16.43 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 118.648 -1.739 . . . . 0.0 111.227 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.532 ' CG1' ' HB2' ' A' ' 199' ' ' LEU . 0.7 OUTLIER -120.54 156.23 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.617 -0.931 . . . . 0.0 109.515 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 130' ' ' SER . . . -128.13 143.09 51.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.861 -1.149 . . . . 0.0 110.686 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.553 HG23 ' CG ' ' A' ' 199' ' ' LEU . 0.7 OUTLIER -115.38 123.13 47.9 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.196 -0.94 . . . . 0.0 110.455 179.74 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.91 -31.03 14.47 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.465 -0.772 . . . . 0.0 109.712 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.695 ' O ' ' C ' ' A' ' 113' ' ' ALA . 1.7 pp -79.22 -11.87 59.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.507 -0.745 . . . . 0.0 110.115 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.695 ' C ' ' O ' ' A' ' 112' ' ' LEU . . . 0.68 103.06 0.02 OUTLIER Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 121.872 -0.518 . . . . 0.0 111.128 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.72 -156.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.137 1.598 . . . . 0.0 110.654 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.481 ' CD1' ' O ' ' A' ' 115' ' ' LEU . 0.5 OUTLIER -160.96 55.26 0.3 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.28 -0.888 . . . . 0.0 109.968 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 115' ' ' LEU . 3.6 tt0 -38.3 -39.83 0.47 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.489 -0.757 . . . . 0.0 110.356 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.532 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -71.46 133.97 46.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.347 -0.845 . . . . 0.0 110.125 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.532 ' C ' ' O ' ' A' ' 117' ' ' ALA . 5.6 t70 -30.89 -82.44 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.499 -0.751 . . . . 0.0 110.76 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.435 ' CB ' ' O ' ' A' ' 118' ' ' ASP . 7.0 t60 65.17 -67.18 0.13 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 110.256 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.504 ' N ' ' O ' ' A' ' 118' ' ' ASP . 0.2 OUTLIER 52.72 63.64 2.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.311 -0.868 . . . . 0.0 110.192 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' A' ' 120' ' ' TYR . . . -55.03 -165.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.246 -0.909 . . . . 0.0 110.246 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.35 -43.92 72.66 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.299 -0.876 . . . . 0.0 110.222 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 125' ' ' GLY . 2.0 pp -162.39 107.95 1.22 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.198 -0.939 . . . . 0.0 110.27 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 53.86 -87.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.371 -0.83 . . . . 0.0 110.246 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 123' ' ' LEU . . . 68.11 145.57 0.13 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 128' ' ' SER . 0.3 OUTLIER -137.73 63.72 1.54 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.267 -1.137 . . . . 0.0 110.181 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -44.84 93.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.277 -0.889 . . . . 0.0 110.173 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 126' ' ' SER . 0.5 OUTLIER -47.65 147.36 1.86 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.904 . . . . 0.0 110.227 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -149.84 128.91 12.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.268 -0.895 . . . . 0.0 109.964 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 2.9 t -120.41 119.35 32.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.16 -0.963 . . . . 0.0 110.501 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -133.94 136.19 44.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.501 -0.749 . . . . 0.0 109.305 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.588 ' O ' ' CD1' ' A' ' 133' ' ' TRP . . . -165.39 -111.34 0.24 Allowed Glycine 0 N--CA 1.486 2.001 0 C-N-CA 119.042 -1.552 . . . . 0.0 110.796 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.735 ' CH2' ' CB ' ' A' ' 180' ' ' TYR . 5.3 m-90 -140.3 122.77 16.1 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 121.168 -1.195 . . . . 0.0 111.634 -178.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.551 ' OD1' ' CG2' ' A' ' 105' ' ' VAL . 0.9 OUTLIER -118.89 148.62 42.72 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.394 -179.638 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.507 HG13 ' HG ' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -69.8 -0.48 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.348 -0.845 . . . . 0.0 110.313 179.561 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.502 ' O ' ' CG ' ' A' ' 139' ' ' LYS . . . -46.16 -20.96 0.58 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.53 ' HD2' ' N ' ' A' ' 137' ' ' ARG . 8.0 mpt_? -57.7 -20.04 31.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.266 -1.138 . . . . 0.0 108.989 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.554 ' HA2' ' CG2' ' A' ' 162' ' ' VAL . . . -80.45 -2.17 89.26 Favored Glycine 0 C--N 1.291 -1.942 0 N-CA-C 107.956 -2.057 . . . . 0.0 107.956 178.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.524 ' O ' ' O ' ' A' ' 138' ' ' GLY . 2.2 mmtm -53.69 -161.26 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.669 -0.901 . . . . 0.0 110.174 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.405 ' O ' ' O ' ' A' ' 141' ' ' TYR . 1.9 mp -117.25 82.98 1.9 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -0.924 . . . . 0.0 110.472 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.405 ' O ' ' O ' ' A' ' 140' ' ' LEU . 4.7 m-85 -52.89 -99.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.235 -0.916 . . . . 0.0 110.318 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.584 ' O ' ' CG ' ' A' ' 142' ' ' HIS . 7.2 p80 -159.53 59.39 0.39 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.932 . . . . 0.0 110.376 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -146.4 -55.14 0.26 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.179 -0.951 . . . . 0.0 110.221 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 144' ' ' SER . 0.9 OUTLIER -87.74 20.33 3.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.343 -0.848 . . . . 0.0 110.19 -179.959 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -52.19 106.38 0.15 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.213 -0.929 . . . . 0.0 110.157 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -152.64 -105.71 0.28 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.47 ' O ' ' HB2' ' A' ' 148' ' ' GLU . 0.5 OUTLIER -140.65 79.04 1.68 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.214 -1.168 . . . . 0.0 110.127 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 147' ' ' LEU . 7.3 tp10 179.94 154.09 0.53 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.898 . . . . 0.0 110.132 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.469 ' O ' ' O ' ' A' ' 154' ' ' ALA . . . -175.64 149.06 1.05 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.165 -0.959 . . . . 0.0 110.328 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.443 ' HA ' ' HA3' ' A' ' 155' ' ' GLY . 47.0 Cg_endo -74.17 1.54 7.14 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.047 1.551 . . . . 0.0 110.613 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -68.0 -94.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.094 -1.004 . . . . 0.0 110.255 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.538 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 0.1 OUTLIER -82.92 -59.11 0.4 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.208 -0.932 . . . . 0.0 110.618 -179.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.538 ' CD ' ' CB ' ' A' ' 152' ' ' TYR . 47.4 Cg_endo -73.89 169.69 21.81 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.861 1.453 . . . . 0.0 110.509 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.469 ' O ' ' O ' ' A' ' 149' ' ' ALA . . . -48.36 166.47 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 110.176 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.476 ' N ' ' CD ' ' A' ' 156' ' ' PRO . . . -146.73 55.26 0.53 Allowed Glycine 0 N--CA 1.48 1.58 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 155' ' ' GLY . 45.4 Cg_endo -72.13 -47.36 0.43 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.154 1.607 . . . . 0.0 110.211 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -65.47 -6.09 9.6 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.269 -0.894 . . . . 0.0 110.278 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.508 ' O ' ' CG2' ' A' ' 162' ' ' VAL . . . -77.47 -45.14 11.47 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.543 ' HA ' ' CG2' ' A' ' 162' ' ' VAL . 0.4 OUTLIER -75.89 6.38 5.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -1.135 . . . . 0.0 110.254 179.855 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -6.81 46.6 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.345 -0.847 . . . . 0.0 109.985 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -149.82 29.82 0.74 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.386 -0.822 . . . . 0.0 109.806 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.554 ' CG2' ' HA2' ' A' ' 138' ' ' GLY . 3.7 t -112.52 -126.61 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.467 -0.771 . . . . 0.0 109.82 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.672 ' N ' ' HD3' ' A' ' 164' ' ' PRO . 0.6 OUTLIER -139.87 44.03 0.68 Allowed Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.057 -1.027 . . . . 0.0 110.299 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.672 ' HD3' ' N ' ' A' ' 163' ' ' VAL . 53.7 Cg_endo -79.76 81.91 2.64 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.785 1.413 . . . . 0.0 110.872 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -167.25 -84.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.05 -1.031 . . . . 0.0 110.106 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.535 ' O ' ' CD2' ' A' ' 167' ' ' LEU . 20.3 ttp180 -151.9 155.84 38.9 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.461 -0.775 . . . . 0.0 109.988 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.605 ' HB3' HG21 ' A' ' 182' ' ' ILE . 9.9 mt -138.15 128.85 26.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.192 -0.943 . . . . 0.0 110.525 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 17.7 tp -103.63 141.34 36.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.259 -0.9 . . . . 0.0 109.167 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.682 ' CG2' ' CE2' ' A' ' 180' ' ' TYR . 6.8 t -125.55 132.22 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.799 -1.188 . . . . 0.0 111.58 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.485 ' O ' ' CG1' ' A' ' 170' ' ' VAL . 11.4 p -138.02 104.93 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.546 ' CD1' ' HB3' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -118.41 141.13 48.85 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.134 -0.979 . . . . 0.0 110.417 -179.083 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 173' ' ' MET . 40.4 t0 -120.2 138.68 53.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.29 -0.881 . . . . 0.0 110.19 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.55 ' CG ' ' O ' ' A' ' 85' ' ' SER . 4.1 tpt -89.97 -39.15 13.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.624 -0.673 . . . . 0.0 109.849 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 173' ' ' MET . 1.4 tt0 -42.09 -27.78 0.15 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.892 . . . . 0.0 109.191 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.505 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 3.0 tt0 -106.99 -27.76 10.46 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.702 0.763 . . . . 0.0 108.97 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 86.11 21.98 50.37 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.596 ' HA ' ' CD2' ' A' ' 194' ' ' LEU . 0.8 OUTLIER -121.76 150.54 41.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.342 -1.093 . . . . 0.0 110.642 -179.651 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.546 ' HB3' ' CD1' ' A' ' 171' ' ' LEU . 0.2 OUTLIER -117.44 153.52 32.95 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.439 -0.788 . . . . 0.0 109.895 179.815 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -134.09 122.03 2.88 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.735 ' CB ' ' CH2' ' A' ' 133' ' ' TRP . 2.4 t80 -119.77 124.8 47.06 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.26 -1.141 . . . . 0.0 109.508 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.452 ' HA ' HG21 ' A' ' 185' ' ' THR . 12.5 t -103.66 122.21 44.55 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 122.135 0.969 . . . . 0.0 109.456 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.817 ' O ' ' N ' ' A' ' 185' ' ' THR . 0.0 OUTLIER -129.42 158.54 42.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.819 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.612 ' C ' ' O ' ' A' ' 182' ' ' ILE . . . -33.63 -34.77 0.03 OUTLIER Glycine 0 N--CA 1.493 2.446 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.686 ' O ' ' CD1' ' A' ' 186' ' ' TYR . . . -105.5 32.66 7.2 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.549 -1.82 . . . . 0.0 108.549 178.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' THR . . . . . 0.817 ' N ' ' O ' ' A' ' 182' ' ' ILE . 53.3 m -37.77 -26.59 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.494 -1.004 . . . . 0.0 110.871 -179.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.7 ' O ' ' CD2' ' A' ' 186' ' ' TYR . 16.9 p90 -41.38 91.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 122.202 1.001 . . . . 0.0 109.316 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.649 ' N ' ' O ' ' A' ' 185' ' ' THR . 0.1 OUTLIER 179.81 31.2 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.542 -0.724 . . . . 0.0 109.221 -178.79 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.865 ' N ' ' CD ' ' A' ' 189' ' ' PRO . . . -105.67 2.08 39.22 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.403 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.865 ' CD ' ' N ' ' A' ' 188' ' ' GLY . 48.7 Cg_endo -75.79 -27.12 9.06 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 N-CA-C 109.426 -1.028 . . . . 0.0 109.426 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -81.43 21.97 0.73 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.631 -0.668 . . . . 0.0 110.476 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -73.2 -48.67 33.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.11 -0.994 . . . . 0.0 109.945 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 9.5 mtm180 -52.87 -19.25 2.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.187 -0.946 . . . . 0.0 109.766 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -107.32 -17.93 10.91 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.166 -1.973 . . . . 0.0 108.166 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.652 HD23 ' C ' ' A' ' 194' ' ' LEU . 6.9 tt -62.2 -31.32 71.83 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.692 -0.887 . . . . 0.0 109.205 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.543 ' HE3' ' N ' ' A' ' 196' ' ' GLY . 0.0 OUTLIER -49.52 -27.83 4.8 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.443 -0.786 . . . . 0.0 109.407 179.534 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.543 ' N ' ' HE3' ' A' ' 195' ' ' LYS . . . -112.29 -21.59 6.17 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.633 ' C ' ' CD ' ' A' ' 197' ' ' ARG . 0.0 OUTLIER -90.77 -10.42 42.95 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.65 -0.912 . . . . 0.0 109.749 179.745 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 194' ' ' LEU . 0.1 OUTLIER -43.83 145.25 0.71 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.907 0.86 . . . . 0.0 111.427 -178.559 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' A' ' 197' ' ' ARG . 0.0 OUTLIER -140.43 171.45 14.12 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.24 0.543 . . . . 0.0 109.725 179.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.468 ' O ' HG11 ' A' ' 108' ' ' VAL . 15.8 m-30 -84.33 136.98 39.75 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.178 -0.951 . . . . 0.0 109.218 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.578 ' HG3' ' CH2' ' A' ' 91' ' ' TRP . 40.8 Cg_endo -67.03 109.82 1.81 Allowed 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 123.862 1.454 . . . . 0.0 110.814 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.532 ' HB3' ' CB ' ' A' ' 81' ' ' LYS . 57.4 p -133.47 137.2 45.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.507 -0.746 . . . . 0.0 109.595 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.565 ' CG2' HG11 ' A' ' 106' ' ' VAL . 4.9 p -128.9 146.55 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.994 -1.066 . . . . 0.0 111.187 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 26.7 m -128.75 127.19 41.54 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.577 ' CB ' ' CG2' ' A' ' 78' ' ' VAL . . . -126.28 166.14 17.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 0.0 110.716 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.583 ' CG1' ' N ' ' A' ' 207' ' ' TRP . 0.9 OUTLIER -101.63 174.66 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 121.363 0.602 . . . . 0.0 110.233 -179.533 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.611 ' HB2' ' CG ' ' A' ' 68' ' ' ARG . 63.9 p-90 -99.01 128.43 45.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.89 . . . . 0.0 110.264 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 144.04 -147.48 18.78 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 211' ' ' GLN . 0.0 OUTLIER -66.18 -25.25 66.85 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.345 -1.091 . . . . 0.0 110.239 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . 0.678 ' O ' ' C ' ' A' ' 211' ' ' GLN . 4.9 t -37.12 -30.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.593 -0.692 . . . . 0.0 110.621 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.678 ' C ' ' O ' ' A' ' 210' ' ' CYS . 10.4 mt-30 0.07 114.59 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 121.65 0.738 . . . . 0.0 111.427 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 210' ' ' CYS . 0.8 OUTLIER -115.62 144.09 24.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.642 -0.661 . . . . 0.0 110.668 -179.164 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 0.558 ' HG3' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -88.54 121.96 31.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.281 -0.887 . . . . 0.0 109.566 179.758 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.623 ' CD1' ' O ' ' A' ' 214' ' ' ILE . 0.0 OUTLIER -123.5 121.59 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 110.896 -179.241 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.653 ' N ' ' O ' ' A' ' 92' ' ' GLU . 0.2 OUTLIER -130.87 139.61 50.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.513 -0.742 . . . . 0.0 109.665 179.495 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . 0.717 ' CE2' ' CD1' ' A' ' 91' ' ' TRP . 0.9 OUTLIER -118.7 150.76 39.21 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.965 -1.085 . . . . 0.0 110.728 -179.439 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' MET . . . . . 0.494 ' CB ' ' O ' ' A' ' 90' ' ' ALA . 2.0 ttm -125.08 107.82 11.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.305 -0.872 . . . . 0.0 110.039 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 116.54 21.59 4.67 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.477 ' OE1' ' N ' ' A' ' 220' ' ' ARG . 0.0 OUTLIER -104.72 117.86 35.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.108 -1.23 . . . . 0.0 110.23 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . 0.477 ' N ' ' OE1' ' A' ' 219' ' ' GLU . 0.9 OUTLIER -126.38 148.26 49.63 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.286 -0.884 . . . . 0.0 110.199 -179.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . 0.516 ' O ' ' C ' ' A' ' 222' ' ' VAL . 0.8 OUTLIER -154.6 94.44 1.68 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.247 -0.908 . . . . 0.0 110.258 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.516 ' C ' ' O ' ' A' ' 221' ' ' ARG . 9.6 p -34.49 135.47 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.485 -0.759 . . . . 0.0 110.476 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.524 ' O ' ' C ' ' A' ' 224' ' ' GLU . 0.8 OUTLIER 179.88 -78.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.934 . . . . 0.0 110.206 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.524 ' C ' ' O ' ' A' ' 223' ' ' GLU . 0.0 OUTLIER -32.1 -51.5 0.25 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.456 -0.777 . . . . 0.0 110.669 -179.779 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.503 ' N ' ' OE1' ' A' ' 224' ' ' GLU . 91.5 m -58.71 81.82 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.204 -0.935 . . . . 0.0 110.218 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 224' ' ' GLU . 0.0 OUTLIER -129.32 14.13 6.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 0.0 110.175 -179.858 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.68 -32.18 72.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.304 -0.872 . . . . 0.0 110.132 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 228' ' ' ILE . 30.5 pt -52.13 139.54 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -0.919 . . . . 0.0 110.167 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -77.57 -44.21 29.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.247 -0.908 . . . . 0.0 110.166 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . 0.418 ' O ' ' OD1' ' A' ' 231' ' ' ASP . 0.3 OUTLIER -47.69 99.83 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.18 -0.95 . . . . 0.0 110.259 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 230' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--N 1.305 -1.351 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.376 179.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.78 172.08 0.79 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.302 -1.117 . . . . 0.0 110.182 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 9' ' ' ALA . 0.1 OUTLIER -163.15 178.92 7.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.332 -0.855 . . . . 0.0 110.165 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.41 ' N ' ' OG ' ' A' ' 8' ' ' SER . . . -124.52 -4.75 7.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.273 -0.892 . . . . 0.0 110.243 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -64.1 -68.08 0.38 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.177 -0.952 . . . . 0.0 110.208 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 10' ' ' ARG . 3.6 tt0 -175.45 -35.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.185 -0.947 . . . . 0.0 110.221 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.8 t -70.7 68.47 0.4 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.343 -0.848 . . . . 0.0 110.185 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.558 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -68.13 -54.11 16.94 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.206 -0.934 . . . . 0.0 110.347 179.89 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 13' ' ' THR . 45.7 Cg_endo -73.0 -167.61 0.36 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.867 1.456 . . . . 0.0 110.467 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.68 -145.9 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.25 -0.906 . . . . 0.0 110.23 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.39 152.63 1.1 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.344 -0.847 . . . . 0.0 110.218 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -115.94 150.92 36.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.302 -0.874 . . . . 0.0 110.15 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.95 101.73 2.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.113 -0.992 . . . . 0.0 110.221 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.8 -5.27 42.53 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 122.245 1.021 . . . . 0.0 110.088 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -55.95 -176.04 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.338 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.101 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.38 -149.03 0.38 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.281 -0.887 . . . . 0.0 110.182 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -120.39 -110.55 0.34 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.298 -0.876 . . . . 0.0 109.896 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.27 -71.41 0.4 Allowed 'General case' 0 C--N 1.284 -2.282 0 CA-C-O 121.384 0.611 . . . . 0.0 110.242 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 t -83.33 125.33 74.52 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.316 -0.865 . . . . 0.0 110.175 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.99 136.5 24.99 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.86 1.453 . . . . 0.0 110.449 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.538 ' CG ' ' CB ' ' A' ' 74' ' ' SER . 44.4 Cg_endo -72.36 160.41 47.02 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.042 1.549 . . . . 0.0 110.631 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -167.54 43.88 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.381 -0.824 . . . . 0.0 109.736 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 29' ' ' LEU . . . 134.74 28.42 0.45 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -42.15 -32.19 0.45 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.324 -1.104 . . . . 0.0 109.982 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.526 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 3.0 pt-20 -48.42 -35.71 13.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.052 -1.03 . . . . 0.0 108.691 179.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -59.13 -26.09 64.42 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -77.73 -36.01 51.35 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.457 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.644 ' C ' ' CD1' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -76.3 -38.85 55.49 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.663 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.551 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -45.92 -26.62 0.73 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.454 0.645 . . . . 0.0 109.925 179.891 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.696 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . . . -52.16 -168.47 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.567 -0.708 . . . . 0.0 109.376 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.696 ' HD2' ' CB ' ' A' ' 35' ' ' ALA . 39.7 Cg_endo -67.07 104.53 0.86 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.448 1.236 . . . . 0.0 109.704 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.689 ' HB2' ' CG2' ' A' ' 41' ' ' VAL . 51.1 Cg_endo -90.84 115.24 0.46 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.284 1.676 . . . . 0.0 111.49 -178.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.902 ' O ' ' N ' ' A' ' 40' ' ' LEU . 50.6 Cg_endo -86.13 152.59 9.57 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 124.087 1.572 . . . . 0.0 110.493 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.676 ' C ' ' O ' ' A' ' 38' ' ' PRO . 0.4 OUTLIER 4.26 53.68 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 122.313 1.054 . . . . 0.0 110.185 -178.258 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.902 ' N ' ' O ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -129.64 -39.62 1.44 Allowed 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.934 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.78 ' O ' ' CD2' ' A' ' 45' ' ' HIS . 1.6 t -78.38 -36.4 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 118.751 -1.179 . . . . 0.0 111.69 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.418 ' HB1' ' OE1' ' A' ' 43' ' ' GLN . . . -74.71 -37.79 62.5 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.585 -1.322 . . . . 0.0 111.681 -178.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.884 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -87.35 -20.27 26.99 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.414 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.798 ' CB ' ' O ' ' A' ' 40' ' ' LEU . 6.6 ttm180 -65.88 -50.6 63.92 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 122.511 1.148 . . . . 0.0 108.085 178.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.78 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 43.2 m-70 -68.68 -17.79 64.14 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.707 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -96.6 -33.19 11.88 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.335 -0.853 . . . . 0.0 109.526 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 43' ' ' GLN . . . -87.3 -113.59 1.0 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.905 ' CD1' ' CG1' ' A' ' 59' ' ' VAL . 11.9 m95 -86.29 74.31 10.02 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.027 -1.278 . . . . 0.0 108.61 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.631 ' OD1' ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -51.29 127.43 29.96 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.507 -0.746 . . . . 0.0 111.104 -178.92 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.629 ' C ' ' H ' ' A' ' 52' ' ' ASP . 50.3 Cg_endo -86.64 2.48 7.16 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.339 2.026 . . . . 0.0 111.884 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 1.012 ' HE2' ' HA ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -57.06 -2.19 0.08 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.651 -1.281 . . . . 0.0 109.365 -179.256 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.649 ' O ' ' NE ' ' A' ' 79' ' ' ARG . 0.3 OUTLIER -117.83 -9.46 10.66 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.668 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.591 ' CB ' ' HB3' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -155.65 -178.6 7.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.422 -0.799 . . . . 0.0 110.705 -179.474 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.557 ' CB ' HD22 ' A' ' 56' ' ' ASN . 5.0 p -68.51 143.09 55.08 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.235 -0.916 . . . . 0.0 109.767 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.654 ' O ' ' N ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -98.78 7.71 45.76 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.654 -0.654 . . . . 0.0 111.199 -178.796 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 76' ' ' ASP . 0.0 OUTLIER -27.16 -38.12 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 122.031 0.919 . . . . 0.0 109.42 -179.751 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.654 ' N ' ' O ' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -140.0 145.81 25.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.704 ' OD1' ' HA ' ' A' ' 44' ' ' ARG . 0.8 OUTLIER -149.99 158.63 44.36 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 118.789 -1.164 . . . . 0.0 110.867 -179.873 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.953 ' HB ' ' C ' ' A' ' 65' ' ' CYS . 1.5 m -114.02 138.45 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.791 0.805 . . . . 0.0 111.92 -177.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.686 ' HA ' ' HB3' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -102.37 152.65 20.84 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.912 179.177 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.459 ' O ' ' O ' ' A' ' 60' ' ' LYS . 1.8 tt0 -60.81 -132.84 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.26 -0.9 . . . . 0.0 110.309 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 44.48 27.71 1.33 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.68 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 131.44 39.73 0.24 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 -179.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.68 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.3 OUTLIER 0.6 87.4 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.897 -0.766 . . . . 0.0 111.026 -179.456 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.953 ' C ' ' HB ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -140.3 134.88 31.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.433 -0.792 . . . . 0.0 110.973 -179.487 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.845 ' CD2' ' CG1' ' A' ' 59' ' ' VAL . 46.1 m-85 -80.14 148.58 30.88 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.599 0.714 . . . . 0.0 110.054 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -128.67 121.63 28.98 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.603 -0.685 . . . . 0.0 109.653 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.573 ' HG3' ' CG2' ' A' ' 57' ' ' ILE . 6.3 ttt-85 -119.06 130.67 55.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.923 . . . . 0.0 110.214 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.699 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 9.0 mtm-85 -69.81 -74.0 0.17 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.926 . . . . 0.0 110.376 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.699 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 57.0 Cg_endo -75.82 -112.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.246 1.13 . . . . 0.0 109.544 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.545 ' O ' ' NH1' ' A' ' 68' ' ' ARG . 1.9 t -140.68 158.14 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.551 -1.343 . . . . 0.0 110.087 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.614 ' HB2' ' CE3' ' A' ' 207' ' ' TRP . . . -97.03 109.94 22.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.135 -0.978 . . . . 0.0 109.823 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.88 53.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.141 -0.975 . . . . 0.0 110.712 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.538 ' CB ' ' CG ' ' A' ' 26' ' ' PRO . 0.5 OUTLIER 179.81 -61.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.054 -1.029 . . . . 0.0 110.636 179.832 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.9 m -81.9 -127.56 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.189 -0.944 . . . . 0.0 110.27 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.613 ' O ' ' O ' ' A' ' 77' ' ' GLY . 0.6 OUTLIER -140.01 116.03 10.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.142 -0.974 . . . . 0.0 109.885 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.613 ' O ' ' O ' ' A' ' 76' ' ' ASP . . . -37.98 -100.03 0.01 OUTLIER Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.508 HG21 ' N ' ' A' ' 79' ' ' ARG . 0.2 OUTLIER -158.87 150.05 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.067 -1.255 . . . . 0.0 110.255 179.379 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.649 ' NE ' ' O ' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -143.56 171.01 14.76 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.666 -0.646 . . . . 0.0 109.82 179.856 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.53 ' N ' ' CG ' ' A' ' 79' ' ' ARG . . . -150.26 133.12 4.22 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.565 ' HB2' ' HA ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -155.07 55.06 0.65 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.297 -1.12 . . . . 0.0 110.245 179.837 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.473 ' O ' ' C ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -125.43 -88.31 0.59 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.915 . . . . 0.0 110.069 179.88 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.473 ' C ' ' O ' ' A' ' 82' ' ' ARG . . . 40.63 58.42 2.57 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -94.45 95.93 9.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.353 -1.087 . . . . 0.0 110.376 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 173' ' ' MET . 38.3 m -136.88 168.07 20.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -0.851 . . . . 0.0 109.948 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.436 ' HA ' ' HG2' ' A' ' 173' ' ' MET . 0.0 OUTLIER -112.47 143.99 42.68 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.22 -0.925 . . . . 0.0 109.835 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.67 -120.34 5.23 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.486 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 13.9 tp -128.36 135.63 49.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.318 -1.107 . . . . 0.0 110.395 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.486 ' CG ' ' C ' ' A' ' 88' ' ' LEU . 8.0 m-70 -147.08 156.34 42.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.207 -0.933 . . . . 0.0 109.569 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.23 138.09 6.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.069 -1.02 . . . . 0.0 110.875 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.721 ' CB ' ' CD2' ' A' ' 216' ' ' TYR . 3.7 p90 -135.27 171.12 14.89 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.404 -0.81 . . . . 0.0 109.456 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 215' ' ' ARG . 23.7 tt0 -135.63 156.82 48.24 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.474 -0.89 . . . . 0.0 111.352 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.579 ' O ' ' OH ' ' A' ' 180' ' ' TYR . 27.9 mm -143.59 141.89 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.555 -0.716 . . . . 0.0 109.637 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.565 ' HB3' ' HA ' ' A' ' 166' ' ' ARG . 2.9 p -155.84 146.36 21.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.886 -1.134 . . . . 0.0 110.777 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.724 ' CH2' ' HA ' ' A' ' 104' ' ' ALA . 39.4 m95 -116.81 87.46 21.98 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.321 -0.862 . . . . 0.0 109.269 178.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.505 ' HG2' ' HG3' ' A' ' 213' ' ' ARG . 51.9 Cg_endo -95.72 108.42 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.719 1.378 . . . . 0.0 111.015 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.627 HD22 ' O ' ' A' ' 210' ' ' CYS . 0.1 OUTLIER -96.68 -67.77 0.83 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.973 -1.079 . . . . 0.0 109.586 178.572 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -98.71 -40.49 8.14 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.571 -0.706 . . . . 0.0 109.574 179.194 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 4.4 tp60 179.65 -27.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.708 -0.62 . . . . 0.0 110.1 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.479 ' NH1' ' HG2' ' A' ' 100' ' ' ARG . 4.2 mmp_? -101.74 -79.79 0.51 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.414 -0.804 . . . . 0.0 110.267 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.498 ' HA2' ' O ' ' A' ' 95' ' ' TRP . . . -175.74 -166.5 33.33 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.482 ' O ' ' O ' ' A' ' 161' ' ' LEU . 0.0 OUTLIER -179.14 -87.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.097 -1.237 . . . . 0.0 110.6 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.617 ' O ' ' CE3' ' A' ' 95' ' ' TRP . 38.0 m-70 -106.22 157.38 17.62 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.205 -0.934 . . . . 0.0 110.584 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.724 ' HA ' ' CH2' ' A' ' 95' ' ' TRP . . . 179.63 133.01 0.1 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.459 -0.776 . . . . 0.0 109.768 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.692 HG21 ' CB ' ' A' ' 204' ' ' SER . 35.1 m -134.95 115.6 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 O-C-N 120.331 -1.481 . . . . 0.0 110.875 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 202' ' ' SER . 2.7 p -150.8 149.72 14.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 O-C-N 121.518 -0.739 . . . . 0.0 109.399 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.583 ' HA2' ' HA3' ' A' ' 132' ' ' GLY . . . -162.7 148.89 16.22 Favored Glycine 0 N--CA 1.485 1.952 0 C-N-CA 118.984 -1.579 . . . . 0.0 110.985 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.611 HG13 ' CG ' ' A' ' 199' ' ' LEU . 11.8 t -105.78 156.97 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.707 -0.878 . . . . 0.0 108.947 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.531 ' N ' HD12 ' A' ' 199' ' ' LEU . . . -150.11 146.69 27.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.728 -1.233 . . . . 0.0 111.501 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.654 ' CG2' ' HB3' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -114.18 138.33 50.59 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.561 0.696 . . . . 0.0 109.65 179.268 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.87 -24.45 18.47 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.532 -0.73 . . . . 0.0 109.064 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.672 ' O ' ' C ' ' A' ' 113' ' ' ALA . 0.7 OUTLIER -86.68 -12.21 49.01 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.555 -0.716 . . . . 0.0 109.268 179.08 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.672 ' C ' ' O ' ' A' ' 112' ' ' LEU . . . 0.12 96.31 0.03 OUTLIER Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 122.04 -0.412 . . . . 0.0 111.192 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.4 -158.3 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.967 1.509 . . . . 0.0 110.363 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.502 ' CG ' ' O ' ' A' ' 115' ' ' LEU . 1.0 OUTLIER -175.84 49.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.148 -0.97 . . . . 0.0 110.271 179.95 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -121.08 -30.7 4.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 110.164 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.531 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -110.5 -5.76 15.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.341 -0.849 . . . . 0.0 110.163 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.531 ' C ' ' O ' ' A' ' 117' ' ' ALA . 12.8 t0 -32.14 149.05 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.539 -0.726 . . . . 0.0 110.789 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.466 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 4.4 m-70 -106.23 113.93 27.75 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.173 -0.955 . . . . 0.0 110.34 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.46 ' HB2' ' O ' ' A' ' 119' ' ' HIS . 3.7 m-85 59.77 13.84 3.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 0.0 110.239 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.517 ' O ' ' CB ' ' A' ' 122' ' ' ALA . . . 42.87 -129.02 0.71 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.187 -0.946 . . . . 0.0 110.259 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.517 ' CB ' ' O ' ' A' ' 121' ' ' ALA . . . 70.82 66.54 0.18 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.216 -0.927 . . . . 0.0 110.269 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.431 HD23 ' O ' ' A' ' 122' ' ' ALA . 0.5 OUTLIER -125.73 149.7 48.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.114 -0.991 . . . . 0.0 110.118 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 tp -87.22 125.73 34.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.324 -0.86 . . . . 0.0 110.228 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 62.39 168.78 0.82 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.09 20.45 3.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -1.149 . . . . 0.0 110.273 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 127' ' ' ASN . 2.0 m120 -97.29 -29.66 13.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.251 -0.906 . . . . 0.0 110.141 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.6 m -150.7 155.07 38.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.244 -0.91 . . . . 0.0 110.076 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 14.7 tm-20 -126.41 115.99 20.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.18 -0.95 . . . . 0.0 109.949 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 48.5 t -120.21 119.37 33.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 110.458 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . 0.445 ' HB2' ' OE2' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -133.55 125.34 28.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.468 -0.77 . . . . 0.0 109.764 179.634 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.583 ' HA3' ' HA2' ' A' ' 107' ' ' GLY . . . -170.18 -143.33 3.89 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.718 ' CZ3' ' CD2' ' A' ' 180' ' ' TYR . 53.7 m0 -115.95 113.48 23.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -1.169 . . . . 0.0 110.317 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.548 ' O ' ' CG2' ' A' ' 135' ' ' ILE . 3.9 p30 -118.25 131.29 56.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.649 -0.657 . . . . 0.0 110.391 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.548 ' CG2' ' O ' ' A' ' 134' ' ' ASP . 1.0 OUTLIER -171.6 34.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.278 -0.889 . . . . 0.0 110.248 179.837 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.543 ' HA3' ' CG1' ' A' ' 105' ' ' VAL . . . -131.89 -49.35 0.1 Allowed Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.62 8.2 35.21 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.432 -1.04 . . . . 0.0 109.721 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.51 ' O ' ' O ' ' A' ' 139' ' ' LYS . . . 54.59 58.44 13.27 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.675 ' O ' ' C ' ' A' ' 140' ' ' LEU . 1.1 mmtt -57.92 -143.56 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.294 -1.121 . . . . 0.0 110.407 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.675 ' C ' ' O ' ' A' ' 139' ' ' LYS . 0.7 OUTLIER 0.69 75.52 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.76 -0.588 . . . . 0.0 111.257 -179.87 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.674 ' C ' ' O ' ' A' ' 140' ' ' LEU . 0.3 OUTLIER 0.18 75.52 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.277 0.56 . . . . 0.0 111.408 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.5 OUTLIER -82.91 10.61 7.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.909 . . . . 0.0 110.122 179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 145' ' ' LYS . 9.8 tp-100 -51.91 -49.74 62.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.309 -0.869 . . . . 0.0 110.261 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 143' ' ' GLN . 22.1 t -42.41 94.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.377 -0.827 . . . . 0.0 110.205 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 143' ' ' GLN . 0.1 OUTLIER -71.35 -156.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 110.228 179.945 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -165.66 -99.94 0.14 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.64 30.52 0.13 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.35 -1.089 . . . . 0.0 110.058 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -53.43 145.02 15.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.336 -0.853 . . . . 0.0 110.219 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 153' ' ' PRO . . . -156.49 148.16 17.11 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 110.105 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.09 -1.38 10.45 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.005 1.529 . . . . 0.0 110.502 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -76.35 -91.37 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 110.245 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.587 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 2.4 m-85 -78.31 -60.69 0.62 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.186 -0.946 . . . . 0.0 110.293 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.587 ' CD ' ' CB ' ' A' ' 152' ' ' TYR . 45.7 Cg_endo -72.72 171.02 18.16 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.964 1.507 . . . . 0.0 110.463 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 155' ' ' GLY . . . -93.19 114.08 26.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.907 . . . . 0.0 110.169 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 154' ' ' ALA . . . -42.26 163.85 0.02 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.577 ' O ' ' CB ' ' A' ' 160' ' ' GLN . 45.2 Cg_endo -72.44 -9.31 24.0 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.963 1.507 . . . . 0.0 110.322 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -0.34 4.16 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.188 -0.945 . . . . 0.0 110.577 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 162' ' ' VAL . . . -92.31 -80.44 1.44 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.584 ' HB3' ' CG2' ' A' ' 163' ' ' VAL . 30.9 mt-10 -109.62 3.27 20.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.234 -1.156 . . . . 0.0 111.069 -179.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.577 ' CB ' ' O ' ' A' ' 156' ' ' PRO . 0.0 OUTLIER -73.06 -17.13 61.45 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.172 -0.955 . . . . 0.0 109.223 179.436 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.503 ' HA ' ' HB ' ' A' ' 135' ' ' ILE . 12.1 mt -156.75 21.29 0.33 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.852 0.834 . . . . 0.0 109.208 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.498 ' CG2' ' O ' ' A' ' 161' ' ' LEU . 2.7 t -163.54 98.2 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.801 -0.562 . . . . 0.0 109.895 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.609 ' H ' ' HD2' ' A' ' 164' ' ' PRO . 1.3 t -134.95 -59.19 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.088 -1.008 . . . . 0.0 110.127 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.609 ' HD2' ' H ' ' A' ' 163' ' ' VAL . 48.6 Cg_endo -77.28 55.22 4.99 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.714 1.376 . . . . 0.0 110.839 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 100' ' ' ARG . 24.2 tt0 -64.0 -58.67 6.0 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.617 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 2.1 ttp180 -151.59 115.44 4.92 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.691 HD13 ' N ' ' A' ' 167' ' ' LEU . 0.7 OUTLIER -150.25 158.27 43.97 Favored 'General case' 0 C--N 1.287 -2.131 0 O-C-N 121.676 -0.64 . . . . 0.0 110.735 -178.711 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.457 ' HA ' ' HG3' ' A' ' 92' ' ' GLU . 1.7 tp -103.86 139.73 38.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.425 -0.797 . . . . 0.0 109.36 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.689 HG22 ' CE1' ' A' ' 180' ' ' TYR . 1.8 t -105.78 130.25 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.091 -1.006 . . . . 0.0 110.439 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.0 t -100.14 125.76 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.524 -0.735 . . . . 0.0 110.058 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.566 ' HB2' ' CZ3' ' A' ' 91' ' ' TRP . 13.3 tp -133.27 106.24 7.44 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.141 -0.975 . . . . 0.0 110.127 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 173' ' ' MET . 50.4 t0 -119.71 137.81 53.69 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.188 -0.945 . . . . 0.0 110.095 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.473 ' HB2' ' O ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -93.48 -40.48 10.31 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.654 -0.654 . . . . 0.0 109.857 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 173' ' ' MET . 37.5 tt0 -43.13 -26.34 0.15 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.272 -0.893 . . . . 0.0 109.11 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.729 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.2 OUTLIER -113.88 -25.75 8.47 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.832 0.825 . . . . 0.0 108.894 179.33 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.521 ' O ' ' CG2' ' A' ' 198' ' ' THR . . . 78.83 27.89 55.73 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 108.139 -1.984 . . . . 0.0 108.139 -178.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.729 ' OG1' ' HB3' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -112.64 143.17 44.29 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.28 -1.129 . . . . 0.0 111.608 -179.182 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.535 HD13 ' CD ' ' A' ' 201' ' ' PRO . 0.5 OUTLIER -148.66 154.2 39.33 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.671 -0.643 . . . . 0.0 109.615 179.377 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.521 ' HA3' ' CD2' ' A' ' 187' ' ' LEU . . . -174.13 166.2 38.15 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.718 ' CD2' ' CZ3' ' A' ' 133' ' ' TRP . 1.7 t80 -118.95 117.52 29.04 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.368 -1.077 . . . . 0.0 109.73 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 186' ' ' TYR . 6.9 t -146.01 165.18 29.8 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.167 -0.958 . . . . 0.0 110.197 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.567 HG23 ' CD2' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -100.12 116.47 43.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.734 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 71.04 6.92 61.43 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.99 43.1 18.07 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 1.7 m -101.18 -69.52 0.77 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.241 -1.152 . . . . 0.0 110.957 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.512 ' N ' ' OG ' ' A' ' 181' ' ' SER . 6.7 m-30 -45.1 -83.52 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.14 -0.975 . . . . 0.0 110.907 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.544 ' O ' ' CE1' ' A' ' 191' ' ' PHE . 0.1 OUTLIER -66.98 43.95 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.87 -1.144 . . . . 0.0 110.202 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 186' ' ' TYR . . . -91.46 -63.4 1.18 Allowed Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.927 -1.13 . . . . 0.0 110.581 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.452 ' HD2' ' O ' ' A' ' 186' ' ' TYR . 46.6 Cg_endo -72.54 -30.25 12.4 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.859 1.452 . . . . 0.0 111.476 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.578 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -74.1 29.4 0.08 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.232 -0.918 . . . . 0.0 111.572 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.544 ' CE1' ' O ' ' A' ' 187' ' ' LEU . 1.2 m-30 -90.53 -14.85 31.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.769 -1.207 . . . . 0.0 110.409 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.522 ' N ' ' HD2' ' A' ' 192' ' ' ARG . 0.0 OUTLIER -90.09 -13.66 35.35 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.328 -0.858 . . . . 0.0 110.283 -179.701 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -110.91 -12.57 15.75 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 107.707 -2.157 . . . . 0.0 107.707 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.7 ' HG ' ' NE ' ' A' ' 197' ' ' ARG . 5.4 tt -67.28 -37.62 83.74 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.56 ' CA ' HG21 ' A' ' 198' ' ' THR . 0.0 OUTLIER -44.66 -37.27 3.56 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.561 -0.712 . . . . 0.0 109.787 179.51 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.91 -27.83 30.47 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.7 ' NE ' ' HG ' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -90.26 -3.34 57.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.707 -0.878 . . . . 0.0 109.942 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.589 ' N ' ' O ' ' A' ' 194' ' ' LEU . 15.8 p -41.1 114.52 0.5 Allowed 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.996 0.903 . . . . 0.0 110.042 -178.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.654 ' HB3' ' CG2' ' A' ' 110' ' ' THR . 2.6 pt? -139.42 171.63 13.98 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.05 -178.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.437 ' N ' ' CD1' ' A' ' 200' ' ' TYR . 5.9 m-85 -84.46 129.44 57.57 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.911 -1.118 . . . . 0.0 110.189 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.549 ' O ' ' CG ' ' A' ' 81' ' ' LYS . 52.8 Cg_endo -84.88 135.98 5.86 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 124.12 1.59 . . . . 0.0 111.164 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.565 ' HA ' ' HB2' ' A' ' 81' ' ' LYS . 3.7 p -133.39 136.99 45.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.292 -0.88 . . . . 0.0 109.993 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.518 ' HA ' ' CG2' ' A' ' 106' ' ' VAL . 3.9 p -122.44 155.39 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -0.961 . . . . 0.0 109.938 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' SER . . . . . 0.692 ' CB ' HG21 ' A' ' 105' ' ' VAL . 2.7 t -130.81 127.5 38.79 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.168 -0.957 . . . . 0.0 110.684 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.61 ' HB3' ' CZ ' ' A' ' 66' ' ' PHE . . . -119.06 154.28 33.4 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.01 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.526 ' CG1' ' OE1' ' A' ' 211' ' ' GLN . 2.9 p -115.11 -172.49 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 110.284 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.614 ' CE3' ' HB2' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -82.77 165.36 19.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.293 -0.879 . . . . 0.0 110.182 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 132.18 131.72 3.25 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.404 ' HG2' ' N ' ' A' ' 210' ' ' CYS . 7.9 tt0 -62.36 -87.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -1.15 . . . . 0.0 110.303 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . 0.627 ' O ' HD22 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -81.18 83.39 6.82 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.323 -0.861 . . . . 0.0 110.541 -179.83 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.528 ' HG3' ' CD2' ' A' ' 97' ' ' LEU . 2.5 tt0 -155.6 -42.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.187 -0.946 . . . . 0.0 110.659 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.643 HG11 ' CH2' ' A' ' 48' ' ' TRP . 88.3 t -127.27 132.68 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.986 -1.071 . . . . 0.0 111.194 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 0.505 ' HG3' ' HG2' ' A' ' 96' ' ' PRO . 0.4 OUTLIER -139.86 149.16 43.08 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.42 -0.8 . . . . 0.0 109.811 179.559 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.694 ' HB ' ' CH2' ' A' ' 48' ' ' TRP . 5.9 tt -144.31 143.89 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.086 -1.009 . . . . 0.0 111.436 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.564 ' O ' ' N ' ' A' ' 92' ' ' GLU . 15.1 mtt180 -130.21 108.72 10.25 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . 0.721 ' CD2' ' CB ' ' A' ' 91' ' ' TRP . 2.4 t80 -116.29 146.76 42.15 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.031 -1.043 . . . . 0.0 111.435 -177.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' MET . . . . . 0.519 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 5.6 tmm? -136.41 107.93 6.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.561 -0.712 . . . . 0.0 109.706 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 149.81 -40.26 0.86 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -95.37 117.93 31.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.165 -1.197 . . . . 0.0 110.205 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . 0.428 ' HG2' ' HG2' ' A' ' 221' ' ' ARG . 0.0 OUTLIER -144.32 -75.92 0.23 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.335 -0.853 . . . . 0.0 110.155 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . 0.5 ' CG ' ' O ' ' A' ' 221' ' ' ARG . 0.7 OUTLIER -170.63 98.3 0.24 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.241 -0.912 . . . . 0.0 110.198 179.89 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.495 ' C ' ' O ' ' A' ' 221' ' ' ARG . 9.1 p -34.24 133.56 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.477 -0.764 . . . . 0.0 110.582 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.529 ' O ' ' C ' ' A' ' 224' ' ' GLU . 0.6 OUTLIER -83.22 20.58 1.25 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.217 -0.927 . . . . 0.0 110.566 -179.846 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.529 ' C ' ' O ' ' A' ' 223' ' ' GLU . 0.0 OUTLIER -31.09 -62.4 0.17 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.496 -0.753 . . . . 0.0 110.781 -179.751 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.416 ' O ' ' O ' ' A' ' 223' ' ' GLU . 14.6 t -48.0 155.36 0.45 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.265 -0.897 . . . . 0.0 110.207 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -148.35 70.57 1.14 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.0 110.243 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.411 ' O ' ' HG3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -84.55 136.09 33.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.207 -0.933 . . . . 0.0 110.233 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 61.4 mt -104.11 -57.16 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.292 -0.88 . . . . 0.0 110.194 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -165.84 60.4 0.11 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.315 -0.865 . . . . 0.0 110.184 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . 0.683 ' O ' ' C ' ' A' ' 231' ' ' ASP . 0.0 OUTLIER -49.47 -87.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.3 -0.875 . . . . 0.0 110.233 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.683 ' C ' ' O ' ' A' ' 230' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 118.073 -0.965 . . . . 0.0 111.515 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.02 -5.6 11.43 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.224 -1.162 . . . . 0.0 110.112 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.7 t 60.05 159.3 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.915 . . . . 0.0 110.231 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -144.88 -41.55 0.24 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.135 -0.978 . . . . 0.0 110.201 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.6 ptt-85 -143.87 39.14 1.35 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.114 -0.991 . . . . 0.0 110.137 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.13 94.33 1.93 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 0.0 110.173 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.5 0.98 55.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.92 . . . . 0.0 110.279 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.487 ' O ' ' CG2' ' A' ' 13' ' ' THR . 9.7 t -111.48 98.25 39.65 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.22 -0.925 . . . . 0.0 110.215 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.17 -89.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.999 1.526 . . . . 0.0 110.405 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.7 12.65 22.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.911 . . . . 0.0 110.159 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.0 p -59.77 127.91 34.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.223 -0.923 . . . . 0.0 110.217 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -115.25 -20.48 10.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.344 -0.847 . . . . 0.0 110.235 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -171.2 113.4 0.38 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.914 . . . . 0.0 110.166 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.414 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 3.9 mm? -66.2 -169.66 0.07 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.264 -0.897 . . . . 0.0 110.201 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.501 ' C ' ' CD1' ' A' ' 20' ' ' TYR . 0.1 OUTLIER -56.11 -169.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.221 -0.925 . . . . 0.0 110.377 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.473 ' O ' ' NE2' ' A' ' 73' ' ' GLN . 6.0 p -150.26 -151.2 0.38 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 0.0 110.134 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -82.8 45.16 0.97 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.892 . . . . 0.0 110.141 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.76 -40.62 15.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 110.236 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.18 137.68 20.83 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.366 -0.834 . . . . 0.0 110.362 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.503 ' HB2' ' HD2' ' A' ' 26' ' ' PRO . 45.9 Cg_endo -73.24 175.35 10.67 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.038 1.547 . . . . 0.0 110.401 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 25' ' ' PRO . 45.2 Cg_endo -72.09 163.84 37.5 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.973 1.512 . . . . 0.0 110.421 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.418 ' HG3' ' C ' ' A' ' 26' ' ' PRO . 31.8 mt-10 -146.24 36.41 1.01 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 110.278 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.08 20.98 74.82 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.486 ' CD1' ' C ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -45.75 -31.57 2.08 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.476 -1.014 . . . . 0.0 109.822 179.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.507 ' HA ' HD22 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -48.81 -34.26 12.04 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.16 -0.963 . . . . 0.0 109.279 179.625 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.77 -21.96 66.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.438 -0.789 . . . . 0.0 109.077 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.464 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -83.37 -35.73 24.9 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.783 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.634 ' HG ' ' N ' ' A' ' 34' ' ' SER . 0.3 OUTLIER -68.56 -37.08 79.62 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 122.071 0.939 . . . . 0.0 109.002 178.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.634 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 3.5 m -76.84 -7.88 56.3 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.387 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.559 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . . . -36.63 -59.61 0.86 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.421 -0.8 . . . . 0.0 110.034 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.676 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 48.2 Cg_endo -74.36 108.42 2.67 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.146 1.603 . . . . 0.0 110.337 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.728 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 48.5 Cg_endo -74.36 -25.2 13.51 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.987 1.519 . . . . 0.0 112.7 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.728 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 43.8 Cg_endo -69.18 152.0 72.32 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 122.944 0.971 . . . . 0.0 112.163 -178.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.689 ' O ' ' CG ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER 3.56 66.83 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 123.121 1.439 . . . . 0.0 111.092 -179.072 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.694 ' C ' ' OE1' ' A' ' 43' ' ' GLN . 0.2 OUTLIER -156.66 -44.97 0.07 Allowed 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 177.863 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.619 ' CG2' HD12 ' A' ' 40' ' ' LEU . 2.8 t -87.71 -31.1 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.785 177.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.54 -44.3 10.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.323 -0.861 . . . . 0.0 111.573 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.862 ' HB2' ' HA ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -74.78 -19.32 60.26 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.178 -0.951 . . . . 0.0 110.523 -179.28 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.757 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 2.8 ttp85 -82.29 -41.6 19.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.869 . . . . 0.0 110.066 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.62 ' N ' ' CD2' ' A' ' 45' ' ' HIS . 19.7 m170 -68.81 -17.03 63.95 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.717 -0.614 . . . . 0.0 111.353 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.416 ' O ' ' O ' ' A' ' 47' ' ' GLY . 6.0 t60 -95.21 -32.96 12.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.752 -1.218 . . . . 0.0 110.102 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.669 ' HA3' ' CG2' ' A' ' 59' ' ' VAL . . . -62.45 -99.43 0.01 OUTLIER Glycine 0 N--CA 1.488 2.164 0 N-CA-C 106.447 -2.661 . . . . 0.0 106.447 178.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.899 ' CE2' ' HB ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -100.14 95.44 6.83 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 175.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.803 ' O ' ' HB3' ' A' ' 53' ' ' CYS . 0.0 OUTLIER -42.33 111.36 0.94 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.644 -0.66 . . . . 0.0 111.679 -178.202 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.605 ' HA ' ' CB ' ' A' ' 53' ' ' CYS . 47.7 Cg_endo -73.49 0.69 7.73 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 122.625 2.217 . . . . 0.0 112.172 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.694 ' CE ' ' N ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -65.02 -31.68 73.04 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 177.928 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.706 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 3.2 m-20 -116.12 -12.58 11.23 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 113.46 -1.7 . . . . 0.0 106.668 176.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.803 ' HB3' ' O ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -108.22 157.82 18.0 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.656 0.741 . . . . 0.0 110.913 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.502 ' HB2' ' O ' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -75.78 142.61 42.29 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.552 0.692 . . . . 0.0 110.008 179.345 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.552 ' HG3' ' CD2' ' A' ' 33' ' ' LEU . 1.1 pm0 -99.33 -4.35 31.92 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.562 -0.711 . . . . 0.0 110.459 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.606 ' ND2' ' O ' ' A' ' 75' ' ' THR . 9.4 m-80 -50.39 -12.67 0.1 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.629 -0.669 . . . . 0.0 110.805 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.61 HG13 ' CZ3' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -124.7 169.0 16.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.288 -0.882 . . . . 0.0 109.242 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.598 ' O ' ' CB ' ' A' ' 67' ' ' GLU . 49.3 t0 -107.2 133.78 51.27 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.899 -1.126 . . . . 0.0 111.087 -177.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.899 ' HB ' ' CE2' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -130.95 137.15 56.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.675 -179.532 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.862 ' HA ' ' HB2' ' A' ' 43' ' ' GLN . 60.0 mttp -123.86 151.58 43.29 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 118.581 -1.248 . . . . 0.0 111.119 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.461 ' O ' ' C ' ' A' ' 62' ' ' GLY . 0.7 OUTLIER -77.6 -128.72 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.474 -0.766 . . . . 0.0 110.274 -179.787 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 41.3 42.28 3.23 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.556 -1.818 . . . . 0.0 108.556 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.683 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 108.82 67.67 0.61 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.683 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER 0.84 88.09 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.847 -0.796 . . . . 0.0 110.983 -179.076 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 1.2 t -99.88 114.33 27.47 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.45 -0.781 . . . . 0.0 111.049 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.807 ' CD1' ' NE1' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -83.56 128.51 34.57 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.136 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.598 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 1.6 tt0 -138.79 121.82 16.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.567 -1.333 . . . . 0.0 110.502 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.661 ' CZ ' ' CZ3' ' A' ' 207' ' ' TRP . 0.0 OUTLIER -130.85 142.85 50.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.38 -0.825 . . . . 0.0 109.406 179.767 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.683 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -130.96 -70.69 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.055 -1.028 . . . . 0.0 110.954 -179.464 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.683 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 55.5 Cg_endo -69.89 -145.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.552 1.291 . . . . 0.0 109.492 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.577 ' HA ' ' CH2' ' A' ' 207' ' ' TRP . 3.9 t -140.02 164.27 23.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 O-C-N 121.417 -0.802 . . . . 0.0 110.175 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.554 ' CB ' ' HB3' ' A' ' 76' ' ' ASP . . . -130.44 94.11 3.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 110.021 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.484 ' O ' ' O ' ' A' ' 72' ' ' ALA . 67.3 mt-30 -48.12 -99.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.281 -0.887 . . . . 0.0 110.106 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.5 p -88.61 39.24 0.91 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.084 -1.01 . . . . 0.0 109.605 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.606 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 3.0 m -144.6 15.73 1.62 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.317 -0.864 . . . . 0.0 110.198 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.617 ' HB2' ' CD1' ' A' ' 207' ' ' TRP . 19.1 p-10 -98.47 155.16 17.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.296 -0.878 . . . . 0.0 109.928 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 54' ' ' SER . . . 106.78 127.73 5.86 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 106.781 -2.528 . . . . 0.0 106.781 -178.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.63 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 1.2 m -117.51 131.67 69.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 120.814 -1.403 . . . . 0.0 111.131 -178.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.706 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 2.5 ttp180 -104.12 175.08 5.6 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.657 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.628 ' HA2' ' CB ' ' A' ' 52' ' ' ASP . . . -167.4 80.7 0.1 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -125.63 130.48 51.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -1.153 . . . . 0.0 110.311 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.531 ' HG2' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -140.41 -31.21 0.64 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -0.89 . . . . 0.0 110.551 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.531 ' N ' ' HG2' ' A' ' 82' ' ' ARG . . . 37.82 40.6 0.78 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.431 ' H ' ' HG2' ' A' ' 82' ' ' ARG . 1.7 t80 -134.71 95.57 3.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.155 -1.203 . . . . 0.0 110.001 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.476 ' CB ' HD22 ' A' ' 171' ' ' LEU . 0.6 OUTLIER -140.27 163.72 32.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.883 . . . . 0.0 110.415 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.604 ' O ' ' CD2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -131.08 158.82 39.37 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.327 -0.858 . . . . 0.0 110.095 179.661 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.521 ' N ' ' HB3' ' A' ' 173' ' ' MET . . . 51.72 -111.59 1.5 Allowed Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 21.2 tp -128.97 134.39 48.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.516 -0.99 . . . . 0.0 111.134 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.604 ' CD2' ' O ' ' A' ' 86' ' ' ARG . 88.6 m-70 -147.31 173.66 12.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.262 -0.899 . . . . 0.0 109.786 179.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.561 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -163.38 158.96 21.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.179 -0.95 . . . . 0.0 110.586 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.726 ' CD1' ' CZ ' ' A' ' 216' ' ' TYR . 1.0 OUTLIER -134.61 170.63 15.51 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.281 -0.887 . . . . 0.0 109.29 179.557 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.666 ' N ' ' O ' ' A' ' 215' ' ' ARG . 6.7 mt-10 -147.82 145.27 28.67 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.178 -0.951 . . . . 0.0 110.748 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.515 ' CD1' HG22 ' A' ' 203' ' ' VAL . 6.3 mt -144.74 153.97 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.283 -0.885 . . . . 0.0 110.879 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.599 ' HB2' ' CB ' ' A' ' 213' ' ' ARG . 2.2 m -135.18 140.95 45.75 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.837 ' CZ2' ' N ' ' A' ' 104' ' ' ALA . 4.9 m95 -99.61 125.58 40.26 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.096 -1.003 . . . . 0.0 111.873 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.719 ' HB3' ' O ' ' A' ' 211' ' ' GLN . 49.4 Cg_endo -79.63 153.24 23.2 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.388 2.059 . . . . 0.0 111.569 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.694 ' CD2' ' N ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -32.89 -34.79 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.481 0.658 . . . . 0.0 110.236 179.288 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.694 ' N ' ' CD2' ' A' ' 97' ' ' LEU . 0.7 OUTLIER -54.14 -11.08 0.42 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.603 -0.686 . . . . 0.0 110.294 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.598 ' HA ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -40.85 -23.51 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.187 -0.946 . . . . 0.0 110.742 -179.92 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.558 ' C ' ' O ' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -31.7 -64.73 0.15 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.404 -0.81 . . . . 0.0 110.437 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.515 ' C ' ' NE2' ' A' ' 103' ' ' HIS . . . -87.59 175.27 45.51 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.572 ' C ' ' CG ' ' A' ' 103' ' ' HIS . 13.4 t -90.23 120.48 31.42 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.352 -1.087 . . . . 0.0 110.458 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.958 ' C ' ' HA ' ' A' ' 205' ' ' ALA . 7.7 m-70 -150.8 -96.46 0.06 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.207 -0.933 . . . . 0.0 110.462 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 1.079 ' N ' ' HA ' ' A' ' 205' ' ' ALA . . . -55.93 38.92 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.658 0 O-C-N 120.857 -1.152 . . . . 0.0 110.982 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.803 ' N ' ' HZ2' ' A' ' 95' ' ' TRP . 0.1 OUTLIER -94.25 145.27 8.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -178.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.538 HG22 ' CG2' ' A' ' 203' ' ' VAL . 2.2 t -127.79 170.16 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.929 -1.107 . . . . 0.0 111.368 -176.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.648 ' CA ' ' HA3' ' A' ' 132' ' ' GLY . . . -179.92 156.83 18.99 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 109.986 -1.245 . . . . 0.0 109.986 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.599 HG11 HD12 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -108.6 140.72 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.41 -1.053 . . . . 0.0 109.538 179.855 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.484 ' O ' ' HB3' ' A' ' 199' ' ' LEU . . . -109.85 140.39 43.85 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.227 -0.921 . . . . 0.0 110.738 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.514 HG23 ' CD2' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -119.46 130.41 55.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.453 -0.78 . . . . 0.0 110.324 179.809 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.73 -27.47 17.22 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.501 -0.749 . . . . 0.0 109.295 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.458 ' O ' ' C ' ' A' ' 113' ' ' ALA . 0.9 OUTLIER -81.69 -12.3 58.71 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.535 -0.728 . . . . 0.0 109.587 179.474 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.534 ' CB ' ' HB2' ' A' ' 129' ' ' GLU . . . -38.25 112.41 0.66 Allowed Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.553 -0.717 . . . . 0.0 110.235 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.46 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 46.5 Cg_endo -73.29 178.42 6.63 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.941 1.495 . . . . 0.0 110.641 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.46 ' HB3' ' O ' ' A' ' 114' ' ' PRO . 0.5 OUTLIER -179.91 62.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 110.123 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.463 ' O ' ' C ' ' A' ' 117' ' ' ALA . 0.0 OUTLIER -65.45 -26.62 68.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.287 -0.883 . . . . 0.0 110.262 -179.805 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.54 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -37.87 127.08 1.23 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.409 -0.807 . . . . 0.0 110.286 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.54 ' C ' ' O ' ' A' ' 117' ' ' ALA . 43.5 t0 -31.1 136.78 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.573 -0.704 . . . . 0.0 110.749 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -91.9 137.73 32.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.371 -0.831 . . . . 0.0 110.179 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -116.65 -2.47 11.92 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.171 -0.955 . . . . 0.0 110.205 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -169.44 68.21 0.06 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.213 -0.929 . . . . 0.0 110.239 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -147.21 129.58 15.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 0.0 110.209 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.25 -65.92 0.97 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 0.0 110.242 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -176.68 -153.63 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 110.229 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 90.23 -129.37 9.7 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 127' ' ' ASN . 10.2 t -151.73 64.47 0.86 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -1.149 . . . . 0.0 110.226 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 126' ' ' SER . 7.0 m120 -51.98 -173.42 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.329 -0.857 . . . . 0.0 110.275 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.426 ' HB3' ' O ' ' A' ' 110' ' ' THR . 14.7 m -161.57 -159.07 0.6 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -0.869 . . . . 0.0 110.211 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.534 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . 4.9 mm-40 -150.25 133.82 16.58 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.323 -0.861 . . . . 0.0 109.861 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.5 t -120.18 119.73 34.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 110.559 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -133.25 136.32 45.48 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.367 -0.833 . . . . 0.0 109.411 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.648 ' HA3' ' CA ' ' A' ' 107' ' ' GLY . . . -158.83 -163.47 13.04 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.436 -1.364 . . . . 0.0 110.309 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.677 ' CE3' ' CG ' ' A' ' 180' ' ' TYR . 24.6 m0 -115.77 113.12 23.01 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.477 -1.013 . . . . 0.0 110.197 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.687 ' HA ' ' CG1' ' A' ' 105' ' ' VAL . 2.1 p-10 -119.48 142.96 47.81 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.717 -0.614 . . . . 0.0 110.154 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.611 HG13 ' CD1' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -121.41 -12.01 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 109.634 179.46 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 99' ' ' GLN . . . -95.61 -25.18 13.99 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.47 ' O ' ' C ' ' A' ' 138' ' ' GLY . 2.5 ttp180 -86.24 4.96 36.54 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.139 -1.213 . . . . 0.0 109.629 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.768 ' O ' ' O ' ' A' ' 139' ' ' LYS . . . 40.47 40.72 2.08 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.768 ' O ' ' O ' ' A' ' 138' ' ' GLY . 0.0 OUTLIER 1.48 -133.14 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 121.694 0.759 . . . . 0.0 112.256 -179.8 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.9 tt -155.71 101.28 2.14 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.458 -0.776 . . . . 0.0 110.352 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.443 ' CE2' ' HG ' ' A' ' 161' ' ' LEU . 0.6 OUTLIER -126.03 29.57 5.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 110.214 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.461 ' CD2' ' N ' ' A' ' 142' ' ' HIS . 7.6 m170 -109.77 65.6 0.62 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.221 -0.924 . . . . 0.0 110.318 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.519 ' CG ' ' N ' ' A' ' 144' ' ' SER . 16.5 pt20 -59.13 -41.99 89.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.898 . . . . 0.0 110.224 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.519 ' N ' ' CG ' ' A' ' 143' ' ' GLN . 21.6 m -100.87 -85.13 0.42 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.261 -0.899 . . . . 0.0 110.145 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -119.54 178.49 4.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.185 -0.947 . . . . 0.0 110.218 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -117.76 174.07 15.09 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -158.45 44.9 0.3 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -1.156 . . . . 0.0 110.096 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.65 175.2 0.19 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.204 -0.935 . . . . 0.0 110.264 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.407 ' O ' ' O ' ' A' ' 153' ' ' PRO . . . -167.42 58.88 0.44 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.884 . . . . 0.0 110.111 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.15 -3.13 13.11 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.098 1.578 . . . . 0.0 110.507 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.02 -97.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.213 -0.93 . . . . 0.0 110.116 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.605 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 0.4 OUTLIER -90.86 -63.52 0.19 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.188 -0.945 . . . . 0.0 110.276 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.605 ' CD ' ' CB ' ' A' ' 152' ' ' TYR . 46.2 Cg_endo -73.43 170.94 18.73 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.673 1.354 . . . . 0.0 110.408 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.423 ' O ' ' C ' ' A' ' 155' ' ' GLY . . . -90.41 130.67 36.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 110.175 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 154' ' ' ALA . . . -43.08 114.79 0.89 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.416 ' O ' ' OE1' ' A' ' 160' ' ' GLN . 47.1 Cg_endo -73.55 -14.07 24.89 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.897 1.472 . . . . 0.0 110.406 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.411 ' OE1' ' NE2' ' A' ' 142' ' ' HIS . 3.3 mm-40 -66.49 -4.21 7.89 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.26 -0.9 . . . . 0.0 110.512 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.525 ' O ' HG11 ' A' ' 162' ' ' VAL . . . -85.53 -62.63 1.61 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.585 ' HA ' ' CG1' ' A' ' 162' ' ' VAL . 3.8 tt0 -73.9 6.69 3.11 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.301 -1.117 . . . . 0.0 110.527 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.509 ' O ' ' CD2' ' A' ' 161' ' ' LEU . 1.2 tp60 -62.03 -11.37 13.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.227 -0.921 . . . . 0.0 110.149 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.509 ' CD2' ' O ' ' A' ' 160' ' ' GLN . 0.1 OUTLIER 179.98 28.81 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.344 -0.848 . . . . 0.0 110.397 179.812 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.585 ' CG1' ' HA ' ' A' ' 159' ' ' GLU . 4.4 p -113.87 -136.64 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.323 -0.861 . . . . 0.0 109.486 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.62 ' CG1' ' HB2' ' A' ' 167' ' ' LEU . 1.5 t -117.94 133.47 23.38 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 120.873 -1.142 . . . . 0.0 109.678 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.491 ' HD2' ' CG2' ' A' ' 182' ' ' ILE . 43.1 Cg_endo -70.56 178.52 4.98 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.859 1.452 . . . . 0.0 110.913 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.506 ' O ' ' HB3' ' A' ' 94' ' ' SER . 11.1 pt-20 -50.07 -18.34 0.54 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.477 -0.764 . . . . 0.0 110.826 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.48 ' NH1' ' HG2' ' A' ' 166' ' ' ARG . 7.9 tpt180 -133.67 154.97 50.53 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.102 -0.999 . . . . 0.0 109.929 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.684 ' CD2' ' N ' ' A' ' 168' ' ' LEU . 0.0 OUTLIER -164.04 146.78 9.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.28 -0.888 . . . . 0.0 109.789 -179.802 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.684 ' N ' ' CD2' ' A' ' 167' ' ' LEU . 1.2 tt -125.77 131.19 52.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.142 -0.974 . . . . 0.0 110.611 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.647 ' CG1' ' CE3' ' A' ' 91' ' ' TRP . 97.2 t -89.52 156.92 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.395 -0.815 . . . . 0.0 109.805 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.449 ' CG2' HD11 ' A' ' 187' ' ' LEU . 22.4 t -134.55 112.1 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.165 -0.959 . . . . 0.0 110.155 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -132.39 122.48 25.07 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.287 -0.883 . . . . 0.0 109.791 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -120.15 139.13 53.08 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.244 -0.91 . . . . 0.0 109.942 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.521 ' HB3' ' N ' ' A' ' 87' ' ' GLY . 0.3 OUTLIER -93.05 -38.25 11.73 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.553 -0.717 . . . . 0.0 109.778 179.768 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 173' ' ' MET . 0.8 OUTLIER -43.11 -27.28 0.2 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 108.7 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.598 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.7 OUTLIER -114.59 -27.38 7.52 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.78 0.8 . . . . 0.0 108.876 179.157 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.483 ' O ' HG21 ' A' ' 198' ' ' THR . . . 84.68 22.54 53.15 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 108.706 -1.757 . . . . 0.0 108.706 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.598 ' OG1' ' HB3' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -115.53 133.72 55.76 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.288 -1.125 . . . . 0.0 111.376 -179.476 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 171' ' ' LEU . 0.1 OUTLIER -143.85 152.63 41.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.569 -0.707 . . . . 0.0 109.423 178.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.523 ' O ' HG11 ' A' ' 169' ' ' VAL . . . -161.67 -156.1 8.21 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.677 ' CG ' ' CE3' ' A' ' 133' ' ' TRP . 0.1 OUTLIER -125.65 138.34 53.9 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.27 -1.135 . . . . 0.0 108.904 -179.905 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.481 ' HB2' ' HB2' ' A' ' 187' ' ' LEU . 9.2 t -144.0 141.59 30.23 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.143 -0.973 . . . . 0.0 110.624 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.593 HD13 ' CD2' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -127.12 116.76 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.655 -0.653 . . . . 0.0 109.563 179.629 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 65.55 10.09 47.5 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 77.0 41.01 23.71 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' THR . . . . . 0.429 HG22 ' CZ ' ' A' ' 186' ' ' TYR . 17.4 m -97.31 -47.56 5.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -1.142 . . . . 0.0 110.643 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.593 ' CD2' HD13 ' A' ' 182' ' ' ILE . 8.6 m-85 -112.08 85.55 2.17 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.097 -1.002 . . . . 0.0 110.683 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.614 ' HG ' ' CE1' ' A' ' 191' ' ' PHE . 0.9 OUTLIER -179.79 28.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.686 -0.634 . . . . 0.0 109.647 179.54 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -94.88 -89.52 1.72 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.491 ' C ' ' H ' ' A' ' 191' ' ' PHE . 49.6 Cg_endo -74.24 -21.02 18.17 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 124.18 1.621 . . . . 0.0 111.21 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.558 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -66.31 15.2 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.527 -0.733 . . . . 0.0 111.877 -178.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.614 ' CE1' ' HG ' ' A' ' 187' ' ' LEU . 1.1 m-30 -90.51 -28.07 18.78 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.854 -1.154 . . . . 0.0 111.146 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.564 ' HA ' ' NE ' ' A' ' 192' ' ' ARG . 0.1 OUTLIER -86.52 -13.13 46.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.949 -1.094 . . . . 0.0 110.744 -179.5 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -107.48 -13.04 21.77 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.659 ' O ' ' N ' ' A' ' 198' ' ' THR . 9.2 tt -72.17 -40.54 67.89 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.572 -0.958 . . . . 0.0 109.012 179.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.52 ' HD2' ' N ' ' A' ' 196' ' ' GLY . 0.0 OUTLIER -44.12 -40.25 4.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.215 -0.928 . . . . 0.0 109.869 179.583 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.52 ' N ' ' HD2' ' A' ' 195' ' ' LYS . . . -86.27 -26.82 32.4 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.854 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.62 -4.38 56.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.686 -0.891 . . . . 0.0 109.905 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.659 ' N ' ' O ' ' A' ' 194' ' ' LEU . 0.8 OUTLIER -43.85 132.08 5.32 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.739 0.78 . . . . 0.0 111.732 -178.441 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.854 ' HG ' ' O ' ' A' ' 197' ' ' ARG . 0.0 OUTLIER -140.68 171.01 14.7 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.656 -0.652 . . . . 0.0 109.444 179.254 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.487 ' CZ ' ' HA3' ' A' ' 83' ' ' GLY . 0.1 OUTLIER -85.98 128.93 56.12 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 120.909 -1.119 . . . . 0.0 109.84 179.358 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.546 ' CA ' HG12 ' A' ' 108' ' ' VAL . 51.0 Cg_endo -85.91 129.16 3.4 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.995 1.524 . . . . 0.0 111.396 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.494 ' O ' HG11 ' A' ' 106' ' ' VAL . 24.5 t -133.46 142.87 48.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.297 -0.877 . . . . 0.0 109.585 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.538 ' CG2' HG22 ' A' ' 106' ' ' VAL . 7.4 p -122.35 153.96 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.825 -1.172 . . . . 0.0 111.43 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' SER . . . . . 0.828 ' O ' ' O ' ' A' ' 103' ' ' HIS . 15.1 p -149.58 145.39 26.78 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 1.079 ' HA ' ' N ' ' A' ' 104' ' ' ALA . . . -150.26 167.36 27.19 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.765 -1.209 . . . . 0.0 112.059 -179.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.807 ' N ' ' HB3' ' A' ' 103' ' ' HIS . 0.3 OUTLIER -69.48 -176.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 121.639 0.733 . . . . 0.0 111.31 -179.02 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.661 ' CZ3' ' CZ ' ' A' ' 68' ' ' ARG . 22.7 p-90 -129.78 -5.12 4.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.672 -0.642 . . . . 0.0 109.823 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 207' ' ' TRP . . . -51.72 -168.97 0.01 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.764 ' O ' ' O ' ' A' ' 210' ' ' CYS . 0.5 OUTLIER -79.67 -51.61 9.02 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.467 -1.02 . . . . 0.0 110.864 -179.562 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . 0.764 ' O ' ' O ' ' A' ' 209' ' ' GLN . 26.4 p 0.99 -129.18 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 121.07 0.462 . . . . 0.0 111.422 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.719 ' O ' ' HB3' ' A' ' 96' ' ' PRO . 0.0 OUTLIER 178.64 93.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.766 -1.209 . . . . 0.0 111.054 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.644 ' HB ' ' CZ ' ' A' ' 66' ' ' PHE . 3.1 t -87.05 123.09 39.67 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 O-C-N 121.381 -0.825 . . . . 0.0 108.84 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 0.599 ' CB ' ' HB2' ' A' ' 94' ' ' SER . 2.0 tpp85 -89.85 147.36 23.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.097 -1.002 . . . . 0.0 110.52 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.583 ' O ' HD23 ' A' ' 64' ' ' LEU . 1.1 mt -144.33 128.46 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 110.474 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.666 ' O ' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -130.59 108.22 9.77 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.297 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . 0.726 ' CZ ' ' CD1' ' A' ' 91' ' ' TRP . 3.6 t80 -119.02 144.98 46.23 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.249 -0.907 . . . . 0.0 111.233 -178.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' MET . . . . . 0.46 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 1.2 ttp -136.59 108.45 7.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.561 -0.712 . . . . 0.0 110.05 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 130.74 70.34 0.11 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' A' ' 220' ' ' ARG . 0.2 OUTLIER -103.02 157.97 16.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.261 -1.141 . . . . 0.0 110.199 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . 0.467 ' O ' ' O ' ' A' ' 219' ' ' GLU . 75.4 mtt180 -55.87 -161.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.251 -0.905 . . . . 0.0 110.28 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . 0.504 ' O ' ' C ' ' A' ' 222' ' ' VAL . 8.9 tpm_? -135.24 89.55 2.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.197 -0.939 . . . . 0.0 110.344 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.504 ' C ' ' O ' ' A' ' 221' ' ' ARG . 8.6 p -34.57 132.71 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.493 -0.755 . . . . 0.0 110.69 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.54 ' O ' ' C ' ' A' ' 224' ' ' GLU . 23.1 tt0 -58.14 -34.91 70.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.179 -0.951 . . . . 0.0 110.216 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.54 ' C ' ' O ' ' A' ' 223' ' ' GLU . 5.3 tt0 -31.82 -85.92 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.406 -0.809 . . . . 0.0 110.768 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.7 m -48.7 125.95 10.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.263 -0.898 . . . . 0.0 110.244 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -60.83 140.58 57.6 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.201 -0.937 . . . . 0.0 110.225 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.461 ' NH1' ' HG2' ' A' ' 227' ' ' ARG . 0.4 OUTLIER -96.11 175.84 6.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 110.264 -179.944 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 46.1 mm -129.28 115.31 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.209 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.509 ' O ' ' N ' ' A' ' 231' ' ' ASP . 0.2 OUTLIER -80.01 148.41 31.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.257 -0.902 . . . . 0.0 110.263 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . 0.683 ' O ' ' C ' ' A' ' 231' ' ' ASP . 0.0 OUTLIER -49.0 91.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.209 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.683 ' C ' ' O ' ' A' ' 230' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.955 -1.021 . . . . 0.0 111.419 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -115.86 127.42 55.01 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.187 -1.184 . . . . 0.0 110.251 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.04 72.83 0.26 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.295 -0.878 . . . . 0.0 110.152 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.19 126.71 31.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.181 -0.949 . . . . 0.0 110.176 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.89 -16.7 63.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.168 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -130.66 141.7 50.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 0.0 110.316 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.2 m -96.11 -166.88 1.49 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.331 -0.855 . . . . 0.0 110.192 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 48.9 p -112.28 155.92 42.85 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.187 -0.945 . . . . 0.0 110.298 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.91 161.62 43.17 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.047 1.551 . . . . 0.0 110.374 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.6 p -128.81 128.59 44.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 110.267 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.6 m -77.76 -3.96 43.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.332 -0.855 . . . . 0.0 110.157 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.469 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 9.1 pt20 -75.52 62.92 1.45 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.185 -0.947 . . . . 0.0 110.253 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -172.92 121.2 0.38 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.181 -0.949 . . . . 0.0 110.206 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.42 ' N ' HD11 ' A' ' 19' ' ' LEU . 7.1 mp -70.07 -161.36 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.192 -0.942 . . . . 0.0 110.223 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -63.52 -94.9 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.203 -0.935 . . . . 0.0 110.174 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.9 179.56 6.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.323 -0.86 . . . . 0.0 110.155 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -175.17 58.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.353 -0.842 . . . . 0.0 110.167 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.93 -42.58 4.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.254 -0.904 . . . . 0.0 110.263 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.09 116.76 53.01 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.345 -0.847 . . . . 0.0 110.386 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.531 ' HB2' ' HD2' ' A' ' 26' ' ' PRO . 46.5 Cg_endo -73.33 176.59 9.01 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.024 1.539 . . . . 0.0 110.456 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.531 ' HD2' ' HB2' ' A' ' 25' ' ' PRO . 42.9 Cg_endo -70.74 161.19 46.93 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.878 1.462 . . . . 0.0 110.542 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -68.69 53.98 0.08 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.374 -0.829 . . . . 0.0 110.014 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 26' ' ' PRO . . . 54.12 19.21 10.88 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.602 ' HG ' ' N ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -43.61 -32.61 0.99 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.225 -1.162 . . . . 0.0 110.026 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.602 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 8.7 mt-10 -52.18 -35.9 50.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.066 -1.021 . . . . 0.0 108.997 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.65 -25.42 60.17 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.444 ' O ' ' HB3' ' A' ' 35' ' ' ALA . 0.5 OUTLIER -82.03 -35.74 28.48 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.707 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.62 ' C ' ' CD1' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -77.87 -38.92 44.86 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.91 0.862 . . . . 0.0 108.873 178.884 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.564 ' O ' ' O ' ' A' ' 35' ' ' ALA . 23.2 t -57.58 -14.31 5.1 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.318 0.58 . . . . 0.0 110.25 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.786 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . . . -52.61 -161.26 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.402 -0.811 . . . . 0.0 109.942 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.786 ' HD2' ' CB ' ' A' ' 35' ' ' ALA . 38.6 Cg_endo -65.8 118.37 5.43 Favored 'Trans proline' 0 C--N 1.315 -1.214 0 O-C-N 123.008 1.004 . . . . 0.0 109.647 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.567 ' CB ' HG23 ' A' ' 41' ' ' VAL . 45.7 Cg_endo -71.35 108.44 2.37 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.28 1.674 . . . . 0.0 112.162 -178.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.761 ' O ' ' N ' ' A' ' 40' ' ' LEU . 50.7 Cg_endo -81.98 151.97 16.49 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.23 1.648 . . . . 0.0 108.676 178.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.662 ' C ' ' O ' ' A' ' 38' ' ' PRO . 3.1 t0 -21.49 -41.89 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.311 -0.868 . . . . 0.0 109.806 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.761 ' N ' ' O ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -37.84 -50.06 1.24 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 122.012 -0.43 . . . . 0.0 109.875 179.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.656 ' N ' ' CD1' ' A' ' 40' ' ' LEU . 13.8 t -62.03 -26.92 41.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.683 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.611 ' N ' ' O ' ' A' ' 39' ' ' ASP . . . -89.06 -44.79 10.11 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.166 -0.958 . . . . 0.0 111.073 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.658 ' NE2' ' C ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -79.05 -25.28 43.17 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 118.405 -1.318 . . . . 0.0 108.648 179.389 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.741 ' CB ' ' O ' ' A' ' 40' ' ' LEU . 9.1 ttp180 -61.39 -52.87 62.81 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 122.343 1.068 . . . . 0.0 108.198 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.591 ' CE1' ' O ' ' A' ' 41' ' ' VAL . 26.0 m170 -60.93 -18.0 54.4 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.989 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -96.87 -30.07 13.35 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 118.207 -1.397 . . . . 0.0 111.648 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.48 ' O ' HD12 ' A' ' 214' ' ' ILE . . . -109.2 -67.12 0.58 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 107.605 -2.198 . . . . 0.0 107.605 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.784 ' CH2' ' N ' ' A' ' 61' ' ' GLU 0.265 0.1 OUTLIER -96.2 71.02 2.81 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.316 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.703 ' OD1' ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -60.26 112.53 5.62 Favored Pre-proline 0 N--CA 1.491 1.616 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.487 -178.809 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.663 ' CD ' ' HE3' ' A' ' 51' ' ' LYS . 44.5 Cg_endo -74.74 0.38 8.84 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 124.535 1.808 . . . . 0.0 112.024 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.913 ' CE ' ' N ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -64.57 -19.72 65.81 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 178.703 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.757 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 8.6 m-20 -133.34 -2.29 3.12 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 114.149 -1.387 . . . . 0.0 107.856 178.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.605 ' HB3' ' HA ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -113.34 152.11 30.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.571 -0.706 . . . . 0.0 110.058 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.492 ' CB ' HD21 ' A' ' 56' ' ' ASN . 0.0 OUTLIER -68.06 104.42 1.76 Allowed 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.13 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.56 ' O ' ' N ' ' A' ' 57' ' ' ILE . 26.1 pt-20 -67.81 -17.01 64.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.105 -0.997 . . . . 0.0 109.064 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.537 ' H ' ' ND2' ' A' ' 56' ' ' ASN . 11.8 m-80 -33.36 -32.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.678 0.752 . . . . 0.0 110.346 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.694 ' HB ' ' O ' ' A' ' 67' ' ' GLU . 9.0 pt -112.92 166.96 6.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.616 -0.677 . . . . 0.0 110.01 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.577 ' O ' ' N ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -107.13 117.11 33.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.247 -0.908 . . . . 0.0 109.372 -179.362 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.765 HG21 ' CD1' ' A' ' 66' ' ' PHE . 2.6 p -124.52 120.36 58.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 O-C-N 121.445 -0.785 . . . . 0.0 111.463 -178.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.685 ' HG2' ' N ' ' A' ' 61' ' ' GLU . 6.6 tttt -137.4 159.54 41.66 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.534 -0.729 . . . . 0.0 110.27 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.784 ' N ' ' CH2' ' A' ' 48' ' ' TRP . 1.2 tt0 -45.45 -106.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.596 -0.69 . . . . 0.0 110.535 -179.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.569 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 35.7 33.76 0.06 OUTLIER Glycine 0 N--CA 1.493 2.487 0 N-CA-C 108.141 -1.984 . . . . 0.0 108.141 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.69 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 107.8 62.83 0.56 Allowed Glycine 0 N--CA 1.485 1.927 0 N-CA-C 108.01 -2.036 . . . . 0.0 108.01 -178.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.69 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.4 OUTLIER 1.18 80.64 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.899 -0.765 . . . . 0.0 110.724 -179.324 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.429 ' N ' ' O ' ' A' ' 63' ' ' GLY . 17.3 p -141.17 136.92 32.3 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 118.418 -1.313 . . . . 0.0 112.176 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.765 ' CD1' HG21 ' A' ' 59' ' ' VAL . 17.9 m-85 -89.34 165.32 14.45 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.694 ' O ' ' HB ' ' A' ' 57' ' ' ILE . 5.5 tm-20 -136.94 121.01 17.76 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.91 -1.119 . . . . 0.0 109.944 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.561 ' CD ' ' O ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -126.32 148.71 49.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.237 -0.915 . . . . 0.0 109.977 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.75 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 1.7 mtm180 -104.93 -78.93 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.024 -1.048 . . . . 0.0 110.454 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.75 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 57.6 Cg_endo -75.08 -152.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.163 1.086 . . . . 0.0 109.368 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.42 ' H ' ' HB2' ' A' ' 70' ' ' PRO . 2.4 t -140.76 162.55 22.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.543 ' CB ' ' HB ' ' A' ' 75' ' ' THR . . . 179.85 175.87 0.75 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.932 -1.105 . . . . 0.0 110.621 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.464 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 2.5 pt20 -66.19 -115.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.385 -0.822 . . . . 0.0 110.31 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 73' ' ' GLN . 11.5 p -41.78 -27.1 0.1 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.195 -0.941 . . . . 0.0 110.225 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.543 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 22.6 m -44.29 -28.51 0.54 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.879 . . . . 0.0 110.028 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.651 ' CB ' ' CD1' ' A' ' 207' ' ' TRP . 12.4 p30 -112.68 155.46 24.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.887 . . . . 0.0 109.992 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 205' ' ' ALA . . . 79.86 123.93 0.47 Allowed Glycine 0 N--CA 1.484 1.899 0 N-CA-C 106.886 -2.485 . . . . 0.0 106.886 -178.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.562 ' HB ' ' CB ' ' A' ' 53' ' ' CYS . 1.2 m -117.74 161.85 16.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 120.851 -1.382 . . . . 0.0 110.939 -178.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.757 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -119.5 173.5 6.95 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.015 179.128 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.665 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -149.47 48.44 0.6 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.555 ' HA ' ' CB ' ' A' ' 202' ' ' SER . 22.7 ttpp -81.95 76.28 8.85 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -1.101 . . . . 0.0 109.985 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.502 ' CG ' ' OD2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -141.47 -91.03 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.381 -0.825 . . . . 0.0 110.064 -179.921 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.415 ' H ' ' CD ' ' A' ' 82' ' ' ARG . . . 49.11 62.69 4.47 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.487 ' CD2' ' O ' ' A' ' 84' ' ' TYR . 52.3 t80 -94.46 96.06 9.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -1.148 . . . . 0.0 109.995 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.572 ' OG ' ' CD2' ' A' ' 89' ' ' HIS . 0.1 OUTLIER -132.13 153.91 50.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.888 . . . . 0.0 110.263 -179.853 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.614 ' O ' ' CD2' ' A' ' 89' ' ' HIS . 46.5 ttp180 -114.72 176.43 5.05 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.321 -0.862 . . . . 0.0 109.779 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.563 ' N ' ' CG ' ' A' ' 86' ' ' ARG . . . 46.78 -111.22 0.66 Allowed Glycine 0 N--CA 1.485 1.959 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.525 ' O ' ' ND1' ' A' ' 89' ' ' HIS . 5.9 tt -129.08 126.83 40.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.478 -1.013 . . . . 0.0 110.751 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.614 ' CD2' ' O ' ' A' ' 86' ' ' ARG . 52.1 m-70 -147.41 173.69 12.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.792 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.51 155.31 17.29 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.347 -0.846 . . . . 0.0 110.263 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.703 ' CZ2' ' CG1' ' A' ' 169' ' ' VAL . 1.2 p90 -135.05 171.12 14.87 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.199 -0.938 . . . . 0.0 110.064 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.571 ' N ' ' O ' ' A' ' 215' ' ' ARG . 2.9 tp10 -132.93 142.63 48.99 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.538 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.534 ' CG2' ' OH ' ' A' ' 180' ' ' TYR . 0.3 OUTLIER -144.78 138.36 22.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.215 -0.928 . . . . 0.0 110.961 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.577 ' HB2' ' CB ' ' A' ' 213' ' ' ARG . 0.7 OUTLIER -117.75 137.3 52.8 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.724 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.858 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 46.9 t-105 -116.0 87.89 20.21 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.046 -1.034 . . . . 0.0 111.631 -178.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 94' ' ' SER . 52.4 Cg_endo -98.16 109.35 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 121.862 1.708 . . . . 0.0 110.046 178.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.84 -68.48 0.8 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.662 -1.274 . . . . 0.0 110.417 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 99' ' ' GLN . 0.4 OUTLIER -99.07 -45.53 5.9 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.256 -0.903 . . . . 0.0 110.012 179.412 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.424 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 6.6 tt0 179.69 -31.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.723 0.773 . . . . 0.0 109.344 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.578 ' HG3' ' N ' ' A' ' 101' ' ' GLY . 9.3 ptp85 -135.03 -35.6 0.84 Allowed 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.418 0.628 . . . . 0.0 109.594 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.581 ' HA2' ' CG2' ' A' ' 162' ' ' VAL . . . -46.77 171.43 0.03 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.542 ' HA ' ' HD1' ' A' ' 95' ' ' TRP . 6.0 m -166.4 92.18 0.47 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.156 -1.202 . . . . 0.0 110.618 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.587 ' N ' ' CD1' ' A' ' 95' ' ' TRP . 27.0 m170 -114.32 53.98 0.78 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.191 -0.943 . . . . 0.0 110.959 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.858 ' HA ' ' CE2' ' A' ' 95' ' ' TRP . . . -60.82 129.24 40.47 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.073 -1.017 . . . . 0.0 109.978 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.791 HG22 ' O ' ' A' ' 105' ' ' VAL . 1.2 m -103.43 116.54 47.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 C-N-CA 118.655 -1.218 . . . . 0.0 109.27 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.572 ' CG1' ' O ' ' A' ' 202' ' ' SER . 78.3 t -135.71 152.26 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 120.999 -1.063 . . . . 0.0 109.926 -178.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.561 ' N ' HG12 ' A' ' 106' ' ' VAL . . . -141.52 135.52 6.86 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.646 ' CG1' HD11 ' A' ' 199' ' ' LEU . 1.3 t -125.79 131.62 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.435 -1.038 . . . . 0.0 108.319 179.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.556 ' CB ' ' HA ' ' A' ' 130' ' ' SER . . . -150.12 149.49 30.33 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.073 -1.017 . . . . 0.0 111.52 -178.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.729 ' OG1' ' N ' ' A' ' 129' ' ' GLU . 0.6 OUTLIER -89.47 112.08 23.14 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 122.209 1.004 . . . . 0.0 109.897 178.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 110' ' ' THR 0.294 . . -32.77 -53.42 0.34 Allowed 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.976 179.161 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.897 ' HB2' ' O ' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -43.7 -26.31 0.23 Allowed 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.448 -178.72 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.655 ' N ' ' O ' ' A' ' 110' ' ' THR . . . -36.53 156.58 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.769 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.288 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.485 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 45.8 Cg_endo -72.12 101.94 1.29 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.893 1.47 . . . . 0.0 110.599 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.552 ' CD2' ' HB3' ' A' ' 113' ' ' ALA . 0.6 OUTLIER -178.81 58.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.309 -0.869 . . . . 0.0 110.199 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.436 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 0.6 OUTLIER -127.35 -34.1 2.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.292 -0.88 . . . . 0.0 110.318 -179.916 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.543 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . 179.97 114.5 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.407 -0.808 . . . . 0.0 110.172 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.543 ' C ' ' O ' ' A' ' 117' ' ' ALA . 50.3 t0 -30.6 94.07 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.53 -0.731 . . . . 0.0 110.787 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' A' ' 117' ' ' ALA . 1.2 t60 -170.84 165.81 7.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.25 -0.906 . . . . 0.0 110.185 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -107.38 49.72 0.79 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.133 -0.979 . . . . 0.0 110.195 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -95.98 61.19 2.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.363 -0.836 . . . . 0.0 110.26 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -146.91 107.16 4.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.205 -0.934 . . . . 0.0 110.222 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 126' ' ' SER . 0.2 OUTLIER -110.29 174.58 5.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.249 -0.907 . . . . 0.0 110.266 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.6 pp -52.35 163.7 0.38 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 0.0 110.197 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 77.65 8.74 87.17 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.48 ' O ' ' O ' ' A' ' 127' ' ' ASN . 0.4 OUTLIER -130.68 61.01 1.62 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.327 -1.102 . . . . 0.0 110.175 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.897 ' O ' ' HB2' ' A' ' 112' ' ' LEU . 5.0 p-10 -39.61 161.05 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.378 -0.826 . . . . 0.0 110.279 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.767 ' HB3' ' HB2' ' A' ' 112' ' ' LEU . 2.4 p 178.42 124.63 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.729 ' N ' ' OG1' ' A' ' 110' ' ' THR . 2.6 tt0 -152.22 160.71 43.32 Favored 'General case' 0 C--N 1.308 -1.229 0 O-C-N 120.323 -1.485 . . . . 0.0 111.213 -178.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.556 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 2.5 t -134.25 126.39 29.72 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.876 -0.515 . . . . 0.0 109.76 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . 0.479 ' CB ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -133.14 155.16 49.8 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 120.929 -1.107 . . . . 0.0 109.855 -179.873 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.512 ' HA2' ' HA2' ' A' ' 107' ' ' GLY . . . -141.58 133.67 5.87 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.58 ' CZ3' HG23 ' A' ' 108' ' ' VAL . 3.8 m0 -104.9 113.53 27.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -1.166 . . . . 0.0 109.689 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.534 ' O ' ' CG2' ' A' ' 135' ' ' ILE . 0.3 OUTLIER -118.48 148.19 42.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.133 -0.979 . . . . 0.0 110.428 -179.843 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.534 ' CG1' ' O ' ' A' ' 104' ' ' ALA . 3.7 pt -158.1 23.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.316 -0.865 . . . . 0.0 110.11 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.558 ' CA ' ' HB3' ' A' ' 103' ' ' HIS . . . -121.24 -50.84 0.25 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.91 8.12 43.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.171 -1.194 . . . . 0.0 110.119 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.543 ' O ' ' NE2' ' A' ' 157' ' ' GLN . . . 54.64 28.69 46.63 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.0 mtpt -58.54 -171.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -1.096 . . . . 0.0 110.176 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 12.8 tp -174.25 109.29 0.14 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.248 -0.908 . . . . 0.0 110.11 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -102.5 -10.62 19.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.218 -0.926 . . . . 0.0 110.262 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.408 ' CE1' ' HE1' ' A' ' 131' ' ' TRP . 84.1 m-70 -105.59 52.06 0.74 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.17 -0.956 . . . . 0.0 110.188 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.471 ' CG ' ' N ' ' A' ' 144' ' ' SER . 5.9 pt20 -51.71 -40.34 59.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.279 -0.888 . . . . 0.0 110.172 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.471 ' N ' ' CG ' ' A' ' 143' ' ' GLN . 0.5 OUTLIER -43.49 -58.46 2.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.272 -0.892 . . . . 0.0 110.122 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.65 29.98 6.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.181 -0.949 . . . . 0.0 110.157 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -132.55 109.23 0.83 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.453 ' O ' ' HG2' ' A' ' 148' ' ' GLU . 3.9 mt -122.49 -111.79 0.32 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.215 -1.168 . . . . 0.0 110.036 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 147' ' ' LEU . 4.9 mt-10 -157.75 131.39 7.89 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.398 -0.814 . . . . 0.0 110.104 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.463 ' O ' ' O ' ' A' ' 153' ' ' PRO . . . -136.51 75.37 51.36 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.892 . . . . 0.0 110.259 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -74.0 -0.52 9.62 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.068 1.562 . . . . 0.0 110.384 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -62.48 -99.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.302 -0.873 . . . . 0.0 110.191 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.52 ' N ' ' HD2' ' A' ' 153' ' ' PRO . 0.1 OUTLIER -76.99 -54.63 1.54 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.115 -0.99 . . . . 0.0 110.188 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 152' ' ' TYR . 45.8 Cg_endo -74.79 142.86 29.11 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.865 1.455 . . . . 0.0 110.24 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.531 ' O ' ' O ' ' A' ' 155' ' ' GLY . . . -100.36 115.41 29.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 110.243 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.531 ' O ' ' O ' ' A' ' 154' ' ' ALA . . . 42.16 98.06 0.01 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.33 -2.43 11.67 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.014 1.533 . . . . 0.0 110.556 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.543 ' NE2' ' O ' ' A' ' 138' ' ' GLY . 4.3 mt-30 -56.64 -13.35 2.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 0.0 110.544 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 93.55 -32.63 5.64 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.481 ' CD ' ' CA ' ' A' ' 138' ' ' GLY . 6.8 pt-20 -88.89 5.27 44.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.185 -1.185 . . . . 0.0 110.114 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.522 ' HB3' ' O ' ' A' ' 154' ' ' ALA . 3.3 tp-100 -91.45 -4.32 55.71 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.381 -0.824 . . . . 0.0 109.787 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.68 ' O ' ' C ' ' A' ' 162' ' ' VAL . 0.1 OUTLIER -128.04 56.43 1.6 Allowed 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.444 -0.785 . . . . 0.0 110.185 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.68 ' C ' ' O ' ' A' ' 161' ' ' LEU . 8.3 p 0.69 91.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.69 0.757 . . . . 0.0 111.232 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.608 ' CG1' ' HD2' ' A' ' 164' ' ' PRO . 42.4 t -44.31 151.52 0.56 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.331 -0.856 . . . . 0.0 109.466 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.608 ' HD2' ' CG1' ' A' ' 163' ' ' VAL . 40.0 Cg_endo -67.01 125.43 13.61 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.656 1.345 . . . . 0.0 110.495 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 94' ' ' SER . 1.4 tt0 -41.05 -24.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.423 -0.798 . . . . 0.0 110.642 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' ' 164' ' ' PRO . 9.7 ttt85 -111.27 137.58 48.82 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.173 -0.954 . . . . 0.0 109.783 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.537 HD21 ' CG1' ' A' ' 163' ' ' VAL . 3.0 mp -138.47 146.31 41.9 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.463 -0.773 . . . . 0.0 110.411 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.93 124.51 49.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.495 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.703 ' CG1' ' CZ2' ' A' ' 91' ' ' TRP . 2.5 t -114.92 139.76 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.073 -1.017 . . . . 0.0 110.683 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.425 ' O ' ' CG1' ' A' ' 170' ' ' VAL . 9.3 p -118.32 124.93 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.578 -0.701 . . . . 0.0 110.062 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.561 ' CD1' ' HB3' ' A' ' 178' ' ' LEU . 9.3 tp -133.37 111.29 10.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.135 -0.978 . . . . 0.0 110.154 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.524 ' OD2' ' CB ' ' A' ' 88' ' ' LEU . 6.5 t70 -116.27 138.31 51.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.296 -0.877 . . . . 0.0 110.14 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.533 ' N ' ' O ' ' A' ' 87' ' ' GLY . 0.0 OUTLIER -94.64 -44.38 7.85 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.71 -0.619 . . . . 0.0 110.041 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.491 ' C ' ' O ' ' A' ' 173' ' ' MET . 2.7 mt-10 -40.19 -28.52 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.115 -0.99 . . . . 0.0 108.791 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.641 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.4 OUTLIER -111.56 -25.15 9.71 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.901 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.597 ' O ' ' CG2' ' A' ' 198' ' ' THR . . . 77.18 24.94 64.97 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.641 ' OG1' ' HB3' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -113.14 134.91 54.33 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.293 -1.122 . . . . 0.0 111.12 -179.429 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.561 ' HB3' ' CD1' ' A' ' 171' ' ' LEU . 0.6 OUTLIER -142.54 154.13 44.19 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.655 -0.653 . . . . 0.0 109.815 179.265 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.495 ' O ' HG12 ' A' ' 169' ' ' VAL . . . -162.11 162.17 34.0 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.654 ' CE1' ' CG2' ' A' ' 169' ' ' VAL . 1.1 t80 -118.68 121.77 40.92 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.459 -1.024 . . . . 0.0 109.657 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.438 ' CB ' HD22 ' A' ' 187' ' ' LEU . 0.3 OUTLIER -144.26 139.7 28.79 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.267 -0.895 . . . . 0.0 110.349 -179.67 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.545 HD13 ' CE2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -102.78 116.72 47.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.37 -0.831 . . . . 0.0 109.666 179.553 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 88.69 -9.13 77.33 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.526 ' HA2' ' CD2' ' A' ' 187' ' ' LEU . . . 86.21 43.61 6.21 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 70.2 m -114.35 -25.32 8.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.287 -1.125 . . . . 0.0 110.618 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.545 ' CE2' HD13 ' A' ' 182' ' ' ILE . 21.2 m-85 -107.97 69.1 0.72 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.172 -0.955 . . . . 0.0 110.42 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.578 ' HB2' ' CE1' ' A' ' 191' ' ' PHE . 0.9 OUTLIER -173.5 26.21 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.748 0.785 . . . . 0.0 109.497 179.719 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -94.64 -81.62 1.54 Allowed Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.033 -1.08 . . . . 0.0 110.7 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.15 -30.05 16.65 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.997 1.525 . . . . 0.0 111.307 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.567 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -74.06 13.78 0.5 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.312 -0.868 . . . . 0.0 111.234 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.578 ' CE1' ' HB2' ' A' ' 187' ' ' LEU . 1.2 m-30 -90.73 -26.79 19.35 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.018 -1.051 . . . . 0.0 110.416 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.62 -13.27 49.2 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.303 -0.873 . . . . 0.0 110.253 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 197' ' ' ARG . . . -108.17 -6.15 32.05 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.166 -1.974 . . . . 0.0 108.166 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.684 ' O ' ' N ' ' A' ' 198' ' ' THR . 7.6 tt -77.64 -41.44 38.38 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.584 ' CA ' HG22 ' A' ' 198' ' ' THR . 1.6 ttmt -43.79 -45.89 7.47 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.761 -0.587 . . . . 0.0 110.163 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -83.54 -24.51 50.19 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.695 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -91.12 -3.8 56.77 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.658 -0.907 . . . . 0.0 110.035 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.684 ' N ' ' O ' ' A' ' 194' ' ' LEU . 21.8 p -42.98 112.81 0.4 Allowed 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.641 0.734 . . . . 0.0 111.86 -177.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.695 ' HG ' ' O ' ' A' ' 197' ' ' ARG . 0.0 OUTLIER -140.44 171.0 14.76 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.713 -0.617 . . . . 0.0 109.647 178.738 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 11.0 m-85 -84.7 129.23 57.79 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.07 -1.019 . . . . 0.0 110.741 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.6 ' CA ' HG12 ' A' ' 108' ' ' VAL . 51.4 Cg_endo -88.62 146.4 5.9 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 124.179 1.62 . . . . 0.0 110.985 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 11.8 p -133.86 157.08 46.86 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.232 -0.918 . . . . 0.0 110.606 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.665 ' O ' ' N ' ' A' ' 80' ' ' GLY . 7.4 p -119.46 157.1 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.076 -1.015 . . . . 0.0 109.693 178.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' SER . . . . . 0.714 ' O ' HG22 ' A' ' 105' ' ' VAL . 0.9 OUTLIER -160.3 156.06 25.75 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 120.922 -1.112 . . . . 0.0 110.623 179.47 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.477 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -150.39 164.74 35.08 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.729 0.776 . . . . 0.0 111.02 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.602 ' CG1' ' N ' ' A' ' 207' ' ' TRP . 1.2 t -60.06 -179.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 121.344 0.592 . . . . 0.0 111.32 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.651 ' CD1' ' CB ' ' A' ' 76' ' ' ASP . 4.3 t90 -26.19 -55.91 0.07 Allowed 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.288 0.566 . . . . 0.0 110.919 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 209' ' ' GLN . . . 138.73 -1.74 2.64 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' ' 208' ' ' GLY . 1.6 tt0 -42.84 -29.92 0.36 Allowed 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.419 -1.048 . . . . 0.0 109.698 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . 0.506 ' C ' ' CG ' ' A' ' 211' ' ' GLN . 28.9 p -94.91 -131.79 0.16 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.433 -0.792 . . . . 0.0 109.855 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.506 ' CG ' ' C ' ' A' ' 210' ' ' CYS . 0.0 OUTLIER -178.59 112.67 0.06 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.933 . . . . 0.0 110.2 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.571 ' O ' ' CD1' ' A' ' 64' ' ' LEU . 33.9 m -89.63 139.55 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.277 -0.89 . . . . 0.0 109.765 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 0.6 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -88.9 135.6 33.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.124 -0.985 . . . . 0.0 109.213 179.676 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.48 HD12 ' O ' ' A' ' 47' ' ' GLY . 0.8 OUTLIER -144.51 112.43 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 120.99 -1.069 . . . . 0.0 111.559 -178.707 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.571 ' O ' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -118.02 108.42 15.22 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.061 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . 0.678 ' CD2' ' CB ' ' A' ' 91' ' ' TRP . 2.1 t80 -106.11 149.14 27.03 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.188 -0.945 . . . . 0.0 111.648 -177.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' MET . . . . . 0.422 ' N ' ' HD1' ' A' ' 216' ' ' TYR . 36.1 ttp -129.72 107.63 9.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.72 -0.613 . . . . 0.0 109.56 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . 0.466 ' O ' ' OG ' ' A' ' 85' ' ' SER . . . 108.7 63.73 0.55 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.556 ' HG2' ' N ' ' A' ' 220' ' ' ARG . 1.5 tm-20 -125.55 151.23 46.66 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.195 -1.18 . . . . 0.0 110.012 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . 0.556 ' N ' ' HG2' ' A' ' 219' ' ' GLU . 2.2 ptt85 -40.47 161.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.264 -0.898 . . . . 0.0 110.274 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . 0.498 ' O ' ' C ' ' A' ' 222' ' ' VAL . 8.1 ptm180 -129.73 85.72 2.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.92 . . . . 0.0 110.244 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.498 ' C ' ' O ' ' A' ' 221' ' ' ARG . 4.9 p -34.82 112.09 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.407 -0.808 . . . . 0.0 110.638 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.489 ' O ' ' C ' ' A' ' 224' ' ' GLU . 0.2 OUTLIER -79.28 43.47 0.54 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.264 -0.897 . . . . 0.0 110.47 -179.871 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.489 ' C ' ' O ' ' A' ' 223' ' ' GLU . 3.0 tt0 -35.2 -68.43 0.12 Allowed 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.372 -0.83 . . . . 0.0 110.674 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.431 ' C ' ' O ' ' A' ' 224' ' ' GLU . 2.8 t -42.28 155.4 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.273 -0.892 . . . . 0.0 110.262 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -117.16 -173.2 2.36 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.271 -0.893 . . . . 0.0 110.138 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.483 ' NH1' ' HG3' ' A' ' 227' ' ' ARG . 0.0 OUTLIER -145.36 11.92 1.33 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.228 -0.92 . . . . 0.0 110.181 -179.963 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.441 HD12 ' HG2' ' A' ' 227' ' ' ARG . 1.8 mp -113.56 127.48 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -0.888 . . . . 0.0 110.148 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.489 ' O ' ' HB3' ' A' ' 230' ' ' ARG . 15.2 t-80 -77.99 123.08 26.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.237 -0.915 . . . . 0.0 110.179 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . 0.677 ' O ' ' C ' ' A' ' 231' ' ' ASP . 0.4 OUTLIER 180.0 -176.8 0.35 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.254 -0.903 . . . . 0.0 110.181 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.677 ' C ' ' O ' ' A' ' 230' ' ' ARG . 1.9 m-20 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.955 -1.021 . . . . 0.0 111.404 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.74 21.16 5.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.246 -1.149 . . . . 0.0 110.174 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -148.2 -176.09 5.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 110.17 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -176.57 170.72 2.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.317 -0.864 . . . . 0.0 110.223 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -146.27 103.42 3.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.279 -0.888 . . . . 0.0 110.238 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -138.72 -63.8 0.53 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 110.173 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.452 ' HB3' ' HD3' ' A' ' 14' ' ' PRO . 0.8 OUTLIER -129.15 143.53 50.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.229 -0.919 . . . . 0.0 110.187 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.2 p -128.47 59.61 42.94 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.25 -0.906 . . . . 0.0 110.196 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.452 ' HD3' ' HB3' ' A' ' 12' ' ' SER . 46.6 Cg_endo -73.02 71.64 3.45 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.965 1.508 . . . . 0.0 110.485 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 16' ' ' SER . 14.6 t -136.56 177.99 7.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -0.914 . . . . 0.0 110.168 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 15' ' ' THR . 0.8 OUTLIER -41.89 164.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 110.287 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -116.71 72.63 0.83 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.2 -0.937 . . . . 0.0 110.325 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -172.91 164.3 5.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 110.193 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tp -63.62 -150.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.369 -0.832 . . . . 0.0 110.21 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.7 -169.88 1.55 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 110.186 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.434 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 39.7 t -106.34 172.26 6.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.279 -0.888 . . . . 0.0 110.148 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 21' ' ' SER . 0.1 OUTLIER 179.94 62.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.203 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.29 -43.41 33.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.184 -0.948 . . . . 0.0 110.205 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.481 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 1.1 p -77.54 139.09 63.02 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.427 -0.795 . . . . 0.0 110.162 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.472 ' CB ' ' HB3' ' A' ' 29' ' ' LEU . 46.0 Cg_endo -72.58 110.3 2.96 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.048 1.551 . . . . 0.0 110.53 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.535 ' C ' ' H ' ' A' ' 28' ' ' GLY . 48.1 Cg_endo -73.82 -165.84 0.28 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 124.011 1.532 . . . . 0.0 110.67 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -73.96 26.09 0.07 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.343 -0.848 . . . . 0.0 109.996 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.535 ' H ' ' C ' ' A' ' 26' ' ' PRO . . . -153.51 12.61 0.57 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.612 ' O ' ' N ' ' A' ' 32' ' ' LEU . 1.1 pt? -44.76 -22.81 0.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.157 -1.202 . . . . 0.0 110.2 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.56 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 59.9 mt-10 -46.66 -26.86 1.0 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.053 -1.03 . . . . 0.0 108.704 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -70.99 -22.21 62.2 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.612 ' N ' ' O ' ' A' ' 29' ' ' LEU . 14.7 tp -83.57 -34.86 25.09 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.611 HD21 ' CG ' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -70.41 -36.56 74.1 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.884 0.849 . . . . 0.0 109.057 179.122 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.584 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 2.9 t -70.48 -14.24 62.45 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.423 0.63 . . . . 0.0 109.945 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.799 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . . . -54.45 -160.73 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.511 -0.743 . . . . 0.0 109.967 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.799 ' HD2' ' CB ' ' A' ' 35' ' ' ALA . 38.2 Cg_endo -65.55 -166.55 0.1 OUTLIER 'Trans proline' 0 N--CA 1.489 1.22 0 O-C-N 123.188 1.099 . . . . 0.0 110.022 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.711 ' CD ' ' HB2' ' A' ' 36' ' ' PRO . 51.2 Cg_endo -96.67 54.42 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 121.394 1.396 . . . . 0.0 113.183 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.704 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 51.7 Cg_endo -76.46 151.06 32.75 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 122.93 0.963 . . . . 0.0 109.761 178.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.706 ' OD1' ' N ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -13.89 -54.41 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.53 -0.731 . . . . 0.0 112.072 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.919 ' O ' ' HB3' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -51.86 -46.56 64.49 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.933 -1.104 . . . . 0.0 110.959 -179.502 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.658 ' CG1' ' CE1' ' A' ' 45' ' ' HIS . 11.9 t -86.11 -19.14 8.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 O-C-N 121.52 -0.738 . . . . 0.0 111.639 -177.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 46' ' ' HIS . . . -88.95 -41.49 12.36 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.667 -1.271 . . . . 0.0 111.197 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.684 ' HB2' ' HA ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -87.65 -19.43 27.72 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 118.848 -1.141 . . . . 0.0 109.426 179.832 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.919 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -77.73 -38.02 48.07 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.113 0.959 . . . . 0.0 108.865 179.276 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.658 ' CE1' ' CG1' ' A' ' 41' ' ' VAL . 6.5 m170 -80.81 -18.2 48.32 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.429 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 42' ' ' ALA . 1.0 OUTLIER -97.42 -34.18 11.13 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.194 -0.941 . . . . 0.0 109.465 178.625 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.617 ' O ' ' CD1' ' A' ' 214' ' ' ILE . . . -68.18 -114.94 0.02 OUTLIER Glycine 0 N--CA 1.489 2.198 0 N-CA-C 107.299 -2.32 . . . . 0.0 107.299 178.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 1.066 ' CZ2' ' HA ' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -85.63 87.86 7.46 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 176.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.552 ' ND2' ' N ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -42.72 153.17 0.33 Allowed Pre-proline 0 N--CA 1.492 1.652 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -177.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.68 ' C ' ' H ' ' A' ' 52' ' ' ASP . 43.7 Cg_endo -70.38 -31.05 18.47 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 O-C-N 124.773 1.933 . . . . 0.0 110.952 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.849 ' N ' ' HE3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -62.37 0.13 0.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.36 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.68 ' H ' ' C ' ' A' ' 50' ' ' PRO . 12.9 m-20 -141.87 2.92 1.59 Allowed 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.112 178.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.811 ' HA ' ' N ' ' A' ' 79' ' ' ARG . 1.6 t -150.69 147.74 27.72 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.377 -0.827 . . . . 0.0 111.545 -179.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.934 ' H ' ' HA ' ' A' ' 78' ' ' VAL . 0.7 OUTLIER -86.92 121.78 29.86 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 120.903 -1.123 . . . . 0.0 109.824 178.648 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.765 ' O ' ' N ' ' A' ' 57' ' ' ILE . 1.1 pt-20 -44.77 -35.27 2.63 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.489 -0.757 . . . . 0.0 112.976 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.752 ' H ' ' ND2' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -32.48 -20.52 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.54 0 O-C-N 121.29 -0.882 . . . . 0.0 111.379 -179.217 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.765 ' N ' ' O ' ' A' ' 55' ' ' GLU . 1.6 mt -111.18 167.18 5.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.307 -0.87 . . . . 0.0 110.131 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.507 ' N ' ' CG2' ' A' ' 57' ' ' ILE . 36.0 t70 -108.54 128.55 54.91 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.376 -0.828 . . . . 0.0 110.357 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 1.003 ' HB ' ' CE2' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -131.28 132.03 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.577 -0.702 . . . . 0.0 111.099 -179.075 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.684 ' HA ' ' HB2' ' A' ' 43' ' ' GLN . 24.6 tttt -136.58 130.7 32.74 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.804 -1.185 . . . . 0.0 110.101 178.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.591 ' H ' ' HB3' ' A' ' 43' ' ' GLN . 1.6 pt-20 -52.58 -117.25 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.442 -0.786 . . . . 0.0 111.079 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 45.69 41.39 9.72 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 107.998 -2.041 . . . . 0.0 107.998 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.698 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 98.81 74.09 1.13 Allowed Glycine 0 N--CA 1.487 2.07 0 N-CA-C 108.293 -1.923 . . . . 0.0 108.293 -178.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.698 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER 0.84 75.38 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.758 -0.848 . . . . 0.0 110.887 -178.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.546 ' N ' ' O ' ' A' ' 63' ' ' GLY . 53.7 t -101.61 114.64 28.86 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.312 -0.868 . . . . 0.0 110.491 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 1.066 ' HA ' ' CZ2' ' A' ' 48' ' ' TRP . 1.6 m-85 -82.68 138.03 34.26 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.395 -0.816 . . . . 0.0 110.268 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.494 ' O ' ' O ' ' A' ' 58' ' ' ASP . 1.8 tt0 -138.2 121.77 17.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.16 -0.962 . . . . 0.0 109.913 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.484 ' HG3' ' HB2' ' A' ' 207' ' ' TRP . 0.6 OUTLIER -131.17 145.74 52.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.181 -0.95 . . . . 0.0 110.343 -179.87 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.64 ' HB3' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -125.1 -67.52 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.361 -0.837 . . . . 0.0 110.317 179.789 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.64 ' CD ' ' HB3' ' A' ' 69' ' ' ARG . 55.9 Cg_endo -69.7 -141.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.385 1.203 . . . . 0.0 109.133 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 t -139.74 164.0 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.053 -1.029 . . . . 0.0 110.045 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.6 119.35 6.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.129 -0.982 . . . . 0.0 110.136 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -84.99 -93.62 0.08 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.178 -0.951 . . . . 0.0 110.267 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.9 p -104.19 23.38 13.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.145 -0.972 . . . . 0.0 110.133 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.553 HG21 ' CB ' ' A' ' 54' ' ' SER . 3.4 t -141.5 -134.84 0.1 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.307 -0.871 . . . . 0.0 110.088 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.733 ' O ' ' C ' ' A' ' 77' ' ' GLY . 4.9 m-20 -140.55 153.62 46.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 110.868 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.733 ' C ' ' O ' ' A' ' 76' ' ' ASP . . . -26.48 -62.28 0.08 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 106.067 -2.813 . . . . 0.0 106.067 179.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.934 ' HA ' ' H ' ' A' ' 54' ' ' SER . 29.0 m -148.92 118.75 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 122.108 -0.643 . . . . 0.0 109.327 176.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.811 ' N ' ' HA ' ' A' ' 53' ' ' CYS . 0.0 OUTLIER -146.6 137.01 23.81 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.687 -0.633 . . . . 0.0 110.681 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.814 ' HA3' ' C ' ' A' ' 51' ' ' LYS . . . -163.38 156.03 27.65 Favored Glycine 0 N--CA 1.481 1.636 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 178.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 201' ' ' PRO . 0.2 OUTLIER -143.66 128.55 18.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.345 -1.091 . . . . 0.0 110.152 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.793 ' HD3' ' H ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -150.35 -95.64 0.07 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.194 -0.941 . . . . 0.0 110.226 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.793 ' H ' ' HD3' ' A' ' 82' ' ' ARG . . . 47.84 63.98 3.22 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -119.16 95.49 4.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.134 -1.216 . . . . 0.0 110.255 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.574 ' HB3' ' CD2' ' A' ' 89' ' ' HIS . 1.0 OUTLIER -140.3 169.37 17.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.249 -0.907 . . . . 0.0 110.098 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.561 ' O ' ' NE2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -117.37 133.48 55.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 110.128 179.792 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 103.76 -117.19 5.63 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.516 ' C ' ' CD2' ' A' ' 89' ' ' HIS . 7.6 tt -128.64 127.0 41.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.398 -1.06 . . . . 0.0 110.39 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.574 ' CD2' ' HB3' ' A' ' 85' ' ' SER . 8.5 m-70 -147.05 161.43 40.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.165 -0.959 . . . . 0.0 110.215 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 169' ' ' VAL . . . -163.52 157.87 20.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.22 -0.925 . . . . 0.0 109.857 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.643 ' CZ2' ' CG1' ' A' ' 169' ' ' VAL . 3.0 p90 -134.79 160.25 38.8 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.065 -1.022 . . . . 0.0 110.403 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.643 ' N ' ' O ' ' A' ' 215' ' ' ARG . 31.3 mt-10 -119.11 121.17 39.18 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.339 0.59 . . . . 0.0 110.648 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.499 HG12 ' HA ' ' A' ' 214' ' ' ILE . 5.3 mt -135.01 149.33 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.215 -0.928 . . . . 0.0 110.168 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.584 ' OG ' ' NH2' ' A' ' 213' ' ' ARG . 0.0 OUTLIER -121.17 135.84 55.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 109.654 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.885 ' HH2' ' O ' ' A' ' 204' ' ' SER . 6.1 t-105 -115.72 87.88 19.01 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.246 -0.909 . . . . 0.0 110.303 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.562 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 51.0 Cg_endo -97.47 114.06 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.156 1.904 . . . . 0.0 110.967 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.462 HD23 ' HB2' ' A' ' 210' ' ' CYS . 0.1 OUTLIER -95.6 -67.65 0.84 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.895 -1.128 . . . . 0.0 109.523 179.126 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.45 -45.23 6.2 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.448 -0.783 . . . . 0.0 109.441 179.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.485 ' HG3' ' HG2' ' A' ' 100' ' ' ARG . 8.2 tp-100 -139.45 -75.36 0.36 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.537 0.684 . . . . 0.0 109.409 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.504 ' HB2' HG11 ' A' ' 162' ' ' VAL . 5.7 mmt-85 -87.64 -39.06 15.35 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.596 -0.69 . . . . 0.0 109.144 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.59 ' HA3' ' O ' ' A' ' 95' ' ' TRP . . . 70.11 115.99 0.04 OUTLIER Glycine 0 N--CA 1.487 2.094 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 179.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.597 ' HA ' ' CD ' ' A' ' 164' ' ' PRO . 99.1 m -73.67 -80.49 0.07 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.337 -1.096 . . . . 0.0 109.375 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.613 ' CD2' HG22 ' A' ' 106' ' ' VAL . 0.1 OUTLIER 179.07 79.79 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.349 -0.845 . . . . 0.0 110.393 179.588 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.646 ' CB ' ' CZ2' ' A' ' 95' ' ' TRP . . . -36.85 -83.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.946 -1.096 . . . . 0.0 108.488 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.834 HG13 ' O ' ' A' ' 204' ' ' SER . 0.5 OUTLIER -126.0 114.31 38.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 C-N-CA 117.774 -1.571 . . . . 0.0 109.981 178.737 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.639 HG21 ' CZ3' ' A' ' 95' ' ' TRP . 9.7 t -152.49 136.94 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.476 -0.765 . . . . 0.0 109.698 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.485 ' HA3' ' HA3' ' A' ' 132' ' ' GLY . . . 154.07 -146.12 14.04 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 118.895 -1.621 . . . . 0.0 110.559 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.605 HG23 ' CD1' ' A' ' 199' ' ' LEU . 2.7 p -149.76 156.93 6.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.689 -0.889 . . . . 0.0 109.597 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.557 ' CB ' ' HA ' ' A' ' 130' ' ' SER . . . -146.41 153.34 40.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.059 -1.025 . . . . 0.0 111.104 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.609 ' CG2' ' HB3' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -110.72 128.61 55.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.468 -0.77 . . . . 0.0 109.738 179.529 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.6 -26.22 17.97 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.31 -0.869 . . . . 0.0 109.726 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.422 ' C ' ' CD1' ' A' ' 112' ' ' LEU . 4.1 pp -84.88 -11.94 54.55 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.417 -0.802 . . . . 0.0 109.481 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -117.11 80.98 12.24 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.397 -0.814 . . . . 0.0 110.548 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.403 ' O ' ' CG ' ' A' ' 115' ' ' LEU . 46.2 Cg_endo -74.12 144.91 34.36 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.025 1.539 . . . . 0.0 110.203 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.451 ' HB3' ' OE2' ' A' ' 129' ' ' GLU . 0.2 OUTLIER 179.91 62.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.177 -0.952 . . . . 0.0 110.292 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.82 -72.22 0.6 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.193 -0.942 . . . . 0.0 110.279 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.517 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -56.65 109.31 0.6 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.25 -0.906 . . . . 0.0 110.282 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.517 ' C ' ' O ' ' A' ' 117' ' ' ALA . 5.9 t0 -33.48 150.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.557 -0.715 . . . . 0.0 110.746 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.508 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 0.1 OUTLIER 41.91 -164.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.315 -0.866 . . . . 0.0 110.237 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -93.45 -13.28 28.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.183 -0.948 . . . . 0.0 110.127 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 50.17 38.29 16.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 110.123 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 47.62 33.58 3.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 0.0 110.156 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -161.46 125.44 3.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.189 -0.944 . . . . 0.0 110.251 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.456 ' C ' ' CD1' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -92.13 105.96 18.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.244 -0.91 . . . . 0.0 110.225 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -96.17 -146.76 21.52 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.04 40.09 0.1 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.259 -1.142 . . . . 0.0 110.126 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -81.86 125.92 31.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.274 -0.891 . . . . 0.0 110.219 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.17 174.52 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.225 -0.922 . . . . 0.0 110.16 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.451 ' OE2' ' HB3' ' A' ' 115' ' ' LEU . 2.9 tp10 -130.45 117.28 19.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 110.147 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.557 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 1.0 OUTLIER -123.96 122.05 36.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -0.914 . . . . 0.0 110.257 -179.876 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 3.2 m0 -125.54 129.53 49.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.245 -0.91 . . . . 0.0 109.958 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.485 ' HA3' ' HA3' ' A' ' 107' ' ' GLY . . . 173.87 -114.8 0.53 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . 0.692 ' CH2' ' CG ' ' A' ' 180' ' ' TYR . 34.3 m0 -129.16 122.96 30.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -1.162 . . . . 0.0 110.303 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.461 ' O ' HG12 ' A' ' 135' ' ' ILE . 0.8 OUTLIER -118.03 107.93 14.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.286 -0.883 . . . . 0.0 110.13 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.591 ' CD1' ' CG2' ' A' ' 102' ' ' THR . 1.3 mt -145.53 11.4 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.296 -0.878 . . . . 0.0 109.949 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -124.23 -38.67 0.51 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.33 1.21 23.61 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.505 -0.997 . . . . 0.0 108.949 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -92.81 -13.12 57.14 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.93 -146.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.503 -0.998 . . . . 0.0 110.154 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.582 ' O ' ' CD2' ' A' ' 141' ' ' TYR . 0.3 OUTLIER -147.37 -97.04 0.09 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.21 -0.931 . . . . 0.0 110.337 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.582 ' CD2' ' O ' ' A' ' 140' ' ' LEU . 1.1 m-85 -167.04 -91.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.181 -0.949 . . . . 0.0 110.155 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -124.29 0.35 8.34 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.407 -0.808 . . . . 0.0 110.325 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.04 -43.86 20.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 110.134 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.96 146.66 41.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.215 -0.928 . . . . 0.0 110.167 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.53 123.11 22.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 110.134 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -173.67 109.26 0.29 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.446 HD23 HD22 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -142.76 67.51 1.31 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -1.166 . . . . 0.0 110.124 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.512 ' CG ' ' HD2' ' A' ' 156' ' ' PRO . 59.2 tt0 -47.98 141.42 5.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.159 -0.963 . . . . 0.0 110.235 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.546 ' CB ' ' CD ' ' A' ' 150' ' ' PRO . . . -179.95 -58.66 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.255 -0.903 . . . . 0.0 110.303 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.546 ' CD ' ' CB ' ' A' ' 149' ' ' ALA . 47.0 Cg_endo -73.51 -8.28 21.46 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.007 1.53 . . . . 0.0 110.597 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.434 ' O ' ' CD2' ' A' ' 152' ' ' TYR . 2.6 mp0 -54.19 -66.94 0.31 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.175 -0.953 . . . . 0.0 110.158 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.56 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 0.2 OUTLIER -179.87 -59.38 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.267 -0.895 . . . . 0.0 110.16 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.56 ' CD ' ' CB ' ' A' ' 152' ' ' TYR . 45.4 Cg_endo -72.95 160.85 45.04 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.025 1.539 . . . . 0.0 110.36 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 155' ' ' GLY . . . -48.39 116.02 1.43 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.918 . . . . 0.0 110.128 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 154' ' ' ALA . . . -42.68 116.24 1.15 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.512 ' HD2' ' CG ' ' A' ' 148' ' ' GLU . 45.1 Cg_endo -73.33 -59.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.986 1.519 . . . . 0.0 110.326 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.474 ' O ' ' HG2' ' A' ' 160' ' ' GLN . 0.0 OUTLIER -69.82 -0.59 7.43 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.176 -0.952 . . . . 0.0 110.475 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.47 ' O ' ' HB ' ' A' ' 162' ' ' VAL . . . -53.35 -17.96 6.48 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -76.73 3.88 10.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.097 -1.237 . . . . 0.0 110.411 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 157' ' ' GLN . 36.2 mm-40 -70.95 -17.85 62.65 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.949 0.88 . . . . 0.0 109.198 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.468 ' O ' HG22 ' A' ' 162' ' ' VAL . 1.3 pp -167.87 25.63 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.661 0.743 . . . . 0.0 109.211 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.585 HG22 ' HA2' ' A' ' 101' ' ' GLY . 2.2 t -161.22 90.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.805 -0.56 . . . . 0.0 109.714 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.847 ' HB ' ' HD3' ' A' ' 164' ' ' PRO . 2.4 t -111.26 -69.37 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.086 -1.009 . . . . 0.0 111.205 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.847 ' HD3' ' HB ' ' A' ' 163' ' ' VAL . 52.9 Cg_endo -95.84 179.21 0.59 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.104 1.055 . . . . 0.0 111.203 -178.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.482 ' CG ' ' HD3' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -108.8 -37.38 5.89 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.753 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.529 ' O ' ' CD1' ' A' ' 167' ' ' LEU . 0.3 OUTLIER -142.71 142.19 31.94 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.106 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.628 ' N ' ' CD2' ' A' ' 167' ' ' LEU . 0.3 OUTLIER -126.79 154.75 43.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.003 -1.06 . . . . 0.0 110.971 -179.24 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.7 tt -123.64 135.08 53.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.496 -0.753 . . . . 0.0 109.653 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.643 ' CG1' ' CZ2' ' A' ' 91' ' ' TRP . 42.3 t -106.41 141.71 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.122 -0.986 . . . . 0.0 110.73 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.444 ' N ' HG11 ' A' ' 169' ' ' VAL . 53.4 t -122.25 114.81 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.357 -0.839 . . . . 0.0 109.742 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.525 ' CD1' ' HB3' ' A' ' 178' ' ' LEU . 0.4 OUTLIER -128.09 124.08 36.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.18 -0.95 . . . . 0.0 110.423 -179.649 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.447 ' N ' HD12 ' A' ' 171' ' ' LEU . 5.5 t70 -116.32 138.36 51.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.312 -0.868 . . . . 0.0 109.914 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.502 ' O ' ' N ' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -93.34 -41.09 10.03 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.05 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.488 ' C ' ' O ' ' A' ' 173' ' ' MET . 0.6 OUTLIER -41.0 -27.84 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.195 -0.94 . . . . 0.0 108.987 179.399 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.557 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 1.8 tp10 -113.45 -27.63 7.84 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.518 ' O ' ' CG2' ' A' ' 198' ' ' THR . . . 83.62 23.74 52.45 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.603 ' CG2' ' CD2' ' A' ' 194' ' ' LEU . 0.7 OUTLIER -116.59 135.52 53.74 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.344 -1.092 . . . . 0.0 111.029 -179.515 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.574 ' N ' ' CD2' ' A' ' 178' ' ' LEU . 0.2 OUTLIER -136.29 150.65 49.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.45 -0.781 . . . . 0.0 109.594 179.361 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -148.15 -175.17 20.58 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.691 -1.242 . . . . 0.0 110.08 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.692 ' CG ' ' CH2' ' A' ' 133' ' ' TRP . 0.2 OUTLIER -138.98 127.2 22.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.4 -1.059 . . . . 0.0 110.082 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 21.2 t -117.99 124.44 48.19 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.174 -0.954 . . . . 0.0 109.881 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.647 ' CD1' ' CZ2' ' A' ' 133' ' ' TRP . 0.1 OUTLIER -116.15 116.48 52.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.506 -0.746 . . . . 0.0 109.777 179.814 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.511 ' C ' ' O ' ' A' ' 182' ' ' ILE . . . 38.51 28.94 0.06 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 182' ' ' ILE . . . 62.32 43.2 99.41 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' THR . . . . . 0.548 ' CB ' HG12 ' A' ' 182' ' ' ILE . 25.2 m -72.24 -78.86 0.08 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.201 -1.176 . . . . 0.0 110.468 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.702 ' CG ' ' O ' ' A' ' 186' ' ' TYR . 8.6 p90 -175.11 104.47 0.09 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.855 -1.153 . . . . 0.0 111.051 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.475 HD21 ' O ' ' A' ' 180' ' ' TYR . 4.8 tp 179.6 23.2 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.366 -0.834 . . . . 0.0 110.778 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.835 ' N ' ' CD ' ' A' ' 189' ' ' PRO . . . -109.65 -5.77 29.31 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.752 -1.213 . . . . 0.0 112.088 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.835 ' CD ' ' N ' ' A' ' 188' ' ' GLY . 50.5 Cg_endo -75.59 -33.03 4.31 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 O-C-N 122.718 0.851 . . . . 0.0 110.97 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.573 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -83.04 41.36 0.75 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.221 -0.924 . . . . 0.0 110.976 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -90.53 -46.22 8.45 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.204 -0.935 . . . . 0.0 110.455 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.548 ' HA ' ' NE ' ' A' ' 192' ' ' ARG . 0.5 OUTLIER -68.11 -14.91 63.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.16 -0.963 . . . . 0.0 110.001 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 197' ' ' ARG . . . -103.47 -10.92 34.69 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.703 ' O ' ' N ' ' A' ' 198' ' ' THR . 9.2 tt -70.35 -43.36 70.35 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.851 -0.793 . . . . 0.0 109.142 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.568 ' CA ' HG22 ' A' ' 198' ' ' THR . 0.1 OUTLIER -43.91 -41.16 5.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.485 -0.759 . . . . 0.0 110.005 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.551 ' N ' ' HE3' ' A' ' 195' ' ' LYS . . . -88.09 -24.87 33.24 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.706 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -91.07 -2.84 57.56 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.838 -0.801 . . . . 0.0 109.737 179.659 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.703 ' N ' ' O ' ' A' ' 194' ' ' LEU . 13.4 p -41.42 125.94 2.72 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.829 0.823 . . . . 0.0 111.212 -177.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.706 ' HG ' ' O ' ' A' ' 197' ' ' ARG . 0.0 OUTLIER -138.11 172.77 12.43 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -179.571 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.518 ' C ' ' CG2' ' A' ' 108' ' ' VAL . 4.2 m-30 -83.76 129.84 57.85 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 120.958 -1.089 . . . . 0.0 109.659 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.571 ' HA ' ' HB ' ' A' ' 108' ' ' VAL . 46.6 Cg_endo -72.49 129.17 14.39 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 124.047 1.551 . . . . 0.0 111.851 -178.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.41 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 1.8 p -133.62 160.27 38.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.486 -0.759 . . . . 0.0 110.101 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 79' ' ' ARG . 14.9 p -137.1 156.51 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.256 -0.903 . . . . 0.0 110.556 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' SER . . . . . 0.885 ' O ' ' HH2' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -160.11 127.93 4.66 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.442 -0.787 . . . . 0.0 109.217 179.052 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.476 ' CB ' ' CG2' ' A' ' 78' ' ' VAL . . . -127.93 159.95 33.37 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.5 -0.75 . . . . 0.0 110.738 -178.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.568 ' CG1' ' N ' ' A' ' 207' ' ' TRP . 1.0 OUTLIER -60.45 175.61 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 CA-C-O 121.334 0.588 . . . . 0.0 110.655 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.568 ' N ' ' CG1' ' A' ' 206' ' ' VAL . 39.7 p90 -120.84 57.71 0.97 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.439 -0.788 . . . . 0.0 110.207 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -134.53 -144.37 5.03 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.411 ' O ' ' C ' ' A' ' 210' ' ' CYS . 2.2 tp60 -67.2 -31.67 72.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.353 -1.086 . . . . 0.0 110.481 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . 0.463 ' SG ' HG12 ' A' ' 206' ' ' VAL . 17.2 p -43.58 153.35 0.12 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.289 -0.882 . . . . 0.0 109.917 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.676 ' HA ' ' CD1' ' A' ' 66' ' ' PHE . 8.2 pt20 -156.56 123.67 5.28 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.103 -0.998 . . . . 0.0 110.628 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.431 ' HA ' ' CD ' ' A' ' 96' ' ' PRO . 1.5 m -101.61 140.32 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.336 -0.852 . . . . 0.0 110.114 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 0.584 ' NH2' ' OG ' ' A' ' 94' ' ' SER . 0.5 OUTLIER -89.43 127.1 35.8 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.237 -0.914 . . . . 0.0 108.999 179.399 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.645 HG12 ' O ' ' A' ' 214' ' ' ILE . 0.1 OUTLIER -103.59 113.5 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-O 121.939 0.876 . . . . 0.0 111.248 -178.621 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.643 ' O ' ' N ' ' A' ' 92' ' ' GLU . 4.0 ttt180 -130.61 126.89 37.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.407 -0.808 . . . . 0.0 108.863 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . 0.59 ' CD2' ' HB3' ' A' ' 91' ' ' TRP . 4.0 t80 -119.27 150.39 40.19 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.921 -1.112 . . . . 0.0 111.017 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' MET . . . . . 0.457 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 6.2 ttp -126.98 107.87 10.45 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.298 -0.876 . . . . 0.0 109.677 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 89.24 59.18 1.58 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.499 ' HG2' ' N ' ' A' ' 220' ' ' ARG . 31.0 tt0 -95.41 157.9 15.69 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.244 -1.15 . . . . 0.0 110.179 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . 0.499 ' N ' ' HG2' ' A' ' 219' ' ' GLU . 34.7 ttp85 -41.65 -26.13 0.07 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.208 -0.933 . . . . 0.0 110.621 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . 0.496 ' O ' ' O ' ' A' ' 222' ' ' VAL . 3.8 mtp180 -142.26 85.6 1.92 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.172 -0.955 . . . . 0.0 110.631 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.496 ' O ' ' O ' ' A' ' 221' ' ' ARG . 5.7 p -40.14 164.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.423 -0.798 . . . . 0.0 110.561 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 224' ' ' GLU . 10.7 tt0 -165.71 46.56 0.08 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.313 -0.867 . . . . 0.0 110.344 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 223' ' ' GLU . 0.1 OUTLIER 179.08 -77.68 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.182 -0.949 . . . . 0.0 110.208 179.453 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.504 HG22 ' N ' ' A' ' 226' ' ' ARG . 53.4 m -48.57 171.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.325 -0.859 . . . . 0.0 110.274 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.504 ' N ' HG22 ' A' ' 225' ' ' THR . 1.0 OUTLIER -59.65 156.13 14.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.921 . . . . 0.0 110.307 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -125.53 75.73 1.5 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.908 . . . . 0.0 110.167 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.494 ' O ' ' CG2' ' A' ' 228' ' ' ILE . 7.3 tt -131.98 106.8 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.204 -0.935 . . . . 0.0 110.164 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -74.16 137.82 43.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -0.931 . . . . 0.0 110.213 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . 0.666 ' O ' ' C ' ' A' ' 231' ' ' ASP . 86.6 mtt-85 -45.12 154.41 0.16 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.238 -0.914 . . . . 0.0 110.182 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.666 ' C ' ' O ' ' A' ' 230' ' ' ARG . 52.6 p30 . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 117.93 -1.033 . . . . 0.0 111.458 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.803 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 121.107 0.479 . . . . 0.0 110.025 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.658 ' HA ' HD23 ' A' ' 33' ' ' LEU . 1.7 tt0 -45.02 -34.72 2.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.053 -1.029 . . . . 0.0 108.988 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.37 -24.05 64.78 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.385 -0.822 . . . . 0.0 108.787 178.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.577 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -83.42 -32.3 26.18 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.901 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.845 HD12 ' C ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -81.52 -38.19 26.65 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.891 0.853 . . . . 0.0 109.284 179.165 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.57 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 0.9 OUTLIER -46.8 -30.72 2.59 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.625 0.726 . . . . 0.0 109.88 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 1.046 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -72.58 -169.99 0.15 Allowed Pre-proline 0 C--N 1.298 -1.652 0 O-C-N 121.497 -0.752 . . . . 0.0 109.364 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 1.046 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 42.0 Cg_endo -69.48 106.18 1.57 Allowed 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.6 1.316 . . . . 0.0 109.765 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.651 ' HG3' HG21 ' A' ' 41' ' ' VAL . 50.5 Cg_endo -88.67 108.59 0.51 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.13 1.595 . . . . 0.0 111.166 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.77 ' O ' ' N ' ' A' ' 40' ' ' LEU . 49.4 Cg_endo -76.81 150.55 30.74 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.925 1.487 . . . . 0.0 109.998 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.723 ' O ' ' CG ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER 3.3 61.39 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 122.617 1.199 . . . . 0.0 110.455 -178.956 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.012 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -149.66 -45.47 0.13 Allowed 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 178.866 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.8 ' N ' HD13 ' A' ' 40' ' ' LEU . 2.2 t -86.38 -35.64 9.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 46' ' ' HIS . . . -89.21 -43.23 11.15 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.38 0.61 . . . . 0.0 110.089 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.579 ' HG3' ' CD ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -68.66 -25.17 64.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.461 -0.774 . . . . 0.0 110.416 -179.685 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.839 ' HA ' HG12 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -79.05 -50.84 10.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.146 -0.971 . . . . 0.0 108.999 179.475 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.78 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 1.6 m-70 -63.8 -16.16 60.53 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.443 ' HB2' ' O ' ' A' ' 42' ' ' ALA . 1.9 t-80 -96.36 -28.75 14.33 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.44 -119.21 0.05 OUTLIER Glycine 0 N--CA 1.477 1.403 0 N-CA-C 107.838 -2.105 . . . . 0.0 107.838 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 1.086 ' CZ2' HD22 ' A' ' 64' ' ' LEU . 0.8 OUTLIER -103.52 70.56 1.04 Allowed 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.011 -1.287 . . . . 0.0 110.478 179.143 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.687 ' CB ' ' HA ' ' A' ' 45' ' ' HIS . 21.4 t-20 -109.24 111.97 59.76 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 121.1 -1.0 . . . . 0.0 111.721 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.853 ' HG2' ' HB2' ' A' ' 53' ' ' CYS . 48.5 Cg_endo -80.57 -59.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.302 -1.902 0 O-C-N 123.78 1.411 . . . . 0.0 108.847 177.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.694 ' HG2' ' O ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER 179.81 -95.73 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.602 -0.686 . . . . 0.0 110.191 178.933 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.604 ' N ' ' HA2' ' A' ' 80' ' ' GLY 0.26 54.1 m-20 -68.97 33.97 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.178 0.989 . . . . 0.0 109.175 178.772 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.853 ' HB2' ' HG2' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -101.07 -176.92 3.3 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.843 -177.38 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.743 ' CA ' HG11 ' A' ' 78' ' ' VAL . 0.3 OUTLIER -50.6 101.73 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.689 -0.804 . . . . 0.0 111.662 -177.17 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.521 ' HG3' ' N ' ' A' ' 56' ' ' ASN . 9.4 pt-20 -102.07 -32.78 9.97 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.826 0.822 . . . . 0.0 109.522 177.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.584 ' HB3' HD21 ' A' ' 29' ' ' LEU . 12.3 m120 -70.01 -7.98 45.42 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.76 -0.587 . . . . 0.0 111.811 -178.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.98 HG22 HG22 ' A' ' 75' ' ' THR . 1.2 pt -112.69 166.17 6.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 120.844 -1.16 . . . . 0.0 109.988 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.832 ' CB ' HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -108.98 126.86 53.55 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.371 -0.831 . . . . 0.0 110.563 -179.13 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.839 HG12 ' HA ' ' A' ' 44' ' ' ARG . 9.6 p -130.42 130.76 65.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 O-C-N 121.46 -0.775 . . . . 0.0 109.275 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.579 ' CD ' ' HG3' ' A' ' 43' ' ' GLN . 19.7 tttm -135.61 153.25 51.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.069 -1.019 . . . . 0.0 110.689 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.484 ' HA ' ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -66.21 -121.8 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.401 -0.812 . . . . 0.0 110.269 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 44.51 26.54 1.06 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.699 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 124.38 61.01 0.18 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.086 HD22 ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER 0.61 88.76 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.796 -0.826 . . . . 0.0 110.758 -179.658 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 42.4 t -127.64 114.73 17.74 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.289 -0.882 . . . . 0.0 111.396 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.673 ' HA ' HG23 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -84.37 134.31 34.49 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.526 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.637 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 2.4 tt0 -126.66 131.03 51.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.74 -1.225 . . . . 0.0 110.847 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.559 ' HD3' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -136.06 156.07 49.27 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.414 -0.804 . . . . 0.0 109.539 179.602 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.671 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -85.37 -69.92 0.13 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.071 -1.018 . . . . 0.0 111.243 -179.105 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.9 ' HD2' HG21 ' A' ' 75' ' ' THR . 55.8 Cg_endo -72.16 -113.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.55 1.289 . . . . 0.0 110.324 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.48 ' O ' ' N ' ' A' ' 73' ' ' GLN . 4.7 t -140.38 164.83 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.454 -1.404 . . . . 0.0 110.369 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.571 ' HB2' ' NE1' ' A' ' 207' ' ' TRP . . . -41.62 -24.45 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.306 -0.872 . . . . 0.0 110.377 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.495 ' C ' ' O ' ' A' ' 72' ' ' ALA . 1.6 pt20 -36.11 -34.33 0.05 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.263 -0.898 . . . . 0.0 110.577 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 72' ' ' ALA . 69.0 p -149.54 -36.52 0.16 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 110.317 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.98 HG22 HG22 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -72.15 -55.1 7.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.189 -0.945 . . . . 0.0 110.134 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.549 ' OD2' ' HA ' ' A' ' 207' ' ' TRP . 4.7 t0 -99.24 155.36 17.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.225 -0.922 . . . . 0.0 109.741 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.63 74.12 1.26 Allowed Glycine 0 N--CA 1.487 2.068 0 N-CA-C 107.23 -2.348 . . . . 0.0 107.23 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.787 HG22 ' HA ' ' A' ' 53' ' ' CYS . 1.4 p -158.08 162.67 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 O-C-N 121.806 -0.82 . . . . 0.0 109.406 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.667 ' CG ' ' O ' ' A' ' 203' ' ' VAL . 0.0 OUTLIER -145.52 137.35 25.36 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.072 -1.051 . . . . 0.0 113.008 -178.419 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.604 ' HA2' ' N ' ' A' ' 52' ' ' ASP . . . -74.73 154.05 46.51 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 107.729 -2.148 . . . . 0.0 107.729 176.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.505 ' HG2' ' N ' ' A' ' 82' ' ' ARG . 1.3 ttmp? -126.18 -97.55 0.42 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.796 -1.414 . . . . 0.0 112.374 -178.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.888 ' HD3' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -43.33 -87.41 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.208 -0.933 . . . . 0.0 111.666 -178.102 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.888 ' N ' ' HD3' ' A' ' 82' ' ' ARG . . . 60.39 76.9 0.2 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.564 ' CE1' ' SD ' ' A' ' 173' ' ' MET . 10.1 t80 -94.42 132.08 39.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.356 -1.085 . . . . 0.0 110.842 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.468 ' O ' ' SD ' ' A' ' 173' ' ' MET . 7.3 t -140.01 161.34 37.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.39 -0.819 . . . . 0.0 109.911 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.464 ' HA ' ' HG2' ' A' ' 173' ' ' MET . 4.1 mtt180 -111.26 160.22 17.19 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.066 -1.022 . . . . 0.0 109.776 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.77 158.29 34.19 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.603 ' O ' HD23 ' A' ' 88' ' ' LEU . 2.5 tt -87.61 123.52 32.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.306 -1.114 . . . . 0.0 110.163 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.469 ' CE1' ' HG ' ' A' ' 171' ' ' LEU . 2.1 p80 -147.36 173.36 12.68 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 110.134 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -149.58 155.4 40.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.351 -0.843 . . . . 0.0 110.037 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.958 ' CZ3' HG11 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -134.72 170.67 15.48 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.116 -0.99 . . . . 0.0 110.352 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.663 ' N ' ' O ' ' A' ' 215' ' ' ARG . 1.0 OUTLIER -129.1 147.89 51.0 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.889 -0.725 . . . . 0.0 110.797 -179.471 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.552 ' CG2' ' OH ' ' A' ' 180' ' ' TYR . 0.6 OUTLIER -144.3 145.48 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.53 -0.731 . . . . 0.0 109.933 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.9 ' O ' HG23 ' A' ' 212' ' ' VAL . 0.0 OUTLIER -145.02 144.32 30.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.173 -0.955 . . . . 0.0 110.204 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.614 ' CH2' ' HA ' ' A' ' 205' ' ' ALA . 41.7 m95 -117.99 107.6 43.71 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.239 -0.913 . . . . 0.0 110.473 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.571 ' HG3' ' CZ ' ' A' ' 213' ' ' ARG . 49.8 Cg_endo -75.04 109.79 2.99 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.875 1.46 . . . . 0.0 109.899 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.114 -0.991 . . . . 0.0 110.225 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.996 HG23 ' HB2' ' A' ' 204' ' ' SER . 17.4 m . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 121.681 0.753 . . . . 0.0 110.612 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.586 HG22 HG23 ' A' ' 203' ' ' VAL . 89.8 t -150.63 170.09 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.623 -0.673 . . . . 0.0 109.341 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.638 ' CA ' ' HA3' ' A' ' 132' ' ' GLY . . . 165.6 167.3 25.99 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.34 -1.409 . . . . 0.0 110.479 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.75 HG12 ' HB2' ' A' ' 199' ' ' LEU . 1.7 t -112.55 141.73 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.551 -0.97 . . . . 0.0 109.507 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 130' ' ' SER . . . -114.53 142.61 46.19 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.081 -1.012 . . . . 0.0 110.655 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.802 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -118.77 131.99 56.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.277 -0.889 . . . . 0.0 110.357 179.718 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.97 -26.79 17.4 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.399 -0.813 . . . . 0.0 109.286 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.637 ' C ' HD12 ' A' ' 112' ' ' LEU . 4.1 pp -83.83 -12.17 55.97 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.558 -0.714 . . . . 0.0 109.448 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.572 ' CB ' ' CB ' ' A' ' 129' ' ' GLU . . . . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.587 -0.695 . . . . 0.0 110.441 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.251 0.548 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.572 ' CB ' ' CB ' ' A' ' 113' ' ' ALA . 3.9 tt0 -150.03 129.64 13.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.313 -0.867 . . . . 0.0 109.997 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 32.3 t -120.43 119.68 33.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.189 -0.944 . . . . 0.0 110.409 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.28 131.62 40.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.349 -0.845 . . . . 0.0 109.841 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.638 ' HA3' ' CA ' ' A' ' 107' ' ' GLY . . . -165.05 -144.67 4.13 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.696 ' CE3' ' CD2' ' A' ' 180' ' ' TYR . 31.5 m0 -116.67 114.45 24.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.343 -1.092 . . . . 0.0 110.556 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -118.13 143.42 46.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.527 -0.733 . . . . 0.0 110.033 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.609 HD12 ' N ' ' A' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.732 0 O-C-N 121.23 -0.919 . . . . 0.0 110.335 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.641 HG21 HD21 ' A' ' 167' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.69 71.8 3.21 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.976 1.514 . . . . 0.0 110.617 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 94' ' ' SER . 1.4 mt-10 -172.29 -81.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.355 -0.841 . . . . 0.0 110.118 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.534 ' HG2' ' N ' ' A' ' 167' ' ' LEU . 0.8 OUTLIER -151.55 154.92 37.42 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.322 -0.861 . . . . 0.0 109.739 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.782 HD22 HG22 ' A' ' 182' ' ' ILE . 0.0 OUTLIER -152.77 139.9 19.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.091 -1.005 . . . . 0.0 110.483 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' A' ' 181' ' ' SER . 17.0 tp -114.3 112.76 23.6 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.226 -0.921 . . . . 0.0 109.748 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.992 HG22 ' CE1' ' A' ' 180' ' ' TYR . 4.2 t -97.1 131.63 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.039 -1.038 . . . . 0.0 110.808 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.6 HG21 HD22 ' A' ' 187' ' ' LEU . 4.3 t -106.65 122.96 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.482 -0.761 . . . . 0.0 109.491 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.643 HD13 HD13 ' A' ' 178' ' ' LEU . 4.6 tp -133.21 115.28 14.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.069 -1.02 . . . . 0.0 110.554 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.539 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 32.1 t0 -120.3 135.15 55.1 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.296 -0.877 . . . . 0.0 110.199 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.587 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -94.58 -39.13 10.53 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.635 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 173' ' ' MET . 5.8 mm-40 -42.65 -27.7 0.19 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.219 -0.926 . . . . 0.0 108.828 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.593 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.1 OUTLIER -112.62 -27.07 8.34 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.235 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 82.57 24.23 54.21 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.955 HG22 ' CD2' ' A' ' 194' ' ' LEU . 0.2 OUTLIER -121.14 128.68 52.76 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.248 -1.148 . . . . 0.0 111.141 -179.458 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 1.061 ' O ' HD11 ' A' ' 194' ' ' LEU . 0.2 OUTLIER -139.99 153.69 46.93 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.459 -0.776 . . . . 0.0 109.588 179.338 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -153.1 174.04 31.89 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.992 ' CE1' HG22 ' A' ' 169' ' ' VAL . 0.7 OUTLIER -118.94 118.67 32.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.351 -1.087 . . . . 0.0 110.119 -179.946 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.536 ' O ' ' CD1' ' A' ' 167' ' ' LEU . 39.3 t -144.76 165.23 28.67 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.177 -0.952 . . . . 0.0 109.96 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.782 HG22 HD22 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -102.64 116.88 47.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 121.452 -0.78 . . . . 0.0 109.674 179.541 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 66.56 8.31 45.5 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 87.05 35.95 9.4 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' THR . . . . . 0.419 ' N ' ' OG ' ' A' ' 181' ' ' SER . 33.0 m -84.89 -74.55 0.39 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.293 -1.122 . . . . 0.0 110.563 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.647 ' CE2' HD11 ' A' ' 182' ' ' ILE . 18.7 m-85 -81.01 88.04 5.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.109 -0.995 . . . . 0.0 110.662 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.602 ' O ' ' CE2' ' A' ' 191' ' ' PHE . 2.3 tp -177.84 28.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.595 -0.691 . . . . 0.0 109.5 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.525 ' H ' ' HD2' ' A' ' 189' ' ' PRO . . . -104.15 -68.27 0.75 Allowed Glycine 0 N--CA 1.491 2.336 0 C-N-CA 120.059 -1.067 . . . . 0.0 110.514 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.525 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 44.4 Cg_endo -71.1 -30.05 16.79 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.843 1.444 . . . . 0.0 111.17 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.565 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -73.12 12.29 0.58 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.175 -0.953 . . . . 0.0 111.17 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.602 ' CE2' ' O ' ' A' ' 187' ' ' LEU . 0.3 OUTLIER -90.13 -13.15 36.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.08 -1.012 . . . . 0.0 109.741 179.255 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.47 -20.37 31.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.436 -0.79 . . . . 0.0 110.718 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -108.97 -24.7 5.92 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.821 -1.711 . . . . 0.0 108.821 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 1.061 HD11 ' O ' ' A' ' 178' ' ' LEU . 6.6 tt -61.99 -32.71 73.2 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.611 -0.935 . . . . 0.0 109.016 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.553 ' HA ' HG23 ' A' ' 177' ' ' THR . 0.1 OUTLIER -47.16 -29.18 2.14 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.434 -0.791 . . . . 0.0 109.409 179.422 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -114.42 -19.38 6.24 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.675 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.91 -8.36 49.59 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.493 -1.004 . . . . 0.0 110.049 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 198' ' ' THR . . . . . 0.552 HG22 ' O ' ' A' ' 194' ' ' LEU . 0.1 OUTLIER -43.52 143.16 1.0 Allowed 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.91 0.862 . . . . 0.0 111.587 -178.152 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 1.028 ' O ' HD11 ' A' ' 178' ' ' LEU . 0.0 OUTLIER -140.41 172.26 12.98 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 22.3 m-85 -83.15 129.82 59.52 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.953 -1.092 . . . . 0.0 109.34 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.642 ' HG3' HD22 ' A' ' 171' ' ' LEU . 48.1 Cg_endo -74.18 129.6 13.28 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.054 1.555 . . . . 0.0 111.73 -178.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.511 ' O ' HG13 ' A' ' 106' ' ' VAL . 8.3 m -133.42 151.58 51.82 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.584 -0.697 . . . . 0.0 109.405 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.784 HG13 ' HG3' ' A' ' 50' ' ' PRO . 1.6 p -135.79 139.49 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.033 -1.042 . . . . 0.0 110.431 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' SER . . . . . 0.996 ' HB2' HG23 ' A' ' 105' ' ' VAL . 74.7 m -119.7 126.88 52.18 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.756 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.614 ' HA ' ' CH2' ' A' ' 95' ' ' TRP . . . -109.79 138.3 46.35 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.772 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.828 HG13 ' N ' ' A' ' 207' ' ' TRP . 0.3 OUTLIER -91.62 -159.68 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.506 -0.746 . . . . 0.0 110.542 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 0.828 ' N ' HG13 ' A' ' 206' ' ' VAL . 0.8 OUTLIER -47.07 176.39 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 110.265 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.422 ' N ' ' OD2' ' A' ' 76' ' ' ASP . . . -82.1 -0.12 89.28 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -72.87 -33.68 66.24 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.616 -0.932 . . . . 0.0 110.155 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' CYS . . . . . 0.668 ' O ' ' C ' ' A' ' 211' ' ' GLN . 11.4 t -97.08 -0.25 47.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.346 -0.846 . . . . 0.0 110.149 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.668 ' C ' ' O ' ' A' ' 210' ' ' CYS . 0.6 OUTLIER 0.49 106.39 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.787 0.803 . . . . 0.0 111.42 -179.804 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.9 HG23 ' O ' ' A' ' 94' ' ' SER . 1.9 p -87.85 145.02 8.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.708 -0.62 . . . . 0.0 109.545 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ARG . . . . . 0.657 ' HA ' HD21 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -87.27 156.45 19.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.17 -0.956 . . . . 0.0 110.466 -178.686 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 1.0 HD12 ' HB3' ' A' ' 48' ' ' TRP . 0.2 OUTLIER -143.86 130.24 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.453 -0.779 . . . . 0.0 110.657 -179.323 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.663 ' O ' ' N ' ' A' ' 92' ' ' GLU . 6.8 mtt180 -130.81 108.86 10.16 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' TYR . . . . . 0.79 ' CD2' ' HB3' ' A' ' 91' ' ' TRP . 1.6 t80 -113.84 139.92 48.76 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 120.976 -1.077 . . . . 0.0 111.693 -177.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' MET . . . . . 0.45 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 0.3 OUTLIER -136.87 125.85 24.32 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.19 0.519 . . . . 0.0 109.89 179.548 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 120.47 -21.8 8.5 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.608 ' HB2' ' CE1' ' A' ' 216' ' ' TYR . 5.9 tm-20 . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.152 -1.205 . . . . 0.0 110.362 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.904 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 121.184 0.516 . . . . 0.0 110.048 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.653 ' HA ' HD23 ' A' ' 33' ' ' LEU . 2.1 pp20? -47.54 -43.05 24.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.917 . . . . 0.0 109.745 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.436 ' N ' ' CD ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -57.75 -21.19 39.85 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.201 179.269 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -83.4 -35.2 25.25 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.977 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.784 HD12 ' C ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -67.8 -35.63 78.98 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 122.059 0.933 . . . . 0.0 109.087 179.15 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.568 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 1.0 OUTLIER -82.65 -6.8 59.56 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.301 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.999 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -45.82 -67.31 0.39 Allowed Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.226 -0.921 . . . . 0.0 111.068 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.999 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 46.1 Cg_endo -70.42 142.49 45.17 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.674 1.355 . . . . 0.0 110.288 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.692 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 53.3 Cg_endo -96.79 20.62 0.44 Allowed 'Trans proline' 0 CA--C 1.552 1.385 0 C-N-CA 121.724 1.616 . . . . 0.0 113.828 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.701 ' CD ' ' HB2' ' A' ' 36' ' ' PRO . 50.6 Cg_endo -79.58 151.01 22.11 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 122.609 0.794 . . . . 0.0 110.625 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.722 ' CG ' ' OE1' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -15.33 -54.7 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.755 -0.59 . . . . 0.0 111.835 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.1 HD13 HG23 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -44.56 -51.48 8.92 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 120.455 -1.403 . . . . 0.0 109.701 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 1.1 HG23 HD13 ' A' ' 40' ' ' LEU . 23.4 t -87.26 -30.47 5.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.146 -0.971 . . . . 0.0 110.614 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.67 -36.8 15.04 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.974 -1.079 . . . . 0.0 111.587 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.751 ' CD ' ' HB2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -82.24 -19.53 39.46 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.252 -0.905 . . . . 0.0 110.01 -179.188 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.627 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 2.1 ttt180 -83.23 -42.68 16.95 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.304 -0.872 . . . . 0.0 109.952 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.713 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 0.6 OUTLIER -60.4 -18.07 48.17 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.609 -0.682 . . . . 0.0 110.703 -179.366 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -96.29 -34.71 11.5 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.032 -1.067 . . . . 0.0 109.556 178.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.523 ' HA3' ' HB2' ' A' ' 61' ' ' GLU . . . -92.42 -101.87 1.44 Allowed Glycine 0 N--CA 1.487 2.056 0 N-CA-C 106.929 -2.468 . . . . 0.0 106.929 178.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.771 ' CZ3' HD12 ' A' ' 214' ' ' ILE . 93.8 m95 -81.27 73.81 8.29 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.05 -1.265 . . . . 0.0 108.044 177.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.713 ' HA ' ' HA ' ' A' ' 45' ' ' HIS . 0.1 OUTLIER -43.69 147.02 0.88 Allowed Pre-proline 0 C--N 1.297 -1.714 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.087 -179.362 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.607 ' HA ' ' O ' ' A' ' 53' ' ' CYS . 40.5 Cg_endo -68.48 -33.04 23.83 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 124.498 1.788 . . . . 0.0 110.142 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.838 ' N ' ' HE3' ' A' ' 51' ' ' LYS . 0.2 OUTLIER -63.58 -16.64 61.4 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.612 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.878 ' O ' ' N ' ' A' ' 79' ' ' ARG . 4.2 m-20 -104.83 0.56 28.2 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 177.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.607 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 21.7 t -167.57 137.31 2.75 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 120.149 -0.621 . . . . 0.0 110.025 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.79 ' CB ' HD21 ' A' ' 56' ' ' ASN . 0.0 OUTLIER -100.77 161.33 13.67 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.209 179.159 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.603 ' HG3' HD21 ' A' ' 29' ' ' LEU . 24.3 pm0 -38.12 -20.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.326 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.79 HD21 ' CB ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -41.81 -29.61 0.21 Allowed 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 118.495 -1.282 . . . . 0.0 108.204 -179.762 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.999 HD11 ' O ' ' A' ' 207' ' ' TRP . 1.2 mt -131.13 166.11 29.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-O 121.63 0.729 . . . . 0.0 111.056 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.52 ' N ' ' CG2' ' A' ' 57' ' ' ILE . 2.8 t70 -128.11 105.67 8.53 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.72 HG12 ' HA ' ' A' ' 66' ' ' PHE . 10.7 m -128.44 135.52 62.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.327 -0.858 . . . . 0.0 110.955 -178.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.751 ' HB2' ' CD ' ' A' ' 43' ' ' GLN . 2.5 tttm -124.02 155.32 38.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.365 -0.835 . . . . 0.0 110.574 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.523 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . 4.2 tt0 -83.98 -131.25 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.387 -0.821 . . . . 0.0 110.142 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 43.24 52.44 6.0 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 108.389 -1.885 . . . . 0.0 108.389 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.667 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 108.88 61.66 0.54 Allowed Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.669 HD21 ' O ' ' A' ' 214' ' ' ILE . 1.5 mm? 0.49 80.06 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.92 -0.753 . . . . 0.0 111.421 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 63' ' ' GLY . 1.6 m -99.51 114.37 27.31 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.266 -0.896 . . . . 0.0 109.599 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.72 ' HA ' HG12 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -104.89 124.74 49.99 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.311 -0.868 . . . . 0.0 110.079 -179.683 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.511 ' O ' ' O ' ' A' ' 58' ' ' ASP . 29.2 tt0 -144.62 145.56 31.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 109.862 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.561 ' HG2' ' O ' ' A' ' 207' ' ' TRP . 0.0 OUTLIER -132.68 118.12 18.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 110.207 -179.791 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.688 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 9.9 mmm-85 -84.73 -71.65 0.1 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.284 -0.885 . . . . 0.0 110.302 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.688 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 56.4 Cg_endo -72.18 -145.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.569 1.3 . . . . 0.0 109.155 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.481 ' O ' ' HG2' ' A' ' 73' ' ' GLN . 3.2 t -140.09 163.77 23.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 O-C-N 121.406 -0.809 . . . . 0.0 109.738 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 71' ' ' VAL . . . -43.19 103.3 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.067 -1.021 . . . . 0.0 109.891 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 15.2 pt20 -128.28 -113.27 0.27 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.211 -0.93 . . . . 0.0 110.593 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.462 ' C ' ' O ' ' A' ' 73' ' ' GLN . 22.0 p -36.06 -52.08 0.76 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.319 -0.863 . . . . 0.0 110.809 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.493 ' CB ' ' HB3' ' A' ' 54' ' ' SER . 0.2 OUTLIER -118.41 -137.39 0.35 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.131 -0.98 . . . . 0.0 109.993 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.701 ' O ' ' C ' ' A' ' 77' ' ' GLY . 1.3 t0 -140.66 154.84 46.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.893 . . . . 0.0 110.387 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.701 ' C ' ' O ' ' A' ' 76' ' ' ASP . . . -12.23 -98.32 0.0 OUTLIER Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.858 ' CG2' ' HB3' ' A' ' 205' ' ' ALA . 3.7 m -128.06 121.64 56.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.038 -1.272 . . . . 0.0 110.003 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.878 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -145.53 133.76 21.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.415 -0.803 . . . . 0.0 110.907 -179.756 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.709 ' HA3' ' HA ' ' A' ' 52' ' ' ASP . . . -163.7 145.23 10.24 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.813 ' CE ' ' HB3' ' A' ' 109' ' ' ALA . 1.5 tttm -138.73 80.84 1.81 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -1.133 . . . . 0.0 110.04 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.48 -92.79 0.28 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.128 -0.983 . . . . 0.0 110.213 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 53.95 69.59 1.19 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -120.78 111.41 17.55 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.195 -1.179 . . . . 0.0 110.308 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.599 ' HB3' ' CE1' ' A' ' 89' ' ' HIS . 0.8 OUTLIER -140.02 173.65 11.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.936 . . . . 0.0 110.165 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.595 ' N ' ' CD ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -118.47 138.16 52.68 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.225 -0.922 . . . . 0.0 110.119 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.491 ' HA2' ' CG ' ' A' ' 174' ' ' GLU . . . 98.05 -116.52 5.56 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.495 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 0.9 OUTLIER -128.6 135.33 49.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.407 -1.055 . . . . 0.0 110.295 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.813 ' HB2' HD23 ' A' ' 171' ' ' LEU . 9.0 m-70 -147.08 161.14 41.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.154 -0.966 . . . . 0.0 109.811 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.556 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -158.02 147.12 19.45 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.042 -1.036 . . . . 0.0 110.517 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 1.043 ' CZ2' HD22 ' A' ' 171' ' ' LEU . 1.3 m0 -134.75 170.23 16.14 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.374 -0.829 . . . . 0.0 109.097 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 1.003 ' CD ' HD12 ' A' ' 168' ' ' LEU . 3.2 mt-10 -136.47 138.96 41.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.118 -0.989 . . . . 0.0 111.23 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.909 HD13 ' O ' ' A' ' 92' ' ' GLU . 8.3 mm -142.93 126.4 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.58 -0.7 . . . . 0.0 109.361 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.718 ' HA ' HD12 ' A' ' 167' ' ' LEU . 1.4 m -143.62 143.51 31.5 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.166 -0.959 . . . . 0.0 110.325 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.6 ' HH2' ' CB ' ' A' ' 205' ' ' ALA . 47.9 m95 -114.4 88.46 15.64 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.322 -0.861 . . . . 0.0 110.282 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 94' ' ' SER . 50.9 Cg_endo -91.92 109.86 0.27 Allowed 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 123.909 1.479 . . . . 0.0 110.255 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.541 ' O ' ' CD1' ' A' ' 97' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 O-C-N 120.809 -1.182 . . . . 0.0 110.492 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.686 HG23 ' C ' ' A' ' 204' ' ' SER . 27.0 m . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 121.396 0.617 . . . . 0.0 110.366 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.842 HG13 ' HA ' ' A' ' 203' ' ' VAL . 8.4 t -150.69 170.04 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.464 -0.773 . . . . 0.0 109.631 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.65 ' CA ' ' HA3' ' A' ' 132' ' ' GLY . . . 164.02 164.05 18.33 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.504 -1.331 . . . . 0.0 110.689 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.815 HG12 ' HB2' ' A' ' 199' ' ' LEU . 2.5 t -114.3 155.7 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.639 -0.919 . . . . 0.0 109.072 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.813 ' HB3' ' CE ' ' A' ' 81' ' ' LYS . . . -142.93 144.75 32.52 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.863 -1.148 . . . . 0.0 111.129 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.684 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.8 OUTLIER -103.47 125.12 49.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.397 -0.815 . . . . 0.0 110.0 179.544 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.85 -28.39 16.55 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.459 -0.775 . . . . 0.0 109.9 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.673 ' O ' ' C ' ' A' ' 113' ' ' ALA . 0.5 OUTLIER -81.22 -12.45 59.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.321 -0.862 . . . . 0.0 109.719 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.673 ' C ' ' O ' ' A' ' 112' ' ' LEU . . . . . . . . 0 N--CA 1.5 2.046 0 O-C-N 121.967 -0.458 . . . . 0.0 111.408 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.232 0.539 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -150.11 128.52 12.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 110.083 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 24.0 t -120.43 119.75 33.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 110.276 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -133.35 130.17 38.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -0.902 . . . . 0.0 109.852 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.65 ' HA3' ' CA ' ' A' ' 107' ' ' GLY . . . -169.41 -146.56 5.1 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.705 ' CZ3' ' CG ' ' A' ' 180' ' ' TYR . 47.4 m0 -121.54 113.74 20.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -1.138 . . . . 0.0 110.501 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.59 ' C ' HG23 ' A' ' 135' ' ' ILE . 3.9 t70 -118.14 122.9 44.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.554 -0.716 . . . . 0.0 110.164 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.59 HG23 ' C ' ' A' ' 134' ' ' ASP . 17.6 pt . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 110.172 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.699 ' HB ' ' HD3' ' A' ' 164' ' ' PRO . 2.7 t . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.699 ' HD3' ' HB ' ' A' ' 163' ' ' VAL . 54.7 Cg_endo -78.89 154.44 26.13 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.457 1.24 . . . . 0.0 109.912 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -58.53 -30.61 67.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.043 -1.036 . . . . 0.0 109.374 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.461 ' HG3' ' OG ' ' A' ' 94' ' ' SER . 1.4 ttt180 -151.82 155.83 38.98 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.631 -0.668 . . . . 0.0 109.321 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 1.011 HD23 HG21 ' A' ' 182' ' ' ILE . 1.2 mp -126.86 138.63 53.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.965 -1.084 . . . . 0.0 110.461 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 1.003 HD12 ' CD ' ' A' ' 92' ' ' GLU . 1.0 OUTLIER -120.76 126.71 50.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.337 -0.852 . . . . 0.0 109.969 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.435 HG11 ' HE3' ' A' ' 91' ' ' TRP . 46.0 t -89.93 136.04 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 109.99 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.503 HG22 ' CD2' ' A' ' 168' ' ' LEU . 3.5 t -124.16 126.47 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.205 -0.934 . . . . 0.0 109.971 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 1.043 HD22 ' CZ2' ' A' ' 91' ' ' TRP . 0.0 OUTLIER -133.04 120.39 21.28 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.116 -0.99 . . . . 0.0 109.843 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 173' ' ' MET . 46.1 t0 -117.92 135.28 54.22 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.33 -0.856 . . . . 0.0 109.928 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.465 ' O ' ' C ' ' A' ' 174' ' ' GLU . 0.0 OUTLIER -98.62 -42.44 7.26 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.796 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.491 ' CG ' ' HA2' ' A' ' 87' ' ' GLY . 1.1 mm-40 -43.62 -26.87 0.26 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.223 -0.923 . . . . 0.0 108.72 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.565 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 2.7 tp10 -112.49 -28.32 7.9 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.717 0.77 . . . . 0.0 108.977 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 85.95 22.53 48.89 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 108.684 -1.766 . . . . 0.0 108.684 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.903 HG22 HD22 ' A' ' 194' ' ' LEU . 0.3 OUTLIER -113.77 123.5 49.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.222 -1.163 . . . . 0.0 111.087 -179.513 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.83 HD13 HD12 ' A' ' 171' ' ' LEU . 0.2 OUTLIER -143.89 154.19 43.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.424 -0.797 . . . . 0.0 109.805 179.458 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -177.86 -161.06 25.43 Favored Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.506 -1.331 . . . . 0.0 110.273 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.83 ' O ' HD13 ' A' ' 187' ' ' LEU . 0.5 OUTLIER -118.7 123.52 45.09 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.493 -1.004 . . . . 0.0 109.724 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.765 ' HB2' HD22 ' A' ' 187' ' ' LEU . 5.7 t -130.15 125.68 35.64 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.417 -0.802 . . . . 0.0 110.356 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 1.011 HG21 HD23 ' A' ' 167' ' ' LEU . 0.1 OUTLIER -110.02 116.9 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.216 -0.928 . . . . 0.0 109.911 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 47.93 23.57 2.64 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 69.14 40.17 82.81 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' THR . . . . . 0.925 HG22 ' CD2' ' A' ' 186' ' ' TYR . 92.4 m -71.36 -76.27 0.11 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.277 -1.131 . . . . 0.0 110.642 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.925 ' CD2' HG22 ' A' ' 185' ' ' THR . 25.7 m-85 -126.5 89.28 2.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.172 -0.955 . . . . 0.0 110.641 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.83 HD13 ' O ' ' A' ' 180' ' ' TYR . 0.2 OUTLIER -176.54 26.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.404 -0.81 . . . . 0.0 109.765 179.641 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.575 ' H ' ' HD2' ' A' ' 189' ' ' PRO . . . -95.52 -61.46 1.01 Allowed Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.97 -1.11 . . . . 0.0 110.568 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.575 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 45.0 Cg_endo -71.94 -29.52 15.02 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.951 1.5 . . . . 0.0 111.001 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -74.65 15.78 0.34 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.197 -0.94 . . . . 0.0 111.03 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -90.35 -12.91 36.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.086 -1.009 . . . . 0.0 110.099 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.09 -15.31 34.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.0 110.187 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -109.99 -18.83 8.5 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.903 HD22 HG22 ' A' ' 177' ' ' THR . 6.3 tt -61.82 -32.25 72.55 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.727 -0.867 . . . . 0.0 108.82 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.655 ' HA ' HG23 ' A' ' 177' ' ' THR . 0.0 OUTLIER -47.2 -29.64 2.48 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.576 -0.702 . . . . 0.0 109.422 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -114.19 -19.33 6.35 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.77 ' HD3' HD11 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.88 -4.87 56.22 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.507 -0.996 . . . . 0.0 109.774 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 198' ' ' THR . . . . . 0.534 ' O ' ' CG2' ' A' ' 110' ' ' THR . 0.1 OUTLIER -43.38 145.59 0.57 Allowed 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.913 0.863 . . . . 0.0 111.396 -178.269 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.815 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -140.11 172.27 12.99 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.667 ' C ' HG13 ' A' ' 108' ' ' VAL . 1.7 m-85 -82.85 129.62 61.12 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 120.887 -1.133 . . . . 0.0 109.274 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.58 ' HD3' HD12 ' A' ' 178' ' ' LEU . 49.8 Cg_endo -78.07 125.92 7.53 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.079 1.568 . . . . 0.0 111.388 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.55 ' HB3' ' CG ' ' A' ' 81' ' ' LYS . 9.3 p -133.59 138.39 45.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.476 -0.765 . . . . 0.0 109.891 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.842 ' HA ' HG13 ' A' ' 106' ' ' VAL . 7.1 p -119.31 159.54 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.142 -0.974 . . . . 0.0 109.402 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' SER . . . . . 0.686 ' C ' HG23 ' A' ' 105' ' ' VAL . 22.3 m -160.15 162.67 33.98 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.129 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.858 ' HB3' ' CG2' ' A' ' 78' ' ' VAL . . . -150.14 160.13 43.9 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.424 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.678 HG13 ' N ' ' A' ' 207' ' ' TRP . 0.4 OUTLIER -49.42 -176.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.635 -0.666 . . . . 0.0 110.329 179.618 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 0.999 ' O ' HD11 ' A' ' 57' ' ' ILE . 22.7 p-90 -92.4 -44.44 8.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.929 . . . . 0.0 110.05 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.628 ' N ' ' CG ' ' A' ' 207' ' ' TRP . . . -164.33 128.28 1.79 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -173.89 -39.8 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.239 -1.153 . . . . 0.0 110.432 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' CYS . . . . . 0.499 ' O ' ' HG3' ' A' ' 211' ' ' GLN . 1.2 m -155.75 -93.48 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.404 -0.81 . . . . 0.0 110.551 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.528 ' HG2' ' HB2' ' A' ' 66' ' ' PHE . 2.1 mt-30 179.53 159.82 0.74 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.067 -1.021 . . . . 0.0 110.161 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.727 ' HB ' ' CH2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -127.5 144.05 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.165 -0.959 . . . . 0.0 110.784 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ARG . . . . . 0.65 ' NE ' ' O ' ' A' ' 213' ' ' ARG . 0.0 OUTLIER -101.46 110.79 22.85 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.256 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.771 HD12 ' CZ3' ' A' ' 48' ' ' TRP . 1.4 tt -118.12 132.84 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.906 -1.121 . . . . 0.0 111.319 -178.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.645 ' O ' ' N ' ' A' ' 92' ' ' GLU . 1.6 mtt180 -130.09 109.41 10.82 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' TYR . . . . . 0.746 ' CZ ' ' CD1' ' A' ' 91' ' ' TRP . 27.3 t80 -113.49 145.49 41.12 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.274 -0.891 . . . . 0.0 111.115 -178.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' MET . . . . . 0.477 ' HA ' ' CE ' ' A' ' 217' ' ' MET . 3.8 tpt -136.56 108.59 7.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.536 -0.727 . . . . 0.0 109.877 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 132.97 7.09 2.67 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.577 ' HB2' ' CD1' ' A' ' 216' ' ' TYR . 22.2 tt0 . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.132 -1.216 . . . . 0.0 110.123 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.636 HD11 ' HB2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 121.137 0.494 . . . . 0.0 110.075 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.765 ' HA ' HD23 ' A' ' 33' ' ' LEU . 10.8 pt-20 -44.49 -45.95 9.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.146 -0.971 . . . . 0.0 109.225 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.22 -20.79 7.53 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.639 -0.824 . . . . 0.0 108.777 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.605 ' N ' ' O ' ' A' ' 29' ' ' LEU . 4.1 tp -83.83 -33.62 24.85 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.088 HD21 ' CG ' ' A' ' 55' ' ' GLU . 0.4 OUTLIER -73.66 -36.12 65.33 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 122.012 0.911 . . . . 0.0 109.179 179.367 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.583 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 7.3 m -85.0 -6.76 59.33 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.324 0.583 . . . . 0.0 109.775 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.983 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -49.45 -67.61 0.42 Allowed Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.307 -0.871 . . . . 0.0 110.879 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.983 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 46.5 Cg_endo -72.14 157.68 53.61 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.655 1.345 . . . . 0.0 110.366 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 36' ' ' PRO . 53.9 Cg_endo -99.14 55.3 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 121.94 1.76 . . . . 0.0 112.006 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.695 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 49.4 Cg_endo -73.7 150.7 45.38 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.064 1.034 . . . . 0.0 110.108 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.741 ' O ' ' HB3' ' A' ' 43' ' ' GLN . 0.5 OUTLIER -41.86 -21.87 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.199 -0.938 . . . . 0.0 109.873 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.091 HD13 ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -61.2 -50.45 73.07 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.014 -1.053 . . . . 0.0 109.184 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 1.091 ' N ' HD13 ' A' ' 40' ' ' LEU . 2.9 t -67.27 -39.84 83.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 C-N-CA 118.481 -1.287 . . . . 0.0 110.845 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.36 -39.9 12.41 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.784 -1.197 . . . . 0.0 112.797 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.849 ' OE1' ' HA ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -82.2 -20.54 37.58 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 118.406 -1.318 . . . . 0.0 109.536 -179.414 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.916 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 5.0 ttp180 -68.68 -52.29 32.64 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.895 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 40.6 m-70 -45.62 -23.57 0.26 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.471 ' N ' ' C ' ' A' ' 44' ' ' ARG . 3.3 t-160 -95.96 -33.01 12.32 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.033 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 49' ' ' ASN . . . -87.72 -115.63 1.16 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 107.065 -2.414 . . . . 0.0 107.065 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.803 ' HH2' HG12 ' A' ' 212' ' ' VAL . 93.7 m95 -67.48 74.47 0.16 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.749 -1.442 . . . . 0.0 108.33 177.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.678 ' OD1' ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -44.11 111.62 1.2 Allowed Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.63 -0.669 . . . . 0.0 110.614 -179.29 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.777 ' O ' ' O ' ' A' ' 53' ' ' CYS . 55.4 Cg_endo -79.49 1.65 9.02 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.166 1.91 . . . . 0.0 111.692 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.752 ' HA ' ' HE3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -50.59 -75.6 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.387 -1.446 . . . . 0.0 108.459 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.821 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 0.6 OUTLIER -64.79 3.43 0.54 Allowed 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.876 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.777 ' O ' ' O ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -124.67 170.45 10.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.423 -0.798 . . . . 0.0 110.797 -178.956 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.581 ' N ' ' SG ' ' A' ' 53' ' ' CYS . 4.4 t -100.51 165.8 11.24 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.015 -1.053 . . . . 0.0 108.906 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 1.088 ' CG ' HD21 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -94.32 1.13 55.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.93 -1.106 . . . . 0.0 110.547 -179.045 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.638 ' ND2' ' N ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -22.17 -42.01 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 122.401 1.096 . . . . 0.0 109.937 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.695 ' N ' ' O ' ' A' ' 55' ' ' GLU . 11.3 pt -126.03 169.61 17.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.555 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.64 ' O ' ' HB3' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -105.69 118.04 35.57 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.324 -0.86 . . . . 0.0 109.299 -178.919 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.734 ' CG1' ' CD1' ' A' ' 48' ' ' TRP . 90.1 t -124.44 136.05 61.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.273 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.849 ' HA ' ' OE1' ' A' ' 43' ' ' GLN . 1.7 ttmt -135.21 155.14 51.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.714 -1.241 . . . . 0.0 111.043 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.552 ' N ' ' OE1' ' A' ' 43' ' ' GLN . 23.2 tt0 -67.47 -109.26 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.453 -0.779 . . . . 0.0 110.226 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.546 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 37.26 35.17 0.15 Allowed Glycine 0 N--CA 1.494 2.558 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.68 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 114.56 56.85 0.38 Allowed Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 -178.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.815 HD22 ' H ' ' A' ' 64' ' ' LEU . 2.0 mm? 0.83 84.98 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.962 -0.728 . . . . 0.0 110.92 -178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 63' ' ' GLY . 1.7 m -128.43 130.61 47.86 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.383 -0.823 . . . . 0.0 110.708 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.69 ' CE2' ' HB ' ' A' ' 212' ' ' VAL . 5.3 m-30 -83.61 152.4 24.84 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.64 ' HB3' ' O ' ' A' ' 58' ' ' ASP . 1.1 tp10 -147.65 121.4 9.25 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.228 -0.92 . . . . 0.0 109.755 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.585 ' HG2' ' CD1' ' A' ' 207' ' ' TRP . 1.0 OUTLIER -118.99 156.32 29.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.419 -0.801 . . . . 0.0 109.416 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.574 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -168.15 -56.94 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 120.98 -1.075 . . . . 0.0 111.043 -179.559 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.636 ' HB2' HD11 ' A' ' 29' ' ' LEU . 41.0 Cg_endo -67.29 -47.14 2.4 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.804 1.423 . . . . 0.0 110.729 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.678 HG11 HG22 ' A' ' 57' ' ' ILE . 2.0 p -78.31 165.38 3.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.879 0.847 . . . . 0.0 111.048 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.554 ' N ' HG22 ' A' ' 71' ' ' VAL . . . -156.59 -40.01 0.08 Allowed 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.049 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 75' ' ' THR . 1.8 mt-30 -74.73 151.56 39.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.906 . . . . 0.0 110.125 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.9 91.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.335 -0.853 . . . . 0.0 110.21 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.51 ' N ' ' O ' ' A' ' 73' ' ' GLN . 2.6 m -97.03 -130.38 0.18 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.32 -0.862 . . . . 0.0 110.061 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.513 ' O ' ' O ' ' A' ' 77' ' ' GLY . 0.2 OUTLIER -120.75 113.8 20.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.186 -0.946 . . . . 0.0 110.452 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.577 ' HA2' ' CE3' ' A' ' 207' ' ' TRP . . . -57.14 -114.24 0.01 OUTLIER Glycine 0 N--CA 1.485 1.925 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -148.42 123.17 2.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.944 -1.327 . . . . 0.0 110.979 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.821 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -104.47 175.08 5.61 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.549 -0.72 . . . . 0.0 109.489 179.313 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.576 ' N ' ' CG ' ' A' ' 79' ' ' ARG . . . -157.42 58.29 0.36 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.533 ' HG3' ' CB ' ' A' ' 202' ' ' SER . 0.7 OUTLIER -89.9 75.02 7.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.075 -1.25 . . . . 0.0 110.122 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.779 ' HD3' ' H ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -141.94 -95.29 0.13 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.316 -0.865 . . . . 0.0 110.292 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.779 ' H ' ' HD3' ' A' ' 82' ' ' ARG . . . 56.54 62.23 6.59 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -105.71 95.7 5.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.177 -1.19 . . . . 0.0 110.261 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.452 ' HB3' HD21 ' A' ' 171' ' ' LEU . 0.4 OUTLIER -140.01 171.51 14.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 110.018 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.714 ' O ' ' CE1' ' A' ' 89' ' ' HIS . 30.1 mtm180 -123.38 175.79 6.52 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.164 -0.96 . . . . 0.0 110.237 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.519 ' N ' ' HB3' ' A' ' 173' ' ' MET . . . 62.52 -116.45 9.39 Favored Glycine 0 N--CA 1.482 1.722 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.448 HD12 ' HB2' ' A' ' 172' ' ' ASP . 11.6 tp -129.37 127.76 41.69 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.559 -0.966 . . . . 0.0 110.995 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.814 ' HB2' HD23 ' A' ' 171' ' ' LEU . 41.0 m80 -147.26 173.16 12.82 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.269 -0.895 . . . . 0.0 109.95 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.544 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -163.81 164.11 23.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.261 -0.899 . . . . 0.0 110.133 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.722 ' CD1' ' CZ ' ' A' ' 216' ' ' TYR . 1.1 m0 -134.86 145.89 48.73 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.301 -0.874 . . . . 0.0 109.54 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.644 ' O ' ' N ' ' A' ' 215' ' ' ARG . 2.1 tt0 -109.97 118.9 37.67 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.431 -0.907 . . . . 0.0 109.883 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.533 HD13 ' O ' ' A' ' 92' ' ' GLU . 17.3 mm -118.08 130.05 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.019 -1.051 . . . . 0.0 111.028 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.558 ' CB ' ' HB3' ' A' ' 213' ' ' ARG . 0.0 OUTLIER -118.53 126.38 51.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.404 -0.81 . . . . 0.0 109.428 179.319 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.703 ' CH2' HG13 ' A' ' 105' ' ' VAL . 7.1 t-105 -117.3 88.19 27.03 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.119 -0.988 . . . . 0.0 110.217 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.535 ' HD2' ' HA ' ' A' ' 212' ' ' VAL . 50.0 Cg_endo -96.21 112.21 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 121.968 1.779 . . . . 0.0 110.673 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.689 0 O-C-N 120.824 -1.173 . . . . 0.0 110.184 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.905 HG12 ' CD1' ' A' ' 135' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.111 0 CA-C-O 121.818 0.818 . . . . 0.0 109.197 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.806 HG13 ' O ' ' A' ' 202' ' ' SER . 22.2 t -152.04 159.8 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.277 -0.889 . . . . 0.0 109.574 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.613 ' HA2' ' HA3' ' A' ' 132' ' ' GLY . . . -175.57 136.77 3.48 Favored Glycine 0 N--CA 1.487 2.078 0 C-N-CA 118.826 -1.654 . . . . 0.0 110.859 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.862 HG13 ' C ' ' A' ' 200' ' ' TYR . 2.8 t -104.42 141.71 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.601 -0.941 . . . . 0.0 108.999 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.904 ' HB3' ' CZ ' ' A' ' 200' ' ' TYR . . . -130.54 152.39 49.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.883 -1.136 . . . . 0.0 111.126 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.977 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -121.13 130.87 53.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.481 -0.762 . . . . 0.0 110.055 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -89.44 -25.96 21.22 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.291 -0.881 . . . . 0.0 109.343 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.4 pp -83.35 -12.49 56.51 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.489 -0.757 . . . . 0.0 109.398 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.59 ' HB3' ' HB ' ' A' ' 110' ' ' THR . . . . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.47 -0.769 . . . . 0.0 110.246 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.5 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.347 0.594 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.578 ' OE2' ' CG ' ' A' ' 131' ' ' TRP . 4.6 tm-20 -145.03 126.84 15.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.902 . . . . 0.0 109.892 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -122.09 119.45 31.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.946 . . . . 0.0 110.666 -179.727 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 131' ' ' TRP . . . . . 0.578 ' CG ' ' OE2' ' A' ' 129' ' ' GLU . 16.7 m0 -133.25 133.27 42.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.47 -0.768 . . . . 0.0 109.519 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.613 ' HA3' ' HA2' ' A' ' 107' ' ' GLY . . . -177.23 -140.94 3.84 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.442 -1.361 . . . . 0.0 110.207 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.564 ' CH2' ' O ' ' A' ' 180' ' ' TYR . 52.0 m0 -117.17 112.95 21.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.207 -1.172 . . . . 0.0 110.75 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.33 148.27 43.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.761 -0.587 . . . . 0.0 110.269 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.905 ' CD1' HG12 ' A' ' 105' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.204 -0.935 . . . . 0.0 109.955 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.682 HG11 HG21 ' A' ' 182' ' ' ILE . 1.7 t . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.85 0.357 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.18 65.16 4.31 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.903 1.475 . . . . 0.0 110.75 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 27.2 tp10 -167.83 -84.14 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.398 -0.814 . . . . 0.0 110.101 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -152.31 155.86 38.49 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.4 -0.812 . . . . 0.0 110.344 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.668 ' HA ' HG22 ' A' ' 182' ' ' ILE . 2.9 mp -135.74 137.02 41.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 109.793 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.585 HD22 ' HA ' ' A' ' 92' ' ' GLU . 0.2 OUTLIER -130.53 114.21 15.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.066 -1.021 . . . . 0.0 110.571 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.878 HG22 ' CE1' ' A' ' 180' ' ' TYR . 18.4 t -89.92 136.04 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.852 . . . . 0.0 109.784 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.434 ' HB ' ' CD1' ' A' ' 187' ' ' LEU . 7.5 t -113.06 111.18 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.089 -1.007 . . . . 0.0 110.519 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 1.045 HD12 HD23 ' A' ' 178' ' ' LEU . 0.0 OUTLIER -119.68 105.6 11.33 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.292 -0.88 . . . . 0.0 109.311 179.607 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.448 ' HB2' HD12 ' A' ' 88' ' ' LEU . 5.5 t0 -120.33 135.3 55.06 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.577 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.576 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 0.3 OUTLIER -95.9 -40.68 9.18 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.414 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -44.73 -26.39 0.38 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.299 -0.876 . . . . 0.0 108.99 179.205 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.618 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.0 OUTLIER -110.78 -26.79 9.18 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.282 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.918 ' O ' HG21 ' A' ' 198' ' ' THR . . . 81.53 25.46 53.9 Favored Glycine 0 N--CA 1.482 1.73 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.925 HG22 ' HB3' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -118.56 112.08 19.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.196 -1.179 . . . . 0.0 111.381 -179.484 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 1.045 HD23 HD12 ' A' ' 171' ' ' LEU . 4.0 mp -118.76 153.85 33.77 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.481 -0.762 . . . . 0.0 109.256 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 177.39 -174.47 46.99 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.07 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.878 ' CE1' HG22 ' A' ' 169' ' ' VAL . 0.3 OUTLIER -123.99 125.62 44.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.341 -1.094 . . . . 0.0 109.949 179.896 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 35.5 t -136.69 132.77 35.37 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.268 -0.895 . . . . 0.0 110.194 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.682 HG21 HG11 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -103.67 116.81 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.309 -0.87 . . . . 0.0 109.756 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 88.76 -10.41 72.44 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 80.61 46.82 7.1 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 185' ' ' THR . 79.8 m -129.41 -2.5 4.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.255 -1.144 . . . . 0.0 110.441 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.432 ' CE2' HD11 ' A' ' 182' ' ' ILE . 0.2 OUTLIER -99.77 -54.96 2.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.207 -0.933 . . . . 0.0 110.264 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.891 HD21 ' CD1' ' A' ' 194' ' ' LEU . 5.3 mt -77.48 44.54 0.44 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.225 -0.922 . . . . 0.0 109.785 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -80.91 -96.78 0.39 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 191' ' ' PHE . 46.9 Cg_endo -72.9 -25.1 16.97 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 124.229 1.647 . . . . 0.0 111.017 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.55 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -68.62 21.42 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.506 -0.746 . . . . 0.0 111.76 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.829 ' CE1' HD22 ' A' ' 187' ' ' LEU . 0.2 OUTLIER -90.23 -13.83 34.63 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.707 -1.246 . . . . 0.0 110.349 179.467 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.05 -14.72 33.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.105 -0.997 . . . . 0.0 110.597 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -112.63 -11.16 15.3 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.925 ' HB3' HG22 ' A' ' 177' ' ' THR . 7.5 tt -74.69 -28.58 60.88 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.474 -1.015 . . . . 0.0 109.108 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.488 ' O ' ' OG1' ' A' ' 198' ' ' THR . 0.0 OUTLIER -54.08 -33.82 58.54 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.385 -0.822 . . . . 0.0 109.714 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -94.23 -26.88 12.98 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.792 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.46 -6.08 55.29 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.68 -0.894 . . . . 0.0 109.943 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 198' ' ' THR . . . . . 0.918 HG21 ' O ' ' A' ' 176' ' ' GLY . 0.2 OUTLIER -44.59 131.86 6.5 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.877 0.846 . . . . 0.0 112.532 -178.114 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.977 ' CB ' HG23 ' A' ' 110' ' ' THR . 0.0 OUTLIER -140.74 170.75 15.18 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.571 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.904 ' CZ ' ' HB3' ' A' ' 109' ' ' ALA . 25.6 p90 -84.6 128.72 60.1 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 120.775 -1.203 . . . . 0.0 109.548 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.766 ' N ' HG13 ' A' ' 108' ' ' VAL . 51.0 Cg_endo -84.49 143.78 9.96 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.138 1.599 . . . . 0.0 111.393 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.806 ' O ' HG13 ' A' ' 106' ' ' VAL . 0.9 OUTLIER -133.54 138.54 46.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.51 -0.744 . . . . 0.0 109.908 179.401 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.54 HG23 HG22 ' A' ' 106' ' ' VAL . 14.6 p -119.64 157.93 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.161 -0.962 . . . . 0.0 110.108 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' SER . . . . . 0.798 ' O ' HG22 ' A' ' 105' ' ' VAL . 0.4 OUTLIER -160.18 145.87 15.28 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.391 -0.818 . . . . 0.0 110.688 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.85 ' CB ' HG11 ' A' ' 212' ' ' VAL . . . -146.21 166.44 26.23 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.56 0.695 . . . . 0.0 110.573 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.581 HG13 ' N ' ' A' ' 207' ' ' TRP . 1.2 t -110.24 176.17 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 CA-C-O 121.456 0.646 . . . . 0.0 110.608 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 0.632 ' CE3' HD13 ' A' ' 57' ' ' ILE . 4.4 p90 -124.97 175.52 7.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.349 -0.844 . . . . 0.0 110.016 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 113.38 -165.57 12.05 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' GLN . . . . . 0.452 ' O ' ' O ' ' A' ' 210' ' ' CYS . 0.0 OUTLIER -44.52 -29.39 0.71 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.393 -1.063 . . . . 0.0 110.3 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 210' ' ' CYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 211' ' ' GLN . 27.0 p -58.03 -154.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.318 -0.864 . . . . 0.0 110.236 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.529 ' O ' ' O ' ' A' ' 96' ' ' PRO . 0.9 OUTLIER 179.59 125.34 0.07 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.248 -0.908 . . . . 0.0 110.377 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.85 HG11 ' CB ' ' A' ' 205' ' ' ALA . 8.3 t -128.6 144.32 38.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 121.671 -0.643 . . . . 0.0 109.941 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ARG . . . . . 0.558 ' HB3' ' CB ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -122.41 124.35 43.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.247 -0.908 . . . . 0.0 109.996 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.804 HG22 HD12 ' A' ' 64' ' ' LEU . 2.3 tt -119.22 128.06 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.013 -1.054 . . . . 0.0 111.183 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.644 ' N ' ' O ' ' A' ' 92' ' ' GLU . 1.1 mtt180 -130.14 136.9 49.8 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.407 -0.808 . . . . 0.0 109.259 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' TYR . . . . . 0.722 ' CZ ' ' CD1' ' A' ' 91' ' ' TRP . 14.0 t80 -118.9 150.17 40.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.04 -1.038 . . . . 0.0 110.908 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' MET . . . . . 0.505 ' CB ' ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -124.57 107.68 11.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.944 . . . . 0.0 110.05 179.371 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 95.71 74.02 1.2 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.528 ' HB2' ' CD1' ' A' ' 216' ' ' TYR . 3.6 tp10 . . . . . 0 N--CA 1.493 1.718 0 O-C-N 121.187 -1.184 . . . . 0.0 110.125 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.903 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.356 0.598 . . . . 0.0 109.657 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 1.003 ' HA ' HD23 ' A' ' 33' ' ' LEU . 16.8 pt-20 -49.42 -28.42 5.15 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.255 -0.903 . . . . 0.0 109.167 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.441 ' N ' ' HG3' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -68.24 -23.3 64.78 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.513 -0.875 . . . . 0.0 108.687 179.011 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.539 ' CB ' HD12 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -83.37 -36.84 24.03 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.697 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.003 HD23 ' HA ' ' A' ' 30' ' ' GLU . 0.3 OUTLIER -69.75 -35.79 75.25 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 122.022 0.915 . . . . 0.0 109.365 179.165 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.62 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 1.5 m -78.99 -7.51 58.13 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.804 -0.56 . . . . 0.0 110.346 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 1.059 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -38.63 -66.54 0.31 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.249 -0.907 . . . . 0.0 110.307 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 1.059 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 49.0 Cg_endo -74.5 151.88 42.75 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.645 1.34 . . . . 0.0 109.938 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 36' ' ' PRO . 54.1 Cg_endo -99.06 53.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.856 1.704 . . . . 0.0 112.235 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.743 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 52.7 Cg_endo -76.7 150.12 30.74 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 122.906 0.95 . . . . 0.0 110.384 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.742 ' HB3' ' NE2' ' A' ' 43' ' ' GLN . 1.6 t0 -40.78 -30.39 0.12 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 108.624 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.116 HD13 ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -40.95 -44.54 2.36 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.414 0.626 . . . . 0.0 109.449 179.926 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 1.116 ' N ' HD13 ' A' ' 40' ' ' LEU . 6.1 t -65.66 -27.25 40.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.797 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 39' ' ' ASP . . . -88.85 -43.57 11.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.91 -1.119 . . . . 0.0 111.587 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.742 ' NE2' ' HB3' ' A' ' 39' ' ' ASP . 2.7 mt-30 -81.32 -20.32 41.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.845 -1.16 . . . . 0.0 109.671 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.891 ' HE ' HD21 ' A' ' 40' ' ' LEU . 4.1 ttp85 -71.87 -55.03 8.28 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.709 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 21.1 m-70 -54.26 -27.56 35.77 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.367 0.603 . . . . 0.0 109.573 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -95.54 -30.62 13.73 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.324 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 43' ' ' GLN . . . -84.41 -103.73 0.6 Allowed Glycine 0 N--CA 1.487 2.056 0 N-CA-C 107.429 -2.269 . . . . 0.0 107.429 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.814 ' HB2' HG21 ' A' ' 59' ' ' VAL . 91.8 m95 -76.88 74.42 3.49 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.206 -1.173 . . . . 0.0 109.184 178.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.709 ' OD1' ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -44.19 110.9 1.07 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.718 -0.614 . . . . 0.0 110.675 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.64 ' CD ' ' HE2' ' A' ' 51' ' ' LYS . 47.1 Cg_endo -72.08 0.93 6.51 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.202 1.935 . . . . 0.0 112.134 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.719 ' H ' ' CE ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -71.79 -33.1 68.29 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 178.36 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.755 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 8.9 m-20 -117.29 -12.59 10.49 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 113.913 -1.494 . . . . 0.0 107.363 177.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.742 ' HA ' ' HB ' ' A' ' 78' ' ' VAL . 9.0 t -105.81 147.15 28.97 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.175 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.475 ' H ' ' CB ' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -77.6 105.29 8.66 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.244 -0.91 . . . . 0.0 109.426 179.059 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.709 ' O ' HD22 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -70.2 4.04 2.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.448 -0.782 . . . . 0.0 110.4 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.88 ' O ' HG11 ' A' ' 71' ' ' VAL . 1.4 m120 -41.4 -29.52 0.15 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.752 0.787 . . . . 0.0 109.446 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.916 HG21 ' CD1' ' A' ' 207' ' ' TRP . 25.2 pt -112.94 168.88 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.605 ' O ' ' HB3' ' A' ' 67' ' ' GLU . 10.2 t0 -105.85 103.48 12.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.894 -1.129 . . . . 0.0 109.925 -178.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.814 HG21 ' HB2' ' A' ' 48' ' ' TRP . 3.6 m -118.24 135.81 57.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.804 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.682 ' HG3' ' CD ' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -124.92 143.3 50.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.011 -1.055 . . . . 0.0 110.844 -179.423 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.535 ' O ' ' C ' ' A' ' 62' ' ' GLY . 46.1 tt0 -63.61 -124.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.452 -0.78 . . . . 0.0 109.954 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.535 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 37.7 50.61 1.93 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.674 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 109.33 46.89 0.9 Allowed Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.106 -1.997 . . . . 0.0 108.106 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.674 ' C ' ' O ' ' A' ' 63' ' ' GLY . 2.2 mm? 0.76 86.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.541 0.686 . . . . 0.0 111.252 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.0 t -120.29 117.55 28.12 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.521 -0.737 . . . . 0.0 110.507 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.738 ' CE1' ' CD2' ' A' ' 48' ' ' TRP . 1.8 m-85 -82.51 130.65 35.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.388 -0.82 . . . . 0.0 109.186 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.605 ' HB3' ' O ' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -132.9 121.81 23.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.902 -1.124 . . . . 0.0 110.528 179.626 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.508 ' O ' ' HD3' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -125.31 156.26 38.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.492 -0.755 . . . . 0.0 109.229 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.544 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 11.5 tpp180 -174.68 -56.92 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 120.773 -1.204 . . . . 0.0 111.183 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 69' ' ' ARG . 41.2 Cg_endo -67.01 -50.39 1.08 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.651 1.343 . . . . 0.0 110.542 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.88 HG11 ' O ' ' A' ' 56' ' ' ASN . 1.3 p -78.57 165.23 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 121.739 0.78 . . . . 0.0 110.852 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.534 ' N ' ' CG2' ' A' ' 71' ' ' VAL . . . -163.83 -43.1 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.257 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 75' ' ' THR . 16.8 mt-30 -56.1 -172.85 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.156 -0.965 . . . . 0.0 110.246 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.74 85.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.916 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.696 HG22 ' CG ' ' A' ' 56' ' ' ASN . 0.1 OUTLIER -136.96 5.36 2.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -0.868 . . . . 0.0 110.312 -179.619 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.585 ' CB ' ' NE1' ' A' ' 207' ' ' TRP . 1.8 p30 -99.16 155.07 17.66 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.217 -0.927 . . . . 0.0 109.962 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 114.65 104.36 2.55 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 106.848 -2.501 . . . . 0.0 106.848 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.806 ' O ' ' HA ' ' A' ' 204' ' ' SER . 2.0 m -116.95 163.0 14.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.161 -1.2 . . . . 0.0 110.322 -178.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.755 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 3.9 ttp180 -120.16 169.34 10.33 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.643 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.559 ' HA2' ' CB ' ' A' ' 52' ' ' ASP . . . -164.22 83.46 0.11 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.496 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 3.7 ttpm? -116.88 16.11 15.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.389 -1.065 . . . . 0.0 110.421 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.456 ' O ' ' C ' ' A' ' 83' ' ' GLY . 1.1 ptt180 -76.16 -101.98 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.106 -0.996 . . . . 0.0 110.228 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 82' ' ' ARG . . . 41.58 46.22 4.62 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.45 ' CE1' ' NH1' ' A' ' 86' ' ' ARG . 0.6 OUTLIER -98.58 103.88 15.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.228 -1.16 . . . . 0.0 110.174 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.561 ' HB3' ' CE1' ' A' ' 89' ' ' HIS . 11.5 t -139.9 173.36 11.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 110.362 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.551 ' N ' ' CD ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -118.53 139.33 51.62 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.372 -0.83 . . . . 0.0 109.827 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 103.36 -112.25 4.17 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.66 ' C ' HD23 ' A' ' 88' ' ' LEU . 7.5 tt -128.18 134.53 49.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -1.128 . . . . 0.0 110.362 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.581 ' CD2' ' O ' ' A' ' 88' ' ' LEU . 7.7 m80 -146.86 161.7 40.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.329 -0.857 . . . . 0.0 109.688 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.06 146.59 10.86 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.082 -1.011 . . . . 0.0 110.508 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 1.122 ' CZ2' HG11 ' A' ' 169' ' ' VAL . 1.7 p90 -135.13 171.3 14.63 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.305 -0.872 . . . . 0.0 109.473 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 215' ' ' ARG . 15.6 tt0 -137.71 140.12 40.55 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.265 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.616 HG13 ' CD1' ' A' ' 91' ' ' TRP . 4.4 mt -140.03 154.22 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.984 ' O ' HG23 ' A' ' 212' ' ' VAL . 0.4 OUTLIER -147.24 122.12 9.98 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.03 -1.068 . . . . 0.0 111.651 -179.005 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.843 ' HH2' ' O ' ' A' ' 204' ' ' SER . 37.0 m95 -111.63 88.45 9.45 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 94' ' ' SER . 52.5 Cg_endo -83.61 108.95 1.51 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.695 1.366 . . . . 0.0 111.524 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.513 HD13 ' HA ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.253 -0.904 . . . . 0.0 109.622 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.975 HG22 ' O ' ' A' ' 204' ' ' SER 0.264 3.6 m . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.769 HG22 ' CE2' ' A' ' 95' ' ' TRP . 1.0 OUTLIER -152.27 122.47 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.399 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 202' ' ' SER . . . 168.76 -161.64 35.36 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 118.832 -1.651 . . . . 0.0 110.898 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.044 HG23 ' C ' ' A' ' 200' ' ' TYR . 1.4 p -141.49 150.67 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.596 -0.943 . . . . 0.0 109.835 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 200' ' ' TYR . . . -128.57 152.78 47.92 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.059 -1.026 . . . . 0.0 110.724 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.768 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -101.24 126.35 47.97 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.264 -0.898 . . . . 0.0 110.296 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.528 ' HB3' ' HE2' ' A' ' 200' ' ' TYR . . . -93.58 -30.22 15.09 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.591 0.71 . . . . 0.0 109.726 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.579 ' O ' ' C ' ' A' ' 113' ' ' ALA . 0.8 OUTLIER -80.96 -11.83 59.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.458 -0.776 . . . . 0.0 109.926 179.819 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.579 ' C ' ' O ' ' A' ' 112' ' ' LEU . . . . . . . . 0 N--CA 1.499 1.977 0 O-C-N 121.829 -0.544 . . . . 0.0 111.222 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.257 0.551 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 110' ' ' THR . 1.7 tt0 -150.02 130.06 13.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.298 -0.876 . . . . 0.0 110.087 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.496 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 47.9 t -120.46 119.92 34.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 110.211 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' TRP . . . . . 0.527 ' O ' ' O ' ' A' ' 108' ' ' VAL . 0.6 OUTLIER -128.1 124.57 37.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -0.939 . . . . 0.0 110.138 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.48 ' HA3' ' HA3' ' A' ' 107' ' ' GLY . . . 170.82 -133.95 2.96 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.709 ' CZ3' HD23 ' A' ' 167' ' ' LEU . 47.3 m0 -121.36 112.84 19.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.09 -1.241 . . . . 0.0 110.404 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -119.22 111.46 18.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.643 -0.661 . . . . 0.0 110.448 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 22.2 pt . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.1 -1.0 . . . . 0.0 110.229 179.648 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 1.046 HG11 HG21 ' A' ' 182' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 95' ' ' TRP . 44.3 Cg_endo -71.51 64.42 2.94 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.067 1.562 . . . . 0.0 110.379 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -168.48 -83.85 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.487 -0.758 . . . . 0.0 109.805 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.735 ' C ' HD12 ' A' ' 167' ' ' LEU . 2.2 ttp180 -152.12 150.43 29.88 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.432 -0.793 . . . . 0.0 110.348 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.837 ' N ' HD12 ' A' ' 167' ' ' LEU . 1.7 mp -144.92 131.04 19.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 110.274 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.706 HD13 ' N ' ' A' ' 169' ' ' VAL . 2.6 tm? -103.79 124.54 49.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.351 -0.843 . . . . 0.0 109.595 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 1.122 HG11 ' CZ2' ' A' ' 91' ' ' TRP . 2.4 t -107.18 135.53 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.943 . . . . 0.0 110.63 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.554 ' CG1' HD11 ' A' ' 187' ' ' LEU . 9.7 p -112.48 133.32 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.507 -0.746 . . . . 0.0 109.836 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.822 HD22 ' HG3' ' A' ' 201' ' ' PRO . 11.5 tp -133.03 105.87 7.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.151 -0.968 . . . . 0.0 110.228 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 173' ' ' MET . 49.1 t0 -103.83 136.02 44.28 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.24 -0.912 . . . . 0.0 109.943 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.519 ' HG2' ' HA ' ' A' ' 86' ' ' ARG . 5.5 tpt -96.91 -41.81 8.24 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.747 -0.595 . . . . 0.0 110.231 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.505 ' C ' ' O ' ' A' ' 173' ' ' MET . 2.7 tm-20 -40.26 -28.66 0.06 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.893 . . . . 0.0 108.666 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.678 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.2 OUTLIER -114.84 -26.64 7.72 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.422 ' O ' ' CG2' ' A' ' 198' ' ' THR . . . 81.2 25.35 55.29 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.491 -1.844 . . . . 0.0 108.491 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' THR . . . . . 1.073 HG22 ' CD2' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -113.42 127.82 56.25 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.335 -1.097 . . . . 0.0 111.436 -179.335 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 1.031 ' O ' HD11 ' A' ' 194' ' ' LEU . 0.1 OUTLIER -134.74 153.71 51.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.473 -0.767 . . . . 0.0 109.378 178.794 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -155.52 172.74 33.67 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.52 -1.324 . . . . 0.0 109.984 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 1.052 ' CE1' HG22 ' A' ' 169' ' ' VAL . 0.4 OUTLIER -118.77 122.89 43.49 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.47 -1.018 . . . . 0.0 109.895 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' A' ' 186' ' ' TYR . 16.7 t -142.79 139.26 30.91 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.31 -0.869 . . . . 0.0 110.051 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 1.046 HG21 HG11 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -98.56 116.76 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.341 -0.849 . . . . 0.0 109.923 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 81.63 -7.26 62.4 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 86.31 42.35 6.63 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.26 -35.94 8.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.31 -1.112 . . . . 0.0 110.415 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.467 ' O ' ' HB2' ' A' ' 181' ' ' SER . 24.6 m-85 -109.12 90.22 3.23 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.187 -0.946 . . . . 0.0 110.312 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.687 HD22 ' CZ ' ' A' ' 191' ' ' PHE . 0.7 OUTLIER -176.7 28.32 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.471 -0.768 . . . . 0.0 109.671 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.478 ' H ' ' HD2' ' A' ' 189' ' ' PRO . . . -110.51 -71.67 0.66 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.842 -1.171 . . . . 0.0 110.403 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.478 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 44.9 Cg_endo -70.87 -28.84 19.41 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.952 1.501 . . . . 0.0 111.026 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -74.17 15.44 0.32 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.299 -0.876 . . . . 0.0 111.142 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.687 ' CZ ' HD22 ' A' ' 187' ' ' LEU . 0.3 OUTLIER -90.52 -16.3 29.12 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.004 -1.06 . . . . 0.0 110.408 179.652 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ARG . . . . . 0.436 ' NE ' ' HA ' ' A' ' 192' ' ' ARG . 0.0 OUTLIER -90.03 -13.97 34.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.319 -0.863 . . . . 0.0 110.75 -179.616 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -112.47 -8.8 20.68 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 108.786 -1.725 . . . . 0.0 108.786 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 1.073 ' CD2' HG22 ' A' ' 177' ' ' THR . 7.7 tt -78.19 -31.66 49.6 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.617 -0.931 . . . . 0.0 109.213 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.453 ' CA ' HG23 ' A' ' 198' ' ' THR . 0.0 OUTLIER -53.56 -39.73 64.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.438 -0.789 . . . . 0.0 109.707 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -86.04 -24.61 40.41 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.836 ' NH1' HD11 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -91.09 -4.59 56.13 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.644 -0.916 . . . . 0.0 110.09 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 198' ' ' THR . . . . . 0.873 HG23 ' O ' ' A' ' 194' ' ' LEU . 26.0 p -43.06 116.44 0.9 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.496 -0.753 . . . . 0.0 110.986 -178.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.993 ' HB2' HG22 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -128.69 171.82 11.83 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.564 -0.71 . . . . 0.0 109.955 179.654 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 1.044 ' C ' HG23 ' A' ' 108' ' ' VAL . 14.9 m-30 -83.49 134.72 44.66 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.196 -0.94 . . . . 0.0 109.952 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.822 ' HG3' HD22 ' A' ' 171' ' ' LEU . 43.9 Cg_endo -68.35 118.58 5.73 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.089 1.573 . . . . 0.0 111.614 -178.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -134.01 148.62 51.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.469 -0.769 . . . . 0.0 110.49 179.737 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.465 HG22 ' N ' ' A' ' 204' ' ' SER . 8.2 p -149.84 159.13 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.125 -0.984 . . . . 0.0 110.311 179.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' SER . . . . . 0.975 ' O ' HG22 ' A' ' 105' ' ' VAL . 0.3 OUTLIER -144.88 125.67 14.29 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.178 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.721 ' H ' HG22 ' A' ' 78' ' ' VAL . . . -115.72 166.55 11.81 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.438 0.637 . . . . 0.0 110.854 -178.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.578 ' CG1' ' HB3' ' A' ' 210' ' ' CYS . 1.1 p -136.88 165.57 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.343 -0.848 . . . . 0.0 109.952 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 0.916 ' CD1' HG21 ' A' ' 57' ' ' ILE . 40.7 p-90 -132.91 -2.68 3.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.092 -1.005 . . . . 0.0 110.175 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -74.62 -0.83 59.94 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -175.99 -41.69 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.449 -1.03 . . . . 0.0 110.724 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' CYS . . . . . 0.578 ' HB3' ' CG1' ' A' ' 206' ' ' VAL . 0.0 OUTLIER -98.96 146.3 26.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.429 -0.795 . . . . 0.0 110.802 -179.542 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -135.01 102.6 5.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.531 -0.731 . . . . 0.0 109.545 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.984 HG23 ' O ' ' A' ' 94' ' ' SER . 7.2 p -104.42 143.84 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.439 -0.788 . . . . 0.0 110.38 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ARG . . . . . 0.559 ' CD ' ' HB2' ' A' ' 94' ' ' SER . 2.9 ptp180 -95.61 131.64 41.61 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.324 -0.86 . . . . 0.0 109.619 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.719 HG22 ' CE2' ' A' ' 48' ' ' TRP . 1.2 tt -118.84 113.95 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.061 -1.024 . . . . 0.0 111.561 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.612 ' O ' ' N ' ' A' ' 92' ' ' GLU . 7.6 ttm180 -112.99 108.81 17.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.073 -1.017 . . . . 0.0 108.896 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' TYR . . . . . 0.707 ' CD2' ' HB2' ' A' ' 91' ' ' TRP . 1.6 t80 -104.44 149.65 25.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.93 . . . . 0.0 111.179 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.24 107.92 7.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.579 -0.7 . . . . 0.0 109.917 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 141.5 -22.02 2.55 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.172 -1.193 . . . . 0.0 110.194 -179.932 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.987 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.21 0.529 . . . . 0.0 109.888 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.708 ' HA ' HD23 ' A' ' 33' ' ' LEU . 0.9 OUTLIER -45.97 -42.8 13.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.307 -0.87 . . . . 0.0 109.783 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -56.92 -23.27 43.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.4 -0.813 . . . . 0.0 109.302 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.716 ' HB3' HD12 ' A' ' 29' ' ' LEU . 16.7 tp -83.22 -34.5 25.86 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.128 HD21 ' CG ' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -72.92 -36.34 67.23 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.917 0.865 . . . . 0.0 109.116 179.124 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.604 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 1.4 m -69.17 -14.29 62.9 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.252 0.549 . . . . 0.0 110.465 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.954 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -51.72 -61.85 3.75 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.164 -0.96 . . . . 0.0 110.201 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.954 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 43.3 Cg_endo -69.86 110.31 2.54 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.988 1.52 . . . . 0.0 110.77 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.775 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 49.1 Cg_endo -74.92 -24.81 12.64 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 124.146 1.603 . . . . 0.0 112.84 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.775 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 42.3 Cg_endo -68.3 152.4 75.74 Favored 'Trans proline' 0 C--N 1.315 -1.214 0 O-C-N 122.892 0.943 . . . . 0.0 112.38 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.611 ' O ' ' CG ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER 4.79 80.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 123.561 1.648 . . . . 0.0 110.887 -178.694 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.98 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER 179.97 -51.7 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 113.655 -1.611 . . . . 0.0 107.705 178.874 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.848 HG22 HD13 ' A' ' 40' ' ' LEU . 1.8 t -87.36 -20.17 7.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 118.933 -1.107 . . . . 0.0 109.661 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.27 -46.49 8.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.154 -0.966 . . . . 0.0 111.954 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.59 ' O ' ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -79.39 -20.89 46.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.662 -1.274 . . . . 0.0 109.411 -179.464 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.833 ' HA ' HG23 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -72.47 -36.22 68.41 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.491 -0.884 . . . . 0.0 108.767 179.283 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.751 ' NE2' HG12 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -81.73 -26.07 34.88 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.866 -0.521 . . . . 0.0 110.272 -179.546 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -96.38 -28.7 14.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.129 -0.982 . . . . 0.0 110.104 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.83 -111.09 1.02 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.961 ' CZ2' HG23 ' A' ' 212' ' ' VAL . 88.6 m95 -91.63 73.97 5.88 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.09 -1.241 . . . . 0.0 109.436 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 1.045 HD22 ' HG3' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -52.4 150.09 9.35 Favored Pre-proline 0 N--CA 1.489 1.495 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.151 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.713 ' O ' ' N ' ' A' ' 53' ' ' CYS . 54.2 Cg_endo -91.81 -0.01 4.39 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 122.273 1.982 . . . . 0.0 113.221 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 1.045 ' HG3' HD22 ' A' ' 49' ' ' ASN . 0.0 OUTLIER 0.69 -98.69 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.639 0 CA-C-O 122.646 1.212 . . . . 0.0 111.192 -178.842 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.819 ' HB3' ' NE ' ' A' ' 79' ' ' ARG 0.259 0.5 OUTLIER -62.19 -28.08 69.42 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.568 -179.707 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.867 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . 0.7 OUTLIER -104.82 -177.02 3.24 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.323 1.059 . . . . 0.0 112.481 -178.096 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.594 ' O ' ' HB3' ' A' ' 50' ' ' PRO . 2.0 m -87.38 165.21 15.76 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.897 0.856 . . . . 0.0 111.257 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 1.128 ' CG ' HD21 ' A' ' 33' ' ' LEU . 2.5 pm0 -94.21 9.71 36.88 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.045 0.926 . . . . 0.0 108.748 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.55 ' C ' ' O ' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -16.27 -38.26 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.263 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.837 ' N ' ' O ' ' A' ' 55' ' ' GLU . 6.6 pt -130.12 167.43 25.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.128 -178.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.933 ' HB2' HD23 ' A' ' 40' ' ' LEU . 6.0 t0 -107.76 141.39 39.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.401 -0.812 . . . . 0.0 110.11 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.833 HG23 ' HA ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -130.42 136.03 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.337 -0.852 . . . . 0.0 110.509 -179.166 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.543 ' NZ ' ' HB2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -135.27 155.05 51.28 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.977 -1.077 . . . . 0.0 110.755 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 62' ' ' GLY . 5.3 mt-10 -78.24 -129.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.515 -0.741 . . . . 0.0 110.115 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 42.15 42.98 4.39 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.666 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 116.11 48.1 0.49 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.807 HD23 ' CZ ' ' A' ' 213' ' ' ARG . 0.5 OUTLIER 0.42 90.5 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.847 -0.796 . . . . 0.0 111.084 -179.438 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -124.96 123.2 39.38 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.493 -0.754 . . . . 0.0 111.194 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.924 ' HE2' HG22 ' A' ' 212' ' ' VAL . 18.2 m-85 -83.39 127.1 33.4 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.61 ' O ' ' HB ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -110.38 121.15 44.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.007 -1.058 . . . . 0.0 110.557 -179.495 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.589 ' HD3' ' N ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -136.11 155.98 49.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.491 -0.755 . . . . 0.0 109.365 179.471 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.589 ' N ' ' HD3' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -173.18 -55.98 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 120.929 -1.107 . . . . 0.0 111.065 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 69' ' ' ARG . 40.9 Cg_endo -67.24 -47.66 2.16 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.756 1.398 . . . . 0.0 110.645 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.547 ' CG2' ' N ' ' A' ' 72' ' ' ALA . 1.6 p -78.49 165.29 3.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-O 121.937 0.875 . . . . 0.0 110.983 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.547 ' N ' ' CG2' ' A' ' 71' ' ' VAL . . . -159.22 -36.52 0.06 Allowed 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.312 0.577 . . . . 0.0 110.026 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -141.99 13.48 2.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.36 -0.838 . . . . 0.0 110.127 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 75' ' ' THR . 0.6 OUTLIER -63.36 -158.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 110.195 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 74' ' ' SER . 0.6 OUTLIER -54.42 -107.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.164 -0.96 . . . . 0.0 110.27 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.529 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 2.4 m-20 -140.32 150.09 43.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.906 -1.121 . . . . 0.0 110.935 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.529 ' O ' ' ND2' ' A' ' 56' ' ' ASN . . . -40.39 -86.49 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.575 ' CG2' ' O ' ' A' ' 49' ' ' ASN . 0.2 OUTLIER -138.05 145.48 28.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.135 -1.214 . . . . 0.0 109.721 178.523 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.867 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 4.2 tmm_? -148.44 133.83 18.55 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.507 ' HA2' ' HB2' ' A' ' 52' ' ' ASP . . . -126.2 143.34 14.33 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.553 ' HE3' ' CB ' ' A' ' 202' ' ' SER . 0.3 OUTLIER -165.47 9.93 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.067 -1.255 . . . . 0.0 111.451 -179.66 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.74 ' HD2' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -135.27 -9.76 2.23 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.676 -1.265 . . . . 0.0 110.83 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.74 ' N ' ' HD2' ' A' ' 82' ' ' ARG . . . -74.81 38.1 1.07 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.733 ' HE1' HD11 ' A' ' 171' ' ' LEU . 15.8 t80 -94.17 119.37 32.89 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.435 -1.038 . . . . 0.0 110.087 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.7 p -99.92 177.48 5.1 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.302 -0.874 . . . . 0.0 110.395 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.592 ' HA ' ' CB ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -108.04 167.38 10.04 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.307 -0.871 . . . . 0.0 109.933 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.473 ' N ' ' HB3' ' A' ' 173' ' ' MET . . . 100.77 -124.71 8.34 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.497 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 1.3 tp -129.06 130.12 46.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.463 -1.022 . . . . 0.0 110.398 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.552 ' NE2' ' O ' ' A' ' 86' ' ' ARG . 8.4 m-70 -147.29 158.64 44.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.129 -0.982 . . . . 0.0 109.968 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.545 ' O ' ' O ' ' A' ' 217' ' ' MET . . . -161.6 135.22 6.54 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.129 -0.982 . . . . 0.0 109.58 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 1.225 ' CZ3' HG11 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -134.09 156.28 48.54 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.917 -1.114 . . . . 0.0 109.846 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.665 ' O ' ' N ' ' A' ' 215' ' ' ARG . 0.8 OUTLIER -109.53 124.07 50.47 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.705 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 1.067 HG23 ' OH ' ' A' ' 180' ' ' TYR . 0.8 OUTLIER -141.85 154.12 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.953 -1.092 . . . . 0.0 110.62 -179.325 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.503 ' CB ' ' HB3' ' A' ' 213' ' ' ARG . 0.6 OUTLIER -134.17 123.09 23.78 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.5 -0.75 . . . . 0.0 109.093 179.425 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.766 ' HH2' ' O ' ' A' ' 204' ' ' SER . 2.1 t90 -127.6 88.21 54.16 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.067 -1.021 . . . . 0.0 110.817 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -95.43 109.08 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 124.154 1.608 . . . . 0.0 110.166 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.637 HD23 ' HE1' ' A' ' 95' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 O-C-N 120.843 -1.16 . . . . 0.0 110.315 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.711 HG13 ' O ' ' A' ' 204' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 121.498 0.666 . . . . 0.0 112.015 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.942 HG23 HD11 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -151.24 112.91 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.687 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.571 ' HA3' ' HA3' ' A' ' 132' ' ' GLY . . . 179.55 -147.31 7.51 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 118.621 -1.752 . . . . 0.0 111.223 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.628 ' CG1' ' HB2' ' A' ' 199' ' ' LEU . 1.4 t -139.66 170.27 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.554 -0.968 . . . . 0.0 109.618 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 130' ' ' SER . . . -121.17 139.88 52.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.998 -1.064 . . . . 0.0 110.766 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.865 ' OG1' HD23 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -136.47 133.73 36.88 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.32 -0.862 . . . . 0.0 110.461 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.16 -26.08 17.57 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.308 -0.87 . . . . 0.0 109.266 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.448 ' O ' ' C ' ' A' ' 113' ' ' ALA . 1.0 OUTLIER -85.37 -12.19 52.74 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.545 -0.722 . . . . 0.0 109.445 179.416 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.579 ' HB2' ' HB ' ' A' ' 110' ' ' THR . . . . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.552 -0.718 . . . . 0.0 110.646 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.194 0.521 . . . . 0.0 110.092 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 113' ' ' ALA . 5.9 tp10 -150.21 141.44 23.17 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.271 -0.893 . . . . 0.0 109.692 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.551 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 13.4 t -119.86 120.05 35.33 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.592 -0.692 . . . . 0.0 109.978 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -133.36 136.38 45.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.378 -0.827 . . . . 0.0 109.619 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.606 ' O ' ' CD1' ' A' ' 133' ' ' TRP . . . -178.0 -107.56 0.22 Allowed Glycine 0 N--CA 1.487 2.093 0 C-N-CA 119.545 -1.312 . . . . 0.0 109.924 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.715 ' CH2' ' HB2' ' A' ' 180' ' ' TYR . 5.2 m-90 -141.0 128.91 21.8 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.26 -1.141 . . . . 0.0 111.568 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -118.74 148.04 43.22 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.723 -0.611 . . . . 0.0 109.743 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.942 HD11 HG23 ' A' ' 106' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.344 -0.848 . . . . 0.0 109.921 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.969 HG13 ' HD2' ' A' ' 164' ' ' PRO . 15.2 t . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.969 ' HD2' HG13 ' A' ' 163' ' ' VAL . 38.2 Cg_endo -64.57 -177.89 0.6 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.693 1.365 . . . . 0.0 110.758 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 94' ' ' SER . 0.3 OUTLIER -48.57 -58.2 5.05 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.43 -0.794 . . . . 0.0 110.389 -179.402 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.469 ' HA ' ' HB3' ' A' ' 94' ' ' SER . 1.3 ttp180 -151.94 155.96 39.1 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.498 -0.751 . . . . 0.0 110.578 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.868 HD23 HG12 ' A' ' 182' ' ' ILE . 0.9 OUTLIER -137.68 157.74 45.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.483 -0.761 . . . . 0.0 109.782 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.416 ' HG ' ' OE1' ' A' ' 92' ' ' GLU . 3.4 tt -103.11 126.72 50.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.93 . . . . 0.0 109.799 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 1.225 HG11 ' CZ3' ' A' ' 91' ' ' TRP . 57.9 t -90.04 138.3 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.349 -0.844 . . . . 0.0 110.829 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 178' ' ' LEU . 85.9 t -116.14 111.51 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.545 -0.722 . . . . 0.0 109.265 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.884 HD12 ' HB3' ' A' ' 178' ' ' LEU . 14.4 tp -118.94 105.51 11.54 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.966 -1.084 . . . . 0.0 110.251 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.438 ' OD2' HD12 ' A' ' 88' ' ' LEU . 4.5 t70 -120.58 133.79 55.34 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.339 -0.851 . . . . 0.0 110.209 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.592 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 1.6 tpt -99.7 -37.96 8.9 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.25 -24.15 1.67 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.474 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.1 OUTLIER -107.04 -26.28 11.22 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.202 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.715 ' O ' HG21 ' A' ' 198' ' ' THR . . . 82.17 24.47 54.62 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 108.604 -1.798 . . . . 0.0 108.604 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.693 ' HA ' HD22 ' A' ' 194' ' ' LEU . 0.6 OUTLIER -130.07 122.91 29.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.093 -1.239 . . . . 0.0 111.486 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.973 HD11 ' O ' ' A' ' 199' ' ' LEU . 0.1 OUTLIER -140.52 153.58 46.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.454 -0.779 . . . . 0.0 109.611 179.168 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.451 ' O ' HG13 ' A' ' 169' ' ' VAL . . . 179.98 -152.2 10.65 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.633 -1.27 . . . . 0.0 110.212 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 1.067 ' OH ' HG23 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -123.0 142.21 51.09 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.331 -1.099 . . . . 0.0 109.332 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.503 ' HA ' ' HB3' ' A' ' 186' ' ' TYR . 15.3 t -140.76 124.78 17.3 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.422 -0.799 . . . . 0.0 110.154 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.868 HG12 HD23 ' A' ' 167' ' ' LEU . 0.1 OUTLIER -107.26 116.64 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.215 -0.928 . . . . 0.0 109.276 179.502 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 79.81 -47.19 3.25 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 137.62 36.39 0.17 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' THR . . . . . 0.435 ' O ' ' C ' ' A' ' 186' ' ' TYR . 73.0 m -122.89 -51.47 1.91 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.242 -1.152 . . . . 0.0 110.859 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.573 ' CD2' HD11 ' A' ' 182' ' ' ILE . 0.1 OUTLIER -40.98 -74.34 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.079 -1.013 . . . . 0.0 110.613 -179.415 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.897 HD23 ' CZ ' ' A' ' 191' ' ' PHE . 1.1 mp -71.25 43.85 0.08 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.001 -1.062 . . . . 0.0 109.886 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 186' ' ' TYR . . . -75.67 -99.28 0.13 Allowed Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.472 ' C ' ' H ' ' A' ' 191' ' ' PHE . 49.6 Cg_endo -74.13 -24.17 15.05 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.207 1.635 . . . . 0.0 110.946 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.557 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -65.86 16.81 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.487 -0.758 . . . . 0.0 111.724 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.897 ' CZ ' HD23 ' A' ' 187' ' ' LEU . 0.3 OUTLIER -90.45 -16.68 28.53 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.828 -1.17 . . . . 0.0 110.394 179.56 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ARG . . . . . 0.43 ' HA ' ' NE ' ' A' ' 192' ' ' ARG . 0.0 OUTLIER -90.2 -15.12 32.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.282 -0.886 . . . . 0.0 110.902 -179.452 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -110.82 -16.95 9.42 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.693 HD22 ' HA ' ' A' ' 177' ' ' THR . 7.5 tt -67.86 -36.31 80.08 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.617 -0.931 . . . . 0.0 108.87 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.507 ' HA ' HG23 ' A' ' 177' ' ' THR . 0.0 OUTLIER -44.69 -34.88 2.4 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.403 -0.811 . . . . 0.0 109.825 179.562 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.443 ' N ' ' HD2' ' A' ' 195' ' ' LYS . . . -94.11 -27.31 12.43 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.748 ' HD3' HD11 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.94 -4.69 56.3 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.603 -0.94 . . . . 0.0 110.108 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 198' ' ' THR . . . . . 0.715 HG21 ' O ' ' A' ' 176' ' ' GLY . 0.7 OUTLIER -44.06 143.49 1.14 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.825 0.821 . . . . 0.0 111.649 -178.327 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.973 ' O ' HD11 ' A' ' 178' ' ' LEU . 0.0 OUTLIER -140.28 171.74 13.73 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.53 ' O ' ' N ' ' A' ' 109' ' ' ALA . 2.8 m-30 -84.18 129.81 56.87 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 120.925 -1.11 . . . . 0.0 109.782 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.499 ' HD3' ' CD1' ' A' ' 178' ' ' LEU . 41.6 Cg_endo -67.51 115.75 3.87 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.888 1.468 . . . . 0.0 111.035 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.553 ' CB ' ' HE3' ' A' ' 81' ' ' LYS . 1.6 p -133.14 154.06 50.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.43 -0.794 . . . . 0.0 110.229 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.687 HG23 ' HA ' ' A' ' 106' ' ' VAL . 2.0 p -158.1 164.11 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.32 -0.863 . . . . 0.0 110.217 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' SER . . . . . 0.766 ' O ' ' HH2' ' A' ' 95' ' ' TRP . 0.1 OUTLIER -157.94 126.56 5.57 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.397 -0.815 . . . . 0.0 109.981 179.309 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -119.23 161.63 20.06 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.312 -0.868 . . . . 0.0 110.831 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.559 ' CG1' ' N ' ' A' ' 207' ' ' TRP . 1.1 t -124.33 176.14 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 CA-C-O 121.251 0.548 . . . . 0.0 110.063 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 0.774 ' HB3' HD12 ' A' ' 57' ' ' ILE . 44.2 p90 -103.31 155.0 18.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -0.883 . . . . 0.0 110.056 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 135.18 -152.84 20.95 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' GLN . . . . . 0.466 ' O ' ' O ' ' A' ' 210' ' ' CYS . 5.1 tm0? -66.89 -29.04 68.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.324 -1.103 . . . . 0.0 110.258 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 209' ' ' GLN . 9.2 t -46.74 175.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.304 -0.872 . . . . 0.0 109.985 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.432 ' HG2' ' C ' ' A' ' 210' ' ' CYS . 0.8 OUTLIER -170.11 111.29 0.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 110.588 -179.868 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.961 HG23 ' CZ2' ' A' ' 48' ' ' TRP . 27.4 m -115.42 145.39 21.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.527 -0.733 . . . . 0.0 109.783 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ARG . . . . . 0.89 ' HE ' ' HA ' ' A' ' 213' ' ' ARG . 0.7 OUTLIER -108.48 128.54 54.89 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.204 179.728 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.723 ' HB ' ' CZ3' ' A' ' 48' ' ' TRP . 5.6 tt -123.51 119.62 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.026 -1.047 . . . . 0.0 111.933 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.665 ' N ' ' O ' ' A' ' 92' ' ' GLU . 23.3 ttt180 -130.33 135.07 47.69 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' TYR . . . . . 0.66 ' HA ' ' HB3' ' A' ' 91' ' ' TRP . 1.8 t80 -119.07 151.02 39.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.651 -1.281 . . . . 0.0 112.265 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' MET . . . . . 0.545 ' O ' ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -131.11 107.77 9.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.686 -0.634 . . . . 0.0 109.612 179.061 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 79.23 61.87 2.28 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.578 ' HB2' ' CD1' ' A' ' 216' ' ' TYR . 16.9 tt0 . . . . . 0 N--CA 1.493 1.722 0 O-C-N 121.138 -1.213 . . . . 0.0 110.237 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.956 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 121.126 0.488 . . . . 0.0 110.092 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 1.03 ' HA ' HD23 ' A' ' 33' ' ' LEU . 16.1 pt-20 -45.74 -37.82 6.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 109.719 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.471 ' N ' ' HG3' ' A' ' 30' ' ' GLU . 1.7 tm-20 -72.4 -23.21 61.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.376 -0.828 . . . . 0.0 109.167 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.609 ' O ' ' HD2' ' A' ' 36' ' ' PRO . 15.3 tp -83.81 -30.49 26.5 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.03 HD23 ' HA ' ' A' ' 30' ' ' GLU . 0.3 OUTLIER -71.0 -34.35 71.26 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 122.081 0.943 . . . . 0.0 108.968 179.304 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.608 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -83.81 -6.93 59.54 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.072 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.995 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -71.5 -65.73 0.84 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.313 -0.867 . . . . 0.0 111.11 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.995 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 49.6 Cg_endo -75.45 143.97 28.3 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.607 1.32 . . . . 0.0 110.441 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 36' ' ' PRO . 53.9 Cg_endo -99.02 54.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.947 1.764 . . . . 0.0 112.251 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.722 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 51.8 Cg_endo -75.52 150.91 36.63 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 122.958 0.978 . . . . 0.0 109.845 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.653 ' O ' ' HB3' ' A' ' 43' ' ' GLN . 0.9 OUTLIER -34.04 -34.52 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.187 -0.946 . . . . 0.0 109.662 179.895 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.245 ' O ' ' HB3' ' A' ' 44' ' ' ARG . 1.8 tp -62.79 -43.91 97.57 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 110.34 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.858 ' HA ' ' CE1' ' A' ' 45' ' ' HIS . 46.6 t -86.68 -36.8 10.65 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 C-N-CA 118.389 -1.324 . . . . 0.0 110.029 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.13 -40.12 11.21 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.436 -0.906 . . . . 0.0 112.696 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.653 ' HB3' ' O ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -87.88 -19.15 27.76 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 120.899 -1.126 . . . . 0.0 110.164 -178.645 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 1.245 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 5.3 ttt180 -84.66 -52.62 5.95 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.795 1.284 . . . . 0.0 109.778 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.858 ' CE1' ' HA ' ' A' ' 41' ' ' VAL . 0.3 OUTLIER -52.35 -15.03 0.54 Allowed 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.26 -179.406 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 20.4 t-160 -82.84 -38.59 22.81 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 118.147 -1.421 . . . . 0.0 110.136 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.736 ' O ' ' N ' ' A' ' 49' ' ' ASN . . . -94.39 -109.93 2.2 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 106.234 -2.746 . . . . 0.0 106.234 177.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.817 ' CZ3' ' HA ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -58.39 71.42 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 177.062 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.736 ' N ' ' O ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -57.66 109.95 2.14 Favored Pre-proline 0 C--N 1.289 -2.052 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.192 -178.615 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.757 ' HA ' HG23 ' A' ' 78' ' ' VAL . 51.5 Cg_endo -92.54 -0.03 3.92 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.171 1.914 . . . . 0.0 110.448 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.698 ' HA ' ' HE3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -44.97 -77.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.147 -0.97 . . . . 0.0 110.425 -179.518 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.626 ' HB3' ' HE ' ' A' ' 79' ' ' ARG . 0.2 OUTLIER -40.57 -19.29 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.708 0.766 . . . . 0.0 109.192 178.784 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.638 ' N ' ' O ' ' A' ' 51' ' ' LYS . 3.1 t -114.69 -178.52 3.39 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.653 0.74 . . . . 0.0 110.776 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.579 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 0.3 OUTLIER -89.0 166.6 13.79 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.84 0.828 . . . . 0.0 110.595 -179.736 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.935 ' CG ' HD22 ' A' ' 33' ' ' LEU . 3.2 pp20? -81.93 8.75 9.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.713 -0.617 . . . . 0.0 110.039 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.579 ' ND2' ' O ' ' A' ' 54' ' ' SER . 0.1 OUTLIER -24.51 -33.1 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.675 0.75 . . . . 0.0 110.134 -179.534 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.797 ' N ' ' O ' ' A' ' 55' ' ' GLU . 6.1 pt -141.73 165.18 18.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.798 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.685 ' CB ' HD13 ' A' ' 40' ' ' LEU . 9.2 t0 -114.91 126.79 55.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.463 -0.773 . . . . 0.0 109.967 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.747 HG11 ' CD1' ' A' ' 48' ' ' TRP . 57.7 t -130.04 127.01 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.115 -0.991 . . . . 0.0 109.907 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.675 ' HA ' ' CH2' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -136.37 157.1 47.6 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.986 -1.071 . . . . 0.0 111.585 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.67 ' N ' ' CH2' ' A' ' 48' ' ' TRP . 1.3 tt0 -52.5 -110.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.694 -0.629 . . . . 0.0 111.076 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 44.54 37.57 5.0 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 107.661 -2.176 . . . . 0.0 107.661 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.73 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 94.35 78.32 1.41 Allowed Glycine 0 N--CA 1.486 1.973 0 N-CA-C 107.809 -2.117 . . . . 0.0 107.809 -178.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.73 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.4 OUTLIER 1.26 88.21 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.661 -0.905 . . . . 0.0 110.126 -178.711 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 46.4 t -122.35 114.64 21.05 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.425 -0.797 . . . . 0.0 111.677 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.658 ' CE2' HG23 ' A' ' 212' ' ' VAL . 0.1 OUTLIER -84.41 135.36 34.3 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.501 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.556 ' O ' ' N ' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -138.39 131.62 30.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.851 -1.156 . . . . 0.0 111.15 -179.535 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.552 ' HG2' ' CA ' ' A' ' 208' ' ' GLY . 0.0 OUTLIER -130.71 141.81 50.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.53 -0.732 . . . . 0.0 109.043 179.133 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.605 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 2.4 ttp180 -110.46 -68.2 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.783 -1.198 . . . . 0.0 111.325 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.605 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 56.3 Cg_endo -71.61 -124.1 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.5 0 O-C-N 123.394 1.207 . . . . 0.0 109.586 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.55 ' O ' ' N ' ' A' ' 73' ' ' GLN . 3.6 t -140.1 164.18 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.441 -1.412 . . . . 0.0 109.874 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.923 ' HB2' ' CE3' ' A' ' 207' ' ' TRP . . . -46.66 91.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.169 -0.957 . . . . 0.0 109.892 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.55 ' N ' ' O ' ' A' ' 71' ' ' VAL . 9.8 mt-30 -50.08 -176.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.932 . . . . 0.0 110.313 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.0 m -51.76 -18.84 1.37 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 0.0 110.127 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 1.3 m -96.87 -131.88 0.2 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.215 -0.928 . . . . 0.0 110.081 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.579 ' O ' ' C ' ' A' ' 77' ' ' GLY . 80.5 m-20 -140.4 154.83 46.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.187 -0.946 . . . . 0.0 110.172 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.579 ' C ' ' O ' ' A' ' 76' ' ' ASP . . . -31.88 -77.78 0.03 OUTLIER Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.757 HG23 ' HA ' ' A' ' 50' ' ' PRO . 0.4 OUTLIER -149.18 153.29 11.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.345 -1.091 . . . . 0.0 109.783 179.024 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.626 ' HE ' ' HB3' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -145.7 174.63 11.03 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.712 -0.617 . . . . 0.0 110.071 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.576 ' N ' ' CG ' ' A' ' 79' ' ' ARG . . . -157.48 152.55 23.83 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.513 ' HB2' ' CB ' ' A' ' 202' ' ' SER . 0.1 OUTLIER 179.85 -27.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.206 -1.173 . . . . 0.0 110.661 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.48 ' HG2' ' OD1' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -72.92 -100.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.137 -0.977 . . . . 0.0 110.334 -179.794 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 82' ' ' ARG . . . 43.0 59.61 3.28 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.526 ' CD2' ' O ' ' A' ' 84' ' ' TYR . 28.2 t80 -95.33 95.68 8.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.18 -1.188 . . . . 0.0 110.185 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.451 ' O ' ' HG2' ' A' ' 173' ' ' MET . 0.1 OUTLIER -140.11 173.67 11.28 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 110.252 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.541 ' HA ' ' CB ' ' A' ' 173' ' ' MET . 2.3 mmt85 -101.42 -174.36 2.58 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.177 -0.952 . . . . 0.0 109.676 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.96 158.35 15.98 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.774 ' O ' HD23 ' A' ' 88' ' ' LEU . 1.8 tt -87.47 127.41 35.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -1.11 . . . . 0.0 109.98 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.421 ' NE2' ' O ' ' A' ' 86' ' ' ARG . 40.9 m-70 -133.25 173.1 11.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 110.162 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -156.76 151.31 25.56 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.07 -1.019 . . . . 0.0 110.389 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.811 ' CZ2' HG11 ' A' ' 169' ' ' VAL . 4.1 p90 -146.2 171.06 15.5 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.246 -0.909 . . . . 0.0 109.936 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.584 ' N ' ' O ' ' A' ' 215' ' ' ARG . 0.7 OUTLIER -138.28 152.14 48.26 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.351 -0.939 . . . . 0.0 111.45 -178.758 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 1.037 HG23 HD21 ' A' ' 167' ' ' LEU . 3.7 tt -144.18 151.58 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.545 -0.722 . . . . 0.0 109.674 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.544 ' HG ' ' HG2' ' A' ' 213' ' ' ARG . 0.1 OUTLIER -142.65 135.85 28.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.092 -1.005 . . . . 0.0 110.672 -179.572 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.608 ' CH2' ' HA ' ' A' ' 205' ' ' ALA . 88.3 m95 -104.47 96.25 9.83 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.775 -0.578 . . . . 0.0 110.204 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.621 ' HD2' ' O ' ' A' ' 211' ' ' GLN . 45.9 Cg_endo -72.29 152.37 55.45 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 121.959 1.772 . . . . 0.0 111.214 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 1.216 HD22 ' O ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.795 0 O-C-N 121.533 -0.729 . . . . 0.0 111.158 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.924 HG23 ' CB ' ' A' ' 204' ' ' SER . 34.9 m . . . . . 0 N--CA 1.485 1.29 0 CA-C-O 121.779 0.8 . . . . 0.0 110.471 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.861 ' HB ' HG23 ' A' ' 203' ' ' VAL . 9.0 p -152.31 166.91 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.396 -0.815 . . . . 0.0 109.121 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.666 ' CA ' ' HA3' ' A' ' 132' ' ' GLY . . . 176.28 167.99 35.8 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 118.987 -1.578 . . . . 0.0 110.941 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.039 ' CG1' HD13 ' A' ' 199' ' ' LEU . 2.2 t -123.91 155.61 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.712 -0.876 . . . . 0.0 109.017 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.997 ' HB3' ' CZ ' ' A' ' 200' ' ' TYR . . . -142.96 150.78 40.15 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.805 -1.185 . . . . 0.0 111.365 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . 1.015 ' OG1' HD23 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -131.45 134.95 46.71 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.513 -0.742 . . . . 0.0 110.087 179.505 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.96 -24.77 18.28 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.343 -0.848 . . . . 0.0 109.337 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.6 pp -86.69 -12.11 49.29 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.583 -0.698 . . . . 0.0 109.255 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.669 ' HB3' ' HB2' ' A' ' 129' ' ' GLU . . . . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.465 -0.772 . . . . 0.0 110.44 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 32.0 t . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.243 0.544 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.669 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 0.2 OUTLIER -133.5 119.64 19.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 110.051 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 3.1 t -120.58 119.99 34.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 110.334 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -123.68 124.91 43.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.851 . . . . 0.0 109.693 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.666 ' HA3' ' CA ' ' A' ' 107' ' ' GLY . . . -164.53 -164.36 19.64 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.607 ' CH2' ' O ' ' A' ' 180' ' ' TYR . 36.4 m0 -114.64 113.17 24.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -1.103 . . . . 0.0 110.462 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -119.63 107.77 13.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.709 -0.62 . . . . 0.0 109.488 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.699 HG23 ' O ' ' A' ' 135' ' ' ILE . 15.7 tt . . . . . 0 C--N 1.298 -1.643 0 O-C-N 121.156 -0.965 . . . . 0.0 110.394 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.858 HG12 ' HD3' ' A' ' 164' ' ' PRO . 8.4 p . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 119.917 -0.087 . . . . 0.0 111.134 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.858 ' HD3' HG12 ' A' ' 163' ' ' VAL . 48.3 Cg_endo -79.3 52.51 4.31 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 O-C-N 123.068 1.036 . . . . 0.0 109.792 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' A' ' 94' ' ' SER . 0.9 OUTLIER 178.77 -72.4 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.693 0.759 . . . . 0.0 109.371 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.422 ' HA ' ' HB3' ' A' ' 94' ' ' SER . 1.4 tpp180 -140.85 144.0 35.08 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 1.037 HD21 HG23 ' A' ' 93' ' ' ILE . 0.6 OUTLIER -164.36 157.08 17.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.041 -1.037 . . . . 0.0 110.745 -179.604 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.502 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . 7.7 tt -123.31 137.14 54.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.286 -0.884 . . . . 0.0 110.082 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.889 HG21 ' CE1' ' A' ' 180' ' ' TYR . 19.0 t -121.4 147.94 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 110.082 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.604 HG21 HD21 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -127.89 128.87 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.181 -0.95 . . . . 0.0 110.438 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.739 HD13 HD22 ' A' ' 178' ' ' LEU . 4.7 tp -133.14 105.91 7.3 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.225 -0.922 . . . . 0.0 109.678 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.509 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 54.3 t0 -114.88 136.64 52.88 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 110.648 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.541 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -93.26 -39.6 10.9 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.799 -0.563 . . . . 0.0 109.689 179.678 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 173' ' ' MET . 3.5 tt0 -42.51 -28.07 0.2 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.323 -0.861 . . . . 0.0 108.894 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.59 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 3.0 tt0 -111.86 -26.22 9.04 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.521 ' O ' ' HB ' ' A' ' 198' ' ' THR . . . 80.0 25.07 58.58 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' THR . . . . . 1.097 HG22 HD22 ' A' ' 194' ' ' LEU . 0.2 OUTLIER -121.81 136.7 54.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.191 -1.182 . . . . 0.0 111.252 -179.431 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 1.098 ' O ' HD11 ' A' ' 194' ' ' LEU . 0.3 OUTLIER -144.66 153.76 42.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.56 -0.713 . . . . 0.0 109.514 179.302 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -154.03 167.6 32.28 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.588 -1.292 . . . . 0.0 110.197 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.889 ' CE1' HG21 ' A' ' 169' ' ' VAL . 0.9 OUTLIER -118.74 125.26 49.23 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.594 -0.945 . . . . 0.0 108.906 179.64 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.539 ' CB ' ' HB2' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -144.41 165.07 28.96 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.069 -1.019 . . . . 0.0 110.646 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 1.009 HD11 ' CD2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -120.81 116.65 50.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 O-C-N 121.667 -0.646 . . . . 0.0 109.38 179.402 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 62.78 11.67 37.8 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 86.92 34.52 10.93 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' THR . . . . . 0.76 HG22 ' CE1' ' A' ' 186' ' ' TYR . 31.8 m -87.43 -79.41 0.28 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -1.161 . . . . 0.0 110.545 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 1.009 ' CD2' HD11 ' A' ' 182' ' ' ILE . 2.0 m-85 -83.66 89.47 7.13 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.971 -1.081 . . . . 0.0 110.389 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.629 ' HG ' ' CE1' ' A' ' 191' ' ' PHE . 12.3 tp 179.9 29.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.589 -0.694 . . . . 0.0 109.504 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.438 ' H ' ' HD2' ' A' ' 189' ' ' PRO . . . -106.73 -72.06 0.8 Allowed Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.754 -1.212 . . . . 0.0 110.984 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.438 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 44.8 Cg_endo -70.48 -30.84 18.35 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.899 1.473 . . . . 0.0 111.727 -178.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.657 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -72.42 17.21 0.11 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.125 -0.984 . . . . 0.0 111.519 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.629 ' CE1' ' HG ' ' A' ' 187' ' ' LEU . 1.1 m-30 -90.83 -22.14 21.13 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.962 -1.086 . . . . 0.0 110.981 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ARG . . . . . 0.476 ' HG2' ' NH1' ' A' ' 192' ' ' ARG . 0.1 OUTLIER -90.02 -14.66 33.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.033 -1.042 . . . . 0.0 110.659 -179.391 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -106.62 -17.36 12.27 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.516 -1.834 . . . . 0.0 108.516 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 1.098 HD11 ' O ' ' A' ' 178' ' ' LEU . 7.2 tt -65.99 -41.44 91.1 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.699 -0.883 . . . . 0.0 109.525 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.559 ' HE3' ' N ' ' A' ' 196' ' ' GLY . 0.0 OUTLIER -47.07 -31.12 3.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.455 -0.778 . . . . 0.0 110.415 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.559 ' N ' ' HE3' ' A' ' 195' ' ' LYS . . . -99.61 -22.91 11.57 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 1.014 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -91.22 -3.66 56.74 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.942 -0.74 . . . . 0.0 110.164 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 198' ' ' THR . . . . . 0.789 HG23 ' O ' ' A' ' 194' ' ' LEU . 33.9 p -42.6 123.17 2.53 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.781 0.801 . . . . 0.0 111.785 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 1.039 HD13 ' CG1' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -140.72 172.9 12.05 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.495 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.997 ' CZ ' ' HB3' ' A' ' 109' ' ' ALA . 41.0 p90 -83.13 131.26 54.13 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 120.934 -1.104 . . . . 0.0 109.625 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.51 ' HA ' HG13 ' A' ' 108' ' ' VAL . 52.2 Cg_endo -81.74 132.43 7.65 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 124.01 1.532 . . . . 0.0 111.935 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.513 ' CB ' ' HB2' ' A' ' 81' ' ' LYS . 20.0 p -133.44 127.31 33.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.61 -0.681 . . . . 0.0 109.346 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.861 HG23 ' HB ' ' A' ' 106' ' ' VAL . 11.8 p -119.66 156.33 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.01 -1.056 . . . . 0.0 110.589 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' SER . . . . . 0.924 ' CB ' HG23 ' A' ' 105' ' ' VAL . 1.4 m -134.18 129.27 35.55 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.527 -0.733 . . . . 0.0 110.726 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 1.001 ' HB1' HG21 ' A' ' 212' ' ' VAL . . . -123.14 131.22 53.6 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.285 0.564 . . . . 0.0 110.202 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.611 HG13 ' N ' ' A' ' 207' ' ' TRP . 1.2 t -47.35 176.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.46 -0.775 . . . . 0.0 110.419 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 0.923 ' CE3' ' HB2' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -101.3 -50.44 3.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.201 -0.937 . . . . 0.0 111.072 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.69 ' N ' ' CG ' ' A' ' 207' ' ' TRP . . . -144.36 -1.19 0.93 Allowed Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.596 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' GLN . . . . . 0.545 ' OE1' ' CH2' ' A' ' 207' ' ' TRP . 4.0 tp60 -66.9 -23.43 65.99 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.424 -1.045 . . . . 0.0 109.646 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' CYS . . . . . 0.549 ' SG ' ' CG1' ' A' ' 206' ' ' VAL . 20.7 p -143.98 -121.98 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.625 0.726 . . . . 0.0 110.018 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.621 ' O ' ' HD2' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -173.53 139.55 0.75 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.634 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 1.001 HG21 ' HB1' ' A' ' 205' ' ' ALA . 2.3 t -127.24 140.6 48.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 120.607 -1.308 . . . . 0.0 111.321 -178.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ARG . . . . . 0.713 ' HA ' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -128.39 109.28 11.28 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.153 178.73 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.665 ' O ' HD11 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -123.54 150.79 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.425 -0.797 . . . . 0.0 110.913 -179.024 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.584 ' O ' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -130.0 108.89 10.44 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.925 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 216' ' ' TYR . . . . . 0.714 ' CD2' ' CB ' ' A' ' 91' ' ' TRP . 1.5 t80 -115.8 140.28 49.37 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.187 -0.945 . . . . 0.0 111.048 -178.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' MET . . . . . 0.421 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 0.0 OUTLIER -136.71 123.99 21.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.648 -0.657 . . . . 0.0 110.142 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 145.8 -37.54 1.26 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.274 -1.133 . . . . 0.0 110.224 -179.949 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.647 HD11 ' HG3' ' A' ' 70' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.153 0.502 . . . . 0.0 110.218 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.705 ' HA ' HD23 ' A' ' 33' ' ' LEU . 10.6 pt-20 -48.57 -29.26 4.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.119 -0.988 . . . . 0.0 108.819 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -66.75 -23.52 66.1 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 29' ' ' LEU . 15.1 tp -83.22 -35.85 25.08 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.833 HD12 ' C ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -73.25 -38.01 66.14 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.903 0.858 . . . . 0.0 109.027 178.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.577 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 23.0 t -58.56 -22.71 56.62 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.444 0.64 . . . . 0.0 110.062 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.985 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -57.95 -173.71 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.454 -0.779 . . . . 0.0 109.555 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.985 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 42.5 Cg_endo -69.16 102.28 0.91 Allowed 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.875 1.461 . . . . 0.0 110.099 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.693 ' HD3' ' O ' ' A' ' 35' ' ' ALA . 49.1 Cg_endo -94.23 121.21 0.35 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.19 1.627 . . . . 0.0 111.215 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.904 ' O ' ' N ' ' A' ' 40' ' ' LEU . 51.6 Cg_endo -83.84 149.58 12.51 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.925 1.487 . . . . 0.0 110.524 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.634 ' C ' ' O ' ' A' ' 38' ' ' PRO . 0.6 OUTLIER 3.02 51.98 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 122.126 0.965 . . . . 0.0 111.358 -179.649 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.068 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -139.63 -48.89 0.47 Allowed 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 178.154 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 1.068 HG23 ' CD1' ' A' ' 40' ' ' LEU . 2.7 t -88.52 -32.76 6.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 119.327 -0.949 . . . . 0.0 108.554 177.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.46 -43.97 10.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.638 -0.664 . . . . 0.0 112.049 -178.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.738 ' OE1' ' HA ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -81.41 -19.99 41.37 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.056 -1.058 . . . . 0.0 109.972 -178.78 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.696 ' HD2' HG22 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -71.85 -51.63 21.42 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.613 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.805 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 2.1 m-70 -56.38 -16.35 5.54 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.638 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -95.04 -33.19 12.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.263 -0.898 . . . . 0.0 109.383 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.645 ' C ' ' CE3' ' A' ' 48' ' ' TRP . . . -83.77 -101.93 0.56 Allowed Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.157 -1.977 . . . . 0.0 108.157 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.786 ' CD2' ' N ' ' A' ' 48' ' ' TRP . 0.3 OUTLIER -86.86 73.06 10.03 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 122.963 1.363 . . . . 0.0 108.479 179.492 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 49' ' ' ASN . 0.1 OUTLIER -46.21 111.67 1.53 Allowed Pre-proline 0 C--N 1.287 -2.148 0 CA-C-N 114.218 -1.356 . . . . 0.0 112.333 -178.295 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.708 ' O ' ' N ' ' A' ' 52' ' ' ASP . 55.4 Cg_endo -91.9 2.09 4.2 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.496 2.131 . . . . 0.0 110.277 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.764 ' HA ' ' CE ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -52.34 71.29 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.909 1.338 . . . . 0.0 111.655 -177.783 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.708 ' N ' ' O ' ' A' ' 50' ' ' PRO . 1.6 m-20 178.03 0.16 0.0 OUTLIER 'General case' 0 C--N 1.262 -3.213 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.2 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.85 ' HB2' ' CB ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -166.01 -175.69 3.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.389 -0.819 . . . . 0.0 111.259 -178.187 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.798 ' HB2' HG21 ' A' ' 75' ' ' THR . 0.0 OUTLIER -51.78 124.5 12.63 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.955 0.883 . . . . 0.0 110.709 -179.016 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.745 ' C ' ' H ' ' A' ' 57' ' ' ILE . 1.6 pt-20 -99.67 8.41 44.37 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.591 0.71 . . . . 0.0 110.956 -179.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.732 ' C ' HD13 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -58.84 22.94 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.666 0.746 . . . . 0.0 110.199 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.745 ' H ' ' C ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -112.99 166.13 7.15 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 CA-C-O 121.679 0.752 . . . . 0.0 110.342 -179.7 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.776 ' HA ' HD23 ' A' ' 40' ' ' LEU . 10.1 t0 -134.72 96.32 3.53 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 121.868 0.842 . . . . 0.0 109.737 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.764 ' HA ' ' O ' ' A' ' 65' ' ' CYS . 1.4 m -121.7 121.33 64.11 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 CA-C-O 121.27 0.557 . . . . 0.0 110.186 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.738 ' HA ' ' OE1' ' A' ' 43' ' ' GLN . 7.9 ttmt -135.75 153.42 51.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 110.658 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.554 ' N ' ' HG2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -55.27 -123.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.431 -0.793 . . . . 0.0 110.724 -179.457 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 44.0 32.37 2.34 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.698 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 110.9 65.47 0.53 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.698 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.2 OUTLIER 0.63 90.23 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.835 -0.803 . . . . 0.0 110.832 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.764 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 1.0 OUTLIER -116.88 114.4 23.83 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.528 -0.733 . . . . 0.0 109.786 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.709 ' CE2' HG11 ' A' ' 59' ' ' VAL . 13.4 t80 -116.25 123.56 48.02 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.461 -0.774 . . . . 0.0 109.541 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -151.82 149.03 28.54 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.909 -1.119 . . . . 0.0 110.886 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.627 ' HB2' HG23 ' A' ' 57' ' ' ILE . 17.4 ttt85 -122.51 152.87 39.9 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.253 -0.904 . . . . 0.0 109.71 179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.68 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 2.7 mtt180 -85.8 -69.02 0.13 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.084 -1.01 . . . . 0.0 110.398 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.68 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 56.1 Cg_endo -71.34 -145.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.706 1.371 . . . . 0.0 109.382 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.502 ' O ' ' HG2' ' A' ' 73' ' ' GLN . 4.8 t -140.01 164.45 22.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 O-C-N 121.378 -0.826 . . . . 0.0 109.954 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.781 ' HB2' ' CE3' ' A' ' 207' ' ' TRP . . . -63.06 111.38 2.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.208 -0.932 . . . . 0.0 110.105 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.502 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 0.9 OUTLIER -140.65 -103.81 0.15 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.238 -0.914 . . . . 0.0 110.393 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.482 ' C ' ' O ' ' A' ' 73' ' ' GLN . 8.4 t -38.26 -29.95 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.166 -0.958 . . . . 0.0 110.39 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.798 HG21 ' HB2' ' A' ' 54' ' ' SER . 2.7 t -137.49 -134.69 0.14 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.254 -0.904 . . . . 0.0 110.049 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.627 ' O ' ' C ' ' A' ' 77' ' ' GLY . 2.3 t0 -140.11 154.6 47.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 109.905 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.639 ' O ' ' OG ' ' A' ' 54' ' ' SER . . . -25.01 -94.0 0.01 OUTLIER Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.65 ' CG1' HG13 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -158.24 163.13 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.098 -1.236 . . . . 0.0 109.521 179.728 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.85 ' CB ' ' HB2' ' A' ' 53' ' ' CYS . 3.1 tmm_? -141.08 134.66 30.05 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.4 -0.813 . . . . 0.0 110.776 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.891 ' C ' HG12 ' A' ' 203' ' ' VAL . . . -116.17 -152.34 9.86 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.001 -2.039 . . . . 0.0 108.001 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.845 ' C ' ' HA ' ' A' ' 202' ' ' SER . 0.0 OUTLIER 2.02 123.33 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.414 -1.05 . . . . 0.0 110.986 179.357 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.556 ' HA ' ' CB ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -126.46 -19.83 4.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.267 -0.896 . . . . 0.0 110.549 -179.444 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.552 ' HA3' ' HB3' ' A' ' 200' ' ' TYR . . . 133.53 37.73 0.23 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.544 ' HB2' ' HD3' ' A' ' 82' ' ' ARG . 7.9 t80 -134.8 95.86 3.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.06 -1.259 . . . . 0.0 110.286 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.691 ' CB ' HD11 ' A' ' 171' ' ' LEU . 0.7 OUTLIER -140.16 140.68 35.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.169 -0.957 . . . . 0.0 110.538 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.58 ' HA ' ' CB ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -131.42 145.44 51.81 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -0.902 . . . . 0.0 109.597 179.654 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.452 ' N ' ' HB3' ' A' ' 173' ' ' MET . . . 81.18 165.71 34.79 Favored Glycine 0 N--CA 1.481 1.693 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.466 ' O ' HD23 ' A' ' 88' ' ' LEU . 4.9 tt -87.23 117.86 26.27 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.34 -1.094 . . . . 0.0 110.047 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.454 ' NE2' ' O ' ' A' ' 86' ' ' ARG . 91.4 m-70 -135.39 173.28 11.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -0.882 . . . . 0.0 109.881 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.36 136.58 23.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.14 -0.975 . . . . 0.0 110.107 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 1.152 ' CZ2' HG11 ' A' ' 169' ' ' VAL . 0.5 OUTLIER -135.07 171.0 15.05 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.156 -0.965 . . . . 0.0 110.632 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 215' ' ' ARG . 2.6 mt-10 -133.41 151.19 51.79 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.745 -0.597 . . . . 0.0 110.004 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.584 HG13 ' CD1' ' A' ' 91' ' ' TRP . 11.5 mt -144.6 154.85 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.237 -0.915 . . . . 0.0 110.799 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . 1.095 ' O ' HG23 ' A' ' 212' ' ' VAL . 14.5 t -141.3 151.43 43.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 109.642 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.764 ' CZ2' HG23 ' A' ' 106' ' ' VAL . 14.4 m95 -137.39 90.92 14.7 Favored Pre-proline 0 C--N 1.296 -1.721 0 O-C-N 121.526 -0.734 . . . . 0.0 110.565 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.535 ' HD2' ' HA ' ' A' ' 212' ' ' VAL . 49.4 Cg_endo -78.93 125.41 6.6 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.977 1.514 . . . . 0.0 110.149 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.586 ' CD2' HD13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.184 -0.947 . . . . 0.0 110.229 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.751 HG13 ' HA ' ' A' ' 134' ' ' ASP . 1.5 t . . . . . 0 N--CA 1.499 2.002 0 CA-C-O 120.982 0.42 . . . . 0.0 111.023 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.764 HG23 ' CZ2' ' A' ' 95' ' ' TRP . 5.5 t -132.84 148.58 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.021 -1.049 . . . . 0.0 109.253 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.664 ' HA3' ' HA2' ' A' ' 132' ' ' GLY . . . 175.62 -156.89 22.83 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 118.916 -1.611 . . . . 0.0 111.658 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.783 HG12 ' HB2' ' A' ' 199' ' ' LEU . 2.4 t -135.8 150.48 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.727 -0.866 . . . . 0.0 109.494 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.545 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -120.36 152.94 37.18 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.066 -1.021 . . . . 0.0 110.933 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.979 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -125.76 130.08 50.76 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.277 -0.889 . . . . 0.0 110.491 179.828 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.39 -27.79 16.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.53 -0.731 . . . . 0.0 109.539 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.428 HD11 ' O ' ' A' ' 196' ' ' GLY . 2.0 pp -83.4 -12.1 56.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.527 -0.733 . . . . 0.0 109.558 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.748 ' HB3' ' HB2' ' A' ' 129' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.512 -0.742 . . . . 0.0 110.462 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.277 0.56 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.748 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -137.98 123.3 19.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.194 -0.941 . . . . 0.0 109.974 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.4 t -142.29 139.52 31.9 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.279 -0.888 . . . . 0.0 110.112 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 8.4 m0 -124.62 128.51 48.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 108.929 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.664 ' HA2' ' HA3' ' A' ' 107' ' ' GLY . . . -127.05 -162.44 11.18 Favored Glycine 0 N--CA 1.484 1.846 0 C-N-CA 118.821 -1.657 . . . . 0.0 111.266 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.716 ' CZ3' ' CD1' ' A' ' 180' ' ' TYR . 6.4 m0 -126.14 118.12 24.58 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.766 -0.843 . . . . 0.0 110.723 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.751 ' HA ' HG13 ' A' ' 105' ' ' VAL . 13.5 t70 -118.68 111.57 18.69 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.599 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.664 HG21 ' CB ' ' A' ' 95' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.747 0 O-C-N 121.156 -0.965 . . . . 0.0 110.315 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 1.003 HG11 ' HG ' ' A' ' 167' ' ' LEU . 1.3 t . . . . . 0 N--CA 1.493 1.717 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 1.002 ' HD2' HG12 ' A' ' 163' ' ' VAL . 39.2 Cg_endo -65.12 -177.54 0.63 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.557 1.293 . . . . 0.0 111.481 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.53 ' O ' ' OG ' ' A' ' 94' ' ' SER . 0.3 OUTLIER -40.49 -41.6 1.46 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.737 -0.602 . . . . 0.0 111.068 -179.086 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.846 ' C ' HD13 ' A' ' 167' ' ' LEU . 8.3 ttt-85 -146.83 155.99 42.77 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.231 -0.918 . . . . 0.0 110.767 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 1.003 ' HG ' HG11 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -157.56 158.42 35.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.459 -0.775 . . . . 0.0 110.658 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.548 ' O ' ' O ' ' A' ' 181' ' ' SER . 0.6 OUTLIER -102.99 141.15 36.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.144 -0.972 . . . . 0.0 109.673 -179.758 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 1.152 HG11 ' CZ2' ' A' ' 91' ' ' TRP . 9.3 t -119.25 139.52 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.078 -1.014 . . . . 0.0 111.107 -179.024 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.695 ' HB ' HD13 ' A' ' 187' ' ' LEU . 12.7 t -114.13 109.27 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.419 -0.8 . . . . 0.0 109.241 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.876 HD12 ' CD2' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -121.56 108.84 14.07 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.134 -0.979 . . . . 0.0 110.476 -179.225 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 36.9 t0 -120.21 132.69 55.46 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.799 0.809 . . . . 0.0 110.018 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.58 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 7.0 tpt -94.79 -37.72 11.11 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.847 -0.533 . . . . 0.0 109.642 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 173' ' ' MET . 3.9 mt-10 -43.65 -27.19 0.29 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.522 -0.871 . . . . 0.0 108.805 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.563 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.0 OUTLIER -112.25 -26.53 8.73 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.036 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.489 ' O ' ' CG2' ' A' ' 198' ' ' THR . . . 82.49 23.49 56.29 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.995 HG22 ' CD2' ' A' ' 194' ' ' LEU . 0.1 OUTLIER -120.26 124.14 44.92 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.139 -1.213 . . . . 0.0 111.189 -179.559 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 1.078 ' O ' HD11 ' A' ' 194' ' ' LEU . 2.3 mp -135.24 152.45 51.55 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.55 -0.719 . . . . 0.0 109.568 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.97 ' C ' HD11 ' A' ' 187' ' ' LEU . . . -155.52 177.84 32.46 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.48 -1.343 . . . . 0.0 110.262 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.731 ' CE2' HG21 ' A' ' 163' ' ' VAL . 0.5 OUTLIER -118.77 125.62 50.02 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.499 -1.0 . . . . 0.0 108.836 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.548 ' O ' ' O ' ' A' ' 168' ' ' LEU . 43.5 t -144.18 140.85 29.58 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.084 -1.01 . . . . 0.0 111.135 -179.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.756 HG22 ' HB3' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -95.66 116.33 37.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.478 -0.763 . . . . 0.0 109.319 179.056 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 87.97 -35.07 3.59 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 116.1 39.6 0.87 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 54.9 m -127.28 -5.42 6.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.21 -1.17 . . . . 0.0 110.725 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.494 ' HB3' ' HB2' ' A' ' 181' ' ' SER . 0.3 OUTLIER -85.05 -46.83 10.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.99 -1.069 . . . . 0.0 110.372 -179.852 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.97 HD11 ' C ' ' A' ' 179' ' ' GLY . 2.4 mt -82.09 41.98 0.7 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.181 -0.95 . . . . 0.0 110.024 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -79.89 -91.17 0.44 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 191' ' ' PHE . 47.6 Cg_endo -73.56 -24.82 15.69 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.012 1.532 . . . . 0.0 110.772 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -69.07 21.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.48 -0.763 . . . . 0.0 111.7 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.66 ' CE1' HD22 ' A' ' 187' ' ' LEU . 0.3 OUTLIER -90.27 -38.0 13.71 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.788 -1.195 . . . . 0.0 110.372 179.57 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.67 -13.57 60.64 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.145 -0.972 . . . . 0.0 110.495 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -107.81 -7.69 31.12 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.791 -1.723 . . . . 0.0 108.791 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 1.078 HD11 ' O ' ' A' ' 178' ' ' LEU . 10.5 tt -78.14 -36.52 47.63 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.498 ' CA ' HG23 ' A' ' 198' ' ' THR . 1.0 OUTLIER -44.07 -44.02 7.22 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.679 -0.638 . . . . 0.0 109.933 179.126 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.428 ' O ' HD11 ' A' ' 112' ' ' LEU . . . -83.29 -26.24 44.62 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.729 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.75 -3.69 57.24 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.699 -0.883 . . . . 0.0 109.934 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 198' ' ' THR . . . . . 0.727 HG23 ' O ' ' A' ' 194' ' ' LEU . 11.2 p -42.73 135.12 3.02 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.825 0.821 . . . . 0.0 111.722 -177.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.979 ' CB ' HG23 ' A' ' 110' ' ' THR . 0.0 OUTLIER -140.15 171.0 14.8 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.68 -0.638 . . . . 0.0 109.381 179.454 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.612 ' C ' HG13 ' A' ' 108' ' ' VAL . 25.1 m-85 -84.56 129.29 57.92 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 120.997 -1.064 . . . . 0.0 110.123 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.854 ' HG3' HD12 ' A' ' 171' ' ' LEU . 52.8 Cg_endo -83.38 111.52 1.83 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.954 1.502 . . . . 0.0 110.78 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.845 ' HA ' ' C ' ' A' ' 81' ' ' LYS . 12.2 p -133.94 160.61 37.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 109.864 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.891 HG12 ' C ' ' A' ' 80' ' ' GLY . 14.4 p -122.87 157.11 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.731 -1.23 . . . . 0.0 110.924 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 105' ' ' VAL . 0.3 OUTLIER -138.57 127.2 23.41 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.496 -0.752 . . . . 0.0 109.094 178.781 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -128.15 157.85 39.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.954 -1.091 . . . . 0.0 110.481 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.805 HG13 ' N ' ' A' ' 207' ' ' TRP . 5.9 p -90.13 -137.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.193 -0.942 . . . . 0.0 110.103 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 0.805 ' N ' HG13 ' A' ' 206' ' ' VAL . 10.1 p90 -126.21 58.47 1.36 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.975 -1.078 . . . . 0.0 110.493 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 83.27 -1.54 88.54 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' GLN . . . . . 0.498 ' HB3' HG11 ' A' ' 206' ' ' VAL . 3.0 tp60 -75.47 -33.21 60.81 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.486 -1.008 . . . . 0.0 110.257 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' CYS . . . . . 0.659 ' O ' ' C ' ' A' ' 211' ' ' GLN . 48.8 t -124.92 17.24 8.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.337 -0.852 . . . . 0.0 110.259 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.659 ' C ' ' O ' ' A' ' 210' ' ' CYS . 3.2 pt20 0.35 114.46 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.592 0.71 . . . . 0.0 111.859 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 1.095 HG23 ' O ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -118.99 145.19 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.441 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ARG . . . . . 0.688 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 20.1 mtm180 -88.61 151.51 22.43 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.094 -1.004 . . . . 0.0 110.144 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.752 HD12 ' HB3' ' A' ' 48' ' ' TRP . 0.8 OUTLIER -136.36 123.59 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.315 -0.865 . . . . 0.0 111.231 -179.023 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 92' ' ' GLU . 75.2 ttt180 -131.01 108.63 9.93 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' TYR . . . . . 0.69 ' CD2' ' CB ' ' A' ' 91' ' ' TRP . 3.2 t80 -118.45 148.94 42.06 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.001 -1.062 . . . . 0.0 111.454 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' MET . . . . . 0.551 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 0.0 OUTLIER -125.25 107.78 11.07 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.522 -0.736 . . . . 0.0 109.706 179.315 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 134.85 -1.61 3.9 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 . . . . . 0 N--CA 1.493 1.676 0 O-C-N 121.062 -1.258 . . . . 0.0 110.116 179.9 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.914 HD13 ' CG ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 121.127 0.489 . . . . 0.0 109.852 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.548 ' HG3' ' CB ' ' A' ' 73' ' ' GLN . 26.6 mt-10 -49.06 -47.83 44.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.119 -0.988 . . . . 0.0 109.304 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -61.07 -27.5 68.39 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 29' ' ' LEU . 5.9 tp -83.67 -29.36 27.68 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.975 HD13 ' CD ' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -88.09 -36.52 16.87 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.722 0.772 . . . . 0.0 109.47 179.585 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.531 ' N ' HD12 ' A' ' 33' ' ' LEU . 11.6 p -45.84 -31.17 1.97 Allowed 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.683 0.754 . . . . 0.0 109.748 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.812 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . -91.46 167.21 16.16 Favored Pre-proline 0 C--N 1.298 -1.644 0 O-C-N 121.572 -0.705 . . . . 0.0 109.354 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.555 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 43.5 Cg_endo -70.18 99.01 0.76 Allowed 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.063 1.56 . . . . 0.0 110.431 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.812 ' HD3' ' O ' ' A' ' 35' ' ' ALA . 47.5 Cg_endo -96.6 -175.45 0.28 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 121.999 1.799 . . . . 0.0 110.397 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 1.017 ' O ' ' N ' ' A' ' 40' ' ' LEU . 39.6 Cg_endo -65.54 153.31 78.79 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.041 1.548 . . . . 0.0 110.043 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.67 ' O ' ' N ' ' A' ' 43' ' ' GLN . 1.9 t0 -15.29 -34.14 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.375 0.607 . . . . 0.0 110.143 -178.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.034 HD13 ' N ' ' A' ' 41' ' ' VAL . 0.1 OUTLIER -29.4 -46.78 0.06 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.435 -0.791 . . . . 0.0 109.551 178.95 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 1.034 ' N ' HD13 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -85.05 -31.5 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 118.657 -1.217 . . . . 0.0 109.94 179.58 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.628 ' N ' ' O ' ' A' ' 39' ' ' ASP . . . -89.89 -43.29 10.7 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.078 -1.014 . . . . 0.0 110.784 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.746 ' HG3' ' HB2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -72.23 -21.12 61.44 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.449 -0.782 . . . . 0.0 110.653 -179.13 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.723 ' HG2' ' HA ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -76.47 -55.31 5.65 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.879 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.627 ' CE1' ' O ' ' A' ' 41' ' ' VAL . 16.8 m170 -58.89 -18.21 31.06 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -97.82 -25.33 15.08 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.718 0.77 . . . . 0.0 109.259 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.451 ' HA3' HG23 ' A' ' 59' ' ' VAL . . . -63.85 -114.57 0.01 OUTLIER Glycine 0 N--CA 1.479 1.528 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.812 ' CA ' HD13 ' A' ' 214' ' ' ILE . 0.0 OUTLIER -103.26 70.88 1.08 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.492 -1.283 . . . . 0.0 111.052 179.208 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.444 ' OD1' ' HB3' ' A' ' 53' ' ' CYS . 23.0 t30 -109.23 116.65 54.79 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.025 -1.047 . . . . 0.0 110.152 178.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.903 ' HB3' HG12 ' A' ' 203' ' ' VAL . 40.7 Cg_endo -69.07 -64.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 N-CA-C 109.432 -1.026 . . . . 0.0 109.432 178.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 1.124 ' HA ' ' CE ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER 175.49 35.22 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 O-C-N 120.976 -1.077 . . . . 0.0 112.02 177.752 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.888 ' HB2' ' HA2' ' A' ' 80' ' ' GLY 0.25 2.2 m-20 -168.58 20.78 0.02 OUTLIER 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.62 -179.451 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.694 ' SG ' ' NH1' ' A' ' 44' ' ' ARG . 1.7 t -102.23 144.57 30.59 Favored 'General case' 0 C--N 1.289 -2.03 0 C-N-CA 118.866 -1.134 . . . . 0.0 111.657 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.803 ' HB3' HG22 ' A' ' 75' ' ' THR . 0.0 OUTLIER -103.0 167.43 9.84 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.624 0.726 . . . . 0.0 109.954 179.306 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.975 ' CD ' HD13 ' A' ' 33' ' ' LEU . 0.9 OUTLIER -71.35 8.26 1.09 Allowed 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.592 -0.693 . . . . 0.0 111.211 -179.306 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.586 ' C ' ' O ' ' A' ' 55' ' ' GLU . 1.0 OUTLIER -29.02 -32.29 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.923 0.868 . . . . 0.0 109.474 179.414 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.728 ' N ' ' O ' ' A' ' 55' ' ' GLU . 3.7 pt -135.29 167.21 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.797 -0.565 . . . . 0.0 110.107 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.99 ' HB2' HD23 ' A' ' 40' ' ' LEU . 3.4 t0 -109.01 113.04 25.57 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.038 -1.039 . . . . 0.0 110.61 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.752 ' HB ' ' CE2' ' A' ' 48' ' ' TRP . 1.2 m -129.78 135.8 60.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 O-C-N 121.49 -0.756 . . . . 0.0 109.086 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.746 ' HB2' ' HG3' ' A' ' 43' ' ' GLN . 9.0 tttm -128.68 155.31 45.24 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 118.826 -1.15 . . . . 0.0 112.29 -178.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.545 ' O ' ' C ' ' A' ' 62' ' ' GLY . 1.1 tt0 -71.54 -126.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.616 -0.677 . . . . 0.0 110.476 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.545 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 38.85 52.39 2.55 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 107.808 -2.117 . . . . 0.0 107.808 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.662 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 97.86 49.56 1.76 Allowed Glycine 0 N--CA 1.485 1.924 0 N-CA-C 107.113 -2.395 . . . . 0.0 107.113 -177.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.057 HD21 ' CE1' ' A' ' 66' ' ' PHE . 2.8 tt 1.54 93.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.719 0.771 . . . . 0.0 111.232 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 35.0 t -105.32 113.87 27.71 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.602 0.715 . . . . 0.0 110.364 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 1.057 ' CE1' HD21 ' A' ' 64' ' ' LEU . 3.2 m-85 -82.63 130.33 35.1 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.511 -0.743 . . . . 0.0 109.908 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.587 ' HB3' ' O ' ' A' ' 58' ' ' ASP . 2.4 tm-20 -145.75 121.3 10.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.801 -1.187 . . . . 0.0 109.94 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.545 ' CB ' ' HB2' ' A' ' 207' ' ' TRP . 0.5 OUTLIER -126.03 155.3 41.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.371 -0.831 . . . . 0.0 109.404 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.694 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.8 OUTLIER -130.1 -72.52 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 120.89 -1.131 . . . . 0.0 110.875 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.914 ' CG ' HD13 ' A' ' 29' ' ' LEU . 57.1 Cg_endo -72.98 -126.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.434 1.228 . . . . 0.0 109.266 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.444 ' O ' ' OE1' ' A' ' 73' ' ' GLN . 2.4 t -140.31 164.24 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.574 -1.329 . . . . 0.0 109.962 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.948 ' HB1' ' HA ' ' A' ' 76' ' ' ASP . . . -59.84 94.24 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.17 -0.956 . . . . 0.0 110.266 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.548 ' CB ' ' HG3' ' A' ' 30' ' ' GLU . 1.2 mp0 -76.08 -90.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.18 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.49 ' OG ' ' N ' ' A' ' 75' ' ' THR . 1.5 t -44.04 -94.64 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.144 -0.972 . . . . 0.0 109.623 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.803 HG22 ' HB3' ' A' ' 54' ' ' SER . 7.6 t -88.57 -124.37 0.05 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.148 -0.97 . . . . 0.0 109.189 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.948 ' HA ' ' HB1' ' A' ' 72' ' ' ALA . 13.2 p30 -140.55 154.63 46.59 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.836 -1.165 . . . . 0.0 110.413 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.733 ' C ' ' O ' ' A' ' 76' ' ' ASP . . . 2.95 -78.2 0.0 OUTLIER Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.721 HG23 ' HD2' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -158.16 137.42 3.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.507 -0.996 . . . . 0.0 110.389 179.185 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.88 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 0.7 OUTLIER -144.33 150.68 38.2 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.401 0.62 . . . . 0.0 109.779 179.711 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.888 ' HA2' ' HB2' ' A' ' 52' ' ' ASP . . . -165.32 116.23 0.68 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.572 -1.811 . . . . 0.0 108.572 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.597 ' O ' ' C ' ' A' ' 82' ' ' ARG . 4.7 ttpm? -124.59 -75.08 0.6 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.113 -1.227 . . . . 0.0 111.549 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.635 ' HG2' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -25.1 -47.38 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.504 -0.747 . . . . 0.0 111.11 -178.634 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.635 ' N ' ' HG2' ' A' ' 82' ' ' ARG . . . 34.24 58.95 0.65 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -93.85 108.25 20.05 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.426 -1.043 . . . . 0.0 110.645 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.0 162.87 34.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.432 -0.792 . . . . 0.0 110.002 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -118.67 137.91 52.98 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.233 -0.917 . . . . 0.0 109.931 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 173' ' ' MET . . . 111.2 158.59 15.32 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.521 HD12 ' HA ' ' A' ' 172' ' ' ASP . 18.6 tp -87.6 133.27 33.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -1.152 . . . . 0.0 110.19 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.493 ' ND1' ' O ' ' A' ' 88' ' ' LEU . 66.3 m-70 -147.11 173.08 12.82 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.135 -0.978 . . . . 0.0 110.064 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.553 ' O ' ' CB ' ' A' ' 217' ' ' MET . . . -154.03 139.99 18.26 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.203 -0.936 . . . . 0.0 109.64 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.559 ' HB3' ' HA ' ' A' ' 216' ' ' TYR . 0.0 OUTLIER -134.74 166.43 22.97 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.968 -1.083 . . . . 0.0 110.442 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.629 ' N ' ' O ' ' A' ' 215' ' ' ARG . 22.5 tt0 -115.16 138.63 50.69 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.545 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.535 HG22 HG23 ' A' ' 169' ' ' VAL . 0.2 OUTLIER -144.02 134.99 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 120.625 -1.297 . . . . 0.0 110.765 -179.662 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.678 ' HB3' ' HA ' ' A' ' 166' ' ' ARG . 0.9 OUTLIER -118.68 126.38 51.79 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.477 -0.764 . . . . 0.0 109.537 179.421 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.746 ' CE3' ' CG1' ' A' ' 106' ' ' VAL . 2.8 t90 -129.9 87.62 51.37 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.179 -0.95 . . . . 0.0 109.93 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 164' ' ' PRO . 51.6 Cg_endo -95.7 109.15 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.776 1.651 . . . . 0.0 110.742 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.691 HD23 ' O ' ' A' ' 97' ' ' LEU . 5.7 tt . . . . . 0 N--CA 1.49 1.567 0 O-C-N 120.968 -1.083 . . . . 0.0 110.285 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.873 HG23 ' HA ' ' A' ' 134' ' ' ASP . 0.6 OUTLIER . . . . . 0 N--CA 1.501 2.076 0 CA-C-O 121.04 0.448 . . . . 0.0 111.912 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.983 ' HA ' HG23 ' A' ' 203' ' ' VAL . 1.3 p -132.52 141.71 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.935 -1.103 . . . . 0.0 109.999 177.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.601 ' HA3' ' HA3' ' A' ' 132' ' ' GLY . . . 160.93 -149.1 17.89 Favored Glycine 0 N--CA 1.487 2.061 0 C-N-CA 119.628 -1.273 . . . . 0.0 109.959 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.123 ' CG2' HD13 ' A' ' 199' ' ' LEU . 1.6 p -148.73 161.3 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.385 -1.068 . . . . 0.0 110.157 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.512 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -133.75 152.24 51.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.129 -0.982 . . . . 0.0 110.714 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.8 HG23 ' HB3' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -105.98 128.62 53.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.846 . . . . 0.0 109.862 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.74 -27.2 17.37 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.541 -0.725 . . . . 0.0 109.71 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.501 ' O ' ' C ' ' A' ' 113' ' ' ALA . 3.8 pp -83.95 -12.1 55.87 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.512 -0.742 . . . . 0.0 109.538 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 112' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.719 0 O-C-N 121.72 -0.612 . . . . 0.0 110.625 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 57.7 m . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.416 0.627 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 110' ' ' THR . 6.5 tm-20 -150.07 129.42 12.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.916 . . . . 0.0 110.051 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 6.9 t -121.14 120.71 36.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.259 -0.901 . . . . 0.0 110.203 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' TRP . . . . . 0.493 ' O ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -128.86 124.74 36.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.288 -0.883 . . . . 0.0 109.915 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.601 ' HA3' ' HA3' ' A' ' 107' ' ' GLY . . . -172.35 -160.01 20.01 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.704 ' CZ3' HD11 ' A' ' 167' ' ' LEU . 33.9 m0 -109.27 115.09 29.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.214 -1.168 . . . . 0.0 110.192 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.873 ' HA ' HG23 ' A' ' 105' ' ' VAL . 4.1 t70 -118.31 148.08 42.83 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.416 0.627 . . . . 0.0 110.536 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.504 -0.748 . . . . 0.0 109.404 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.869 HG21 HD21 ' A' ' 167' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.437 ' O ' ' HG3' ' A' ' 165' ' ' GLU . 45.4 Cg_endo -72.26 65.97 3.53 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.086 1.571 . . . . 0.0 110.852 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' A' ' 94' ' ' SER . 3.6 mt-10 -167.26 -85.74 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.319 -0.863 . . . . 0.0 109.854 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.678 ' HA ' ' HB3' ' A' ' 94' ' ' SER . 23.6 ttp180 -152.65 156.22 38.82 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.367 -0.833 . . . . 0.0 110.29 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.869 HD21 HG21 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -139.8 133.91 31.03 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.272 -0.892 . . . . 0.0 110.7 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.411 ' O ' ' O ' ' A' ' 181' ' ' SER . 0.4 OUTLIER -103.83 130.78 51.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.329 -0.857 . . . . 0.0 109.228 179.285 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.651 ' CG2' ' CE1' ' A' ' 180' ' ' TYR . 2.7 t -124.57 144.47 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.966 -1.084 . . . . 0.0 111.087 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.451 HG23 HD22 ' A' ' 187' ' ' LEU . 2.3 t -119.84 129.31 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.555 -0.716 . . . . 0.0 109.079 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.987 HD21 ' HE1' ' A' ' 173' ' ' MET . 12.4 tp -133.09 109.82 9.77 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.93 -1.106 . . . . 0.0 110.808 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.521 ' HA ' HD12 ' A' ' 88' ' ' LEU . 5.2 t0 -99.51 139.08 35.7 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.393 -0.817 . . . . 0.0 109.203 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.987 ' HE1' HD21 ' A' ' 171' ' ' LEU . 23.9 mmt -98.95 -44.62 6.26 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.227 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.53 ' HG2' ' N ' ' A' ' 175' ' ' GLU . 3.8 pt-20 -43.48 -24.96 0.12 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.12 -0.987 . . . . 0.0 108.565 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.53 ' N ' ' HG2' ' A' ' 174' ' ' GLU . 3.5 tp10 -115.12 -26.28 7.75 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.06 27.24 58.56 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 -178.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.647 ' HB ' HD22 ' A' ' 194' ' ' LEU . 1.4 p -113.09 139.94 48.29 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.414 -1.051 . . . . 0.0 111.313 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.904 HD21 ' O ' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -146.62 154.05 41.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.533 -0.729 . . . . 0.0 109.73 179.58 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.735 ' C ' HD11 ' A' ' 187' ' ' LEU . . . -141.52 163.69 26.79 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.848 ' N ' HD11 ' A' ' 187' ' ' LEU . 0.9 OUTLIER -118.63 118.31 31.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -1.146 . . . . 0.0 109.484 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.555 ' CB ' ' HB2' ' A' ' 186' ' ' TYR . 2.7 t -144.64 159.05 43.45 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.33 -0.856 . . . . 0.0 110.085 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.536 ' H ' HD13 ' A' ' 182' ' ' ILE . 0.0 OUTLIER -96.08 116.4 37.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.443 -0.785 . . . . 0.0 109.316 179.191 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 72.76 5.71 65.15 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.86 43.31 18.08 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' THR . . . . . 0.494 ' N ' ' OG ' ' A' ' 181' ' ' SER . 95.4 m -116.18 -1.38 12.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.199 -1.177 . . . . 0.0 110.561 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.555 ' HB2' ' CB ' ' A' ' 181' ' ' SER . 0.1 OUTLIER -111.22 -25.08 9.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.153 -0.967 . . . . 0.0 110.359 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.848 HD11 ' N ' ' A' ' 180' ' ' TYR . 4.0 mp -84.46 48.29 1.49 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.252 -0.905 . . . . 0.0 110.105 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.411 ' H ' ' HD2' ' A' ' 189' ' ' PRO . . . -106.86 -73.51 0.85 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.411 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 46.3 Cg_endo -72.6 -29.31 13.29 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.979 1.515 . . . . 0.0 111.167 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.667 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -73.42 12.27 0.63 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.267 -0.896 . . . . 0.0 111.429 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.602 ' CE2' ' O ' ' A' ' 187' ' ' LEU . 0.3 OUTLIER -90.17 -10.68 43.58 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.141 -0.974 . . . . 0.0 109.802 179.132 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.74 -20.22 27.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.381 -0.824 . . . . 0.0 110.908 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.555 ' O ' ' HB3' ' A' ' 197' ' ' ARG . . . -111.15 -13.32 13.67 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.926 HD23 ' O ' ' A' ' 194' ' ' LEU . 3.7 tt -74.56 -19.99 60.12 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.459 ' CE ' ' HA ' ' A' ' 195' ' ' LYS . 0.0 OUTLIER -59.64 -32.08 70.11 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.715 -0.615 . . . . 0.0 109.53 179.119 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -106.83 -25.36 6.24 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.867 ' NH2' HD21 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -82.93 -3.3 56.88 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.855 0.836 . . . . 0.0 109.944 179.653 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 198' ' ' THR . . . . . 0.588 ' HB ' ' CG2' ' A' ' 177' ' ' THR . 0.4 OUTLIER -41.0 136.85 1.38 Allowed 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 122.096 0.951 . . . . 0.0 111.24 -178.1 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 1.123 HD13 ' CG2' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -141.85 171.31 14.23 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.372 -179.653 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.808 ' O ' HG23 ' A' ' 108' ' ' VAL . 97.1 m-85 -86.84 129.7 51.39 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.15 -0.969 . . . . 0.0 109.523 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.691 ' HG3' HD22 ' A' ' 171' ' ' LEU . 42.0 Cg_endo -68.24 121.12 8.08 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.863 1.454 . . . . 0.0 111.19 -179.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.572 ' CB ' ' HA ' ' A' ' 81' ' ' LYS . 97.0 p -133.81 142.06 47.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.342 -0.849 . . . . 0.0 110.939 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.983 HG23 ' HA ' ' A' ' 106' ' ' VAL . 1.1 p -146.4 160.51 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.391 -0.818 . . . . 0.0 109.391 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' SER . . . . . 0.514 ' O ' ' HH2' ' A' ' 95' ' ' TRP . 0.3 OUTLIER -160.35 127.19 4.3 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.415 -0.803 . . . . 0.0 109.645 179.683 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.481 ' H ' HG13 ' A' ' 78' ' ' VAL . . . -114.13 162.1 16.92 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.834 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.67 HG12 ' SG ' ' A' ' 210' ' ' CYS . 1.1 t -105.69 -179.13 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.587 -0.696 . . . . 0.0 110.47 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 0.647 ' N ' HG13 ' A' ' 206' ' ' VAL . 23.0 p90 -94.14 -33.07 13.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.332 -0.855 . . . . 0.0 110.593 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.515 ' H ' HG13 ' A' ' 206' ' ' VAL . . . -44.21 171.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 211' ' ' GLN . 0.0 OUTLIER -40.58 -49.24 2.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.35 -1.088 . . . . 0.0 110.572 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 210' ' ' CYS . . . . . 0.67 ' SG ' HG12 ' A' ' 206' ' ' VAL . 6.9 p -36.83 93.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.461 -0.774 . . . . 0.0 110.436 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.526 ' N ' ' O ' ' A' ' 209' ' ' GLN . 2.1 pt20 -115.41 123.69 49.29 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.233 -0.917 . . . . 0.0 110.107 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.647 ' O ' ' CZ ' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -101.53 144.52 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.599 -0.688 . . . . 0.0 109.701 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ARG . . . . . 0.873 ' HA ' HD22 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -87.64 159.57 18.49 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.194 -0.941 . . . . 0.0 110.279 -179.078 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.894 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -138.33 124.65 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -0.944 . . . . 0.0 111.362 -178.911 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.629 ' O ' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -130.94 137.49 49.31 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.745 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 216' ' ' TYR . . . . . 0.559 ' HA ' ' HB3' ' A' ' 91' ' ' TRP . 5.5 t80 -119.35 150.64 39.82 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.792 -1.192 . . . . 0.0 111.121 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' MET . . . . . 0.553 ' CB ' ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -131.05 107.95 9.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.354 -0.841 . . . . 0.0 110.044 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 72.47 85.18 0.22 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.517 ' HG3' ' CZ ' ' A' ' 216' ' ' TYR . 31.4 tt0 . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.285 -1.127 . . . . 0.0 110.14 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.943 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.176 0.512 . . . . 0.0 109.771 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.887 ' HA ' HD23 ' A' ' 33' ' ' LEU . 6.4 tm-20 -47.61 -35.47 9.31 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.294 -0.879 . . . . 0.0 109.356 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -60.49 -24.99 65.73 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.277 -0.889 . . . . 0.0 108.856 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -83.35 -33.87 25.74 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.933 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.9 HD21 ' HB2' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -78.72 -36.65 43.01 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.861 0.839 . . . . 0.0 109.311 179.274 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.586 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 1.2 t -80.74 -7.39 59.35 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 121.171 0.51 . . . . 0.0 109.937 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.96 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -37.96 -65.32 0.37 Allowed Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.44 -0.787 . . . . 0.0 110.538 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.96 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 47.8 Cg_endo -73.25 143.05 34.78 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.773 1.407 . . . . 0.0 109.928 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 36' ' ' PRO . 54.0 Cg_endo -98.58 53.32 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 121.813 1.675 . . . . 0.0 112.568 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.76 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 52.5 Cg_endo -77.1 150.3 29.35 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 122.89 0.942 . . . . 0.0 109.845 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.664 ' C ' ' NE2' ' A' ' 43' ' ' GLN . 2.1 t0 -39.71 -32.56 0.15 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.056 -1.028 . . . . 0.0 108.81 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.101 HD13 ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -40.95 -45.22 2.52 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.314 0.578 . . . . 0.0 109.628 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 1.101 ' N ' HD13 ' A' ' 40' ' ' LEU . 10.0 t -68.01 -26.82 35.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.017 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 39' ' ' ASP . . . -89.41 -43.94 10.53 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.018 -1.051 . . . . 0.0 111.703 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.665 ' O ' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -80.59 -24.77 38.93 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.24 -1.384 . . . . 0.0 108.929 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.725 ' CB ' ' O ' ' A' ' 40' ' ' LEU . 21.4 ttt-85 -64.28 -57.71 8.64 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.222 1.011 . . . . 0.0 108.739 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.74 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 54.3 m170 -53.57 -17.26 1.97 Allowed 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.703 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -95.9 -31.75 12.97 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.132 -1.427 . . . . 0.0 111.155 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.61 -60.26 0.51 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 106.845 -2.502 . . . . 0.0 106.845 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.826 ' HD1' ' CE2' ' A' ' 66' ' ' PHE 0.267 0.3 OUTLIER -98.37 71.27 2.04 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.171 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.785 ' O ' ' HB3' ' A' ' 53' ' ' CYS . 0.0 OUTLIER -61.91 168.31 3.77 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.701 -0.624 . . . . 0.0 112.104 -178.874 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.693 ' O ' ' O ' ' A' ' 53' ' ' CYS . 37.4 Cg_endo -61.38 -61.37 0.17 Allowed 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 121.572 1.515 . . . . 0.0 113.17 -178.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.778 ' HE2' ' OD1' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -67.67 -74.35 0.12 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.045 -1.659 . . . . 0.0 108.323 179.745 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.736 ' N ' ' HA3' ' A' ' 80' ' ' GLY . 0.9 OUTLIER -38.12 -27.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.203 -0.936 . . . . 0.0 109.529 179.15 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.785 ' HB3' ' O ' ' A' ' 49' ' ' ASN . 0.2 OUTLIER -138.48 129.99 27.6 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 118.736 -1.186 . . . . 0.0 111.951 -179.794 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.96 ' H ' ' HA ' ' A' ' 78' ' ' VAL . 0.9 OUTLIER -58.28 123.5 16.28 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.2 179.278 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.9 ' HB2' HD21 ' A' ' 33' ' ' LEU . 3.6 pt-20 -69.78 -24.48 63.51 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.439 -0.788 . . . . 0.0 109.693 179.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.61 ' ND2' ' OG ' ' A' ' 74' ' ' SER . 5.8 m120 -28.96 -36.03 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.683 0.754 . . . . 0.0 110.874 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.765 HG22 ' HG2' ' A' ' 68' ' ' ARG . 2.6 pt -116.66 166.69 10.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 O-C-N 121.705 -0.622 . . . . 0.0 110.773 -178.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.521 ' OD1' ' CG ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -107.59 116.16 31.44 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 1.079 HG21 ' CD2' ' A' ' 66' ' ' PHE . 6.3 p -130.01 128.72 65.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 CA-C-O 121.409 0.623 . . . . 0.0 111.55 -178.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.698 ' HG2' ' N ' ' A' ' 61' ' ' GLU . 5.2 tttm -136.96 157.92 45.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.342 -0.849 . . . . 0.0 110.715 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.788 ' N ' ' CH2' ' A' ' 48' ' ' TRP . 19.0 tp10 -42.54 -111.65 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.678 -0.639 . . . . 0.0 111.238 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.56 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 36.67 45.78 1.05 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.669 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 93.14 55.58 1.58 Allowed Glycine 0 N--CA 1.487 2.058 0 N-CA-C 107.369 -2.292 . . . . 0.0 107.369 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.932 HD21 HG22 ' A' ' 214' ' ' ILE . 0.2 OUTLIER 1.11 92.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.792 0.806 . . . . 0.0 111.182 -178.216 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.716 ' C ' HG23 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -140.66 134.88 31.06 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.542 -179.787 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 1.079 ' CD2' HG21 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -102.18 142.79 32.87 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.142 178.775 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.564 ' O ' ' HB ' ' A' ' 57' ' ' ILE . 67.9 tt0 -114.38 121.32 43.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 110.174 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.765 ' HG2' HG22 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -121.23 149.8 42.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.477 -0.764 . . . . 0.0 109.966 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.678 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -127.89 -71.37 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.063 -1.023 . . . . 0.0 110.797 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.678 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 55.8 Cg_endo -73.86 -108.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.35 1.184 . . . . 0.0 110.177 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.44 HG12 ' HZ2' ' A' ' 207' ' ' TRP . 3.9 t -140.48 164.35 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.638 -1.289 . . . . 0.0 110.27 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.408 ' HA ' ' HB3' ' A' ' 56' ' ' ASN . . . -99.63 87.58 3.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -0.867 . . . . 0.0 109.931 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.551 ' HG3' ' N ' ' A' ' 74' ' ' SER . 2.5 pt20 -70.39 -44.58 67.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.258 -0.901 . . . . 0.0 110.642 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.61 ' OG ' ' ND2' ' A' ' 56' ' ' ASN . 0.4 OUTLIER -55.84 -74.8 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.161 -0.962 . . . . 0.0 109.969 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.94 HG23 ' HB3' ' A' ' 54' ' ' SER . 0.3 OUTLIER -129.61 -140.37 0.23 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.308 -0.87 . . . . 0.0 109.405 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.666 ' O ' ' N ' ' A' ' 78' ' ' VAL . 22.7 p-10 -141.1 154.75 46.07 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.976 -1.077 . . . . 0.0 110.788 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.675 ' C ' HG13 ' A' ' 78' ' ' VAL . . . 34.78 -95.16 0.01 OUTLIER Glycine 0 N--CA 1.487 2.055 0 N-CA-C 106.715 -2.554 . . . . 0.0 106.715 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.96 ' HA ' ' H ' ' A' ' 54' ' ' SER . 31.0 m -158.2 119.42 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 O-C-N 121.872 -0.781 . . . . 0.0 109.823 176.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.69 ' O ' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -147.32 133.87 19.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.361 -0.837 . . . . 0.0 110.982 -179.147 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.736 ' HA3' ' N ' ' A' ' 52' ' ' ASP . . . -143.36 166.14 26.88 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 178.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.433 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 0.7 OUTLIER -140.2 75.62 1.52 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.345 -1.091 . . . . 0.0 110.078 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.571 ' CD ' ' HZ2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -145.53 -108.73 0.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.312 -0.867 . . . . 0.0 110.128 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.531 ' N ' ' CZ ' ' A' ' 82' ' ' ARG . . . 70.42 80.78 0.28 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -134.24 104.38 6.15 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.285 -1.127 . . . . 0.0 110.21 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.574 ' HB2' ' CE1' ' A' ' 89' ' ' HIS . 11.4 p -140.03 164.87 28.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.153 -0.967 . . . . 0.0 110.255 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.465 ' HA ' ' CG ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -119.75 135.93 54.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.295 -0.878 . . . . 0.0 109.972 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.34 -119.94 5.15 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.488 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 7.8 tp -128.33 138.1 52.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -1.147 . . . . 0.0 110.327 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.969 ' HB2' HD23 ' A' ' 171' ' ' LEU . 43.2 m-70 -147.06 164.81 31.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.273 -0.892 . . . . 0.0 109.992 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.607 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -163.13 152.95 15.55 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.191 -0.943 . . . . 0.0 110.302 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.974 ' CE3' HG11 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -134.62 170.34 15.94 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.079 -1.013 . . . . 0.0 109.891 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.659 ' N ' ' O ' ' A' ' 215' ' ' ARG . 0.6 OUTLIER -140.62 147.54 39.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.368 -0.832 . . . . 0.0 110.672 -179.505 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.861 ' HB ' HD12 ' A' ' 167' ' ' LEU . 2.2 mm -144.68 154.25 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.34 -0.85 . . . . 0.0 110.024 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . 1.123 ' O ' HG23 ' A' ' 212' ' ' VAL . 0.0 OUTLIER -151.2 124.38 8.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.338 -0.851 . . . . 0.0 109.614 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 1.069 ' CB ' HD12 ' A' ' 135' ' ' ILE . 34.6 m95 -106.84 89.42 4.32 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.267 -0.896 . . . . 0.0 110.561 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.74 ' HD3' ' O ' ' A' ' 94' ' ' SER . 52.7 Cg_endo -91.92 124.37 0.76 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.496 1.464 . . . . 0.0 111.013 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.593 HD13 ' SG ' ' A' ' 210' ' ' CYS . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.756 0 O-C-N 121.277 -0.889 . . . . 0.0 109.599 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 1.032 HG23 ' HA ' ' A' ' 205' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.499 2.021 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.946 HG11 ' OH ' ' A' ' 180' ' ' TYR . 4.9 p -145.85 167.5 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 120.416 -1.428 . . . . 0.0 111.905 -178.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.687 ' CA ' ' HA3' ' A' ' 132' ' ' GLY . . . 164.57 146.63 4.83 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.075 HG22 ' HB2' ' A' ' 199' ' ' LEU . 7.8 p -94.82 155.19 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.116 -1.226 . . . . 0.0 109.691 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.702 ' C ' ' HB3' ' A' ' 199' ' ' LEU . . . -132.6 149.02 52.37 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.679 -0.809 . . . . 0.0 111.006 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . 1.038 ' OG1' HD23 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -106.28 131.05 53.98 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.399 -0.813 . . . . 0.0 109.946 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -84.97 -26.4 27.17 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.444 -0.785 . . . . 0.0 109.418 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.47 -12.14 54.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.419 -0.8 . . . . 0.0 109.352 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.509 ' HB1' ' OE1' ' A' ' 129' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.378 -0.827 . . . . 0.0 110.444 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.282 0.563 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.517 ' O ' ' CA ' ' A' ' 109' ' ' ALA . 5.5 mt-10 -140.58 123.9 16.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.892 . . . . 0.0 110.111 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.482 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 1.9 t -121.06 121.17 37.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.474 -0.766 . . . . 0.0 110.354 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' TRP . . . . . 0.437 ' CD1' ' O ' ' A' ' 130' ' ' SER . 33.3 m0 -130.94 131.8 44.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.172 -0.955 . . . . 0.0 110.243 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.687 ' HA3' ' CA ' ' A' ' 107' ' ' GLY . . . -172.73 -152.47 8.68 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.963 ' HB3' HG11 ' A' ' 163' ' ' VAL . 43.5 m0 -112.79 113.27 25.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.161 -1.199 . . . . 0.0 111.11 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.819 ' HA ' ' CG1' ' A' ' 105' ' ' VAL . 18.9 m-20 -120.96 148.12 44.53 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.735 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 1.069 HD12 ' CB ' ' A' ' 95' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.049 -1.032 . . . . 0.0 110.454 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.963 HG11 ' HB3' ' A' ' 133' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 119.647 -0.216 . . . . 0.0 111.076 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.785 ' CD ' ' N ' ' A' ' 163' ' ' VAL . 43.4 Cg_endo -72.12 59.3 2.99 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 N-CA-C 109.574 -0.971 . . . . 0.0 109.574 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.523 ' O ' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER 179.91 -76.33 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.361 0.601 . . . . 0.0 109.454 -179.732 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.544 ' HB2' ' NH1' ' A' ' 166' ' ' ARG . 3.0 ttm105 -152.0 156.17 39.45 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.477 -0.765 . . . . 0.0 110.233 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 1.156 HD22 ' N ' ' A' ' 168' ' ' LEU . 0.0 OUTLIER -159.05 138.63 11.65 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.181 -0.949 . . . . 0.0 110.261 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 1.156 ' N ' HD22 ' A' ' 167' ' ' LEU . 2.9 tt -112.86 121.38 44.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 109.829 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.974 HG11 ' CE3' ' A' ' 91' ' ' TRP . 3.6 t -101.43 146.72 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.956 -1.09 . . . . 0.0 110.759 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.5 t -134.26 108.56 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.502 -0.749 . . . . 0.0 109.667 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.969 HD23 ' HB2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -118.29 121.16 39.74 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.044 -1.035 . . . . 0.0 110.006 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 173' ' ' MET . 46.1 t0 -111.44 137.29 49.42 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.278 -0.889 . . . . 0.0 109.896 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.509 ' N ' ' OD1' ' A' ' 172' ' ' ASP . 2.0 tmt? -95.23 -40.21 9.68 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.6 -0.687 . . . . 0.0 109.931 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.474 ' C ' ' O ' ' A' ' 173' ' ' MET . 0.3 OUTLIER -41.77 -27.81 0.13 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.189 -0.945 . . . . 0.0 108.858 179.209 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.645 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.6 OUTLIER -114.42 -27.32 7.6 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.202 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 83.83 23.88 51.28 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 108.559 -1.816 . . . . 0.0 108.559 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' THR . . . . . 1.033 HG22 ' CD2' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -113.17 121.71 45.32 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.311 -1.111 . . . . 0.0 111.243 -179.444 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 1.06 ' O ' HD11 ' A' ' 194' ' ' LEU . 0.2 OUTLIER -124.87 151.28 45.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.401 -0.812 . . . . 0.0 109.671 179.03 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -149.31 166.89 29.59 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.946 ' OH ' HG11 ' A' ' 106' ' ' VAL . 0.7 OUTLIER -123.58 117.86 26.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.408 -1.054 . . . . 0.0 108.439 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.563 ' O ' ' CD2' ' A' ' 167' ' ' LEU . 35.2 t -145.66 155.63 43.13 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.971 -1.081 . . . . 0.0 110.724 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.603 HG23 ' CZ3' ' A' ' 133' ' ' TRP . 0.0 OUTLIER -95.7 116.3 37.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.453 -0.779 . . . . 0.0 108.941 178.554 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 64.42 9.65 38.26 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.26 42.97 33.56 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 3.5 m -121.99 -2.43 9.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.17 -1.194 . . . . 0.0 110.705 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.607 ' CD2' ' CZ2' ' A' ' 133' ' ' TRP . 0.1 OUTLIER -101.28 -71.12 0.72 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.193 -0.942 . . . . 0.0 110.413 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.752 HD23 ' O ' ' A' ' 180' ' ' TYR . 3.9 mm? -67.0 47.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 110.258 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 186' ' ' TYR . . . -71.23 -73.4 0.8 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.416 ' C ' ' H ' ' A' ' 191' ' ' PHE . 49.7 Cg_endo -75.29 -25.48 11.39 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.922 1.486 . . . . 0.0 111.145 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.6 ' HB3' HD13 ' A' ' 187' ' ' LEU . . . -68.31 23.79 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.448 -0.783 . . . . 0.0 112.2 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.601 ' CD2' ' O ' ' A' ' 187' ' ' LEU . 2.1 m-85 -90.43 -38.68 13.12 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.66 -1.275 . . . . 0.0 110.536 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -13.61 61.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.198 -0.938 . . . . 0.0 110.162 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -106.43 -8.95 32.22 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.104 -1.999 . . . . 0.0 108.104 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 1.06 HD11 ' O ' ' A' ' 178' ' ' LEU . 8.7 tt -73.1 -42.59 62.8 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.892 -0.77 . . . . 0.0 109.071 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.521 ' HA ' HG23 ' A' ' 177' ' ' THR . 0.0 OUTLIER -45.27 -42.48 9.63 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.472 -0.767 . . . . 0.0 110.012 179.755 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.457 ' N ' ' HD2' ' A' ' 195' ' ' LYS . . . -85.06 -23.75 47.56 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.839 ' HD3' HD11 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -91.04 -4.47 56.33 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.693 -0.886 . . . . 0.0 110.082 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 198' ' ' THR . . . . . 0.787 HG23 ' O ' ' A' ' 194' ' ' LEU . 24.5 p -44.56 129.49 6.78 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 121.471 0.653 . . . . 0.0 111.742 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 1.075 ' HB2' HG22 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -140.39 171.82 13.61 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.482 -0.761 . . . . 0.0 109.849 179.49 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 1.014 ' C ' HG23 ' A' ' 108' ' ' VAL . 3.8 m-85 -83.9 129.55 58.6 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.012 -1.055 . . . . 0.0 109.963 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.638 ' HG3' HD13 ' A' ' 171' ' ' LEU . 49.6 Cg_endo -76.18 124.86 8.15 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 124.055 1.555 . . . . 0.0 111.787 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 80' ' ' GLY . 52.1 m -133.68 160.42 37.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.443 -0.786 . . . . 0.0 109.282 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.631 HG12 ' O ' ' A' ' 52' ' ' ASP . 1.1 t -119.42 162.41 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.835 -1.166 . . . . 0.0 110.608 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' SER . . . . . 0.645 ' O ' ' N ' ' A' ' 105' ' ' VAL . 1.6 m -160.68 138.44 9.55 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 1.032 ' HA ' HG23 ' A' ' 105' ' ' VAL . . . -144.77 129.13 17.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.753 -1.217 . . . . 0.0 111.582 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.498 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 1.0 OUTLIER -38.56 160.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-O 121.178 0.514 . . . . 0.0 110.135 178.857 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 0.44 ' HZ2' HG12 ' A' ' 71' ' ' VAL . 0.9 OUTLIER -50.68 -43.73 57.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.172 -0.955 . . . . 0.0 109.584 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.441 ' N ' HG12 ' A' ' 206' ' ' VAL . . . 170.73 134.75 1.8 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.61 -63.28 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -1.133 . . . . 0.0 110.559 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' CYS . . . . . 0.593 ' SG ' HD13 ' A' ' 97' ' ' LEU . 0.5 OUTLIER -136.29 85.55 2.16 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.339 -0.851 . . . . 0.0 110.623 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.544 ' C ' ' O ' ' A' ' 210' ' ' CYS . 1.0 OUTLIER -26.59 126.54 0.06 Allowed 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 122.233 1.016 . . . . 0.0 111.608 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 1.123 HG23 ' O ' ' A' ' 94' ' ' SER . 0.7 OUTLIER -113.16 143.78 22.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.064 179.119 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ARG . . . . . 0.928 ' HA ' HD22 ' A' ' 64' ' ' LEU . 40.5 mtm180 -88.65 144.4 26.32 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.024 -1.048 . . . . 0.0 111.104 -178.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.932 HG22 HD21 ' A' ' 64' ' ' LEU . 4.2 tt -144.59 139.51 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.507 -0.745 . . . . 0.0 110.446 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.659 ' O ' ' N ' ' A' ' 92' ' ' GLU . 4.2 mtt180 -130.41 109.18 10.53 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' TYR . . . . . 0.715 ' CZ ' ' CD1' ' A' ' 91' ' ' TRP . 4.3 t80 -117.33 140.37 49.65 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.945 -1.097 . . . . 0.0 111.588 -178.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -136.68 114.98 11.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.818 -0.551 . . . . 0.0 109.996 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 123.38 17.98 3.14 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.521 ' HG3' ' NH1' ' A' ' 82' ' ' ARG . 4.9 tt0 . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.236 -1.155 . . . . 0.0 110.142 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.487 ' HG ' ' N ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.313 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.487 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 3.5 tt0 -55.02 -43.86 74.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.223 -0.923 . . . . 0.0 109.117 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -52.35 -24.46 7.64 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.489 HD22 ' HA ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -83.11 -32.23 26.83 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.838 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.03 HD12 ' C ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -85.44 -38.55 18.53 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.759 0.79 . . . . 0.0 109.313 179.211 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.629 ' N ' HD12 ' A' ' 33' ' ' LEU . 37.6 t -45.85 -25.51 0.53 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.449 0.642 . . . . 0.0 109.817 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.903 ' HB1' ' CD ' ' A' ' 36' ' ' PRO . . . -80.68 -164.54 0.05 OUTLIER Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 121.634 -0.666 . . . . 0.0 109.623 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.903 ' CD ' ' HB1' ' A' ' 35' ' ' ALA . 53.2 Cg_endo -95.95 74.61 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.679 1.586 . . . . 0.0 110.96 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.708 ' HD3' ' O ' ' A' ' 35' ' ' ALA . 44.4 Cg_endo -69.29 157.28 61.88 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.458 1.241 . . . . 0.0 110.323 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.735 ' O ' ' N ' ' A' ' 40' ' ' LEU . 50.0 Cg_endo -79.92 152.33 21.88 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 124.103 1.58 . . . . 0.0 111.716 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.719 ' O ' ' CG ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER 4.13 60.35 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 122.845 1.307 . . . . 0.0 110.792 -179.288 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.92 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -144.63 -45.3 0.24 Allowed 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.144 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.826 ' N ' HD13 ' A' ' 40' ' ' LEU . 2.1 t -86.85 -35.1 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 119.076 -1.049 . . . . 0.0 108.575 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.527 ' O ' ' CB ' ' A' ' 46' ' ' HIS . . . -88.55 -36.53 16.32 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.462 -0.774 . . . . 0.0 110.183 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.679 ' HG3' ' HB2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -76.42 -22.98 53.99 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.414 -0.804 . . . . 0.0 110.469 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.706 ' HA ' HG22 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -84.45 -47.58 10.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.233 -0.917 . . . . 0.0 109.965 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.463 ' ND1' ' O ' ' A' ' 41' ' ' VAL . 31.4 m170 -73.35 -16.43 61.35 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.535 -0.728 . . . . 0.0 109.424 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.527 ' CB ' ' O ' ' A' ' 42' ' ' ALA . 3.2 t60 -96.7 -31.02 12.89 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.639 0.733 . . . . 0.0 109.085 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 46' ' ' HIS . . . -61.08 -115.47 0.01 OUTLIER Glycine 0 N--CA 1.479 1.534 0 N-CA-C 108.114 -1.995 . . . . 0.0 108.114 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.888 ' CA ' HD13 ' A' ' 214' ' ' ILE . 6.4 p-90 -103.31 71.3 1.1 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.573 -1.251 . . . . 0.0 111.194 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.461 ' OD1' ' HB3' ' A' ' 53' ' ' CYS . 34.3 t30 -108.93 114.57 58.24 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 120.873 -1.142 . . . . 0.0 110.183 178.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.618 ' HG2' ' CA ' ' A' ' 80' ' ' GLY . 39.1 Cg_endo -67.35 -63.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.767 0 N-CA-C 109.323 -1.068 . . . . 0.0 109.323 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.964 ' HA ' ' CE ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER 176.02 31.48 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.781 -1.2 . . . . 0.0 112.912 177.423 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.875 ' HB3' ' HG2' ' A' ' 79' ' ' ARG 0.256 0.2 OUTLIER -162.22 19.72 0.1 Allowed 'General case' 0 C--N 1.265 -3.087 0 CA-C-O 122.16 0.981 . . . . 0.0 109.134 -179.207 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.54 ' SG ' ' CZ ' ' A' ' 44' ' ' ARG . 18.9 t -102.29 128.64 48.76 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-O 122.336 1.065 . . . . 0.0 111.203 -177.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.623 ' CB ' HD21 ' A' ' 56' ' ' ASN . 0.1 OUTLIER -91.86 166.72 12.59 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.894 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.915 ' OE2' HD13 ' A' ' 33' ' ' LEU . 1.7 pm0 -75.98 6.25 5.46 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.619 -0.675 . . . . 0.0 110.846 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.623 HD21 ' CB ' ' A' ' 54' ' ' SER . 0.1 OUTLIER -28.33 -33.37 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.182 0 CA-C-O 122.065 0.936 . . . . 0.0 109.882 179.256 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.713 ' HB ' ' HG2' ' A' ' 68' ' ' ARG . 0.4 OUTLIER -134.64 169.02 22.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.863 -0.523 . . . . 0.0 109.724 -178.833 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.548 ' O ' ' HB3' ' A' ' 67' ' ' GLU . 3.4 t70 -107.53 106.93 17.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.821 -1.174 . . . . 0.0 111.034 -178.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.715 HG11 ' CZ2' ' A' ' 48' ' ' TRP . 2.1 m -122.62 135.54 62.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.679 ' HB2' ' HG3' ' A' ' 43' ' ' GLN . 11.1 ttpp -127.42 155.41 43.7 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.632 -1.293 . . . . 0.0 112.09 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.584 ' HA ' HD13 ' A' ' 64' ' ' LEU . 19.0 tt0 -65.17 -128.89 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.741 -0.599 . . . . 0.0 110.397 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 41.05 47.02 4.21 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.679 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 102.76 50.59 1.08 Allowed Glycine 0 N--CA 1.486 2.017 0 N-CA-C 107.904 -2.078 . . . . 0.0 107.904 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.901 HD22 ' H ' ' A' ' 64' ' ' LEU . 2.3 mm? 1.14 81.35 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.763 0.792 . . . . 0.0 110.806 -178.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.413 ' N ' ' O ' ' A' ' 63' ' ' GLY . 6.3 t -99.29 114.96 28.08 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.686 -0.634 . . . . 0.0 109.976 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.864 ' CE1' ' CE2' ' A' ' 48' ' ' TRP . 1.9 m-85 -82.83 129.9 35.06 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.461 -0.774 . . . . 0.0 109.539 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.548 ' HB3' ' O ' ' A' ' 58' ' ' ASP . 1.2 tm-20 -137.37 121.58 18.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.868 -1.145 . . . . 0.0 110.339 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.748 ' HD3' ' HB3' ' A' ' 207' ' ' TRP . 9.2 mtp180 -115.57 154.76 28.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 0.0 109.55 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.681 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 16.5 ttt85 -95.72 -69.08 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 120.956 -1.09 . . . . 0.0 109.859 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.681 ' HD3' ' HB3' ' A' ' 69' ' ' ARG . 57.6 Cg_endo -77.48 -123.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 N-CA-C 108.713 -1.303 . . . . 0.0 108.713 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 73' ' ' GLN . 2.6 t -140.07 164.33 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.52 -1.363 . . . . 0.0 109.589 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.968 ' HB2' ' CZ3' ' A' ' 207' ' ' TRP . . . -41.66 92.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.176 -0.953 . . . . 0.0 110.314 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.552 ' N ' ' O ' ' A' ' 71' ' ' VAL . 6.3 tp60 -179.97 -31.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.221 -0.924 . . . . 0.0 110.294 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.463 ' C ' ' O ' ' A' ' 73' ' ' GLN . 10.4 p -40.12 -50.61 2.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.343 -0.848 . . . . 0.0 110.228 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.607 HG22 ' N ' ' A' ' 76' ' ' ASP . 7.5 m -169.03 -84.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.269 -0.894 . . . . 0.0 110.031 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.623 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 66.2 t0 -140.13 113.19 8.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.221 -0.924 . . . . 0.0 110.36 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.533 ' O ' ' O ' ' A' ' 76' ' ' ASP . . . -42.59 -91.41 0.01 OUTLIER Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.046 -2.022 . . . . 0.0 108.046 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.964 HG13 ' O ' ' A' ' 205' ' ' ALA . 0.3 OUTLIER -144.15 139.39 24.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.123 -1.222 . . . . 0.0 109.88 179.302 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.875 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 29.3 ttp180 -145.65 148.08 32.69 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.844 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.709 ' CA ' ' HB2' ' A' ' 52' ' ' ASP . . . -136.99 124.6 3.15 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.511 ' HB3' ' OD1' ' A' ' 52' ' ' ASP . 6.1 ttpm? -134.26 -71.38 0.5 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.855 -1.379 . . . . 0.0 111.74 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.559 ' CZ ' ' NZ ' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -58.32 -93.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.19 -0.944 . . . . 0.0 110.799 -178.893 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.427 ' HA2' ' HG3' ' A' ' 51' ' ' LYS . . . 51.13 70.04 0.97 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.679 -1.769 . . . . 0.0 108.679 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.575 ' C ' ' CD1' ' A' ' 84' ' ' TYR . 1.0 OUTLIER -94.57 142.16 27.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.341 -1.094 . . . . 0.0 110.495 -179.308 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.58 ' HB3' ' CE1' ' A' ' 89' ' ' HIS . 1.4 m -135.87 174.34 10.73 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.548 -0.72 . . . . 0.0 109.886 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.579 ' O ' ' CE1' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -126.62 138.51 53.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.18 -0.95 . . . . 0.0 110.7 -179.746 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.486 ' N ' ' HB3' ' A' ' 173' ' ' MET . . . 92.15 -119.46 5.8 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.743 HD12 ' OD2' ' A' ' 172' ' ' ASP . 4.5 tt -128.74 139.63 52.11 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.676 -0.896 . . . . 0.0 110.123 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.58 ' CE1' ' HB3' ' A' ' 85' ' ' SER . 18.3 m-70 -147.23 162.38 39.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.162 -0.961 . . . . 0.0 110.186 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 217' ' ' MET . . . -160.65 138.66 9.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.219 -0.926 . . . . 0.0 109.949 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 1.098 ' CZ2' HG11 ' A' ' 169' ' ' VAL . 1.3 p90 -134.89 170.75 15.39 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.242 -0.911 . . . . 0.0 110.36 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.608 ' N ' ' O ' ' A' ' 215' ' ' ARG . 38.1 mt-10 -141.82 152.58 43.82 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.637 -0.664 . . . . 0.0 110.497 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.755 HG23 ' O ' ' A' ' 213' ' ' ARG . 10.1 mt -144.48 154.2 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.902 . . . . 0.0 110.57 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.564 ' OG ' ' HB2' ' A' ' 213' ' ' ARG . 1.2 m -119.35 133.5 55.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.354 -0.841 . . . . 0.0 109.469 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.936 ' CH2' HG13 ' A' ' 105' ' ' VAL 0.261 2.3 t-105 -136.52 88.12 20.46 Favored Pre-proline 0 C--N 1.297 -1.697 0 O-C-N 121.441 -0.787 . . . . 0.0 110.332 -178.759 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.564 ' HD2' ' O ' ' A' ' 211' ' ' GLN . 51.7 Cg_endo -91.99 107.02 0.24 Allowed 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.095 1.05 . . . . 0.0 110.682 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.615 ' HB2' ' HG2' ' A' ' 164' ' ' PRO . 5.6 tt . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.09 -1.006 . . . . 0.0 109.934 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 1.079 HG22 ' O ' ' A' ' 204' ' ' SER . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 1.102 ' CG2' HG23 ' A' ' 203' ' ' VAL . 34.3 t -148.76 169.15 2.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.156 -0.965 . . . . 0.0 110.267 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.709 ' HA2' ' HA3' ' A' ' 132' ' ' GLY . . . -175.35 131.41 1.93 Allowed Glycine 0 N--CA 1.483 1.797 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.136 ' CG1' HD13 ' A' ' 199' ' ' LEU . 0.3 OUTLIER -102.41 143.41 14.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.618 -0.93 . . . . 0.0 109.628 -179.569 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.534 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -109.79 129.76 55.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.128 -0.982 . . . . 0.0 110.704 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.913 HG23 ' CG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -110.55 131.74 54.79 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.309 -0.869 . . . . 0.0 110.065 179.65 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -91.25 -27.13 18.64 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.502 0.668 . . . . 0.0 109.238 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.426 ' CD2' ' O ' ' A' ' 196' ' ' GLY . 1.8 pp -82.15 -12.59 58.08 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.505 -0.747 . . . . 0.0 109.492 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.631 ' HB2' ' HB ' ' A' ' 110' ' ' THR . . . . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.404 -0.81 . . . . 0.0 110.091 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.1 p . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.29 0.567 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.492 ' HB3' ' CB ' ' A' ' 113' ' ' ALA . 21.6 tt0 -150.11 131.08 14.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.225 -0.922 . . . . 0.0 109.874 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.4 t -120.41 119.6 33.54 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.195 -0.941 . . . . 0.0 110.503 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -133.47 141.99 48.06 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.471 -0.768 . . . . 0.0 109.192 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.709 ' HA3' ' HA2' ' A' ' 107' ' ' GLY . . . -173.27 -138.92 2.74 Favored Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.336 -1.411 . . . . 0.0 110.652 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.825 ' CH2' HG23 ' A' ' 182' ' ' ILE . 45.9 m0 -113.11 118.18 34.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.392 -1.063 . . . . 0.0 110.611 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.734 ' O ' HG23 ' A' ' 135' ' ' ILE . 4.2 p30 -118.06 126.5 52.41 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.359 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.734 HG23 ' O ' ' A' ' 134' ' ' ASP . 7.3 pt . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.338 -0.851 . . . . 0.0 110.055 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.868 ' N ' ' HD3' ' A' ' 164' ' ' PRO . 4.0 p . . . . . 0 N--CA 1.485 1.302 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.868 ' HD3' ' N ' ' A' ' 163' ' ' VAL . 55.2 Cg_endo -93.78 152.08 2.28 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.609 1.32 . . . . 0.0 111.22 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.553 ' O ' ' HA ' ' A' ' 94' ' ' SER . 5.7 tp10 178.83 -70.33 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.412 -0.805 . . . . 0.0 109.663 178.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -147.88 141.47 25.49 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.579 -0.7 . . . . 0.0 109.378 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.874 ' O ' HD12 ' A' ' 167' ' ' LEU . 0.5 OUTLIER -162.52 157.14 21.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.128 -0.982 . . . . 0.0 110.455 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.772 ' C ' HD23 ' A' ' 168' ' ' LEU . 6.5 tt -120.68 134.8 55.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.332 -0.855 . . . . 0.0 110.15 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 1.098 HG11 ' CZ2' ' A' ' 91' ' ' TRP . 94.1 t -109.97 128.62 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.272 -0.893 . . . . 0.0 110.412 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 4.7 t -103.75 110.47 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.343 -0.848 . . . . 0.0 109.815 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.754 HD13 HD22 ' A' ' 178' ' ' LEU . 13.7 tp -121.5 106.06 11.05 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.18 -0.95 . . . . 0.0 109.983 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.743 ' OD2' HD12 ' A' ' 88' ' ' LEU . 5.5 t70 -111.43 136.8 50.06 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.283 -0.885 . . . . 0.0 110.477 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.538 ' CE ' ' CE2' ' A' ' 84' ' ' TYR . 12.5 tpp -92.3 -40.07 11.14 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 120.412 -0.515 . . . . 0.0 109.702 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 173' ' ' MET . 15.2 tt0 -41.95 -28.89 0.19 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.279 -0.888 . . . . 0.0 108.91 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.512 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.0 OUTLIER -109.4 -25.83 10.32 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.949 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.443 ' O ' ' OG1' ' A' ' 198' ' ' THR . . . 78.96 24.63 61.48 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.881 ' HB ' HD22 ' A' ' 194' ' ' LEU . 1.1 p -125.38 148.74 48.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.206 -1.173 . . . . 0.0 111.112 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 1.002 HD13 ' HG3' ' A' ' 201' ' ' PRO . 0.4 OUTLIER -148.1 154.33 40.06 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.525 -0.734 . . . . 0.0 109.952 179.804 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -149.25 164.68 29.34 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.745 ' CD1' HG22 ' A' ' 169' ' ' VAL . 0.4 OUTLIER -118.86 121.88 41.03 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.14 -1.212 . . . . 0.0 109.859 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.695 ' HB2' HD22 ' A' ' 187' ' ' LEU . 11.4 t -113.01 124.5 52.78 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.371 -0.83 . . . . 0.0 110.078 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.825 HG23 ' CH2' ' A' ' 133' ' ' TRP . 0.0 OUTLIER -104.21 116.82 48.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.594 -0.691 . . . . 0.0 109.715 179.756 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 72.93 4.59 62.84 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.174 -1.571 . . . . 0.0 109.174 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 68.65 47.49 55.97 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' THR . . . . . 0.576 HG22 ' CE1' ' A' ' 186' ' ' TYR . 46.3 m -137.07 -27.09 1.0 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -1.173 . . . . 0.0 110.802 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.576 ' CE1' HG22 ' A' ' 185' ' ' THR . 21.8 m-85 -116.8 76.55 1.04 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.949 -1.095 . . . . 0.0 110.676 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.695 HD22 ' HB2' ' A' ' 181' ' ' SER . 0.6 OUTLIER 179.7 29.41 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.529 0.68 . . . . 0.0 109.196 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.638 ' H ' ' HD2' ' A' ' 189' ' ' PRO . . . -105.48 -62.01 0.63 Allowed Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.915 -1.136 . . . . 0.0 111.447 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.638 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 43.5 Cg_endo -70.24 -31.6 18.12 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.685 1.361 . . . . 0.0 111.791 -178.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.621 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -71.83 9.2 0.95 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.077 -1.014 . . . . 0.0 111.367 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.568 ' CE1' ' HG ' ' A' ' 187' ' ' LEU . 1.4 m-85 -90.53 -10.78 42.28 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.278 -0.889 . . . . 0.0 110.161 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ARG . . . . . 0.474 ' HA ' ' NE ' ' A' ' 192' ' ' ARG . 0.2 OUTLIER -90.12 -15.21 32.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.353 -0.842 . . . . 0.0 110.191 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 197' ' ' ARG . . . -112.07 -17.01 8.62 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.018 -2.033 . . . . 0.0 108.018 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.963 HD23 ' O ' ' A' ' 194' ' ' LEU . 3.8 tt -65.52 -26.31 67.84 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.831 -0.805 . . . . 0.0 109.134 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.582 ' HA ' HG21 ' A' ' 177' ' ' THR . 0.0 OUTLIER -54.51 -26.25 30.51 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.599 -0.688 . . . . 0.0 109.773 179.242 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.426 ' O ' ' CD2' ' A' ' 112' ' ' LEU . . . -118.87 -17.62 5.0 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.762 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.32 -3.96 57.43 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.459 -1.024 . . . . 0.0 110.322 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 198' ' ' THR . . . . . 0.812 ' HB ' HG22 ' A' ' 177' ' ' THR . 0.5 OUTLIER -42.1 132.3 3.28 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 122.325 1.059 . . . . 0.0 112.052 -178.094 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 1.136 HD13 ' CG1' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -142.61 171.32 14.21 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.431 178.923 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.621 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 2.6 m-85 -84.89 128.43 60.6 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 120.814 -1.179 . . . . 0.0 109.817 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 1.002 ' HG3' HD13 ' A' ' 178' ' ' LEU . 55.7 Cg_endo -87.43 142.33 6.04 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 124.022 1.538 . . . . 0.0 112.4 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 43.1 m -133.91 134.92 43.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.677 -0.639 . . . . 0.0 109.5 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 1.102 HG23 ' CG2' ' A' ' 106' ' ' VAL . 4.0 p -119.5 161.31 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.811 -1.181 . . . . 0.0 110.335 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' SER . . . . . 1.079 ' O ' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -160.51 161.48 32.77 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.971 0.891 . . . . 0.0 110.822 179.687 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.964 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -150.65 165.92 31.93 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 121.956 0.884 . . . . 0.0 110.868 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 1.116 HG22 ' CE3' ' A' ' 207' ' ' TRP . 0.3 OUTLIER -98.79 -152.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.037 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 1.116 ' CE3' HG22 ' A' ' 206' ' ' VAL . 48.7 p90 -91.07 -140.66 0.17 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.123 -0.986 . . . . 0.0 110.415 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.526 ' O ' ' NE2' ' A' ' 211' ' ' GLN . . . -65.91 0.29 6.06 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' GLN . . . . . 0.792 ' HB3' HG11 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -66.09 -28.26 68.69 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.287 -1.125 . . . . 0.0 110.407 -179.818 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 210' ' ' CYS . . . . . 0.904 ' SG ' HG12 ' A' ' 206' ' ' VAL . 22.9 p -145.52 14.9 1.43 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 110.853 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.671 ' C ' ' O ' ' A' ' 210' ' ' CYS . 0.0 OUTLIER -6.04 117.74 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.655 0.741 . . . . 0.0 111.466 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.67 HG13 ' CZ ' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -121.88 144.77 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.76 -0.588 . . . . 0.0 109.985 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ARG . . . . . 0.755 ' O ' HG23 ' A' ' 93' ' ' ILE . 0.8 OUTLIER -88.07 171.8 10.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.217 -0.927 . . . . 0.0 110.229 -179.482 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.888 HD13 ' CA ' ' A' ' 48' ' ' TRP . 0.7 OUTLIER -143.36 118.53 4.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-O 122.013 0.911 . . . . 0.0 111.805 -178.346 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.608 ' O ' ' N ' ' A' ' 92' ' ' GLU . 66.4 mtt-85 -130.62 108.91 10.26 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' TYR . . . . . 0.651 ' CE2' ' HB3' ' A' ' 91' ' ' TRP . 3.2 t80 -105.82 149.3 26.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.094 -1.004 . . . . 0.0 111.094 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' MET . . . . . 0.465 ' O ' ' O ' ' A' ' 90' ' ' ALA . 1.0 OUTLIER -131.5 121.05 23.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.48 -0.762 . . . . 0.0 110.154 179.745 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 132.58 -32.82 2.74 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.236 -1.155 . . . . 0.0 110.226 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.935 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.091 0.472 . . . . 0.0 110.08 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.855 ' HA ' HD23 ' A' ' 33' ' ' LEU . 24.8 pt-20 -47.06 -35.12 6.51 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.304 -0.872 . . . . 0.0 109.579 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.49 ' N ' ' HG3' ' A' ' 30' ' ' GLU . 1.1 tm-20 -63.91 -23.51 67.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.446 -0.784 . . . . 0.0 108.992 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.647 HD13 ' O ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -83.29 -33.88 25.86 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.993 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.855 HD23 ' HA ' ' A' ' 30' ' ' GLU . 0.3 OUTLIER -73.55 -35.98 65.59 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 122.058 0.933 . . . . 0.0 108.917 179.293 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.649 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 23.5 t -71.24 -12.57 61.53 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.605 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 1.01 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -45.31 -64.97 0.72 Allowed Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.19 -0.944 . . . . 0.0 110.268 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 1.01 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 50.0 Cg_endo -72.8 147.8 45.15 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.75 1.395 . . . . 0.0 110.15 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.494 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 54.7 Cg_endo -99.3 42.84 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.001 1.801 . . . . 0.0 112.912 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.76 ' HD3' ' HB2' ' A' ' 36' ' ' PRO . 50.8 Cg_endo -76.23 151.13 33.83 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 122.908 0.951 . . . . 0.0 110.303 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.712 ' O ' ' HB3' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -28.62 -36.08 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.587 -0.696 . . . . 0.0 110.659 179.676 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.973 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -49.91 -48.52 51.6 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.786 -1.197 . . . . 0.0 110.501 -179.605 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.953 HG23 ' CD1' ' A' ' 40' ' ' LEU . 41.1 t -83.93 -32.55 8.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 121.161 -0.962 . . . . 0.0 110.296 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 46' ' ' HIS . . . -89.72 -41.13 12.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.092 -1.005 . . . . 0.0 111.731 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.712 ' HB3' ' O ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -78.46 -20.54 50.73 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.095 -1.003 . . . . 0.0 110.39 -179.215 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.718 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 7.6 tpt180 -76.42 -55.02 5.93 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.426 ' ND1' ' O ' ' A' ' 41' ' ' VAL . 32.7 m170 -65.73 -17.19 64.44 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.544 ' HB2' ' O ' ' A' ' 42' ' ' ALA . 74.1 t60 -96.77 -17.15 20.44 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.697 0.76 . . . . 0.0 109.355 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.97 -112.3 0.12 Allowed Glycine 0 N--CA 1.477 1.367 0 N-CA-C 108.156 -1.977 . . . . 0.0 108.156 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 1.176 ' CZ2' HD22 ' A' ' 64' ' ' LEU . 4.6 m95 -102.97 70.93 1.11 Allowed 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.849 -1.14 . . . . 0.0 110.844 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.524 ' OD1' ' HB3' ' A' ' 53' ' ' CYS . 28.2 t30 -108.41 111.97 61.22 Favored Pre-proline 0 C--N 1.302 -1.491 0 O-C-N 121.139 -0.976 . . . . 0.0 109.694 178.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.826 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 40.9 Cg_endo -68.03 -63.68 0.05 OUTLIER 'Trans proline' 0 C--N 1.301 -1.949 0 O-C-N 123.291 1.153 . . . . 0.0 109.764 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 1.123 ' HA ' ' CE ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER 176.07 36.98 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 122.502 1.144 . . . . 0.0 111.561 178.059 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.769 ' HB3' ' HG2' ' A' ' 79' ' ' ARG 0.255 0.7 OUTLIER -169.8 23.23 0.02 OUTLIER 'General case' 0 C--N 1.269 -2.921 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.331 -179.385 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.559 ' SG ' ' CZ ' ' A' ' 44' ' ' ARG . 8.3 t -101.27 127.42 47.88 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-O 122.523 1.154 . . . . 0.0 111.337 -177.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.66 ' CB ' HD22 ' A' ' 56' ' ' ASN . 0.6 OUTLIER -90.11 166.23 13.52 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.337 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.814 ' HG3' HD11 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -74.45 1.97 10.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.693 -0.629 . . . . 0.0 110.981 -179.146 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.66 HD22 ' CB ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -31.64 -32.63 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.642 0.734 . . . . 0.0 109.833 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.69 HD11 ' NH2' ' A' ' 44' ' ' ARG . 4.6 pt -136.34 166.39 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.562 -0.711 . . . . 0.0 110.41 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.92 ' HB2' HD23 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -109.21 121.59 45.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 110.458 -179.263 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.71 HG11 ' HD1' ' A' ' 48' ' ' TRP . 58.4 t -130.32 132.69 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.287 -0.883 . . . . 0.0 110.21 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.664 ' HB2' ' HG3' ' A' ' 43' ' ' GLN . 3.1 ttpt -135.26 155.07 51.25 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.218 -0.926 . . . . 0.0 110.397 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 63' ' ' GLY . 4.2 tt0 -74.87 -118.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.351 -0.843 . . . . 0.0 110.203 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 42.08 28.81 0.53 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.674 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 129.65 60.55 0.1 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.176 HD22 ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER 0.44 84.83 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.751 -0.852 . . . . 0.0 111.172 -179.716 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 31.5 t -126.65 114.82 18.54 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.162 -0.961 . . . . 0.0 111.005 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.596 ' HA ' HG13 ' A' ' 59' ' ' VAL . 3.6 m-85 -90.23 124.72 35.1 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.576 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 3.4 tt0 -125.37 147.53 49.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.737 -1.227 . . . . 0.0 110.516 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.574 ' HB3' ' CG2' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -136.09 115.68 12.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.434 -0.791 . . . . 0.0 109.777 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.65 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -68.94 -65.99 1.12 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.024 -1.048 . . . . 0.0 110.255 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.65 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 56.1 Cg_endo -70.49 -143.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.924 1.487 . . . . 0.0 109.354 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.556 HG13 ' CH2' ' A' ' 207' ' ' TRP . 3.5 t -139.6 164.11 24.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 O-C-N 121.319 -0.863 . . . . 0.0 109.965 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.839 ' HB2' ' CD1' ' A' ' 207' ' ' TRP . . . -66.92 59.25 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 0.0 110.113 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.484 ' N ' ' O ' ' A' ' 71' ' ' VAL . 12.5 mt-30 -53.38 -92.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.181 -0.949 . . . . 0.0 110.378 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.71 27.86 1.48 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.93 . . . . 0.0 110.367 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.462 ' CG2' ' OE1' ' A' ' 30' ' ' GLU . 1.4 m -103.5 -134.19 0.32 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.19 -0.944 . . . . 0.0 109.761 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.48 ' O ' ' CG ' ' A' ' 56' ' ' ASN . 22.8 t70 -140.67 113.14 8.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 110.363 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.536 ' O ' ' NH2' ' A' ' 44' ' ' ARG . . . -51.44 -90.96 0.01 OUTLIER Glycine 0 N--CA 1.488 2.105 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 178.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.993 ' CG1' ' HB3' ' A' ' 205' ' ' ALA . 0.1 OUTLIER -132.29 134.68 59.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.296 -1.12 . . . . 0.0 109.181 178.405 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.769 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 45.1 ttp180 -146.13 161.99 38.95 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.813 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.742 ' HA2' ' HB2' ' A' ' 52' ' ' ASP . . . -152.94 117.04 0.78 Allowed Glycine 0 N--CA 1.495 2.62 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.505 ' HG3' ' HB3' ' A' ' 202' ' ' SER . 2.5 ttmp? -155.75 -117.26 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.959 -1.318 . . . . 0.0 111.262 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.677 ' HD3' ' H ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -48.53 -17.19 0.14 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.336 -0.853 . . . . 0.0 111.481 -179.131 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.677 ' H ' ' HD3' ' A' ' 82' ' ' ARG . . . -77.5 36.24 1.58 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.45 ' OH ' ' NE1' ' A' ' 91' ' ' TRP . 0.6 OUTLIER -111.49 156.61 21.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.105 -1.233 . . . . 0.0 110.405 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.29 177.83 5.08 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.443 -0.786 . . . . 0.0 110.667 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.557 ' HA ' ' CB ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -99.45 -173.47 2.48 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.394 -0.816 . . . . 0.0 110.024 -179.669 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.48 160.65 28.04 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.647 ' O ' HD23 ' A' ' 88' ' ' LEU . 7.8 tt -87.66 114.22 24.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.172 -1.193 . . . . 0.0 110.479 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -147.41 173.22 12.84 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.378 -0.826 . . . . 0.0 109.935 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.562 ' O ' ' O ' ' A' ' 217' ' ' MET . . . -151.63 148.85 28.46 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.149 -0.969 . . . . 0.0 109.79 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.896 ' CZ3' HG11 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -134.75 161.33 35.48 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.846 -1.159 . . . . 0.0 110.216 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.802 ' C ' HD12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -109.47 124.84 51.72 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.515 179.642 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.802 HD12 ' C ' ' A' ' 92' ' ' GLU . 1.6 mp -126.14 154.31 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.14 -0.975 . . . . 0.0 110.385 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.699 ' O ' HG23 ' A' ' 212' ' ' VAL . 0.0 OUTLIER -135.52 119.85 17.89 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.541 -0.724 . . . . 0.0 109.415 179.667 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 1.029 ' CE3' HG21 ' A' ' 212' ' ' VAL . 2.3 t-105 -128.61 89.14 50.21 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.106 -0.997 . . . . 0.0 110.87 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.601 ' HG2' ' HB3' ' A' ' 211' ' ' GLN . 50.5 Cg_endo -88.06 115.09 0.91 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.097 1.578 . . . . 0.0 110.277 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.608 HD23 HG13 ' A' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.049 -1.032 . . . . 0.0 110.311 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.797 HG13 ' O ' ' A' ' 204' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 121.447 0.641 . . . . 0.0 111.88 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.674 HG22 ' CD2' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -151.53 118.82 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.555 -0.715 . . . . 0.0 109.521 178.286 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 132' ' ' GLY . . . 161.62 -154.34 25.3 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 118.887 -1.625 . . . . 0.0 110.725 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.88 HG13 ' C ' ' A' ' 200' ' ' TYR . 58.2 t -138.77 157.92 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.687 -0.89 . . . . 0.0 109.785 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.547 ' O ' ' N ' ' A' ' 200' ' ' TYR . . . -133.93 153.38 51.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.043 -1.036 . . . . 0.0 110.436 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . 1.073 HG23 ' HB3' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -101.08 128.28 47.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.234 -0.917 . . . . 0.0 109.817 179.618 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.21 -27.76 17.46 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.509 -0.744 . . . . 0.0 109.588 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.444 ' O ' ' C ' ' A' ' 113' ' ' ALA . 0.8 OUTLIER -81.7 -12.54 58.6 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.411 -0.806 . . . . 0.0 109.57 179.312 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.554 ' CB ' ' HB2' ' A' ' 129' ' ' GLU . . . . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.515 -0.741 . . . . 0.0 110.263 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.26 0.553 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.554 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . 0.3 OUTLIER -150.0 129.9 13.38 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 110.107 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.54 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 47.8 t -120.36 119.94 34.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.332 -0.855 . . . . 0.0 110.181 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' TRP . . . . . 0.48 ' O ' ' O ' ' A' ' 108' ' ' VAL . 0.8 OUTLIER -129.69 124.74 34.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.374 -0.829 . . . . 0.0 109.906 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 107' ' ' GLY . . . 174.92 -133.23 2.4 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.701 ' CE3' HG11 ' A' ' 163' ' ' VAL . 54.8 m0 -110.68 113.65 26.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.122 -1.223 . . . . 0.0 110.694 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.469 ' C ' HD13 ' A' ' 135' ' ' ILE . 6.0 t0 -117.97 134.84 54.58 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.741 -0.599 . . . . 0.0 110.263 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.824 HD13 ' N ' ' A' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.275 -0.891 . . . . 0.0 110.308 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.878 HG13 ' HD2' ' A' ' 164' ' ' PRO . 53.8 t . . . . . 0 N--CA 1.494 1.743 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.878 ' HD2' HG13 ' A' ' 163' ' ' VAL . 38.1 Cg_endo -64.48 134.15 40.25 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.808 1.425 . . . . 0.0 110.771 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.563 ' CB ' ' HB3' ' A' ' 96' ' ' PRO . 24.4 pt-20 -41.23 -25.22 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.604 -0.685 . . . . 0.0 111.317 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 164' ' ' PRO . 0.0 OUTLIER -116.08 138.38 51.29 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.944 -1.097 . . . . 0.0 110.698 -179.388 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.956 HD13 ' CE1' ' A' ' 180' ' ' TYR . 2.5 pp -158.9 154.64 26.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.615 -0.678 . . . . 0.0 109.924 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' A' ' 181' ' ' SER . 18.0 tp -112.78 141.08 47.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.116 -0.99 . . . . 0.0 110.128 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.896 HG11 ' CZ3' ' A' ' 91' ' ' TRP . 6.5 t -124.06 136.3 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.147 -0.97 . . . . 0.0 110.486 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.737 HG12 HD23 ' A' ' 187' ' ' LEU . 9.8 p -115.3 121.4 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.449 -0.782 . . . . 0.0 109.377 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.767 HD12 ' HG3' ' A' ' 201' ' ' PRO . 0.0 OUTLIER -127.16 107.82 10.36 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.042 -1.036 . . . . 0.0 110.104 -179.512 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -120.01 129.49 54.28 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.876 0.846 . . . . 0.0 109.903 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.557 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -98.77 -39.46 8.62 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.576 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 173' ' ' MET . 0.1 OUTLIER -46.37 -26.47 0.84 Allowed 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.439 -0.905 . . . . 0.0 108.698 178.999 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.545 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 3.3 tt0 -110.16 -27.43 9.14 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 198' ' ' THR . . . 84.15 23.36 52.11 Favored Glycine 0 N--CA 1.483 1.77 0 N-CA-C 108.756 -1.738 . . . . 0.0 108.756 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.923 HG22 HD22 ' A' ' 194' ' ' LEU . 0.1 OUTLIER -118.46 116.96 27.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.166 -1.197 . . . . 0.0 111.402 -179.55 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.812 ' N ' HD12 ' A' ' 178' ' ' LEU . 3.3 mp -130.6 153.71 48.62 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.421 -0.799 . . . . 0.0 109.501 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.999 ' C ' HD21 ' A' ' 187' ' ' LEU . . . -161.93 166.96 36.45 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.14 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.956 ' CE1' HD13 ' A' ' 167' ' ' LEU . 1.1 t80 -125.01 118.28 25.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.439 -1.036 . . . . 0.0 109.85 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.704 ' HB2' HD13 ' A' ' 187' ' ' LEU . 0.6 OUTLIER -145.15 165.25 28.86 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.334 -0.854 . . . . 0.0 110.072 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.642 HG21 ' HG2' ' A' ' 164' ' ' PRO . 0.0 OUTLIER -110.18 116.6 52.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 O-C-N 121.501 -0.749 . . . . 0.0 109.543 179.195 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 79.6 -1.72 76.27 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 87.9 39.99 6.82 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' THR . . . . . 0.503 HG22 ' N ' ' A' ' 186' ' ' TYR . 32.1 m -94.38 -86.84 0.27 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.214 -1.168 . . . . 0.0 110.65 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.592 ' CE2' HD11 ' A' ' 182' ' ' ILE . 22.5 m-85 -40.15 -40.74 1.15 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.263 -0.898 . . . . 0.0 110.78 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.999 HD21 ' C ' ' A' ' 179' ' ' GLY . 5.8 mp -80.56 47.2 0.92 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.08 -1.013 . . . . 0.0 109.948 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -108.72 -82.15 1.38 Allowed Glycine 0 N--CA 1.491 2.3 0 C-N-CA 119.853 -1.165 . . . . 0.0 110.326 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.98 -28.39 16.28 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.926 1.488 . . . . 0.0 111.081 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.613 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -72.67 20.71 0.07 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.27 -0.894 . . . . 0.0 111.363 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -90.2 -13.55 35.29 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.928 -1.107 . . . . 0.0 110.325 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ARG . . . . . 0.489 ' HA ' ' NE ' ' A' ' 192' ' ' ARG . 0.1 OUTLIER -90.28 -14.69 32.74 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.317 -0.865 . . . . 0.0 110.563 -179.76 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 197' ' ' ARG . . . -111.28 -18.91 7.84 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.923 HD22 HG22 ' A' ' 177' ' ' THR . 6.2 tt -61.95 -33.72 74.81 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.799 -0.824 . . . . 0.0 108.818 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.667 ' HA ' HG23 ' A' ' 177' ' ' THR . 0.0 OUTLIER -45.59 -29.84 1.32 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.553 -0.717 . . . . 0.0 109.529 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -115.59 -21.16 5.18 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.783 ' O ' HD23 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.99 -9.24 46.72 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.661 -0.905 . . . . 0.0 109.666 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 198' ' ' THR . . . . . 0.683 ' HB ' HD23 ' A' ' 194' ' ' LEU . 0.0 OUTLIER -43.5 148.95 0.29 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.015 0.912 . . . . 0.0 111.961 -177.785 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 1.073 ' HB3' HG23 ' A' ' 110' ' ' THR . 0.1 OUTLIER -140.59 169.81 16.96 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.511 179.519 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.88 ' C ' HG13 ' A' ' 108' ' ' VAL . 19.0 m-85 -84.75 129.92 54.96 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.017 -1.052 . . . . 0.0 109.499 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.844 ' HA ' HG22 ' A' ' 108' ' ' VAL . 41.4 Cg_endo -67.87 125.13 12.71 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.805 1.424 . . . . 0.0 110.407 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.581 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 57.5 p -133.29 152.27 51.92 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.253 -0.904 . . . . 0.0 111.195 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.619 HG23 ' HA ' ' A' ' 106' ' ' VAL . 4.0 p -158.93 160.6 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.648 -0.657 . . . . 0.0 109.532 179.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' SER . . . . . 0.797 ' O ' HG13 ' A' ' 105' ' ' VAL . 0.3 OUTLIER -160.38 130.32 5.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.307 -0.87 . . . . 0.0 110.319 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.993 ' HB3' ' CG1' ' A' ' 78' ' ' VAL . . . -108.74 150.53 27.46 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.031 -1.043 . . . . 0.0 110.398 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.46 HG12 ' H ' ' A' ' 208' ' ' GLY . 1.2 t -91.19 159.97 2.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.542 0.687 . . . . 0.0 110.712 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 0.839 ' CD1' ' HB2' ' A' ' 72' ' ' ALA . 16.7 p-90 -82.54 46.61 1.08 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.286 -0.884 . . . . 0.0 109.646 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.46 ' H ' HG12 ' A' ' 206' ' ' VAL . . . -108.88 -128.95 5.8 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' GLN . . . . . 0.791 ' O ' ' O ' ' A' ' 210' ' ' CYS . 1.0 OUTLIER -127.51 -22.59 3.62 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.357 -1.084 . . . . 0.0 110.548 -179.538 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 210' ' ' CYS . . . . . 0.791 ' O ' ' O ' ' A' ' 209' ' ' GLN . 31.4 p 1.6 -133.42 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.032 0.444 . . . . 0.0 111.875 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.601 ' HB3' ' HG2' ' A' ' 96' ' ' PRO . 0.0 OUTLIER 178.88 33.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.847 -1.158 . . . . 0.0 110.808 -179.595 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 1.029 HG21 ' CE3' ' A' ' 95' ' ' TRP . 2.5 p -86.63 124.96 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.032 -1.042 . . . . 0.0 110.267 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' ARG . . . . . 0.575 ' HA ' HD21 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -96.97 170.51 9.1 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.624 -0.672 . . . . 0.0 110.868 -179.3 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.829 ' CD1' ' HB3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -132.25 122.37 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.244 -0.91 . . . . 0.0 110.612 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.591 ' HB3' ' CB ' ' A' ' 92' ' ' GLU . 0.5 OUTLIER -130.63 140.15 50.4 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.563 -0.711 . . . . 0.0 109.96 179.464 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 216' ' ' TYR . . . . . 0.568 ' HA ' ' HB3' ' A' ' 91' ' ' TRP . 8.2 t80 -118.93 150.92 39.08 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.257 -0.902 . . . . 0.0 110.924 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 217' ' ' MET . . . . . 0.562 ' O ' ' O ' ' A' ' 90' ' ' ALA . 9.0 tpp -134.99 108.01 7.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.933 . . . . 0.0 110.244 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 128.44 -9.48 6.53 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.485 ' HB2' ' CD1' ' A' ' 216' ' ' TYR . 3.9 mm-40 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.203 -1.175 . . . . 0.0 110.044 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.587 ' HG ' ' N ' ' A' ' 30' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.019 0.438 . . . . 0.0 110.122 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.668 ' HA ' HD23 ' A' ' 33' ' ' LEU . 19.1 pt-20 -47.99 -29.78 3.75 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.095 -1.003 . . . . 0.0 108.538 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -64.59 -23.95 67.43 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.543 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -82.68 -37.25 25.07 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.826 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.801 HD12 ' C ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -71.39 -38.28 71.49 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.823 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.672 ' O ' ' O ' ' A' ' 35' ' ' ALA . 1.8 m -78.45 -7.08 57.01 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.252 0.548 . . . . 0.0 110.007 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 1.039 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -49.43 -153.73 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.689 -0.632 . . . . 0.0 110.645 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 1.039 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 38.1 Cg_endo -65.3 -170.74 0.17 Allowed 'Trans proline' 0 N--CA 1.488 1.177 0 O-C-N 122.734 0.86 . . . . 0.0 110.349 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.758 ' O ' ' HB2' ' A' ' 42' ' ' ALA . 52.0 Cg_endo -97.17 50.2 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.525 1.483 . . . . 0.0 113.413 -178.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.781 ' HD2' ' O ' ' A' ' 36' ' ' PRO . 46.7 Cg_endo -73.07 150.67 48.66 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 N-CA-C 108.671 -1.319 . . . . 0.0 108.671 178.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.644 ' C ' ' O ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -21.32 -52.93 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.108 -0.995 . . . . 0.0 111.23 -179.171 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.048 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -54.38 -45.97 72.95 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 120.786 -1.196 . . . . 0.0 110.096 -179.344 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.751 ' CG2' HD13 ' A' ' 40' ' ' LEU . 6.2 t -86.99 -33.6 7.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 O-C-N 121.021 -1.049 . . . . 0.0 110.29 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.758 ' HB2' ' O ' ' A' ' 37' ' ' PRO . . . -90.91 -39.54 12.23 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.003 -1.06 . . . . 0.0 112.435 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.816 ' OE1' ' HA ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -83.0 -20.07 35.79 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.936 -1.102 . . . . 0.0 109.988 -178.832 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.752 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -80.45 -46.67 15.53 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.242 -0.911 . . . . 0.0 109.371 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.834 ' CE1' ' HG3' ' A' ' 50' ' ' PRO . 0.4 OUTLIER -54.86 -16.9 2.99 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.645 179.746 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.57 ' CG ' ' OE1' ' A' ' 61' ' ' GLU . 6.0 t60 -95.46 -35.06 11.85 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.079 -1.048 . . . . 0.0 109.271 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.48 ' HA2' ' OE2' ' A' ' 61' ' ' GLU . . . -93.53 -107.01 1.85 Allowed Glycine 0 N--CA 1.488 2.128 0 N-CA-C 107.116 -2.394 . . . . 0.0 107.116 178.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.931 ' HH2' HG12 ' A' ' 212' ' ' VAL . 98.9 m95 -79.83 73.57 6.58 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.001 -1.293 . . . . 0.0 108.271 177.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.618 ' HA ' ' HA ' ' A' ' 45' ' ' HIS . 0.1 OUTLIER -46.95 138.81 7.15 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.503 -0.748 . . . . 0.0 111.262 -179.357 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.834 ' HG3' ' CE1' ' A' ' 45' ' ' HIS . 39.8 Cg_endo -69.55 -27.01 27.98 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 124.387 1.73 . . . . 0.0 110.862 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.853 ' CE ' ' N ' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -63.16 -17.9 62.88 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 178.293 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.826 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 7.4 m-20 -121.12 3.25 10.43 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.223 177.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.89 ' SG ' HG12 ' A' ' 78' ' ' VAL . 2.4 t -138.56 128.29 25.01 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.949 0.88 . . . . 0.0 111.045 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.728 ' CB ' ' ND2' ' A' ' 56' ' ' ASN . 0.7 OUTLIER -70.12 118.07 12.49 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.634 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.71 ' HB3' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -51.38 -27.93 11.26 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.079 -1.013 . . . . 0.0 111.211 -179.258 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.729 ' H ' ' ND2' ' A' ' 56' ' ' ASN . 1.4 m-80 -28.29 -34.5 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.747 0.784 . . . . 0.0 110.279 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.661 ' N ' ' O ' ' A' ' 55' ' ' GLU . 15.9 pt -112.29 166.62 6.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.585 -0.697 . . . . 0.0 109.444 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.547 ' N ' ' O ' ' A' ' 67' ' ' GLU . 13.7 t70 -108.51 109.75 21.07 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.13 -0.981 . . . . 0.0 109.788 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.76 ' CG1' ' CD1' ' A' ' 48' ' ' TRP . 95.7 t -130.56 135.16 61.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 O-C-N 121.78 -0.575 . . . . 0.0 110.462 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.816 ' HA ' ' OE1' ' A' ' 43' ' ' GLN . 2.8 tttt -136.3 155.41 50.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.88 -1.138 . . . . 0.0 111.227 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.57 ' OE1' ' CG ' ' A' ' 46' ' ' HIS . 3.1 tt0 -69.07 -120.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.47 -0.769 . . . . 0.0 110.265 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.518 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 38.48 48.99 2.33 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 108.346 -1.901 . . . . 0.0 108.346 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.688 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 102.07 58.65 0.78 Allowed Glycine 0 N--CA 1.487 2.047 0 N-CA-C 107.932 -2.067 . . . . 0.0 107.932 -178.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.824 HD22 ' H ' ' A' ' 64' ' ' LEU . 2.0 mm? 0.91 82.98 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.886 -0.773 . . . . 0.0 111.105 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 3.7 t -99.76 114.65 27.92 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.514 -0.741 . . . . 0.0 109.885 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.61 ' CE1' ' CD2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -97.21 124.89 41.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.414 -0.804 . . . . 0.0 109.538 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 58' ' ' ASP . 8.3 tt0 -145.88 122.01 10.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.826 -1.171 . . . . 0.0 110.23 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.555 ' CD ' ' O ' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -122.81 142.66 50.51 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.332 -0.855 . . . . 0.0 109.674 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.675 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 44.7 mtt180 -112.91 -71.44 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.033 -1.042 . . . . 0.0 110.591 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.675 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 56.6 Cg_endo -73.6 -122.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.502 1.264 . . . . 0.0 109.184 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 t -140.05 164.09 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.5 -1.375 . . . . 0.0 109.96 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.869 ' HB1' ' HA ' ' A' ' 76' ' ' ASP . . . -62.46 88.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.226 -0.921 . . . . 0.0 110.192 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.558 ' N ' ' OD1' ' A' ' 56' ' ' ASN . 2.7 tp60 -66.79 -77.5 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.171 -0.956 . . . . 0.0 110.368 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 73' ' ' GLN . 1.9 p -50.86 -101.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.112 -0.992 . . . . 0.0 110.03 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.712 HG23 ' OG ' ' A' ' 54' ' ' SER . 7.1 t -82.93 -129.25 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.929 -1.107 . . . . 0.0 109.203 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.869 ' HA ' ' HB1' ' A' ' 72' ' ' ALA . 0.9 OUTLIER -140.9 154.39 46.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.966 -1.084 . . . . 0.0 110.802 179.555 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.644 ' O ' HG13 ' A' ' 78' ' ' VAL . . . 29.88 -89.87 0.01 OUTLIER Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.429 -1.868 . . . . 0.0 108.429 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.112 ' CG2' ' HB3' ' A' ' 205' ' ' ALA . 17.1 m -155.26 138.73 7.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 O-C-N 121.736 -0.861 . . . . 0.0 109.999 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.762 ' C ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -144.95 133.22 21.66 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.239 -0.913 . . . . 0.0 112.047 -178.454 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.826 ' CA ' ' HA ' ' A' ' 52' ' ' ASP . . . -115.43 162.68 12.41 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.236 -1.545 . . . . 0.0 109.236 178.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.436 ' HA ' ' HB2' ' A' ' 202' ' ' SER . 13.0 ttpp -160.57 -28.21 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.134 -1.215 . . . . 0.0 110.452 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.552 ' CD ' ' HB3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -82.18 -73.51 0.39 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.978 -1.076 . . . . 0.0 109.872 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.47 ' C ' ' O ' ' A' ' 82' ' ' ARG . . . 36.49 53.15 1.37 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.423 ' CD1' ' C ' ' A' ' 84' ' ' TYR . 2.1 t80 -94.55 125.29 39.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -1.137 . . . . 0.0 110.603 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.592 ' HB3' ' CD2' ' A' ' 89' ' ' HIS . 30.7 m -139.9 166.68 23.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.163 -0.961 . . . . 0.0 110.022 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.505 ' O ' ' NE2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -116.87 133.77 55.6 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.059 -1.026 . . . . 0.0 110.201 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 101.03 -114.92 5.15 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.524 ' O ' ' CD2' ' A' ' 89' ' ' HIS . 17.7 tp -128.49 132.18 48.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.359 -1.083 . . . . 0.0 110.248 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.592 ' CD2' ' HB3' ' A' ' 85' ' ' SER . 2.9 m80 -147.16 156.78 43.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.12 -0.987 . . . . 0.0 109.915 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.546 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -163.04 155.45 18.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.939 . . . . 0.0 110.074 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 1.124 ' CZ3' HG11 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -134.67 158.86 43.0 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.275 -0.891 . . . . 0.0 109.238 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.611 ' HB3' ' HB3' ' A' ' 215' ' ' ARG . 3.0 tt0 -109.81 134.11 52.4 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.876 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.989 HD13 HG13 ' A' ' 214' ' ' ILE . 8.3 mm -129.18 132.25 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.421 -0.8 . . . . 0.0 109.657 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.7 ' HB3' ' HA ' ' A' ' 166' ' ' ARG . 13.3 p -155.22 154.31 32.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.188 -0.945 . . . . 0.0 110.271 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.912 ' CE3' HG22 ' A' ' 212' ' ' VAL . 14.4 m95 -123.32 86.41 51.86 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.09 -1.006 . . . . 0.0 109.8 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.595 ' CD ' ' HB2' ' A' ' 213' ' ' ARG . 52.2 Cg_endo -99.06 109.0 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 121.978 1.785 . . . . 0.0 110.634 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.633 HD11 ' NE2' ' A' ' 211' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 O-C-N 120.883 -1.136 . . . . 0.0 109.764 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.793 HG23 ' CB ' ' A' ' 204' ' ' SER . 18.4 m . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 1.122 HG13 ' O ' ' A' ' 202' ' ' SER . 36.9 t -149.23 156.26 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.14 -0.975 . . . . 0.0 110.757 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.578 ' HA2' ' HA3' ' A' ' 132' ' ' GLY . . . -149.96 150.23 22.26 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.967 ' CG1' HD13 ' A' ' 199' ' ' LEU . 2.9 t -122.38 141.88 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -1.098 . . . . 0.0 109.666 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.551 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -124.25 156.67 36.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.095 -1.003 . . . . 0.0 110.77 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.866 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -120.52 133.63 55.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.35 -0.844 . . . . 0.0 110.207 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -88.9 -25.03 22.33 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.344 -0.848 . . . . 0.0 109.335 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.6 pp -86.67 -11.96 49.77 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.516 -0.74 . . . . 0.0 109.251 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.654 ' HB2' ' HB ' ' A' ' 110' ' ' THR . . . . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.535 -0.728 . . . . 0.0 110.378 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.246 0.546 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.435 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 0.6 OUTLIER -149.98 128.97 12.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.355 -0.841 . . . . 0.0 110.076 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 39.1 t -120.55 120.13 34.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.292 -0.88 . . . . 0.0 110.224 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' TRP . . . . . 0.465 ' O ' ' O ' ' A' ' 108' ' ' VAL . 1.5 m95 -132.82 124.87 28.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.91 . . . . 0.0 109.99 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.578 ' HA3' ' HA2' ' A' ' 107' ' ' GLY . . . -155.18 -172.13 22.52 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.626 ' O ' ' CD1' ' A' ' 133' ' ' TRP . 3.5 p90 -145.26 140.4 27.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.368 -1.077 . . . . 0.0 110.902 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -120.45 149.05 43.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.778 -0.576 . . . . 0.0 109.709 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.641 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 O-C-N 120.966 -1.084 . . . . 0.0 110.361 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.9 HG11 ' HB2' ' A' ' 167' ' ' LEU . 48.0 t . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.854 ' HD2' HG13 ' A' ' 163' ' ' VAL . 38.0 Cg_endo -64.05 176.09 2.74 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.718 1.378 . . . . 0.0 110.572 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 164' ' ' PRO . 12.9 mt-10 -35.75 -32.18 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.503 -0.748 . . . . 0.0 110.681 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.7 ' HA ' ' HB3' ' A' ' 94' ' ' SER . 21.2 ttm180 -152.26 156.71 40.22 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.269 -0.894 . . . . 0.0 111.087 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.9 ' HB2' HG11 ' A' ' 163' ' ' VAL . 7.2 tt -126.21 157.1 39.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.584 -0.697 . . . . 0.0 109.719 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.685 ' N ' HD23 ' A' ' 167' ' ' LEU . 24.9 tp -123.6 116.61 23.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.087 -1.008 . . . . 0.0 110.739 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 1.124 HG11 ' CZ3' ' A' ' 91' ' ' TRP . 10.6 t -91.93 141.91 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.101 -0.999 . . . . 0.0 109.61 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 178' ' ' LEU . 11.4 t -118.93 124.71 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.917 . . . . 0.0 111.133 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.589 HD13 ' HG3' ' A' ' 201' ' ' PRO . 13.0 tp -133.4 105.68 7.07 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.384 -0.822 . . . . 0.0 109.346 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -115.47 139.32 50.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 110.544 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.517 ' O ' ' C ' ' A' ' 174' ' ' GLU . 0.0 OUTLIER -93.43 -41.0 10.05 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 120.174 -0.611 . . . . 0.0 109.996 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.517 ' C ' ' O ' ' A' ' 173' ' ' MET . 15.9 tt0 -39.11 -30.93 0.06 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 0.0 108.497 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.519 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 4.7 tt0 -113.2 -24.97 9.11 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.616 ' O ' ' HB ' ' A' ' 198' ' ' THR . . . 76.81 25.97 63.65 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 -179.031 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.859 HG22 ' HG ' ' A' ' 194' ' ' LEU . 2.2 p -113.14 144.45 42.64 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.346 -1.091 . . . . 0.0 110.77 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.712 ' H ' HD21 ' A' ' 194' ' ' LEU . 0.1 OUTLIER -153.03 154.04 34.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.405 -0.809 . . . . 0.0 110.169 -179.545 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.602 ' HA3' HD12 ' A' ' 187' ' ' LEU . . . -166.05 -173.17 34.23 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.712 ' CE1' HG22 ' A' ' 169' ' ' VAL . 0.7 OUTLIER -118.05 122.48 43.27 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.363 -1.08 . . . . 0.0 109.431 -179.75 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.633 ' HA ' ' CD2' ' A' ' 186' ' ' TYR . 41.9 t -144.24 142.5 30.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.288 -0.883 . . . . 0.0 110.822 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.774 HG21 ' HD2' ' A' ' 164' ' ' PRO . 0.0 OUTLIER -90.75 116.34 31.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.405 -0.809 . . . . 0.0 109.321 179.046 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 94.96 -26.03 20.83 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.608 ' CA ' HD23 ' A' ' 168' ' ' LEU . . . 102.54 42.18 2.21 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 187' ' ' LEU . 4.7 m -137.53 -54.84 0.68 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.158 -1.201 . . . . 0.0 110.444 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.729 ' HD2' HD13 ' A' ' 182' ' ' ILE . 0.1 OUTLIER -62.0 77.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.129 0.966 . . . . 0.0 109.962 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.828 HD21 ' CZ ' ' A' ' 191' ' ' PHE . 1.7 tt 179.87 24.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.48 0.657 . . . . 0.0 109.793 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.763 ' N ' ' CD ' ' A' ' 189' ' ' PRO . . . -104.94 -21.3 9.11 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.892 -1.147 . . . . 0.0 112.074 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.763 ' CD ' ' N ' ' A' ' 188' ' ' GLY . 47.5 Cg_endo -74.21 -42.76 0.64 Allowed 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 122.812 0.901 . . . . 0.0 111.386 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -90.18 10.43 24.55 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.996 -1.065 . . . . 0.0 111.004 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 1.003 ' CE1' HD23 ' A' ' 194' ' ' LEU . 1.5 m-85 -89.98 -13.3 36.42 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.13 -0.981 . . . . 0.0 109.786 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ARG . . . . . 0.465 ' HA ' ' NE ' ' A' ' 192' ' ' ARG . 0.0 OUTLIER -70.19 -29.23 66.05 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.158 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.533 ' O ' ' HB3' ' A' ' 197' ' ' ARG . . . -102.41 -18.76 15.61 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.111 -1.996 . . . . 0.0 108.111 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 1.003 HD23 ' CE1' ' A' ' 191' ' ' PHE . 0.9 OUTLIER -61.61 -20.32 63.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.792 -0.828 . . . . 0.0 109.454 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 195' ' ' LYS . 0.1 OUTLIER -64.32 -22.25 66.89 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.441 -0.787 . . . . 0.0 109.367 179.257 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.45 ' N ' ' HE3' ' A' ' 195' ' ' LYS . . . -125.43 -20.23 2.21 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.728 ' HD2' ' HA ' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -90.45 -4.19 57.15 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.479 -1.012 . . . . 0.0 109.267 179.661 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 198' ' ' THR . . . . . 0.616 ' HB ' ' O ' ' A' ' 176' ' ' GLY . 0.1 OUTLIER -43.19 138.54 2.18 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 122.401 1.096 . . . . 0.0 112.43 -177.987 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.967 HD13 ' CG1' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -141.39 172.93 12.01 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.772 179.399 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.53 ' N ' ' O ' ' A' ' 109' ' ' ALA . 8.5 m-85 -82.3 128.66 66.57 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.619 -1.301 . . . . 0.0 109.502 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.611 ' CG ' HD13 ' A' ' 178' ' ' LEU . 53.2 Cg_endo -78.44 144.79 20.53 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 124.045 1.55 . . . . 0.0 112.556 -178.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' SER . . . . . 1.122 ' O ' HG13 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -133.58 147.56 51.54 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.247 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 1.002 ' HA ' HG22 ' A' ' 106' ' ' VAL . 8.4 p -119.14 163.5 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.722 -1.236 . . . . 0.0 110.388 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' SER . . . . . 0.793 ' CB ' HG23 ' A' ' 105' ' ' VAL . 0.4 OUTLIER -155.07 134.65 12.66 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.013 0.911 . . . . 0.0 110.466 179.606 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 1.112 ' HB3' ' CG2' ' A' ' 78' ' ' VAL . . . -138.91 147.42 42.3 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.792 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.505 ' CG1' ' HB3' ' A' ' 211' ' ' GLN . 2.5 p -66.25 173.41 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.405 -0.81 . . . . 0.0 110.54 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 0.585 ' O ' ' CG ' ' A' ' 207' ' ' TRP . 33.0 p-90 -107.02 114.26 28.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.281 -0.887 . . . . 0.0 110.257 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 66' ' ' PHE . . . 172.32 174.18 39.5 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -78.38 -73.53 0.32 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -1.157 . . . . 0.0 110.436 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' CYS . . . . . 0.463 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 89.1 m -86.29 86.24 7.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.356 -0.84 . . . . 0.0 110.292 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.633 ' NE2' HD11 ' A' ' 97' ' ' LEU . 25.1 mm-40 -154.3 -49.92 0.09 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.211 -0.931 . . . . 0.0 110.365 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.931 HG12 ' HH2' ' A' ' 48' ' ' TRP . 47.9 t -127.81 143.73 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.119 -0.988 . . . . 0.0 112.033 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' ARG . . . . . 0.595 ' HB2' ' CD ' ' A' ' 96' ' ' PRO . 15.6 tpp85 -128.9 137.79 51.63 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.989 HG13 HD13 ' A' ' 93' ' ' ILE . 3.1 tt -142.36 136.32 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.643 -1.286 . . . . 0.0 112.289 -178.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.611 ' HB3' ' HB3' ' A' ' 92' ' ' GLU . 12.7 tpt180 -130.11 109.43 10.82 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 216' ' ' TYR . . . . . 0.715 ' CZ ' ' CD1' ' A' ' 91' ' ' TRP . 2.1 t80 -89.0 149.59 23.19 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.055 -1.028 . . . . 0.0 111.531 -178.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 44.2 tpp -132.79 107.92 8.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.671 -0.643 . . . . 0.0 109.632 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 93.39 87.46 1.6 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.257 -1.143 . . . . 0.0 110.406 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.601 ' O ' ' N ' ' A' ' 32' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.321 0.581 . . . . 0.0 109.796 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.938 ' HA ' HD23 ' A' ' 33' ' ' LEU . 1.6 tt0 -46.64 -26.86 1.0 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.408 -0.808 . . . . 0.0 109.159 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -74.85 -22.58 58.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.463 -0.773 . . . . 0.0 108.933 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.601 ' N ' ' O ' ' A' ' 29' ' ' LEU . 1.1 mm? -83.84 -32.17 25.4 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.062 HD11 ' HB2' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -71.11 -35.93 71.98 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 122.064 0.935 . . . . 0.0 109.139 179.299 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.65 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 3.7 t -79.71 -7.62 58.72 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.323 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 1.047 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -70.42 -70.96 0.29 Allowed Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.122 -0.986 . . . . 0.0 110.899 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 1.047 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 51.6 Cg_endo -75.39 160.92 38.37 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.495 1.261 . . . . 0.0 110.483 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 36' ' ' PRO . 53.5 Cg_endo -99.81 52.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.123 1.882 . . . . 0.0 112.113 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.685 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 48.6 Cg_endo -72.89 151.04 50.35 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.125 1.066 . . . . 0.0 110.703 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.744 ' OD2' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -15.2 -65.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.757 -0.59 . . . . 0.0 111.786 179.282 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.098 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -45.28 -43.71 10.79 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.413 -0.804 . . . . 0.0 110.412 -179.434 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.827 ' CG2' HD13 ' A' ' 40' ' ' LEU . 3.8 t -85.08 -19.33 8.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 O-C-N 121.168 -0.958 . . . . 0.0 111.185 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.52 -44.12 10.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.89 -1.132 . . . . 0.0 112.339 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.744 ' NE2' ' OD2' ' A' ' 39' ' ' ASP . 1.8 mt-30 -85.39 -19.48 31.32 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 118.385 -1.326 . . . . 0.0 109.425 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.686 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -69.31 -41.81 76.22 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 122.165 0.983 . . . . 0.0 108.472 179.218 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.69 ' NE2' HG12 ' A' ' 41' ' ' VAL . 0.8 OUTLIER -63.74 -28.82 70.15 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.748 -179.825 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -96.35 -29.64 13.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.874 -1.141 . . . . 0.0 109.608 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.09 -89.83 1.47 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 107.339 -2.304 . . . . 0.0 107.339 178.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.77 ' HH2' HG12 ' A' ' 212' ' ' VAL . 97.4 m95 -90.77 74.37 6.59 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.58 ' ND2' ' N ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -43.26 137.94 2.74 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.527 -0.733 . . . . 0.0 111.428 -179.045 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.705 ' HA ' ' O ' ' A' ' 53' ' ' CYS . 40.0 Cg_endo -67.67 -23.31 42.65 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 124.435 1.755 . . . . 0.0 111.168 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.835 ' CE ' ' N ' ' A' ' 51' ' ' LYS . 0.6 OUTLIER -65.29 -15.58 62.66 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 178.326 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 1.103 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 11.2 m-20 -121.97 3.15 9.95 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.162 177.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.873 ' SG ' HG12 ' A' ' 78' ' ' VAL . 9.5 t -148.0 138.08 22.7 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.507 0.67 . . . . 0.0 110.292 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.762 ' HB2' ' O ' ' A' ' 76' ' ' ASP . 1.5 m -80.29 130.68 35.37 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.175 -0.953 . . . . 0.0 109.835 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 1.062 ' HB2' HD11 ' A' ' 33' ' ' LEU . 4.3 pm0 -44.63 -24.36 0.19 Allowed 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.808 ' ND2' HG21 ' A' ' 75' ' ' THR . 0.2 OUTLIER -55.5 -4.58 0.1 Allowed 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.575 -1.328 . . . . 0.0 109.866 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.576 HG22 HG22 ' A' ' 59' ' ' VAL . 22.8 mm -111.96 157.75 12.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.477 -0.765 . . . . 0.0 110.518 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.654 ' HA ' HD23 ' A' ' 40' ' ' LEU . 35.9 t0 -118.87 105.4 11.46 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.709 0.766 . . . . 0.0 109.534 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.7 ' CG1' ' CD1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -131.08 136.12 58.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 O-C-N 121.628 -0.67 . . . . 0.0 110.919 -178.942 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.667 ' HD3' ' OD2' ' A' ' 39' ' ' ASP . 28.7 mttp -135.53 155.28 50.75 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.282 -0.886 . . . . 0.0 110.535 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.483 ' HG3' ' N ' ' A' ' 62' ' ' GLY . 7.8 pt-20 -75.82 -130.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.227 -0.921 . . . . 0.0 110.408 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.483 ' N ' ' HG3' ' A' ' 61' ' ' GLU . . . 45.73 45.12 12.99 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.661 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 108.9 60.55 0.53 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.953 HD21 ' O ' ' A' ' 214' ' ' ILE . 0.3 OUTLIER -0.32 78.98 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.878 -0.778 . . . . 0.0 111.27 -179.283 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.499 ' O ' ' SG ' ' A' ' 65' ' ' CYS . 31.9 p -99.58 114.33 27.29 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.13 -0.981 . . . . 0.0 109.647 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.7 ' CD1' ' CG1' ' A' ' 59' ' ' VAL . 1.2 t80 -90.55 124.84 35.35 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.479 -0.763 . . . . 0.0 110.211 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 4.9 tt0 -139.99 152.89 46.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.172 -0.955 . . . . 0.0 109.674 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.527 ' HG3' ' HB3' ' A' ' 207' ' ' TRP . 0.1 OUTLIER -135.93 140.25 43.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.022 -1.049 . . . . 0.0 110.83 -179.578 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.629 ' CB ' ' HD2' ' A' ' 70' ' ' PRO . 1.4 mtp85 -61.13 -173.94 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.386 -0.821 . . . . 0.0 109.208 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.629 ' HD2' ' CB ' ' A' ' 69' ' ' ARG . 50.9 Cg_endo -66.28 -138.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.591 1.311 . . . . 0.0 108.958 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.72 152.61 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.966 -1.083 . . . . 0.0 110.015 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.6 -39.95 0.13 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.161 -0.962 . . . . 0.0 110.188 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.549 ' O ' ' N ' ' A' ' 75' ' ' THR . 0.2 OUTLIER -170.14 147.12 3.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.286 -0.884 . . . . 0.0 110.145 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 73' ' ' GLN . 9.2 t -43.74 91.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 110.353 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.808 HG21 ' ND2' ' A' ' 56' ' ' ASN . 1.5 m -99.17 -129.4 0.2 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.296 -0.877 . . . . 0.0 110.053 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.762 ' O ' ' HB2' ' A' ' 54' ' ' SER . 72.5 m-20 -137.73 113.91 10.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.195 -0.94 . . . . 0.0 110.486 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.506 ' O ' ' O ' ' A' ' 76' ' ' ASP . . . -50.73 -96.16 0.01 OUTLIER Glycine 0 N--CA 1.484 1.837 0 N-CA-C 107.759 -2.136 . . . . 0.0 107.759 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.873 HG12 ' SG ' ' A' ' 53' ' ' CYS . 6.9 m -143.05 126.93 14.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.215 -1.168 . . . . 0.0 110.237 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.651 ' C ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -145.57 134.16 22.11 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.131 -0.981 . . . . 0.0 112.536 -178.615 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 1.103 ' CA ' ' HA ' ' A' ' 52' ' ' ASP . . . -133.13 161.56 24.17 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 178.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.505 ' HG3' ' HB3' ' A' ' 202' ' ' SER . 0.4 OUTLIER -169.96 24.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.237 -1.155 . . . . 0.0 110.345 -179.851 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.469 ' O ' ' CD2' ' A' ' 200' ' ' TYR . 1.1 ptt180 -91.36 -102.44 0.11 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.075 -1.016 . . . . 0.0 110.428 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.452 ' HA3' ' CG ' ' A' ' 201' ' ' PRO . . . 81.03 66.6 1.61 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -121.77 95.8 4.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -1.166 . . . . 0.0 110.361 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 173' ' ' MET . 69.7 m -140.09 155.6 46.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.207 -0.933 . . . . 0.0 110.286 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.518 ' C ' ' NE2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -118.2 135.42 54.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.207 -0.933 . . . . 0.0 109.809 179.832 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 106.45 -118.32 5.64 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.476 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 51.3 tp -128.79 123.09 31.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.408 -1.054 . . . . 0.0 110.904 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.518 ' NE2' ' C ' ' A' ' 86' ' ' ARG . 4.2 m-70 -147.2 153.17 39.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.205 -0.934 . . . . 0.0 109.758 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.54 ' C ' ' CE3' ' A' ' 91' ' ' TRP . . . -163.71 156.85 18.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.025 -1.047 . . . . 0.0 110.201 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.985 ' HB2' HD11 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -134.98 154.69 51.63 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.184 -0.948 . . . . 0.0 110.108 179.484 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.893 ' C ' HD13 ' A' ' 93' ' ' ILE . 0.5 OUTLIER -109.56 118.93 37.89 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.318 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.985 HD11 ' HB2' ' A' ' 91' ' ' TRP . 0.1 OUTLIER -132.95 133.86 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.819 -1.176 . . . . 0.0 111.491 -178.659 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.567 ' O ' ' HD3' ' A' ' 96' ' ' PRO . 0.1 OUTLIER -116.84 120.08 37.39 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.441 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.904 ' HH2' ' O ' ' A' ' 204' ' ' SER . 6.3 t-105 -116.13 87.39 19.25 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.106 -0.997 . . . . 0.0 110.332 -178.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.577 ' HG2' ' O ' ' A' ' 211' ' ' GLN . 49.9 Cg_endo -99.24 138.66 0.32 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.257 1.972 . . . . 0.0 110.319 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.716 HD13 ' C ' ' A' ' 97' ' ' LEU . 1.9 tm? . . . . . 0 N--CA 1.492 1.641 0 O-C-N 120.866 -1.146 . . . . 0.0 109.405 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 204' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 121.496 0.665 . . . . 0.0 112.657 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.702 HG22 ' CE3' ' A' ' 95' ' ' TRP . 1.0 OUTLIER -152.16 122.82 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.62 -0.675 . . . . 0.0 109.431 177.413 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.529 ' HA3' ' HA3' ' A' ' 132' ' ' GLY . . . 160.44 -158.56 30.0 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 118.711 -1.709 . . . . 0.0 111.097 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.645 HG12 ' HB2' ' A' ' 199' ' ' LEU . 2.3 t -120.78 169.34 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.725 -0.867 . . . . 0.0 109.717 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.539 ' C ' ' HB3' ' A' ' 199' ' ' LEU . . . -146.19 132.66 19.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.996 -1.065 . . . . 0.0 110.263 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.745 HG23 ' CG ' ' A' ' 199' ' ' LEU . 9.7 p -89.43 120.85 31.12 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.146 -0.971 . . . . 0.0 110.304 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.17 -31.55 14.74 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.638 -0.664 . . . . 0.0 109.817 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.492 HD23 ' H ' ' A' ' 112' ' ' LEU . 0.6 OUTLIER -76.91 -12.47 59.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.401 -0.812 . . . . 0.0 110.01 179.807 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.444 ' O ' ' OE1' ' A' ' 129' ' ' GLU . . . . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.376 -0.828 . . . . 0.0 110.261 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.341 0.591 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.444 ' OE1' ' O ' ' A' ' 113' ' ' ALA . 0.9 OUTLIER -150.4 138.1 19.89 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.224 -0.923 . . . . 0.0 109.766 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 8.9 t -120.06 120.71 37.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.386 -0.821 . . . . 0.0 110.006 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' TRP . . . . . 0.465 ' O ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -132.2 133.36 44.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.882 . . . . 0.0 110.255 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.529 ' HA3' ' HA3' ' A' ' 107' ' ' GLY . . . 165.72 -120.38 0.92 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.662 ' CZ3' ' CD2' ' A' ' 180' ' ' TYR . 47.0 m0 -119.48 112.81 19.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.043 -1.269 . . . . 0.0 110.025 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.804 ' C ' HD13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -118.92 148.22 43.17 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.397 0.618 . . . . 0.0 110.685 -179.545 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.821 HD13 ' N ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.946 . . . . 0.0 110.116 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.59 HG12 ' N ' ' A' ' 164' ' ' PRO . 1.3 t . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.59 ' N ' HG12 ' A' ' 163' ' ' VAL . 45.6 Cg_endo -73.29 68.6 4.19 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.74 1.389 . . . . 0.0 110.705 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -80.72 -81.27 0.13 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.304 -0.873 . . . . 0.0 109.116 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 1.134 ' O ' HD13 ' A' ' 167' ' ' LEU . 9.7 ttp180 -119.09 115.53 24.48 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.394 -0.816 . . . . 0.0 108.961 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 1.134 HD13 ' O ' ' A' ' 166' ' ' ARG . 0.3 OUTLIER -132.14 157.46 44.2 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 121.424 0.631 . . . . 0.0 110.474 -179.015 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.754 HD12 ' CD ' ' A' ' 92' ' ' GLU . 0.7 OUTLIER -107.42 125.82 51.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.371 -0.831 . . . . 0.0 109.736 179.401 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.716 HG22 ' CE1' ' A' ' 180' ' ' TYR . 19.3 t -89.53 132.37 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.139 -0.975 . . . . 0.0 110.062 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.577 HG13 HD21 ' A' ' 168' ' ' LEU . 0.1 OUTLIER -125.3 111.48 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.398 -0.814 . . . . 0.0 110.186 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.691 ' HB3' ' CZ2' ' A' ' 91' ' ' TRP . 2.0 tp -107.41 114.04 27.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.339 -0.851 . . . . 0.0 110.022 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.496 ' N ' HD12 ' A' ' 171' ' ' LEU . 53.1 t0 -116.22 129.85 56.5 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.268 -0.895 . . . . 0.0 110.067 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.494 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 12.4 tpp -100.85 -42.02 6.62 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 173' ' ' MET . 0.7 OUTLIER -45.87 -25.62 0.56 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.078 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.548 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.0 OUTLIER -111.59 -28.07 8.3 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.751 0.786 . . . . 0.0 108.895 179.29 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.812 ' O ' HG21 ' A' ' 198' ' ' THR . . . 85.37 22.66 50.65 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.649 ' CA ' HD22 ' A' ' 194' ' ' LEU . 0.2 OUTLIER -119.73 111.43 18.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.258 -1.142 . . . . 0.0 111.081 -179.631 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.718 HD11 ' O ' ' A' ' 199' ' ' LEU . 0.3 OUTLIER -136.01 154.34 51.1 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.251 -0.906 . . . . 0.0 110.225 179.345 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.445 ' HA2' HG21 ' A' ' 108' ' ' VAL . . . 172.49 -153.21 18.46 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.886 ' C ' HD22 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -118.79 125.21 49.09 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.192 -1.181 . . . . 0.0 109.768 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.431 ' HA ' ' HB3' ' A' ' 187' ' ' LEU . 17.0 t -116.72 124.88 50.76 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.381 -0.825 . . . . 0.0 110.171 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 1.023 HG22 HD12 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -103.7 116.71 47.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.495 -0.753 . . . . 0.0 109.645 179.889 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 49.66 22.49 4.12 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 57.26 48.43 80.27 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' THR . . . . . 0.863 HG22 ' CD1' ' A' ' 186' ' ' TYR . 69.1 m -110.48 -86.53 0.54 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.326 -1.102 . . . . 0.0 110.892 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.863 ' CD1' HG22 ' A' ' 185' ' ' THR . 8.9 m-30 -59.67 -56.57 20.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.26 -0.9 . . . . 0.0 110.809 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.886 HD22 ' C ' ' A' ' 180' ' ' TYR . 0.6 OUTLIER -76.25 43.94 0.31 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.002 -1.061 . . . . 0.0 110.12 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.489 ' H ' ' HD2' ' A' ' 189' ' ' PRO . . . -105.32 -70.47 0.78 Allowed Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.913 -1.137 . . . . 0.0 110.269 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.489 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 45.3 Cg_endo -71.5 -29.71 16.1 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.899 1.473 . . . . 0.0 111.151 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.539 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -72.74 34.17 0.07 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.339 -0.851 . . . . 0.0 111.267 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.406 ' H ' ' C ' ' A' ' 189' ' ' PRO . 0.4 OUTLIER -90.51 -43.94 9.91 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.982 -1.074 . . . . 0.0 109.884 179.351 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -16.65 61.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.32 -0.863 . . . . 0.0 110.107 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -106.23 -13.38 23.16 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.782 HD23 ' O ' ' A' ' 194' ' ' LEU . 7.2 tt -70.94 -29.92 66.08 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.589 -0.948 . . . . 0.0 109.433 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.569 ' HE3' ' N ' ' A' ' 196' ' ' GLY . 0.1 OUTLIER -53.92 -32.61 54.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.224 -0.922 . . . . 0.0 109.493 179.745 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.569 ' N ' ' HE3' ' A' ' 195' ' ' LYS . . . -94.93 -25.97 13.66 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 1.003 ' HD3' HD11 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.67 -4.76 56.53 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.764 -0.845 . . . . 0.0 109.632 179.499 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 198' ' ' THR . . . . . 0.812 HG21 ' O ' ' A' ' 176' ' ' GLY . 0.2 OUTLIER -44.01 136.96 3.51 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.76 0.79 . . . . 0.0 111.747 -178.243 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 1.003 HD11 ' HD3' ' A' ' 197' ' ' ARG . 0.0 OUTLIER -140.37 170.81 15.12 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.381 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.542 ' C ' HG13 ' A' ' 108' ' ' VAL . 3.1 m-30 -84.76 139.03 37.54 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.934 . . . . 0.0 109.752 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.452 ' CG ' ' HA3' ' A' ' 83' ' ' GLY . 40.6 Cg_endo -67.8 113.74 3.09 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.871 1.458 . . . . 0.0 110.203 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.505 ' HB3' ' HG3' ' A' ' 81' ' ' LYS . 25.1 p -133.11 152.95 51.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.296 -0.877 . . . . 0.0 110.81 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 79' ' ' ARG . 6.1 p -160.2 149.91 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.524 -0.735 . . . . 0.0 110.049 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' SER . . . . . 0.904 ' O ' ' HH2' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -139.86 126.53 20.51 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.303 -0.873 . . . . 0.0 109.134 178.887 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.559 ' HB3' ' CG2' ' A' ' 78' ' ' VAL . . . -127.81 163.5 24.25 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.746 -1.221 . . . . 0.0 111.678 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.57 HG13 ' N ' ' A' ' 207' ' ' TRP . 1.2 t -50.2 174.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.752 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 0.57 ' N ' HG13 ' A' ' 206' ' ' VAL . 79.0 m95 -51.29 -74.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.375 -0.828 . . . . 0.0 109.259 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.631 ' HA2' ' CD2' ' A' ' 66' ' ' PHE . . . 177.03 103.86 0.17 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' GLN . . . . . 0.487 ' HB2' ' O ' ' A' ' 208' ' ' GLY . 18.6 tt0 179.68 -49.11 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.767 -0.843 . . . . 0.0 110.195 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' CYS . . . . . 0.521 ' O ' ' CG ' ' A' ' 211' ' ' GLN . 1.7 m -43.0 -96.78 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.62 -0.675 . . . . 0.0 110.658 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.577 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 0.0 OUTLIER 179.53 45.23 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.24 -0.912 . . . . 0.0 109.523 -179.603 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.77 HG12 ' HH2' ' A' ' 48' ' ' TRP . 29.2 t -86.08 138.22 19.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-O 121.558 0.694 . . . . 0.0 110.758 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' ARG . . . . . 0.454 ' HA ' ' HZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -125.71 143.7 50.93 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.48 -0.763 . . . . 0.0 110.139 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.953 ' O ' HD21 ' A' ' 64' ' ' LEU . 1.5 tt -140.12 127.59 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.086 -1.009 . . . . 0.0 110.488 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -129.96 144.23 51.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.306 -0.871 . . . . 0.0 109.596 179.519 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 216' ' ' TYR . . . . . 0.731 ' CE2' ' CE3' ' A' ' 91' ' ' TRP . 1.2 t80 -118.62 151.37 38.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.248 -0.908 . . . . 0.0 111.318 -178.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 217' ' ' MET . . . . . 0.483 ' HB3' ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -127.79 107.83 10.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.469 -0.77 . . . . 0.0 109.658 179.332 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 71.75 76.51 0.59 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.57 ' HB2' ' CD2' ' A' ' 216' ' ' TYR . 32.1 tt0 . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.22 -1.164 . . . . 0.0 110.296 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.897 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.203 0.525 . . . . 0.0 109.918 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.61 ' HA ' HD23 ' A' ' 33' ' ' LEU . 1.4 pp20? -46.17 -37.37 6.94 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.135 -0.978 . . . . 0.0 109.165 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -57.44 -25.56 59.84 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.381 -0.825 . . . . 0.0 108.823 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 29' ' ' LEU . 5.9 tp -83.12 -32.21 26.82 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.831 HD12 ' C ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -84.94 -38.42 19.36 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 121.82 0.819 . . . . 0.0 109.237 179.164 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.565 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 1.1 t -49.23 -20.63 0.65 Allowed 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.388 0.613 . . . . 0.0 110.189 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 1.051 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -52.34 -161.37 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.516 -0.74 . . . . 0.0 109.692 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 1.051 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 39.2 Cg_endo -66.61 121.85 9.16 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 O-C-N 123.001 1.0 . . . . 0.0 109.754 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.991 ' CB ' HG21 ' A' ' 41' ' ' VAL . 44.0 Cg_endo -70.08 109.27 2.33 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.154 1.607 . . . . 0.0 111.732 -178.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.774 ' O ' ' N ' ' A' ' 40' ' ' LEU . 52.0 Cg_endo -79.74 151.62 22.01 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.238 1.652 . . . . 0.0 109.239 178.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.733 ' C ' HE22 ' A' ' 43' ' ' GLN . 0.9 OUTLIER -12.83 -51.23 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 122.167 0.984 . . . . 0.0 110.062 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.073 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -34.78 -43.23 0.17 Allowed 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.934 -179.346 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.991 HG21 ' CB ' ' A' ' 37' ' ' PRO . 2.9 t -70.87 -24.81 25.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 O-C-N 121.168 -0.957 . . . . 0.0 110.678 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.607 ' N ' ' O ' ' A' ' 39' ' ' ASP . . . -90.69 -41.54 11.24 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 118.981 -1.087 . . . . 0.0 113.104 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.733 HE22 ' C ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -87.37 -19.37 28.24 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.862 -1.149 . . . . 0.0 109.829 -179.1 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 1.034 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 7.5 ttm-85 -72.44 -53.98 10.64 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.756 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 4.0 m-70 -55.49 -27.98 51.76 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.556 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -96.07 -30.43 13.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.02 -1.05 . . . . 0.0 109.586 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.87 -74.11 1.27 Allowed Glycine 0 N--CA 1.488 2.131 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.736 ' CD2' ' CE1' ' A' ' 66' ' ' PHE . 99.2 m95 -100.36 74.09 1.71 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.618 ' HA ' ' HA ' ' A' ' 45' ' ' HIS . 0.1 OUTLIER -43.65 145.71 1.11 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.5 -0.75 . . . . 0.0 110.984 -179.419 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.756 ' HD3' ' HA ' ' A' ' 45' ' ' HIS . 42.8 Cg_endo -70.88 -31.07 16.16 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 124.297 1.682 . . . . 0.0 110.681 -178.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.932 ' O ' ' HA2' ' A' ' 80' ' ' GLY . 0.3 OUTLIER -64.17 -16.15 61.32 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.225 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.996 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 4.8 m-20 -118.72 0.28 11.43 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.638 177.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.702 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 16.0 t -150.04 132.9 16.04 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.21 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.555 ' H ' ' HA ' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -75.23 117.65 17.29 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.593 0.711 . . . . 0.0 109.688 179.186 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.646 ' O ' ' N ' ' A' ' 57' ' ' ILE . 6.7 pt-20 -42.54 -28.67 0.23 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.595 -0.69 . . . . 0.0 112.801 -178.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.984 ' ND2' HG22 ' A' ' 75' ' ' THR . 0.5 OUTLIER -40.34 -16.0 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.298 0 O-C-N 120.96 -1.087 . . . . 0.0 111.04 -179.114 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.747 HG22 HG13 ' A' ' 59' ' ' VAL . 1.2 mt -111.55 165.6 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 120.998 -1.064 . . . . 0.0 110.329 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 67' ' ' GLU . 4.2 t70 -117.54 104.27 10.9 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.76 0.791 . . . . 0.0 110.455 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.782 HG11 ' CE1' ' A' ' 66' ' ' PHE . 34.8 m -130.38 135.42 60.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 121.73 -0.606 . . . . 0.0 110.034 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.755 ' HG2' ' HA ' ' A' ' 40' ' ' LEU . 24.7 mttt -133.04 141.31 48.18 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.763 -1.211 . . . . 0.0 111.377 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.552 ' CG ' ' HB3' ' A' ' 43' ' ' GLN . 0.4 OUTLIER -59.95 -129.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.495 -0.753 . . . . 0.0 110.508 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 44.53 51.11 8.01 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 107.978 -2.049 . . . . 0.0 107.978 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.663 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 103.01 61.58 0.71 Allowed Glycine 0 N--CA 1.486 2.005 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 -178.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.036 HD11 HG22 ' A' ' 214' ' ' ILE . 0.2 OUTLIER 0.83 80.81 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.0 -0.706 . . . . 0.0 111.215 -178.737 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.426 ' N ' ' O ' ' A' ' 63' ' ' GLY . 0.5 OUTLIER -99.96 113.89 26.78 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.44 -0.788 . . . . 0.0 110.241 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.782 ' CE1' HG11 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -103.22 124.62 48.96 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.555 -0.716 . . . . 0.0 109.422 179.455 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.621 ' O ' HG23 ' A' ' 57' ' ' ILE . 1.1 tp10 -150.73 149.72 30.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.015 -1.053 . . . . 0.0 110.465 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.598 ' HG2' ' CE2' ' A' ' 207' ' ' TRP . 0.0 OUTLIER -119.54 151.74 38.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.309 -0.87 . . . . 0.0 109.969 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.637 ' CB ' ' HD3' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -94.85 -67.05 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 110.577 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.637 ' HD3' ' CB ' ' A' ' 69' ' ' ARG . 55.9 Cg_endo -73.53 -119.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.584 1.307 . . . . 0.0 109.583 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.408 ' H ' ' HB2' ' A' ' 70' ' ' PRO . 4.0 t -139.97 164.23 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.317 -1.489 . . . . 0.0 110.21 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.912 ' HB2' ' CG ' ' A' ' 207' ' ' TRP . . . -70.48 69.94 0.42 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 0.0 110.108 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -87.29 -160.26 0.58 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.276 -0.89 . . . . 0.0 110.39 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.2 m -73.25 1.22 9.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.928 . . . . 0.0 110.313 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.984 HG22 ' ND2' ' A' ' 56' ' ' ASN . 3.7 m -116.43 0.41 12.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.923 . . . . 0.0 110.104 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.558 ' CB ' ' HA ' ' A' ' 72' ' ' ALA . 0.4 OUTLIER -99.81 154.8 18.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 110.149 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.54 ' O ' ' HB2' ' A' ' 54' ' ' SER . . . 132.47 145.87 5.55 Favored Glycine 0 N--CA 1.483 1.771 0 N-CA-C 108.07 -2.012 . . . . 0.0 108.07 -179.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.105 ' CG2' ' HB3' ' A' ' 205' ' ' ALA . 4.4 m -117.27 128.61 74.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 O-C-N 121.16 -1.2 . . . . 0.0 109.846 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.635 ' C ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -145.11 134.61 23.2 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.966 -0.693 . . . . 0.0 112.521 -177.674 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.996 ' CA ' ' HA ' ' A' ' 52' ' ' ASP . . . -123.09 165.58 15.69 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 178.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 201' ' ' PRO . 0.1 OUTLIER -177.52 68.18 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.409 -1.054 . . . . 0.0 110.23 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.948 ' HD3' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -163.38 -91.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.139 -0.975 . . . . 0.0 110.783 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.948 ' N ' ' HD3' ' A' ' 82' ' ' ARG . . . 83.64 87.5 0.81 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -115.59 97.19 6.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.264 -1.139 . . . . 0.0 110.437 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.535 ' O ' ' CG ' ' A' ' 173' ' ' MET . 1.5 m -139.97 160.31 40.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.33 -0.856 . . . . 0.0 110.059 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.515 ' C ' ' NE2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -118.6 134.27 55.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.078 -1.014 . . . . 0.0 110.211 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 101.56 -115.58 5.3 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.506 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 13.2 tp -128.52 130.48 47.52 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.391 -1.064 . . . . 0.0 110.565 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.527 ' CE1' ' HB3' ' A' ' 85' ' ' SER . 4.1 m-70 -147.23 158.5 43.97 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.26 -0.9 . . . . 0.0 109.962 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -162.95 156.43 19.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.134 -0.979 . . . . 0.0 110.354 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 1.026 ' CZ2' HG21 ' A' ' 169' ' ' VAL . 5.4 p90 -143.76 170.82 15.16 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.353 -0.842 . . . . 0.0 110.01 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 215' ' ' ARG . 3.6 tt0 -145.86 157.52 43.9 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.429 -0.794 . . . . 0.0 110.932 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.914 HG22 ' OH ' ' A' ' 180' ' ' TYR . 7.0 tp -143.15 154.37 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.545 -0.722 . . . . 0.0 109.848 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.696 ' O ' ' HD3' ' A' ' 96' ' ' PRO . 0.1 OUTLIER -149.88 137.09 19.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.321 -0.862 . . . . 0.0 110.3 -179.63 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.706 ' CG ' HG23 ' A' ' 212' ' ' VAL . 49.7 m95 -108.93 88.3 5.37 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 121.258 -0.901 . . . . 0.0 110.655 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.696 ' HD3' ' O ' ' A' ' 94' ' ' SER . 52.3 Cg_endo -97.26 108.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.348 1.365 . . . . 0.0 110.215 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.719 0 O-C-N 120.781 -1.2 . . . . 0.0 110.187 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.825 HG23 ' CB ' ' A' ' 204' ' ' SER . 34.2 m . . . . . 0 N--CA 1.482 1.135 0 CA-C-O 121.891 0.853 . . . . 0.0 110.357 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.685 HG22 HG23 ' A' ' 203' ' ' VAL . 76.5 t -151.15 170.21 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.67 ' CA ' ' HA3' ' A' ' 132' ' ' GLY . . . 168.75 169.22 31.89 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 118.798 -1.667 . . . . 0.0 111.251 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.112 ' CG1' HD13 ' A' ' 199' ' ' LEU . 2.2 t -121.74 159.82 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.694 -0.886 . . . . 0.0 109.321 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.557 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -140.07 143.8 36.5 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.977 -1.077 . . . . 0.0 111.401 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . 1.008 ' OG1' HD23 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -126.07 135.52 51.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.522 -0.736 . . . . 0.0 110.161 179.473 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.15 -25.35 17.9 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.445 -0.784 . . . . 0.0 109.173 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.48 ' O ' ' C ' ' A' ' 113' ' ' ALA . 2.7 pp -85.54 -12.22 52.18 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.581 -0.7 . . . . 0.0 109.356 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.555 ' HB2' ' HB ' ' A' ' 110' ' ' THR . . . . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.57 -0.706 . . . . 0.0 110.352 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 24.5 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.175 0.512 . . . . 0.0 110.234 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.408 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -150.18 134.33 17.08 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.217 -0.927 . . . . 0.0 109.821 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 14.1 t -151.4 118.61 5.94 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.301 -0.874 . . . . 0.0 110.391 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' TRP . . . . . 0.52 ' CD1' ' N ' ' A' ' 131' ' ' TRP . 2.7 p-90 -135.59 166.23 23.69 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.67 ' HA3' ' CA ' ' A' ' 107' ' ' GLY . . . 177.67 -138.26 3.75 Favored Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.773 -1.203 . . . . 0.0 110.431 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.831 ' HB3' HG11 ' A' ' 163' ' ' VAL . 53.5 m0 -104.8 113.4 26.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.365 -1.08 . . . . 0.0 110.657 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.708 ' O ' HG23 ' A' ' 135' ' ' ILE . 1.9 p30 -118.74 113.31 20.95 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.45 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.954 HD11 ' HB ' ' A' ' 163' ' ' VAL . 3.5 pt . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.171 -0.956 . . . . 0.0 110.027 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.954 ' HB ' HD11 ' A' ' 135' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.634 ' HA ' ' HB2' ' A' ' 95' ' ' TRP . 48.8 Cg_endo -82.8 62.41 7.76 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.548 1.288 . . . . 0.0 109.118 178.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.644 ' O ' ' CB ' ' A' ' 94' ' ' SER . 11.0 tp10 -173.75 -78.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.64 -0.662 . . . . 0.0 109.61 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 1.088 ' C ' HD22 ' A' ' 167' ' ' LEU . 7.7 ttt180 -151.6 132.96 14.59 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.537 -0.727 . . . . 0.0 109.645 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 1.088 HD22 ' C ' ' A' ' 166' ' ' ARG . 3.0 mm? -140.33 153.61 46.49 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.366 -0.834 . . . . 0.0 110.8 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.424 ' N ' ' HE1' ' A' ' 180' ' ' TYR . 6.2 tp -129.07 130.24 46.28 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.567 -0.708 . . . . 0.0 109.259 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 1.064 HG12 ' CE1' ' A' ' 180' ' ' TYR . 0.2 OUTLIER -127.25 144.1 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.955 -1.091 . . . . 0.0 110.262 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.584 HG11 ' HZ ' ' A' ' 191' ' ' PHE . 4.3 p -102.53 133.19 46.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.815 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.992 HD13 HD23 ' A' ' 178' ' ' LEU . 2.7 tp -124.76 105.89 9.64 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.433 -0.792 . . . . 0.0 109.824 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.514 ' OD1' ' CG ' ' A' ' 174' ' ' GLU . 5.1 t70 -119.97 134.44 55.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 110.488 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.535 ' CG ' ' O ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -98.8 -42.23 7.29 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.278 0.561 . . . . 0.0 109.63 179.491 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.514 ' CG ' ' OD1' ' A' ' 172' ' ' ASP . 7.9 pt-20 -45.01 -24.91 0.26 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.246 -0.908 . . . . 0.0 108.828 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.622 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.2 OUTLIER -112.25 -27.01 8.5 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.16 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.453 ' O ' ' CG2' ' A' ' 198' ' ' THR . . . 80.88 25.73 55.24 Favored Glycine 0 N--CA 1.483 1.787 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' THR . . . . . 1.124 HG22 ' CD2' ' A' ' 194' ' ' LEU . 0.1 OUTLIER -112.7 124.05 51.69 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.096 -1.238 . . . . 0.0 111.093 -179.434 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.992 HD23 HD13 ' A' ' 171' ' ' LEU . 2.6 mp -129.08 153.47 47.61 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.51 -0.744 . . . . 0.0 109.434 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.918 ' O ' HG23 ' A' ' 169' ' ' VAL . . . -178.9 163.67 31.5 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.2 -1.476 . . . . 0.0 110.633 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 1.064 ' CE1' HG12 ' A' ' 169' ' ' VAL . 0.1 OUTLIER -118.28 128.17 54.42 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.455 -1.026 . . . . 0.0 109.492 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.597 ' OG ' ' N ' ' A' ' 186' ' ' TYR . 5.7 t -132.34 165.15 24.86 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.662 0.744 . . . . 0.0 110.186 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.813 HG22 ' CD1' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -105.46 116.7 49.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 O-C-N 121.792 -0.568 . . . . 0.0 109.556 179.356 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 64.4 8.86 33.79 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 86.81 35.18 10.31 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' THR . . . . . 0.477 ' O ' ' C ' ' A' ' 186' ' ' TYR . 37.3 m -106.77 -65.93 1.05 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.117 -1.225 . . . . 0.0 110.71 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.597 ' N ' ' OG ' ' A' ' 181' ' ' SER . 0.1 OUTLIER -35.98 -74.3 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.315 -0.866 . . . . 0.0 110.761 -179.618 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.84 HD11 HD12 ' A' ' 194' ' ' LEU . 2.7 mm? -67.69 46.19 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.037 -1.039 . . . . 0.0 110.081 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 186' ' ' TYR . . . -73.51 -99.05 0.08 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.536 ' C ' ' H ' ' A' ' 191' ' ' PHE . 49.2 Cg_endo -73.65 -23.99 16.34 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.109 1.583 . . . . 0.0 111.242 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.53 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -62.39 29.39 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.39 -0.819 . . . . 0.0 111.797 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.727 ' HE1' HD12 ' A' ' 187' ' ' LEU . 1.0 OUTLIER -90.54 -22.33 21.35 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.782 -1.199 . . . . 0.0 110.461 179.391 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ARG . . . . . 0.496 ' N ' ' HD2' ' A' ' 192' ' ' ARG . 0.0 OUTLIER -87.82 -13.02 43.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.178 -0.951 . . . . 0.0 110.443 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -108.77 -10.46 24.78 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.334 -1.906 . . . . 0.0 108.334 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 1.124 ' CD2' HG22 ' A' ' 177' ' ' THR . 7.8 tt -72.86 -41.56 64.63 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.731 -0.864 . . . . 0.0 108.808 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.503 ' HD2' ' N ' ' A' ' 196' ' ' GLY . 0.0 OUTLIER -43.92 -42.14 5.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.486 -0.759 . . . . 0.0 109.975 179.61 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.503 ' N ' ' HD2' ' A' ' 195' ' ' LYS . . . -85.32 -25.64 39.12 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.881 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.66 -3.74 57.28 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.789 -0.83 . . . . 0.0 109.911 179.835 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 198' ' ' THR . . . . . 0.734 HG23 ' O ' ' A' ' 194' ' ' LEU . 15.9 p -42.75 125.59 3.44 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.811 0.815 . . . . 0.0 111.85 -177.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 1.112 HD13 ' CG1' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -140.39 171.44 14.15 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.136 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.417 ' CD2' ' HA ' ' A' ' 82' ' ' ARG . 3.2 m-85 -84.2 129.16 59.36 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.949 -1.094 . . . . 0.0 109.97 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.559 ' HA ' HG13 ' A' ' 108' ' ' VAL . 50.7 Cg_endo -76.92 136.01 16.21 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 124.014 1.534 . . . . 0.0 111.012 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 4.7 t -133.18 140.21 47.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.449 -0.782 . . . . 0.0 109.945 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.685 HG23 HG22 ' A' ' 106' ' ' VAL . 6.0 p -120.3 153.5 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.237 -0.914 . . . . 0.0 110.153 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' SER . . . . . 0.825 ' CB ' HG23 ' A' ' 105' ' ' VAL . 6.3 t -142.39 127.39 18.41 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.27 -0.894 . . . . 0.0 110.051 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 1.105 ' HB3' ' CG2' ' A' ' 78' ' ' VAL . . . -124.88 140.36 53.0 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.455 0.645 . . . . 0.0 110.415 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.84 HG13 ' N ' ' A' ' 207' ' ' TRP . 0.3 OUTLIER -64.56 -158.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.552 -0.718 . . . . 0.0 110.672 -179.527 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 0.912 ' CG ' ' HB2' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -121.1 154.98 35.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.409 -0.807 . . . . 0.0 109.932 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.458 ' O ' ' OE1' ' A' ' 211' ' ' GLN . . . 134.23 -175.18 20.55 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' GLN . . . . . 0.533 ' CG ' ' OE1' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -98.21 -30.04 12.86 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.207 -1.172 . . . . 0.0 110.401 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 1.6 t -116.36 81.25 1.59 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.334 -0.854 . . . . 0.0 110.468 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.458 ' OE1' ' O ' ' A' ' 208' ' ' GLY . 0.0 OUTLIER -123.68 -90.49 0.57 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.165 -0.96 . . . . 0.0 110.241 179.683 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.706 HG23 ' CG ' ' A' ' 95' ' ' TRP . 4.2 p -127.5 143.26 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.085 -1.009 . . . . 0.0 111.276 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' ARG . . . . . 0.564 ' CD ' ' HB3' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -102.18 145.59 29.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.469 -0.769 . . . . 0.0 108.953 178.64 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 1.036 HG22 HD11 ' A' ' 64' ' ' LEU . 4.8 tt -115.97 140.44 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.954 -1.091 . . . . 0.0 111.266 -178.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.606 ' O ' ' N ' ' A' ' 92' ' ' GLU . 7.9 ttm180 -130.6 109.32 10.57 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 216' ' ' TYR . . . . . 0.65 ' CD2' ' CB ' ' A' ' 91' ' ' TRP . 3.2 t80 -118.13 146.99 43.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.035 -1.041 . . . . 0.0 111.248 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 217' ' ' MET . . . . . 0.505 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 2.6 mmt -136.39 115.84 12.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.564 -0.71 . . . . 0.0 110.0 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 126.69 -4.45 7.54 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.59 ' HB2' ' CE1' ' A' ' 216' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.248 -1.148 . . . . 0.0 110.229 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.9 HD13 ' HB2' ' A' ' 70' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 120.928 0.394 . . . . 0.0 110.459 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.78 ' HA ' HD23 ' A' ' 33' ' ' LEU . 42.9 mt-10 -43.87 -35.59 2.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.157 -0.964 . . . . 0.0 108.973 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -58.9 -24.26 62.09 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.631 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -83.46 -32.96 25.74 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.777 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.81 HD12 ' C ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -82.2 -37.18 26.44 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.696 0.76 . . . . 0.0 109.488 179.389 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.549 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 14.9 m -61.61 -11.38 11.18 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.279 0.561 . . . . 0.0 110.264 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 1.088 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -51.95 -168.04 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.431 -0.793 . . . . 0.0 110.272 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 1.088 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 40.7 Cg_endo -67.91 -169.81 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.55 1.289 . . . . 0.0 110.059 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.649 ' CD ' ' HB2' ' A' ' 36' ' ' PRO . 51.6 Cg_endo -96.77 63.55 0.13 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.528 1.486 . . . . 0.0 112.269 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.692 ' CD ' ' O ' ' A' ' 36' ' ' PRO . 51.2 Cg_endo -73.54 151.56 47.47 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.275 1.144 . . . . 0.0 109.583 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.592 ' O ' ' HB3' ' A' ' 43' ' ' GLN . 1.3 t0 -33.67 -30.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.3 -0.875 . . . . 0.0 109.833 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.073 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -57.2 -44.88 84.08 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.279 -0.888 . . . . 0.0 110.72 -179.354 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.697 ' N ' HD13 ' A' ' 40' ' ' LEU . 22.3 t -85.74 -34.4 8.4 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 C-N-CA 118.54 -1.264 . . . . 0.0 110.327 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.62 -39.08 12.07 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.134 -0.979 . . . . 0.0 113.114 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.592 ' HB3' ' O ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -87.13 -18.75 29.7 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 120.82 -1.175 . . . . 0.0 109.885 -178.741 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.994 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 3.0 ttp85 -76.84 -55.36 5.55 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.28 -0.887 . . . . 0.0 108.918 178.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.635 ' ND1' ' O ' ' A' ' 41' ' ' VAL . 65.9 m170 -45.4 -23.58 0.22 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.407 ' N ' ' O ' ' A' ' 44' ' ' ARG . 7.0 t60 -84.5 -39.67 18.58 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.491 ' CA ' ' HG3' ' A' ' 61' ' ' GLU . . . -83.52 -80.57 1.01 Allowed Glycine 0 N--CA 1.487 2.054 0 N-CA-C 106.679 -2.568 . . . . 0.0 106.679 177.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.701 ' HB2' HG23 ' A' ' 59' ' ' VAL . 99.5 m95 -90.42 73.5 6.95 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.299 -1.118 . . . . 0.0 108.87 177.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.727 ' O ' ' HB3' ' A' ' 53' ' ' CYS . 0.1 OUTLIER -44.88 163.1 0.2 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.721 -0.612 . . . . 0.0 110.997 179.835 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.764 ' O ' ' O ' ' A' ' 53' ' ' CYS . 41.0 Cg_endo -67.66 -60.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.818 1.431 . . . . 0.0 110.887 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.804 ' HA ' ' HE3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -40.17 -84.82 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.661 -1.274 . . . . 0.0 109.121 179.385 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.768 ' HA ' ' N ' ' A' ' 80' ' ' GLY . 2.0 m-20 -47.92 0.89 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.337 -0.852 . . . . 0.0 111.548 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.764 ' O ' ' O ' ' A' ' 50' ' ' PRO . 1.3 t -166.07 129.95 2.16 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.631 -1.293 . . . . 0.0 112.199 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.91 ' H ' ' HA ' ' A' ' 78' ' ' VAL . 1.8 m -81.85 124.1 29.39 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.437 -0.789 . . . . 0.0 109.753 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.673 ' HB3' ' NH2' ' A' ' 44' ' ' ARG . 3.2 pt-20 -51.6 -2.03 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.377 -0.827 . . . . 0.0 110.746 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.822 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -49.46 -21.5 0.95 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.835 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.009 HD11 ' CB ' ' A' ' 207' ' ' TRP . 0.9 OUTLIER -112.04 166.73 6.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.676 -0.64 . . . . 0.0 109.916 -179.705 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.514 ' N ' ' CG2' ' A' ' 57' ' ' ILE . 2.0 t70 -109.12 96.11 6.09 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.006 0.908 . . . . 0.0 110.054 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.971 HG13 HG22 ' A' ' 57' ' ' ILE . 33.3 m -128.35 135.45 62.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.711 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.641 ' HG2' ' HA ' ' A' ' 40' ' ' LEU . 13.1 mtpt -125.62 155.41 40.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.006 -1.058 . . . . 0.0 111.558 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.492 ' O ' ' C ' ' A' ' 62' ' ' GLY . 1.4 tt0 -80.24 -130.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.384 -0.823 . . . . 0.0 110.06 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.492 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 39.92 53.87 3.08 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.676 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 105.84 66.05 0.66 Allowed Glycine 0 N--CA 1.486 2.009 0 N-CA-C 107.785 -2.126 . . . . 0.0 107.785 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.077 HD11 HG22 ' A' ' 214' ' ' ILE . 0.2 OUTLIER 0.77 86.31 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 122.026 -0.691 . . . . 0.0 111.454 -178.522 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -99.66 113.93 26.68 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.703 179.564 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.693 ' CD1' ' CE2' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -114.38 124.67 52.53 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.569 -0.707 . . . . 0.0 109.193 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.631 ' H ' HG12 ' A' ' 59' ' ' VAL . 3.7 tm-20 -150.36 130.32 13.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.982 -1.074 . . . . 0.0 110.921 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.548 ' HD2' ' O ' ' A' ' 68' ' ' ARG . 0.6 OUTLIER -110.85 156.15 21.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.372 -0.83 . . . . 0.0 109.449 179.209 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.608 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 2.3 tpt180 -173.94 -52.95 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 120.982 -1.074 . . . . 0.0 111.687 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.9 ' HB2' HD13 ' A' ' 29' ' ' LEU . 40.0 Cg_endo -66.09 -52.79 0.8 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.508 1.268 . . . . 0.0 111.298 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 56' ' ' ASN . 25.4 t -78.55 164.97 3.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.244 -0.91 . . . . 0.0 110.867 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.471 ' N ' HG12 ' A' ' 71' ' ' VAL . . . -179.47 -30.49 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.445 0.64 . . . . 0.0 109.429 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -73.93 -116.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.373 -0.829 . . . . 0.0 110.202 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.9 t -124.48 50.07 1.74 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.019 -1.051 . . . . 0.0 110.397 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.506 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 4.2 m -83.41 -125.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 0.0 110.054 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.549 ' CB ' ' OD1' ' A' ' 56' ' ' ASN . 0.4 OUTLIER -136.6 112.69 9.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.089 -1.007 . . . . 0.0 110.71 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.642 ' C ' HG13 ' A' ' 78' ' ' VAL . . . -57.23 -92.89 0.01 OUTLIER Glycine 0 N--CA 1.482 1.765 0 N-CA-C 105.359 -3.096 . . . . 0.0 105.359 177.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.205 ' CG2' ' HB3' ' A' ' 205' ' ' ALA . 32.7 m -152.9 119.5 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.229 -1.16 . . . . 0.0 110.047 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.741 ' O ' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -146.87 134.09 20.55 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.602 -0.686 . . . . 0.0 111.224 -179.299 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.768 ' N ' ' HA ' ' A' ' 52' ' ' ASP . . . -132.2 -179.64 16.4 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.587 ' N ' ' HZ3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER 179.98 26.5 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.432 -1.04 . . . . 0.0 110.28 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.73 ' CD ' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -69.77 -18.59 63.5 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.164 -0.96 . . . . 0.0 110.722 -179.674 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.73 ' N ' ' CD ' ' A' ' 82' ' ' ARG . . . 27.8 44.37 0.04 OUTLIER Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.503 ' N ' ' O ' ' A' ' 82' ' ' ARG . 1.2 t80 -103.63 95.56 6.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.218 -1.166 . . . . 0.0 110.482 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . 1.034 ' OG ' HD21 ' A' ' 171' ' ' LEU . 3.6 p -140.47 166.58 24.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.311 -0.868 . . . . 0.0 110.172 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.576 ' HA ' ' CB ' ' A' ' 173' ' ' MET . 0.5 OUTLIER -136.31 156.52 48.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 109.928 179.584 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.586 ' N ' ' HB3' ' A' ' 173' ' ' MET . . . 62.31 -114.45 6.83 Favored Glycine 0 N--CA 1.483 1.816 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.19 131.26 47.09 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.513 -0.992 . . . . 0.0 110.968 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.704 ' HB2' HD23 ' A' ' 171' ' ' LEU . 74.1 m-70 -147.25 173.38 12.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.199 -0.938 . . . . 0.0 109.997 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.6 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -163.59 154.36 16.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.362 -0.836 . . . . 0.0 110.583 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.84 ' CE3' HG11 ' A' ' 169' ' ' VAL . 0.1 OUTLIER -134.66 170.79 15.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.171 -0.955 . . . . 0.0 109.3 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.925 ' O ' HD13 ' A' ' 93' ' ' ILE . 0.9 OUTLIER -146.8 152.66 39.12 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.699 -179.511 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.925 HD13 ' O ' ' A' ' 92' ' ' GLU . 7.8 mm -142.71 153.66 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.675 -0.641 . . . . 0.0 109.433 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.561 ' O ' ' HA ' ' A' ' 212' ' ' VAL . 0.0 OUTLIER -155.35 127.56 7.71 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.788 -1.195 . . . . 0.0 111.511 -179.564 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.643 ' CD1' ' N ' ' A' ' 95' ' ' TRP . 5.8 m95 -114.21 87.9 14.16 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.221 -0.924 . . . . 0.0 109.922 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.534 ' O ' ' NE2' ' A' ' 211' ' ' GLN . 51.7 Cg_endo -95.14 107.13 0.12 Allowed 'Trans proline' 0 C--N 1.302 -1.891 0 O-C-N 123.399 1.21 . . . . 0.0 110.333 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 23.5 tp . . . . . 0 N--CA 1.49 1.56 0 O-C-N 120.9 -1.125 . . . . 0.0 109.091 178.485 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.772 HG23 ' CB ' ' A' ' 204' ' ' SER . 3.7 m . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 1.05 HG23 ' O ' ' A' ' 202' ' ' SER . 0.7 OUTLIER -150.33 149.61 14.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.459 -0.776 . . . . 0.0 110.584 -178.302 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.599 ' HA2' ' HA3' ' A' ' 132' ' ' GLY . . . -153.91 142.79 9.44 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.096 ' CG2' HD13 ' A' ' 199' ' ' LEU . 2.8 m -98.46 155.17 3.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.251 -1.146 . . . . 0.0 110.299 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.557 ' C ' ' HB3' ' A' ' 199' ' ' LEU . . . -124.47 141.32 52.17 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.356 -0.84 . . . . 0.0 110.614 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . 1.088 ' OG1' HD23 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -121.07 131.62 54.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.397 -0.815 . . . . 0.0 110.127 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.95 -26.4 17.58 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.346 -0.846 . . . . 0.0 109.358 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.0 pp -83.91 -12.31 55.63 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.572 -0.705 . . . . 0.0 109.329 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.691 ' HB3' ' HB ' ' A' ' 110' ' ' THR . . . . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.542 -0.724 . . . . 0.0 110.245 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 66.7 p . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.276 0.56 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -145.12 125.66 14.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.302 -0.874 . . . . 0.0 109.977 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 1.1 t -121.59 119.73 32.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 110.484 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' TRP . . . . . 0.648 ' O ' HG22 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -133.37 135.16 44.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.882 . . . . 0.0 109.781 179.679 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.599 ' HA3' ' HA2' ' A' ' 107' ' ' GLY . . . -175.66 -137.76 2.64 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.028 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.641 ' CH2' ' CD1' ' A' ' 182' ' ' ILE . 42.4 m0 -118.79 113.63 21.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.419 -1.048 . . . . 0.0 110.843 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.44 ' C ' HG12 ' A' ' 135' ' ' ILE . 45.5 t0 -118.63 147.64 43.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.512 -0.742 . . . . 0.0 109.895 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.561 HG13 HG12 ' A' ' 105' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.116 -0.99 . . . . 0.0 110.239 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 1.08 HG12 ' HD3' ' A' ' 164' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.863 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 1.08 ' HD3' HG12 ' A' ' 163' ' ' VAL . 43.8 Cg_endo -72.29 178.76 5.7 Favored 'Trans proline' 0 C--N 1.318 -1.03 0 O-C-N 122.481 0.727 . . . . 0.0 110.999 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.525 ' O ' ' HB3' ' A' ' 94' ' ' SER . 2.2 mt-10 -46.51 -32.2 3.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.428 -0.795 . . . . 0.0 111.232 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.54 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 18.2 ttp180 -151.83 156.17 39.64 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.981 -1.075 . . . . 0.0 111.13 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.831 HD21 ' CG2' ' A' ' 163' ' ' VAL . 1.7 mp -126.85 157.31 39.65 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.543 -0.723 . . . . 0.0 109.436 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.543 HD21 HG22 ' A' ' 170' ' ' VAL . 1.1 tt -117.44 121.41 40.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.065 -1.022 . . . . 0.0 110.728 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.84 HG11 ' CE3' ' A' ' 91' ' ' TRP . 16.4 t -89.65 128.78 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.3 -0.875 . . . . 0.0 109.494 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.543 HG22 HD21 ' A' ' 168' ' ' LEU . 19.2 t -109.99 115.62 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.004 -1.06 . . . . 0.0 110.675 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 1.034 HD21 ' OG ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -129.27 123.12 31.1 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.285 -0.884 . . . . 0.0 109.491 179.505 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 173' ' ' MET . 47.3 t0 -120.13 137.96 53.86 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.177 -0.952 . . . . 0.0 110.021 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.586 ' HB3' ' N ' ' A' ' 87' ' ' GLY . 0.0 OUTLIER -98.56 -40.68 8.11 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.56 179.676 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -50.85 -22.61 2.27 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.318 -0.864 . . . . 0.0 109.073 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.581 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.3 OUTLIER -109.26 -27.97 9.25 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.803 0.811 . . . . 0.0 108.924 179.473 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.583 ' O ' ' CB ' ' A' ' 198' ' ' THR . . . 86.84 22.34 46.48 Favored Glycine 0 N--CA 1.482 1.709 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.862 HG22 HD22 ' A' ' 194' ' ' LEU . 0.0 OUTLIER -112.52 133.45 54.57 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.099 -1.236 . . . . 0.0 111.466 -179.389 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.997 HD23 HD12 ' A' ' 171' ' ' LEU . 2.6 mp -130.52 153.59 48.68 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.654 -0.654 . . . . 0.0 109.472 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 176.16 -175.29 47.39 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.231 -1.461 . . . . 0.0 110.538 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.729 ' CZ ' HG22 ' A' ' 169' ' ' VAL . 0.2 OUTLIER -127.18 131.51 50.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.67 -0.9 . . . . 0.0 109.173 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 168' ' ' LEU . 3.4 t -136.7 131.22 33.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.122 -0.986 . . . . 0.0 110.536 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.864 HD11 ' CD2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -102.27 116.84 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.372 -0.83 . . . . 0.0 109.393 179.212 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 83.45 -11.87 53.85 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 81.43 47.05 6.59 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 32.4 m -136.13 -36.46 0.74 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.135 -1.215 . . . . 0.0 110.775 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.864 ' CD2' HD11 ' A' ' 182' ' ' ILE . 5.1 m-30 -67.0 -77.23 0.07 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.005 -1.06 . . . . 0.0 110.506 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.602 ' O ' ' CE2' ' A' ' 191' ' ' PHE . 2.4 mm? -68.46 44.28 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.906 -1.121 . . . . 0.0 109.88 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.53 ' H ' ' HD2' ' A' ' 189' ' ' PRO . . . -94.95 -63.89 1.0 Allowed Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.99 -1.1 . . . . 0.0 110.611 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.53 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 45.1 Cg_endo -72.01 -30.99 13.0 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.802 1.422 . . . . 0.0 111.3 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.754 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -74.58 16.59 0.26 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.239 -0.913 . . . . 0.0 111.418 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.602 ' CE2' ' O ' ' A' ' 187' ' ' LEU . 0.3 OUTLIER -89.57 -8.34 52.88 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.063 -1.023 . . . . 0.0 109.982 179.204 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.06 -15.3 32.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.568 -0.707 . . . . 0.0 110.126 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -115.71 -11.17 10.54 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 107.483 -2.247 . . . . 0.0 107.483 179.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.9 ' HA ' ' HD2' ' A' ' 197' ' ' ARG . 0.4 OUTLIER -70.56 -22.17 62.62 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.796 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.588 ' HA ' HG23 ' A' ' 177' ' ' THR . 0.0 OUTLIER -57.29 -26.55 61.04 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.355 -0.84 . . . . 0.0 109.378 179.038 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.539 ' N ' ' HE3' ' A' ' 195' ' ' LYS . . . -106.08 -37.74 2.45 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.9 ' HD2' ' HA ' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -79.62 -4.52 51.98 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.448 -1.031 . . . . 0.0 110.567 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 198' ' ' THR . . . . . 0.583 ' CB ' ' O ' ' A' ' 176' ' ' GLY . 0.2 OUTLIER -43.37 133.82 4.08 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-O 122.194 0.997 . . . . 0.0 112.174 -177.968 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 1.096 HD13 ' CG2' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -141.73 171.06 14.57 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.218 179.19 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.673 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 46.5 m-85 -90.21 126.79 55.68 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.827 -1.171 . . . . 0.0 109.373 178.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.772 ' CA ' HG12 ' A' ' 108' ' ' VAL . 53.2 Cg_endo -82.16 150.36 15.64 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 124.196 1.629 . . . . 0.0 112.489 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' SER . . . . . 1.05 ' O ' HG23 ' A' ' 106' ' ' VAL . 73.6 p -133.69 149.84 51.52 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.583 HG22 ' N ' ' A' ' 204' ' ' SER . 14.5 p -118.62 168.17 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.406 -1.434 . . . . 0.0 110.623 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' SER . . . . . 0.772 ' CB ' HG23 ' A' ' 105' ' ' VAL . 0.4 OUTLIER -156.0 145.16 20.64 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.425 0.631 . . . . 0.0 109.923 179.681 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 1.205 ' HB3' ' CG2' ' A' ' 78' ' ' VAL . . . -145.47 135.96 24.18 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.74 -0.6 . . . . 0.0 109.705 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.572 ' CG1' ' N ' ' A' ' 207' ' ' TRP . 1.5 t -76.57 172.06 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.459 -0.776 . . . . 0.0 110.512 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 1.009 ' CB ' HD11 ' A' ' 57' ' ' ILE . 14.2 p90 -121.91 128.51 51.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.307 -0.871 . . . . 0.0 110.089 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.539 ' N ' ' HG2' ' A' ' 68' ' ' ARG . . . 154.4 -167.12 32.39 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' GLN . . . . . 0.449 ' C ' ' O ' ' A' ' 208' ' ' GLY . 0.0 OUTLIER -40.21 -28.74 0.06 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.381 -1.07 . . . . 0.0 110.142 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 210' ' ' CYS . . . . . 0.483 ' C ' ' HG3' ' A' ' 211' ' ' GLN . 9.7 t -64.26 164.29 11.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.321 -0.862 . . . . 0.0 110.219 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.534 ' NE2' ' O ' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -164.24 109.55 1.01 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.358 -0.839 . . . . 0.0 109.655 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.645 ' O ' ' CH2' ' A' ' 48' ' ' TRP . 5.7 p -102.65 143.77 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.437 -0.79 . . . . 0.0 110.308 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' ARG . . . . . 0.458 ' HB2' ' OG ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -93.93 156.2 16.75 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.364 -0.835 . . . . 0.0 109.41 179.361 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 1.077 HG22 HD11 ' A' ' 64' ' ' LEU . 4.9 tt -139.06 131.54 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.046 -1.034 . . . . 0.0 110.812 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.596 ' HB3' ' HB3' ' A' ' 92' ' ' GLU . 12.6 ttt180 -130.1 108.29 9.96 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' TYR . . . . . 0.736 ' CZ ' ' CD1' ' A' ' 91' ' ' TRP . 4.2 t80 -118.92 142.94 47.32 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.385 -0.822 . . . . 0.0 111.15 -177.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.58 115.57 12.34 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.558 -0.713 . . . . 0.0 110.102 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 133.85 53.85 0.07 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.265 -1.138 . . . . 0.0 110.114 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.576 ' HG ' ' N ' ' A' ' 30' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.184 0.516 . . . . 0.0 110.285 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.944 ' HA ' HD23 ' A' ' 33' ' ' LEU . 1.3 mt-10 -47.69 -35.12 9.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.101 -0.999 . . . . 0.0 109.192 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -62.27 -24.07 67.07 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.309 -0.87 . . . . 0.0 108.841 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.545 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.7 OUTLIER -83.44 -34.06 25.54 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.981 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.102 HD21 ' CG ' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -76.17 -36.06 58.88 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.877 0.846 . . . . 0.0 109.42 179.323 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.606 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -80.46 -7.37 59.13 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.161 179.878 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.982 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -54.87 -66.81 0.82 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.213 -0.929 . . . . 0.0 110.488 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.982 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 48.9 Cg_endo -73.65 143.22 33.62 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.692 1.364 . . . . 0.0 110.316 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 36' ' ' PRO . 53.8 Cg_endo -98.88 56.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 121.898 1.732 . . . . 0.0 112.034 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.726 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 52.8 Cg_endo -75.82 150.91 35.35 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 122.979 0.989 . . . . 0.0 110.118 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.615 ' O ' ' HB3' ' A' ' 43' ' ' GLN . 1.0 OUTLIER -34.26 -33.52 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.313 -0.867 . . . . 0.0 109.457 179.557 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.088 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -57.41 -46.88 83.02 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.242 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.991 HG23 HD13 ' A' ' 40' ' ' LEU . 54.4 t -86.6 -33.7 7.32 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 O-C-N 120.647 -1.283 . . . . 0.0 110.415 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.21 -39.17 12.25 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.401 -0.812 . . . . 0.0 113.058 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.615 ' HB3' ' O ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -86.67 -19.65 28.93 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 120.726 -1.234 . . . . 0.0 109.455 -178.964 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 1.086 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -79.36 -51.09 9.87 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 122.078 0.942 . . . . 0.0 109.528 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.834 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 59.5 m170 -51.52 -17.57 0.85 Allowed 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.632 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -84.46 -39.21 19.21 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.443 -1.303 . . . . 0.0 110.029 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.942 ' O ' HD12 ' A' ' 214' ' ' ILE . . . -97.98 -68.19 0.93 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 106.597 -2.601 . . . . 0.0 106.597 177.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.838 ' CD1' ' CG2' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -89.26 72.61 8.13 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 177.229 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.834 ' HA ' ' HA ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER -55.22 151.45 18.15 Favored Pre-proline 0 N--CA 1.494 1.754 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.412 -178.514 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.734 ' HD3' ' HA ' ' A' ' 45' ' ' HIS . 45.0 Cg_endo -78.49 -25.86 6.43 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 124.522 1.801 . . . . 0.0 110.563 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.852 ' N ' ' HE3' ' A' ' 51' ' ' LYS . 0.4 OUTLIER -64.48 -14.3 56.4 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.145 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 1.081 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 9.8 m-20 -122.75 2.16 9.45 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.644 178.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.863 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 10.1 t -151.73 132.94 14.45 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.877 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.597 ' HB2' ' O ' ' A' ' 76' ' ' ASP . 0.8 OUTLIER -71.81 118.49 14.73 Favored 'General case' 0 C--N 1.292 -1.926 0 O-C-N 121.548 -0.72 . . . . 0.0 110.34 179.434 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 1.102 ' CG ' HD21 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -40.25 -20.49 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.503 -0.748 . . . . 0.0 111.786 -179.641 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.657 ' H ' ' ND2' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -54.45 -1.9 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.762 -1.211 . . . . 0.0 109.638 179.755 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.706 HG23 ' O ' ' A' ' 67' ' ' GLU . 26.9 mm -111.68 155.35 13.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.923 0.868 . . . . 0.0 111.323 -177.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.582 ' N ' ' O ' ' A' ' 67' ' ' GLU . 1.4 t70 -118.14 95.36 4.86 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.718 0.77 . . . . 0.0 109.266 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.952 HG21 ' CD1' ' A' ' 66' ' ' PHE . 1.1 p -131.56 118.99 41.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 O-C-N 121.808 -0.557 . . . . 0.0 111.397 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.607 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -136.76 157.57 46.44 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.066 -1.021 . . . . 0.0 111.265 179.551 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.771 ' N ' ' CH2' ' A' ' 48' ' ' TRP . 1.0 OUTLIER -39.27 -112.98 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.717 -0.614 . . . . 0.0 112.029 -179.157 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.514 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 42.11 44.57 4.82 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 107.291 -2.324 . . . . 0.0 107.291 -177.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.743 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 84.64 87.08 0.89 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 106.881 -2.488 . . . . 0.0 106.881 -177.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.765 HD13 ' HE1' ' A' ' 48' ' ' TRP . 0.2 OUTLIER 1.48 82.88 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.632 -0.922 . . . . 0.0 109.901 -177.875 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.703 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -101.57 114.15 27.93 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.879 -0.728 . . . . 0.0 110.48 -178.985 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.952 ' CD1' HG21 ' A' ' 59' ' ' VAL . 4.5 t80 -114.42 123.39 49.33 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.706 ' O ' HG23 ' A' ' 57' ' ' ILE . 1.3 tm-20 -151.7 163.05 39.96 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.16 -0.963 . . . . 0.0 110.497 -179.11 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.621 ' CG ' ' HB2' ' A' ' 207' ' ' TRP . 0.2 OUTLIER -111.42 153.37 26.19 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.222 -0.923 . . . . 0.0 109.841 179.223 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.714 ' CB ' ' HD3' ' A' ' 70' ' ' PRO . 34.8 mtp180 -85.2 -73.87 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 120.978 -1.076 . . . . 0.0 109.665 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.714 ' HD3' ' CB ' ' A' ' 69' ' ' ARG . 57.5 Cg_endo -76.23 -124.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 N-CA-C 108.384 -1.429 . . . . 0.0 108.384 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.42 ' H ' ' HB2' ' A' ' 70' ' ' PRO . 2.6 t -140.44 164.51 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.455 -1.403 . . . . 0.0 109.947 179.152 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.579 ' HB2' ' CD1' ' A' ' 207' ' ' TRP . . . -80.04 33.45 0.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.178 -0.951 . . . . 0.0 110.357 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -45.98 -47.47 16.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.258 -0.901 . . . . 0.0 110.361 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.9 p -172.67 30.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.27 -0.894 . . . . 0.0 110.154 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.565 HG23 ' N ' ' A' ' 76' ' ' ASP . 9.9 t -97.87 -132.06 0.22 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.883 . . . . 0.0 109.992 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.597 ' O ' ' HB2' ' A' ' 54' ' ' SER . 12.5 m-20 -140.41 114.05 8.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.157 -0.964 . . . . 0.0 110.572 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 76' ' ' ASP . . . -55.83 -106.52 0.01 OUTLIER Glycine 0 N--CA 1.486 1.986 0 N-CA-C 107.942 -2.063 . . . . 0.0 107.942 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.03 ' CG2' ' HB3' ' A' ' 205' ' ' ALA . 4.4 m -138.16 123.91 24.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 120.998 -1.295 . . . . 0.0 110.078 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.662 ' NE ' ' O ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -145.42 133.83 21.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.18 -0.95 . . . . 0.0 112.161 -178.616 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 1.081 ' CA ' ' HA ' ' A' ' 52' ' ' ASP . . . -131.79 163.84 23.72 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 178.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.548 ' CB ' ' HB3' ' A' ' 202' ' ' SER . 2.5 ttpm? -171.01 87.28 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.494 -1.003 . . . . 0.0 109.513 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.818 ' HD3' ' H ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -152.31 -91.18 0.05 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.227 -0.92 . . . . 0.0 110.542 -179.366 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.818 ' H ' ' HD3' ' A' ' 82' ' ' ARG . . . 45.75 42.78 11.2 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -97.21 106.2 18.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -1.11 . . . . 0.0 110.217 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.595 ' HB2' ' CE1' ' A' ' 89' ' ' HIS . 75.5 p -138.28 167.17 22.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 0.0 110.071 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.538 ' HA ' ' CB ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -120.14 135.44 54.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.216 -0.927 . . . . 0.0 110.285 -179.824 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 172' ' ' ASP . . . 102.83 -116.64 5.54 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.476 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 2.5 tp -128.36 130.27 47.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.321 -1.105 . . . . 0.0 110.282 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.595 ' CE1' ' HB2' ' A' ' 85' ' ' SER . 33.4 m-70 -146.33 166.2 27.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.099 -1.001 . . . . 0.0 109.997 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.539 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -158.99 153.71 24.63 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.054 -1.029 . . . . 0.0 109.92 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 1.001 ' CZ2' HD22 ' A' ' 171' ' ' LEU . 1.4 m0 -134.81 148.57 50.22 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.298 -0.876 . . . . 0.0 109.911 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.731 ' C ' HD12 ' A' ' 93' ' ' ILE . 7.8 mt-10 -109.56 118.42 36.55 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.52 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.731 HD12 ' C ' ' A' ' 92' ' ' GLU . 1.2 mp -133.69 154.52 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.054 -1.029 . . . . 0.0 110.877 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.589 ' HA ' ' HG ' ' A' ' 167' ' ' LEU . 0.3 OUTLIER -140.88 119.94 12.8 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.16 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 1.134 ' CE3' HG22 ' A' ' 106' ' ' VAL . 3.0 t-105 -117.41 89.5 31.91 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.072 -1.018 . . . . 0.0 110.657 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 94' ' ' SER . 51.0 Cg_endo -89.18 109.53 0.47 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.085 1.571 . . . . 0.0 110.153 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.99 HD23 ' HE1' ' A' ' 95' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.758 0 O-C-N 121.128 -0.982 . . . . 0.0 110.399 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.897 HG23 ' HA ' ' A' ' 134' ' ' ASP . 4.9 p . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 121.244 0.545 . . . . 0.0 112.405 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 1.134 HG22 ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -122.31 115.93 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 177.114 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.591 ' HA3' ' HA3' ' A' ' 132' ' ' GLY . . . -160.54 -164.96 16.43 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 118.648 -1.739 . . . . 0.0 111.227 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.654 ' HB ' HD13 ' A' ' 199' ' ' LEU . 0.7 OUTLIER -120.54 156.23 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.617 -0.931 . . . . 0.0 109.515 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 130' ' ' SER . . . -128.13 143.09 51.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.861 -1.149 . . . . 0.0 110.686 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.886 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.7 OUTLIER -115.38 123.13 47.9 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.196 -0.94 . . . . 0.0 110.455 179.74 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.91 -31.03 14.47 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.465 -0.772 . . . . 0.0 109.712 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.695 ' O ' ' C ' ' A' ' 113' ' ' ALA . 1.7 pp -79.22 -11.87 59.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.507 -0.745 . . . . 0.0 110.115 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.695 ' C ' ' O ' ' A' ' 112' ' ' LEU . . . . . . . . 0 N--CA 1.499 2.01 0 O-C-N 121.872 -0.518 . . . . 0.0 111.128 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.17 0.51 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -149.84 128.91 12.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.268 -0.895 . . . . 0.0 109.964 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 2.9 t -120.41 119.35 32.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.16 -0.963 . . . . 0.0 110.501 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -133.94 136.19 44.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.501 -0.749 . . . . 0.0 109.305 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.591 ' HA3' ' HA3' ' A' ' 107' ' ' GLY . . . -165.39 -111.34 0.24 Allowed Glycine 0 N--CA 1.486 2.001 0 C-N-CA 119.042 -1.552 . . . . 0.0 110.796 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.764 ' CH2' ' HB2' ' A' ' 180' ' ' TYR . 5.3 m-90 -140.3 122.77 16.1 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 121.168 -1.195 . . . . 0.0 111.634 -178.064 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.897 ' HA ' HG23 ' A' ' 105' ' ' VAL . 0.9 OUTLIER -118.89 148.62 42.72 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.394 -179.638 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.549 HD13 ' N ' ' A' ' 135' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.79 0 O-C-N 121.348 -0.845 . . . . 0.0 110.313 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.88 HG11 ' HB ' ' A' ' 182' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.457 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.686 ' HD3' ' N ' ' A' ' 163' ' ' VAL . 53.7 Cg_endo -79.76 81.91 2.64 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.785 1.413 . . . . 0.0 110.872 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -167.25 -84.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.05 -1.031 . . . . 0.0 110.106 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 1.03 ' O ' HD23 ' A' ' 167' ' ' LEU . 20.3 ttp180 -151.9 155.84 38.9 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.461 -0.775 . . . . 0.0 109.988 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 1.03 HD23 ' O ' ' A' ' 166' ' ' ARG . 9.9 mt -138.15 128.85 26.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.192 -0.943 . . . . 0.0 110.525 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 17.7 tp -103.63 141.34 36.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.259 -0.9 . . . . 0.0 109.167 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.703 HG13 ' CD2' ' A' ' 180' ' ' TYR . 6.8 t -125.55 132.22 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.799 -1.188 . . . . 0.0 111.58 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.743 HG13 ' O ' ' A' ' 170' ' ' VAL . 11.4 p -138.02 104.93 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 1.001 HD22 ' CZ2' ' A' ' 91' ' ' TRP . 0.0 OUTLIER -118.41 141.13 48.85 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.134 -0.979 . . . . 0.0 110.417 -179.083 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 173' ' ' MET . 40.4 t0 -120.2 138.68 53.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.29 -0.881 . . . . 0.0 110.19 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.55 ' CG ' ' O ' ' A' ' 85' ' ' SER . 4.1 tpt -89.97 -39.15 13.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.624 -0.673 . . . . 0.0 109.849 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 173' ' ' MET . 1.4 tt0 -42.09 -27.78 0.15 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.892 . . . . 0.0 109.191 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.515 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 3.0 tt0 -106.99 -27.76 10.46 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.702 0.763 . . . . 0.0 108.97 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 86.11 21.98 50.37 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.98 HG22 ' CD2' ' A' ' 194' ' ' LEU . 0.8 OUTLIER -121.76 150.54 41.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.342 -1.093 . . . . 0.0 110.642 -179.651 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.963 ' HB3' HD12 ' A' ' 171' ' ' LEU . 0.2 OUTLIER -117.44 153.52 32.95 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.439 -0.788 . . . . 0.0 109.895 179.815 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -134.09 122.03 2.88 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.764 ' HB2' ' CH2' ' A' ' 133' ' ' TRP . 2.4 t80 -119.77 124.8 47.06 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.26 -1.141 . . . . 0.0 109.508 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.462 ' HA ' HG23 ' A' ' 185' ' ' THR . 12.5 t -103.66 122.21 44.55 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 122.135 0.969 . . . . 0.0 109.456 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 1.009 HG22 ' CD2' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -129.42 158.54 42.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.819 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.612 ' C ' ' O ' ' A' ' 182' ' ' ILE . . . -33.63 -34.77 0.03 OUTLIER Glycine 0 N--CA 1.493 2.446 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.686 ' O ' ' CD1' ' A' ' 186' ' ' TYR . . . -105.5 32.66 7.2 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.549 -1.82 . . . . 0.0 108.549 178.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' THR . . . . . 0.817 ' N ' ' O ' ' A' ' 182' ' ' ILE . 53.3 m -37.77 -26.59 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.494 -1.004 . . . . 0.0 110.871 -179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.7 ' O ' ' CD2' ' A' ' 186' ' ' TYR . 16.9 p90 -41.38 91.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 122.202 1.001 . . . . 0.0 109.316 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.669 ' C ' ' HD2' ' A' ' 189' ' ' PRO . 0.1 OUTLIER 179.81 31.2 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.542 -0.724 . . . . 0.0 109.221 -178.79 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.865 ' N ' ' CD ' ' A' ' 189' ' ' PRO . . . -105.67 2.08 39.22 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.403 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.865 ' CD ' ' N ' ' A' ' 188' ' ' GLY . 48.7 Cg_endo -75.79 -27.12 9.06 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 N-CA-C 109.426 -1.028 . . . . 0.0 109.426 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -81.43 21.97 0.73 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.631 -0.668 . . . . 0.0 110.476 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.401 ' HA ' ' HB2' ' A' ' 194' ' ' LEU . 1.8 m-85 -73.2 -48.67 33.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.11 -0.994 . . . . 0.0 109.945 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 9.5 mtm180 -52.87 -19.25 2.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.187 -0.946 . . . . 0.0 109.766 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -107.32 -17.93 10.91 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.166 -1.973 . . . . 0.0 108.166 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.98 ' CD2' HG22 ' A' ' 177' ' ' THR . 6.9 tt -62.2 -31.32 71.83 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.692 -0.887 . . . . 0.0 109.205 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.554 ' HE3' ' N ' ' A' ' 196' ' ' GLY . 0.0 OUTLIER -49.52 -27.83 4.8 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.443 -0.786 . . . . 0.0 109.407 179.534 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.554 ' N ' ' HE3' ' A' ' 195' ' ' LYS . . . -112.29 -21.59 6.17 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.642 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.77 -10.42 42.95 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.65 -0.912 . . . . 0.0 109.749 179.745 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 198' ' ' THR . . . . . 0.623 HG22 ' O ' ' A' ' 194' ' ' LEU . 0.1 OUTLIER -43.83 145.25 0.71 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.907 0.86 . . . . 0.0 111.427 -178.559 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.886 ' CB ' HG23 ' A' ' 110' ' ' THR . 0.0 OUTLIER -140.43 171.45 14.12 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.24 0.543 . . . . 0.0 109.725 179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.421 ' C ' ' CG1' ' A' ' 108' ' ' VAL . 15.8 m-30 -84.33 136.98 39.75 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.178 -0.951 . . . . 0.0 109.218 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.584 ' HG3' ' CH2' ' A' ' 91' ' ' TRP . 40.8 Cg_endo -67.03 109.82 1.81 Allowed 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 123.862 1.454 . . . . 0.0 110.814 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.548 ' HB3' ' CB ' ' A' ' 81' ' ' LYS . 57.4 p -133.47 137.2 45.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.507 -0.746 . . . . 0.0 109.595 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 79' ' ' ARG . 4.9 p -128.9 146.55 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.994 -1.066 . . . . 0.0 111.187 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 26.7 m -128.75 127.19 41.54 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 1.03 ' HB3' ' CG2' ' A' ' 78' ' ' VAL . . . -126.28 166.14 17.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 0.0 110.716 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.583 ' CG1' ' N ' ' A' ' 207' ' ' TRP . 0.9 OUTLIER -101.63 174.66 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 121.363 0.602 . . . . 0.0 110.233 -179.533 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 0.621 ' HB2' ' CG ' ' A' ' 68' ' ' ARG . 63.9 p-90 -99.01 128.43 45.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.89 . . . . 0.0 110.264 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 144.04 -147.48 18.78 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 211' ' ' GLN . 0.0 OUTLIER -66.18 -25.25 66.85 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.345 -1.091 . . . . 0.0 110.239 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 210' ' ' CYS . . . . . 0.678 ' O ' ' C ' ' A' ' 211' ' ' GLN . 4.9 t -37.12 -30.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.593 -0.692 . . . . 0.0 110.621 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.678 ' C ' ' O ' ' A' ' 210' ' ' CYS . 10.4 mt-30 0.07 114.59 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 121.65 0.738 . . . . 0.0 111.427 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.66 ' O ' HD11 ' A' ' 64' ' ' LEU . 0.8 OUTLIER -115.62 144.09 24.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.642 -0.661 . . . . 0.0 110.668 -179.164 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 213' ' ' ARG . . . . . 0.554 ' HG3' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -88.54 121.96 31.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.281 -0.887 . . . . 0.0 109.566 179.758 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 1.061 ' O ' HD13 ' A' ' 214' ' ' ILE . 0.0 OUTLIER -123.5 121.59 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 110.896 -179.241 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.653 ' N ' ' O ' ' A' ' 92' ' ' GLU . 0.2 OUTLIER -130.87 139.61 50.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.513 -0.742 . . . . 0.0 109.665 179.495 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 216' ' ' TYR . . . . . 0.717 ' CE2' ' CD1' ' A' ' 91' ' ' TRP . 0.9 OUTLIER -118.7 150.76 39.21 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.965 -1.085 . . . . 0.0 110.728 -179.439 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 217' ' ' MET . . . . . 0.494 ' CB ' ' O ' ' A' ' 90' ' ' ALA . 2.0 ttm -125.08 107.82 11.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.305 -0.872 . . . . 0.0 110.039 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 116.54 21.59 4.67 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.108 -1.23 . . . . 0.0 110.23 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.935 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.052 0.453 . . . . 0.0 109.982 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.54 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 3.0 pt-20 -48.42 -35.71 13.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.052 -1.03 . . . . 0.0 108.691 179.049 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -59.13 -26.09 64.42 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -77.73 -36.01 51.35 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.457 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.896 HD12 ' C ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -76.3 -38.85 55.49 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.663 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.564 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -45.92 -26.62 0.73 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.454 0.645 . . . . 0.0 109.925 179.891 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 1.087 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -52.16 -168.47 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.567 -0.708 . . . . 0.0 109.376 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 1.087 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 39.7 Cg_endo -67.07 104.53 0.86 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.448 1.236 . . . . 0.0 109.704 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.846 ' HG2' HG21 ' A' ' 41' ' ' VAL . 51.1 Cg_endo -90.84 115.24 0.46 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.284 1.676 . . . . 0.0 111.49 -178.391 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.902 ' O ' ' N ' ' A' ' 40' ' ' LEU . 50.6 Cg_endo -86.13 152.59 9.57 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 124.087 1.572 . . . . 0.0 110.493 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.676 ' C ' ' O ' ' A' ' 38' ' ' PRO . 0.4 OUTLIER 4.26 53.68 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 122.313 1.054 . . . . 0.0 110.185 -178.258 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.203 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -129.64 -39.62 1.44 Allowed 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.934 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.846 HG21 ' HG2' ' A' ' 37' ' ' PRO . 1.6 t -78.38 -36.4 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 118.751 -1.179 . . . . 0.0 111.69 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.67 ' HB3' ' NE2' ' A' ' 43' ' ' GLN . . . -74.71 -37.79 62.5 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.585 -1.322 . . . . 0.0 111.681 -178.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.745 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 14.6 mp0 -87.35 -20.27 26.99 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.822 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 6.6 ttm180 -65.88 -50.6 63.92 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 122.511 1.148 . . . . 0.0 108.085 178.469 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.699 ' CE1' HG12 ' A' ' 41' ' ' VAL . 34.5 m170 -68.68 -17.79 64.14 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.707 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -96.6 -33.19 11.88 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.335 -0.853 . . . . 0.0 109.526 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 43' ' ' GLN . . . -87.3 -113.59 1.0 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.995 ' HE1' HG21 ' A' ' 59' ' ' VAL . 11.9 m95 -86.29 74.31 10.02 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.027 -1.278 . . . . 0.0 108.61 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.633 ' OD1' ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -51.29 127.43 29.96 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.507 -0.746 . . . . 0.0 111.104 -178.92 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.59 ' C ' ' H ' ' A' ' 52' ' ' ASP . 50.3 Cg_endo -86.64 2.48 7.16 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.339 2.026 . . . . 0.0 111.884 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.958 ' HE2' ' HA ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -57.06 -2.19 0.08 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.651 -1.281 . . . . 0.0 109.365 -179.256 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.668 ' HB3' ' HE ' ' A' ' 79' ' ' ARG . 0.3 OUTLIER -117.83 -9.46 10.66 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.668 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.589 ' CB ' ' HB3' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -155.65 -178.6 7.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.422 -0.799 . . . . 0.0 110.705 -179.474 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.684 ' HB2' HD22 ' A' ' 56' ' ' ASN . 5.0 p -68.51 143.09 55.08 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.235 -0.916 . . . . 0.0 109.767 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.749 ' CG ' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -98.78 7.71 45.76 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.654 -0.654 . . . . 0.0 111.199 -178.796 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.684 HD22 ' HB2' ' A' ' 54' ' ' SER . 0.0 OUTLIER -27.16 -38.12 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 122.031 0.919 . . . . 0.0 109.42 -179.751 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.654 ' N ' ' O ' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -140.0 145.81 25.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.729 ' OD1' ' HA ' ' A' ' 44' ' ' ARG . 0.8 OUTLIER -149.99 158.63 44.36 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 118.789 -1.164 . . . . 0.0 110.867 -179.873 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.995 HG21 ' HE1' ' A' ' 48' ' ' TRP . 1.5 m -114.02 138.45 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.791 0.805 . . . . 0.0 111.92 -177.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.745 ' HA ' ' HB3' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -102.37 152.65 20.84 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.912 179.177 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.459 ' O ' ' O ' ' A' ' 60' ' ' LYS . 1.8 tt0 -60.81 -132.84 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.26 -0.9 . . . . 0.0 110.309 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 44.48 27.71 1.33 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.68 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 131.44 39.73 0.24 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 -179.322 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.68 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.3 OUTLIER 0.6 87.4 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.897 -0.766 . . . . 0.0 111.026 -179.456 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.967 ' C ' ' HB ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -140.3 134.88 31.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.433 -0.792 . . . . 0.0 110.973 -179.487 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.845 ' CD2' ' CG1' ' A' ' 59' ' ' VAL . 46.1 m-85 -80.14 148.58 30.88 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.599 0.714 . . . . 0.0 110.054 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -128.67 121.63 28.98 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.603 -0.685 . . . . 0.0 109.653 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.866 ' NE ' ' HB2' ' A' ' 72' ' ' ALA . 6.3 ttt-85 -119.06 130.67 55.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.923 . . . . 0.0 110.214 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.706 ' CB ' ' HD3' ' A' ' 70' ' ' PRO . 9.0 mtm-85 -69.81 -74.0 0.17 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.926 . . . . 0.0 110.376 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.706 ' HD3' ' CB ' ' A' ' 69' ' ' ARG . 57.0 Cg_endo -75.82 -112.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.246 1.13 . . . . 0.0 109.544 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.545 ' O ' ' NH1' ' A' ' 68' ' ' ARG . 1.9 t -140.68 158.14 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.551 -1.343 . . . . 0.0 110.087 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.866 ' HB2' ' NE ' ' A' ' 68' ' ' ARG . . . -97.03 109.94 22.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.135 -0.978 . . . . 0.0 109.823 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.88 53.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.141 -0.975 . . . . 0.0 110.712 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 179.81 -61.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.054 -1.029 . . . . 0.0 110.636 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.9 m -81.9 -127.56 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.189 -0.944 . . . . 0.0 110.27 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.613 ' O ' ' O ' ' A' ' 77' ' ' GLY . 0.6 OUTLIER -140.01 116.03 10.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.142 -0.974 . . . . 0.0 109.885 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.613 ' O ' ' O ' ' A' ' 76' ' ' ASP . . . -37.98 -100.03 0.01 OUTLIER Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.455 HG21 ' O ' ' A' ' 48' ' ' TRP . 0.2 OUTLIER -158.87 150.05 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.067 -1.255 . . . . 0.0 110.255 179.379 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.668 ' HE ' ' HB3' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -143.56 171.01 14.76 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.666 -0.646 . . . . 0.0 109.82 179.856 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.53 ' N ' ' CG ' ' A' ' 79' ' ' ARG . . . -150.26 133.12 4.22 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.549 ' CG ' ' O ' ' A' ' 201' ' ' PRO . 0.0 OUTLIER -155.07 55.06 0.65 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.297 -1.12 . . . . 0.0 110.245 179.837 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.473 ' O ' ' C ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -125.43 -88.31 0.59 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.915 . . . . 0.0 110.069 179.88 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.473 ' C ' ' O ' ' A' ' 82' ' ' ARG . . . 40.63 58.42 2.57 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -94.45 95.93 9.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.353 -1.087 . . . . 0.0 110.376 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' A' ' 173' ' ' MET . 38.3 m -136.88 168.07 20.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -0.851 . . . . 0.0 109.948 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.456 ' HA ' ' HB3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -112.47 143.99 42.68 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.22 -0.925 . . . . 0.0 109.835 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.67 -120.34 5.23 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.486 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 13.9 tp -128.36 135.63 49.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.318 -1.107 . . . . 0.0 110.395 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.486 ' CG ' ' C ' ' A' ' 88' ' ' LEU . 8.0 m-70 -147.08 156.34 42.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.207 -0.933 . . . . 0.0 109.569 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.23 138.09 6.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.069 -1.02 . . . . 0.0 110.875 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 1.028 ' CZ2' HG11 ' A' ' 169' ' ' VAL . 3.7 p90 -135.27 171.12 14.89 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.404 -0.81 . . . . 0.0 109.456 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 215' ' ' ARG . 23.7 tt0 -135.63 156.82 48.24 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.474 -0.89 . . . . 0.0 111.352 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.668 HD13 HG13 ' A' ' 214' ' ' ILE . 27.9 mm -143.59 141.89 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.555 -0.716 . . . . 0.0 109.637 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.574 ' HB3' ' HA ' ' A' ' 166' ' ' ARG . 2.9 p -155.84 146.36 21.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.886 -1.134 . . . . 0.0 110.777 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.924 ' CE3' HG22 ' A' ' 212' ' ' VAL . 39.4 m95 -116.81 87.46 21.98 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.321 -0.862 . . . . 0.0 109.269 178.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.532 ' HG2' ' HG3' ' A' ' 213' ' ' ARG . 51.9 Cg_endo -95.72 108.42 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.719 1.378 . . . . 0.0 111.015 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.814 HD22 ' HA ' ' A' ' 211' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 O-C-N 120.973 -1.079 . . . . 0.0 109.586 178.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.779 HG23 ' CB ' ' A' ' 204' ' ' SER . 35.1 m . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 121.587 0.708 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.796 ' HB ' HG23 ' A' ' 203' ' ' VAL . 2.7 p -150.8 149.72 14.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 O-C-N 121.518 -0.739 . . . . 0.0 109.399 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.612 ' HA2' ' HA3' ' A' ' 132' ' ' GLY . . . -162.7 148.89 16.22 Favored Glycine 0 N--CA 1.485 1.952 0 C-N-CA 118.984 -1.579 . . . . 0.0 110.985 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.875 HG12 ' HG ' ' A' ' 199' ' ' LEU . 11.8 t -105.78 156.97 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.707 -0.878 . . . . 0.0 108.947 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.802 ' CA ' HD12 ' A' ' 199' ' ' LEU . . . -150.11 146.69 27.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.728 -1.233 . . . . 0.0 111.501 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . 1.0 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -114.18 138.33 50.59 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.561 0.696 . . . . 0.0 109.65 179.268 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.87 -24.45 18.47 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.532 -0.73 . . . . 0.0 109.064 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.672 ' O ' ' C ' ' A' ' 113' ' ' ALA . 0.7 OUTLIER -86.68 -12.21 49.01 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.555 -0.716 . . . . 0.0 109.268 179.08 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.672 ' C ' ' O ' ' A' ' 112' ' ' LEU . . . . . . . . 0 N--CA 1.499 2.021 0 O-C-N 122.04 -0.412 . . . . 0.0 111.192 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.6 m . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.161 0.505 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 14.7 tm-20 -126.41 115.99 20.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.18 -0.95 . . . . 0.0 109.949 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 48.5 t -120.21 119.37 33.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 110.458 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' TRP . . . . . 0.448 ' HB2' ' OE2' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -133.55 125.34 28.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.468 -0.77 . . . . 0.0 109.764 179.634 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.612 ' HA3' ' HA2' ' A' ' 107' ' ' GLY . . . -170.18 -143.33 3.89 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.948 ' CZ3' HD22 ' A' ' 167' ' ' LEU . 53.7 m0 -115.95 113.48 23.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -1.169 . . . . 0.0 110.317 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.936 ' O ' HG23 ' A' ' 135' ' ' ILE . 3.9 p30 -118.25 131.29 56.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.649 -0.657 . . . . 0.0 110.391 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.936 HG23 ' O ' ' A' ' 134' ' ' ASP . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.278 -0.889 . . . . 0.0 110.248 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.61 HG12 ' N ' ' A' ' 164' ' ' PRO . 1.3 t . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.728 ' CD ' HD11 ' A' ' 135' ' ' ILE . 48.6 Cg_endo -77.28 55.22 4.99 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.714 1.376 . . . . 0.0 110.839 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -64.0 -58.67 6.0 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.629 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 2.1 ttp180 -151.59 115.44 4.92 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.98 HD23 HG23 ' A' ' 182' ' ' ILE . 0.7 OUTLIER -150.25 158.27 43.97 Favored 'General case' 0 C--N 1.287 -2.131 0 O-C-N 121.676 -0.64 . . . . 0.0 110.735 -178.711 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.428 ' HA ' ' HG3' ' A' ' 92' ' ' GLU . 1.7 tp -103.86 139.73 38.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.425 -0.797 . . . . 0.0 109.36 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 1.028 HG11 ' CZ2' ' A' ' 91' ' ' TRP . 1.8 t -105.78 130.25 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.091 -1.006 . . . . 0.0 110.439 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.0 t -100.14 125.76 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.524 -0.735 . . . . 0.0 110.058 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.708 HD22 ' HZ3' ' A' ' 91' ' ' TRP . 13.3 tp -133.27 106.24 7.44 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.141 -0.975 . . . . 0.0 110.127 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 173' ' ' MET . 50.4 t0 -119.71 137.81 53.69 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.188 -0.945 . . . . 0.0 110.095 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.489 ' HB2' ' O ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -93.48 -40.48 10.31 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.654 -0.654 . . . . 0.0 109.857 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 173' ' ' MET . 37.5 tt0 -43.13 -26.34 0.15 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.272 -0.893 . . . . 0.0 109.11 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.736 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.2 OUTLIER -113.88 -25.75 8.47 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.832 0.825 . . . . 0.0 108.894 179.33 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.564 ' O ' HG22 ' A' ' 198' ' ' THR . . . 78.83 27.89 55.73 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 108.139 -1.984 . . . . 0.0 108.139 -178.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' THR . . . . . 1.123 ' CG2' HD22 ' A' ' 194' ' ' LEU . 0.0 OUTLIER -112.64 143.17 44.29 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.28 -1.129 . . . . 0.0 111.608 -179.182 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.71 HD21 ' O ' ' A' ' 199' ' ' LEU . 0.5 OUTLIER -148.66 154.2 39.33 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.671 -0.643 . . . . 0.0 109.615 179.377 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.976 ' HA3' HD22 ' A' ' 187' ' ' LEU . . . -174.13 166.2 38.15 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.994 ' CD1' HG22 ' A' ' 169' ' ' VAL . 1.7 t80 -118.95 117.52 29.04 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.368 -1.077 . . . . 0.0 109.73 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 186' ' ' TYR . 6.9 t -146.01 165.18 29.8 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.167 -0.958 . . . . 0.0 110.197 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.98 HG23 HD23 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -100.12 116.47 43.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.734 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 71.04 6.92 61.43 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.99 43.1 18.07 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 1.7 m -101.18 -69.52 0.77 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.241 -1.152 . . . . 0.0 110.957 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.539 ' O ' ' N ' ' A' ' 188' ' ' GLY . 6.7 m-30 -45.1 -83.52 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.14 -0.975 . . . . 0.0 110.907 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.976 HD22 ' HA3' ' A' ' 179' ' ' GLY . 0.1 OUTLIER -66.98 43.95 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.87 -1.144 . . . . 0.0 110.202 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 186' ' ' TYR . . . -91.46 -63.4 1.18 Allowed Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.927 -1.13 . . . . 0.0 110.581 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.491 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 46.6 Cg_endo -72.54 -30.25 12.4 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.859 1.452 . . . . 0.0 111.476 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.591 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -74.1 29.4 0.08 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.232 -0.918 . . . . 0.0 111.572 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.544 ' CE1' ' O ' ' A' ' 187' ' ' LEU . 1.2 m-30 -90.53 -14.85 31.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.769 -1.207 . . . . 0.0 110.409 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ARG . . . . . 0.505 ' N ' ' HD2' ' A' ' 192' ' ' ARG . 0.0 OUTLIER -90.09 -13.66 35.35 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.328 -0.858 . . . . 0.0 110.283 -179.701 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -110.91 -12.57 15.75 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 107.707 -2.157 . . . . 0.0 107.707 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 1.123 HD22 ' CG2' ' A' ' 177' ' ' THR . 5.4 tt -67.28 -37.62 83.74 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.002 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.486 ' CA ' HG23 ' A' ' 198' ' ' THR . 0.0 OUTLIER -44.66 -37.27 3.56 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.561 -0.712 . . . . 0.0 109.787 179.51 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.91 -27.83 30.47 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.715 ' NE ' ' HG ' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -90.26 -3.34 57.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.707 -0.878 . . . . 0.0 109.942 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 198' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 194' ' ' LEU . 15.8 p -41.1 114.52 0.5 Allowed 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.996 0.903 . . . . 0.0 110.042 -178.051 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 1.0 ' CB ' HG23 ' A' ' 110' ' ' THR . 2.6 pt? -139.42 171.63 13.98 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.05 -178.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.437 ' N ' ' CD1' ' A' ' 200' ' ' TYR . 5.9 m-85 -84.46 129.44 57.57 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.911 -1.118 . . . . 0.0 110.189 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.854 ' HA ' HG13 ' A' ' 108' ' ' VAL . 52.8 Cg_endo -84.88 135.98 5.86 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 124.12 1.59 . . . . 0.0 111.164 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.548 ' CB ' ' HB2' ' A' ' 81' ' ' LYS . 3.7 p -133.39 136.99 45.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.292 -0.88 . . . . 0.0 109.993 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.796 HG23 ' HB ' ' A' ' 106' ' ' VAL . 3.9 p -122.44 155.39 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -0.961 . . . . 0.0 109.938 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' SER . . . . . 0.779 ' CB ' HG23 ' A' ' 105' ' ' VAL . 2.7 t -130.81 127.5 38.79 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.168 -0.957 . . . . 0.0 110.684 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.695 ' HB1' HG11 ' A' ' 212' ' ' VAL . . . -119.06 154.28 33.4 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.01 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.717 HG12 ' OE1' ' A' ' 211' ' ' GLN . 2.9 p -115.11 -172.49 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 110.284 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 0.743 ' CE3' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -82.77 165.36 19.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.293 -0.879 . . . . 0.0 110.182 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 132.18 131.72 3.25 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' GLN . . . . . 0.405 ' HG2' ' N ' ' A' ' 210' ' ' CYS . 7.9 tt0 -62.36 -87.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -1.15 . . . . 0.0 110.303 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' CYS . . . . . 0.527 ' O ' HD22 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -81.18 83.39 6.82 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.323 -0.861 . . . . 0.0 110.541 -179.83 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.814 ' HA ' HD22 ' A' ' 97' ' ' LEU . 2.5 tt0 -155.6 -42.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.187 -0.946 . . . . 0.0 110.659 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.924 HG22 ' CE3' ' A' ' 95' ' ' TRP . 88.3 t -127.27 132.68 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.986 -1.071 . . . . 0.0 111.194 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' ARG . . . . . 0.532 ' HG3' ' HG2' ' A' ' 96' ' ' PRO . 0.4 OUTLIER -139.86 149.16 43.08 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.42 -0.8 . . . . 0.0 109.811 179.559 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.825 HG22 ' CZ2' ' A' ' 48' ' ' TRP . 5.9 tt -144.31 143.89 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.086 -1.009 . . . . 0.0 111.436 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.564 ' O ' ' N ' ' A' ' 92' ' ' GLU . 15.1 mtt180 -130.21 108.72 10.25 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.157 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' TYR . . . . . 0.721 ' CD2' ' CB ' ' A' ' 91' ' ' TRP . 2.4 t80 -116.29 146.76 42.15 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.031 -1.043 . . . . 0.0 111.435 -177.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 217' ' ' MET . . . . . 0.519 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 5.6 tmm? -136.41 107.93 6.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.561 -0.712 . . . . 0.0 109.706 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 149.81 -40.26 0.86 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.165 -1.197 . . . . 0.0 110.205 -179.89 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.947 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.204 0.526 . . . . 0.0 109.822 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.711 ' HA ' HD23 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -48.81 -34.26 12.04 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.16 -0.963 . . . . 0.0 109.279 179.625 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.77 -21.96 66.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.438 -0.789 . . . . 0.0 109.077 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.452 HD22 ' HA ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -83.37 -35.73 24.9 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.783 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.925 HD11 HH21 ' A' ' 44' ' ' ARG . 0.3 OUTLIER -68.56 -37.08 79.62 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 122.071 0.939 . . . . 0.0 109.002 178.959 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.637 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 3.5 m -76.84 -7.88 56.3 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.387 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 1.025 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -36.63 -59.61 0.86 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.421 -0.8 . . . . 0.0 110.034 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 1.039 ' O ' HD12 ' A' ' 40' ' ' LEU . 48.2 Cg_endo -74.36 108.42 2.67 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.146 1.603 . . . . 0.0 110.337 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.756 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 48.5 Cg_endo -74.36 -25.2 13.51 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.987 1.519 . . . . 0.0 112.7 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.756 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 43.8 Cg_endo -69.18 152.0 72.32 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 122.944 0.971 . . . . 0.0 112.163 -178.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.744 ' HA ' ' HG3' ' A' ' 43' ' ' GLN . 0.0 OUTLIER 3.56 66.83 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 123.121 1.439 . . . . 0.0 111.092 -179.072 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.039 HD12 ' O ' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -156.66 -44.97 0.07 Allowed 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 177.863 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.754 ' O ' ' CD2' ' A' ' 45' ' ' HIS . 2.8 t -87.71 -31.1 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.785 177.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.54 -44.3 10.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.323 -0.861 . . . . 0.0 111.573 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.865 ' HB2' ' HA ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -74.78 -19.32 60.26 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.178 -0.951 . . . . 0.0 110.523 -179.28 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.925 HH21 HD11 ' A' ' 33' ' ' LEU . 2.8 ttp85 -82.29 -41.6 19.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.869 . . . . 0.0 110.066 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.754 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 1.7 m-70 -68.81 -17.03 63.95 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.717 -0.614 . . . . 0.0 111.353 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.416 ' O ' ' O ' ' A' ' 47' ' ' GLY . 6.0 t60 -95.21 -32.96 12.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.752 -1.218 . . . . 0.0 110.102 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.671 ' HA2' HD22 ' A' ' 64' ' ' LEU . . . -62.45 -99.43 0.01 OUTLIER Glycine 0 N--CA 1.488 2.164 0 N-CA-C 106.447 -2.661 . . . . 0.0 106.447 178.322 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.906 ' CE2' ' HB ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -100.14 95.44 6.83 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 175.945 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.822 ' O ' ' HB3' ' A' ' 53' ' ' CYS . 0.0 OUTLIER -42.33 111.36 0.94 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.644 -0.66 . . . . 0.0 111.679 -178.202 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.614 ' HA ' ' CB ' ' A' ' 53' ' ' CYS . 47.7 Cg_endo -73.49 0.69 7.73 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 122.625 2.217 . . . . 0.0 112.172 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.733 ' H ' ' CE ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -65.02 -31.68 73.04 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 177.928 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.727 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 3.2 m-20 -116.12 -12.58 11.23 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 113.46 -1.7 . . . . 0.0 106.668 176.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.822 ' HB3' ' O ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -108.22 157.82 18.0 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.656 0.741 . . . . 0.0 110.913 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.503 ' HB2' ' O ' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -75.78 142.61 42.29 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.552 0.692 . . . . 0.0 110.008 179.345 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.639 ' HG3' HD21 ' A' ' 33' ' ' LEU . 1.1 pm0 -99.33 -4.35 31.92 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.562 -0.711 . . . . 0.0 110.459 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.904 HD22 ' CG2' ' A' ' 75' ' ' THR . 7.5 m120 -50.39 -12.67 0.1 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.629 -0.669 . . . . 0.0 110.805 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.61 HG13 ' CZ3' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -124.7 169.0 16.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.288 -0.882 . . . . 0.0 109.242 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.598 ' O ' ' CB ' ' A' ' 67' ' ' GLU . 49.3 t0 -107.2 133.78 51.27 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.899 -1.126 . . . . 0.0 111.087 -177.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.906 ' HB ' ' CE2' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -130.95 137.15 56.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.675 -179.532 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.865 ' HA ' ' HB2' ' A' ' 43' ' ' GLN . 60.0 mttp -123.86 151.58 43.29 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 118.581 -1.248 . . . . 0.0 111.119 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.461 ' O ' ' C ' ' A' ' 62' ' ' GLY . 0.7 OUTLIER -77.6 -128.72 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.474 -0.766 . . . . 0.0 110.274 -179.787 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 41.3 42.28 3.23 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.556 -1.818 . . . . 0.0 108.556 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.683 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 108.82 67.67 0.61 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.683 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER 0.84 88.09 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.847 -0.796 . . . . 0.0 110.983 -179.076 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 1.2 t -99.88 114.33 27.47 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.45 -0.781 . . . . 0.0 111.049 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.807 ' CD1' ' NE1' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -83.56 128.51 34.57 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.136 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.598 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 1.6 tt0 -138.79 121.82 16.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.567 -1.333 . . . . 0.0 110.502 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.661 ' CZ ' ' CZ3' ' A' ' 207' ' ' TRP . 0.0 OUTLIER -130.85 142.85 50.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.38 -0.825 . . . . 0.0 109.406 179.767 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.683 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -130.96 -70.69 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.055 -1.028 . . . . 0.0 110.954 -179.464 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.683 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 55.5 Cg_endo -69.89 -145.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.552 1.291 . . . . 0.0 109.492 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.745 HG13 ' CZ2' ' A' ' 207' ' ' TRP . 3.9 t -140.02 164.27 23.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 O-C-N 121.417 -0.802 . . . . 0.0 110.175 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.973 ' HB3' ' HB3' ' A' ' 76' ' ' ASP . . . -130.44 94.11 3.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 110.021 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.484 ' O ' ' O ' ' A' ' 72' ' ' ALA . 67.3 mt-30 -48.12 -99.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.281 -0.887 . . . . 0.0 110.106 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.5 p -88.61 39.24 0.91 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.084 -1.01 . . . . 0.0 109.605 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.904 ' CG2' HD22 ' A' ' 56' ' ' ASN . 3.0 m -144.6 15.73 1.62 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.317 -0.864 . . . . 0.0 110.198 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.973 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 19.1 p-10 -98.47 155.16 17.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.296 -0.878 . . . . 0.0 109.928 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.503 ' O ' ' HB2' ' A' ' 54' ' ' SER . . . 106.78 127.73 5.86 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 106.781 -2.528 . . . . 0.0 106.781 -178.025 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.641 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 1.2 m -117.51 131.67 69.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 120.814 -1.403 . . . . 0.0 111.131 -178.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.727 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 2.5 ttp180 -104.12 175.08 5.6 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.657 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.63 ' HA2' ' CB ' ' A' ' 52' ' ' ASP . . . -167.4 80.7 0.1 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -125.63 130.48 51.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -1.153 . . . . 0.0 110.311 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.518 ' HG2' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -140.41 -31.21 0.64 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -0.89 . . . . 0.0 110.551 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.518 ' N ' ' HG2' ' A' ' 82' ' ' ARG . . . 37.82 40.6 0.78 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.447 ' H ' ' HG2' ' A' ' 82' ' ' ARG . 1.7 t80 -134.71 95.57 3.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.155 -1.203 . . . . 0.0 110.001 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.809 ' CB ' HD21 ' A' ' 171' ' ' LEU . 0.6 OUTLIER -140.27 163.72 32.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.883 . . . . 0.0 110.415 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.604 ' O ' ' CD2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -131.08 158.82 39.37 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.327 -0.858 . . . . 0.0 110.095 179.661 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.53 ' N ' ' HB3' ' A' ' 173' ' ' MET . . . 51.72 -111.59 1.5 Allowed Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 21.2 tp -128.97 134.39 48.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.516 -0.99 . . . . 0.0 111.134 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.604 ' CD2' ' O ' ' A' ' 86' ' ' ARG . 88.6 m-70 -147.31 173.66 12.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.262 -0.899 . . . . 0.0 109.786 179.13 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.561 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -163.38 158.96 21.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.179 -0.95 . . . . 0.0 110.586 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.968 ' CE3' HG11 ' A' ' 169' ' ' VAL . 1.0 OUTLIER -134.61 170.63 15.51 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.281 -0.887 . . . . 0.0 109.29 179.557 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 1.0 ' OE2' HD12 ' A' ' 168' ' ' LEU . 6.7 mt-10 -147.82 145.27 28.67 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.178 -0.951 . . . . 0.0 110.748 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.533 ' HB ' HD12 ' A' ' 167' ' ' LEU . 6.3 mt -144.74 153.97 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.283 -0.885 . . . . 0.0 110.879 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.596 ' HB2' ' CB ' ' A' ' 213' ' ' ARG . 2.2 m -135.18 140.95 45.75 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.094 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.806 ' HZ2' ' N ' ' A' ' 105' ' ' VAL . 4.9 m95 -99.61 125.58 40.26 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.096 -1.003 . . . . 0.0 111.873 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.714 ' HB3' ' O ' ' A' ' 211' ' ' GLN . 49.4 Cg_endo -79.63 153.24 23.2 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.388 2.059 . . . . 0.0 111.569 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.829 ' C ' HD23 ' A' ' 97' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.481 0.658 . . . . 0.0 110.236 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 1.009 HG12 ' HA ' ' A' ' 134' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.973 HG22 HG23 ' A' ' 203' ' ' VAL . 2.2 t -127.79 170.16 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.929 -1.107 . . . . 0.0 111.368 -176.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.679 ' CA ' ' HA3' ' A' ' 132' ' ' GLY . . . -179.92 156.83 18.99 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 109.986 -1.245 . . . . 0.0 109.986 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.921 ' HB ' HD13 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -108.6 140.72 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.41 -1.053 . . . . 0.0 109.538 179.855 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.504 ' O ' ' HB3' ' A' ' 199' ' ' LEU . . . -109.85 140.39 43.85 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.227 -0.921 . . . . 0.0 110.738 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.833 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -119.46 130.41 55.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.453 -0.78 . . . . 0.0 110.324 179.809 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.73 -27.47 17.22 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.501 -0.749 . . . . 0.0 109.295 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.524 HD11 ' O ' ' A' ' 196' ' ' GLY . 0.9 OUTLIER -81.69 -12.3 58.71 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.535 -0.728 . . . . 0.0 109.587 179.474 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.543 ' CB ' ' HB2' ' A' ' 129' ' ' GLU . . . . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.553 -0.717 . . . . 0.0 110.235 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 110' ' ' THR . 14.7 m . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.26 0.552 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.543 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . 4.9 mm-40 -150.25 133.82 16.58 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.323 -0.861 . . . . 0.0 109.861 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.5 t -120.18 119.73 34.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 110.559 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -133.25 136.32 45.48 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.367 -0.833 . . . . 0.0 109.411 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.679 ' HA3' ' CA ' ' A' ' 107' ' ' GLY . . . -158.83 -163.47 13.04 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.436 -1.364 . . . . 0.0 110.309 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.677 ' CE3' ' CG ' ' A' ' 180' ' ' TYR . 24.6 m0 -115.77 113.12 23.01 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.477 -1.013 . . . . 0.0 110.197 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 1.009 ' HA ' HG12 ' A' ' 105' ' ' VAL . 2.1 p-10 -119.48 142.96 47.81 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.717 -0.614 . . . . 0.0 110.154 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.889 HD13 ' C ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 109.634 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.639 ' CG1' ' HB2' ' A' ' 167' ' ' LEU . 1.5 t . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.935 ' HD2' HG21 ' A' ' 182' ' ' ILE . 43.1 Cg_endo -70.56 178.52 4.98 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.859 1.452 . . . . 0.0 110.913 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.498 ' O ' ' HB3' ' A' ' 94' ' ' SER . 11.1 pt-20 -50.07 -18.34 0.54 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.477 -0.764 . . . . 0.0 110.826 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.475 ' O ' ' HG2' ' A' ' 164' ' ' PRO . 7.9 tpt180 -133.67 154.97 50.53 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.102 -0.999 . . . . 0.0 109.929 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 1.198 HD22 ' N ' ' A' ' 168' ' ' LEU . 0.0 OUTLIER -164.04 146.78 9.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.28 -0.888 . . . . 0.0 109.789 -179.802 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 1.198 ' N ' HD22 ' A' ' 167' ' ' LEU . 1.2 tt -125.77 131.19 52.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.142 -0.974 . . . . 0.0 110.611 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.968 HG11 ' CE3' ' A' ' 91' ' ' TRP . 97.2 t -89.52 156.92 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.395 -0.815 . . . . 0.0 109.805 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.64 HG11 HD21 ' A' ' 187' ' ' LEU . 22.4 t -134.55 112.1 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.165 -0.959 . . . . 0.0 110.155 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.888 HD22 ' CZ2' ' A' ' 91' ' ' TRP . 0.0 OUTLIER -132.39 122.48 25.07 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.287 -0.883 . . . . 0.0 109.791 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -120.15 139.13 53.08 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.244 -0.91 . . . . 0.0 109.942 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.53 ' HB3' ' N ' ' A' ' 87' ' ' GLY . 0.3 OUTLIER -93.05 -38.25 11.73 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.553 -0.717 . . . . 0.0 109.778 179.768 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 173' ' ' MET . 0.8 OUTLIER -43.11 -27.28 0.2 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 108.7 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.609 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.7 OUTLIER -114.59 -27.38 7.52 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.78 0.8 . . . . 0.0 108.876 179.157 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.428 ' O ' HG21 ' A' ' 198' ' ' THR . . . 84.68 22.54 53.15 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 108.706 -1.757 . . . . 0.0 108.706 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.961 HG22 ' CD2' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -115.53 133.72 55.76 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.288 -1.125 . . . . 0.0 111.376 -179.476 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.672 ' O ' HD11 ' A' ' 194' ' ' LEU . 0.1 OUTLIER -143.85 152.63 41.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.569 -0.707 . . . . 0.0 109.423 178.982 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.414 ' O ' HG13 ' A' ' 169' ' ' VAL . . . -161.67 -156.1 8.21 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 1.019 ' CE1' HD21 ' A' ' 167' ' ' LEU . 0.1 OUTLIER -125.65 138.34 53.9 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.27 -1.135 . . . . 0.0 108.904 -179.905 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.489 ' HB2' ' HB2' ' A' ' 187' ' ' LEU . 9.2 t -144.0 141.59 30.23 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.143 -0.973 . . . . 0.0 110.624 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.992 HD11 ' CD2' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -127.12 116.76 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.655 -0.653 . . . . 0.0 109.563 179.629 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 65.55 10.09 47.5 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 77.0 41.01 23.71 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' THR . . . . . 0.73 HG22 ' CE1' ' A' ' 186' ' ' TYR . 17.4 m -97.31 -47.56 5.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -1.142 . . . . 0.0 110.643 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.992 ' CD2' HD11 ' A' ' 182' ' ' ILE . 8.6 m-85 -112.08 85.55 2.17 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.097 -1.002 . . . . 0.0 110.683 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.64 HD21 HG11 ' A' ' 170' ' ' VAL . 0.9 OUTLIER -179.79 28.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.686 -0.634 . . . . 0.0 109.647 179.54 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -94.88 -89.52 1.72 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.448 ' C ' ' H ' ' A' ' 191' ' ' PHE . 49.6 Cg_endo -74.24 -21.02 18.17 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 124.18 1.621 . . . . 0.0 111.21 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.578 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -66.31 15.2 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.527 -0.733 . . . . 0.0 111.877 -178.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.624 ' CE1' ' HG ' ' A' ' 187' ' ' LEU . 1.1 m-30 -90.51 -28.07 18.78 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.854 -1.154 . . . . 0.0 111.146 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' ARG . . . . . 0.533 ' HA ' ' NE ' ' A' ' 192' ' ' ARG . 0.1 OUTLIER -86.52 -13.13 46.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.949 -1.094 . . . . 0.0 110.744 -179.5 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -107.48 -13.04 21.77 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.961 ' CD2' HG22 ' A' ' 177' ' ' THR . 9.2 tt -72.17 -40.54 67.89 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.572 -0.958 . . . . 0.0 109.012 179.161 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.512 ' HD2' ' N ' ' A' ' 196' ' ' GLY . 0.0 OUTLIER -44.12 -40.25 4.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.215 -0.928 . . . . 0.0 109.869 179.583 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.524 ' O ' HD11 ' A' ' 112' ' ' LEU . . . -86.27 -26.82 32.4 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.866 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.62 -4.38 56.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.686 -0.891 . . . . 0.0 109.905 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 198' ' ' THR . . . . . 0.8 HG23 HD23 ' A' ' 194' ' ' LEU . 0.8 OUTLIER -43.85 132.08 5.32 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.739 0.78 . . . . 0.0 111.732 -178.441 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.921 HD13 ' HB ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -140.68 171.01 14.7 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.656 -0.652 . . . . 0.0 109.444 179.254 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.486 ' CZ ' ' HA3' ' A' ' 83' ' ' GLY . 0.1 OUTLIER -85.98 128.93 56.12 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 120.909 -1.119 . . . . 0.0 109.84 179.358 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.58 ' CA ' HG13 ' A' ' 108' ' ' VAL . 51.0 Cg_endo -85.91 129.16 3.4 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.995 1.524 . . . . 0.0 111.396 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.459 ' O ' HG13 ' A' ' 106' ' ' VAL . 24.5 t -133.46 142.87 48.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.297 -0.877 . . . . 0.0 109.585 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.973 HG23 HG22 ' A' ' 106' ' ' VAL . 7.4 p -122.35 153.96 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.825 -1.172 . . . . 0.0 111.43 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 15.1 p -149.58 145.39 26.78 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -150.26 167.36 27.19 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.765 -1.209 . . . . 0.0 112.059 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.512 HG13 ' N ' ' A' ' 207' ' ' TRP . 0.3 OUTLIER -69.48 -176.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 121.639 0.733 . . . . 0.0 111.31 -179.02 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 0.745 ' CZ2' HG13 ' A' ' 71' ' ' VAL . 22.7 p-90 -129.78 -5.12 4.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.672 -0.642 . . . . 0.0 109.823 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 207' ' ' TRP . . . -51.72 -168.97 0.01 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 209' ' ' GLN . . . . . 0.764 ' O ' ' O ' ' A' ' 210' ' ' CYS . 0.5 OUTLIER -79.67 -51.61 9.02 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.467 -1.02 . . . . 0.0 110.864 -179.562 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 210' ' ' CYS . . . . . 0.764 ' O ' ' O ' ' A' ' 209' ' ' GLN . 26.4 p 0.99 -129.18 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 121.07 0.462 . . . . 0.0 111.422 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.714 ' O ' ' HB3' ' A' ' 96' ' ' PRO . 0.0 OUTLIER 178.64 93.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.766 -1.209 . . . . 0.0 111.054 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.652 ' HB ' ' CZ ' ' A' ' 66' ' ' PHE . 3.1 t -87.05 123.09 39.67 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 O-C-N 121.381 -0.825 . . . . 0.0 108.84 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' ARG . . . . . 0.596 ' CB ' ' HB2' ' A' ' 94' ' ' SER . 2.0 tpp85 -89.85 147.36 23.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.097 -1.002 . . . . 0.0 110.52 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.604 HD12 ' HB3' ' A' ' 48' ' ' TRP . 1.1 mt -144.33 128.46 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 110.474 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.666 ' O ' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -130.59 108.22 9.77 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.297 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 216' ' ' TYR . . . . . 0.726 ' CZ ' ' CD1' ' A' ' 91' ' ' TRP . 3.6 t80 -119.02 144.98 46.23 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.249 -0.907 . . . . 0.0 111.233 -178.037 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 217' ' ' MET . . . . . 0.46 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 1.2 ttp -136.59 108.45 7.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.561 -0.712 . . . . 0.0 110.05 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 130.74 70.34 0.11 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.261 -1.141 . . . . 0.0 110.199 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.794 HD21 HD21 ' A' ' 56' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.244 0.545 . . . . 0.0 110.026 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.617 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 8.7 mt-10 -52.18 -35.9 50.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.066 -1.021 . . . . 0.0 108.997 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.65 -25.42 60.17 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 0.5 OUTLIER -82.03 -35.74 28.48 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.707 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.886 HD12 ' C ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -77.87 -38.92 44.86 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.91 0.862 . . . . 0.0 108.873 178.884 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.564 ' O ' ' O ' ' A' ' 35' ' ' ALA . 23.2 t -57.58 -14.31 5.1 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.318 0.58 . . . . 0.0 110.25 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 1.067 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -52.61 -161.26 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.402 -0.811 . . . . 0.0 109.942 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 1.067 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 38.6 Cg_endo -65.8 118.37 5.43 Favored 'Trans proline' 0 C--N 1.315 -1.214 0 O-C-N 123.008 1.004 . . . . 0.0 109.647 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.677 ' CB ' HG21 ' A' ' 41' ' ' VAL . 45.7 Cg_endo -71.35 108.44 2.37 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.28 1.674 . . . . 0.0 112.162 -178.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.761 ' O ' ' N ' ' A' ' 40' ' ' LEU . 50.7 Cg_endo -81.98 151.97 16.49 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.23 1.648 . . . . 0.0 108.676 178.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.701 ' CG ' ' NE2' ' A' ' 43' ' ' GLN . 3.1 t0 -21.49 -41.89 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.311 -0.868 . . . . 0.0 109.806 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.127 HD13 ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -37.84 -50.06 1.24 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 122.012 -0.43 . . . . 0.0 109.875 179.919 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 1.127 ' N ' HD13 ' A' ' 40' ' ' LEU . 13.8 t -62.03 -26.92 41.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.683 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.611 ' N ' ' O ' ' A' ' 39' ' ' ASP . . . -89.06 -44.79 10.11 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.166 -0.958 . . . . 0.0 111.073 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.701 ' NE2' ' CG ' ' A' ' 39' ' ' ASP . 2.2 mt-30 -79.05 -25.28 43.17 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 118.405 -1.318 . . . . 0.0 108.648 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.741 ' CB ' ' O ' ' A' ' 40' ' ' LEU . 9.1 ttp180 -61.39 -52.87 62.81 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 122.343 1.068 . . . . 0.0 108.198 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.726 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 2.1 m-70 -60.93 -18.0 54.4 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.989 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -96.87 -30.07 13.35 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 118.207 -1.397 . . . . 0.0 111.648 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.91 ' O ' HD13 ' A' ' 214' ' ' ILE . . . -109.2 -67.12 0.58 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 107.605 -2.198 . . . . 0.0 107.605 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.784 ' CH2' ' N ' ' A' ' 61' ' ' GLU 0.265 0.1 OUTLIER -96.2 71.02 2.81 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.316 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.708 ' OD1' ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -60.26 112.53 5.62 Favored Pre-proline 0 N--CA 1.491 1.616 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.487 -178.809 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.667 ' CD ' ' HE3' ' A' ' 51' ' ' LYS . 44.5 Cg_endo -74.74 0.38 8.84 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 124.535 1.808 . . . . 0.0 112.024 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.913 ' CE ' ' N ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -64.57 -19.72 65.81 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 178.703 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.77 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 8.6 m-20 -133.34 -2.29 3.12 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 114.149 -1.387 . . . . 0.0 107.856 178.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.591 ' HB3' ' HA ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -113.34 152.11 30.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.571 -0.706 . . . . 0.0 110.058 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.513 ' OG ' HG12 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -68.06 104.42 1.76 Allowed 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.13 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.705 ' HG3' HD22 ' A' ' 33' ' ' LEU . 26.1 pt-20 -67.81 -17.01 64.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.105 -0.997 . . . . 0.0 109.064 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.81 ' HB3' HG23 ' A' ' 75' ' ' THR . 9.5 m120 -33.36 -32.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.678 0.752 . . . . 0.0 110.346 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.706 ' HB ' ' O ' ' A' ' 67' ' ' GLU . 9.0 pt -112.92 166.96 6.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.616 -0.677 . . . . 0.0 110.01 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.577 ' O ' ' N ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -107.13 117.11 33.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.247 -0.908 . . . . 0.0 109.372 -179.362 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.955 HG21 ' CD1' ' A' ' 66' ' ' PHE . 2.6 p -124.52 120.36 58.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 O-C-N 121.445 -0.785 . . . . 0.0 111.463 -178.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.694 ' HG2' ' N ' ' A' ' 61' ' ' GLU . 6.6 tttt -137.4 159.54 41.66 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.534 -0.729 . . . . 0.0 110.27 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.784 ' N ' ' CH2' ' A' ' 48' ' ' TRP . 1.2 tt0 -45.45 -106.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.596 -0.69 . . . . 0.0 110.535 -179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.569 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 35.7 33.76 0.06 OUTLIER Glycine 0 N--CA 1.493 2.487 0 N-CA-C 108.141 -1.984 . . . . 0.0 108.141 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.69 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 107.8 62.83 0.56 Allowed Glycine 0 N--CA 1.485 1.927 0 N-CA-C 108.01 -2.036 . . . . 0.0 108.01 -178.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.712 HD13 ' HE1' ' A' ' 48' ' ' TRP . 0.4 OUTLIER 1.18 80.64 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.899 -0.765 . . . . 0.0 110.724 -179.324 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.429 ' N ' ' O ' ' A' ' 63' ' ' GLY . 17.3 p -141.17 136.92 32.3 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 118.418 -1.313 . . . . 0.0 112.176 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.955 ' CD1' HG21 ' A' ' 59' ' ' VAL . 17.9 m-85 -89.34 165.32 14.45 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.706 ' O ' ' HB ' ' A' ' 57' ' ' ILE . 5.5 tm-20 -136.94 121.01 17.76 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.91 -1.119 . . . . 0.0 109.944 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.561 ' CD ' ' O ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -126.32 148.71 49.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.237 -0.915 . . . . 0.0 109.977 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.75 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 1.7 mtm180 -104.93 -78.93 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.024 -1.048 . . . . 0.0 110.454 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.75 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 57.6 Cg_endo -75.08 -152.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.163 1.086 . . . . 0.0 109.368 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.686 HG13 ' CZ2' ' A' ' 207' ' ' TRP . 2.4 t -140.76 162.55 22.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 1.014 ' HB3' ' CB ' ' A' ' 75' ' ' THR . . . 179.85 175.87 0.75 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.932 -1.105 . . . . 0.0 110.621 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.464 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 1.6 pt20 -66.19 -115.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.385 -0.822 . . . . 0.0 110.31 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 73' ' ' GLN . 11.5 p -41.78 -27.1 0.1 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.195 -0.941 . . . . 0.0 110.225 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . 1.014 ' CB ' ' HB3' ' A' ' 72' ' ' ALA . 22.6 m -44.29 -28.51 0.54 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.879 . . . . 0.0 110.028 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.651 ' CB ' ' CD1' ' A' ' 207' ' ' TRP . 12.4 p30 -112.68 155.46 24.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.887 . . . . 0.0 109.992 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.496 ' HA2' ' O ' ' A' ' 205' ' ' ALA . . . 79.86 123.93 0.47 Allowed Glycine 0 N--CA 1.484 1.899 0 N-CA-C 106.886 -2.485 . . . . 0.0 106.886 -178.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.572 ' HB ' ' CB ' ' A' ' 53' ' ' CYS . 1.2 m -117.74 161.85 16.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 120.851 -1.382 . . . . 0.0 110.939 -178.4 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.77 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -119.5 173.5 6.95 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.015 179.128 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.724 ' HA3' HG12 ' A' ' 203' ' ' VAL . . . -149.47 48.44 0.6 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.508 ' HA ' ' CB ' ' A' ' 202' ' ' SER . 22.7 ttpp -81.95 76.28 8.85 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -1.101 . . . . 0.0 109.985 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.502 ' CG ' ' OD2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -141.47 -91.03 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.381 -0.825 . . . . 0.0 110.064 -179.921 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.421 ' H ' ' CD ' ' A' ' 82' ' ' ARG . . . 49.11 62.69 4.47 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.487 ' CD2' ' O ' ' A' ' 84' ' ' TYR . 52.3 t80 -94.46 96.06 9.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -1.148 . . . . 0.0 109.995 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 218' ' ' GLY . 0.1 OUTLIER -132.13 153.91 50.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.888 . . . . 0.0 110.263 -179.853 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.567 ' HA ' ' CB ' ' A' ' 173' ' ' MET . 46.5 ttp180 -114.72 176.43 5.05 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.321 -0.862 . . . . 0.0 109.779 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.563 ' N ' ' CG ' ' A' ' 86' ' ' ARG . . . 46.78 -111.22 0.66 Allowed Glycine 0 N--CA 1.485 1.959 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.725 ' O ' ' CD2' ' A' ' 89' ' ' HIS . 5.9 tt -129.08 126.83 40.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.478 -1.013 . . . . 0.0 110.751 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.725 ' CD2' ' O ' ' A' ' 88' ' ' LEU . 33.5 m170 -147.41 173.69 12.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.792 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.51 155.31 17.29 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.347 -0.846 . . . . 0.0 110.263 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 1.211 ' CZ2' HG11 ' A' ' 169' ' ' VAL . 1.2 p90 -135.05 171.12 14.87 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.199 -0.938 . . . . 0.0 110.064 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.571 ' N ' ' O ' ' A' ' 215' ' ' ARG . 2.9 tp10 -132.93 142.63 48.99 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.538 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.753 HG23 ' OH ' ' A' ' 180' ' ' TYR . 0.3 OUTLIER -144.78 138.36 22.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.215 -0.928 . . . . 0.0 110.961 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.568 ' CB ' ' HB3' ' A' ' 213' ' ' ARG . 0.7 OUTLIER -117.75 137.3 52.8 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.724 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.578 ' HH2' ' O ' ' A' ' 204' ' ' SER . 46.9 t-105 -116.0 87.89 20.21 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.046 -1.034 . . . . 0.0 111.631 -178.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 94' ' ' SER . 52.4 Cg_endo -98.16 109.35 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 121.862 1.708 . . . . 0.0 110.046 178.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.443 HD22 ' HA ' ' A' ' 97' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 O-C-N 120.662 -1.274 . . . . 0.0 110.417 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 1.175 HG22 ' O ' ' A' ' 204' ' ' SER . 1.2 m . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 121.674 0.75 . . . . 0.0 109.27 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.996 HG13 ' O ' ' A' ' 202' ' ' SER . 78.3 t -135.71 152.26 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 120.999 -1.063 . . . . 0.0 109.926 -178.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.536 ' HA2' ' HA2' ' A' ' 132' ' ' GLY . . . -141.52 135.52 6.86 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.06 HG12 HD12 ' A' ' 199' ' ' LEU . 1.3 t -125.79 131.62 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.435 -1.038 . . . . 0.0 108.319 179.033 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.667 ' HB1' ' HA ' ' A' ' 130' ' ' SER . . . -150.12 149.49 30.33 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.073 -1.017 . . . . 0.0 111.52 -178.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.735 HG23 ' HB3' ' A' ' 199' ' ' LEU . 0.6 OUTLIER -89.47 112.08 23.14 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 122.209 1.004 . . . . 0.0 109.897 178.977 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 110' ' ' THR 0.294 . . -32.77 -53.42 0.34 Allowed 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.976 179.161 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.768 ' HB2' ' HB3' ' A' ' 128' ' ' SER . 0.0 OUTLIER -43.7 -26.31 0.23 Allowed 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.448 -178.72 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.655 ' N ' ' O ' ' A' ' 110' ' ' THR . . . . . . . . 0 N--CA 1.494 1.769 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.288 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.768 ' HB3' ' HB2' ' A' ' 112' ' ' LEU . 2.4 p . . . . . 0 N--CA 1.501 2.079 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.729 ' N ' ' OG1' ' A' ' 110' ' ' THR . 2.6 tt0 -152.22 160.71 43.32 Favored 'General case' 0 C--N 1.308 -1.229 0 O-C-N 120.323 -1.485 . . . . 0.0 111.213 -178.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.667 ' HA ' ' HB1' ' A' ' 109' ' ' ALA . 2.5 t -134.25 126.39 29.72 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.876 -0.515 . . . . 0.0 109.76 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' TRP . . . . . 0.479 ' CB ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -133.14 155.16 49.8 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 120.929 -1.107 . . . . 0.0 109.855 -179.873 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.536 ' HA2' ' HA2' ' A' ' 107' ' ' GLY . . . -141.58 133.67 5.87 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.857 ' CZ3' HG21 ' A' ' 108' ' ' VAL . 3.8 m0 -104.9 113.53 27.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -1.166 . . . . 0.0 109.689 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.615 ' O ' HG23 ' A' ' 135' ' ' ILE . 0.3 OUTLIER -118.48 148.19 42.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.133 -0.979 . . . . 0.0 110.428 -179.843 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.615 HG23 ' O ' ' A' ' 134' ' ' ASP . 3.7 pt . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.316 -0.865 . . . . 0.0 110.11 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.865 HG13 ' HD2' ' A' ' 164' ' ' PRO . 42.4 t . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.865 ' HD2' HG13 ' A' ' 163' ' ' VAL . 40.0 Cg_endo -67.01 125.43 13.61 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.656 1.345 . . . . 0.0 110.495 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 94' ' ' SER . 1.4 tt0 -41.05 -24.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.423 -0.798 . . . . 0.0 110.642 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' ' 164' ' ' PRO . 9.7 ttt85 -111.27 137.58 48.82 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.173 -0.954 . . . . 0.0 109.783 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.836 HD21 ' CG1' ' A' ' 163' ' ' VAL . 3.0 mp -138.47 146.31 41.9 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.463 -0.773 . . . . 0.0 110.411 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.438 HD12 ' OE1' ' A' ' 92' ' ' GLU . 0.7 OUTLIER -116.93 124.51 49.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.495 179.636 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 1.211 HG11 ' CZ2' ' A' ' 91' ' ' TRP . 2.5 t -114.92 139.76 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.073 -1.017 . . . . 0.0 110.683 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 170' ' ' VAL . 9.3 p -118.32 124.93 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.578 -0.701 . . . . 0.0 110.062 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.58 ' CD1' ' HB3' ' A' ' 178' ' ' LEU . 9.3 tp -133.37 111.29 10.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.135 -0.978 . . . . 0.0 110.154 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.524 ' OD2' ' CB ' ' A' ' 88' ' ' LEU . 6.5 t70 -116.27 138.31 51.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.296 -0.877 . . . . 0.0 110.14 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.567 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -94.64 -44.38 7.85 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.71 -0.619 . . . . 0.0 110.041 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.491 ' C ' ' O ' ' A' ' 173' ' ' MET . 2.7 mt-10 -40.19 -28.52 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.115 -0.99 . . . . 0.0 108.791 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.646 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.4 OUTLIER -111.56 -25.15 9.71 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.901 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.597 ' O ' ' CG2' ' A' ' 198' ' ' THR . . . 77.18 24.94 64.97 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' THR . . . . . 1.081 HG22 ' CD2' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -113.14 134.91 54.33 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.293 -1.122 . . . . 0.0 111.12 -179.429 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 1.092 ' O ' HD11 ' A' ' 194' ' ' LEU . 0.6 OUTLIER -142.54 154.13 44.19 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.655 -0.653 . . . . 0.0 109.815 179.265 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -162.11 162.17 34.0 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 1.031 ' CD1' HG22 ' A' ' 169' ' ' VAL . 1.1 t80 -118.68 121.77 40.92 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.459 -1.024 . . . . 0.0 109.657 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.476 ' OG ' HD23 ' A' ' 187' ' ' LEU . 0.3 OUTLIER -144.26 139.7 28.79 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.267 -0.895 . . . . 0.0 110.349 -179.67 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.637 HG22 ' HA ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -102.78 116.72 47.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.37 -0.831 . . . . 0.0 109.666 179.553 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 88.69 -9.13 77.33 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.535 ' HA2' ' CD2' ' A' ' 187' ' ' LEU . . . 86.21 43.61 6.21 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 70.2 m -114.35 -25.32 8.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.287 -1.125 . . . . 0.0 110.618 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.465 ' CE2' HD11 ' A' ' 182' ' ' ILE . 21.2 m-85 -107.97 69.1 0.72 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.172 -0.955 . . . . 0.0 110.42 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.576 ' HB2' ' CE1' ' A' ' 191' ' ' PHE . 0.9 OUTLIER -173.5 26.21 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.748 0.785 . . . . 0.0 109.497 179.719 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -94.64 -81.62 1.54 Allowed Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.033 -1.08 . . . . 0.0 110.7 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.15 -30.05 16.65 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.997 1.525 . . . . 0.0 111.307 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.584 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -74.06 13.78 0.5 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.312 -0.868 . . . . 0.0 111.234 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.576 ' CE1' ' HB2' ' A' ' 187' ' ' LEU . 1.2 m-30 -90.73 -26.79 19.35 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.018 -1.051 . . . . 0.0 110.416 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.62 -13.27 49.2 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.303 -0.873 . . . . 0.0 110.253 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 197' ' ' ARG . . . -108.17 -6.15 32.05 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.166 -1.974 . . . . 0.0 108.166 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 1.092 HD11 ' O ' ' A' ' 178' ' ' LEU . 7.6 tt -77.64 -41.44 38.38 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.51 ' CA ' HG23 ' A' ' 198' ' ' THR . 1.6 ttmt -43.79 -45.89 7.47 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.761 -0.587 . . . . 0.0 110.163 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -83.54 -24.51 50.19 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.698 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -91.12 -3.8 56.77 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.658 -0.907 . . . . 0.0 110.035 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 198' ' ' THR . . . . . 0.75 HG23 ' O ' ' A' ' 194' ' ' LEU . 21.8 p -42.98 112.81 0.4 Allowed 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.641 0.734 . . . . 0.0 111.86 -177.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 1.06 HD12 HG12 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -140.44 171.0 14.76 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.713 -0.617 . . . . 0.0 109.647 178.738 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 11.0 m-85 -84.7 129.23 57.79 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.07 -1.019 . . . . 0.0 110.741 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.814 ' CA ' HG13 ' A' ' 108' ' ' VAL . 51.4 Cg_endo -88.62 146.4 5.9 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 124.179 1.62 . . . . 0.0 110.985 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.996 ' O ' HG13 ' A' ' 106' ' ' VAL . 11.8 p -133.86 157.08 46.86 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.232 -0.918 . . . . 0.0 110.606 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.724 HG12 ' HA3' ' A' ' 80' ' ' GLY . 7.4 p -119.46 157.1 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.076 -1.015 . . . . 0.0 109.693 178.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' SER . . . . . 1.175 ' O ' HG22 ' A' ' 105' ' ' VAL . 0.9 OUTLIER -160.3 156.06 25.75 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 120.922 -1.112 . . . . 0.0 110.623 179.47 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.496 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -150.39 164.74 35.08 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.729 0.776 . . . . 0.0 111.02 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.649 HG13 ' N ' ' A' ' 207' ' ' TRP . 1.2 t -60.06 -179.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 121.344 0.592 . . . . 0.0 111.32 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 0.686 ' CZ2' HG13 ' A' ' 71' ' ' VAL . 4.3 t90 -26.19 -55.91 0.07 Allowed 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.288 0.566 . . . . 0.0 110.919 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 209' ' ' GLN . . . 138.73 -1.74 2.64 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 209' ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' ' 208' ' ' GLY . 1.6 tt0 -42.84 -29.92 0.36 Allowed 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.419 -1.048 . . . . 0.0 109.698 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' CYS . . . . . 0.506 ' C ' ' CG ' ' A' ' 211' ' ' GLN . 28.9 p -94.91 -131.79 0.16 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.433 -0.792 . . . . 0.0 109.855 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.506 ' CG ' ' C ' ' A' ' 210' ' ' CYS . 0.0 OUTLIER -178.59 112.67 0.06 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.933 . . . . 0.0 110.2 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.69 ' O ' HD11 ' A' ' 64' ' ' LEU . 33.9 m -89.63 139.55 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.277 -0.89 . . . . 0.0 109.765 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' ARG . . . . . 0.576 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -88.9 135.6 33.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.124 -0.985 . . . . 0.0 109.213 179.676 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.91 HD13 ' O ' ' A' ' 47' ' ' GLY . 0.8 OUTLIER -144.51 112.43 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 120.99 -1.069 . . . . 0.0 111.559 -178.707 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.571 ' O ' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -118.02 108.42 15.22 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.061 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 216' ' ' TYR . . . . . 0.678 ' CD2' ' CB ' ' A' ' 91' ' ' TRP . 2.1 t80 -106.11 149.14 27.03 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.188 -0.945 . . . . 0.0 111.648 -177.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 217' ' ' MET . . . . . 0.425 ' N ' ' HD1' ' A' ' 216' ' ' TYR . 36.1 ttp -129.72 107.63 9.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.72 -0.613 . . . . 0.0 109.56 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 218' ' ' GLY . . . . . 0.466 ' O ' ' OG ' ' A' ' 85' ' ' SER . . . 108.7 63.73 0.55 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 . . . . . 0 N--CA 1.494 1.759 0 O-C-N 121.195 -1.18 . . . . 0.0 110.012 179.881 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.612 ' O ' ' N ' ' A' ' 32' ' ' LEU . 1.1 pt? . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.182 0.515 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.857 ' HA ' HD23 ' A' ' 33' ' ' LEU . 59.9 mt-10 -46.66 -26.86 1.0 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.053 -1.03 . . . . 0.0 108.704 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -70.99 -22.21 62.2 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.612 ' N ' ' O ' ' A' ' 29' ' ' LEU . 14.7 tp -83.57 -34.86 25.09 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.06 HD22 ' HB2' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -70.41 -36.56 74.1 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.884 0.849 . . . . 0.0 109.057 179.122 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.597 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 2.9 t -70.48 -14.24 62.45 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.423 0.63 . . . . 0.0 109.945 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 1.023 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -54.45 -160.73 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.511 -0.743 . . . . 0.0 109.967 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 1.023 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 38.2 Cg_endo -65.55 -166.55 0.1 OUTLIER 'Trans proline' 0 N--CA 1.489 1.22 0 O-C-N 123.188 1.099 . . . . 0.0 110.022 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.722 ' CD ' ' HB2' ' A' ' 36' ' ' PRO . 51.2 Cg_endo -96.67 54.42 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 121.394 1.396 . . . . 0.0 113.183 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.739 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 51.7 Cg_endo -76.46 151.06 32.75 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 122.93 0.963 . . . . 0.0 109.761 178.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.818 ' CG ' HE22 ' A' ' 43' ' ' GLN . 0.0 OUTLIER -13.89 -54.41 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.53 -0.731 . . . . 0.0 112.072 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.954 ' O ' ' HB3' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -51.86 -46.56 64.49 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.933 -1.104 . . . . 0.0 110.959 -179.502 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.842 HG13 ' CE1' ' A' ' 45' ' ' HIS . 11.9 t -86.11 -19.14 8.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 O-C-N 121.52 -0.738 . . . . 0.0 111.639 -177.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 46' ' ' HIS . . . -88.95 -41.49 12.36 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.667 -1.271 . . . . 0.0 111.197 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.818 HE22 ' CG ' ' A' ' 39' ' ' ASP . 1.0 OUTLIER -87.65 -19.43 27.72 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 118.848 -1.141 . . . . 0.0 109.426 179.832 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.954 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -77.73 -38.02 48.07 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.113 0.959 . . . . 0.0 108.865 179.276 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.842 ' CE1' HG13 ' A' ' 41' ' ' VAL . 1.2 m80 -80.81 -18.2 48.32 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.429 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.479 ' HB2' ' O ' ' A' ' 42' ' ' ALA . 1.0 OUTLIER -97.42 -34.18 11.13 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.194 -0.941 . . . . 0.0 109.465 178.625 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.617 ' O ' ' CD1' ' A' ' 214' ' ' ILE . . . -68.18 -114.94 0.02 OUTLIER Glycine 0 N--CA 1.489 2.198 0 N-CA-C 107.299 -2.32 . . . . 0.0 107.299 178.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 1.105 ' CZ2' ' HA ' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -85.63 87.86 7.46 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 176.924 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.891 HD22 ' HB2' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -42.72 153.17 0.33 Allowed Pre-proline 0 N--CA 1.492 1.652 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -177.952 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.657 ' HA ' ' O ' ' A' ' 53' ' ' CYS . 43.7 Cg_endo -70.38 -31.05 18.47 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 O-C-N 124.773 1.933 . . . . 0.0 110.952 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.891 ' HB2' HD22 ' A' ' 49' ' ' ASN . 0.0 OUTLIER -62.37 0.13 0.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.36 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.792 ' HB3' HG11 ' A' ' 203' ' ' VAL . 12.9 m-20 -141.87 2.92 1.59 Allowed 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.112 178.271 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.874 ' HA ' ' N ' ' A' ' 79' ' ' ARG . 1.6 t -150.69 147.74 27.72 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.377 -0.827 . . . . 0.0 111.545 -179.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.946 ' H ' ' HA ' ' A' ' 78' ' ' VAL . 0.7 OUTLIER -86.92 121.78 29.86 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 120.903 -1.123 . . . . 0.0 109.824 178.648 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 1.06 ' HB2' HD22 ' A' ' 33' ' ' LEU . 1.1 pt-20 -44.77 -35.27 2.63 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.489 -0.757 . . . . 0.0 112.976 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.6 ' OD1' HG21 ' A' ' 75' ' ' THR . 0.2 OUTLIER -32.48 -20.52 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.54 0 O-C-N 121.29 -0.882 . . . . 0.0 111.379 -179.217 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.04 HD11 ' CB ' ' A' ' 207' ' ' TRP . 1.6 mt -111.18 167.18 5.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.307 -0.87 . . . . 0.0 110.131 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.507 ' N ' ' CG2' ' A' ' 57' ' ' ILE . 36.0 t70 -108.54 128.55 54.91 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.376 -0.828 . . . . 0.0 110.357 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 1.037 ' HB ' ' CE2' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -131.28 132.03 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.577 -0.702 . . . . 0.0 111.099 -179.075 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.719 ' HA ' ' HB2' ' A' ' 43' ' ' GLN . 24.6 tttt -136.58 130.7 32.74 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.804 -1.185 . . . . 0.0 110.101 178.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.589 ' H ' ' HB3' ' A' ' 43' ' ' GLN . 1.6 pt-20 -52.58 -117.25 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.442 -0.786 . . . . 0.0 111.079 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 45.69 41.39 9.72 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 107.998 -2.041 . . . . 0.0 107.998 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.698 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 98.81 74.09 1.13 Allowed Glycine 0 N--CA 1.487 2.07 0 N-CA-C 108.293 -1.923 . . . . 0.0 108.293 -178.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.698 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER 0.84 75.38 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.758 -0.848 . . . . 0.0 110.887 -178.967 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.546 ' N ' ' O ' ' A' ' 63' ' ' GLY . 53.7 t -101.61 114.64 28.86 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.312 -0.868 . . . . 0.0 110.491 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 1.105 ' HA ' ' CZ2' ' A' ' 48' ' ' TRP . 1.6 m-85 -82.68 138.03 34.26 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.395 -0.816 . . . . 0.0 110.268 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.507 ' O ' HG23 ' A' ' 57' ' ' ILE . 1.8 tt0 -138.2 121.77 17.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.16 -0.962 . . . . 0.0 109.913 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.488 ' HG3' ' HB2' ' A' ' 207' ' ' TRP . 0.6 OUTLIER -131.17 145.74 52.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.181 -0.95 . . . . 0.0 110.343 -179.87 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.628 ' HB3' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -125.1 -67.52 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.361 -0.837 . . . . 0.0 110.317 179.789 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.628 ' CD ' ' HB3' ' A' ' 69' ' ' ARG . 55.9 Cg_endo -69.7 -141.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.385 1.203 . . . . 0.0 109.133 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.447 ' H ' ' HB2' ' A' ' 70' ' ' PRO . 3.5 t -139.74 164.0 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.053 -1.029 . . . . 0.0 110.045 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.6 119.35 6.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.129 -0.982 . . . . 0.0 110.136 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -84.99 -93.62 0.08 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.178 -0.951 . . . . 0.0 110.267 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.9 p -104.19 23.38 13.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.145 -0.972 . . . . 0.0 110.133 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.637 HG21 ' HB3' ' A' ' 54' ' ' SER . 3.4 t -141.5 -134.84 0.1 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.307 -0.871 . . . . 0.0 110.088 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.733 ' O ' ' C ' ' A' ' 77' ' ' GLY . 4.9 m-20 -140.55 153.62 46.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 110.868 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.733 ' C ' ' O ' ' A' ' 76' ' ' ASP . . . -26.48 -62.28 0.08 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 106.067 -2.813 . . . . 0.0 106.067 179.025 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.959 ' CG2' ' HB3' ' A' ' 205' ' ' ALA . 29.0 m -148.92 118.75 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 122.108 -0.643 . . . . 0.0 109.327 176.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.874 ' N ' ' HA ' ' A' ' 53' ' ' CYS . 0.0 OUTLIER -146.6 137.01 23.81 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.687 -0.633 . . . . 0.0 110.681 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.83 ' HA3' ' C ' ' A' ' 51' ' ' LYS . . . -163.38 156.03 27.65 Favored Glycine 0 N--CA 1.481 1.636 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 178.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 201' ' ' PRO . 0.2 OUTLIER -143.66 128.55 18.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.345 -1.091 . . . . 0.0 110.152 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.796 ' HD3' ' H ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -150.35 -95.64 0.07 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.194 -0.941 . . . . 0.0 110.226 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.796 ' H ' ' HD3' ' A' ' 82' ' ' ARG . . . 47.84 63.98 3.22 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -119.16 95.49 4.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.134 -1.216 . . . . 0.0 110.255 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.58 ' HB3' ' CD2' ' A' ' 89' ' ' HIS . 1.0 OUTLIER -140.3 169.37 17.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.249 -0.907 . . . . 0.0 110.098 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.561 ' O ' ' NE2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -117.37 133.48 55.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 110.128 179.792 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 103.76 -117.19 5.63 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.706 ' C ' HD23 ' A' ' 88' ' ' LEU . 7.6 tt -128.64 127.0 41.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.398 -1.06 . . . . 0.0 110.39 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.58 ' CD2' ' HB3' ' A' ' 85' ' ' SER . 8.5 m-70 -147.05 161.43 40.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.165 -0.959 . . . . 0.0 110.215 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.677 ' HB1' ' O ' ' A' ' 169' ' ' VAL . . . -163.52 157.87 20.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.22 -0.925 . . . . 0.0 109.857 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 1.142 ' CZ2' HG11 ' A' ' 169' ' ' VAL . 3.0 p90 -134.79 160.25 38.8 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.065 -1.022 . . . . 0.0 110.403 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.643 ' N ' ' O ' ' A' ' 215' ' ' ARG . 31.3 mt-10 -119.11 121.17 39.18 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.339 0.59 . . . . 0.0 110.648 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.538 HG12 ' HA ' ' A' ' 214' ' ' ILE . 5.3 mt -135.01 149.33 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.215 -0.928 . . . . 0.0 110.168 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.584 ' OG ' ' NH2' ' A' ' 213' ' ' ARG . 0.0 OUTLIER -121.17 135.84 55.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 109.654 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.898 ' HH2' ' O ' ' A' ' 204' ' ' SER . 6.1 t-105 -115.72 87.88 19.01 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.246 -0.909 . . . . 0.0 110.303 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 94' ' ' SER . 51.0 Cg_endo -97.47 114.06 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.156 1.904 . . . . 0.0 110.967 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 O-C-N 120.895 -1.128 . . . . 0.0 109.523 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 1.235 HG13 ' O ' ' A' ' 204' ' ' SER . 0.5 OUTLIER . . . . . 0 N--CA 1.477 0.893 0 CA-C-O 121.482 0.658 . . . . 0.0 109.981 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.679 HG22 ' CZ3' ' A' ' 95' ' ' TRP . 9.7 t -152.49 136.94 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.476 -0.765 . . . . 0.0 109.698 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.519 ' HA3' ' HA3' ' A' ' 132' ' ' GLY . . . 154.07 -146.12 14.04 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 118.895 -1.621 . . . . 0.0 110.559 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.041 HG23 ' C ' ' A' ' 200' ' ' TYR . 2.7 p -149.76 156.93 6.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.689 -0.889 . . . . 0.0 109.597 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.538 ' C ' ' HB3' ' A' ' 199' ' ' LEU . . . -146.41 153.34 40.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.059 -1.025 . . . . 0.0 111.104 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.931 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -110.72 128.61 55.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.468 -0.77 . . . . 0.0 109.738 179.529 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.6 -26.22 17.97 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.31 -0.869 . . . . 0.0 109.726 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.671 ' C ' HD12 ' A' ' 112' ' ' LEU . 4.1 pp -84.88 -11.94 54.55 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.417 -0.802 . . . . 0.0 109.481 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.592 ' HB3' ' HB ' ' A' ' 110' ' ' THR . . . . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.397 -0.814 . . . . 0.0 110.548 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.315 0.578 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -130.45 117.28 19.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 110.147 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.525 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 1.0 OUTLIER -123.96 122.05 36.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -0.914 . . . . 0.0 110.257 -179.876 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 3.2 m0 -125.54 129.53 49.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.245 -0.91 . . . . 0.0 109.958 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.519 ' HA3' ' HA3' ' A' ' 107' ' ' GLY . . . 173.87 -114.8 0.53 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' TRP . . . . . 0.869 ' CZ2' HD22 ' A' ' 187' ' ' LEU . 34.3 m0 -129.16 122.96 30.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -1.162 . . . . 0.0 110.303 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.474 ' O ' HG12 ' A' ' 135' ' ' ILE . 0.8 OUTLIER -118.03 107.93 14.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.286 -0.883 . . . . 0.0 110.13 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 134' ' ' ASP . 1.3 mt . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.296 -0.878 . . . . 0.0 109.949 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.875 ' HB ' ' HD3' ' A' ' 164' ' ' PRO . 2.4 t . . . . . 0 N--CA 1.497 1.897 0 CA-C-O 119.678 -0.201 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.875 ' HD3' ' HB ' ' A' ' 163' ' ' VAL . 52.9 Cg_endo -95.84 179.21 0.59 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.104 1.055 . . . . 0.0 111.203 -178.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.8 -37.38 5.89 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 1.073 ' O ' HD13 ' A' ' 167' ' ' LEU . 0.3 OUTLIER -142.71 142.19 31.94 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.106 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 1.073 HD13 ' O ' ' A' ' 166' ' ' ARG . 0.3 OUTLIER -126.79 154.75 43.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.003 -1.06 . . . . 0.0 110.971 -179.24 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.7 tt -123.64 135.08 53.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.496 -0.753 . . . . 0.0 109.653 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 1.142 HG11 ' CZ2' ' A' ' 91' ' ' TRP . 42.3 t -106.41 141.71 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.122 -0.986 . . . . 0.0 110.73 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 53.4 t -122.25 114.81 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.357 -0.839 . . . . 0.0 109.742 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.86 HD12 ' N ' ' A' ' 172' ' ' ASP . 0.4 OUTLIER -128.09 124.08 36.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.18 -0.95 . . . . 0.0 110.423 -179.649 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.86 ' N ' HD12 ' A' ' 171' ' ' LEU . 5.5 t70 -116.32 138.36 51.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.312 -0.868 . . . . 0.0 109.914 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.502 ' O ' ' N ' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -93.34 -41.09 10.03 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.05 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.488 ' C ' ' O ' ' A' ' 173' ' ' MET . 0.6 OUTLIER -41.0 -27.84 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.195 -0.94 . . . . 0.0 108.987 179.399 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.566 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 1.8 tp10 -113.45 -27.63 7.84 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.518 ' O ' ' CG2' ' A' ' 198' ' ' THR . . . 83.62 23.74 52.45 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' THR . . . . . 1.026 HG22 ' CD2' ' A' ' 194' ' ' LEU . 0.7 OUTLIER -116.59 135.52 53.74 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.344 -1.092 . . . . 0.0 111.029 -179.515 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.999 ' O ' HD11 ' A' ' 194' ' ' LEU . 0.2 OUTLIER -136.29 150.65 49.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.45 -0.781 . . . . 0.0 109.594 179.361 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -148.15 -175.17 20.58 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.691 -1.242 . . . . 0.0 110.08 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.692 ' CG ' ' CH2' ' A' ' 133' ' ' TRP . 0.2 OUTLIER -138.98 127.2 22.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.4 -1.059 . . . . 0.0 110.082 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 21.2 t -117.99 124.44 48.19 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.174 -0.954 . . . . 0.0 109.881 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.799 HD12 ' CZ2' ' A' ' 133' ' ' TRP . 0.1 OUTLIER -116.15 116.48 52.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.506 -0.746 . . . . 0.0 109.777 179.814 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.511 ' C ' ' O ' ' A' ' 182' ' ' ILE . . . 38.51 28.94 0.06 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 182' ' ' ILE . . . 62.32 43.2 99.41 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' THR . . . . . 0.881 HG22 ' HD1' ' A' ' 186' ' ' TYR . 25.2 m -72.24 -78.86 0.08 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.201 -1.176 . . . . 0.0 110.468 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.881 ' HD1' HG22 ' A' ' 185' ' ' THR . 8.6 p90 -175.11 104.47 0.09 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.855 -1.153 . . . . 0.0 111.051 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.869 HD22 ' CZ2' ' A' ' 133' ' ' TRP . 4.8 tp 179.6 23.2 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.366 -0.834 . . . . 0.0 110.778 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.835 ' N ' ' CD ' ' A' ' 189' ' ' PRO . . . -109.65 -5.77 29.31 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.752 -1.213 . . . . 0.0 112.088 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.835 ' CD ' ' N ' ' A' ' 188' ' ' GLY . 50.5 Cg_endo -75.59 -33.03 4.31 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 O-C-N 122.718 0.851 . . . . 0.0 110.97 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.585 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -83.04 41.36 0.75 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.221 -0.924 . . . . 0.0 110.976 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -90.53 -46.22 8.45 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.204 -0.935 . . . . 0.0 110.455 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' ARG . . . . . 0.523 ' HA ' ' NE ' ' A' ' 192' ' ' ARG . 0.5 OUTLIER -68.11 -14.91 63.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.16 -0.963 . . . . 0.0 110.001 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 197' ' ' ARG . . . -103.47 -10.92 34.69 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 1.026 ' CD2' HG22 ' A' ' 177' ' ' THR . 9.2 tt -70.35 -43.36 70.35 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.851 -0.793 . . . . 0.0 109.142 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.555 ' HE3' ' N ' ' A' ' 196' ' ' GLY . 0.1 OUTLIER -43.91 -41.16 5.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.485 -0.759 . . . . 0.0 110.005 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.555 ' N ' ' HE3' ' A' ' 195' ' ' LYS . . . -88.09 -24.87 33.24 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' ARG . . . . . 0.708 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -91.07 -2.84 57.56 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.838 -0.801 . . . . 0.0 109.737 179.659 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 198' ' ' THR . . . . . 0.711 HG23 ' O ' ' A' ' 194' ' ' LEU . 13.4 p -41.42 125.94 2.72 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.829 0.823 . . . . 0.0 111.212 -177.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.949 ' CD1' HG13 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -138.11 172.77 12.43 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -179.571 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 1.041 ' C ' HG23 ' A' ' 108' ' ' VAL . 4.2 m-30 -83.76 129.84 57.85 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 120.958 -1.089 . . . . 0.0 109.659 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.521 ' HA ' ' HB ' ' A' ' 108' ' ' VAL . 46.6 Cg_endo -72.49 129.17 14.39 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 124.047 1.551 . . . . 0.0 111.851 -178.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.417 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 1.8 p -133.62 160.27 38.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.486 -0.759 . . . . 0.0 110.101 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.792 HG11 ' HB3' ' A' ' 52' ' ' ASP . 14.9 p -137.1 156.51 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.256 -0.903 . . . . 0.0 110.556 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' SER . . . . . 1.235 ' O ' HG13 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -160.11 127.93 4.66 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.442 -0.787 . . . . 0.0 109.217 179.052 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.959 ' HB3' ' CG2' ' A' ' 78' ' ' VAL . . . -127.93 159.95 33.37 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.5 -0.75 . . . . 0.0 110.738 -178.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.568 ' CG1' ' N ' ' A' ' 207' ' ' TRP . 1.0 OUTLIER -60.45 175.61 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 CA-C-O 121.334 0.588 . . . . 0.0 110.655 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 1.04 ' CB ' HD11 ' A' ' 57' ' ' ILE . 39.7 p90 -120.84 57.71 0.97 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.439 -0.788 . . . . 0.0 110.207 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -134.53 -144.37 5.03 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' GLN . . . . . 0.411 ' O ' ' C ' ' A' ' 210' ' ' CYS . 2.2 tp60 -67.2 -31.67 72.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.353 -1.086 . . . . 0.0 110.481 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' CYS . . . . . 0.566 ' SG ' HG12 ' A' ' 206' ' ' VAL . 17.2 p -43.58 153.35 0.12 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.289 -0.882 . . . . 0.0 109.917 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.68 ' HA ' ' CD1' ' A' ' 66' ' ' PHE . 8.2 pt20 -156.56 123.67 5.28 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.103 -0.998 . . . . 0.0 110.628 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.424 ' HA ' ' CD ' ' A' ' 96' ' ' PRO . 1.5 m -101.61 140.32 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.336 -0.852 . . . . 0.0 110.114 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' ARG . . . . . 0.584 ' NH2' ' OG ' ' A' ' 94' ' ' SER . 0.5 OUTLIER -89.43 127.1 35.8 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.237 -0.914 . . . . 0.0 108.999 179.399 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.956 HG21 ' HA ' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -103.59 113.5 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-O 121.939 0.876 . . . . 0.0 111.248 -178.621 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 215' ' ' ARG . . . . . 0.643 ' O ' ' N ' ' A' ' 92' ' ' GLU . 4.0 ttt180 -130.61 126.89 37.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.407 -0.808 . . . . 0.0 108.863 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 216' ' ' TYR . . . . . 0.616 ' CD2' ' HB3' ' A' ' 91' ' ' TRP . 4.0 t80 -119.27 150.39 40.19 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.921 -1.112 . . . . 0.0 111.017 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 217' ' ' MET . . . . . 0.457 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 6.2 ttp -126.98 107.87 10.45 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.298 -0.876 . . . . 0.0 109.677 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 89.24 59.18 1.58 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.244 -1.15 . . . . 0.0 110.179 179.942 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.16 44.66 1.33 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -1.162 . . . . 0.0 110.18 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.8 m -93.04 -19.76 21.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.204 -0.935 . . . . 0.0 110.257 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.93 -179.64 3.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -0.936 . . . . 0.0 110.154 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -89.67 -71.93 0.58 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.261 -0.899 . . . . 0.0 110.235 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -47.49 116.6 1.49 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.214 -0.929 . . . . 0.0 110.249 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 88.1 p -127.79 -153.39 0.57 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 110.281 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.9 t -147.4 126.11 6.23 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.24 -0.912 . . . . 0.0 110.151 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.16 110.98 3.17 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.957 1.504 . . . . 0.0 110.387 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.48 68.43 0.71 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -0.901 . . . . 0.0 110.17 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -133.31 118.42 18.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.3 -0.875 . . . . 0.0 110.275 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -139.26 75.54 1.52 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 110.15 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.708 ' O ' HD12 ' A' ' 19' ' ' LEU . . . -58.28 101.45 0.08 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.263 -0.898 . . . . 0.0 110.145 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.708 HD12 ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER 179.85 -155.08 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.201 -0.937 . . . . 0.0 110.201 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.46 ' CG ' ' N ' ' A' ' 21' ' ' SER . 25.3 t80 -91.79 -102.38 0.11 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.29 -0.881 . . . . 0.0 110.22 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.46 ' N ' ' CG ' ' A' ' 20' ' ' TYR . 2.0 t -150.21 140.41 22.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.133 -0.979 . . . . 0.0 110.176 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 1.8 p30 -167.72 66.91 0.08 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.207 -0.933 . . . . 0.0 110.267 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.443 ' CG ' ' N ' ' A' ' 24' ' ' SER . 13.7 t80 -76.7 -104.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 110.017 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.443 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 2.8 m -123.4 104.86 34.07 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.552 -0.717 . . . . 0.0 110.111 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -78.11 164.32 27.19 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.018 1.536 . . . . 0.0 110.446 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.97 158.03 50.34 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.002 1.527 . . . . 0.0 110.539 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 179.68 45.11 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.476 -0.765 . . . . 0.0 110.12 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 168.99 -19.94 0.08 OUTLIER Glycine 0 N--CA 1.49 2.299 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.378 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.803 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -71.97 -49.69 35.18 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.064 -1.256 . . . . 0.0 110.025 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.658 ' HA ' HD23 ' A' ' 33' ' ' LEU . 1.7 tt0 -45.02 -34.72 2.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.053 -1.029 . . . . 0.0 108.988 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.37 -24.05 64.78 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.385 -0.822 . . . . 0.0 108.787 178.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.577 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -83.42 -32.3 26.18 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.901 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.845 HD12 ' C ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -81.52 -38.19 26.65 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.891 0.853 . . . . 0.0 109.284 179.165 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.57 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 0.9 OUTLIER -46.8 -30.72 2.59 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.625 0.726 . . . . 0.0 109.88 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 1.046 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -72.58 -169.99 0.15 Allowed Pre-proline 0 C--N 1.298 -1.652 0 O-C-N 121.497 -0.752 . . . . 0.0 109.364 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 1.046 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 42.0 Cg_endo -69.48 106.18 1.57 Allowed 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.6 1.316 . . . . 0.0 109.765 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.651 ' HG3' HG21 ' A' ' 41' ' ' VAL . 50.5 Cg_endo -88.67 108.59 0.51 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.13 1.595 . . . . 0.0 111.166 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.77 ' O ' ' N ' ' A' ' 40' ' ' LEU . 49.4 Cg_endo -76.81 150.55 30.74 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.925 1.487 . . . . 0.0 109.998 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.723 ' O ' ' CG ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER 3.3 61.39 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 122.617 1.199 . . . . 0.0 110.455 -178.956 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.012 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -149.66 -45.47 0.13 Allowed 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 178.866 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.8 ' N ' HD13 ' A' ' 40' ' ' LEU . 2.2 t -86.38 -35.64 9.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 46' ' ' HIS . . . -89.21 -43.23 11.15 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.38 0.61 . . . . 0.0 110.089 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.579 ' HG3' ' CD ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -68.66 -25.17 64.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.461 -0.774 . . . . 0.0 110.416 -179.685 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.839 ' HA ' HG12 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -79.05 -50.84 10.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.146 -0.971 . . . . 0.0 108.999 179.475 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.78 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 1.6 m-70 -63.8 -16.16 60.53 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.443 ' HB2' ' O ' ' A' ' 42' ' ' ALA . 1.9 t-80 -96.36 -28.75 14.33 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.44 -119.21 0.05 OUTLIER Glycine 0 N--CA 1.477 1.403 0 N-CA-C 107.838 -2.105 . . . . 0.0 107.838 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 1.086 ' CZ2' HD22 ' A' ' 64' ' ' LEU . 0.8 OUTLIER -103.52 70.56 1.04 Allowed 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.011 -1.287 . . . . 0.0 110.478 179.143 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.687 ' CB ' ' HA ' ' A' ' 45' ' ' HIS . 21.4 t-20 -109.24 111.97 59.76 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 121.1 -1.0 . . . . 0.0 111.721 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.853 ' HG2' ' HB2' ' A' ' 53' ' ' CYS . 48.5 Cg_endo -80.57 -59.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.302 -1.902 0 O-C-N 123.78 1.411 . . . . 0.0 108.847 177.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.694 ' HG2' ' O ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER 179.81 -95.73 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.602 -0.686 . . . . 0.0 110.191 178.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.604 ' N ' ' HA2' ' A' ' 80' ' ' GLY 0.26 54.1 m-20 -68.97 33.97 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.178 0.989 . . . . 0.0 109.175 178.772 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.853 ' HB2' ' HG2' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -101.07 -176.92 3.3 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.843 -177.38 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.743 ' CA ' HG11 ' A' ' 78' ' ' VAL . 0.3 OUTLIER -50.6 101.73 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.689 -0.804 . . . . 0.0 111.662 -177.17 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.521 ' HG3' ' N ' ' A' ' 56' ' ' ASN . 9.4 pt-20 -102.07 -32.78 9.97 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.826 0.822 . . . . 0.0 109.522 177.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.584 ' HB3' HD21 ' A' ' 29' ' ' LEU . 12.3 m120 -70.01 -7.98 45.42 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.76 -0.587 . . . . 0.0 111.811 -178.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.98 HG22 HG22 ' A' ' 75' ' ' THR . 1.2 pt -112.69 166.17 6.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 120.844 -1.16 . . . . 0.0 109.988 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.832 ' CB ' HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -108.98 126.86 53.55 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.371 -0.831 . . . . 0.0 110.563 -179.13 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.839 HG12 ' HA ' ' A' ' 44' ' ' ARG . 9.6 p -130.42 130.76 65.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 O-C-N 121.46 -0.775 . . . . 0.0 109.275 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.579 ' CD ' ' HG3' ' A' ' 43' ' ' GLN . 19.7 tttm -135.61 153.25 51.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.069 -1.019 . . . . 0.0 110.689 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.484 ' HA ' ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -66.21 -121.8 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.401 -0.812 . . . . 0.0 110.269 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 44.51 26.54 1.06 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.699 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 124.38 61.01 0.18 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.086 HD22 ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER 0.61 88.76 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.796 -0.826 . . . . 0.0 110.758 -179.658 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 42.4 t -127.64 114.73 17.74 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.289 -0.882 . . . . 0.0 111.396 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.673 ' HA ' HG23 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -84.37 134.31 34.49 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.526 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.637 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 2.4 tt0 -126.66 131.03 51.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.74 -1.225 . . . . 0.0 110.847 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.559 ' HD3' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -136.06 156.07 49.27 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.414 -0.804 . . . . 0.0 109.539 179.602 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.671 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -85.37 -69.92 0.13 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.071 -1.018 . . . . 0.0 111.243 -179.105 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.9 ' HD2' HG21 ' A' ' 75' ' ' THR . 55.8 Cg_endo -72.16 -113.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.55 1.289 . . . . 0.0 110.324 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.48 ' O ' ' N ' ' A' ' 73' ' ' GLN . 4.7 t -140.38 164.83 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.454 -1.404 . . . . 0.0 110.369 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.571 ' HB2' ' NE1' ' A' ' 207' ' ' TRP . . . -41.62 -24.45 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.306 -0.872 . . . . 0.0 110.377 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.495 ' C ' ' O ' ' A' ' 72' ' ' ALA . 1.6 pt20 -36.11 -34.33 0.05 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.263 -0.898 . . . . 0.0 110.577 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 72' ' ' ALA . 69.0 p -149.54 -36.52 0.16 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 110.317 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.98 HG22 HG22 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -72.15 -55.1 7.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.189 -0.945 . . . . 0.0 110.134 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.549 ' OD2' ' HA ' ' A' ' 207' ' ' TRP . 4.7 t0 -99.24 155.36 17.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.225 -0.922 . . . . 0.0 109.741 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.63 74.12 1.26 Allowed Glycine 0 N--CA 1.487 2.068 0 N-CA-C 107.23 -2.348 . . . . 0.0 107.23 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.787 HG22 ' HA ' ' A' ' 53' ' ' CYS . 1.4 p -158.08 162.67 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 O-C-N 121.806 -0.82 . . . . 0.0 109.406 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.667 ' CG ' ' O ' ' A' ' 203' ' ' VAL . 0.0 OUTLIER -145.52 137.35 25.36 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.072 -1.051 . . . . 0.0 113.008 -178.419 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.604 ' HA2' ' N ' ' A' ' 52' ' ' ASP . . . -74.73 154.05 46.51 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 107.729 -2.148 . . . . 0.0 107.729 176.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.505 ' HG2' ' N ' ' A' ' 82' ' ' ARG . 1.3 ttmp? -126.18 -97.55 0.42 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.796 -1.414 . . . . 0.0 112.374 -178.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.888 ' HD3' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -43.33 -87.41 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.208 -0.933 . . . . 0.0 111.666 -178.102 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.888 ' N ' ' HD3' ' A' ' 82' ' ' ARG . . . 60.39 76.9 0.2 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.564 ' CE1' ' SD ' ' A' ' 173' ' ' MET . 10.1 t80 -94.42 132.08 39.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.356 -1.085 . . . . 0.0 110.842 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.468 ' O ' ' SD ' ' A' ' 173' ' ' MET . 7.3 t -140.01 161.34 37.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.39 -0.819 . . . . 0.0 109.911 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.464 ' HA ' ' HG2' ' A' ' 173' ' ' MET . 4.1 mtt180 -111.26 160.22 17.19 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.066 -1.022 . . . . 0.0 109.776 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.77 158.29 34.19 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.603 ' O ' HD23 ' A' ' 88' ' ' LEU . 2.5 tt -87.61 123.52 32.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.306 -1.114 . . . . 0.0 110.163 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.469 ' CE1' ' HG ' ' A' ' 171' ' ' LEU . 2.1 p80 -147.36 173.36 12.68 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 110.134 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -149.58 155.4 40.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.351 -0.843 . . . . 0.0 110.037 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.958 ' CZ3' HG11 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -134.72 170.67 15.48 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.116 -0.99 . . . . 0.0 110.352 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.663 ' N ' ' O ' ' A' ' 215' ' ' ARG . 1.0 OUTLIER -129.1 147.89 51.0 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.889 -0.725 . . . . 0.0 110.797 -179.471 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.552 ' CG2' ' OH ' ' A' ' 180' ' ' TYR . 0.6 OUTLIER -144.3 145.48 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.53 -0.731 . . . . 0.0 109.933 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.9 ' O ' HG23 ' A' ' 212' ' ' VAL . 0.0 OUTLIER -145.02 144.32 30.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.173 -0.955 . . . . 0.0 110.204 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.785 ' CZ3' ' HA ' ' A' ' 104' ' ' ALA . 41.7 m95 -117.99 107.6 43.71 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.239 -0.913 . . . . 0.0 110.473 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.571 ' HG3' ' CZ ' ' A' ' 213' ' ' ARG . 49.8 Cg_endo -75.04 109.79 2.99 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.875 1.46 . . . . 0.0 109.899 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.543 HD22 ' OG1' ' A' ' 102' ' ' THR . 0.0 OUTLIER -95.44 -12.03 26.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.114 -0.991 . . . . 0.0 110.225 -179.725 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 97' ' ' LEU . 2.8 tm-20 -40.44 -33.32 0.25 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.239 -0.913 . . . . 0.0 110.577 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 209' ' ' GLN . 1.0 OUTLIER -42.61 -83.71 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.258 -0.901 . . . . 0.0 110.607 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.51 ' HB2' ' NH1' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -167.67 -59.75 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.418 -0.801 . . . . 0.0 110.304 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.614 ' C ' HG23 ' A' ' 102' ' ' THR . . . -149.34 126.0 2.13 Favored Glycine 0 N--CA 1.485 1.903 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.614 HG23 ' C ' ' A' ' 101' ' ' GLY . 75.5 p -156.21 -150.55 0.29 Allowed 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.305 -1.115 . . . . 0.0 110.014 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.597 ' CG ' ' O ' ' A' ' 102' ' ' THR . 0.5 OUTLIER -179.68 113.05 0.05 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.055 -1.028 . . . . 0.0 110.873 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.785 ' HA ' ' CZ3' ' A' ' 95' ' ' TRP . . . -76.19 131.91 39.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.27 -0.894 . . . . 0.0 109.377 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.996 HG23 ' HB2' ' A' ' 204' ' ' SER . 17.4 m -132.2 116.48 29.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 C-N-CA 117.961 -1.496 . . . . 0.0 110.612 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.586 HG22 HG23 ' A' ' 203' ' ' VAL . 89.8 t -150.63 170.09 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.623 -0.673 . . . . 0.0 109.341 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.638 ' CA ' ' HA3' ' A' ' 132' ' ' GLY . . . 165.6 167.3 25.99 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.34 -1.409 . . . . 0.0 110.479 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.75 HG12 ' HB2' ' A' ' 199' ' ' LEU . 1.7 t -112.55 141.73 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.551 -0.97 . . . . 0.0 109.507 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 130' ' ' SER . . . -114.53 142.61 46.19 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.081 -1.012 . . . . 0.0 110.655 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.802 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -118.77 131.99 56.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.277 -0.889 . . . . 0.0 110.357 179.718 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.97 -26.79 17.4 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.399 -0.813 . . . . 0.0 109.286 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.637 ' C ' HD12 ' A' ' 112' ' ' LEU . 4.1 pp -83.83 -12.17 55.97 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.558 -0.714 . . . . 0.0 109.448 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.572 ' CB ' ' CB ' ' A' ' 129' ' ' GLU . . . -36.02 109.99 0.43 Allowed Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.587 -0.695 . . . . 0.0 110.441 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.699 ' C ' HD23 ' A' ' 115' ' ' LEU . 45.5 Cg_endo -72.81 -156.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.024 1.539 . . . . 0.0 110.431 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.945 HD13 ' HA3' ' A' ' 125' ' ' GLY . 0.3 OUTLIER -171.87 59.21 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.176 -0.953 . . . . 0.0 110.306 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -102.07 -70.99 0.73 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.384 -0.822 . . . . 0.0 110.241 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.515 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -114.59 56.61 0.72 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 110.255 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.515 ' C ' ' O ' ' A' ' 117' ' ' ALA . 8.2 t70 -32.06 146.65 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.512 -0.743 . . . . 0.0 110.66 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -44.96 -37.54 4.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.307 -0.87 . . . . 0.0 110.223 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.632 ' O ' ' HB2' ' A' ' 121' ' ' ALA . 1.6 m-30 -63.86 -56.4 15.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.33 -0.856 . . . . 0.0 110.21 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.632 ' HB2' ' O ' ' A' ' 120' ' ' TYR . . . 173.48 -67.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.149 -0.969 . . . . 0.0 110.161 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.534 ' HB2' ' O ' ' A' ' 121' ' ' ALA . . . 178.65 88.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.257 -0.902 . . . . 0.0 110.22 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.561 ' O ' HD12 ' A' ' 124' ' ' LEU . 17.2 mt -98.88 -66.52 0.9 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.239 -0.913 . . . . 0.0 110.191 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.561 HD12 ' O ' ' A' ' 123' ' ' LEU . 0.1 OUTLIER 177.27 -153.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -0.887 . . . . 0.0 110.212 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.945 ' HA3' HD13 ' A' ' 115' ' ' LEU . . . -156.75 158.04 28.46 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.462 ' OG ' ' N ' ' A' ' 127' ' ' ASN . 4.7 t -123.91 -101.04 0.4 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.274 -1.133 . . . . 0.0 110.043 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.462 ' N ' ' OG ' ' A' ' 126' ' ' SER . 0.5 OUTLIER -126.66 -27.55 3.1 Favored 'General case' 0 C--N 1.286 -2.152 0 CA-C-O 121.222 0.534 . . . . 0.0 110.193 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.1 m -160.49 -166.42 1.65 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 110.315 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.572 ' CB ' ' CB ' ' A' ' 113' ' ' ALA . 3.9 tt0 -150.03 129.64 13.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.313 -0.867 . . . . 0.0 109.997 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 32.3 t -120.43 119.68 33.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.189 -0.944 . . . . 0.0 110.409 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.28 131.62 40.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.349 -0.845 . . . . 0.0 109.841 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.638 ' HA3' ' CA ' ' A' ' 107' ' ' GLY . . . -165.05 -144.67 4.13 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.696 ' CE3' ' CD2' ' A' ' 180' ' ' TYR . 31.5 m0 -116.67 114.45 24.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.343 -1.092 . . . . 0.0 110.556 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.492 ' H ' HD23 ' A' ' 161' ' ' LEU . 2.9 p-10 -118.13 143.42 46.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.527 -0.733 . . . . 0.0 110.033 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.704 HD12 ' N ' ' A' ' 136' ' ' GLY . 0.1 OUTLIER -77.64 2.35 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.23 -0.919 . . . . 0.0 110.335 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.704 ' N ' HD12 ' A' ' 135' ' ' ILE . . . -66.01 -9.84 48.91 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.78 4.39 44.5 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.279 -1.13 . . . . 0.0 109.286 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 139' ' ' LYS . . . -125.6 -7.08 5.84 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.497 ' CD ' ' HA2' ' A' ' 136' ' ' GLY . 48.1 mtpt -54.21 -164.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.416 -1.05 . . . . 0.0 110.177 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.5 mt -86.38 4.61 38.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.207 -0.933 . . . . 0.0 110.151 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.41 ' C ' ' CG ' ' A' ' 142' ' ' HIS . 0.1 OUTLIER -85.04 3.44 38.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 110.243 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.41 ' CG ' ' C ' ' A' ' 141' ' ' TYR . 72.9 m80 -150.18 85.81 1.41 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.163 -0.961 . . . . 0.0 110.25 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -142.07 -69.85 0.35 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.228 -0.92 . . . . 0.0 110.212 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 78.9 p -45.14 -41.66 8.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.296 -0.878 . . . . 0.0 110.221 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -99.33 84.61 3.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.259 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -138.5 126.58 3.5 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.05 10.7 7.49 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.233 -1.157 . . . . 0.0 110.209 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.404 ' O ' ' HD3' ' A' ' 150' ' ' PRO . 2.6 mt-10 -63.31 173.72 1.45 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.32 -0.863 . . . . 0.0 110.262 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -56.31 109.83 1.93 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 110.175 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 44.9 Cg_endo -72.87 -10.89 25.32 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.95 1.5 . . . . 0.0 110.487 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 12.9 mp0 -83.31 -62.91 1.46 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.226 -0.921 . . . . 0.0 110.258 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.459 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 84.7 m-85 -119.27 165.77 16.31 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.337 -0.852 . . . . 0.0 110.136 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.459 ' HD2' ' HB3' ' A' ' 152' ' ' TYR . 45.7 Cg_endo -72.66 110.92 3.12 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.037 1.546 . . . . 0.0 110.453 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -173.13 159.43 3.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 110.215 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 179.31 110.51 0.28 Allowed Glycine 0 N--CA 1.48 1.614 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.86 -43.82 0.75 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.876 1.461 . . . . 0.0 110.374 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 160' ' ' GLN . 27.4 mm-40 -68.94 -2.09 8.94 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.309 -0.87 . . . . 0.0 110.469 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.19 -24.06 77.0 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.53 ' HG2' HG13 ' A' ' 163' ' ' VAL . 0.5 OUTLIER -83.18 6.63 18.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.146 -1.208 . . . . 0.0 110.272 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.7 ' C ' HD12 ' A' ' 161' ' ' LEU . 1.0 OUTLIER -68.94 -16.48 63.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.273 -0.892 . . . . 0.0 109.437 179.551 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.746 ' O ' HG23 ' A' ' 162' ' ' VAL . 1.0 OUTLIER -161.24 22.52 0.13 Allowed 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.802 0.811 . . . . 0.0 109.488 179.338 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.786 HG12 ' O ' ' A' ' 162' ' ' VAL . 2.4 t -161.46 88.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.652 -0.655 . . . . 0.0 109.875 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.641 HG21 HD21 ' A' ' 167' ' ' LEU . 0.2 OUTLIER -113.06 83.84 6.52 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 0.0 109.961 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.69 71.8 3.21 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.976 1.514 . . . . 0.0 110.617 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 94' ' ' SER . 1.4 mt-10 -172.29 -81.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.355 -0.841 . . . . 0.0 110.118 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.534 ' HG2' ' N ' ' A' ' 167' ' ' LEU . 0.8 OUTLIER -151.55 154.92 37.42 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.322 -0.861 . . . . 0.0 109.739 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.782 HD22 HG22 ' A' ' 182' ' ' ILE . 0.0 OUTLIER -152.77 139.9 19.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.091 -1.005 . . . . 0.0 110.483 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' A' ' 181' ' ' SER . 17.0 tp -114.3 112.76 23.6 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.226 -0.921 . . . . 0.0 109.748 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.992 HG22 ' CE1' ' A' ' 180' ' ' TYR . 4.2 t -97.1 131.63 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.039 -1.038 . . . . 0.0 110.808 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.6 HG21 HD22 ' A' ' 187' ' ' LEU . 4.3 t -106.65 122.96 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.482 -0.761 . . . . 0.0 109.491 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.643 HD13 HD13 ' A' ' 178' ' ' LEU . 4.6 tp -133.21 115.28 14.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.069 -1.02 . . . . 0.0 110.554 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.539 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 32.1 t0 -120.3 135.15 55.1 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.296 -0.877 . . . . 0.0 110.199 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.587 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -94.58 -39.13 10.53 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.635 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 173' ' ' MET . 5.8 mm-40 -42.65 -27.7 0.19 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.219 -0.926 . . . . 0.0 108.828 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.593 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.1 OUTLIER -112.62 -27.07 8.34 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.235 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 82.57 24.23 54.21 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.955 HG22 ' CD2' ' A' ' 194' ' ' LEU . 0.2 OUTLIER -121.14 128.68 52.76 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.248 -1.148 . . . . 0.0 111.141 -179.458 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 1.061 ' O ' HD11 ' A' ' 194' ' ' LEU . 0.2 OUTLIER -139.99 153.69 46.93 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.459 -0.776 . . . . 0.0 109.588 179.338 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -153.1 174.04 31.89 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.992 ' CE1' HG22 ' A' ' 169' ' ' VAL . 0.7 OUTLIER -118.94 118.67 32.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.351 -1.087 . . . . 0.0 110.119 -179.946 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.536 ' O ' ' CD1' ' A' ' 167' ' ' LEU . 39.3 t -144.76 165.23 28.67 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.177 -0.952 . . . . 0.0 109.96 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.782 HG22 HD22 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -102.64 116.88 47.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 121.452 -0.78 . . . . 0.0 109.674 179.541 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 66.56 8.31 45.5 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 87.05 35.95 9.4 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' THR . . . . . 0.419 ' N ' ' OG ' ' A' ' 181' ' ' SER . 33.0 m -84.89 -74.55 0.39 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.293 -1.122 . . . . 0.0 110.563 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.647 ' CE2' HD11 ' A' ' 182' ' ' ILE . 18.7 m-85 -81.01 88.04 5.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.109 -0.995 . . . . 0.0 110.662 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.602 ' O ' ' CE2' ' A' ' 191' ' ' PHE . 2.3 tp -177.84 28.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.595 -0.691 . . . . 0.0 109.5 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.525 ' H ' ' HD2' ' A' ' 189' ' ' PRO . . . -104.15 -68.27 0.75 Allowed Glycine 0 N--CA 1.491 2.336 0 C-N-CA 120.059 -1.067 . . . . 0.0 110.514 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.525 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 44.4 Cg_endo -71.1 -30.05 16.79 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.843 1.444 . . . . 0.0 111.17 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.565 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -73.12 12.29 0.58 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.175 -0.953 . . . . 0.0 111.17 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.602 ' CE2' ' O ' ' A' ' 187' ' ' LEU . 0.3 OUTLIER -90.13 -13.15 36.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.08 -1.012 . . . . 0.0 109.741 179.255 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.47 -20.37 31.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.436 -0.79 . . . . 0.0 110.718 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -108.97 -24.7 5.92 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.821 -1.711 . . . . 0.0 108.821 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 1.061 HD11 ' O ' ' A' ' 178' ' ' LEU . 6.6 tt -61.99 -32.71 73.2 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.611 -0.935 . . . . 0.0 109.016 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.553 ' HA ' HG23 ' A' ' 177' ' ' THR . 0.1 OUTLIER -47.16 -29.18 2.14 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.434 -0.791 . . . . 0.0 109.409 179.422 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -114.42 -19.38 6.24 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.675 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.91 -8.36 49.59 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.493 -1.004 . . . . 0.0 110.049 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.552 HG22 ' O ' ' A' ' 194' ' ' LEU . 0.1 OUTLIER -43.52 143.16 1.0 Allowed 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.91 0.862 . . . . 0.0 111.587 -178.152 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 1.028 ' O ' HD11 ' A' ' 178' ' ' LEU . 0.0 OUTLIER -140.41 172.26 12.98 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 22.3 m-85 -83.15 129.82 59.52 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.953 -1.092 . . . . 0.0 109.34 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.642 ' HG3' HD22 ' A' ' 171' ' ' LEU . 48.1 Cg_endo -74.18 129.6 13.28 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.054 1.555 . . . . 0.0 111.73 -178.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.511 ' O ' HG13 ' A' ' 106' ' ' VAL . 8.3 m -133.42 151.58 51.82 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.584 -0.697 . . . . 0.0 109.405 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.784 HG13 ' HG3' ' A' ' 50' ' ' PRO . 1.6 p -135.79 139.49 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.033 -1.042 . . . . 0.0 110.431 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' SER . . . . . 0.996 ' HB2' HG23 ' A' ' 105' ' ' VAL . 74.7 m -119.7 126.88 52.18 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.756 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.614 ' HA ' ' CH2' ' A' ' 95' ' ' TRP . . . -109.79 138.3 46.35 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.772 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.828 HG13 ' N ' ' A' ' 207' ' ' TRP . 0.3 OUTLIER -91.62 -159.68 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.506 -0.746 . . . . 0.0 110.542 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 0.828 ' N ' HG13 ' A' ' 206' ' ' VAL . 0.8 OUTLIER -47.07 176.39 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 110.265 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.422 ' N ' ' OD2' ' A' ' 76' ' ' ASP . . . -82.1 -0.12 89.28 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.474 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 0.5 OUTLIER -72.87 -33.68 66.24 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.616 -0.932 . . . . 0.0 110.155 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 210' ' ' CYS . . . . . 0.668 ' O ' ' C ' ' A' ' 211' ' ' GLN . 11.4 t -97.08 -0.25 47.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.346 -0.846 . . . . 0.0 110.149 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.668 ' C ' ' O ' ' A' ' 210' ' ' CYS . 0.6 OUTLIER 0.49 106.39 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.787 0.803 . . . . 0.0 111.42 -179.804 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.9 HG23 ' O ' ' A' ' 94' ' ' SER . 1.9 p -87.85 145.02 8.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.708 -0.62 . . . . 0.0 109.545 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.657 ' HA ' HD21 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -87.27 156.45 19.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.17 -0.956 . . . . 0.0 110.466 -178.686 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 1.0 HD12 ' HB3' ' A' ' 48' ' ' TRP . 0.2 OUTLIER -143.86 130.24 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.453 -0.779 . . . . 0.0 110.657 -179.323 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.663 ' O ' ' N ' ' A' ' 92' ' ' GLU . 6.8 mtt180 -130.81 108.86 10.16 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' TYR . . . . . 0.79 ' CD2' ' HB3' ' A' ' 91' ' ' TRP . 1.6 t80 -113.84 139.92 48.76 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 120.976 -1.077 . . . . 0.0 111.693 -177.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' MET . . . . . 0.45 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 0.3 OUTLIER -136.87 125.85 24.32 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.19 0.519 . . . . 0.0 109.89 179.548 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 120.47 -21.8 8.5 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.608 ' HB2' ' CE1' ' A' ' 216' ' ' TYR . 5.9 tm-20 -95.72 150.21 20.63 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.152 -1.205 . . . . 0.0 110.362 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.408 ' O ' ' OE2' ' A' ' 219' ' ' GLU . 6.4 mtm180 -136.32 -141.09 0.16 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.297 -0.877 . . . . 0.0 110.142 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ARG . . . . . 0.521 ' O ' ' C ' ' A' ' 222' ' ' VAL . 8.0 ttp180 -159.13 82.55 0.78 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.248 -0.907 . . . . 0.0 110.087 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.521 ' C ' ' O ' ' A' ' 221' ' ' ARG . 13.6 p -33.67 151.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.642 -0.661 . . . . 0.0 110.673 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 222' ' ' VAL . 5.4 tp10 -179.02 -51.32 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.275 -0.89 . . . . 0.0 110.147 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 223' ' ' GLU . 18.9 tp10 179.2 -29.89 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.217 -0.927 . . . . 0.0 110.304 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.431 ' C ' ' O ' ' A' ' 224' ' ' GLU . 2.5 t -41.72 142.78 0.59 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.254 -0.904 . . . . 0.0 110.307 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.39 109.3 3.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.256 -0.903 . . . . 0.0 110.24 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.57 -170.45 1.86 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.314 -0.866 . . . . 0.0 110.23 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 98.4 mt -77.91 135.02 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.91 . . . . 0.0 110.203 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.424 ' O ' ' CD ' ' A' ' 230' ' ' ARG . 38.6 t-80 -135.45 79.04 1.76 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.226 -0.921 . . . . 0.0 110.258 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ARG . . . . . 0.676 ' O ' ' C ' ' A' ' 231' ' ' ASP . 0.9 OUTLIER 179.86 33.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.314 -0.866 . . . . 0.0 110.215 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.676 ' C ' ' O ' ' A' ' 230' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 117.979 -1.01 . . . . 0.0 111.421 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.21 161.21 13.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -1.158 . . . . 0.0 110.235 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 9' ' ' ALA . 0.4 OUTLIER -116.0 132.22 56.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.209 -0.932 . . . . 0.0 110.209 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 8' ' ' SER . . . -177.04 -157.9 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.255 -0.903 . . . . 0.0 110.152 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.84 143.92 48.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.258 -0.901 . . . . 0.0 110.283 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -97.58 28.09 3.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.209 -0.932 . . . . 0.0 110.2 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.8 t -129.73 -1.49 4.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.198 -0.939 . . . . 0.0 110.212 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.8 m -124.33 132.18 24.27 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.245 -0.909 . . . . 0.0 110.129 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.29 75.34 2.9 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.006 1.529 . . . . 0.0 110.342 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.655 HG23 ' O ' ' A' ' 15' ' ' THR . 7.0 t -62.26 105.38 0.6 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -0.872 . . . . 0.0 110.225 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.422 ' O ' ' HG2' ' A' ' 17' ' ' GLN . 1.1 m -103.43 -174.28 2.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.882 . . . . 0.0 110.198 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 16' ' ' SER . 0.5 OUTLIER -161.52 -64.14 0.06 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.904 . . . . 0.0 110.184 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -171.63 165.97 6.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.223 -0.923 . . . . 0.0 110.218 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.44 -160.9 0.11 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 110.263 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.7 -78.57 0.6 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.282 -0.886 . . . . 0.0 110.301 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.21 -155.24 0.56 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.528 -0.733 . . . . 0.0 110.21 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 2.8 p-10 -121.85 -110.82 0.33 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.249 -0.907 . . . . 0.0 109.912 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.32 -58.45 0.79 Allowed 'General case' 0 C--N 1.284 -2.276 0 CA-C-O 121.433 0.635 . . . . 0.0 110.241 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.8 m -74.34 164.35 61.9 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.463 -0.773 . . . . 0.0 110.306 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.15 143.28 35.53 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.984 1.518 . . . . 0.0 110.559 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.66 ' O ' ' C ' ' A' ' 27' ' ' GLU . 46.1 Cg_endo -73.41 -167.66 0.38 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.999 1.526 . . . . 0.0 110.503 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.66 ' C ' ' O ' ' A' ' 26' ' ' PRO . 3.1 mm-40 1.33 68.43 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.541 0.686 . . . . 0.0 111.183 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 26' ' ' PRO . . . 179.15 -26.41 0.05 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.904 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -76.89 -30.03 56.02 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.276 -1.132 . . . . 0.0 110.048 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.653 ' HA ' HD23 ' A' ' 33' ' ' LEU . 2.1 pp20? -47.54 -43.05 24.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.917 . . . . 0.0 109.745 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.436 ' N ' ' CD ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -57.75 -21.19 39.85 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.201 179.269 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -83.4 -35.2 25.25 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.977 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.784 HD12 ' C ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -67.8 -35.63 78.98 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 122.059 0.933 . . . . 0.0 109.087 179.15 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.568 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 1.0 OUTLIER -82.65 -6.8 59.56 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.301 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.999 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -45.82 -67.31 0.39 Allowed Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.226 -0.921 . . . . 0.0 111.068 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.999 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 46.1 Cg_endo -70.42 142.49 45.17 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.674 1.355 . . . . 0.0 110.288 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.692 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 53.3 Cg_endo -96.79 20.62 0.44 Allowed 'Trans proline' 0 CA--C 1.552 1.385 0 C-N-CA 121.724 1.616 . . . . 0.0 113.828 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.701 ' CD ' ' HB2' ' A' ' 36' ' ' PRO . 50.6 Cg_endo -79.58 151.01 22.11 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 122.609 0.794 . . . . 0.0 110.625 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.722 ' CG ' ' OE1' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -15.33 -54.7 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.755 -0.59 . . . . 0.0 111.835 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.1 HD13 HG23 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -44.56 -51.48 8.92 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 120.455 -1.403 . . . . 0.0 109.701 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.1 HG23 HD13 ' A' ' 40' ' ' LEU . 23.4 t -87.26 -30.47 5.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.146 -0.971 . . . . 0.0 110.614 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.67 -36.8 15.04 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.974 -1.079 . . . . 0.0 111.587 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.751 ' CD ' ' HB2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -82.24 -19.53 39.46 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.252 -0.905 . . . . 0.0 110.01 -179.188 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.627 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 2.1 ttt180 -83.23 -42.68 16.95 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.304 -0.872 . . . . 0.0 109.952 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.713 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 0.6 OUTLIER -60.4 -18.07 48.17 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.609 -0.682 . . . . 0.0 110.703 -179.366 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -96.29 -34.71 11.5 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.032 -1.067 . . . . 0.0 109.556 178.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.523 ' HA3' ' HB2' ' A' ' 61' ' ' GLU . . . -92.42 -101.87 1.44 Allowed Glycine 0 N--CA 1.487 2.056 0 N-CA-C 106.929 -2.468 . . . . 0.0 106.929 178.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.771 ' CZ3' HD12 ' A' ' 214' ' ' ILE . 93.8 m95 -81.27 73.81 8.29 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.05 -1.265 . . . . 0.0 108.044 177.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.713 ' HA ' ' HA ' ' A' ' 45' ' ' HIS . 0.1 OUTLIER -43.69 147.02 0.88 Allowed Pre-proline 0 C--N 1.297 -1.714 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.087 -179.362 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.607 ' HA ' ' O ' ' A' ' 53' ' ' CYS . 40.5 Cg_endo -68.48 -33.04 23.83 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 124.498 1.788 . . . . 0.0 110.142 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.838 ' N ' ' HE3' ' A' ' 51' ' ' LYS . 0.2 OUTLIER -63.58 -16.64 61.4 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.612 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.878 ' O ' ' N ' ' A' ' 79' ' ' ARG . 4.2 m-20 -104.83 0.56 28.2 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 177.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.607 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 21.7 t -167.57 137.31 2.75 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 120.149 -0.621 . . . . 0.0 110.025 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.79 ' CB ' HD21 ' A' ' 56' ' ' ASN . 0.0 OUTLIER -100.77 161.33 13.67 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.209 179.159 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.603 ' HG3' HD21 ' A' ' 29' ' ' LEU . 24.3 pm0 -38.12 -20.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.326 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.79 HD21 ' CB ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -41.81 -29.61 0.21 Allowed 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 118.495 -1.282 . . . . 0.0 108.204 -179.762 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.999 HD11 ' O ' ' A' ' 207' ' ' TRP . 1.2 mt -131.13 166.11 29.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-O 121.63 0.729 . . . . 0.0 111.056 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.52 ' N ' ' CG2' ' A' ' 57' ' ' ILE . 2.8 t70 -128.11 105.67 8.53 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.72 HG12 ' HA ' ' A' ' 66' ' ' PHE . 10.7 m -128.44 135.52 62.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.327 -0.858 . . . . 0.0 110.955 -178.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.751 ' HB2' ' CD ' ' A' ' 43' ' ' GLN . 2.5 tttm -124.02 155.32 38.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.365 -0.835 . . . . 0.0 110.574 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.523 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . 4.2 tt0 -83.98 -131.25 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.387 -0.821 . . . . 0.0 110.142 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 43.24 52.44 6.0 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 108.389 -1.885 . . . . 0.0 108.389 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.667 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 108.88 61.66 0.54 Allowed Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.669 HD21 ' O ' ' A' ' 214' ' ' ILE . 1.5 mm? 0.49 80.06 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.92 -0.753 . . . . 0.0 111.421 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 63' ' ' GLY . 1.6 m -99.51 114.37 27.31 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.266 -0.896 . . . . 0.0 109.599 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.72 ' HA ' HG12 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -104.89 124.74 49.99 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.311 -0.868 . . . . 0.0 110.079 -179.683 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.511 ' O ' ' O ' ' A' ' 58' ' ' ASP . 29.2 tt0 -144.62 145.56 31.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 109.862 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.561 ' HG2' ' O ' ' A' ' 207' ' ' TRP . 0.0 OUTLIER -132.68 118.12 18.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 110.207 -179.791 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.688 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 9.9 mmm-85 -84.73 -71.65 0.1 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.284 -0.885 . . . . 0.0 110.302 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.688 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 56.4 Cg_endo -72.18 -145.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.569 1.3 . . . . 0.0 109.155 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.481 ' O ' ' HG2' ' A' ' 73' ' ' GLN . 3.2 t -140.09 163.77 23.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 O-C-N 121.406 -0.809 . . . . 0.0 109.738 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 71' ' ' VAL . . . -43.19 103.3 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.067 -1.021 . . . . 0.0 109.891 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 15.2 pt20 -128.28 -113.27 0.27 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.211 -0.93 . . . . 0.0 110.593 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.589 ' CB ' ' HA ' ' A' ' 26' ' ' PRO . 22.0 p -36.06 -52.08 0.76 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.319 -0.863 . . . . 0.0 110.809 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.493 ' CB ' ' HB3' ' A' ' 54' ' ' SER . 0.2 OUTLIER -118.41 -137.39 0.35 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.131 -0.98 . . . . 0.0 109.993 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.701 ' O ' ' C ' ' A' ' 77' ' ' GLY . 1.3 t0 -140.66 154.84 46.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.893 . . . . 0.0 110.387 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.701 ' C ' ' O ' ' A' ' 76' ' ' ASP . . . -12.23 -98.32 0.0 OUTLIER Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.858 ' CG2' ' HB3' ' A' ' 205' ' ' ALA . 3.7 m -128.06 121.64 56.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.038 -1.272 . . . . 0.0 110.003 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.878 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -145.53 133.76 21.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.415 -0.803 . . . . 0.0 110.907 -179.756 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.709 ' HA3' ' HA ' ' A' ' 52' ' ' ASP . . . -163.7 145.23 10.24 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.813 ' CE ' ' HB3' ' A' ' 109' ' ' ALA . 1.5 tttm -138.73 80.84 1.81 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -1.133 . . . . 0.0 110.04 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.48 -92.79 0.28 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.128 -0.983 . . . . 0.0 110.213 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 53.95 69.59 1.19 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -120.78 111.41 17.55 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.195 -1.179 . . . . 0.0 110.308 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.599 ' HB3' ' CE1' ' A' ' 89' ' ' HIS . 0.8 OUTLIER -140.02 173.65 11.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.936 . . . . 0.0 110.165 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.595 ' N ' ' CD ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -118.47 138.16 52.68 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.225 -0.922 . . . . 0.0 110.119 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.491 ' HA2' ' CG ' ' A' ' 174' ' ' GLU . . . 98.05 -116.52 5.56 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.495 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 0.9 OUTLIER -128.6 135.33 49.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.407 -1.055 . . . . 0.0 110.295 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.813 ' HB2' HD23 ' A' ' 171' ' ' LEU . 9.0 m-70 -147.08 161.14 41.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.154 -0.966 . . . . 0.0 109.811 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.556 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -158.02 147.12 19.45 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.042 -1.036 . . . . 0.0 110.517 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 1.043 ' CZ2' HD22 ' A' ' 171' ' ' LEU . 1.3 m0 -134.75 170.23 16.14 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.374 -0.829 . . . . 0.0 109.097 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 1.003 ' CD ' HD12 ' A' ' 168' ' ' LEU . 3.2 mt-10 -136.47 138.96 41.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.118 -0.989 . . . . 0.0 111.23 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.909 HD13 ' O ' ' A' ' 92' ' ' GLU . 8.3 mm -142.93 126.4 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.58 -0.7 . . . . 0.0 109.361 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.718 ' HA ' HD12 ' A' ' 167' ' ' LEU . 1.4 m -143.62 143.51 31.5 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.166 -0.959 . . . . 0.0 110.325 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.784 ' CG ' ' HB2' ' A' ' 104' ' ' ALA . 47.9 m95 -114.4 88.46 15.64 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.322 -0.861 . . . . 0.0 110.282 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.568 ' O ' ' N ' ' A' ' 101' ' ' GLY . 50.9 Cg_endo -91.92 109.86 0.27 Allowed 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 123.909 1.479 . . . . 0.0 110.255 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.929 HD22 ' O ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -88.86 -12.91 40.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.809 -1.182 . . . . 0.0 110.492 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 97' ' ' LEU . 13.9 tp10 -42.87 -32.58 0.64 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.091 -1.005 . . . . 0.0 109.262 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.545 ' CB ' ' HD3' ' A' ' 100' ' ' ARG . 4.2 mt-30 -147.81 12.42 1.0 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.589 -0.694 . . . . 0.0 109.47 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.929 ' O ' HD22 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -179.21 -108.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.472 -0.768 . . . . 0.0 109.768 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.638 ' O ' ' CB ' ' A' ' 210' ' ' CYS . . . 47.28 172.29 0.01 OUTLIER Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.532 ' HB ' ' O ' ' A' ' 101' ' ' GLY . 8.9 t 179.59 -177.11 0.32 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.098 -1.236 . . . . 0.0 110.097 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.567 ' HB2' ' CG2' ' A' ' 206' ' ' VAL . 0.0 OUTLIER -42.32 95.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.228 -0.92 . . . . 0.0 109.52 179.609 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.784 ' HB2' ' CG ' ' A' ' 95' ' ' TRP . . . -74.32 119.71 18.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 110.971 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.686 HG23 ' C ' ' A' ' 204' ' ' SER . 27.0 m -136.19 115.97 16.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 118.91 -1.116 . . . . 0.0 110.366 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.842 HG13 ' HA ' ' A' ' 203' ' ' VAL . 8.4 t -150.69 170.04 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.464 -0.773 . . . . 0.0 109.631 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.65 ' CA ' ' HA3' ' A' ' 132' ' ' GLY . . . 164.02 164.05 18.33 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.504 -1.331 . . . . 0.0 110.689 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.815 HG12 ' HB2' ' A' ' 199' ' ' LEU . 2.5 t -114.3 155.7 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.639 -0.919 . . . . 0.0 109.072 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.813 ' HB3' ' CE ' ' A' ' 81' ' ' LYS . . . -142.93 144.75 32.52 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.863 -1.148 . . . . 0.0 111.129 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.684 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.8 OUTLIER -103.47 125.12 49.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.397 -0.815 . . . . 0.0 110.0 179.544 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.85 -28.39 16.55 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.459 -0.775 . . . . 0.0 109.9 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.673 ' O ' ' C ' ' A' ' 113' ' ' ALA . 0.5 OUTLIER -81.22 -12.45 59.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.321 -0.862 . . . . 0.0 109.719 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.673 ' C ' ' O ' ' A' ' 112' ' ' LEU . . . -1.58 76.53 0.04 OUTLIER Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.967 -0.458 . . . . 0.0 111.408 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.546 ' N ' ' O ' ' A' ' 112' ' ' LEU . 45.1 Cg_endo -74.41 -61.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.967 1.509 . . . . 0.0 110.385 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.642 ' C ' HD12 ' A' ' 115' ' ' LEU . 1.2 pp 179.9 50.77 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 0.0 110.125 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 118' ' ' ASP . 0.8 OUTLIER -41.68 -68.06 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 110.294 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.537 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -61.3 75.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.298 -0.876 . . . . 0.0 110.206 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.537 ' C ' ' O ' ' A' ' 117' ' ' ALA . 7.5 t0 -31.64 -68.44 0.09 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.544 -0.723 . . . . 0.0 110.669 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.424 ' O ' ' O ' ' A' ' 117' ' ' ALA . 0.1 OUTLIER -69.96 -158.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 110.14 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.515 ' CD2' ' O ' ' A' ' 120' ' ' TYR . 34.5 p90 -123.28 59.22 1.09 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.322 -0.861 . . . . 0.0 110.163 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -47.19 -66.47 0.4 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 110.265 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -168.26 -43.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 110.222 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.1 mt -73.31 102.12 3.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.949 . . . . 0.0 110.186 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.26 174.7 10.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.295 -0.878 . . . . 0.0 110.147 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 179.84 138.73 3.46 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.419 ' O ' ' OD1' ' A' ' 127' ' ' ASN . 94.0 p -161.89 28.8 0.12 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.314 -1.109 . . . . 0.0 110.204 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 126' ' ' SER . 1.5 m-20 -163.72 -44.95 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.372 -0.83 . . . . 0.0 110.209 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -167.16 161.74 14.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.33 -0.856 . . . . 0.0 110.193 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -150.11 128.52 12.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 110.083 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 24.0 t -120.43 119.75 33.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 110.276 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -133.35 130.17 38.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -0.902 . . . . 0.0 109.852 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.65 ' HA3' ' CA ' ' A' ' 107' ' ' GLY . . . -169.41 -146.56 5.1 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.705 ' CZ3' ' CG ' ' A' ' 180' ' ' TYR . 47.4 m0 -121.54 113.74 20.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -1.138 . . . . 0.0 110.501 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.59 ' C ' HG23 ' A' ' 135' ' ' ILE . 3.9 t70 -118.14 122.9 44.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.554 -0.716 . . . . 0.0 110.164 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.592 ' CG1' ' HA ' ' A' ' 161' ' ' LEU . 17.6 pt -156.84 36.21 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 110.172 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.562 ' O ' ' CE1' ' A' ' 103' ' ' HIS . . . -87.21 -71.91 1.29 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.459 ' HB3' ' CG ' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -81.35 7.98 10.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -1.164 . . . . 0.0 110.229 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 56.43 43.14 90.28 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.681 ' O ' ' C ' ' A' ' 140' ' ' LEU . 19.6 mtpt -86.38 -178.0 6.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -1.119 . . . . 0.0 110.182 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.681 ' C ' ' O ' ' A' ' 139' ' ' LYS . 3.2 tp 0.29 74.05 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.401 0.62 . . . . 0.0 111.334 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.559 ' N ' ' O ' ' A' ' 139' ' ' LYS . 31.7 p90 -106.07 32.37 4.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.927 . . . . 0.0 110.213 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -98.99 60.04 1.2 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 110.262 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -119.66 -74.5 0.61 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.221 -0.924 . . . . 0.0 110.195 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.28 162.73 0.12 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 110.274 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.507 ' HG3' ' N ' ' A' ' 146' ' ' GLY . 44.3 pttt -167.79 -143.1 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.255 -0.903 . . . . 0.0 110.256 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.507 ' N ' ' HG3' ' A' ' 145' ' ' LYS . . . 78.41 -129.07 9.08 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.45 39.25 3.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.198 -1.178 . . . . 0.0 110.218 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -44.47 164.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.153 -0.967 . . . . 0.0 110.287 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.495 ' HB1' ' HD2' ' A' ' 150' ' ' PRO . . . -174.24 165.26 2.61 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.353 -0.842 . . . . 0.0 110.218 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.506 ' HA ' ' N ' ' A' ' 155' ' ' GLY . 46.9 Cg_endo -74.37 1.82 6.94 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.027 1.54 . . . . 0.0 110.461 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.81 -94.72 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.256 -0.903 . . . . 0.0 110.292 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.542 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 3.0 m-85 -79.68 -58.73 0.62 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.113 -0.992 . . . . 0.0 110.412 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.542 ' CD ' ' CB ' ' A' ' 152' ' ' TYR . 45.2 Cg_endo -72.64 164.89 34.27 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.918 1.483 . . . . 0.0 110.49 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.478 ' O ' ' O ' ' A' ' 155' ' ' GLY . . . -67.78 112.94 5.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.329 -0.857 . . . . 0.0 110.316 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.506 ' N ' ' HA ' ' A' ' 150' ' ' PRO . . . -48.76 178.54 0.01 OUTLIER Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.91 -27.13 14.72 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.988 1.52 . . . . 0.0 110.397 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.32 -6.98 11.32 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.318 -0.864 . . . . 0.0 110.456 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -125.77 -10.9 4.2 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 159' ' ' GLU . 1.2 tm-20 -80.51 7.11 10.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.254 -1.145 . . . . 0.0 110.338 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.471 ' O ' ' HB3' ' A' ' 161' ' ' LEU . 26.3 mm100 -45.88 -25.2 0.49 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.307 -0.871 . . . . 0.0 109.753 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.872 ' O ' HG23 ' A' ' 162' ' ' VAL . 2.4 pt? -178.86 27.1 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.393 0.616 . . . . 0.0 110.307 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.872 HG23 ' O ' ' A' ' 161' ' ' LEU . 2.3 t -166.43 96.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.473 -0.767 . . . . 0.0 110.156 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.699 ' HB ' ' HD3' ' A' ' 164' ' ' PRO . 2.7 t -78.15 -67.92 0.25 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.102 -0.998 . . . . 0.0 109.722 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.699 ' HD3' ' HB ' ' A' ' 163' ' ' VAL . 54.7 Cg_endo -78.89 154.44 26.13 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.457 1.24 . . . . 0.0 109.912 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -58.53 -30.61 67.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.043 -1.036 . . . . 0.0 109.374 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.461 ' HG3' ' OG ' ' A' ' 94' ' ' SER . 1.4 ttt180 -151.82 155.83 38.98 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.631 -0.668 . . . . 0.0 109.321 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 1.011 HD23 HG21 ' A' ' 182' ' ' ILE . 1.2 mp -126.86 138.63 53.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.965 -1.084 . . . . 0.0 110.461 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 1.003 HD12 ' CD ' ' A' ' 92' ' ' GLU . 1.0 OUTLIER -120.76 126.71 50.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.337 -0.852 . . . . 0.0 109.969 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.435 HG11 ' HE3' ' A' ' 91' ' ' TRP . 46.0 t -89.93 136.04 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 109.99 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.503 HG22 ' CD2' ' A' ' 168' ' ' LEU . 3.5 t -124.16 126.47 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.205 -0.934 . . . . 0.0 109.971 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 1.043 HD22 ' CZ2' ' A' ' 91' ' ' TRP . 0.0 OUTLIER -133.04 120.39 21.28 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.116 -0.99 . . . . 0.0 109.843 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 173' ' ' MET . 46.1 t0 -117.92 135.28 54.22 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.33 -0.856 . . . . 0.0 109.928 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.465 ' O ' ' C ' ' A' ' 174' ' ' GLU . 0.0 OUTLIER -98.62 -42.44 7.26 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.796 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.491 ' CG ' ' HA2' ' A' ' 87' ' ' GLY . 1.1 mm-40 -43.62 -26.87 0.26 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.223 -0.923 . . . . 0.0 108.72 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.565 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 2.7 tp10 -112.49 -28.32 7.9 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.717 0.77 . . . . 0.0 108.977 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 85.95 22.53 48.89 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 108.684 -1.766 . . . . 0.0 108.684 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.903 HG22 HD22 ' A' ' 194' ' ' LEU . 0.3 OUTLIER -113.77 123.5 49.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.222 -1.163 . . . . 0.0 111.087 -179.513 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.83 HD13 HD12 ' A' ' 171' ' ' LEU . 0.2 OUTLIER -143.89 154.19 43.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.424 -0.797 . . . . 0.0 109.805 179.458 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -177.86 -161.06 25.43 Favored Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.506 -1.331 . . . . 0.0 110.273 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.83 ' O ' HD13 ' A' ' 187' ' ' LEU . 0.5 OUTLIER -118.7 123.52 45.09 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.493 -1.004 . . . . 0.0 109.724 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.765 ' HB2' HD22 ' A' ' 187' ' ' LEU . 5.7 t -130.15 125.68 35.64 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.417 -0.802 . . . . 0.0 110.356 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 1.011 HG21 HD23 ' A' ' 167' ' ' LEU . 0.1 OUTLIER -110.02 116.9 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.216 -0.928 . . . . 0.0 109.911 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 47.93 23.57 2.64 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 69.14 40.17 82.81 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' THR . . . . . 0.925 HG22 ' CD2' ' A' ' 186' ' ' TYR . 92.4 m -71.36 -76.27 0.11 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.277 -1.131 . . . . 0.0 110.642 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.925 ' CD2' HG22 ' A' ' 185' ' ' THR . 25.7 m-85 -126.5 89.28 2.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.172 -0.955 . . . . 0.0 110.641 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.83 HD13 ' O ' ' A' ' 180' ' ' TYR . 0.2 OUTLIER -176.54 26.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.404 -0.81 . . . . 0.0 109.765 179.641 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.575 ' H ' ' HD2' ' A' ' 189' ' ' PRO . . . -95.52 -61.46 1.01 Allowed Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.97 -1.11 . . . . 0.0 110.568 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.575 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 45.0 Cg_endo -71.94 -29.52 15.02 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.951 1.5 . . . . 0.0 111.001 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -74.65 15.78 0.34 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.197 -0.94 . . . . 0.0 111.03 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -90.35 -12.91 36.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.086 -1.009 . . . . 0.0 110.099 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.09 -15.31 34.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.0 110.187 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -109.99 -18.83 8.5 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.903 HD22 HG22 ' A' ' 177' ' ' THR . 6.3 tt -61.82 -32.25 72.55 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.727 -0.867 . . . . 0.0 108.82 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.655 ' HA ' HG23 ' A' ' 177' ' ' THR . 0.0 OUTLIER -47.2 -29.64 2.48 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.576 -0.702 . . . . 0.0 109.422 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -114.19 -19.33 6.35 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.77 ' HD3' HD11 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.88 -4.87 56.22 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.507 -0.996 . . . . 0.0 109.774 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.534 ' O ' ' CG2' ' A' ' 110' ' ' THR . 0.1 OUTLIER -43.38 145.59 0.57 Allowed 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.913 0.863 . . . . 0.0 111.396 -178.269 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.815 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -140.11 172.27 12.99 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.667 ' C ' HG13 ' A' ' 108' ' ' VAL . 1.7 m-85 -82.85 129.62 61.12 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 120.887 -1.133 . . . . 0.0 109.274 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.58 ' HD3' HD12 ' A' ' 178' ' ' LEU . 49.8 Cg_endo -78.07 125.92 7.53 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.079 1.568 . . . . 0.0 111.388 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.55 ' HB3' ' CG ' ' A' ' 81' ' ' LYS . 9.3 p -133.59 138.39 45.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.476 -0.765 . . . . 0.0 109.891 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.842 ' HA ' HG13 ' A' ' 106' ' ' VAL . 7.1 p -119.31 159.54 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.142 -0.974 . . . . 0.0 109.402 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' SER . . . . . 0.686 ' C ' HG23 ' A' ' 105' ' ' VAL . 22.3 m -160.15 162.67 33.98 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.129 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.858 ' HB3' ' CG2' ' A' ' 78' ' ' VAL . . . -150.14 160.13 43.9 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.424 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.678 HG13 ' N ' ' A' ' 207' ' ' TRP . 0.4 OUTLIER -49.42 -176.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.635 -0.666 . . . . 0.0 110.329 179.618 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 0.999 ' O ' HD11 ' A' ' 57' ' ' ILE . 22.7 p-90 -92.4 -44.44 8.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.929 . . . . 0.0 110.05 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.628 ' N ' ' CG ' ' A' ' 207' ' ' TRP . . . -164.33 128.28 1.79 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -173.89 -39.8 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.239 -1.153 . . . . 0.0 110.432 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' CYS . . . . . 0.638 ' CB ' ' O ' ' A' ' 101' ' ' GLY . 1.2 m -155.75 -93.48 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.404 -0.81 . . . . 0.0 110.551 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.601 ' CB ' ' HB2' ' A' ' 100' ' ' ARG . 2.1 mt-30 179.53 159.82 0.74 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.067 -1.021 . . . . 0.0 110.161 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.727 ' HB ' ' CH2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -127.5 144.05 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.165 -0.959 . . . . 0.0 110.784 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.65 ' NE ' ' O ' ' A' ' 213' ' ' ARG . 0.0 OUTLIER -101.46 110.79 22.85 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.256 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.771 HD12 ' CZ3' ' A' ' 48' ' ' TRP . 1.4 tt -118.12 132.84 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.906 -1.121 . . . . 0.0 111.319 -178.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.645 ' O ' ' N ' ' A' ' 92' ' ' GLU . 1.6 mtt180 -130.09 109.41 10.82 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' TYR . . . . . 0.746 ' CZ ' ' CD1' ' A' ' 91' ' ' TRP . 27.3 t80 -113.49 145.49 41.12 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.274 -0.891 . . . . 0.0 111.115 -178.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' MET . . . . . 0.477 ' HA ' ' CE ' ' A' ' 217' ' ' MET . 3.8 tpt -136.56 108.59 7.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.536 -0.727 . . . . 0.0 109.877 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 132.97 7.09 2.67 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.577 ' HB2' ' CD1' ' A' ' 216' ' ' TYR . 22.2 tt0 -95.34 157.66 15.8 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.132 -1.216 . . . . 0.0 110.123 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.08 -162.66 0.96 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.931 . . . . 0.0 110.308 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ARG . . . . . 0.546 ' O ' ' C ' ' A' ' 222' ' ' VAL . 0.0 OUTLIER -160.88 108.05 1.5 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.283 -0.886 . . . . 0.0 110.075 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.546 ' C ' ' O ' ' A' ' 221' ' ' ARG . 2.0 p -29.77 111.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.52 -0.738 . . . . 0.0 110.854 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.538 ' O ' ' C ' ' A' ' 224' ' ' GLU . 0.8 OUTLIER -74.45 53.18 0.52 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.233 -0.917 . . . . 0.0 110.192 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.538 ' C ' ' O ' ' A' ' 223' ' ' GLU . 11.0 pt-20 -29.46 -41.1 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.561 -0.712 . . . . 0.0 110.818 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.602 HG23 ' O ' ' A' ' 225' ' ' THR . 7.0 t -50.24 115.69 1.54 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -0.961 . . . . 0.0 110.211 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.18 57.51 4.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.27 -0.894 . . . . 0.0 110.275 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -157.5 -168.98 2.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.205 -0.934 . . . . 0.0 110.251 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.433 ' O ' ' C ' ' A' ' 229' ' ' HIS . 25.4 mt -111.67 101.76 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.327 -0.858 . . . . 0.0 110.197 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.53 ' O ' ' N ' ' A' ' 231' ' ' ASP . 26.0 t-80 -42.71 -76.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.284 -0.885 . . . . 0.0 110.228 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ARG . . . . . 0.684 ' O ' ' C ' ' A' ' 231' ' ' ASP . 0.9 OUTLIER -56.57 82.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.325 -0.859 . . . . 0.0 110.231 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.684 ' C ' ' O ' ' A' ' 230' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.951 -1.023 . . . . 0.0 111.48 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.8 m -99.74 -56.33 2.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.168 -1.195 . . . . 0.0 110.191 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 t -143.99 -54.18 0.35 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 110.314 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -167.49 -167.04 0.83 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.327 -0.858 . . . . 0.0 110.168 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -83.12 50.4 1.73 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.21 -0.931 . . . . 0.0 110.179 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.25 124.12 9.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.254 -0.904 . . . . 0.0 110.231 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.3 110.1 8.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.915 . . . . 0.0 110.205 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.12 143.85 98.54 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.277 -0.889 . . . . 0.0 110.156 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.94 85.87 1.14 Allowed 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 124.001 1.527 . . . . 0.0 110.453 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.1 t -70.38 171.49 9.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.257 -0.902 . . . . 0.0 110.155 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 18' ' ' ALA . 8.5 t -84.9 -171.96 3.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.198 -0.939 . . . . 0.0 110.058 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -43.5 93.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.921 . . . . 0.0 110.23 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 16' ' ' SER . . . -55.48 -173.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.305 -0.872 . . . . 0.0 110.263 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 19' ' ' LEU . 4.3 mt -55.28 -161.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 110.336 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -63.36 -10.6 17.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 110.35 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.439 ' OG ' ' N ' ' A' ' 22' ' ' ASP . 8.9 t -178.62 -173.42 0.32 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 0.0 110.228 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.439 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.4 OUTLIER -177.41 30.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 110.219 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -145.6 -71.27 0.26 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.304 -0.873 . . . . 0.0 110.265 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.405 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 1.4 p -131.63 105.46 14.31 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.292 -0.88 . . . . 0.0 110.199 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.492 ' HB2' ' HD2' ' A' ' 26' ' ' PRO . 45.9 Cg_endo -73.26 175.13 10.98 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.069 1.563 . . . . 0.0 110.314 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 25' ' ' PRO . 43.3 Cg_endo -71.9 160.37 47.93 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.872 1.459 . . . . 0.0 110.473 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -83.46 43.03 0.86 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.383 -0.823 . . . . 0.0 109.867 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.65 27.14 69.35 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.636 HD11 ' HB2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -70.78 -51.9 24.05 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.46 -1.023 . . . . 0.0 110.075 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.765 ' HA ' HD23 ' A' ' 33' ' ' LEU . 10.8 pt-20 -44.49 -45.95 9.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.146 -0.971 . . . . 0.0 109.225 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.22 -20.79 7.53 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.639 -0.824 . . . . 0.0 108.777 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.605 ' N ' ' O ' ' A' ' 29' ' ' LEU . 4.1 tp -83.83 -33.62 24.85 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.088 HD21 ' CG ' ' A' ' 55' ' ' GLU . 0.4 OUTLIER -73.66 -36.12 65.33 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 122.012 0.911 . . . . 0.0 109.179 179.367 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.583 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 7.3 m -85.0 -6.76 59.33 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.324 0.583 . . . . 0.0 109.775 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.983 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -49.45 -67.61 0.42 Allowed Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.307 -0.871 . . . . 0.0 110.879 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.983 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 46.5 Cg_endo -72.14 157.68 53.61 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.655 1.345 . . . . 0.0 110.366 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 36' ' ' PRO . 53.9 Cg_endo -99.14 55.3 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 121.94 1.76 . . . . 0.0 112.006 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.695 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 49.4 Cg_endo -73.7 150.7 45.38 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.064 1.034 . . . . 0.0 110.108 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.741 ' O ' ' HB3' ' A' ' 43' ' ' GLN . 0.5 OUTLIER -41.86 -21.87 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.199 -0.938 . . . . 0.0 109.873 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.091 HD13 ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -61.2 -50.45 73.07 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.014 -1.053 . . . . 0.0 109.184 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.091 ' N ' HD13 ' A' ' 40' ' ' LEU . 2.9 t -67.27 -39.84 83.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 C-N-CA 118.481 -1.287 . . . . 0.0 110.845 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.36 -39.9 12.41 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.784 -1.197 . . . . 0.0 112.797 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.849 ' OE1' ' HA ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -82.2 -20.54 37.58 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 118.406 -1.318 . . . . 0.0 109.536 -179.414 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.916 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 5.0 ttp180 -68.68 -52.29 32.64 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.895 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 40.6 m-70 -45.62 -23.57 0.26 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.471 ' N ' ' C ' ' A' ' 44' ' ' ARG . 3.3 t-160 -95.96 -33.01 12.32 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.033 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 49' ' ' ASN . . . -87.72 -115.63 1.16 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 107.065 -2.414 . . . . 0.0 107.065 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.803 ' HH2' HG12 ' A' ' 212' ' ' VAL . 93.7 m95 -67.48 74.47 0.16 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.749 -1.442 . . . . 0.0 108.33 177.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.678 ' OD1' ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -44.11 111.62 1.2 Allowed Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.63 -0.669 . . . . 0.0 110.614 -179.29 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.777 ' O ' ' O ' ' A' ' 53' ' ' CYS . 55.4 Cg_endo -79.49 1.65 9.02 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.166 1.91 . . . . 0.0 111.692 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.752 ' HA ' ' HE3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -50.59 -75.6 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.387 -1.446 . . . . 0.0 108.459 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.821 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 0.6 OUTLIER -64.79 3.43 0.54 Allowed 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.876 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.777 ' O ' ' O ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -124.67 170.45 10.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.423 -0.798 . . . . 0.0 110.797 -178.956 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.581 ' N ' ' SG ' ' A' ' 53' ' ' CYS . 4.4 t -100.51 165.8 11.24 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.015 -1.053 . . . . 0.0 108.906 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 1.088 ' CG ' HD21 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -94.32 1.13 55.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.93 -1.106 . . . . 0.0 110.547 -179.045 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.638 ' ND2' ' N ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -22.17 -42.01 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 122.401 1.096 . . . . 0.0 109.937 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.695 ' N ' ' O ' ' A' ' 55' ' ' GLU . 11.3 pt -126.03 169.61 17.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.555 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.64 ' O ' ' HB3' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -105.69 118.04 35.57 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.324 -0.86 . . . . 0.0 109.299 -178.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.734 ' CG1' ' CD1' ' A' ' 48' ' ' TRP . 90.1 t -124.44 136.05 61.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.273 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.849 ' HA ' ' OE1' ' A' ' 43' ' ' GLN . 1.7 ttmt -135.21 155.14 51.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.714 -1.241 . . . . 0.0 111.043 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.552 ' N ' ' OE1' ' A' ' 43' ' ' GLN . 23.2 tt0 -67.47 -109.26 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.453 -0.779 . . . . 0.0 110.226 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.546 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 37.26 35.17 0.15 Allowed Glycine 0 N--CA 1.494 2.558 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.68 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 114.56 56.85 0.38 Allowed Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 -178.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.815 HD22 ' H ' ' A' ' 64' ' ' LEU . 2.0 mm? 0.83 84.98 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.962 -0.728 . . . . 0.0 110.92 -178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 63' ' ' GLY . 1.7 m -128.43 130.61 47.86 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.383 -0.823 . . . . 0.0 110.708 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.69 ' CE2' ' HB ' ' A' ' 212' ' ' VAL . 5.3 m-30 -83.61 152.4 24.84 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.64 ' HB3' ' O ' ' A' ' 58' ' ' ASP . 1.1 tp10 -147.65 121.4 9.25 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.228 -0.92 . . . . 0.0 109.755 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.585 ' HG2' ' CD1' ' A' ' 207' ' ' TRP . 1.0 OUTLIER -118.99 156.32 29.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.419 -0.801 . . . . 0.0 109.416 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.574 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -168.15 -56.94 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 120.98 -1.075 . . . . 0.0 111.043 -179.559 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.636 ' HB2' HD11 ' A' ' 29' ' ' LEU . 41.0 Cg_endo -67.29 -47.14 2.4 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.804 1.423 . . . . 0.0 110.729 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.678 HG11 HG22 ' A' ' 57' ' ' ILE . 2.0 p -78.31 165.38 3.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.879 0.847 . . . . 0.0 111.048 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.554 ' N ' HG22 ' A' ' 71' ' ' VAL . . . -156.59 -40.01 0.08 Allowed 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.049 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 75' ' ' THR . 1.8 mt-30 -74.73 151.56 39.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.906 . . . . 0.0 110.125 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.9 91.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.335 -0.853 . . . . 0.0 110.21 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.51 ' N ' ' O ' ' A' ' 73' ' ' GLN . 2.6 m -97.03 -130.38 0.18 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.32 -0.862 . . . . 0.0 110.061 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.513 ' O ' ' O ' ' A' ' 77' ' ' GLY . 0.2 OUTLIER -120.75 113.8 20.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.186 -0.946 . . . . 0.0 110.452 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.577 ' HA2' ' CE3' ' A' ' 207' ' ' TRP . . . -57.14 -114.24 0.01 OUTLIER Glycine 0 N--CA 1.485 1.925 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -148.42 123.17 2.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.944 -1.327 . . . . 0.0 110.979 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.821 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -104.47 175.08 5.61 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.549 -0.72 . . . . 0.0 109.489 179.313 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.576 ' N ' ' CG ' ' A' ' 79' ' ' ARG . . . -157.42 58.29 0.36 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.533 ' HG3' ' CB ' ' A' ' 202' ' ' SER . 0.7 OUTLIER -89.9 75.02 7.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.075 -1.25 . . . . 0.0 110.122 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.779 ' HD3' ' H ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -141.94 -95.29 0.13 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.316 -0.865 . . . . 0.0 110.292 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.779 ' H ' ' HD3' ' A' ' 82' ' ' ARG . . . 56.54 62.23 6.59 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -105.71 95.7 5.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.177 -1.19 . . . . 0.0 110.261 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.452 ' HB3' HD21 ' A' ' 171' ' ' LEU . 0.4 OUTLIER -140.01 171.51 14.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 110.018 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.714 ' O ' ' CE1' ' A' ' 89' ' ' HIS . 30.1 mtm180 -123.38 175.79 6.52 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.164 -0.96 . . . . 0.0 110.237 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.519 ' N ' ' HB3' ' A' ' 173' ' ' MET . . . 62.52 -116.45 9.39 Favored Glycine 0 N--CA 1.482 1.722 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.448 HD12 ' HB2' ' A' ' 172' ' ' ASP . 11.6 tp -129.37 127.76 41.69 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.559 -0.966 . . . . 0.0 110.995 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.814 ' HB2' HD23 ' A' ' 171' ' ' LEU . 41.0 m80 -147.26 173.16 12.82 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.269 -0.895 . . . . 0.0 109.95 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.544 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -163.81 164.11 23.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.261 -0.899 . . . . 0.0 110.133 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.722 ' CD1' ' CZ ' ' A' ' 216' ' ' TYR . 1.1 m0 -134.86 145.89 48.73 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.301 -0.874 . . . . 0.0 109.54 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.644 ' O ' ' N ' ' A' ' 215' ' ' ARG . 2.1 tt0 -109.97 118.9 37.67 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.431 -0.907 . . . . 0.0 109.883 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.533 HD13 ' O ' ' A' ' 92' ' ' GLU . 17.3 mm -118.08 130.05 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.019 -1.051 . . . . 0.0 111.028 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.558 ' CB ' ' HB3' ' A' ' 213' ' ' ARG . 0.0 OUTLIER -118.53 126.38 51.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.404 -0.81 . . . . 0.0 109.428 179.319 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.769 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 7.1 t-105 -117.3 88.19 27.03 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.119 -0.988 . . . . 0.0 110.217 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.535 ' HD2' ' HA ' ' A' ' 212' ' ' VAL . 50.0 Cg_endo -96.21 112.21 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 121.968 1.779 . . . . 0.0 110.673 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.852 HD22 ' OG1' ' A' ' 102' ' ' THR . 0.5 OUTLIER -95.07 -67.41 0.85 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.824 -1.173 . . . . 0.0 110.184 179.641 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.517 ' CG ' HD23 ' A' ' 97' ' ' LEU . 3.3 mt-10 -98.0 -24.81 15.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 0.0 109.808 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.477 ' OE1' ' CB ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER 179.96 -29.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.643 0.735 . . . . 0.0 109.614 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.435 ' HG2' ' CG ' ' A' ' 99' ' ' GLN . 5.6 mmt180 -119.58 -50.62 2.31 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.529 -0.732 . . . . 0.0 109.649 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.669 ' HA2' ' O ' ' A' ' 95' ' ' TRP . . . 170.15 -164.86 38.21 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.852 ' OG1' HD22 ' A' ' 97' ' ' LEU . 2.8 m -170.62 -55.39 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.235 -1.156 . . . . 0.0 110.523 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.755 ' CE1' HG23 ' A' ' 162' ' ' VAL . 7.1 m-70 -167.32 103.37 0.52 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.094 -1.003 . . . . 0.0 111.103 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.769 ' HA ' ' CE2' ' A' ' 95' ' ' TRP . . . -88.62 146.78 24.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.222 -0.924 . . . . 0.0 109.165 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.905 HG12 ' CD1' ' A' ' 135' ' ' ILE . 0.7 OUTLIER -110.61 114.57 47.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 C-N-CA 117.778 -1.569 . . . . 0.0 109.197 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.806 HG13 ' O ' ' A' ' 202' ' ' SER . 22.2 t -152.04 159.8 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.277 -0.889 . . . . 0.0 109.574 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.613 ' HA2' ' HA3' ' A' ' 132' ' ' GLY . . . -175.57 136.77 3.48 Favored Glycine 0 N--CA 1.487 2.078 0 C-N-CA 118.826 -1.654 . . . . 0.0 110.859 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.862 HG13 ' C ' ' A' ' 200' ' ' TYR . 2.8 t -104.42 141.71 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.601 -0.941 . . . . 0.0 108.999 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.904 ' HB3' ' CZ ' ' A' ' 200' ' ' TYR . . . -130.54 152.39 49.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.883 -1.136 . . . . 0.0 111.126 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.977 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -121.13 130.87 53.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.481 -0.762 . . . . 0.0 110.055 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -89.44 -25.96 21.22 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.291 -0.881 . . . . 0.0 109.343 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.501 ' O ' ' HD3' ' A' ' 114' ' ' PRO . 1.4 pp -83.35 -12.49 56.51 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.489 -0.757 . . . . 0.0 109.398 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.59 ' HB3' ' HB ' ' A' ' 110' ' ' THR . . . -107.65 85.12 2.19 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.47 -0.769 . . . . 0.0 110.246 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 112' ' ' LEU . 46.4 Cg_endo -73.14 104.78 1.84 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.922 1.485 . . . . 0.0 110.5 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.484 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 0.2 OUTLIER 179.95 60.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.277 -0.889 . . . . 0.0 110.162 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 9.8 tt0 -66.92 -40.98 87.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.942 . . . . 0.0 110.33 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.534 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . 179.87 -72.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.246 -0.909 . . . . 0.0 110.181 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.888 ' OD1' ' HB3' ' A' ' 121' ' ' ALA . 11.2 t0 -31.28 126.83 0.19 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.511 -0.743 . . . . 0.0 110.769 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -93.83 -75.55 0.5 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.293 -0.879 . . . . 0.0 110.177 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -118.45 8.65 12.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.929 . . . . 0.0 110.198 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.888 ' HB3' ' OD1' ' A' ' 118' ' ' ASP . . . -70.39 -22.29 62.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.186 -0.946 . . . . 0.0 110.217 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.716 ' HB3' ' OD2' ' A' ' 118' ' ' ASP . . . -152.55 25.97 0.58 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.934 . . . . 0.0 110.224 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.834 ' C ' HD13 ' A' ' 124' ' ' LEU . 25.2 mt 47.52 -147.39 0.2 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.322 -0.861 . . . . 0.0 110.212 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.93 ' N ' HD13 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -160.49 -171.96 3.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.34 -0.85 . . . . 0.0 110.41 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 121.22 -3.84 11.33 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.1 m -152.59 47.97 0.74 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.243 -1.151 . . . . 0.0 110.199 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -157.61 160.08 37.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.365 -0.834 . . . . 0.0 110.117 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.5 p -114.67 -160.37 0.73 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.907 . . . . 0.0 110.131 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.578 ' OE2' ' CG ' ' A' ' 131' ' ' TRP . 4.6 tm-20 -145.03 126.84 15.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.902 . . . . 0.0 109.892 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -122.09 119.45 31.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.946 . . . . 0.0 110.666 -179.727 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 131' ' ' TRP . . . . . 0.578 ' CG ' ' OE2' ' A' ' 129' ' ' GLU . 16.7 m0 -133.25 133.27 42.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.47 -0.768 . . . . 0.0 109.519 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.613 ' HA3' ' HA2' ' A' ' 107' ' ' GLY . . . -177.23 -140.94 3.84 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.442 -1.361 . . . . 0.0 110.207 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.564 ' CH2' ' O ' ' A' ' 180' ' ' TYR . 52.0 m0 -117.17 112.95 21.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.207 -1.172 . . . . 0.0 110.75 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.537 ' O ' ' CD2' ' A' ' 161' ' ' LEU . 0.3 OUTLIER -119.33 148.27 43.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.761 -0.587 . . . . 0.0 110.269 179.608 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.905 ' CD1' HG12 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -101.86 -11.2 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.204 -0.935 . . . . 0.0 109.955 179.574 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.78 -8.49 52.98 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.636 HH21 HD11 ' A' ' 161' ' ' LEU . 1.1 mtm-85 -83.75 0.49 47.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.401 -1.058 . . . . 0.0 109.312 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.744 ' O ' ' O ' ' A' ' 139' ' ' LYS . . . -116.22 -16.74 6.52 Favored Glycine 0 N--CA 1.485 1.908 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.744 ' O ' ' O ' ' A' ' 138' ' ' GLY . 0.1 OUTLIER 0.98 -131.1 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 CA-C-O 121.771 0.796 . . . . 0.0 112.283 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.454 ' C ' ' O ' ' A' ' 139' ' ' LYS . 38.9 mt -37.66 -67.5 0.19 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.574 -0.704 . . . . 0.0 110.443 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -139.34 -104.8 0.17 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.209 -0.932 . . . . 0.0 110.282 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -148.26 72.75 1.22 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.215 -0.928 . . . . 0.0 110.219 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.488 ' CG ' ' N ' ' A' ' 144' ' ' SER . 10.5 pt20 -45.31 -40.61 7.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.314 -0.866 . . . . 0.0 110.195 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.488 ' N ' ' CG ' ' A' ' 143' ' ' GLN . 58.4 m -68.97 102.88 1.69 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.188 -0.945 . . . . 0.0 110.33 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.04 98.88 11.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.183 -0.948 . . . . 0.0 110.122 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.4 -105.63 0.99 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 148' ' ' GLU . 0.5 OUTLIER -159.02 86.01 0.82 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.291 -1.123 . . . . 0.0 110.187 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 147' ' ' LEU . 0.7 OUTLIER -44.59 115.49 0.87 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.213 -0.929 . . . . 0.0 110.141 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.547 ' N ' ' CD ' ' A' ' 150' ' ' PRO . . . -130.02 49.39 4.66 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.343 -0.848 . . . . 0.0 110.132 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.547 ' CD ' ' N ' ' A' ' 149' ' ' ALA . 46.1 Cg_endo -73.23 -1.02 9.97 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.989 1.52 . . . . 0.0 110.404 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -66.93 -91.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.159 -0.963 . . . . 0.0 110.265 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.563 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 0.5 OUTLIER -77.5 -59.73 0.81 Allowed Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.191 -0.943 . . . . 0.0 110.247 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.563 ' CD ' ' CB ' ' A' ' 152' ' ' TYR . 45.8 Cg_endo -72.98 152.59 51.82 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.026 1.54 . . . . 0.0 110.397 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 155' ' ' GLY . . . -91.28 127.1 36.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.146 -0.971 . . . . 0.0 110.238 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 154' ' ' ALA . . . -42.1 110.59 0.25 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.42 -20.8 23.55 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.967 1.509 . . . . 0.0 110.369 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.539 ' HA ' ' HB2' ' A' ' 160' ' ' GLN . 0.0 OUTLIER -68.62 -1.51 6.97 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.334 -0.854 . . . . 0.0 110.601 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.439 ' O ' ' HB ' ' A' ' 162' ' ' VAL . . . -61.86 -61.75 6.42 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -92.33 4.84 52.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.209 -1.171 . . . . 0.0 110.213 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.999 ' O ' HD12 ' A' ' 161' ' ' LEU . 15.4 tt0 -73.53 -18.43 61.09 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.329 -0.857 . . . . 0.0 109.222 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.999 HD12 ' O ' ' A' ' 160' ' ' GLN . 0.2 OUTLIER -159.73 21.62 0.17 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.864 0.84 . . . . 0.0 109.444 179.414 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 161' ' ' LEU . 2.5 t -163.14 95.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.716 -0.615 . . . . 0.0 109.937 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.682 HG11 HG21 ' A' ' 182' ' ' ILE . 1.7 t -108.47 76.32 0.65 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.15 -0.969 . . . . 0.0 110.149 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.588 ' HD3' HG12 ' A' ' 162' ' ' VAL . 46.8 Cg_endo -73.18 65.16 4.31 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.903 1.475 . . . . 0.0 110.75 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 27.2 tp10 -167.83 -84.14 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.398 -0.814 . . . . 0.0 110.101 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -152.31 155.86 38.49 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.4 -0.812 . . . . 0.0 110.344 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.668 ' HA ' HG22 ' A' ' 182' ' ' ILE . 2.9 mp -135.74 137.02 41.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 109.793 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.585 HD22 ' HA ' ' A' ' 92' ' ' GLU . 0.2 OUTLIER -130.53 114.21 15.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.066 -1.021 . . . . 0.0 110.571 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.878 HG22 ' CE1' ' A' ' 180' ' ' TYR . 18.4 t -89.92 136.04 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.852 . . . . 0.0 109.784 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.434 ' HB ' ' CD1' ' A' ' 187' ' ' LEU . 7.5 t -113.06 111.18 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.089 -1.007 . . . . 0.0 110.519 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 1.045 HD12 HD23 ' A' ' 178' ' ' LEU . 0.0 OUTLIER -119.68 105.6 11.33 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.292 -0.88 . . . . 0.0 109.311 179.607 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.448 ' HB2' HD12 ' A' ' 88' ' ' LEU . 5.5 t0 -120.33 135.3 55.06 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.577 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.576 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 0.3 OUTLIER -95.9 -40.68 9.18 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.414 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -44.73 -26.39 0.38 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.299 -0.876 . . . . 0.0 108.99 179.205 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.618 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.0 OUTLIER -110.78 -26.79 9.18 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.282 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.918 ' O ' HG21 ' A' ' 198' ' ' THR . . . 81.53 25.46 53.9 Favored Glycine 0 N--CA 1.482 1.73 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.925 HG22 ' HB3' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -118.56 112.08 19.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.196 -1.179 . . . . 0.0 111.381 -179.484 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 1.045 HD23 HD12 ' A' ' 171' ' ' LEU . 4.0 mp -118.76 153.85 33.77 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.481 -0.762 . . . . 0.0 109.256 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 177.39 -174.47 46.99 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.07 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.878 ' CE1' HG22 ' A' ' 169' ' ' VAL . 0.3 OUTLIER -123.99 125.62 44.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.341 -1.094 . . . . 0.0 109.949 179.896 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 35.5 t -136.69 132.77 35.37 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.268 -0.895 . . . . 0.0 110.194 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.682 HG21 HG11 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -103.67 116.81 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.309 -0.87 . . . . 0.0 109.756 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 88.76 -10.41 72.44 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 80.61 46.82 7.1 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 185' ' ' THR . 79.8 m -129.41 -2.5 4.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.255 -1.144 . . . . 0.0 110.441 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.432 ' CE2' HD11 ' A' ' 182' ' ' ILE . 0.2 OUTLIER -99.77 -54.96 2.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.207 -0.933 . . . . 0.0 110.264 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.891 HD21 ' CD1' ' A' ' 194' ' ' LEU . 5.3 mt -77.48 44.54 0.44 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.225 -0.922 . . . . 0.0 109.785 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -80.91 -96.78 0.39 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 191' ' ' PHE . 46.9 Cg_endo -72.9 -25.1 16.97 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 124.229 1.647 . . . . 0.0 111.017 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.55 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -68.62 21.42 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.506 -0.746 . . . . 0.0 111.76 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.829 ' CE1' HD22 ' A' ' 187' ' ' LEU . 0.2 OUTLIER -90.23 -13.83 34.63 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.707 -1.246 . . . . 0.0 110.349 179.467 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.05 -14.72 33.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.105 -0.997 . . . . 0.0 110.597 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -112.63 -11.16 15.3 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.925 ' HB3' HG22 ' A' ' 177' ' ' THR . 7.5 tt -74.69 -28.58 60.88 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.474 -1.015 . . . . 0.0 109.108 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.488 ' O ' ' OG1' ' A' ' 198' ' ' THR . 0.0 OUTLIER -54.08 -33.82 58.54 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.385 -0.822 . . . . 0.0 109.714 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -94.23 -26.88 12.98 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.792 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.46 -6.08 55.29 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.68 -0.894 . . . . 0.0 109.943 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.918 HG21 ' O ' ' A' ' 176' ' ' GLY . 0.2 OUTLIER -44.59 131.86 6.5 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.877 0.846 . . . . 0.0 112.532 -178.114 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.977 ' CB ' HG23 ' A' ' 110' ' ' THR . 0.0 OUTLIER -140.74 170.75 15.18 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.571 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.904 ' CZ ' ' HB3' ' A' ' 109' ' ' ALA . 25.6 p90 -84.6 128.72 60.1 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 120.775 -1.203 . . . . 0.0 109.548 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.766 ' N ' HG13 ' A' ' 108' ' ' VAL . 51.0 Cg_endo -84.49 143.78 9.96 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.138 1.599 . . . . 0.0 111.393 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.806 ' O ' HG13 ' A' ' 106' ' ' VAL . 0.9 OUTLIER -133.54 138.54 46.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.51 -0.744 . . . . 0.0 109.908 179.401 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.54 HG23 HG22 ' A' ' 106' ' ' VAL . 14.6 p -119.64 157.93 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.161 -0.962 . . . . 0.0 110.108 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' SER . . . . . 0.798 ' O ' HG22 ' A' ' 105' ' ' VAL . 0.4 OUTLIER -160.18 145.87 15.28 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.391 -0.818 . . . . 0.0 110.688 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.85 ' CB ' HG11 ' A' ' 212' ' ' VAL . . . -146.21 166.44 26.23 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.56 0.695 . . . . 0.0 110.573 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.581 HG13 ' N ' ' A' ' 207' ' ' TRP . 1.2 t -110.24 176.17 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 CA-C-O 121.456 0.646 . . . . 0.0 110.608 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 0.632 ' CE3' HD13 ' A' ' 57' ' ' ILE . 4.4 p90 -124.97 175.52 7.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.349 -0.844 . . . . 0.0 110.016 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 113.38 -165.57 12.05 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.452 ' O ' ' O ' ' A' ' 210' ' ' CYS . 0.0 OUTLIER -44.52 -29.39 0.71 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.393 -1.063 . . . . 0.0 110.3 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 210' ' ' CYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 211' ' ' GLN . 27.0 p -58.03 -154.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.318 -0.864 . . . . 0.0 110.236 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.529 ' O ' ' O ' ' A' ' 96' ' ' PRO . 0.9 OUTLIER 179.59 125.34 0.07 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.248 -0.908 . . . . 0.0 110.377 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.85 HG11 ' CB ' ' A' ' 205' ' ' ALA . 8.3 t -128.6 144.32 38.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 121.671 -0.643 . . . . 0.0 109.941 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.558 ' HB3' ' CB ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -122.41 124.35 43.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.247 -0.908 . . . . 0.0 109.996 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.804 HG22 HD12 ' A' ' 64' ' ' LEU . 2.3 tt -119.22 128.06 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.013 -1.054 . . . . 0.0 111.183 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.644 ' N ' ' O ' ' A' ' 92' ' ' GLU . 1.1 mtt180 -130.14 136.9 49.8 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.407 -0.808 . . . . 0.0 109.259 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' TYR . . . . . 0.722 ' CZ ' ' CD1' ' A' ' 91' ' ' TRP . 14.0 t80 -118.9 150.17 40.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.04 -1.038 . . . . 0.0 110.908 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' MET . . . . . 0.505 ' CB ' ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -124.57 107.68 11.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.944 . . . . 0.0 110.05 179.371 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 95.71 74.02 1.2 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.528 ' HB2' ' CD1' ' A' ' 216' ' ' TYR . 3.6 tp10 -135.52 130.58 34.83 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.187 -1.184 . . . . 0.0 110.125 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.492 ' O ' ' CG ' ' A' ' 220' ' ' ARG . 0.0 OUTLIER -126.58 109.52 12.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.122 -0.986 . . . . 0.0 110.341 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ARG . . . . . 0.636 ' O ' HG23 ' A' ' 222' ' ' VAL . 2.5 tpm_? -178.78 100.62 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.255 -0.903 . . . . 0.0 110.224 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 221' ' ' ARG . 1.0 OUTLIER -169.22 127.12 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.115 -0.991 . . . . 0.0 110.333 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.531 ' O ' ' C ' ' A' ' 224' ' ' GLU . 0.1 OUTLIER 179.83 -31.1 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.192 -0.943 . . . . 0.0 110.227 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.531 ' C ' ' O ' ' A' ' 223' ' ' GLU . 2.1 mt-10 -32.4 -44.19 0.09 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.349 -0.844 . . . . 0.0 110.725 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.575 HG22 ' H ' ' A' ' 227' ' ' ARG . 27.0 m -47.07 135.73 9.4 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.19 -0.944 . . . . 0.0 110.202 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.43 18.45 7.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.902 . . . . 0.0 110.218 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.575 ' H ' HG22 ' A' ' 225' ' ' THR . 7.3 ptm180 -160.56 -170.54 2.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.277 -0.89 . . . . 0.0 110.174 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.493 ' O ' HG23 ' A' ' 228' ' ' ILE . 3.8 tp -162.91 117.58 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 110.212 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 23.4 p80 -117.44 -0.01 12.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 110.167 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ARG . . . . . 0.682 ' O ' ' C ' ' A' ' 231' ' ' ASP . 0.0 OUTLIER -50.33 110.06 0.36 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.235 -0.915 . . . . 0.0 110.191 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.682 ' C ' ' O ' ' A' ' 230' ' ' ARG . 8.9 t0 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.971 -1.014 . . . . 0.0 111.432 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.3 p -49.14 -24.67 1.76 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.272 -1.134 . . . . 0.0 110.183 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.24 -47.96 0.27 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.296 -0.877 . . . . 0.0 110.185 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.38 166.41 23.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.223 -0.923 . . . . 0.0 110.186 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.446 ' O ' ' O ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -99.81 -28.12 13.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.314 -0.866 . . . . 0.0 110.197 -179.889 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.446 ' O ' ' O ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -47.22 175.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.199 -0.938 . . . . 0.0 110.186 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.78 74.95 1.68 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.912 . . . . 0.0 110.172 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.546 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -47.24 -55.73 14.86 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 110.241 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 13' ' ' THR . 46.5 Cg_endo -72.75 121.58 7.48 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.124 1.592 . . . . 0.0 110.556 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.445 ' O ' ' HB3' ' A' ' 16' ' ' SER . 0.1 OUTLIER -92.5 64.58 4.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 110.233 -179.912 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.445 ' HB3' ' O ' ' A' ' 15' ' ' THR . 10.6 p -178.3 63.91 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.309 -0.869 . . . . 0.0 110.2 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -104.18 96.21 6.49 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.249 -0.907 . . . . 0.0 110.245 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.75 134.51 41.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.116 -0.99 . . . . 0.0 110.269 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.92 -5.24 58.11 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.328 1.061 . . . . 0.0 110.301 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -170.92 -141.01 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.233 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.7 m -103.01 33.77 3.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.181 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -83.15 44.23 0.93 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.168 -0.958 . . . . 0.0 110.312 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.23 -41.87 16.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 110.159 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.36 105.36 56.51 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.333 -0.854 . . . . 0.0 110.063 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.2 133.89 20.22 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.017 1.535 . . . . 0.0 110.583 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.706 ' O ' ' N ' ' A' ' 28' ' ' GLY . 46.1 Cg_endo -72.79 -161.09 0.1 Allowed 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.052 1.554 . . . . 0.0 110.512 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.674 ' C ' ' O ' ' A' ' 26' ' ' PRO . 28.9 mm-40 1.71 64.78 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.615 0.721 . . . . 0.0 111.125 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.706 ' N ' ' O ' ' A' ' 26' ' ' PRO . . . 160.8 27.9 0.02 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.903 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -60.23 -19.91 56.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.268 -1.137 . . . . 0.0 109.657 179.743 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 1.003 ' HA ' HD23 ' A' ' 33' ' ' LEU . 16.8 pt-20 -49.42 -28.42 5.15 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.255 -0.903 . . . . 0.0 109.167 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.441 ' N ' ' HG3' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -68.24 -23.3 64.78 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.513 -0.875 . . . . 0.0 108.687 179.011 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.539 ' CB ' HD12 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -83.37 -36.84 24.03 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.697 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.003 HD23 ' HA ' ' A' ' 30' ' ' GLU . 0.3 OUTLIER -69.75 -35.79 75.25 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 122.022 0.915 . . . . 0.0 109.365 179.165 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.62 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 1.5 m -78.99 -7.51 58.13 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.804 -0.56 . . . . 0.0 110.346 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 1.059 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -38.63 -66.54 0.31 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.249 -0.907 . . . . 0.0 110.307 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 1.059 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 49.0 Cg_endo -74.5 151.88 42.75 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.645 1.34 . . . . 0.0 109.938 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 36' ' ' PRO . 54.1 Cg_endo -99.06 53.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.856 1.704 . . . . 0.0 112.235 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.743 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 52.7 Cg_endo -76.7 150.12 30.74 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 122.906 0.95 . . . . 0.0 110.384 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.742 ' HB3' ' NE2' ' A' ' 43' ' ' GLN . 1.6 t0 -40.78 -30.39 0.12 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 108.624 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.116 HD13 ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -40.95 -44.54 2.36 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.414 0.626 . . . . 0.0 109.449 179.926 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.116 ' N ' HD13 ' A' ' 40' ' ' LEU . 6.1 t -65.66 -27.25 40.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.797 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 39' ' ' ASP . . . -88.85 -43.57 11.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.91 -1.119 . . . . 0.0 111.587 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.742 ' NE2' ' HB3' ' A' ' 39' ' ' ASP . 2.7 mt-30 -81.32 -20.32 41.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.845 -1.16 . . . . 0.0 109.671 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.891 ' HE ' HD21 ' A' ' 40' ' ' LEU . 4.1 ttp85 -71.87 -55.03 8.28 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.709 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 21.1 m-70 -54.26 -27.56 35.77 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.367 0.603 . . . . 0.0 109.573 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.585 ' CE1' ' HG2' ' A' ' 220' ' ' ARG . 0.9 OUTLIER -95.54 -30.62 13.73 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.324 179.083 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 43' ' ' GLN . . . -84.41 -103.73 0.6 Allowed Glycine 0 N--CA 1.487 2.056 0 N-CA-C 107.429 -2.269 . . . . 0.0 107.429 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.814 ' HB2' HG21 ' A' ' 59' ' ' VAL . 91.8 m95 -76.88 74.42 3.49 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.206 -1.173 . . . . 0.0 109.184 178.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.709 ' OD1' ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -44.19 110.9 1.07 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.718 -0.614 . . . . 0.0 110.675 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.64 ' CD ' ' HE2' ' A' ' 51' ' ' LYS . 47.1 Cg_endo -72.08 0.93 6.51 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.202 1.935 . . . . 0.0 112.134 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.719 ' H ' ' CE ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -71.79 -33.1 68.29 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 178.36 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.755 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 8.9 m-20 -117.29 -12.59 10.49 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 113.913 -1.494 . . . . 0.0 107.363 177.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.742 ' HA ' ' HB ' ' A' ' 78' ' ' VAL . 9.0 t -105.81 147.15 28.97 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.175 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.475 ' H ' ' CB ' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -77.6 105.29 8.66 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.244 -0.91 . . . . 0.0 109.426 179.059 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.709 ' O ' HD22 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -70.2 4.04 2.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.448 -0.782 . . . . 0.0 110.4 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.88 ' O ' HG11 ' A' ' 71' ' ' VAL . 1.4 m120 -41.4 -29.52 0.15 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.752 0.787 . . . . 0.0 109.446 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.916 HG21 ' CD1' ' A' ' 207' ' ' TRP . 25.2 pt -112.94 168.88 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.605 ' O ' ' HB3' ' A' ' 67' ' ' GLU . 10.2 t0 -105.85 103.48 12.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.894 -1.129 . . . . 0.0 109.925 -178.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.814 HG21 ' HB2' ' A' ' 48' ' ' TRP . 3.6 m -118.24 135.81 57.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.804 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.682 ' HG3' ' CD ' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -124.92 143.3 50.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.011 -1.055 . . . . 0.0 110.844 -179.423 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.535 ' O ' ' C ' ' A' ' 62' ' ' GLY . 46.1 tt0 -63.61 -124.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.452 -0.78 . . . . 0.0 109.954 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.535 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 37.7 50.61 1.93 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.674 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 109.33 46.89 0.9 Allowed Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.106 -1.997 . . . . 0.0 108.106 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.674 ' C ' ' O ' ' A' ' 63' ' ' GLY . 2.2 mm? 0.76 86.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.541 0.686 . . . . 0.0 111.252 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.0 t -120.29 117.55 28.12 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.521 -0.737 . . . . 0.0 110.507 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.738 ' CE1' ' CD2' ' A' ' 48' ' ' TRP . 1.8 m-85 -82.51 130.65 35.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.388 -0.82 . . . . 0.0 109.186 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.605 ' HB3' ' O ' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -132.9 121.81 23.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.902 -1.124 . . . . 0.0 110.528 179.626 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.508 ' O ' ' HD3' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -125.31 156.26 38.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.492 -0.755 . . . . 0.0 109.229 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.544 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 11.5 tpp180 -174.68 -56.92 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 120.773 -1.204 . . . . 0.0 111.183 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 69' ' ' ARG . 41.2 Cg_endo -67.01 -50.39 1.08 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.651 1.343 . . . . 0.0 110.542 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.88 HG11 ' O ' ' A' ' 56' ' ' ASN . 1.3 p -78.57 165.23 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 121.739 0.78 . . . . 0.0 110.852 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.534 ' N ' ' CG2' ' A' ' 71' ' ' VAL . . . -163.83 -43.1 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.257 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 75' ' ' THR . 16.8 mt-30 -56.1 -172.85 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.156 -0.965 . . . . 0.0 110.246 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.74 85.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.916 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.696 HG22 ' CG ' ' A' ' 56' ' ' ASN . 0.1 OUTLIER -136.96 5.36 2.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -0.868 . . . . 0.0 110.312 -179.619 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.585 ' CB ' ' NE1' ' A' ' 207' ' ' TRP . 1.8 p30 -99.16 155.07 17.66 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.217 -0.927 . . . . 0.0 109.962 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 114.65 104.36 2.55 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 106.848 -2.501 . . . . 0.0 106.848 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.806 ' O ' ' HA ' ' A' ' 204' ' ' SER . 2.0 m -116.95 163.0 14.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.161 -1.2 . . . . 0.0 110.322 -178.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.755 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 3.9 ttp180 -120.16 169.34 10.33 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.643 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.559 ' HA2' ' CB ' ' A' ' 52' ' ' ASP . . . -164.22 83.46 0.11 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.496 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 3.7 ttpm? -116.88 16.11 15.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.389 -1.065 . . . . 0.0 110.421 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.456 ' O ' ' C ' ' A' ' 83' ' ' GLY . 1.1 ptt180 -76.16 -101.98 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.106 -0.996 . . . . 0.0 110.228 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 82' ' ' ARG . . . 41.58 46.22 4.62 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.45 ' CE1' ' NH1' ' A' ' 86' ' ' ARG . 0.6 OUTLIER -98.58 103.88 15.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.228 -1.16 . . . . 0.0 110.174 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.561 ' HB3' ' CE1' ' A' ' 89' ' ' HIS . 11.5 t -139.9 173.36 11.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 110.362 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.551 ' N ' ' CD ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -118.53 139.33 51.62 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.372 -0.83 . . . . 0.0 109.827 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 103.36 -112.25 4.17 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.66 ' C ' HD23 ' A' ' 88' ' ' LEU . 7.5 tt -128.18 134.53 49.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -1.128 . . . . 0.0 110.362 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.581 ' CD2' ' O ' ' A' ' 88' ' ' LEU . 7.7 m80 -146.86 161.7 40.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.329 -0.857 . . . . 0.0 109.688 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.06 146.59 10.86 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.082 -1.011 . . . . 0.0 110.508 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 1.122 ' CZ2' HG11 ' A' ' 169' ' ' VAL . 1.7 p90 -135.13 171.3 14.63 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.305 -0.872 . . . . 0.0 109.473 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 215' ' ' ARG . 15.6 tt0 -137.71 140.12 40.55 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.265 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.616 HG13 ' CD1' ' A' ' 91' ' ' TRP . 4.4 mt -140.03 154.22 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.984 ' O ' HG23 ' A' ' 212' ' ' VAL . 0.4 OUTLIER -147.24 122.12 9.98 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.03 -1.068 . . . . 0.0 111.651 -179.005 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 1.023 ' CZ3' ' HB3' ' A' ' 104' ' ' ALA . 37.0 m95 -111.63 88.45 9.45 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 94' ' ' SER . 52.5 Cg_endo -83.61 108.95 1.51 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.695 1.366 . . . . 0.0 111.524 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.669 HD23 ' HB2' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -96.86 -26.69 15.0 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.253 -0.904 . . . . 0.0 109.622 178.861 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -37.36 -45.39 0.68 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.468 -0.77 . . . . 0.0 110.808 -179.196 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.77 -95.99 0.15 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.077 -1.014 . . . . 0.0 109.682 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.497 ' O ' ' O ' ' A' ' 101' ' ' GLY . 2.2 ptp180 -121.41 -141.63 0.33 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.405 -0.809 . . . . 0.0 109.571 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' A' ' 210' ' ' CYS . . . 37.29 94.07 0.01 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.289 -1.125 . . . . 0.0 110.289 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.663 ' N ' ' HA ' ' A' ' 210' ' ' CYS . 0.0 OUTLIER -54.94 -160.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -1.144 . . . . 0.0 110.294 179.457 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.833 ' CE1' HD11 ' A' ' 135' ' ' ILE . 35.2 t-80 -127.44 165.73 19.25 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.305 -0.872 . . . . 0.0 109.742 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 1.023 ' HB3' ' CZ3' ' A' ' 95' ' ' TRP . . . -146.8 -92.77 0.09 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.824 -1.172 . . . . 0.0 111.744 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.975 HG22 ' O ' ' A' ' 204' ' ' SER 0.264 3.6 m -136.9 138.91 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 117.506 -1.678 . . . . 0.0 114.964 -175.979 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.769 HG22 ' CE2' ' A' ' 95' ' ' TRP . 1.0 OUTLIER -152.27 122.47 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.399 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 202' ' ' SER . . . 168.76 -161.64 35.36 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 118.832 -1.651 . . . . 0.0 110.898 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.044 HG23 ' C ' ' A' ' 200' ' ' TYR . 1.4 p -141.49 150.67 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.596 -0.943 . . . . 0.0 109.835 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 200' ' ' TYR . . . -128.57 152.78 47.92 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.059 -1.026 . . . . 0.0 110.724 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.768 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -101.24 126.35 47.97 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.264 -0.898 . . . . 0.0 110.296 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.528 ' HB3' ' HE2' ' A' ' 200' ' ' TYR . . . -93.58 -30.22 15.09 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.591 0.71 . . . . 0.0 109.726 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.609 ' O ' ' N ' ' A' ' 114' ' ' PRO . 0.8 OUTLIER -80.96 -11.83 59.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.458 -0.776 . . . . 0.0 109.926 179.819 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.579 ' C ' ' O ' ' A' ' 112' ' ' LEU . . . -23.59 87.19 0.04 OUTLIER Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 121.829 -0.544 . . . . 0.0 111.222 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.609 ' N ' ' O ' ' A' ' 112' ' ' LEU . 50.1 Cg_endo -77.05 49.89 2.94 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 124.115 1.587 . . . . 0.0 110.493 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 179.87 53.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -0.951 . . . . 0.0 110.273 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.484 ' NE2' ' O ' ' A' ' 128' ' ' SER . 4.1 tp60 -75.6 -90.01 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 110.171 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.511 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . 179.98 -163.2 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 110.29 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.511 ' C ' ' O ' ' A' ' 117' ' ' ALA . 28.8 t0 -31.64 100.77 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.58 -0.7 . . . . 0.0 110.721 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.514 ' CG ' ' O ' ' A' ' 119' ' ' HIS . 18.5 t-80 -89.73 5.86 44.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 110.3 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -55.55 -40.45 71.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.898 . . . . 0.0 110.174 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -51.14 -86.48 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.9 . . . . 0.0 110.212 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 50.96 91.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.0 110.289 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 tt -173.01 -43.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.289 -0.882 . . . . 0.0 110.12 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.666 HD12 ' C ' ' A' ' 124' ' ' LEU . 1.0 OUTLIER -131.1 40.84 3.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 110.261 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 81.72 115.79 0.42 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -172.32 34.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -1.165 . . . . 0.0 110.263 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -144.23 41.19 1.37 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.169 -0.957 . . . . 0.0 110.272 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.484 ' O ' ' NE2' ' A' ' 116' ' ' GLN . 13.4 t -127.18 -176.24 3.67 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.261 -0.899 . . . . 0.0 110.164 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 110' ' ' THR . 1.7 tt0 -150.02 130.06 13.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.298 -0.876 . . . . 0.0 110.087 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.496 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 47.9 t -120.46 119.92 34.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 110.211 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' TRP . . . . . 0.527 ' O ' ' O ' ' A' ' 108' ' ' VAL . 0.6 OUTLIER -128.1 124.57 37.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -0.939 . . . . 0.0 110.138 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.48 ' HA3' ' HA3' ' A' ' 107' ' ' GLY . . . 170.82 -133.95 2.96 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.709 ' CZ3' HD23 ' A' ' 167' ' ' LEU . 47.3 m0 -121.36 112.84 19.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.09 -1.241 . . . . 0.0 110.404 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.478 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 32.2 t0 -119.22 111.46 18.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.643 -0.661 . . . . 0.0 110.448 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.871 HG21 ' CG2' ' A' ' 162' ' ' VAL . 22.2 pt -139.97 26.74 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.1 -1.0 . . . . 0.0 110.229 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -101.6 -27.95 6.91 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.85 8.27 17.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.29 -1.123 . . . . 0.0 109.986 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.71 51.06 4.7 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -57.57 -18.83 21.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.261 -1.141 . . . . 0.0 110.299 -179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.402 ' HA ' HD13 ' A' ' 140' ' ' LEU . 0.2 OUTLIER -42.86 -40.63 2.98 Favored 'General case' 0 C--N 1.277 -2.561 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.142 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -131.9 36.51 3.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.303 -0.873 . . . . 0.0 110.15 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.431 ' CG ' ' N ' ' A' ' 143' ' ' GLN . 22.2 p-80 -51.0 -35.12 32.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.28 -0.888 . . . . 0.0 110.228 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.431 ' N ' ' CG ' ' A' ' 142' ' ' HIS . 3.4 tp-100 -132.49 -85.78 0.47 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.183 -0.948 . . . . 0.0 110.307 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 35.1 m -121.53 141.79 50.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.206 -0.934 . . . . 0.0 110.249 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.26 104.33 16.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.893 . . . . 0.0 110.185 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -67.85 -116.24 0.02 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.23 13.66 2.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.239 -1.154 . . . . 0.0 110.184 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -47.6 161.25 0.09 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.306 -0.871 . . . . 0.0 110.17 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -51.48 126.52 29.84 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 110.213 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.98 -2.69 12.39 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.971 1.511 . . . . 0.0 110.445 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.57 ' O ' ' CD2' ' A' ' 152' ' ' TYR . 0.3 OUTLIER -62.6 -72.72 0.12 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.276 -0.89 . . . . 0.0 110.25 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.584 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 0.3 OUTLIER -176.03 -60.58 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.301 -0.874 . . . . 0.0 110.229 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.584 ' CD ' ' CB ' ' A' ' 152' ' ' TYR . 46.1 Cg_endo -72.79 126.57 11.48 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.912 1.48 . . . . 0.0 110.445 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 155' ' ' GLY . . . -59.71 144.25 48.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.208 -0.932 . . . . 0.0 110.174 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 154' ' ' ALA . . . 42.26 -157.39 0.07 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -73.23 -62.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.016 1.535 . . . . 0.0 110.422 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.417 ' OE1' ' OH ' ' A' ' 186' ' ' TYR . 0.8 OUTLIER -56.42 -60.87 2.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.169 -0.957 . . . . 0.0 110.299 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 68.66 6.23 49.16 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -93.53 6.51 47.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.289 -1.124 . . . . 0.0 110.257 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.442 ' O ' ' HG3' ' A' ' 160' ' ' GLN . 2.8 tp-100 -58.42 -17.48 20.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.265 -0.897 . . . . 0.0 109.338 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.687 ' O ' HG23 ' A' ' 162' ' ' VAL . 0.7 OUTLIER -173.25 26.87 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.647 0.737 . . . . 0.0 109.548 179.511 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.871 ' CG2' HG21 ' A' ' 135' ' ' ILE . 2.4 t -159.34 88.1 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.599 -0.688 . . . . 0.0 109.863 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 1.046 HG11 HG21 ' A' ' 182' ' ' ILE . 0.9 OUTLIER -109.96 90.37 9.32 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.333 -0.854 . . . . 0.0 109.915 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 95' ' ' TRP . 44.3 Cg_endo -71.51 64.42 2.94 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.067 1.562 . . . . 0.0 110.379 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -168.48 -83.85 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.487 -0.758 . . . . 0.0 109.805 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.735 ' C ' HD12 ' A' ' 167' ' ' LEU . 2.2 ttp180 -152.12 150.43 29.88 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.432 -0.793 . . . . 0.0 110.348 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.837 ' N ' HD12 ' A' ' 167' ' ' LEU . 1.7 mp -144.92 131.04 19.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 110.274 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.706 HD13 ' N ' ' A' ' 169' ' ' VAL . 2.6 tm? -103.79 124.54 49.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.351 -0.843 . . . . 0.0 109.595 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 1.122 HG11 ' CZ2' ' A' ' 91' ' ' TRP . 2.4 t -107.18 135.53 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.943 . . . . 0.0 110.63 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.554 ' CG1' HD11 ' A' ' 187' ' ' LEU . 9.7 p -112.48 133.32 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.507 -0.746 . . . . 0.0 109.836 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.822 HD22 ' HG3' ' A' ' 201' ' ' PRO . 11.5 tp -133.03 105.87 7.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.151 -0.968 . . . . 0.0 110.228 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 173' ' ' MET . 49.1 t0 -103.83 136.02 44.28 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.24 -0.912 . . . . 0.0 109.943 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.519 ' HG2' ' HA ' ' A' ' 86' ' ' ARG . 5.5 tpt -96.91 -41.81 8.24 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.747 -0.595 . . . . 0.0 110.231 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.505 ' C ' ' O ' ' A' ' 173' ' ' MET . 2.7 tm-20 -40.26 -28.66 0.06 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.893 . . . . 0.0 108.666 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.678 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.2 OUTLIER -114.84 -26.64 7.72 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.422 ' O ' ' CG2' ' A' ' 198' ' ' THR . . . 81.2 25.35 55.29 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.491 -1.844 . . . . 0.0 108.491 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' THR . . . . . 1.073 HG22 ' CD2' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -113.42 127.82 56.25 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.335 -1.097 . . . . 0.0 111.436 -179.335 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 1.031 ' O ' HD11 ' A' ' 194' ' ' LEU . 0.1 OUTLIER -134.74 153.71 51.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.473 -0.767 . . . . 0.0 109.378 178.794 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -155.52 172.74 33.67 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.52 -1.324 . . . . 0.0 109.984 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 1.052 ' CE1' HG22 ' A' ' 169' ' ' VAL . 0.4 OUTLIER -118.77 122.89 43.49 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.47 -1.018 . . . . 0.0 109.895 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' A' ' 186' ' ' TYR . 16.7 t -142.79 139.26 30.91 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.31 -0.869 . . . . 0.0 110.051 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 1.046 HG21 HG11 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -98.56 116.76 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.341 -0.849 . . . . 0.0 109.923 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 81.63 -7.26 62.4 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 86.31 42.35 6.63 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.26 -35.94 8.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.31 -1.112 . . . . 0.0 110.415 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.467 ' O ' ' HB2' ' A' ' 181' ' ' SER . 24.6 m-85 -109.12 90.22 3.23 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.187 -0.946 . . . . 0.0 110.312 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.687 HD22 ' CZ ' ' A' ' 191' ' ' PHE . 0.7 OUTLIER -176.7 28.32 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.471 -0.768 . . . . 0.0 109.671 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.478 ' H ' ' HD2' ' A' ' 189' ' ' PRO . . . -110.51 -71.67 0.66 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.842 -1.171 . . . . 0.0 110.403 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.478 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 44.9 Cg_endo -70.87 -28.84 19.41 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.952 1.501 . . . . 0.0 111.026 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -74.17 15.44 0.32 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.299 -0.876 . . . . 0.0 111.142 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.687 ' CZ ' HD22 ' A' ' 187' ' ' LEU . 0.3 OUTLIER -90.52 -16.3 29.12 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.004 -1.06 . . . . 0.0 110.408 179.652 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.436 ' NE ' ' HA ' ' A' ' 192' ' ' ARG . 0.0 OUTLIER -90.03 -13.97 34.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.319 -0.863 . . . . 0.0 110.75 -179.616 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -112.47 -8.8 20.68 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 108.786 -1.725 . . . . 0.0 108.786 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 1.073 ' CD2' HG22 ' A' ' 177' ' ' THR . 7.7 tt -78.19 -31.66 49.6 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.617 -0.931 . . . . 0.0 109.213 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.453 ' CA ' HG23 ' A' ' 198' ' ' THR . 0.0 OUTLIER -53.56 -39.73 64.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.438 -0.789 . . . . 0.0 109.707 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -86.04 -24.61 40.41 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.836 ' NH1' HD11 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -91.09 -4.59 56.13 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.644 -0.916 . . . . 0.0 110.09 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.873 HG23 ' O ' ' A' ' 194' ' ' LEU . 26.0 p -43.06 116.44 0.9 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.496 -0.753 . . . . 0.0 110.986 -178.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.993 ' HB2' HG22 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -128.69 171.82 11.83 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.564 -0.71 . . . . 0.0 109.955 179.654 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 1.044 ' C ' HG23 ' A' ' 108' ' ' VAL . 14.9 m-30 -83.49 134.72 44.66 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.196 -0.94 . . . . 0.0 109.952 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.822 ' HG3' HD22 ' A' ' 171' ' ' LEU . 43.9 Cg_endo -68.35 118.58 5.73 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.089 1.573 . . . . 0.0 111.614 -178.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -134.01 148.62 51.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.469 -0.769 . . . . 0.0 110.49 179.737 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.465 HG22 ' N ' ' A' ' 204' ' ' SER . 8.2 p -149.84 159.13 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.125 -0.984 . . . . 0.0 110.311 179.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' SER . . . . . 0.975 ' O ' HG22 ' A' ' 105' ' ' VAL . 0.3 OUTLIER -144.88 125.67 14.29 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.178 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.721 ' H ' HG22 ' A' ' 78' ' ' VAL . . . -115.72 166.55 11.81 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.438 0.637 . . . . 0.0 110.854 -178.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.578 ' CG1' ' HB3' ' A' ' 210' ' ' CYS . 1.1 p -136.88 165.57 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.343 -0.848 . . . . 0.0 109.952 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 0.916 ' CD1' HG21 ' A' ' 57' ' ' ILE . 40.7 p-90 -132.91 -2.68 3.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.092 -1.005 . . . . 0.0 110.175 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -74.62 -0.83 59.94 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.484 ' O ' ' HA2' ' A' ' 101' ' ' GLY . 4.7 tt0 -175.99 -41.69 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.449 -1.03 . . . . 0.0 110.724 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' CYS . . . . . 0.663 ' HA ' ' N ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -98.96 146.3 26.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.429 -0.795 . . . . 0.0 110.802 -179.542 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.513 ' HG3' ' CA ' ' A' ' 101' ' ' GLY . 3.6 mt-30 -135.01 102.6 5.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.531 -0.731 . . . . 0.0 109.545 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.984 HG23 ' O ' ' A' ' 94' ' ' SER . 7.2 p -104.42 143.84 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.439 -0.788 . . . . 0.0 110.38 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.559 ' CD ' ' HB2' ' A' ' 94' ' ' SER . 2.9 ptp180 -95.61 131.64 41.61 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.324 -0.86 . . . . 0.0 109.619 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.719 HG22 ' CE2' ' A' ' 48' ' ' TRP . 1.2 tt -118.84 113.95 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.061 -1.024 . . . . 0.0 111.561 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.612 ' O ' ' N ' ' A' ' 92' ' ' GLU . 7.6 ttm180 -112.99 108.81 17.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.073 -1.017 . . . . 0.0 108.896 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' TYR . . . . . 0.707 ' CD2' ' HB2' ' A' ' 91' ' ' TRP . 1.6 t80 -104.44 149.65 25.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.93 . . . . 0.0 111.179 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.24 107.92 7.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.579 -0.7 . . . . 0.0 109.917 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 141.5 -22.02 2.55 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -95.37 144.89 25.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.172 -1.193 . . . . 0.0 110.194 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.585 ' HG2' ' CE1' ' A' ' 46' ' ' HIS . 0.1 OUTLIER -178.02 132.13 0.15 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.133 -0.98 . . . . 0.0 110.274 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ARG . . . . . 0.483 ' O ' ' C ' ' A' ' 222' ' ' VAL . 0.0 OUTLIER -129.54 80.16 1.95 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 110.153 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 222' ' ' VAL . 3.3 p -36.27 115.94 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.6 -0.688 . . . . 0.0 110.577 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.512 ' O ' ' C ' ' A' ' 224' ' ' GLU . 9.6 tm-20 -178.77 -71.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.321 -0.862 . . . . 0.0 110.149 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.512 ' C ' ' O ' ' A' ' 223' ' ' GLU . 6.7 mt-10 -34.06 -46.14 0.23 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.406 -0.809 . . . . 0.0 110.613 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.416 ' C ' ' O ' ' A' ' 224' ' ' GLU . 0.1 OUTLIER -42.61 161.7 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.281 -0.887 . . . . 0.0 110.235 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.23 32.46 0.76 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 110.23 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.39 120.93 1.87 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 0.0 110.21 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 24.6 pt -77.79 1.69 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.33 -0.856 . . . . 0.0 110.225 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.4 127.71 33.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.243 -0.911 . . . . 0.0 110.149 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ARG . . . . . 0.414 ' O ' ' HB3' ' A' ' 231' ' ' ASP . 5.0 tpp180 -46.72 -28.24 1.44 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.126 -0.984 . . . . 0.0 110.162 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.414 ' HB3' ' O ' ' A' ' 230' ' ' ARG . 1.1 p30 . . . . . 0 C--N 1.304 -1.377 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.263 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.0 t -144.86 14.09 1.51 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.16 -1.2 . . . . 0.0 110.213 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.57 63.99 7.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.153 -0.967 . . . . 0.0 110.188 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -162.3 33.8 0.11 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 110.251 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.509 ' O ' ' CG ' ' A' ' 10' ' ' ARG . 0.1 OUTLIER -96.99 66.72 2.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.279 -0.888 . . . . 0.0 110.202 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -156.1 141.12 17.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.162 -0.962 . . . . 0.0 110.204 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.8 t -87.55 110.04 20.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -0.894 . . . . 0.0 110.228 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.3 113.13 19.77 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 110.258 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.89 171.01 18.31 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.979 1.515 . . . . 0.0 110.401 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.3 p -92.11 83.73 5.17 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.316 -0.865 . . . . 0.0 110.211 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.35 -143.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -0.922 . . . . 0.0 110.201 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -101.71 -155.29 0.51 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.107 -0.995 . . . . 0.0 110.265 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.43 135.14 45.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 110.188 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.89 -160.61 0.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.255 -0.903 . . . . 0.0 110.203 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.7 -158.21 0.64 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.304 -0.872 . . . . 0.0 110.121 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.63 161.02 28.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.368 -0.832 . . . . 0.0 110.168 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -174.29 32.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.252 -0.905 . . . . 0.0 110.257 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.38 -78.01 0.44 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.888 . . . . 0.0 110.211 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.486 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.9 OUTLIER -102.88 155.03 37.08 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.222 -0.924 . . . . 0.0 110.147 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.36 110.3 3.03 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.971 1.511 . . . . 0.0 110.559 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.671 ' O ' ' N ' ' A' ' 28' ' ' GLY . 48.0 Cg_endo -74.36 -164.64 0.23 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.086 1.572 . . . . 0.0 110.497 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.663 ' C ' ' O ' ' A' ' 26' ' ' PRO . 1.5 tt0 1.46 66.22 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.589 0.709 . . . . 0.0 111.192 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.671 ' N ' ' O ' ' A' ' 26' ' ' PRO . . . -153.61 -34.4 0.03 OUTLIER Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.987 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -73.77 -32.56 63.86 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.449 -1.03 . . . . 0.0 109.888 179.731 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.708 ' HA ' HD23 ' A' ' 33' ' ' LEU . 0.9 OUTLIER -45.97 -42.8 13.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.307 -0.87 . . . . 0.0 109.783 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -56.92 -23.27 43.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.4 -0.813 . . . . 0.0 109.302 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.716 ' HB3' HD12 ' A' ' 29' ' ' LEU . 16.7 tp -83.22 -34.5 25.86 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.128 HD21 ' CG ' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -72.92 -36.34 67.23 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.917 0.865 . . . . 0.0 109.116 179.124 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.604 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 1.4 m -69.17 -14.29 62.9 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.252 0.549 . . . . 0.0 110.465 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.954 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -51.72 -61.85 3.75 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.164 -0.96 . . . . 0.0 110.201 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.954 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 43.3 Cg_endo -69.86 110.31 2.54 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.988 1.52 . . . . 0.0 110.77 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.775 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 49.1 Cg_endo -74.92 -24.81 12.64 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 124.146 1.603 . . . . 0.0 112.84 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.775 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 42.3 Cg_endo -68.3 152.4 75.74 Favored 'Trans proline' 0 C--N 1.315 -1.214 0 O-C-N 122.892 0.943 . . . . 0.0 112.38 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.611 ' O ' ' CG ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER 4.79 80.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 123.561 1.648 . . . . 0.0 110.887 -178.694 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.98 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER 179.97 -51.7 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 113.655 -1.611 . . . . 0.0 107.705 178.874 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.848 HG22 HD13 ' A' ' 40' ' ' LEU . 1.8 t -87.36 -20.17 7.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 118.933 -1.107 . . . . 0.0 109.661 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.27 -46.49 8.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.154 -0.966 . . . . 0.0 111.954 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.59 ' O ' ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -79.39 -20.89 46.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.662 -1.274 . . . . 0.0 109.411 -179.464 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.833 ' HA ' HG23 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -72.47 -36.22 68.41 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.491 -0.884 . . . . 0.0 108.767 179.283 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.751 ' NE2' HG12 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -81.73 -26.07 34.88 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.866 -0.521 . . . . 0.0 110.272 -179.546 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -96.38 -28.7 14.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.129 -0.982 . . . . 0.0 110.104 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.83 -111.09 1.02 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.961 ' CZ2' HG23 ' A' ' 212' ' ' VAL . 88.6 m95 -91.63 73.97 5.88 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.09 -1.241 . . . . 0.0 109.436 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 1.045 HD22 ' HG3' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -52.4 150.09 9.35 Favored Pre-proline 0 N--CA 1.489 1.495 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.151 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.713 ' O ' ' N ' ' A' ' 53' ' ' CYS . 54.2 Cg_endo -91.81 -0.01 4.39 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 122.273 1.982 . . . . 0.0 113.221 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 1.045 ' HG3' HD22 ' A' ' 49' ' ' ASN . 0.0 OUTLIER 0.69 -98.69 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.639 0 CA-C-O 122.646 1.212 . . . . 0.0 111.192 -178.842 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.819 ' HB3' ' NE ' ' A' ' 79' ' ' ARG 0.259 0.5 OUTLIER -62.19 -28.08 69.42 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.568 -179.707 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.867 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . 0.7 OUTLIER -104.82 -177.02 3.24 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.323 1.059 . . . . 0.0 112.481 -178.096 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.594 ' O ' ' HB3' ' A' ' 50' ' ' PRO . 2.0 m -87.38 165.21 15.76 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.897 0.856 . . . . 0.0 111.257 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 1.128 ' CG ' HD21 ' A' ' 33' ' ' LEU . 2.5 pm0 -94.21 9.71 36.88 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.045 0.926 . . . . 0.0 108.748 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.55 ' C ' ' O ' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -16.27 -38.26 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.263 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.837 ' N ' ' O ' ' A' ' 55' ' ' GLU . 6.6 pt -130.12 167.43 25.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.128 -178.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.933 ' HB2' HD23 ' A' ' 40' ' ' LEU . 6.0 t0 -107.76 141.39 39.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.401 -0.812 . . . . 0.0 110.11 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.833 HG23 ' HA ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -130.42 136.03 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.337 -0.852 . . . . 0.0 110.509 -179.166 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.543 ' NZ ' ' HB2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -135.27 155.05 51.28 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.977 -1.077 . . . . 0.0 110.755 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 62' ' ' GLY . 5.3 mt-10 -78.24 -129.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.515 -0.741 . . . . 0.0 110.115 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 42.15 42.98 4.39 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.666 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 116.11 48.1 0.49 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.807 HD23 ' CZ ' ' A' ' 213' ' ' ARG . 0.5 OUTLIER 0.42 90.5 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.847 -0.796 . . . . 0.0 111.084 -179.438 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -124.96 123.2 39.38 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.493 -0.754 . . . . 0.0 111.194 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.924 ' HE2' HG22 ' A' ' 212' ' ' VAL . 18.2 m-85 -83.39 127.1 33.4 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.61 ' O ' ' HB ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -110.38 121.15 44.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.007 -1.058 . . . . 0.0 110.557 -179.495 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.589 ' HD3' ' N ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -136.11 155.98 49.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.491 -0.755 . . . . 0.0 109.365 179.471 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.589 ' N ' ' HD3' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -173.18 -55.98 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 120.929 -1.107 . . . . 0.0 111.065 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 69' ' ' ARG . 40.9 Cg_endo -67.24 -47.66 2.16 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.756 1.398 . . . . 0.0 110.645 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.547 ' CG2' ' N ' ' A' ' 72' ' ' ALA . 1.6 p -78.49 165.29 3.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-O 121.937 0.875 . . . . 0.0 110.983 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.547 ' N ' ' CG2' ' A' ' 71' ' ' VAL . . . -159.22 -36.52 0.06 Allowed 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.312 0.577 . . . . 0.0 110.026 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -141.99 13.48 2.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.36 -0.838 . . . . 0.0 110.127 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 75' ' ' THR . 0.6 OUTLIER -63.36 -158.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 110.195 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 74' ' ' SER . 0.6 OUTLIER -54.42 -107.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.164 -0.96 . . . . 0.0 110.27 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.529 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 2.4 m-20 -140.32 150.09 43.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.906 -1.121 . . . . 0.0 110.935 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.529 ' O ' ' ND2' ' A' ' 56' ' ' ASN . . . -40.39 -86.49 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.575 ' CG2' ' O ' ' A' ' 49' ' ' ASN . 0.2 OUTLIER -138.05 145.48 28.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.135 -1.214 . . . . 0.0 109.721 178.523 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.867 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 4.2 tmm_? -148.44 133.83 18.55 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.507 ' HA2' ' HB2' ' A' ' 52' ' ' ASP . . . -126.2 143.34 14.33 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.553 ' HE3' ' CB ' ' A' ' 202' ' ' SER . 0.3 OUTLIER -165.47 9.93 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.067 -1.255 . . . . 0.0 111.451 -179.66 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.74 ' HD2' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -135.27 -9.76 2.23 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.676 -1.265 . . . . 0.0 110.83 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.74 ' N ' ' HD2' ' A' ' 82' ' ' ARG . . . -74.81 38.1 1.07 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.733 ' HE1' HD11 ' A' ' 171' ' ' LEU . 15.8 t80 -94.17 119.37 32.89 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.435 -1.038 . . . . 0.0 110.087 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.7 p -99.92 177.48 5.1 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.302 -0.874 . . . . 0.0 110.395 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.592 ' HA ' ' CB ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -108.04 167.38 10.04 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.307 -0.871 . . . . 0.0 109.933 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.473 ' N ' ' HB3' ' A' ' 173' ' ' MET . . . 100.77 -124.71 8.34 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.497 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 1.3 tp -129.06 130.12 46.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.463 -1.022 . . . . 0.0 110.398 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.552 ' NE2' ' O ' ' A' ' 86' ' ' ARG . 8.4 m-70 -147.29 158.64 44.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.129 -0.982 . . . . 0.0 109.968 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.545 ' O ' ' O ' ' A' ' 217' ' ' MET . . . -161.6 135.22 6.54 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.129 -0.982 . . . . 0.0 109.58 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 1.225 ' CZ3' HG11 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -134.09 156.28 48.54 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.917 -1.114 . . . . 0.0 109.846 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.665 ' O ' ' N ' ' A' ' 215' ' ' ARG . 0.8 OUTLIER -109.53 124.07 50.47 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.705 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 1.067 HG23 ' OH ' ' A' ' 180' ' ' TYR . 0.8 OUTLIER -141.85 154.12 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.953 -1.092 . . . . 0.0 110.62 -179.325 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.503 ' CB ' ' HB3' ' A' ' 213' ' ' ARG . 0.6 OUTLIER -134.17 123.09 23.78 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.5 -0.75 . . . . 0.0 109.093 179.425 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.766 ' HH2' ' O ' ' A' ' 204' ' ' SER . 2.1 t90 -127.6 88.21 54.16 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.067 -1.021 . . . . 0.0 110.817 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -95.43 109.08 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 124.154 1.608 . . . . 0.0 110.166 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.637 HD23 ' HE1' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -96.06 -7.41 36.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.843 -1.16 . . . . 0.0 110.315 179.701 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.463 ' OE2' ' HG3' ' A' ' 99' ' ' GLN . 0.9 OUTLIER -55.55 -15.44 2.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.288 -0.882 . . . . 0.0 110.384 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.503 ' O ' ' HD2' ' A' ' 100' ' ' ARG . 2.7 mt-30 -76.22 -29.41 57.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.111 -0.993 . . . . 0.0 110.426 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.503 ' HD2' ' O ' ' A' ' 99' ' ' GLN . 31.5 mmm180 -150.06 -136.35 0.07 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.444 -0.785 . . . . 0.0 110.206 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.526 ' HA2' ' CD1' ' A' ' 97' ' ' LEU . . . -178.85 127.08 1.11 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.499 ' O ' ' HA3' ' A' ' 136' ' ' GLY . 2.4 m -166.4 -132.25 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.252 -1.146 . . . . 0.0 110.164 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.443 ' H ' HG22 ' A' ' 102' ' ' THR . 0.1 OUTLIER -108.78 23.78 14.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.178 -0.951 . . . . 0.0 110.221 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.744 ' HB1' ' HE1' ' A' ' 95' ' ' TRP . . . -48.07 138.9 8.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.222 -0.924 . . . . 0.0 110.033 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.711 HG13 ' O ' ' A' ' 204' ' ' SER . 0.1 OUTLIER -135.33 136.98 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.961 -1.087 . . . . 0.0 112.015 -178.876 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.942 HG23 HD11 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -151.24 112.91 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.687 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.571 ' HA3' ' HA3' ' A' ' 132' ' ' GLY . . . 179.55 -147.31 7.51 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 118.621 -1.752 . . . . 0.0 111.223 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.628 ' CG1' ' HB2' ' A' ' 199' ' ' LEU . 1.4 t -139.66 170.27 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.554 -0.968 . . . . 0.0 109.618 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 130' ' ' SER . . . -121.17 139.88 52.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.998 -1.064 . . . . 0.0 110.766 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.865 ' OG1' HD23 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -136.47 133.73 36.88 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.32 -0.862 . . . . 0.0 110.461 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.16 -26.08 17.57 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.308 -0.87 . . . . 0.0 109.266 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.448 ' O ' ' C ' ' A' ' 113' ' ' ALA . 1.0 OUTLIER -85.37 -12.19 52.74 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.545 -0.722 . . . . 0.0 109.445 179.416 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.858 ' HB3' ' HD3' ' A' ' 114' ' ' PRO . . . -39.42 -53.98 3.9 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.552 -0.718 . . . . 0.0 110.646 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.858 ' HD3' ' HB3' ' A' ' 113' ' ' ALA . 46.4 Cg_endo -72.93 102.97 1.51 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.879 1.463 . . . . 0.0 110.497 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.446 ' CD2' ' O ' ' A' ' 114' ' ' PRO . 0.0 OUTLIER 179.89 48.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.338 -0.851 . . . . 0.0 110.221 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 0.5 OUTLIER -128.54 -33.72 2.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.913 . . . . 0.0 110.24 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.523 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -177.14 150.62 0.75 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 110.24 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.523 ' C ' ' O ' ' A' ' 117' ' ' ALA . 22.7 t0 -31.83 109.47 0.06 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.565 -0.709 . . . . 0.0 110.724 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -81.13 157.17 25.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.319 -0.863 . . . . 0.0 110.263 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.457 ' O ' ' HB3' ' A' ' 121' ' ' ALA . 8.3 t80 -127.36 138.95 53.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.287 -0.883 . . . . 0.0 110.226 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 120' ' ' TYR . . . 56.64 -88.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.921 . . . . 0.0 110.164 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.477 ' O ' ' CB ' ' A' ' 123' ' ' LEU . . . 47.43 26.17 0.72 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.27 -0.894 . . . . 0.0 110.224 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.477 ' CB ' ' O ' ' A' ' 122' ' ' ALA . 0.2 OUTLIER 66.66 103.13 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.259 -0.901 . . . . 0.0 110.234 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 125' ' ' GLY . 0.4 OUTLIER 55.25 -156.25 0.25 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.243 -0.91 . . . . 0.0 110.31 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 124' ' ' LEU . . . -60.46 -145.64 0.01 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 36.9 p -148.7 20.76 1.02 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -1.121 . . . . 0.0 110.207 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -44.66 -89.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.228 -0.92 . . . . 0.0 110.141 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.65 170.57 14.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.289 -0.882 . . . . 0.0 110.092 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 113' ' ' ALA . 5.9 tp10 -150.21 141.44 23.17 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.271 -0.893 . . . . 0.0 109.692 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.551 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 13.4 t -119.86 120.05 35.33 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.592 -0.692 . . . . 0.0 109.978 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -133.36 136.38 45.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.378 -0.827 . . . . 0.0 109.619 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.606 ' O ' ' CD1' ' A' ' 133' ' ' TRP . . . -178.0 -107.56 0.22 Allowed Glycine 0 N--CA 1.487 2.093 0 C-N-CA 119.545 -1.312 . . . . 0.0 109.924 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.715 ' CH2' ' HB2' ' A' ' 180' ' ' TYR . 5.2 m-90 -141.0 128.91 21.8 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.26 -1.141 . . . . 0.0 111.568 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -118.74 148.04 43.22 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.723 -0.611 . . . . 0.0 109.743 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.942 HD11 HG23 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -131.89 -29.28 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.344 -0.848 . . . . 0.0 109.921 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 102' ' ' THR . . . -63.41 -27.81 71.37 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.441 ' HB3' ' HG2' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -85.35 8.19 19.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -1.12 . . . . 0.0 109.925 179.873 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 139' ' ' LYS . . . 44.13 41.56 6.32 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.477 ' O ' ' O ' ' A' ' 138' ' ' GLY . 6.6 mmmt -52.8 -169.94 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -1.165 . . . . 0.0 110.151 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.692 ' HA ' HD11 ' A' ' 161' ' ' LEU . 1.4 pp -160.41 104.3 1.43 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.172 -0.955 . . . . 0.0 110.317 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -152.27 24.51 0.62 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.301 -0.874 . . . . 0.0 110.165 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.633 ' ND1' HD12 ' A' ' 161' ' ' LEU . 11.3 p-80 -93.83 33.46 1.31 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -0.924 . . . . 0.0 110.263 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -72.43 -41.07 66.59 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.277 -0.889 . . . . 0.0 110.252 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 78.1 p -58.39 -161.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.245 -0.91 . . . . 0.0 110.223 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -55.53 167.19 0.54 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.886 . . . . 0.0 110.234 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 147' ' ' LEU . . . 103.58 84.11 1.76 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 146' ' ' GLY . 0.1 OUTLIER -179.88 56.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.2 -1.177 . . . . 0.0 110.144 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.416 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 0.5 OUTLIER 179.81 71.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.885 . . . . 0.0 110.343 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.589 ' N ' ' CD ' ' A' ' 150' ' ' PRO . . . -147.54 47.23 0.54 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.216 -0.928 . . . . 0.0 110.356 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 149' ' ' ALA . 48.0 Cg_endo -74.06 1.78 6.8 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.991 1.522 . . . . 0.0 110.551 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 150' ' ' PRO . 3.6 mp0 -44.6 -96.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 110.44 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.565 ' HB3' ' HD3' ' A' ' 153' ' ' PRO . 0.3 OUTLIER -84.08 -59.26 0.36 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.181 -0.949 . . . . 0.0 110.535 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.565 ' HD3' ' HB3' ' A' ' 152' ' ' TYR . 46.6 Cg_endo -72.56 162.84 40.24 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.873 1.459 . . . . 0.0 110.632 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.643 ' HB1' ' HB2' ' A' ' 157' ' ' GLN . . . -68.58 112.47 5.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 0.0 110.318 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 154' ' ' ALA . . . -54.05 -106.98 0.01 OUTLIER Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.83 -9.36 22.34 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.966 1.508 . . . . 0.0 110.565 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.643 ' HB2' ' HB1' ' A' ' 154' ' ' ALA . 2.4 mm100 -65.85 -4.37 6.66 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.16 -0.962 . . . . 0.0 110.563 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -150.72 -37.09 0.03 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -79.22 7.02 8.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.337 -1.096 . . . . 0.0 110.282 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.495 ' O ' ' HB2' ' A' ' 161' ' ' LEU . 2.7 tt0 -52.37 -18.32 1.56 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.283 -0.886 . . . . 0.0 110.386 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.692 HD11 ' HA ' ' A' ' 140' ' ' LEU . 13.5 tp -179.39 30.34 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.444 -0.785 . . . . 0.0 110.286 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.882 HG13 ' CG2' ' A' ' 135' ' ' ILE . 14.7 t -138.49 -124.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.355 -0.84 . . . . 0.0 110.103 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.969 HG13 ' HD2' ' A' ' 164' ' ' PRO . 15.2 t -130.23 155.05 81.43 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.178 -0.951 . . . . 0.0 109.436 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.969 ' HD2' HG13 ' A' ' 163' ' ' VAL . 38.2 Cg_endo -64.57 -177.89 0.6 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.693 1.365 . . . . 0.0 110.758 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 153' ' ' PRO . 0.3 OUTLIER -48.57 -58.2 5.05 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.43 -0.794 . . . . 0.0 110.389 -179.402 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.469 ' HA ' ' HB3' ' A' ' 94' ' ' SER . 1.3 ttp180 -151.94 155.96 39.1 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.498 -0.751 . . . . 0.0 110.578 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.868 HD23 HG12 ' A' ' 182' ' ' ILE . 0.9 OUTLIER -137.68 157.74 45.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.483 -0.761 . . . . 0.0 109.782 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.416 ' HG ' ' OE1' ' A' ' 92' ' ' GLU . 3.4 tt -103.11 126.72 50.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.93 . . . . 0.0 109.799 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 1.225 HG11 ' CZ3' ' A' ' 91' ' ' TRP . 57.9 t -90.04 138.3 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.349 -0.844 . . . . 0.0 110.829 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 178' ' ' LEU . 85.9 t -116.14 111.51 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.545 -0.722 . . . . 0.0 109.265 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.884 HD12 ' HB3' ' A' ' 178' ' ' LEU . 14.4 tp -118.94 105.51 11.54 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.966 -1.084 . . . . 0.0 110.251 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.438 ' OD2' HD12 ' A' ' 88' ' ' LEU . 4.5 t70 -120.58 133.79 55.34 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.339 -0.851 . . . . 0.0 110.209 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.592 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 1.6 tpt -99.7 -37.96 8.9 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.25 -24.15 1.67 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.474 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.1 OUTLIER -107.04 -26.28 11.22 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.202 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.715 ' O ' HG21 ' A' ' 198' ' ' THR . . . 82.17 24.47 54.62 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 108.604 -1.798 . . . . 0.0 108.604 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.693 ' HA ' HD22 ' A' ' 194' ' ' LEU . 0.6 OUTLIER -130.07 122.91 29.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.093 -1.239 . . . . 0.0 111.486 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.973 HD11 ' O ' ' A' ' 199' ' ' LEU . 0.1 OUTLIER -140.52 153.58 46.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.454 -0.779 . . . . 0.0 109.611 179.168 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.451 ' O ' HG13 ' A' ' 169' ' ' VAL . . . 179.98 -152.2 10.65 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.633 -1.27 . . . . 0.0 110.212 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 1.067 ' OH ' HG23 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -123.0 142.21 51.09 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.331 -1.099 . . . . 0.0 109.332 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.503 ' HA ' ' HB3' ' A' ' 186' ' ' TYR . 15.3 t -140.76 124.78 17.3 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.422 -0.799 . . . . 0.0 110.154 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.868 HG12 HD23 ' A' ' 167' ' ' LEU . 0.1 OUTLIER -107.26 116.64 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.215 -0.928 . . . . 0.0 109.276 179.502 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 79.81 -47.19 3.25 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 137.62 36.39 0.17 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' THR . . . . . 0.435 ' O ' ' C ' ' A' ' 186' ' ' TYR . 73.0 m -122.89 -51.47 1.91 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.242 -1.152 . . . . 0.0 110.859 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.573 ' CD2' HD11 ' A' ' 182' ' ' ILE . 0.1 OUTLIER -40.98 -74.34 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.079 -1.013 . . . . 0.0 110.613 -179.415 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.897 HD23 ' CZ ' ' A' ' 191' ' ' PHE . 1.1 mp -71.25 43.85 0.08 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.001 -1.062 . . . . 0.0 109.886 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 186' ' ' TYR . . . -75.67 -99.28 0.13 Allowed Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.472 ' C ' ' H ' ' A' ' 191' ' ' PHE . 49.6 Cg_endo -74.13 -24.17 15.05 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.207 1.635 . . . . 0.0 110.946 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.557 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -65.86 16.81 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.487 -0.758 . . . . 0.0 111.724 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.897 ' CZ ' HD23 ' A' ' 187' ' ' LEU . 0.3 OUTLIER -90.45 -16.68 28.53 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.828 -1.17 . . . . 0.0 110.394 179.56 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.43 ' HA ' ' NE ' ' A' ' 192' ' ' ARG . 0.0 OUTLIER -90.2 -15.12 32.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.282 -0.886 . . . . 0.0 110.902 -179.452 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -110.82 -16.95 9.42 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.693 HD22 ' HA ' ' A' ' 177' ' ' THR . 7.5 tt -67.86 -36.31 80.08 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.617 -0.931 . . . . 0.0 108.87 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.507 ' HA ' HG23 ' A' ' 177' ' ' THR . 0.0 OUTLIER -44.69 -34.88 2.4 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.403 -0.811 . . . . 0.0 109.825 179.562 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.443 ' N ' ' HD2' ' A' ' 195' ' ' LYS . . . -94.11 -27.31 12.43 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.748 ' HD3' HD11 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.94 -4.69 56.3 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.603 -0.94 . . . . 0.0 110.108 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.715 HG21 ' O ' ' A' ' 176' ' ' GLY . 0.7 OUTLIER -44.06 143.49 1.14 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.825 0.821 . . . . 0.0 111.649 -178.327 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.973 ' O ' HD11 ' A' ' 178' ' ' LEU . 0.0 OUTLIER -140.28 171.74 13.73 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.53 ' O ' ' N ' ' A' ' 109' ' ' ALA . 2.8 m-30 -84.18 129.81 56.87 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 120.925 -1.11 . . . . 0.0 109.782 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.499 ' HD3' ' CD1' ' A' ' 178' ' ' LEU . 41.6 Cg_endo -67.51 115.75 3.87 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.888 1.468 . . . . 0.0 111.035 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.553 ' CB ' ' HE3' ' A' ' 81' ' ' LYS . 1.6 p -133.14 154.06 50.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.43 -0.794 . . . . 0.0 110.229 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.687 HG23 ' HA ' ' A' ' 106' ' ' VAL . 2.0 p -158.1 164.11 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.32 -0.863 . . . . 0.0 110.217 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' SER . . . . . 0.766 ' O ' ' HH2' ' A' ' 95' ' ' TRP . 0.1 OUTLIER -157.94 126.56 5.57 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.397 -0.815 . . . . 0.0 109.981 179.309 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -119.23 161.63 20.06 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.312 -0.868 . . . . 0.0 110.831 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.559 ' CG1' ' N ' ' A' ' 207' ' ' TRP . 1.1 t -124.33 176.14 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 CA-C-O 121.251 0.548 . . . . 0.0 110.063 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 0.774 ' HB3' HD12 ' A' ' 57' ' ' ILE . 44.2 p90 -103.31 155.0 18.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -0.883 . . . . 0.0 110.056 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 135.18 -152.84 20.95 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.496 ' OE1' ' HG3' ' A' ' 100' ' ' ARG . 5.1 tm0? -66.89 -29.04 68.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.324 -1.103 . . . . 0.0 110.258 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 209' ' ' GLN . 9.2 t -46.74 175.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.304 -0.872 . . . . 0.0 109.985 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.432 ' HG2' ' C ' ' A' ' 210' ' ' CYS . 1.4 pt20 -170.11 111.29 0.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 110.588 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.961 HG23 ' CZ2' ' A' ' 48' ' ' TRP . 27.4 m -115.42 145.39 21.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.527 -0.733 . . . . 0.0 109.783 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.89 ' HE ' ' HA ' ' A' ' 213' ' ' ARG . 0.7 OUTLIER -108.48 128.54 54.89 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.204 179.728 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.723 ' HB ' ' CZ3' ' A' ' 48' ' ' TRP . 5.6 tt -123.51 119.62 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.026 -1.047 . . . . 0.0 111.933 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.665 ' N ' ' O ' ' A' ' 92' ' ' GLU . 23.3 ttt180 -130.33 135.07 47.69 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' TYR . . . . . 0.66 ' HA ' ' HB3' ' A' ' 91' ' ' TRP . 1.8 t80 -119.07 151.02 39.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.651 -1.281 . . . . 0.0 112.265 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' MET . . . . . 0.545 ' O ' ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -131.11 107.77 9.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.686 -0.634 . . . . 0.0 109.612 179.061 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 79.23 61.87 2.28 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.578 ' HB2' ' CD1' ' A' ' 216' ' ' TYR . 16.9 tt0 -95.4 150.44 20.28 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.138 -1.213 . . . . 0.0 110.237 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.464 ' N ' ' HG2' ' A' ' 219' ' ' GLU . 0.0 OUTLIER -43.24 136.42 2.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.236 -0.915 . . . . 0.0 110.266 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ARG . . . . . 0.504 ' O ' ' C ' ' A' ' 222' ' ' VAL . 4.8 mtt85 -119.28 85.58 2.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 110.316 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.504 ' C ' ' O ' ' A' ' 221' ' ' ARG . 2.6 p -33.54 118.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.504 -0.748 . . . . 0.0 110.582 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.508 ' O ' ' C ' ' A' ' 224' ' ' GLU . 1.9 tt0 179.85 -74.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.254 -0.904 . . . . 0.0 110.251 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.508 ' C ' ' O ' ' A' ' 223' ' ' GLU . 7.7 tt0 -33.89 -89.1 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.466 -0.771 . . . . 0.0 110.638 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.54 111.18 0.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.261 -0.899 . . . . 0.0 110.326 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.78 133.83 53.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.285 -0.885 . . . . 0.0 110.058 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.64 -38.1 5.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.343 -0.848 . . . . 0.0 110.267 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.45 ' O ' HG13 ' A' ' 228' ' ' ILE . 17.1 pt -130.16 133.46 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.217 -0.927 . . . . 0.0 110.295 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.406 ' O ' ' C ' ' A' ' 230' ' ' ARG . 22.2 m-70 -97.95 -35.9 10.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.283 -0.886 . . . . 0.0 110.158 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ARG . . . . . 0.67 ' O ' ' C ' ' A' ' 231' ' ' ASP . 0.0 OUTLIER -44.12 153.69 0.13 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.209 -0.932 . . . . 0.0 110.178 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.67 ' C ' ' O ' ' A' ' 230' ' ' ARG . 38.9 m-20 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.986 -1.007 . . . . 0.0 111.421 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.98 96.07 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -1.154 . . . . 0.0 110.145 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 51.59 66.66 1.13 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.27 -0.894 . . . . 0.0 110.217 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.63 60.75 6.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.893 . . . . 0.0 110.17 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.89 34.37 0.15 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 110.285 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -77.03 118.52 19.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.212 -0.93 . . . . 0.0 110.198 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.1 m -82.1 96.42 7.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.217 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 37.1 p -137.94 143.57 40.36 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.201 -0.937 . . . . 0.0 110.199 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -73.08 -36.25 4.47 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.001 1.527 . . . . 0.0 110.387 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 90.6 m -97.45 149.81 21.74 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.27 -0.894 . . . . 0.0 110.194 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.2 m -103.91 154.78 19.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -0.88 . . . . 0.0 110.224 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.92 48.67 0.96 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -0.847 . . . . 0.0 110.297 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.38 143.6 57.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.265 -0.897 . . . . 0.0 110.219 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.493 HD23 ' N ' ' A' ' 19' ' ' LEU . 4.3 mt -52.02 173.95 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.922 . . . . 0.0 110.231 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -60.71 -172.38 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.208 -0.932 . . . . 0.0 110.445 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.5 t -94.65 -164.04 1.12 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.285 -0.884 . . . . 0.0 110.347 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -164.55 37.01 0.07 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.906 . . . . 0.0 110.302 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.42 -74.49 0.46 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 0.0 110.209 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.6 109.0 42.27 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.346 -0.847 . . . . 0.0 110.053 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.91 163.89 37.1 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.914 1.481 . . . . 0.0 110.616 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.458 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 47.4 Cg_endo -73.24 165.32 32.93 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.06 1.558 . . . . 0.0 110.443 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 1.2 tt0 -179.28 39.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.328 -0.858 . . . . 0.0 110.156 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.18 22.3 57.35 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.956 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -63.82 -33.23 75.22 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.35 -1.088 . . . . 0.0 110.092 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 1.03 ' HA ' HD23 ' A' ' 33' ' ' LEU . 16.1 pt-20 -45.74 -37.82 6.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 109.719 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.471 ' N ' ' HG3' ' A' ' 30' ' ' GLU . 1.7 tm-20 -72.4 -23.21 61.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.376 -0.828 . . . . 0.0 109.167 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.609 ' O ' ' HD2' ' A' ' 36' ' ' PRO . 15.3 tp -83.81 -30.49 26.5 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.03 HD23 ' HA ' ' A' ' 30' ' ' GLU . 0.3 OUTLIER -71.0 -34.35 71.26 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 122.081 0.943 . . . . 0.0 108.968 179.304 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.608 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -83.81 -6.93 59.54 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.072 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.995 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -71.5 -65.73 0.84 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.313 -0.867 . . . . 0.0 111.11 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.995 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 49.6 Cg_endo -75.45 143.97 28.3 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.607 1.32 . . . . 0.0 110.441 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 36' ' ' PRO . 53.9 Cg_endo -99.02 54.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.947 1.764 . . . . 0.0 112.251 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.722 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 51.8 Cg_endo -75.52 150.91 36.63 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 122.958 0.978 . . . . 0.0 109.845 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.653 ' O ' ' HB3' ' A' ' 43' ' ' GLN . 0.9 OUTLIER -34.04 -34.52 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.187 -0.946 . . . . 0.0 109.662 179.895 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.245 ' O ' ' HB3' ' A' ' 44' ' ' ARG . 1.8 tp -62.79 -43.91 97.57 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 110.34 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.858 ' HA ' ' CE1' ' A' ' 45' ' ' HIS . 46.6 t -86.68 -36.8 10.65 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 C-N-CA 118.389 -1.324 . . . . 0.0 110.029 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.13 -40.12 11.21 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.436 -0.906 . . . . 0.0 112.696 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.653 ' HB3' ' O ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -87.88 -19.15 27.76 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 120.899 -1.126 . . . . 0.0 110.164 -178.645 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 1.245 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 5.3 ttt180 -84.66 -52.62 5.95 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.795 1.284 . . . . 0.0 109.778 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.858 ' CE1' ' HA ' ' A' ' 41' ' ' VAL . 0.3 OUTLIER -52.35 -15.03 0.54 Allowed 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.26 -179.406 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 20.4 t-160 -82.84 -38.59 22.81 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 118.147 -1.421 . . . . 0.0 110.136 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.736 ' O ' ' N ' ' A' ' 49' ' ' ASN . . . -94.39 -109.93 2.2 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 106.234 -2.746 . . . . 0.0 106.234 177.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.817 ' CZ3' ' HA ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -58.39 71.42 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 177.062 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.736 ' N ' ' O ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -57.66 109.95 2.14 Favored Pre-proline 0 C--N 1.289 -2.052 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.192 -178.615 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.757 ' HA ' HG23 ' A' ' 78' ' ' VAL . 51.5 Cg_endo -92.54 -0.03 3.92 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.171 1.914 . . . . 0.0 110.448 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.698 ' HA ' ' HE3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -44.97 -77.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.147 -0.97 . . . . 0.0 110.425 -179.518 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.626 ' HB3' ' HE ' ' A' ' 79' ' ' ARG . 0.2 OUTLIER -40.57 -19.29 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.708 0.766 . . . . 0.0 109.192 178.784 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.638 ' N ' ' O ' ' A' ' 51' ' ' LYS . 3.1 t -114.69 -178.52 3.39 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.653 0.74 . . . . 0.0 110.776 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.579 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 0.3 OUTLIER -89.0 166.6 13.79 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.84 0.828 . . . . 0.0 110.595 -179.736 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.935 ' CG ' HD22 ' A' ' 33' ' ' LEU . 3.2 pp20? -81.93 8.75 9.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.713 -0.617 . . . . 0.0 110.039 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.579 ' ND2' ' O ' ' A' ' 54' ' ' SER . 0.1 OUTLIER -24.51 -33.1 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.675 0.75 . . . . 0.0 110.134 -179.534 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.797 ' N ' ' O ' ' A' ' 55' ' ' GLU . 6.1 pt -141.73 165.18 18.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.798 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.685 ' CB ' HD13 ' A' ' 40' ' ' LEU . 9.2 t0 -114.91 126.79 55.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.463 -0.773 . . . . 0.0 109.967 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.747 HG11 ' CD1' ' A' ' 48' ' ' TRP . 57.7 t -130.04 127.01 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.115 -0.991 . . . . 0.0 109.907 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.675 ' HA ' ' CH2' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -136.37 157.1 47.6 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.986 -1.071 . . . . 0.0 111.585 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.67 ' N ' ' CH2' ' A' ' 48' ' ' TRP . 1.3 tt0 -52.5 -110.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.694 -0.629 . . . . 0.0 111.076 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 44.54 37.57 5.0 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 107.661 -2.176 . . . . 0.0 107.661 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.73 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 94.35 78.32 1.41 Allowed Glycine 0 N--CA 1.486 1.973 0 N-CA-C 107.809 -2.117 . . . . 0.0 107.809 -178.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.73 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.4 OUTLIER 1.26 88.21 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.661 -0.905 . . . . 0.0 110.126 -178.711 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 46.4 t -122.35 114.64 21.05 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.425 -0.797 . . . . 0.0 111.677 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.658 ' CE2' HG23 ' A' ' 212' ' ' VAL . 0.1 OUTLIER -84.41 135.36 34.3 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.501 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.556 ' O ' ' N ' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -138.39 131.62 30.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.851 -1.156 . . . . 0.0 111.15 -179.535 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.552 ' HG2' ' CA ' ' A' ' 208' ' ' GLY . 0.0 OUTLIER -130.71 141.81 50.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.53 -0.732 . . . . 0.0 109.043 179.133 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.605 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 2.4 ttp180 -110.46 -68.2 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.783 -1.198 . . . . 0.0 111.325 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.605 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 56.3 Cg_endo -71.61 -124.1 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.5 0 O-C-N 123.394 1.207 . . . . 0.0 109.586 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.55 ' O ' ' N ' ' A' ' 73' ' ' GLN . 3.6 t -140.1 164.18 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.441 -1.412 . . . . 0.0 109.874 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.923 ' HB2' ' CE3' ' A' ' 207' ' ' TRP . . . -46.66 91.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.169 -0.957 . . . . 0.0 109.892 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.55 ' N ' ' O ' ' A' ' 71' ' ' VAL . 9.8 mt-30 -50.08 -176.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.932 . . . . 0.0 110.313 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.0 m -51.76 -18.84 1.37 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 0.0 110.127 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 1.3 m -96.87 -131.88 0.2 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.215 -0.928 . . . . 0.0 110.081 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.579 ' O ' ' C ' ' A' ' 77' ' ' GLY . 80.5 m-20 -140.4 154.83 46.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.187 -0.946 . . . . 0.0 110.172 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.579 ' C ' ' O ' ' A' ' 76' ' ' ASP . . . -31.88 -77.78 0.03 OUTLIER Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.757 HG23 ' HA ' ' A' ' 50' ' ' PRO . 0.4 OUTLIER -149.18 153.29 11.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.345 -1.091 . . . . 0.0 109.783 179.024 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.626 ' HE ' ' HB3' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -145.7 174.63 11.03 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.712 -0.617 . . . . 0.0 110.071 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.576 ' N ' ' CG ' ' A' ' 79' ' ' ARG . . . -157.48 152.55 23.83 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.513 ' HB2' ' CB ' ' A' ' 202' ' ' SER . 0.1 OUTLIER 179.85 -27.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.206 -1.173 . . . . 0.0 110.661 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.48 ' HG2' ' OD1' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -72.92 -100.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.137 -0.977 . . . . 0.0 110.334 -179.794 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 82' ' ' ARG . . . 43.0 59.61 3.28 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.526 ' CD2' ' O ' ' A' ' 84' ' ' TYR . 28.2 t80 -95.33 95.68 8.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.18 -1.188 . . . . 0.0 110.185 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.451 ' O ' ' HG2' ' A' ' 173' ' ' MET . 0.1 OUTLIER -140.11 173.67 11.28 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 110.252 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.541 ' HA ' ' CB ' ' A' ' 173' ' ' MET . 2.3 mmt85 -101.42 -174.36 2.58 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.177 -0.952 . . . . 0.0 109.676 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.96 158.35 15.98 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.774 ' O ' HD23 ' A' ' 88' ' ' LEU . 1.8 tt -87.47 127.41 35.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -1.11 . . . . 0.0 109.98 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.421 ' NE2' ' O ' ' A' ' 86' ' ' ARG . 40.9 m-70 -133.25 173.1 11.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 110.162 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -156.76 151.31 25.56 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.07 -1.019 . . . . 0.0 110.389 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.811 ' CZ2' HG11 ' A' ' 169' ' ' VAL . 4.1 p90 -146.2 171.06 15.5 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.246 -0.909 . . . . 0.0 109.936 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.584 ' N ' ' O ' ' A' ' 215' ' ' ARG . 0.7 OUTLIER -138.28 152.14 48.26 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.351 -0.939 . . . . 0.0 111.45 -178.758 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 1.037 HG23 HD21 ' A' ' 167' ' ' LEU . 3.7 tt -144.18 151.58 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.545 -0.722 . . . . 0.0 109.674 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.544 ' HG ' ' HG2' ' A' ' 213' ' ' ARG . 0.1 OUTLIER -142.65 135.85 28.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.092 -1.005 . . . . 0.0 110.672 -179.572 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.802 ' CH2' ' HA ' ' A' ' 104' ' ' ALA . 88.3 m95 -104.47 96.25 9.83 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.775 -0.578 . . . . 0.0 110.204 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.621 ' HD2' ' O ' ' A' ' 211' ' ' GLN . 45.9 Cg_endo -72.29 152.37 55.45 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 121.959 1.772 . . . . 0.0 111.214 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 1.216 HD22 ' O ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -32.87 -42.69 0.08 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.533 -0.729 . . . . 0.0 111.158 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 1.161 ' N ' HD13 ' A' ' 97' ' ' LEU . 3.1 mt-10 -35.71 -28.33 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.687 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.769 ' HA ' ' HB3' ' A' ' 210' ' ' CYS . 7.3 pt20 -67.16 50.41 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.247 -0.908 . . . . 0.0 110.304 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.813 ' NH1' HD21 ' A' ' 97' ' ' LEU . 1.9 mtt-85 -56.03 -99.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.173 -0.955 . . . . 0.0 110.233 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 100' ' ' ARG . . . -44.88 -93.13 0.01 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.461 ' OG1' HG21 ' A' ' 206' ' ' VAL . 1.2 p -59.45 136.81 58.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.249 -1.148 . . . . 0.0 110.071 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.578 ' O ' ' CZ3' ' A' ' 95' ' ' TRP . 4.9 m80 -98.95 -135.49 0.28 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -0.888 . . . . 0.0 110.212 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.802 ' HA ' ' CH2' ' A' ' 95' ' ' TRP . . . -94.88 131.51 40.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.184 -0.948 . . . . 0.0 110.352 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.924 HG23 ' CB ' ' A' ' 204' ' ' SER . 34.9 m -128.01 114.12 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 118.003 -1.479 . . . . 0.0 110.471 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.861 ' HB ' HG23 ' A' ' 203' ' ' VAL . 9.0 p -152.31 166.91 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.396 -0.815 . . . . 0.0 109.121 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.666 ' CA ' ' HA3' ' A' ' 132' ' ' GLY . . . 176.28 167.99 35.8 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 118.987 -1.578 . . . . 0.0 110.941 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.039 ' CG1' HD13 ' A' ' 199' ' ' LEU . 2.2 t -123.91 155.61 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.712 -0.876 . . . . 0.0 109.017 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.997 ' HB3' ' CZ ' ' A' ' 200' ' ' TYR . . . -142.96 150.78 40.15 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.805 -1.185 . . . . 0.0 111.365 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . 1.015 ' OG1' HD23 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -131.45 134.95 46.71 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.513 -0.742 . . . . 0.0 110.087 179.505 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.96 -24.77 18.28 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.343 -0.848 . . . . 0.0 109.337 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.6 pp -86.69 -12.11 49.29 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.583 -0.698 . . . . 0.0 109.255 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.96 ' HB3' ' HD3' ' A' ' 114' ' ' PRO . . . -41.82 -57.61 3.91 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.465 -0.772 . . . . 0.0 110.44 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.96 ' HD3' ' HB3' ' A' ' 113' ' ' ALA . 46.6 Cg_endo -73.84 149.95 43.44 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.956 1.503 . . . . 0.0 110.505 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.609 HD23 ' O ' ' A' ' 113' ' ' ALA . 0.7 OUTLIER -178.39 47.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 110.016 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -91.73 -86.75 0.22 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.329 -0.857 . . . . 0.0 110.257 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.533 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -150.74 67.17 0.94 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.152 -0.968 . . . . 0.0 110.156 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 120' ' ' TYR . 43.0 t0 -30.68 -53.14 0.18 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.464 -0.772 . . . . 0.0 110.778 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.479 ' HB3' ' O ' ' A' ' 118' ' ' ASP . 9.2 t-80 62.42 -71.37 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.357 -0.839 . . . . 0.0 110.239 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.56 ' O ' ' HB2' ' A' ' 121' ' ' ALA . 0.4 OUTLIER -149.32 -51.07 0.15 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 110.165 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 120' ' ' TYR . . . 176.97 -52.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.959 . . . . 0.0 110.172 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 121' ' ' ALA . . . 59.83 167.69 0.07 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.236 -0.915 . . . . 0.0 110.202 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.63 ' O ' HD12 ' A' ' 124' ' ' LEU . 34.0 tp -81.05 -19.22 44.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.16 -0.963 . . . . 0.0 110.237 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.63 HD12 ' O ' ' A' ' 123' ' ' LEU . 1.3 tp -148.25 44.27 1.05 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.254 -0.903 . . . . 0.0 110.193 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -65.61 -119.47 0.01 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.98 58.47 1.54 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.203 -1.175 . . . . 0.0 110.212 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.3 m-20 -47.1 -69.38 0.13 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.256 -0.902 . . . . 0.0 110.166 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.546 ' HA ' ' HG3' ' A' ' 114' ' ' PRO . 32.0 t -156.65 175.8 13.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.252 -0.905 . . . . 0.0 110.211 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.669 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 0.2 OUTLIER -133.5 119.64 19.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 110.051 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 3.1 t -120.58 119.99 34.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 110.334 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -123.68 124.91 43.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.851 . . . . 0.0 109.693 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.666 ' HA3' ' CA ' ' A' ' 107' ' ' GLY . . . -164.53 -164.36 19.64 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.607 ' CH2' ' O ' ' A' ' 180' ' ' TYR . 36.4 m0 -114.64 113.17 24.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -1.103 . . . . 0.0 110.462 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -119.63 107.77 13.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.709 -0.62 . . . . 0.0 109.488 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.699 HG23 ' O ' ' A' ' 135' ' ' ILE . 15.7 tt -144.26 48.15 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.156 -0.965 . . . . 0.0 110.394 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.479 ' HA2' ' HB2' ' A' ' 103' ' ' HIS . . . -91.9 -23.65 27.27 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.94 4.25 23.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -1.175 . . . . 0.0 109.989 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.465 ' O ' ' HG2' ' A' ' 139' ' ' LYS . . . 79.32 -11.67 29.7 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.189 -1.165 . . . . 0.0 110.189 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 7.8 mmtt -145.31 -164.1 1.86 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.047 -1.267 . . . . 0.0 110.459 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 139' ' ' LYS . 0.6 OUTLIER -178.44 61.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.414 -0.804 . . . . 0.0 110.178 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.427 ' CG ' ' O ' ' A' ' 141' ' ' TYR . 40.8 t80 -72.7 68.06 0.82 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.189 -0.944 . . . . 0.0 110.333 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 5.6 m170 -71.67 -71.47 0.27 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 110.311 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -95.55 -80.89 0.41 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.249 -0.907 . . . . 0.0 110.169 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.31 -162.21 1.48 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.325 -0.859 . . . . 0.0 110.184 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.39 96.17 0.08 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.201 -0.937 . . . . 0.0 110.182 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -146.14 23.16 1.75 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 148' ' ' GLU . 0.5 OUTLIER -172.07 49.65 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.187 -1.184 . . . . 0.0 110.159 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 147' ' ' LEU . 7.3 tp10 179.93 94.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 110.036 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -122.67 98.59 43.01 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.229 -0.92 . . . . 0.0 110.2 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.98 53.45 2.88 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.973 1.512 . . . . 0.0 110.504 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -77.79 -91.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 0.0 110.184 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.634 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 5.0 m-85 -107.34 -66.44 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.272 -0.893 . . . . 0.0 110.505 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.634 ' CD ' ' CB ' ' A' ' 152' ' ' TYR . 47.3 Cg_endo -73.03 142.91 35.33 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.574 1.302 . . . . 0.0 110.383 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.507 ' O ' ' O ' ' A' ' 155' ' ' GLY . . . -66.48 132.46 48.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 110.117 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.507 ' O ' ' O ' ' A' ' 154' ' ' ALA . . . 58.75 125.53 0.01 OUTLIER Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.07 -49.67 0.29 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.842 1.443 . . . . 0.0 110.494 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -61.96 -10.2 9.06 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.265 -0.897 . . . . 0.0 110.413 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.743 ' O ' HG23 ' A' ' 162' ' ' VAL . . . 59.74 62.1 6.48 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.488 ' O ' ' HG2' ' A' ' 164' ' ' PRO . 3.2 pp20? -69.5 6.47 1.07 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.405 -1.056 . . . . 0.0 110.682 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -76.52 0.13 21.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.891 . . . . 0.0 109.957 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.449 ' HA ' ' OE1' ' A' ' 165' ' ' GLU . 0.6 OUTLIER -167.42 35.43 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.312 -0.868 . . . . 0.0 110.008 179.964 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 158' ' ' GLY . 24.1 t -106.79 -115.3 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.275 -0.89 . . . . 0.0 110.422 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.858 HG12 ' HD3' ' A' ' 164' ' ' PRO . 8.4 p -87.17 -25.91 0.34 Allowed Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.188 -0.945 . . . . 0.0 111.134 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.858 ' HD3' HG12 ' A' ' 163' ' ' VAL . 48.3 Cg_endo -79.3 52.51 4.31 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 O-C-N 123.068 1.036 . . . . 0.0 109.792 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' A' ' 94' ' ' SER . 0.9 OUTLIER 178.77 -72.4 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.693 0.759 . . . . 0.0 109.371 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.422 ' HA ' ' HB3' ' A' ' 94' ' ' SER . 1.4 tpp180 -140.85 144.0 35.08 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 1.037 HD21 HG23 ' A' ' 93' ' ' ILE . 0.6 OUTLIER -164.36 157.08 17.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.041 -1.037 . . . . 0.0 110.745 -179.604 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.502 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . 7.7 tt -123.31 137.14 54.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.286 -0.884 . . . . 0.0 110.082 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.889 HG21 ' CE1' ' A' ' 180' ' ' TYR . 19.0 t -121.4 147.94 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 110.082 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.604 HG21 HD21 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -127.89 128.87 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.181 -0.95 . . . . 0.0 110.438 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.739 HD13 HD22 ' A' ' 178' ' ' LEU . 4.7 tp -133.14 105.91 7.3 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.225 -0.922 . . . . 0.0 109.678 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.509 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 54.3 t0 -114.88 136.64 52.88 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 110.648 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.541 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -93.26 -39.6 10.9 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.799 -0.563 . . . . 0.0 109.689 179.678 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 173' ' ' MET . 3.5 tt0 -42.51 -28.07 0.2 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.323 -0.861 . . . . 0.0 108.894 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.59 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 3.0 tt0 -111.86 -26.22 9.04 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.521 ' O ' ' HB ' ' A' ' 198' ' ' THR . . . 80.0 25.07 58.58 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' THR . . . . . 1.097 HG22 HD22 ' A' ' 194' ' ' LEU . 0.2 OUTLIER -121.81 136.7 54.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.191 -1.182 . . . . 0.0 111.252 -179.431 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 1.098 ' O ' HD11 ' A' ' 194' ' ' LEU . 0.3 OUTLIER -144.66 153.76 42.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.56 -0.713 . . . . 0.0 109.514 179.302 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -154.03 167.6 32.28 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.588 -1.292 . . . . 0.0 110.197 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.889 ' CE1' HG21 ' A' ' 169' ' ' VAL . 0.9 OUTLIER -118.74 125.26 49.23 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.594 -0.945 . . . . 0.0 108.906 179.64 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.539 ' CB ' ' HB2' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -144.41 165.07 28.96 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.069 -1.019 . . . . 0.0 110.646 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 1.009 HD11 ' CD2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -120.81 116.65 50.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 O-C-N 121.667 -0.646 . . . . 0.0 109.38 179.402 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 62.78 11.67 37.8 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 86.92 34.52 10.93 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' THR . . . . . 0.76 HG22 ' CE1' ' A' ' 186' ' ' TYR . 31.8 m -87.43 -79.41 0.28 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -1.161 . . . . 0.0 110.545 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 1.009 ' CD2' HD11 ' A' ' 182' ' ' ILE . 2.0 m-85 -83.66 89.47 7.13 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.971 -1.081 . . . . 0.0 110.389 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.629 ' HG ' ' CE1' ' A' ' 191' ' ' PHE . 12.3 tp 179.9 29.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.589 -0.694 . . . . 0.0 109.504 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.438 ' H ' ' HD2' ' A' ' 189' ' ' PRO . . . -106.73 -72.06 0.8 Allowed Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.754 -1.212 . . . . 0.0 110.984 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.438 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 44.8 Cg_endo -70.48 -30.84 18.35 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.899 1.473 . . . . 0.0 111.727 -178.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.657 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -72.42 17.21 0.11 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.125 -0.984 . . . . 0.0 111.519 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.629 ' CE1' ' HG ' ' A' ' 187' ' ' LEU . 1.1 m-30 -90.83 -22.14 21.13 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.962 -1.086 . . . . 0.0 110.981 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.476 ' HG2' ' NH1' ' A' ' 192' ' ' ARG . 0.1 OUTLIER -90.02 -14.66 33.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.033 -1.042 . . . . 0.0 110.659 -179.391 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -106.62 -17.36 12.27 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.516 -1.834 . . . . 0.0 108.516 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 1.098 HD11 ' O ' ' A' ' 178' ' ' LEU . 7.2 tt -65.99 -41.44 91.1 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.699 -0.883 . . . . 0.0 109.525 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.559 ' HE3' ' N ' ' A' ' 196' ' ' GLY . 0.0 OUTLIER -47.07 -31.12 3.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.455 -0.778 . . . . 0.0 110.415 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.559 ' N ' ' HE3' ' A' ' 195' ' ' LYS . . . -99.61 -22.91 11.57 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 1.014 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -91.22 -3.66 56.74 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.942 -0.74 . . . . 0.0 110.164 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.789 HG23 ' O ' ' A' ' 194' ' ' LEU . 33.9 p -42.6 123.17 2.53 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.781 0.801 . . . . 0.0 111.785 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 1.039 HD13 ' CG1' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -140.72 172.9 12.05 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.495 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.997 ' CZ ' ' HB3' ' A' ' 109' ' ' ALA . 41.0 p90 -83.13 131.26 54.13 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 120.934 -1.104 . . . . 0.0 109.625 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.51 ' HA ' HG13 ' A' ' 108' ' ' VAL . 52.2 Cg_endo -81.74 132.43 7.65 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 124.01 1.532 . . . . 0.0 111.935 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.513 ' CB ' ' HB2' ' A' ' 81' ' ' LYS . 20.0 p -133.44 127.31 33.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.61 -0.681 . . . . 0.0 109.346 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.861 HG23 ' HB ' ' A' ' 106' ' ' VAL . 11.8 p -119.66 156.33 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.01 -1.056 . . . . 0.0 110.589 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' SER . . . . . 0.924 ' CB ' HG23 ' A' ' 105' ' ' VAL . 1.4 m -134.18 129.27 35.55 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.527 -0.733 . . . . 0.0 110.726 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 1.001 ' HB1' HG21 ' A' ' 212' ' ' VAL . . . -123.14 131.22 53.6 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.285 0.564 . . . . 0.0 110.202 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.611 HG13 ' N ' ' A' ' 207' ' ' TRP . 1.2 t -47.35 176.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.46 -0.775 . . . . 0.0 110.419 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 0.923 ' CE3' ' HB2' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -101.3 -50.44 3.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.201 -0.937 . . . . 0.0 111.072 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.69 ' N ' ' CG ' ' A' ' 207' ' ' TRP . . . -144.36 -1.19 0.93 Allowed Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.596 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.545 ' OE1' ' CH2' ' A' ' 207' ' ' TRP . 4.0 tp60 -66.9 -23.43 65.99 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.424 -1.045 . . . . 0.0 109.646 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' CYS . . . . . 0.769 ' HB3' ' HA ' ' A' ' 99' ' ' GLN . 20.7 p -143.98 -121.98 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.625 0.726 . . . . 0.0 110.018 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.621 ' O ' ' HD2' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -173.53 139.55 0.75 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.634 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 1.001 HG21 ' HB1' ' A' ' 205' ' ' ALA . 2.3 t -127.24 140.6 48.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 120.607 -1.308 . . . . 0.0 111.321 -178.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.713 ' HA ' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -128.39 109.28 11.28 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.153 178.73 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.665 ' O ' HD11 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -123.54 150.79 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.425 -0.797 . . . . 0.0 110.913 -179.024 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.584 ' O ' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -130.0 108.89 10.44 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.925 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 216' ' ' TYR . . . . . 0.714 ' CD2' ' CB ' ' A' ' 91' ' ' TRP . 1.5 t80 -115.8 140.28 49.37 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.187 -0.945 . . . . 0.0 111.048 -178.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' MET . . . . . 0.421 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 0.0 OUTLIER -136.71 123.99 21.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.648 -0.657 . . . . 0.0 110.142 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 145.8 -37.54 1.26 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -95.5 142.47 27.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.274 -1.133 . . . . 0.0 110.224 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.471 ' HG3' ' N ' ' A' ' 221' ' ' ARG . 2.8 ptp180 -161.75 -139.48 0.05 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.906 . . . . 0.0 110.221 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ARG . . . . . 0.488 ' O ' ' C ' ' A' ' 222' ' ' VAL . 6.0 ttm180 -102.13 79.18 1.84 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.199 -0.938 . . . . 0.0 110.162 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.683 HG13 ' O ' ' A' ' 222' ' ' VAL . 9.3 p -35.03 116.16 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.552 -0.717 . . . . 0.0 110.559 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.505 ' O ' ' C ' ' A' ' 224' ' ' GLU . 49.8 mt-10 -83.81 34.41 0.49 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.176 -0.953 . . . . 0.0 110.53 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.505 ' C ' ' O ' ' A' ' 223' ' ' GLU . 4.7 tp10 -33.73 -70.72 0.07 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.425 -0.797 . . . . 0.0 110.715 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.624 HG23 ' O ' ' A' ' 225' ' ' THR . 5.1 t -42.78 109.83 0.15 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.235 -0.915 . . . . 0.0 110.159 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.51 137.63 23.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.339 -0.851 . . . . 0.0 110.139 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 11.0 ptt85 -103.1 28.85 5.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 110.238 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 228' ' ' ILE . 5.9 tp -131.13 24.99 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.915 . . . . 0.0 110.232 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.427 ' O ' ' CG ' ' A' ' 231' ' ' ASP . 4.2 m170 -88.14 2.59 51.73 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.217 -0.927 . . . . 0.0 110.149 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ARG . . . . . 0.448 ' O ' ' HB3' ' A' ' 231' ' ' ASP . 0.0 OUTLIER -51.54 107.78 0.22 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.214 -0.929 . . . . 0.0 110.221 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.448 ' HB3' ' O ' ' A' ' 230' ' ' ARG . 3.6 p30 . . . . . 0 C--N 1.307 -1.279 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.306 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.408 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -55.4 161.56 1.87 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -1.171 . . . . 0.0 110.137 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -159.96 69.25 0.41 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.266 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.74 45.48 1.19 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.288 -0.882 . . . . 0.0 110.115 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.67 75.17 5.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.178 -0.951 . . . . 0.0 110.275 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -48.71 146.36 3.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.926 . . . . 0.0 110.219 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.6 m -161.18 -81.8 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.304 -0.873 . . . . 0.0 110.176 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.4 m -160.32 123.73 1.95 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 0.0 110.121 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.17 -170.69 0.67 Allowed 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.921 1.485 . . . . 0.0 110.439 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.38 -163.34 1.58 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.921 . . . . 0.0 110.179 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.407 ' O ' ' OG ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -95.43 14.63 21.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.266 -0.896 . . . . 0.0 110.159 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.406 ' OE1' ' HA ' ' A' ' 17' ' ' GLN . 4.1 mm100 -72.6 141.29 48.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.209 -0.932 . . . . 0.0 110.208 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.62 177.1 0.97 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.281 -0.887 . . . . 0.0 110.269 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.02 -154.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.889 . . . . 0.0 110.258 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.507 ' O ' ' O ' ' A' ' 21' ' ' SER . 1.0 OUTLIER -76.71 -155.83 0.07 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 110.023 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.507 ' O ' ' O ' ' A' ' 20' ' ' TYR . 0.7 OUTLIER -52.05 -167.94 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.234 -0.916 . . . . 0.0 110.404 -179.859 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.58 40.89 0.25 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.901 . . . . 0.0 110.326 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -56.29 -57.43 12.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 110.152 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.49 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -134.27 130.59 20.25 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.352 -0.843 . . . . 0.0 110.111 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.4 110.09 2.99 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.035 1.545 . . . . 0.0 110.494 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 24' ' ' SER . 47.6 Cg_endo -74.2 164.98 32.98 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.127 1.593 . . . . 0.0 110.304 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 2.3 tt0 -175.94 37.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.883 . . . . 0.0 110.057 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.481 ' O ' ' HG2' ' A' ' 30' ' ' GLU . . . 48.41 25.89 4.68 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.647 HD11 ' HG3' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -41.83 -25.64 0.06 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.429 -1.042 . . . . 0.0 110.218 -179.676 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.705 ' HA ' HD23 ' A' ' 33' ' ' LEU . 10.6 pt-20 -48.57 -29.26 4.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.119 -0.988 . . . . 0.0 108.819 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -66.75 -23.52 66.1 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 29' ' ' LEU . 15.1 tp -83.22 -35.85 25.08 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.833 HD12 ' C ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -73.25 -38.01 66.14 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.903 0.858 . . . . 0.0 109.027 178.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.577 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 23.0 t -58.56 -22.71 56.62 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.444 0.64 . . . . 0.0 110.062 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.985 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -57.95 -173.71 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.454 -0.779 . . . . 0.0 109.555 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.985 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 42.5 Cg_endo -69.16 102.28 0.91 Allowed 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.875 1.461 . . . . 0.0 110.099 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.693 ' HD3' ' O ' ' A' ' 35' ' ' ALA . 49.1 Cg_endo -94.23 121.21 0.35 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.19 1.627 . . . . 0.0 111.215 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.904 ' O ' ' N ' ' A' ' 40' ' ' LEU . 51.6 Cg_endo -83.84 149.58 12.51 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.925 1.487 . . . . 0.0 110.524 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.634 ' C ' ' O ' ' A' ' 38' ' ' PRO . 0.6 OUTLIER 3.02 51.98 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 122.126 0.965 . . . . 0.0 111.358 -179.649 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.068 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -139.63 -48.89 0.47 Allowed 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 178.154 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.068 HG23 ' CD1' ' A' ' 40' ' ' LEU . 2.7 t -88.52 -32.76 6.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 119.327 -0.949 . . . . 0.0 108.554 177.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.46 -43.97 10.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.638 -0.664 . . . . 0.0 112.049 -178.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.738 ' OE1' ' HA ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -81.41 -19.99 41.37 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.056 -1.058 . . . . 0.0 109.972 -178.78 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.696 ' HD2' HG22 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -71.85 -51.63 21.42 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.613 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.805 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 2.1 m-70 -56.38 -16.35 5.54 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.638 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -95.04 -33.19 12.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.263 -0.898 . . . . 0.0 109.383 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.645 ' C ' ' CE3' ' A' ' 48' ' ' TRP . . . -83.77 -101.93 0.56 Allowed Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.157 -1.977 . . . . 0.0 108.157 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.786 ' CD2' ' N ' ' A' ' 48' ' ' TRP . 0.3 OUTLIER -86.86 73.06 10.03 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 122.963 1.363 . . . . 0.0 108.479 179.492 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 49' ' ' ASN . 0.1 OUTLIER -46.21 111.67 1.53 Allowed Pre-proline 0 C--N 1.287 -2.148 0 CA-C-N 114.218 -1.356 . . . . 0.0 112.333 -178.295 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.708 ' O ' ' N ' ' A' ' 52' ' ' ASP . 55.4 Cg_endo -91.9 2.09 4.2 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.496 2.131 . . . . 0.0 110.277 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.764 ' HA ' ' CE ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -52.34 71.29 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.909 1.338 . . . . 0.0 111.655 -177.783 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.708 ' N ' ' O ' ' A' ' 50' ' ' PRO . 1.6 m-20 178.03 0.16 0.0 OUTLIER 'General case' 0 C--N 1.262 -3.213 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.2 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.85 ' HB2' ' CB ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -166.01 -175.69 3.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.389 -0.819 . . . . 0.0 111.259 -178.187 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.798 ' HB2' HG21 ' A' ' 75' ' ' THR . 0.0 OUTLIER -51.78 124.5 12.63 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.955 0.883 . . . . 0.0 110.709 -179.016 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.745 ' C ' ' H ' ' A' ' 57' ' ' ILE . 1.6 pt-20 -99.67 8.41 44.37 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.591 0.71 . . . . 0.0 110.956 -179.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.732 ' C ' HD13 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -58.84 22.94 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.666 0.746 . . . . 0.0 110.199 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.745 ' H ' ' C ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -112.99 166.13 7.15 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 CA-C-O 121.679 0.752 . . . . 0.0 110.342 -179.7 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.776 ' HA ' HD23 ' A' ' 40' ' ' LEU . 10.1 t0 -134.72 96.32 3.53 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 121.868 0.842 . . . . 0.0 109.737 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.764 ' HA ' ' O ' ' A' ' 65' ' ' CYS . 1.4 m -121.7 121.33 64.11 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 CA-C-O 121.27 0.557 . . . . 0.0 110.186 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.738 ' HA ' ' OE1' ' A' ' 43' ' ' GLN . 7.9 ttmt -135.75 153.42 51.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 110.658 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.554 ' N ' ' HG2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -55.27 -123.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.431 -0.793 . . . . 0.0 110.724 -179.457 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 44.0 32.37 2.34 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.698 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 110.9 65.47 0.53 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.698 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.2 OUTLIER 0.63 90.23 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.835 -0.803 . . . . 0.0 110.832 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.764 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 1.0 OUTLIER -116.88 114.4 23.83 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.528 -0.733 . . . . 0.0 109.786 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.709 ' CE2' HG11 ' A' ' 59' ' ' VAL . 13.4 t80 -116.25 123.56 48.02 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.461 -0.774 . . . . 0.0 109.541 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -151.82 149.03 28.54 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.909 -1.119 . . . . 0.0 110.886 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.627 ' HB2' HG23 ' A' ' 57' ' ' ILE . 17.4 ttt85 -122.51 152.87 39.9 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.253 -0.904 . . . . 0.0 109.71 179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.68 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 2.7 mtt180 -85.8 -69.02 0.13 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.084 -1.01 . . . . 0.0 110.398 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.68 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 56.1 Cg_endo -71.34 -145.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.706 1.371 . . . . 0.0 109.382 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.502 ' O ' ' HG2' ' A' ' 73' ' ' GLN . 4.8 t -140.01 164.45 22.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 O-C-N 121.378 -0.826 . . . . 0.0 109.954 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.781 ' HB2' ' CE3' ' A' ' 207' ' ' TRP . . . -63.06 111.38 2.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.208 -0.932 . . . . 0.0 110.105 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.502 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 0.9 OUTLIER -140.65 -103.81 0.15 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.238 -0.914 . . . . 0.0 110.393 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.482 ' C ' ' O ' ' A' ' 73' ' ' GLN . 8.4 t -38.26 -29.95 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.166 -0.958 . . . . 0.0 110.39 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.798 HG21 ' HB2' ' A' ' 54' ' ' SER . 2.7 t -137.49 -134.69 0.14 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.254 -0.904 . . . . 0.0 110.049 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.627 ' O ' ' C ' ' A' ' 77' ' ' GLY . 2.3 t0 -140.11 154.6 47.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 109.905 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.639 ' O ' ' OG ' ' A' ' 54' ' ' SER . . . -25.01 -94.0 0.01 OUTLIER Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.65 ' CG1' HG13 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -158.24 163.13 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.098 -1.236 . . . . 0.0 109.521 179.728 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.85 ' CB ' ' HB2' ' A' ' 53' ' ' CYS . 3.1 tmm_? -141.08 134.66 30.05 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.4 -0.813 . . . . 0.0 110.776 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.891 ' C ' HG12 ' A' ' 203' ' ' VAL . . . -116.17 -152.34 9.86 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.001 -2.039 . . . . 0.0 108.001 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.845 ' C ' ' HA ' ' A' ' 202' ' ' SER . 0.0 OUTLIER 2.02 123.33 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.414 -1.05 . . . . 0.0 110.986 179.357 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.556 ' HA ' ' CB ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -126.46 -19.83 4.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.267 -0.896 . . . . 0.0 110.549 -179.444 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.552 ' HA3' ' HB3' ' A' ' 200' ' ' TYR . . . 133.53 37.73 0.23 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.544 ' HB2' ' HD3' ' A' ' 82' ' ' ARG . 7.9 t80 -134.8 95.86 3.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.06 -1.259 . . . . 0.0 110.286 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.691 ' CB ' HD11 ' A' ' 171' ' ' LEU . 0.7 OUTLIER -140.16 140.68 35.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.169 -0.957 . . . . 0.0 110.538 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.58 ' HA ' ' CB ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -131.42 145.44 51.81 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -0.902 . . . . 0.0 109.597 179.654 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.452 ' N ' ' HB3' ' A' ' 173' ' ' MET . . . 81.18 165.71 34.79 Favored Glycine 0 N--CA 1.481 1.693 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.466 ' O ' HD23 ' A' ' 88' ' ' LEU . 4.9 tt -87.23 117.86 26.27 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.34 -1.094 . . . . 0.0 110.047 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.454 ' NE2' ' O ' ' A' ' 86' ' ' ARG . 91.4 m-70 -135.39 173.28 11.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -0.882 . . . . 0.0 109.881 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.36 136.58 23.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.14 -0.975 . . . . 0.0 110.107 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 1.152 ' CZ2' HG11 ' A' ' 169' ' ' VAL . 0.5 OUTLIER -135.07 171.0 15.05 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.156 -0.965 . . . . 0.0 110.632 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 215' ' ' ARG . 2.6 mt-10 -133.41 151.19 51.79 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.745 -0.597 . . . . 0.0 110.004 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.584 HG13 ' CD1' ' A' ' 91' ' ' TRP . 11.5 mt -144.6 154.85 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.237 -0.915 . . . . 0.0 110.799 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . 1.095 ' O ' HG23 ' A' ' 212' ' ' VAL . 14.5 t -141.3 151.43 43.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 109.642 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.764 ' CZ2' HG23 ' A' ' 106' ' ' VAL . 14.4 m95 -137.39 90.92 14.7 Favored Pre-proline 0 C--N 1.296 -1.721 0 O-C-N 121.526 -0.734 . . . . 0.0 110.565 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.535 ' HD2' ' HA ' ' A' ' 212' ' ' VAL . 49.4 Cg_endo -78.93 125.41 6.6 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.977 1.514 . . . . 0.0 110.149 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.586 ' CD2' HD13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -95.09 -6.44 42.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.184 -0.947 . . . . 0.0 110.229 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.447 ' HG3' ' N ' ' A' ' 99' ' ' GLN . 11.6 pt-20 -43.65 -31.21 0.72 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.891 . . . . 0.0 110.449 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.486 ' HG2' ' NE2' ' A' ' 211' ' ' GLN . 0.9 OUTLIER -74.67 -86.79 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.162 -0.961 . . . . 0.0 110.457 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.52 ' O ' HD11 ' A' ' 97' ' ' LEU . 45.3 mmm-85 -139.96 -53.77 0.53 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.377 -0.827 . . . . 0.0 110.244 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.658 ' O ' HG23 ' A' ' 102' ' ' THR . . . 61.26 138.39 0.01 OUTLIER Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.658 HG23 ' O ' ' A' ' 101' ' ' GLY . 0.0 OUTLIER 179.79 -45.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.242 -1.152 . . . . 0.0 110.183 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.709 ' O ' HG22 ' A' ' 105' ' ' VAL . 2.2 m80 -123.43 -91.75 0.54 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.244 -0.91 . . . . 0.0 110.157 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.768 ' HB2' ' HB ' ' A' ' 206' ' ' VAL . . . 0.64 115.59 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 121.38 0.61 . . . . 0.0 112.084 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.751 HG13 ' HA ' ' A' ' 134' ' ' ASP . 1.5 t -139.29 158.71 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.126 -0.984 . . . . 0.0 111.023 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.764 HG23 ' CZ2' ' A' ' 95' ' ' TRP . 5.5 t -132.84 148.58 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.021 -1.049 . . . . 0.0 109.253 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.664 ' HA3' ' HA2' ' A' ' 132' ' ' GLY . . . 175.62 -156.89 22.83 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 118.916 -1.611 . . . . 0.0 111.658 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.783 HG12 ' HB2' ' A' ' 199' ' ' LEU . 2.4 t -135.8 150.48 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.727 -0.866 . . . . 0.0 109.494 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.545 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -120.36 152.94 37.18 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.066 -1.021 . . . . 0.0 110.933 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.979 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -125.76 130.08 50.76 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.277 -0.889 . . . . 0.0 110.491 179.828 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.461 ' O ' ' HD2' ' A' ' 114' ' ' PRO . . . -93.39 -27.79 16.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.53 -0.731 . . . . 0.0 109.539 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.428 HD11 ' O ' ' A' ' 196' ' ' GLY . 2.0 pp -83.4 -12.1 56.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.527 -0.733 . . . . 0.0 109.558 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.819 ' HB3' ' HD3' ' A' ' 114' ' ' PRO . . . -47.12 -51.43 41.15 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.512 -0.742 . . . . 0.0 110.462 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.819 ' HD3' ' HB3' ' A' ' 113' ' ' ALA . 45.3 Cg_endo -72.91 106.84 2.22 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.858 1.452 . . . . 0.0 110.469 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.837 HD21 ' CE1' ' A' ' 120' ' ' TYR . 2.2 tp 179.82 61.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.285 -0.884 . . . . 0.0 110.241 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -105.79 -29.93 9.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.281 -0.887 . . . . 0.0 110.2 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.519 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -65.64 168.27 7.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.357 -0.84 . . . . 0.0 110.227 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.519 ' C ' ' O ' ' A' ' 117' ' ' ALA . 32.3 t70 -33.39 151.76 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.449 -0.782 . . . . 0.0 110.697 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.44 ' C ' ' O ' ' A' ' 118' ' ' ASP . 16.1 m80 -41.85 131.48 3.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.342 -0.849 . . . . 0.0 110.173 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.837 ' CE1' HD21 ' A' ' 115' ' ' LEU . 33.3 p90 -82.13 133.26 35.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.363 -0.836 . . . . 0.0 110.274 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.634 ' O ' ' HB3' ' A' ' 122' ' ' ALA . . . -130.12 103.66 6.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.183 -0.948 . . . . 0.0 110.235 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' A' ' 121' ' ' ALA . . . 64.15 16.33 9.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.252 -0.905 . . . . 0.0 110.187 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 125' ' ' GLY . 13.0 tp -103.1 -19.94 14.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.291 -0.881 . . . . 0.0 110.299 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 7.7 mt 56.89 -84.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.121 -0.987 . . . . 0.0 110.218 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 123' ' ' LEU . . . 132.33 135.62 3.7 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 38.4 p -95.61 27.81 3.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.298 -1.119 . . . . 0.0 110.206 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -129.01 178.67 6.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.924 . . . . 0.0 110.259 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.515 ' HA ' ' HG3' ' A' ' 114' ' ' PRO . 1.1 p -161.5 161.77 30.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.923 . . . . 0.0 110.148 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.748 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -137.98 123.3 19.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.194 -0.941 . . . . 0.0 109.974 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.4 t -142.29 139.52 31.9 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.279 -0.888 . . . . 0.0 110.112 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 8.4 m0 -124.62 128.51 48.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 108.929 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.664 ' HA2' ' HA3' ' A' ' 107' ' ' GLY . . . -127.05 -162.44 11.18 Favored Glycine 0 N--CA 1.484 1.846 0 C-N-CA 118.821 -1.657 . . . . 0.0 111.266 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.716 ' CZ3' ' CD1' ' A' ' 180' ' ' TYR . 6.4 m0 -126.14 118.12 24.58 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.766 -0.843 . . . . 0.0 110.723 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.751 ' HA ' HG13 ' A' ' 105' ' ' VAL . 13.5 t70 -118.68 111.57 18.69 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.599 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.698 HD12 ' N ' ' A' ' 136' ' ' GLY . 0.1 OUTLIER -79.3 4.92 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.156 -0.965 . . . . 0.0 110.315 179.41 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.698 ' N ' HD12 ' A' ' 135' ' ' ILE . . . -41.61 -25.54 0.2 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.501 ' O ' ' N ' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -79.97 4.88 15.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.982 -1.305 . . . . 0.0 110.284 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.544 ' O ' ' CG ' ' A' ' 139' ' ' LYS . . . 40.11 26.39 0.1 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.544 ' CG ' ' O ' ' A' ' 138' ' ' GLY . 12.8 mttp -166.39 -159.03 0.35 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.272 -1.134 . . . . 0.0 110.236 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.787 ' HA ' HG11 ' A' ' 162' ' ' VAL . 1.2 mp -133.87 -51.86 0.85 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.263 -0.898 . . . . 0.0 110.055 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.574 ' O ' ' CD2' ' A' ' 141' ' ' TYR . 33.1 p90 -166.18 107.66 0.72 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.315 -0.866 . . . . 0.0 110.036 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -90.85 38.82 0.96 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.306 -0.871 . . . . 0.0 110.298 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -101.71 -82.12 0.48 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 110.185 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.45 -172.91 3.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -0.89 . . . . 0.0 110.197 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -113.4 -162.05 0.79 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.195 -0.94 . . . . 0.0 110.202 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 113.75 149.18 10.17 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 148' ' ' GLU . 0.7 OUTLIER -96.33 22.38 7.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -1.161 . . . . 0.0 110.253 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 147' ' ' LEU . 31.5 tp10 179.94 122.8 0.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 110.208 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -50.96 107.92 0.93 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.174 -0.954 . . . . 0.0 110.126 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 46.2 Cg_endo -73.13 -12.92 25.91 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.982 1.517 . . . . 0.0 110.358 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -86.85 -85.55 0.16 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.317 -0.864 . . . . 0.0 110.185 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.591 ' CG ' ' HD2' ' A' ' 153' ' ' PRO . 0.1 OUTLIER -115.78 -178.62 0.53 Allowed Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 0.0 110.065 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.591 ' HD2' ' CG ' ' A' ' 152' ' ' TYR . 45.2 Cg_endo -72.8 111.16 3.19 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.877 1.462 . . . . 0.0 110.476 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 153' ' ' PRO . . . -178.91 111.49 0.05 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.268 -0.895 . . . . 0.0 110.133 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 154' ' ' ALA . . . -42.75 132.28 5.01 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.46 -34.53 5.72 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.957 1.504 . . . . 0.0 110.49 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.511 ' HG2' ' CG ' ' A' ' 159' ' ' GLU . 0.1 OUTLIER -64.91 -6.79 9.15 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.235 -0.916 . . . . 0.0 110.404 -179.73 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 54.99 44.54 82.93 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.653 ' OE2' HD12 ' A' ' 182' ' ' ILE . 8.1 mt-10 -80.9 5.23 16.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.208 -1.172 . . . . 0.0 109.981 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.431 ' HB3' HD23 ' A' ' 161' ' ' LEU . 0.0 OUTLIER -59.89 -16.6 30.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.353 -0.842 . . . . 0.0 109.3 179.477 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.746 ' O ' HG23 ' A' ' 162' ' ' VAL . 0.6 OUTLIER -172.68 26.89 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.706 0.765 . . . . 0.0 109.482 179.579 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.787 HG11 ' HA ' ' A' ' 140' ' ' LEU . 2.4 t -161.23 91.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.585 -0.697 . . . . 0.0 110.141 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 1.003 HG11 ' HG ' ' A' ' 167' ' ' LEU . 1.3 t -85.81 155.9 58.5 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.339 -0.851 . . . . 0.0 109.069 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 1.002 ' HD2' HG12 ' A' ' 163' ' ' VAL . 39.2 Cg_endo -65.12 -177.54 0.63 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.557 1.293 . . . . 0.0 111.481 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.53 ' O ' ' OG ' ' A' ' 94' ' ' SER . 0.3 OUTLIER -40.49 -41.6 1.46 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.737 -0.602 . . . . 0.0 111.068 -179.086 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.846 ' C ' HD13 ' A' ' 167' ' ' LEU . 8.3 ttt-85 -146.83 155.99 42.77 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.231 -0.918 . . . . 0.0 110.767 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 1.003 ' HG ' HG11 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -157.56 158.42 35.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.459 -0.775 . . . . 0.0 110.658 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.548 ' O ' ' O ' ' A' ' 181' ' ' SER . 0.6 OUTLIER -102.99 141.15 36.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.144 -0.972 . . . . 0.0 109.673 -179.758 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 1.152 HG11 ' CZ2' ' A' ' 91' ' ' TRP . 9.3 t -119.25 139.52 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.078 -1.014 . . . . 0.0 111.107 -179.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.695 ' HB ' HD13 ' A' ' 187' ' ' LEU . 12.7 t -114.13 109.27 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.419 -0.8 . . . . 0.0 109.241 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.876 HD12 ' CD2' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -121.56 108.84 14.07 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.134 -0.979 . . . . 0.0 110.476 -179.225 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 36.9 t0 -120.21 132.69 55.46 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.799 0.809 . . . . 0.0 110.018 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.58 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 7.0 tpt -94.79 -37.72 11.11 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.847 -0.533 . . . . 0.0 109.642 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 173' ' ' MET . 3.9 mt-10 -43.65 -27.19 0.29 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.522 -0.871 . . . . 0.0 108.805 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.563 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.0 OUTLIER -112.25 -26.53 8.73 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.036 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.489 ' O ' ' CG2' ' A' ' 198' ' ' THR . . . 82.49 23.49 56.29 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.995 HG22 ' CD2' ' A' ' 194' ' ' LEU . 0.1 OUTLIER -120.26 124.14 44.92 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.139 -1.213 . . . . 0.0 111.189 -179.559 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 1.078 ' O ' HD11 ' A' ' 194' ' ' LEU . 2.3 mp -135.24 152.45 51.55 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.55 -0.719 . . . . 0.0 109.568 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.97 ' C ' HD11 ' A' ' 187' ' ' LEU . . . -155.52 177.84 32.46 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.48 -1.343 . . . . 0.0 110.262 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.731 ' CE2' HG21 ' A' ' 163' ' ' VAL . 0.5 OUTLIER -118.77 125.62 50.02 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.499 -1.0 . . . . 0.0 108.836 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.548 ' O ' ' O ' ' A' ' 168' ' ' LEU . 43.5 t -144.18 140.85 29.58 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.084 -1.01 . . . . 0.0 111.135 -179.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.756 HG22 ' HB3' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -95.66 116.33 37.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.478 -0.763 . . . . 0.0 109.319 179.056 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 87.97 -35.07 3.59 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 116.1 39.6 0.87 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 54.9 m -127.28 -5.42 6.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.21 -1.17 . . . . 0.0 110.725 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.494 ' HB3' ' HB2' ' A' ' 181' ' ' SER . 0.3 OUTLIER -85.05 -46.83 10.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.99 -1.069 . . . . 0.0 110.372 -179.852 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.97 HD11 ' C ' ' A' ' 179' ' ' GLY . 2.4 mt -82.09 41.98 0.7 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.181 -0.95 . . . . 0.0 110.024 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -79.89 -91.17 0.44 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 191' ' ' PHE . 47.6 Cg_endo -73.56 -24.82 15.69 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.012 1.532 . . . . 0.0 110.772 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -69.07 21.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.48 -0.763 . . . . 0.0 111.7 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.66 ' CE1' HD22 ' A' ' 187' ' ' LEU . 0.3 OUTLIER -90.27 -38.0 13.71 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.788 -1.195 . . . . 0.0 110.372 179.57 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.67 -13.57 60.64 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.145 -0.972 . . . . 0.0 110.495 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -107.81 -7.69 31.12 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.791 -1.723 . . . . 0.0 108.791 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 1.078 HD11 ' O ' ' A' ' 178' ' ' LEU . 10.5 tt -78.14 -36.52 47.63 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.498 ' CA ' HG23 ' A' ' 198' ' ' THR . 1.0 OUTLIER -44.07 -44.02 7.22 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.679 -0.638 . . . . 0.0 109.933 179.126 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.428 ' O ' HD11 ' A' ' 112' ' ' LEU . . . -83.29 -26.24 44.62 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.729 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.75 -3.69 57.24 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.699 -0.883 . . . . 0.0 109.934 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.727 HG23 ' O ' ' A' ' 194' ' ' LEU . 11.2 p -42.73 135.12 3.02 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.825 0.821 . . . . 0.0 111.722 -177.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.979 ' CB ' HG23 ' A' ' 110' ' ' THR . 0.0 OUTLIER -140.15 171.0 14.8 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.68 -0.638 . . . . 0.0 109.381 179.454 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.612 ' C ' HG13 ' A' ' 108' ' ' VAL . 25.1 m-85 -84.56 129.29 57.92 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 120.997 -1.064 . . . . 0.0 110.123 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.854 ' HG3' HD12 ' A' ' 171' ' ' LEU . 52.8 Cg_endo -83.38 111.52 1.83 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.954 1.502 . . . . 0.0 110.78 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.845 ' HA ' ' C ' ' A' ' 81' ' ' LYS . 12.2 p -133.94 160.61 37.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 109.864 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.891 HG12 ' C ' ' A' ' 80' ' ' GLY . 14.4 p -122.87 157.11 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.731 -1.23 . . . . 0.0 110.924 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 105' ' ' VAL . 0.3 OUTLIER -138.57 127.2 23.41 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.496 -0.752 . . . . 0.0 109.094 178.781 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.466 ' HA ' ' HB1' ' A' ' 104' ' ' ALA . . . -128.15 157.85 39.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.954 -1.091 . . . . 0.0 110.481 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.805 HG13 ' N ' ' A' ' 207' ' ' TRP . 5.9 p -90.13 -137.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.193 -0.942 . . . . 0.0 110.103 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 0.805 ' N ' HG13 ' A' ' 206' ' ' VAL . 10.1 p90 -126.21 58.47 1.36 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.975 -1.078 . . . . 0.0 110.493 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 83.27 -1.54 88.54 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.498 ' HB3' HG11 ' A' ' 206' ' ' VAL . 3.0 tp60 -75.47 -33.21 60.81 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.486 -1.008 . . . . 0.0 110.257 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' CYS . . . . . 0.659 ' O ' ' C ' ' A' ' 211' ' ' GLN . 48.8 t -124.92 17.24 8.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.337 -0.852 . . . . 0.0 110.259 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.659 ' C ' ' O ' ' A' ' 210' ' ' CYS . 2.0 pt20 0.35 114.46 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.592 0.71 . . . . 0.0 111.859 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 1.095 HG23 ' O ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -118.99 145.19 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.441 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.688 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 20.1 mtm180 -88.61 151.51 22.43 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.094 -1.004 . . . . 0.0 110.144 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.752 HD12 ' HB3' ' A' ' 48' ' ' TRP . 0.8 OUTLIER -136.36 123.59 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.315 -0.865 . . . . 0.0 111.231 -179.023 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 92' ' ' GLU . 75.2 ttt180 -131.01 108.63 9.93 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' TYR . . . . . 0.69 ' CD2' ' CB ' ' A' ' 91' ' ' TRP . 3.2 t80 -118.45 148.94 42.06 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.001 -1.062 . . . . 0.0 111.454 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' MET . . . . . 0.551 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 0.0 OUTLIER -125.25 107.78 11.07 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.522 -0.736 . . . . 0.0 109.706 179.315 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 134.85 -1.61 3.9 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.463 ' OE1' ' O ' ' A' ' 220' ' ' ARG . 9.1 tm-20 -95.28 153.58 17.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.062 -1.258 . . . . 0.0 110.116 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.463 ' O ' ' OE1' ' A' ' 219' ' ' GLU . 26.9 mmt180 -42.25 128.4 3.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.241 -0.912 . . . . 0.0 110.416 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ARG . . . . . 0.522 ' O ' ' C ' ' A' ' 222' ' ' VAL . 36.7 ttt-85 -172.65 112.32 0.25 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 110.103 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 222' ' ' VAL . 5.2 p -33.89 105.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.441 -0.787 . . . . 0.0 110.588 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.418 ' O ' ' HB3' ' A' ' 224' ' ' GLU . 29.9 tp10 -62.99 -9.94 11.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.307 -0.871 . . . . 0.0 110.344 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.457 ' O ' ' HB ' ' A' ' 225' ' ' THR . 2.6 pt-20 179.29 -30.18 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.185 -0.947 . . . . 0.0 110.296 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' A' ' 224' ' ' GLU . 3.3 t 179.9 136.18 0.11 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.189 -0.944 . . . . 0.0 110.219 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.11 -153.4 0.07 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.277 -0.889 . . . . 0.0 110.2 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.99 -58.61 2.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -0.877 . . . . 0.0 110.258 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.51 ' O ' ' N ' ' A' ' 230' ' ' ARG . 33.1 mm -80.77 -57.74 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.219 -0.926 . . . . 0.0 110.237 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -60.73 77.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.222 -0.924 . . . . 0.0 110.137 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ARG . . . . . 0.671 ' O ' ' C ' ' A' ' 231' ' ' ASP . 0.0 OUTLIER -49.74 159.52 0.37 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.342 -0.848 . . . . 0.0 110.262 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.671 ' C ' ' O ' ' A' ' 230' ' ' ARG . 3.3 m-20 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.952 -1.023 . . . . 0.0 111.479 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.43 164.28 12.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.192 -1.181 . . . . 0.0 110.144 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.37 32.02 4.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 0.0 110.198 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.35 132.88 44.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.881 . . . . 0.0 110.202 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.2 99.65 0.95 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.206 -0.933 . . . . 0.0 110.262 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -129.3 118.24 21.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.251 -0.906 . . . . 0.0 110.257 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.612 ' O ' HG23 ' A' ' 13' ' ' THR . 0.1 OUTLIER -78.33 116.23 18.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.314 -0.866 . . . . 0.0 110.23 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -178.06 -60.0 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.315 -0.865 . . . . 0.0 110.189 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.575 ' CD ' ' CB ' ' A' ' 13' ' ' THR . 45.6 Cg_endo -72.5 -44.03 0.84 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.051 1.553 . . . . 0.0 110.393 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 71.8 p -129.67 112.07 13.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.187 -0.946 . . . . 0.0 110.195 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.1 t -147.74 -178.77 6.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.901 . . . . 0.0 110.225 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 1.7 tp60 -77.69 -71.01 0.44 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.352 -0.842 . . . . 0.0 110.246 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 17' ' ' GLN . . . -176.51 105.52 0.07 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.176 -0.953 . . . . 0.0 110.244 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.55 -154.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.179 -0.95 . . . . 0.0 110.271 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.446 ' CG ' ' N ' ' A' ' 21' ' ' SER . 25.1 t80 -108.8 -105.53 0.35 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.301 -0.875 . . . . 0.0 110.243 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.446 ' N ' ' CG ' ' A' ' 20' ' ' TYR . 0.7 OUTLIER -117.81 153.57 33.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.061 -1.025 . . . . 0.0 110.175 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 5.4 p-10 -174.38 40.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.284 -0.885 . . . . 0.0 110.29 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -46.58 -73.1 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.271 -0.893 . . . . 0.0 110.1 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.482 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 50.6 p -103.49 105.07 45.29 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.208 -0.932 . . . . 0.0 109.943 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.03 110.06 3.01 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.031 1.543 . . . . 0.0 110.649 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 24' ' ' SER . 46.0 Cg_endo -74.1 160.19 43.1 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.992 1.522 . . . . 0.0 110.489 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.461 ' O ' ' CG ' ' A' ' 27' ' ' GLU . 0.4 OUTLIER -124.3 35.08 4.89 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.458 -0.776 . . . . 0.0 109.707 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 32' ' ' LEU . . . 63.65 22.25 65.85 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.914 HD13 ' CG ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -80.97 -54.32 5.67 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.428 -1.042 . . . . 0.0 109.852 -179.819 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.548 ' HG3' ' CB ' ' A' ' 73' ' ' GLN . 26.6 mt-10 -49.06 -47.83 44.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.119 -0.988 . . . . 0.0 109.304 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -61.07 -27.5 68.39 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 29' ' ' LEU . 5.9 tp -83.67 -29.36 27.68 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.975 HD13 ' CD ' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -88.09 -36.52 16.87 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.722 0.772 . . . . 0.0 109.47 179.585 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.531 ' N ' HD12 ' A' ' 33' ' ' LEU . 11.6 p -45.84 -31.17 1.97 Allowed 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.683 0.754 . . . . 0.0 109.748 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.812 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . -91.46 167.21 16.16 Favored Pre-proline 0 C--N 1.298 -1.644 0 O-C-N 121.572 -0.705 . . . . 0.0 109.354 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.555 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 43.5 Cg_endo -70.18 99.01 0.76 Allowed 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.063 1.56 . . . . 0.0 110.431 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.812 ' HD3' ' O ' ' A' ' 35' ' ' ALA . 47.5 Cg_endo -96.6 -175.45 0.28 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 121.999 1.799 . . . . 0.0 110.397 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 1.017 ' O ' ' N ' ' A' ' 40' ' ' LEU . 39.6 Cg_endo -65.54 153.31 78.79 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.041 1.548 . . . . 0.0 110.043 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.67 ' O ' ' N ' ' A' ' 43' ' ' GLN . 1.9 t0 -15.29 -34.14 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.375 0.607 . . . . 0.0 110.143 -178.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.034 HD13 ' N ' ' A' ' 41' ' ' VAL . 0.1 OUTLIER -29.4 -46.78 0.06 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.435 -0.791 . . . . 0.0 109.551 178.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.034 ' N ' HD13 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -85.05 -31.5 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 118.657 -1.217 . . . . 0.0 109.94 179.58 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.628 ' N ' ' O ' ' A' ' 39' ' ' ASP . . . -89.89 -43.29 10.7 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.078 -1.014 . . . . 0.0 110.784 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.746 ' HG3' ' HB2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -72.23 -21.12 61.44 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.449 -0.782 . . . . 0.0 110.653 -179.13 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.723 ' HG2' ' HA ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -76.47 -55.31 5.65 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.879 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.627 ' CE1' ' O ' ' A' ' 41' ' ' VAL . 16.8 m170 -58.89 -18.21 31.06 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -97.82 -25.33 15.08 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.718 0.77 . . . . 0.0 109.259 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.451 ' HA3' HG23 ' A' ' 59' ' ' VAL . . . -63.85 -114.57 0.01 OUTLIER Glycine 0 N--CA 1.479 1.528 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.812 ' CA ' HD13 ' A' ' 214' ' ' ILE . 0.0 OUTLIER -103.26 70.88 1.08 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.492 -1.283 . . . . 0.0 111.052 179.208 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.444 ' OD1' ' HB3' ' A' ' 53' ' ' CYS . 23.0 t30 -109.23 116.65 54.79 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.025 -1.047 . . . . 0.0 110.152 178.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.903 ' HB3' HG12 ' A' ' 203' ' ' VAL . 40.7 Cg_endo -69.07 -64.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 N-CA-C 109.432 -1.026 . . . . 0.0 109.432 178.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 1.124 ' HA ' ' CE ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER 175.49 35.22 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 O-C-N 120.976 -1.077 . . . . 0.0 112.02 177.752 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.888 ' HB2' ' HA2' ' A' ' 80' ' ' GLY 0.25 2.2 m-20 -168.58 20.78 0.02 OUTLIER 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.62 -179.451 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.694 ' SG ' ' NH1' ' A' ' 44' ' ' ARG . 1.7 t -102.23 144.57 30.59 Favored 'General case' 0 C--N 1.289 -2.03 0 C-N-CA 118.866 -1.134 . . . . 0.0 111.657 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.803 ' HB3' HG22 ' A' ' 75' ' ' THR . 0.0 OUTLIER -103.0 167.43 9.84 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.624 0.726 . . . . 0.0 109.954 179.306 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.975 ' CD ' HD13 ' A' ' 33' ' ' LEU . 0.9 OUTLIER -71.35 8.26 1.09 Allowed 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.592 -0.693 . . . . 0.0 111.211 -179.306 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.586 ' C ' ' O ' ' A' ' 55' ' ' GLU . 1.0 OUTLIER -29.02 -32.29 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.923 0.868 . . . . 0.0 109.474 179.414 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.728 ' N ' ' O ' ' A' ' 55' ' ' GLU . 3.7 pt -135.29 167.21 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.797 -0.565 . . . . 0.0 110.107 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.99 ' HB2' HD23 ' A' ' 40' ' ' LEU . 3.4 t0 -109.01 113.04 25.57 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.038 -1.039 . . . . 0.0 110.61 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.752 ' HB ' ' CE2' ' A' ' 48' ' ' TRP . 1.2 m -129.78 135.8 60.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 O-C-N 121.49 -0.756 . . . . 0.0 109.086 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.746 ' HB2' ' HG3' ' A' ' 43' ' ' GLN . 9.0 tttm -128.68 155.31 45.24 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 118.826 -1.15 . . . . 0.0 112.29 -178.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.545 ' O ' ' C ' ' A' ' 62' ' ' GLY . 1.1 tt0 -71.54 -126.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.616 -0.677 . . . . 0.0 110.476 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.545 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 38.85 52.39 2.55 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 107.808 -2.117 . . . . 0.0 107.808 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.662 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 97.86 49.56 1.76 Allowed Glycine 0 N--CA 1.485 1.924 0 N-CA-C 107.113 -2.395 . . . . 0.0 107.113 -177.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.057 HD21 ' CE1' ' A' ' 66' ' ' PHE . 2.8 tt 1.54 93.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.719 0.771 . . . . 0.0 111.232 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 35.0 t -105.32 113.87 27.71 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.602 0.715 . . . . 0.0 110.364 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 1.057 ' CE1' HD21 ' A' ' 64' ' ' LEU . 3.2 m-85 -82.63 130.33 35.1 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.511 -0.743 . . . . 0.0 109.908 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.587 ' HB3' ' O ' ' A' ' 58' ' ' ASP . 2.4 tm-20 -145.75 121.3 10.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.801 -1.187 . . . . 0.0 109.94 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.545 ' CB ' ' HB2' ' A' ' 207' ' ' TRP . 0.5 OUTLIER -126.03 155.3 41.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.371 -0.831 . . . . 0.0 109.404 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.694 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.8 OUTLIER -130.1 -72.52 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 120.89 -1.131 . . . . 0.0 110.875 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.914 ' CG ' HD13 ' A' ' 29' ' ' LEU . 57.1 Cg_endo -72.98 -126.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.434 1.228 . . . . 0.0 109.266 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.444 ' O ' ' OE1' ' A' ' 73' ' ' GLN . 2.4 t -140.31 164.24 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.574 -1.329 . . . . 0.0 109.962 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.948 ' HB1' ' HA ' ' A' ' 76' ' ' ASP . . . -59.84 94.24 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.17 -0.956 . . . . 0.0 110.266 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.548 ' CB ' ' HG3' ' A' ' 30' ' ' GLU . 1.2 mp0 -76.08 -90.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.18 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.49 ' OG ' ' N ' ' A' ' 75' ' ' THR . 1.5 t -44.04 -94.64 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.144 -0.972 . . . . 0.0 109.623 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.803 HG22 ' HB3' ' A' ' 54' ' ' SER . 7.6 t -88.57 -124.37 0.05 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.148 -0.97 . . . . 0.0 109.189 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.948 ' HA ' ' HB1' ' A' ' 72' ' ' ALA . 13.2 p30 -140.55 154.63 46.59 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.836 -1.165 . . . . 0.0 110.413 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.733 ' C ' ' O ' ' A' ' 76' ' ' ASP . . . 2.95 -78.2 0.0 OUTLIER Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.721 HG23 ' HD2' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -158.16 137.42 3.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.507 -0.996 . . . . 0.0 110.389 179.185 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.88 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 0.7 OUTLIER -144.33 150.68 38.2 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.401 0.62 . . . . 0.0 109.779 179.711 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.888 ' HA2' ' HB2' ' A' ' 52' ' ' ASP . . . -165.32 116.23 0.68 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.572 -1.811 . . . . 0.0 108.572 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.597 ' O ' ' C ' ' A' ' 82' ' ' ARG . 4.7 ttpm? -124.59 -75.08 0.6 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.113 -1.227 . . . . 0.0 111.549 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.635 ' HG2' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -25.1 -47.38 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.504 -0.747 . . . . 0.0 111.11 -178.634 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.635 ' N ' ' HG2' ' A' ' 82' ' ' ARG . . . 34.24 58.95 0.65 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -93.85 108.25 20.05 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.426 -1.043 . . . . 0.0 110.645 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.0 162.87 34.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.432 -0.792 . . . . 0.0 110.002 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -118.67 137.91 52.98 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.233 -0.917 . . . . 0.0 109.931 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 173' ' ' MET . . . 111.2 158.59 15.32 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.521 HD12 ' HA ' ' A' ' 172' ' ' ASP . 18.6 tp -87.6 133.27 33.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -1.152 . . . . 0.0 110.19 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.493 ' ND1' ' O ' ' A' ' 88' ' ' LEU . 66.3 m-70 -147.11 173.08 12.82 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.135 -0.978 . . . . 0.0 110.064 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.553 ' O ' ' CB ' ' A' ' 217' ' ' MET . . . -154.03 139.99 18.26 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.203 -0.936 . . . . 0.0 109.64 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.559 ' HB3' ' HA ' ' A' ' 216' ' ' TYR . 0.0 OUTLIER -134.74 166.43 22.97 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.968 -1.083 . . . . 0.0 110.442 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.629 ' N ' ' O ' ' A' ' 215' ' ' ARG . 22.5 tt0 -115.16 138.63 50.69 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.545 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.535 HG22 HG23 ' A' ' 169' ' ' VAL . 0.2 OUTLIER -144.02 134.99 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 120.625 -1.297 . . . . 0.0 110.765 -179.662 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.678 ' HB3' ' HA ' ' A' ' 166' ' ' ARG . 0.9 OUTLIER -118.68 126.38 51.79 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.477 -0.764 . . . . 0.0 109.537 179.421 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.828 ' HE1' ' HE2' ' A' ' 103' ' ' HIS . 2.8 t90 -129.9 87.62 51.37 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.179 -0.95 . . . . 0.0 109.93 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 164' ' ' PRO . 51.6 Cg_endo -95.7 109.15 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.776 1.651 . . . . 0.0 110.742 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.97 HD21 ' C ' ' A' ' 101' ' ' GLY . 5.7 tt -96.15 -22.03 17.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.968 -1.083 . . . . 0.0 110.285 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -44.88 -30.07 0.92 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.348 -0.845 . . . . 0.0 110.686 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.499 ' O ' ' NE ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -94.99 7.06 47.28 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.094 -1.004 . . . . 0.0 110.451 -179.816 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.583 ' CB ' ' HA ' ' A' ' 210' ' ' CYS . 0.9 OUTLIER -134.94 -115.02 0.19 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.145 -0.972 . . . . 0.0 110.322 -179.849 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.97 ' C ' HD21 ' A' ' 97' ' ' LEU . . . -166.77 156.81 28.93 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.61 HG23 ' CA ' ' A' ' 136' ' ' GLY . 0.7 OUTLIER -38.69 139.94 0.39 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.429 -1.042 . . . . 0.0 110.366 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.828 ' HE2' ' HE1' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -178.28 -146.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.072 -1.018 . . . . 0.0 111.376 179.817 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 1.083 ' HB1' ' O ' ' A' ' 204' ' ' SER . . . -38.85 168.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.797 0.808 . . . . 0.0 112.503 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.873 HG23 ' HA ' ' A' ' 134' ' ' ASP . 0.6 OUTLIER -137.93 159.6 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.665 -0.647 . . . . 0.0 111.912 -178.346 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.983 ' HA ' HG23 ' A' ' 203' ' ' VAL . 1.3 p -132.52 141.71 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.935 -1.103 . . . . 0.0 109.999 177.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.601 ' HA3' ' HA3' ' A' ' 132' ' ' GLY . . . 160.93 -149.1 17.89 Favored Glycine 0 N--CA 1.487 2.061 0 C-N-CA 119.628 -1.273 . . . . 0.0 109.959 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.123 ' CG2' HD13 ' A' ' 199' ' ' LEU . 1.6 p -148.73 161.3 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.385 -1.068 . . . . 0.0 110.157 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.512 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -133.75 152.24 51.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.129 -0.982 . . . . 0.0 110.714 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.8 HG23 ' HB3' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -105.98 128.62 53.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.846 . . . . 0.0 109.862 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.74 -27.2 17.37 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.541 -0.725 . . . . 0.0 109.71 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.692 HD12 ' HD3' ' A' ' 114' ' ' PRO . 3.8 pp -83.95 -12.1 55.87 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.512 -0.742 . . . . 0.0 109.538 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 112' ' ' LEU . . . -35.29 95.34 0.09 OUTLIER Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.72 -0.612 . . . . 0.0 110.625 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.692 ' HD3' HD12 ' A' ' 112' ' ' LEU . 50.9 Cg_endo -77.92 -96.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.077 1.567 . . . . 0.0 110.329 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 114' ' ' PRO . 3.8 tp 179.71 49.3 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.118 -0.989 . . . . 0.0 110.108 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' A' ' 118' ' ' ASP . 6.0 tt0 -64.04 -37.17 86.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.177 -0.952 . . . . 0.0 110.202 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.542 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -60.91 79.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.346 -0.846 . . . . 0.0 110.202 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.542 ' C ' ' O ' ' A' ' 117' ' ' ALA . 13.5 t70 -31.67 -63.01 0.18 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.46 -0.775 . . . . 0.0 110.743 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.469 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.0 OUTLIER 60.79 135.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.291 -0.88 . . . . 0.0 110.203 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -81.54 -77.99 0.2 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -0.922 . . . . 0.0 110.19 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.5 84.61 0.1 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.227 -0.92 . . . . 0.0 110.185 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.31 136.04 6.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.193 -0.942 . . . . 0.0 110.19 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.497 HD12 ' H ' ' A' ' 123' ' ' LEU . 1.3 mp -87.39 -154.45 0.25 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 110.185 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 124' ' ' LEU . 33.3 mt -106.51 158.53 16.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 110.254 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -158.96 156.9 27.95 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.14 23.16 1.35 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.174 -1.192 . . . . 0.0 110.233 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -85.94 -138.07 0.08 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.218 -0.926 . . . . 0.0 110.145 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 57.7 m -116.7 -165.42 1.06 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.113 -0.992 . . . . 0.0 110.218 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 110' ' ' THR . 6.5 tm-20 -150.07 129.42 12.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.916 . . . . 0.0 110.051 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 6.9 t -121.14 120.71 36.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.259 -0.901 . . . . 0.0 110.203 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' TRP . . . . . 0.493 ' O ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -128.86 124.74 36.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.288 -0.883 . . . . 0.0 109.915 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.601 ' HA3' ' HA3' ' A' ' 107' ' ' GLY . . . -172.35 -160.01 20.01 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.704 ' CZ3' HD11 ' A' ' 167' ' ' LEU . 33.9 m0 -109.27 115.09 29.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.214 -1.168 . . . . 0.0 110.192 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.873 ' HA ' HG23 ' A' ' 105' ' ' VAL . 4.1 t70 -118.31 148.08 42.83 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.416 0.627 . . . . 0.0 110.536 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.554 ' CG2' HG22 ' A' ' 162' ' ' VAL . 0.3 OUTLIER -143.52 17.59 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.504 -0.748 . . . . 0.0 109.404 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.61 ' CA ' HG23 ' A' ' 102' ' ' THR . . . -115.53 -40.54 0.85 Allowed Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.451 ' O ' ' C ' ' A' ' 138' ' ' GLY . 0.0 OUTLIER -90.7 8.03 36.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.076 -1.249 . . . . 0.0 110.02 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.531 ' O ' ' O ' ' A' ' 139' ' ' LYS . . . 41.4 45.87 4.35 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.531 ' O ' ' O ' ' A' ' 138' ' ' GLY . 2.2 mmmp? -52.23 -164.24 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.506 -0.997 . . . . 0.0 110.593 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.98 64.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 110.386 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.537 ' HA ' ' CD2' ' A' ' 161' ' ' LEU . 29.6 p90 -80.2 8.3 7.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.916 . . . . 0.0 110.284 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.558 ' O ' ' CG ' ' A' ' 142' ' ' HIS . 13.9 p80 -137.88 79.16 1.73 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.93 . . . . 0.0 110.151 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -64.32 -57.45 9.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.979 . . . . 0.0 110.297 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.67 165.33 14.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 110.265 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.08 8.52 44.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.163 -0.961 . . . . 0.0 110.205 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.23 -130.72 3.11 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.504 ' O ' ' HD2' ' A' ' 150' ' ' PRO . 0.3 OUTLIER -174.0 80.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.19 -1.183 . . . . 0.0 110.145 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.501 ' O ' ' HB2' ' A' ' 149' ' ' ALA . 3.0 mt-10 -62.62 108.99 1.26 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.301 -0.874 . . . . 0.0 110.369 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 1.009 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . . . 179.91 -60.88 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.218 -0.926 . . . . 0.0 110.327 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 1.009 ' HD3' ' HB3' ' A' ' 149' ' ' ALA . 47.5 Cg_endo -73.04 -10.53 24.66 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 124.016 1.535 . . . . 0.0 110.605 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.431 ' O ' ' CD2' ' A' ' 152' ' ' TYR . 2.3 mp0 -55.03 -62.87 1.38 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.163 -0.961 . . . . 0.0 110.176 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.544 ' HB3' ' HD3' ' A' ' 153' ' ' PRO . 0.2 OUTLIER 179.84 -57.67 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 110.081 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 152' ' ' TYR . 46.8 Cg_endo -73.21 144.62 37.58 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.949 1.5 . . . . 0.0 110.199 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 155' ' ' GLY . . . -41.6 127.03 3.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.221 -0.924 . . . . 0.0 110.081 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.463 ' C ' ' O ' ' A' ' 154' ' ' ALA . . . -40.36 107.5 0.08 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' A' ' 148' ' ' GLU . 45.2 Cg_endo -71.72 -41.36 2.25 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.925 1.487 . . . . 0.0 110.47 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.493 ' HA ' ' HG3' ' A' ' 160' ' ' GLN . 1.2 tp60 -67.27 -3.55 8.25 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.282 -0.886 . . . . 0.0 110.392 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.427 ' O ' ' HB ' ' A' ' 162' ' ' VAL . . . -81.43 -55.3 3.26 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -82.61 6.52 17.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -1.163 . . . . 0.0 110.253 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.493 ' HG3' ' HA ' ' A' ' 157' ' ' GLN . 3.1 mm-40 -68.3 -17.39 64.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.897 . . . . 0.0 109.269 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.672 ' O ' HG23 ' A' ' 162' ' ' VAL . 1.0 OUTLIER -166.78 24.94 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.704 0.764 . . . . 0.0 109.363 179.454 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.801 HG12 ' O ' ' A' ' 162' ' ' VAL . 2.4 t -158.8 85.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.401 0.619 . . . . 0.0 109.825 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.869 HG21 HD21 ' A' ' 167' ' ' LEU . 0.2 OUTLIER -117.97 86.96 26.7 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.429 -0.794 . . . . 0.0 109.671 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.437 ' O ' ' HG3' ' A' ' 165' ' ' GLU . 45.4 Cg_endo -72.26 65.97 3.53 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.086 1.571 . . . . 0.0 110.852 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' A' ' 94' ' ' SER . 3.6 mt-10 -167.26 -85.74 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.319 -0.863 . . . . 0.0 109.854 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.678 ' HA ' ' HB3' ' A' ' 94' ' ' SER . 23.6 ttp180 -152.65 156.22 38.82 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.367 -0.833 . . . . 0.0 110.29 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.869 HD21 HG21 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -139.8 133.91 31.03 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.272 -0.892 . . . . 0.0 110.7 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.411 ' O ' ' O ' ' A' ' 181' ' ' SER . 0.4 OUTLIER -103.83 130.78 51.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.329 -0.857 . . . . 0.0 109.228 179.285 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.651 ' CG2' ' CE1' ' A' ' 180' ' ' TYR . 2.7 t -124.57 144.47 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.966 -1.084 . . . . 0.0 111.087 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.451 HG23 HD22 ' A' ' 187' ' ' LEU . 2.3 t -119.84 129.31 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.555 -0.716 . . . . 0.0 109.079 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.987 HD21 ' HE1' ' A' ' 173' ' ' MET . 12.4 tp -133.09 109.82 9.77 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.93 -1.106 . . . . 0.0 110.808 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.521 ' HA ' HD12 ' A' ' 88' ' ' LEU . 5.2 t0 -99.51 139.08 35.7 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.393 -0.817 . . . . 0.0 109.203 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.987 ' HE1' HD21 ' A' ' 171' ' ' LEU . 23.9 mmt -98.95 -44.62 6.26 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.227 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.53 ' HG2' ' N ' ' A' ' 175' ' ' GLU . 3.8 pt-20 -43.48 -24.96 0.12 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.12 -0.987 . . . . 0.0 108.565 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.53 ' N ' ' HG2' ' A' ' 174' ' ' GLU . 3.5 tp10 -115.12 -26.28 7.75 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.06 27.24 58.56 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 -178.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.647 ' HB ' HD22 ' A' ' 194' ' ' LEU . 1.4 p -113.09 139.94 48.29 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.414 -1.051 . . . . 0.0 111.313 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.904 HD21 ' O ' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -146.62 154.05 41.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.533 -0.729 . . . . 0.0 109.73 179.58 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.735 ' C ' HD11 ' A' ' 187' ' ' LEU . . . -141.52 163.69 26.79 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.848 ' N ' HD11 ' A' ' 187' ' ' LEU . 0.9 OUTLIER -118.63 118.31 31.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -1.146 . . . . 0.0 109.484 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.555 ' CB ' ' HB2' ' A' ' 186' ' ' TYR . 2.7 t -144.64 159.05 43.45 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.33 -0.856 . . . . 0.0 110.085 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.536 ' H ' HD13 ' A' ' 182' ' ' ILE . 0.0 OUTLIER -96.08 116.4 37.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.443 -0.785 . . . . 0.0 109.316 179.191 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 72.76 5.71 65.15 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.86 43.31 18.08 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' THR . . . . . 0.494 ' N ' ' OG ' ' A' ' 181' ' ' SER . 95.4 m -116.18 -1.38 12.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.199 -1.177 . . . . 0.0 110.561 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.555 ' HB2' ' CB ' ' A' ' 181' ' ' SER . 0.1 OUTLIER -111.22 -25.08 9.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.153 -0.967 . . . . 0.0 110.359 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.848 HD11 ' N ' ' A' ' 180' ' ' TYR . 4.0 mp -84.46 48.29 1.49 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.252 -0.905 . . . . 0.0 110.105 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.411 ' H ' ' HD2' ' A' ' 189' ' ' PRO . . . -106.86 -73.51 0.85 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.411 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 46.3 Cg_endo -72.6 -29.31 13.29 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.979 1.515 . . . . 0.0 111.167 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.667 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -73.42 12.27 0.63 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.267 -0.896 . . . . 0.0 111.429 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.602 ' CE2' ' O ' ' A' ' 187' ' ' LEU . 0.3 OUTLIER -90.17 -10.68 43.58 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.141 -0.974 . . . . 0.0 109.802 179.132 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.74 -20.22 27.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.381 -0.824 . . . . 0.0 110.908 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.555 ' O ' ' HB3' ' A' ' 197' ' ' ARG . . . -111.15 -13.32 13.67 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.926 HD23 ' O ' ' A' ' 194' ' ' LEU . 3.7 tt -74.56 -19.99 60.12 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.459 ' CE ' ' HA ' ' A' ' 195' ' ' LYS . 0.0 OUTLIER -59.64 -32.08 70.11 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.715 -0.615 . . . . 0.0 109.53 179.119 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -106.83 -25.36 6.24 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.867 ' NH2' HD21 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -82.93 -3.3 56.88 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.855 0.836 . . . . 0.0 109.944 179.653 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.588 ' HB ' ' CG2' ' A' ' 177' ' ' THR . 0.4 OUTLIER -41.0 136.85 1.38 Allowed 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 122.096 0.951 . . . . 0.0 111.24 -178.1 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 1.123 HD13 ' CG2' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -141.85 171.31 14.23 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.372 -179.653 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.808 ' O ' HG23 ' A' ' 108' ' ' VAL . 97.1 m-85 -86.84 129.7 51.39 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.15 -0.969 . . . . 0.0 109.523 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.691 ' HG3' HD22 ' A' ' 171' ' ' LEU . 42.0 Cg_endo -68.24 121.12 8.08 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.863 1.454 . . . . 0.0 111.19 -179.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.572 ' CB ' ' HA ' ' A' ' 81' ' ' LYS . 97.0 p -133.81 142.06 47.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.342 -0.849 . . . . 0.0 110.939 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.983 HG23 ' HA ' ' A' ' 106' ' ' VAL . 1.1 p -146.4 160.51 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.391 -0.818 . . . . 0.0 109.391 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' SER . . . . . 1.083 ' O ' ' HB1' ' A' ' 104' ' ' ALA . 0.3 OUTLIER -160.35 127.19 4.3 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.415 -0.803 . . . . 0.0 109.645 179.683 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.976 ' HA ' ' CB ' ' A' ' 104' ' ' ALA . . . -114.13 162.1 16.92 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.834 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.67 HG12 ' SG ' ' A' ' 210' ' ' CYS . 1.1 t -105.69 -179.13 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.587 -0.696 . . . . 0.0 110.47 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 0.647 ' N ' HG13 ' A' ' 206' ' ' VAL . 23.0 p90 -94.14 -33.07 13.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.332 -0.855 . . . . 0.0 110.593 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.515 ' H ' HG13 ' A' ' 206' ' ' VAL . . . -44.21 171.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 211' ' ' GLN . 0.0 OUTLIER -40.58 -49.24 2.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.35 -1.088 . . . . 0.0 110.572 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 210' ' ' CYS . . . . . 0.67 ' SG ' HG12 ' A' ' 206' ' ' VAL . 6.9 p -36.83 93.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.461 -0.774 . . . . 0.0 110.436 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.526 ' N ' ' O ' ' A' ' 209' ' ' GLN . 2.1 pt20 -115.41 123.69 49.29 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.233 -0.917 . . . . 0.0 110.107 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.647 ' O ' ' CZ ' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -101.53 144.52 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.599 -0.688 . . . . 0.0 109.701 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.873 ' HA ' HD22 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -87.64 159.57 18.49 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.194 -0.941 . . . . 0.0 110.279 -179.078 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.894 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -138.33 124.65 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -0.944 . . . . 0.0 111.362 -178.911 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.629 ' O ' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -130.94 137.49 49.31 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.745 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 216' ' ' TYR . . . . . 0.559 ' HA ' ' HB3' ' A' ' 91' ' ' TRP . 5.5 t80 -119.35 150.64 39.82 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.792 -1.192 . . . . 0.0 111.121 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' MET . . . . . 0.553 ' CB ' ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -131.05 107.95 9.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.354 -0.841 . . . . 0.0 110.044 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 72.47 85.18 0.22 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.517 ' HG3' ' CZ ' ' A' ' 216' ' ' TYR . 31.4 tt0 -111.74 157.81 20.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.285 -1.127 . . . . 0.0 110.14 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.498 ' HG3' ' N ' ' A' ' 221' ' ' ARG . 0.1 OUTLIER -114.21 148.94 36.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.915 . . . . 0.0 110.342 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ARG . . . . . 0.55 ' O ' ' N ' ' A' ' 223' ' ' GLU . 1.4 mpp_? -136.23 82.84 1.97 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.335 -0.853 . . . . 0.0 110.091 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.605 HG13 ' O ' ' A' ' 222' ' ' VAL . 5.3 p -34.72 92.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.515 -0.741 . . . . 0.0 110.816 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 221' ' ' ARG . 1.5 mm-40 -78.96 -81.54 0.11 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.244 -0.91 . . . . 0.0 110.22 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 223' ' ' GLU . 0.8 OUTLIER 179.36 41.49 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.304 -0.872 . . . . 0.0 110.168 179.549 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.434 ' O ' ' CG ' ' A' ' 226' ' ' ARG . 0.0 OUTLIER -42.74 107.31 0.08 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.322 -0.861 . . . . 0.0 110.332 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.434 ' CG ' ' O ' ' A' ' 225' ' ' THR . 0.0 OUTLIER -179.97 85.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.21 -0.931 . . . . 0.0 110.21 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -165.53 -62.85 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.384 -0.822 . . . . 0.0 110.213 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 27.9 mm -104.1 85.52 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.355 -0.841 . . . . 0.0 110.292 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -110.36 168.48 9.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.328 -0.857 . . . . 0.0 110.105 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ARG . . . . . 0.671 ' O ' ' C ' ' A' ' 231' ' ' ASP . 4.3 mtp180 -45.21 -46.07 12.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.363 -0.836 . . . . 0.0 110.236 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.671 ' C ' ' O ' ' A' ' 230' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.974 -1.012 . . . . 0.0 111.494 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.447 ' OG ' ' N ' ' A' ' 8' ' ' SER . 54.3 p -79.82 -59.65 2.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.213 -1.169 . . . . 0.0 110.204 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.447 ' N ' ' OG ' ' A' ' 7' ' ' SER . 23.9 p -77.58 55.46 1.31 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 110.235 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.81 -150.12 0.46 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.173 -0.954 . . . . 0.0 110.215 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -143.14 160.37 40.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.917 . . . . 0.0 110.163 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -103.38 76.57 1.44 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.195 -0.941 . . . . 0.0 110.221 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.75 123.06 18.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 110.211 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.689 ' O ' HG23 ' A' ' 13' ' ' THR . 14.9 t -95.35 116.08 66.0 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.21 -0.931 . . . . 0.0 110.186 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.402 ' C ' HG23 ' A' ' 15' ' ' THR . 46.7 Cg_endo -73.03 147.99 44.18 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.98 1.516 . . . . 0.0 110.47 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.402 HG23 ' C ' ' A' ' 14' ' ' PRO . 20.1 p -151.06 139.96 20.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 110.201 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.85 171.13 13.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.375 -0.828 . . . . 0.0 110.274 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -133.78 126.65 31.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.0 110.206 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.9 152.8 41.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.239 -0.913 . . . . 0.0 110.2 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.8 -159.54 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.257 -0.902 . . . . 0.0 110.197 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.79 -146.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 110.128 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.2 t -119.13 50.07 1.26 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.229 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -82.31 44.37 0.87 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.354 -0.841 . . . . 0.0 110.376 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.482 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -111.62 -66.89 1.04 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.09 -1.006 . . . . 0.0 110.126 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.02 110.06 27.72 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.464 -0.773 . . . . 0.0 110.162 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 23' ' ' PHE . 46.6 Cg_endo -72.97 174.47 11.9 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.957 1.504 . . . . 0.0 110.439 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 25' ' ' PRO . 46.6 Cg_endo -73.32 166.43 29.94 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.019 1.536 . . . . 0.0 110.362 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.7 mp0 -128.67 35.6 4.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.242 -0.911 . . . . 0.0 110.246 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.444 ' O ' ' HG2' ' A' ' 31' ' ' GLU . . . 78.21 19.1 75.21 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.943 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -49.56 -32.54 12.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.284 -1.127 . . . . 0.0 109.771 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.887 ' HA ' HD23 ' A' ' 33' ' ' LEU . 6.4 tm-20 -47.61 -35.47 9.31 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.294 -0.879 . . . . 0.0 109.356 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 28' ' ' GLY . 16.5 pt-20 -60.49 -24.99 65.73 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.277 -0.889 . . . . 0.0 108.856 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -83.35 -33.87 25.74 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.933 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.9 HD21 ' HB2' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -78.72 -36.65 43.01 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.861 0.839 . . . . 0.0 109.311 179.274 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.586 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 1.2 t -80.74 -7.39 59.35 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 121.171 0.51 . . . . 0.0 109.937 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.96 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -37.96 -65.32 0.37 Allowed Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.44 -0.787 . . . . 0.0 110.538 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.96 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 47.8 Cg_endo -73.25 143.05 34.78 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.773 1.407 . . . . 0.0 109.928 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 36' ' ' PRO . 54.0 Cg_endo -98.58 53.32 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 121.813 1.675 . . . . 0.0 112.568 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.76 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 52.5 Cg_endo -77.1 150.3 29.35 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 122.89 0.942 . . . . 0.0 109.845 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.664 ' C ' ' NE2' ' A' ' 43' ' ' GLN . 2.1 t0 -39.71 -32.56 0.15 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.056 -1.028 . . . . 0.0 108.81 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.101 HD13 ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -40.95 -45.22 2.52 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.314 0.578 . . . . 0.0 109.628 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.101 ' N ' HD13 ' A' ' 40' ' ' LEU . 10.0 t -68.01 -26.82 35.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.017 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 39' ' ' ASP . . . -89.41 -43.94 10.53 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.018 -1.051 . . . . 0.0 111.703 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.665 ' O ' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -80.59 -24.77 38.93 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.24 -1.384 . . . . 0.0 108.929 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.725 ' CB ' ' O ' ' A' ' 40' ' ' LEU . 21.4 ttt-85 -64.28 -57.71 8.64 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.222 1.011 . . . . 0.0 108.739 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.74 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 54.3 m170 -53.57 -17.26 1.97 Allowed 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.703 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -95.9 -31.75 12.97 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.132 -1.427 . . . . 0.0 111.155 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.61 -60.26 0.51 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 106.845 -2.502 . . . . 0.0 106.845 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.826 ' HD1' ' CE2' ' A' ' 66' ' ' PHE 0.267 0.3 OUTLIER -98.37 71.27 2.04 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.171 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.785 ' O ' ' HB3' ' A' ' 53' ' ' CYS . 0.0 OUTLIER -61.91 168.31 3.77 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.701 -0.624 . . . . 0.0 112.104 -178.874 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.693 ' O ' ' O ' ' A' ' 53' ' ' CYS . 37.4 Cg_endo -61.38 -61.37 0.17 Allowed 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 121.572 1.515 . . . . 0.0 113.17 -178.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.778 ' HE2' ' OD1' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -67.67 -74.35 0.12 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.045 -1.659 . . . . 0.0 108.323 179.745 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.736 ' N ' ' HA3' ' A' ' 80' ' ' GLY . 0.9 OUTLIER -38.12 -27.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.203 -0.936 . . . . 0.0 109.529 179.15 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.785 ' HB3' ' O ' ' A' ' 49' ' ' ASN . 0.2 OUTLIER -138.48 129.99 27.6 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 118.736 -1.186 . . . . 0.0 111.951 -179.794 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.96 ' H ' ' HA ' ' A' ' 78' ' ' VAL . 0.9 OUTLIER -58.28 123.5 16.28 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.2 179.278 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.9 ' HB2' HD21 ' A' ' 33' ' ' LEU . 3.6 pt-20 -69.78 -24.48 63.51 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.439 -0.788 . . . . 0.0 109.693 179.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.61 ' ND2' ' OG ' ' A' ' 74' ' ' SER . 5.8 m120 -28.96 -36.03 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.683 0.754 . . . . 0.0 110.874 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.765 HG22 ' HG2' ' A' ' 68' ' ' ARG . 2.6 pt -116.66 166.69 10.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 O-C-N 121.705 -0.622 . . . . 0.0 110.773 -178.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.521 ' OD1' ' CG ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -107.59 116.16 31.44 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 1.079 HG21 ' CD2' ' A' ' 66' ' ' PHE . 6.3 p -130.01 128.72 65.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 CA-C-O 121.409 0.623 . . . . 0.0 111.55 -178.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.698 ' HG2' ' N ' ' A' ' 61' ' ' GLU . 5.2 tttm -136.96 157.92 45.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.342 -0.849 . . . . 0.0 110.715 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.788 ' N ' ' CH2' ' A' ' 48' ' ' TRP . 19.0 tp10 -42.54 -111.65 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.678 -0.639 . . . . 0.0 111.238 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.56 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 36.67 45.78 1.05 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.669 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 93.14 55.58 1.58 Allowed Glycine 0 N--CA 1.487 2.058 0 N-CA-C 107.369 -2.292 . . . . 0.0 107.369 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.932 HD21 HG22 ' A' ' 214' ' ' ILE . 0.2 OUTLIER 1.11 92.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.792 0.806 . . . . 0.0 111.182 -178.216 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.716 ' C ' HG23 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -140.66 134.88 31.06 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.542 -179.787 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 1.079 ' CD2' HG21 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -102.18 142.79 32.87 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.142 178.775 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.564 ' O ' ' HB ' ' A' ' 57' ' ' ILE . 67.9 tt0 -114.38 121.32 43.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 110.174 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.765 ' HG2' HG22 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -121.23 149.8 42.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.477 -0.764 . . . . 0.0 109.966 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.678 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -127.89 -71.37 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.063 -1.023 . . . . 0.0 110.797 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.678 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 55.8 Cg_endo -73.86 -108.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.35 1.184 . . . . 0.0 110.177 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.44 HG12 ' HZ2' ' A' ' 207' ' ' TRP . 3.9 t -140.48 164.35 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.638 -1.289 . . . . 0.0 110.27 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.408 ' HA ' ' HB3' ' A' ' 56' ' ' ASN . . . -99.63 87.58 3.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -0.867 . . . . 0.0 109.931 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.551 ' HG3' ' N ' ' A' ' 74' ' ' SER . 2.5 pt20 -70.39 -44.58 67.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.258 -0.901 . . . . 0.0 110.642 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.61 ' OG ' ' ND2' ' A' ' 56' ' ' ASN . 0.4 OUTLIER -55.84 -74.8 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.161 -0.962 . . . . 0.0 109.969 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.94 HG23 ' HB3' ' A' ' 54' ' ' SER . 0.3 OUTLIER -129.61 -140.37 0.23 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.308 -0.87 . . . . 0.0 109.405 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.666 ' O ' ' N ' ' A' ' 78' ' ' VAL . 22.7 p-10 -141.1 154.75 46.07 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.976 -1.077 . . . . 0.0 110.788 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.675 ' C ' HG13 ' A' ' 78' ' ' VAL . . . 34.78 -95.16 0.01 OUTLIER Glycine 0 N--CA 1.487 2.055 0 N-CA-C 106.715 -2.554 . . . . 0.0 106.715 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.96 ' HA ' ' H ' ' A' ' 54' ' ' SER . 31.0 m -158.2 119.42 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 O-C-N 121.872 -0.781 . . . . 0.0 109.823 176.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.69 ' O ' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -147.32 133.87 19.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.361 -0.837 . . . . 0.0 110.982 -179.147 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.736 ' HA3' ' N ' ' A' ' 52' ' ' ASP . . . -143.36 166.14 26.88 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 178.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.433 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 0.7 OUTLIER -140.2 75.62 1.52 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.345 -1.091 . . . . 0.0 110.078 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.571 ' CD ' ' HZ2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -145.53 -108.73 0.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.312 -0.867 . . . . 0.0 110.128 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.531 ' N ' ' CZ ' ' A' ' 82' ' ' ARG . . . 70.42 80.78 0.28 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -134.24 104.38 6.15 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.285 -1.127 . . . . 0.0 110.21 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.574 ' HB2' ' CE1' ' A' ' 89' ' ' HIS . 11.4 p -140.03 164.87 28.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.153 -0.967 . . . . 0.0 110.255 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.465 ' HA ' ' CG ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -119.75 135.93 54.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.295 -0.878 . . . . 0.0 109.972 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.34 -119.94 5.15 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.488 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 7.8 tp -128.33 138.1 52.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -1.147 . . . . 0.0 110.327 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.969 ' HB2' HD23 ' A' ' 171' ' ' LEU . 43.2 m-70 -147.06 164.81 31.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.273 -0.892 . . . . 0.0 109.992 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.607 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -163.13 152.95 15.55 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.191 -0.943 . . . . 0.0 110.302 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.974 ' CE3' HG11 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -134.62 170.34 15.94 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.079 -1.013 . . . . 0.0 109.891 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.659 ' N ' ' O ' ' A' ' 215' ' ' ARG . 0.6 OUTLIER -140.62 147.54 39.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.368 -0.832 . . . . 0.0 110.672 -179.505 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.861 ' HB ' HD12 ' A' ' 167' ' ' LEU . 2.2 mm -144.68 154.25 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.34 -0.85 . . . . 0.0 110.024 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . 1.123 ' O ' HG23 ' A' ' 212' ' ' VAL . 0.0 OUTLIER -151.2 124.38 8.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.338 -0.851 . . . . 0.0 109.614 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 1.069 ' CB ' HD12 ' A' ' 135' ' ' ILE . 34.6 m95 -106.84 89.42 4.32 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.267 -0.896 . . . . 0.0 110.561 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.74 ' HD3' ' O ' ' A' ' 94' ' ' SER . 52.7 Cg_endo -91.92 124.37 0.76 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.496 1.464 . . . . 0.0 111.013 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.593 HD13 ' SG ' ' A' ' 210' ' ' CYS . 0.2 OUTLIER -95.45 -5.98 41.8 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.277 -0.889 . . . . 0.0 109.599 179.198 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 97' ' ' LEU . 2.7 tp10 -37.35 -45.36 0.68 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.347 -0.845 . . . . 0.0 111.963 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.532 ' C ' ' HG2' ' A' ' 100' ' ' ARG . 33.2 tt0 -125.58 -114.1 0.29 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.657 -1.277 . . . . 0.0 110.848 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.554 ' O ' ' N ' ' A' ' 211' ' ' GLN . 13.0 mmt85 -152.11 -134.3 0.05 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.27 -0.894 . . . . 0.0 110.226 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.527 ' HA3' ' HB2' ' A' ' 211' ' ' GLN . . . 95.69 173.82 36.6 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.758 ' HA ' ' HA2' ' A' ' 208' ' ' GLY . 0.2 OUTLIER -60.19 -143.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.017 -1.284 . . . . 0.0 109.907 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.685 ' HA ' HG12 ' A' ' 212' ' ' VAL . 0.2 OUTLIER -154.92 -166.08 2.21 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.768 -1.208 . . . . 0.0 111.575 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 1.026 ' HA ' ' HB2' ' A' ' 205' ' ' ALA . . . -177.1 90.64 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.63 -0.669 . . . . 0.0 110.001 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 1.032 HG23 ' HA ' ' A' ' 205' ' ' ALA . 0.6 OUTLIER -94.01 152.09 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.946 HG11 ' OH ' ' A' ' 180' ' ' TYR . 4.9 p -145.85 167.5 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 120.416 -1.428 . . . . 0.0 111.905 -178.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.687 ' CA ' ' HA3' ' A' ' 132' ' ' GLY . . . 164.57 146.63 4.83 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.075 HG22 ' HB2' ' A' ' 199' ' ' LEU . 7.8 p -94.82 155.19 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.116 -1.226 . . . . 0.0 109.691 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.702 ' C ' ' HB3' ' A' ' 199' ' ' LEU . . . -132.6 149.02 52.37 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.679 -0.809 . . . . 0.0 111.006 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . 1.038 ' OG1' HD23 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -106.28 131.05 53.98 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.399 -0.813 . . . . 0.0 109.946 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -84.97 -26.4 27.17 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.444 -0.785 . . . . 0.0 109.418 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.47 -12.14 54.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.419 -0.8 . . . . 0.0 109.352 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.89 ' HB3' ' HD3' ' A' ' 114' ' ' PRO . . . -43.87 -54.06 11.66 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.378 -0.827 . . . . 0.0 110.444 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.89 ' HD3' ' HB3' ' A' ' 113' ' ' ALA . 46.3 Cg_endo -72.54 143.0 37.46 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.875 1.461 . . . . 0.0 110.599 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 114' ' ' PRO . 16.3 tp -178.83 58.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 110.136 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -49.61 -85.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 110.255 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.525 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -125.68 137.46 53.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.287 -0.883 . . . . 0.0 110.293 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.525 ' C ' ' O ' ' A' ' 117' ' ' ALA . 8.0 t70 -32.05 110.03 0.07 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.534 -0.729 . . . . 0.0 110.745 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.466 ' O ' ' O ' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -126.04 -72.02 0.67 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.889 . . . . 0.0 110.142 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.466 ' O ' ' O ' ' A' ' 119' ' ' HIS . 13.1 t80 58.03 116.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.222 -0.923 . . . . 0.0 110.254 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 124' ' ' LEU . . . -170.13 72.27 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.184 -0.948 . . . . 0.0 110.125 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 54.36 -142.99 0.76 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.251 -0.906 . . . . 0.0 110.177 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.34 50.07 1.14 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.258 -0.901 . . . . 0.0 110.237 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 121' ' ' ALA . 0.8 OUTLIER -78.8 78.78 5.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.292 -0.88 . . . . 0.0 110.129 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 105.36 146.77 14.93 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.19 21.05 7.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.187 -1.184 . . . . 0.0 110.183 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' A' ' 127' ' ' ASN . 7.9 m-20 -56.63 132.81 52.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.349 -0.844 . . . . 0.0 110.141 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.485 ' HA ' ' HG3' ' A' ' 114' ' ' PRO . 2.0 p -146.38 -156.34 0.7 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.306 -0.871 . . . . 0.0 110.179 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.517 ' O ' ' CA ' ' A' ' 109' ' ' ALA . 5.5 mt-10 -140.58 123.9 16.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.892 . . . . 0.0 110.111 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.482 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 1.9 t -121.06 121.17 37.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.474 -0.766 . . . . 0.0 110.354 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' TRP . . . . . 0.437 ' CD1' ' O ' ' A' ' 130' ' ' SER . 33.3 m0 -130.94 131.8 44.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.172 -0.955 . . . . 0.0 110.243 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.687 ' HA3' ' CA ' ' A' ' 107' ' ' GLY . . . -172.73 -152.47 8.68 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.963 ' HB3' HG11 ' A' ' 163' ' ' VAL . 43.5 m0 -112.79 113.27 25.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.161 -1.199 . . . . 0.0 111.11 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.819 ' HA ' ' CG1' ' A' ' 105' ' ' VAL . 18.9 m-20 -120.96 148.12 44.53 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.735 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 1.069 HD12 ' CB ' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -139.96 -26.82 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.049 -1.032 . . . . 0.0 110.454 179.387 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.38 -55.82 6.61 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.531 ' HG3' ' N ' ' A' ' 138' ' ' GLY . 2.1 ptt180 -79.96 -21.12 44.11 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.389 1.09 . . . . 0.0 109.412 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.531 ' N ' ' HG3' ' A' ' 137' ' ' ARG . . . -90.5 3.21 81.58 Favored Glycine 0 C--N 1.288 -2.135 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 141' ' ' TYR . 13.0 tttt -58.53 -140.24 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.379 -1.071 . . . . 0.0 110.449 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.494 ' HA ' HD12 ' A' ' 140' ' ' LEU . 3.9 tp -65.61 64.13 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.636 -0.665 . . . . 0.0 110.282 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.726 ' O ' ' N ' ' A' ' 143' ' ' GLN . 22.8 t80 -149.81 77.74 1.34 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.296 -0.878 . . . . 0.0 110.192 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.652 ' C ' ' O ' ' A' ' 141' ' ' TYR . 68.3 m-70 1.56 63.05 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.635 0.731 . . . . 0.0 111.37 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.726 ' N ' ' O ' ' A' ' 141' ' ' TYR . 0.1 OUTLIER -80.73 -69.91 0.57 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.621 -0.674 . . . . 0.0 110.299 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.9 m -44.96 154.49 0.14 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.191 -0.943 . . . . 0.0 110.28 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -80.25 -56.83 3.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.281 -0.887 . . . . 0.0 110.184 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 136.45 108.94 0.93 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.7 tp -175.07 95.01 0.07 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.198 -1.178 . . . . 0.0 110.29 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -58.22 115.87 3.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.13 -0.981 . . . . 0.0 110.257 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -117.07 70.79 5.49 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.253 -0.905 . . . . 0.0 110.165 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 151' ' ' GLN . 46.8 Cg_endo -72.85 -1.12 9.96 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.066 1.561 . . . . 0.0 110.584 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.454 ' O ' ' O ' ' A' ' 150' ' ' PRO . 10.0 mp0 -47.96 -97.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.892 . . . . 0.0 110.202 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.624 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 0.6 OUTLIER -98.62 -65.14 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.243 -0.911 . . . . 0.0 110.423 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.624 ' CD ' ' CB ' ' A' ' 152' ' ' TYR . 46.4 Cg_endo -72.85 155.69 53.3 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.621 1.327 . . . . 0.0 110.444 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 155' ' ' GLY . . . -66.21 149.17 50.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.151 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.504 ' O ' ' O ' ' A' ' 154' ' ' ALA . . . -58.32 -146.79 0.01 OUTLIER Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.71 -31.34 10.68 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.935 1.492 . . . . 0.0 110.411 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.8 -2.23 8.97 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.346 -0.846 . . . . 0.0 110.508 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.861 ' O ' HG23 ' A' ' 162' ' ' VAL . . . -79.31 3.89 65.26 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.59 6.58 5.64 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.25 -1.147 . . . . 0.0 110.429 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -73.89 -2.14 22.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.328 -0.858 . . . . 0.0 110.326 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.721 ' C ' HD12 ' A' ' 161' ' ' LEU . 2.5 pp -172.09 36.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.217 -0.927 . . . . 0.0 110.329 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.861 HG23 ' O ' ' A' ' 158' ' ' GLY . 70.5 t -92.29 -88.56 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.353 -0.842 . . . . 0.0 110.47 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.963 HG11 ' HB3' ' A' ' 133' ' ' TRP . 0.1 OUTLIER -91.98 -19.89 0.24 Allowed Pre-proline 0 C--N 1.29 -1.983 0 O-C-N 121.823 -0.548 . . . . 0.0 111.076 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.785 ' CD ' ' N ' ' A' ' 163' ' ' VAL . 43.4 Cg_endo -72.12 59.3 2.99 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 N-CA-C 109.574 -0.971 . . . . 0.0 109.574 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.523 ' O ' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER 179.91 -76.33 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.361 0.601 . . . . 0.0 109.454 -179.732 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.544 ' HB2' ' NH1' ' A' ' 166' ' ' ARG . 3.0 ttm105 -152.0 156.17 39.45 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.477 -0.765 . . . . 0.0 110.233 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 1.156 HD22 ' N ' ' A' ' 168' ' ' LEU . 0.0 OUTLIER -159.05 138.63 11.65 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.181 -0.949 . . . . 0.0 110.261 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 1.156 ' N ' HD22 ' A' ' 167' ' ' LEU . 2.9 tt -112.86 121.38 44.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 109.829 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.974 HG11 ' CE3' ' A' ' 91' ' ' TRP . 3.6 t -101.43 146.72 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.956 -1.09 . . . . 0.0 110.759 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.5 t -134.26 108.56 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.502 -0.749 . . . . 0.0 109.667 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.969 HD23 ' HB2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -118.29 121.16 39.74 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.044 -1.035 . . . . 0.0 110.006 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 173' ' ' MET . 46.1 t0 -111.44 137.29 49.42 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.278 -0.889 . . . . 0.0 109.896 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.509 ' N ' ' OD1' ' A' ' 172' ' ' ASP . 2.0 tmt? -95.23 -40.21 9.68 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.6 -0.687 . . . . 0.0 109.931 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.474 ' C ' ' O ' ' A' ' 173' ' ' MET . 0.3 OUTLIER -41.77 -27.81 0.13 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.189 -0.945 . . . . 0.0 108.858 179.209 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.645 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.6 OUTLIER -114.42 -27.32 7.6 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.202 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 83.83 23.88 51.28 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 108.559 -1.816 . . . . 0.0 108.559 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' THR . . . . . 1.033 HG22 ' CD2' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -113.17 121.71 45.32 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.311 -1.111 . . . . 0.0 111.243 -179.444 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 1.06 ' O ' HD11 ' A' ' 194' ' ' LEU . 0.2 OUTLIER -124.87 151.28 45.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.401 -0.812 . . . . 0.0 109.671 179.03 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -149.31 166.89 29.59 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.946 ' OH ' HG11 ' A' ' 106' ' ' VAL . 0.7 OUTLIER -123.58 117.86 26.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.408 -1.054 . . . . 0.0 108.439 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.563 ' O ' ' CD2' ' A' ' 167' ' ' LEU . 35.2 t -145.66 155.63 43.13 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.971 -1.081 . . . . 0.0 110.724 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.603 HG23 ' CZ3' ' A' ' 133' ' ' TRP . 0.0 OUTLIER -95.7 116.3 37.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.453 -0.779 . . . . 0.0 108.941 178.554 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 64.42 9.65 38.26 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.26 42.97 33.56 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 3.5 m -121.99 -2.43 9.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.17 -1.194 . . . . 0.0 110.705 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.607 ' CD2' ' CZ2' ' A' ' 133' ' ' TRP . 0.1 OUTLIER -101.28 -71.12 0.72 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.193 -0.942 . . . . 0.0 110.413 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.752 HD23 ' O ' ' A' ' 180' ' ' TYR . 3.9 mm? -67.0 47.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 110.258 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 186' ' ' TYR . . . -71.23 -73.4 0.8 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.416 ' C ' ' H ' ' A' ' 191' ' ' PHE . 49.7 Cg_endo -75.29 -25.48 11.39 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.922 1.486 . . . . 0.0 111.145 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.6 ' HB3' HD13 ' A' ' 187' ' ' LEU . . . -68.31 23.79 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.448 -0.783 . . . . 0.0 112.2 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.601 ' CD2' ' O ' ' A' ' 187' ' ' LEU . 2.1 m-85 -90.43 -38.68 13.12 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.66 -1.275 . . . . 0.0 110.536 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -13.61 61.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.198 -0.938 . . . . 0.0 110.162 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -106.43 -8.95 32.22 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.104 -1.999 . . . . 0.0 108.104 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 1.06 HD11 ' O ' ' A' ' 178' ' ' LEU . 8.7 tt -73.1 -42.59 62.8 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.892 -0.77 . . . . 0.0 109.071 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.521 ' HA ' HG23 ' A' ' 177' ' ' THR . 0.0 OUTLIER -45.27 -42.48 9.63 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.472 -0.767 . . . . 0.0 110.012 179.755 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.457 ' N ' ' HD2' ' A' ' 195' ' ' LYS . . . -85.06 -23.75 47.56 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.839 ' HD3' HD11 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -91.04 -4.47 56.33 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.693 -0.886 . . . . 0.0 110.082 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.787 HG23 ' O ' ' A' ' 194' ' ' LEU . 24.5 p -44.56 129.49 6.78 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 121.471 0.653 . . . . 0.0 111.742 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 1.075 ' HB2' HG22 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -140.39 171.82 13.61 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.482 -0.761 . . . . 0.0 109.849 179.49 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 1.014 ' C ' HG23 ' A' ' 108' ' ' VAL . 3.8 m-85 -83.9 129.55 58.6 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.012 -1.055 . . . . 0.0 109.963 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.638 ' HG3' HD13 ' A' ' 171' ' ' LEU . 49.6 Cg_endo -76.18 124.86 8.15 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 124.055 1.555 . . . . 0.0 111.787 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 80' ' ' GLY . 52.1 m -133.68 160.42 37.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.443 -0.786 . . . . 0.0 109.282 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.631 HG12 ' O ' ' A' ' 52' ' ' ASP . 1.1 t -119.42 162.41 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.835 -1.166 . . . . 0.0 110.608 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' SER . . . . . 0.645 ' O ' ' N ' ' A' ' 105' ' ' VAL . 1.6 m -160.68 138.44 9.55 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 1.032 ' HA ' HG23 ' A' ' 105' ' ' VAL . . . -144.77 129.13 17.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.753 -1.217 . . . . 0.0 111.582 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.498 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 1.0 OUTLIER -38.56 160.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-O 121.178 0.514 . . . . 0.0 110.135 178.857 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 0.44 ' HZ2' HG12 ' A' ' 71' ' ' VAL . 0.9 OUTLIER -50.68 -43.73 57.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.172 -0.955 . . . . 0.0 109.584 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.758 ' HA2' ' HA ' ' A' ' 102' ' ' THR . . . 170.73 134.75 1.8 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.629 ' HB3' ' CD2' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -164.61 -63.28 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -1.133 . . . . 0.0 110.559 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 210' ' ' CYS . . . . . 0.641 ' CB ' ' CE1' ' A' ' 103' ' ' HIS . 0.5 OUTLIER -136.29 85.55 2.16 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.339 -0.851 . . . . 0.0 110.623 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.554 ' N ' ' O ' ' A' ' 100' ' ' ARG . 1.0 OUTLIER -26.59 126.54 0.06 Allowed 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 122.233 1.016 . . . . 0.0 111.608 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 1.123 HG23 ' O ' ' A' ' 94' ' ' SER . 0.7 OUTLIER -113.16 143.78 22.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.064 179.119 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.928 ' HA ' HD22 ' A' ' 64' ' ' LEU . 40.5 mtm180 -88.65 144.4 26.32 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.024 -1.048 . . . . 0.0 111.104 -178.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.932 HG22 HD21 ' A' ' 64' ' ' LEU . 4.2 tt -144.59 139.51 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.507 -0.745 . . . . 0.0 110.446 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.659 ' O ' ' N ' ' A' ' 92' ' ' GLU . 4.2 mtt180 -130.41 109.18 10.53 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' TYR . . . . . 0.715 ' CZ ' ' CD1' ' A' ' 91' ' ' TRP . 4.3 t80 -117.33 140.37 49.65 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.945 -1.097 . . . . 0.0 111.588 -178.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -136.68 114.98 11.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.818 -0.551 . . . . 0.0 109.996 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 123.38 17.98 3.14 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.521 ' HG3' ' NH1' ' A' ' 82' ' ' ARG . 4.9 tt0 -97.0 117.81 31.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.236 -1.155 . . . . 0.0 110.142 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.74 -168.48 1.99 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.253 -0.904 . . . . 0.0 110.154 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ARG . . . . . 0.51 ' O ' ' C ' ' A' ' 222' ' ' VAL . 0.0 OUTLIER -158.45 95.06 1.31 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.339 -0.851 . . . . 0.0 110.252 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.51 ' C ' ' O ' ' A' ' 221' ' ' ARG . 2.6 p -34.55 136.89 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.454 -0.778 . . . . 0.0 110.588 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.508 ' O ' ' C ' ' A' ' 224' ' ' GLU . 0.4 OUTLIER 179.91 52.63 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.188 -0.945 . . . . 0.0 110.292 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.508 ' C ' ' O ' ' A' ' 223' ' ' GLU . 0.8 OUTLIER -33.36 -77.04 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.44 -0.787 . . . . 0.0 110.676 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.441 ' O ' ' OE2' ' A' ' 223' ' ' GLU . 7.0 t -52.46 132.15 34.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 110.158 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.484 ' HD2' ' O ' ' A' ' 226' ' ' ARG . 0.0 OUTLIER -111.12 -3.6 15.38 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.386 -0.821 . . . . 0.0 110.221 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -64.59 -30.17 71.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.269 -0.895 . . . . 0.0 110.211 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.443 ' H ' HG22 ' A' ' 228' ' ' ILE . 5.6 tt -86.08 136.48 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.182 -0.949 . . . . 0.0 110.138 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -178.95 -42.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.288 -0.883 . . . . 0.0 110.259 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ARG . . . . . 0.671 ' O ' ' C ' ' A' ' 231' ' ' ASP . 0.2 OUTLIER -50.54 167.27 0.07 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 110.255 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.671 ' C ' ' O ' ' A' ' 230' ' ' ARG . 17.0 t70 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.008 -0.996 . . . . 0.0 111.489 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.01 -155.98 0.33 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -1.138 . . . . 0.0 110.264 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.7 t -166.85 43.62 0.05 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.262 -0.899 . . . . 0.0 110.278 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -130.44 -38.03 1.37 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.311 -0.868 . . . . 0.0 110.264 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.0 mtm-85 -106.66 130.23 54.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.343 -0.848 . . . . 0.0 110.185 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -159.86 -39.45 0.05 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.306 -0.872 . . . . 0.0 110.153 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.65 177.46 10.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.285 -0.884 . . . . 0.0 110.201 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.401 ' HA ' ' HD2' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -149.46 105.6 3.3 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.299 -0.876 . . . . 0.0 110.189 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 13' ' ' THR . 46.7 Cg_endo -72.98 -40.7 1.65 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.014 1.534 . . . . 0.0 110.495 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.434 ' O ' ' HB3' ' A' ' 16' ' ' SER . 0.1 OUTLIER -126.65 120.31 29.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.341 -0.849 . . . . 0.0 110.134 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.434 ' HB3' ' O ' ' A' ' 15' ' ' THR . 89.0 p -178.32 -65.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.906 . . . . 0.0 110.29 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -77.98 107.13 10.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.323 -0.861 . . . . 0.0 110.283 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.771 ' C ' HD13 ' A' ' 19' ' ' LEU . . . -62.59 -171.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 110.239 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.88 ' N ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -163.21 -171.34 2.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.354 -0.841 . . . . 0.0 110.426 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -166.32 -144.56 0.07 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.159 -0.963 . . . . 0.0 110.301 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.847 ' O ' ' N ' ' A' ' 23' ' ' PHE . 21.3 p -103.77 -145.28 0.37 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.252 -0.905 . . . . 0.0 110.313 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.646 ' C ' ' O ' ' A' ' 21' ' ' SER . 1.1 m-20 2.44 55.88 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.847 0.832 . . . . 0.0 111.114 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.847 ' N ' ' O ' ' A' ' 21' ' ' SER . 0.1 OUTLIER -38.48 -70.85 0.09 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.343 0.592 . . . . 0.0 110.219 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.83 112.71 21.41 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.475 -0.765 . . . . 0.0 110.073 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 23' ' ' PHE . 46.6 Cg_endo -72.66 172.04 16.02 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.01 1.531 . . . . 0.0 110.486 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.559 ' HG3' ' CB ' ' A' ' 30' ' ' GLU . 45.7 Cg_endo -72.51 -179.3 3.97 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.186 1.624 . . . . 0.0 110.347 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -84.28 36.42 0.58 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 110.003 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.93 12.32 60.54 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.487 ' HG ' ' N ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -81.44 -54.64 5.28 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.153 -1.204 . . . . 0.0 109.737 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.559 ' CB ' ' HG3' ' A' ' 26' ' ' PRO . 3.5 tt0 -55.02 -43.86 74.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.223 -0.923 . . . . 0.0 109.117 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -52.35 -24.46 7.64 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.489 HD22 ' HA ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -83.11 -32.23 26.83 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.838 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.03 HD12 ' C ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -85.44 -38.55 18.53 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.759 0.79 . . . . 0.0 109.313 179.211 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.629 ' N ' HD12 ' A' ' 33' ' ' LEU . 37.6 t -45.85 -25.51 0.53 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.449 0.642 . . . . 0.0 109.817 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.903 ' HB1' ' CD ' ' A' ' 36' ' ' PRO . . . -80.68 -164.54 0.05 OUTLIER Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 121.634 -0.666 . . . . 0.0 109.623 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.903 ' CD ' ' HB1' ' A' ' 35' ' ' ALA . 53.2 Cg_endo -95.95 74.61 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.679 1.586 . . . . 0.0 110.96 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.708 ' HD3' ' O ' ' A' ' 35' ' ' ALA . 44.4 Cg_endo -69.29 157.28 61.88 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.458 1.241 . . . . 0.0 110.323 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.735 ' O ' ' N ' ' A' ' 40' ' ' LEU . 50.0 Cg_endo -79.92 152.33 21.88 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 124.103 1.58 . . . . 0.0 111.716 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.719 ' O ' ' CG ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER 4.13 60.35 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 122.845 1.307 . . . . 0.0 110.792 -179.288 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.92 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -144.63 -45.3 0.24 Allowed 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.144 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.826 ' N ' HD13 ' A' ' 40' ' ' LEU . 2.1 t -86.85 -35.1 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 119.076 -1.049 . . . . 0.0 108.575 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.527 ' O ' ' CB ' ' A' ' 46' ' ' HIS . . . -88.55 -36.53 16.32 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.462 -0.774 . . . . 0.0 110.183 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.679 ' HG3' ' HB2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -76.42 -22.98 53.99 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.414 -0.804 . . . . 0.0 110.469 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.706 ' HA ' HG22 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -84.45 -47.58 10.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.233 -0.917 . . . . 0.0 109.965 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.463 ' ND1' ' O ' ' A' ' 41' ' ' VAL . 31.4 m170 -73.35 -16.43 61.35 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.535 -0.728 . . . . 0.0 109.424 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.527 ' CB ' ' O ' ' A' ' 42' ' ' ALA . 3.2 t60 -96.7 -31.02 12.89 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.639 0.733 . . . . 0.0 109.085 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 46' ' ' HIS . . . -61.08 -115.47 0.01 OUTLIER Glycine 0 N--CA 1.479 1.534 0 N-CA-C 108.114 -1.995 . . . . 0.0 108.114 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.888 ' CA ' HD13 ' A' ' 214' ' ' ILE . 6.4 p-90 -103.31 71.3 1.1 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.573 -1.251 . . . . 0.0 111.194 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.461 ' OD1' ' HB3' ' A' ' 53' ' ' CYS . 34.3 t30 -108.93 114.57 58.24 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 120.873 -1.142 . . . . 0.0 110.183 178.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.618 ' HG2' ' CA ' ' A' ' 80' ' ' GLY . 39.1 Cg_endo -67.35 -63.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.767 0 N-CA-C 109.323 -1.068 . . . . 0.0 109.323 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.964 ' HA ' ' CE ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER 176.02 31.48 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.781 -1.2 . . . . 0.0 112.912 177.423 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.875 ' HB3' ' HG2' ' A' ' 79' ' ' ARG 0.256 0.2 OUTLIER -162.22 19.72 0.1 Allowed 'General case' 0 C--N 1.265 -3.087 0 CA-C-O 122.16 0.981 . . . . 0.0 109.134 -179.207 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.54 ' SG ' ' CZ ' ' A' ' 44' ' ' ARG . 18.9 t -102.29 128.64 48.76 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-O 122.336 1.065 . . . . 0.0 111.203 -177.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.623 ' CB ' HD21 ' A' ' 56' ' ' ASN . 0.1 OUTLIER -91.86 166.72 12.59 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.894 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.915 ' OE2' HD13 ' A' ' 33' ' ' LEU . 1.7 pm0 -75.98 6.25 5.46 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.619 -0.675 . . . . 0.0 110.846 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.623 HD21 ' CB ' ' A' ' 54' ' ' SER . 0.1 OUTLIER -28.33 -33.37 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.182 0 CA-C-O 122.065 0.936 . . . . 0.0 109.882 179.256 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.713 ' HB ' ' HG2' ' A' ' 68' ' ' ARG . 0.4 OUTLIER -134.64 169.02 22.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.863 -0.523 . . . . 0.0 109.724 -178.833 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.548 ' O ' ' HB3' ' A' ' 67' ' ' GLU . 3.4 t70 -107.53 106.93 17.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.821 -1.174 . . . . 0.0 111.034 -178.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.715 HG11 ' CZ2' ' A' ' 48' ' ' TRP . 2.1 m -122.62 135.54 62.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.679 ' HB2' ' HG3' ' A' ' 43' ' ' GLN . 11.1 ttpp -127.42 155.41 43.7 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.632 -1.293 . . . . 0.0 112.09 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.584 ' HA ' HD13 ' A' ' 64' ' ' LEU . 19.0 tt0 -65.17 -128.89 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.741 -0.599 . . . . 0.0 110.397 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 41.05 47.02 4.21 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.679 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 102.76 50.59 1.08 Allowed Glycine 0 N--CA 1.486 2.017 0 N-CA-C 107.904 -2.078 . . . . 0.0 107.904 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.901 HD22 ' H ' ' A' ' 64' ' ' LEU . 2.3 mm? 1.14 81.35 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.763 0.792 . . . . 0.0 110.806 -178.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.413 ' N ' ' O ' ' A' ' 63' ' ' GLY . 6.3 t -99.29 114.96 28.08 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.686 -0.634 . . . . 0.0 109.976 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.864 ' CE1' ' CE2' ' A' ' 48' ' ' TRP . 1.9 m-85 -82.83 129.9 35.06 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.461 -0.774 . . . . 0.0 109.539 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.548 ' HB3' ' O ' ' A' ' 58' ' ' ASP . 1.2 tm-20 -137.37 121.58 18.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.868 -1.145 . . . . 0.0 110.339 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.748 ' HD3' ' HB3' ' A' ' 207' ' ' TRP . 9.2 mtp180 -115.57 154.76 28.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 0.0 109.55 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.681 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 16.5 ttt85 -95.72 -69.08 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 120.956 -1.09 . . . . 0.0 109.859 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.681 ' HD3' ' HB3' ' A' ' 69' ' ' ARG . 57.6 Cg_endo -77.48 -123.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 N-CA-C 108.713 -1.303 . . . . 0.0 108.713 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 73' ' ' GLN . 2.6 t -140.07 164.33 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.52 -1.363 . . . . 0.0 109.589 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.968 ' HB2' ' CZ3' ' A' ' 207' ' ' TRP . . . -41.66 92.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.176 -0.953 . . . . 0.0 110.314 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.552 ' N ' ' O ' ' A' ' 71' ' ' VAL . 6.3 tp60 -179.97 -31.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.221 -0.924 . . . . 0.0 110.294 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.463 ' C ' ' O ' ' A' ' 73' ' ' GLN . 10.4 p -40.12 -50.61 2.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.343 -0.848 . . . . 0.0 110.228 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.607 HG22 ' N ' ' A' ' 76' ' ' ASP . 7.5 m -169.03 -84.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.269 -0.894 . . . . 0.0 110.031 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.623 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 66.2 t0 -140.13 113.19 8.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.221 -0.924 . . . . 0.0 110.36 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.533 ' O ' ' O ' ' A' ' 76' ' ' ASP . . . -42.59 -91.41 0.01 OUTLIER Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.046 -2.022 . . . . 0.0 108.046 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.964 HG13 ' O ' ' A' ' 205' ' ' ALA . 0.3 OUTLIER -144.15 139.39 24.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.123 -1.222 . . . . 0.0 109.88 179.302 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.875 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 29.3 ttp180 -145.65 148.08 32.69 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.844 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.709 ' CA ' ' HB2' ' A' ' 52' ' ' ASP . . . -136.99 124.6 3.15 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.511 ' HB3' ' OD1' ' A' ' 52' ' ' ASP . 6.1 ttpm? -134.26 -71.38 0.5 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.855 -1.379 . . . . 0.0 111.74 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.559 ' CZ ' ' NZ ' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -58.32 -93.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.19 -0.944 . . . . 0.0 110.799 -178.893 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.427 ' HA2' ' HG3' ' A' ' 51' ' ' LYS . . . 51.13 70.04 0.97 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.679 -1.769 . . . . 0.0 108.679 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.575 ' C ' ' CD1' ' A' ' 84' ' ' TYR . 1.0 OUTLIER -94.57 142.16 27.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.341 -1.094 . . . . 0.0 110.495 -179.308 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.58 ' HB3' ' CE1' ' A' ' 89' ' ' HIS . 1.4 m -135.87 174.34 10.73 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.548 -0.72 . . . . 0.0 109.886 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.579 ' O ' ' CE1' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -126.62 138.51 53.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.18 -0.95 . . . . 0.0 110.7 -179.746 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.486 ' N ' ' HB3' ' A' ' 173' ' ' MET . . . 92.15 -119.46 5.8 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.743 HD12 ' OD2' ' A' ' 172' ' ' ASP . 4.5 tt -128.74 139.63 52.11 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.676 -0.896 . . . . 0.0 110.123 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.58 ' CE1' ' HB3' ' A' ' 85' ' ' SER . 18.3 m-70 -147.23 162.38 39.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.162 -0.961 . . . . 0.0 110.186 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 217' ' ' MET . . . -160.65 138.66 9.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.219 -0.926 . . . . 0.0 109.949 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 1.098 ' CZ2' HG11 ' A' ' 169' ' ' VAL . 1.3 p90 -134.89 170.75 15.39 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.242 -0.911 . . . . 0.0 110.36 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.608 ' N ' ' O ' ' A' ' 215' ' ' ARG . 38.1 mt-10 -141.82 152.58 43.82 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.637 -0.664 . . . . 0.0 110.497 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.755 HG23 ' O ' ' A' ' 213' ' ' ARG . 10.1 mt -144.48 154.2 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.902 . . . . 0.0 110.57 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.564 ' OG ' ' HB2' ' A' ' 213' ' ' ARG . 1.2 m -119.35 133.5 55.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.354 -0.841 . . . . 0.0 109.469 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.936 ' CH2' HG13 ' A' ' 105' ' ' VAL 0.261 2.3 t-105 -136.52 88.12 20.46 Favored Pre-proline 0 C--N 1.297 -1.697 0 O-C-N 121.441 -0.787 . . . . 0.0 110.332 -178.759 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.564 ' HD2' ' O ' ' A' ' 211' ' ' GLN . 51.7 Cg_endo -91.99 107.02 0.24 Allowed 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.095 1.05 . . . . 0.0 110.682 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.648 HD22 ' HG3' ' A' ' 98' ' ' GLU . 5.6 tt -97.84 -68.2 0.81 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.09 -1.006 . . . . 0.0 109.934 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.648 ' HG3' HD22 ' A' ' 97' ' ' LEU . 12.9 mt-10 -99.02 -45.43 5.94 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.508 -0.745 . . . . 0.0 110.261 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.504 ' HG2' ' CG ' ' A' ' 100' ' ' ARG . 64.9 tt0 -152.74 -99.31 0.05 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.31 -0.869 . . . . 0.0 110.491 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.554 ' C ' ' HB2' ' A' ' 165' ' ' GLU . 1.4 mmt180 -113.36 -140.75 0.38 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.08 -1.012 . . . . 0.0 110.656 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.734 ' O ' ' HB3' ' A' ' 165' ' ' GLU . . . 103.42 -141.34 15.2 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.619 HG22 ' C ' ' A' ' 101' ' ' GLY . 0.0 OUTLIER 178.47 109.62 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.165 -1.197 . . . . 0.0 110.153 179.773 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.72 ' N ' ' HA ' ' A' ' 164' ' ' PRO . 0.2 OUTLIER 179.67 -176.22 0.3 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.677 -1.264 . . . . 0.0 112.222 -179.818 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.707 ' N ' HD11 ' A' ' 135' ' ' ILE . . . 179.81 -178.32 0.4 Allowed 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 1.079 HG22 ' O ' ' A' ' 204' ' ' SER . 0.9 OUTLIER -94.56 115.16 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 116.675 -2.01 . . . . 0.0 107.763 178.487 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 1.102 ' CG2' HG23 ' A' ' 203' ' ' VAL . 34.3 t -148.76 169.15 2.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.156 -0.965 . . . . 0.0 110.267 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.709 ' HA2' ' HA3' ' A' ' 132' ' ' GLY . . . -175.35 131.41 1.93 Allowed Glycine 0 N--CA 1.483 1.797 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.136 ' CG1' HD13 ' A' ' 199' ' ' LEU . 0.3 OUTLIER -102.41 143.41 14.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.618 -0.93 . . . . 0.0 109.628 -179.569 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.534 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -109.79 129.76 55.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.128 -0.982 . . . . 0.0 110.704 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.913 HG23 ' CG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -110.55 131.74 54.79 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.309 -0.869 . . . . 0.0 110.065 179.65 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -91.25 -27.13 18.64 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.502 0.668 . . . . 0.0 109.238 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.426 ' CD2' ' O ' ' A' ' 196' ' ' GLY . 1.8 pp -82.15 -12.59 58.08 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.505 -0.747 . . . . 0.0 109.492 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.631 ' HB2' ' HB ' ' A' ' 110' ' ' THR . . . -52.26 143.86 24.29 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.404 -0.81 . . . . 0.0 110.091 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' A' ' 115' ' ' LEU . 46.2 Cg_endo -72.5 165.04 33.83 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.922 1.485 . . . . 0.0 110.411 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.783 HD12 ' O ' ' A' ' 128' ' ' SER . 1.2 tt -179.97 62.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 110.249 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -85.08 -39.19 18.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.163 -0.96 . . . . 0.0 110.208 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.524 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -131.15 74.84 1.62 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.317 -0.864 . . . . 0.0 110.161 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.524 ' C ' ' O ' ' A' ' 117' ' ' ALA . 12.1 t70 -31.55 146.08 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.413 -0.805 . . . . 0.0 110.771 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -98.32 -44.69 6.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.145 -0.972 . . . . 0.0 110.213 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.453 ' O ' ' OD2' ' A' ' 118' ' ' ASP . 0.3 OUTLIER -128.02 178.08 6.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.251 -0.906 . . . . 0.0 110.152 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 120' ' ' TYR . . . -42.87 130.98 4.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -0.934 . . . . 0.0 110.132 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.13 -167.16 0.83 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.912 . . . . 0.0 110.304 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.453 ' HA ' HD12 ' A' ' 123' ' ' LEU . 1.4 tp -114.27 -170.87 1.81 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.939 . . . . 0.0 110.202 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -50.63 -26.53 5.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.299 -0.876 . . . . 0.0 110.144 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -105.52 132.15 10.98 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 13.5 m -100.0 26.15 6.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.213 -1.169 . . . . 0.0 110.247 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.408 ' O ' ' HB3' ' A' ' 128' ' ' SER . 0.9 OUTLIER -146.06 52.69 1.14 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 110.305 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.783 ' O ' HD12 ' A' ' 115' ' ' LEU . 17.1 p -179.64 -171.32 0.18 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 110.345 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.492 ' HB3' ' CB ' ' A' ' 113' ' ' ALA . 21.6 tt0 -150.11 131.08 14.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.225 -0.922 . . . . 0.0 109.874 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.4 t -120.41 119.6 33.54 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.195 -0.941 . . . . 0.0 110.503 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -133.47 141.99 48.06 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.471 -0.768 . . . . 0.0 109.192 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.709 ' HA3' ' HA2' ' A' ' 107' ' ' GLY . . . -173.27 -138.92 2.74 Favored Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.336 -1.411 . . . . 0.0 110.652 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.825 ' CH2' HG23 ' A' ' 182' ' ' ILE . 45.9 m0 -113.11 118.18 34.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.392 -1.063 . . . . 0.0 110.611 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.734 ' O ' HG23 ' A' ' 135' ' ' ILE . 4.2 p30 -118.06 126.5 52.41 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.359 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.734 HG23 ' O ' ' A' ' 134' ' ' ASP . 7.3 pt -160.34 37.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.338 -0.851 . . . . 0.0 110.055 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.46 -58.36 8.72 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.503 ' HB3' ' HG2' ' A' ' 139' ' ' LYS . 3.5 mpt_? -86.46 5.63 34.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.108 -1.23 . . . . 0.0 110.403 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 137' ' ' ARG . . . 38.86 28.74 0.07 OUTLIER Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.686 ' O ' HD13 ' A' ' 161' ' ' LEU . 0.4 OUTLIER -65.45 -162.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.124 -1.221 . . . . 0.0 110.363 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.663 ' O ' ' C ' ' A' ' 141' ' ' TYR . 1.5 pp -160.31 100.89 1.37 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.331 -0.856 . . . . 0.0 110.192 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.663 ' C ' ' O ' ' A' ' 140' ' ' LEU . 1.8 m-85 0.17 75.95 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.694 -0.629 . . . . 0.0 111.308 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.521 ' N ' ' O ' ' A' ' 140' ' ' LEU . 1.2 m80 -55.49 -36.85 67.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.295 -0.878 . . . . 0.0 110.283 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.3 -44.95 96.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.896 . . . . 0.0 110.287 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.404 ' HB3' ' HB3' ' A' ' 141' ' ' TYR . 10.0 p -57.32 -168.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 110.26 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.6 mmtt -114.68 -55.23 2.51 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.277 -0.889 . . . . 0.0 110.195 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 121.08 170.25 13.98 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -172.24 39.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.198 -1.178 . . . . 0.0 110.336 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 149' ' ' ALA . 16.1 pt-20 -45.87 157.87 0.1 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.282 -0.886 . . . . 0.0 110.231 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.523 ' HB1' ' NE2' ' A' ' 151' ' ' GLN . . . -179.99 102.74 0.17 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.181 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.66 53.01 2.62 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.994 1.523 . . . . 0.0 110.406 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.523 ' NE2' ' HB1' ' A' ' 149' ' ' ALA . 0.0 OUTLIER -84.49 -50.24 7.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.916 . . . . 0.0 110.32 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.541 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 0.1 OUTLIER -177.37 -58.77 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.32 -0.862 . . . . 0.0 110.249 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.541 ' CD ' ' CB ' ' A' ' 152' ' ' TYR . 46.1 Cg_endo -72.58 171.08 17.9 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.043 1.549 . . . . 0.0 110.422 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 153' ' ' PRO . . . -40.65 144.23 0.27 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 0.0 110.425 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -179.08 -83.9 0.06 OUTLIER Glycine 0 N--CA 1.481 1.641 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.43 -2.59 12.34 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.065 1.56 . . . . 0.0 110.489 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 158' ' ' GLY . 1.9 mp0 -64.63 -6.75 8.35 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.259 -0.901 . . . . 0.0 110.496 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 157' ' ' GLN . . . 42.18 28.88 0.56 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.893 ' OE2' HG21 ' A' ' 163' ' ' VAL . 22.6 tt0 -79.36 6.43 10.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.237 -1.155 . . . . 0.0 110.184 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.629 ' O ' HD12 ' A' ' 161' ' ' LEU . 0.5 OUTLIER -59.48 -15.92 20.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.344 -0.848 . . . . 0.0 109.516 179.601 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.686 HD13 ' O ' ' A' ' 139' ' ' LYS . 0.2 OUTLIER -174.98 27.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.585 0.707 . . . . 0.0 109.791 179.487 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.812 HG12 ' O ' ' A' ' 162' ' ' VAL . 2.5 t -157.14 81.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-O 121.686 0.755 . . . . 0.0 109.717 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.893 HG21 ' OE2' ' A' ' 159' ' ' GLU . 4.0 p -150.17 41.83 0.23 Allowed Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 121.407 -0.808 . . . . 0.0 110.376 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.868 ' HD3' ' N ' ' A' ' 163' ' ' VAL . 55.2 Cg_endo -93.78 152.08 2.28 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.609 1.32 . . . . 0.0 111.22 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.734 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 5.7 tp10 178.83 -70.33 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.412 -0.805 . . . . 0.0 109.663 178.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.472 ' O ' ' HB ' ' A' ' 102' ' ' THR . 3.0 ttp180 -147.88 141.47 25.49 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.579 -0.7 . . . . 0.0 109.378 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.874 ' O ' HD12 ' A' ' 167' ' ' LEU . 0.5 OUTLIER -162.52 157.14 21.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.128 -0.982 . . . . 0.0 110.455 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.772 ' C ' HD23 ' A' ' 168' ' ' LEU . 6.5 tt -120.68 134.8 55.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.332 -0.855 . . . . 0.0 110.15 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 1.098 HG11 ' CZ2' ' A' ' 91' ' ' TRP . 94.1 t -109.97 128.62 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.272 -0.893 . . . . 0.0 110.412 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 4.7 t -103.75 110.47 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.343 -0.848 . . . . 0.0 109.815 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.754 HD13 HD22 ' A' ' 178' ' ' LEU . 13.7 tp -121.5 106.06 11.05 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.18 -0.95 . . . . 0.0 109.983 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.743 ' OD2' HD12 ' A' ' 88' ' ' LEU . 5.5 t70 -111.43 136.8 50.06 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.283 -0.885 . . . . 0.0 110.477 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.538 ' CE ' ' CE2' ' A' ' 84' ' ' TYR . 12.5 tpp -92.3 -40.07 11.14 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 120.412 -0.515 . . . . 0.0 109.702 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 173' ' ' MET . 15.2 tt0 -41.95 -28.89 0.19 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.279 -0.888 . . . . 0.0 108.91 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.512 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.0 OUTLIER -109.4 -25.83 10.32 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.949 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.443 ' O ' ' OG1' ' A' ' 198' ' ' THR . . . 78.96 24.63 61.48 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.881 ' HB ' HD22 ' A' ' 194' ' ' LEU . 1.1 p -125.38 148.74 48.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.206 -1.173 . . . . 0.0 111.112 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 1.002 HD13 ' HG3' ' A' ' 201' ' ' PRO . 0.4 OUTLIER -148.1 154.33 40.06 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.525 -0.734 . . . . 0.0 109.952 179.804 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -149.25 164.68 29.34 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.745 ' CD1' HG22 ' A' ' 169' ' ' VAL . 0.4 OUTLIER -118.86 121.88 41.03 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.14 -1.212 . . . . 0.0 109.859 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.695 ' HB2' HD22 ' A' ' 187' ' ' LEU . 11.4 t -113.01 124.5 52.78 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.371 -0.83 . . . . 0.0 110.078 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.825 HG23 ' CH2' ' A' ' 133' ' ' TRP . 0.0 OUTLIER -104.21 116.82 48.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.594 -0.691 . . . . 0.0 109.715 179.756 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 72.93 4.59 62.84 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.174 -1.571 . . . . 0.0 109.174 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 68.65 47.49 55.97 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' THR . . . . . 0.576 HG22 ' CE1' ' A' ' 186' ' ' TYR . 46.3 m -137.07 -27.09 1.0 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -1.173 . . . . 0.0 110.802 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.576 ' CE1' HG22 ' A' ' 185' ' ' THR . 21.8 m-85 -116.8 76.55 1.04 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.949 -1.095 . . . . 0.0 110.676 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.695 HD22 ' HB2' ' A' ' 181' ' ' SER . 0.6 OUTLIER 179.7 29.41 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.529 0.68 . . . . 0.0 109.196 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.638 ' H ' ' HD2' ' A' ' 189' ' ' PRO . . . -105.48 -62.01 0.63 Allowed Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.915 -1.136 . . . . 0.0 111.447 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.638 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 43.5 Cg_endo -70.24 -31.6 18.12 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.685 1.361 . . . . 0.0 111.791 -178.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.621 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -71.83 9.2 0.95 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.077 -1.014 . . . . 0.0 111.367 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.568 ' CE1' ' HG ' ' A' ' 187' ' ' LEU . 1.4 m-85 -90.53 -10.78 42.28 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.278 -0.889 . . . . 0.0 110.161 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.474 ' HA ' ' NE ' ' A' ' 192' ' ' ARG . 0.2 OUTLIER -90.12 -15.21 32.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.353 -0.842 . . . . 0.0 110.191 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 197' ' ' ARG . . . -112.07 -17.01 8.62 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.018 -2.033 . . . . 0.0 108.018 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.963 HD23 ' O ' ' A' ' 194' ' ' LEU . 3.8 tt -65.52 -26.31 67.84 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.831 -0.805 . . . . 0.0 109.134 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.582 ' HA ' HG21 ' A' ' 177' ' ' THR . 0.0 OUTLIER -54.51 -26.25 30.51 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.599 -0.688 . . . . 0.0 109.773 179.242 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.426 ' O ' ' CD2' ' A' ' 112' ' ' LEU . . . -118.87 -17.62 5.0 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.762 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.32 -3.96 57.43 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.459 -1.024 . . . . 0.0 110.322 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.812 ' HB ' HG22 ' A' ' 177' ' ' THR . 0.5 OUTLIER -42.1 132.3 3.28 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 122.325 1.059 . . . . 0.0 112.052 -178.094 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 1.136 HD13 ' CG1' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -142.61 171.32 14.21 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.431 178.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.621 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 2.6 m-85 -84.89 128.43 60.6 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 120.814 -1.179 . . . . 0.0 109.817 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 1.002 ' HG3' HD13 ' A' ' 178' ' ' LEU . 55.7 Cg_endo -87.43 142.33 6.04 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 124.022 1.538 . . . . 0.0 112.4 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 43.1 m -133.91 134.92 43.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.677 -0.639 . . . . 0.0 109.5 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 1.102 HG23 ' CG2' ' A' ' 106' ' ' VAL . 4.0 p -119.5 161.31 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.811 -1.181 . . . . 0.0 110.335 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' SER . . . . . 1.079 ' O ' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -160.51 161.48 32.77 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.971 0.891 . . . . 0.0 110.822 179.687 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.964 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -150.65 165.92 31.93 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 121.956 0.884 . . . . 0.0 110.868 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 1.116 HG22 ' CE3' ' A' ' 207' ' ' TRP . 0.3 OUTLIER -98.79 -152.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.037 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 1.116 ' CE3' HG22 ' A' ' 206' ' ' VAL . 48.7 p90 -91.07 -140.66 0.17 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.123 -0.986 . . . . 0.0 110.415 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.526 ' O ' ' NE2' ' A' ' 211' ' ' GLN . . . -65.91 0.29 6.06 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.792 ' HB3' HG11 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -66.09 -28.26 68.69 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.287 -1.125 . . . . 0.0 110.407 -179.818 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 210' ' ' CYS . . . . . 0.904 ' SG ' HG12 ' A' ' 206' ' ' VAL . 22.9 p -145.52 14.9 1.43 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 110.853 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.671 ' C ' ' O ' ' A' ' 210' ' ' CYS . 0.0 OUTLIER -6.04 117.74 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.655 0.741 . . . . 0.0 111.466 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.67 HG13 ' CZ ' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -121.88 144.77 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.76 -0.588 . . . . 0.0 109.985 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.755 ' O ' HG23 ' A' ' 93' ' ' ILE . 0.8 OUTLIER -88.07 171.8 10.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.217 -0.927 . . . . 0.0 110.229 -179.482 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.888 HD13 ' CA ' ' A' ' 48' ' ' TRP . 0.7 OUTLIER -143.36 118.53 4.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-O 122.013 0.911 . . . . 0.0 111.805 -178.346 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.608 ' O ' ' N ' ' A' ' 92' ' ' GLU . 66.4 mtt-85 -130.62 108.91 10.26 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' TYR . . . . . 0.651 ' CE2' ' HB3' ' A' ' 91' ' ' TRP . 3.2 t80 -105.82 149.3 26.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.094 -1.004 . . . . 0.0 111.094 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' MET . . . . . 0.465 ' O ' ' O ' ' A' ' 90' ' ' ALA . 1.0 OUTLIER -131.5 121.05 23.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.48 -0.762 . . . . 0.0 110.154 179.745 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 132.58 -32.82 2.74 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.472 ' O ' ' HG2' ' A' ' 220' ' ' ARG . 0.9 OUTLIER -95.57 136.36 36.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.236 -1.155 . . . . 0.0 110.226 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.69 ' O ' ' C ' ' A' ' 221' ' ' ARG . 18.9 mtm180 -150.41 120.26 7.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 0.0 110.271 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ARG . . . . . 0.69 ' C ' ' O ' ' A' ' 220' ' ' ARG . 3.9 mtp180 0.03 78.48 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.431 0.634 . . . . 0.0 111.265 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.49 ' C ' ' O ' ' A' ' 221' ' ' ARG . 2.6 p -35.68 156.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.649 -0.657 . . . . 0.0 110.532 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.518 ' O ' ' C ' ' A' ' 224' ' ' GLU . 11.4 tt0 179.94 70.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.198 -0.939 . . . . 0.0 110.287 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.518 ' C ' ' O ' ' A' ' 223' ' ' GLU . 4.6 mt-10 -33.17 -37.11 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.483 -0.761 . . . . 0.0 110.728 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 223' ' ' GLU . 86.1 m -41.81 112.17 0.3 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.332 -0.855 . . . . 0.0 110.209 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 225' ' ' THR . 13.7 mmm180 -141.7 19.87 2.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 110.272 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.99 -31.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.217 -0.927 . . . . 0.0 110.306 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.455 HG22 ' H ' ' A' ' 229' ' ' HIS . 2.8 mt -95.8 -132.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.32 -0.863 . . . . 0.0 110.016 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.479 ' O ' ' HB2' ' A' ' 230' ' ' ARG . 1.0 OUTLIER -170.34 -146.66 0.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.11 -0.994 . . . . 0.0 110.284 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ARG . . . . . 0.682 ' O ' ' C ' ' A' ' 231' ' ' ASP . 1.4 tpt180 -179.57 142.05 0.17 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.392 -0.818 . . . . 0.0 110.056 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.682 ' C ' ' O ' ' A' ' 230' ' ' ARG . 1.2 m-20 . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 117.989 -1.005 . . . . 0.0 111.422 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 8' ' ' SER . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.6 p -59.47 87.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.201 -1.176 . . . . 0.0 110.228 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 6' ' ' GLY . 34.3 t -171.13 143.18 1.89 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.204 -0.935 . . . . 0.0 110.163 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.401 ' O ' ' O ' ' A' ' 10' ' ' ARG . . . -100.09 147.83 25.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.101 -0.999 . . . . 0.0 110.239 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.401 ' O ' ' O ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -46.72 170.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.893 . . . . 0.0 110.243 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.56 131.92 47.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.174 -0.954 . . . . 0.0 110.199 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.4 m -124.87 14.83 8.6 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.905 . . . . 0.0 110.212 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.419 ' HB ' ' HD2' ' A' ' 14' ' ' PRO . 6.3 p -80.39 165.39 46.67 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.336 -0.853 . . . . 0.0 110.131 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.419 ' HD2' ' HB ' ' A' ' 13' ' ' THR . 46.1 Cg_endo -73.15 86.7 1.1 Allowed 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.047 1.551 . . . . 0.0 110.434 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.67 -169.79 0.93 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.264 -0.897 . . . . 0.0 110.278 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.5 p -162.81 -149.47 0.15 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.912 . . . . 0.0 110.192 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.97 4.47 25.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 110.161 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.26 139.02 55.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.136 -0.977 . . . . 0.0 110.266 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.08 -164.43 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.357 -0.84 . . . . 0.0 110.235 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -122.51 -158.23 0.77 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 0.0 110.207 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 52.6 p -148.02 131.12 16.34 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.219 -0.926 . . . . 0.0 110.166 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.41 79.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.203 -0.936 . . . . 0.0 110.259 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.463 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -96.7 -71.36 0.68 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.235 -0.915 . . . . 0.0 110.174 179.926 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.47 105.29 24.8 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.3 -0.875 . . . . 0.0 110.1 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 23' ' ' PHE . 47.0 Cg_endo -73.35 168.65 24.22 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.936 1.493 . . . . 0.0 110.444 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.496 ' HB3' ' HB3' ' A' ' 74' ' ' SER . 45.7 Cg_endo -72.94 165.23 33.36 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.035 1.545 . . . . 0.0 110.364 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.97 37.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.202 -0.936 . . . . 0.0 110.324 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.05 23.19 31.05 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.935 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -51.89 -32.98 34.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.434 -1.039 . . . . 0.0 110.08 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.855 ' HA ' HD23 ' A' ' 33' ' ' LEU . 24.8 pt-20 -47.06 -35.12 6.51 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.304 -0.872 . . . . 0.0 109.579 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.49 ' N ' ' HG3' ' A' ' 30' ' ' GLU . 1.1 tm-20 -63.91 -23.51 67.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.446 -0.784 . . . . 0.0 108.992 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.647 HD13 ' O ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -83.29 -33.88 25.86 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.855 HD23 ' HA ' ' A' ' 30' ' ' GLU . 0.3 OUTLIER -73.55 -35.98 65.59 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 122.058 0.933 . . . . 0.0 108.917 179.293 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.649 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 23.5 t -71.24 -12.57 61.53 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.605 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 1.01 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -45.31 -64.97 0.72 Allowed Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.19 -0.944 . . . . 0.0 110.268 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 1.01 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 50.0 Cg_endo -72.8 147.8 45.15 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.75 1.395 . . . . 0.0 110.15 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.494 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 54.7 Cg_endo -99.3 42.84 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.001 1.801 . . . . 0.0 112.912 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.76 ' HD3' ' HB2' ' A' ' 36' ' ' PRO . 50.8 Cg_endo -76.23 151.13 33.83 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 122.908 0.951 . . . . 0.0 110.303 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.712 ' O ' ' HB3' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -28.62 -36.08 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.587 -0.696 . . . . 0.0 110.659 179.676 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.973 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -49.91 -48.52 51.6 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.786 -1.197 . . . . 0.0 110.501 -179.605 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.953 HG23 ' CD1' ' A' ' 40' ' ' LEU . 41.1 t -83.93 -32.55 8.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 121.161 -0.962 . . . . 0.0 110.296 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 46' ' ' HIS . . . -89.72 -41.13 12.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.092 -1.005 . . . . 0.0 111.731 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.712 ' HB3' ' O ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -78.46 -20.54 50.73 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.095 -1.003 . . . . 0.0 110.39 -179.215 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.718 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 7.6 tpt180 -76.42 -55.02 5.93 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.426 ' ND1' ' O ' ' A' ' 41' ' ' VAL . 32.7 m170 -65.73 -17.19 64.44 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.544 ' HB2' ' O ' ' A' ' 42' ' ' ALA . 74.1 t60 -96.77 -17.15 20.44 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.697 0.76 . . . . 0.0 109.355 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.97 -112.3 0.12 Allowed Glycine 0 N--CA 1.477 1.367 0 N-CA-C 108.156 -1.977 . . . . 0.0 108.156 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 1.176 ' CZ2' HD22 ' A' ' 64' ' ' LEU . 4.6 m95 -102.97 70.93 1.11 Allowed 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.849 -1.14 . . . . 0.0 110.844 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.524 ' OD1' ' HB3' ' A' ' 53' ' ' CYS . 28.2 t30 -108.41 111.97 61.22 Favored Pre-proline 0 C--N 1.302 -1.491 0 O-C-N 121.139 -0.976 . . . . 0.0 109.694 178.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.826 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 40.9 Cg_endo -68.03 -63.68 0.05 OUTLIER 'Trans proline' 0 C--N 1.301 -1.949 0 O-C-N 123.291 1.153 . . . . 0.0 109.764 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 1.123 ' HA ' ' CE ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER 176.07 36.98 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 122.502 1.144 . . . . 0.0 111.561 178.059 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.769 ' HB3' ' HG2' ' A' ' 79' ' ' ARG 0.255 0.7 OUTLIER -169.8 23.23 0.02 OUTLIER 'General case' 0 C--N 1.269 -2.921 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.331 -179.385 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.559 ' SG ' ' CZ ' ' A' ' 44' ' ' ARG . 8.3 t -101.27 127.42 47.88 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-O 122.523 1.154 . . . . 0.0 111.337 -177.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.66 ' CB ' HD22 ' A' ' 56' ' ' ASN . 0.6 OUTLIER -90.11 166.23 13.52 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.337 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.814 ' HG3' HD11 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -74.45 1.97 10.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.693 -0.629 . . . . 0.0 110.981 -179.146 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.66 HD22 ' CB ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -31.64 -32.63 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.642 0.734 . . . . 0.0 109.833 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.69 HD11 ' NH2' ' A' ' 44' ' ' ARG . 4.6 pt -136.34 166.39 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.562 -0.711 . . . . 0.0 110.41 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.92 ' HB2' HD23 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -109.21 121.59 45.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 110.458 -179.263 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.71 HG11 ' HD1' ' A' ' 48' ' ' TRP . 58.4 t -130.32 132.69 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.287 -0.883 . . . . 0.0 110.21 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.664 ' HB2' ' HG3' ' A' ' 43' ' ' GLN . 3.1 ttpt -135.26 155.07 51.25 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.218 -0.926 . . . . 0.0 110.397 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 63' ' ' GLY . 4.2 tt0 -74.87 -118.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.351 -0.843 . . . . 0.0 110.203 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 42.08 28.81 0.53 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.674 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 129.65 60.55 0.1 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.176 HD22 ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER 0.44 84.83 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.751 -0.852 . . . . 0.0 111.172 -179.716 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 31.5 t -126.65 114.82 18.54 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.162 -0.961 . . . . 0.0 111.005 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.596 ' HA ' HG13 ' A' ' 59' ' ' VAL . 3.6 m-85 -90.23 124.72 35.1 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.576 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 3.4 tt0 -125.37 147.53 49.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.737 -1.227 . . . . 0.0 110.516 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.574 ' HB3' ' CG2' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -136.09 115.68 12.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.434 -0.791 . . . . 0.0 109.777 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.65 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -68.94 -65.99 1.12 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.024 -1.048 . . . . 0.0 110.255 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.65 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 56.1 Cg_endo -70.49 -143.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.924 1.487 . . . . 0.0 109.354 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.556 HG13 ' CH2' ' A' ' 207' ' ' TRP . 3.5 t -139.6 164.11 24.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 O-C-N 121.319 -0.863 . . . . 0.0 109.965 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.839 ' HB2' ' CD1' ' A' ' 207' ' ' TRP . . . -66.92 59.25 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 0.0 110.113 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.484 ' N ' ' O ' ' A' ' 71' ' ' VAL . 12.5 mt-30 -53.38 -92.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.181 -0.949 . . . . 0.0 110.378 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.496 ' HB3' ' HB3' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -143.71 27.86 1.48 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.93 . . . . 0.0 110.367 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.462 ' CG2' ' OE1' ' A' ' 30' ' ' GLU . 1.4 m -103.5 -134.19 0.32 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.19 -0.944 . . . . 0.0 109.761 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.48 ' O ' ' CG ' ' A' ' 56' ' ' ASN . 22.8 t70 -140.67 113.14 8.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 110.363 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.536 ' O ' ' NH2' ' A' ' 44' ' ' ARG . . . -51.44 -90.96 0.01 OUTLIER Glycine 0 N--CA 1.488 2.105 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 178.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.993 ' CG1' ' HB3' ' A' ' 205' ' ' ALA . 0.1 OUTLIER -132.29 134.68 59.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.296 -1.12 . . . . 0.0 109.181 178.405 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.769 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 45.1 ttp180 -146.13 161.99 38.95 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.813 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.742 ' HA2' ' HB2' ' A' ' 52' ' ' ASP . . . -152.94 117.04 0.78 Allowed Glycine 0 N--CA 1.495 2.62 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.505 ' HG3' ' HB3' ' A' ' 202' ' ' SER . 2.5 ttmp? -155.75 -117.26 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.959 -1.318 . . . . 0.0 111.262 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.677 ' HD3' ' H ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -48.53 -17.19 0.14 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.336 -0.853 . . . . 0.0 111.481 -179.131 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.677 ' H ' ' HD3' ' A' ' 82' ' ' ARG . . . -77.5 36.24 1.58 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.45 ' OH ' ' NE1' ' A' ' 91' ' ' TRP . 0.6 OUTLIER -111.49 156.61 21.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.105 -1.233 . . . . 0.0 110.405 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.29 177.83 5.08 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.443 -0.786 . . . . 0.0 110.667 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.557 ' HA ' ' CB ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -99.45 -173.47 2.48 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.394 -0.816 . . . . 0.0 110.024 -179.669 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.48 160.65 28.04 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.647 ' O ' HD23 ' A' ' 88' ' ' LEU . 7.8 tt -87.66 114.22 24.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.172 -1.193 . . . . 0.0 110.479 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -147.41 173.22 12.84 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.378 -0.826 . . . . 0.0 109.935 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.562 ' O ' ' O ' ' A' ' 217' ' ' MET . . . -151.63 148.85 28.46 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.149 -0.969 . . . . 0.0 109.79 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.896 ' CZ3' HG11 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -134.75 161.33 35.48 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.846 -1.159 . . . . 0.0 110.216 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.802 ' C ' HD12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -109.47 124.84 51.72 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.515 179.642 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.802 HD12 ' C ' ' A' ' 92' ' ' GLU . 1.6 mp -126.14 154.31 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.14 -0.975 . . . . 0.0 110.385 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.699 ' O ' HG23 ' A' ' 212' ' ' VAL . 0.0 OUTLIER -135.52 119.85 17.89 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.541 -0.724 . . . . 0.0 109.415 179.667 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 1.029 ' CE3' HG21 ' A' ' 212' ' ' VAL . 2.3 t-105 -128.61 89.14 50.21 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.106 -0.997 . . . . 0.0 110.87 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.601 ' HG2' ' HB3' ' A' ' 211' ' ' GLN . 50.5 Cg_endo -88.06 115.09 0.91 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.097 1.578 . . . . 0.0 110.277 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.64 ' HB3' HG22 ' A' ' 162' ' ' VAL . 0.1 OUTLIER -95.08 -6.48 41.93 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.049 -1.032 . . . . 0.0 110.311 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -65.78 -8.75 23.09 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.152 -0.968 . . . . 0.0 110.24 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.429 ' C ' ' HG2' ' A' ' 100' ' ' ARG . 18.5 mm-40 -87.93 -102.7 0.08 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -0.886 . . . . 0.0 110.259 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.429 ' HG2' ' C ' ' A' ' 99' ' ' GLN . 17.7 mmm180 -134.83 -126.76 0.16 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.065 -1.022 . . . . 0.0 110.172 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.498 ' HA3' ' HB3' ' A' ' 210' ' ' CYS . . . 65.24 112.59 0.01 OUTLIER Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.85 -62.7 1.61 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.312 -1.111 . . . . 0.0 110.223 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.533 ' HB2' ' CG2' ' A' ' 206' ' ' VAL . 10.4 m170 -98.32 173.71 6.85 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.308 -0.87 . . . . 0.0 110.439 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.907 ' HB1' ' HE1' ' A' ' 95' ' ' TRP . . . 179.85 133.32 0.1 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.318 -0.864 . . . . 0.0 110.035 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.797 HG13 ' O ' ' A' ' 204' ' ' SER . 0.1 OUTLIER -135.19 134.91 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.962 -1.086 . . . . 0.0 111.88 -179.125 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.674 HG22 ' CD2' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -151.53 118.82 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.555 -0.715 . . . . 0.0 109.521 178.286 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 132' ' ' GLY . . . 161.62 -154.34 25.3 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 118.887 -1.625 . . . . 0.0 110.725 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.88 HG13 ' C ' ' A' ' 200' ' ' TYR . 58.2 t -138.77 157.92 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.687 -0.89 . . . . 0.0 109.785 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.547 ' O ' ' N ' ' A' ' 200' ' ' TYR . . . -133.93 153.38 51.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.043 -1.036 . . . . 0.0 110.436 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . 1.073 HG23 ' HB3' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -101.08 128.28 47.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.234 -0.917 . . . . 0.0 109.817 179.618 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.21 -27.76 17.46 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.509 -0.744 . . . . 0.0 109.588 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.444 ' O ' ' C ' ' A' ' 113' ' ' ALA . 0.8 OUTLIER -81.7 -12.54 58.6 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.411 -0.806 . . . . 0.0 109.57 179.312 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.554 ' CB ' ' HB2' ' A' ' 129' ' ' GLU . . . -40.87 150.44 0.29 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.515 -0.741 . . . . 0.0 110.263 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -73.17 -81.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.003 1.528 . . . . 0.0 110.593 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.481 ' HG ' ' HA ' ' A' ' 127' ' ' ASN . 0.4 OUTLIER 179.82 63.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.161 -0.962 . . . . 0.0 110.15 179.899 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 115' ' ' LEU . 28.3 tp60 -39.14 -39.25 0.57 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.307 -0.87 . . . . 0.0 110.266 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.552 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -41.8 160.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.367 -0.833 . . . . 0.0 110.128 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.552 ' C ' ' O ' ' A' ' 117' ' ' ALA . 21.9 t70 -30.53 -89.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.474 -0.766 . . . . 0.0 110.774 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -168.79 -52.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.212 -0.93 . . . . 0.0 110.169 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.5 93.75 2.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.313 -0.867 . . . . 0.0 110.2 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.428 ' HB1' ' HA3' ' A' ' 125' ' ' GLY . . . -130.85 67.52 1.5 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.155 -0.966 . . . . 0.0 110.197 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 123' ' ' LEU . . . -100.22 135.52 41.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 0.0 110.213 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER 60.87 102.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.25 -0.906 . . . . 0.0 110.216 179.919 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 124' ' ' LEU . 0.4 OUTLIER 62.66 47.83 4.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.311 -0.868 . . . . 0.0 110.26 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.428 ' HA3' ' HB1' ' A' ' 121' ' ' ALA . . . -100.52 -124.88 5.41 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.1 m -148.38 62.72 1.09 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -1.164 . . . . 0.0 110.193 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.481 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 2.4 t-20 -77.33 -6.52 53.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -0.895 . . . . 0.0 110.169 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 33.3 t -102.72 171.02 7.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.303 -0.873 . . . . 0.0 110.228 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.554 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . 0.3 OUTLIER -150.0 129.9 13.38 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 110.107 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.54 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 47.8 t -120.36 119.94 34.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.332 -0.855 . . . . 0.0 110.181 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' TRP . . . . . 0.48 ' O ' ' O ' ' A' ' 108' ' ' VAL . 0.8 OUTLIER -129.69 124.74 34.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.374 -0.829 . . . . 0.0 109.906 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 107' ' ' GLY . . . 174.92 -133.23 2.4 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.701 ' CE3' HG11 ' A' ' 163' ' ' VAL . 54.8 m0 -110.68 113.65 26.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.122 -1.223 . . . . 0.0 110.694 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.469 ' C ' HD13 ' A' ' 135' ' ' ILE . 6.0 t0 -117.97 134.84 54.58 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.741 -0.599 . . . . 0.0 110.263 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.824 HD13 ' N ' ' A' ' 135' ' ' ILE . 0.1 OUTLIER -141.64 7.5 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.275 -0.891 . . . . 0.0 110.308 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -101.23 -48.37 1.45 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.74 6.31 36.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.355 -1.085 . . . . 0.0 109.67 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -118.08 -12.98 7.32 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.759 ' HE3' HG23 ' A' ' 162' ' ' VAL . 7.1 tptm -67.29 -140.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -1.103 . . . . 0.0 110.512 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.673 ' C ' ' O ' ' A' ' 139' ' ' LYS . 0.7 OUTLIER 0.39 74.03 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.328 0.585 . . . . 0.0 111.306 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.543 ' N ' ' O ' ' A' ' 139' ' ' LYS . 20.8 t80 -154.64 101.22 2.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.358 -0.838 . . . . 0.0 110.144 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -153.38 86.35 1.22 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.168 -0.957 . . . . 0.0 110.22 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -104.38 -67.4 0.9 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.269 -0.894 . . . . 0.0 110.241 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.97 124.53 49.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.18 -0.95 . . . . 0.0 110.177 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.28 -173.76 4.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.936 . . . . 0.0 110.235 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 75.38 49.86 8.88 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.9 tt -151.76 83.41 1.28 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -1.104 . . . . 0.0 110.22 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 149' ' ' ALA . 36.1 tt0 179.83 140.34 0.13 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.28 -0.887 . . . . 0.0 110.178 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 148' ' ' GLU . . . -177.08 79.29 0.25 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.197 -0.939 . . . . 0.0 110.421 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.415 ' HB3' ' HA3' ' A' ' 155' ' ' GLY . 47.4 Cg_endo -74.57 52.51 2.9 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.027 1.541 . . . . 0.0 110.46 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.48 -90.37 0.08 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.232 -0.917 . . . . 0.0 110.26 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.568 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 3.1 m-85 -76.68 -60.26 0.88 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.247 -0.908 . . . . 0.0 110.259 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.568 ' CD ' ' CB ' ' A' ' 152' ' ' TYR . 46.7 Cg_endo -72.67 169.92 20.75 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.983 1.518 . . . . 0.0 110.41 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 155' ' ' GLY . . . -80.54 104.75 11.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.26 -0.9 . . . . 0.0 110.295 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 154' ' ' ALA . . . -43.61 136.6 4.73 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.423 ' HG2' ' OE1' ' A' ' 157' ' ' GLN . 47.1 Cg_endo -73.54 -17.59 23.4 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.909 1.478 . . . . 0.0 110.344 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.52 ' HA ' ' HB2' ' A' ' 160' ' ' GLN . 3.2 mp0 -68.6 -0.76 5.54 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.256 -0.903 . . . . 0.0 110.685 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -46.06 -43.94 13.64 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -89.34 6.54 40.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -1.15 . . . . 0.0 110.207 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.52 ' HB2' ' HA ' ' A' ' 157' ' ' GLN . 0.0 OUTLIER -89.85 0.56 56.97 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.428 -0.795 . . . . 0.0 110.144 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.692 ' O ' ' C ' ' A' ' 162' ' ' VAL . 1.1 mt -127.31 71.41 1.33 Allowed 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.209 -0.932 . . . . 0.0 110.086 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.759 HG23 ' HE3' ' A' ' 139' ' ' LYS . 2.5 t 1.0 92.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 121.557 0.694 . . . . 0.0 110.926 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.878 HG13 ' HD2' ' A' ' 164' ' ' PRO . 53.8 t -35.52 153.0 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.904 -0.498 . . . . 0.0 110.081 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.878 ' HD2' HG13 ' A' ' 163' ' ' VAL . 38.1 Cg_endo -64.48 134.15 40.25 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.808 1.425 . . . . 0.0 110.771 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.563 ' CB ' ' HB3' ' A' ' 96' ' ' PRO . 24.4 pt-20 -41.23 -25.22 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.604 -0.685 . . . . 0.0 111.317 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 164' ' ' PRO . 0.0 OUTLIER -116.08 138.38 51.29 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.944 -1.097 . . . . 0.0 110.698 -179.388 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.956 HD13 ' CE1' ' A' ' 180' ' ' TYR . 2.5 pp -158.9 154.64 26.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.615 -0.678 . . . . 0.0 109.924 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' A' ' 181' ' ' SER . 18.0 tp -112.78 141.08 47.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.116 -0.99 . . . . 0.0 110.128 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.896 HG11 ' CZ3' ' A' ' 91' ' ' TRP . 6.5 t -124.06 136.3 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.147 -0.97 . . . . 0.0 110.486 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.737 HG12 HD23 ' A' ' 187' ' ' LEU . 9.8 p -115.3 121.4 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.449 -0.782 . . . . 0.0 109.377 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.767 HD12 ' HG3' ' A' ' 201' ' ' PRO . 0.0 OUTLIER -127.16 107.82 10.36 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.042 -1.036 . . . . 0.0 110.104 -179.512 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -120.01 129.49 54.28 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.876 0.846 . . . . 0.0 109.903 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.557 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -98.77 -39.46 8.62 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.576 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 173' ' ' MET . 0.1 OUTLIER -46.37 -26.47 0.84 Allowed 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.439 -0.905 . . . . 0.0 108.698 178.999 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.545 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 3.3 tt0 -110.16 -27.43 9.14 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 198' ' ' THR . . . 84.15 23.36 52.11 Favored Glycine 0 N--CA 1.483 1.77 0 N-CA-C 108.756 -1.738 . . . . 0.0 108.756 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.923 HG22 HD22 ' A' ' 194' ' ' LEU . 0.1 OUTLIER -118.46 116.96 27.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.166 -1.197 . . . . 0.0 111.402 -179.55 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.812 ' N ' HD12 ' A' ' 178' ' ' LEU . 3.3 mp -130.6 153.71 48.62 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.421 -0.799 . . . . 0.0 109.501 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.999 ' C ' HD21 ' A' ' 187' ' ' LEU . . . -161.93 166.96 36.45 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.14 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.956 ' CE1' HD13 ' A' ' 167' ' ' LEU . 1.1 t80 -125.01 118.28 25.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.439 -1.036 . . . . 0.0 109.85 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.704 ' HB2' HD13 ' A' ' 187' ' ' LEU . 0.6 OUTLIER -145.15 165.25 28.86 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.334 -0.854 . . . . 0.0 110.072 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.642 HG21 ' HG2' ' A' ' 164' ' ' PRO . 0.0 OUTLIER -110.18 116.6 52.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 O-C-N 121.501 -0.749 . . . . 0.0 109.543 179.195 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 79.6 -1.72 76.27 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 87.9 39.99 6.82 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' THR . . . . . 0.503 HG22 ' N ' ' A' ' 186' ' ' TYR . 32.1 m -94.38 -86.84 0.27 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.214 -1.168 . . . . 0.0 110.65 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.592 ' CE2' HD11 ' A' ' 182' ' ' ILE . 22.5 m-85 -40.15 -40.74 1.15 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.263 -0.898 . . . . 0.0 110.78 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.999 HD21 ' C ' ' A' ' 179' ' ' GLY . 5.8 mp -80.56 47.2 0.92 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.08 -1.013 . . . . 0.0 109.948 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -108.72 -82.15 1.38 Allowed Glycine 0 N--CA 1.491 2.3 0 C-N-CA 119.853 -1.165 . . . . 0.0 110.326 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.98 -28.39 16.28 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.926 1.488 . . . . 0.0 111.081 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.613 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -72.67 20.71 0.07 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.27 -0.894 . . . . 0.0 111.363 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -90.2 -13.55 35.29 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.928 -1.107 . . . . 0.0 110.325 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.489 ' HA ' ' NE ' ' A' ' 192' ' ' ARG . 0.1 OUTLIER -90.28 -14.69 32.74 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.317 -0.865 . . . . 0.0 110.563 -179.76 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 197' ' ' ARG . . . -111.28 -18.91 7.84 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.923 HD22 HG22 ' A' ' 177' ' ' THR . 6.2 tt -61.95 -33.72 74.81 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.799 -0.824 . . . . 0.0 108.818 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.667 ' HA ' HG23 ' A' ' 177' ' ' THR . 0.0 OUTLIER -45.59 -29.84 1.32 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.553 -0.717 . . . . 0.0 109.529 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -115.59 -21.16 5.18 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.783 ' O ' HD23 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.99 -9.24 46.72 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.661 -0.905 . . . . 0.0 109.666 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.683 ' HB ' HD23 ' A' ' 194' ' ' LEU . 0.0 OUTLIER -43.5 148.95 0.29 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.015 0.912 . . . . 0.0 111.961 -177.785 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 1.073 ' HB3' HG23 ' A' ' 110' ' ' THR . 0.1 OUTLIER -140.59 169.81 16.96 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.511 179.519 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.88 ' C ' HG13 ' A' ' 108' ' ' VAL . 19.0 m-85 -84.75 129.92 54.96 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.017 -1.052 . . . . 0.0 109.499 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.844 ' HA ' HG22 ' A' ' 108' ' ' VAL . 41.4 Cg_endo -67.87 125.13 12.71 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.805 1.424 . . . . 0.0 110.407 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.581 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 57.5 p -133.29 152.27 51.92 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.253 -0.904 . . . . 0.0 111.195 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.619 HG23 ' HA ' ' A' ' 106' ' ' VAL . 4.0 p -158.93 160.6 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.648 -0.657 . . . . 0.0 109.532 179.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' SER . . . . . 0.797 ' O ' HG13 ' A' ' 105' ' ' VAL . 0.3 OUTLIER -160.38 130.32 5.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.307 -0.87 . . . . 0.0 110.319 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.993 ' HB3' ' CG1' ' A' ' 78' ' ' VAL . . . -108.74 150.53 27.46 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.031 -1.043 . . . . 0.0 110.398 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.533 ' CG2' ' HB2' ' A' ' 103' ' ' HIS . 1.2 t -91.19 159.97 2.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.542 0.687 . . . . 0.0 110.712 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 0.839 ' CD1' ' HB2' ' A' ' 72' ' ' ALA . 16.7 p-90 -82.54 46.61 1.08 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.286 -0.884 . . . . 0.0 109.646 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.46 ' H ' HG12 ' A' ' 206' ' ' VAL . . . -108.88 -128.95 5.8 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.791 ' O ' ' O ' ' A' ' 210' ' ' CYS . 1.0 OUTLIER -127.51 -22.59 3.62 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.357 -1.084 . . . . 0.0 110.548 -179.538 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 210' ' ' CYS . . . . . 0.791 ' O ' ' O ' ' A' ' 209' ' ' GLN . 31.4 p 1.6 -133.42 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.032 0.444 . . . . 0.0 111.875 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.601 ' HB3' ' HG2' ' A' ' 96' ' ' PRO . 0.0 OUTLIER 178.88 33.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.847 -1.158 . . . . 0.0 110.808 -179.595 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 1.029 HG21 ' CE3' ' A' ' 95' ' ' TRP . 2.5 p -86.63 124.96 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.032 -1.042 . . . . 0.0 110.267 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.575 ' HA ' HD21 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -96.97 170.51 9.1 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.624 -0.672 . . . . 0.0 110.868 -179.3 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.829 ' CD1' ' HB3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -132.25 122.37 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.244 -0.91 . . . . 0.0 110.612 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.591 ' HB3' ' CB ' ' A' ' 92' ' ' GLU . 0.5 OUTLIER -130.63 140.15 50.4 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.563 -0.711 . . . . 0.0 109.96 179.464 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 216' ' ' TYR . . . . . 0.568 ' HA ' ' HB3' ' A' ' 91' ' ' TRP . 8.2 t80 -118.93 150.92 39.08 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.257 -0.902 . . . . 0.0 110.924 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' MET . . . . . 0.562 ' O ' ' O ' ' A' ' 90' ' ' ALA . 9.0 tpp -134.99 108.01 7.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.933 . . . . 0.0 110.244 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 128.44 -9.48 6.53 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.485 ' HB2' ' CD1' ' A' ' 216' ' ' TYR . 3.9 mm-40 -95.49 117.76 30.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.203 -1.175 . . . . 0.0 110.044 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -105.04 176.74 5.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.29 -0.881 . . . . 0.0 110.312 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' ARG . . . . . 0.518 ' O ' ' C ' ' A' ' 222' ' ' VAL . 0.0 OUTLIER -123.85 83.28 2.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 0.0 110.054 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.518 ' C ' ' O ' ' A' ' 221' ' ' ARG . 8.5 p -33.21 144.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.493 -0.755 . . . . 0.0 110.593 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.657 ' O ' ' C ' ' A' ' 224' ' ' GLU . 30.6 mm-40 -73.24 52.42 0.35 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.195 -0.941 . . . . 0.0 110.333 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.657 ' C ' ' O ' ' A' ' 223' ' ' GLU . 1.1 tt0 0.77 70.35 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.329 0.585 . . . . 0.0 111.395 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.929 ' CG2' HD13 ' A' ' 228' ' ' ILE . 15.6 m -170.11 96.94 0.28 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.548 -0.72 . . . . 0.0 110.097 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.734 ' O ' HG23 ' A' ' 228' ' ' ILE . 3.1 tpp180 -43.7 167.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.32 -0.863 . . . . 0.0 110.118 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -43.08 138.09 2.25 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.16 -0.962 . . . . 0.0 110.199 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.929 HD13 ' CG2' ' A' ' 225' ' ' THR . 4.9 pt -142.13 129.34 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 110.166 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.452 ' CD2' ' H ' ' A' ' 229' ' ' HIS . 21.9 p80 -66.35 -25.45 66.81 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.267 -0.896 . . . . 0.0 110.202 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' ARG . . . . . 0.676 ' O ' ' C ' ' A' ' 231' ' ' ASP . 0.0 OUTLIER 179.8 -35.01 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.161 -0.962 . . . . 0.0 110.184 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.676 ' C ' ' O ' ' A' ' 230' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 117.961 -1.019 . . . . 0.0 111.437 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 50.06 -175.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.254 -1.145 . . . . 0.0 110.207 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.2 m -105.68 -147.29 0.4 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.912 . . . . 0.0 110.163 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -164.58 128.05 2.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.229 -0.919 . . . . 0.0 110.235 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.462 ' O ' ' CG ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -97.54 72.61 2.35 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.904 . . . . 0.0 110.201 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -148.6 -152.43 0.44 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.331 -0.855 . . . . 0.0 110.236 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.49 30.28 1.03 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.372 -0.83 . . . . 0.0 110.179 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.557 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -63.34 -54.87 40.75 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.0 110.27 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 13' ' ' THR . 46.1 Cg_endo -73.04 -158.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.981 1.516 . . . . 0.0 110.452 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.425 ' C ' ' O ' ' A' ' 14' ' ' PRO . 15.0 t -41.03 151.18 0.07 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.292 -0.88 . . . . 0.0 110.292 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.13 170.79 0.06 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -0.922 . . . . 0.0 110.299 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -106.5 -45.84 4.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 0.0 110.324 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -170.83 105.03 0.25 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 0.0 110.383 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.91 -162.58 0.87 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.209 -0.932 . . . . 0.0 110.287 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.1 m-30 -77.29 -160.43 0.17 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.161 -0.962 . . . . 0.0 110.138 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.0 t -149.03 155.4 40.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 0.0 110.252 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -176.14 40.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.89 . . . . 0.0 110.176 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -104.84 -73.38 0.68 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -0.891 . . . . 0.0 110.245 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -125.13 164.53 31.24 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.335 -0.853 . . . . 0.0 110.228 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.99 113.29 3.73 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.01 1.532 . . . . 0.0 110.429 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.681 ' O ' ' C ' ' A' ' 27' ' ' GLU . 46.5 Cg_endo -72.95 -168.95 0.45 Allowed 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 124.01 1.532 . . . . 0.0 110.348 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.681 ' C ' ' O ' ' A' ' 26' ' ' PRO . 27.9 tt0 1.23 68.49 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.585 0.707 . . . . 0.0 111.062 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.642 ' N ' ' O ' ' A' ' 26' ' ' PRO . . . 169.04 -21.26 0.08 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.587 ' HG ' ' N ' ' A' ' 30' ' ' GLU . 0.9 OUTLIER -42.48 -24.86 0.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.16 -1.2 . . . . 0.0 110.122 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.668 ' HA ' HD23 ' A' ' 33' ' ' LEU . 19.1 pt-20 -47.99 -29.78 3.75 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.095 -1.003 . . . . 0.0 108.538 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -64.59 -23.95 67.43 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.543 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -82.68 -37.25 25.07 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.826 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.801 HD12 ' C ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -71.39 -38.28 71.49 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.823 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.672 ' O ' ' O ' ' A' ' 35' ' ' ALA . 1.8 m -78.45 -7.08 57.01 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.252 0.548 . . . . 0.0 110.007 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 1.039 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -49.43 -153.73 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.689 -0.632 . . . . 0.0 110.645 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 1.039 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 38.1 Cg_endo -65.3 -170.74 0.17 Allowed 'Trans proline' 0 N--CA 1.488 1.177 0 O-C-N 122.734 0.86 . . . . 0.0 110.349 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.758 ' O ' ' HB2' ' A' ' 42' ' ' ALA . 52.0 Cg_endo -97.17 50.2 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.525 1.483 . . . . 0.0 113.413 -178.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.781 ' HD2' ' O ' ' A' ' 36' ' ' PRO . 46.7 Cg_endo -73.07 150.67 48.66 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 N-CA-C 108.671 -1.319 . . . . 0.0 108.671 178.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.644 ' C ' ' O ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -21.32 -52.93 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.108 -0.995 . . . . 0.0 111.23 -179.171 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.048 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -54.38 -45.97 72.95 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 120.786 -1.196 . . . . 0.0 110.096 -179.344 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.751 ' CG2' HD13 ' A' ' 40' ' ' LEU . 6.2 t -86.99 -33.6 7.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 O-C-N 121.021 -1.049 . . . . 0.0 110.29 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.758 ' HB2' ' O ' ' A' ' 37' ' ' PRO . . . -90.91 -39.54 12.23 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.003 -1.06 . . . . 0.0 112.435 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.816 ' OE1' ' HA ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -83.0 -20.07 35.79 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.936 -1.102 . . . . 0.0 109.988 -178.832 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.752 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -80.45 -46.67 15.53 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.242 -0.911 . . . . 0.0 109.371 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.834 ' CE1' ' HG3' ' A' ' 50' ' ' PRO . 0.4 OUTLIER -54.86 -16.9 2.99 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.645 179.746 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.57 ' CG ' ' OE1' ' A' ' 61' ' ' GLU . 6.0 t60 -95.46 -35.06 11.85 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.079 -1.048 . . . . 0.0 109.271 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.48 ' HA2' ' OE2' ' A' ' 61' ' ' GLU . . . -93.53 -107.01 1.85 Allowed Glycine 0 N--CA 1.488 2.128 0 N-CA-C 107.116 -2.394 . . . . 0.0 107.116 178.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.931 ' HH2' HG12 ' A' ' 212' ' ' VAL . 98.9 m95 -79.83 73.57 6.58 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.001 -1.293 . . . . 0.0 108.271 177.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.618 ' HA ' ' HA ' ' A' ' 45' ' ' HIS . 0.1 OUTLIER -46.95 138.81 7.15 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.503 -0.748 . . . . 0.0 111.262 -179.357 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.834 ' HG3' ' CE1' ' A' ' 45' ' ' HIS . 39.8 Cg_endo -69.55 -27.01 27.98 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 124.387 1.73 . . . . 0.0 110.862 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.853 ' CE ' ' N ' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -63.16 -17.9 62.88 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 178.293 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.826 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 7.4 m-20 -121.12 3.25 10.43 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.223 177.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.89 ' SG ' HG12 ' A' ' 78' ' ' VAL . 2.4 t -138.56 128.29 25.01 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.949 0.88 . . . . 0.0 111.045 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.728 ' CB ' ' ND2' ' A' ' 56' ' ' ASN . 0.7 OUTLIER -70.12 118.07 12.49 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.634 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.71 ' HB3' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -51.38 -27.93 11.26 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.079 -1.013 . . . . 0.0 111.211 -179.258 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.729 ' H ' ' ND2' ' A' ' 56' ' ' ASN . 1.4 m-80 -28.29 -34.5 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.747 0.784 . . . . 0.0 110.279 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.661 ' N ' ' O ' ' A' ' 55' ' ' GLU . 15.9 pt -112.29 166.62 6.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.585 -0.697 . . . . 0.0 109.444 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.547 ' N ' ' O ' ' A' ' 67' ' ' GLU . 13.7 t70 -108.51 109.75 21.07 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.13 -0.981 . . . . 0.0 109.788 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.76 ' CG1' ' CD1' ' A' ' 48' ' ' TRP . 95.7 t -130.56 135.16 61.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 O-C-N 121.78 -0.575 . . . . 0.0 110.462 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.816 ' HA ' ' OE1' ' A' ' 43' ' ' GLN . 2.8 tttt -136.3 155.41 50.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.88 -1.138 . . . . 0.0 111.227 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.57 ' OE1' ' CG ' ' A' ' 46' ' ' HIS . 3.1 tt0 -69.07 -120.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.47 -0.769 . . . . 0.0 110.265 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.518 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 38.48 48.99 2.33 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 108.346 -1.901 . . . . 0.0 108.346 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.688 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 102.07 58.65 0.78 Allowed Glycine 0 N--CA 1.487 2.047 0 N-CA-C 107.932 -2.067 . . . . 0.0 107.932 -178.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.824 HD22 ' H ' ' A' ' 64' ' ' LEU . 2.0 mm? 0.91 82.98 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.886 -0.773 . . . . 0.0 111.105 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 3.7 t -99.76 114.65 27.92 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.514 -0.741 . . . . 0.0 109.885 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.61 ' CE1' ' CD2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -97.21 124.89 41.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.414 -0.804 . . . . 0.0 109.538 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 58' ' ' ASP . 8.3 tt0 -145.88 122.01 10.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.826 -1.171 . . . . 0.0 110.23 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.555 ' CD ' ' O ' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -122.81 142.66 50.51 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.332 -0.855 . . . . 0.0 109.674 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.675 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 44.7 mtt180 -112.91 -71.44 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.033 -1.042 . . . . 0.0 110.591 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.675 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 56.6 Cg_endo -73.6 -122.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.502 1.264 . . . . 0.0 109.184 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 t -140.05 164.09 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.5 -1.375 . . . . 0.0 109.96 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.869 ' HB1' ' HA ' ' A' ' 76' ' ' ASP . . . -62.46 88.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.226 -0.921 . . . . 0.0 110.192 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.558 ' N ' ' OD1' ' A' ' 56' ' ' ASN . 2.7 tp60 -66.79 -77.5 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.171 -0.956 . . . . 0.0 110.368 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 73' ' ' GLN . 1.9 p -50.86 -101.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.112 -0.992 . . . . 0.0 110.03 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.712 HG23 ' OG ' ' A' ' 54' ' ' SER . 7.1 t -82.93 -129.25 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.929 -1.107 . . . . 0.0 109.203 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.869 ' HA ' ' HB1' ' A' ' 72' ' ' ALA . 0.9 OUTLIER -140.9 154.39 46.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.966 -1.084 . . . . 0.0 110.802 179.555 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.644 ' O ' HG13 ' A' ' 78' ' ' VAL . . . 29.88 -89.87 0.01 OUTLIER Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.429 -1.868 . . . . 0.0 108.429 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.112 ' CG2' ' HB3' ' A' ' 205' ' ' ALA . 17.1 m -155.26 138.73 7.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 O-C-N 121.736 -0.861 . . . . 0.0 109.999 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.762 ' C ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -144.95 133.22 21.66 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.239 -0.913 . . . . 0.0 112.047 -178.454 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.826 ' CA ' ' HA ' ' A' ' 52' ' ' ASP . . . -115.43 162.68 12.41 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.236 -1.545 . . . . 0.0 109.236 178.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.436 ' HA ' ' HB2' ' A' ' 202' ' ' SER . 13.0 ttpp -160.57 -28.21 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.134 -1.215 . . . . 0.0 110.452 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.552 ' CD ' ' HB3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -82.18 -73.51 0.39 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.978 -1.076 . . . . 0.0 109.872 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.47 ' C ' ' O ' ' A' ' 82' ' ' ARG . . . 36.49 53.15 1.37 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.423 ' CD1' ' C ' ' A' ' 84' ' ' TYR . 2.1 t80 -94.55 125.29 39.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -1.137 . . . . 0.0 110.603 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.592 ' HB3' ' CD2' ' A' ' 89' ' ' HIS . 30.7 m -139.9 166.68 23.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.163 -0.961 . . . . 0.0 110.022 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.505 ' O ' ' NE2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -116.87 133.77 55.6 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.059 -1.026 . . . . 0.0 110.201 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 101.03 -114.92 5.15 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.524 ' O ' ' CD2' ' A' ' 89' ' ' HIS . 17.7 tp -128.49 132.18 48.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.359 -1.083 . . . . 0.0 110.248 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.592 ' CD2' ' HB3' ' A' ' 85' ' ' SER . 2.9 m80 -147.16 156.78 43.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.12 -0.987 . . . . 0.0 109.915 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.546 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -163.04 155.45 18.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.939 . . . . 0.0 110.074 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 1.124 ' CZ3' HG11 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -134.67 158.86 43.0 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.275 -0.891 . . . . 0.0 109.238 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.611 ' HB3' ' HB3' ' A' ' 215' ' ' ARG . 3.0 tt0 -109.81 134.11 52.4 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.876 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.989 HD13 HG13 ' A' ' 214' ' ' ILE . 8.3 mm -129.18 132.25 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.421 -0.8 . . . . 0.0 109.657 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.7 ' HB3' ' HA ' ' A' ' 166' ' ' ARG . 13.3 p -155.22 154.31 32.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.188 -0.945 . . . . 0.0 110.271 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.979 ' CZ2' ' HA ' ' A' ' 104' ' ' ALA . 14.4 m95 -123.32 86.41 51.86 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.09 -1.006 . . . . 0.0 109.8 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.595 ' CD ' ' HB2' ' A' ' 213' ' ' ARG . 52.2 Cg_endo -99.06 109.0 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 121.978 1.785 . . . . 0.0 110.634 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.633 HD11 ' NE2' ' A' ' 211' ' ' GLN . 0.2 OUTLIER -96.03 -66.05 0.93 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.883 -1.136 . . . . 0.0 109.764 179.125 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -97.63 -45.09 6.52 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.24 -0.913 . . . . 0.0 110.001 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.486 ' O ' ' HG2' ' A' ' 100' ' ' ARG . 0.5 OUTLIER 179.93 46.83 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.243 -0.911 . . . . 0.0 110.102 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.486 ' HG2' ' O ' ' A' ' 99' ' ' GLN . 1.8 mtt180 -149.71 -135.1 0.07 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.169 -0.957 . . . . 0.0 110.319 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 95' ' ' TRP . . . -165.36 178.64 40.21 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.572 ' O ' ' CD1' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -164.69 164.42 21.36 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.186 -1.185 . . . . 0.0 110.238 179.782 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.571 ' HA ' ' CG2' ' A' ' 163' ' ' VAL . 3.7 t-80 -66.46 161.08 23.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.311 -0.868 . . . . 0.0 110.426 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.979 ' HA ' ' CZ2' ' A' ' 95' ' ' TRP . . . -111.79 165.44 12.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 110.205 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.793 HG23 ' CB ' ' A' ' 204' ' ' SER . 18.4 m -101.85 116.56 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 118.459 -1.296 . . . . 0.0 107.64 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 1.122 HG13 ' O ' ' A' ' 202' ' ' SER . 36.9 t -149.23 156.26 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.14 -0.975 . . . . 0.0 110.757 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.578 ' HA2' ' HA3' ' A' ' 132' ' ' GLY . . . -149.96 150.23 22.26 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.967 ' CG1' HD13 ' A' ' 199' ' ' LEU . 2.9 t -122.38 141.88 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -1.098 . . . . 0.0 109.666 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.551 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -124.25 156.67 36.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.095 -1.003 . . . . 0.0 110.77 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.866 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -120.52 133.63 55.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.35 -0.844 . . . . 0.0 110.207 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -88.9 -25.03 22.33 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.344 -0.848 . . . . 0.0 109.335 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.6 pp -86.67 -11.96 49.77 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.516 -0.74 . . . . 0.0 109.251 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.654 ' HB2' ' HB ' ' A' ' 110' ' ' THR . . . -48.72 109.03 1.06 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.535 -0.728 . . . . 0.0 110.378 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.653 ' O ' HD12 ' A' ' 115' ' ' LEU . 46.1 Cg_endo -73.45 -155.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.032 1.543 . . . . 0.0 110.196 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.699 HD22 ' H ' ' A' ' 125' ' ' GLY . 0.2 OUTLIER -161.57 54.25 0.26 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.093 -1.004 . . . . 0.0 110.14 179.877 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.409 ' O ' ' O ' ' A' ' 117' ' ' ALA . 2.4 tt0 -101.66 -28.48 12.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.225 -0.922 . . . . 0.0 110.107 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.529 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -61.17 -148.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -0.915 . . . . 0.0 110.231 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.529 ' C ' ' O ' ' A' ' 117' ' ' ALA . 43.4 t0 -31.53 124.11 0.25 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.502 -0.749 . . . . 0.0 110.772 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.501 ' O ' ' N ' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -112.67 -79.95 0.59 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.885 . . . . 0.0 110.231 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.468 ' CB ' ' O ' ' A' ' 119' ' ' HIS . 0.1 OUTLIER 66.22 -63.95 0.23 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.352 -0.843 . . . . 0.0 110.142 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 119' ' ' HIS . . . -91.18 -158.04 0.53 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.217 -0.927 . . . . 0.0 110.183 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -167.07 29.99 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.274 -0.891 . . . . 0.0 110.184 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.08 -44.4 16.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 0.0 110.297 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.3 mt -89.49 -96.84 0.1 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.328 -0.858 . . . . 0.0 110.186 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.699 ' H ' HD22 ' A' ' 115' ' ' LEU . . . 70.01 4.54 49.19 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.94 43.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.159 -1.2 . . . . 0.0 110.21 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -128.99 -165.4 1.5 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 0.0 110.285 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.4 p -86.84 -174.32 4.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.302 -0.874 . . . . 0.0 110.171 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.435 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 0.6 OUTLIER -149.98 128.97 12.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.355 -0.841 . . . . 0.0 110.076 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 39.1 t -120.55 120.13 34.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.292 -0.88 . . . . 0.0 110.224 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' TRP . . . . . 0.465 ' O ' ' O ' ' A' ' 108' ' ' VAL . 1.5 m95 -132.82 124.87 28.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.91 . . . . 0.0 109.99 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.578 ' HA3' ' HA2' ' A' ' 107' ' ' GLY . . . -155.18 -172.13 22.52 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.626 ' O ' ' CD1' ' A' ' 133' ' ' TRP . 3.5 p90 -145.26 140.4 27.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.368 -1.077 . . . . 0.0 110.902 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 136' ' ' GLY . 0.7 OUTLIER -120.45 149.05 43.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.778 -0.576 . . . . 0.0 109.709 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.641 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -109.7 -6.75 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.966 -1.084 . . . . 0.0 110.361 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.521 ' N ' ' OD1' ' A' ' 134' ' ' ASP . . . -85.76 -40.78 7.51 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.71 4.57 49.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.279 -1.13 . . . . 0.0 109.454 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 139' ' ' LYS . . . -119.61 -5.36 11.19 Favored Glycine 0 N--CA 1.484 1.855 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 141' ' ' TYR . 1.2 tttt -59.02 -140.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.428 -1.042 . . . . 0.0 110.475 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.698 ' O ' HD12 ' A' ' 140' ' ' LEU . 1.0 OUTLIER -65.67 61.54 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.538 -0.726 . . . . 0.0 110.367 -179.872 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.522 ' N ' ' O ' ' A' ' 139' ' ' LYS . 8.1 t80 -128.29 -6.65 5.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.212 -0.93 . . . . 0.0 110.255 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -111.88 43.32 1.58 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.192 -0.942 . . . . 0.0 110.256 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.61 -40.1 50.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.284 -0.885 . . . . 0.0 110.203 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 15.0 m -61.7 -152.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.29 -0.881 . . . . 0.0 110.283 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -102.98 61.59 0.79 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.276 -0.89 . . . . 0.0 110.223 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.46 -95.26 0.07 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -172.26 60.83 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.185 -1.185 . . . . 0.0 110.268 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 149' ' ' ALA . 4.5 mm-40 -56.93 177.04 0.09 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.215 -0.928 . . . . 0.0 110.22 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.469 ' O ' ' HG2' ' A' ' 153' ' ' PRO . . . -176.9 60.1 0.17 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.285 -0.884 . . . . 0.0 110.23 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.493 ' HA ' ' N ' ' A' ' 155' ' ' GLY . 48.1 Cg_endo -73.86 1.44 7.05 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.007 1.53 . . . . 0.0 110.526 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -63.93 -92.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.171 -0.956 . . . . 0.0 110.302 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.517 ' N ' ' HD2' ' A' ' 153' ' ' PRO . 0.4 OUTLIER -78.2 -57.4 0.92 Allowed Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.307 -0.871 . . . . 0.0 110.494 -179.789 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 152' ' ' TYR . 46.3 Cg_endo -72.71 131.65 17.53 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.946 1.498 . . . . 0.0 110.569 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.491 ' O ' ' O ' ' A' ' 155' ' ' GLY . . . -45.2 104.45 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.362 -0.836 . . . . 0.0 110.359 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.493 ' N ' ' HA ' ' A' ' 150' ' ' PRO . . . -59.96 -139.99 0.01 OUTLIER Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.474 ' O ' ' OE2' ' A' ' 159' ' ' GLU . 45.2 Cg_endo -73.14 -6.48 19.02 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.926 1.487 . . . . 0.0 110.312 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.434 ' HA ' ' HB3' ' A' ' 160' ' ' GLN . 0.0 OUTLIER -68.46 -3.09 10.21 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.325 -0.86 . . . . 0.0 110.544 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -61.25 -55.04 31.55 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.589 ' HB3' ' CG2' ' A' ' 135' ' ' ILE . 0.4 OUTLIER -108.24 5.05 25.34 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.238 -1.154 . . . . 0.0 110.098 179.777 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 156' ' ' PRO . 0.0 OUTLIER -67.06 -9.87 43.81 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.444 -0.785 . . . . 0.0 109.154 179.2 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.704 ' O ' ' C ' ' A' ' 162' ' ' VAL . 0.2 OUTLIER -114.83 39.37 2.88 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.579 -0.701 . . . . 0.0 110.162 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.704 ' C ' ' O ' ' A' ' 161' ' ' LEU . 2.3 t 1.2 99.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-O 121.597 0.713 . . . . 0.0 110.402 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.9 HG11 ' HB2' ' A' ' 167' ' ' LEU . 48.0 t -33.72 151.08 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.882 -0.511 . . . . 0.0 109.927 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.854 ' HD2' HG13 ' A' ' 163' ' ' VAL . 38.0 Cg_endo -64.05 176.09 2.74 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.718 1.378 . . . . 0.0 110.572 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 164' ' ' PRO . 12.9 mt-10 -35.75 -32.18 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.503 -0.748 . . . . 0.0 110.681 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.7 ' HA ' ' HB3' ' A' ' 94' ' ' SER . 21.2 ttm180 -152.26 156.71 40.22 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.269 -0.894 . . . . 0.0 111.087 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.9 ' HB2' HG11 ' A' ' 163' ' ' VAL . 7.2 tt -126.21 157.1 39.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.584 -0.697 . . . . 0.0 109.719 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.685 ' N ' HD23 ' A' ' 167' ' ' LEU . 24.9 tp -123.6 116.61 23.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.087 -1.008 . . . . 0.0 110.739 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 1.124 HG11 ' CZ3' ' A' ' 91' ' ' TRP . 10.6 t -91.93 141.91 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.101 -0.999 . . . . 0.0 109.61 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 178' ' ' LEU . 11.4 t -118.93 124.71 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.917 . . . . 0.0 111.133 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.589 HD13 ' HG3' ' A' ' 201' ' ' PRO . 13.0 tp -133.4 105.68 7.07 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.384 -0.822 . . . . 0.0 109.346 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -115.47 139.32 50.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 110.544 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.517 ' O ' ' C ' ' A' ' 174' ' ' GLU . 0.0 OUTLIER -93.43 -41.0 10.05 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 120.174 -0.611 . . . . 0.0 109.996 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.517 ' C ' ' O ' ' A' ' 173' ' ' MET . 15.9 tt0 -39.11 -30.93 0.06 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 0.0 108.497 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.519 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 4.7 tt0 -113.2 -24.97 9.11 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.616 ' O ' ' HB ' ' A' ' 198' ' ' THR . . . 76.81 25.97 63.65 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 -179.031 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.859 HG22 ' HG ' ' A' ' 194' ' ' LEU . 2.2 p -113.14 144.45 42.64 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.346 -1.091 . . . . 0.0 110.77 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.712 ' H ' HD21 ' A' ' 194' ' ' LEU . 0.1 OUTLIER -153.03 154.04 34.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.405 -0.809 . . . . 0.0 110.169 -179.545 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.602 ' HA3' HD12 ' A' ' 187' ' ' LEU . . . -166.05 -173.17 34.23 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.712 ' CE1' HG22 ' A' ' 169' ' ' VAL . 0.7 OUTLIER -118.05 122.48 43.27 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.363 -1.08 . . . . 0.0 109.431 -179.75 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.633 ' HA ' ' CD2' ' A' ' 186' ' ' TYR . 41.9 t -144.24 142.5 30.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.288 -0.883 . . . . 0.0 110.822 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.774 HG21 ' HD2' ' A' ' 164' ' ' PRO . 0.0 OUTLIER -90.75 116.34 31.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.405 -0.809 . . . . 0.0 109.321 179.046 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 94.96 -26.03 20.83 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.608 ' CA ' HD23 ' A' ' 168' ' ' LEU . . . 102.54 42.18 2.21 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 187' ' ' LEU . 4.7 m -137.53 -54.84 0.68 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.158 -1.201 . . . . 0.0 110.444 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.729 ' HD2' HD13 ' A' ' 182' ' ' ILE . 0.1 OUTLIER -62.0 77.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.129 0.966 . . . . 0.0 109.962 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.828 HD21 ' CZ ' ' A' ' 191' ' ' PHE . 1.7 tt 179.87 24.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.48 0.657 . . . . 0.0 109.793 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.763 ' N ' ' CD ' ' A' ' 189' ' ' PRO . . . -104.94 -21.3 9.11 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.892 -1.147 . . . . 0.0 112.074 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.763 ' CD ' ' N ' ' A' ' 188' ' ' GLY . 47.5 Cg_endo -74.21 -42.76 0.64 Allowed 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 122.812 0.901 . . . . 0.0 111.386 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -90.18 10.43 24.55 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.996 -1.065 . . . . 0.0 111.004 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 1.003 ' CE1' HD23 ' A' ' 194' ' ' LEU . 1.5 m-85 -89.98 -13.3 36.42 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.13 -0.981 . . . . 0.0 109.786 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.465 ' HA ' ' NE ' ' A' ' 192' ' ' ARG . 0.0 OUTLIER -70.19 -29.23 66.05 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.158 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.533 ' O ' ' HB3' ' A' ' 197' ' ' ARG . . . -102.41 -18.76 15.61 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.111 -1.996 . . . . 0.0 108.111 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 1.003 HD23 ' CE1' ' A' ' 191' ' ' PHE . 0.9 OUTLIER -61.61 -20.32 63.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.792 -0.828 . . . . 0.0 109.454 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 195' ' ' LYS . 0.1 OUTLIER -64.32 -22.25 66.89 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.441 -0.787 . . . . 0.0 109.367 179.257 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.45 ' N ' ' HE3' ' A' ' 195' ' ' LYS . . . -125.43 -20.23 2.21 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.728 ' HD2' ' HA ' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -90.45 -4.19 57.15 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.479 -1.012 . . . . 0.0 109.267 179.661 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.616 ' HB ' ' O ' ' A' ' 176' ' ' GLY . 0.1 OUTLIER -43.19 138.54 2.18 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 122.401 1.096 . . . . 0.0 112.43 -177.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.967 HD13 ' CG1' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -141.39 172.93 12.01 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.772 179.399 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.53 ' N ' ' O ' ' A' ' 109' ' ' ALA . 8.5 m-85 -82.3 128.66 66.57 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.619 -1.301 . . . . 0.0 109.502 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.611 ' CG ' HD13 ' A' ' 178' ' ' LEU . 53.2 Cg_endo -78.44 144.79 20.53 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 124.045 1.55 . . . . 0.0 112.556 -178.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' SER . . . . . 1.122 ' O ' HG13 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -133.58 147.56 51.54 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.247 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 1.002 ' HA ' HG22 ' A' ' 106' ' ' VAL . 8.4 p -119.14 163.5 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.722 -1.236 . . . . 0.0 110.388 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' SER . . . . . 0.793 ' CB ' HG23 ' A' ' 105' ' ' VAL . 0.4 OUTLIER -155.07 134.65 12.66 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.013 0.911 . . . . 0.0 110.466 179.606 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 1.112 ' HB3' ' CG2' ' A' ' 78' ' ' VAL . . . -138.91 147.42 42.3 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.792 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.505 ' CG1' ' HB3' ' A' ' 211' ' ' GLN . 2.5 p -66.25 173.41 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.405 -0.81 . . . . 0.0 110.54 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 0.585 ' O ' ' CG ' ' A' ' 207' ' ' TRP . 33.0 p-90 -107.02 114.26 28.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.281 -0.887 . . . . 0.0 110.257 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 66' ' ' PHE . . . 172.32 174.18 39.5 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -78.38 -73.53 0.32 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -1.157 . . . . 0.0 110.436 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' CYS . . . . . 0.463 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 89.1 m -86.29 86.24 7.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.356 -0.84 . . . . 0.0 110.292 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.633 ' NE2' HD11 ' A' ' 97' ' ' LEU . 25.1 mm-40 -154.3 -49.92 0.09 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.211 -0.931 . . . . 0.0 110.365 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.931 HG12 ' HH2' ' A' ' 48' ' ' TRP . 47.9 t -127.81 143.73 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.119 -0.988 . . . . 0.0 112.033 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.595 ' HB2' ' CD ' ' A' ' 96' ' ' PRO . 15.6 tpp85 -128.9 137.79 51.63 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.989 HG13 HD13 ' A' ' 93' ' ' ILE . 3.1 tt -142.36 136.32 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.643 -1.286 . . . . 0.0 112.289 -178.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.611 ' HB3' ' HB3' ' A' ' 92' ' ' GLU . 12.7 tpt180 -130.11 109.43 10.82 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' TYR . . . . . 0.715 ' CZ ' ' CD1' ' A' ' 91' ' ' TRP . 2.1 t80 -89.0 149.59 23.19 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.055 -1.028 . . . . 0.0 111.531 -178.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 44.2 tpp -132.79 107.92 8.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.671 -0.643 . . . . 0.0 109.632 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 93.39 87.46 1.6 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 221' ' ' ARG . 0.3 OUTLIER -95.33 157.88 15.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.257 -1.143 . . . . 0.0 110.406 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 221' ' ' ARG . 27.6 ttt85 -41.27 96.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.375 -0.828 . . . . 0.0 110.245 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' ARG . . . . . 0.535 ' O ' ' C ' ' A' ' 222' ' ' VAL . 0.0 OUTLIER -177.74 115.11 0.08 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.247 -0.908 . . . . 0.0 109.985 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.535 ' C ' ' O ' ' A' ' 221' ' ' ARG . 0.5 OUTLIER -30.31 121.47 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.428 -0.795 . . . . 0.0 110.614 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.662 ' O ' ' C ' ' A' ' 224' ' ' GLU . 1.4 mt-10 -57.64 -75.68 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.228 -0.92 . . . . 0.0 110.33 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.662 ' C ' ' O ' ' A' ' 223' ' ' GLU . 19.5 mt-10 0.75 70.26 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.347 0.594 . . . . 0.0 111.317 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.614 ' N ' ' O ' ' A' ' 223' ' ' GLU . 68.6 p -45.25 93.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.52 -0.737 . . . . 0.0 110.15 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 224' ' ' GLU . 0.1 OUTLIER -146.57 -164.72 2.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -0.88 . . . . 0.0 110.331 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.412 ' O ' ' HG3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -155.55 61.03 0.61 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.927 . . . . 0.0 110.2 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.683 ' C ' HD12 ' A' ' 228' ' ' ILE . 2.2 pp -135.02 41.78 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.153 -0.967 . . . . 0.0 110.308 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.427 ' C ' ' O ' ' A' ' 228' ' ' ILE . 94.9 m-70 -42.68 -47.98 5.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.293 -0.88 . . . . 0.0 110.249 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' ARG . . . . . 0.676 ' O ' ' C ' ' A' ' 231' ' ' ASP . 6.9 ttp180 -47.88 131.57 15.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 110.273 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.676 ' C ' ' O ' ' A' ' 230' ' ' ARG . 5.9 m-20 . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 117.988 -1.006 . . . . 0.0 111.413 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 7' ' ' SER . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 6' ' ' GLY . 8.0 t 59.05 120.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -1.156 . . . . 0.0 110.211 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 9' ' ' ALA . 0.5 OUTLIER -72.39 -42.7 64.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -0.868 . . . . 0.0 110.194 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 8' ' ' SER . . . -177.15 105.94 0.06 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.351 -0.843 . . . . 0.0 110.148 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.59 85.89 2.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.315 -0.866 . . . . 0.0 110.178 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.33 115.4 3.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -0.897 . . . . 0.0 110.223 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.0 t -53.75 -88.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.193 -0.942 . . . . 0.0 110.071 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.477 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 3.0 t -170.27 53.4 0.21 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.93 . . . . 0.0 110.216 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 13' ' ' THR . 45.4 Cg_endo -72.96 149.88 47.9 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.016 1.535 . . . . 0.0 110.38 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 15' ' ' THR . 7.5 t -109.37 48.12 0.89 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.307 -0.871 . . . . 0.0 110.219 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.11 -20.59 60.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.315 -0.866 . . . . 0.0 110.166 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -97.4 -147.75 0.31 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.288 -0.883 . . . . 0.0 110.205 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -44.07 153.11 0.15 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.202 -0.936 . . . . 0.0 110.28 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.442 HD23 ' H ' ' A' ' 20' ' ' TYR . 0.2 OUTLIER -75.46 -149.36 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.257 -0.902 . . . . 0.0 110.164 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.442 ' H ' HD23 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -72.34 -158.78 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.295 -0.878 . . . . 0.0 110.055 179.826 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.8 p -69.59 105.84 2.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.198 -0.939 . . . . 0.0 110.022 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -80.31 43.79 0.65 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 110.394 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.86 -48.16 83.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.892 . . . . 0.0 110.201 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.6 147.24 45.99 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.454 -0.779 . . . . 0.0 110.114 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.0 135.5 23.26 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.007 1.53 . . . . 0.0 110.512 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.694 ' O ' ' N ' ' A' ' 28' ' ' GLY . 45.9 Cg_endo -72.44 -161.01 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 124.089 1.573 . . . . 0.0 110.456 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.656 ' C ' ' O ' ' A' ' 26' ' ' PRO . 16.1 mm-40 1.72 65.55 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.586 0.708 . . . . 0.0 110.988 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.694 ' N ' ' O ' ' A' ' 26' ' ' PRO . . . 156.16 31.24 0.03 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.782 ' H ' HD23 ' A' ' 29' ' ' LEU . 1.0 OUTLIER -74.02 -13.85 60.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -1.139 . . . . 0.0 109.796 179.826 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.938 ' HA ' HD23 ' A' ' 33' ' ' LEU . 1.6 tt0 -46.64 -26.86 1.0 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.408 -0.808 . . . . 0.0 109.159 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -74.85 -22.58 58.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.463 -0.773 . . . . 0.0 108.933 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.601 ' N ' ' O ' ' A' ' 29' ' ' LEU . 1.1 mm? -83.84 -32.17 25.4 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.062 HD11 ' HB2' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -71.11 -35.93 71.98 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 122.064 0.935 . . . . 0.0 109.139 179.299 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.65 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 3.7 t -79.71 -7.62 58.72 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.323 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 1.047 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -70.42 -70.96 0.29 Allowed Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.122 -0.986 . . . . 0.0 110.899 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 1.047 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 51.6 Cg_endo -75.39 160.92 38.37 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.495 1.261 . . . . 0.0 110.483 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 36' ' ' PRO . 53.5 Cg_endo -99.81 52.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.123 1.882 . . . . 0.0 112.113 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.685 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 48.6 Cg_endo -72.89 151.04 50.35 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.125 1.066 . . . . 0.0 110.703 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.744 ' OD2' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -15.2 -65.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.757 -0.59 . . . . 0.0 111.786 179.282 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.098 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -45.28 -43.71 10.79 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.413 -0.804 . . . . 0.0 110.412 -179.434 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.827 ' CG2' HD13 ' A' ' 40' ' ' LEU . 3.8 t -85.08 -19.33 8.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 O-C-N 121.168 -0.958 . . . . 0.0 111.185 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.52 -44.12 10.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.89 -1.132 . . . . 0.0 112.339 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.744 ' NE2' ' OD2' ' A' ' 39' ' ' ASP . 1.8 mt-30 -85.39 -19.48 31.32 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 118.385 -1.326 . . . . 0.0 109.425 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.686 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -69.31 -41.81 76.22 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 122.165 0.983 . . . . 0.0 108.472 179.218 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.69 ' NE2' HG12 ' A' ' 41' ' ' VAL . 0.8 OUTLIER -63.74 -28.82 70.15 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.748 -179.825 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -96.35 -29.64 13.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.874 -1.141 . . . . 0.0 109.608 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.09 -89.83 1.47 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 107.339 -2.304 . . . . 0.0 107.339 178.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.77 ' HH2' HG12 ' A' ' 212' ' ' VAL . 97.4 m95 -90.77 74.37 6.59 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.58 ' ND2' ' N ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -43.26 137.94 2.74 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.527 -0.733 . . . . 0.0 111.428 -179.045 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.705 ' HA ' ' O ' ' A' ' 53' ' ' CYS . 40.0 Cg_endo -67.67 -23.31 42.65 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 124.435 1.755 . . . . 0.0 111.168 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.835 ' CE ' ' N ' ' A' ' 51' ' ' LYS . 0.6 OUTLIER -65.29 -15.58 62.66 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 178.326 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 1.103 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 11.2 m-20 -121.97 3.15 9.95 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.162 177.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.873 ' SG ' HG12 ' A' ' 78' ' ' VAL . 9.5 t -148.0 138.08 22.7 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.507 0.67 . . . . 0.0 110.292 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.762 ' HB2' ' O ' ' A' ' 76' ' ' ASP . 1.5 m -80.29 130.68 35.37 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.175 -0.953 . . . . 0.0 109.835 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 1.062 ' HB2' HD11 ' A' ' 33' ' ' LEU . 4.3 pm0 -44.63 -24.36 0.19 Allowed 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.808 ' ND2' HG21 ' A' ' 75' ' ' THR . 0.2 OUTLIER -55.5 -4.58 0.1 Allowed 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.575 -1.328 . . . . 0.0 109.866 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.576 HG22 HG22 ' A' ' 59' ' ' VAL . 22.8 mm -111.96 157.75 12.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.477 -0.765 . . . . 0.0 110.518 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.654 ' HA ' HD23 ' A' ' 40' ' ' LEU . 35.9 t0 -118.87 105.4 11.46 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.709 0.766 . . . . 0.0 109.534 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.7 ' CG1' ' CD1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -131.08 136.12 58.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 O-C-N 121.628 -0.67 . . . . 0.0 110.919 -178.942 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.667 ' HD3' ' OD2' ' A' ' 39' ' ' ASP . 28.7 mttp -135.53 155.28 50.75 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.282 -0.886 . . . . 0.0 110.535 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.483 ' HG3' ' N ' ' A' ' 62' ' ' GLY . 7.8 pt-20 -75.82 -130.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.227 -0.921 . . . . 0.0 110.408 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.483 ' N ' ' HG3' ' A' ' 61' ' ' GLU . . . 45.73 45.12 12.99 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.661 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 108.9 60.55 0.53 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.953 HD21 ' O ' ' A' ' 214' ' ' ILE . 0.3 OUTLIER -0.32 78.98 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.878 -0.778 . . . . 0.0 111.27 -179.283 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.499 ' O ' ' SG ' ' A' ' 65' ' ' CYS . 31.9 p -99.58 114.33 27.29 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.13 -0.981 . . . . 0.0 109.647 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.7 ' CD1' ' CG1' ' A' ' 59' ' ' VAL . 1.2 t80 -90.55 124.84 35.35 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.479 -0.763 . . . . 0.0 110.211 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 4.9 tt0 -139.99 152.89 46.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.172 -0.955 . . . . 0.0 109.674 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.527 ' HG3' ' HB3' ' A' ' 207' ' ' TRP . 0.1 OUTLIER -135.93 140.25 43.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.022 -1.049 . . . . 0.0 110.83 -179.578 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.629 ' CB ' ' HD2' ' A' ' 70' ' ' PRO . 1.4 mtp85 -61.13 -173.94 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.386 -0.821 . . . . 0.0 109.208 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.629 ' HD2' ' CB ' ' A' ' 69' ' ' ARG . 50.9 Cg_endo -66.28 -138.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.591 1.311 . . . . 0.0 108.958 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.72 152.61 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.966 -1.083 . . . . 0.0 110.015 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.6 -39.95 0.13 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.161 -0.962 . . . . 0.0 110.188 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.549 ' O ' ' N ' ' A' ' 75' ' ' THR . 0.2 OUTLIER -170.14 147.12 3.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.286 -0.884 . . . . 0.0 110.145 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 73' ' ' GLN . 9.2 t -43.74 91.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 110.353 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.808 HG21 ' ND2' ' A' ' 56' ' ' ASN . 1.5 m -99.17 -129.4 0.2 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.296 -0.877 . . . . 0.0 110.053 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.762 ' O ' ' HB2' ' A' ' 54' ' ' SER . 72.5 m-20 -137.73 113.91 10.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.195 -0.94 . . . . 0.0 110.486 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.506 ' O ' ' O ' ' A' ' 76' ' ' ASP . . . -50.73 -96.16 0.01 OUTLIER Glycine 0 N--CA 1.484 1.837 0 N-CA-C 107.759 -2.136 . . . . 0.0 107.759 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.873 HG12 ' SG ' ' A' ' 53' ' ' CYS . 6.9 m -143.05 126.93 14.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.215 -1.168 . . . . 0.0 110.237 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.651 ' C ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -145.57 134.16 22.11 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.131 -0.981 . . . . 0.0 112.536 -178.615 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 1.103 ' CA ' ' HA ' ' A' ' 52' ' ' ASP . . . -133.13 161.56 24.17 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 178.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.505 ' HG3' ' HB3' ' A' ' 202' ' ' SER . 0.4 OUTLIER -169.96 24.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.237 -1.155 . . . . 0.0 110.345 -179.851 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.469 ' O ' ' CD2' ' A' ' 200' ' ' TYR . 1.1 ptt180 -91.36 -102.44 0.11 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.075 -1.016 . . . . 0.0 110.428 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.452 ' HA3' ' CG ' ' A' ' 201' ' ' PRO . . . 81.03 66.6 1.61 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -121.77 95.8 4.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -1.166 . . . . 0.0 110.361 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 173' ' ' MET . 69.7 m -140.09 155.6 46.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.207 -0.933 . . . . 0.0 110.286 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.518 ' C ' ' NE2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -118.2 135.42 54.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.207 -0.933 . . . . 0.0 109.809 179.832 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 106.45 -118.32 5.64 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.476 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 51.3 tp -128.79 123.09 31.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.408 -1.054 . . . . 0.0 110.904 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.518 ' NE2' ' C ' ' A' ' 86' ' ' ARG . 4.2 m-70 -147.2 153.17 39.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.205 -0.934 . . . . 0.0 109.758 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.54 ' C ' ' CE3' ' A' ' 91' ' ' TRP . . . -163.71 156.85 18.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.025 -1.047 . . . . 0.0 110.201 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.985 ' HB2' HD11 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -134.98 154.69 51.63 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.184 -0.948 . . . . 0.0 110.108 179.484 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.893 ' C ' HD13 ' A' ' 93' ' ' ILE . 0.5 OUTLIER -109.56 118.93 37.89 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.318 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.985 HD11 ' HB2' ' A' ' 91' ' ' TRP . 0.1 OUTLIER -132.95 133.86 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.819 -1.176 . . . . 0.0 111.491 -178.659 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.567 ' O ' ' HD3' ' A' ' 96' ' ' PRO . 0.1 OUTLIER -116.84 120.08 37.39 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.441 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 1.007 ' HZ2' ' HB3' ' A' ' 104' ' ' ALA . 6.3 t-105 -116.13 87.39 19.25 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.106 -0.997 . . . . 0.0 110.332 -178.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.608 ' HA ' ' O ' ' A' ' 101' ' ' GLY . 49.9 Cg_endo -99.24 138.66 0.32 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.257 1.972 . . . . 0.0 110.319 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.766 HD23 ' HB3' ' A' ' 103' ' ' HIS . 1.9 tm? -95.03 -67.05 0.87 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.866 -1.146 . . . . 0.0 109.405 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 99' ' ' GLN . 4.3 mt-10 -96.68 -14.57 21.99 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.437 -0.79 . . . . 0.0 109.203 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.536 ' O ' ' HG2' ' A' ' 100' ' ' ARG . 0.1 OUTLIER 179.99 -32.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.538 0.685 . . . . 0.0 109.893 179.772 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.536 ' HG2' ' O ' ' A' ' 99' ' ' GLN . 3.1 mtt180 -152.23 -43.99 0.1 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.51 -0.744 . . . . 0.0 110.469 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.608 ' O ' ' HA ' ' A' ' 96' ' ' PRO . . . -55.34 -175.04 0.13 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.973 HG23 HG21 ' A' ' 135' ' ' ILE . 0.9 OUTLIER -121.9 -154.9 0.61 Allowed 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.434 -1.039 . . . . 0.0 110.1 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.766 ' HB3' HD23 ' A' ' 97' ' ' LEU . 13.7 t-80 179.74 -50.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.199 -0.938 . . . . 0.0 110.701 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 1.007 ' HB3' ' HZ2' ' A' ' 95' ' ' TRP . . . -85.45 -109.52 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 0.0 110.859 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 204' ' ' SER . 0.1 OUTLIER -136.23 138.59 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.414 -1.429 . . . . 0.0 112.657 -178.286 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.702 HG22 ' CE3' ' A' ' 95' ' ' TRP . 1.0 OUTLIER -152.16 122.82 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.62 -0.675 . . . . 0.0 109.431 177.413 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.529 ' HA3' ' HA3' ' A' ' 132' ' ' GLY . . . 160.44 -158.56 30.0 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 118.711 -1.709 . . . . 0.0 111.097 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.645 HG12 ' HB2' ' A' ' 199' ' ' LEU . 2.3 t -120.78 169.34 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.725 -0.867 . . . . 0.0 109.717 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.539 ' C ' ' HB3' ' A' ' 199' ' ' LEU . . . -146.19 132.66 19.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.996 -1.065 . . . . 0.0 110.263 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.745 HG23 ' CG ' ' A' ' 199' ' ' LEU . 9.7 p -89.43 120.85 31.12 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.146 -0.971 . . . . 0.0 110.304 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.17 -31.55 14.74 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.638 -0.664 . . . . 0.0 109.817 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.492 HD23 ' H ' ' A' ' 112' ' ' LEU . 0.6 OUTLIER -76.91 -12.47 59.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.401 -0.812 . . . . 0.0 110.01 179.807 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.444 ' O ' ' OE1' ' A' ' 129' ' ' GLU . . . -112.83 68.46 1.05 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.376 -0.828 . . . . 0.0 110.261 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.49 ' HD3' ' C ' ' A' ' 112' ' ' LEU . 46.5 Cg_endo -72.7 -44.55 0.66 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.917 1.482 . . . . 0.0 110.362 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.672 ' O ' HD12 ' A' ' 115' ' ' LEU . 1.2 pp -179.88 53.14 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.247 -0.908 . . . . 0.0 110.222 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -56.06 -77.28 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.205 -0.935 . . . . 0.0 110.214 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.524 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -43.58 -45.16 6.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.402 -0.811 . . . . 0.0 110.225 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.524 ' C ' ' O ' ' A' ' 117' ' ' ALA . 2.7 t70 -31.75 142.45 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.454 -0.779 . . . . 0.0 110.823 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.21 35.07 1.09 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.395 -0.816 . . . . 0.0 110.177 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.469 ' O ' ' CG ' ' A' ' 120' ' ' TYR . 1.9 p90 -167.28 131.23 1.85 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 110.203 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.638 ' O ' ' HB3' ' A' ' 122' ' ' ALA . . . 42.53 -162.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.884 . . . . 0.0 110.149 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 121' ' ' ALA . . . 64.06 77.62 0.31 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -0.87 . . . . 0.0 110.255 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.525 ' O ' HD12 ' A' ' 123' ' ' LEU . 0.9 OUTLIER -175.53 71.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.0 110.185 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.56 -69.58 0.1 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.158 -0.963 . . . . 0.0 110.276 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -132.56 2.96 5.01 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.95 49.29 0.87 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.105 -1.232 . . . . 0.0 110.27 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.447 ' ND2' ' HB3' ' A' ' 114' ' ' PRO . 6.9 t30 -95.2 78.54 3.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.898 . . . . 0.0 110.251 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -175.74 172.58 2.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 110.218 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.444 ' OE1' ' O ' ' A' ' 113' ' ' ALA . 0.9 OUTLIER -150.4 138.1 19.89 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.224 -0.923 . . . . 0.0 109.766 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 8.9 t -120.06 120.71 37.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.386 -0.821 . . . . 0.0 110.006 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' TRP . . . . . 0.465 ' O ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -132.2 133.36 44.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.882 . . . . 0.0 110.255 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.529 ' HA3' ' HA3' ' A' ' 107' ' ' GLY . . . 165.72 -120.38 0.92 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.662 ' CZ3' ' CD2' ' A' ' 180' ' ' TYR . 47.0 m0 -119.48 112.81 19.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.043 -1.269 . . . . 0.0 110.025 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.804 ' C ' HD13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -118.92 148.22 43.17 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.397 0.618 . . . . 0.0 110.685 -179.545 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.973 HG21 HG23 ' A' ' 102' ' ' THR . 0.0 OUTLIER -139.34 3.45 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.946 . . . . 0.0 110.116 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.94 -14.79 61.61 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -85.0 3.05 40.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -1.132 . . . . 0.0 109.413 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.786 ' O ' ' O ' ' A' ' 139' ' ' LYS . . . -148.57 13.25 1.19 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.786 ' O ' ' O ' ' A' ' 138' ' ' GLY . 0.4 OUTLIER 1.12 -133.51 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 121.795 0.807 . . . . 0.0 112.196 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.77 -72.12 0.09 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.449 -0.782 . . . . 0.0 110.127 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.584 ' CE2' HD21 ' A' ' 161' ' ' LEU . 0.1 OUTLIER 179.87 106.54 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 110.308 179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -93.58 -2.05 54.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 0.0 110.244 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -100.59 -75.11 0.59 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.36 -0.837 . . . . 0.0 110.323 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.24 156.53 39.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.18 -0.95 . . . . 0.0 110.242 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.437 ' O ' ' HG3' ' A' ' 145' ' ' LYS . 0.1 OUTLIER -77.98 80.93 4.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.892 . . . . 0.0 110.336 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -160.64 142.52 8.2 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 148' ' ' GLU . 1.8 tp -89.88 13.51 14.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.199 -1.177 . . . . 0.0 110.131 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.472 ' O ' ' HD3' ' A' ' 150' ' ' PRO . 0.8 OUTLIER -179.75 100.18 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.233 -0.917 . . . . 0.0 110.09 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.886 ' CB ' ' HB3' ' A' ' 154' ' ' ALA . . . -41.6 101.18 0.24 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.208 -0.933 . . . . 0.0 110.109 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 47.1 Cg_endo -74.71 -14.86 21.77 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.019 1.536 . . . . 0.0 110.42 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -91.61 -99.69 0.12 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.335 -0.853 . . . . 0.0 110.179 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.602 ' CG ' ' HD2' ' A' ' 153' ' ' PRO . 0.1 OUTLIER -73.31 -178.56 0.72 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.156 -0.965 . . . . 0.0 109.991 179.861 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.602 ' HD2' ' CG ' ' A' ' 152' ' ' TYR . 45.5 Cg_endo -72.76 110.98 3.14 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.978 1.515 . . . . 0.0 110.335 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.886 ' HB3' ' CB ' ' A' ' 149' ' ' ALA . . . -174.98 163.48 3.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.189 -0.944 . . . . 0.0 110.228 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.576 ' N ' ' CD ' ' A' ' 156' ' ' PRO . . . 49.03 47.03 32.95 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 155' ' ' GLY . 46.9 Cg_endo -74.08 -63.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.801 1.421 . . . . 0.0 110.565 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.506 ' HB3' ' HG2' ' A' ' 159' ' ' GLU . 3.3 mp0 -75.93 -0.89 23.06 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.216 -0.928 . . . . 0.0 110.425 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.497 ' O ' ' HB ' ' A' ' 162' ' ' VAL . . . 43.89 26.68 0.84 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.624 ' CB ' HG21 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -92.11 4.06 53.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -1.142 . . . . 0.0 110.277 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.19 -16.99 23.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -0.88 . . . . 0.0 108.929 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.62 ' C ' HD12 ' A' ' 161' ' ' LEU . 0.9 OUTLIER -173.96 27.7 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.562 0.696 . . . . 0.0 109.403 179.47 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.821 HG12 ' O ' ' A' ' 162' ' ' VAL . 2.4 t -155.02 84.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.587 -0.696 . . . . 0.0 110.355 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.665 ' H ' ' HD2' ' A' ' 164' ' ' PRO . 1.3 t -154.29 -58.43 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.388 -0.82 . . . . 0.0 110.272 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.665 ' HD2' ' H ' ' A' ' 163' ' ' VAL . 45.6 Cg_endo -73.29 68.6 4.19 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.74 1.389 . . . . 0.0 110.705 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.475 ' HG2' ' CB ' ' A' ' 100' ' ' ARG . 94.5 mt-10 -80.72 -81.27 0.13 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.304 -0.873 . . . . 0.0 109.116 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 1.134 ' O ' HD13 ' A' ' 167' ' ' LEU . 9.7 ttp180 -119.09 115.53 24.48 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.394 -0.816 . . . . 0.0 108.961 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 1.134 HD13 ' O ' ' A' ' 166' ' ' ARG . 0.3 OUTLIER -132.14 157.46 44.2 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 121.424 0.631 . . . . 0.0 110.474 -179.015 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.754 HD12 ' CD ' ' A' ' 92' ' ' GLU . 0.7 OUTLIER -107.42 125.82 51.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.371 -0.831 . . . . 0.0 109.736 179.401 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.716 HG22 ' CE1' ' A' ' 180' ' ' TYR . 19.3 t -89.53 132.37 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.139 -0.975 . . . . 0.0 110.062 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.577 HG13 HD21 ' A' ' 168' ' ' LEU . 0.1 OUTLIER -125.3 111.48 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.398 -0.814 . . . . 0.0 110.186 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.691 ' HB3' ' CZ2' ' A' ' 91' ' ' TRP . 2.0 tp -107.41 114.04 27.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.339 -0.851 . . . . 0.0 110.022 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.496 ' N ' HD12 ' A' ' 171' ' ' LEU . 53.1 t0 -116.22 129.85 56.5 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.268 -0.895 . . . . 0.0 110.067 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.494 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 12.4 tpp -100.85 -42.02 6.62 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 173' ' ' MET . 0.7 OUTLIER -45.87 -25.62 0.56 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.078 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.548 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.0 OUTLIER -111.59 -28.07 8.3 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.751 0.786 . . . . 0.0 108.895 179.29 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.812 ' O ' HG21 ' A' ' 198' ' ' THR . . . 85.37 22.66 50.65 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.649 ' CA ' HD22 ' A' ' 194' ' ' LEU . 0.2 OUTLIER -119.73 111.43 18.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.258 -1.142 . . . . 0.0 111.081 -179.631 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.718 HD11 ' O ' ' A' ' 199' ' ' LEU . 0.3 OUTLIER -136.01 154.34 51.1 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.251 -0.906 . . . . 0.0 110.225 179.345 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.445 ' HA2' HG21 ' A' ' 108' ' ' VAL . . . 172.49 -153.21 18.46 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.886 ' C ' HD22 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -118.79 125.21 49.09 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.192 -1.181 . . . . 0.0 109.768 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.431 ' HA ' ' HB3' ' A' ' 187' ' ' LEU . 17.0 t -116.72 124.88 50.76 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.381 -0.825 . . . . 0.0 110.171 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 1.023 HG22 HD12 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -103.7 116.71 47.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.495 -0.753 . . . . 0.0 109.645 179.889 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 49.66 22.49 4.12 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 57.26 48.43 80.27 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' THR . . . . . 0.863 HG22 ' CD1' ' A' ' 186' ' ' TYR . 69.1 m -110.48 -86.53 0.54 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.326 -1.102 . . . . 0.0 110.892 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.863 ' CD1' HG22 ' A' ' 185' ' ' THR . 8.9 m-30 -59.67 -56.57 20.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.26 -0.9 . . . . 0.0 110.809 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.886 HD22 ' C ' ' A' ' 180' ' ' TYR . 0.6 OUTLIER -76.25 43.94 0.31 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.002 -1.061 . . . . 0.0 110.12 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.489 ' H ' ' HD2' ' A' ' 189' ' ' PRO . . . -105.32 -70.47 0.78 Allowed Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.913 -1.137 . . . . 0.0 110.269 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.489 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 45.3 Cg_endo -71.5 -29.71 16.1 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.899 1.473 . . . . 0.0 111.151 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.539 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -72.74 34.17 0.07 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.339 -0.851 . . . . 0.0 111.267 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.406 ' H ' ' C ' ' A' ' 189' ' ' PRO . 0.4 OUTLIER -90.51 -43.94 9.91 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.982 -1.074 . . . . 0.0 109.884 179.351 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -16.65 61.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.32 -0.863 . . . . 0.0 110.107 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -106.23 -13.38 23.16 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.782 HD23 ' O ' ' A' ' 194' ' ' LEU . 7.2 tt -70.94 -29.92 66.08 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.589 -0.948 . . . . 0.0 109.433 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.569 ' HE3' ' N ' ' A' ' 196' ' ' GLY . 0.1 OUTLIER -53.92 -32.61 54.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.224 -0.922 . . . . 0.0 109.493 179.745 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.569 ' N ' ' HE3' ' A' ' 195' ' ' LYS . . . -94.93 -25.97 13.66 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 1.003 ' HD3' HD11 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.67 -4.76 56.53 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.764 -0.845 . . . . 0.0 109.632 179.499 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.812 HG21 ' O ' ' A' ' 176' ' ' GLY . 0.2 OUTLIER -44.01 136.96 3.51 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.76 0.79 . . . . 0.0 111.747 -178.243 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 1.003 HD11 ' HD3' ' A' ' 197' ' ' ARG . 0.0 OUTLIER -140.37 170.81 15.12 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.381 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.542 ' C ' HG13 ' A' ' 108' ' ' VAL . 3.1 m-30 -84.76 139.03 37.54 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.934 . . . . 0.0 109.752 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.452 ' CG ' ' HA3' ' A' ' 83' ' ' GLY . 40.6 Cg_endo -67.8 113.74 3.09 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.871 1.458 . . . . 0.0 110.203 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.505 ' HB3' ' HG3' ' A' ' 81' ' ' LYS . 25.1 p -133.11 152.95 51.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.296 -0.877 . . . . 0.0 110.81 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 79' ' ' ARG . 6.1 p -160.2 149.91 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.524 -0.735 . . . . 0.0 110.049 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' SER . . . . . 0.904 ' O ' ' HH2' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -139.86 126.53 20.51 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.303 -0.873 . . . . 0.0 109.134 178.887 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.559 ' HB3' ' CG2' ' A' ' 78' ' ' VAL . . . -127.81 163.5 24.25 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.746 -1.221 . . . . 0.0 111.678 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.57 HG13 ' N ' ' A' ' 207' ' ' TRP . 1.2 t -50.2 174.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.752 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 0.57 ' N ' HG13 ' A' ' 206' ' ' VAL . 79.0 m95 -51.29 -74.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.375 -0.828 . . . . 0.0 109.259 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.631 ' HA2' ' CD2' ' A' ' 66' ' ' PHE . . . 177.03 103.86 0.17 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.487 ' HB2' ' O ' ' A' ' 208' ' ' GLY . 18.6 tt0 179.68 -49.11 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.767 -0.843 . . . . 0.0 110.195 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' CYS . . . . . 0.521 ' O ' ' CG ' ' A' ' 211' ' ' GLN . 1.7 m -43.0 -96.78 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.62 -0.675 . . . . 0.0 110.658 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.577 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 0.0 OUTLIER 179.53 45.23 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.24 -0.912 . . . . 0.0 109.523 -179.603 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.77 HG12 ' HH2' ' A' ' 48' ' ' TRP . 29.2 t -86.08 138.22 19.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-O 121.558 0.694 . . . . 0.0 110.758 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.454 ' HA ' ' HZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -125.71 143.7 50.93 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.48 -0.763 . . . . 0.0 110.139 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.953 ' O ' HD21 ' A' ' 64' ' ' LEU . 1.5 tt -140.12 127.59 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.086 -1.009 . . . . 0.0 110.488 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -129.96 144.23 51.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.306 -0.871 . . . . 0.0 109.596 179.519 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 216' ' ' TYR . . . . . 0.731 ' CE2' ' CE3' ' A' ' 91' ' ' TRP . 1.2 t80 -118.62 151.37 38.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.248 -0.908 . . . . 0.0 111.318 -178.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' MET . . . . . 0.483 ' HB3' ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -127.79 107.83 10.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.469 -0.77 . . . . 0.0 109.658 179.332 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 71.75 76.51 0.59 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.57 ' HB2' ' CD2' ' A' ' 216' ' ' TYR . 32.1 tt0 -95.39 156.87 16.14 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.22 -1.164 . . . . 0.0 110.296 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.5 ' NE ' ' HA ' ' A' ' 220' ' ' ARG . 0.2 OUTLIER -110.19 -141.15 0.38 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 0.0 110.123 179.781 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 221' ' ' ARG . . . . . 0.483 ' O ' ' O ' ' A' ' 222' ' ' VAL . 4.1 tpp180 -178.18 97.75 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 110.346 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 221' ' ' ARG . 14.2 p -38.66 161.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.302 -0.874 . . . . 0.0 110.467 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.516 ' O ' ' C ' ' A' ' 224' ' ' GLU . 0.1 OUTLIER -173.4 78.49 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 110.218 179.812 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.516 ' C ' ' O ' ' A' ' 223' ' ' GLU . 1.7 mp0 -32.87 -68.12 0.11 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.49 -0.756 . . . . 0.0 110.683 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 224' ' ' GLU . 22.8 p -42.8 149.28 0.2 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 0.0 110.244 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.422 ' HD2' ' O ' ' A' ' 224' ' ' GLU . 0.0 OUTLIER -162.87 89.83 0.67 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.287 -0.883 . . . . 0.0 110.228 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -47.21 -63.09 1.13 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 110.278 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.5 mt -54.52 141.87 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.282 -0.886 . . . . 0.0 110.337 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.445 ' O ' ' C ' ' A' ' 230' ' ' ARG . 0.2 OUTLIER -115.97 123.76 48.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.921 . . . . 0.0 110.016 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 230' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 231' ' ' ASP . 11.3 mtp180 -41.44 -80.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 110.223 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 230' ' ' ARG . 6.7 t70 . . . . . 0 C--N 1.306 -1.314 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.314 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.97 -158.62 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.162 -1.199 . . . . 0.0 110.244 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.1 m 53.63 80.24 0.11 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 110.156 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 11' ' ' GLN . . . -119.21 -161.44 0.85 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.88 . . . . 0.0 110.208 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -53.56 89.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 110.307 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -179.86 102.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.337 -0.852 . . . . 0.0 110.256 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.47 101.97 1.7 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 110.179 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 11' ' ' GLN . 20.4 p -136.75 76.19 47.87 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.131 -0.981 . . . . 0.0 110.174 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.453 ' O ' ' N ' ' A' ' 16' ' ' SER . 46.4 Cg_endo -73.14 148.21 44.02 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.942 1.496 . . . . 0.0 110.456 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.56 HG23 ' O ' ' A' ' 15' ' ' THR . 9.1 t -68.64 63.81 0.11 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.201 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -153.02 167.39 29.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.143 -0.973 . . . . 0.0 110.181 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.443 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 6.6 pm0 -55.72 128.77 36.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.135 -0.978 . . . . 0.0 110.234 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 17' ' ' GLN . . . -177.52 156.42 1.17 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.201 -0.937 . . . . 0.0 110.178 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -69.81 -163.67 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 0.0 110.223 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.55 -155.08 0.59 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.353 -0.842 . . . . 0.0 110.109 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 p -83.46 103.66 12.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.251 -0.905 . . . . 0.0 110.054 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -81.8 41.22 0.64 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.912 . . . . 0.0 110.334 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.83 -73.76 0.53 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 109.973 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.8 m -78.98 115.16 50.26 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.455 -0.778 . . . . 0.0 110.133 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.72 118.36 5.54 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.963 1.507 . . . . 0.0 110.495 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.681 ' O ' ' N ' ' A' ' 28' ' ' GLY . 46.3 Cg_endo -73.14 -165.11 0.22 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.998 1.526 . . . . 0.0 110.498 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.668 ' C ' ' O ' ' A' ' 26' ' ' PRO . 10.0 mm-40 1.33 66.09 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.49 0.662 . . . . 0.0 111.059 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.681 ' N ' ' O ' ' A' ' 26' ' ' PRO . . . -153.01 -35.0 0.03 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.897 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -74.43 -40.18 62.13 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.437 -1.037 . . . . 0.0 109.918 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.61 ' HA ' HD23 ' A' ' 33' ' ' LEU . 1.4 pp20? -46.17 -37.37 6.94 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.135 -0.978 . . . . 0.0 109.165 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -57.44 -25.56 59.84 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.381 -0.825 . . . . 0.0 108.823 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 29' ' ' LEU . 5.9 tp -83.12 -32.21 26.82 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.831 HD12 ' C ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -84.94 -38.42 19.36 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 121.82 0.819 . . . . 0.0 109.237 179.164 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.565 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 1.1 t -49.23 -20.63 0.65 Allowed 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.388 0.613 . . . . 0.0 110.189 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 1.051 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -52.34 -161.37 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.516 -0.74 . . . . 0.0 109.692 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 1.051 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 39.2 Cg_endo -66.61 121.85 9.16 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 O-C-N 123.001 1.0 . . . . 0.0 109.754 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.991 ' CB ' HG21 ' A' ' 41' ' ' VAL . 44.0 Cg_endo -70.08 109.27 2.33 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.154 1.607 . . . . 0.0 111.732 -178.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.774 ' O ' ' N ' ' A' ' 40' ' ' LEU . 52.0 Cg_endo -79.74 151.62 22.01 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.238 1.652 . . . . 0.0 109.239 178.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.733 ' C ' HE22 ' A' ' 43' ' ' GLN . 0.9 OUTLIER -12.83 -51.23 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 122.167 0.984 . . . . 0.0 110.062 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.073 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -34.78 -43.23 0.17 Allowed 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.934 -179.346 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.991 HG21 ' CB ' ' A' ' 37' ' ' PRO . 2.9 t -70.87 -24.81 25.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 O-C-N 121.168 -0.957 . . . . 0.0 110.678 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.607 ' N ' ' O ' ' A' ' 39' ' ' ASP . . . -90.69 -41.54 11.24 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 118.981 -1.087 . . . . 0.0 113.104 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.733 HE22 ' C ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -87.37 -19.37 28.24 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.862 -1.149 . . . . 0.0 109.829 -179.1 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 1.034 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 7.5 ttm-85 -72.44 -53.98 10.64 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.756 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 4.0 m-70 -55.49 -27.98 51.76 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.556 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -96.07 -30.43 13.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.02 -1.05 . . . . 0.0 109.586 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.87 -74.11 1.27 Allowed Glycine 0 N--CA 1.488 2.131 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.736 ' CD2' ' CE1' ' A' ' 66' ' ' PHE . 99.2 m95 -100.36 74.09 1.71 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.618 ' HA ' ' HA ' ' A' ' 45' ' ' HIS . 0.1 OUTLIER -43.65 145.71 1.11 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.5 -0.75 . . . . 0.0 110.984 -179.419 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.756 ' HD3' ' HA ' ' A' ' 45' ' ' HIS . 42.8 Cg_endo -70.88 -31.07 16.16 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 124.297 1.682 . . . . 0.0 110.681 -178.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.932 ' O ' ' HA2' ' A' ' 80' ' ' GLY . 0.3 OUTLIER -64.17 -16.15 61.32 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.225 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.996 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 4.8 m-20 -118.72 0.28 11.43 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.638 177.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.702 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 16.0 t -150.04 132.9 16.04 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.21 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.555 ' H ' ' HA ' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -75.23 117.65 17.29 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.593 0.711 . . . . 0.0 109.688 179.186 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.646 ' O ' ' N ' ' A' ' 57' ' ' ILE . 6.7 pt-20 -42.54 -28.67 0.23 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.595 -0.69 . . . . 0.0 112.801 -178.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.984 ' ND2' HG22 ' A' ' 75' ' ' THR . 0.5 OUTLIER -40.34 -16.0 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.298 0 O-C-N 120.96 -1.087 . . . . 0.0 111.04 -179.114 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.747 HG22 HG13 ' A' ' 59' ' ' VAL . 1.2 mt -111.55 165.6 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 120.998 -1.064 . . . . 0.0 110.329 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 67' ' ' GLU . 4.2 t70 -117.54 104.27 10.9 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.76 0.791 . . . . 0.0 110.455 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.782 HG11 ' CE1' ' A' ' 66' ' ' PHE . 34.8 m -130.38 135.42 60.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 121.73 -0.606 . . . . 0.0 110.034 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.755 ' HG2' ' HA ' ' A' ' 40' ' ' LEU . 24.7 mttt -133.04 141.31 48.18 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.763 -1.211 . . . . 0.0 111.377 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.552 ' CG ' ' HB3' ' A' ' 43' ' ' GLN . 0.4 OUTLIER -59.95 -129.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.495 -0.753 . . . . 0.0 110.508 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 44.53 51.11 8.01 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 107.978 -2.049 . . . . 0.0 107.978 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.663 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 103.01 61.58 0.71 Allowed Glycine 0 N--CA 1.486 2.005 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 -178.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.036 HD11 HG22 ' A' ' 214' ' ' ILE . 0.2 OUTLIER 0.83 80.81 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.0 -0.706 . . . . 0.0 111.215 -178.737 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.426 ' N ' ' O ' ' A' ' 63' ' ' GLY . 0.5 OUTLIER -99.96 113.89 26.78 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.44 -0.788 . . . . 0.0 110.241 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.782 ' CE1' HG11 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -103.22 124.62 48.96 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.555 -0.716 . . . . 0.0 109.422 179.455 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.621 ' O ' HG23 ' A' ' 57' ' ' ILE . 1.1 tp10 -150.73 149.72 30.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.015 -1.053 . . . . 0.0 110.465 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.598 ' HG2' ' CE2' ' A' ' 207' ' ' TRP . 0.0 OUTLIER -119.54 151.74 38.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.309 -0.87 . . . . 0.0 109.969 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.637 ' CB ' ' HD3' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -94.85 -67.05 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 110.577 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.637 ' HD3' ' CB ' ' A' ' 69' ' ' ARG . 55.9 Cg_endo -73.53 -119.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.584 1.307 . . . . 0.0 109.583 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.408 ' H ' ' HB2' ' A' ' 70' ' ' PRO . 4.0 t -139.97 164.23 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.317 -1.489 . . . . 0.0 110.21 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.912 ' HB2' ' CG ' ' A' ' 207' ' ' TRP . . . -70.48 69.94 0.42 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 0.0 110.108 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -87.29 -160.26 0.58 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.276 -0.89 . . . . 0.0 110.39 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.2 m -73.25 1.22 9.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.928 . . . . 0.0 110.313 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.984 HG22 ' ND2' ' A' ' 56' ' ' ASN . 3.7 m -116.43 0.41 12.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.923 . . . . 0.0 110.104 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.558 ' CB ' ' HA ' ' A' ' 72' ' ' ALA . 0.4 OUTLIER -99.81 154.8 18.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 110.149 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.54 ' O ' ' HB2' ' A' ' 54' ' ' SER . . . 132.47 145.87 5.55 Favored Glycine 0 N--CA 1.483 1.771 0 N-CA-C 108.07 -2.012 . . . . 0.0 108.07 -179.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.105 ' CG2' ' HB3' ' A' ' 205' ' ' ALA . 4.4 m -117.27 128.61 74.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 O-C-N 121.16 -1.2 . . . . 0.0 109.846 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.635 ' C ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -145.11 134.61 23.2 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.966 -0.693 . . . . 0.0 112.521 -177.674 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.996 ' CA ' ' HA ' ' A' ' 52' ' ' ASP . . . -123.09 165.58 15.69 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 178.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 201' ' ' PRO . 0.1 OUTLIER -177.52 68.18 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.409 -1.054 . . . . 0.0 110.23 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.948 ' HD3' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -163.38 -91.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.139 -0.975 . . . . 0.0 110.783 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.948 ' N ' ' HD3' ' A' ' 82' ' ' ARG . . . 83.64 87.5 0.81 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -115.59 97.19 6.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.264 -1.139 . . . . 0.0 110.437 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.535 ' O ' ' CG ' ' A' ' 173' ' ' MET . 1.5 m -139.97 160.31 40.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.33 -0.856 . . . . 0.0 110.059 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.515 ' C ' ' NE2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -118.6 134.27 55.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.078 -1.014 . . . . 0.0 110.211 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 101.56 -115.58 5.3 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.506 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 13.2 tp -128.52 130.48 47.52 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.391 -1.064 . . . . 0.0 110.565 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.527 ' CE1' ' HB3' ' A' ' 85' ' ' SER . 4.1 m-70 -147.23 158.5 43.97 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.26 -0.9 . . . . 0.0 109.962 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -162.95 156.43 19.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.134 -0.979 . . . . 0.0 110.354 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 1.026 ' CZ2' HG21 ' A' ' 169' ' ' VAL . 5.4 p90 -143.76 170.82 15.16 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.353 -0.842 . . . . 0.0 110.01 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 215' ' ' ARG . 3.6 tt0 -145.86 157.52 43.9 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.429 -0.794 . . . . 0.0 110.932 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.914 HG22 ' OH ' ' A' ' 180' ' ' TYR . 7.0 tp -143.15 154.37 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.545 -0.722 . . . . 0.0 109.848 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.696 ' O ' ' HD3' ' A' ' 96' ' ' PRO . 0.1 OUTLIER -149.88 137.09 19.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.321 -0.862 . . . . 0.0 110.3 -179.63 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.816 ' CH2' ' HA ' ' A' ' 104' ' ' ALA . 49.7 m95 -108.93 88.3 5.37 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 121.258 -0.901 . . . . 0.0 110.655 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.696 ' HD3' ' O ' ' A' ' 94' ' ' SER . 52.3 Cg_endo -97.26 108.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.348 1.365 . . . . 0.0 110.215 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.29 -67.99 0.82 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.781 -1.2 . . . . 0.0 110.187 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.47 -27.79 13.9 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.271 -0.893 . . . . 0.0 109.637 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -179.96 -29.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.625 0.726 . . . . 0.0 109.652 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.451 ' NH1' ' HG3' ' A' ' 100' ' ' ARG . 2.5 mtt85 -115.92 -67.91 0.96 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.464 -0.773 . . . . 0.0 109.787 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.581 ' HA2' ' O ' ' A' ' 95' ' ' TRP . . . 167.52 -162.95 36.74 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 101' ' ' GLY . 8.5 t -178.63 -29.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.201 -1.176 . . . . 0.0 110.721 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.563 ' O ' ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -155.56 166.31 33.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.073 -1.017 . . . . 0.0 110.867 -179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.816 ' HA ' ' CH2' ' A' ' 95' ' ' TRP . . . 179.87 137.46 0.11 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.406 -0.809 . . . . 0.0 109.754 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.825 HG23 ' CB ' ' A' ' 204' ' ' SER . 34.2 m -131.95 115.67 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 O-C-N 120.245 -1.534 . . . . 0.0 110.357 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.685 HG22 HG23 ' A' ' 203' ' ' VAL . 76.5 t -151.15 170.21 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.67 ' CA ' ' HA3' ' A' ' 132' ' ' GLY . . . 168.75 169.22 31.89 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 118.798 -1.667 . . . . 0.0 111.251 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.112 ' CG1' HD13 ' A' ' 199' ' ' LEU . 2.2 t -121.74 159.82 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.694 -0.886 . . . . 0.0 109.321 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.557 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -140.07 143.8 36.5 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.977 -1.077 . . . . 0.0 111.401 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . 1.008 ' OG1' HD23 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -126.07 135.52 51.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.522 -0.736 . . . . 0.0 110.161 179.473 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.15 -25.35 17.9 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.445 -0.784 . . . . 0.0 109.173 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.648 HD12 ' HD3' ' A' ' 114' ' ' PRO . 2.7 pp -85.54 -12.22 52.18 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.581 -0.7 . . . . 0.0 109.356 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.555 ' HB2' ' HB ' ' A' ' 110' ' ' THR . . . -37.4 98.35 0.16 Allowed Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.57 -0.706 . . . . 0.0 110.352 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.648 ' HD3' HD12 ' A' ' 112' ' ' LEU . 46.5 Cg_endo -73.62 -168.64 0.46 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.936 1.493 . . . . 0.0 110.516 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -179.99 48.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.32 -0.862 . . . . 0.0 110.162 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 1.5 tp-100 -129.39 -70.11 0.67 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.893 . . . . 0.0 110.223 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.604 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . . . -179.99 115.48 0.05 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.415 -0.803 . . . . 0.0 110.17 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.525 ' C ' ' O ' ' A' ' 117' ' ' ALA . 19.0 t70 -31.72 -56.94 0.28 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.543 -0.723 . . . . 0.0 110.84 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.86 -57.53 4.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.879 . . . . 0.0 110.196 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.604 ' HB3' ' HB3' ' A' ' 117' ' ' ALA . 0.1 OUTLIER -70.24 96.67 1.13 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.186 -0.946 . . . . 0.0 110.155 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -111.86 87.85 2.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.308 -0.87 . . . . 0.0 110.11 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.475 ' O ' ' CB ' ' A' ' 123' ' ' LEU . . . -80.75 4.93 17.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.242 -0.911 . . . . 0.0 110.216 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.475 ' CB ' ' O ' ' A' ' 122' ' ' ALA . 0.1 OUTLIER 66.75 -68.84 0.13 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.293 -0.879 . . . . 0.0 110.251 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 122' ' ' ALA . 0.6 OUTLIER 51.42 -161.09 0.08 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.299 -0.875 . . . . 0.0 110.267 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -73.63 -161.35 6.97 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 127' ' ' ASN . 5.1 t -144.89 67.14 1.25 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.273 -1.134 . . . . 0.0 110.237 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.417 ' O ' ' O ' ' A' ' 126' ' ' SER . 1.0 OUTLIER -53.9 -171.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 110.182 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 24.5 p -123.07 160.14 26.98 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 110.234 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.408 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -150.18 134.33 17.08 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.217 -0.927 . . . . 0.0 109.821 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 14.1 t -151.4 118.61 5.94 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.301 -0.874 . . . . 0.0 110.391 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' TRP . . . . . 0.52 ' CD1' ' N ' ' A' ' 131' ' ' TRP . 2.7 p-90 -135.59 166.23 23.69 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.67 ' HA3' ' CA ' ' A' ' 107' ' ' GLY . . . 177.67 -138.26 3.75 Favored Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.773 -1.203 . . . . 0.0 110.431 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.831 ' HB3' HG11 ' A' ' 163' ' ' VAL . 53.5 m0 -104.8 113.4 26.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.365 -1.08 . . . . 0.0 110.657 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.708 ' O ' HG23 ' A' ' 135' ' ' ILE . 1.9 p30 -118.74 113.31 20.95 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.45 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.954 HD11 ' HB ' ' A' ' 163' ' ' VAL . 3.5 pt -159.74 42.51 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.171 -0.956 . . . . 0.0 110.027 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 103' ' ' HIS . . . -49.88 -59.19 7.64 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 139' ' ' LYS . 0.5 OUTLIER -100.4 5.51 44.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.213 -1.169 . . . . 0.0 110.338 -179.94 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.492 ' C ' ' O ' ' A' ' 137' ' ' ARG . . . 37.06 30.36 0.04 OUTLIER Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 137' ' ' ARG . 0.1 OUTLIER -177.12 -139.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.121 -1.223 . . . . 0.0 110.553 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.678 ' O ' ' C ' ' A' ' 141' ' ' TYR . 5.9 tp -156.07 95.68 1.64 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.719 -0.613 . . . . 0.0 110.223 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.721 ' O ' ' N ' ' A' ' 143' ' ' GLN . 2.9 t80 0.31 78.0 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.807 -0.558 . . . . 0.0 111.297 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.66 ' C ' ' O ' ' A' ' 141' ' ' TYR . 17.6 p80 1.73 63.3 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.748 0.785 . . . . 0.0 111.36 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.721 ' N ' ' O ' ' A' ' 141' ' ' TYR . 31.6 tp60 -56.5 -54.84 41.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.685 -0.635 . . . . 0.0 110.29 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 143' ' ' GLN . 30.3 t -179.98 -78.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 0.0 110.208 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -134.41 94.13 3.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.275 -0.891 . . . . 0.0 110.295 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 176.08 102.3 0.15 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.436 HD12 ' H ' ' A' ' 147' ' ' LEU . 2.7 mp -109.44 38.62 2.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -1.141 . . . . 0.0 110.124 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.91 134.34 0.1 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.273 -0.892 . . . . 0.0 110.089 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.488 ' O ' ' HD3' ' A' ' 156' ' ' PRO . . . -155.65 89.7 2.91 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.137 -0.977 . . . . 0.0 110.335 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.571 ' HA ' ' CG ' ' A' ' 156' ' ' PRO . 46.2 Cg_endo -72.8 73.63 2.96 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.935 1.492 . . . . 0.0 110.311 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -129.4 -45.44 1.22 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.242 -0.911 . . . . 0.0 110.687 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.506 ' N ' ' HD2' ' A' ' 153' ' ' PRO . 0.1 OUTLIER -175.36 -57.07 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.192 -0.943 . . . . 0.0 110.632 -179.732 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.54 ' O ' ' C ' ' A' ' 154' ' ' ALA . 45.0 Cg_endo -72.22 171.32 17.11 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.917 1.483 . . . . 0.0 110.633 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.54 ' C ' ' O ' ' A' ' 153' ' ' PRO . . . -31.14 115.98 0.15 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.559 -0.713 . . . . 0.0 110.751 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 176.23 -80.63 0.07 OUTLIER Glycine 0 N--CA 1.48 1.571 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.571 ' CG ' ' HA ' ' A' ' 150' ' ' PRO . 49.8 Cg_endo -76.92 -3.45 13.79 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.028 1.541 . . . . 0.0 110.309 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 134' ' ' ASP . 0.3 OUTLIER -48.05 -61.06 2.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.309 -0.869 . . . . 0.0 110.575 -179.699 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 103.8 85.37 1.86 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.91 5.33 1.59 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.284 -1.127 . . . . 0.0 110.771 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.23 -12.3 55.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.163 -0.961 . . . . 0.0 109.507 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.89 HD13 ' CE2' ' A' ' 186' ' ' TYR . 6.3 mt -98.58 49.4 0.98 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.501 -0.75 . . . . 0.0 109.509 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.88 HG13 ' O ' ' A' ' 162' ' ' VAL . 6.3 p 0.65 86.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.645 0.736 . . . . 0.0 111.914 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.954 ' HB ' HD11 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -96.2 -42.38 0.27 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.345 -0.847 . . . . 0.0 109.0 178.961 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.634 ' HA ' ' HB2' ' A' ' 95' ' ' TRP . 48.8 Cg_endo -82.8 62.41 7.76 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.548 1.288 . . . . 0.0 109.118 178.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.877 ' HB3' HG22 ' A' ' 162' ' ' VAL . 11.0 tp10 -173.75 -78.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.64 -0.662 . . . . 0.0 109.61 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 1.088 ' C ' HD22 ' A' ' 167' ' ' LEU . 7.7 ttt180 -151.6 132.96 14.59 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.537 -0.727 . . . . 0.0 109.645 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 1.088 HD22 ' C ' ' A' ' 166' ' ' ARG . 3.0 mm? -140.33 153.61 46.49 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.366 -0.834 . . . . 0.0 110.8 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.424 ' N ' ' HE1' ' A' ' 180' ' ' TYR . 6.2 tp -129.07 130.24 46.28 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.567 -0.708 . . . . 0.0 109.259 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 1.064 HG12 ' CE1' ' A' ' 180' ' ' TYR . 0.2 OUTLIER -127.25 144.1 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.955 -1.091 . . . . 0.0 110.262 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.584 HG11 ' HZ ' ' A' ' 191' ' ' PHE . 4.3 p -102.53 133.19 46.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.815 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.992 HD13 HD23 ' A' ' 178' ' ' LEU . 2.7 tp -124.76 105.89 9.64 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.433 -0.792 . . . . 0.0 109.824 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.514 ' OD1' ' CG ' ' A' ' 174' ' ' GLU . 5.1 t70 -119.97 134.44 55.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 110.488 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.535 ' CG ' ' O ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -98.8 -42.23 7.29 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.278 0.561 . . . . 0.0 109.63 179.491 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.514 ' CG ' ' OD1' ' A' ' 172' ' ' ASP . 7.9 pt-20 -45.01 -24.91 0.26 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.246 -0.908 . . . . 0.0 108.828 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.622 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.2 OUTLIER -112.25 -27.01 8.5 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.16 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.453 ' O ' ' CG2' ' A' ' 198' ' ' THR . . . 80.88 25.73 55.24 Favored Glycine 0 N--CA 1.483 1.787 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' THR . . . . . 1.124 HG22 ' CD2' ' A' ' 194' ' ' LEU . 0.1 OUTLIER -112.7 124.05 51.69 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.096 -1.238 . . . . 0.0 111.093 -179.434 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.992 HD23 HD13 ' A' ' 171' ' ' LEU . 2.6 mp -129.08 153.47 47.61 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.51 -0.744 . . . . 0.0 109.434 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.918 ' O ' HG23 ' A' ' 169' ' ' VAL . . . -178.9 163.67 31.5 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.2 -1.476 . . . . 0.0 110.633 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 1.064 ' CE1' HG12 ' A' ' 169' ' ' VAL . 0.1 OUTLIER -118.28 128.17 54.42 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.455 -1.026 . . . . 0.0 109.492 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.597 ' OG ' ' N ' ' A' ' 186' ' ' TYR . 5.7 t -132.34 165.15 24.86 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.662 0.744 . . . . 0.0 110.186 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.813 HG22 ' CD1' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -105.46 116.7 49.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 O-C-N 121.792 -0.568 . . . . 0.0 109.556 179.356 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 64.4 8.86 33.79 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 86.81 35.18 10.31 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' THR . . . . . 0.477 ' O ' ' C ' ' A' ' 186' ' ' TYR . 37.3 m -106.77 -65.93 1.05 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.117 -1.225 . . . . 0.0 110.71 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.89 ' CE2' HD13 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -35.98 -74.3 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.315 -0.866 . . . . 0.0 110.761 -179.618 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.84 HD11 HD12 ' A' ' 194' ' ' LEU . 2.7 mm? -67.69 46.19 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.037 -1.039 . . . . 0.0 110.081 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 186' ' ' TYR . . . -73.51 -99.05 0.08 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.536 ' C ' ' H ' ' A' ' 191' ' ' PHE . 49.2 Cg_endo -73.65 -23.99 16.34 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.109 1.583 . . . . 0.0 111.242 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.53 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -62.39 29.39 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.39 -0.819 . . . . 0.0 111.797 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.727 ' HE1' HD12 ' A' ' 187' ' ' LEU . 1.0 OUTLIER -90.54 -22.33 21.35 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.782 -1.199 . . . . 0.0 110.461 179.391 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.496 ' N ' ' HD2' ' A' ' 192' ' ' ARG . 0.0 OUTLIER -87.82 -13.02 43.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.178 -0.951 . . . . 0.0 110.443 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -108.77 -10.46 24.78 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.334 -1.906 . . . . 0.0 108.334 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 1.124 ' CD2' HG22 ' A' ' 177' ' ' THR . 7.8 tt -72.86 -41.56 64.63 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.731 -0.864 . . . . 0.0 108.808 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.503 ' HD2' ' N ' ' A' ' 196' ' ' GLY . 0.0 OUTLIER -43.92 -42.14 5.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.486 -0.759 . . . . 0.0 109.975 179.61 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.503 ' N ' ' HD2' ' A' ' 195' ' ' LYS . . . -85.32 -25.64 39.12 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.881 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.66 -3.74 57.28 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.789 -0.83 . . . . 0.0 109.911 179.835 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.734 HG23 ' O ' ' A' ' 194' ' ' LEU . 15.9 p -42.75 125.59 3.44 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.811 0.815 . . . . 0.0 111.85 -177.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 1.112 HD13 ' CG1' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -140.39 171.44 14.15 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.136 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.417 ' CD2' ' HA ' ' A' ' 82' ' ' ARG . 3.2 m-85 -84.2 129.16 59.36 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.949 -1.094 . . . . 0.0 109.97 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.559 ' HA ' HG13 ' A' ' 108' ' ' VAL . 50.7 Cg_endo -76.92 136.01 16.21 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 124.014 1.534 . . . . 0.0 111.012 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 4.7 t -133.18 140.21 47.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.449 -0.782 . . . . 0.0 109.945 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.685 HG23 HG22 ' A' ' 106' ' ' VAL . 6.0 p -120.3 153.5 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.237 -0.914 . . . . 0.0 110.153 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' SER . . . . . 0.825 ' CB ' HG23 ' A' ' 105' ' ' VAL . 6.3 t -142.39 127.39 18.41 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.27 -0.894 . . . . 0.0 110.051 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 1.105 ' HB3' ' CG2' ' A' ' 78' ' ' VAL . . . -124.88 140.36 53.0 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.455 0.645 . . . . 0.0 110.415 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.84 HG13 ' N ' ' A' ' 207' ' ' TRP . 0.3 OUTLIER -64.56 -158.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.552 -0.718 . . . . 0.0 110.672 -179.527 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 0.912 ' CG ' ' HB2' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -121.1 154.98 35.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.409 -0.807 . . . . 0.0 109.932 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.458 ' O ' ' OE1' ' A' ' 211' ' ' GLN . . . 134.23 -175.18 20.55 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.533 ' CG ' ' OE1' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -98.21 -30.04 12.86 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.207 -1.172 . . . . 0.0 110.401 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 1.6 t -116.36 81.25 1.59 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.334 -0.854 . . . . 0.0 110.468 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.458 ' OE1' ' O ' ' A' ' 208' ' ' GLY . 0.0 OUTLIER -123.68 -90.49 0.57 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.165 -0.96 . . . . 0.0 110.241 179.683 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.706 HG23 ' CG ' ' A' ' 95' ' ' TRP . 4.2 p -127.5 143.26 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.085 -1.009 . . . . 0.0 111.276 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.564 ' CD ' ' HB3' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -102.18 145.59 29.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.469 -0.769 . . . . 0.0 108.953 178.64 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 1.036 HG22 HD11 ' A' ' 64' ' ' LEU . 4.8 tt -115.97 140.44 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.954 -1.091 . . . . 0.0 111.266 -178.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.606 ' O ' ' N ' ' A' ' 92' ' ' GLU . 7.9 ttm180 -130.6 109.32 10.57 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' TYR . . . . . 0.65 ' CD2' ' CB ' ' A' ' 91' ' ' TRP . 3.2 t80 -118.13 146.99 43.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.035 -1.041 . . . . 0.0 111.248 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' MET . . . . . 0.505 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 2.6 mmt -136.39 115.84 12.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.564 -0.71 . . . . 0.0 110.0 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 126.69 -4.45 7.54 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.59 ' HB2' ' CE1' ' A' ' 216' ' ' TYR . 0.4 OUTLIER -106.44 136.62 45.88 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.248 -1.148 . . . . 0.0 110.229 -179.946 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.434 ' N ' ' CD ' ' A' ' 219' ' ' GLU . 0.0 OUTLIER 179.95 -81.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 110.168 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 221' ' ' ARG . . . . . 0.482 ' O ' ' C ' ' A' ' 222' ' ' VAL . 24.0 ttt85 -166.87 81.34 0.23 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.306 -0.871 . . . . 0.0 110.259 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.558 HG13 ' O ' ' A' ' 222' ' ' VAL . 12.7 p -35.96 124.56 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.494 -0.754 . . . . 0.0 110.616 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.529 ' O ' ' C ' ' A' ' 224' ' ' GLU . 1.8 tt0 179.93 -89.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.285 -0.884 . . . . 0.0 110.256 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.529 ' C ' ' O ' ' A' ' 223' ' ' GLU . 20.2 mm-40 -32.14 -64.05 0.18 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.555 -0.716 . . . . 0.0 110.722 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.38 134.91 22.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.296 -0.877 . . . . 0.0 110.197 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -158.34 112.97 2.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 0.0 110.13 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.505 ' O ' ' CG ' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -42.72 107.4 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.329 -0.857 . . . . 0.0 110.276 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.0 tt -113.77 -1.19 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.305 -0.872 . . . . 0.0 110.226 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.491 ' O ' ' CG ' ' A' ' 230' ' ' ARG . 0.7 OUTLIER -106.53 -159.03 0.68 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.162 -0.961 . . . . 0.0 110.242 179.917 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 230' ' ' ARG . . . . . 0.677 ' O ' ' C ' ' A' ' 231' ' ' ASP . 0.1 OUTLIER 179.78 122.3 0.06 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.273 -0.892 . . . . 0.0 110.21 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.677 ' C ' ' O ' ' A' ' 230' ' ' ARG . 9.3 p-10 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.057 -0.973 . . . . 0.0 111.472 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 37.7 p -49.89 115.0 1.21 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -1.14 . . . . 0.0 110.21 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.64 -31.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.288 -0.882 . . . . 0.0 110.227 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.16 -177.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.222 -0.924 . . . . 0.0 110.25 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.6 mtt180 -113.97 21.29 14.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.241 -0.912 . . . . 0.0 110.225 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -105.44 1.36 27.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 110.171 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 94.4 p -97.19 59.73 1.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.252 -0.905 . . . . 0.0 110.106 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.2 m -50.85 109.19 1.24 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 0.0 110.267 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.433 ' C ' ' OG1' ' A' ' 15' ' ' THR . 46.0 Cg_endo -73.42 54.2 2.8 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.993 1.523 . . . . 0.0 110.383 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 16' ' ' SER . 0.1 OUTLIER -167.97 25.92 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.199 -0.938 . . . . 0.0 110.144 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 17' ' ' GLN . 34.9 t -177.79 -170.94 0.28 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.0 110.184 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 16' ' ' SER . 2.5 tt0 -179.55 -61.05 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.303 -0.873 . . . . 0.0 110.163 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.52 136.86 42.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 110.267 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -72.24 -159.93 0.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 110.254 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -108.14 -146.11 0.4 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.189 -0.944 . . . . 0.0 110.272 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.98 152.28 24.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -0.903 . . . . 0.0 110.358 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -83.41 44.66 0.98 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.323 -0.861 . . . . 0.0 110.32 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.19 -57.06 4.05 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.328 -0.857 . . . . 0.0 110.146 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.23 160.23 76.16 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.457 -0.777 . . . . 0.0 110.215 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.46 ' HB3' ' CD ' ' A' ' 30' ' ' GLU . 46.5 Cg_endo -72.83 167.1 28.16 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.991 1.521 . . . . 0.0 110.435 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.739 ' O ' ' N ' ' A' ' 28' ' ' GLY . 43.9 Cg_endo -72.3 157.69 53.04 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.024 1.539 . . . . 0.0 110.709 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.627 ' C ' ' O ' ' A' ' 26' ' ' PRO . 1.8 mp0 0.88 61.11 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 121.131 0.491 . . . . 0.0 111.793 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.739 ' N ' ' O ' ' A' ' 26' ' ' PRO . . . 36.89 30.74 0.04 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.9 HD13 ' HB2' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -73.41 -53.71 10.05 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.455 -1.027 . . . . 0.0 110.459 -179.619 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.78 ' HA ' HD23 ' A' ' 33' ' ' LEU . 42.9 mt-10 -43.87 -35.59 2.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.157 -0.964 . . . . 0.0 108.973 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -58.9 -24.26 62.09 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.631 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -83.46 -32.96 25.74 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.777 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.81 HD12 ' C ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -82.2 -37.18 26.44 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.696 0.76 . . . . 0.0 109.488 179.389 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.549 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 14.9 m -61.61 -11.38 11.18 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.279 0.561 . . . . 0.0 110.264 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 1.088 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -51.95 -168.04 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.431 -0.793 . . . . 0.0 110.272 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 1.088 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 40.7 Cg_endo -67.91 -169.81 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.55 1.289 . . . . 0.0 110.059 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.649 ' CD ' ' HB2' ' A' ' 36' ' ' PRO . 51.6 Cg_endo -96.77 63.55 0.13 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.528 1.486 . . . . 0.0 112.269 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.692 ' CD ' ' O ' ' A' ' 36' ' ' PRO . 51.2 Cg_endo -73.54 151.56 47.47 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.275 1.144 . . . . 0.0 109.583 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.592 ' O ' ' HB3' ' A' ' 43' ' ' GLN . 1.3 t0 -33.67 -30.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.3 -0.875 . . . . 0.0 109.833 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.073 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -57.2 -44.88 84.08 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.279 -0.888 . . . . 0.0 110.72 -179.354 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.697 ' N ' HD13 ' A' ' 40' ' ' LEU . 22.3 t -85.74 -34.4 8.4 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 C-N-CA 118.54 -1.264 . . . . 0.0 110.327 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.62 -39.08 12.07 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.134 -0.979 . . . . 0.0 113.114 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.592 ' HB3' ' O ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -87.13 -18.75 29.7 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 120.82 -1.175 . . . . 0.0 109.885 -178.741 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.994 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 3.0 ttp85 -76.84 -55.36 5.55 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.28 -0.887 . . . . 0.0 108.918 178.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.635 ' ND1' ' O ' ' A' ' 41' ' ' VAL . 65.9 m170 -45.4 -23.58 0.22 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.407 ' N ' ' O ' ' A' ' 44' ' ' ARG . 7.0 t60 -84.5 -39.67 18.58 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.491 ' CA ' ' HG3' ' A' ' 61' ' ' GLU . . . -83.52 -80.57 1.01 Allowed Glycine 0 N--CA 1.487 2.054 0 N-CA-C 106.679 -2.568 . . . . 0.0 106.679 177.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.701 ' HB2' HG23 ' A' ' 59' ' ' VAL . 99.5 m95 -90.42 73.5 6.95 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.299 -1.118 . . . . 0.0 108.87 177.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.727 ' O ' ' HB3' ' A' ' 53' ' ' CYS . 0.1 OUTLIER -44.88 163.1 0.2 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.721 -0.612 . . . . 0.0 110.997 179.835 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.764 ' O ' ' O ' ' A' ' 53' ' ' CYS . 41.0 Cg_endo -67.66 -60.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.818 1.431 . . . . 0.0 110.887 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.804 ' HA ' ' HE3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -40.17 -84.82 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.661 -1.274 . . . . 0.0 109.121 179.385 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.768 ' HA ' ' N ' ' A' ' 80' ' ' GLY . 2.0 m-20 -47.92 0.89 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.337 -0.852 . . . . 0.0 111.548 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.764 ' O ' ' O ' ' A' ' 50' ' ' PRO . 1.3 t -166.07 129.95 2.16 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.631 -1.293 . . . . 0.0 112.199 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.91 ' H ' ' HA ' ' A' ' 78' ' ' VAL . 1.8 m -81.85 124.1 29.39 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.437 -0.789 . . . . 0.0 109.753 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.673 ' HB3' ' NH2' ' A' ' 44' ' ' ARG . 3.2 pt-20 -51.6 -2.03 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.377 -0.827 . . . . 0.0 110.746 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.822 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -49.46 -21.5 0.95 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.835 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.009 HD11 ' CB ' ' A' ' 207' ' ' TRP . 0.9 OUTLIER -112.04 166.73 6.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.676 -0.64 . . . . 0.0 109.916 -179.705 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.514 ' N ' ' CG2' ' A' ' 57' ' ' ILE . 2.0 t70 -109.12 96.11 6.09 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.006 0.908 . . . . 0.0 110.054 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.971 HG13 HG22 ' A' ' 57' ' ' ILE . 33.3 m -128.35 135.45 62.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.711 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.641 ' HG2' ' HA ' ' A' ' 40' ' ' LEU . 13.1 mtpt -125.62 155.41 40.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.006 -1.058 . . . . 0.0 111.558 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.492 ' O ' ' C ' ' A' ' 62' ' ' GLY . 1.4 tt0 -80.24 -130.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.384 -0.823 . . . . 0.0 110.06 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.492 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 39.92 53.87 3.08 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.676 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 105.84 66.05 0.66 Allowed Glycine 0 N--CA 1.486 2.009 0 N-CA-C 107.785 -2.126 . . . . 0.0 107.785 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.077 HD11 HG22 ' A' ' 214' ' ' ILE . 0.2 OUTLIER 0.77 86.31 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 122.026 -0.691 . . . . 0.0 111.454 -178.522 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -99.66 113.93 26.68 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.703 179.564 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.693 ' CD1' ' CE2' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -114.38 124.67 52.53 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.569 -0.707 . . . . 0.0 109.193 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.631 ' H ' HG12 ' A' ' 59' ' ' VAL . 3.7 tm-20 -150.36 130.32 13.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.982 -1.074 . . . . 0.0 110.921 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.548 ' HD2' ' O ' ' A' ' 68' ' ' ARG . 0.6 OUTLIER -110.85 156.15 21.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.372 -0.83 . . . . 0.0 109.449 179.209 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.608 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 2.3 tpt180 -173.94 -52.95 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 120.982 -1.074 . . . . 0.0 111.687 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.9 ' HB2' HD13 ' A' ' 29' ' ' LEU . 40.0 Cg_endo -66.09 -52.79 0.8 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.508 1.268 . . . . 0.0 111.298 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 56' ' ' ASN . 25.4 t -78.55 164.97 3.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.244 -0.91 . . . . 0.0 110.867 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.471 ' N ' HG12 ' A' ' 71' ' ' VAL . . . -179.47 -30.49 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.445 0.64 . . . . 0.0 109.429 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -73.93 -116.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.373 -0.829 . . . . 0.0 110.202 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.9 t -124.48 50.07 1.74 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.019 -1.051 . . . . 0.0 110.397 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.506 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 4.2 m -83.41 -125.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 0.0 110.054 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.549 ' CB ' ' OD1' ' A' ' 56' ' ' ASN . 0.4 OUTLIER -136.6 112.69 9.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.089 -1.007 . . . . 0.0 110.71 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.642 ' C ' HG13 ' A' ' 78' ' ' VAL . . . -57.23 -92.89 0.01 OUTLIER Glycine 0 N--CA 1.482 1.765 0 N-CA-C 105.359 -3.096 . . . . 0.0 105.359 177.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.205 ' CG2' ' HB3' ' A' ' 205' ' ' ALA . 32.7 m -152.9 119.5 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.229 -1.16 . . . . 0.0 110.047 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.741 ' O ' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -146.87 134.09 20.55 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.602 -0.686 . . . . 0.0 111.224 -179.299 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.768 ' N ' ' HA ' ' A' ' 52' ' ' ASP . . . -132.2 -179.64 16.4 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.587 ' N ' ' HZ3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER 179.98 26.5 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.432 -1.04 . . . . 0.0 110.28 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.73 ' CD ' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -69.77 -18.59 63.5 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.164 -0.96 . . . . 0.0 110.722 -179.674 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.73 ' N ' ' CD ' ' A' ' 82' ' ' ARG . . . 27.8 44.37 0.04 OUTLIER Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.503 ' N ' ' O ' ' A' ' 82' ' ' ARG . 1.2 t80 -103.63 95.56 6.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.218 -1.166 . . . . 0.0 110.482 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . 1.034 ' OG ' HD21 ' A' ' 171' ' ' LEU . 3.6 p -140.47 166.58 24.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.311 -0.868 . . . . 0.0 110.172 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.576 ' HA ' ' CB ' ' A' ' 173' ' ' MET . 0.5 OUTLIER -136.31 156.52 48.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 109.928 179.584 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.586 ' N ' ' HB3' ' A' ' 173' ' ' MET . . . 62.31 -114.45 6.83 Favored Glycine 0 N--CA 1.483 1.816 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.19 131.26 47.09 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.513 -0.992 . . . . 0.0 110.968 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.704 ' HB2' HD23 ' A' ' 171' ' ' LEU . 74.1 m-70 -147.25 173.38 12.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.199 -0.938 . . . . 0.0 109.997 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.6 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -163.59 154.36 16.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.362 -0.836 . . . . 0.0 110.583 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.84 ' CE3' HG11 ' A' ' 169' ' ' VAL . 0.1 OUTLIER -134.66 170.79 15.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.171 -0.955 . . . . 0.0 109.3 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.925 ' O ' HD13 ' A' ' 93' ' ' ILE . 0.9 OUTLIER -146.8 152.66 39.12 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.699 -179.511 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.925 HD13 ' O ' ' A' ' 92' ' ' GLU . 7.8 mm -142.71 153.66 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.675 -0.641 . . . . 0.0 109.433 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.561 ' O ' ' HA ' ' A' ' 212' ' ' VAL . 0.0 OUTLIER -155.35 127.56 7.71 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.788 -1.195 . . . . 0.0 111.511 -179.564 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.843 ' CZ2' ' HA ' ' A' ' 104' ' ' ALA . 5.8 m95 -114.21 87.9 14.16 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.221 -0.924 . . . . 0.0 109.922 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.534 ' O ' ' NE2' ' A' ' 211' ' ' GLN . 51.7 Cg_endo -95.14 107.13 0.12 Allowed 'Trans proline' 0 C--N 1.302 -1.891 0 O-C-N 123.399 1.21 . . . . 0.0 110.333 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 23.5 tp -96.94 -69.45 0.76 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.9 -1.125 . . . . 0.0 109.091 178.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 99' ' ' GLN . 10.0 mt-10 -100.31 -45.72 5.5 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.826 0.822 . . . . 0.0 108.996 178.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.514 ' O ' ' O ' ' A' ' 100' ' ' ARG . 1.3 tm0? 178.87 -26.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.226 0.536 . . . . 0.0 110.03 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.514 ' O ' ' O ' ' A' ' 99' ' ' GLN . 10.7 mpt_? -28.97 -99.06 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.822 -0.549 . . . . 0.0 111.548 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 163' ' ' VAL . . . -163.24 -96.97 0.11 Allowed Glycine 0 N--CA 1.487 2.059 0 C-N-CA 119.668 -1.254 . . . . 0.0 110.28 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . 1.032 ' CG2' HD11 ' A' ' 167' ' ' LEU . 3.4 t -139.04 -160.05 1.02 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.934 -1.333 . . . . 0.0 111.962 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.815 ' HB2' HG22 ' A' ' 162' ' ' VAL . 3.2 t-80 179.33 29.59 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.764 -0.585 . . . . 0.0 109.88 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.843 ' HA ' ' CZ2' ' A' ' 95' ' ' TRP . . . -54.7 123.53 13.54 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.407 -0.808 . . . . 0.0 111.396 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.772 HG23 ' CB ' ' A' ' 204' ' ' SER . 3.7 m -97.99 114.27 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 118.147 -1.421 . . . . 0.0 108.358 178.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 1.05 HG23 ' O ' ' A' ' 202' ' ' SER . 0.7 OUTLIER -150.33 149.61 14.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.459 -0.776 . . . . 0.0 110.584 -178.302 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.599 ' HA2' ' HA3' ' A' ' 132' ' ' GLY . . . -153.91 142.79 9.44 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.096 ' CG2' HD13 ' A' ' 199' ' ' LEU . 2.8 m -98.46 155.17 3.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.251 -1.146 . . . . 0.0 110.299 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.557 ' C ' ' HB3' ' A' ' 199' ' ' LEU . . . -124.47 141.32 52.17 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.356 -0.84 . . . . 0.0 110.614 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . 1.088 ' OG1' HD23 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -121.07 131.62 54.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.397 -0.815 . . . . 0.0 110.127 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.95 -26.4 17.58 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.346 -0.846 . . . . 0.0 109.358 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.454 ' C ' ' HD3' ' A' ' 114' ' ' PRO . 2.0 pp -83.91 -12.31 55.63 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.572 -0.705 . . . . 0.0 109.329 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.691 ' HB3' ' HB ' ' A' ' 110' ' ' THR . . . -111.14 73.05 0.9 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.542 -0.724 . . . . 0.0 110.245 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.778 ' HB2' HD23 ' A' ' 115' ' ' LEU . 46.8 Cg_endo -73.23 -26.54 14.59 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.064 1.56 . . . . 0.0 110.364 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.778 HD23 ' HB2' ' A' ' 114' ' ' PRO . 0.6 OUTLIER 179.93 53.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.304 -0.872 . . . . 0.0 110.102 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -85.45 -70.14 0.61 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.88 . . . . 0.0 110.359 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.519 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -74.42 -39.09 62.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.374 -0.829 . . . . 0.0 110.225 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.519 ' C ' ' O ' ' A' ' 117' ' ' ALA . 17.6 t70 -31.76 97.01 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.47 -0.768 . . . . 0.0 110.74 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.471 ' N ' ' O ' ' A' ' 117' ' ' ALA . 3.8 m-70 -92.33 -21.64 20.16 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.345 -0.847 . . . . 0.0 110.176 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.406 ' O ' ' C ' ' A' ' 121' ' ' ALA . 23.1 m-85 -88.48 116.13 26.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.199 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.604 ' O ' ' HB3' ' A' ' 122' ' ' ALA . . . -43.22 -76.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -0.919 . . . . 0.0 110.141 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 121' ' ' ALA . . . 62.57 -165.09 0.24 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.106 -0.997 . . . . 0.0 110.161 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.47 46.74 1.99 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.189 -0.944 . . . . 0.0 110.176 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.51 71.82 1.47 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.333 -0.854 . . . . 0.0 110.136 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -134.41 4.48 4.45 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 21.5 p -100.88 36.34 1.97 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -1.152 . . . . 0.0 110.204 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.41 ' O ' ' O ' ' A' ' 128' ' ' SER . 3.1 t-20 179.93 -176.12 0.32 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.225 -0.922 . . . . 0.0 110.274 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.41 ' O ' ' O ' ' A' ' 127' ' ' ASN . 66.7 p -60.42 -150.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.943 . . . . 0.0 110.256 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -145.12 125.66 14.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.302 -0.874 . . . . 0.0 109.977 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 1.1 t -121.59 119.73 32.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 110.484 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' TRP . . . . . 0.648 ' O ' HG22 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -133.37 135.16 44.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.882 . . . . 0.0 109.781 179.679 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.599 ' HA3' ' HA2' ' A' ' 107' ' ' GLY . . . -175.66 -137.76 2.64 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.028 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.641 ' CD2' ' HG2' ' A' ' 159' ' ' GLU . 42.4 m0 -118.79 113.63 21.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.419 -1.048 . . . . 0.0 110.843 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.44 ' C ' HG12 ' A' ' 135' ' ' ILE . 45.5 t0 -118.63 147.64 43.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.512 -0.742 . . . . 0.0 109.895 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.595 ' CG2' ' NE2' ' A' ' 103' ' ' HIS . 0.1 OUTLIER -149.02 14.17 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.116 -0.99 . . . . 0.0 110.239 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -113.46 -51.56 0.5 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.42 8.18 25.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.326 -1.102 . . . . 0.0 109.577 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 139' ' ' LYS . . . -134.68 8.27 4.57 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -58.16 -147.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.282 -1.128 . . . . 0.0 110.326 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.68 ' O ' ' C ' ' A' ' 141' ' ' TYR . 5.9 tt 179.87 94.63 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.522 -0.737 . . . . 0.0 110.25 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.68 ' C ' ' O ' ' A' ' 140' ' ' LEU . 43.2 m-85 0.13 76.81 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.803 -0.561 . . . . 0.0 111.095 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.523 ' N ' ' O ' ' A' ' 140' ' ' LEU . 9.1 p80 -74.64 51.79 0.48 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.374 -0.829 . . . . 0.0 110.385 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.428 ' O ' ' C ' ' A' ' 144' ' ' SER . 24.1 tp60 -71.07 -50.04 38.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.184 -0.947 . . . . 0.0 110.241 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 143' ' ' GLN . 1.9 p -42.27 162.81 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.28 -0.887 . . . . 0.0 110.222 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.8 -171.31 2.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.336 -0.853 . . . . 0.0 110.219 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.75 -148.5 19.95 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.453 ' HA ' HD22 ' A' ' 147' ' ' LEU . 0.1 OUTLIER -130.56 45.2 2.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -1.163 . . . . 0.0 110.161 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 149' ' ' ALA . 0.2 OUTLIER 179.9 144.04 0.18 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.897 . . . . 0.0 110.122 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.84 ' HB1' ' HD2' ' A' ' 150' ' ' PRO . . . -49.1 176.53 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.282 -0.886 . . . . 0.0 110.225 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.84 ' HD2' ' HB1' ' A' ' 149' ' ' ALA . 45.8 Cg_endo -72.64 -12.78 27.02 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.99 1.521 . . . . 0.0 110.545 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.428 ' NE2' ' HG2' ' A' ' 150' ' ' PRO . 20.0 mp0 -99.74 -159.29 0.73 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.291 -0.881 . . . . 0.0 110.198 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.638 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 1.8 m-30 -94.92 -66.17 0.1 OUTLIER Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.229 -0.92 . . . . 0.0 110.326 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.638 ' CD ' ' CB ' ' A' ' 152' ' ' TYR . 49.3 Cg_endo -74.19 110.57 3.12 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.574 1.302 . . . . 0.0 110.299 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.5 ' CB ' ' HB3' ' A' ' 149' ' ' ALA . . . 179.61 161.67 0.87 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.211 -0.931 . . . . 0.0 110.338 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.489 ' N ' ' CD ' ' A' ' 156' ' ' PRO . . . -173.19 53.17 0.16 Allowed Glycine 0 N--CA 1.48 1.585 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.493 ' HB2' ' HB3' ' A' ' 160' ' ' GLN . 48.6 Cg_endo -75.01 -5.39 16.72 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.975 1.513 . . . . 0.0 110.298 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.451 ' HA ' ' HB2' ' A' ' 161' ' ' LEU . 32.7 tp60 -68.85 -0.5 5.56 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.305 -0.872 . . . . 0.0 110.864 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.804 ' O ' HG22 ' A' ' 163' ' ' VAL . . . -86.93 -79.08 1.23 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.641 ' HG2' ' CD2' ' A' ' 133' ' ' TRP . 1.0 OUTLIER -109.76 -2.97 17.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.298 -1.119 . . . . 0.0 110.014 -179.793 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.493 ' HB3' ' HB2' ' A' ' 156' ' ' PRO . 0.1 OUTLIER -97.59 2.18 49.66 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.638 0.732 . . . . 0.0 109.23 179.344 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.667 ' O ' ' C ' ' A' ' 162' ' ' VAL . 1.3 mt -158.34 98.6 1.57 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.831 HG22 ' O ' ' A' ' 102' ' ' THR . 2.2 t 4.47 109.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-O 122.244 1.021 . . . . 0.0 110.568 -178.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 1.08 HG12 ' HD3' ' A' ' 164' ' ' PRO . 0.2 OUTLIER -67.46 -155.4 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.314 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 1.08 ' HD3' HG12 ' A' ' 163' ' ' VAL . 43.8 Cg_endo -72.29 178.76 5.7 Favored 'Trans proline' 0 C--N 1.318 -1.03 0 O-C-N 122.481 0.727 . . . . 0.0 110.999 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.525 ' O ' ' HB3' ' A' ' 94' ' ' SER . 2.2 mt-10 -46.51 -32.2 3.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.428 -0.795 . . . . 0.0 111.232 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.54 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 18.2 ttp180 -151.83 156.17 39.64 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.981 -1.075 . . . . 0.0 111.13 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 1.032 HD11 ' CG2' ' A' ' 102' ' ' THR . 1.7 mp -126.85 157.31 39.65 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.543 -0.723 . . . . 0.0 109.436 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.543 HD21 HG22 ' A' ' 170' ' ' VAL . 1.1 tt -117.44 121.41 40.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.065 -1.022 . . . . 0.0 110.728 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.84 HG11 ' CE3' ' A' ' 91' ' ' TRP . 16.4 t -89.65 128.78 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.3 -0.875 . . . . 0.0 109.494 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.543 HG22 HD21 ' A' ' 168' ' ' LEU . 19.2 t -109.99 115.62 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.004 -1.06 . . . . 0.0 110.675 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 1.034 HD21 ' OG ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -129.27 123.12 31.1 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.285 -0.884 . . . . 0.0 109.491 179.505 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 173' ' ' MET . 47.3 t0 -120.13 137.96 53.86 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.177 -0.952 . . . . 0.0 110.021 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.586 ' HB3' ' N ' ' A' ' 87' ' ' GLY . 0.0 OUTLIER -98.56 -40.68 8.11 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.56 179.676 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -50.85 -22.61 2.27 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.318 -0.864 . . . . 0.0 109.073 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.581 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.3 OUTLIER -109.26 -27.97 9.25 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.803 0.811 . . . . 0.0 108.924 179.473 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.583 ' O ' ' CB ' ' A' ' 198' ' ' THR . . . 86.84 22.34 46.48 Favored Glycine 0 N--CA 1.482 1.709 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.862 HG22 HD22 ' A' ' 194' ' ' LEU . 0.0 OUTLIER -112.52 133.45 54.57 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.099 -1.236 . . . . 0.0 111.466 -179.389 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.997 HD23 HD12 ' A' ' 171' ' ' LEU . 2.6 mp -130.52 153.59 48.68 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.654 -0.654 . . . . 0.0 109.472 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 176.16 -175.29 47.39 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.231 -1.461 . . . . 0.0 110.538 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.729 ' CZ ' HG22 ' A' ' 169' ' ' VAL . 0.2 OUTLIER -127.18 131.51 50.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.67 -0.9 . . . . 0.0 109.173 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 168' ' ' LEU . 3.4 t -136.7 131.22 33.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.122 -0.986 . . . . 0.0 110.536 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.864 HD11 ' CD2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -102.27 116.84 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.372 -0.83 . . . . 0.0 109.393 179.212 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 83.45 -11.87 53.85 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 81.43 47.05 6.59 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 32.4 m -136.13 -36.46 0.74 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.135 -1.215 . . . . 0.0 110.775 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.864 ' CD2' HD11 ' A' ' 182' ' ' ILE . 5.1 m-30 -67.0 -77.23 0.07 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.005 -1.06 . . . . 0.0 110.506 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.602 ' O ' ' CE2' ' A' ' 191' ' ' PHE . 2.4 mm? -68.46 44.28 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.906 -1.121 . . . . 0.0 109.88 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.53 ' H ' ' HD2' ' A' ' 189' ' ' PRO . . . -94.95 -63.89 1.0 Allowed Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.99 -1.1 . . . . 0.0 110.611 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.53 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 45.1 Cg_endo -72.01 -30.99 13.0 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.802 1.422 . . . . 0.0 111.3 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.754 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -74.58 16.59 0.26 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.239 -0.913 . . . . 0.0 111.418 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.602 ' CE2' ' O ' ' A' ' 187' ' ' LEU . 0.3 OUTLIER -89.57 -8.34 52.88 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.063 -1.023 . . . . 0.0 109.982 179.204 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.06 -15.3 32.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.568 -0.707 . . . . 0.0 110.126 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -115.71 -11.17 10.54 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 107.483 -2.247 . . . . 0.0 107.483 179.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.9 ' HA ' ' HD2' ' A' ' 197' ' ' ARG . 0.4 OUTLIER -70.56 -22.17 62.62 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.796 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.588 ' HA ' HG23 ' A' ' 177' ' ' THR . 0.0 OUTLIER -57.29 -26.55 61.04 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.355 -0.84 . . . . 0.0 109.378 179.038 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.539 ' N ' ' HE3' ' A' ' 195' ' ' LYS . . . -106.08 -37.74 2.45 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.9 ' HD2' ' HA ' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -79.62 -4.52 51.98 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.448 -1.031 . . . . 0.0 110.567 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.583 ' CB ' ' O ' ' A' ' 176' ' ' GLY . 0.2 OUTLIER -43.37 133.82 4.08 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-O 122.194 0.997 . . . . 0.0 112.174 -177.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 1.096 HD13 ' CG2' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -141.73 171.06 14.57 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.218 179.19 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.673 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 46.5 m-85 -90.21 126.79 55.68 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.827 -1.171 . . . . 0.0 109.373 178.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.772 ' CA ' HG12 ' A' ' 108' ' ' VAL . 53.2 Cg_endo -82.16 150.36 15.64 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 124.196 1.629 . . . . 0.0 112.489 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' SER . . . . . 1.05 ' O ' HG23 ' A' ' 106' ' ' VAL . 73.6 p -133.69 149.84 51.52 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.583 HG22 ' N ' ' A' ' 204' ' ' SER . 14.5 p -118.62 168.17 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.406 -1.434 . . . . 0.0 110.623 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' SER . . . . . 0.772 ' CB ' HG23 ' A' ' 105' ' ' VAL . 0.4 OUTLIER -156.0 145.16 20.64 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.425 0.631 . . . . 0.0 109.923 179.681 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 1.205 ' HB3' ' CG2' ' A' ' 78' ' ' VAL . . . -145.47 135.96 24.18 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.74 -0.6 . . . . 0.0 109.705 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.572 ' CG1' ' N ' ' A' ' 207' ' ' TRP . 1.5 t -76.57 172.06 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.459 -0.776 . . . . 0.0 110.512 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 1.009 ' CB ' HD11 ' A' ' 57' ' ' ILE . 14.2 p90 -121.91 128.51 51.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.307 -0.871 . . . . 0.0 110.089 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.539 ' N ' ' HG2' ' A' ' 68' ' ' ARG . . . 154.4 -167.12 32.39 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.449 ' C ' ' O ' ' A' ' 208' ' ' GLY . 0.0 OUTLIER -40.21 -28.74 0.06 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.381 -1.07 . . . . 0.0 110.142 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 210' ' ' CYS . . . . . 0.483 ' C ' ' HG3' ' A' ' 211' ' ' GLN . 9.7 t -64.26 164.29 11.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.321 -0.862 . . . . 0.0 110.219 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.534 ' NE2' ' O ' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -164.24 109.55 1.01 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.358 -0.839 . . . . 0.0 109.655 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.645 ' O ' ' CH2' ' A' ' 48' ' ' TRP . 5.7 p -102.65 143.77 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.437 -0.79 . . . . 0.0 110.308 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.458 ' HB2' ' OG ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -93.93 156.2 16.75 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.364 -0.835 . . . . 0.0 109.41 179.361 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 1.077 HG22 HD11 ' A' ' 64' ' ' LEU . 4.9 tt -139.06 131.54 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.046 -1.034 . . . . 0.0 110.812 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.596 ' HB3' ' HB3' ' A' ' 92' ' ' GLU . 12.6 ttt180 -130.1 108.29 9.96 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' TYR . . . . . 0.736 ' CZ ' ' CD1' ' A' ' 91' ' ' TRP . 4.2 t80 -118.92 142.94 47.32 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.385 -0.822 . . . . 0.0 111.15 -177.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.58 115.57 12.34 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.558 -0.713 . . . . 0.0 110.102 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 133.85 53.85 0.07 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -133.63 138.66 46.05 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.265 -1.138 . . . . 0.0 110.114 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.413 ' C ' ' HG3' ' A' ' 221' ' ' ARG . 5.0 ptm180 -78.22 155.98 30.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.242 -0.911 . . . . 0.0 110.381 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' ARG . . . . . 0.495 ' O ' ' C ' ' A' ' 222' ' ' VAL . 0.1 OUTLIER -134.62 93.73 3.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.242 -0.911 . . . . 0.0 110.124 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.681 HG13 ' O ' ' A' ' 222' ' ' VAL . 7.3 p -34.57 96.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.368 -0.833 . . . . 0.0 110.742 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.665 ' O ' ' C ' ' A' ' 224' ' ' GLU . 1.0 OUTLIER 179.86 86.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.333 -0.854 . . . . 0.0 110.168 179.856 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.665 ' C ' ' O ' ' A' ' 223' ' ' GLU . 3.4 pt-20 0.73 68.67 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.379 0.609 . . . . 0.0 111.517 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.63 ' N ' ' O ' ' A' ' 223' ' ' GLU . 13.1 t -68.72 161.63 27.89 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.323 -0.86 . . . . 0.0 110.312 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.12 89.31 7.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 110.186 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.494 ' HG2' HG23 ' A' ' 225' ' ' THR . 2.8 ptm180 -124.28 -174.59 3.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.19 -0.944 . . . . 0.0 110.249 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.415 ' O ' ' HB2' ' A' ' 229' ' ' HIS . 1.2 tt -166.28 158.52 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.209 -0.932 . . . . 0.0 110.158 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.43 ' O ' ' C ' ' A' ' 230' ' ' ARG . 58.4 t60 -179.97 -30.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.237 -0.915 . . . . 0.0 110.285 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' ARG . . . . . 0.68 ' O ' ' C ' ' A' ' 231' ' ' ASP . 36.9 mmm-85 -42.14 126.47 3.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 110.246 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.68 ' C ' ' O ' ' A' ' 230' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 117.984 -1.008 . . . . 0.0 111.541 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 t -110.9 -46.97 3.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.336 -1.097 . . . . 0.0 110.14 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.23 -81.74 0.06 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.261 -0.9 . . . . 0.0 110.129 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -145.55 94.03 2.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.247 -0.908 . . . . 0.0 110.186 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.3 mtp180 -132.92 171.63 13.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.269 -0.895 . . . . 0.0 110.214 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -154.36 80.79 1.11 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.917 . . . . 0.0 110.166 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -79.88 -51.73 8.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 110.336 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.414 ' O ' HG23 ' A' ' 13' ' ' THR . 1.4 t -121.17 117.92 30.38 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 0.0 110.159 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.4 151.48 48.11 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.014 1.534 . . . . 0.0 110.383 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.5 m -105.34 92.19 4.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.309 -0.869 . . . . 0.0 110.219 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.7 t -141.84 25.91 1.93 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.294 -0.879 . . . . 0.0 110.197 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -153.31 -79.14 0.1 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 110.298 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.51 164.93 24.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.296 -0.878 . . . . 0.0 110.198 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.483 HD23 ' H ' ' A' ' 20' ' ' TYR . 0.3 OUTLIER -173.88 -145.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.257 -0.902 . . . . 0.0 110.194 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.483 ' H ' HD23 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -125.51 -5.43 7.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.192 -0.943 . . . . 0.0 110.232 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 22' ' ' ASP . 79.9 p -140.04 -149.63 0.29 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 110.218 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 21' ' ' SER . 25.2 t70 -176.22 89.02 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.193 -0.942 . . . . 0.0 110.146 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.41 -76.52 0.1 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.937 . . . . 0.0 110.15 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.6 m -78.8 116.11 57.25 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.343 -0.848 . . . . 0.0 110.135 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.03 159.07 48.6 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.042 1.549 . . . . 0.0 110.439 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.654 ' O ' ' N ' ' A' ' 28' ' ' GLY . 46.3 Cg_endo -72.79 -171.39 0.75 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.008 1.53 . . . . 0.0 110.505 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.654 ' C ' ' O ' ' A' ' 26' ' ' PRO . 20.1 mt-10 1.25 67.18 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.533 0.683 . . . . 0.0 111.31 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.654 ' N ' ' O ' ' A' ' 26' ' ' PRO . . . -160.74 -32.2 0.02 OUTLIER Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.587 ' H ' HD23 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -76.45 -22.54 54.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -1.147 . . . . 0.0 110.285 -179.923 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.944 ' HA ' HD23 ' A' ' 33' ' ' LEU . 1.3 mt-10 -47.69 -35.12 9.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.101 -0.999 . . . . 0.0 109.192 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -62.27 -24.07 67.07 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.309 -0.87 . . . . 0.0 108.841 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.545 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.7 OUTLIER -83.44 -34.06 25.54 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.102 HD21 ' CG ' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -76.17 -36.06 58.88 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.877 0.846 . . . . 0.0 109.42 179.323 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.606 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -80.46 -7.37 59.13 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.161 179.878 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.982 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -54.87 -66.81 0.82 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.213 -0.929 . . . . 0.0 110.488 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.982 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 48.9 Cg_endo -73.65 143.22 33.62 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.692 1.364 . . . . 0.0 110.316 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 36' ' ' PRO . 53.8 Cg_endo -98.88 56.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 121.898 1.732 . . . . 0.0 112.034 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.726 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 52.8 Cg_endo -75.82 150.91 35.35 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 122.979 0.989 . . . . 0.0 110.118 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.615 ' O ' ' HB3' ' A' ' 43' ' ' GLN . 1.0 OUTLIER -34.26 -33.52 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.313 -0.867 . . . . 0.0 109.457 179.557 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.088 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -57.41 -46.88 83.02 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.242 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.991 HG23 HD13 ' A' ' 40' ' ' LEU . 54.4 t -86.6 -33.7 7.32 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 O-C-N 120.647 -1.283 . . . . 0.0 110.415 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.21 -39.17 12.25 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.401 -0.812 . . . . 0.0 113.058 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.615 ' HB3' ' O ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -86.67 -19.65 28.93 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 120.726 -1.234 . . . . 0.0 109.455 -178.964 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 1.086 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -79.36 -51.09 9.87 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 122.078 0.942 . . . . 0.0 109.528 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.834 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 59.5 m170 -51.52 -17.57 0.85 Allowed 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.632 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -84.46 -39.21 19.21 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.443 -1.303 . . . . 0.0 110.029 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.942 ' O ' HD12 ' A' ' 214' ' ' ILE . . . -97.98 -68.19 0.93 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 106.597 -2.601 . . . . 0.0 106.597 177.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.838 ' CD1' ' CG2' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -89.26 72.61 8.13 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 177.229 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.834 ' HA ' ' HA ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER -55.22 151.45 18.15 Favored Pre-proline 0 N--CA 1.494 1.754 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.412 -178.514 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.734 ' HD3' ' HA ' ' A' ' 45' ' ' HIS . 45.0 Cg_endo -78.49 -25.86 6.43 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 124.522 1.801 . . . . 0.0 110.563 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.852 ' N ' ' HE3' ' A' ' 51' ' ' LYS . 0.4 OUTLIER -64.48 -14.3 56.4 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.145 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 1.081 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 9.8 m-20 -122.75 2.16 9.45 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.644 178.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.863 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 10.1 t -151.73 132.94 14.45 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.877 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.597 ' HB2' ' O ' ' A' ' 76' ' ' ASP . 0.8 OUTLIER -71.81 118.49 14.73 Favored 'General case' 0 C--N 1.292 -1.926 0 O-C-N 121.548 -0.72 . . . . 0.0 110.34 179.434 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 1.102 ' CG ' HD21 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -40.25 -20.49 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.503 -0.748 . . . . 0.0 111.786 -179.641 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.657 ' H ' ' ND2' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -54.45 -1.9 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.762 -1.211 . . . . 0.0 109.638 179.755 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.706 HG23 ' O ' ' A' ' 67' ' ' GLU . 26.9 mm -111.68 155.35 13.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.923 0.868 . . . . 0.0 111.323 -177.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.582 ' N ' ' O ' ' A' ' 67' ' ' GLU . 1.4 t70 -118.14 95.36 4.86 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.718 0.77 . . . . 0.0 109.266 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.952 HG21 ' CD1' ' A' ' 66' ' ' PHE . 1.1 p -131.56 118.99 41.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 O-C-N 121.808 -0.557 . . . . 0.0 111.397 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.607 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -136.76 157.57 46.44 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.066 -1.021 . . . . 0.0 111.265 179.551 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.771 ' N ' ' CH2' ' A' ' 48' ' ' TRP . 1.0 OUTLIER -39.27 -112.98 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.717 -0.614 . . . . 0.0 112.029 -179.157 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.514 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 42.11 44.57 4.82 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 107.291 -2.324 . . . . 0.0 107.291 -177.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.743 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 84.64 87.08 0.89 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 106.881 -2.488 . . . . 0.0 106.881 -177.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.765 HD13 ' HE1' ' A' ' 48' ' ' TRP . 0.2 OUTLIER 1.48 82.88 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.632 -0.922 . . . . 0.0 109.901 -177.875 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.703 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -101.57 114.15 27.93 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.879 -0.728 . . . . 0.0 110.48 -178.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.952 ' CD1' HG21 ' A' ' 59' ' ' VAL . 4.5 t80 -114.42 123.39 49.33 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.706 ' O ' HG23 ' A' ' 57' ' ' ILE . 1.3 tm-20 -151.7 163.05 39.96 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.16 -0.963 . . . . 0.0 110.497 -179.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.621 ' CG ' ' HB2' ' A' ' 207' ' ' TRP . 0.2 OUTLIER -111.42 153.37 26.19 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.222 -0.923 . . . . 0.0 109.841 179.223 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.714 ' CB ' ' HD3' ' A' ' 70' ' ' PRO . 34.8 mtp180 -85.2 -73.87 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 120.978 -1.076 . . . . 0.0 109.665 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.714 ' HD3' ' CB ' ' A' ' 69' ' ' ARG . 57.5 Cg_endo -76.23 -124.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 N-CA-C 108.384 -1.429 . . . . 0.0 108.384 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.42 ' H ' ' HB2' ' A' ' 70' ' ' PRO . 2.6 t -140.44 164.51 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.455 -1.403 . . . . 0.0 109.947 179.152 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.579 ' HB2' ' CD1' ' A' ' 207' ' ' TRP . . . -80.04 33.45 0.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.178 -0.951 . . . . 0.0 110.357 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -45.98 -47.47 16.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.258 -0.901 . . . . 0.0 110.361 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.9 p -172.67 30.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.27 -0.894 . . . . 0.0 110.154 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.565 HG23 ' N ' ' A' ' 76' ' ' ASP . 9.9 t -97.87 -132.06 0.22 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.883 . . . . 0.0 109.992 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.597 ' O ' ' HB2' ' A' ' 54' ' ' SER . 12.5 m-20 -140.41 114.05 8.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.157 -0.964 . . . . 0.0 110.572 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 76' ' ' ASP . . . -55.83 -106.52 0.01 OUTLIER Glycine 0 N--CA 1.486 1.986 0 N-CA-C 107.942 -2.063 . . . . 0.0 107.942 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.03 ' CG2' ' HB3' ' A' ' 205' ' ' ALA . 4.4 m -138.16 123.91 24.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 120.998 -1.295 . . . . 0.0 110.078 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.662 ' NE ' ' O ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -145.42 133.83 21.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.18 -0.95 . . . . 0.0 112.161 -178.616 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 1.081 ' CA ' ' HA ' ' A' ' 52' ' ' ASP . . . -131.79 163.84 23.72 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 178.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.548 ' CB ' ' HB3' ' A' ' 202' ' ' SER . 2.5 ttpm? -171.01 87.28 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.494 -1.003 . . . . 0.0 109.513 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.818 ' HD3' ' H ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -152.31 -91.18 0.05 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.227 -0.92 . . . . 0.0 110.542 -179.366 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.818 ' H ' ' HD3' ' A' ' 82' ' ' ARG . . . 45.75 42.78 11.2 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -97.21 106.2 18.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -1.11 . . . . 0.0 110.217 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.595 ' HB2' ' CE1' ' A' ' 89' ' ' HIS . 75.5 p -138.28 167.17 22.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 0.0 110.071 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.538 ' HA ' ' CB ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -120.14 135.44 54.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.216 -0.927 . . . . 0.0 110.285 -179.824 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 172' ' ' ASP . . . 102.83 -116.64 5.54 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.476 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 2.5 tp -128.36 130.27 47.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.321 -1.105 . . . . 0.0 110.282 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.595 ' CE1' ' HB2' ' A' ' 85' ' ' SER . 33.4 m-70 -146.33 166.2 27.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.099 -1.001 . . . . 0.0 109.997 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.539 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -158.99 153.71 24.63 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.054 -1.029 . . . . 0.0 109.92 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 1.001 ' CZ2' HD22 ' A' ' 171' ' ' LEU . 1.4 m0 -134.81 148.57 50.22 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.298 -0.876 . . . . 0.0 109.911 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.731 ' C ' HD12 ' A' ' 93' ' ' ILE . 7.8 mt-10 -109.56 118.42 36.55 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.52 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.731 HD12 ' C ' ' A' ' 92' ' ' GLU . 1.2 mp -133.69 154.52 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.054 -1.029 . . . . 0.0 110.877 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.589 ' HA ' ' HG ' ' A' ' 167' ' ' LEU . 0.3 OUTLIER -140.88 119.94 12.8 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.16 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 1.134 ' CE3' HG22 ' A' ' 106' ' ' VAL . 3.0 t-105 -117.41 89.5 31.91 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.072 -1.018 . . . . 0.0 110.657 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 94' ' ' SER . 51.0 Cg_endo -89.18 109.53 0.47 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.085 1.571 . . . . 0.0 110.153 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.99 HD23 ' HE1' ' A' ' 95' ' ' TRP . 0.3 OUTLIER -95.59 -6.35 40.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.128 -0.982 . . . . 0.0 110.399 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.515 ' HG3' ' N ' ' A' ' 99' ' ' GLN . 0.4 OUTLIER -40.25 -25.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.256 -0.902 . . . . 0.0 110.308 -179.858 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.538 ' NE2' ' O ' ' A' ' 209' ' ' GLN . 3.7 mt-30 -73.51 -99.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 110.195 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.769 ' O ' HD11 ' A' ' 97' ' ' LEU . 2.5 mmm180 -136.21 -84.52 0.37 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.109 -0.994 . . . . 0.0 110.261 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.869 ' O ' HG23 ' A' ' 102' ' ' THR . . . 57.81 -157.11 16.57 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.869 HG23 ' O ' ' A' ' 101' ' ' GLY . 0.1 OUTLIER -179.69 -90.87 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -1.144 . . . . 0.0 110.128 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.462 ' O ' ' C ' ' A' ' 104' ' ' ALA . 8.0 t-160 -85.61 -19.72 30.58 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.255 -0.903 . . . . 0.0 110.004 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.692 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -39.43 122.46 1.32 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.372 -0.83 . . . . 0.0 110.147 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.897 HG23 ' HA ' ' A' ' 134' ' ' ASP . 4.9 p -137.72 159.81 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.198 -0.939 . . . . 0.0 112.405 -178.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 1.134 HG22 ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -122.31 115.93 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 177.114 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.591 ' HA3' ' HA3' ' A' ' 132' ' ' GLY . . . -160.54 -164.96 16.43 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 118.648 -1.739 . . . . 0.0 111.227 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.654 ' HB ' HD13 ' A' ' 199' ' ' LEU . 0.7 OUTLIER -120.54 156.23 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.617 -0.931 . . . . 0.0 109.515 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 130' ' ' SER . . . -128.13 143.09 51.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.861 -1.149 . . . . 0.0 110.686 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.886 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.7 OUTLIER -115.38 123.13 47.9 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.196 -0.94 . . . . 0.0 110.455 179.74 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.91 -31.03 14.47 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.465 -0.772 . . . . 0.0 109.712 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.695 ' O ' ' C ' ' A' ' 113' ' ' ALA . 1.7 pp -79.22 -11.87 59.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.507 -0.745 . . . . 0.0 110.115 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.695 ' C ' ' O ' ' A' ' 112' ' ' LEU . . . 0.68 103.06 0.02 OUTLIER Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 121.872 -0.518 . . . . 0.0 111.128 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.72 -156.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.137 1.598 . . . . 0.0 110.654 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.571 ' C ' HD12 ' A' ' 115' ' ' LEU . 0.5 OUTLIER -160.96 55.26 0.3 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.28 -0.888 . . . . 0.0 109.968 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 115' ' ' LEU . 3.6 tt0 -38.3 -39.83 0.47 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.489 -0.757 . . . . 0.0 110.356 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.532 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -71.46 133.97 46.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.347 -0.845 . . . . 0.0 110.125 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.532 ' C ' ' O ' ' A' ' 117' ' ' ALA . 5.6 t70 -30.89 -82.44 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.499 -0.751 . . . . 0.0 110.76 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.438 ' HB3' ' O ' ' A' ' 118' ' ' ASP . 7.0 t60 65.17 -67.18 0.13 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 110.256 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.504 ' N ' ' O ' ' A' ' 118' ' ' ASP . 0.2 OUTLIER 52.72 63.64 2.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.311 -0.868 . . . . 0.0 110.192 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' A' ' 120' ' ' TYR . . . -55.03 -165.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.246 -0.909 . . . . 0.0 110.246 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.35 -43.92 72.66 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.299 -0.876 . . . . 0.0 110.222 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.644 ' O ' HD12 ' A' ' 123' ' ' LEU . 2.0 pp -162.39 107.95 1.22 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.198 -0.939 . . . . 0.0 110.27 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 53.86 -87.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.371 -0.83 . . . . 0.0 110.246 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 123' ' ' LEU . . . 68.11 145.57 0.13 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 128' ' ' SER . 0.3 OUTLIER -137.73 63.72 1.54 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.267 -1.137 . . . . 0.0 110.181 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -44.84 93.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.277 -0.889 . . . . 0.0 110.173 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 126' ' ' SER . 0.5 OUTLIER -47.65 147.36 1.86 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.904 . . . . 0.0 110.227 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -149.84 128.91 12.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.268 -0.895 . . . . 0.0 109.964 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 2.9 t -120.41 119.35 32.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.16 -0.963 . . . . 0.0 110.501 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -133.94 136.19 44.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.501 -0.749 . . . . 0.0 109.305 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.591 ' HA3' ' HA3' ' A' ' 107' ' ' GLY . . . -165.39 -111.34 0.24 Allowed Glycine 0 N--CA 1.486 2.001 0 C-N-CA 119.042 -1.552 . . . . 0.0 110.796 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.764 ' CH2' ' HB2' ' A' ' 180' ' ' TYR . 5.3 m-90 -140.3 122.77 16.1 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 121.168 -1.195 . . . . 0.0 111.634 -178.064 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.897 ' HA ' HG23 ' A' ' 105' ' ' VAL . 0.9 OUTLIER -118.89 148.62 42.72 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.394 -179.638 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.549 HD13 ' N ' ' A' ' 135' ' ' ILE . 0.2 OUTLIER -69.8 -0.48 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.348 -0.845 . . . . 0.0 110.313 179.561 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.502 ' O ' ' CG ' ' A' ' 139' ' ' LYS . . . -46.16 -20.96 0.58 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.921 ' HB2' HG13 ' A' ' 162' ' ' VAL . 8.0 mpt_? -57.7 -20.04 31.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.266 -1.138 . . . . 0.0 108.989 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.568 ' HA2' ' CG2' ' A' ' 162' ' ' VAL . . . -80.45 -2.17 89.26 Favored Glycine 0 C--N 1.291 -1.942 0 N-CA-C 107.956 -2.057 . . . . 0.0 107.956 178.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.524 ' O ' ' O ' ' A' ' 138' ' ' GLY . 2.2 mmtm -53.69 -161.26 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.669 -0.901 . . . . 0.0 110.174 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.405 ' O ' ' O ' ' A' ' 141' ' ' TYR . 1.9 mp -117.25 82.98 1.9 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -0.924 . . . . 0.0 110.472 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.405 ' O ' ' O ' ' A' ' 140' ' ' LEU . 4.7 m-85 -52.89 -99.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.235 -0.916 . . . . 0.0 110.318 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.584 ' O ' ' CG ' ' A' ' 142' ' ' HIS . 7.2 p80 -159.53 59.39 0.39 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.932 . . . . 0.0 110.376 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -146.4 -55.14 0.26 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.179 -0.951 . . . . 0.0 110.221 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 144' ' ' SER . 0.9 OUTLIER -87.74 20.33 3.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.343 -0.848 . . . . 0.0 110.19 -179.959 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -52.19 106.38 0.15 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.213 -0.929 . . . . 0.0 110.157 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -152.64 -105.71 0.28 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' A' ' 148' ' ' GLU . 0.5 OUTLIER -140.65 79.04 1.68 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.214 -1.168 . . . . 0.0 110.127 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 147' ' ' LEU . 7.3 tp10 179.94 154.09 0.53 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.898 . . . . 0.0 110.132 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.469 ' O ' ' O ' ' A' ' 154' ' ' ALA . . . -175.64 149.06 1.05 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.165 -0.959 . . . . 0.0 110.328 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.17 1.54 7.14 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.047 1.551 . . . . 0.0 110.613 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -68.0 -94.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.094 -1.004 . . . . 0.0 110.255 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.553 ' HB3' ' HD3' ' A' ' 153' ' ' PRO . 0.1 OUTLIER -82.92 -59.11 0.4 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.208 -0.932 . . . . 0.0 110.618 -179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 152' ' ' TYR . 47.4 Cg_endo -73.89 169.69 21.81 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.861 1.453 . . . . 0.0 110.509 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.469 ' O ' ' O ' ' A' ' 149' ' ' ALA . . . -48.36 166.47 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 110.176 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.476 ' N ' ' CD ' ' A' ' 156' ' ' PRO . . . -146.73 55.26 0.53 Allowed Glycine 0 N--CA 1.48 1.58 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 155' ' ' GLY . 45.4 Cg_endo -72.13 -47.36 0.43 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.154 1.607 . . . . 0.0 110.211 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -65.47 -6.09 9.6 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.269 -0.894 . . . . 0.0 110.278 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.548 ' O ' HG23 ' A' ' 162' ' ' VAL . . . -77.47 -45.14 11.47 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.563 ' HA ' ' CG2' ' A' ' 162' ' ' VAL . 0.4 OUTLIER -75.89 6.38 5.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -1.135 . . . . 0.0 110.254 179.855 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -6.81 46.6 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.345 -0.847 . . . . 0.0 109.985 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.494 HD23 ' HA ' ' A' ' 161' ' ' LEU . 1.0 OUTLIER -149.82 29.82 0.74 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.386 -0.822 . . . . 0.0 109.806 179.651 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.921 HG13 ' HB2' ' A' ' 137' ' ' ARG . 3.7 t -112.52 -126.61 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.467 -0.771 . . . . 0.0 109.82 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.88 HG11 ' HB ' ' A' ' 182' ' ' ILE . 0.6 OUTLIER -139.87 44.03 0.68 Allowed Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.057 -1.027 . . . . 0.0 110.299 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.686 ' HD3' ' N ' ' A' ' 163' ' ' VAL . 53.7 Cg_endo -79.76 81.91 2.64 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.785 1.413 . . . . 0.0 110.872 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -167.25 -84.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.05 -1.031 . . . . 0.0 110.106 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 1.03 ' O ' HD23 ' A' ' 167' ' ' LEU . 20.3 ttp180 -151.9 155.84 38.9 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.461 -0.775 . . . . 0.0 109.988 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 1.03 HD23 ' O ' ' A' ' 166' ' ' ARG . 9.9 mt -138.15 128.85 26.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.192 -0.943 . . . . 0.0 110.525 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 17.7 tp -103.63 141.34 36.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.259 -0.9 . . . . 0.0 109.167 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.703 HG13 ' CD2' ' A' ' 180' ' ' TYR . 6.8 t -125.55 132.22 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.799 -1.188 . . . . 0.0 111.58 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.743 HG13 ' O ' ' A' ' 170' ' ' VAL . 11.4 p -138.02 104.93 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 1.001 HD22 ' CZ2' ' A' ' 91' ' ' TRP . 0.0 OUTLIER -118.41 141.13 48.85 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.134 -0.979 . . . . 0.0 110.417 -179.083 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 173' ' ' MET . 40.4 t0 -120.2 138.68 53.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.29 -0.881 . . . . 0.0 110.19 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.55 ' CG ' ' O ' ' A' ' 85' ' ' SER . 4.1 tpt -89.97 -39.15 13.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.624 -0.673 . . . . 0.0 109.849 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 173' ' ' MET . 1.4 tt0 -42.09 -27.78 0.15 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.892 . . . . 0.0 109.191 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.515 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 3.0 tt0 -106.99 -27.76 10.46 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.702 0.763 . . . . 0.0 108.97 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 86.11 21.98 50.37 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.98 HG22 ' CD2' ' A' ' 194' ' ' LEU . 0.8 OUTLIER -121.76 150.54 41.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.342 -1.093 . . . . 0.0 110.642 -179.651 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.963 ' HB3' HD12 ' A' ' 171' ' ' LEU . 0.2 OUTLIER -117.44 153.52 32.95 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.439 -0.788 . . . . 0.0 109.895 179.815 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -134.09 122.03 2.88 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.764 ' HB2' ' CH2' ' A' ' 133' ' ' TRP . 2.4 t80 -119.77 124.8 47.06 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.26 -1.141 . . . . 0.0 109.508 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.462 ' HA ' HG23 ' A' ' 185' ' ' THR . 12.5 t -103.66 122.21 44.55 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 122.135 0.969 . . . . 0.0 109.456 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 1.009 HG22 ' CD2' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -129.42 158.54 42.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.819 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.612 ' C ' ' O ' ' A' ' 182' ' ' ILE . . . -33.63 -34.77 0.03 OUTLIER Glycine 0 N--CA 1.493 2.446 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.686 ' O ' ' CD1' ' A' ' 186' ' ' TYR . . . -105.5 32.66 7.2 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.549 -1.82 . . . . 0.0 108.549 178.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' THR . . . . . 0.817 ' N ' ' O ' ' A' ' 182' ' ' ILE . 53.3 m -37.77 -26.59 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.494 -1.004 . . . . 0.0 110.871 -179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.7 ' O ' ' CD2' ' A' ' 186' ' ' TYR . 16.9 p90 -41.38 91.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 122.202 1.001 . . . . 0.0 109.316 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.669 ' C ' ' HD2' ' A' ' 189' ' ' PRO . 0.1 OUTLIER 179.81 31.2 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.542 -0.724 . . . . 0.0 109.221 -178.79 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.865 ' N ' ' CD ' ' A' ' 189' ' ' PRO . . . -105.67 2.08 39.22 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.403 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.865 ' CD ' ' N ' ' A' ' 188' ' ' GLY . 48.7 Cg_endo -75.79 -27.12 9.06 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 N-CA-C 109.426 -1.028 . . . . 0.0 109.426 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -81.43 21.97 0.73 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.631 -0.668 . . . . 0.0 110.476 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.401 ' HA ' ' HB2' ' A' ' 194' ' ' LEU . 1.8 m-85 -73.2 -48.67 33.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.11 -0.994 . . . . 0.0 109.945 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 9.5 mtm180 -52.87 -19.25 2.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.187 -0.946 . . . . 0.0 109.766 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -107.32 -17.93 10.91 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.166 -1.973 . . . . 0.0 108.166 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.98 ' CD2' HG22 ' A' ' 177' ' ' THR . 6.9 tt -62.2 -31.32 71.83 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.692 -0.887 . . . . 0.0 109.205 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.554 ' HE3' ' N ' ' A' ' 196' ' ' GLY . 0.0 OUTLIER -49.52 -27.83 4.8 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.443 -0.786 . . . . 0.0 109.407 179.534 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.554 ' N ' ' HE3' ' A' ' 195' ' ' LYS . . . -112.29 -21.59 6.17 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.642 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.77 -10.42 42.95 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.65 -0.912 . . . . 0.0 109.749 179.745 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.623 HG22 ' O ' ' A' ' 194' ' ' LEU . 0.1 OUTLIER -43.83 145.25 0.71 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.907 0.86 . . . . 0.0 111.427 -178.559 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.886 ' CB ' HG23 ' A' ' 110' ' ' THR . 0.0 OUTLIER -140.43 171.45 14.12 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.24 0.543 . . . . 0.0 109.725 179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.421 ' C ' ' CG1' ' A' ' 108' ' ' VAL . 15.8 m-30 -84.33 136.98 39.75 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.178 -0.951 . . . . 0.0 109.218 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.584 ' HG3' ' CH2' ' A' ' 91' ' ' TRP . 40.8 Cg_endo -67.03 109.82 1.81 Allowed 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 123.862 1.454 . . . . 0.0 110.814 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.548 ' HB3' ' CB ' ' A' ' 81' ' ' LYS . 57.4 p -133.47 137.2 45.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.507 -0.746 . . . . 0.0 109.595 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 79' ' ' ARG . 4.9 p -128.9 146.55 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.994 -1.066 . . . . 0.0 111.187 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 26.7 m -128.75 127.19 41.54 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 1.03 ' HB3' ' CG2' ' A' ' 78' ' ' VAL . . . -126.28 166.14 17.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 0.0 110.716 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.583 ' CG1' ' N ' ' A' ' 207' ' ' TRP . 0.9 OUTLIER -101.63 174.66 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 121.363 0.602 . . . . 0.0 110.233 -179.533 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 0.621 ' HB2' ' CG ' ' A' ' 68' ' ' ARG . 63.9 p-90 -99.01 128.43 45.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.89 . . . . 0.0 110.264 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 144.04 -147.48 18.78 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.538 ' O ' ' NE2' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -66.18 -25.25 66.85 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.345 -1.091 . . . . 0.0 110.239 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 210' ' ' CYS . . . . . 0.678 ' O ' ' C ' ' A' ' 211' ' ' GLN . 4.9 t -37.12 -30.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.593 -0.692 . . . . 0.0 110.621 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.678 ' C ' ' O ' ' A' ' 210' ' ' CYS . 10.4 mt-30 0.07 114.59 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 121.65 0.738 . . . . 0.0 111.427 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.66 ' O ' HD11 ' A' ' 64' ' ' LEU . 0.8 OUTLIER -115.62 144.09 24.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.642 -0.661 . . . . 0.0 110.668 -179.164 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.554 ' HG3' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -88.54 121.96 31.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.281 -0.887 . . . . 0.0 109.566 179.758 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 1.061 ' O ' HD13 ' A' ' 214' ' ' ILE . 0.0 OUTLIER -123.5 121.59 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 110.896 -179.241 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.653 ' N ' ' O ' ' A' ' 92' ' ' GLU . 0.2 OUTLIER -130.87 139.61 50.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.513 -0.742 . . . . 0.0 109.665 179.495 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 216' ' ' TYR . . . . . 0.717 ' CE2' ' CD1' ' A' ' 91' ' ' TRP . 0.9 OUTLIER -118.7 150.76 39.21 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.965 -1.085 . . . . 0.0 110.728 -179.439 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 217' ' ' MET . . . . . 0.494 ' CB ' ' O ' ' A' ' 90' ' ' ALA . 2.0 ttm -125.08 107.82 11.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.305 -0.872 . . . . 0.0 110.039 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 116.54 21.59 4.67 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.477 ' OE1' ' N ' ' A' ' 220' ' ' ARG . 0.0 OUTLIER -104.72 117.86 35.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.108 -1.23 . . . . 0.0 110.23 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.477 ' N ' ' OE1' ' A' ' 219' ' ' GLU . 0.9 OUTLIER -126.38 148.26 49.63 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.286 -0.884 . . . . 0.0 110.199 -179.923 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 221' ' ' ARG . . . . . 0.516 ' O ' ' C ' ' A' ' 222' ' ' VAL . 0.8 OUTLIER -154.6 94.44 1.68 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.247 -0.908 . . . . 0.0 110.258 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.516 ' C ' ' O ' ' A' ' 221' ' ' ARG . 9.6 p -34.49 135.47 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.485 -0.759 . . . . 0.0 110.476 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.524 ' O ' ' C ' ' A' ' 224' ' ' GLU . 0.8 OUTLIER 179.88 -78.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.934 . . . . 0.0 110.206 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.524 ' C ' ' O ' ' A' ' 223' ' ' GLU . 0.0 OUTLIER -32.1 -51.5 0.25 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.456 -0.777 . . . . 0.0 110.669 -179.779 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.503 ' N ' ' OE1' ' A' ' 224' ' ' GLU . 91.5 m -58.71 81.82 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.204 -0.935 . . . . 0.0 110.218 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 224' ' ' GLU . 0.0 OUTLIER -129.32 14.13 6.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 0.0 110.175 -179.858 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.68 -32.18 72.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.304 -0.872 . . . . 0.0 110.132 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 30.5 pt -52.13 139.54 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -0.919 . . . . 0.0 110.167 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -77.57 -44.21 29.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.247 -0.908 . . . . 0.0 110.166 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' ARG . . . . . 0.418 ' O ' ' OD1' ' A' ' 231' ' ' ASP . 0.3 OUTLIER -47.69 99.83 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.18 -0.95 . . . . 0.0 110.259 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 230' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--N 1.305 -1.351 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.376 179.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.78 172.08 0.79 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.302 -1.117 . . . . 0.0 110.182 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 9' ' ' ALA . 0.1 OUTLIER -163.15 178.92 7.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.332 -0.855 . . . . 0.0 110.165 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.41 ' N ' ' OG ' ' A' ' 8' ' ' SER . . . -124.52 -4.75 7.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.273 -0.892 . . . . 0.0 110.243 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.1 -68.08 0.38 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.177 -0.952 . . . . 0.0 110.208 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -175.45 -35.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.185 -0.947 . . . . 0.0 110.221 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.8 t -70.7 68.47 0.4 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.343 -0.848 . . . . 0.0 110.185 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.572 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -68.13 -54.11 16.94 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.206 -0.934 . . . . 0.0 110.347 179.89 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 13' ' ' THR . 45.7 Cg_endo -73.0 -167.61 0.36 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.867 1.456 . . . . 0.0 110.467 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 16' ' ' SER . 0.3 OUTLIER -78.68 -145.9 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.25 -0.906 . . . . 0.0 110.23 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.435 ' H ' HG22 ' A' ' 15' ' ' THR . 0.1 OUTLIER -176.39 152.63 1.1 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.344 -0.847 . . . . 0.0 110.218 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -115.94 150.92 36.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.302 -0.874 . . . . 0.0 110.15 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.95 101.73 2.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.113 -0.992 . . . . 0.0 110.221 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.8 -5.27 42.53 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 122.245 1.021 . . . . 0.0 110.088 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -55.95 -176.04 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.338 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.101 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.38 -149.03 0.38 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.281 -0.887 . . . . 0.0 110.182 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.428 ' OD1' ' NE2' ' A' ' 73' ' ' GLN . 1.2 p-10 -120.39 -110.55 0.34 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.298 -0.876 . . . . 0.0 109.896 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.27 -71.41 0.4 Allowed 'General case' 0 C--N 1.284 -2.282 0 CA-C-O 121.384 0.611 . . . . 0.0 110.242 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 t -83.33 125.33 74.52 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.316 -0.865 . . . . 0.0 110.175 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.99 136.5 24.99 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.86 1.453 . . . . 0.0 110.449 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.541 ' HG2' ' CB ' ' A' ' 74' ' ' SER . 44.4 Cg_endo -72.36 160.41 47.02 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.042 1.549 . . . . 0.0 110.631 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -167.54 43.88 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.381 -0.824 . . . . 0.0 109.736 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.418 ' O ' ' HG2' ' A' ' 30' ' ' GLU . . . 134.74 28.42 0.45 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.935 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -42.15 -32.19 0.45 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.324 -1.104 . . . . 0.0 109.982 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.54 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 3.0 pt-20 -48.42 -35.71 13.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.052 -1.03 . . . . 0.0 108.691 179.049 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -59.13 -26.09 64.42 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -77.73 -36.01 51.35 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.457 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.896 HD12 ' C ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -76.3 -38.85 55.49 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.663 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.564 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -45.92 -26.62 0.73 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.454 0.645 . . . . 0.0 109.925 179.891 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 1.087 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -52.16 -168.47 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.567 -0.708 . . . . 0.0 109.376 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 1.087 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 39.7 Cg_endo -67.07 104.53 0.86 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.448 1.236 . . . . 0.0 109.704 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.846 ' HG2' HG21 ' A' ' 41' ' ' VAL . 51.1 Cg_endo -90.84 115.24 0.46 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.284 1.676 . . . . 0.0 111.49 -178.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.902 ' O ' ' N ' ' A' ' 40' ' ' LEU . 50.6 Cg_endo -86.13 152.59 9.57 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 124.087 1.572 . . . . 0.0 110.493 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.676 ' C ' ' O ' ' A' ' 38' ' ' PRO . 0.4 OUTLIER 4.26 53.68 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 122.313 1.054 . . . . 0.0 110.185 -178.258 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.203 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -129.64 -39.62 1.44 Allowed 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.934 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.846 HG21 ' HG2' ' A' ' 37' ' ' PRO . 1.6 t -78.38 -36.4 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 118.751 -1.179 . . . . 0.0 111.69 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.67 ' HB3' ' NE2' ' A' ' 43' ' ' GLN . . . -74.71 -37.79 62.5 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.585 -1.322 . . . . 0.0 111.681 -178.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.745 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 14.6 mp0 -87.35 -20.27 26.99 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.822 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 6.6 ttm180 -65.88 -50.6 63.92 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 122.511 1.148 . . . . 0.0 108.085 178.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.699 ' CE1' HG12 ' A' ' 41' ' ' VAL . 34.5 m170 -68.68 -17.79 64.14 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.707 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -96.6 -33.19 11.88 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.335 -0.853 . . . . 0.0 109.526 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 43' ' ' GLN . . . -87.3 -113.59 1.0 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.995 ' HE1' HG21 ' A' ' 59' ' ' VAL . 11.9 m95 -86.29 74.31 10.02 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.027 -1.278 . . . . 0.0 108.61 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.633 ' OD1' ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -51.29 127.43 29.96 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.507 -0.746 . . . . 0.0 111.104 -178.92 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.59 ' C ' ' H ' ' A' ' 52' ' ' ASP . 50.3 Cg_endo -86.64 2.48 7.16 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.339 2.026 . . . . 0.0 111.884 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.958 ' HE2' ' HA ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -57.06 -2.19 0.08 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.651 -1.281 . . . . 0.0 109.365 -179.256 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.668 ' HB3' ' HE ' ' A' ' 79' ' ' ARG . 0.3 OUTLIER -117.83 -9.46 10.66 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.668 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.589 ' CB ' ' HB3' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -155.65 -178.6 7.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.422 -0.799 . . . . 0.0 110.705 -179.474 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.684 ' HB2' HD22 ' A' ' 56' ' ' ASN . 5.0 p -68.51 143.09 55.08 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.235 -0.916 . . . . 0.0 109.767 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.749 ' CG ' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -98.78 7.71 45.76 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.654 -0.654 . . . . 0.0 111.199 -178.796 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.684 HD22 ' HB2' ' A' ' 54' ' ' SER . 0.0 OUTLIER -27.16 -38.12 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 122.031 0.919 . . . . 0.0 109.42 -179.751 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.654 ' N ' ' O ' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -140.0 145.81 25.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.729 ' OD1' ' HA ' ' A' ' 44' ' ' ARG . 0.8 OUTLIER -149.99 158.63 44.36 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 118.789 -1.164 . . . . 0.0 110.867 -179.873 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.995 HG21 ' HE1' ' A' ' 48' ' ' TRP . 1.5 m -114.02 138.45 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.791 0.805 . . . . 0.0 111.92 -177.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.745 ' HA ' ' HB3' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -102.37 152.65 20.84 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.912 179.177 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.459 ' O ' ' O ' ' A' ' 60' ' ' LYS . 1.8 tt0 -60.81 -132.84 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.26 -0.9 . . . . 0.0 110.309 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 44.48 27.71 1.33 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.68 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 131.44 39.73 0.24 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 -179.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.68 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.3 OUTLIER 0.6 87.4 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.897 -0.766 . . . . 0.0 111.026 -179.456 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.967 ' C ' ' HB ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -140.3 134.88 31.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.433 -0.792 . . . . 0.0 110.973 -179.487 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.845 ' CD2' ' CG1' ' A' ' 59' ' ' VAL . 46.1 m-85 -80.14 148.58 30.88 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.599 0.714 . . . . 0.0 110.054 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -128.67 121.63 28.98 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.603 -0.685 . . . . 0.0 109.653 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.866 ' NE ' ' HB2' ' A' ' 72' ' ' ALA . 6.3 ttt-85 -119.06 130.67 55.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.923 . . . . 0.0 110.214 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.706 ' CB ' ' HD3' ' A' ' 70' ' ' PRO . 9.0 mtm-85 -69.81 -74.0 0.17 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.926 . . . . 0.0 110.376 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.706 ' HD3' ' CB ' ' A' ' 69' ' ' ARG . 57.0 Cg_endo -75.82 -112.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.246 1.13 . . . . 0.0 109.544 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.545 ' O ' ' NH1' ' A' ' 68' ' ' ARG . 1.9 t -140.68 158.14 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.551 -1.343 . . . . 0.0 110.087 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.866 ' HB2' ' NE ' ' A' ' 68' ' ' ARG . . . -97.03 109.94 22.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.135 -0.978 . . . . 0.0 109.823 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.428 ' NE2' ' OD1' ' A' ' 22' ' ' ASP . 0.0 OUTLIER 179.88 53.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.141 -0.975 . . . . 0.0 110.712 -179.48 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.541 ' CB ' ' HG2' ' A' ' 26' ' ' PRO . 0.5 OUTLIER 179.81 -61.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.054 -1.029 . . . . 0.0 110.636 179.832 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.9 m -81.9 -127.56 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.189 -0.944 . . . . 0.0 110.27 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.613 ' O ' ' O ' ' A' ' 77' ' ' GLY . 0.6 OUTLIER -140.01 116.03 10.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.142 -0.974 . . . . 0.0 109.885 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.613 ' O ' ' O ' ' A' ' 76' ' ' ASP . . . -37.98 -100.03 0.01 OUTLIER Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.455 HG21 ' O ' ' A' ' 48' ' ' TRP . 0.2 OUTLIER -158.87 150.05 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.067 -1.255 . . . . 0.0 110.255 179.379 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.668 ' HE ' ' HB3' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -143.56 171.01 14.76 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.666 -0.646 . . . . 0.0 109.82 179.856 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.53 ' N ' ' CG ' ' A' ' 79' ' ' ARG . . . -150.26 133.12 4.22 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.549 ' CG ' ' O ' ' A' ' 201' ' ' PRO . 0.0 OUTLIER -155.07 55.06 0.65 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.297 -1.12 . . . . 0.0 110.245 179.837 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.473 ' O ' ' C ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -125.43 -88.31 0.59 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.915 . . . . 0.0 110.069 179.88 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.473 ' C ' ' O ' ' A' ' 82' ' ' ARG . . . 40.63 58.42 2.57 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -94.45 95.93 9.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.353 -1.087 . . . . 0.0 110.376 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' A' ' 173' ' ' MET . 38.3 m -136.88 168.07 20.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -0.851 . . . . 0.0 109.948 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.456 ' HA ' ' HB3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -112.47 143.99 42.68 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.22 -0.925 . . . . 0.0 109.835 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.67 -120.34 5.23 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.486 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 13.9 tp -128.36 135.63 49.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.318 -1.107 . . . . 0.0 110.395 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.486 ' CG ' ' C ' ' A' ' 88' ' ' LEU . 8.0 m-70 -147.08 156.34 42.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.207 -0.933 . . . . 0.0 109.569 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.23 138.09 6.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.069 -1.02 . . . . 0.0 110.875 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 1.028 ' CZ2' HG11 ' A' ' 169' ' ' VAL . 3.7 p90 -135.27 171.12 14.89 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.404 -0.81 . . . . 0.0 109.456 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 215' ' ' ARG . 23.7 tt0 -135.63 156.82 48.24 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.474 -0.89 . . . . 0.0 111.352 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.668 HD13 HG13 ' A' ' 214' ' ' ILE . 27.9 mm -143.59 141.89 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.555 -0.716 . . . . 0.0 109.637 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.574 ' HB3' ' HA ' ' A' ' 166' ' ' ARG . 2.9 p -155.84 146.36 21.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.886 -1.134 . . . . 0.0 110.777 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.924 ' CE3' HG22 ' A' ' 212' ' ' VAL . 39.4 m95 -116.81 87.46 21.98 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.321 -0.862 . . . . 0.0 109.269 178.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.532 ' HG2' ' HG3' ' A' ' 213' ' ' ARG . 51.9 Cg_endo -95.72 108.42 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.719 1.378 . . . . 0.0 111.015 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.814 HD22 ' HA ' ' A' ' 211' ' ' GLN . 0.1 OUTLIER -96.68 -67.77 0.83 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.973 -1.079 . . . . 0.0 109.586 178.572 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -98.71 -40.49 8.14 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.571 -0.706 . . . . 0.0 109.574 179.194 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.454 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 4.4 tp60 179.65 -27.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.708 -0.62 . . . . 0.0 110.1 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.479 ' NH1' ' HG2' ' A' ' 100' ' ' ARG . 4.2 mmp_? -101.74 -79.79 0.51 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.414 -0.804 . . . . 0.0 110.267 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.728 ' O ' HG23 ' A' ' 102' ' ' THR . . . -175.74 -166.5 33.33 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.728 HG23 ' O ' ' A' ' 101' ' ' GLY . 0.0 OUTLIER -179.14 -87.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.097 -1.237 . . . . 0.0 110.6 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.617 ' O ' ' CE3' ' A' ' 95' ' ' TRP . 38.0 m-70 -106.22 157.38 17.62 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.205 -0.934 . . . . 0.0 110.584 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.773 ' HA ' ' CH2' ' A' ' 95' ' ' TRP . . . 179.63 133.01 0.1 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.459 -0.776 . . . . 0.0 109.768 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.779 HG23 ' CB ' ' A' ' 204' ' ' SER . 35.1 m -134.95 115.6 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 O-C-N 120.331 -1.481 . . . . 0.0 110.875 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.796 ' HB ' HG23 ' A' ' 203' ' ' VAL . 2.7 p -150.8 149.72 14.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 O-C-N 121.518 -0.739 . . . . 0.0 109.399 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.612 ' HA2' ' HA3' ' A' ' 132' ' ' GLY . . . -162.7 148.89 16.22 Favored Glycine 0 N--CA 1.485 1.952 0 C-N-CA 118.984 -1.579 . . . . 0.0 110.985 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.875 HG12 ' HG ' ' A' ' 199' ' ' LEU . 11.8 t -105.78 156.97 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.707 -0.878 . . . . 0.0 108.947 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.802 ' CA ' HD12 ' A' ' 199' ' ' LEU . . . -150.11 146.69 27.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.728 -1.233 . . . . 0.0 111.501 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . 1.0 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -114.18 138.33 50.59 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.561 0.696 . . . . 0.0 109.65 179.268 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.87 -24.45 18.47 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.532 -0.73 . . . . 0.0 109.064 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.672 ' O ' ' C ' ' A' ' 113' ' ' ALA . 0.7 OUTLIER -86.68 -12.21 49.01 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.555 -0.716 . . . . 0.0 109.268 179.08 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.672 ' C ' ' O ' ' A' ' 112' ' ' LEU . . . 0.12 96.31 0.03 OUTLIER Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 122.04 -0.412 . . . . 0.0 111.192 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.4 -158.3 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.967 1.509 . . . . 0.0 110.363 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.684 HD23 ' O ' ' A' ' 115' ' ' LEU . 1.0 OUTLIER -175.84 49.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.148 -0.97 . . . . 0.0 110.271 179.95 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -121.08 -30.7 4.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 110.164 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.531 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -110.5 -5.76 15.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.341 -0.849 . . . . 0.0 110.163 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.531 ' C ' ' O ' ' A' ' 117' ' ' ALA . 12.8 t0 -32.14 149.05 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.539 -0.726 . . . . 0.0 110.789 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.466 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 4.4 m-70 -106.23 113.93 27.75 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.173 -0.955 . . . . 0.0 110.34 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.462 ' HB2' ' O ' ' A' ' 119' ' ' HIS . 3.7 m-85 59.77 13.84 3.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 0.0 110.239 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.753 ' O ' ' HB3' ' A' ' 122' ' ' ALA . . . 42.87 -129.02 0.71 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.187 -0.946 . . . . 0.0 110.259 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.753 ' HB3' ' O ' ' A' ' 121' ' ' ALA . . . 70.82 66.54 0.18 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.216 -0.927 . . . . 0.0 110.269 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.474 HD22 ' O ' ' A' ' 122' ' ' ALA . 0.5 OUTLIER -125.73 149.7 48.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.114 -0.991 . . . . 0.0 110.118 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 tp -87.22 125.73 34.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.324 -0.86 . . . . 0.0 110.228 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 62.39 168.78 0.82 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.09 20.45 3.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -1.149 . . . . 0.0 110.273 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 127' ' ' ASN . 2.0 m120 -97.29 -29.66 13.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.251 -0.906 . . . . 0.0 110.141 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.6 m -150.7 155.07 38.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.244 -0.91 . . . . 0.0 110.076 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 14.7 tm-20 -126.41 115.99 20.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.18 -0.95 . . . . 0.0 109.949 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 48.5 t -120.21 119.37 33.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 110.458 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' TRP . . . . . 0.448 ' HB2' ' OE2' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -133.55 125.34 28.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.468 -0.77 . . . . 0.0 109.764 179.634 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.612 ' HA3' ' HA2' ' A' ' 107' ' ' GLY . . . -170.18 -143.33 3.89 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.948 ' CZ3' HD22 ' A' ' 167' ' ' LEU . 53.7 m0 -115.95 113.48 23.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -1.169 . . . . 0.0 110.317 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.936 ' O ' HG23 ' A' ' 135' ' ' ILE . 3.9 p30 -118.25 131.29 56.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.649 -0.657 . . . . 0.0 110.391 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.936 HG23 ' O ' ' A' ' 134' ' ' ASP . 1.0 OUTLIER -171.6 34.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.278 -0.889 . . . . 0.0 110.248 179.837 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.54 ' HA3' ' CG1' ' A' ' 105' ' ' VAL . . . -131.89 -49.35 0.1 Allowed Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.62 8.2 35.21 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.432 -1.04 . . . . 0.0 109.721 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.51 ' O ' ' O ' ' A' ' 139' ' ' LYS . . . 54.59 58.44 13.27 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.675 ' O ' ' C ' ' A' ' 140' ' ' LEU . 1.1 mmtt -57.92 -143.56 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.294 -1.121 . . . . 0.0 110.407 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.675 ' C ' ' O ' ' A' ' 139' ' ' LYS . 0.7 OUTLIER 0.69 75.52 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.76 -0.588 . . . . 0.0 111.257 -179.87 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.674 ' C ' ' O ' ' A' ' 140' ' ' LEU . 0.3 OUTLIER 0.18 75.52 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.277 0.56 . . . . 0.0 111.408 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -82.91 10.61 7.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.909 . . . . 0.0 110.122 179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 145' ' ' LYS . 9.8 tp-100 -51.91 -49.74 62.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.309 -0.869 . . . . 0.0 110.261 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 143' ' ' GLN . 22.1 t -42.41 94.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.377 -0.827 . . . . 0.0 110.205 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 143' ' ' GLN . 0.1 OUTLIER -71.35 -156.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 110.228 179.945 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.448 ' C ' HD23 ' A' ' 147' ' ' LEU . . . -165.66 -99.94 0.14 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.448 HD23 ' C ' ' A' ' 146' ' ' GLY . 0.3 OUTLIER -161.64 30.52 0.13 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.35 -1.089 . . . . 0.0 110.058 -179.941 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -53.43 145.02 15.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.336 -0.853 . . . . 0.0 110.219 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 153' ' ' PRO . . . -156.49 148.16 17.11 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 110.105 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.09 -1.38 10.45 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.005 1.529 . . . . 0.0 110.502 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 9.5 mp0 -76.35 -91.37 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 110.245 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.587 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 2.4 m-85 -78.31 -60.69 0.62 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.186 -0.946 . . . . 0.0 110.293 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.587 ' CD ' ' CB ' ' A' ' 152' ' ' TYR . 45.7 Cg_endo -72.72 171.02 18.16 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.964 1.507 . . . . 0.0 110.463 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 155' ' ' GLY . . . -93.19 114.08 26.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.907 . . . . 0.0 110.169 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 154' ' ' ALA . . . -42.26 163.85 0.02 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.577 ' O ' ' CB ' ' A' ' 160' ' ' GLN . 45.2 Cg_endo -72.44 -9.31 24.0 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.963 1.507 . . . . 0.0 110.322 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -0.34 4.16 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.188 -0.945 . . . . 0.0 110.577 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 162' ' ' VAL . . . -92.31 -80.44 1.44 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.572 ' HA ' HG23 ' A' ' 163' ' ' VAL . 30.9 mt-10 -109.62 3.27 20.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.234 -1.156 . . . . 0.0 111.069 -179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.63 ' O ' HG22 ' A' ' 135' ' ' ILE . 0.9 OUTLIER -73.06 -17.13 61.45 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.172 -0.955 . . . . 0.0 109.223 179.436 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.822 ' O ' HG23 ' A' ' 162' ' ' VAL . 12.1 mt -156.75 21.29 0.33 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.852 0.834 . . . . 0.0 109.208 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 161' ' ' LEU . 2.7 t -163.54 98.2 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.801 -0.562 . . . . 0.0 109.895 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.715 ' H ' ' HD2' ' A' ' 164' ' ' PRO . 1.3 t -134.95 -59.19 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.088 -1.008 . . . . 0.0 110.127 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.728 ' CD ' HD11 ' A' ' 135' ' ' ILE . 48.6 Cg_endo -77.28 55.22 4.99 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.714 1.376 . . . . 0.0 110.839 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 100' ' ' ARG . 24.2 tt0 -64.0 -58.67 6.0 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.629 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 2.1 ttp180 -151.59 115.44 4.92 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.98 HD23 HG23 ' A' ' 182' ' ' ILE . 0.7 OUTLIER -150.25 158.27 43.97 Favored 'General case' 0 C--N 1.287 -2.131 0 O-C-N 121.676 -0.64 . . . . 0.0 110.735 -178.711 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.428 ' HA ' ' HG3' ' A' ' 92' ' ' GLU . 1.7 tp -103.86 139.73 38.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.425 -0.797 . . . . 0.0 109.36 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 1.028 HG11 ' CZ2' ' A' ' 91' ' ' TRP . 1.8 t -105.78 130.25 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.091 -1.006 . . . . 0.0 110.439 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.0 t -100.14 125.76 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.524 -0.735 . . . . 0.0 110.058 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.708 HD22 ' HZ3' ' A' ' 91' ' ' TRP . 13.3 tp -133.27 106.24 7.44 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.141 -0.975 . . . . 0.0 110.127 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 173' ' ' MET . 50.4 t0 -119.71 137.81 53.69 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.188 -0.945 . . . . 0.0 110.095 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.489 ' HB2' ' O ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -93.48 -40.48 10.31 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.654 -0.654 . . . . 0.0 109.857 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 173' ' ' MET . 37.5 tt0 -43.13 -26.34 0.15 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.272 -0.893 . . . . 0.0 109.11 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.736 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.2 OUTLIER -113.88 -25.75 8.47 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.832 0.825 . . . . 0.0 108.894 179.33 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.564 ' O ' HG22 ' A' ' 198' ' ' THR . . . 78.83 27.89 55.73 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 108.139 -1.984 . . . . 0.0 108.139 -178.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' THR . . . . . 1.123 ' CG2' HD22 ' A' ' 194' ' ' LEU . 0.0 OUTLIER -112.64 143.17 44.29 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.28 -1.129 . . . . 0.0 111.608 -179.182 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.71 HD21 ' O ' ' A' ' 199' ' ' LEU . 0.5 OUTLIER -148.66 154.2 39.33 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.671 -0.643 . . . . 0.0 109.615 179.377 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.976 ' HA3' HD22 ' A' ' 187' ' ' LEU . . . -174.13 166.2 38.15 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.994 ' CD1' HG22 ' A' ' 169' ' ' VAL . 1.7 t80 -118.95 117.52 29.04 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.368 -1.077 . . . . 0.0 109.73 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 186' ' ' TYR . 6.9 t -146.01 165.18 29.8 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.167 -0.958 . . . . 0.0 110.197 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.98 HG23 HD23 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -100.12 116.47 43.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.734 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 71.04 6.92 61.43 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.99 43.1 18.07 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 1.7 m -101.18 -69.52 0.77 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.241 -1.152 . . . . 0.0 110.957 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.539 ' O ' ' N ' ' A' ' 188' ' ' GLY . 6.7 m-30 -45.1 -83.52 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.14 -0.975 . . . . 0.0 110.907 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.976 HD22 ' HA3' ' A' ' 179' ' ' GLY . 0.1 OUTLIER -66.98 43.95 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.87 -1.144 . . . . 0.0 110.202 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 186' ' ' TYR . . . -91.46 -63.4 1.18 Allowed Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.927 -1.13 . . . . 0.0 110.581 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.491 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 46.6 Cg_endo -72.54 -30.25 12.4 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.859 1.452 . . . . 0.0 111.476 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.591 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -74.1 29.4 0.08 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.232 -0.918 . . . . 0.0 111.572 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.544 ' CE1' ' O ' ' A' ' 187' ' ' LEU . 1.2 m-30 -90.53 -14.85 31.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.769 -1.207 . . . . 0.0 110.409 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.505 ' N ' ' HD2' ' A' ' 192' ' ' ARG . 0.0 OUTLIER -90.09 -13.66 35.35 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.328 -0.858 . . . . 0.0 110.283 -179.701 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -110.91 -12.57 15.75 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 107.707 -2.157 . . . . 0.0 107.707 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 1.123 HD22 ' CG2' ' A' ' 177' ' ' THR . 5.4 tt -67.28 -37.62 83.74 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.486 ' CA ' HG23 ' A' ' 198' ' ' THR . 0.0 OUTLIER -44.66 -37.27 3.56 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.561 -0.712 . . . . 0.0 109.787 179.51 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.91 -27.83 30.47 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.715 ' NE ' ' HG ' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -90.26 -3.34 57.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.707 -0.878 . . . . 0.0 109.942 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 194' ' ' LEU . 15.8 p -41.1 114.52 0.5 Allowed 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.996 0.903 . . . . 0.0 110.042 -178.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 1.0 ' CB ' HG23 ' A' ' 110' ' ' THR . 2.6 pt? -139.42 171.63 13.98 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.05 -178.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.437 ' N ' ' CD1' ' A' ' 200' ' ' TYR . 5.9 m-85 -84.46 129.44 57.57 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.911 -1.118 . . . . 0.0 110.189 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.854 ' HA ' HG13 ' A' ' 108' ' ' VAL . 52.8 Cg_endo -84.88 135.98 5.86 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 124.12 1.59 . . . . 0.0 111.164 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.548 ' CB ' ' HB2' ' A' ' 81' ' ' LYS . 3.7 p -133.39 136.99 45.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.292 -0.88 . . . . 0.0 109.993 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.796 HG23 ' HB ' ' A' ' 106' ' ' VAL . 3.9 p -122.44 155.39 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -0.961 . . . . 0.0 109.938 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' SER . . . . . 0.779 ' CB ' HG23 ' A' ' 105' ' ' VAL . 2.7 t -130.81 127.5 38.79 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.168 -0.957 . . . . 0.0 110.684 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.695 ' HB1' HG11 ' A' ' 212' ' ' VAL . . . -119.06 154.28 33.4 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.01 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.717 HG12 ' OE1' ' A' ' 211' ' ' GLN . 2.9 p -115.11 -172.49 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 110.284 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 0.743 ' CE3' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -82.77 165.36 19.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.293 -0.879 . . . . 0.0 110.182 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 132.18 131.72 3.25 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.405 ' HG2' ' N ' ' A' ' 210' ' ' CYS . 7.9 tt0 -62.36 -87.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -1.15 . . . . 0.0 110.303 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' CYS . . . . . 0.527 ' O ' HD22 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -81.18 83.39 6.82 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.323 -0.861 . . . . 0.0 110.541 -179.83 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.814 ' HA ' HD22 ' A' ' 97' ' ' LEU . 2.5 tt0 -155.6 -42.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.187 -0.946 . . . . 0.0 110.659 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.924 HG22 ' CE3' ' A' ' 95' ' ' TRP . 88.3 t -127.27 132.68 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.986 -1.071 . . . . 0.0 111.194 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.532 ' HG3' ' HG2' ' A' ' 96' ' ' PRO . 0.4 OUTLIER -139.86 149.16 43.08 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.42 -0.8 . . . . 0.0 109.811 179.559 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.825 HG22 ' CZ2' ' A' ' 48' ' ' TRP . 5.9 tt -144.31 143.89 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.086 -1.009 . . . . 0.0 111.436 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.564 ' O ' ' N ' ' A' ' 92' ' ' GLU . 15.1 mtt180 -130.21 108.72 10.25 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' TYR . . . . . 0.721 ' CD2' ' CB ' ' A' ' 91' ' ' TRP . 2.4 t80 -116.29 146.76 42.15 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.031 -1.043 . . . . 0.0 111.435 -177.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' MET . . . . . 0.519 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 5.6 tmm? -136.41 107.93 6.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.561 -0.712 . . . . 0.0 109.706 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 149.81 -40.26 0.86 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -95.37 117.93 31.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.165 -1.197 . . . . 0.0 110.205 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.449 ' HG2' ' HG2' ' A' ' 221' ' ' ARG . 0.0 OUTLIER -144.32 -75.92 0.23 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.335 -0.853 . . . . 0.0 110.155 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 221' ' ' ARG . . . . . 0.5 ' CG ' ' O ' ' A' ' 221' ' ' ARG . 0.7 OUTLIER -170.63 98.3 0.24 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.241 -0.912 . . . . 0.0 110.198 179.89 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.495 ' C ' ' O ' ' A' ' 221' ' ' ARG . 9.1 p -34.24 133.56 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.477 -0.764 . . . . 0.0 110.582 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.529 ' O ' ' C ' ' A' ' 224' ' ' GLU . 0.6 OUTLIER -83.22 20.58 1.25 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.217 -0.927 . . . . 0.0 110.566 -179.846 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.529 ' C ' ' O ' ' A' ' 223' ' ' GLU . 0.0 OUTLIER -31.09 -62.4 0.17 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.496 -0.753 . . . . 0.0 110.781 -179.751 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.416 ' O ' ' O ' ' A' ' 223' ' ' GLU . 14.6 t -48.0 155.36 0.45 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.265 -0.897 . . . . 0.0 110.207 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -148.35 70.57 1.14 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.0 110.243 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.55 136.09 33.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.207 -0.933 . . . . 0.0 110.233 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 61.4 mt -104.11 -57.16 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.292 -0.88 . . . . 0.0 110.194 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -165.84 60.4 0.11 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.315 -0.865 . . . . 0.0 110.184 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' ARG . . . . . 0.683 ' O ' ' C ' ' A' ' 231' ' ' ASP . 0.0 OUTLIER -49.47 -87.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.3 -0.875 . . . . 0.0 110.233 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.683 ' C ' ' O ' ' A' ' 230' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 118.073 -0.965 . . . . 0.0 111.515 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.02 -5.6 11.43 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.224 -1.162 . . . . 0.0 110.112 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.7 t 60.05 159.3 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.915 . . . . 0.0 110.231 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -144.88 -41.55 0.24 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.135 -0.978 . . . . 0.0 110.201 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.6 ptt-85 -143.87 39.14 1.35 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.114 -0.991 . . . . 0.0 110.137 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.13 94.33 1.93 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 0.0 110.173 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.5 0.98 55.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.92 . . . . 0.0 110.279 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.749 ' O ' HG23 ' A' ' 13' ' ' THR . 9.7 t -111.48 98.25 39.65 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.22 -0.925 . . . . 0.0 110.215 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.17 -89.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.999 1.526 . . . . 0.0 110.405 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.7 12.65 22.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.911 . . . . 0.0 110.159 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.0 p -59.77 127.91 34.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.223 -0.923 . . . . 0.0 110.217 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -115.25 -20.48 10.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.344 -0.847 . . . . 0.0 110.235 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -171.2 113.4 0.38 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.914 . . . . 0.0 110.166 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.414 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 3.9 mm? -66.2 -169.66 0.07 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.264 -0.897 . . . . 0.0 110.201 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.501 ' C ' ' CD1' ' A' ' 20' ' ' TYR . 0.1 OUTLIER -56.11 -169.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.221 -0.925 . . . . 0.0 110.377 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.0 p -150.26 -151.2 0.38 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 0.0 110.134 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -82.8 45.16 0.97 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.892 . . . . 0.0 110.141 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.76 -40.62 15.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 110.236 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.18 137.68 20.83 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.366 -0.834 . . . . 0.0 110.362 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.511 ' HB2' ' HD2' ' A' ' 26' ' ' PRO . 45.9 Cg_endo -73.24 175.35 10.67 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.038 1.547 . . . . 0.0 110.401 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.511 ' HD2' ' HB2' ' A' ' 25' ' ' PRO . 45.2 Cg_endo -72.09 163.84 37.5 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.973 1.512 . . . . 0.0 110.421 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.436 ' HG3' ' C ' ' A' ' 26' ' ' PRO . 31.8 mt-10 -146.24 36.41 1.01 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 110.278 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.08 20.98 74.82 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.947 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -45.75 -31.57 2.08 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.476 -1.014 . . . . 0.0 109.822 179.963 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.711 ' HA ' HD23 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -48.81 -34.26 12.04 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.16 -0.963 . . . . 0.0 109.279 179.625 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.77 -21.96 66.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.438 -0.789 . . . . 0.0 109.077 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.452 HD22 ' HA ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -83.37 -35.73 24.9 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.783 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.925 HD11 HH21 ' A' ' 44' ' ' ARG . 0.3 OUTLIER -68.56 -37.08 79.62 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 122.071 0.939 . . . . 0.0 109.002 178.959 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.637 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 3.5 m -76.84 -7.88 56.3 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.387 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 1.025 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -36.63 -59.61 0.86 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.421 -0.8 . . . . 0.0 110.034 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 1.039 ' O ' HD12 ' A' ' 40' ' ' LEU . 48.2 Cg_endo -74.36 108.42 2.67 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.146 1.603 . . . . 0.0 110.337 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.756 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 48.5 Cg_endo -74.36 -25.2 13.51 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.987 1.519 . . . . 0.0 112.7 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.756 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 43.8 Cg_endo -69.18 152.0 72.32 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 122.944 0.971 . . . . 0.0 112.163 -178.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.744 ' HA ' ' HG3' ' A' ' 43' ' ' GLN . 0.0 OUTLIER 3.56 66.83 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 123.121 1.439 . . . . 0.0 111.092 -179.072 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.039 HD12 ' O ' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -156.66 -44.97 0.07 Allowed 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 177.863 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.754 ' O ' ' CD2' ' A' ' 45' ' ' HIS . 2.8 t -87.71 -31.1 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.785 177.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.54 -44.3 10.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.323 -0.861 . . . . 0.0 111.573 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.865 ' HB2' ' HA ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -74.78 -19.32 60.26 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.178 -0.951 . . . . 0.0 110.523 -179.28 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.925 HH21 HD11 ' A' ' 33' ' ' LEU . 2.8 ttp85 -82.29 -41.6 19.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.869 . . . . 0.0 110.066 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.754 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 1.7 m-70 -68.81 -17.03 63.95 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.717 -0.614 . . . . 0.0 111.353 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.416 ' O ' ' O ' ' A' ' 47' ' ' GLY . 6.0 t60 -95.21 -32.96 12.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.752 -1.218 . . . . 0.0 110.102 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.671 ' HA2' HD22 ' A' ' 64' ' ' LEU . . . -62.45 -99.43 0.01 OUTLIER Glycine 0 N--CA 1.488 2.164 0 N-CA-C 106.447 -2.661 . . . . 0.0 106.447 178.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.906 ' CE2' ' HB ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -100.14 95.44 6.83 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 175.945 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.822 ' O ' ' HB3' ' A' ' 53' ' ' CYS . 0.0 OUTLIER -42.33 111.36 0.94 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.644 -0.66 . . . . 0.0 111.679 -178.202 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.614 ' HA ' ' CB ' ' A' ' 53' ' ' CYS . 47.7 Cg_endo -73.49 0.69 7.73 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 122.625 2.217 . . . . 0.0 112.172 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.733 ' H ' ' CE ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -65.02 -31.68 73.04 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 177.928 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.727 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 3.2 m-20 -116.12 -12.58 11.23 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 113.46 -1.7 . . . . 0.0 106.668 176.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.822 ' HB3' ' O ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -108.22 157.82 18.0 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.656 0.741 . . . . 0.0 110.913 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.503 ' HB2' ' O ' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -75.78 142.61 42.29 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.552 0.692 . . . . 0.0 110.008 179.345 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.639 ' HG3' HD21 ' A' ' 33' ' ' LEU . 1.1 pm0 -99.33 -4.35 31.92 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.562 -0.711 . . . . 0.0 110.459 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.904 HD22 ' CG2' ' A' ' 75' ' ' THR . 7.5 m120 -50.39 -12.67 0.1 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.629 -0.669 . . . . 0.0 110.805 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.61 HG13 ' CZ3' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -124.7 169.0 16.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.288 -0.882 . . . . 0.0 109.242 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.598 ' O ' ' CB ' ' A' ' 67' ' ' GLU . 49.3 t0 -107.2 133.78 51.27 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.899 -1.126 . . . . 0.0 111.087 -177.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.906 ' HB ' ' CE2' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -130.95 137.15 56.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.675 -179.532 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.865 ' HA ' ' HB2' ' A' ' 43' ' ' GLN . 60.0 mttp -123.86 151.58 43.29 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 118.581 -1.248 . . . . 0.0 111.119 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.461 ' O ' ' C ' ' A' ' 62' ' ' GLY . 0.7 OUTLIER -77.6 -128.72 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.474 -0.766 . . . . 0.0 110.274 -179.787 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 41.3 42.28 3.23 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.556 -1.818 . . . . 0.0 108.556 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.683 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 108.82 67.67 0.61 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.683 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER 0.84 88.09 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.847 -0.796 . . . . 0.0 110.983 -179.076 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 1.2 t -99.88 114.33 27.47 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.45 -0.781 . . . . 0.0 111.049 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.807 ' CD1' ' NE1' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -83.56 128.51 34.57 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.136 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.598 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 1.6 tt0 -138.79 121.82 16.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.567 -1.333 . . . . 0.0 110.502 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.661 ' CZ ' ' CZ3' ' A' ' 207' ' ' TRP . 0.0 OUTLIER -130.85 142.85 50.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.38 -0.825 . . . . 0.0 109.406 179.767 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.683 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -130.96 -70.69 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.055 -1.028 . . . . 0.0 110.954 -179.464 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.683 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 55.5 Cg_endo -69.89 -145.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.552 1.291 . . . . 0.0 109.492 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.745 HG13 ' CZ2' ' A' ' 207' ' ' TRP . 3.9 t -140.02 164.27 23.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 O-C-N 121.417 -0.802 . . . . 0.0 110.175 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.973 ' HB3' ' HB3' ' A' ' 76' ' ' ASP . . . -130.44 94.11 3.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 110.021 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.484 ' O ' ' O ' ' A' ' 72' ' ' ALA . 38.8 mt-30 -48.12 -99.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.281 -0.887 . . . . 0.0 110.106 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.5 p -88.61 39.24 0.91 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.084 -1.01 . . . . 0.0 109.605 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.904 ' CG2' HD22 ' A' ' 56' ' ' ASN . 3.0 m -144.6 15.73 1.62 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.317 -0.864 . . . . 0.0 110.198 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.973 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 19.1 p-10 -98.47 155.16 17.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.296 -0.878 . . . . 0.0 109.928 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.503 ' O ' ' HB2' ' A' ' 54' ' ' SER . . . 106.78 127.73 5.86 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 106.781 -2.528 . . . . 0.0 106.781 -178.025 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.641 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 1.2 m -117.51 131.67 69.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 120.814 -1.403 . . . . 0.0 111.131 -178.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.727 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 2.5 ttp180 -104.12 175.08 5.6 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.657 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.63 ' HA2' ' CB ' ' A' ' 52' ' ' ASP . . . -167.4 80.7 0.1 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -125.63 130.48 51.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -1.153 . . . . 0.0 110.311 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.518 ' HG2' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -140.41 -31.21 0.64 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -0.89 . . . . 0.0 110.551 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.518 ' N ' ' HG2' ' A' ' 82' ' ' ARG . . . 37.82 40.6 0.78 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.447 ' H ' ' HG2' ' A' ' 82' ' ' ARG . 1.7 t80 -134.71 95.57 3.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.155 -1.203 . . . . 0.0 110.001 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.809 ' CB ' HD21 ' A' ' 171' ' ' LEU . 0.6 OUTLIER -140.27 163.72 32.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.883 . . . . 0.0 110.415 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.604 ' O ' ' CD2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -131.08 158.82 39.37 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.327 -0.858 . . . . 0.0 110.095 179.661 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.53 ' N ' ' HB3' ' A' ' 173' ' ' MET . . . 51.72 -111.59 1.5 Allowed Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 21.2 tp -128.97 134.39 48.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.516 -0.99 . . . . 0.0 111.134 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.604 ' CD2' ' O ' ' A' ' 86' ' ' ARG . 88.6 m-70 -147.31 173.66 12.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.262 -0.899 . . . . 0.0 109.786 179.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.561 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -163.38 158.96 21.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.179 -0.95 . . . . 0.0 110.586 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.968 ' CE3' HG11 ' A' ' 169' ' ' VAL . 1.0 OUTLIER -134.61 170.63 15.51 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.281 -0.887 . . . . 0.0 109.29 179.557 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 1.0 ' OE2' HD12 ' A' ' 168' ' ' LEU . 6.7 mt-10 -147.82 145.27 28.67 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.178 -0.951 . . . . 0.0 110.748 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.533 ' HB ' HD12 ' A' ' 167' ' ' LEU . 6.3 mt -144.74 153.97 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.283 -0.885 . . . . 0.0 110.879 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.596 ' HB2' ' CB ' ' A' ' 213' ' ' ARG . 2.2 m -135.18 140.95 45.75 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.094 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.837 ' CZ2' ' N ' ' A' ' 104' ' ' ALA . 4.9 m95 -99.61 125.58 40.26 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.096 -1.003 . . . . 0.0 111.873 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.714 ' HB3' ' O ' ' A' ' 211' ' ' GLN . 49.4 Cg_endo -79.63 153.24 23.2 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.388 2.059 . . . . 0.0 111.569 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 1.164 HD23 ' N ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -32.89 -34.79 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.481 0.658 . . . . 0.0 110.236 179.288 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 1.164 ' N ' HD23 ' A' ' 97' ' ' LEU . 0.7 OUTLIER -54.14 -11.08 0.42 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.603 -0.686 . . . . 0.0 110.294 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.594 ' HA ' ' CZ3' ' A' ' 95' ' ' TRP . 0.9 OUTLIER -40.85 -23.51 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.187 -0.946 . . . . 0.0 110.742 -179.92 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.558 ' C ' ' O ' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -31.7 -64.73 0.15 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.404 -0.81 . . . . 0.0 110.437 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.515 ' C ' ' NE2' ' A' ' 103' ' ' HIS . . . -87.59 175.27 45.51 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 102' ' ' THR . 13.4 t -90.23 120.48 31.42 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.352 -1.087 . . . . 0.0 110.458 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.976 ' C ' ' HA ' ' A' ' 205' ' ' ALA . 7.7 m-70 -150.8 -96.46 0.06 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.207 -0.933 . . . . 0.0 110.462 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 1.065 ' N ' ' HA ' ' A' ' 205' ' ' ALA . . . -55.93 38.92 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.658 0 O-C-N 120.857 -1.152 . . . . 0.0 110.982 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 1.009 HG12 ' HA ' ' A' ' 134' ' ' ASP . 0.1 OUTLIER -94.25 145.27 8.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -178.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.973 HG22 HG23 ' A' ' 203' ' ' VAL . 2.2 t -127.79 170.16 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.929 -1.107 . . . . 0.0 111.368 -176.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.679 ' CA ' ' HA3' ' A' ' 132' ' ' GLY . . . -179.92 156.83 18.99 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 109.986 -1.245 . . . . 0.0 109.986 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.921 ' HB ' HD13 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -108.6 140.72 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.41 -1.053 . . . . 0.0 109.538 179.855 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.504 ' O ' ' HB3' ' A' ' 199' ' ' LEU . . . -109.85 140.39 43.85 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.227 -0.921 . . . . 0.0 110.738 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.833 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -119.46 130.41 55.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.453 -0.78 . . . . 0.0 110.324 179.809 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.73 -27.47 17.22 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.501 -0.749 . . . . 0.0 109.295 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.524 HD11 ' O ' ' A' ' 196' ' ' GLY . 0.9 OUTLIER -81.69 -12.3 58.71 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.535 -0.728 . . . . 0.0 109.587 179.474 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.543 ' CB ' ' HB2' ' A' ' 129' ' ' GLU . . . -38.25 112.41 0.66 Allowed Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.553 -0.717 . . . . 0.0 110.235 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.477 ' C ' HD23 ' A' ' 115' ' ' LEU . 46.5 Cg_endo -73.29 178.42 6.63 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.941 1.495 . . . . 0.0 110.641 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.477 HD23 ' C ' ' A' ' 114' ' ' PRO . 0.5 OUTLIER -179.91 62.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 110.123 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.463 ' O ' ' C ' ' A' ' 117' ' ' ALA . 0.0 OUTLIER -65.45 -26.62 68.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.287 -0.883 . . . . 0.0 110.262 -179.805 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.54 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -37.87 127.08 1.23 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.409 -0.807 . . . . 0.0 110.286 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.54 ' C ' ' O ' ' A' ' 117' ' ' ALA . 43.5 t0 -31.1 136.78 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.573 -0.704 . . . . 0.0 110.749 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.9 m80 -91.9 137.73 32.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.371 -0.831 . . . . 0.0 110.179 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -116.65 -2.47 11.92 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.171 -0.955 . . . . 0.0 110.205 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -169.44 68.21 0.06 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.213 -0.929 . . . . 0.0 110.239 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -147.21 129.58 15.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 0.0 110.209 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.25 -65.92 0.97 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 0.0 110.242 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -176.68 -153.63 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 110.229 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 90.23 -129.37 9.7 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 127' ' ' ASN . 10.2 t -151.73 64.47 0.86 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -1.149 . . . . 0.0 110.226 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 126' ' ' SER . 7.0 m120 -51.98 -173.42 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.329 -0.857 . . . . 0.0 110.275 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 110' ' ' THR . 14.7 m -161.57 -159.07 0.6 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -0.869 . . . . 0.0 110.211 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.543 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . 4.9 mm-40 -150.25 133.82 16.58 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.323 -0.861 . . . . 0.0 109.861 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.5 t -120.18 119.73 34.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 110.559 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -133.25 136.32 45.48 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.367 -0.833 . . . . 0.0 109.411 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.679 ' HA3' ' CA ' ' A' ' 107' ' ' GLY . . . -158.83 -163.47 13.04 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.436 -1.364 . . . . 0.0 110.309 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.677 ' CE3' ' CG ' ' A' ' 180' ' ' TYR . 24.6 m0 -115.77 113.12 23.01 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.477 -1.013 . . . . 0.0 110.197 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 1.009 ' HA ' HG12 ' A' ' 105' ' ' VAL . 2.1 p-10 -119.48 142.96 47.81 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.717 -0.614 . . . . 0.0 110.154 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.889 HD13 ' C ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -121.41 -12.01 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 109.634 179.46 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.568 ' HA2' ' O ' ' A' ' 99' ' ' GLN . . . -95.61 -25.18 13.99 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.47 ' O ' ' C ' ' A' ' 138' ' ' GLY . 2.5 ttp180 -86.24 4.96 36.54 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.139 -1.213 . . . . 0.0 109.629 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.768 ' O ' ' O ' ' A' ' 139' ' ' LYS . . . 40.47 40.72 2.08 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.768 ' O ' ' O ' ' A' ' 138' ' ' GLY . 0.0 OUTLIER 1.48 -133.14 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 121.694 0.759 . . . . 0.0 112.256 -179.8 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.9 tt -155.71 101.28 2.14 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.458 -0.776 . . . . 0.0 110.352 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.45 ' CE2' ' HG ' ' A' ' 161' ' ' LEU . 0.6 OUTLIER -126.03 29.57 5.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 110.214 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.461 ' CD2' ' N ' ' A' ' 142' ' ' HIS . 7.6 m170 -109.77 65.6 0.62 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.221 -0.924 . . . . 0.0 110.318 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.519 ' CG ' ' N ' ' A' ' 144' ' ' SER . 16.5 pt20 -59.13 -41.99 89.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.898 . . . . 0.0 110.224 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.519 ' N ' ' CG ' ' A' ' 143' ' ' GLN . 21.6 m -100.87 -85.13 0.42 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.261 -0.899 . . . . 0.0 110.145 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -119.54 178.49 4.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.185 -0.947 . . . . 0.0 110.218 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -117.76 174.07 15.09 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.588 HD23 ' O ' ' A' ' 147' ' ' LEU . 0.9 OUTLIER -158.45 44.9 0.3 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -1.156 . . . . 0.0 110.096 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.65 175.2 0.19 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.204 -0.935 . . . . 0.0 110.264 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.407 ' O ' ' O ' ' A' ' 153' ' ' PRO . . . -167.42 58.88 0.44 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.884 . . . . 0.0 110.111 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.15 -3.13 13.11 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.098 1.578 . . . . 0.0 110.507 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.02 -97.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.213 -0.93 . . . . 0.0 110.116 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.605 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 0.4 OUTLIER -90.86 -63.52 0.19 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.188 -0.945 . . . . 0.0 110.276 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.605 ' CD ' ' CB ' ' A' ' 152' ' ' TYR . 46.2 Cg_endo -73.43 170.94 18.73 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.673 1.354 . . . . 0.0 110.408 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.423 ' O ' ' C ' ' A' ' 155' ' ' GLY . . . -90.41 130.67 36.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 110.175 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 154' ' ' ALA . . . -43.08 114.79 0.89 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.416 ' O ' ' OE1' ' A' ' 160' ' ' GLN . 47.1 Cg_endo -73.55 -14.07 24.89 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.897 1.472 . . . . 0.0 110.406 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.411 ' OE1' ' NE2' ' A' ' 142' ' ' HIS . 3.3 mm-40 -66.49 -4.21 7.89 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.26 -0.9 . . . . 0.0 110.512 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -85.53 -62.63 1.61 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.989 ' HA ' HG12 ' A' ' 162' ' ' VAL . 3.8 tt0 -73.9 6.69 3.11 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.301 -1.117 . . . . 0.0 110.527 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.509 ' O ' ' CD2' ' A' ' 161' ' ' LEU . 1.2 tp60 -62.03 -11.37 13.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.227 -0.921 . . . . 0.0 110.149 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.509 ' CD2' ' O ' ' A' ' 160' ' ' GLN . 0.1 OUTLIER 179.98 28.81 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.344 -0.848 . . . . 0.0 110.397 179.812 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.989 HG12 ' HA ' ' A' ' 159' ' ' GLU . 4.4 p -113.87 -136.64 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.323 -0.861 . . . . 0.0 109.486 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.863 ' N ' HG13 ' A' ' 162' ' ' VAL . 1.5 t -117.94 133.47 23.38 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 120.873 -1.142 . . . . 0.0 109.678 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.935 ' HD2' HG21 ' A' ' 182' ' ' ILE . 43.1 Cg_endo -70.56 178.52 4.98 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.859 1.452 . . . . 0.0 110.913 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.498 ' O ' ' HB3' ' A' ' 94' ' ' SER . 11.1 pt-20 -50.07 -18.34 0.54 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.477 -0.764 . . . . 0.0 110.826 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.475 ' O ' ' HG2' ' A' ' 164' ' ' PRO . 7.9 tpt180 -133.67 154.97 50.53 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.102 -0.999 . . . . 0.0 109.929 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 1.198 HD22 ' N ' ' A' ' 168' ' ' LEU . 0.0 OUTLIER -164.04 146.78 9.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.28 -0.888 . . . . 0.0 109.789 -179.802 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 1.198 ' N ' HD22 ' A' ' 167' ' ' LEU . 1.2 tt -125.77 131.19 52.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.142 -0.974 . . . . 0.0 110.611 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.968 HG11 ' CE3' ' A' ' 91' ' ' TRP . 97.2 t -89.52 156.92 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.395 -0.815 . . . . 0.0 109.805 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.64 HG11 HD21 ' A' ' 187' ' ' LEU . 22.4 t -134.55 112.1 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.165 -0.959 . . . . 0.0 110.155 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.888 HD22 ' CZ2' ' A' ' 91' ' ' TRP . 0.0 OUTLIER -132.39 122.48 25.07 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.287 -0.883 . . . . 0.0 109.791 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -120.15 139.13 53.08 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.244 -0.91 . . . . 0.0 109.942 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.53 ' HB3' ' N ' ' A' ' 87' ' ' GLY . 0.3 OUTLIER -93.05 -38.25 11.73 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.553 -0.717 . . . . 0.0 109.778 179.768 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 173' ' ' MET . 0.8 OUTLIER -43.11 -27.28 0.2 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 108.7 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.609 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.7 OUTLIER -114.59 -27.38 7.52 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.78 0.8 . . . . 0.0 108.876 179.157 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.428 ' O ' HG21 ' A' ' 198' ' ' THR . . . 84.68 22.54 53.15 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 108.706 -1.757 . . . . 0.0 108.706 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.961 HG22 ' CD2' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -115.53 133.72 55.76 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.288 -1.125 . . . . 0.0 111.376 -179.476 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.672 ' O ' HD11 ' A' ' 194' ' ' LEU . 0.1 OUTLIER -143.85 152.63 41.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.569 -0.707 . . . . 0.0 109.423 178.982 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.414 ' O ' HG13 ' A' ' 169' ' ' VAL . . . -161.67 -156.1 8.21 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 1.019 ' CE1' HD21 ' A' ' 167' ' ' LEU . 0.1 OUTLIER -125.65 138.34 53.9 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.27 -1.135 . . . . 0.0 108.904 -179.905 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.489 ' HB2' ' HB2' ' A' ' 187' ' ' LEU . 9.2 t -144.0 141.59 30.23 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.143 -0.973 . . . . 0.0 110.624 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.992 HD11 ' CD2' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -127.12 116.76 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.655 -0.653 . . . . 0.0 109.563 179.629 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 65.55 10.09 47.5 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 77.0 41.01 23.71 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' THR . . . . . 0.73 HG22 ' CE1' ' A' ' 186' ' ' TYR . 17.4 m -97.31 -47.56 5.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -1.142 . . . . 0.0 110.643 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.992 ' CD2' HD11 ' A' ' 182' ' ' ILE . 8.6 m-85 -112.08 85.55 2.17 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.097 -1.002 . . . . 0.0 110.683 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.64 HD21 HG11 ' A' ' 170' ' ' VAL . 0.9 OUTLIER -179.79 28.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.686 -0.634 . . . . 0.0 109.647 179.54 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -94.88 -89.52 1.72 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.448 ' C ' ' H ' ' A' ' 191' ' ' PHE . 49.6 Cg_endo -74.24 -21.02 18.17 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 124.18 1.621 . . . . 0.0 111.21 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.578 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -66.31 15.2 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.527 -0.733 . . . . 0.0 111.877 -178.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.624 ' CE1' ' HG ' ' A' ' 187' ' ' LEU . 1.1 m-30 -90.51 -28.07 18.78 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.854 -1.154 . . . . 0.0 111.146 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.533 ' HA ' ' NE ' ' A' ' 192' ' ' ARG . 0.1 OUTLIER -86.52 -13.13 46.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.949 -1.094 . . . . 0.0 110.744 -179.5 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -107.48 -13.04 21.77 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.961 ' CD2' HG22 ' A' ' 177' ' ' THR . 9.2 tt -72.17 -40.54 67.89 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.572 -0.958 . . . . 0.0 109.012 179.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.512 ' HD2' ' N ' ' A' ' 196' ' ' GLY . 0.0 OUTLIER -44.12 -40.25 4.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.215 -0.928 . . . . 0.0 109.869 179.583 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.524 ' O ' HD11 ' A' ' 112' ' ' LEU . . . -86.27 -26.82 32.4 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.866 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.62 -4.38 56.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.686 -0.891 . . . . 0.0 109.905 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.8 HG23 HD23 ' A' ' 194' ' ' LEU . 0.8 OUTLIER -43.85 132.08 5.32 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.739 0.78 . . . . 0.0 111.732 -178.441 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.921 HD13 ' HB ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -140.68 171.01 14.7 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.656 -0.652 . . . . 0.0 109.444 179.254 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.486 ' CZ ' ' HA3' ' A' ' 83' ' ' GLY . 0.1 OUTLIER -85.98 128.93 56.12 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 120.909 -1.119 . . . . 0.0 109.84 179.358 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.58 ' CA ' HG13 ' A' ' 108' ' ' VAL . 51.0 Cg_endo -85.91 129.16 3.4 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.995 1.524 . . . . 0.0 111.396 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.459 ' O ' HG13 ' A' ' 106' ' ' VAL . 24.5 t -133.46 142.87 48.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.297 -0.877 . . . . 0.0 109.585 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.973 HG23 HG22 ' A' ' 106' ' ' VAL . 7.4 p -122.35 153.96 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.825 -1.172 . . . . 0.0 111.43 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' SER . . . . . 0.828 ' O ' ' O ' ' A' ' 103' ' ' HIS . 15.1 p -149.58 145.39 26.78 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 1.065 ' HA ' ' N ' ' A' ' 104' ' ' ALA . . . -150.26 167.36 27.19 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.765 -1.209 . . . . 0.0 112.059 -179.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.838 ' N ' ' HB3' ' A' ' 103' ' ' HIS . 0.3 OUTLIER -69.48 -176.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 121.639 0.733 . . . . 0.0 111.31 -179.02 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 0.745 ' CZ2' HG13 ' A' ' 71' ' ' VAL . 22.7 p-90 -129.78 -5.12 4.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.672 -0.642 . . . . 0.0 109.823 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 207' ' ' TRP . . . -51.72 -168.97 0.01 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.764 ' O ' ' O ' ' A' ' 210' ' ' CYS . 0.5 OUTLIER -79.67 -51.61 9.02 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.467 -1.02 . . . . 0.0 110.864 -179.562 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 210' ' ' CYS . . . . . 0.764 ' O ' ' O ' ' A' ' 209' ' ' GLN . 26.4 p 0.99 -129.18 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 121.07 0.462 . . . . 0.0 111.422 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.714 ' O ' ' HB3' ' A' ' 96' ' ' PRO . 0.0 OUTLIER 178.64 93.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.766 -1.209 . . . . 0.0 111.054 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.652 ' HB ' ' CZ ' ' A' ' 66' ' ' PHE . 3.1 t -87.05 123.09 39.67 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 O-C-N 121.381 -0.825 . . . . 0.0 108.84 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.596 ' CB ' ' HB2' ' A' ' 94' ' ' SER . 2.0 tpp85 -89.85 147.36 23.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.097 -1.002 . . . . 0.0 110.52 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.604 HD12 ' HB3' ' A' ' 48' ' ' TRP . 1.1 mt -144.33 128.46 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 110.474 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.666 ' O ' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -130.59 108.22 9.77 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.297 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 216' ' ' TYR . . . . . 0.726 ' CZ ' ' CD1' ' A' ' 91' ' ' TRP . 3.6 t80 -119.02 144.98 46.23 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.249 -0.907 . . . . 0.0 111.233 -178.037 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' MET . . . . . 0.46 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 1.2 ttp -136.59 108.45 7.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.561 -0.712 . . . . 0.0 110.05 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 130.74 70.34 0.11 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' A' ' 220' ' ' ARG . 0.2 OUTLIER -103.02 157.97 16.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.261 -1.141 . . . . 0.0 110.199 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.467 ' O ' ' O ' ' A' ' 219' ' ' GLU . 75.4 mtt180 -55.87 -161.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.251 -0.905 . . . . 0.0 110.28 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' ARG . . . . . 0.504 ' O ' ' C ' ' A' ' 222' ' ' VAL . 8.9 tpm_? -135.24 89.55 2.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.197 -0.939 . . . . 0.0 110.344 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.504 ' C ' ' O ' ' A' ' 221' ' ' ARG . 8.6 p -34.57 132.71 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.493 -0.755 . . . . 0.0 110.69 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.54 ' O ' ' C ' ' A' ' 224' ' ' GLU . 23.1 tt0 -58.14 -34.91 70.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.179 -0.951 . . . . 0.0 110.216 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.54 ' C ' ' O ' ' A' ' 223' ' ' GLU . 5.3 tt0 -31.82 -85.92 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.406 -0.809 . . . . 0.0 110.768 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.7 m -48.7 125.95 10.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.263 -0.898 . . . . 0.0 110.244 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -60.83 140.58 57.6 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.201 -0.937 . . . . 0.0 110.225 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.459 ' NH1' ' HG2' ' A' ' 227' ' ' ARG . 0.4 OUTLIER -96.11 175.84 6.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 110.264 -179.944 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 46.1 mm -129.28 115.31 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.209 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.509 ' O ' ' N ' ' A' ' 231' ' ' ASP . 0.2 OUTLIER -80.01 148.41 31.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.257 -0.902 . . . . 0.0 110.263 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 230' ' ' ARG . . . . . 0.683 ' O ' ' C ' ' A' ' 231' ' ' ASP . 0.0 OUTLIER -49.0 91.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.209 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.683 ' C ' ' O ' ' A' ' 230' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.955 -1.021 . . . . 0.0 111.419 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -115.86 127.42 55.01 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.187 -1.184 . . . . 0.0 110.251 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.04 72.83 0.26 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.295 -0.878 . . . . 0.0 110.152 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.19 126.71 31.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.181 -0.949 . . . . 0.0 110.176 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.89 -16.7 63.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.168 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -130.66 141.7 50.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 0.0 110.316 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.2 m -96.11 -166.88 1.49 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.331 -0.855 . . . . 0.0 110.192 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 48.9 p -112.28 155.92 42.85 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.187 -0.945 . . . . 0.0 110.298 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.91 161.62 43.17 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.047 1.551 . . . . 0.0 110.374 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.6 p -128.81 128.59 44.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 110.267 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.6 m -77.76 -3.96 43.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.332 -0.855 . . . . 0.0 110.157 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.481 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 9.1 pt20 -75.52 62.92 1.45 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.185 -0.947 . . . . 0.0 110.253 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -172.92 121.2 0.38 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.181 -0.949 . . . . 0.0 110.206 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.1 mp -70.07 -161.36 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.192 -0.942 . . . . 0.0 110.223 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -63.52 -94.9 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.203 -0.935 . . . . 0.0 110.174 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.9 179.56 6.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.323 -0.86 . . . . 0.0 110.155 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -175.17 58.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.353 -0.842 . . . . 0.0 110.167 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.93 -42.58 4.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.254 -0.904 . . . . 0.0 110.263 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.09 116.76 53.01 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.345 -0.847 . . . . 0.0 110.386 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.549 ' HB2' ' HD2' ' A' ' 26' ' ' PRO . 46.5 Cg_endo -73.33 176.59 9.01 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.024 1.539 . . . . 0.0 110.456 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.549 ' HD2' ' HB2' ' A' ' 25' ' ' PRO . 42.9 Cg_endo -70.74 161.19 46.93 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.878 1.462 . . . . 0.0 110.542 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -68.69 53.98 0.08 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.374 -0.829 . . . . 0.0 110.014 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 26' ' ' PRO . . . 54.12 19.21 10.88 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.794 HD21 HD21 ' A' ' 56' ' ' ASN . 0.1 OUTLIER -43.61 -32.61 0.99 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.225 -1.162 . . . . 0.0 110.026 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.617 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 8.7 mt-10 -52.18 -35.9 50.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.066 -1.021 . . . . 0.0 108.997 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.65 -25.42 60.17 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 0.5 OUTLIER -82.03 -35.74 28.48 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.707 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.886 HD12 ' C ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -77.87 -38.92 44.86 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.91 0.862 . . . . 0.0 108.873 178.884 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.564 ' O ' ' O ' ' A' ' 35' ' ' ALA . 23.2 t -57.58 -14.31 5.1 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.318 0.58 . . . . 0.0 110.25 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 1.067 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -52.61 -161.26 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.402 -0.811 . . . . 0.0 109.942 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 1.067 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 38.6 Cg_endo -65.8 118.37 5.43 Favored 'Trans proline' 0 C--N 1.315 -1.214 0 O-C-N 123.008 1.004 . . . . 0.0 109.647 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.677 ' CB ' HG21 ' A' ' 41' ' ' VAL . 45.7 Cg_endo -71.35 108.44 2.37 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.28 1.674 . . . . 0.0 112.162 -178.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.761 ' O ' ' N ' ' A' ' 40' ' ' LEU . 50.7 Cg_endo -81.98 151.97 16.49 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.23 1.648 . . . . 0.0 108.676 178.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.701 ' CG ' ' NE2' ' A' ' 43' ' ' GLN . 3.1 t0 -21.49 -41.89 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.311 -0.868 . . . . 0.0 109.806 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.127 HD13 ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -37.84 -50.06 1.24 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 122.012 -0.43 . . . . 0.0 109.875 179.919 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.127 ' N ' HD13 ' A' ' 40' ' ' LEU . 13.8 t -62.03 -26.92 41.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.683 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.611 ' N ' ' O ' ' A' ' 39' ' ' ASP . . . -89.06 -44.79 10.11 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.166 -0.958 . . . . 0.0 111.073 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.701 ' NE2' ' CG ' ' A' ' 39' ' ' ASP . 2.2 mt-30 -79.05 -25.28 43.17 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 118.405 -1.318 . . . . 0.0 108.648 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.741 ' CB ' ' O ' ' A' ' 40' ' ' LEU . 9.1 ttp180 -61.39 -52.87 62.81 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 122.343 1.068 . . . . 0.0 108.198 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.726 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 2.1 m-70 -60.93 -18.0 54.4 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.989 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -96.87 -30.07 13.35 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 118.207 -1.397 . . . . 0.0 111.648 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.91 ' O ' HD13 ' A' ' 214' ' ' ILE . . . -109.2 -67.12 0.58 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 107.605 -2.198 . . . . 0.0 107.605 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.784 ' CH2' ' N ' ' A' ' 61' ' ' GLU 0.265 0.1 OUTLIER -96.2 71.02 2.81 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.316 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.708 ' OD1' ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -60.26 112.53 5.62 Favored Pre-proline 0 N--CA 1.491 1.616 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.487 -178.809 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.667 ' CD ' ' HE3' ' A' ' 51' ' ' LYS . 44.5 Cg_endo -74.74 0.38 8.84 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 124.535 1.808 . . . . 0.0 112.024 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.913 ' CE ' ' N ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -64.57 -19.72 65.81 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 178.703 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.77 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 8.6 m-20 -133.34 -2.29 3.12 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 114.149 -1.387 . . . . 0.0 107.856 178.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.591 ' HB3' ' HA ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -113.34 152.11 30.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.571 -0.706 . . . . 0.0 110.058 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.513 ' OG ' HG12 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -68.06 104.42 1.76 Allowed 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.13 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.705 ' HG3' HD22 ' A' ' 33' ' ' LEU . 26.1 pt-20 -67.81 -17.01 64.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.105 -0.997 . . . . 0.0 109.064 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.81 ' HB3' HG23 ' A' ' 75' ' ' THR . 9.5 m120 -33.36 -32.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.678 0.752 . . . . 0.0 110.346 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.706 ' HB ' ' O ' ' A' ' 67' ' ' GLU . 9.0 pt -112.92 166.96 6.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.616 -0.677 . . . . 0.0 110.01 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.577 ' O ' ' N ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -107.13 117.11 33.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.247 -0.908 . . . . 0.0 109.372 -179.362 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.955 HG21 ' CD1' ' A' ' 66' ' ' PHE . 2.6 p -124.52 120.36 58.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 O-C-N 121.445 -0.785 . . . . 0.0 111.463 -178.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.694 ' HG2' ' N ' ' A' ' 61' ' ' GLU . 6.6 tttt -137.4 159.54 41.66 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.534 -0.729 . . . . 0.0 110.27 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.784 ' N ' ' CH2' ' A' ' 48' ' ' TRP . 1.2 tt0 -45.45 -106.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.596 -0.69 . . . . 0.0 110.535 -179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.569 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 35.7 33.76 0.06 OUTLIER Glycine 0 N--CA 1.493 2.487 0 N-CA-C 108.141 -1.984 . . . . 0.0 108.141 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.69 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 107.8 62.83 0.56 Allowed Glycine 0 N--CA 1.485 1.927 0 N-CA-C 108.01 -2.036 . . . . 0.0 108.01 -178.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.712 HD13 ' HE1' ' A' ' 48' ' ' TRP . 0.4 OUTLIER 1.18 80.64 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.899 -0.765 . . . . 0.0 110.724 -179.324 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.429 ' N ' ' O ' ' A' ' 63' ' ' GLY . 17.3 p -141.17 136.92 32.3 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 118.418 -1.313 . . . . 0.0 112.176 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.955 ' CD1' HG21 ' A' ' 59' ' ' VAL . 17.9 m-85 -89.34 165.32 14.45 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.706 ' O ' ' HB ' ' A' ' 57' ' ' ILE . 5.5 tm-20 -136.94 121.01 17.76 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.91 -1.119 . . . . 0.0 109.944 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.561 ' CD ' ' O ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -126.32 148.71 49.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.237 -0.915 . . . . 0.0 109.977 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.75 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 1.7 mtm180 -104.93 -78.93 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.024 -1.048 . . . . 0.0 110.454 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.75 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 57.6 Cg_endo -75.08 -152.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.163 1.086 . . . . 0.0 109.368 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.686 HG13 ' CZ2' ' A' ' 207' ' ' TRP . 2.4 t -140.76 162.55 22.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 1.014 ' HB3' ' CB ' ' A' ' 75' ' ' THR . . . 179.85 175.87 0.75 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.932 -1.105 . . . . 0.0 110.621 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.464 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 1.6 pt20 -66.19 -115.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.385 -0.822 . . . . 0.0 110.31 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 73' ' ' GLN . 11.5 p -41.78 -27.1 0.1 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.195 -0.941 . . . . 0.0 110.225 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . 1.014 ' CB ' ' HB3' ' A' ' 72' ' ' ALA . 22.6 m -44.29 -28.51 0.54 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.879 . . . . 0.0 110.028 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.651 ' CB ' ' CD1' ' A' ' 207' ' ' TRP . 12.4 p30 -112.68 155.46 24.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.887 . . . . 0.0 109.992 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.496 ' HA2' ' O ' ' A' ' 205' ' ' ALA . . . 79.86 123.93 0.47 Allowed Glycine 0 N--CA 1.484 1.899 0 N-CA-C 106.886 -2.485 . . . . 0.0 106.886 -178.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.572 ' HB ' ' CB ' ' A' ' 53' ' ' CYS . 1.2 m -117.74 161.85 16.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 120.851 -1.382 . . . . 0.0 110.939 -178.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.77 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -119.5 173.5 6.95 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.015 179.128 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.724 ' HA3' HG12 ' A' ' 203' ' ' VAL . . . -149.47 48.44 0.6 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.508 ' HA ' ' CB ' ' A' ' 202' ' ' SER . 22.7 ttpp -81.95 76.28 8.85 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -1.101 . . . . 0.0 109.985 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.502 ' CG ' ' OD2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -141.47 -91.03 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.381 -0.825 . . . . 0.0 110.064 -179.921 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.421 ' H ' ' CD ' ' A' ' 82' ' ' ARG . . . 49.11 62.69 4.47 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.487 ' CD2' ' O ' ' A' ' 84' ' ' TYR . 52.3 t80 -94.46 96.06 9.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -1.148 . . . . 0.0 109.995 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 218' ' ' GLY . 0.1 OUTLIER -132.13 153.91 50.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.888 . . . . 0.0 110.263 -179.853 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.567 ' HA ' ' CB ' ' A' ' 173' ' ' MET . 46.5 ttp180 -114.72 176.43 5.05 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.321 -0.862 . . . . 0.0 109.779 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.563 ' N ' ' CG ' ' A' ' 86' ' ' ARG . . . 46.78 -111.22 0.66 Allowed Glycine 0 N--CA 1.485 1.959 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.725 ' O ' ' CD2' ' A' ' 89' ' ' HIS . 5.9 tt -129.08 126.83 40.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.478 -1.013 . . . . 0.0 110.751 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.725 ' CD2' ' O ' ' A' ' 88' ' ' LEU . 33.5 m170 -147.41 173.69 12.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.792 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.51 155.31 17.29 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.347 -0.846 . . . . 0.0 110.263 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 1.211 ' CZ2' HG11 ' A' ' 169' ' ' VAL . 1.2 p90 -135.05 171.12 14.87 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.199 -0.938 . . . . 0.0 110.064 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.571 ' N ' ' O ' ' A' ' 215' ' ' ARG . 2.9 tp10 -132.93 142.63 48.99 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.538 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.753 HG23 ' OH ' ' A' ' 180' ' ' TYR . 0.3 OUTLIER -144.78 138.36 22.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.215 -0.928 . . . . 0.0 110.961 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.568 ' CB ' ' HB3' ' A' ' 213' ' ' ARG . 0.7 OUTLIER -117.75 137.3 52.8 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.724 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.834 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 46.9 t-105 -116.0 87.89 20.21 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.046 -1.034 . . . . 0.0 111.631 -178.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 94' ' ' SER . 52.4 Cg_endo -98.16 109.35 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 121.862 1.708 . . . . 0.0 110.046 178.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.443 HD22 ' HA ' ' A' ' 97' ' ' LEU . 0.4 OUTLIER -95.84 -68.48 0.8 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.662 -1.274 . . . . 0.0 110.417 179.806 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 99' ' ' GLN . 0.4 OUTLIER -99.07 -45.53 5.9 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.256 -0.903 . . . . 0.0 110.012 179.412 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 39.5 tt0 179.69 -31.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.723 0.773 . . . . 0.0 109.344 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.592 ' HG3' ' N ' ' A' ' 101' ' ' GLY . 9.3 ptp85 -135.03 -35.6 0.84 Allowed 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.418 0.628 . . . . 0.0 109.594 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.744 ' HA2' HG23 ' A' ' 162' ' ' VAL . . . -46.77 171.43 0.03 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.615 ' HA ' ' HD1' ' A' ' 95' ' ' TRP . 6.0 m -166.4 92.18 0.47 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.156 -1.202 . . . . 0.0 110.618 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.587 ' N ' ' CD1' ' A' ' 95' ' ' TRP . 30.4 m-70 -114.32 53.98 0.78 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.191 -0.943 . . . . 0.0 110.959 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.834 ' HA ' ' CE2' ' A' ' 95' ' ' TRP . . . -60.82 129.24 40.47 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.073 -1.017 . . . . 0.0 109.978 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 1.175 HG22 ' O ' ' A' ' 204' ' ' SER . 1.2 m -103.43 116.54 47.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 C-N-CA 118.655 -1.218 . . . . 0.0 109.27 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.996 HG13 ' O ' ' A' ' 202' ' ' SER . 78.3 t -135.71 152.26 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 120.999 -1.063 . . . . 0.0 109.926 -178.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.536 ' HA2' ' HA2' ' A' ' 132' ' ' GLY . . . -141.52 135.52 6.86 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.06 HG12 HD12 ' A' ' 199' ' ' LEU . 1.3 t -125.79 131.62 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.435 -1.038 . . . . 0.0 108.319 179.033 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.667 ' HB1' ' HA ' ' A' ' 130' ' ' SER . . . -150.12 149.49 30.33 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.073 -1.017 . . . . 0.0 111.52 -178.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.735 HG23 ' HB3' ' A' ' 199' ' ' LEU . 0.6 OUTLIER -89.47 112.08 23.14 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 122.209 1.004 . . . . 0.0 109.897 178.977 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 110' ' ' THR 0.294 . . -32.77 -53.42 0.34 Allowed 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.976 179.161 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.918 ' HB2' ' O ' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -43.7 -26.31 0.23 Allowed 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.448 -178.72 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.655 ' N ' ' O ' ' A' ' 110' ' ' THR . . . -36.53 156.58 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.769 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.288 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.48 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 45.8 Cg_endo -72.12 101.94 1.29 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.893 1.47 . . . . 0.0 110.599 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.54 ' CG ' ' O ' ' A' ' 115' ' ' LEU . 0.6 OUTLIER -178.81 58.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.309 -0.869 . . . . 0.0 110.199 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.498 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 0.6 OUTLIER -127.35 -34.1 2.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.292 -0.88 . . . . 0.0 110.318 -179.916 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.543 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . 179.97 114.5 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.407 -0.808 . . . . 0.0 110.172 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.543 ' C ' ' O ' ' A' ' 117' ' ' ALA . 50.3 t0 -30.6 94.07 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.53 -0.731 . . . . 0.0 110.787 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' A' ' 117' ' ' ALA . 1.2 t60 -170.84 165.81 7.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.25 -0.906 . . . . 0.0 110.185 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -107.38 49.72 0.79 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.133 -0.979 . . . . 0.0 110.195 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -95.98 61.19 2.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.363 -0.836 . . . . 0.0 110.26 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -146.91 107.16 4.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.205 -0.934 . . . . 0.0 110.222 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.485 ' O ' ' HB2' ' A' ' 126' ' ' SER . 0.2 OUTLIER -110.29 174.58 5.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.249 -0.907 . . . . 0.0 110.266 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.546 HD12 ' C ' ' A' ' 124' ' ' LEU . 3.6 pp -52.35 163.7 0.38 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 0.0 110.197 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 77.65 8.74 87.17 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -130.68 61.01 1.62 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.327 -1.102 . . . . 0.0 110.175 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.918 ' O ' ' HB2' ' A' ' 112' ' ' LEU . 5.0 p-10 -39.61 161.05 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.378 -0.826 . . . . 0.0 110.279 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.768 ' HB3' ' HB2' ' A' ' 112' ' ' LEU . 2.4 p 178.42 124.63 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.729 ' N ' ' OG1' ' A' ' 110' ' ' THR . 2.6 tt0 -152.22 160.71 43.32 Favored 'General case' 0 C--N 1.308 -1.229 0 O-C-N 120.323 -1.485 . . . . 0.0 111.213 -178.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.667 ' HA ' ' HB1' ' A' ' 109' ' ' ALA . 2.5 t -134.25 126.39 29.72 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.876 -0.515 . . . . 0.0 109.76 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' TRP . . . . . 0.479 ' CB ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -133.14 155.16 49.8 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 120.929 -1.107 . . . . 0.0 109.855 -179.873 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.536 ' HA2' ' HA2' ' A' ' 107' ' ' GLY . . . -141.58 133.67 5.87 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.857 ' CZ3' HG21 ' A' ' 108' ' ' VAL . 3.8 m0 -104.9 113.53 27.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -1.166 . . . . 0.0 109.689 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.615 ' O ' HG23 ' A' ' 135' ' ' ILE . 0.3 OUTLIER -118.48 148.19 42.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.133 -0.979 . . . . 0.0 110.428 -179.843 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.648 HD11 ' HB3' ' A' ' 104' ' ' ALA . 3.7 pt -158.1 23.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.316 -0.865 . . . . 0.0 110.11 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.554 ' CA ' ' HB3' ' A' ' 103' ' ' HIS . . . -121.24 -50.84 0.25 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.91 8.12 43.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.171 -1.194 . . . . 0.0 110.119 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.543 ' O ' ' NE2' ' A' ' 157' ' ' GLN . . . 54.64 28.69 46.63 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.0 mtpt -58.54 -171.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -1.096 . . . . 0.0 110.176 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 12.8 tp -174.25 109.29 0.14 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.248 -0.908 . . . . 0.0 110.11 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -102.5 -10.62 19.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.218 -0.926 . . . . 0.0 110.262 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -105.59 52.06 0.74 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.17 -0.956 . . . . 0.0 110.188 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.471 ' CG ' ' N ' ' A' ' 144' ' ' SER . 5.9 pt20 -51.71 -40.34 59.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.279 -0.888 . . . . 0.0 110.172 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.471 ' N ' ' CG ' ' A' ' 143' ' ' GLN . 0.5 OUTLIER -43.49 -58.46 2.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.272 -0.892 . . . . 0.0 110.122 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.65 29.98 6.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.181 -0.949 . . . . 0.0 110.157 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -132.55 109.23 0.83 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.468 ' O ' ' HG2' ' A' ' 148' ' ' GLU . 3.9 mt -122.49 -111.79 0.32 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.215 -1.168 . . . . 0.0 110.036 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 147' ' ' LEU . 4.9 mt-10 -157.75 131.39 7.89 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.398 -0.814 . . . . 0.0 110.104 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.463 ' O ' ' O ' ' A' ' 153' ' ' PRO . . . -136.51 75.37 51.36 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.892 . . . . 0.0 110.259 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -74.0 -0.52 9.62 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.068 1.562 . . . . 0.0 110.384 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -62.48 -99.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.302 -0.873 . . . . 0.0 110.191 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.537 ' N ' ' HD2' ' A' ' 153' ' ' PRO . 0.1 OUTLIER -76.99 -54.63 1.54 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.115 -0.99 . . . . 0.0 110.188 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 152' ' ' TYR . 45.8 Cg_endo -74.79 142.86 29.11 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.865 1.455 . . . . 0.0 110.24 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.531 ' O ' ' O ' ' A' ' 155' ' ' GLY . . . -100.36 115.41 29.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 110.243 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.531 ' O ' ' O ' ' A' ' 154' ' ' ALA . . . 42.16 98.06 0.01 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.33 -2.43 11.67 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.014 1.533 . . . . 0.0 110.556 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.543 ' NE2' ' O ' ' A' ' 138' ' ' GLY . 4.3 mt-30 -56.64 -13.35 2.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 0.0 110.544 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 93.55 -32.63 5.64 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.531 ' HB3' ' HA ' ' A' ' 135' ' ' ILE . 6.8 pt-20 -88.89 5.27 44.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.185 -1.185 . . . . 0.0 110.114 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.528 ' HB3' ' O ' ' A' ' 154' ' ' ALA . 21.4 tp60 -91.45 -4.32 55.71 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.381 -0.824 . . . . 0.0 109.787 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.68 ' O ' ' C ' ' A' ' 162' ' ' VAL . 0.1 OUTLIER -128.04 56.43 1.6 Allowed 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.444 -0.785 . . . . 0.0 110.185 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.87 HG13 ' O ' ' A' ' 162' ' ' VAL . 8.3 p 0.69 91.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.69 0.757 . . . . 0.0 111.232 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.865 HG13 ' HD2' ' A' ' 164' ' ' PRO . 42.4 t -44.31 151.52 0.56 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.331 -0.856 . . . . 0.0 109.466 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.865 ' HD2' HG13 ' A' ' 163' ' ' VAL . 40.0 Cg_endo -67.01 125.43 13.61 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.656 1.345 . . . . 0.0 110.495 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 94' ' ' SER . 1.4 tt0 -41.05 -24.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.423 -0.798 . . . . 0.0 110.642 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' ' 164' ' ' PRO . 9.7 ttt85 -111.27 137.58 48.82 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.173 -0.954 . . . . 0.0 109.783 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.836 HD21 ' CG1' ' A' ' 163' ' ' VAL . 3.0 mp -138.47 146.31 41.9 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.463 -0.773 . . . . 0.0 110.411 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.438 HD12 ' OE1' ' A' ' 92' ' ' GLU . 0.7 OUTLIER -116.93 124.51 49.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.495 179.636 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 1.211 HG11 ' CZ2' ' A' ' 91' ' ' TRP . 2.5 t -114.92 139.76 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.073 -1.017 . . . . 0.0 110.683 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 170' ' ' VAL . 9.3 p -118.32 124.93 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.578 -0.701 . . . . 0.0 110.062 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.58 ' CD1' ' HB3' ' A' ' 178' ' ' LEU . 9.3 tp -133.37 111.29 10.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.135 -0.978 . . . . 0.0 110.154 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.524 ' OD2' ' CB ' ' A' ' 88' ' ' LEU . 6.5 t70 -116.27 138.31 51.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.296 -0.877 . . . . 0.0 110.14 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.567 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -94.64 -44.38 7.85 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.71 -0.619 . . . . 0.0 110.041 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.491 ' C ' ' O ' ' A' ' 173' ' ' MET . 2.7 mt-10 -40.19 -28.52 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.115 -0.99 . . . . 0.0 108.791 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.646 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.4 OUTLIER -111.56 -25.15 9.71 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.901 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.597 ' O ' ' CG2' ' A' ' 198' ' ' THR . . . 77.18 24.94 64.97 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' THR . . . . . 1.081 HG22 ' CD2' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -113.14 134.91 54.33 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.293 -1.122 . . . . 0.0 111.12 -179.429 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 1.092 ' O ' HD11 ' A' ' 194' ' ' LEU . 0.6 OUTLIER -142.54 154.13 44.19 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.655 -0.653 . . . . 0.0 109.815 179.265 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -162.11 162.17 34.0 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 1.031 ' CD1' HG22 ' A' ' 169' ' ' VAL . 1.1 t80 -118.68 121.77 40.92 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.459 -1.024 . . . . 0.0 109.657 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.476 ' OG ' HD23 ' A' ' 187' ' ' LEU . 0.3 OUTLIER -144.26 139.7 28.79 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.267 -0.895 . . . . 0.0 110.349 -179.67 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.637 HG22 ' HA ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -102.78 116.72 47.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.37 -0.831 . . . . 0.0 109.666 179.553 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 88.69 -9.13 77.33 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.535 ' HA2' ' CD2' ' A' ' 187' ' ' LEU . . . 86.21 43.61 6.21 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 70.2 m -114.35 -25.32 8.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.287 -1.125 . . . . 0.0 110.618 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.465 ' CE2' HD11 ' A' ' 182' ' ' ILE . 21.2 m-85 -107.97 69.1 0.72 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.172 -0.955 . . . . 0.0 110.42 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.576 ' HB2' ' CE1' ' A' ' 191' ' ' PHE . 0.9 OUTLIER -173.5 26.21 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.748 0.785 . . . . 0.0 109.497 179.719 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -94.64 -81.62 1.54 Allowed Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.033 -1.08 . . . . 0.0 110.7 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.15 -30.05 16.65 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.997 1.525 . . . . 0.0 111.307 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.584 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -74.06 13.78 0.5 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.312 -0.868 . . . . 0.0 111.234 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.576 ' CE1' ' HB2' ' A' ' 187' ' ' LEU . 1.2 m-30 -90.73 -26.79 19.35 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.018 -1.051 . . . . 0.0 110.416 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.62 -13.27 49.2 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.303 -0.873 . . . . 0.0 110.253 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 197' ' ' ARG . . . -108.17 -6.15 32.05 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.166 -1.974 . . . . 0.0 108.166 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 1.092 HD11 ' O ' ' A' ' 178' ' ' LEU . 7.6 tt -77.64 -41.44 38.38 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.51 ' CA ' HG23 ' A' ' 198' ' ' THR . 1.6 ttmt -43.79 -45.89 7.47 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.761 -0.587 . . . . 0.0 110.163 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -83.54 -24.51 50.19 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.698 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -91.12 -3.8 56.77 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.658 -0.907 . . . . 0.0 110.035 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.75 HG23 ' O ' ' A' ' 194' ' ' LEU . 21.8 p -42.98 112.81 0.4 Allowed 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.641 0.734 . . . . 0.0 111.86 -177.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 1.06 HD12 HG12 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -140.44 171.0 14.76 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.713 -0.617 . . . . 0.0 109.647 178.738 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 11.0 m-85 -84.7 129.23 57.79 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.07 -1.019 . . . . 0.0 110.741 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.814 ' CA ' HG13 ' A' ' 108' ' ' VAL . 51.4 Cg_endo -88.62 146.4 5.9 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 124.179 1.62 . . . . 0.0 110.985 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.996 ' O ' HG13 ' A' ' 106' ' ' VAL . 11.8 p -133.86 157.08 46.86 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.232 -0.918 . . . . 0.0 110.606 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.724 HG12 ' HA3' ' A' ' 80' ' ' GLY . 7.4 p -119.46 157.1 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.076 -1.015 . . . . 0.0 109.693 178.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' SER . . . . . 1.175 ' O ' HG22 ' A' ' 105' ' ' VAL . 0.9 OUTLIER -160.3 156.06 25.75 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 120.922 -1.112 . . . . 0.0 110.623 179.47 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.496 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -150.39 164.74 35.08 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.729 0.776 . . . . 0.0 111.02 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.649 HG13 ' N ' ' A' ' 207' ' ' TRP . 1.2 t -60.06 -179.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 121.344 0.592 . . . . 0.0 111.32 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 0.686 ' CZ2' HG13 ' A' ' 71' ' ' VAL . 4.3 t90 -26.19 -55.91 0.07 Allowed 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.288 0.566 . . . . 0.0 110.919 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 209' ' ' GLN . . . 138.73 -1.74 2.64 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' ' 208' ' ' GLY . 1.6 tt0 -42.84 -29.92 0.36 Allowed 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.419 -1.048 . . . . 0.0 109.698 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' CYS . . . . . 0.506 ' C ' ' CG ' ' A' ' 211' ' ' GLN . 28.9 p -94.91 -131.79 0.16 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.433 -0.792 . . . . 0.0 109.855 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.506 ' CG ' ' C ' ' A' ' 210' ' ' CYS . 0.0 OUTLIER -178.59 112.67 0.06 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.933 . . . . 0.0 110.2 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.69 ' O ' HD11 ' A' ' 64' ' ' LEU . 33.9 m -89.63 139.55 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.277 -0.89 . . . . 0.0 109.765 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.576 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -88.9 135.6 33.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.124 -0.985 . . . . 0.0 109.213 179.676 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.91 HD13 ' O ' ' A' ' 47' ' ' GLY . 0.8 OUTLIER -144.51 112.43 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 120.99 -1.069 . . . . 0.0 111.559 -178.707 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.571 ' O ' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -118.02 108.42 15.22 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.061 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 216' ' ' TYR . . . . . 0.678 ' CD2' ' CB ' ' A' ' 91' ' ' TRP . 2.1 t80 -106.11 149.14 27.03 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.188 -0.945 . . . . 0.0 111.648 -177.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' MET . . . . . 0.425 ' N ' ' HD1' ' A' ' 216' ' ' TYR . 36.1 ttp -129.72 107.63 9.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.72 -0.613 . . . . 0.0 109.56 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' GLY . . . . . 0.466 ' O ' ' OG ' ' A' ' 85' ' ' SER . . . 108.7 63.73 0.55 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.55 ' HG2' ' N ' ' A' ' 220' ' ' ARG . 1.5 tm-20 -125.55 151.23 46.66 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.195 -1.18 . . . . 0.0 110.012 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.55 ' N ' ' HG2' ' A' ' 219' ' ' GLU . 2.2 ptt85 -40.47 161.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.264 -0.898 . . . . 0.0 110.274 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' ARG . . . . . 0.498 ' O ' ' C ' ' A' ' 222' ' ' VAL . 8.1 ptm180 -129.73 85.72 2.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.92 . . . . 0.0 110.244 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.562 HG13 ' O ' ' A' ' 222' ' ' VAL . 4.9 p -34.82 112.09 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.407 -0.808 . . . . 0.0 110.638 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.489 ' O ' ' C ' ' A' ' 224' ' ' GLU . 0.2 OUTLIER -79.28 43.47 0.54 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.264 -0.897 . . . . 0.0 110.47 -179.871 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.489 ' C ' ' O ' ' A' ' 223' ' ' GLU . 3.0 tt0 -35.2 -68.43 0.12 Allowed 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.372 -0.83 . . . . 0.0 110.674 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.431 ' C ' ' O ' ' A' ' 224' ' ' GLU . 2.8 t -42.28 155.4 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.273 -0.892 . . . . 0.0 110.262 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -117.16 -173.2 2.36 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.271 -0.893 . . . . 0.0 110.138 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.486 ' NH1' ' HG3' ' A' ' 227' ' ' ARG . 0.0 OUTLIER -145.36 11.92 1.33 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.228 -0.92 . . . . 0.0 110.181 -179.963 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 1.8 mp -113.56 127.48 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -0.888 . . . . 0.0 110.148 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.478 ' O ' ' HB3' ' A' ' 230' ' ' ARG . 15.2 t-80 -77.99 123.08 26.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.237 -0.915 . . . . 0.0 110.179 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' ARG . . . . . 0.677 ' O ' ' C ' ' A' ' 231' ' ' ASP . 0.4 OUTLIER 180.0 -176.8 0.35 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.254 -0.903 . . . . 0.0 110.181 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.677 ' C ' ' O ' ' A' ' 230' ' ' ARG . 1.9 m-20 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.955 -1.021 . . . . 0.0 111.404 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.74 21.16 5.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.246 -1.149 . . . . 0.0 110.174 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 9' ' ' ALA . 1.0 OUTLIER -148.2 -176.09 5.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 110.17 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 8' ' ' SER . . . -176.57 170.72 2.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.317 -0.864 . . . . 0.0 110.223 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -146.27 103.42 3.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.279 -0.888 . . . . 0.0 110.238 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -138.72 -63.8 0.53 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 110.173 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.471 ' HB3' ' HD3' ' A' ' 14' ' ' PRO . 0.8 OUTLIER -129.15 143.53 50.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.229 -0.919 . . . . 0.0 110.187 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.2 p -128.47 59.61 42.94 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.25 -0.906 . . . . 0.0 110.196 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' A' ' 12' ' ' SER . 46.6 Cg_endo -73.02 71.64 3.45 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.965 1.508 . . . . 0.0 110.485 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 16' ' ' SER . 14.6 t -136.56 177.99 7.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -0.914 . . . . 0.0 110.168 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 15' ' ' THR . 0.8 OUTLIER -41.89 164.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 110.287 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -116.71 72.63 0.83 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.2 -0.937 . . . . 0.0 110.325 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -172.91 164.3 5.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 110.193 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tp -63.62 -150.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.369 -0.832 . . . . 0.0 110.21 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.7 -169.88 1.55 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 110.186 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.434 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 39.7 t -106.34 172.26 6.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.279 -0.888 . . . . 0.0 110.148 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 21' ' ' SER . 0.1 OUTLIER 179.94 62.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.203 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.29 -43.41 33.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.184 -0.948 . . . . 0.0 110.205 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.479 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 1.1 p -77.54 139.09 63.02 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.427 -0.795 . . . . 0.0 110.162 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.495 ' CB ' ' HB3' ' A' ' 29' ' ' LEU . 46.0 Cg_endo -72.58 110.3 2.96 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.048 1.551 . . . . 0.0 110.53 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.507 ' C ' ' H ' ' A' ' 28' ' ' GLY . 48.1 Cg_endo -73.82 -165.84 0.28 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 124.011 1.532 . . . . 0.0 110.67 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -73.96 26.09 0.07 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.343 -0.848 . . . . 0.0 109.996 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.507 ' H ' ' C ' ' A' ' 26' ' ' PRO . . . -153.51 12.61 0.57 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.612 ' O ' ' N ' ' A' ' 32' ' ' LEU . 1.1 pt? -44.76 -22.81 0.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.157 -1.202 . . . . 0.0 110.2 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.857 ' HA ' HD23 ' A' ' 33' ' ' LEU . 59.9 mt-10 -46.66 -26.86 1.0 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.053 -1.03 . . . . 0.0 108.704 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -70.99 -22.21 62.2 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.612 ' N ' ' O ' ' A' ' 29' ' ' LEU . 14.7 tp -83.57 -34.86 25.09 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.06 HD22 ' HB2' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -70.41 -36.56 74.1 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.884 0.849 . . . . 0.0 109.057 179.122 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.597 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 2.9 t -70.48 -14.24 62.45 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.423 0.63 . . . . 0.0 109.945 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 1.023 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -54.45 -160.73 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.511 -0.743 . . . . 0.0 109.967 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 1.023 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 38.2 Cg_endo -65.55 -166.55 0.1 OUTLIER 'Trans proline' 0 N--CA 1.489 1.22 0 O-C-N 123.188 1.099 . . . . 0.0 110.022 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.722 ' CD ' ' HB2' ' A' ' 36' ' ' PRO . 51.2 Cg_endo -96.67 54.42 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 121.394 1.396 . . . . 0.0 113.183 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.739 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 51.7 Cg_endo -76.46 151.06 32.75 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 122.93 0.963 . . . . 0.0 109.761 178.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.818 ' CG ' HE22 ' A' ' 43' ' ' GLN . 0.0 OUTLIER -13.89 -54.41 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.53 -0.731 . . . . 0.0 112.072 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.954 ' O ' ' HB3' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -51.86 -46.56 64.49 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.933 -1.104 . . . . 0.0 110.959 -179.502 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.842 HG13 ' CE1' ' A' ' 45' ' ' HIS . 11.9 t -86.11 -19.14 8.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 O-C-N 121.52 -0.738 . . . . 0.0 111.639 -177.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 46' ' ' HIS . . . -88.95 -41.49 12.36 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.667 -1.271 . . . . 0.0 111.197 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.818 HE22 ' CG ' ' A' ' 39' ' ' ASP . 1.0 OUTLIER -87.65 -19.43 27.72 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 118.848 -1.141 . . . . 0.0 109.426 179.832 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.954 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -77.73 -38.02 48.07 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.113 0.959 . . . . 0.0 108.865 179.276 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.842 ' CE1' HG13 ' A' ' 41' ' ' VAL . 1.2 m80 -80.81 -18.2 48.32 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.429 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.479 ' HB2' ' O ' ' A' ' 42' ' ' ALA . 1.0 OUTLIER -97.42 -34.18 11.13 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.194 -0.941 . . . . 0.0 109.465 178.625 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.617 ' O ' ' CD1' ' A' ' 214' ' ' ILE . . . -68.18 -114.94 0.02 OUTLIER Glycine 0 N--CA 1.489 2.198 0 N-CA-C 107.299 -2.32 . . . . 0.0 107.299 178.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 1.105 ' CZ2' ' HA ' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -85.63 87.86 7.46 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 176.924 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.891 HD22 ' HB2' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -42.72 153.17 0.33 Allowed Pre-proline 0 N--CA 1.492 1.652 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -177.952 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.657 ' HA ' ' O ' ' A' ' 53' ' ' CYS . 43.7 Cg_endo -70.38 -31.05 18.47 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 O-C-N 124.773 1.933 . . . . 0.0 110.952 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.891 ' HB2' HD22 ' A' ' 49' ' ' ASN . 0.0 OUTLIER -62.37 0.13 0.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.36 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.792 ' HB3' HG11 ' A' ' 203' ' ' VAL . 12.9 m-20 -141.87 2.92 1.59 Allowed 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.112 178.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.874 ' HA ' ' N ' ' A' ' 79' ' ' ARG . 1.6 t -150.69 147.74 27.72 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.377 -0.827 . . . . 0.0 111.545 -179.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.946 ' H ' ' HA ' ' A' ' 78' ' ' VAL . 0.7 OUTLIER -86.92 121.78 29.86 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 120.903 -1.123 . . . . 0.0 109.824 178.648 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 1.06 ' HB2' HD22 ' A' ' 33' ' ' LEU . 1.1 pt-20 -44.77 -35.27 2.63 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.489 -0.757 . . . . 0.0 112.976 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.6 ' OD1' HG21 ' A' ' 75' ' ' THR . 0.2 OUTLIER -32.48 -20.52 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.54 0 O-C-N 121.29 -0.882 . . . . 0.0 111.379 -179.217 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.04 HD11 ' CB ' ' A' ' 207' ' ' TRP . 1.6 mt -111.18 167.18 5.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.307 -0.87 . . . . 0.0 110.131 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.507 ' N ' ' CG2' ' A' ' 57' ' ' ILE . 36.0 t70 -108.54 128.55 54.91 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.376 -0.828 . . . . 0.0 110.357 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 1.037 ' HB ' ' CE2' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -131.28 132.03 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.577 -0.702 . . . . 0.0 111.099 -179.075 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.719 ' HA ' ' HB2' ' A' ' 43' ' ' GLN . 24.6 tttt -136.58 130.7 32.74 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.804 -1.185 . . . . 0.0 110.101 178.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.589 ' H ' ' HB3' ' A' ' 43' ' ' GLN . 1.6 pt-20 -52.58 -117.25 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.442 -0.786 . . . . 0.0 111.079 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 45.69 41.39 9.72 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 107.998 -2.041 . . . . 0.0 107.998 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.698 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 98.81 74.09 1.13 Allowed Glycine 0 N--CA 1.487 2.07 0 N-CA-C 108.293 -1.923 . . . . 0.0 108.293 -178.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.698 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER 0.84 75.38 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.758 -0.848 . . . . 0.0 110.887 -178.967 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.546 ' N ' ' O ' ' A' ' 63' ' ' GLY . 53.7 t -101.61 114.64 28.86 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.312 -0.868 . . . . 0.0 110.491 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 1.105 ' HA ' ' CZ2' ' A' ' 48' ' ' TRP . 1.6 m-85 -82.68 138.03 34.26 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.395 -0.816 . . . . 0.0 110.268 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.507 ' O ' HG23 ' A' ' 57' ' ' ILE . 1.8 tt0 -138.2 121.77 17.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.16 -0.962 . . . . 0.0 109.913 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.488 ' HG3' ' HB2' ' A' ' 207' ' ' TRP . 0.6 OUTLIER -131.17 145.74 52.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.181 -0.95 . . . . 0.0 110.343 -179.87 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.628 ' HB3' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -125.1 -67.52 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.361 -0.837 . . . . 0.0 110.317 179.789 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.628 ' CD ' ' HB3' ' A' ' 69' ' ' ARG . 55.9 Cg_endo -69.7 -141.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.385 1.203 . . . . 0.0 109.133 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.447 ' H ' ' HB2' ' A' ' 70' ' ' PRO . 3.5 t -139.74 164.0 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.053 -1.029 . . . . 0.0 110.045 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.6 119.35 6.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.129 -0.982 . . . . 0.0 110.136 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -84.99 -93.62 0.08 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.178 -0.951 . . . . 0.0 110.267 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.9 p -104.19 23.38 13.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.145 -0.972 . . . . 0.0 110.133 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.637 HG21 ' HB3' ' A' ' 54' ' ' SER . 3.4 t -141.5 -134.84 0.1 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.307 -0.871 . . . . 0.0 110.088 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.733 ' O ' ' C ' ' A' ' 77' ' ' GLY . 4.9 m-20 -140.55 153.62 46.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 110.868 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.733 ' C ' ' O ' ' A' ' 76' ' ' ASP . . . -26.48 -62.28 0.08 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 106.067 -2.813 . . . . 0.0 106.067 179.025 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.959 ' CG2' ' HB3' ' A' ' 205' ' ' ALA . 29.0 m -148.92 118.75 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 122.108 -0.643 . . . . 0.0 109.327 176.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.874 ' N ' ' HA ' ' A' ' 53' ' ' CYS . 0.0 OUTLIER -146.6 137.01 23.81 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.687 -0.633 . . . . 0.0 110.681 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.83 ' HA3' ' C ' ' A' ' 51' ' ' LYS . . . -163.38 156.03 27.65 Favored Glycine 0 N--CA 1.481 1.636 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 178.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 201' ' ' PRO . 0.2 OUTLIER -143.66 128.55 18.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.345 -1.091 . . . . 0.0 110.152 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.796 ' HD3' ' H ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -150.35 -95.64 0.07 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.194 -0.941 . . . . 0.0 110.226 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.796 ' H ' ' HD3' ' A' ' 82' ' ' ARG . . . 47.84 63.98 3.22 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -119.16 95.49 4.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.134 -1.216 . . . . 0.0 110.255 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.58 ' HB3' ' CD2' ' A' ' 89' ' ' HIS . 1.0 OUTLIER -140.3 169.37 17.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.249 -0.907 . . . . 0.0 110.098 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.561 ' O ' ' NE2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -117.37 133.48 55.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 110.128 179.792 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 103.76 -117.19 5.63 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.706 ' C ' HD23 ' A' ' 88' ' ' LEU . 7.6 tt -128.64 127.0 41.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.398 -1.06 . . . . 0.0 110.39 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.58 ' CD2' ' HB3' ' A' ' 85' ' ' SER . 8.5 m-70 -147.05 161.43 40.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.165 -0.959 . . . . 0.0 110.215 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.677 ' HB1' ' O ' ' A' ' 169' ' ' VAL . . . -163.52 157.87 20.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.22 -0.925 . . . . 0.0 109.857 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 1.142 ' CZ2' HG11 ' A' ' 169' ' ' VAL . 3.0 p90 -134.79 160.25 38.8 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.065 -1.022 . . . . 0.0 110.403 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.643 ' N ' ' O ' ' A' ' 215' ' ' ARG . 31.3 mt-10 -119.11 121.17 39.18 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.339 0.59 . . . . 0.0 110.648 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.538 HG12 ' HA ' ' A' ' 214' ' ' ILE . 5.3 mt -135.01 149.33 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.215 -0.928 . . . . 0.0 110.168 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.584 ' OG ' ' NH2' ' A' ' 213' ' ' ARG . 0.0 OUTLIER -121.17 135.84 55.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 109.654 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 1.169 ' CZ2' ' HB3' ' A' ' 104' ' ' ALA . 6.1 t-105 -115.72 87.88 19.01 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.246 -0.909 . . . . 0.0 110.303 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.63 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 51.0 Cg_endo -97.47 114.06 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.156 1.904 . . . . 0.0 110.967 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.465 ' H ' ' CA ' ' A' ' 101' ' ' GLY . 0.1 OUTLIER -95.6 -67.65 0.84 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.895 -1.128 . . . . 0.0 109.523 179.126 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.45 -45.23 6.2 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.448 -0.783 . . . . 0.0 109.441 179.056 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.508 ' HG3' ' HG2' ' A' ' 100' ' ' ARG . 51.3 tp60 -139.45 -75.36 0.36 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.537 0.684 . . . . 0.0 109.409 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.513 ' HD3' ' CG ' ' A' ' 165' ' ' GLU . 5.7 mmt-85 -87.64 -39.06 15.35 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.596 -0.69 . . . . 0.0 109.144 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.831 ' H ' HG22 ' A' ' 162' ' ' VAL . . . 70.11 115.99 0.04 OUTLIER Glycine 0 N--CA 1.487 2.094 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 179.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.644 HG22 HD12 ' A' ' 135' ' ' ILE . 99.1 m -73.67 -80.49 0.07 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.337 -1.096 . . . . 0.0 109.375 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.723 ' CD2' ' CE3' ' A' ' 133' ' ' TRP . 0.2 OUTLIER 179.07 79.79 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.349 -0.845 . . . . 0.0 110.393 179.588 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 1.169 ' HB3' ' CZ2' ' A' ' 95' ' ' TRP . . . -36.85 -83.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.946 -1.096 . . . . 0.0 108.488 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 1.235 HG13 ' O ' ' A' ' 204' ' ' SER . 0.5 OUTLIER -126.0 114.31 38.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 C-N-CA 117.774 -1.571 . . . . 0.0 109.981 178.737 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.679 HG22 ' CZ3' ' A' ' 95' ' ' TRP . 9.7 t -152.49 136.94 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.476 -0.765 . . . . 0.0 109.698 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.519 ' HA3' ' HA3' ' A' ' 132' ' ' GLY . . . 154.07 -146.12 14.04 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 118.895 -1.621 . . . . 0.0 110.559 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.041 HG23 ' C ' ' A' ' 200' ' ' TYR . 2.7 p -149.76 156.93 6.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.689 -0.889 . . . . 0.0 109.597 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.538 ' C ' ' HB3' ' A' ' 199' ' ' LEU . . . -146.41 153.34 40.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.059 -1.025 . . . . 0.0 111.104 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.931 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -110.72 128.61 55.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.468 -0.77 . . . . 0.0 109.738 179.529 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.6 -26.22 17.97 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.31 -0.869 . . . . 0.0 109.726 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.671 ' C ' HD12 ' A' ' 112' ' ' LEU . 4.1 pp -84.88 -11.94 54.55 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.417 -0.802 . . . . 0.0 109.481 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.592 ' HB3' ' HB ' ' A' ' 110' ' ' THR . . . -117.11 80.98 12.24 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.397 -0.814 . . . . 0.0 110.548 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.403 ' O ' ' CG ' ' A' ' 115' ' ' LEU . 46.2 Cg_endo -74.12 144.91 34.36 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.025 1.539 . . . . 0.0 110.203 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.476 ' HB3' ' OE2' ' A' ' 129' ' ' GLU . 0.2 OUTLIER 179.91 62.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.177 -0.952 . . . . 0.0 110.292 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.82 -72.22 0.6 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.193 -0.942 . . . . 0.0 110.279 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.517 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -56.65 109.31 0.6 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.25 -0.906 . . . . 0.0 110.282 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.517 ' C ' ' O ' ' A' ' 117' ' ' ALA . 5.9 t0 -33.48 150.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.557 -0.715 . . . . 0.0 110.746 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.508 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 0.1 OUTLIER 41.91 -164.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.315 -0.866 . . . . 0.0 110.237 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -93.45 -13.28 28.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.183 -0.948 . . . . 0.0 110.127 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 50.17 38.29 16.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 110.123 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 47.62 33.58 3.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 0.0 110.156 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -161.46 125.44 3.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.189 -0.944 . . . . 0.0 110.251 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.59 HD13 ' C ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -92.13 105.96 18.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.244 -0.91 . . . . 0.0 110.225 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -96.17 -146.76 21.52 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.04 40.09 0.1 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.259 -1.142 . . . . 0.0 110.126 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -81.86 125.92 31.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.274 -0.891 . . . . 0.0 110.219 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.17 174.52 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.225 -0.922 . . . . 0.0 110.16 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.476 ' OE2' ' HB3' ' A' ' 115' ' ' LEU . 2.9 tp10 -130.45 117.28 19.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 110.147 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.525 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 1.0 OUTLIER -123.96 122.05 36.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -0.914 . . . . 0.0 110.257 -179.876 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 3.2 m0 -125.54 129.53 49.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.245 -0.91 . . . . 0.0 109.958 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.519 ' HA3' ' HA3' ' A' ' 107' ' ' GLY . . . 173.87 -114.8 0.53 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' TRP . . . . . 0.869 ' CZ2' HD22 ' A' ' 187' ' ' LEU . 34.3 m0 -129.16 122.96 30.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -1.162 . . . . 0.0 110.303 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.474 ' O ' HG12 ' A' ' 135' ' ' ILE . 0.8 OUTLIER -118.03 107.93 14.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.286 -0.883 . . . . 0.0 110.13 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.644 HD12 HG22 ' A' ' 102' ' ' THR . 1.3 mt -145.53 11.4 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.296 -0.878 . . . . 0.0 109.949 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -124.23 -38.67 0.51 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.33 1.21 23.61 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.505 -0.997 . . . . 0.0 108.949 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -92.81 -13.12 57.14 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.93 -146.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.503 -0.998 . . . . 0.0 110.154 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.582 ' O ' ' CD2' ' A' ' 141' ' ' TYR . 0.3 OUTLIER -147.37 -97.04 0.09 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.21 -0.931 . . . . 0.0 110.337 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.582 ' CD2' ' O ' ' A' ' 140' ' ' LEU . 1.1 m-85 -167.04 -91.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.181 -0.949 . . . . 0.0 110.155 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -124.29 0.35 8.34 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.407 -0.808 . . . . 0.0 110.325 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.04 -43.86 20.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 110.134 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.96 146.66 41.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.215 -0.928 . . . . 0.0 110.167 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.53 123.11 22.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 110.134 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -173.67 109.26 0.29 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.98 HD21 HD21 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -142.76 67.51 1.31 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -1.166 . . . . 0.0 110.124 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.536 ' CG ' ' HD2' ' A' ' 156' ' ' PRO . 59.2 tt0 -47.98 141.42 5.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.159 -0.963 . . . . 0.0 110.235 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.979 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . . . -179.95 -58.66 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.255 -0.903 . . . . 0.0 110.303 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.979 ' HD3' ' HB3' ' A' ' 149' ' ' ALA . 47.0 Cg_endo -73.51 -8.28 21.46 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.007 1.53 . . . . 0.0 110.597 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.434 ' O ' ' CD2' ' A' ' 152' ' ' TYR . 2.9 mp0 -54.19 -66.94 0.31 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.175 -0.953 . . . . 0.0 110.158 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.56 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 0.2 OUTLIER -179.87 -59.38 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.267 -0.895 . . . . 0.0 110.16 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.56 ' CD ' ' CB ' ' A' ' 152' ' ' TYR . 45.4 Cg_endo -72.95 160.85 45.04 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.025 1.539 . . . . 0.0 110.36 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 155' ' ' GLY . . . -48.39 116.02 1.43 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.918 . . . . 0.0 110.128 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 154' ' ' ALA . . . -42.68 116.24 1.15 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.536 ' HD2' ' CG ' ' A' ' 148' ' ' GLU . 45.1 Cg_endo -73.33 -59.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.986 1.519 . . . . 0.0 110.326 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.493 ' O ' ' HG2' ' A' ' 160' ' ' GLN . 0.0 OUTLIER -69.82 -0.59 7.43 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.176 -0.952 . . . . 0.0 110.475 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.477 ' O ' ' HB ' ' A' ' 162' ' ' VAL . . . -53.35 -17.96 6.48 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.426 ' CD ' HG22 ' A' ' 163' ' ' VAL . 1.6 mm-40 -76.73 3.88 10.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.097 -1.237 . . . . 0.0 110.411 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' A' ' 157' ' ' GLN . 36.2 mm-40 -70.95 -17.85 62.65 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.949 0.88 . . . . 0.0 109.198 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.98 HD21 HD21 ' A' ' 147' ' ' LEU . 1.3 pp -167.87 25.63 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.661 0.743 . . . . 0.0 109.211 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.831 HG22 ' H ' ' A' ' 101' ' ' GLY . 2.2 t -161.22 90.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.805 -0.56 . . . . 0.0 109.714 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.875 ' HB ' ' HD3' ' A' ' 164' ' ' PRO . 2.4 t -111.26 -69.37 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.086 -1.009 . . . . 0.0 111.205 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.875 ' HD3' ' HB ' ' A' ' 163' ' ' VAL . 52.9 Cg_endo -95.84 179.21 0.59 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.104 1.055 . . . . 0.0 111.203 -178.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.513 ' CG ' ' HD3' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -108.8 -37.38 5.89 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.753 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 1.073 ' O ' HD13 ' A' ' 167' ' ' LEU . 0.3 OUTLIER -142.71 142.19 31.94 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.106 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 1.073 HD13 ' O ' ' A' ' 166' ' ' ARG . 0.3 OUTLIER -126.79 154.75 43.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.003 -1.06 . . . . 0.0 110.971 -179.24 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.7 tt -123.64 135.08 53.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.496 -0.753 . . . . 0.0 109.653 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 1.142 HG11 ' CZ2' ' A' ' 91' ' ' TRP . 42.3 t -106.41 141.71 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.122 -0.986 . . . . 0.0 110.73 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 53.4 t -122.25 114.81 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.357 -0.839 . . . . 0.0 109.742 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.86 HD12 ' N ' ' A' ' 172' ' ' ASP . 0.4 OUTLIER -128.09 124.08 36.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.18 -0.95 . . . . 0.0 110.423 -179.649 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.86 ' N ' HD12 ' A' ' 171' ' ' LEU . 5.5 t70 -116.32 138.36 51.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.312 -0.868 . . . . 0.0 109.914 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.502 ' O ' ' N ' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -93.34 -41.09 10.03 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.05 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.488 ' C ' ' O ' ' A' ' 173' ' ' MET . 0.6 OUTLIER -41.0 -27.84 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.195 -0.94 . . . . 0.0 108.987 179.399 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.566 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 1.8 tp10 -113.45 -27.63 7.84 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.518 ' O ' ' CG2' ' A' ' 198' ' ' THR . . . 83.62 23.74 52.45 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' THR . . . . . 1.026 HG22 ' CD2' ' A' ' 194' ' ' LEU . 0.7 OUTLIER -116.59 135.52 53.74 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.344 -1.092 . . . . 0.0 111.029 -179.515 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.999 ' O ' HD11 ' A' ' 194' ' ' LEU . 0.2 OUTLIER -136.29 150.65 49.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.45 -0.781 . . . . 0.0 109.594 179.361 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -148.15 -175.17 20.58 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.691 -1.242 . . . . 0.0 110.08 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.692 ' CG ' ' CH2' ' A' ' 133' ' ' TRP . 0.2 OUTLIER -138.98 127.2 22.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.4 -1.059 . . . . 0.0 110.082 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 21.2 t -117.99 124.44 48.19 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.174 -0.954 . . . . 0.0 109.881 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.799 HD12 ' CZ2' ' A' ' 133' ' ' TRP . 0.1 OUTLIER -116.15 116.48 52.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.506 -0.746 . . . . 0.0 109.777 179.814 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.511 ' C ' ' O ' ' A' ' 182' ' ' ILE . . . 38.51 28.94 0.06 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 182' ' ' ILE . . . 62.32 43.2 99.41 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' THR . . . . . 0.881 HG22 ' HD1' ' A' ' 186' ' ' TYR . 25.2 m -72.24 -78.86 0.08 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.201 -1.176 . . . . 0.0 110.468 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.881 ' HD1' HG22 ' A' ' 185' ' ' THR . 8.6 p90 -175.11 104.47 0.09 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.855 -1.153 . . . . 0.0 111.051 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.869 HD22 ' CZ2' ' A' ' 133' ' ' TRP . 4.8 tp 179.6 23.2 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.366 -0.834 . . . . 0.0 110.778 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.835 ' N ' ' CD ' ' A' ' 189' ' ' PRO . . . -109.65 -5.77 29.31 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.752 -1.213 . . . . 0.0 112.088 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.835 ' CD ' ' N ' ' A' ' 188' ' ' GLY . 50.5 Cg_endo -75.59 -33.03 4.31 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 O-C-N 122.718 0.851 . . . . 0.0 110.97 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.585 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -83.04 41.36 0.75 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.221 -0.924 . . . . 0.0 110.976 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -90.53 -46.22 8.45 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.204 -0.935 . . . . 0.0 110.455 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.523 ' HA ' ' NE ' ' A' ' 192' ' ' ARG . 0.5 OUTLIER -68.11 -14.91 63.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.16 -0.963 . . . . 0.0 110.001 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 197' ' ' ARG . . . -103.47 -10.92 34.69 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 1.026 ' CD2' HG22 ' A' ' 177' ' ' THR . 9.2 tt -70.35 -43.36 70.35 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.851 -0.793 . . . . 0.0 109.142 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.555 ' HE3' ' N ' ' A' ' 196' ' ' GLY . 0.1 OUTLIER -43.91 -41.16 5.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.485 -0.759 . . . . 0.0 110.005 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.555 ' N ' ' HE3' ' A' ' 195' ' ' LYS . . . -88.09 -24.87 33.24 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.708 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -91.07 -2.84 57.56 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.838 -0.801 . . . . 0.0 109.737 179.659 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.711 HG23 ' O ' ' A' ' 194' ' ' LEU . 13.4 p -41.42 125.94 2.72 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.829 0.823 . . . . 0.0 111.212 -177.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.949 ' CD1' HG13 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -138.11 172.77 12.43 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -179.571 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 1.041 ' C ' HG23 ' A' ' 108' ' ' VAL . 4.2 m-30 -83.76 129.84 57.85 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 120.958 -1.089 . . . . 0.0 109.659 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.521 ' HA ' ' HB ' ' A' ' 108' ' ' VAL . 46.6 Cg_endo -72.49 129.17 14.39 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 124.047 1.551 . . . . 0.0 111.851 -178.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.417 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 1.8 p -133.62 160.27 38.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.486 -0.759 . . . . 0.0 110.101 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.792 HG11 ' HB3' ' A' ' 52' ' ' ASP . 14.9 p -137.1 156.51 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.256 -0.903 . . . . 0.0 110.556 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' SER . . . . . 1.235 ' O ' HG13 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -160.11 127.93 4.66 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.442 -0.787 . . . . 0.0 109.217 179.052 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.959 ' HB3' ' CG2' ' A' ' 78' ' ' VAL . . . -127.93 159.95 33.37 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.5 -0.75 . . . . 0.0 110.738 -178.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.568 ' CG1' ' N ' ' A' ' 207' ' ' TRP . 1.0 OUTLIER -60.45 175.61 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 CA-C-O 121.334 0.588 . . . . 0.0 110.655 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 1.04 ' CB ' HD11 ' A' ' 57' ' ' ILE . 39.7 p90 -120.84 57.71 0.97 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.439 -0.788 . . . . 0.0 110.207 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -134.53 -144.37 5.03 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.411 ' O ' ' C ' ' A' ' 210' ' ' CYS . 2.2 tp60 -67.2 -31.67 72.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.353 -1.086 . . . . 0.0 110.481 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' CYS . . . . . 0.566 ' SG ' HG12 ' A' ' 206' ' ' VAL . 17.2 p -43.58 153.35 0.12 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.289 -0.882 . . . . 0.0 109.917 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.68 ' HA ' ' CD1' ' A' ' 66' ' ' PHE . 8.2 pt20 -156.56 123.67 5.28 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.103 -0.998 . . . . 0.0 110.628 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.424 ' HA ' ' CD ' ' A' ' 96' ' ' PRO . 1.5 m -101.61 140.32 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.336 -0.852 . . . . 0.0 110.114 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.584 ' NH2' ' OG ' ' A' ' 94' ' ' SER . 0.5 OUTLIER -89.43 127.1 35.8 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.237 -0.914 . . . . 0.0 108.999 179.399 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.956 HG21 ' HA ' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -103.59 113.5 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-O 121.939 0.876 . . . . 0.0 111.248 -178.621 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.643 ' O ' ' N ' ' A' ' 92' ' ' GLU . 4.0 ttt180 -130.61 126.89 37.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.407 -0.808 . . . . 0.0 108.863 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' TYR . . . . . 0.616 ' CD2' ' HB3' ' A' ' 91' ' ' TRP . 4.0 t80 -119.27 150.39 40.19 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.921 -1.112 . . . . 0.0 111.017 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 217' ' ' MET . . . . . 0.457 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 6.2 ttp -126.98 107.87 10.45 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.298 -0.876 . . . . 0.0 109.677 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 89.24 59.18 1.58 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.501 ' HG2' ' N ' ' A' ' 220' ' ' ARG . 31.0 tt0 -95.41 157.9 15.69 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.244 -1.15 . . . . 0.0 110.179 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.501 ' N ' ' HG2' ' A' ' 219' ' ' GLU . 34.7 ttp85 -41.65 -26.13 0.07 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.208 -0.933 . . . . 0.0 110.621 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' ARG . . . . . 0.496 ' O ' ' O ' ' A' ' 222' ' ' VAL . 3.8 mtp180 -142.26 85.6 1.92 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.172 -0.955 . . . . 0.0 110.631 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.496 ' O ' ' O ' ' A' ' 221' ' ' ARG . 5.7 p -40.14 164.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.423 -0.798 . . . . 0.0 110.561 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 224' ' ' GLU . 10.7 tt0 -165.71 46.56 0.08 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.313 -0.867 . . . . 0.0 110.344 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 223' ' ' GLU . 0.1 OUTLIER 179.08 -77.68 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.182 -0.949 . . . . 0.0 110.208 179.453 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.584 HG22 ' N ' ' A' ' 226' ' ' ARG . 53.4 m -48.57 171.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.325 -0.859 . . . . 0.0 110.274 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.584 ' N ' HG22 ' A' ' 225' ' ' THR . 1.0 OUTLIER -59.65 156.13 14.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.921 . . . . 0.0 110.307 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -125.53 75.73 1.5 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.908 . . . . 0.0 110.167 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.739 ' O ' HG23 ' A' ' 228' ' ' ILE . 7.3 tt -131.98 106.8 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.204 -0.935 . . . . 0.0 110.164 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -74.16 137.82 43.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -0.931 . . . . 0.0 110.213 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' ARG . . . . . 0.666 ' O ' ' C ' ' A' ' 231' ' ' ASP . 86.6 mtt-85 -45.12 154.41 0.16 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.238 -0.914 . . . . 0.0 110.182 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.666 ' C ' ' O ' ' A' ' 230' ' ' ARG . 52.6 p30 . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 117.93 -1.033 . . . . 0.0 111.458 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.803 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 121.107 0.479 . . . . 0.0 110.025 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.658 ' HA ' HD23 ' A' ' 33' ' ' LEU . 1.7 tt0 -45.02 -34.72 2.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.053 -1.029 . . . . 0.0 108.988 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.37 -24.05 64.78 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.385 -0.822 . . . . 0.0 108.787 178.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.577 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -83.42 -32.3 26.18 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.845 HD12 ' C ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -81.52 -38.19 26.65 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.891 0.853 . . . . 0.0 109.284 179.165 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.57 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 0.9 OUTLIER -46.8 -30.72 2.59 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.625 0.726 . . . . 0.0 109.88 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 1.046 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -72.58 -169.99 0.15 Allowed Pre-proline 0 C--N 1.298 -1.652 0 O-C-N 121.497 -0.752 . . . . 0.0 109.364 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 1.046 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 42.0 Cg_endo -69.48 106.18 1.57 Allowed 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.6 1.316 . . . . 0.0 109.765 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.651 ' HG3' HG21 ' A' ' 41' ' ' VAL . 50.5 Cg_endo -88.67 108.59 0.51 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.13 1.595 . . . . 0.0 111.166 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.77 ' O ' ' N ' ' A' ' 40' ' ' LEU . 49.4 Cg_endo -76.81 150.55 30.74 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.925 1.487 . . . . 0.0 109.998 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.723 ' O ' ' CG ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER 3.3 61.39 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 122.617 1.199 . . . . 0.0 110.455 -178.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.012 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -149.66 -45.47 0.13 Allowed 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 178.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.8 ' N ' HD13 ' A' ' 40' ' ' LEU . 2.2 t -86.38 -35.64 9.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 46' ' ' HIS . . . -89.21 -43.23 11.15 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.38 0.61 . . . . 0.0 110.089 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.579 ' HG3' ' CD ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -68.66 -25.17 64.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.461 -0.774 . . . . 0.0 110.416 -179.685 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.839 ' HA ' HG12 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -79.05 -50.84 10.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.146 -0.971 . . . . 0.0 108.999 179.475 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.687 ' HA ' ' CB ' ' A' ' 49' ' ' ASN . 9.3 m170 -63.8 -16.16 60.53 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.443 ' HB2' ' O ' ' A' ' 42' ' ' ALA . 3.7 t-160 -96.36 -28.75 14.33 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.44 -119.21 0.05 OUTLIER Glycine 0 N--CA 1.477 1.403 0 N-CA-C 107.838 -2.105 . . . . 0.0 107.838 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 1.086 ' CZ2' HD22 ' A' ' 64' ' ' LEU . 0.8 OUTLIER -103.52 70.56 1.04 Allowed 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.011 -1.287 . . . . 0.0 110.478 179.143 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.687 ' CB ' ' HA ' ' A' ' 45' ' ' HIS . 0.3 OUTLIER -109.24 111.97 59.76 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 121.1 -1.0 . . . . 0.0 111.721 179.578 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.853 ' HG2' ' HB2' ' A' ' 53' ' ' CYS . 48.5 Cg_endo -80.57 -59.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.302 -1.902 0 O-C-N 123.78 1.411 . . . . 0.0 108.847 177.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.694 ' HG2' ' O ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER 179.81 -95.73 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.602 -0.686 . . . . 0.0 110.191 178.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.604 ' N ' ' HA2' ' A' ' 80' ' ' GLY 0.26 54.1 m-20 -68.97 33.97 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.178 0.989 . . . . 0.0 109.175 178.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.853 ' HB2' ' HG2' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -101.07 -176.92 3.3 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.843 -177.38 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.743 ' CA ' HG11 ' A' ' 78' ' ' VAL . 0.3 OUTLIER -50.6 101.73 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.689 -0.804 . . . . 0.0 111.662 -177.17 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.521 ' HG3' ' N ' ' A' ' 56' ' ' ASN . 9.4 pt-20 -102.07 -32.78 9.97 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.826 0.822 . . . . 0.0 109.522 177.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.584 ' HB3' HD21 ' A' ' 29' ' ' LEU . 21.6 m-80 -70.01 -7.98 45.42 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.76 -0.587 . . . . 0.0 111.811 -178.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.98 HG22 HG22 ' A' ' 75' ' ' THR . 1.2 pt -112.69 166.17 6.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 120.844 -1.16 . . . . 0.0 109.988 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.832 ' CB ' HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -108.98 126.86 53.55 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.371 -0.831 . . . . 0.0 110.563 -179.13 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.839 HG12 ' HA ' ' A' ' 44' ' ' ARG . 9.6 p -130.42 130.76 65.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 O-C-N 121.46 -0.775 . . . . 0.0 109.275 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.579 ' CD ' ' HG3' ' A' ' 43' ' ' GLN . 19.7 tttm -135.61 153.25 51.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.069 -1.019 . . . . 0.0 110.689 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.484 ' HA ' ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -66.21 -121.8 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.401 -0.812 . . . . 0.0 110.269 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 44.51 26.54 1.06 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.699 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 124.38 61.01 0.18 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.086 HD22 ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER 0.61 88.76 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.796 -0.826 . . . . 0.0 110.758 -179.658 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 42.4 t -127.64 114.73 17.74 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.289 -0.882 . . . . 0.0 111.396 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.673 ' HA ' HG23 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -84.37 134.31 34.49 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.526 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.637 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 2.4 tt0 -126.66 131.03 51.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.74 -1.225 . . . . 0.0 110.847 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.559 ' HD3' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -136.06 156.07 49.27 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.414 -0.804 . . . . 0.0 109.539 179.602 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.671 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -85.37 -69.92 0.13 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.071 -1.018 . . . . 0.0 111.243 -179.105 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.9 ' HD2' HG21 ' A' ' 75' ' ' THR . 55.8 Cg_endo -72.16 -113.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.55 1.289 . . . . 0.0 110.324 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.48 ' O ' ' N ' ' A' ' 73' ' ' GLN . 4.7 t -140.38 164.83 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.454 -1.404 . . . . 0.0 110.369 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.571 ' HB2' ' NE1' ' A' ' 207' ' ' TRP . . . -41.62 -24.45 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.306 -0.872 . . . . 0.0 110.377 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.495 ' C ' ' O ' ' A' ' 72' ' ' ALA . 1.6 pt20 -36.11 -34.33 0.05 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.263 -0.898 . . . . 0.0 110.577 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 72' ' ' ALA . 69.0 p -149.54 -36.52 0.16 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 110.317 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.98 HG22 HG22 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -72.15 -55.1 7.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.189 -0.945 . . . . 0.0 110.134 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.549 ' OD2' ' HA ' ' A' ' 207' ' ' TRP . 4.7 t0 -99.24 155.36 17.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.225 -0.922 . . . . 0.0 109.741 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.63 74.12 1.26 Allowed Glycine 0 N--CA 1.487 2.068 0 N-CA-C 107.23 -2.348 . . . . 0.0 107.23 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.787 HG22 ' HA ' ' A' ' 53' ' ' CYS . 1.4 p -158.08 162.67 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 O-C-N 121.806 -0.82 . . . . 0.0 109.406 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.667 ' CG ' ' O ' ' A' ' 203' ' ' VAL . 0.0 OUTLIER -145.52 137.35 25.36 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.072 -1.051 . . . . 0.0 113.008 -178.419 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.604 ' HA2' ' N ' ' A' ' 52' ' ' ASP . . . -74.73 154.05 46.51 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 107.729 -2.148 . . . . 0.0 107.729 176.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.505 ' HG2' ' N ' ' A' ' 82' ' ' ARG . 1.3 ttmp? -126.18 -97.55 0.42 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.796 -1.414 . . . . 0.0 112.374 -178.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.888 ' HD3' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -43.33 -87.41 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.208 -0.933 . . . . 0.0 111.666 -178.102 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.888 ' N ' ' HD3' ' A' ' 82' ' ' ARG . . . 60.39 76.9 0.2 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.564 ' CE1' ' SD ' ' A' ' 173' ' ' MET . 10.1 t80 -94.42 132.08 39.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.356 -1.085 . . . . 0.0 110.842 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.468 ' O ' ' SD ' ' A' ' 173' ' ' MET . 7.3 t -140.01 161.34 37.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.39 -0.819 . . . . 0.0 109.911 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.464 ' HA ' ' HG2' ' A' ' 173' ' ' MET . 4.1 mtt180 -111.26 160.22 17.19 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.066 -1.022 . . . . 0.0 109.776 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.77 158.29 34.19 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.603 ' O ' HD23 ' A' ' 88' ' ' LEU . 2.5 tt -87.61 123.52 32.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.306 -1.114 . . . . 0.0 110.163 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.567 ' CD2' ' O ' ' A' ' 171' ' ' LEU . 0.6 OUTLIER -147.36 173.36 12.68 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 110.134 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -149.58 155.4 40.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.351 -0.843 . . . . 0.0 110.037 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.958 ' CZ3' HG11 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -134.72 170.67 15.48 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.116 -0.99 . . . . 0.0 110.352 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.663 ' N ' ' O ' ' A' ' 215' ' ' ARG . 1.0 OUTLIER -129.1 147.89 51.0 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.889 -0.725 . . . . 0.0 110.797 -179.471 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.552 ' CG2' ' OH ' ' A' ' 180' ' ' TYR . 0.6 OUTLIER -144.3 145.48 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.53 -0.731 . . . . 0.0 109.933 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.9 ' O ' HG23 ' A' ' 212' ' ' VAL . 0.0 OUTLIER -145.02 144.32 30.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.173 -0.955 . . . . 0.0 110.204 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.614 ' CH2' ' HA ' ' A' ' 205' ' ' ALA . 41.7 m95 -117.99 107.6 43.71 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.239 -0.913 . . . . 0.0 110.473 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.571 ' HG3' ' CZ ' ' A' ' 213' ' ' ARG . 49.8 Cg_endo -75.04 109.79 2.99 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.875 1.46 . . . . 0.0 109.899 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.114 -0.991 . . . . 0.0 110.225 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.996 HG23 ' HB2' ' A' ' 204' ' ' SER . 17.4 m . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 121.681 0.753 . . . . 0.0 110.612 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.586 HG22 HG23 ' A' ' 203' ' ' VAL . 89.8 t -150.63 170.09 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.623 -0.673 . . . . 0.0 109.341 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.638 ' CA ' ' HA3' ' A' ' 132' ' ' GLY . . . 165.6 167.3 25.99 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.34 -1.409 . . . . 0.0 110.479 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.75 HG12 ' HB2' ' A' ' 199' ' ' LEU . 1.7 t -112.55 141.73 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.551 -0.97 . . . . 0.0 109.507 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 130' ' ' SER . . . -114.53 142.61 46.19 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.081 -1.012 . . . . 0.0 110.655 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.802 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -118.77 131.99 56.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.277 -0.889 . . . . 0.0 110.357 179.718 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.97 -26.79 17.4 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.399 -0.813 . . . . 0.0 109.286 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.637 ' C ' HD12 ' A' ' 112' ' ' LEU . 4.1 pp -83.83 -12.17 55.97 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.558 -0.714 . . . . 0.0 109.448 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.572 ' CB ' ' CB ' ' A' ' 129' ' ' GLU . . . . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.587 -0.695 . . . . 0.0 110.441 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.251 0.548 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.572 ' CB ' ' CB ' ' A' ' 113' ' ' ALA . 3.9 tt0 -150.03 129.64 13.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.313 -0.867 . . . . 0.0 109.997 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 32.3 t -120.43 119.68 33.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.189 -0.944 . . . . 0.0 110.409 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.28 131.62 40.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.349 -0.845 . . . . 0.0 109.841 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.638 ' HA3' ' CA ' ' A' ' 107' ' ' GLY . . . -165.05 -144.67 4.13 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.696 ' CE3' ' CD2' ' A' ' 180' ' ' TYR . 31.5 m0 -116.67 114.45 24.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.343 -1.092 . . . . 0.0 110.556 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -118.13 143.42 46.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.527 -0.733 . . . . 0.0 110.033 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.609 HD12 ' N ' ' A' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.732 0 O-C-N 121.23 -0.919 . . . . 0.0 110.335 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.641 HG21 HD21 ' A' ' 167' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.69 71.8 3.21 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.976 1.514 . . . . 0.0 110.617 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 94' ' ' SER . 1.4 mt-10 -172.29 -81.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.355 -0.841 . . . . 0.0 110.118 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.534 ' HG2' ' N ' ' A' ' 167' ' ' LEU . 0.8 OUTLIER -151.55 154.92 37.42 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.322 -0.861 . . . . 0.0 109.739 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.782 HD22 HG22 ' A' ' 182' ' ' ILE . 0.0 OUTLIER -152.77 139.9 19.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.091 -1.005 . . . . 0.0 110.483 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' A' ' 181' ' ' SER . 17.0 tp -114.3 112.76 23.6 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.226 -0.921 . . . . 0.0 109.748 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.992 HG22 ' CE1' ' A' ' 180' ' ' TYR . 4.2 t -97.1 131.63 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.039 -1.038 . . . . 0.0 110.808 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.6 HG21 HD22 ' A' ' 187' ' ' LEU . 4.3 t -106.65 122.96 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.482 -0.761 . . . . 0.0 109.491 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.643 HD13 HD13 ' A' ' 178' ' ' LEU . 4.6 tp -133.21 115.28 14.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.069 -1.02 . . . . 0.0 110.554 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.539 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 32.1 t0 -120.3 135.15 55.1 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.296 -0.877 . . . . 0.0 110.199 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.587 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -94.58 -39.13 10.53 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.635 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 173' ' ' MET . 5.8 mm-40 -42.65 -27.7 0.19 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.219 -0.926 . . . . 0.0 108.828 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.593 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.1 OUTLIER -112.62 -27.07 8.34 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.235 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 82.57 24.23 54.21 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.955 HG22 ' CD2' ' A' ' 194' ' ' LEU . 0.2 OUTLIER -121.14 128.68 52.76 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.248 -1.148 . . . . 0.0 111.141 -179.458 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 1.061 ' O ' HD11 ' A' ' 194' ' ' LEU . 0.2 OUTLIER -139.99 153.69 46.93 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.459 -0.776 . . . . 0.0 109.588 179.338 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -153.1 174.04 31.89 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.992 ' CE1' HG22 ' A' ' 169' ' ' VAL . 0.7 OUTLIER -118.94 118.67 32.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.351 -1.087 . . . . 0.0 110.119 -179.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.536 ' O ' ' CD1' ' A' ' 167' ' ' LEU . 39.3 t -144.76 165.23 28.67 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.177 -0.952 . . . . 0.0 109.96 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.782 HG22 HD22 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -102.64 116.88 47.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 121.452 -0.78 . . . . 0.0 109.674 179.541 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 66.56 8.31 45.5 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 87.05 35.95 9.4 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . 0.419 ' N ' ' OG ' ' A' ' 181' ' ' SER . 33.0 m -84.89 -74.55 0.39 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.293 -1.122 . . . . 0.0 110.563 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.647 ' CE2' HD11 ' A' ' 182' ' ' ILE . 18.7 m-85 -81.01 88.04 5.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.109 -0.995 . . . . 0.0 110.662 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.602 ' O ' ' CE2' ' A' ' 191' ' ' PHE . 2.3 tp -177.84 28.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.595 -0.691 . . . . 0.0 109.5 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.525 ' H ' ' HD2' ' A' ' 189' ' ' PRO . . . -104.15 -68.27 0.75 Allowed Glycine 0 N--CA 1.491 2.336 0 C-N-CA 120.059 -1.067 . . . . 0.0 110.514 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.525 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 44.4 Cg_endo -71.1 -30.05 16.79 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.843 1.444 . . . . 0.0 111.17 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.565 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -73.12 12.29 0.58 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.175 -0.953 . . . . 0.0 111.17 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.602 ' CE2' ' O ' ' A' ' 187' ' ' LEU . 0.3 OUTLIER -90.13 -13.15 36.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.08 -1.012 . . . . 0.0 109.741 179.255 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.47 -20.37 31.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.436 -0.79 . . . . 0.0 110.718 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -108.97 -24.7 5.92 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.821 -1.711 . . . . 0.0 108.821 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 1.061 HD11 ' O ' ' A' ' 178' ' ' LEU . 6.6 tt -61.99 -32.71 73.2 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.611 -0.935 . . . . 0.0 109.016 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.553 ' HA ' HG23 ' A' ' 177' ' ' THR . 0.1 OUTLIER -47.16 -29.18 2.14 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.434 -0.791 . . . . 0.0 109.409 179.422 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -114.42 -19.38 6.24 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.675 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.91 -8.36 49.59 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.493 -1.004 . . . . 0.0 110.049 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . 0.552 HG22 ' O ' ' A' ' 194' ' ' LEU . 0.1 OUTLIER -43.52 143.16 1.0 Allowed 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.91 0.862 . . . . 0.0 111.587 -178.152 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 1.028 ' O ' HD11 ' A' ' 178' ' ' LEU . 0.0 OUTLIER -140.41 172.26 12.98 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 22.3 m-85 -83.15 129.82 59.52 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.953 -1.092 . . . . 0.0 109.34 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.642 ' HG3' HD22 ' A' ' 171' ' ' LEU . 48.1 Cg_endo -74.18 129.6 13.28 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.054 1.555 . . . . 0.0 111.73 -178.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.511 ' O ' HG13 ' A' ' 106' ' ' VAL . 8.3 m -133.42 151.58 51.82 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.584 -0.697 . . . . 0.0 109.405 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.784 HG13 ' HG3' ' A' ' 50' ' ' PRO . 1.6 p -135.79 139.49 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.033 -1.042 . . . . 0.0 110.431 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . 0.996 ' HB2' HG23 ' A' ' 105' ' ' VAL . 74.7 m -119.7 126.88 52.18 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.756 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.614 ' HA ' ' CH2' ' A' ' 95' ' ' TRP . . . -109.79 138.3 46.35 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.772 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.828 HG13 ' N ' ' A' ' 207' ' ' TRP . 0.3 OUTLIER -91.62 -159.68 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.506 -0.746 . . . . 0.0 110.542 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 0.828 ' N ' HG13 ' A' ' 206' ' ' VAL . 0.8 OUTLIER -47.07 176.39 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 110.265 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.422 ' N ' ' OD2' ' A' ' 76' ' ' ASP . . . -82.1 -0.12 89.28 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -72.87 -33.68 66.24 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.616 -0.932 . . . . 0.0 110.155 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . 0.668 ' O ' ' C ' ' A' ' 211' ' ' GLN . 11.4 t -97.08 -0.25 47.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.346 -0.846 . . . . 0.0 110.149 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.668 ' C ' ' O ' ' A' ' 210' ' ' CYS . 0.6 OUTLIER 0.49 106.39 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.787 0.803 . . . . 0.0 111.42 -179.804 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.9 HG23 ' O ' ' A' ' 94' ' ' SER . 1.9 p -87.85 145.02 8.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.708 -0.62 . . . . 0.0 109.545 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . 0.657 ' HA ' HD21 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -87.27 156.45 19.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.17 -0.956 . . . . 0.0 110.466 -178.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 1.0 HD12 ' HB3' ' A' ' 48' ' ' TRP . 0.2 OUTLIER -143.86 130.24 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.453 -0.779 . . . . 0.0 110.657 -179.323 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.663 ' O ' ' N ' ' A' ' 92' ' ' GLU . 6.8 mtt180 -130.81 108.86 10.16 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . 0.79 ' CD2' ' HB3' ' A' ' 91' ' ' TRP . 1.6 t80 -113.84 139.92 48.76 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 120.976 -1.077 . . . . 0.0 111.693 -177.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . 0.45 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 0.3 OUTLIER -136.87 125.85 24.32 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.19 0.519 . . . . 0.0 109.89 179.548 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 120.47 -21.8 8.5 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.608 ' HB2' ' CE1' ' A' ' 216' ' ' TYR . 5.9 tm-20 . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.152 -1.205 . . . . 0.0 110.362 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.904 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 121.184 0.516 . . . . 0.0 110.048 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.653 ' HA ' HD23 ' A' ' 33' ' ' LEU . 2.1 pp20? -47.54 -43.05 24.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.917 . . . . 0.0 109.745 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.436 ' N ' ' CD ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -57.75 -21.19 39.85 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.201 179.269 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -83.4 -35.2 25.25 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.784 HD12 ' C ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -67.8 -35.63 78.98 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 122.059 0.933 . . . . 0.0 109.087 179.15 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.568 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 1.0 OUTLIER -82.65 -6.8 59.56 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.301 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.999 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -45.82 -67.31 0.39 Allowed Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.226 -0.921 . . . . 0.0 111.068 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.999 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 46.1 Cg_endo -70.42 142.49 45.17 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.674 1.355 . . . . 0.0 110.288 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.692 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 53.3 Cg_endo -96.79 20.62 0.44 Allowed 'Trans proline' 0 CA--C 1.552 1.385 0 C-N-CA 121.724 1.616 . . . . 0.0 113.828 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.701 ' CD ' ' HB2' ' A' ' 36' ' ' PRO . 50.6 Cg_endo -79.58 151.01 22.11 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 122.609 0.794 . . . . 0.0 110.625 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.722 ' CG ' ' OE1' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -15.33 -54.7 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.755 -0.59 . . . . 0.0 111.835 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.1 HD13 HG23 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -44.56 -51.48 8.92 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 120.455 -1.403 . . . . 0.0 109.701 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 1.1 HG23 HD13 ' A' ' 40' ' ' LEU . 23.4 t -87.26 -30.47 5.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.146 -0.971 . . . . 0.0 110.614 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.67 -36.8 15.04 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.974 -1.079 . . . . 0.0 111.587 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.751 ' CD ' ' HB2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -82.24 -19.53 39.46 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.252 -0.905 . . . . 0.0 110.01 -179.188 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.627 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 2.1 ttt180 -83.23 -42.68 16.95 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.304 -0.872 . . . . 0.0 109.952 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.892 ' CE1' HG13 ' A' ' 41' ' ' VAL . 14.7 m170 -60.4 -18.07 48.17 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.609 -0.682 . . . . 0.0 110.703 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -96.29 -34.71 11.5 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.032 -1.067 . . . . 0.0 109.556 178.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.523 ' HA3' ' HB2' ' A' ' 61' ' ' GLU . . . -92.42 -101.87 1.44 Allowed Glycine 0 N--CA 1.487 2.056 0 N-CA-C 106.929 -2.468 . . . . 0.0 106.929 178.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.771 ' CZ3' HD12 ' A' ' 214' ' ' ILE . 93.8 m95 -81.27 73.81 8.29 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.05 -1.265 . . . . 0.0 108.044 177.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.713 ' HA ' ' HA ' ' A' ' 45' ' ' HIS . 0.1 OUTLIER -43.69 147.02 0.88 Allowed Pre-proline 0 C--N 1.297 -1.714 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.087 -179.362 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.682 ' HD3' ' CD2' ' A' ' 45' ' ' HIS . 40.5 Cg_endo -68.48 -33.04 23.83 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 124.498 1.788 . . . . 0.0 110.142 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.838 ' N ' ' HE3' ' A' ' 51' ' ' LYS . 0.2 OUTLIER -63.58 -16.64 61.4 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.612 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.878 ' O ' ' N ' ' A' ' 79' ' ' ARG . 4.2 m-20 -104.83 0.56 28.2 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 177.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.607 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 21.7 t -167.57 137.31 2.75 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 120.149 -0.621 . . . . 0.0 110.025 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.79 ' CB ' HD21 ' A' ' 56' ' ' ASN . 0.0 OUTLIER -100.77 161.33 13.67 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.209 179.159 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.603 ' HG3' HD21 ' A' ' 29' ' ' LEU . 24.3 pm0 -38.12 -20.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.326 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.79 HD21 ' CB ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -41.81 -29.61 0.21 Allowed 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 118.495 -1.282 . . . . 0.0 108.204 -179.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.999 HD11 ' O ' ' A' ' 207' ' ' TRP . 1.2 mt -131.13 166.11 29.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-O 121.63 0.729 . . . . 0.0 111.056 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.52 ' N ' ' CG2' ' A' ' 57' ' ' ILE . 2.8 t70 -128.11 105.67 8.53 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.72 HG12 ' HA ' ' A' ' 66' ' ' PHE . 10.7 m -128.44 135.52 62.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.327 -0.858 . . . . 0.0 110.955 -178.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.751 ' HB2' ' CD ' ' A' ' 43' ' ' GLN . 2.5 tttm -124.02 155.32 38.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.365 -0.835 . . . . 0.0 110.574 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.523 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . 4.2 tt0 -83.98 -131.25 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.387 -0.821 . . . . 0.0 110.142 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 43.24 52.44 6.0 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 108.389 -1.885 . . . . 0.0 108.389 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.667 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 108.88 61.66 0.54 Allowed Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.669 HD21 ' O ' ' A' ' 214' ' ' ILE . 1.5 mm? 0.49 80.06 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.92 -0.753 . . . . 0.0 111.421 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 63' ' ' GLY . 1.6 m -99.51 114.37 27.31 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.266 -0.896 . . . . 0.0 109.599 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.72 ' HA ' HG12 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -104.89 124.74 49.99 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.311 -0.868 . . . . 0.0 110.079 -179.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.511 ' O ' ' O ' ' A' ' 58' ' ' ASP . 29.2 tt0 -144.62 145.56 31.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 109.862 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.561 ' HG2' ' O ' ' A' ' 207' ' ' TRP . 0.0 OUTLIER -132.68 118.12 18.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 110.207 -179.791 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.688 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 9.9 mmm-85 -84.73 -71.65 0.1 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.284 -0.885 . . . . 0.0 110.302 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.688 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 56.4 Cg_endo -72.18 -145.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.569 1.3 . . . . 0.0 109.155 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.481 ' O ' ' HG2' ' A' ' 73' ' ' GLN . 3.2 t -140.09 163.77 23.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 O-C-N 121.406 -0.809 . . . . 0.0 109.738 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 71' ' ' VAL . . . -43.19 103.3 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.067 -1.021 . . . . 0.0 109.891 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 3.8 pt20 -128.28 -113.27 0.27 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.211 -0.93 . . . . 0.0 110.593 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.462 ' C ' ' O ' ' A' ' 73' ' ' GLN . 22.0 p -36.06 -52.08 0.76 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.319 -0.863 . . . . 0.0 110.809 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.493 ' CB ' ' HB3' ' A' ' 54' ' ' SER . 0.2 OUTLIER -118.41 -137.39 0.35 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.131 -0.98 . . . . 0.0 109.993 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.701 ' O ' ' C ' ' A' ' 77' ' ' GLY . 1.3 t0 -140.66 154.84 46.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.893 . . . . 0.0 110.387 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.701 ' C ' ' O ' ' A' ' 76' ' ' ASP . . . -12.23 -98.32 0.0 OUTLIER Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.858 ' CG2' ' HB3' ' A' ' 205' ' ' ALA . 3.7 m -128.06 121.64 56.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.038 -1.272 . . . . 0.0 110.003 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.878 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -145.53 133.76 21.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.415 -0.803 . . . . 0.0 110.907 -179.756 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.709 ' HA3' ' HA ' ' A' ' 52' ' ' ASP . . . -163.7 145.23 10.24 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.813 ' CE ' ' HB3' ' A' ' 109' ' ' ALA . 1.5 tttm -138.73 80.84 1.81 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -1.133 . . . . 0.0 110.04 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.48 -92.79 0.28 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.128 -0.983 . . . . 0.0 110.213 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 53.95 69.59 1.19 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -120.78 111.41 17.55 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.195 -1.179 . . . . 0.0 110.308 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.599 ' HB3' ' CE1' ' A' ' 89' ' ' HIS . 0.8 OUTLIER -140.02 173.65 11.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.936 . . . . 0.0 110.165 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.595 ' N ' ' CD ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -118.47 138.16 52.68 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.225 -0.922 . . . . 0.0 110.119 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.491 ' HA2' ' CG ' ' A' ' 174' ' ' GLU . . . 98.05 -116.52 5.56 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.495 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 0.9 OUTLIER -128.6 135.33 49.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.407 -1.055 . . . . 0.0 110.295 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.813 ' HB2' HD23 ' A' ' 171' ' ' LEU . 9.0 m-70 -147.08 161.14 41.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.154 -0.966 . . . . 0.0 109.811 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.556 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -158.02 147.12 19.45 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.042 -1.036 . . . . 0.0 110.517 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 1.043 ' CZ2' HD22 ' A' ' 171' ' ' LEU . 1.3 m0 -134.75 170.23 16.14 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.374 -0.829 . . . . 0.0 109.097 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 1.003 ' CD ' HD12 ' A' ' 168' ' ' LEU . 3.2 mt-10 -136.47 138.96 41.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.118 -0.989 . . . . 0.0 111.23 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.909 HD13 ' O ' ' A' ' 92' ' ' GLU . 8.3 mm -142.93 126.4 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.58 -0.7 . . . . 0.0 109.361 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.718 ' HA ' HD12 ' A' ' 167' ' ' LEU . 1.4 m -143.62 143.51 31.5 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.166 -0.959 . . . . 0.0 110.325 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.6 ' HH2' ' CB ' ' A' ' 205' ' ' ALA . 47.9 m95 -114.4 88.46 15.64 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.322 -0.861 . . . . 0.0 110.282 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 94' ' ' SER . 50.9 Cg_endo -91.92 109.86 0.27 Allowed 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 123.909 1.479 . . . . 0.0 110.255 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.541 ' O ' ' CD1' ' A' ' 97' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 O-C-N 120.809 -1.182 . . . . 0.0 110.492 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.686 HG23 ' C ' ' A' ' 204' ' ' SER . 27.0 m . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 121.396 0.617 . . . . 0.0 110.366 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.842 HG13 ' HA ' ' A' ' 203' ' ' VAL . 8.4 t -150.69 170.04 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.464 -0.773 . . . . 0.0 109.631 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.65 ' CA ' ' HA3' ' A' ' 132' ' ' GLY . . . 164.02 164.05 18.33 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.504 -1.331 . . . . 0.0 110.689 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.815 HG12 ' HB2' ' A' ' 199' ' ' LEU . 2.5 t -114.3 155.7 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.639 -0.919 . . . . 0.0 109.072 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.813 ' HB3' ' CE ' ' A' ' 81' ' ' LYS . . . -142.93 144.75 32.52 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.863 -1.148 . . . . 0.0 111.129 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.684 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.8 OUTLIER -103.47 125.12 49.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.397 -0.815 . . . . 0.0 110.0 179.544 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.85 -28.39 16.55 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.459 -0.775 . . . . 0.0 109.9 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.673 ' O ' ' C ' ' A' ' 113' ' ' ALA . 0.5 OUTLIER -81.22 -12.45 59.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.321 -0.862 . . . . 0.0 109.719 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.673 ' C ' ' O ' ' A' ' 112' ' ' LEU . . . . . . . . 0 N--CA 1.5 2.046 0 O-C-N 121.967 -0.458 . . . . 0.0 111.408 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.232 0.539 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -150.11 128.52 12.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 110.083 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 24.0 t -120.43 119.75 33.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 110.276 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -133.35 130.17 38.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -0.902 . . . . 0.0 109.852 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.65 ' HA3' ' CA ' ' A' ' 107' ' ' GLY . . . -169.41 -146.56 5.1 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.705 ' CZ3' ' CG ' ' A' ' 180' ' ' TYR . 47.4 m0 -121.54 113.74 20.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -1.138 . . . . 0.0 110.501 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.59 ' C ' HG23 ' A' ' 135' ' ' ILE . 3.9 t70 -118.14 122.9 44.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.554 -0.716 . . . . 0.0 110.164 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.59 HG23 ' C ' ' A' ' 134' ' ' ASP . 17.6 pt . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 110.172 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.699 ' HB ' ' HD3' ' A' ' 164' ' ' PRO . 2.7 t . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.699 ' HD3' ' HB ' ' A' ' 163' ' ' VAL . 54.7 Cg_endo -78.89 154.44 26.13 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.457 1.24 . . . . 0.0 109.912 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -58.53 -30.61 67.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.043 -1.036 . . . . 0.0 109.374 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.461 ' HG3' ' OG ' ' A' ' 94' ' ' SER . 1.4 ttt180 -151.82 155.83 38.98 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.631 -0.668 . . . . 0.0 109.321 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 1.011 HD23 HG21 ' A' ' 182' ' ' ILE . 1.2 mp -126.86 138.63 53.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.965 -1.084 . . . . 0.0 110.461 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 1.003 HD12 ' CD ' ' A' ' 92' ' ' GLU . 1.0 OUTLIER -120.76 126.71 50.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.337 -0.852 . . . . 0.0 109.969 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.435 HG11 ' HE3' ' A' ' 91' ' ' TRP . 46.0 t -89.93 136.04 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 109.99 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.503 HG22 ' CD2' ' A' ' 168' ' ' LEU . 3.5 t -124.16 126.47 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.205 -0.934 . . . . 0.0 109.971 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 1.043 HD22 ' CZ2' ' A' ' 91' ' ' TRP . 0.0 OUTLIER -133.04 120.39 21.28 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.116 -0.99 . . . . 0.0 109.843 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 173' ' ' MET . 46.1 t0 -117.92 135.28 54.22 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.33 -0.856 . . . . 0.0 109.928 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.465 ' O ' ' C ' ' A' ' 174' ' ' GLU . 0.0 OUTLIER -98.62 -42.44 7.26 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.796 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.491 ' CG ' ' HA2' ' A' ' 87' ' ' GLY . 1.1 mm-40 -43.62 -26.87 0.26 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.223 -0.923 . . . . 0.0 108.72 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.565 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 2.7 tp10 -112.49 -28.32 7.9 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.717 0.77 . . . . 0.0 108.977 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 85.95 22.53 48.89 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 108.684 -1.766 . . . . 0.0 108.684 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.903 HG22 HD22 ' A' ' 194' ' ' LEU . 0.3 OUTLIER -113.77 123.5 49.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.222 -1.163 . . . . 0.0 111.087 -179.513 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.83 HD13 HD12 ' A' ' 171' ' ' LEU . 0.2 OUTLIER -143.89 154.19 43.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.424 -0.797 . . . . 0.0 109.805 179.458 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -177.86 -161.06 25.43 Favored Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.506 -1.331 . . . . 0.0 110.273 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.83 ' O ' HD13 ' A' ' 187' ' ' LEU . 0.5 OUTLIER -118.7 123.52 45.09 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.493 -1.004 . . . . 0.0 109.724 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.765 ' HB2' HD22 ' A' ' 187' ' ' LEU . 5.7 t -130.15 125.68 35.64 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.417 -0.802 . . . . 0.0 110.356 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 1.011 HG21 HD23 ' A' ' 167' ' ' LEU . 0.1 OUTLIER -110.02 116.9 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.216 -0.928 . . . . 0.0 109.911 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 47.93 23.57 2.64 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 69.14 40.17 82.81 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . 0.925 HG22 ' CD2' ' A' ' 186' ' ' TYR . 92.4 m -71.36 -76.27 0.11 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.277 -1.131 . . . . 0.0 110.642 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.925 ' CD2' HG22 ' A' ' 185' ' ' THR . 25.7 m-85 -126.5 89.28 2.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.172 -0.955 . . . . 0.0 110.641 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.83 HD13 ' O ' ' A' ' 180' ' ' TYR . 0.2 OUTLIER -176.54 26.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.404 -0.81 . . . . 0.0 109.765 179.641 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.575 ' H ' ' HD2' ' A' ' 189' ' ' PRO . . . -95.52 -61.46 1.01 Allowed Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.97 -1.11 . . . . 0.0 110.568 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.575 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 45.0 Cg_endo -71.94 -29.52 15.02 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.951 1.5 . . . . 0.0 111.001 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -74.65 15.78 0.34 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.197 -0.94 . . . . 0.0 111.03 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -90.35 -12.91 36.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.086 -1.009 . . . . 0.0 110.099 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.09 -15.31 34.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.0 110.187 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -109.99 -18.83 8.5 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.903 HD22 HG22 ' A' ' 177' ' ' THR . 6.3 tt -61.82 -32.25 72.55 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.727 -0.867 . . . . 0.0 108.82 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.655 ' HA ' HG23 ' A' ' 177' ' ' THR . 0.0 OUTLIER -47.2 -29.64 2.48 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.576 -0.702 . . . . 0.0 109.422 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -114.19 -19.33 6.35 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.77 ' HD3' HD11 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.88 -4.87 56.22 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.507 -0.996 . . . . 0.0 109.774 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . 0.534 ' O ' ' CG2' ' A' ' 110' ' ' THR . 0.1 OUTLIER -43.38 145.59 0.57 Allowed 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.913 0.863 . . . . 0.0 111.396 -178.269 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.815 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -140.11 172.27 12.99 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.667 ' C ' HG13 ' A' ' 108' ' ' VAL . 1.7 m-85 -82.85 129.62 61.12 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 120.887 -1.133 . . . . 0.0 109.274 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.58 ' HD3' HD12 ' A' ' 178' ' ' LEU . 49.8 Cg_endo -78.07 125.92 7.53 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.079 1.568 . . . . 0.0 111.388 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.55 ' HB3' ' CG ' ' A' ' 81' ' ' LYS . 9.3 p -133.59 138.39 45.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.476 -0.765 . . . . 0.0 109.891 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.842 ' HA ' HG13 ' A' ' 106' ' ' VAL . 7.1 p -119.31 159.54 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.142 -0.974 . . . . 0.0 109.402 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . 0.686 ' C ' HG23 ' A' ' 105' ' ' VAL . 22.3 m -160.15 162.67 33.98 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.129 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.858 ' HB3' ' CG2' ' A' ' 78' ' ' VAL . . . -150.14 160.13 43.9 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.424 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.678 HG13 ' N ' ' A' ' 207' ' ' TRP . 0.4 OUTLIER -49.42 -176.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.635 -0.666 . . . . 0.0 110.329 179.618 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 0.999 ' O ' HD11 ' A' ' 57' ' ' ILE . 22.7 p-90 -92.4 -44.44 8.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.929 . . . . 0.0 110.05 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.628 ' N ' ' CG ' ' A' ' 207' ' ' TRP . . . -164.33 128.28 1.79 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -173.89 -39.8 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.239 -1.153 . . . . 0.0 110.432 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . 0.499 ' O ' ' HG3' ' A' ' 211' ' ' GLN . 1.2 m -155.75 -93.48 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.404 -0.81 . . . . 0.0 110.551 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.528 ' HG2' ' HB2' ' A' ' 66' ' ' PHE . 2.1 mt-30 179.53 159.82 0.74 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.067 -1.021 . . . . 0.0 110.161 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.727 ' HB ' ' CH2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -127.5 144.05 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.165 -0.959 . . . . 0.0 110.784 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . 0.65 ' NE ' ' O ' ' A' ' 213' ' ' ARG . 0.0 OUTLIER -101.46 110.79 22.85 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.256 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.771 HD12 ' CZ3' ' A' ' 48' ' ' TRP . 1.4 tt -118.12 132.84 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.906 -1.121 . . . . 0.0 111.319 -178.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.645 ' O ' ' N ' ' A' ' 92' ' ' GLU . 1.6 mtt180 -130.09 109.41 10.82 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . 0.746 ' CZ ' ' CD1' ' A' ' 91' ' ' TRP . 27.3 t80 -113.49 145.49 41.12 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.274 -0.891 . . . . 0.0 111.115 -178.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . 0.477 ' HA ' ' CE ' ' A' ' 217' ' ' MET . 3.8 tpt -136.56 108.59 7.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.536 -0.727 . . . . 0.0 109.877 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 132.97 7.09 2.67 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.577 ' HB2' ' CD1' ' A' ' 216' ' ' TYR . 22.2 tt0 . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.132 -1.216 . . . . 0.0 110.123 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.636 HD11 ' HB2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 121.137 0.494 . . . . 0.0 110.075 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.765 ' HA ' HD23 ' A' ' 33' ' ' LEU . 10.8 pt-20 -44.49 -45.95 9.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.146 -0.971 . . . . 0.0 109.225 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.22 -20.79 7.53 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.639 -0.824 . . . . 0.0 108.777 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.605 ' N ' ' O ' ' A' ' 29' ' ' LEU . 4.1 tp -83.83 -33.62 24.85 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.088 HD21 ' CG ' ' A' ' 55' ' ' GLU . 0.4 OUTLIER -73.66 -36.12 65.33 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 122.012 0.911 . . . . 0.0 109.179 179.367 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.583 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 7.3 m -85.0 -6.76 59.33 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.324 0.583 . . . . 0.0 109.775 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.983 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -49.45 -67.61 0.42 Allowed Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.307 -0.871 . . . . 0.0 110.879 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.983 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 46.5 Cg_endo -72.14 157.68 53.61 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.655 1.345 . . . . 0.0 110.366 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 36' ' ' PRO . 53.9 Cg_endo -99.14 55.3 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 121.94 1.76 . . . . 0.0 112.006 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.695 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 49.4 Cg_endo -73.7 150.7 45.38 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.064 1.034 . . . . 0.0 110.108 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.741 ' O ' ' HB3' ' A' ' 43' ' ' GLN . 0.5 OUTLIER -41.86 -21.87 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.199 -0.938 . . . . 0.0 109.873 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.091 HD13 ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -61.2 -50.45 73.07 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.014 -1.053 . . . . 0.0 109.184 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 1.091 ' N ' HD13 ' A' ' 40' ' ' LEU . 2.9 t -67.27 -39.84 83.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 C-N-CA 118.481 -1.287 . . . . 0.0 110.845 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.36 -39.9 12.41 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.784 -1.197 . . . . 0.0 112.797 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.849 ' OE1' ' HA ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -82.2 -20.54 37.58 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 118.406 -1.318 . . . . 0.0 109.536 -179.414 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.916 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 5.0 ttp180 -68.68 -52.29 32.64 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.895 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 40.6 m-70 -45.62 -23.57 0.26 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.471 ' N ' ' C ' ' A' ' 44' ' ' ARG . 3.3 t-160 -95.96 -33.01 12.32 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.033 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 49' ' ' ASN . . . -87.72 -115.63 1.16 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 107.065 -2.414 . . . . 0.0 107.065 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.803 ' HH2' HG12 ' A' ' 212' ' ' VAL . 93.7 m95 -67.48 74.47 0.16 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.749 -1.442 . . . . 0.0 108.33 177.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.678 ' OD1' ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -44.11 111.62 1.2 Allowed Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.63 -0.669 . . . . 0.0 110.614 -179.29 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.777 ' O ' ' O ' ' A' ' 53' ' ' CYS . 55.4 Cg_endo -79.49 1.65 9.02 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.166 1.91 . . . . 0.0 111.692 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.752 ' HA ' ' HE3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -50.59 -75.6 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.387 -1.446 . . . . 0.0 108.459 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.821 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 0.6 OUTLIER -64.79 3.43 0.54 Allowed 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.777 ' O ' ' O ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -124.67 170.45 10.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.423 -0.798 . . . . 0.0 110.797 -178.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.581 ' N ' ' SG ' ' A' ' 53' ' ' CYS . 4.4 t -100.51 165.8 11.24 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.015 -1.053 . . . . 0.0 108.906 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 1.088 ' CG ' HD21 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -94.32 1.13 55.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.93 -1.106 . . . . 0.0 110.547 -179.045 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.638 ' ND2' ' N ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -22.17 -42.01 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 122.401 1.096 . . . . 0.0 109.937 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.695 ' N ' ' O ' ' A' ' 55' ' ' GLU . 11.3 pt -126.03 169.61 17.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.555 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.64 ' O ' ' HB3' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -105.69 118.04 35.57 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.324 -0.86 . . . . 0.0 109.299 -178.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.734 ' CG1' ' CD1' ' A' ' 48' ' ' TRP . 90.1 t -124.44 136.05 61.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.273 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.849 ' HA ' ' OE1' ' A' ' 43' ' ' GLN . 1.7 ttmt -135.21 155.14 51.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.714 -1.241 . . . . 0.0 111.043 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.552 ' N ' ' OE1' ' A' ' 43' ' ' GLN . 23.2 tt0 -67.47 -109.26 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.453 -0.779 . . . . 0.0 110.226 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.546 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 37.26 35.17 0.15 Allowed Glycine 0 N--CA 1.494 2.558 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.68 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 114.56 56.85 0.38 Allowed Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 -178.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.815 HD22 ' H ' ' A' ' 64' ' ' LEU . 2.0 mm? 0.83 84.98 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.962 -0.728 . . . . 0.0 110.92 -178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 63' ' ' GLY . 1.7 m -128.43 130.61 47.86 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.383 -0.823 . . . . 0.0 110.708 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.69 ' CE2' ' HB ' ' A' ' 212' ' ' VAL . 5.3 m-30 -83.61 152.4 24.84 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.64 ' HB3' ' O ' ' A' ' 58' ' ' ASP . 1.1 tp10 -147.65 121.4 9.25 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.228 -0.92 . . . . 0.0 109.755 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.585 ' HG2' ' CD1' ' A' ' 207' ' ' TRP . 1.0 OUTLIER -118.99 156.32 29.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.419 -0.801 . . . . 0.0 109.416 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.574 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -168.15 -56.94 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 120.98 -1.075 . . . . 0.0 111.043 -179.559 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.636 ' HB2' HD11 ' A' ' 29' ' ' LEU . 41.0 Cg_endo -67.29 -47.14 2.4 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.804 1.423 . . . . 0.0 110.729 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.678 HG11 HG22 ' A' ' 57' ' ' ILE . 2.0 p -78.31 165.38 3.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.879 0.847 . . . . 0.0 111.048 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.554 ' N ' HG22 ' A' ' 71' ' ' VAL . . . -156.59 -40.01 0.08 Allowed 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.049 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 75' ' ' THR . 1.8 mt-30 -74.73 151.56 39.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.906 . . . . 0.0 110.125 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.9 91.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.335 -0.853 . . . . 0.0 110.21 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.51 ' N ' ' O ' ' A' ' 73' ' ' GLN . 2.6 m -97.03 -130.38 0.18 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.32 -0.862 . . . . 0.0 110.061 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.513 ' O ' ' O ' ' A' ' 77' ' ' GLY . 0.2 OUTLIER -120.75 113.8 20.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.186 -0.946 . . . . 0.0 110.452 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.577 ' HA2' ' CE3' ' A' ' 207' ' ' TRP . . . -57.14 -114.24 0.01 OUTLIER Glycine 0 N--CA 1.485 1.925 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -148.42 123.17 2.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.944 -1.327 . . . . 0.0 110.979 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.821 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -104.47 175.08 5.61 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.549 -0.72 . . . . 0.0 109.489 179.313 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.576 ' N ' ' CG ' ' A' ' 79' ' ' ARG . . . -157.42 58.29 0.36 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.533 ' HG3' ' CB ' ' A' ' 202' ' ' SER . 0.7 OUTLIER -89.9 75.02 7.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.075 -1.25 . . . . 0.0 110.122 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.779 ' HD3' ' H ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -141.94 -95.29 0.13 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.316 -0.865 . . . . 0.0 110.292 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.779 ' H ' ' HD3' ' A' ' 82' ' ' ARG . . . 56.54 62.23 6.59 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -105.71 95.7 5.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.177 -1.19 . . . . 0.0 110.261 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.584 ' OG ' ' CD2' ' A' ' 89' ' ' HIS . 0.4 OUTLIER -140.01 171.51 14.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 110.018 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.64 ' O ' ' CD2' ' A' ' 89' ' ' HIS . 30.1 mtm180 -123.38 175.79 6.52 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.164 -0.96 . . . . 0.0 110.237 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.519 ' N ' ' HB3' ' A' ' 173' ' ' MET . . . 62.52 -116.45 9.39 Favored Glycine 0 N--CA 1.482 1.722 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.448 HD12 ' HB2' ' A' ' 172' ' ' ASP . 11.6 tp -129.37 127.76 41.69 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.559 -0.966 . . . . 0.0 110.995 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.814 ' HB2' HD23 ' A' ' 171' ' ' LEU . 93.3 m-70 -147.26 173.16 12.82 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.269 -0.895 . . . . 0.0 109.95 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.544 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -163.81 164.11 23.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.261 -0.899 . . . . 0.0 110.133 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.722 ' CD1' ' CZ ' ' A' ' 216' ' ' TYR . 1.1 m0 -134.86 145.89 48.73 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.301 -0.874 . . . . 0.0 109.54 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.644 ' O ' ' N ' ' A' ' 215' ' ' ARG . 2.1 tt0 -109.97 118.9 37.67 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.431 -0.907 . . . . 0.0 109.883 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.533 HD13 ' O ' ' A' ' 92' ' ' GLU . 17.3 mm -118.08 130.05 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.019 -1.051 . . . . 0.0 111.028 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.558 ' CB ' ' HB3' ' A' ' 213' ' ' ARG . 0.0 OUTLIER -118.53 126.38 51.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.404 -0.81 . . . . 0.0 109.428 179.319 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.703 ' CH2' HG13 ' A' ' 105' ' ' VAL . 7.1 t-105 -117.3 88.19 27.03 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.119 -0.988 . . . . 0.0 110.217 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.535 ' HD2' ' HA ' ' A' ' 212' ' ' VAL . 50.0 Cg_endo -96.21 112.21 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 121.968 1.779 . . . . 0.0 110.673 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.689 0 O-C-N 120.824 -1.173 . . . . 0.0 110.184 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.905 HG12 ' CD1' ' A' ' 135' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.111 0 CA-C-O 121.818 0.818 . . . . 0.0 109.197 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.806 HG13 ' O ' ' A' ' 202' ' ' SER . 22.2 t -152.04 159.8 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.277 -0.889 . . . . 0.0 109.574 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.613 ' HA2' ' HA3' ' A' ' 132' ' ' GLY . . . -175.57 136.77 3.48 Favored Glycine 0 N--CA 1.487 2.078 0 C-N-CA 118.826 -1.654 . . . . 0.0 110.859 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.862 HG13 ' C ' ' A' ' 200' ' ' TYR . 2.8 t -104.42 141.71 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.601 -0.941 . . . . 0.0 108.999 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.904 ' HB3' ' CZ ' ' A' ' 200' ' ' TYR . . . -130.54 152.39 49.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.883 -1.136 . . . . 0.0 111.126 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.977 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -121.13 130.87 53.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.481 -0.762 . . . . 0.0 110.055 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -89.44 -25.96 21.22 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.291 -0.881 . . . . 0.0 109.343 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.4 pp -83.35 -12.49 56.51 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.489 -0.757 . . . . 0.0 109.398 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.59 ' HB3' ' HB ' ' A' ' 110' ' ' THR . . . . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.47 -0.769 . . . . 0.0 110.246 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.5 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.347 0.594 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.578 ' OE2' ' CG ' ' A' ' 131' ' ' TRP . 4.6 tm-20 -145.03 126.84 15.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.902 . . . . 0.0 109.892 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -122.09 119.45 31.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.946 . . . . 0.0 110.666 -179.727 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . 0.578 ' CG ' ' OE2' ' A' ' 129' ' ' GLU . 16.7 m0 -133.25 133.27 42.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.47 -0.768 . . . . 0.0 109.519 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.613 ' HA3' ' HA2' ' A' ' 107' ' ' GLY . . . -177.23 -140.94 3.84 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.442 -1.361 . . . . 0.0 110.207 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.564 ' CH2' ' O ' ' A' ' 180' ' ' TYR . 52.0 m0 -117.17 112.95 21.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.207 -1.172 . . . . 0.0 110.75 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.33 148.27 43.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.761 -0.587 . . . . 0.0 110.269 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.905 ' CD1' HG12 ' A' ' 105' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.204 -0.935 . . . . 0.0 109.955 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.682 HG11 HG21 ' A' ' 182' ' ' ILE . 1.7 t . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.85 0.357 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.18 65.16 4.31 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.903 1.475 . . . . 0.0 110.75 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 27.2 tp10 -167.83 -84.14 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.398 -0.814 . . . . 0.0 110.101 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -152.31 155.86 38.49 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.4 -0.812 . . . . 0.0 110.344 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.668 ' HA ' HG22 ' A' ' 182' ' ' ILE . 2.9 mp -135.74 137.02 41.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 109.793 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.585 HD22 ' HA ' ' A' ' 92' ' ' GLU . 0.2 OUTLIER -130.53 114.21 15.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.066 -1.021 . . . . 0.0 110.571 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.878 HG22 ' CE1' ' A' ' 180' ' ' TYR . 18.4 t -89.92 136.04 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.852 . . . . 0.0 109.784 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.434 ' HB ' ' CD1' ' A' ' 187' ' ' LEU . 7.5 t -113.06 111.18 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.089 -1.007 . . . . 0.0 110.519 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 1.045 HD12 HD23 ' A' ' 178' ' ' LEU . 0.0 OUTLIER -119.68 105.6 11.33 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.292 -0.88 . . . . 0.0 109.311 179.607 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.448 ' HB2' HD12 ' A' ' 88' ' ' LEU . 5.5 t0 -120.33 135.3 55.06 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.577 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.576 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 0.3 OUTLIER -95.9 -40.68 9.18 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.414 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -44.73 -26.39 0.38 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.299 -0.876 . . . . 0.0 108.99 179.205 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.618 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.0 OUTLIER -110.78 -26.79 9.18 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.282 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.918 ' O ' HG21 ' A' ' 198' ' ' THR . . . 81.53 25.46 53.9 Favored Glycine 0 N--CA 1.482 1.73 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.925 HG22 ' HB3' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -118.56 112.08 19.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.196 -1.179 . . . . 0.0 111.381 -179.484 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 1.045 HD23 HD12 ' A' ' 171' ' ' LEU . 4.0 mp -118.76 153.85 33.77 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.481 -0.762 . . . . 0.0 109.256 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 177.39 -174.47 46.99 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.07 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.878 ' CE1' HG22 ' A' ' 169' ' ' VAL . 0.3 OUTLIER -123.99 125.62 44.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.341 -1.094 . . . . 0.0 109.949 179.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 35.5 t -136.69 132.77 35.37 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.268 -0.895 . . . . 0.0 110.194 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.682 HG21 HG11 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -103.67 116.81 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.309 -0.87 . . . . 0.0 109.756 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 88.76 -10.41 72.44 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 80.61 46.82 7.1 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 185' ' ' THR . 79.8 m -129.41 -2.5 4.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.255 -1.144 . . . . 0.0 110.441 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.432 ' CE2' HD11 ' A' ' 182' ' ' ILE . 0.2 OUTLIER -99.77 -54.96 2.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.207 -0.933 . . . . 0.0 110.264 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.891 HD21 ' CD1' ' A' ' 194' ' ' LEU . 5.3 mt -77.48 44.54 0.44 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.225 -0.922 . . . . 0.0 109.785 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -80.91 -96.78 0.39 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 191' ' ' PHE . 46.9 Cg_endo -72.9 -25.1 16.97 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 124.229 1.647 . . . . 0.0 111.017 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.55 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -68.62 21.42 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.506 -0.746 . . . . 0.0 111.76 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.829 ' CE1' HD22 ' A' ' 187' ' ' LEU . 0.2 OUTLIER -90.23 -13.83 34.63 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.707 -1.246 . . . . 0.0 110.349 179.467 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.05 -14.72 33.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.105 -0.997 . . . . 0.0 110.597 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -112.63 -11.16 15.3 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.925 ' HB3' HG22 ' A' ' 177' ' ' THR . 7.5 tt -74.69 -28.58 60.88 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.474 -1.015 . . . . 0.0 109.108 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.488 ' O ' ' OG1' ' A' ' 198' ' ' THR . 0.0 OUTLIER -54.08 -33.82 58.54 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.385 -0.822 . . . . 0.0 109.714 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -94.23 -26.88 12.98 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.792 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.46 -6.08 55.29 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.68 -0.894 . . . . 0.0 109.943 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . 0.918 HG21 ' O ' ' A' ' 176' ' ' GLY . 0.2 OUTLIER -44.59 131.86 6.5 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.877 0.846 . . . . 0.0 112.532 -178.114 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.977 ' CB ' HG23 ' A' ' 110' ' ' THR . 0.0 OUTLIER -140.74 170.75 15.18 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.571 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.904 ' CZ ' ' HB3' ' A' ' 109' ' ' ALA . 25.6 p90 -84.6 128.72 60.1 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 120.775 -1.203 . . . . 0.0 109.548 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.766 ' N ' HG13 ' A' ' 108' ' ' VAL . 51.0 Cg_endo -84.49 143.78 9.96 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.138 1.599 . . . . 0.0 111.393 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.806 ' O ' HG13 ' A' ' 106' ' ' VAL . 0.9 OUTLIER -133.54 138.54 46.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.51 -0.744 . . . . 0.0 109.908 179.401 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.54 HG23 HG22 ' A' ' 106' ' ' VAL . 14.6 p -119.64 157.93 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.161 -0.962 . . . . 0.0 110.108 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . 0.798 ' O ' HG22 ' A' ' 105' ' ' VAL . 0.4 OUTLIER -160.18 145.87 15.28 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.391 -0.818 . . . . 0.0 110.688 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.85 ' CB ' HG11 ' A' ' 212' ' ' VAL . . . -146.21 166.44 26.23 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.56 0.695 . . . . 0.0 110.573 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.581 HG13 ' N ' ' A' ' 207' ' ' TRP . 1.2 t -110.24 176.17 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 CA-C-O 121.456 0.646 . . . . 0.0 110.608 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 0.632 ' CE3' HD13 ' A' ' 57' ' ' ILE . 4.4 p90 -124.97 175.52 7.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.349 -0.844 . . . . 0.0 110.016 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 113.38 -165.57 12.05 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.452 ' O ' ' O ' ' A' ' 210' ' ' CYS . 0.0 OUTLIER -44.52 -29.39 0.71 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.393 -1.063 . . . . 0.0 110.3 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 211' ' ' GLN . 27.0 p -58.03 -154.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.318 -0.864 . . . . 0.0 110.236 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.529 ' O ' ' O ' ' A' ' 96' ' ' PRO . 0.9 OUTLIER 179.59 125.34 0.07 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.248 -0.908 . . . . 0.0 110.377 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.85 HG11 ' CB ' ' A' ' 205' ' ' ALA . 8.3 t -128.6 144.32 38.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 121.671 -0.643 . . . . 0.0 109.941 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . 0.558 ' HB3' ' CB ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -122.41 124.35 43.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.247 -0.908 . . . . 0.0 109.996 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.804 HG22 HD12 ' A' ' 64' ' ' LEU . 2.3 tt -119.22 128.06 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.013 -1.054 . . . . 0.0 111.183 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.644 ' N ' ' O ' ' A' ' 92' ' ' GLU . 1.1 mtt180 -130.14 136.9 49.8 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.407 -0.808 . . . . 0.0 109.259 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . 0.722 ' CZ ' ' CD1' ' A' ' 91' ' ' TRP . 14.0 t80 -118.9 150.17 40.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.04 -1.038 . . . . 0.0 110.908 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . 0.505 ' CB ' ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -124.57 107.68 11.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.944 . . . . 0.0 110.05 179.371 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 95.71 74.02 1.2 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.528 ' HB2' ' CD1' ' A' ' 216' ' ' TYR . 3.6 tp10 . . . . . 0 N--CA 1.493 1.718 0 O-C-N 121.187 -1.184 . . . . 0.0 110.125 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.903 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.356 0.598 . . . . 0.0 109.657 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 1.003 ' HA ' HD23 ' A' ' 33' ' ' LEU . 16.8 pt-20 -49.42 -28.42 5.15 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.255 -0.903 . . . . 0.0 109.167 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.441 ' N ' ' HG3' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -68.24 -23.3 64.78 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.513 -0.875 . . . . 0.0 108.687 179.011 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.539 ' CB ' HD12 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -83.37 -36.84 24.03 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.697 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.003 HD23 ' HA ' ' A' ' 30' ' ' GLU . 0.3 OUTLIER -69.75 -35.79 75.25 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 122.022 0.915 . . . . 0.0 109.365 179.165 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.62 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 1.5 m -78.99 -7.51 58.13 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.804 -0.56 . . . . 0.0 110.346 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 1.059 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -38.63 -66.54 0.31 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.249 -0.907 . . . . 0.0 110.307 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 1.059 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 49.0 Cg_endo -74.5 151.88 42.75 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.645 1.34 . . . . 0.0 109.938 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 36' ' ' PRO . 54.1 Cg_endo -99.06 53.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.856 1.704 . . . . 0.0 112.235 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.743 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 52.7 Cg_endo -76.7 150.12 30.74 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 122.906 0.95 . . . . 0.0 110.384 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.681 ' C ' ' NE2' ' A' ' 43' ' ' GLN . 1.6 t0 -40.78 -30.39 0.12 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 108.624 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.116 HD13 ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -40.95 -44.54 2.36 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.414 0.626 . . . . 0.0 109.449 179.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 1.116 ' N ' HD13 ' A' ' 40' ' ' LEU . 6.1 t -65.66 -27.25 40.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.797 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 39' ' ' ASP . . . -88.85 -43.57 11.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.91 -1.119 . . . . 0.0 111.587 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.682 ' CD ' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -81.32 -20.32 41.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.845 -1.16 . . . . 0.0 109.671 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.891 ' HE ' HD21 ' A' ' 40' ' ' LEU . 4.1 ttp85 -71.87 -55.03 8.28 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.709 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 21.1 m-70 -54.26 -27.56 35.77 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.367 0.603 . . . . 0.0 109.573 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -95.54 -30.62 13.73 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.324 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 43' ' ' GLN . . . -84.41 -103.73 0.6 Allowed Glycine 0 N--CA 1.487 2.056 0 N-CA-C 107.429 -2.269 . . . . 0.0 107.429 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.814 ' HB2' HG21 ' A' ' 59' ' ' VAL . 91.8 m95 -76.88 74.42 3.49 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.206 -1.173 . . . . 0.0 109.184 178.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.709 ' OD1' ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -44.19 110.9 1.07 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.718 -0.614 . . . . 0.0 110.675 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.64 ' CD ' ' HE2' ' A' ' 51' ' ' LYS . 47.1 Cg_endo -72.08 0.93 6.51 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.202 1.935 . . . . 0.0 112.134 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.719 ' H ' ' CE ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -71.79 -33.1 68.29 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 178.36 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.755 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 8.9 m-20 -117.29 -12.59 10.49 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 113.913 -1.494 . . . . 0.0 107.363 177.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.742 ' HA ' ' HB ' ' A' ' 78' ' ' VAL . 9.0 t -105.81 147.15 28.97 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.175 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.475 ' H ' ' CB ' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -77.6 105.29 8.66 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.244 -0.91 . . . . 0.0 109.426 179.059 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.709 ' O ' HD22 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -70.2 4.04 2.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.448 -0.782 . . . . 0.0 110.4 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.88 ' O ' HG11 ' A' ' 71' ' ' VAL . 1.4 m120 -41.4 -29.52 0.15 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.752 0.787 . . . . 0.0 109.446 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.916 HG21 ' CD1' ' A' ' 207' ' ' TRP . 25.2 pt -112.94 168.88 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.605 ' O ' ' HB3' ' A' ' 67' ' ' GLU . 10.2 t0 -105.85 103.48 12.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.894 -1.129 . . . . 0.0 109.925 -178.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.814 HG21 ' HB2' ' A' ' 48' ' ' TRP . 3.6 m -118.24 135.81 57.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.804 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.682 ' HG3' ' CD ' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -124.92 143.3 50.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.011 -1.055 . . . . 0.0 110.844 -179.423 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.535 ' O ' ' C ' ' A' ' 62' ' ' GLY . 46.1 tt0 -63.61 -124.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.452 -0.78 . . . . 0.0 109.954 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.535 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 37.7 50.61 1.93 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.674 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 109.33 46.89 0.9 Allowed Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.106 -1.997 . . . . 0.0 108.106 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.674 ' C ' ' O ' ' A' ' 63' ' ' GLY . 2.2 mm? 0.76 86.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.541 0.686 . . . . 0.0 111.252 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.0 t -120.29 117.55 28.12 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.521 -0.737 . . . . 0.0 110.507 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.738 ' CE1' ' CD2' ' A' ' 48' ' ' TRP . 1.8 m-85 -82.51 130.65 35.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.388 -0.82 . . . . 0.0 109.186 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.605 ' HB3' ' O ' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -132.9 121.81 23.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.902 -1.124 . . . . 0.0 110.528 179.626 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.508 ' O ' ' HD3' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -125.31 156.26 38.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.492 -0.755 . . . . 0.0 109.229 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.544 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 11.5 tpp180 -174.68 -56.92 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 120.773 -1.204 . . . . 0.0 111.183 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 69' ' ' ARG . 41.2 Cg_endo -67.01 -50.39 1.08 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.651 1.343 . . . . 0.0 110.542 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.88 HG11 ' O ' ' A' ' 56' ' ' ASN . 1.3 p -78.57 165.23 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 121.739 0.78 . . . . 0.0 110.852 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.534 ' N ' ' CG2' ' A' ' 71' ' ' VAL . . . -163.83 -43.1 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.257 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 75' ' ' THR . 16.8 mt-30 -56.1 -172.85 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.156 -0.965 . . . . 0.0 110.246 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.74 85.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.916 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.696 HG22 ' CG ' ' A' ' 56' ' ' ASN . 0.1 OUTLIER -136.96 5.36 2.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -0.868 . . . . 0.0 110.312 -179.619 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.585 ' CB ' ' NE1' ' A' ' 207' ' ' TRP . 1.8 p30 -99.16 155.07 17.66 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.217 -0.927 . . . . 0.0 109.962 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 114.65 104.36 2.55 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 106.848 -2.501 . . . . 0.0 106.848 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.806 ' O ' ' HA ' ' A' ' 204' ' ' SER . 2.0 m -116.95 163.0 14.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.161 -1.2 . . . . 0.0 110.322 -178.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.755 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 3.9 ttp180 -120.16 169.34 10.33 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.643 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.559 ' HA2' ' CB ' ' A' ' 52' ' ' ASP . . . -164.22 83.46 0.11 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.496 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 3.7 ttpm? -116.88 16.11 15.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.389 -1.065 . . . . 0.0 110.421 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.456 ' O ' ' C ' ' A' ' 83' ' ' GLY . 1.1 ptt180 -76.16 -101.98 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.106 -0.996 . . . . 0.0 110.228 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 82' ' ' ARG . . . 41.58 46.22 4.62 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.45 ' CE1' ' NH1' ' A' ' 86' ' ' ARG . 0.6 OUTLIER -98.58 103.88 15.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.228 -1.16 . . . . 0.0 110.174 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.561 ' HB3' ' CE1' ' A' ' 89' ' ' HIS . 11.5 t -139.9 173.36 11.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 110.362 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.551 ' N ' ' CD ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -118.53 139.33 51.62 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.372 -0.83 . . . . 0.0 109.827 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 103.36 -112.25 4.17 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.66 ' C ' HD23 ' A' ' 88' ' ' LEU . 7.5 tt -128.18 134.53 49.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -1.128 . . . . 0.0 110.362 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.581 ' CD2' ' O ' ' A' ' 88' ' ' LEU . 7.7 m80 -146.86 161.7 40.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.329 -0.857 . . . . 0.0 109.688 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.06 146.59 10.86 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.082 -1.011 . . . . 0.0 110.508 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 1.122 ' CZ2' HG11 ' A' ' 169' ' ' VAL . 1.7 p90 -135.13 171.3 14.63 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.305 -0.872 . . . . 0.0 109.473 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 215' ' ' ARG . 15.6 tt0 -137.71 140.12 40.55 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.265 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.616 HG13 ' CD1' ' A' ' 91' ' ' TRP . 4.4 mt -140.03 154.22 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.984 ' O ' HG23 ' A' ' 212' ' ' VAL . 0.4 OUTLIER -147.24 122.12 9.98 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.03 -1.068 . . . . 0.0 111.651 -179.005 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.843 ' HH2' ' O ' ' A' ' 204' ' ' SER . 37.0 m95 -111.63 88.45 9.45 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 94' ' ' SER . 52.5 Cg_endo -83.61 108.95 1.51 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.695 1.366 . . . . 0.0 111.524 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.513 HD13 ' HA ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.253 -0.904 . . . . 0.0 109.622 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.975 HG22 ' O ' ' A' ' 204' ' ' SER 0.264 3.6 m . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.769 HG22 ' CE2' ' A' ' 95' ' ' TRP . 1.0 OUTLIER -152.27 122.47 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.399 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 202' ' ' SER . . . 168.76 -161.64 35.36 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 118.832 -1.651 . . . . 0.0 110.898 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.044 HG23 ' C ' ' A' ' 200' ' ' TYR . 1.4 p -141.49 150.67 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.596 -0.943 . . . . 0.0 109.835 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 200' ' ' TYR . . . -128.57 152.78 47.92 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.059 -1.026 . . . . 0.0 110.724 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.768 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -101.24 126.35 47.97 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.264 -0.898 . . . . 0.0 110.296 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.528 ' HB3' ' HE2' ' A' ' 200' ' ' TYR . . . -93.58 -30.22 15.09 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.591 0.71 . . . . 0.0 109.726 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.579 ' O ' ' C ' ' A' ' 113' ' ' ALA . 0.8 OUTLIER -80.96 -11.83 59.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.458 -0.776 . . . . 0.0 109.926 179.819 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.579 ' C ' ' O ' ' A' ' 112' ' ' LEU . . . . . . . . 0 N--CA 1.499 1.977 0 O-C-N 121.829 -0.544 . . . . 0.0 111.222 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.257 0.551 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 110' ' ' THR . 1.7 tt0 -150.02 130.06 13.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.298 -0.876 . . . . 0.0 110.087 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.496 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 47.9 t -120.46 119.92 34.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 110.211 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . 0.527 ' O ' ' O ' ' A' ' 108' ' ' VAL . 0.6 OUTLIER -128.1 124.57 37.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -0.939 . . . . 0.0 110.138 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.48 ' HA3' ' HA3' ' A' ' 107' ' ' GLY . . . 170.82 -133.95 2.96 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.709 ' CZ3' HD23 ' A' ' 167' ' ' LEU . 47.3 m0 -121.36 112.84 19.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.09 -1.241 . . . . 0.0 110.404 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -119.22 111.46 18.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.643 -0.661 . . . . 0.0 110.448 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 22.2 pt . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.1 -1.0 . . . . 0.0 110.229 179.648 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 1.046 HG11 HG21 ' A' ' 182' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 95' ' ' TRP . 44.3 Cg_endo -71.51 64.42 2.94 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.067 1.562 . . . . 0.0 110.379 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -168.48 -83.85 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.487 -0.758 . . . . 0.0 109.805 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.735 ' C ' HD12 ' A' ' 167' ' ' LEU . 2.2 ttp180 -152.12 150.43 29.88 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.432 -0.793 . . . . 0.0 110.348 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.837 ' N ' HD12 ' A' ' 167' ' ' LEU . 1.7 mp -144.92 131.04 19.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 110.274 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.706 HD13 ' N ' ' A' ' 169' ' ' VAL . 2.6 tm? -103.79 124.54 49.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.351 -0.843 . . . . 0.0 109.595 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 1.122 HG11 ' CZ2' ' A' ' 91' ' ' TRP . 2.4 t -107.18 135.53 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.943 . . . . 0.0 110.63 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.554 ' CG1' HD11 ' A' ' 187' ' ' LEU . 9.7 p -112.48 133.32 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.507 -0.746 . . . . 0.0 109.836 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.822 HD22 ' HG3' ' A' ' 201' ' ' PRO . 11.5 tp -133.03 105.87 7.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.151 -0.968 . . . . 0.0 110.228 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 173' ' ' MET . 49.1 t0 -103.83 136.02 44.28 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.24 -0.912 . . . . 0.0 109.943 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.519 ' HG2' ' HA ' ' A' ' 86' ' ' ARG . 5.5 tpt -96.91 -41.81 8.24 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.747 -0.595 . . . . 0.0 110.231 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.505 ' C ' ' O ' ' A' ' 173' ' ' MET . 2.7 tm-20 -40.26 -28.66 0.06 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.893 . . . . 0.0 108.666 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.678 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.2 OUTLIER -114.84 -26.64 7.72 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.422 ' O ' ' CG2' ' A' ' 198' ' ' THR . . . 81.2 25.35 55.29 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.491 -1.844 . . . . 0.0 108.491 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 1.073 HG22 ' CD2' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -113.42 127.82 56.25 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.335 -1.097 . . . . 0.0 111.436 -179.335 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 1.031 ' O ' HD11 ' A' ' 194' ' ' LEU . 0.1 OUTLIER -134.74 153.71 51.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.473 -0.767 . . . . 0.0 109.378 178.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -155.52 172.74 33.67 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.52 -1.324 . . . . 0.0 109.984 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 1.052 ' CE1' HG22 ' A' ' 169' ' ' VAL . 0.4 OUTLIER -118.77 122.89 43.49 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.47 -1.018 . . . . 0.0 109.895 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' A' ' 186' ' ' TYR . 16.7 t -142.79 139.26 30.91 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.31 -0.869 . . . . 0.0 110.051 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 1.046 HG21 HG11 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -98.56 116.76 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.341 -0.849 . . . . 0.0 109.923 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 81.63 -7.26 62.4 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 86.31 42.35 6.63 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.26 -35.94 8.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.31 -1.112 . . . . 0.0 110.415 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.467 ' O ' ' HB2' ' A' ' 181' ' ' SER . 24.6 m-85 -109.12 90.22 3.23 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.187 -0.946 . . . . 0.0 110.312 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.687 HD22 ' CZ ' ' A' ' 191' ' ' PHE . 0.7 OUTLIER -176.7 28.32 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.471 -0.768 . . . . 0.0 109.671 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.478 ' H ' ' HD2' ' A' ' 189' ' ' PRO . . . -110.51 -71.67 0.66 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.842 -1.171 . . . . 0.0 110.403 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.478 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 44.9 Cg_endo -70.87 -28.84 19.41 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.952 1.501 . . . . 0.0 111.026 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -74.17 15.44 0.32 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.299 -0.876 . . . . 0.0 111.142 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.687 ' CZ ' HD22 ' A' ' 187' ' ' LEU . 0.3 OUTLIER -90.52 -16.3 29.12 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.004 -1.06 . . . . 0.0 110.408 179.652 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . 0.436 ' NE ' ' HA ' ' A' ' 192' ' ' ARG . 0.0 OUTLIER -90.03 -13.97 34.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.319 -0.863 . . . . 0.0 110.75 -179.616 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -112.47 -8.8 20.68 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 108.786 -1.725 . . . . 0.0 108.786 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 1.073 ' CD2' HG22 ' A' ' 177' ' ' THR . 7.7 tt -78.19 -31.66 49.6 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.617 -0.931 . . . . 0.0 109.213 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.453 ' CA ' HG23 ' A' ' 198' ' ' THR . 0.0 OUTLIER -53.56 -39.73 64.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.438 -0.789 . . . . 0.0 109.707 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -86.04 -24.61 40.41 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.836 ' NH1' HD11 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -91.09 -4.59 56.13 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.644 -0.916 . . . . 0.0 110.09 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . 0.873 HG23 ' O ' ' A' ' 194' ' ' LEU . 26.0 p -43.06 116.44 0.9 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.496 -0.753 . . . . 0.0 110.986 -178.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.993 ' HB2' HG22 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -128.69 171.82 11.83 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.564 -0.71 . . . . 0.0 109.955 179.654 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 1.044 ' C ' HG23 ' A' ' 108' ' ' VAL . 14.9 m-30 -83.49 134.72 44.66 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.196 -0.94 . . . . 0.0 109.952 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.822 ' HG3' HD22 ' A' ' 171' ' ' LEU . 43.9 Cg_endo -68.35 118.58 5.73 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.089 1.573 . . . . 0.0 111.614 -178.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -134.01 148.62 51.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.469 -0.769 . . . . 0.0 110.49 179.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.465 HG22 ' N ' ' A' ' 204' ' ' SER . 8.2 p -149.84 159.13 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.125 -0.984 . . . . 0.0 110.311 179.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . 0.975 ' O ' HG22 ' A' ' 105' ' ' VAL . 0.3 OUTLIER -144.88 125.67 14.29 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.178 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.721 ' H ' HG22 ' A' ' 78' ' ' VAL . . . -115.72 166.55 11.81 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.438 0.637 . . . . 0.0 110.854 -178.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.578 ' CG1' ' HB3' ' A' ' 210' ' ' CYS . 1.1 p -136.88 165.57 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.343 -0.848 . . . . 0.0 109.952 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 0.916 ' CD1' HG21 ' A' ' 57' ' ' ILE . 40.7 p-90 -132.91 -2.68 3.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.092 -1.005 . . . . 0.0 110.175 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -74.62 -0.83 59.94 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -175.99 -41.69 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.449 -1.03 . . . . 0.0 110.724 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . 0.578 ' HB3' ' CG1' ' A' ' 206' ' ' VAL . 0.0 OUTLIER -98.96 146.3 26.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.429 -0.795 . . . . 0.0 110.802 -179.542 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -135.01 102.6 5.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.531 -0.731 . . . . 0.0 109.545 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.984 HG23 ' O ' ' A' ' 94' ' ' SER . 7.2 p -104.42 143.84 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.439 -0.788 . . . . 0.0 110.38 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . 0.559 ' CD ' ' HB2' ' A' ' 94' ' ' SER . 2.9 ptp180 -95.61 131.64 41.61 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.324 -0.86 . . . . 0.0 109.619 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.719 HG22 ' CE2' ' A' ' 48' ' ' TRP . 1.2 tt -118.84 113.95 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.061 -1.024 . . . . 0.0 111.561 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.612 ' O ' ' N ' ' A' ' 92' ' ' GLU . 7.6 ttm180 -112.99 108.81 17.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.073 -1.017 . . . . 0.0 108.896 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . 0.707 ' CD2' ' HB2' ' A' ' 91' ' ' TRP . 1.6 t80 -104.44 149.65 25.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.93 . . . . 0.0 111.179 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.24 107.92 7.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.579 -0.7 . . . . 0.0 109.917 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 141.5 -22.02 2.55 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.172 -1.193 . . . . 0.0 110.194 -179.932 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.987 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.21 0.529 . . . . 0.0 109.888 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.708 ' HA ' HD23 ' A' ' 33' ' ' LEU . 0.9 OUTLIER -45.97 -42.8 13.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.307 -0.87 . . . . 0.0 109.783 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -56.92 -23.27 43.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.4 -0.813 . . . . 0.0 109.302 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.716 ' HB3' HD12 ' A' ' 29' ' ' LEU . 16.7 tp -83.22 -34.5 25.86 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.128 HD21 ' CG ' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -72.92 -36.34 67.23 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.917 0.865 . . . . 0.0 109.116 179.124 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.604 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 1.4 m -69.17 -14.29 62.9 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.252 0.549 . . . . 0.0 110.465 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.954 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -51.72 -61.85 3.75 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.164 -0.96 . . . . 0.0 110.201 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.954 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 43.3 Cg_endo -69.86 110.31 2.54 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.988 1.52 . . . . 0.0 110.77 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.775 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 49.1 Cg_endo -74.92 -24.81 12.64 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 124.146 1.603 . . . . 0.0 112.84 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.775 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 42.3 Cg_endo -68.3 152.4 75.74 Favored 'Trans proline' 0 C--N 1.315 -1.214 0 O-C-N 122.892 0.943 . . . . 0.0 112.38 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.611 ' O ' ' CG ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER 4.79 80.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 123.561 1.648 . . . . 0.0 110.887 -178.694 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.98 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER 179.97 -51.7 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 113.655 -1.611 . . . . 0.0 107.705 178.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.951 HG12 ' CE1' ' A' ' 45' ' ' HIS . 1.8 t -87.36 -20.17 7.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 118.933 -1.107 . . . . 0.0 109.661 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.27 -46.49 8.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.154 -0.966 . . . . 0.0 111.954 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.59 ' O ' ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -79.39 -20.89 46.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.662 -1.274 . . . . 0.0 109.411 -179.464 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.833 ' HA ' HG23 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -72.47 -36.22 68.41 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.491 -0.884 . . . . 0.0 108.767 179.283 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.951 ' CE1' HG12 ' A' ' 41' ' ' VAL . 7.2 m170 -81.73 -26.07 34.88 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.866 -0.521 . . . . 0.0 110.272 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -96.38 -28.7 14.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.129 -0.982 . . . . 0.0 110.104 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.83 -111.09 1.02 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.961 ' CZ2' HG23 ' A' ' 212' ' ' VAL . 88.6 m95 -91.63 73.97 5.88 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.09 -1.241 . . . . 0.0 109.436 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.781 ' OD1' ' HG3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -52.4 150.09 9.35 Favored Pre-proline 0 N--CA 1.489 1.495 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.151 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.713 ' O ' ' N ' ' A' ' 53' ' ' CYS . 54.2 Cg_endo -91.81 -0.01 4.39 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 122.273 1.982 . . . . 0.0 113.221 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.781 ' HG3' ' OD1' ' A' ' 49' ' ' ASN . 0.0 OUTLIER 0.69 -98.69 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.639 0 CA-C-O 122.646 1.212 . . . . 0.0 111.192 -178.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.819 ' HB3' ' NE ' ' A' ' 79' ' ' ARG 0.259 0.5 OUTLIER -62.19 -28.08 69.42 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.568 -179.707 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.867 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . 0.7 OUTLIER -104.82 -177.02 3.24 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.323 1.059 . . . . 0.0 112.481 -178.096 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.594 ' O ' ' HB3' ' A' ' 50' ' ' PRO . 2.0 m -87.38 165.21 15.76 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.897 0.856 . . . . 0.0 111.257 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 1.128 ' CG ' HD21 ' A' ' 33' ' ' LEU . 2.5 pm0 -94.21 9.71 36.88 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.045 0.926 . . . . 0.0 108.748 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.55 ' C ' ' O ' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -16.27 -38.26 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.263 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.837 ' N ' ' O ' ' A' ' 55' ' ' GLU . 6.6 pt -130.12 167.43 25.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.128 -178.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.933 ' HB2' HD23 ' A' ' 40' ' ' LEU . 6.0 t0 -107.76 141.39 39.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.401 -0.812 . . . . 0.0 110.11 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.833 HG23 ' HA ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -130.42 136.03 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.337 -0.852 . . . . 0.0 110.509 -179.166 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.543 ' NZ ' ' HB2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -135.27 155.05 51.28 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.977 -1.077 . . . . 0.0 110.755 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 62' ' ' GLY . 5.3 mt-10 -78.24 -129.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.515 -0.741 . . . . 0.0 110.115 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 42.15 42.98 4.39 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.666 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 116.11 48.1 0.49 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.807 HD23 ' CZ ' ' A' ' 213' ' ' ARG . 0.5 OUTLIER 0.42 90.5 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.847 -0.796 . . . . 0.0 111.084 -179.438 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -124.96 123.2 39.38 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.493 -0.754 . . . . 0.0 111.194 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.924 ' HE2' HG22 ' A' ' 212' ' ' VAL . 18.2 m-85 -83.39 127.1 33.4 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.61 ' O ' ' HB ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -110.38 121.15 44.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.007 -1.058 . . . . 0.0 110.557 -179.495 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.589 ' HD3' ' N ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -136.11 155.98 49.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.491 -0.755 . . . . 0.0 109.365 179.471 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.589 ' N ' ' HD3' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -173.18 -55.98 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 120.929 -1.107 . . . . 0.0 111.065 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 69' ' ' ARG . 40.9 Cg_endo -67.24 -47.66 2.16 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.756 1.398 . . . . 0.0 110.645 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.547 ' CG2' ' N ' ' A' ' 72' ' ' ALA . 1.6 p -78.49 165.29 3.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-O 121.937 0.875 . . . . 0.0 110.983 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.547 ' N ' ' CG2' ' A' ' 71' ' ' VAL . . . -159.22 -36.52 0.06 Allowed 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.312 0.577 . . . . 0.0 110.026 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -141.99 13.48 2.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.36 -0.838 . . . . 0.0 110.127 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 75' ' ' THR . 0.6 OUTLIER -63.36 -158.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 110.195 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 74' ' ' SER . 0.6 OUTLIER -54.42 -107.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.164 -0.96 . . . . 0.0 110.27 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.529 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 2.4 m-20 -140.32 150.09 43.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.906 -1.121 . . . . 0.0 110.935 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.529 ' O ' ' ND2' ' A' ' 56' ' ' ASN . . . -40.39 -86.49 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.575 ' CG2' ' O ' ' A' ' 49' ' ' ASN . 0.2 OUTLIER -138.05 145.48 28.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.135 -1.214 . . . . 0.0 109.721 178.523 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.867 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 4.2 tmm_? -148.44 133.83 18.55 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.507 ' HA2' ' HB2' ' A' ' 52' ' ' ASP . . . -126.2 143.34 14.33 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.553 ' HE3' ' CB ' ' A' ' 202' ' ' SER . 0.3 OUTLIER -165.47 9.93 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.067 -1.255 . . . . 0.0 111.451 -179.66 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.74 ' HD2' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -135.27 -9.76 2.23 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.676 -1.265 . . . . 0.0 110.83 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.74 ' N ' ' HD2' ' A' ' 82' ' ' ARG . . . -74.81 38.1 1.07 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.733 ' HE1' HD11 ' A' ' 171' ' ' LEU . 15.8 t80 -94.17 119.37 32.89 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.435 -1.038 . . . . 0.0 110.087 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.7 p -99.92 177.48 5.1 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.302 -0.874 . . . . 0.0 110.395 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.592 ' HA ' ' CB ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -108.04 167.38 10.04 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.307 -0.871 . . . . 0.0 109.933 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.473 ' N ' ' HB3' ' A' ' 173' ' ' MET . . . 100.77 -124.71 8.34 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.497 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 1.3 tp -129.06 130.12 46.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.463 -1.022 . . . . 0.0 110.398 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.552 ' NE2' ' O ' ' A' ' 86' ' ' ARG . 8.4 m-70 -147.29 158.64 44.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.129 -0.982 . . . . 0.0 109.968 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.545 ' O ' ' O ' ' A' ' 217' ' ' MET . . . -161.6 135.22 6.54 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.129 -0.982 . . . . 0.0 109.58 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 1.225 ' CZ3' HG11 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -134.09 156.28 48.54 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.917 -1.114 . . . . 0.0 109.846 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.665 ' O ' ' N ' ' A' ' 215' ' ' ARG . 0.8 OUTLIER -109.53 124.07 50.47 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.705 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 1.067 HG23 ' OH ' ' A' ' 180' ' ' TYR . 0.8 OUTLIER -141.85 154.12 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.953 -1.092 . . . . 0.0 110.62 -179.325 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.503 ' CB ' ' HB3' ' A' ' 213' ' ' ARG . 0.6 OUTLIER -134.17 123.09 23.78 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.5 -0.75 . . . . 0.0 109.093 179.425 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.766 ' HH2' ' O ' ' A' ' 204' ' ' SER . 2.1 t90 -127.6 88.21 54.16 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.067 -1.021 . . . . 0.0 110.817 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -95.43 109.08 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 124.154 1.608 . . . . 0.0 110.166 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.637 HD23 ' HE1' ' A' ' 95' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 O-C-N 120.843 -1.16 . . . . 0.0 110.315 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.711 HG13 ' O ' ' A' ' 204' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 121.498 0.666 . . . . 0.0 112.015 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.942 HG23 HD11 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -151.24 112.91 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.687 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.571 ' HA3' ' HA3' ' A' ' 132' ' ' GLY . . . 179.55 -147.31 7.51 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 118.621 -1.752 . . . . 0.0 111.223 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.628 ' CG1' ' HB2' ' A' ' 199' ' ' LEU . 1.4 t -139.66 170.27 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.554 -0.968 . . . . 0.0 109.618 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 130' ' ' SER . . . -121.17 139.88 52.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.998 -1.064 . . . . 0.0 110.766 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.865 ' OG1' HD23 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -136.47 133.73 36.88 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.32 -0.862 . . . . 0.0 110.461 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.16 -26.08 17.57 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.308 -0.87 . . . . 0.0 109.266 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.448 ' O ' ' C ' ' A' ' 113' ' ' ALA . 1.0 OUTLIER -85.37 -12.19 52.74 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.545 -0.722 . . . . 0.0 109.445 179.416 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.579 ' HB2' ' HB ' ' A' ' 110' ' ' THR . . . . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.552 -0.718 . . . . 0.0 110.646 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.194 0.521 . . . . 0.0 110.092 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 113' ' ' ALA . 5.9 tp10 -150.21 141.44 23.17 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.271 -0.893 . . . . 0.0 109.692 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.551 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 13.4 t -119.86 120.05 35.33 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.592 -0.692 . . . . 0.0 109.978 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -133.36 136.38 45.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.378 -0.827 . . . . 0.0 109.619 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.606 ' O ' ' CD1' ' A' ' 133' ' ' TRP . . . -178.0 -107.56 0.22 Allowed Glycine 0 N--CA 1.487 2.093 0 C-N-CA 119.545 -1.312 . . . . 0.0 109.924 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.715 ' CH2' ' HB2' ' A' ' 180' ' ' TYR . 5.2 m-90 -141.0 128.91 21.8 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.26 -1.141 . . . . 0.0 111.568 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -118.74 148.04 43.22 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.723 -0.611 . . . . 0.0 109.743 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.942 HD11 HG23 ' A' ' 106' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.344 -0.848 . . . . 0.0 109.921 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.969 HG13 ' HD2' ' A' ' 164' ' ' PRO . 15.2 t . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.969 ' HD2' HG13 ' A' ' 163' ' ' VAL . 38.2 Cg_endo -64.57 -177.89 0.6 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.693 1.365 . . . . 0.0 110.758 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 94' ' ' SER . 0.3 OUTLIER -48.57 -58.2 5.05 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.43 -0.794 . . . . 0.0 110.389 -179.402 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.469 ' HA ' ' HB3' ' A' ' 94' ' ' SER . 1.3 ttp180 -151.94 155.96 39.1 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.498 -0.751 . . . . 0.0 110.578 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.868 HD23 HG12 ' A' ' 182' ' ' ILE . 0.9 OUTLIER -137.68 157.74 45.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.483 -0.761 . . . . 0.0 109.782 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.416 ' HG ' ' OE1' ' A' ' 92' ' ' GLU . 3.4 tt -103.11 126.72 50.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.93 . . . . 0.0 109.799 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 1.225 HG11 ' CZ3' ' A' ' 91' ' ' TRP . 57.9 t -90.04 138.3 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.349 -0.844 . . . . 0.0 110.829 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 178' ' ' LEU . 85.9 t -116.14 111.51 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.545 -0.722 . . . . 0.0 109.265 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.884 HD12 ' HB3' ' A' ' 178' ' ' LEU . 14.4 tp -118.94 105.51 11.54 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.966 -1.084 . . . . 0.0 110.251 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.438 ' OD2' HD12 ' A' ' 88' ' ' LEU . 4.5 t70 -120.58 133.79 55.34 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.339 -0.851 . . . . 0.0 110.209 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.592 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 1.6 tpt -99.7 -37.96 8.9 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.25 -24.15 1.67 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.474 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.1 OUTLIER -107.04 -26.28 11.22 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.202 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.715 ' O ' HG21 ' A' ' 198' ' ' THR . . . 82.17 24.47 54.62 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 108.604 -1.798 . . . . 0.0 108.604 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.693 ' HA ' HD22 ' A' ' 194' ' ' LEU . 0.6 OUTLIER -130.07 122.91 29.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.093 -1.239 . . . . 0.0 111.486 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.973 HD11 ' O ' ' A' ' 199' ' ' LEU . 0.1 OUTLIER -140.52 153.58 46.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.454 -0.779 . . . . 0.0 109.611 179.168 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.451 ' O ' HG13 ' A' ' 169' ' ' VAL . . . 179.98 -152.2 10.65 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.633 -1.27 . . . . 0.0 110.212 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 1.067 ' OH ' HG23 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -123.0 142.21 51.09 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.331 -1.099 . . . . 0.0 109.332 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.503 ' HA ' ' HB3' ' A' ' 186' ' ' TYR . 15.3 t -140.76 124.78 17.3 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.422 -0.799 . . . . 0.0 110.154 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.868 HG12 HD23 ' A' ' 167' ' ' LEU . 0.1 OUTLIER -107.26 116.64 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.215 -0.928 . . . . 0.0 109.276 179.502 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 79.81 -47.19 3.25 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 137.62 36.39 0.17 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . 0.435 ' O ' ' C ' ' A' ' 186' ' ' TYR . 73.0 m -122.89 -51.47 1.91 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.242 -1.152 . . . . 0.0 110.859 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.573 ' CD2' HD11 ' A' ' 182' ' ' ILE . 0.1 OUTLIER -40.98 -74.34 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.079 -1.013 . . . . 0.0 110.613 -179.415 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.897 HD23 ' CZ ' ' A' ' 191' ' ' PHE . 1.1 mp -71.25 43.85 0.08 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.001 -1.062 . . . . 0.0 109.886 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 186' ' ' TYR . . . -75.67 -99.28 0.13 Allowed Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.472 ' C ' ' H ' ' A' ' 191' ' ' PHE . 49.6 Cg_endo -74.13 -24.17 15.05 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.207 1.635 . . . . 0.0 110.946 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.557 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -65.86 16.81 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.487 -0.758 . . . . 0.0 111.724 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.897 ' CZ ' HD23 ' A' ' 187' ' ' LEU . 0.3 OUTLIER -90.45 -16.68 28.53 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.828 -1.17 . . . . 0.0 110.394 179.56 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . 0.43 ' HA ' ' NE ' ' A' ' 192' ' ' ARG . 0.0 OUTLIER -90.2 -15.12 32.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.282 -0.886 . . . . 0.0 110.902 -179.452 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -110.82 -16.95 9.42 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.693 HD22 ' HA ' ' A' ' 177' ' ' THR . 7.5 tt -67.86 -36.31 80.08 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.617 -0.931 . . . . 0.0 108.87 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.507 ' HA ' HG23 ' A' ' 177' ' ' THR . 0.0 OUTLIER -44.69 -34.88 2.4 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.403 -0.811 . . . . 0.0 109.825 179.562 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.443 ' N ' ' HD2' ' A' ' 195' ' ' LYS . . . -94.11 -27.31 12.43 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.748 ' HD3' HD11 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.94 -4.69 56.3 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.603 -0.94 . . . . 0.0 110.108 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . 0.715 HG21 ' O ' ' A' ' 176' ' ' GLY . 0.7 OUTLIER -44.06 143.49 1.14 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.825 0.821 . . . . 0.0 111.649 -178.327 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.973 ' O ' HD11 ' A' ' 178' ' ' LEU . 0.0 OUTLIER -140.28 171.74 13.73 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.53 ' O ' ' N ' ' A' ' 109' ' ' ALA . 2.8 m-30 -84.18 129.81 56.87 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 120.925 -1.11 . . . . 0.0 109.782 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.499 ' HD3' ' CD1' ' A' ' 178' ' ' LEU . 41.6 Cg_endo -67.51 115.75 3.87 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.888 1.468 . . . . 0.0 111.035 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.553 ' CB ' ' HE3' ' A' ' 81' ' ' LYS . 1.6 p -133.14 154.06 50.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.43 -0.794 . . . . 0.0 110.229 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.687 HG23 ' HA ' ' A' ' 106' ' ' VAL . 2.0 p -158.1 164.11 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.32 -0.863 . . . . 0.0 110.217 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . 0.766 ' O ' ' HH2' ' A' ' 95' ' ' TRP . 0.1 OUTLIER -157.94 126.56 5.57 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.397 -0.815 . . . . 0.0 109.981 179.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -119.23 161.63 20.06 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.312 -0.868 . . . . 0.0 110.831 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.559 ' CG1' ' N ' ' A' ' 207' ' ' TRP . 1.1 t -124.33 176.14 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 CA-C-O 121.251 0.548 . . . . 0.0 110.063 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 0.774 ' HB3' HD12 ' A' ' 57' ' ' ILE . 44.2 p90 -103.31 155.0 18.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -0.883 . . . . 0.0 110.056 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 135.18 -152.84 20.95 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.466 ' O ' ' O ' ' A' ' 210' ' ' CYS . 5.1 tm0? -66.89 -29.04 68.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.324 -1.103 . . . . 0.0 110.258 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 209' ' ' GLN . 9.2 t -46.74 175.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.304 -0.872 . . . . 0.0 109.985 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.432 ' HG2' ' C ' ' A' ' 210' ' ' CYS . 0.8 OUTLIER -170.11 111.29 0.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 110.588 -179.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.961 HG23 ' CZ2' ' A' ' 48' ' ' TRP . 27.4 m -115.42 145.39 21.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.527 -0.733 . . . . 0.0 109.783 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . 0.89 ' HE ' ' HA ' ' A' ' 213' ' ' ARG . 0.7 OUTLIER -108.48 128.54 54.89 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.204 179.728 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.723 ' HB ' ' CZ3' ' A' ' 48' ' ' TRP . 5.6 tt -123.51 119.62 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.026 -1.047 . . . . 0.0 111.933 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.665 ' N ' ' O ' ' A' ' 92' ' ' GLU . 23.3 ttt180 -130.33 135.07 47.69 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . 0.66 ' HA ' ' HB3' ' A' ' 91' ' ' TRP . 1.8 t80 -119.07 151.02 39.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.651 -1.281 . . . . 0.0 112.265 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . 0.545 ' O ' ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -131.11 107.77 9.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.686 -0.634 . . . . 0.0 109.612 179.061 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 79.23 61.87 2.28 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.578 ' HB2' ' CD1' ' A' ' 216' ' ' TYR . 16.9 tt0 . . . . . 0 N--CA 1.493 1.722 0 O-C-N 121.138 -1.213 . . . . 0.0 110.237 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.956 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 121.126 0.488 . . . . 0.0 110.092 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 1.03 ' HA ' HD23 ' A' ' 33' ' ' LEU . 16.1 pt-20 -45.74 -37.82 6.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 109.719 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.471 ' N ' ' HG3' ' A' ' 30' ' ' GLU . 1.7 tm-20 -72.4 -23.21 61.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.376 -0.828 . . . . 0.0 109.167 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.609 ' O ' ' HD2' ' A' ' 36' ' ' PRO . 15.3 tp -83.81 -30.49 26.5 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.03 HD23 ' HA ' ' A' ' 30' ' ' GLU . 0.3 OUTLIER -71.0 -34.35 71.26 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 122.081 0.943 . . . . 0.0 108.968 179.304 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.608 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -83.81 -6.93 59.54 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.072 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.995 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -71.5 -65.73 0.84 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.313 -0.867 . . . . 0.0 111.11 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.995 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 49.6 Cg_endo -75.45 143.97 28.3 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.607 1.32 . . . . 0.0 110.441 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 36' ' ' PRO . 53.9 Cg_endo -99.02 54.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.947 1.764 . . . . 0.0 112.251 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.722 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 51.8 Cg_endo -75.52 150.91 36.63 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 122.958 0.978 . . . . 0.0 109.845 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.653 ' O ' ' HB3' ' A' ' 43' ' ' GLN . 0.9 OUTLIER -34.04 -34.52 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.187 -0.946 . . . . 0.0 109.662 179.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.245 ' O ' ' HB3' ' A' ' 44' ' ' ARG . 1.8 tp -62.79 -43.91 97.57 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 110.34 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.688 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 46.6 t -86.68 -36.8 10.65 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 C-N-CA 118.389 -1.324 . . . . 0.0 110.029 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.13 -40.12 11.21 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.436 -0.906 . . . . 0.0 112.696 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.653 ' HB3' ' O ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -87.88 -19.15 27.76 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 120.899 -1.126 . . . . 0.0 110.164 -178.645 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 1.245 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 5.3 ttt180 -84.66 -52.62 5.95 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.795 1.284 . . . . 0.0 109.778 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.693 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 13.7 m170 -52.35 -15.03 0.54 Allowed 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.26 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 20.4 t-160 -82.84 -38.59 22.81 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 118.147 -1.421 . . . . 0.0 110.136 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.736 ' O ' ' N ' ' A' ' 49' ' ' ASN . . . -94.39 -109.93 2.2 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 106.234 -2.746 . . . . 0.0 106.234 177.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.817 ' CZ3' ' HA ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -58.39 71.42 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 177.062 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.736 ' N ' ' O ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -57.66 109.95 2.14 Favored Pre-proline 0 C--N 1.289 -2.052 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.192 -178.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.757 ' HA ' HG23 ' A' ' 78' ' ' VAL . 51.5 Cg_endo -92.54 -0.03 3.92 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.171 1.914 . . . . 0.0 110.448 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.698 ' HA ' ' HE3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -44.97 -77.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.147 -0.97 . . . . 0.0 110.425 -179.518 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.626 ' HB3' ' HE ' ' A' ' 79' ' ' ARG . 0.2 OUTLIER -40.57 -19.29 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.708 0.766 . . . . 0.0 109.192 178.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.638 ' N ' ' O ' ' A' ' 51' ' ' LYS . 3.1 t -114.69 -178.52 3.39 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.653 0.74 . . . . 0.0 110.776 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.579 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 0.3 OUTLIER -89.0 166.6 13.79 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.84 0.828 . . . . 0.0 110.595 -179.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.935 ' CG ' HD22 ' A' ' 33' ' ' LEU . 3.2 pp20? -81.93 8.75 9.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.713 -0.617 . . . . 0.0 110.039 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.579 ' ND2' ' O ' ' A' ' 54' ' ' SER . 0.1 OUTLIER -24.51 -33.1 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.675 0.75 . . . . 0.0 110.134 -179.534 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.797 ' N ' ' O ' ' A' ' 55' ' ' GLU . 6.1 pt -141.73 165.18 18.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.798 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.685 ' CB ' HD13 ' A' ' 40' ' ' LEU . 9.2 t0 -114.91 126.79 55.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.463 -0.773 . . . . 0.0 109.967 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.747 HG11 ' CD1' ' A' ' 48' ' ' TRP . 57.7 t -130.04 127.01 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.115 -0.991 . . . . 0.0 109.907 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.675 ' HA ' ' CH2' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -136.37 157.1 47.6 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.986 -1.071 . . . . 0.0 111.585 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.67 ' N ' ' CH2' ' A' ' 48' ' ' TRP . 1.3 tt0 -52.5 -110.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.694 -0.629 . . . . 0.0 111.076 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 44.54 37.57 5.0 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 107.661 -2.176 . . . . 0.0 107.661 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.73 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 94.35 78.32 1.41 Allowed Glycine 0 N--CA 1.486 1.973 0 N-CA-C 107.809 -2.117 . . . . 0.0 107.809 -178.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.73 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.4 OUTLIER 1.26 88.21 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.661 -0.905 . . . . 0.0 110.126 -178.711 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 46.4 t -122.35 114.64 21.05 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.425 -0.797 . . . . 0.0 111.677 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.658 ' CE2' HG23 ' A' ' 212' ' ' VAL . 0.1 OUTLIER -84.41 135.36 34.3 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.501 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.556 ' O ' ' N ' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -138.39 131.62 30.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.851 -1.156 . . . . 0.0 111.15 -179.535 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.552 ' HG2' ' CA ' ' A' ' 208' ' ' GLY . 0.0 OUTLIER -130.71 141.81 50.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.53 -0.732 . . . . 0.0 109.043 179.133 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.605 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 2.4 ttp180 -110.46 -68.2 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.783 -1.198 . . . . 0.0 111.325 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.605 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 56.3 Cg_endo -71.61 -124.1 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.5 0 O-C-N 123.394 1.207 . . . . 0.0 109.586 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.55 ' O ' ' N ' ' A' ' 73' ' ' GLN . 3.6 t -140.1 164.18 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.441 -1.412 . . . . 0.0 109.874 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.923 ' HB2' ' CE3' ' A' ' 207' ' ' TRP . . . -46.66 91.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.169 -0.957 . . . . 0.0 109.892 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.55 ' N ' ' O ' ' A' ' 71' ' ' VAL . 9.8 mt-30 -50.08 -176.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.932 . . . . 0.0 110.313 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.0 m -51.76 -18.84 1.37 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 0.0 110.127 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 1.3 m -96.87 -131.88 0.2 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.215 -0.928 . . . . 0.0 110.081 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.579 ' O ' ' C ' ' A' ' 77' ' ' GLY . 80.5 m-20 -140.4 154.83 46.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.187 -0.946 . . . . 0.0 110.172 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.579 ' C ' ' O ' ' A' ' 76' ' ' ASP . . . -31.88 -77.78 0.03 OUTLIER Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.757 HG23 ' HA ' ' A' ' 50' ' ' PRO . 0.4 OUTLIER -149.18 153.29 11.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.345 -1.091 . . . . 0.0 109.783 179.024 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.626 ' HE ' ' HB3' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -145.7 174.63 11.03 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.712 -0.617 . . . . 0.0 110.071 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.576 ' N ' ' CG ' ' A' ' 79' ' ' ARG . . . -157.48 152.55 23.83 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.513 ' HB2' ' CB ' ' A' ' 202' ' ' SER . 0.1 OUTLIER 179.85 -27.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.206 -1.173 . . . . 0.0 110.661 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.48 ' HG2' ' OD1' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -72.92 -100.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.137 -0.977 . . . . 0.0 110.334 -179.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 82' ' ' ARG . . . 43.0 59.61 3.28 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.526 ' CD2' ' O ' ' A' ' 84' ' ' TYR . 28.2 t80 -95.33 95.68 8.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.18 -1.188 . . . . 0.0 110.185 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.451 ' O ' ' HG2' ' A' ' 173' ' ' MET . 0.1 OUTLIER -140.11 173.67 11.28 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 110.252 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.541 ' HA ' ' CB ' ' A' ' 173' ' ' MET . 2.3 mmt85 -101.42 -174.36 2.58 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.177 -0.952 . . . . 0.0 109.676 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.96 158.35 15.98 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.774 ' O ' HD23 ' A' ' 88' ' ' LEU . 1.8 tt -87.47 127.41 35.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -1.11 . . . . 0.0 109.98 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.421 ' NE2' ' O ' ' A' ' 86' ' ' ARG . 40.9 m-70 -133.25 173.1 11.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 110.162 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -156.76 151.31 25.56 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.07 -1.019 . . . . 0.0 110.389 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.811 ' CZ2' HG11 ' A' ' 169' ' ' VAL . 4.1 p90 -146.2 171.06 15.5 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.246 -0.909 . . . . 0.0 109.936 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.584 ' N ' ' O ' ' A' ' 215' ' ' ARG . 0.7 OUTLIER -138.28 152.14 48.26 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.351 -0.939 . . . . 0.0 111.45 -178.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 1.037 HG23 HD21 ' A' ' 167' ' ' LEU . 3.7 tt -144.18 151.58 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.545 -0.722 . . . . 0.0 109.674 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.544 ' HG ' ' HG2' ' A' ' 213' ' ' ARG . 0.1 OUTLIER -142.65 135.85 28.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.092 -1.005 . . . . 0.0 110.672 -179.572 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.608 ' CH2' ' HA ' ' A' ' 205' ' ' ALA . 88.3 m95 -104.47 96.25 9.83 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.775 -0.578 . . . . 0.0 110.204 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.621 ' HD2' ' O ' ' A' ' 211' ' ' GLN . 45.9 Cg_endo -72.29 152.37 55.45 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 121.959 1.772 . . . . 0.0 111.214 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 1.216 HD22 ' O ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.795 0 O-C-N 121.533 -0.729 . . . . 0.0 111.158 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.924 HG23 ' CB ' ' A' ' 204' ' ' SER . 34.9 m . . . . . 0 N--CA 1.485 1.29 0 CA-C-O 121.779 0.8 . . . . 0.0 110.471 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.861 ' HB ' HG23 ' A' ' 203' ' ' VAL . 9.0 p -152.31 166.91 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.396 -0.815 . . . . 0.0 109.121 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.666 ' CA ' ' HA3' ' A' ' 132' ' ' GLY . . . 176.28 167.99 35.8 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 118.987 -1.578 . . . . 0.0 110.941 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.039 ' CG1' HD13 ' A' ' 199' ' ' LEU . 2.2 t -123.91 155.61 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.712 -0.876 . . . . 0.0 109.017 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.997 ' HB3' ' CZ ' ' A' ' 200' ' ' TYR . . . -142.96 150.78 40.15 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.805 -1.185 . . . . 0.0 111.365 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 1.015 ' OG1' HD23 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -131.45 134.95 46.71 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.513 -0.742 . . . . 0.0 110.087 179.505 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.96 -24.77 18.28 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.343 -0.848 . . . . 0.0 109.337 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.6 pp -86.69 -12.11 49.29 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.583 -0.698 . . . . 0.0 109.255 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.669 ' HB3' ' HB2' ' A' ' 129' ' ' GLU . . . . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.465 -0.772 . . . . 0.0 110.44 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 32.0 t . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.243 0.544 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.669 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 0.2 OUTLIER -133.5 119.64 19.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 110.051 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 3.1 t -120.58 119.99 34.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 110.334 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -123.68 124.91 43.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.851 . . . . 0.0 109.693 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.666 ' HA3' ' CA ' ' A' ' 107' ' ' GLY . . . -164.53 -164.36 19.64 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.607 ' CH2' ' O ' ' A' ' 180' ' ' TYR . 36.4 m0 -114.64 113.17 24.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -1.103 . . . . 0.0 110.462 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -119.63 107.77 13.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.709 -0.62 . . . . 0.0 109.488 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.699 HG23 ' O ' ' A' ' 135' ' ' ILE . 15.7 tt . . . . . 0 C--N 1.298 -1.643 0 O-C-N 121.156 -0.965 . . . . 0.0 110.394 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.858 HG12 ' HD3' ' A' ' 164' ' ' PRO . 8.4 p . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 119.917 -0.087 . . . . 0.0 111.134 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.858 ' HD3' HG12 ' A' ' 163' ' ' VAL . 48.3 Cg_endo -79.3 52.51 4.31 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 O-C-N 123.068 1.036 . . . . 0.0 109.792 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' A' ' 94' ' ' SER . 0.9 OUTLIER 178.77 -72.4 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.693 0.759 . . . . 0.0 109.371 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.422 ' HA ' ' HB3' ' A' ' 94' ' ' SER . 1.4 tpp180 -140.85 144.0 35.08 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 1.037 HD21 HG23 ' A' ' 93' ' ' ILE . 0.6 OUTLIER -164.36 157.08 17.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.041 -1.037 . . . . 0.0 110.745 -179.604 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.502 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . 7.7 tt -123.31 137.14 54.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.286 -0.884 . . . . 0.0 110.082 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.889 HG21 ' CE1' ' A' ' 180' ' ' TYR . 19.0 t -121.4 147.94 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 110.082 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.604 HG21 HD21 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -127.89 128.87 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.181 -0.95 . . . . 0.0 110.438 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.739 HD13 HD22 ' A' ' 178' ' ' LEU . 4.7 tp -133.14 105.91 7.3 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.225 -0.922 . . . . 0.0 109.678 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.509 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 54.3 t0 -114.88 136.64 52.88 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 110.648 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.541 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -93.26 -39.6 10.9 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.799 -0.563 . . . . 0.0 109.689 179.678 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 173' ' ' MET . 3.5 tt0 -42.51 -28.07 0.2 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.323 -0.861 . . . . 0.0 108.894 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.59 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 3.0 tt0 -111.86 -26.22 9.04 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.521 ' O ' ' HB ' ' A' ' 198' ' ' THR . . . 80.0 25.07 58.58 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 1.097 HG22 HD22 ' A' ' 194' ' ' LEU . 0.2 OUTLIER -121.81 136.7 54.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.191 -1.182 . . . . 0.0 111.252 -179.431 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 1.098 ' O ' HD11 ' A' ' 194' ' ' LEU . 0.3 OUTLIER -144.66 153.76 42.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.56 -0.713 . . . . 0.0 109.514 179.302 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -154.03 167.6 32.28 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.588 -1.292 . . . . 0.0 110.197 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.889 ' CE1' HG21 ' A' ' 169' ' ' VAL . 0.9 OUTLIER -118.74 125.26 49.23 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.594 -0.945 . . . . 0.0 108.906 179.64 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.539 ' CB ' ' HB2' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -144.41 165.07 28.96 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.069 -1.019 . . . . 0.0 110.646 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 1.009 HD11 ' CD2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -120.81 116.65 50.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 O-C-N 121.667 -0.646 . . . . 0.0 109.38 179.402 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 62.78 11.67 37.8 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 86.92 34.52 10.93 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . 0.76 HG22 ' CE1' ' A' ' 186' ' ' TYR . 31.8 m -87.43 -79.41 0.28 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -1.161 . . . . 0.0 110.545 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 1.009 ' CD2' HD11 ' A' ' 182' ' ' ILE . 2.0 m-85 -83.66 89.47 7.13 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.971 -1.081 . . . . 0.0 110.389 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.629 ' HG ' ' CE1' ' A' ' 191' ' ' PHE . 12.3 tp 179.9 29.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.589 -0.694 . . . . 0.0 109.504 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.438 ' H ' ' HD2' ' A' ' 189' ' ' PRO . . . -106.73 -72.06 0.8 Allowed Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.754 -1.212 . . . . 0.0 110.984 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.438 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 44.8 Cg_endo -70.48 -30.84 18.35 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.899 1.473 . . . . 0.0 111.727 -178.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.657 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -72.42 17.21 0.11 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.125 -0.984 . . . . 0.0 111.519 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.629 ' CE1' ' HG ' ' A' ' 187' ' ' LEU . 1.1 m-30 -90.83 -22.14 21.13 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.962 -1.086 . . . . 0.0 110.981 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . 0.476 ' HG2' ' NH1' ' A' ' 192' ' ' ARG . 0.1 OUTLIER -90.02 -14.66 33.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.033 -1.042 . . . . 0.0 110.659 -179.391 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -106.62 -17.36 12.27 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.516 -1.834 . . . . 0.0 108.516 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 1.098 HD11 ' O ' ' A' ' 178' ' ' LEU . 7.2 tt -65.99 -41.44 91.1 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.699 -0.883 . . . . 0.0 109.525 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.559 ' HE3' ' N ' ' A' ' 196' ' ' GLY . 0.0 OUTLIER -47.07 -31.12 3.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.455 -0.778 . . . . 0.0 110.415 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.559 ' N ' ' HE3' ' A' ' 195' ' ' LYS . . . -99.61 -22.91 11.57 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 1.014 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -91.22 -3.66 56.74 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.942 -0.74 . . . . 0.0 110.164 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . 0.789 HG23 ' O ' ' A' ' 194' ' ' LEU . 33.9 p -42.6 123.17 2.53 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.781 0.801 . . . . 0.0 111.785 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 1.039 HD13 ' CG1' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -140.72 172.9 12.05 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.495 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.997 ' CZ ' ' HB3' ' A' ' 109' ' ' ALA . 41.0 p90 -83.13 131.26 54.13 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 120.934 -1.104 . . . . 0.0 109.625 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.51 ' HA ' HG13 ' A' ' 108' ' ' VAL . 52.2 Cg_endo -81.74 132.43 7.65 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 124.01 1.532 . . . . 0.0 111.935 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.513 ' CB ' ' HB2' ' A' ' 81' ' ' LYS . 20.0 p -133.44 127.31 33.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.61 -0.681 . . . . 0.0 109.346 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.861 HG23 ' HB ' ' A' ' 106' ' ' VAL . 11.8 p -119.66 156.33 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.01 -1.056 . . . . 0.0 110.589 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . 0.924 ' CB ' HG23 ' A' ' 105' ' ' VAL . 1.4 m -134.18 129.27 35.55 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.527 -0.733 . . . . 0.0 110.726 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 1.001 ' HB1' HG21 ' A' ' 212' ' ' VAL . . . -123.14 131.22 53.6 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.285 0.564 . . . . 0.0 110.202 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.611 HG13 ' N ' ' A' ' 207' ' ' TRP . 1.2 t -47.35 176.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.46 -0.775 . . . . 0.0 110.419 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 0.923 ' CE3' ' HB2' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -101.3 -50.44 3.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.201 -0.937 . . . . 0.0 111.072 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.69 ' N ' ' CG ' ' A' ' 207' ' ' TRP . . . -144.36 -1.19 0.93 Allowed Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.596 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.545 ' OE1' ' CH2' ' A' ' 207' ' ' TRP . 4.0 tp60 -66.9 -23.43 65.99 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.424 -1.045 . . . . 0.0 109.646 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . 0.549 ' SG ' ' CG1' ' A' ' 206' ' ' VAL . 20.7 p -143.98 -121.98 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.625 0.726 . . . . 0.0 110.018 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.621 ' O ' ' HD2' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -173.53 139.55 0.75 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.634 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 1.001 HG21 ' HB1' ' A' ' 205' ' ' ALA . 2.3 t -127.24 140.6 48.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 120.607 -1.308 . . . . 0.0 111.321 -178.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . 0.713 ' HA ' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -128.39 109.28 11.28 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.153 178.73 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.665 ' O ' HD11 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -123.54 150.79 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.425 -0.797 . . . . 0.0 110.913 -179.024 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.584 ' O ' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -130.0 108.89 10.44 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . 0.714 ' CD2' ' CB ' ' A' ' 91' ' ' TRP . 1.5 t80 -115.8 140.28 49.37 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.187 -0.945 . . . . 0.0 111.048 -178.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . 0.421 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 0.0 OUTLIER -136.71 123.99 21.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.648 -0.657 . . . . 0.0 110.142 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 145.8 -37.54 1.26 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.274 -1.133 . . . . 0.0 110.224 -179.949 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.647 HD11 ' HG3' ' A' ' 70' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.153 0.502 . . . . 0.0 110.218 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.705 ' HA ' HD23 ' A' ' 33' ' ' LEU . 10.6 pt-20 -48.57 -29.26 4.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.119 -0.988 . . . . 0.0 108.819 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -66.75 -23.52 66.1 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 29' ' ' LEU . 15.1 tp -83.22 -35.85 25.08 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.833 HD12 ' C ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -73.25 -38.01 66.14 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.903 0.858 . . . . 0.0 109.027 178.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.577 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 23.0 t -58.56 -22.71 56.62 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.444 0.64 . . . . 0.0 110.062 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.985 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -57.95 -173.71 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.454 -0.779 . . . . 0.0 109.555 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.985 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 42.5 Cg_endo -69.16 102.28 0.91 Allowed 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.875 1.461 . . . . 0.0 110.099 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.693 ' HD3' ' O ' ' A' ' 35' ' ' ALA . 49.1 Cg_endo -94.23 121.21 0.35 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.19 1.627 . . . . 0.0 111.215 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.904 ' O ' ' N ' ' A' ' 40' ' ' LEU . 51.6 Cg_endo -83.84 149.58 12.51 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.925 1.487 . . . . 0.0 110.524 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.634 ' C ' ' O ' ' A' ' 38' ' ' PRO . 0.6 OUTLIER 3.02 51.98 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 122.126 0.965 . . . . 0.0 111.358 -179.649 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.068 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -139.63 -48.89 0.47 Allowed 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 178.154 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 1.068 HG23 ' CD1' ' A' ' 40' ' ' LEU . 2.7 t -88.52 -32.76 6.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 119.327 -0.949 . . . . 0.0 108.554 177.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.46 -43.97 10.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.638 -0.664 . . . . 0.0 112.049 -178.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.738 ' OE1' ' HA ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -81.41 -19.99 41.37 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.056 -1.058 . . . . 0.0 109.972 -178.78 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.696 ' HD2' HG22 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -71.85 -51.63 21.42 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.613 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.628 ' CE1' ' O ' ' A' ' 41' ' ' VAL . 29.6 m170 -56.38 -16.35 5.54 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.638 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -95.04 -33.19 12.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.263 -0.898 . . . . 0.0 109.383 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.645 ' C ' ' CE3' ' A' ' 48' ' ' TRP . . . -83.77 -101.93 0.56 Allowed Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.157 -1.977 . . . . 0.0 108.157 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.786 ' CD2' ' N ' ' A' ' 48' ' ' TRP . 0.3 OUTLIER -86.86 73.06 10.03 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 122.963 1.363 . . . . 0.0 108.479 179.492 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 49' ' ' ASN . 0.1 OUTLIER -46.21 111.67 1.53 Allowed Pre-proline 0 C--N 1.287 -2.148 0 CA-C-N 114.218 -1.356 . . . . 0.0 112.333 -178.295 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.708 ' O ' ' N ' ' A' ' 52' ' ' ASP . 55.4 Cg_endo -91.9 2.09 4.2 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.496 2.131 . . . . 0.0 110.277 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.764 ' HA ' ' CE ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -52.34 71.29 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.909 1.338 . . . . 0.0 111.655 -177.783 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.708 ' N ' ' O ' ' A' ' 50' ' ' PRO . 1.6 m-20 178.03 0.16 0.0 OUTLIER 'General case' 0 C--N 1.262 -3.213 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.2 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.85 ' HB2' ' CB ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -166.01 -175.69 3.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.389 -0.819 . . . . 0.0 111.259 -178.187 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.798 ' HB2' HG21 ' A' ' 75' ' ' THR . 0.0 OUTLIER -51.78 124.5 12.63 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.955 0.883 . . . . 0.0 110.709 -179.016 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.745 ' C ' ' H ' ' A' ' 57' ' ' ILE . 1.6 pt-20 -99.67 8.41 44.37 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.591 0.71 . . . . 0.0 110.956 -179.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.732 ' C ' HD13 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -58.84 22.94 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.666 0.746 . . . . 0.0 110.199 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.745 ' H ' ' C ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -112.99 166.13 7.15 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 CA-C-O 121.679 0.752 . . . . 0.0 110.342 -179.7 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.776 ' HA ' HD23 ' A' ' 40' ' ' LEU . 10.1 t0 -134.72 96.32 3.53 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 121.868 0.842 . . . . 0.0 109.737 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.764 ' HA ' ' O ' ' A' ' 65' ' ' CYS . 1.4 m -121.7 121.33 64.11 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 CA-C-O 121.27 0.557 . . . . 0.0 110.186 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.738 ' HA ' ' OE1' ' A' ' 43' ' ' GLN . 7.9 ttmt -135.75 153.42 51.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 110.658 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.554 ' N ' ' HG2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -55.27 -123.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.431 -0.793 . . . . 0.0 110.724 -179.457 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 44.0 32.37 2.34 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.698 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 110.9 65.47 0.53 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.698 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.2 OUTLIER 0.63 90.23 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.835 -0.803 . . . . 0.0 110.832 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.764 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 1.0 OUTLIER -116.88 114.4 23.83 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.528 -0.733 . . . . 0.0 109.786 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.709 ' CE2' HG11 ' A' ' 59' ' ' VAL . 13.4 t80 -116.25 123.56 48.02 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.461 -0.774 . . . . 0.0 109.541 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -151.82 149.03 28.54 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.909 -1.119 . . . . 0.0 110.886 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.627 ' HB2' HG23 ' A' ' 57' ' ' ILE . 17.4 ttt85 -122.51 152.87 39.9 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.253 -0.904 . . . . 0.0 109.71 179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.68 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 2.7 mtt180 -85.8 -69.02 0.13 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.084 -1.01 . . . . 0.0 110.398 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.68 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 56.1 Cg_endo -71.34 -145.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.706 1.371 . . . . 0.0 109.382 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.502 ' O ' ' HG2' ' A' ' 73' ' ' GLN . 4.8 t -140.01 164.45 22.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 O-C-N 121.378 -0.826 . . . . 0.0 109.954 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.781 ' HB2' ' CE3' ' A' ' 207' ' ' TRP . . . -63.06 111.38 2.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.208 -0.932 . . . . 0.0 110.105 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.502 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 0.9 OUTLIER -140.65 -103.81 0.15 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.238 -0.914 . . . . 0.0 110.393 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.482 ' C ' ' O ' ' A' ' 73' ' ' GLN . 8.4 t -38.26 -29.95 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.166 -0.958 . . . . 0.0 110.39 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.798 HG21 ' HB2' ' A' ' 54' ' ' SER . 2.7 t -137.49 -134.69 0.14 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.254 -0.904 . . . . 0.0 110.049 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.627 ' O ' ' C ' ' A' ' 77' ' ' GLY . 2.3 t0 -140.11 154.6 47.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 109.905 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.638 ' O ' ' OG ' ' A' ' 54' ' ' SER . . . -25.01 -94.0 0.01 OUTLIER Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.65 ' CG1' HG13 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -158.24 163.13 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.098 -1.236 . . . . 0.0 109.521 179.728 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.85 ' CB ' ' HB2' ' A' ' 53' ' ' CYS . 3.1 tmm_? -141.08 134.66 30.05 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.4 -0.813 . . . . 0.0 110.776 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.891 ' C ' HG12 ' A' ' 203' ' ' VAL . . . -116.17 -152.34 9.86 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.001 -2.039 . . . . 0.0 108.001 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.845 ' C ' ' HA ' ' A' ' 202' ' ' SER . 0.0 OUTLIER 2.02 123.33 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.414 -1.05 . . . . 0.0 110.986 179.357 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.556 ' HA ' ' CB ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -126.46 -19.83 4.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.267 -0.896 . . . . 0.0 110.549 -179.444 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.552 ' HA3' ' HB3' ' A' ' 200' ' ' TYR . . . 133.53 37.73 0.23 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.544 ' HB2' ' HD3' ' A' ' 82' ' ' ARG . 7.9 t80 -134.8 95.86 3.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.06 -1.259 . . . . 0.0 110.286 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.691 ' CB ' HD11 ' A' ' 171' ' ' LEU . 0.7 OUTLIER -140.16 140.68 35.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.169 -0.957 . . . . 0.0 110.538 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.58 ' HA ' ' CB ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -131.42 145.44 51.81 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -0.902 . . . . 0.0 109.597 179.654 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.452 ' N ' ' HB3' ' A' ' 173' ' ' MET . . . 81.18 165.71 34.79 Favored Glycine 0 N--CA 1.481 1.693 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.466 ' O ' HD23 ' A' ' 88' ' ' LEU . 4.9 tt -87.23 117.86 26.27 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.34 -1.094 . . . . 0.0 110.047 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.454 ' NE2' ' O ' ' A' ' 86' ' ' ARG . 91.4 m-70 -135.39 173.28 11.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -0.882 . . . . 0.0 109.881 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.36 136.58 23.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.14 -0.975 . . . . 0.0 110.107 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 1.152 ' CZ2' HG11 ' A' ' 169' ' ' VAL . 0.5 OUTLIER -135.07 171.0 15.05 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.156 -0.965 . . . . 0.0 110.632 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 215' ' ' ARG . 2.6 mt-10 -133.41 151.19 51.79 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.745 -0.597 . . . . 0.0 110.004 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.584 HG13 ' CD1' ' A' ' 91' ' ' TRP . 11.5 mt -144.6 154.85 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.237 -0.915 . . . . 0.0 110.799 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 1.095 ' O ' HG23 ' A' ' 212' ' ' VAL . 14.5 t -141.3 151.43 43.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 109.642 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.764 ' CZ2' HG23 ' A' ' 106' ' ' VAL . 14.4 m95 -137.39 90.92 14.7 Favored Pre-proline 0 C--N 1.296 -1.721 0 O-C-N 121.526 -0.734 . . . . 0.0 110.565 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.535 ' HD2' ' HA ' ' A' ' 212' ' ' VAL . 49.4 Cg_endo -78.93 125.41 6.6 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.977 1.514 . . . . 0.0 110.149 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.586 ' CD2' HD13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.184 -0.947 . . . . 0.0 110.229 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.751 HG13 ' HA ' ' A' ' 134' ' ' ASP . 1.5 t . . . . . 0 N--CA 1.499 2.002 0 CA-C-O 120.982 0.42 . . . . 0.0 111.023 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.764 HG23 ' CZ2' ' A' ' 95' ' ' TRP . 5.5 t -132.84 148.58 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.021 -1.049 . . . . 0.0 109.253 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.664 ' HA3' ' HA2' ' A' ' 132' ' ' GLY . . . 175.62 -156.89 22.83 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 118.916 -1.611 . . . . 0.0 111.658 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.783 HG12 ' HB2' ' A' ' 199' ' ' LEU . 2.4 t -135.8 150.48 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.727 -0.866 . . . . 0.0 109.494 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.545 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -120.36 152.94 37.18 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.066 -1.021 . . . . 0.0 110.933 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.979 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -125.76 130.08 50.76 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.277 -0.889 . . . . 0.0 110.491 179.828 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.39 -27.79 16.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.53 -0.731 . . . . 0.0 109.539 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.428 HD11 ' O ' ' A' ' 196' ' ' GLY . 2.0 pp -83.4 -12.1 56.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.527 -0.733 . . . . 0.0 109.558 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.748 ' HB3' ' HB2' ' A' ' 129' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.512 -0.742 . . . . 0.0 110.462 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.277 0.56 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.748 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -137.98 123.3 19.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.194 -0.941 . . . . 0.0 109.974 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.4 t -142.29 139.52 31.9 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.279 -0.888 . . . . 0.0 110.112 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 8.4 m0 -124.62 128.51 48.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 108.929 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.664 ' HA2' ' HA3' ' A' ' 107' ' ' GLY . . . -127.05 -162.44 11.18 Favored Glycine 0 N--CA 1.484 1.846 0 C-N-CA 118.821 -1.657 . . . . 0.0 111.266 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.716 ' CZ3' ' CD1' ' A' ' 180' ' ' TYR . 6.4 m0 -126.14 118.12 24.58 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.766 -0.843 . . . . 0.0 110.723 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.751 ' HA ' HG13 ' A' ' 105' ' ' VAL . 13.5 t70 -118.68 111.57 18.69 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.599 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.664 HG21 ' CB ' ' A' ' 95' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.747 0 O-C-N 121.156 -0.965 . . . . 0.0 110.315 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 1.003 HG11 ' HG ' ' A' ' 167' ' ' LEU . 1.3 t . . . . . 0 N--CA 1.493 1.717 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 1.002 ' HD2' HG12 ' A' ' 163' ' ' VAL . 39.2 Cg_endo -65.12 -177.54 0.63 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.557 1.293 . . . . 0.0 111.481 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.53 ' O ' ' OG ' ' A' ' 94' ' ' SER . 0.3 OUTLIER -40.49 -41.6 1.46 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.737 -0.602 . . . . 0.0 111.068 -179.086 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.846 ' C ' HD13 ' A' ' 167' ' ' LEU . 8.3 ttt-85 -146.83 155.99 42.77 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.231 -0.918 . . . . 0.0 110.767 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 1.003 ' HG ' HG11 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -157.56 158.42 35.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.459 -0.775 . . . . 0.0 110.658 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.548 ' O ' ' O ' ' A' ' 181' ' ' SER . 0.6 OUTLIER -102.99 141.15 36.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.144 -0.972 . . . . 0.0 109.673 -179.758 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 1.152 HG11 ' CZ2' ' A' ' 91' ' ' TRP . 9.3 t -119.25 139.52 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.078 -1.014 . . . . 0.0 111.107 -179.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.695 ' HB ' HD13 ' A' ' 187' ' ' LEU . 12.7 t -114.13 109.27 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.419 -0.8 . . . . 0.0 109.241 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.876 HD12 ' CD2' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -121.56 108.84 14.07 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.134 -0.979 . . . . 0.0 110.476 -179.225 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 36.9 t0 -120.21 132.69 55.46 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.799 0.809 . . . . 0.0 110.018 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.58 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 7.0 tpt -94.79 -37.72 11.11 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.847 -0.533 . . . . 0.0 109.642 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 173' ' ' MET . 3.9 mt-10 -43.65 -27.19 0.29 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.522 -0.871 . . . . 0.0 108.805 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.563 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.0 OUTLIER -112.25 -26.53 8.73 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.036 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.489 ' O ' ' CG2' ' A' ' 198' ' ' THR . . . 82.49 23.49 56.29 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.995 HG22 ' CD2' ' A' ' 194' ' ' LEU . 0.1 OUTLIER -120.26 124.14 44.92 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.139 -1.213 . . . . 0.0 111.189 -179.559 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 1.078 ' O ' HD11 ' A' ' 194' ' ' LEU . 2.3 mp -135.24 152.45 51.55 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.55 -0.719 . . . . 0.0 109.568 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.97 ' C ' HD11 ' A' ' 187' ' ' LEU . . . -155.52 177.84 32.46 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.48 -1.343 . . . . 0.0 110.262 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.731 ' CE2' HG21 ' A' ' 163' ' ' VAL . 0.5 OUTLIER -118.77 125.62 50.02 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.499 -1.0 . . . . 0.0 108.836 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.548 ' O ' ' O ' ' A' ' 168' ' ' LEU . 43.5 t -144.18 140.85 29.58 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.084 -1.01 . . . . 0.0 111.135 -179.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.756 HG22 ' HB3' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -95.66 116.33 37.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.478 -0.763 . . . . 0.0 109.319 179.056 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 87.97 -35.07 3.59 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 116.1 39.6 0.87 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 54.9 m -127.28 -5.42 6.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.21 -1.17 . . . . 0.0 110.725 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.494 ' HB3' ' HB2' ' A' ' 181' ' ' SER . 0.3 OUTLIER -85.05 -46.83 10.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.99 -1.069 . . . . 0.0 110.372 -179.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.97 HD11 ' C ' ' A' ' 179' ' ' GLY . 2.4 mt -82.09 41.98 0.7 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.181 -0.95 . . . . 0.0 110.024 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -79.89 -91.17 0.44 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 191' ' ' PHE . 47.6 Cg_endo -73.56 -24.82 15.69 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.012 1.532 . . . . 0.0 110.772 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -69.07 21.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.48 -0.763 . . . . 0.0 111.7 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.66 ' CE1' HD22 ' A' ' 187' ' ' LEU . 0.3 OUTLIER -90.27 -38.0 13.71 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.788 -1.195 . . . . 0.0 110.372 179.57 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.67 -13.57 60.64 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.145 -0.972 . . . . 0.0 110.495 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -107.81 -7.69 31.12 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.791 -1.723 . . . . 0.0 108.791 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 1.078 HD11 ' O ' ' A' ' 178' ' ' LEU . 10.5 tt -78.14 -36.52 47.63 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.498 ' CA ' HG23 ' A' ' 198' ' ' THR . 1.0 OUTLIER -44.07 -44.02 7.22 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.679 -0.638 . . . . 0.0 109.933 179.126 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.428 ' O ' HD11 ' A' ' 112' ' ' LEU . . . -83.29 -26.24 44.62 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.729 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.75 -3.69 57.24 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.699 -0.883 . . . . 0.0 109.934 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . 0.727 HG23 ' O ' ' A' ' 194' ' ' LEU . 11.2 p -42.73 135.12 3.02 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.825 0.821 . . . . 0.0 111.722 -177.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.979 ' CB ' HG23 ' A' ' 110' ' ' THR . 0.0 OUTLIER -140.15 171.0 14.8 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.68 -0.638 . . . . 0.0 109.381 179.454 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.612 ' C ' HG13 ' A' ' 108' ' ' VAL . 25.1 m-85 -84.56 129.29 57.92 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 120.997 -1.064 . . . . 0.0 110.123 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.854 ' HG3' HD12 ' A' ' 171' ' ' LEU . 52.8 Cg_endo -83.38 111.52 1.83 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.954 1.502 . . . . 0.0 110.78 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.845 ' HA ' ' C ' ' A' ' 81' ' ' LYS . 12.2 p -133.94 160.61 37.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 109.864 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.891 HG12 ' C ' ' A' ' 80' ' ' GLY . 14.4 p -122.87 157.11 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.731 -1.23 . . . . 0.0 110.924 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 105' ' ' VAL . 0.3 OUTLIER -138.57 127.2 23.41 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.496 -0.752 . . . . 0.0 109.094 178.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -128.15 157.85 39.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.954 -1.091 . . . . 0.0 110.481 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.805 HG13 ' N ' ' A' ' 207' ' ' TRP . 5.9 p -90.13 -137.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.193 -0.942 . . . . 0.0 110.103 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 0.805 ' N ' HG13 ' A' ' 206' ' ' VAL . 10.1 p90 -126.21 58.47 1.36 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.975 -1.078 . . . . 0.0 110.493 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 83.27 -1.54 88.54 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.498 ' HB3' HG11 ' A' ' 206' ' ' VAL . 3.0 tp60 -75.47 -33.21 60.81 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.486 -1.008 . . . . 0.0 110.257 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . 0.659 ' O ' ' C ' ' A' ' 211' ' ' GLN . 48.8 t -124.92 17.24 8.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.337 -0.852 . . . . 0.0 110.259 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.659 ' C ' ' O ' ' A' ' 210' ' ' CYS . 3.2 pt20 0.35 114.46 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.592 0.71 . . . . 0.0 111.859 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 1.095 HG23 ' O ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -118.99 145.19 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.441 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . 0.688 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 20.1 mtm180 -88.61 151.51 22.43 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.094 -1.004 . . . . 0.0 110.144 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.752 HD12 ' HB3' ' A' ' 48' ' ' TRP . 0.8 OUTLIER -136.36 123.59 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.315 -0.865 . . . . 0.0 111.231 -179.023 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 92' ' ' GLU . 75.2 ttt180 -131.01 108.63 9.93 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . 0.69 ' CD2' ' CB ' ' A' ' 91' ' ' TRP . 3.2 t80 -118.45 148.94 42.06 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.001 -1.062 . . . . 0.0 111.454 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . 0.551 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 0.0 OUTLIER -125.25 107.78 11.07 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.522 -0.736 . . . . 0.0 109.706 179.315 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 134.85 -1.61 3.9 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 . . . . . 0 N--CA 1.493 1.676 0 O-C-N 121.062 -1.258 . . . . 0.0 110.116 179.9 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.914 HD13 ' CG ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 121.127 0.489 . . . . 0.0 109.852 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.548 ' HG3' ' CB ' ' A' ' 73' ' ' GLN . 26.6 mt-10 -49.06 -47.83 44.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.119 -0.988 . . . . 0.0 109.304 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -61.07 -27.5 68.39 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 29' ' ' LEU . 5.9 tp -83.67 -29.36 27.68 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.975 HD13 ' CD ' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -88.09 -36.52 16.87 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.722 0.772 . . . . 0.0 109.47 179.585 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.531 ' N ' HD12 ' A' ' 33' ' ' LEU . 11.6 p -45.84 -31.17 1.97 Allowed 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.683 0.754 . . . . 0.0 109.748 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.812 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . -91.46 167.21 16.16 Favored Pre-proline 0 C--N 1.298 -1.644 0 O-C-N 121.572 -0.705 . . . . 0.0 109.354 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.555 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 43.5 Cg_endo -70.18 99.01 0.76 Allowed 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.063 1.56 . . . . 0.0 110.431 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.812 ' HD3' ' O ' ' A' ' 35' ' ' ALA . 47.5 Cg_endo -96.6 -175.45 0.28 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 121.999 1.799 . . . . 0.0 110.397 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 1.017 ' O ' ' N ' ' A' ' 40' ' ' LEU . 39.6 Cg_endo -65.54 153.31 78.79 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.041 1.548 . . . . 0.0 110.043 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.67 ' O ' ' N ' ' A' ' 43' ' ' GLN . 1.9 t0 -15.29 -34.14 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.375 0.607 . . . . 0.0 110.143 -178.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.034 HD13 ' N ' ' A' ' 41' ' ' VAL . 0.1 OUTLIER -29.4 -46.78 0.06 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.435 -0.791 . . . . 0.0 109.551 178.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 1.034 ' N ' HD13 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -85.05 -31.5 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 118.657 -1.217 . . . . 0.0 109.94 179.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.628 ' N ' ' O ' ' A' ' 39' ' ' ASP . . . -89.89 -43.29 10.7 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.078 -1.014 . . . . 0.0 110.784 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.746 ' HG3' ' HB2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -72.23 -21.12 61.44 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.449 -0.782 . . . . 0.0 110.653 -179.13 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.723 ' HG2' ' HA ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -76.47 -55.31 5.65 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.627 ' CE1' ' O ' ' A' ' 41' ' ' VAL . 16.8 m170 -58.89 -18.21 31.06 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -97.82 -25.33 15.08 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.718 0.77 . . . . 0.0 109.259 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.451 ' HA3' HG23 ' A' ' 59' ' ' VAL . . . -63.85 -114.57 0.01 OUTLIER Glycine 0 N--CA 1.479 1.528 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.812 ' CA ' HD13 ' A' ' 214' ' ' ILE . 0.0 OUTLIER -103.26 70.88 1.08 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.492 -1.283 . . . . 0.0 111.052 179.208 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.596 HD22 ' HD2' ' A' ' 50' ' ' PRO . 1.0 OUTLIER -109.23 116.65 54.79 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.025 -1.047 . . . . 0.0 110.152 178.37 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.903 ' HB3' HG12 ' A' ' 203' ' ' VAL . 40.7 Cg_endo -69.07 -64.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 N-CA-C 109.432 -1.026 . . . . 0.0 109.432 178.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 1.124 ' HA ' ' CE ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER 175.49 35.22 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 O-C-N 120.976 -1.077 . . . . 0.0 112.02 177.752 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.888 ' HB2' ' HA2' ' A' ' 80' ' ' GLY 0.25 2.2 m-20 -168.58 20.78 0.02 OUTLIER 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.62 -179.451 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.694 ' SG ' ' NH1' ' A' ' 44' ' ' ARG . 1.7 t -102.23 144.57 30.59 Favored 'General case' 0 C--N 1.289 -2.03 0 C-N-CA 118.866 -1.134 . . . . 0.0 111.657 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.803 ' HB3' HG22 ' A' ' 75' ' ' THR . 0.0 OUTLIER -103.0 167.43 9.84 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.624 0.726 . . . . 0.0 109.954 179.306 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.975 ' CD ' HD13 ' A' ' 33' ' ' LEU . 0.9 OUTLIER -71.35 8.26 1.09 Allowed 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.592 -0.693 . . . . 0.0 111.211 -179.306 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.61 ' ND2' ' O ' ' A' ' 54' ' ' SER . 0.4 OUTLIER -29.02 -32.29 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.923 0.868 . . . . 0.0 109.474 179.414 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.728 ' N ' ' O ' ' A' ' 55' ' ' GLU . 3.7 pt -135.29 167.21 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.797 -0.565 . . . . 0.0 110.107 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.99 ' HB2' HD23 ' A' ' 40' ' ' LEU . 3.4 t0 -109.01 113.04 25.57 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.038 -1.039 . . . . 0.0 110.61 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.752 ' HB ' ' CE2' ' A' ' 48' ' ' TRP . 1.2 m -129.78 135.8 60.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 O-C-N 121.49 -0.756 . . . . 0.0 109.086 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.746 ' HB2' ' HG3' ' A' ' 43' ' ' GLN . 9.0 tttm -128.68 155.31 45.24 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 118.826 -1.15 . . . . 0.0 112.29 -178.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.545 ' O ' ' C ' ' A' ' 62' ' ' GLY . 1.1 tt0 -71.54 -126.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.616 -0.677 . . . . 0.0 110.476 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.545 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 38.85 52.39 2.55 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 107.808 -2.117 . . . . 0.0 107.808 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.662 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 97.86 49.56 1.76 Allowed Glycine 0 N--CA 1.485 1.924 0 N-CA-C 107.113 -2.395 . . . . 0.0 107.113 -177.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.057 HD21 ' CE1' ' A' ' 66' ' ' PHE . 2.8 tt 1.54 93.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.719 0.771 . . . . 0.0 111.232 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 35.0 t -105.32 113.87 27.71 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.602 0.715 . . . . 0.0 110.364 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 1.057 ' CE1' HD21 ' A' ' 64' ' ' LEU . 3.2 m-85 -82.63 130.33 35.1 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.511 -0.743 . . . . 0.0 109.908 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.587 ' HB3' ' O ' ' A' ' 58' ' ' ASP . 2.4 tm-20 -145.75 121.3 10.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.801 -1.187 . . . . 0.0 109.94 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.545 ' CB ' ' HB2' ' A' ' 207' ' ' TRP . 0.5 OUTLIER -126.03 155.3 41.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.371 -0.831 . . . . 0.0 109.404 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.694 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.8 OUTLIER -130.1 -72.52 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 120.89 -1.131 . . . . 0.0 110.875 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.914 ' CG ' HD13 ' A' ' 29' ' ' LEU . 57.1 Cg_endo -72.98 -126.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.434 1.228 . . . . 0.0 109.266 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.444 ' O ' ' OE1' ' A' ' 73' ' ' GLN . 2.4 t -140.31 164.24 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.574 -1.329 . . . . 0.0 109.962 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.948 ' HB1' ' HA ' ' A' ' 76' ' ' ASP . . . -59.84 94.24 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.17 -0.956 . . . . 0.0 110.266 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.548 ' CB ' ' HG3' ' A' ' 30' ' ' GLU . 1.2 mp0 -76.08 -90.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.18 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.49 ' OG ' ' N ' ' A' ' 75' ' ' THR . 1.5 t -44.04 -94.64 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.144 -0.972 . . . . 0.0 109.623 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.803 HG22 ' HB3' ' A' ' 54' ' ' SER . 7.6 t -88.57 -124.37 0.05 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.148 -0.97 . . . . 0.0 109.189 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.948 ' HA ' ' HB1' ' A' ' 72' ' ' ALA . 13.2 p30 -140.55 154.63 46.59 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.836 -1.165 . . . . 0.0 110.413 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.733 ' C ' ' O ' ' A' ' 76' ' ' ASP . . . 2.95 -78.2 0.0 OUTLIER Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.721 HG23 ' HD2' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -158.16 137.42 3.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.507 -0.996 . . . . 0.0 110.389 179.185 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.88 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 0.7 OUTLIER -144.33 150.68 38.2 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.401 0.62 . . . . 0.0 109.779 179.711 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.888 ' HA2' ' HB2' ' A' ' 52' ' ' ASP . . . -165.32 116.23 0.68 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.572 -1.811 . . . . 0.0 108.572 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.597 ' O ' ' C ' ' A' ' 82' ' ' ARG . 4.7 ttpm? -124.59 -75.08 0.6 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.113 -1.227 . . . . 0.0 111.549 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.635 ' HG2' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -25.1 -47.38 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.504 -0.747 . . . . 0.0 111.11 -178.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.635 ' N ' ' HG2' ' A' ' 82' ' ' ARG . . . 34.24 58.95 0.65 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -93.85 108.25 20.05 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.426 -1.043 . . . . 0.0 110.645 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.0 162.87 34.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.432 -0.792 . . . . 0.0 110.002 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -118.67 137.91 52.98 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.233 -0.917 . . . . 0.0 109.931 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 173' ' ' MET . . . 111.2 158.59 15.32 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.521 HD12 ' HA ' ' A' ' 172' ' ' ASP . 18.6 tp -87.6 133.27 33.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -1.152 . . . . 0.0 110.19 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.493 ' ND1' ' O ' ' A' ' 88' ' ' LEU . 66.3 m-70 -147.11 173.08 12.82 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.135 -0.978 . . . . 0.0 110.064 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.553 ' O ' ' CB ' ' A' ' 217' ' ' MET . . . -154.03 139.99 18.26 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.203 -0.936 . . . . 0.0 109.64 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.559 ' HB3' ' HA ' ' A' ' 216' ' ' TYR . 0.0 OUTLIER -134.74 166.43 22.97 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.968 -1.083 . . . . 0.0 110.442 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.629 ' N ' ' O ' ' A' ' 215' ' ' ARG . 22.5 tt0 -115.16 138.63 50.69 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.545 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.535 HG22 HG23 ' A' ' 169' ' ' VAL . 0.2 OUTLIER -144.02 134.99 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 120.625 -1.297 . . . . 0.0 110.765 -179.662 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.678 ' HB3' ' HA ' ' A' ' 166' ' ' ARG . 0.9 OUTLIER -118.68 126.38 51.79 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.477 -0.764 . . . . 0.0 109.537 179.421 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.746 ' CE3' ' CG1' ' A' ' 106' ' ' VAL . 2.8 t90 -129.9 87.62 51.37 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.179 -0.95 . . . . 0.0 109.93 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 164' ' ' PRO . 51.6 Cg_endo -95.7 109.15 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.776 1.651 . . . . 0.0 110.742 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.691 HD23 ' O ' ' A' ' 97' ' ' LEU . 5.7 tt . . . . . 0 N--CA 1.49 1.567 0 O-C-N 120.968 -1.083 . . . . 0.0 110.285 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.873 HG23 ' HA ' ' A' ' 134' ' ' ASP . 0.6 OUTLIER . . . . . 0 N--CA 1.501 2.076 0 CA-C-O 121.04 0.448 . . . . 0.0 111.912 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.983 ' HA ' HG23 ' A' ' 203' ' ' VAL . 1.3 p -132.52 141.71 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.935 -1.103 . . . . 0.0 109.999 177.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.601 ' HA3' ' HA3' ' A' ' 132' ' ' GLY . . . 160.93 -149.1 17.89 Favored Glycine 0 N--CA 1.487 2.061 0 C-N-CA 119.628 -1.273 . . . . 0.0 109.959 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.123 ' CG2' HD13 ' A' ' 199' ' ' LEU . 1.6 p -148.73 161.3 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.385 -1.068 . . . . 0.0 110.157 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.512 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -133.75 152.24 51.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.129 -0.982 . . . . 0.0 110.714 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.8 HG23 ' HB3' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -105.98 128.62 53.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.846 . . . . 0.0 109.862 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.74 -27.2 17.37 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.541 -0.725 . . . . 0.0 109.71 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.501 ' O ' ' C ' ' A' ' 113' ' ' ALA . 3.8 pp -83.95 -12.1 55.87 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.512 -0.742 . . . . 0.0 109.538 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 112' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.719 0 O-C-N 121.72 -0.612 . . . . 0.0 110.625 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 57.7 m . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.416 0.627 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 110' ' ' THR . 6.5 tm-20 -150.07 129.42 12.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.916 . . . . 0.0 110.051 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 6.9 t -121.14 120.71 36.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.259 -0.901 . . . . 0.0 110.203 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . 0.493 ' O ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -128.86 124.74 36.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.288 -0.883 . . . . 0.0 109.915 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.601 ' HA3' ' HA3' ' A' ' 107' ' ' GLY . . . -172.35 -160.01 20.01 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.704 ' CZ3' HD11 ' A' ' 167' ' ' LEU . 33.9 m0 -109.27 115.09 29.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.214 -1.168 . . . . 0.0 110.192 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.873 ' HA ' HG23 ' A' ' 105' ' ' VAL . 4.1 t70 -118.31 148.08 42.83 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.416 0.627 . . . . 0.0 110.536 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.504 -0.748 . . . . 0.0 109.404 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.869 HG21 HD21 ' A' ' 167' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.437 ' O ' ' HG3' ' A' ' 165' ' ' GLU . 45.4 Cg_endo -72.26 65.97 3.53 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.086 1.571 . . . . 0.0 110.852 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' A' ' 94' ' ' SER . 3.6 mt-10 -167.26 -85.74 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.319 -0.863 . . . . 0.0 109.854 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.678 ' HA ' ' HB3' ' A' ' 94' ' ' SER . 23.6 ttp180 -152.65 156.22 38.82 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.367 -0.833 . . . . 0.0 110.29 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.869 HD21 HG21 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -139.8 133.91 31.03 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.272 -0.892 . . . . 0.0 110.7 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.411 ' O ' ' O ' ' A' ' 181' ' ' SER . 0.4 OUTLIER -103.83 130.78 51.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.329 -0.857 . . . . 0.0 109.228 179.285 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.651 ' CG2' ' CE1' ' A' ' 180' ' ' TYR . 2.7 t -124.57 144.47 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.966 -1.084 . . . . 0.0 111.087 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.451 HG23 HD22 ' A' ' 187' ' ' LEU . 2.3 t -119.84 129.31 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.555 -0.716 . . . . 0.0 109.079 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.987 HD21 ' HE1' ' A' ' 173' ' ' MET . 12.4 tp -133.09 109.82 9.77 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.93 -1.106 . . . . 0.0 110.808 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.521 ' HA ' HD12 ' A' ' 88' ' ' LEU . 5.2 t0 -99.51 139.08 35.7 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.393 -0.817 . . . . 0.0 109.203 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.987 ' HE1' HD21 ' A' ' 171' ' ' LEU . 23.9 mmt -98.95 -44.62 6.26 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.227 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.53 ' HG2' ' N ' ' A' ' 175' ' ' GLU . 3.8 pt-20 -43.48 -24.96 0.12 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.12 -0.987 . . . . 0.0 108.565 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.53 ' N ' ' HG2' ' A' ' 174' ' ' GLU . 3.5 tp10 -115.12 -26.28 7.75 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.06 27.24 58.56 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 -178.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.647 ' HB ' HD22 ' A' ' 194' ' ' LEU . 1.4 p -113.09 139.94 48.29 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.414 -1.051 . . . . 0.0 111.313 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.904 HD21 ' O ' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -146.62 154.05 41.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.533 -0.729 . . . . 0.0 109.73 179.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.735 ' C ' HD11 ' A' ' 187' ' ' LEU . . . -141.52 163.69 26.79 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.848 ' N ' HD11 ' A' ' 187' ' ' LEU . 0.9 OUTLIER -118.63 118.31 31.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -1.146 . . . . 0.0 109.484 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.555 ' CB ' ' HB2' ' A' ' 186' ' ' TYR . 2.7 t -144.64 159.05 43.45 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.33 -0.856 . . . . 0.0 110.085 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.536 ' H ' HD13 ' A' ' 182' ' ' ILE . 0.0 OUTLIER -96.08 116.4 37.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.443 -0.785 . . . . 0.0 109.316 179.191 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 72.76 5.71 65.15 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.86 43.31 18.08 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . 0.494 ' N ' ' OG ' ' A' ' 181' ' ' SER . 95.4 m -116.18 -1.38 12.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.199 -1.177 . . . . 0.0 110.561 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.555 ' HB2' ' CB ' ' A' ' 181' ' ' SER . 0.1 OUTLIER -111.22 -25.08 9.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.153 -0.967 . . . . 0.0 110.359 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.848 HD11 ' N ' ' A' ' 180' ' ' TYR . 4.0 mp -84.46 48.29 1.49 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.252 -0.905 . . . . 0.0 110.105 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.411 ' H ' ' HD2' ' A' ' 189' ' ' PRO . . . -106.86 -73.51 0.85 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.411 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 46.3 Cg_endo -72.6 -29.31 13.29 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.979 1.515 . . . . 0.0 111.167 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.667 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -73.42 12.27 0.63 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.267 -0.896 . . . . 0.0 111.429 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.602 ' CE2' ' O ' ' A' ' 187' ' ' LEU . 0.3 OUTLIER -90.17 -10.68 43.58 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.141 -0.974 . . . . 0.0 109.802 179.132 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.74 -20.22 27.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.381 -0.824 . . . . 0.0 110.908 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.555 ' O ' ' HB3' ' A' ' 197' ' ' ARG . . . -111.15 -13.32 13.67 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.926 HD23 ' O ' ' A' ' 194' ' ' LEU . 3.7 tt -74.56 -19.99 60.12 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.459 ' CE ' ' HA ' ' A' ' 195' ' ' LYS . 0.0 OUTLIER -59.64 -32.08 70.11 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.715 -0.615 . . . . 0.0 109.53 179.119 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -106.83 -25.36 6.24 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.867 ' NH2' HD21 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -82.93 -3.3 56.88 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.855 0.836 . . . . 0.0 109.944 179.653 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . 0.588 ' HB ' ' CG2' ' A' ' 177' ' ' THR . 0.4 OUTLIER -41.0 136.85 1.38 Allowed 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 122.096 0.951 . . . . 0.0 111.24 -178.1 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 1.123 HD13 ' CG2' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -141.85 171.31 14.23 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.372 -179.653 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.808 ' O ' HG23 ' A' ' 108' ' ' VAL . 97.1 m-85 -86.84 129.7 51.39 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.15 -0.969 . . . . 0.0 109.523 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.691 ' HG3' HD22 ' A' ' 171' ' ' LEU . 42.0 Cg_endo -68.24 121.12 8.08 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.863 1.454 . . . . 0.0 111.19 -179.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.572 ' CB ' ' HA ' ' A' ' 81' ' ' LYS . 97.0 p -133.81 142.06 47.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.342 -0.849 . . . . 0.0 110.939 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.983 HG23 ' HA ' ' A' ' 106' ' ' VAL . 1.1 p -146.4 160.51 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.391 -0.818 . . . . 0.0 109.391 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . 0.514 ' O ' ' HH2' ' A' ' 95' ' ' TRP . 0.3 OUTLIER -160.35 127.19 4.3 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.415 -0.803 . . . . 0.0 109.645 179.683 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.481 ' H ' HG13 ' A' ' 78' ' ' VAL . . . -114.13 162.1 16.92 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.834 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.67 HG12 ' SG ' ' A' ' 210' ' ' CYS . 1.1 t -105.69 -179.13 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.587 -0.696 . . . . 0.0 110.47 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 0.647 ' N ' HG13 ' A' ' 206' ' ' VAL . 23.0 p90 -94.14 -33.07 13.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.332 -0.855 . . . . 0.0 110.593 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.515 ' H ' HG13 ' A' ' 206' ' ' VAL . . . -44.21 171.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 211' ' ' GLN . 0.0 OUTLIER -40.58 -49.24 2.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.35 -1.088 . . . . 0.0 110.572 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . 0.67 ' SG ' HG12 ' A' ' 206' ' ' VAL . 6.9 p -36.83 93.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.461 -0.774 . . . . 0.0 110.436 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.526 ' N ' ' O ' ' A' ' 209' ' ' GLN . 2.1 pt20 -115.41 123.69 49.29 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.233 -0.917 . . . . 0.0 110.107 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.647 ' O ' ' CZ ' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -101.53 144.52 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.599 -0.688 . . . . 0.0 109.701 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . 0.873 ' HA ' HD22 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -87.64 159.57 18.49 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.194 -0.941 . . . . 0.0 110.279 -179.078 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.894 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -138.33 124.65 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -0.944 . . . . 0.0 111.362 -178.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.629 ' O ' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -130.94 137.49 49.31 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . 0.559 ' HA ' ' HB3' ' A' ' 91' ' ' TRP . 5.5 t80 -119.35 150.64 39.82 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.792 -1.192 . . . . 0.0 111.121 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . 0.553 ' CB ' ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -131.05 107.95 9.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.354 -0.841 . . . . 0.0 110.044 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 72.47 85.18 0.22 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.517 ' HG3' ' CZ ' ' A' ' 216' ' ' TYR . 31.4 tt0 . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.285 -1.127 . . . . 0.0 110.14 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.943 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.176 0.512 . . . . 0.0 109.771 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.887 ' HA ' HD23 ' A' ' 33' ' ' LEU . 6.4 tm-20 -47.61 -35.47 9.31 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.294 -0.879 . . . . 0.0 109.356 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -60.49 -24.99 65.73 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.277 -0.889 . . . . 0.0 108.856 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -83.35 -33.87 25.74 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.9 HD21 ' HB2' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -78.72 -36.65 43.01 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.861 0.839 . . . . 0.0 109.311 179.274 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.586 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 1.2 t -80.74 -7.39 59.35 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 121.171 0.51 . . . . 0.0 109.937 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.96 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -37.96 -65.32 0.37 Allowed Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.44 -0.787 . . . . 0.0 110.538 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.96 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 47.8 Cg_endo -73.25 143.05 34.78 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.773 1.407 . . . . 0.0 109.928 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 36' ' ' PRO . 54.0 Cg_endo -98.58 53.32 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 121.813 1.675 . . . . 0.0 112.568 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.76 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 52.5 Cg_endo -77.1 150.3 29.35 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 122.89 0.942 . . . . 0.0 109.845 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.664 ' C ' ' NE2' ' A' ' 43' ' ' GLN . 2.1 t0 -39.71 -32.56 0.15 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.056 -1.028 . . . . 0.0 108.81 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.101 HD13 ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -40.95 -45.22 2.52 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.314 0.578 . . . . 0.0 109.628 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 1.101 ' N ' HD13 ' A' ' 40' ' ' LEU . 10.0 t -68.01 -26.82 35.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.017 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 39' ' ' ASP . . . -89.41 -43.94 10.53 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.018 -1.051 . . . . 0.0 111.703 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.665 ' O ' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -80.59 -24.77 38.93 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.24 -1.384 . . . . 0.0 108.929 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.725 ' CB ' ' O ' ' A' ' 40' ' ' LEU . 21.4 ttt-85 -64.28 -57.71 8.64 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.222 1.011 . . . . 0.0 108.739 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.74 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 54.3 m170 -53.57 -17.26 1.97 Allowed 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.703 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -95.9 -31.75 12.97 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.132 -1.427 . . . . 0.0 111.155 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.61 -60.26 0.51 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 106.845 -2.502 . . . . 0.0 106.845 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.826 ' HD1' ' CE2' ' A' ' 66' ' ' PHE 0.267 0.3 OUTLIER -98.37 71.27 2.04 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.171 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.785 ' O ' ' HB3' ' A' ' 53' ' ' CYS . 0.0 OUTLIER -61.91 168.31 3.77 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.701 -0.624 . . . . 0.0 112.104 -178.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.693 ' O ' ' O ' ' A' ' 53' ' ' CYS . 37.4 Cg_endo -61.38 -61.37 0.17 Allowed 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 121.572 1.515 . . . . 0.0 113.17 -178.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.778 ' HE2' ' OD1' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -67.67 -74.35 0.12 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.045 -1.659 . . . . 0.0 108.323 179.745 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.736 ' N ' ' HA3' ' A' ' 80' ' ' GLY . 0.9 OUTLIER -38.12 -27.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.203 -0.936 . . . . 0.0 109.529 179.15 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.785 ' HB3' ' O ' ' A' ' 49' ' ' ASN . 0.2 OUTLIER -138.48 129.99 27.6 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 118.736 -1.186 . . . . 0.0 111.951 -179.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.96 ' H ' ' HA ' ' A' ' 78' ' ' VAL . 0.9 OUTLIER -58.28 123.5 16.28 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.2 179.278 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.9 ' HB2' HD21 ' A' ' 33' ' ' LEU . 3.6 pt-20 -69.78 -24.48 63.51 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.439 -0.788 . . . . 0.0 109.693 179.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.749 ' ND2' ' HB3' ' A' ' 54' ' ' SER . 3.7 m-80 -28.96 -36.03 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.683 0.754 . . . . 0.0 110.874 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.765 HG22 ' HG2' ' A' ' 68' ' ' ARG . 2.6 pt -116.66 166.69 10.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 O-C-N 121.705 -0.622 . . . . 0.0 110.773 -178.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.521 ' OD1' ' CG ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -107.59 116.16 31.44 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 1.079 HG21 ' CD2' ' A' ' 66' ' ' PHE . 6.3 p -130.01 128.72 65.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 CA-C-O 121.409 0.623 . . . . 0.0 111.55 -178.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.698 ' HG2' ' N ' ' A' ' 61' ' ' GLU . 5.2 tttm -136.96 157.92 45.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.342 -0.849 . . . . 0.0 110.715 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.788 ' N ' ' CH2' ' A' ' 48' ' ' TRP . 19.0 tp10 -42.54 -111.65 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.678 -0.639 . . . . 0.0 111.238 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.56 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 36.67 45.78 1.05 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.669 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 93.14 55.58 1.58 Allowed Glycine 0 N--CA 1.487 2.058 0 N-CA-C 107.369 -2.292 . . . . 0.0 107.369 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.932 HD21 HG22 ' A' ' 214' ' ' ILE . 0.2 OUTLIER 1.11 92.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.792 0.806 . . . . 0.0 111.182 -178.216 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.716 ' C ' HG23 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -140.66 134.88 31.06 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.542 -179.787 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 1.079 ' CD2' HG21 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -102.18 142.79 32.87 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.142 178.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.564 ' O ' ' HB ' ' A' ' 57' ' ' ILE . 67.9 tt0 -114.38 121.32 43.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 110.174 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.765 ' HG2' HG22 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -121.23 149.8 42.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.477 -0.764 . . . . 0.0 109.966 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.678 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -127.89 -71.37 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.063 -1.023 . . . . 0.0 110.797 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.678 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 55.8 Cg_endo -73.86 -108.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.35 1.184 . . . . 0.0 110.177 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.44 HG12 ' HZ2' ' A' ' 207' ' ' TRP . 3.9 t -140.48 164.35 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.638 -1.289 . . . . 0.0 110.27 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.408 ' HA ' ' HB3' ' A' ' 56' ' ' ASN . . . -99.63 87.58 3.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -0.867 . . . . 0.0 109.931 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.551 ' HG3' ' N ' ' A' ' 74' ' ' SER . 2.5 pt20 -70.39 -44.58 67.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.258 -0.901 . . . . 0.0 110.642 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.551 ' N ' ' HG3' ' A' ' 73' ' ' GLN . 0.4 OUTLIER -55.84 -74.8 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.161 -0.962 . . . . 0.0 109.969 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.94 HG23 ' HB3' ' A' ' 54' ' ' SER . 0.3 OUTLIER -129.61 -140.37 0.23 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.308 -0.87 . . . . 0.0 109.405 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.666 ' O ' ' N ' ' A' ' 78' ' ' VAL . 22.7 p-10 -141.1 154.75 46.07 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.976 -1.077 . . . . 0.0 110.788 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.675 ' C ' HG13 ' A' ' 78' ' ' VAL . . . 34.78 -95.16 0.01 OUTLIER Glycine 0 N--CA 1.487 2.055 0 N-CA-C 106.715 -2.554 . . . . 0.0 106.715 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.96 ' HA ' ' H ' ' A' ' 54' ' ' SER . 31.0 m -158.2 119.42 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 O-C-N 121.872 -0.781 . . . . 0.0 109.823 176.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.69 ' O ' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -147.32 133.87 19.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.361 -0.837 . . . . 0.0 110.982 -179.147 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.736 ' HA3' ' N ' ' A' ' 52' ' ' ASP . . . -143.36 166.14 26.88 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 178.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.433 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 0.7 OUTLIER -140.2 75.62 1.52 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.345 -1.091 . . . . 0.0 110.078 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.571 ' CD ' ' HZ2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -145.53 -108.73 0.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.312 -0.867 . . . . 0.0 110.128 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.531 ' N ' ' CZ ' ' A' ' 82' ' ' ARG . . . 70.42 80.78 0.28 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -134.24 104.38 6.15 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.285 -1.127 . . . . 0.0 110.21 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.574 ' HB2' ' CE1' ' A' ' 89' ' ' HIS . 11.4 p -140.03 164.87 28.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.153 -0.967 . . . . 0.0 110.255 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.465 ' HA ' ' CG ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -119.75 135.93 54.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.295 -0.878 . . . . 0.0 109.972 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.34 -119.94 5.15 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.488 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 7.8 tp -128.33 138.1 52.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -1.147 . . . . 0.0 110.327 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.969 ' HB2' HD23 ' A' ' 171' ' ' LEU . 43.2 m-70 -147.06 164.81 31.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.273 -0.892 . . . . 0.0 109.992 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.607 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -163.13 152.95 15.55 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.191 -0.943 . . . . 0.0 110.302 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.974 ' CE3' HG11 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -134.62 170.34 15.94 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.079 -1.013 . . . . 0.0 109.891 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.659 ' N ' ' O ' ' A' ' 215' ' ' ARG . 0.6 OUTLIER -140.62 147.54 39.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.368 -0.832 . . . . 0.0 110.672 -179.505 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.861 ' HB ' HD12 ' A' ' 167' ' ' LEU . 2.2 mm -144.68 154.25 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.34 -0.85 . . . . 0.0 110.024 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 1.123 ' O ' HG23 ' A' ' 212' ' ' VAL . 0.0 OUTLIER -151.2 124.38 8.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.338 -0.851 . . . . 0.0 109.614 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 1.069 ' CB ' HD12 ' A' ' 135' ' ' ILE . 34.6 m95 -106.84 89.42 4.32 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.267 -0.896 . . . . 0.0 110.561 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.74 ' HD3' ' O ' ' A' ' 94' ' ' SER . 52.7 Cg_endo -91.92 124.37 0.76 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.496 1.464 . . . . 0.0 111.013 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.593 HD13 ' SG ' ' A' ' 210' ' ' CYS . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.756 0 O-C-N 121.277 -0.889 . . . . 0.0 109.599 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 1.032 HG23 ' HA ' ' A' ' 205' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.499 2.021 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.946 HG11 ' OH ' ' A' ' 180' ' ' TYR . 4.9 p -145.85 167.5 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 120.416 -1.428 . . . . 0.0 111.905 -178.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.687 ' CA ' ' HA3' ' A' ' 132' ' ' GLY . . . 164.57 146.63 4.83 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.075 HG22 ' HB2' ' A' ' 199' ' ' LEU . 7.8 p -94.82 155.19 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.116 -1.226 . . . . 0.0 109.691 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.702 ' C ' ' HB3' ' A' ' 199' ' ' LEU . . . -132.6 149.02 52.37 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.679 -0.809 . . . . 0.0 111.006 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 1.038 ' OG1' HD23 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -106.28 131.05 53.98 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.399 -0.813 . . . . 0.0 109.946 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -84.97 -26.4 27.17 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.444 -0.785 . . . . 0.0 109.418 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.47 -12.14 54.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.419 -0.8 . . . . 0.0 109.352 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.509 ' HB1' ' OE1' ' A' ' 129' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.378 -0.827 . . . . 0.0 110.444 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.282 0.563 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.517 ' O ' ' CA ' ' A' ' 109' ' ' ALA . 5.5 mt-10 -140.58 123.9 16.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.892 . . . . 0.0 110.111 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.482 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 1.9 t -121.06 121.17 37.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.474 -0.766 . . . . 0.0 110.354 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . 0.437 ' CD1' ' O ' ' A' ' 130' ' ' SER . 33.3 m0 -130.94 131.8 44.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.172 -0.955 . . . . 0.0 110.243 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.687 ' HA3' ' CA ' ' A' ' 107' ' ' GLY . . . -172.73 -152.47 8.68 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.963 ' HB3' HG11 ' A' ' 163' ' ' VAL . 43.5 m0 -112.79 113.27 25.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.161 -1.199 . . . . 0.0 111.11 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.819 ' HA ' ' CG1' ' A' ' 105' ' ' VAL . 18.9 m-20 -120.96 148.12 44.53 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.735 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 1.069 HD12 ' CB ' ' A' ' 95' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.049 -1.032 . . . . 0.0 110.454 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.963 HG11 ' HB3' ' A' ' 133' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 119.647 -0.216 . . . . 0.0 111.076 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.785 ' CD ' ' N ' ' A' ' 163' ' ' VAL . 43.4 Cg_endo -72.12 59.3 2.99 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 N-CA-C 109.574 -0.971 . . . . 0.0 109.574 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.523 ' O ' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER 179.91 -76.33 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.361 0.601 . . . . 0.0 109.454 -179.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.544 ' HB2' ' NH1' ' A' ' 166' ' ' ARG . 3.0 ttm105 -152.0 156.17 39.45 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.477 -0.765 . . . . 0.0 110.233 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 1.156 HD22 ' N ' ' A' ' 168' ' ' LEU . 0.0 OUTLIER -159.05 138.63 11.65 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.181 -0.949 . . . . 0.0 110.261 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 1.156 ' N ' HD22 ' A' ' 167' ' ' LEU . 2.9 tt -112.86 121.38 44.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 109.829 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.974 HG11 ' CE3' ' A' ' 91' ' ' TRP . 3.6 t -101.43 146.72 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.956 -1.09 . . . . 0.0 110.759 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.5 t -134.26 108.56 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.502 -0.749 . . . . 0.0 109.667 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.969 HD23 ' HB2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -118.29 121.16 39.74 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.044 -1.035 . . . . 0.0 110.006 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 173' ' ' MET . 46.1 t0 -111.44 137.29 49.42 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.278 -0.889 . . . . 0.0 109.896 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.509 ' N ' ' OD1' ' A' ' 172' ' ' ASP . 2.0 tmt? -95.23 -40.21 9.68 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.6 -0.687 . . . . 0.0 109.931 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.474 ' C ' ' O ' ' A' ' 173' ' ' MET . 0.3 OUTLIER -41.77 -27.81 0.13 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.189 -0.945 . . . . 0.0 108.858 179.209 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.645 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.6 OUTLIER -114.42 -27.32 7.6 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.202 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 83.83 23.88 51.28 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 108.559 -1.816 . . . . 0.0 108.559 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 1.033 HG22 ' CD2' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -113.17 121.71 45.32 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.311 -1.111 . . . . 0.0 111.243 -179.444 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 1.06 ' O ' HD11 ' A' ' 194' ' ' LEU . 0.2 OUTLIER -124.87 151.28 45.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.401 -0.812 . . . . 0.0 109.671 179.03 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -149.31 166.89 29.59 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.946 ' OH ' HG11 ' A' ' 106' ' ' VAL . 0.7 OUTLIER -123.58 117.86 26.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.408 -1.054 . . . . 0.0 108.439 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.563 ' O ' ' CD2' ' A' ' 167' ' ' LEU . 35.2 t -145.66 155.63 43.13 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.971 -1.081 . . . . 0.0 110.724 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.603 HG23 ' CZ3' ' A' ' 133' ' ' TRP . 0.0 OUTLIER -95.7 116.3 37.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.453 -0.779 . . . . 0.0 108.941 178.554 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 64.42 9.65 38.26 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.26 42.97 33.56 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 3.5 m -121.99 -2.43 9.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.17 -1.194 . . . . 0.0 110.705 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.607 ' CD2' ' CZ2' ' A' ' 133' ' ' TRP . 0.1 OUTLIER -101.28 -71.12 0.72 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.193 -0.942 . . . . 0.0 110.413 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.752 HD23 ' O ' ' A' ' 180' ' ' TYR . 3.9 mm? -67.0 47.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 110.258 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 186' ' ' TYR . . . -71.23 -73.4 0.8 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.416 ' C ' ' H ' ' A' ' 191' ' ' PHE . 49.7 Cg_endo -75.29 -25.48 11.39 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.922 1.486 . . . . 0.0 111.145 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.6 ' HB3' HD13 ' A' ' 187' ' ' LEU . . . -68.31 23.79 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.448 -0.783 . . . . 0.0 112.2 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.601 ' CD2' ' O ' ' A' ' 187' ' ' LEU . 2.1 m-85 -90.43 -38.68 13.12 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.66 -1.275 . . . . 0.0 110.536 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -13.61 61.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.198 -0.938 . . . . 0.0 110.162 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -106.43 -8.95 32.22 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.104 -1.999 . . . . 0.0 108.104 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 1.06 HD11 ' O ' ' A' ' 178' ' ' LEU . 8.7 tt -73.1 -42.59 62.8 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.892 -0.77 . . . . 0.0 109.071 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.521 ' HA ' HG23 ' A' ' 177' ' ' THR . 0.0 OUTLIER -45.27 -42.48 9.63 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.472 -0.767 . . . . 0.0 110.012 179.755 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.457 ' N ' ' HD2' ' A' ' 195' ' ' LYS . . . -85.06 -23.75 47.56 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.839 ' HD3' HD11 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -91.04 -4.47 56.33 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.693 -0.886 . . . . 0.0 110.082 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . 0.787 HG23 ' O ' ' A' ' 194' ' ' LEU . 24.5 p -44.56 129.49 6.78 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 121.471 0.653 . . . . 0.0 111.742 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 1.075 ' HB2' HG22 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -140.39 171.82 13.61 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.482 -0.761 . . . . 0.0 109.849 179.49 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 1.014 ' C ' HG23 ' A' ' 108' ' ' VAL . 3.8 m-85 -83.9 129.55 58.6 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.012 -1.055 . . . . 0.0 109.963 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.638 ' HG3' HD13 ' A' ' 171' ' ' LEU . 49.6 Cg_endo -76.18 124.86 8.15 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 124.055 1.555 . . . . 0.0 111.787 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 80' ' ' GLY . 52.1 m -133.68 160.42 37.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.443 -0.786 . . . . 0.0 109.282 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.631 HG12 ' O ' ' A' ' 52' ' ' ASP . 1.1 t -119.42 162.41 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.835 -1.166 . . . . 0.0 110.608 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . 0.645 ' O ' ' N ' ' A' ' 105' ' ' VAL . 1.6 m -160.68 138.44 9.55 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 1.032 ' HA ' HG23 ' A' ' 105' ' ' VAL . . . -144.77 129.13 17.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.753 -1.217 . . . . 0.0 111.582 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.498 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 1.0 OUTLIER -38.56 160.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-O 121.178 0.514 . . . . 0.0 110.135 178.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 0.44 ' HZ2' HG12 ' A' ' 71' ' ' VAL . 0.9 OUTLIER -50.68 -43.73 57.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.172 -0.955 . . . . 0.0 109.584 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.441 ' N ' HG12 ' A' ' 206' ' ' VAL . . . 170.73 134.75 1.8 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -164.61 -63.28 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -1.133 . . . . 0.0 110.559 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . 0.593 ' SG ' HD13 ' A' ' 97' ' ' LEU . 0.5 OUTLIER -136.29 85.55 2.16 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.339 -0.851 . . . . 0.0 110.623 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.544 ' C ' ' O ' ' A' ' 210' ' ' CYS . 1.0 OUTLIER -26.59 126.54 0.06 Allowed 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 122.233 1.016 . . . . 0.0 111.608 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 1.123 HG23 ' O ' ' A' ' 94' ' ' SER . 0.7 OUTLIER -113.16 143.78 22.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.064 179.119 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . 0.928 ' HA ' HD22 ' A' ' 64' ' ' LEU . 40.5 mtm180 -88.65 144.4 26.32 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.024 -1.048 . . . . 0.0 111.104 -178.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.932 HG22 HD21 ' A' ' 64' ' ' LEU . 4.2 tt -144.59 139.51 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.507 -0.745 . . . . 0.0 110.446 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.659 ' O ' ' N ' ' A' ' 92' ' ' GLU . 4.2 mtt180 -130.41 109.18 10.53 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . 0.715 ' CZ ' ' CD1' ' A' ' 91' ' ' TRP . 4.3 t80 -117.33 140.37 49.65 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.945 -1.097 . . . . 0.0 111.588 -178.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -136.68 114.98 11.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.818 -0.551 . . . . 0.0 109.996 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 123.38 17.98 3.14 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.521 ' HG3' ' NH1' ' A' ' 82' ' ' ARG . 4.9 tt0 . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.236 -1.155 . . . . 0.0 110.142 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.487 ' HG ' ' N ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.313 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.487 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 3.5 tt0 -55.02 -43.86 74.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.223 -0.923 . . . . 0.0 109.117 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -52.35 -24.46 7.64 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.489 HD22 ' HA ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -83.11 -32.23 26.83 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.838 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.03 HD12 ' C ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -85.44 -38.55 18.53 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.759 0.79 . . . . 0.0 109.313 179.211 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.629 ' N ' HD12 ' A' ' 33' ' ' LEU . 37.6 t -45.85 -25.51 0.53 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.449 0.642 . . . . 0.0 109.817 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.903 ' HB1' ' CD ' ' A' ' 36' ' ' PRO . . . -80.68 -164.54 0.05 OUTLIER Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 121.634 -0.666 . . . . 0.0 109.623 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.903 ' CD ' ' HB1' ' A' ' 35' ' ' ALA . 53.2 Cg_endo -95.95 74.61 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.679 1.586 . . . . 0.0 110.96 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.708 ' HD3' ' O ' ' A' ' 35' ' ' ALA . 44.4 Cg_endo -69.29 157.28 61.88 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.458 1.241 . . . . 0.0 110.323 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.735 ' O ' ' N ' ' A' ' 40' ' ' LEU . 50.0 Cg_endo -79.92 152.33 21.88 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 124.103 1.58 . . . . 0.0 111.716 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.719 ' O ' ' CG ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER 4.13 60.35 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 122.845 1.307 . . . . 0.0 110.792 -179.288 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.92 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -144.63 -45.3 0.24 Allowed 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.144 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.826 ' N ' HD13 ' A' ' 40' ' ' LEU . 2.1 t -86.85 -35.1 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 119.076 -1.049 . . . . 0.0 108.575 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.527 ' O ' ' CB ' ' A' ' 46' ' ' HIS . . . -88.55 -36.53 16.32 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.462 -0.774 . . . . 0.0 110.183 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.679 ' HG3' ' HB2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -76.42 -22.98 53.99 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.414 -0.804 . . . . 0.0 110.469 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.706 ' HA ' HG22 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -84.45 -47.58 10.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.233 -0.917 . . . . 0.0 109.965 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.663 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 40.6 m-70 -73.35 -16.43 61.35 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.535 -0.728 . . . . 0.0 109.424 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.527 ' CB ' ' O ' ' A' ' 42' ' ' ALA . 3.2 t60 -96.7 -31.02 12.89 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.639 0.733 . . . . 0.0 109.085 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 46' ' ' HIS . . . -61.08 -115.47 0.01 OUTLIER Glycine 0 N--CA 1.479 1.534 0 N-CA-C 108.114 -1.995 . . . . 0.0 108.114 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.888 ' CA ' HD13 ' A' ' 214' ' ' ILE . 6.4 p-90 -103.31 71.3 1.1 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.573 -1.251 . . . . 0.0 111.194 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.627 ' ND2' ' HB3' ' A' ' 53' ' ' CYS . 0.9 OUTLIER -108.93 114.57 58.24 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 120.873 -1.142 . . . . 0.0 110.183 178.397 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.618 ' HG2' ' CA ' ' A' ' 80' ' ' GLY . 39.1 Cg_endo -67.35 -63.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.767 0 N-CA-C 109.323 -1.068 . . . . 0.0 109.323 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.964 ' HA ' ' CE ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER 176.02 31.48 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.781 -1.2 . . . . 0.0 112.912 177.423 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.875 ' HB3' ' HG2' ' A' ' 79' ' ' ARG 0.256 0.2 OUTLIER -162.22 19.72 0.1 Allowed 'General case' 0 C--N 1.265 -3.087 0 CA-C-O 122.16 0.981 . . . . 0.0 109.134 -179.207 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.627 ' HB3' ' ND2' ' A' ' 49' ' ' ASN . 18.9 t -102.29 128.64 48.76 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-O 122.336 1.065 . . . . 0.0 111.203 -177.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.623 ' CB ' HD21 ' A' ' 56' ' ' ASN . 0.1 OUTLIER -91.86 166.72 12.59 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.894 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.915 ' OE2' HD13 ' A' ' 33' ' ' LEU . 1.7 pm0 -75.98 6.25 5.46 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.619 -0.675 . . . . 0.0 110.846 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.623 HD21 ' CB ' ' A' ' 54' ' ' SER . 0.1 OUTLIER -28.33 -33.37 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.182 0 CA-C-O 122.065 0.936 . . . . 0.0 109.882 179.256 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.713 ' HB ' ' HG2' ' A' ' 68' ' ' ARG . 0.4 OUTLIER -134.64 169.02 22.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.863 -0.523 . . . . 0.0 109.724 -178.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.548 ' O ' ' HB3' ' A' ' 67' ' ' GLU . 3.4 t70 -107.53 106.93 17.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.821 -1.174 . . . . 0.0 111.034 -178.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.715 HG11 ' CZ2' ' A' ' 48' ' ' TRP . 2.1 m -122.62 135.54 62.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.679 ' HB2' ' HG3' ' A' ' 43' ' ' GLN . 11.1 ttpp -127.42 155.41 43.7 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.632 -1.293 . . . . 0.0 112.09 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.584 ' HA ' HD13 ' A' ' 64' ' ' LEU . 19.0 tt0 -65.17 -128.89 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.741 -0.599 . . . . 0.0 110.397 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 41.05 47.02 4.21 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.679 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 102.76 50.59 1.08 Allowed Glycine 0 N--CA 1.486 2.017 0 N-CA-C 107.904 -2.078 . . . . 0.0 107.904 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.901 HD22 ' H ' ' A' ' 64' ' ' LEU . 2.3 mm? 1.14 81.35 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.763 0.792 . . . . 0.0 110.806 -178.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.413 ' N ' ' O ' ' A' ' 63' ' ' GLY . 6.3 t -99.29 114.96 28.08 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.686 -0.634 . . . . 0.0 109.976 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.864 ' CE1' ' CE2' ' A' ' 48' ' ' TRP . 1.9 m-85 -82.83 129.9 35.06 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.461 -0.774 . . . . 0.0 109.539 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.548 ' HB3' ' O ' ' A' ' 58' ' ' ASP . 1.2 tm-20 -137.37 121.58 18.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.868 -1.145 . . . . 0.0 110.339 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.748 ' HD3' ' HB3' ' A' ' 207' ' ' TRP . 9.2 mtp180 -115.57 154.76 28.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 0.0 109.55 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.681 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 16.5 ttt85 -95.72 -69.08 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 120.956 -1.09 . . . . 0.0 109.859 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.681 ' HD3' ' HB3' ' A' ' 69' ' ' ARG . 57.6 Cg_endo -77.48 -123.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 N-CA-C 108.713 -1.303 . . . . 0.0 108.713 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 73' ' ' GLN . 2.6 t -140.07 164.33 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.52 -1.363 . . . . 0.0 109.589 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.968 ' HB2' ' CZ3' ' A' ' 207' ' ' TRP . . . -41.66 92.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.176 -0.953 . . . . 0.0 110.314 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.552 ' N ' ' O ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -179.97 -31.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.221 -0.924 . . . . 0.0 110.294 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.463 ' C ' ' O ' ' A' ' 73' ' ' GLN . 10.4 p -40.12 -50.61 2.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.343 -0.848 . . . . 0.0 110.228 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.607 HG22 ' N ' ' A' ' 76' ' ' ASP . 7.5 m -169.03 -84.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.269 -0.894 . . . . 0.0 110.031 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.623 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 66.2 t0 -140.13 113.19 8.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.221 -0.924 . . . . 0.0 110.36 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.533 ' O ' ' O ' ' A' ' 76' ' ' ASP . . . -42.59 -91.41 0.01 OUTLIER Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.046 -2.022 . . . . 0.0 108.046 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.964 HG13 ' O ' ' A' ' 205' ' ' ALA . 0.3 OUTLIER -144.15 139.39 24.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.123 -1.222 . . . . 0.0 109.88 179.302 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.875 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 29.3 ttp180 -145.65 148.08 32.69 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.844 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.709 ' CA ' ' HB2' ' A' ' 52' ' ' ASP . . . -136.99 124.6 3.15 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.511 ' HB3' ' OD1' ' A' ' 52' ' ' ASP . 6.1 ttpm? -134.26 -71.38 0.5 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.855 -1.379 . . . . 0.0 111.74 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.559 ' CZ ' ' NZ ' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -58.32 -93.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.19 -0.944 . . . . 0.0 110.799 -178.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.427 ' HA2' ' HG3' ' A' ' 51' ' ' LYS . . . 51.13 70.04 0.97 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.679 -1.769 . . . . 0.0 108.679 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.575 ' C ' ' CD1' ' A' ' 84' ' ' TYR . 1.0 OUTLIER -94.57 142.16 27.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.341 -1.094 . . . . 0.0 110.495 -179.308 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.58 ' HB3' ' CE1' ' A' ' 89' ' ' HIS . 1.4 m -135.87 174.34 10.73 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.548 -0.72 . . . . 0.0 109.886 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.579 ' O ' ' CE1' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -126.62 138.51 53.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.18 -0.95 . . . . 0.0 110.7 -179.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.486 ' N ' ' HB3' ' A' ' 173' ' ' MET . . . 92.15 -119.46 5.8 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.743 HD12 ' OD2' ' A' ' 172' ' ' ASP . 4.5 tt -128.74 139.63 52.11 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.676 -0.896 . . . . 0.0 110.123 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.58 ' CE1' ' HB3' ' A' ' 85' ' ' SER . 18.3 m-70 -147.23 162.38 39.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.162 -0.961 . . . . 0.0 110.186 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 217' ' ' MET . . . -160.65 138.66 9.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.219 -0.926 . . . . 0.0 109.949 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 1.098 ' CZ2' HG11 ' A' ' 169' ' ' VAL . 1.3 p90 -134.89 170.75 15.39 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.242 -0.911 . . . . 0.0 110.36 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.608 ' N ' ' O ' ' A' ' 215' ' ' ARG . 38.1 mt-10 -141.82 152.58 43.82 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.637 -0.664 . . . . 0.0 110.497 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.755 HG23 ' O ' ' A' ' 213' ' ' ARG . 10.1 mt -144.48 154.2 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.902 . . . . 0.0 110.57 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.564 ' OG ' ' HB2' ' A' ' 213' ' ' ARG . 1.2 m -119.35 133.5 55.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.354 -0.841 . . . . 0.0 109.469 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.936 ' CH2' HG13 ' A' ' 105' ' ' VAL 0.261 2.3 t-105 -136.52 88.12 20.46 Favored Pre-proline 0 C--N 1.297 -1.697 0 O-C-N 121.441 -0.787 . . . . 0.0 110.332 -178.759 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.564 ' HD2' ' O ' ' A' ' 211' ' ' GLN . 51.7 Cg_endo -91.99 107.02 0.24 Allowed 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.095 1.05 . . . . 0.0 110.682 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.615 ' HB2' ' HG2' ' A' ' 164' ' ' PRO . 5.6 tt . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.09 -1.006 . . . . 0.0 109.934 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 1.079 HG22 ' O ' ' A' ' 204' ' ' SER . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 1.102 ' CG2' HG23 ' A' ' 203' ' ' VAL . 34.3 t -148.76 169.15 2.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.156 -0.965 . . . . 0.0 110.267 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.709 ' HA2' ' HA3' ' A' ' 132' ' ' GLY . . . -175.35 131.41 1.93 Allowed Glycine 0 N--CA 1.483 1.797 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.136 ' CG1' HD13 ' A' ' 199' ' ' LEU . 0.3 OUTLIER -102.41 143.41 14.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.618 -0.93 . . . . 0.0 109.628 -179.569 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.534 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -109.79 129.76 55.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.128 -0.982 . . . . 0.0 110.704 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.913 HG23 ' CG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -110.55 131.74 54.79 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.309 -0.869 . . . . 0.0 110.065 179.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -91.25 -27.13 18.64 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.502 0.668 . . . . 0.0 109.238 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.426 ' CD2' ' O ' ' A' ' 196' ' ' GLY . 1.8 pp -82.15 -12.59 58.08 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.505 -0.747 . . . . 0.0 109.492 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.631 ' HB2' ' HB ' ' A' ' 110' ' ' THR . . . . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.404 -0.81 . . . . 0.0 110.091 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.1 p . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.29 0.567 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.492 ' HB3' ' CB ' ' A' ' 113' ' ' ALA . 21.6 tt0 -150.11 131.08 14.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.225 -0.922 . . . . 0.0 109.874 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.4 t -120.41 119.6 33.54 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.195 -0.941 . . . . 0.0 110.503 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -133.47 141.99 48.06 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.471 -0.768 . . . . 0.0 109.192 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.709 ' HA3' ' HA2' ' A' ' 107' ' ' GLY . . . -173.27 -138.92 2.74 Favored Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.336 -1.411 . . . . 0.0 110.652 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.825 ' CH2' HG23 ' A' ' 182' ' ' ILE . 45.9 m0 -113.11 118.18 34.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.392 -1.063 . . . . 0.0 110.611 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.734 ' O ' HG23 ' A' ' 135' ' ' ILE . 4.2 p30 -118.06 126.5 52.41 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.359 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.734 HG23 ' O ' ' A' ' 134' ' ' ASP . 7.3 pt . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.338 -0.851 . . . . 0.0 110.055 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.868 ' N ' ' HD3' ' A' ' 164' ' ' PRO . 4.0 p . . . . . 0 N--CA 1.485 1.302 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.868 ' HD3' ' N ' ' A' ' 163' ' ' VAL . 55.2 Cg_endo -93.78 152.08 2.28 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.609 1.32 . . . . 0.0 111.22 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.553 ' O ' ' HA ' ' A' ' 94' ' ' SER . 5.7 tp10 178.83 -70.33 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.412 -0.805 . . . . 0.0 109.663 178.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -147.88 141.47 25.49 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.579 -0.7 . . . . 0.0 109.378 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.874 ' O ' HD12 ' A' ' 167' ' ' LEU . 0.5 OUTLIER -162.52 157.14 21.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.128 -0.982 . . . . 0.0 110.455 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.772 ' C ' HD23 ' A' ' 168' ' ' LEU . 6.5 tt -120.68 134.8 55.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.332 -0.855 . . . . 0.0 110.15 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 1.098 HG11 ' CZ2' ' A' ' 91' ' ' TRP . 94.1 t -109.97 128.62 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.272 -0.893 . . . . 0.0 110.412 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 4.7 t -103.75 110.47 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.343 -0.848 . . . . 0.0 109.815 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.754 HD13 HD22 ' A' ' 178' ' ' LEU . 13.7 tp -121.5 106.06 11.05 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.18 -0.95 . . . . 0.0 109.983 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.743 ' OD2' HD12 ' A' ' 88' ' ' LEU . 5.5 t70 -111.43 136.8 50.06 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.283 -0.885 . . . . 0.0 110.477 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.538 ' CE ' ' CE2' ' A' ' 84' ' ' TYR . 12.5 tpp -92.3 -40.07 11.14 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 120.412 -0.515 . . . . 0.0 109.702 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 173' ' ' MET . 15.2 tt0 -41.95 -28.89 0.19 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.279 -0.888 . . . . 0.0 108.91 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.512 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.0 OUTLIER -109.4 -25.83 10.32 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.443 ' O ' ' OG1' ' A' ' 198' ' ' THR . . . 78.96 24.63 61.48 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.881 ' HB ' HD22 ' A' ' 194' ' ' LEU . 1.1 p -125.38 148.74 48.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.206 -1.173 . . . . 0.0 111.112 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 1.002 HD13 ' HG3' ' A' ' 201' ' ' PRO . 0.4 OUTLIER -148.1 154.33 40.06 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.525 -0.734 . . . . 0.0 109.952 179.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -149.25 164.68 29.34 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.745 ' CD1' HG22 ' A' ' 169' ' ' VAL . 0.4 OUTLIER -118.86 121.88 41.03 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.14 -1.212 . . . . 0.0 109.859 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.695 ' HB2' HD22 ' A' ' 187' ' ' LEU . 11.4 t -113.01 124.5 52.78 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.371 -0.83 . . . . 0.0 110.078 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.825 HG23 ' CH2' ' A' ' 133' ' ' TRP . 0.0 OUTLIER -104.21 116.82 48.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.594 -0.691 . . . . 0.0 109.715 179.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 72.93 4.59 62.84 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.174 -1.571 . . . . 0.0 109.174 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 68.65 47.49 55.97 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . 0.576 HG22 ' CE1' ' A' ' 186' ' ' TYR . 46.3 m -137.07 -27.09 1.0 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -1.173 . . . . 0.0 110.802 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.576 ' CE1' HG22 ' A' ' 185' ' ' THR . 21.8 m-85 -116.8 76.55 1.04 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.949 -1.095 . . . . 0.0 110.676 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.695 HD22 ' HB2' ' A' ' 181' ' ' SER . 0.6 OUTLIER 179.7 29.41 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.529 0.68 . . . . 0.0 109.196 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.638 ' H ' ' HD2' ' A' ' 189' ' ' PRO . . . -105.48 -62.01 0.63 Allowed Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.915 -1.136 . . . . 0.0 111.447 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.638 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 43.5 Cg_endo -70.24 -31.6 18.12 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.685 1.361 . . . . 0.0 111.791 -178.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.621 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -71.83 9.2 0.95 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.077 -1.014 . . . . 0.0 111.367 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.568 ' CE1' ' HG ' ' A' ' 187' ' ' LEU . 1.4 m-85 -90.53 -10.78 42.28 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.278 -0.889 . . . . 0.0 110.161 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . 0.474 ' HA ' ' NE ' ' A' ' 192' ' ' ARG . 0.2 OUTLIER -90.12 -15.21 32.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.353 -0.842 . . . . 0.0 110.191 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 197' ' ' ARG . . . -112.07 -17.01 8.62 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.018 -2.033 . . . . 0.0 108.018 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.963 HD23 ' O ' ' A' ' 194' ' ' LEU . 3.8 tt -65.52 -26.31 67.84 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.831 -0.805 . . . . 0.0 109.134 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.582 ' HA ' HG21 ' A' ' 177' ' ' THR . 0.0 OUTLIER -54.51 -26.25 30.51 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.599 -0.688 . . . . 0.0 109.773 179.242 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.426 ' O ' ' CD2' ' A' ' 112' ' ' LEU . . . -118.87 -17.62 5.0 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.762 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.32 -3.96 57.43 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.459 -1.024 . . . . 0.0 110.322 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . 0.812 ' HB ' HG22 ' A' ' 177' ' ' THR . 0.5 OUTLIER -42.1 132.3 3.28 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 122.325 1.059 . . . . 0.0 112.052 -178.094 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 1.136 HD13 ' CG1' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -142.61 171.32 14.21 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.431 178.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.621 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 2.6 m-85 -84.89 128.43 60.6 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 120.814 -1.179 . . . . 0.0 109.817 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 1.002 ' HG3' HD13 ' A' ' 178' ' ' LEU . 55.7 Cg_endo -87.43 142.33 6.04 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 124.022 1.538 . . . . 0.0 112.4 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 43.1 m -133.91 134.92 43.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.677 -0.639 . . . . 0.0 109.5 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 1.102 HG23 ' CG2' ' A' ' 106' ' ' VAL . 4.0 p -119.5 161.31 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.811 -1.181 . . . . 0.0 110.335 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . 1.079 ' O ' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -160.51 161.48 32.77 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.971 0.891 . . . . 0.0 110.822 179.687 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.964 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -150.65 165.92 31.93 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 121.956 0.884 . . . . 0.0 110.868 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 1.116 HG22 ' CE3' ' A' ' 207' ' ' TRP . 0.3 OUTLIER -98.79 -152.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.037 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 1.116 ' CE3' HG22 ' A' ' 206' ' ' VAL . 48.7 p90 -91.07 -140.66 0.17 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.123 -0.986 . . . . 0.0 110.415 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.526 ' O ' ' NE2' ' A' ' 211' ' ' GLN . . . -65.91 0.29 6.06 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.792 ' HB3' HG11 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -66.09 -28.26 68.69 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.287 -1.125 . . . . 0.0 110.407 -179.818 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . 0.904 ' SG ' HG12 ' A' ' 206' ' ' VAL . 22.9 p -145.52 14.9 1.43 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 110.853 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.671 ' C ' ' O ' ' A' ' 210' ' ' CYS . 0.0 OUTLIER -6.04 117.74 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.655 0.741 . . . . 0.0 111.466 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.67 HG13 ' CZ ' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -121.88 144.77 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.76 -0.588 . . . . 0.0 109.985 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . 0.755 ' O ' HG23 ' A' ' 93' ' ' ILE . 0.8 OUTLIER -88.07 171.8 10.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.217 -0.927 . . . . 0.0 110.229 -179.482 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.888 HD13 ' CA ' ' A' ' 48' ' ' TRP . 0.7 OUTLIER -143.36 118.53 4.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-O 122.013 0.911 . . . . 0.0 111.805 -178.346 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.608 ' O ' ' N ' ' A' ' 92' ' ' GLU . 66.4 mtt-85 -130.62 108.91 10.26 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . 0.651 ' CE2' ' HB3' ' A' ' 91' ' ' TRP . 3.2 t80 -105.82 149.3 26.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.094 -1.004 . . . . 0.0 111.094 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . 0.465 ' O ' ' O ' ' A' ' 90' ' ' ALA . 1.0 OUTLIER -131.5 121.05 23.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.48 -0.762 . . . . 0.0 110.154 179.745 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 132.58 -32.82 2.74 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.236 -1.155 . . . . 0.0 110.226 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.935 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.091 0.472 . . . . 0.0 110.08 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.855 ' HA ' HD23 ' A' ' 33' ' ' LEU . 24.8 pt-20 -47.06 -35.12 6.51 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.304 -0.872 . . . . 0.0 109.579 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.49 ' N ' ' HG3' ' A' ' 30' ' ' GLU . 1.1 tm-20 -63.91 -23.51 67.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.446 -0.784 . . . . 0.0 108.992 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.647 HD13 ' O ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -83.29 -33.88 25.86 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.855 HD23 ' HA ' ' A' ' 30' ' ' GLU . 0.3 OUTLIER -73.55 -35.98 65.59 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 122.058 0.933 . . . . 0.0 108.917 179.293 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.649 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 23.5 t -71.24 -12.57 61.53 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.605 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 1.01 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -45.31 -64.97 0.72 Allowed Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.19 -0.944 . . . . 0.0 110.268 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 1.01 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 50.0 Cg_endo -72.8 147.8 45.15 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.75 1.395 . . . . 0.0 110.15 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.494 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 54.7 Cg_endo -99.3 42.84 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.001 1.801 . . . . 0.0 112.912 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.76 ' HD3' ' HB2' ' A' ' 36' ' ' PRO . 50.8 Cg_endo -76.23 151.13 33.83 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 122.908 0.951 . . . . 0.0 110.303 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.712 ' O ' ' HB3' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -28.62 -36.08 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.587 -0.696 . . . . 0.0 110.659 179.676 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.973 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -49.91 -48.52 51.6 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.786 -1.197 . . . . 0.0 110.501 -179.605 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.953 HG23 ' CD1' ' A' ' 40' ' ' LEU . 41.1 t -83.93 -32.55 8.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 121.161 -0.962 . . . . 0.0 110.296 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 46' ' ' HIS . . . -89.72 -41.13 12.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.092 -1.005 . . . . 0.0 111.731 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.712 ' HB3' ' O ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -78.46 -20.54 50.73 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.095 -1.003 . . . . 0.0 110.39 -179.215 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.718 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 7.6 tpt180 -76.42 -55.02 5.93 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.626 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 38.3 m-70 -65.73 -17.19 64.44 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.544 ' HB2' ' O ' ' A' ' 42' ' ' ALA . 74.1 t60 -96.77 -17.15 20.44 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.697 0.76 . . . . 0.0 109.355 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.97 -112.3 0.12 Allowed Glycine 0 N--CA 1.477 1.367 0 N-CA-C 108.156 -1.977 . . . . 0.0 108.156 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 1.176 ' CZ2' HD22 ' A' ' 64' ' ' LEU . 4.6 m95 -102.97 70.93 1.11 Allowed 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.849 -1.14 . . . . 0.0 110.844 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.674 ' ND2' ' HB3' ' A' ' 53' ' ' CYS . 0.9 OUTLIER -108.41 111.97 61.22 Favored Pre-proline 0 C--N 1.302 -1.491 0 O-C-N 121.139 -0.976 . . . . 0.0 109.694 178.017 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.826 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 40.9 Cg_endo -68.03 -63.68 0.05 OUTLIER 'Trans proline' 0 C--N 1.301 -1.949 0 O-C-N 123.291 1.153 . . . . 0.0 109.764 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 1.123 ' HA ' ' CE ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER 176.07 36.98 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 122.502 1.144 . . . . 0.0 111.561 178.059 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.769 ' HB3' ' HG2' ' A' ' 79' ' ' ARG 0.255 0.7 OUTLIER -169.8 23.23 0.02 OUTLIER 'General case' 0 C--N 1.269 -2.921 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.331 -179.385 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.674 ' HB3' ' ND2' ' A' ' 49' ' ' ASN . 8.3 t -101.27 127.42 47.88 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-O 122.523 1.154 . . . . 0.0 111.337 -177.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.569 ' CB ' HD21 ' A' ' 56' ' ' ASN . 0.6 OUTLIER -90.11 166.23 13.52 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.337 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.814 ' HG3' HD11 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -74.45 1.97 10.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.693 -0.629 . . . . 0.0 110.981 -179.146 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.591 ' ND2' ' O ' ' A' ' 76' ' ' ASP . 0.0 OUTLIER -31.64 -32.63 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.642 0.734 . . . . 0.0 109.833 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.69 HD11 ' NH2' ' A' ' 44' ' ' ARG . 4.6 pt -136.34 166.39 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.562 -0.711 . . . . 0.0 110.41 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.92 ' HB2' HD23 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -109.21 121.59 45.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 110.458 -179.263 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.71 HG11 ' HD1' ' A' ' 48' ' ' TRP . 58.4 t -130.32 132.69 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.287 -0.883 . . . . 0.0 110.21 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.664 ' HB2' ' HG3' ' A' ' 43' ' ' GLN . 3.1 ttpt -135.26 155.07 51.25 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.218 -0.926 . . . . 0.0 110.397 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 63' ' ' GLY . 4.2 tt0 -74.87 -118.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.351 -0.843 . . . . 0.0 110.203 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 42.08 28.81 0.53 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.674 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 129.65 60.55 0.1 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.176 HD22 ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER 0.44 84.83 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.751 -0.852 . . . . 0.0 111.172 -179.716 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 31.5 t -126.65 114.82 18.54 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.162 -0.961 . . . . 0.0 111.005 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.596 ' HA ' HG13 ' A' ' 59' ' ' VAL . 3.6 m-85 -90.23 124.72 35.1 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.576 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 3.4 tt0 -125.37 147.53 49.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.737 -1.227 . . . . 0.0 110.516 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.574 ' HB3' ' CG2' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -136.09 115.68 12.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.434 -0.791 . . . . 0.0 109.777 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.65 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -68.94 -65.99 1.12 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.024 -1.048 . . . . 0.0 110.255 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.65 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 56.1 Cg_endo -70.49 -143.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.924 1.487 . . . . 0.0 109.354 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.556 HG13 ' CH2' ' A' ' 207' ' ' TRP . 3.5 t -139.6 164.11 24.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 O-C-N 121.319 -0.863 . . . . 0.0 109.965 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.839 ' HB2' ' CD1' ' A' ' 207' ' ' TRP . . . -66.92 59.25 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 0.0 110.113 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.484 ' N ' ' O ' ' A' ' 71' ' ' VAL . 4.7 mt-30 -53.38 -92.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.181 -0.949 . . . . 0.0 110.378 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.71 27.86 1.48 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.93 . . . . 0.0 110.367 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.462 ' CG2' ' OE1' ' A' ' 30' ' ' GLU . 1.4 m -103.5 -134.19 0.32 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.19 -0.944 . . . . 0.0 109.761 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.591 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 22.8 t70 -140.67 113.14 8.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 110.363 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.554 ' O ' ' ND2' ' A' ' 56' ' ' ASN . . . -51.44 -90.96 0.01 OUTLIER Glycine 0 N--CA 1.488 2.105 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 178.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.993 ' CG1' ' HB3' ' A' ' 205' ' ' ALA . 0.1 OUTLIER -132.29 134.68 59.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.296 -1.12 . . . . 0.0 109.181 178.405 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.769 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 45.1 ttp180 -146.13 161.99 38.95 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.813 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.742 ' HA2' ' HB2' ' A' ' 52' ' ' ASP . . . -152.94 117.04 0.78 Allowed Glycine 0 N--CA 1.495 2.62 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.505 ' HG3' ' HB3' ' A' ' 202' ' ' SER . 2.5 ttmp? -155.75 -117.26 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.959 -1.318 . . . . 0.0 111.262 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.677 ' HD3' ' H ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -48.53 -17.19 0.14 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.336 -0.853 . . . . 0.0 111.481 -179.131 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.677 ' H ' ' HD3' ' A' ' 82' ' ' ARG . . . -77.5 36.24 1.58 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.45 ' OH ' ' NE1' ' A' ' 91' ' ' TRP . 0.6 OUTLIER -111.49 156.61 21.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.105 -1.233 . . . . 0.0 110.405 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.29 177.83 5.08 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.443 -0.786 . . . . 0.0 110.667 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.557 ' HA ' ' CB ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -99.45 -173.47 2.48 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.394 -0.816 . . . . 0.0 110.024 -179.669 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.48 160.65 28.04 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.647 ' O ' HD23 ' A' ' 88' ' ' LEU . 7.8 tt -87.66 114.22 24.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.172 -1.193 . . . . 0.0 110.479 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -147.41 173.22 12.84 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.378 -0.826 . . . . 0.0 109.935 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.562 ' O ' ' O ' ' A' ' 217' ' ' MET . . . -151.63 148.85 28.46 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.149 -0.969 . . . . 0.0 109.79 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.896 ' CZ3' HG11 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -134.75 161.33 35.48 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.846 -1.159 . . . . 0.0 110.216 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.802 ' C ' HD12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -109.47 124.84 51.72 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.515 179.642 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.802 HD12 ' C ' ' A' ' 92' ' ' GLU . 1.6 mp -126.14 154.31 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.14 -0.975 . . . . 0.0 110.385 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.699 ' O ' HG23 ' A' ' 212' ' ' VAL . 0.0 OUTLIER -135.52 119.85 17.89 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.541 -0.724 . . . . 0.0 109.415 179.667 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 1.029 ' CE3' HG21 ' A' ' 212' ' ' VAL . 2.3 t-105 -128.61 89.14 50.21 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.106 -0.997 . . . . 0.0 110.87 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.601 ' HG2' ' HB3' ' A' ' 211' ' ' GLN . 50.5 Cg_endo -88.06 115.09 0.91 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.097 1.578 . . . . 0.0 110.277 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.608 HD23 HG13 ' A' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.049 -1.032 . . . . 0.0 110.311 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.797 HG13 ' O ' ' A' ' 204' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 121.447 0.641 . . . . 0.0 111.88 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.674 HG22 ' CD2' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -151.53 118.82 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.555 -0.715 . . . . 0.0 109.521 178.286 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 132' ' ' GLY . . . 161.62 -154.34 25.3 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 118.887 -1.625 . . . . 0.0 110.725 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.88 HG13 ' C ' ' A' ' 200' ' ' TYR . 58.2 t -138.77 157.92 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.687 -0.89 . . . . 0.0 109.785 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.547 ' O ' ' N ' ' A' ' 200' ' ' TYR . . . -133.93 153.38 51.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.043 -1.036 . . . . 0.0 110.436 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 1.073 HG23 ' HB3' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -101.08 128.28 47.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.234 -0.917 . . . . 0.0 109.817 179.618 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.21 -27.76 17.46 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.509 -0.744 . . . . 0.0 109.588 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.444 ' O ' ' C ' ' A' ' 113' ' ' ALA . 0.8 OUTLIER -81.7 -12.54 58.6 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.411 -0.806 . . . . 0.0 109.57 179.312 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.554 ' CB ' ' HB2' ' A' ' 129' ' ' GLU . . . . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.515 -0.741 . . . . 0.0 110.263 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.26 0.553 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.554 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . 0.3 OUTLIER -150.0 129.9 13.38 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 110.107 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.54 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 47.8 t -120.36 119.94 34.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.332 -0.855 . . . . 0.0 110.181 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . 0.48 ' O ' ' O ' ' A' ' 108' ' ' VAL . 0.8 OUTLIER -129.69 124.74 34.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.374 -0.829 . . . . 0.0 109.906 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 107' ' ' GLY . . . 174.92 -133.23 2.4 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.701 ' CE3' HG11 ' A' ' 163' ' ' VAL . 54.8 m0 -110.68 113.65 26.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.122 -1.223 . . . . 0.0 110.694 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.469 ' C ' HD13 ' A' ' 135' ' ' ILE . 6.0 t0 -117.97 134.84 54.58 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.741 -0.599 . . . . 0.0 110.263 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.824 HD13 ' N ' ' A' ' 135' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.275 -0.891 . . . . 0.0 110.308 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.878 HG13 ' HD2' ' A' ' 164' ' ' PRO . 53.8 t . . . . . 0 N--CA 1.494 1.743 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.878 ' HD2' HG13 ' A' ' 163' ' ' VAL . 38.1 Cg_endo -64.48 134.15 40.25 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.808 1.425 . . . . 0.0 110.771 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.563 ' CB ' ' HB3' ' A' ' 96' ' ' PRO . 24.4 pt-20 -41.23 -25.22 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.604 -0.685 . . . . 0.0 111.317 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 164' ' ' PRO . 0.0 OUTLIER -116.08 138.38 51.29 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.944 -1.097 . . . . 0.0 110.698 -179.388 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.956 HD13 ' CE1' ' A' ' 180' ' ' TYR . 2.5 pp -158.9 154.64 26.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.615 -0.678 . . . . 0.0 109.924 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' A' ' 181' ' ' SER . 18.0 tp -112.78 141.08 47.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.116 -0.99 . . . . 0.0 110.128 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.896 HG11 ' CZ3' ' A' ' 91' ' ' TRP . 6.5 t -124.06 136.3 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.147 -0.97 . . . . 0.0 110.486 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.737 HG12 HD23 ' A' ' 187' ' ' LEU . 9.8 p -115.3 121.4 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.449 -0.782 . . . . 0.0 109.377 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.767 HD12 ' HG3' ' A' ' 201' ' ' PRO . 0.0 OUTLIER -127.16 107.82 10.36 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.042 -1.036 . . . . 0.0 110.104 -179.512 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -120.01 129.49 54.28 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.876 0.846 . . . . 0.0 109.903 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.557 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -98.77 -39.46 8.62 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.576 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 173' ' ' MET . 0.1 OUTLIER -46.37 -26.47 0.84 Allowed 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.439 -0.905 . . . . 0.0 108.698 178.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.545 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 3.3 tt0 -110.16 -27.43 9.14 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 198' ' ' THR . . . 84.15 23.36 52.11 Favored Glycine 0 N--CA 1.483 1.77 0 N-CA-C 108.756 -1.738 . . . . 0.0 108.756 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.923 HG22 HD22 ' A' ' 194' ' ' LEU . 0.1 OUTLIER -118.46 116.96 27.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.166 -1.197 . . . . 0.0 111.402 -179.55 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.812 ' N ' HD12 ' A' ' 178' ' ' LEU . 3.3 mp -130.6 153.71 48.62 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.421 -0.799 . . . . 0.0 109.501 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.999 ' C ' HD21 ' A' ' 187' ' ' LEU . . . -161.93 166.96 36.45 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.14 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.956 ' CE1' HD13 ' A' ' 167' ' ' LEU . 1.1 t80 -125.01 118.28 25.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.439 -1.036 . . . . 0.0 109.85 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.704 ' HB2' HD13 ' A' ' 187' ' ' LEU . 0.6 OUTLIER -145.15 165.25 28.86 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.334 -0.854 . . . . 0.0 110.072 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.642 HG21 ' HG2' ' A' ' 164' ' ' PRO . 0.0 OUTLIER -110.18 116.6 52.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 O-C-N 121.501 -0.749 . . . . 0.0 109.543 179.195 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 79.6 -1.72 76.27 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 87.9 39.99 6.82 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . 0.503 HG22 ' N ' ' A' ' 186' ' ' TYR . 32.1 m -94.38 -86.84 0.27 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.214 -1.168 . . . . 0.0 110.65 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.592 ' CE2' HD11 ' A' ' 182' ' ' ILE . 22.5 m-85 -40.15 -40.74 1.15 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.263 -0.898 . . . . 0.0 110.78 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.999 HD21 ' C ' ' A' ' 179' ' ' GLY . 5.8 mp -80.56 47.2 0.92 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.08 -1.013 . . . . 0.0 109.948 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -108.72 -82.15 1.38 Allowed Glycine 0 N--CA 1.491 2.3 0 C-N-CA 119.853 -1.165 . . . . 0.0 110.326 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.98 -28.39 16.28 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.926 1.488 . . . . 0.0 111.081 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.613 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -72.67 20.71 0.07 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.27 -0.894 . . . . 0.0 111.363 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -90.2 -13.55 35.29 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.928 -1.107 . . . . 0.0 110.325 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . 0.489 ' HA ' ' NE ' ' A' ' 192' ' ' ARG . 0.1 OUTLIER -90.28 -14.69 32.74 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.317 -0.865 . . . . 0.0 110.563 -179.76 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 197' ' ' ARG . . . -111.28 -18.91 7.84 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.923 HD22 HG22 ' A' ' 177' ' ' THR . 6.2 tt -61.95 -33.72 74.81 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.799 -0.824 . . . . 0.0 108.818 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.667 ' HA ' HG23 ' A' ' 177' ' ' THR . 0.0 OUTLIER -45.59 -29.84 1.32 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.553 -0.717 . . . . 0.0 109.529 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -115.59 -21.16 5.18 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.783 ' O ' HD23 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.99 -9.24 46.72 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.661 -0.905 . . . . 0.0 109.666 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . 0.683 ' HB ' HD23 ' A' ' 194' ' ' LEU . 0.0 OUTLIER -43.5 148.95 0.29 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.015 0.912 . . . . 0.0 111.961 -177.785 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 1.073 ' HB3' HG23 ' A' ' 110' ' ' THR . 0.1 OUTLIER -140.59 169.81 16.96 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.511 179.519 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.88 ' C ' HG13 ' A' ' 108' ' ' VAL . 19.0 m-85 -84.75 129.92 54.96 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.017 -1.052 . . . . 0.0 109.499 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.844 ' HA ' HG22 ' A' ' 108' ' ' VAL . 41.4 Cg_endo -67.87 125.13 12.71 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.805 1.424 . . . . 0.0 110.407 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.581 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 57.5 p -133.29 152.27 51.92 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.253 -0.904 . . . . 0.0 111.195 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.619 HG23 ' HA ' ' A' ' 106' ' ' VAL . 4.0 p -158.93 160.6 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.648 -0.657 . . . . 0.0 109.532 179.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . 0.797 ' O ' HG13 ' A' ' 105' ' ' VAL . 0.3 OUTLIER -160.38 130.32 5.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.307 -0.87 . . . . 0.0 110.319 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.993 ' HB3' ' CG1' ' A' ' 78' ' ' VAL . . . -108.74 150.53 27.46 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.031 -1.043 . . . . 0.0 110.398 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.46 HG12 ' H ' ' A' ' 208' ' ' GLY . 1.2 t -91.19 159.97 2.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.542 0.687 . . . . 0.0 110.712 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 0.839 ' CD1' ' HB2' ' A' ' 72' ' ' ALA . 16.7 p-90 -82.54 46.61 1.08 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.286 -0.884 . . . . 0.0 109.646 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.46 ' H ' HG12 ' A' ' 206' ' ' VAL . . . -108.88 -128.95 5.8 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.791 ' O ' ' O ' ' A' ' 210' ' ' CYS . 1.0 OUTLIER -127.51 -22.59 3.62 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.357 -1.084 . . . . 0.0 110.548 -179.538 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . 0.791 ' O ' ' O ' ' A' ' 209' ' ' GLN . 31.4 p 1.6 -133.42 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.032 0.444 . . . . 0.0 111.875 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.601 ' HB3' ' HG2' ' A' ' 96' ' ' PRO . 0.0 OUTLIER 178.88 33.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.847 -1.158 . . . . 0.0 110.808 -179.595 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 1.029 HG21 ' CE3' ' A' ' 95' ' ' TRP . 2.5 p -86.63 124.96 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.032 -1.042 . . . . 0.0 110.267 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . 0.575 ' HA ' HD21 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -96.97 170.51 9.1 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.624 -0.672 . . . . 0.0 110.868 -179.3 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.829 ' CD1' ' HB3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -132.25 122.37 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.244 -0.91 . . . . 0.0 110.612 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.591 ' HB3' ' CB ' ' A' ' 92' ' ' GLU . 0.5 OUTLIER -130.63 140.15 50.4 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.563 -0.711 . . . . 0.0 109.96 179.464 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . 0.568 ' HA ' ' HB3' ' A' ' 91' ' ' TRP . 8.2 t80 -118.93 150.92 39.08 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.257 -0.902 . . . . 0.0 110.924 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . 0.562 ' O ' ' O ' ' A' ' 90' ' ' ALA . 9.0 tpp -134.99 108.01 7.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.933 . . . . 0.0 110.244 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 128.44 -9.48 6.53 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.485 ' HB2' ' CD1' ' A' ' 216' ' ' TYR . 3.9 mm-40 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.203 -1.175 . . . . 0.0 110.044 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.587 ' HG ' ' N ' ' A' ' 30' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.019 0.438 . . . . 0.0 110.122 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.668 ' HA ' HD23 ' A' ' 33' ' ' LEU . 19.1 pt-20 -47.99 -29.78 3.75 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.095 -1.003 . . . . 0.0 108.538 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -64.59 -23.95 67.43 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.543 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -82.68 -37.25 25.07 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.826 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.801 HD12 ' C ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -71.39 -38.28 71.49 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.823 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.672 ' O ' ' O ' ' A' ' 35' ' ' ALA . 1.8 m -78.45 -7.08 57.01 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.252 0.548 . . . . 0.0 110.007 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 1.039 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -49.43 -153.73 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.689 -0.632 . . . . 0.0 110.645 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 1.039 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 38.1 Cg_endo -65.3 -170.74 0.17 Allowed 'Trans proline' 0 N--CA 1.488 1.177 0 O-C-N 122.734 0.86 . . . . 0.0 110.349 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.758 ' O ' ' HB2' ' A' ' 42' ' ' ALA . 52.0 Cg_endo -97.17 50.2 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.525 1.483 . . . . 0.0 113.413 -178.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.781 ' HD2' ' O ' ' A' ' 36' ' ' PRO . 46.7 Cg_endo -73.07 150.67 48.66 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 N-CA-C 108.671 -1.319 . . . . 0.0 108.671 178.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.644 ' C ' ' O ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -21.32 -52.93 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.108 -0.995 . . . . 0.0 111.23 -179.171 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.048 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -54.38 -45.97 72.95 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 120.786 -1.196 . . . . 0.0 110.096 -179.344 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.751 ' CG2' HD13 ' A' ' 40' ' ' LEU . 6.2 t -86.99 -33.6 7.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 O-C-N 121.021 -1.049 . . . . 0.0 110.29 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.758 ' HB2' ' O ' ' A' ' 37' ' ' PRO . . . -90.91 -39.54 12.23 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.003 -1.06 . . . . 0.0 112.435 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.816 ' OE1' ' HA ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -83.0 -20.07 35.79 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.936 -1.102 . . . . 0.0 109.988 -178.832 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.752 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -80.45 -46.67 15.53 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.242 -0.911 . . . . 0.0 109.371 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.719 ' CG ' ' O ' ' A' ' 41' ' ' VAL . 14.7 m170 -54.86 -16.9 2.99 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.645 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.57 ' CG ' ' OE1' ' A' ' 61' ' ' GLU . 6.0 t60 -95.46 -35.06 11.85 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.079 -1.048 . . . . 0.0 109.271 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.48 ' HA2' ' OE2' ' A' ' 61' ' ' GLU . . . -93.53 -107.01 1.85 Allowed Glycine 0 N--CA 1.488 2.128 0 N-CA-C 107.116 -2.394 . . . . 0.0 107.116 178.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.931 ' HH2' HG12 ' A' ' 212' ' ' VAL . 98.9 m95 -79.83 73.57 6.58 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.001 -1.293 . . . . 0.0 108.271 177.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.618 ' HA ' ' HA ' ' A' ' 45' ' ' HIS . 0.1 OUTLIER -46.95 138.81 7.15 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.503 -0.748 . . . . 0.0 111.262 -179.357 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.646 ' HG2' ' HE3' ' A' ' 51' ' ' LYS . 39.8 Cg_endo -69.55 -27.01 27.98 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 124.387 1.73 . . . . 0.0 110.862 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.853 ' CE ' ' N ' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -63.16 -17.9 62.88 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 178.293 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.826 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 7.4 m-20 -121.12 3.25 10.43 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.223 177.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.89 ' SG ' HG12 ' A' ' 78' ' ' VAL . 2.4 t -138.56 128.29 25.01 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.949 0.88 . . . . 0.0 111.045 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.728 ' CB ' ' ND2' ' A' ' 56' ' ' ASN . 0.7 OUTLIER -70.12 118.07 12.49 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.634 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.71 ' HB3' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -51.38 -27.93 11.26 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.079 -1.013 . . . . 0.0 111.211 -179.258 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.729 ' H ' ' ND2' ' A' ' 56' ' ' ASN . 1.4 m-80 -28.29 -34.5 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.747 0.784 . . . . 0.0 110.279 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.661 ' N ' ' O ' ' A' ' 55' ' ' GLU . 15.9 pt -112.29 166.62 6.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.585 -0.697 . . . . 0.0 109.444 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.547 ' N ' ' O ' ' A' ' 67' ' ' GLU . 13.7 t70 -108.51 109.75 21.07 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.13 -0.981 . . . . 0.0 109.788 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.76 ' CG1' ' CD1' ' A' ' 48' ' ' TRP . 95.7 t -130.56 135.16 61.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 O-C-N 121.78 -0.575 . . . . 0.0 110.462 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.816 ' HA ' ' OE1' ' A' ' 43' ' ' GLN . 2.8 tttt -136.3 155.41 50.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.88 -1.138 . . . . 0.0 111.227 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.57 ' OE1' ' CG ' ' A' ' 46' ' ' HIS . 3.1 tt0 -69.07 -120.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.47 -0.769 . . . . 0.0 110.265 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.518 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 38.48 48.99 2.33 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 108.346 -1.901 . . . . 0.0 108.346 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.688 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 102.07 58.65 0.78 Allowed Glycine 0 N--CA 1.487 2.047 0 N-CA-C 107.932 -2.067 . . . . 0.0 107.932 -178.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.824 HD22 ' H ' ' A' ' 64' ' ' LEU . 2.0 mm? 0.91 82.98 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.886 -0.773 . . . . 0.0 111.105 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 3.7 t -99.76 114.65 27.92 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.514 -0.741 . . . . 0.0 109.885 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.61 ' CE1' ' CD2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -97.21 124.89 41.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.414 -0.804 . . . . 0.0 109.538 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 58' ' ' ASP . 8.3 tt0 -145.88 122.01 10.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.826 -1.171 . . . . 0.0 110.23 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.555 ' CD ' ' O ' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -122.81 142.66 50.51 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.332 -0.855 . . . . 0.0 109.674 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.675 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 44.7 mtt180 -112.91 -71.44 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.033 -1.042 . . . . 0.0 110.591 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.675 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 56.6 Cg_endo -73.6 -122.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.502 1.264 . . . . 0.0 109.184 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 t -140.05 164.09 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.5 -1.375 . . . . 0.0 109.96 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.869 ' HB1' ' HA ' ' A' ' 76' ' ' ASP . . . -62.46 88.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.226 -0.921 . . . . 0.0 110.192 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.558 ' N ' ' OD1' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -66.79 -77.5 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.171 -0.956 . . . . 0.0 110.368 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 73' ' ' GLN . 1.9 p -50.86 -101.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.112 -0.992 . . . . 0.0 110.03 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.712 HG23 ' OG ' ' A' ' 54' ' ' SER . 7.1 t -82.93 -129.25 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.929 -1.107 . . . . 0.0 109.203 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.869 ' HA ' ' HB1' ' A' ' 72' ' ' ALA . 0.9 OUTLIER -140.9 154.39 46.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.966 -1.084 . . . . 0.0 110.802 179.555 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.644 ' O ' HG13 ' A' ' 78' ' ' VAL . . . 29.88 -89.87 0.01 OUTLIER Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.429 -1.868 . . . . 0.0 108.429 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.112 ' CG2' ' HB3' ' A' ' 205' ' ' ALA . 17.1 m -155.26 138.73 7.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 O-C-N 121.736 -0.861 . . . . 0.0 109.999 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.762 ' C ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -144.95 133.22 21.66 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.239 -0.913 . . . . 0.0 112.047 -178.454 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.826 ' CA ' ' HA ' ' A' ' 52' ' ' ASP . . . -115.43 162.68 12.41 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.236 -1.545 . . . . 0.0 109.236 178.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.436 ' HA ' ' HB2' ' A' ' 202' ' ' SER . 13.0 ttpp -160.57 -28.21 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.134 -1.215 . . . . 0.0 110.452 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.552 ' CD ' ' HB3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -82.18 -73.51 0.39 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.978 -1.076 . . . . 0.0 109.872 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.47 ' C ' ' O ' ' A' ' 82' ' ' ARG . . . 36.49 53.15 1.37 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.423 ' CD1' ' C ' ' A' ' 84' ' ' TYR . 2.1 t80 -94.55 125.29 39.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -1.137 . . . . 0.0 110.603 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.592 ' HB3' ' CD2' ' A' ' 89' ' ' HIS . 30.7 m -139.9 166.68 23.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.163 -0.961 . . . . 0.0 110.022 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.505 ' O ' ' NE2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -116.87 133.77 55.6 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.059 -1.026 . . . . 0.0 110.201 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 101.03 -114.92 5.15 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.524 ' O ' ' CD2' ' A' ' 89' ' ' HIS . 17.7 tp -128.49 132.18 48.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.359 -1.083 . . . . 0.0 110.248 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.592 ' CD2' ' HB3' ' A' ' 85' ' ' SER . 2.9 m80 -147.16 156.78 43.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.12 -0.987 . . . . 0.0 109.915 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.546 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -163.04 155.45 18.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.939 . . . . 0.0 110.074 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 1.124 ' CZ3' HG11 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -134.67 158.86 43.0 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.275 -0.891 . . . . 0.0 109.238 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.611 ' HB3' ' HB3' ' A' ' 215' ' ' ARG . 3.0 tt0 -109.81 134.11 52.4 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.876 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.989 HD13 HG13 ' A' ' 214' ' ' ILE . 8.3 mm -129.18 132.25 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.421 -0.8 . . . . 0.0 109.657 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.7 ' HB3' ' HA ' ' A' ' 166' ' ' ARG . 13.3 p -155.22 154.31 32.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.188 -0.945 . . . . 0.0 110.271 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.912 ' CE3' HG22 ' A' ' 212' ' ' VAL . 14.4 m95 -123.32 86.41 51.86 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.09 -1.006 . . . . 0.0 109.8 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.595 ' CD ' ' HB2' ' A' ' 213' ' ' ARG . 52.2 Cg_endo -99.06 109.0 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 121.978 1.785 . . . . 0.0 110.634 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.633 HD11 ' NE2' ' A' ' 211' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 O-C-N 120.883 -1.136 . . . . 0.0 109.764 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.793 HG23 ' CB ' ' A' ' 204' ' ' SER . 18.4 m . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 1.122 HG13 ' O ' ' A' ' 202' ' ' SER . 36.9 t -149.23 156.26 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.14 -0.975 . . . . 0.0 110.757 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.578 ' HA2' ' HA3' ' A' ' 132' ' ' GLY . . . -149.96 150.23 22.26 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.967 ' CG1' HD13 ' A' ' 199' ' ' LEU . 2.9 t -122.38 141.88 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -1.098 . . . . 0.0 109.666 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.551 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -124.25 156.67 36.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.095 -1.003 . . . . 0.0 110.77 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.866 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -120.52 133.63 55.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.35 -0.844 . . . . 0.0 110.207 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -88.9 -25.03 22.33 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.344 -0.848 . . . . 0.0 109.335 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.6 pp -86.67 -11.96 49.77 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.516 -0.74 . . . . 0.0 109.251 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.654 ' HB2' ' HB ' ' A' ' 110' ' ' THR . . . . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.535 -0.728 . . . . 0.0 110.378 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.246 0.546 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.435 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 0.6 OUTLIER -149.98 128.97 12.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.355 -0.841 . . . . 0.0 110.076 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 39.1 t -120.55 120.13 34.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.292 -0.88 . . . . 0.0 110.224 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . 0.465 ' O ' ' O ' ' A' ' 108' ' ' VAL . 1.5 m95 -132.82 124.87 28.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.91 . . . . 0.0 109.99 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.578 ' HA3' ' HA2' ' A' ' 107' ' ' GLY . . . -155.18 -172.13 22.52 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.626 ' O ' ' CD1' ' A' ' 133' ' ' TRP . 3.5 p90 -145.26 140.4 27.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.368 -1.077 . . . . 0.0 110.902 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -120.45 149.05 43.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.778 -0.576 . . . . 0.0 109.709 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.641 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 O-C-N 120.966 -1.084 . . . . 0.0 110.361 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.9 HG11 ' HB2' ' A' ' 167' ' ' LEU . 48.0 t . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.854 ' HD2' HG13 ' A' ' 163' ' ' VAL . 38.0 Cg_endo -64.05 176.09 2.74 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.718 1.378 . . . . 0.0 110.572 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 164' ' ' PRO . 12.9 mt-10 -35.75 -32.18 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.503 -0.748 . . . . 0.0 110.681 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.7 ' HA ' ' HB3' ' A' ' 94' ' ' SER . 21.2 ttm180 -152.26 156.71 40.22 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.269 -0.894 . . . . 0.0 111.087 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.9 ' HB2' HG11 ' A' ' 163' ' ' VAL . 7.2 tt -126.21 157.1 39.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.584 -0.697 . . . . 0.0 109.719 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.685 ' N ' HD23 ' A' ' 167' ' ' LEU . 24.9 tp -123.6 116.61 23.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.087 -1.008 . . . . 0.0 110.739 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 1.124 HG11 ' CZ3' ' A' ' 91' ' ' TRP . 10.6 t -91.93 141.91 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.101 -0.999 . . . . 0.0 109.61 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 178' ' ' LEU . 11.4 t -118.93 124.71 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.917 . . . . 0.0 111.133 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.589 HD13 ' HG3' ' A' ' 201' ' ' PRO . 13.0 tp -133.4 105.68 7.07 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.384 -0.822 . . . . 0.0 109.346 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -115.47 139.32 50.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 110.544 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.517 ' O ' ' C ' ' A' ' 174' ' ' GLU . 0.0 OUTLIER -93.43 -41.0 10.05 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 120.174 -0.611 . . . . 0.0 109.996 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.517 ' C ' ' O ' ' A' ' 173' ' ' MET . 15.9 tt0 -39.11 -30.93 0.06 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 0.0 108.497 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.519 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 4.7 tt0 -113.2 -24.97 9.11 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.616 ' O ' ' HB ' ' A' ' 198' ' ' THR . . . 76.81 25.97 63.65 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 -179.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.859 HG22 ' HG ' ' A' ' 194' ' ' LEU . 2.2 p -113.14 144.45 42.64 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.346 -1.091 . . . . 0.0 110.77 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.712 ' H ' HD21 ' A' ' 194' ' ' LEU . 0.1 OUTLIER -153.03 154.04 34.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.405 -0.809 . . . . 0.0 110.169 -179.545 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.602 ' HA3' HD12 ' A' ' 187' ' ' LEU . . . -166.05 -173.17 34.23 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.712 ' CE1' HG22 ' A' ' 169' ' ' VAL . 0.7 OUTLIER -118.05 122.48 43.27 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.363 -1.08 . . . . 0.0 109.431 -179.75 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.633 ' HA ' ' CD2' ' A' ' 186' ' ' TYR . 41.9 t -144.24 142.5 30.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.288 -0.883 . . . . 0.0 110.822 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.774 HG21 ' HD2' ' A' ' 164' ' ' PRO . 0.0 OUTLIER -90.75 116.34 31.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.405 -0.809 . . . . 0.0 109.321 179.046 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 94.96 -26.03 20.83 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.608 ' CA ' HD23 ' A' ' 168' ' ' LEU . . . 102.54 42.18 2.21 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 187' ' ' LEU . 4.7 m -137.53 -54.84 0.68 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.158 -1.201 . . . . 0.0 110.444 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.729 ' HD2' HD13 ' A' ' 182' ' ' ILE . 0.1 OUTLIER -62.0 77.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.129 0.966 . . . . 0.0 109.962 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.828 HD21 ' CZ ' ' A' ' 191' ' ' PHE . 1.7 tt 179.87 24.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.48 0.657 . . . . 0.0 109.793 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.763 ' N ' ' CD ' ' A' ' 189' ' ' PRO . . . -104.94 -21.3 9.11 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.892 -1.147 . . . . 0.0 112.074 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.763 ' CD ' ' N ' ' A' ' 188' ' ' GLY . 47.5 Cg_endo -74.21 -42.76 0.64 Allowed 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 122.812 0.901 . . . . 0.0 111.386 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -90.18 10.43 24.55 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.996 -1.065 . . . . 0.0 111.004 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 1.003 ' CE1' HD23 ' A' ' 194' ' ' LEU . 1.5 m-85 -89.98 -13.3 36.42 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.13 -0.981 . . . . 0.0 109.786 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . 0.465 ' HA ' ' NE ' ' A' ' 192' ' ' ARG . 0.0 OUTLIER -70.19 -29.23 66.05 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.158 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.533 ' O ' ' HB3' ' A' ' 197' ' ' ARG . . . -102.41 -18.76 15.61 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.111 -1.996 . . . . 0.0 108.111 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 1.003 HD23 ' CE1' ' A' ' 191' ' ' PHE . 0.9 OUTLIER -61.61 -20.32 63.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.792 -0.828 . . . . 0.0 109.454 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 195' ' ' LYS . 0.1 OUTLIER -64.32 -22.25 66.89 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.441 -0.787 . . . . 0.0 109.367 179.257 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.45 ' N ' ' HE3' ' A' ' 195' ' ' LYS . . . -125.43 -20.23 2.21 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.728 ' HD2' ' HA ' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -90.45 -4.19 57.15 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.479 -1.012 . . . . 0.0 109.267 179.661 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . 0.616 ' HB ' ' O ' ' A' ' 176' ' ' GLY . 0.1 OUTLIER -43.19 138.54 2.18 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 122.401 1.096 . . . . 0.0 112.43 -177.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.967 HD13 ' CG1' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -141.39 172.93 12.01 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.772 179.399 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.53 ' N ' ' O ' ' A' ' 109' ' ' ALA . 8.5 m-85 -82.3 128.66 66.57 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.619 -1.301 . . . . 0.0 109.502 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.611 ' CG ' HD13 ' A' ' 178' ' ' LEU . 53.2 Cg_endo -78.44 144.79 20.53 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 124.045 1.55 . . . . 0.0 112.556 -178.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 1.122 ' O ' HG13 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -133.58 147.56 51.54 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.247 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 1.002 ' HA ' HG22 ' A' ' 106' ' ' VAL . 8.4 p -119.14 163.5 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.722 -1.236 . . . . 0.0 110.388 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . 0.793 ' CB ' HG23 ' A' ' 105' ' ' VAL . 0.4 OUTLIER -155.07 134.65 12.66 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.013 0.911 . . . . 0.0 110.466 179.606 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 1.112 ' HB3' ' CG2' ' A' ' 78' ' ' VAL . . . -138.91 147.42 42.3 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.792 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.505 ' CG1' ' HB3' ' A' ' 211' ' ' GLN . 2.5 p -66.25 173.41 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.405 -0.81 . . . . 0.0 110.54 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 0.585 ' O ' ' CG ' ' A' ' 207' ' ' TRP . 33.0 p-90 -107.02 114.26 28.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.281 -0.887 . . . . 0.0 110.257 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 66' ' ' PHE . . . 172.32 174.18 39.5 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -78.38 -73.53 0.32 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -1.157 . . . . 0.0 110.436 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . 0.463 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 89.1 m -86.29 86.24 7.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.356 -0.84 . . . . 0.0 110.292 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.633 ' NE2' HD11 ' A' ' 97' ' ' LEU . 25.1 mm-40 -154.3 -49.92 0.09 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.211 -0.931 . . . . 0.0 110.365 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.931 HG12 ' HH2' ' A' ' 48' ' ' TRP . 47.9 t -127.81 143.73 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.119 -0.988 . . . . 0.0 112.033 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . 0.595 ' HB2' ' CD ' ' A' ' 96' ' ' PRO . 15.6 tpp85 -128.9 137.79 51.63 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.989 HG13 HD13 ' A' ' 93' ' ' ILE . 3.1 tt -142.36 136.32 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.643 -1.286 . . . . 0.0 112.289 -178.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.611 ' HB3' ' HB3' ' A' ' 92' ' ' GLU . 12.7 tpt180 -130.11 109.43 10.82 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . 0.715 ' CZ ' ' CD1' ' A' ' 91' ' ' TRP . 2.1 t80 -89.0 149.59 23.19 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.055 -1.028 . . . . 0.0 111.531 -178.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 44.2 tpp -132.79 107.92 8.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.671 -0.643 . . . . 0.0 109.632 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 93.39 87.46 1.6 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.257 -1.143 . . . . 0.0 110.406 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.601 ' O ' ' N ' ' A' ' 32' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.321 0.581 . . . . 0.0 109.796 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.938 ' HA ' HD23 ' A' ' 33' ' ' LEU . 1.6 tt0 -46.64 -26.86 1.0 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.408 -0.808 . . . . 0.0 109.159 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -74.85 -22.58 58.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.463 -0.773 . . . . 0.0 108.933 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.601 ' N ' ' O ' ' A' ' 29' ' ' LEU . 1.1 mm? -83.84 -32.17 25.4 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.062 HD11 ' HB2' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -71.11 -35.93 71.98 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 122.064 0.935 . . . . 0.0 109.139 179.299 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.65 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 3.7 t -79.71 -7.62 58.72 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.323 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 1.047 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -70.42 -70.96 0.29 Allowed Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.122 -0.986 . . . . 0.0 110.899 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 1.047 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 51.6 Cg_endo -75.39 160.92 38.37 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.495 1.261 . . . . 0.0 110.483 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 36' ' ' PRO . 53.5 Cg_endo -99.81 52.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.123 1.882 . . . . 0.0 112.113 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.685 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 48.6 Cg_endo -72.89 151.04 50.35 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.125 1.066 . . . . 0.0 110.703 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.667 ' OD2' ' HD3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -15.2 -65.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.757 -0.59 . . . . 0.0 111.786 179.282 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.098 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -45.28 -43.71 10.79 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.413 -0.804 . . . . 0.0 110.412 -179.434 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.89 HG12 ' CE1' ' A' ' 45' ' ' HIS . 3.8 t -85.08 -19.33 8.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 O-C-N 121.168 -0.958 . . . . 0.0 111.185 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.52 -44.12 10.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.89 -1.132 . . . . 0.0 112.339 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.683 ' NE2' ' HG2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -85.39 -19.48 31.32 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 118.385 -1.326 . . . . 0.0 109.425 -179.737 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.686 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -69.31 -41.81 76.22 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 122.165 0.983 . . . . 0.0 108.472 179.218 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.89 ' CE1' HG12 ' A' ' 41' ' ' VAL . 20.3 m170 -63.74 -28.82 70.15 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.748 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -96.35 -29.64 13.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.874 -1.141 . . . . 0.0 109.608 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.09 -89.83 1.47 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 107.339 -2.304 . . . . 0.0 107.339 178.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.77 ' HH2' HG12 ' A' ' 212' ' ' VAL . 97.4 m95 -90.77 74.37 6.59 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.58 ' ND2' ' N ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -43.26 137.94 2.74 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.527 -0.733 . . . . 0.0 111.428 -179.045 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.705 ' HA ' ' O ' ' A' ' 53' ' ' CYS . 40.0 Cg_endo -67.67 -23.31 42.65 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 124.435 1.755 . . . . 0.0 111.168 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.835 ' CE ' ' N ' ' A' ' 51' ' ' LYS . 0.6 OUTLIER -65.29 -15.58 62.66 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 178.326 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 1.103 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 11.2 m-20 -121.97 3.15 9.95 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.162 177.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.873 ' SG ' HG12 ' A' ' 78' ' ' VAL . 9.5 t -148.0 138.08 22.7 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.507 0.67 . . . . 0.0 110.292 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.762 ' HB2' ' O ' ' A' ' 76' ' ' ASP . 1.5 m -80.29 130.68 35.37 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.175 -0.953 . . . . 0.0 109.835 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 1.062 ' HB2' HD11 ' A' ' 33' ' ' LEU . 4.3 pm0 -44.63 -24.36 0.19 Allowed 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.669 ' ND2' ' HB2' ' A' ' 54' ' ' SER . 0.1 OUTLIER -55.5 -4.58 0.1 Allowed 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.575 -1.328 . . . . 0.0 109.866 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.576 HG22 HG22 ' A' ' 59' ' ' VAL . 22.8 mm -111.96 157.75 12.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.477 -0.765 . . . . 0.0 110.518 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.654 ' HA ' HD23 ' A' ' 40' ' ' LEU . 35.9 t0 -118.87 105.4 11.46 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.709 0.766 . . . . 0.0 109.534 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.7 ' CG1' ' CD1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -131.08 136.12 58.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 O-C-N 121.628 -0.67 . . . . 0.0 110.919 -178.942 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.683 ' HG2' ' NE2' ' A' ' 43' ' ' GLN . 28.7 mttp -135.53 155.28 50.75 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.282 -0.886 . . . . 0.0 110.535 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.483 ' HG3' ' N ' ' A' ' 62' ' ' GLY . 7.8 pt-20 -75.82 -130.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.227 -0.921 . . . . 0.0 110.408 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.483 ' N ' ' HG3' ' A' ' 61' ' ' GLU . . . 45.73 45.12 12.99 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.661 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 108.9 60.55 0.53 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.953 HD21 ' O ' ' A' ' 214' ' ' ILE . 0.3 OUTLIER -0.32 78.98 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.878 -0.778 . . . . 0.0 111.27 -179.283 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.499 ' O ' ' SG ' ' A' ' 65' ' ' CYS . 31.9 p -99.58 114.33 27.29 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.13 -0.981 . . . . 0.0 109.647 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.7 ' CD1' ' CG1' ' A' ' 59' ' ' VAL . 1.2 t80 -90.55 124.84 35.35 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.479 -0.763 . . . . 0.0 110.211 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 4.9 tt0 -139.99 152.89 46.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.172 -0.955 . . . . 0.0 109.674 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.527 ' HG3' ' HB3' ' A' ' 207' ' ' TRP . 0.1 OUTLIER -135.93 140.25 43.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.022 -1.049 . . . . 0.0 110.83 -179.578 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.629 ' CB ' ' HD2' ' A' ' 70' ' ' PRO . 1.4 mtp85 -61.13 -173.94 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.386 -0.821 . . . . 0.0 109.208 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.629 ' HD2' ' CB ' ' A' ' 69' ' ' ARG . 50.9 Cg_endo -66.28 -138.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.591 1.311 . . . . 0.0 108.958 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.72 152.61 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.966 -1.083 . . . . 0.0 110.015 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.6 -39.95 0.13 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.161 -0.962 . . . . 0.0 110.188 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.549 ' O ' ' N ' ' A' ' 75' ' ' THR . 0.2 OUTLIER -170.14 147.12 3.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.286 -0.884 . . . . 0.0 110.145 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 73' ' ' GLN . 9.2 t -43.74 91.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 110.353 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.647 HG21 ' OD1' ' A' ' 56' ' ' ASN . 1.5 m -99.17 -129.4 0.2 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.296 -0.877 . . . . 0.0 110.053 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.762 ' O ' ' HB2' ' A' ' 54' ' ' SER . 72.5 m-20 -137.73 113.91 10.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.195 -0.94 . . . . 0.0 110.486 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.506 ' O ' ' O ' ' A' ' 76' ' ' ASP . . . -50.73 -96.16 0.01 OUTLIER Glycine 0 N--CA 1.484 1.837 0 N-CA-C 107.759 -2.136 . . . . 0.0 107.759 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.873 HG12 ' SG ' ' A' ' 53' ' ' CYS . 6.9 m -143.05 126.93 14.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.215 -1.168 . . . . 0.0 110.237 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.651 ' C ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -145.57 134.16 22.11 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.131 -0.981 . . . . 0.0 112.536 -178.615 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 1.103 ' CA ' ' HA ' ' A' ' 52' ' ' ASP . . . -133.13 161.56 24.17 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 178.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.505 ' HG3' ' HB3' ' A' ' 202' ' ' SER . 0.4 OUTLIER -169.96 24.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.237 -1.155 . . . . 0.0 110.345 -179.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.469 ' O ' ' CD2' ' A' ' 200' ' ' TYR . 1.1 ptt180 -91.36 -102.44 0.11 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.075 -1.016 . . . . 0.0 110.428 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.452 ' HA3' ' CG ' ' A' ' 201' ' ' PRO . . . 81.03 66.6 1.61 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -121.77 95.8 4.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -1.166 . . . . 0.0 110.361 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 173' ' ' MET . 69.7 m -140.09 155.6 46.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.207 -0.933 . . . . 0.0 110.286 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.518 ' C ' ' NE2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -118.2 135.42 54.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.207 -0.933 . . . . 0.0 109.809 179.832 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 106.45 -118.32 5.64 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.476 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 51.3 tp -128.79 123.09 31.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.408 -1.054 . . . . 0.0 110.904 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.518 ' NE2' ' C ' ' A' ' 86' ' ' ARG . 4.2 m-70 -147.2 153.17 39.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.205 -0.934 . . . . 0.0 109.758 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.54 ' C ' ' CE3' ' A' ' 91' ' ' TRP . . . -163.71 156.85 18.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.025 -1.047 . . . . 0.0 110.201 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.985 ' HB2' HD11 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -134.98 154.69 51.63 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.184 -0.948 . . . . 0.0 110.108 179.484 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.893 ' C ' HD13 ' A' ' 93' ' ' ILE . 0.5 OUTLIER -109.56 118.93 37.89 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.318 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.985 HD11 ' HB2' ' A' ' 91' ' ' TRP . 0.1 OUTLIER -132.95 133.86 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.819 -1.176 . . . . 0.0 111.491 -178.659 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.567 ' O ' ' HD3' ' A' ' 96' ' ' PRO . 0.1 OUTLIER -116.84 120.08 37.39 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.441 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.904 ' HH2' ' O ' ' A' ' 204' ' ' SER . 6.3 t-105 -116.13 87.39 19.25 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.106 -0.997 . . . . 0.0 110.332 -178.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.577 ' HG2' ' O ' ' A' ' 211' ' ' GLN . 49.9 Cg_endo -99.24 138.66 0.32 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.257 1.972 . . . . 0.0 110.319 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.716 HD13 ' C ' ' A' ' 97' ' ' LEU . 1.9 tm? . . . . . 0 N--CA 1.492 1.641 0 O-C-N 120.866 -1.146 . . . . 0.0 109.405 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 204' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 121.496 0.665 . . . . 0.0 112.657 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.702 HG22 ' CE3' ' A' ' 95' ' ' TRP . 1.0 OUTLIER -152.16 122.82 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.62 -0.675 . . . . 0.0 109.431 177.413 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.529 ' HA3' ' HA3' ' A' ' 132' ' ' GLY . . . 160.44 -158.56 30.0 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 118.711 -1.709 . . . . 0.0 111.097 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.645 HG12 ' HB2' ' A' ' 199' ' ' LEU . 2.3 t -120.78 169.34 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.725 -0.867 . . . . 0.0 109.717 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.539 ' C ' ' HB3' ' A' ' 199' ' ' LEU . . . -146.19 132.66 19.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.996 -1.065 . . . . 0.0 110.263 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.745 HG23 ' CG ' ' A' ' 199' ' ' LEU . 9.7 p -89.43 120.85 31.12 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.146 -0.971 . . . . 0.0 110.304 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.17 -31.55 14.74 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.638 -0.664 . . . . 0.0 109.817 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.492 HD23 ' H ' ' A' ' 112' ' ' LEU . 0.6 OUTLIER -76.91 -12.47 59.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.401 -0.812 . . . . 0.0 110.01 179.807 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.444 ' O ' ' OE1' ' A' ' 129' ' ' GLU . . . . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.376 -0.828 . . . . 0.0 110.261 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.341 0.591 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.444 ' OE1' ' O ' ' A' ' 113' ' ' ALA . 0.9 OUTLIER -150.4 138.1 19.89 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.224 -0.923 . . . . 0.0 109.766 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 8.9 t -120.06 120.71 37.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.386 -0.821 . . . . 0.0 110.006 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . 0.465 ' O ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -132.2 133.36 44.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.882 . . . . 0.0 110.255 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.529 ' HA3' ' HA3' ' A' ' 107' ' ' GLY . . . 165.72 -120.38 0.92 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.662 ' CZ3' ' CD2' ' A' ' 180' ' ' TYR . 47.0 m0 -119.48 112.81 19.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.043 -1.269 . . . . 0.0 110.025 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.804 ' C ' HD13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -118.92 148.22 43.17 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.397 0.618 . . . . 0.0 110.685 -179.545 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.821 HD13 ' N ' ' A' ' 135' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.946 . . . . 0.0 110.116 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.59 HG12 ' N ' ' A' ' 164' ' ' PRO . 1.3 t . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.59 ' N ' HG12 ' A' ' 163' ' ' VAL . 45.6 Cg_endo -73.29 68.6 4.19 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.74 1.389 . . . . 0.0 110.705 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -80.72 -81.27 0.13 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.304 -0.873 . . . . 0.0 109.116 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 1.134 ' O ' HD13 ' A' ' 167' ' ' LEU . 9.7 ttp180 -119.09 115.53 24.48 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.394 -0.816 . . . . 0.0 108.961 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 1.134 HD13 ' O ' ' A' ' 166' ' ' ARG . 0.3 OUTLIER -132.14 157.46 44.2 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 121.424 0.631 . . . . 0.0 110.474 -179.015 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.754 HD12 ' CD ' ' A' ' 92' ' ' GLU . 0.7 OUTLIER -107.42 125.82 51.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.371 -0.831 . . . . 0.0 109.736 179.401 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.716 HG22 ' CE1' ' A' ' 180' ' ' TYR . 19.3 t -89.53 132.37 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.139 -0.975 . . . . 0.0 110.062 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.577 HG13 HD21 ' A' ' 168' ' ' LEU . 0.1 OUTLIER -125.3 111.48 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.398 -0.814 . . . . 0.0 110.186 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.691 ' HB3' ' CZ2' ' A' ' 91' ' ' TRP . 2.0 tp -107.41 114.04 27.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.339 -0.851 . . . . 0.0 110.022 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.496 ' N ' HD12 ' A' ' 171' ' ' LEU . 53.1 t0 -116.22 129.85 56.5 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.268 -0.895 . . . . 0.0 110.067 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.494 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 12.4 tpp -100.85 -42.02 6.62 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 173' ' ' MET . 0.7 OUTLIER -45.87 -25.62 0.56 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.078 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.548 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.0 OUTLIER -111.59 -28.07 8.3 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.751 0.786 . . . . 0.0 108.895 179.29 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.812 ' O ' HG21 ' A' ' 198' ' ' THR . . . 85.37 22.66 50.65 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.649 ' CA ' HD22 ' A' ' 194' ' ' LEU . 0.2 OUTLIER -119.73 111.43 18.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.258 -1.142 . . . . 0.0 111.081 -179.631 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.718 HD11 ' O ' ' A' ' 199' ' ' LEU . 0.3 OUTLIER -136.01 154.34 51.1 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.251 -0.906 . . . . 0.0 110.225 179.345 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.445 ' HA2' HG21 ' A' ' 108' ' ' VAL . . . 172.49 -153.21 18.46 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.886 ' C ' HD22 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -118.79 125.21 49.09 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.192 -1.181 . . . . 0.0 109.768 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.431 ' HA ' ' HB3' ' A' ' 187' ' ' LEU . 17.0 t -116.72 124.88 50.76 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.381 -0.825 . . . . 0.0 110.171 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 1.023 HG22 HD12 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -103.7 116.71 47.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.495 -0.753 . . . . 0.0 109.645 179.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 49.66 22.49 4.12 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 57.26 48.43 80.27 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . 0.863 HG22 ' CD1' ' A' ' 186' ' ' TYR . 69.1 m -110.48 -86.53 0.54 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.326 -1.102 . . . . 0.0 110.892 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.863 ' CD1' HG22 ' A' ' 185' ' ' THR . 8.9 m-30 -59.67 -56.57 20.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.26 -0.9 . . . . 0.0 110.809 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.886 HD22 ' C ' ' A' ' 180' ' ' TYR . 0.6 OUTLIER -76.25 43.94 0.31 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.002 -1.061 . . . . 0.0 110.12 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.489 ' H ' ' HD2' ' A' ' 189' ' ' PRO . . . -105.32 -70.47 0.78 Allowed Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.913 -1.137 . . . . 0.0 110.269 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.489 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 45.3 Cg_endo -71.5 -29.71 16.1 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.899 1.473 . . . . 0.0 111.151 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.539 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -72.74 34.17 0.07 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.339 -0.851 . . . . 0.0 111.267 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.406 ' H ' ' C ' ' A' ' 189' ' ' PRO . 0.4 OUTLIER -90.51 -43.94 9.91 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.982 -1.074 . . . . 0.0 109.884 179.351 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -16.65 61.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.32 -0.863 . . . . 0.0 110.107 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -106.23 -13.38 23.16 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.782 HD23 ' O ' ' A' ' 194' ' ' LEU . 7.2 tt -70.94 -29.92 66.08 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.589 -0.948 . . . . 0.0 109.433 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.569 ' HE3' ' N ' ' A' ' 196' ' ' GLY . 0.1 OUTLIER -53.92 -32.61 54.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.224 -0.922 . . . . 0.0 109.493 179.745 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.569 ' N ' ' HE3' ' A' ' 195' ' ' LYS . . . -94.93 -25.97 13.66 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 1.003 ' HD3' HD11 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.67 -4.76 56.53 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.764 -0.845 . . . . 0.0 109.632 179.499 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . 0.812 HG21 ' O ' ' A' ' 176' ' ' GLY . 0.2 OUTLIER -44.01 136.96 3.51 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.76 0.79 . . . . 0.0 111.747 -178.243 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 1.003 HD11 ' HD3' ' A' ' 197' ' ' ARG . 0.0 OUTLIER -140.37 170.81 15.12 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.381 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.542 ' C ' HG13 ' A' ' 108' ' ' VAL . 3.1 m-30 -84.76 139.03 37.54 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.934 . . . . 0.0 109.752 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.452 ' CG ' ' HA3' ' A' ' 83' ' ' GLY . 40.6 Cg_endo -67.8 113.74 3.09 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.871 1.458 . . . . 0.0 110.203 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.505 ' HB3' ' HG3' ' A' ' 81' ' ' LYS . 25.1 p -133.11 152.95 51.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.296 -0.877 . . . . 0.0 110.81 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 79' ' ' ARG . 6.1 p -160.2 149.91 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.524 -0.735 . . . . 0.0 110.049 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . 0.904 ' O ' ' HH2' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -139.86 126.53 20.51 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.303 -0.873 . . . . 0.0 109.134 178.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.559 ' HB3' ' CG2' ' A' ' 78' ' ' VAL . . . -127.81 163.5 24.25 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.746 -1.221 . . . . 0.0 111.678 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.57 HG13 ' N ' ' A' ' 207' ' ' TRP . 1.2 t -50.2 174.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.752 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 0.57 ' N ' HG13 ' A' ' 206' ' ' VAL . 79.0 m95 -51.29 -74.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.375 -0.828 . . . . 0.0 109.259 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.631 ' HA2' ' CD2' ' A' ' 66' ' ' PHE . . . 177.03 103.86 0.17 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.487 ' HB2' ' O ' ' A' ' 208' ' ' GLY . 18.6 tt0 179.68 -49.11 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.767 -0.843 . . . . 0.0 110.195 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . 0.521 ' O ' ' CG ' ' A' ' 211' ' ' GLN . 1.7 m -43.0 -96.78 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.62 -0.675 . . . . 0.0 110.658 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.577 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 0.0 OUTLIER 179.53 45.23 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.24 -0.912 . . . . 0.0 109.523 -179.603 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.77 HG12 ' HH2' ' A' ' 48' ' ' TRP . 29.2 t -86.08 138.22 19.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-O 121.558 0.694 . . . . 0.0 110.758 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . 0.454 ' HA ' ' HZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -125.71 143.7 50.93 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.48 -0.763 . . . . 0.0 110.139 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.953 ' O ' HD21 ' A' ' 64' ' ' LEU . 1.5 tt -140.12 127.59 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.086 -1.009 . . . . 0.0 110.488 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -129.96 144.23 51.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.306 -0.871 . . . . 0.0 109.596 179.519 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . 0.731 ' CE2' ' CE3' ' A' ' 91' ' ' TRP . 1.2 t80 -118.62 151.37 38.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.248 -0.908 . . . . 0.0 111.318 -178.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . 0.483 ' HB3' ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -127.79 107.83 10.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.469 -0.77 . . . . 0.0 109.658 179.332 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 71.75 76.51 0.59 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.57 ' HB2' ' CD2' ' A' ' 216' ' ' TYR . 32.1 tt0 . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.22 -1.164 . . . . 0.0 110.296 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.897 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.203 0.525 . . . . 0.0 109.918 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.61 ' HA ' HD23 ' A' ' 33' ' ' LEU . 1.4 pp20? -46.17 -37.37 6.94 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.135 -0.978 . . . . 0.0 109.165 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -57.44 -25.56 59.84 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.381 -0.825 . . . . 0.0 108.823 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 29' ' ' LEU . 5.9 tp -83.12 -32.21 26.82 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.831 HD12 ' C ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -84.94 -38.42 19.36 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 121.82 0.819 . . . . 0.0 109.237 179.164 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.565 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 1.1 t -49.23 -20.63 0.65 Allowed 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.388 0.613 . . . . 0.0 110.189 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 1.051 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -52.34 -161.37 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.516 -0.74 . . . . 0.0 109.692 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 1.051 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 39.2 Cg_endo -66.61 121.85 9.16 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 O-C-N 123.001 1.0 . . . . 0.0 109.754 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.991 ' CB ' HG21 ' A' ' 41' ' ' VAL . 44.0 Cg_endo -70.08 109.27 2.33 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.154 1.607 . . . . 0.0 111.732 -178.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.774 ' O ' ' N ' ' A' ' 40' ' ' LEU . 52.0 Cg_endo -79.74 151.62 22.01 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.238 1.652 . . . . 0.0 109.239 178.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.733 ' C ' HE22 ' A' ' 43' ' ' GLN . 0.9 OUTLIER -12.83 -51.23 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 122.167 0.984 . . . . 0.0 110.062 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.073 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -34.78 -43.23 0.17 Allowed 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.934 -179.346 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.991 HG21 ' CB ' ' A' ' 37' ' ' PRO . 2.9 t -70.87 -24.81 25.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 O-C-N 121.168 -0.957 . . . . 0.0 110.678 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.607 ' N ' ' O ' ' A' ' 39' ' ' ASP . . . -90.69 -41.54 11.24 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 118.981 -1.087 . . . . 0.0 113.104 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.733 HE22 ' C ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -87.37 -19.37 28.24 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.862 -1.149 . . . . 0.0 109.829 -179.1 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 1.034 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 7.5 ttm-85 -72.44 -53.98 10.64 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.756 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 66.3 m170 -55.49 -27.98 51.76 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.556 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -96.07 -30.43 13.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.02 -1.05 . . . . 0.0 109.586 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.87 -74.11 1.27 Allowed Glycine 0 N--CA 1.488 2.131 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.736 ' CD2' ' CE1' ' A' ' 66' ' ' PHE . 99.2 m95 -100.36 74.09 1.71 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.618 ' HA ' ' HA ' ' A' ' 45' ' ' HIS . 0.1 OUTLIER -43.65 145.71 1.11 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.5 -0.75 . . . . 0.0 110.984 -179.419 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.756 ' HD3' ' HA ' ' A' ' 45' ' ' HIS . 42.8 Cg_endo -70.88 -31.07 16.16 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 124.297 1.682 . . . . 0.0 110.681 -178.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.932 ' O ' ' HA2' ' A' ' 80' ' ' GLY . 0.3 OUTLIER -64.17 -16.15 61.32 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.225 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.996 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 4.8 m-20 -118.72 0.28 11.43 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.638 177.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.702 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 16.0 t -150.04 132.9 16.04 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.21 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.649 ' CB ' ' ND2' ' A' ' 56' ' ' ASN . 0.5 OUTLIER -75.23 117.65 17.29 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.593 0.711 . . . . 0.0 109.688 179.186 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.646 ' O ' ' N ' ' A' ' 57' ' ' ILE . 6.7 pt-20 -42.54 -28.67 0.23 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.595 -0.69 . . . . 0.0 112.801 -178.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.834 ' OD1' HG22 ' A' ' 75' ' ' THR . 0.1 OUTLIER -40.34 -16.0 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.298 0 O-C-N 120.96 -1.087 . . . . 0.0 111.04 -179.114 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.747 HG22 HG13 ' A' ' 59' ' ' VAL . 1.2 mt -111.55 165.6 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 120.998 -1.064 . . . . 0.0 110.329 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 67' ' ' GLU . 4.2 t70 -117.54 104.27 10.9 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.76 0.791 . . . . 0.0 110.455 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.782 HG11 ' CE1' ' A' ' 66' ' ' PHE . 34.8 m -130.38 135.42 60.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 121.73 -0.606 . . . . 0.0 110.034 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.755 ' HG2' ' HA ' ' A' ' 40' ' ' LEU . 24.7 mttt -133.04 141.31 48.18 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.763 -1.211 . . . . 0.0 111.377 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.552 ' CG ' ' HB3' ' A' ' 43' ' ' GLN . 0.4 OUTLIER -59.95 -129.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.495 -0.753 . . . . 0.0 110.508 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 44.53 51.11 8.01 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 107.978 -2.049 . . . . 0.0 107.978 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.663 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 103.01 61.58 0.71 Allowed Glycine 0 N--CA 1.486 2.005 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 -178.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.036 HD11 HG22 ' A' ' 214' ' ' ILE . 0.2 OUTLIER 0.83 80.81 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.0 -0.706 . . . . 0.0 111.215 -178.737 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.426 ' N ' ' O ' ' A' ' 63' ' ' GLY . 0.5 OUTLIER -99.96 113.89 26.78 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.44 -0.788 . . . . 0.0 110.241 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.782 ' CE1' HG11 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -103.22 124.62 48.96 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.555 -0.716 . . . . 0.0 109.422 179.455 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.621 ' O ' HG23 ' A' ' 57' ' ' ILE . 1.1 tp10 -150.73 149.72 30.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.015 -1.053 . . . . 0.0 110.465 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.598 ' HG2' ' CE2' ' A' ' 207' ' ' TRP . 0.0 OUTLIER -119.54 151.74 38.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.309 -0.87 . . . . 0.0 109.969 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.637 ' CB ' ' HD3' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -94.85 -67.05 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 110.577 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.637 ' HD3' ' CB ' ' A' ' 69' ' ' ARG . 55.9 Cg_endo -73.53 -119.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.584 1.307 . . . . 0.0 109.583 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.408 ' H ' ' HB2' ' A' ' 70' ' ' PRO . 4.0 t -139.97 164.23 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.317 -1.489 . . . . 0.0 110.21 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.912 ' HB2' ' CG ' ' A' ' 207' ' ' TRP . . . -70.48 69.94 0.42 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 0.0 110.108 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -87.29 -160.26 0.58 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.276 -0.89 . . . . 0.0 110.39 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.2 m -73.25 1.22 9.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.928 . . . . 0.0 110.313 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.834 HG22 ' OD1' ' A' ' 56' ' ' ASN . 3.7 m -116.43 0.41 12.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.923 . . . . 0.0 110.104 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.558 ' CB ' ' HA ' ' A' ' 72' ' ' ALA . 0.4 OUTLIER -99.81 154.8 18.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 110.149 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.54 ' O ' ' HB2' ' A' ' 54' ' ' SER . . . 132.47 145.87 5.55 Favored Glycine 0 N--CA 1.483 1.771 0 N-CA-C 108.07 -2.012 . . . . 0.0 108.07 -179.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.105 ' CG2' ' HB3' ' A' ' 205' ' ' ALA . 4.4 m -117.27 128.61 74.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 O-C-N 121.16 -1.2 . . . . 0.0 109.846 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.635 ' C ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -145.11 134.61 23.2 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.966 -0.693 . . . . 0.0 112.521 -177.674 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.996 ' CA ' ' HA ' ' A' ' 52' ' ' ASP . . . -123.09 165.58 15.69 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 178.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 201' ' ' PRO . 0.1 OUTLIER -177.52 68.18 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.409 -1.054 . . . . 0.0 110.23 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.948 ' HD3' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -163.38 -91.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.139 -0.975 . . . . 0.0 110.783 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.948 ' N ' ' HD3' ' A' ' 82' ' ' ARG . . . 83.64 87.5 0.81 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -115.59 97.19 6.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.264 -1.139 . . . . 0.0 110.437 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.535 ' O ' ' CG ' ' A' ' 173' ' ' MET . 1.5 m -139.97 160.31 40.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.33 -0.856 . . . . 0.0 110.059 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.515 ' C ' ' NE2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -118.6 134.27 55.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.078 -1.014 . . . . 0.0 110.211 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 101.56 -115.58 5.3 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.506 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 13.2 tp -128.52 130.48 47.52 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.391 -1.064 . . . . 0.0 110.565 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.527 ' CE1' ' HB3' ' A' ' 85' ' ' SER . 4.1 m-70 -147.23 158.5 43.97 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.26 -0.9 . . . . 0.0 109.962 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -162.95 156.43 19.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.134 -0.979 . . . . 0.0 110.354 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 1.026 ' CZ2' HG21 ' A' ' 169' ' ' VAL . 5.4 p90 -143.76 170.82 15.16 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.353 -0.842 . . . . 0.0 110.01 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 215' ' ' ARG . 3.6 tt0 -145.86 157.52 43.9 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.429 -0.794 . . . . 0.0 110.932 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.914 HG22 ' OH ' ' A' ' 180' ' ' TYR . 7.0 tp -143.15 154.37 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.545 -0.722 . . . . 0.0 109.848 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.696 ' O ' ' HD3' ' A' ' 96' ' ' PRO . 0.1 OUTLIER -149.88 137.09 19.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.321 -0.862 . . . . 0.0 110.3 -179.63 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.706 ' CG ' HG23 ' A' ' 212' ' ' VAL . 49.7 m95 -108.93 88.3 5.37 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 121.258 -0.901 . . . . 0.0 110.655 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.696 ' HD3' ' O ' ' A' ' 94' ' ' SER . 52.3 Cg_endo -97.26 108.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.348 1.365 . . . . 0.0 110.215 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.719 0 O-C-N 120.781 -1.2 . . . . 0.0 110.187 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.825 HG23 ' CB ' ' A' ' 204' ' ' SER . 34.2 m . . . . . 0 N--CA 1.482 1.135 0 CA-C-O 121.891 0.853 . . . . 0.0 110.357 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.685 HG22 HG23 ' A' ' 203' ' ' VAL . 76.5 t -151.15 170.21 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.67 ' CA ' ' HA3' ' A' ' 132' ' ' GLY . . . 168.75 169.22 31.89 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 118.798 -1.667 . . . . 0.0 111.251 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.112 ' CG1' HD13 ' A' ' 199' ' ' LEU . 2.2 t -121.74 159.82 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.694 -0.886 . . . . 0.0 109.321 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.557 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -140.07 143.8 36.5 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.977 -1.077 . . . . 0.0 111.401 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 1.008 ' OG1' HD23 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -126.07 135.52 51.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.522 -0.736 . . . . 0.0 110.161 179.473 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.15 -25.35 17.9 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.445 -0.784 . . . . 0.0 109.173 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.48 ' O ' ' C ' ' A' ' 113' ' ' ALA . 2.7 pp -85.54 -12.22 52.18 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.581 -0.7 . . . . 0.0 109.356 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.555 ' HB2' ' HB ' ' A' ' 110' ' ' THR . . . . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.57 -0.706 . . . . 0.0 110.352 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 24.5 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.175 0.512 . . . . 0.0 110.234 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.408 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -150.18 134.33 17.08 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.217 -0.927 . . . . 0.0 109.821 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 14.1 t -151.4 118.61 5.94 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.301 -0.874 . . . . 0.0 110.391 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . 0.52 ' CD1' ' N ' ' A' ' 131' ' ' TRP . 2.7 p-90 -135.59 166.23 23.69 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.67 ' HA3' ' CA ' ' A' ' 107' ' ' GLY . . . 177.67 -138.26 3.75 Favored Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.773 -1.203 . . . . 0.0 110.431 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.831 ' HB3' HG11 ' A' ' 163' ' ' VAL . 53.5 m0 -104.8 113.4 26.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.365 -1.08 . . . . 0.0 110.657 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.708 ' O ' HG23 ' A' ' 135' ' ' ILE . 1.9 p30 -118.74 113.31 20.95 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.45 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.954 HD11 ' HB ' ' A' ' 163' ' ' VAL . 3.5 pt . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.171 -0.956 . . . . 0.0 110.027 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.954 ' HB ' HD11 ' A' ' 135' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.634 ' HA ' ' HB2' ' A' ' 95' ' ' TRP . 48.8 Cg_endo -82.8 62.41 7.76 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.548 1.288 . . . . 0.0 109.118 178.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.644 ' O ' ' CB ' ' A' ' 94' ' ' SER . 11.0 tp10 -173.75 -78.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.64 -0.662 . . . . 0.0 109.61 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 1.088 ' C ' HD22 ' A' ' 167' ' ' LEU . 7.7 ttt180 -151.6 132.96 14.59 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.537 -0.727 . . . . 0.0 109.645 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 1.088 HD22 ' C ' ' A' ' 166' ' ' ARG . 3.0 mm? -140.33 153.61 46.49 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.366 -0.834 . . . . 0.0 110.8 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.424 ' N ' ' HE1' ' A' ' 180' ' ' TYR . 6.2 tp -129.07 130.24 46.28 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.567 -0.708 . . . . 0.0 109.259 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 1.064 HG12 ' CE1' ' A' ' 180' ' ' TYR . 0.2 OUTLIER -127.25 144.1 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.955 -1.091 . . . . 0.0 110.262 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.584 HG11 ' HZ ' ' A' ' 191' ' ' PHE . 4.3 p -102.53 133.19 46.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.815 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.992 HD13 HD23 ' A' ' 178' ' ' LEU . 2.7 tp -124.76 105.89 9.64 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.433 -0.792 . . . . 0.0 109.824 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.514 ' OD1' ' CG ' ' A' ' 174' ' ' GLU . 5.1 t70 -119.97 134.44 55.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 110.488 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.535 ' CG ' ' O ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -98.8 -42.23 7.29 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.278 0.561 . . . . 0.0 109.63 179.491 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.514 ' CG ' ' OD1' ' A' ' 172' ' ' ASP . 7.9 pt-20 -45.01 -24.91 0.26 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.246 -0.908 . . . . 0.0 108.828 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.622 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.2 OUTLIER -112.25 -27.01 8.5 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.16 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.453 ' O ' ' CG2' ' A' ' 198' ' ' THR . . . 80.88 25.73 55.24 Favored Glycine 0 N--CA 1.483 1.787 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 1.124 HG22 ' CD2' ' A' ' 194' ' ' LEU . 0.1 OUTLIER -112.7 124.05 51.69 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.096 -1.238 . . . . 0.0 111.093 -179.434 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.992 HD23 HD13 ' A' ' 171' ' ' LEU . 2.6 mp -129.08 153.47 47.61 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.51 -0.744 . . . . 0.0 109.434 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.918 ' O ' HG23 ' A' ' 169' ' ' VAL . . . -178.9 163.67 31.5 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.2 -1.476 . . . . 0.0 110.633 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 1.064 ' CE1' HG12 ' A' ' 169' ' ' VAL . 0.1 OUTLIER -118.28 128.17 54.42 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.455 -1.026 . . . . 0.0 109.492 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.597 ' OG ' ' N ' ' A' ' 186' ' ' TYR . 5.7 t -132.34 165.15 24.86 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.662 0.744 . . . . 0.0 110.186 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.813 HG22 ' CD1' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -105.46 116.7 49.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 O-C-N 121.792 -0.568 . . . . 0.0 109.556 179.356 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 64.4 8.86 33.79 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 86.81 35.18 10.31 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . 0.477 ' O ' ' C ' ' A' ' 186' ' ' TYR . 37.3 m -106.77 -65.93 1.05 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.117 -1.225 . . . . 0.0 110.71 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.597 ' N ' ' OG ' ' A' ' 181' ' ' SER . 0.1 OUTLIER -35.98 -74.3 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.315 -0.866 . . . . 0.0 110.761 -179.618 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.84 HD11 HD12 ' A' ' 194' ' ' LEU . 2.7 mm? -67.69 46.19 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.037 -1.039 . . . . 0.0 110.081 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 186' ' ' TYR . . . -73.51 -99.05 0.08 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.536 ' C ' ' H ' ' A' ' 191' ' ' PHE . 49.2 Cg_endo -73.65 -23.99 16.34 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.109 1.583 . . . . 0.0 111.242 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.53 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -62.39 29.39 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.39 -0.819 . . . . 0.0 111.797 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.727 ' HE1' HD12 ' A' ' 187' ' ' LEU . 1.0 OUTLIER -90.54 -22.33 21.35 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.782 -1.199 . . . . 0.0 110.461 179.391 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . 0.496 ' N ' ' HD2' ' A' ' 192' ' ' ARG . 0.0 OUTLIER -87.82 -13.02 43.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.178 -0.951 . . . . 0.0 110.443 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -108.77 -10.46 24.78 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.334 -1.906 . . . . 0.0 108.334 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 1.124 ' CD2' HG22 ' A' ' 177' ' ' THR . 7.8 tt -72.86 -41.56 64.63 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.731 -0.864 . . . . 0.0 108.808 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.503 ' HD2' ' N ' ' A' ' 196' ' ' GLY . 0.0 OUTLIER -43.92 -42.14 5.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.486 -0.759 . . . . 0.0 109.975 179.61 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.503 ' N ' ' HD2' ' A' ' 195' ' ' LYS . . . -85.32 -25.64 39.12 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.881 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.66 -3.74 57.28 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.789 -0.83 . . . . 0.0 109.911 179.835 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . 0.734 HG23 ' O ' ' A' ' 194' ' ' LEU . 15.9 p -42.75 125.59 3.44 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.811 0.815 . . . . 0.0 111.85 -177.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 1.112 HD13 ' CG1' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -140.39 171.44 14.15 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.136 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.417 ' CD2' ' HA ' ' A' ' 82' ' ' ARG . 3.2 m-85 -84.2 129.16 59.36 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.949 -1.094 . . . . 0.0 109.97 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.559 ' HA ' HG13 ' A' ' 108' ' ' VAL . 50.7 Cg_endo -76.92 136.01 16.21 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 124.014 1.534 . . . . 0.0 111.012 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 4.7 t -133.18 140.21 47.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.449 -0.782 . . . . 0.0 109.945 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.685 HG23 HG22 ' A' ' 106' ' ' VAL . 6.0 p -120.3 153.5 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.237 -0.914 . . . . 0.0 110.153 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . 0.825 ' CB ' HG23 ' A' ' 105' ' ' VAL . 6.3 t -142.39 127.39 18.41 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.27 -0.894 . . . . 0.0 110.051 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 1.105 ' HB3' ' CG2' ' A' ' 78' ' ' VAL . . . -124.88 140.36 53.0 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.455 0.645 . . . . 0.0 110.415 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.84 HG13 ' N ' ' A' ' 207' ' ' TRP . 0.3 OUTLIER -64.56 -158.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.552 -0.718 . . . . 0.0 110.672 -179.527 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 0.912 ' CG ' ' HB2' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -121.1 154.98 35.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.409 -0.807 . . . . 0.0 109.932 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.458 ' O ' ' OE1' ' A' ' 211' ' ' GLN . . . 134.23 -175.18 20.55 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.533 ' CG ' ' OE1' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -98.21 -30.04 12.86 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.207 -1.172 . . . . 0.0 110.401 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 1.6 t -116.36 81.25 1.59 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.334 -0.854 . . . . 0.0 110.468 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.458 ' OE1' ' O ' ' A' ' 208' ' ' GLY . 0.0 OUTLIER -123.68 -90.49 0.57 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.165 -0.96 . . . . 0.0 110.241 179.683 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.706 HG23 ' CG ' ' A' ' 95' ' ' TRP . 4.2 p -127.5 143.26 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.085 -1.009 . . . . 0.0 111.276 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . 0.564 ' CD ' ' HB3' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -102.18 145.59 29.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.469 -0.769 . . . . 0.0 108.953 178.64 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 1.036 HG22 HD11 ' A' ' 64' ' ' LEU . 4.8 tt -115.97 140.44 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.954 -1.091 . . . . 0.0 111.266 -178.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.606 ' O ' ' N ' ' A' ' 92' ' ' GLU . 7.9 ttm180 -130.6 109.32 10.57 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . 0.65 ' CD2' ' CB ' ' A' ' 91' ' ' TRP . 3.2 t80 -118.13 146.99 43.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.035 -1.041 . . . . 0.0 111.248 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . 0.505 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 2.6 mmt -136.39 115.84 12.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.564 -0.71 . . . . 0.0 110.0 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 126.69 -4.45 7.54 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.59 ' HB2' ' CE1' ' A' ' 216' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.248 -1.148 . . . . 0.0 110.229 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.9 HD13 ' HB2' ' A' ' 70' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 120.928 0.394 . . . . 0.0 110.459 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.78 ' HA ' HD23 ' A' ' 33' ' ' LEU . 42.9 mt-10 -43.87 -35.59 2.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.157 -0.964 . . . . 0.0 108.973 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -58.9 -24.26 62.09 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.631 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -83.46 -32.96 25.74 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.777 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.81 HD12 ' C ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -82.2 -37.18 26.44 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.696 0.76 . . . . 0.0 109.488 179.389 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.549 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 14.9 m -61.61 -11.38 11.18 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.279 0.561 . . . . 0.0 110.264 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 1.088 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -51.95 -168.04 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.431 -0.793 . . . . 0.0 110.272 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 1.088 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 40.7 Cg_endo -67.91 -169.81 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.55 1.289 . . . . 0.0 110.059 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.649 ' CD ' ' HB2' ' A' ' 36' ' ' PRO . 51.6 Cg_endo -96.77 63.55 0.13 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.528 1.486 . . . . 0.0 112.269 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.692 ' CD ' ' O ' ' A' ' 36' ' ' PRO . 51.2 Cg_endo -73.54 151.56 47.47 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.275 1.144 . . . . 0.0 109.583 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.592 ' O ' ' HB3' ' A' ' 43' ' ' GLN . 1.3 t0 -33.67 -30.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.3 -0.875 . . . . 0.0 109.833 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.073 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -57.2 -44.88 84.08 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.279 -0.888 . . . . 0.0 110.72 -179.354 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.697 ' N ' HD13 ' A' ' 40' ' ' LEU . 22.3 t -85.74 -34.4 8.4 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 C-N-CA 118.54 -1.264 . . . . 0.0 110.327 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.62 -39.08 12.07 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.134 -0.979 . . . . 0.0 113.114 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.64 ' NE2' ' HB3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -87.13 -18.75 29.7 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 120.82 -1.175 . . . . 0.0 109.885 -178.741 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.994 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 3.0 ttp85 -76.84 -55.36 5.55 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.28 -0.887 . . . . 0.0 108.918 178.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.635 ' ND1' ' O ' ' A' ' 41' ' ' VAL . 65.9 m170 -45.4 -23.58 0.22 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.407 ' N ' ' O ' ' A' ' 44' ' ' ARG . 7.0 t60 -84.5 -39.67 18.58 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.491 ' CA ' ' HG3' ' A' ' 61' ' ' GLU . . . -83.52 -80.57 1.01 Allowed Glycine 0 N--CA 1.487 2.054 0 N-CA-C 106.679 -2.568 . . . . 0.0 106.679 177.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.701 ' HB2' HG23 ' A' ' 59' ' ' VAL . 99.5 m95 -90.42 73.5 6.95 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.299 -1.118 . . . . 0.0 108.87 177.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.727 ' O ' ' HB3' ' A' ' 53' ' ' CYS . 0.0 OUTLIER -44.88 163.1 0.2 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.721 -0.612 . . . . 0.0 110.997 179.835 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.764 ' O ' ' O ' ' A' ' 53' ' ' CYS . 41.0 Cg_endo -67.66 -60.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.818 1.431 . . . . 0.0 110.887 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.804 ' HA ' ' HE3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -40.17 -84.82 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.661 -1.274 . . . . 0.0 109.121 179.385 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.768 ' HA ' ' N ' ' A' ' 80' ' ' GLY . 2.0 m-20 -47.92 0.89 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.337 -0.852 . . . . 0.0 111.548 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.764 ' O ' ' O ' ' A' ' 50' ' ' PRO . 1.3 t -166.07 129.95 2.16 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.631 -1.293 . . . . 0.0 112.199 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.91 ' H ' ' HA ' ' A' ' 78' ' ' VAL . 1.8 m -81.85 124.1 29.39 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.437 -0.789 . . . . 0.0 109.753 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.673 ' HB3' ' NH2' ' A' ' 44' ' ' ARG . 3.2 pt-20 -51.6 -2.03 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.377 -0.827 . . . . 0.0 110.746 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.822 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -49.46 -21.5 0.95 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.835 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.009 HD11 ' CB ' ' A' ' 207' ' ' TRP . 0.9 OUTLIER -112.04 166.73 6.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.676 -0.64 . . . . 0.0 109.916 -179.705 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.514 ' N ' ' CG2' ' A' ' 57' ' ' ILE . 2.0 t70 -109.12 96.11 6.09 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.006 0.908 . . . . 0.0 110.054 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.971 HG13 HG22 ' A' ' 57' ' ' ILE . 33.3 m -128.35 135.45 62.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.711 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.641 ' HG2' ' HA ' ' A' ' 40' ' ' LEU . 13.1 mtpt -125.62 155.41 40.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.006 -1.058 . . . . 0.0 111.558 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.492 ' O ' ' C ' ' A' ' 62' ' ' GLY . 1.4 tt0 -80.24 -130.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.384 -0.823 . . . . 0.0 110.06 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.492 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 39.92 53.87 3.08 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.676 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 105.84 66.05 0.66 Allowed Glycine 0 N--CA 1.486 2.009 0 N-CA-C 107.785 -2.126 . . . . 0.0 107.785 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.077 HD11 HG22 ' A' ' 214' ' ' ILE . 0.2 OUTLIER 0.77 86.31 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 122.026 -0.691 . . . . 0.0 111.454 -178.522 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -99.66 113.93 26.68 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.703 179.564 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.693 ' CD1' ' CE2' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -114.38 124.67 52.53 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.569 -0.707 . . . . 0.0 109.193 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.631 ' H ' HG12 ' A' ' 59' ' ' VAL . 3.7 tm-20 -150.36 130.32 13.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.982 -1.074 . . . . 0.0 110.921 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.548 ' HD2' ' O ' ' A' ' 68' ' ' ARG . 0.6 OUTLIER -110.85 156.15 21.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.372 -0.83 . . . . 0.0 109.449 179.209 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.608 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 2.3 tpt180 -173.94 -52.95 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 120.982 -1.074 . . . . 0.0 111.687 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.9 ' HB2' HD13 ' A' ' 29' ' ' LEU . 40.0 Cg_endo -66.09 -52.79 0.8 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.508 1.268 . . . . 0.0 111.298 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 56' ' ' ASN . 25.4 t -78.55 164.97 3.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.244 -0.91 . . . . 0.0 110.867 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.471 ' N ' HG12 ' A' ' 71' ' ' VAL . . . -179.47 -30.49 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.445 0.64 . . . . 0.0 109.429 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -73.93 -116.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.373 -0.829 . . . . 0.0 110.202 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.9 t -124.48 50.07 1.74 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.019 -1.051 . . . . 0.0 110.397 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.506 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 4.2 m -83.41 -125.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 0.0 110.054 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.549 ' CB ' ' OD1' ' A' ' 56' ' ' ASN . 0.4 OUTLIER -136.6 112.69 9.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.089 -1.007 . . . . 0.0 110.71 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.642 ' C ' HG13 ' A' ' 78' ' ' VAL . . . -57.23 -92.89 0.01 OUTLIER Glycine 0 N--CA 1.482 1.765 0 N-CA-C 105.359 -3.096 . . . . 0.0 105.359 177.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.205 ' CG2' ' HB3' ' A' ' 205' ' ' ALA . 32.7 m -152.9 119.5 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.229 -1.16 . . . . 0.0 110.047 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.741 ' O ' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -146.87 134.09 20.55 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.602 -0.686 . . . . 0.0 111.224 -179.299 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.768 ' N ' ' HA ' ' A' ' 52' ' ' ASP . . . -132.2 -179.64 16.4 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.587 ' N ' ' HZ3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER 179.98 26.5 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.432 -1.04 . . . . 0.0 110.28 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.73 ' CD ' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -69.77 -18.59 63.5 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.164 -0.96 . . . . 0.0 110.722 -179.674 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.73 ' N ' ' CD ' ' A' ' 82' ' ' ARG . . . 27.8 44.37 0.04 OUTLIER Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.503 ' N ' ' O ' ' A' ' 82' ' ' ARG . 1.2 t80 -103.63 95.56 6.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.218 -1.166 . . . . 0.0 110.482 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 1.034 ' OG ' HD21 ' A' ' 171' ' ' LEU . 3.6 p -140.47 166.58 24.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.311 -0.868 . . . . 0.0 110.172 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.576 ' HA ' ' CB ' ' A' ' 173' ' ' MET . 0.5 OUTLIER -136.31 156.52 48.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 109.928 179.584 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.586 ' N ' ' HB3' ' A' ' 173' ' ' MET . . . 62.31 -114.45 6.83 Favored Glycine 0 N--CA 1.483 1.816 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.19 131.26 47.09 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.513 -0.992 . . . . 0.0 110.968 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.704 ' HB2' HD23 ' A' ' 171' ' ' LEU . 74.1 m-70 -147.25 173.38 12.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.199 -0.938 . . . . 0.0 109.997 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.6 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -163.59 154.36 16.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.362 -0.836 . . . . 0.0 110.583 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.84 ' CE3' HG11 ' A' ' 169' ' ' VAL . 0.1 OUTLIER -134.66 170.79 15.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.171 -0.955 . . . . 0.0 109.3 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.925 ' O ' HD13 ' A' ' 93' ' ' ILE . 0.9 OUTLIER -146.8 152.66 39.12 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.699 -179.511 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.925 HD13 ' O ' ' A' ' 92' ' ' GLU . 7.8 mm -142.71 153.66 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.675 -0.641 . . . . 0.0 109.433 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.561 ' O ' ' HA ' ' A' ' 212' ' ' VAL . 0.0 OUTLIER -155.35 127.56 7.71 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.788 -1.195 . . . . 0.0 111.511 -179.564 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.643 ' CD1' ' N ' ' A' ' 95' ' ' TRP . 5.8 m95 -114.21 87.9 14.16 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.221 -0.924 . . . . 0.0 109.922 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.534 ' O ' ' NE2' ' A' ' 211' ' ' GLN . 51.7 Cg_endo -95.14 107.13 0.12 Allowed 'Trans proline' 0 C--N 1.302 -1.891 0 O-C-N 123.399 1.21 . . . . 0.0 110.333 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 23.5 tp . . . . . 0 N--CA 1.49 1.56 0 O-C-N 120.9 -1.125 . . . . 0.0 109.091 178.485 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.772 HG23 ' CB ' ' A' ' 204' ' ' SER . 3.7 m . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 1.05 HG23 ' O ' ' A' ' 202' ' ' SER . 0.7 OUTLIER -150.33 149.61 14.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.459 -0.776 . . . . 0.0 110.584 -178.302 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.599 ' HA2' ' HA3' ' A' ' 132' ' ' GLY . . . -153.91 142.79 9.44 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.096 ' CG2' HD13 ' A' ' 199' ' ' LEU . 2.8 m -98.46 155.17 3.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.251 -1.146 . . . . 0.0 110.299 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.557 ' C ' ' HB3' ' A' ' 199' ' ' LEU . . . -124.47 141.32 52.17 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.356 -0.84 . . . . 0.0 110.614 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 1.088 ' OG1' HD23 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -121.07 131.62 54.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.397 -0.815 . . . . 0.0 110.127 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.95 -26.4 17.58 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.346 -0.846 . . . . 0.0 109.358 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.0 pp -83.91 -12.31 55.63 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.572 -0.705 . . . . 0.0 109.329 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.691 ' HB3' ' HB ' ' A' ' 110' ' ' THR . . . . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.542 -0.724 . . . . 0.0 110.245 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 66.7 p . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.276 0.56 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -145.12 125.66 14.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.302 -0.874 . . . . 0.0 109.977 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 1.1 t -121.59 119.73 32.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 110.484 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . 0.648 ' O ' HG22 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -133.37 135.16 44.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.882 . . . . 0.0 109.781 179.679 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.599 ' HA3' ' HA2' ' A' ' 107' ' ' GLY . . . -175.66 -137.76 2.64 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.028 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.641 ' CH2' ' CD1' ' A' ' 182' ' ' ILE . 42.4 m0 -118.79 113.63 21.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.419 -1.048 . . . . 0.0 110.843 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.44 ' C ' HG12 ' A' ' 135' ' ' ILE . 45.5 t0 -118.63 147.64 43.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.512 -0.742 . . . . 0.0 109.895 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.561 HG13 HG12 ' A' ' 105' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.116 -0.99 . . . . 0.0 110.239 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 1.08 HG12 ' HD3' ' A' ' 164' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.863 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 1.08 ' HD3' HG12 ' A' ' 163' ' ' VAL . 43.8 Cg_endo -72.29 178.76 5.7 Favored 'Trans proline' 0 C--N 1.318 -1.03 0 O-C-N 122.481 0.727 . . . . 0.0 110.999 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.525 ' O ' ' HB3' ' A' ' 94' ' ' SER . 2.2 mt-10 -46.51 -32.2 3.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.428 -0.795 . . . . 0.0 111.232 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.54 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 18.2 ttp180 -151.83 156.17 39.64 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.981 -1.075 . . . . 0.0 111.13 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.831 HD21 ' CG2' ' A' ' 163' ' ' VAL . 1.7 mp -126.85 157.31 39.65 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.543 -0.723 . . . . 0.0 109.436 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.543 HD21 HG22 ' A' ' 170' ' ' VAL . 1.1 tt -117.44 121.41 40.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.065 -1.022 . . . . 0.0 110.728 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.84 HG11 ' CE3' ' A' ' 91' ' ' TRP . 16.4 t -89.65 128.78 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.3 -0.875 . . . . 0.0 109.494 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.543 HG22 HD21 ' A' ' 168' ' ' LEU . 19.2 t -109.99 115.62 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.004 -1.06 . . . . 0.0 110.675 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 1.034 HD21 ' OG ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -129.27 123.12 31.1 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.285 -0.884 . . . . 0.0 109.491 179.505 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 173' ' ' MET . 47.3 t0 -120.13 137.96 53.86 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.177 -0.952 . . . . 0.0 110.021 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.586 ' HB3' ' N ' ' A' ' 87' ' ' GLY . 0.0 OUTLIER -98.56 -40.68 8.11 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.56 179.676 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -50.85 -22.61 2.27 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.318 -0.864 . . . . 0.0 109.073 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.581 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.3 OUTLIER -109.26 -27.97 9.25 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.803 0.811 . . . . 0.0 108.924 179.473 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.583 ' O ' ' CB ' ' A' ' 198' ' ' THR . . . 86.84 22.34 46.48 Favored Glycine 0 N--CA 1.482 1.709 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.862 HG22 HD22 ' A' ' 194' ' ' LEU . 0.0 OUTLIER -112.52 133.45 54.57 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.099 -1.236 . . . . 0.0 111.466 -179.389 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.997 HD23 HD12 ' A' ' 171' ' ' LEU . 2.6 mp -130.52 153.59 48.68 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.654 -0.654 . . . . 0.0 109.472 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 176.16 -175.29 47.39 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.231 -1.461 . . . . 0.0 110.538 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.729 ' CZ ' HG22 ' A' ' 169' ' ' VAL . 0.2 OUTLIER -127.18 131.51 50.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.67 -0.9 . . . . 0.0 109.173 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 168' ' ' LEU . 3.4 t -136.7 131.22 33.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.122 -0.986 . . . . 0.0 110.536 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.864 HD11 ' CD2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -102.27 116.84 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.372 -0.83 . . . . 0.0 109.393 179.212 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 83.45 -11.87 53.85 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 81.43 47.05 6.59 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 32.4 m -136.13 -36.46 0.74 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.135 -1.215 . . . . 0.0 110.775 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.864 ' CD2' HD11 ' A' ' 182' ' ' ILE . 5.1 m-30 -67.0 -77.23 0.07 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.005 -1.06 . . . . 0.0 110.506 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.602 ' O ' ' CE2' ' A' ' 191' ' ' PHE . 2.4 mm? -68.46 44.28 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.906 -1.121 . . . . 0.0 109.88 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.53 ' H ' ' HD2' ' A' ' 189' ' ' PRO . . . -94.95 -63.89 1.0 Allowed Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.99 -1.1 . . . . 0.0 110.611 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.53 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 45.1 Cg_endo -72.01 -30.99 13.0 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.802 1.422 . . . . 0.0 111.3 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.754 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -74.58 16.59 0.26 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.239 -0.913 . . . . 0.0 111.418 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.602 ' CE2' ' O ' ' A' ' 187' ' ' LEU . 0.3 OUTLIER -89.57 -8.34 52.88 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.063 -1.023 . . . . 0.0 109.982 179.204 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.06 -15.3 32.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.568 -0.707 . . . . 0.0 110.126 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -115.71 -11.17 10.54 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 107.483 -2.247 . . . . 0.0 107.483 179.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.9 ' HA ' ' HD2' ' A' ' 197' ' ' ARG . 0.4 OUTLIER -70.56 -22.17 62.62 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.796 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.588 ' HA ' HG23 ' A' ' 177' ' ' THR . 0.0 OUTLIER -57.29 -26.55 61.04 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.355 -0.84 . . . . 0.0 109.378 179.038 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.539 ' N ' ' HE3' ' A' ' 195' ' ' LYS . . . -106.08 -37.74 2.45 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.9 ' HD2' ' HA ' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -79.62 -4.52 51.98 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.448 -1.031 . . . . 0.0 110.567 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . 0.583 ' CB ' ' O ' ' A' ' 176' ' ' GLY . 0.2 OUTLIER -43.37 133.82 4.08 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-O 122.194 0.997 . . . . 0.0 112.174 -177.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 1.096 HD13 ' CG2' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -141.73 171.06 14.57 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.218 179.19 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.673 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 46.5 m-85 -90.21 126.79 55.68 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.827 -1.171 . . . . 0.0 109.373 178.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.772 ' CA ' HG12 ' A' ' 108' ' ' VAL . 53.2 Cg_endo -82.16 150.36 15.64 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 124.196 1.629 . . . . 0.0 112.489 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 1.05 ' O ' HG23 ' A' ' 106' ' ' VAL . 73.6 p -133.69 149.84 51.52 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.583 HG22 ' N ' ' A' ' 204' ' ' SER . 14.5 p -118.62 168.17 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.406 -1.434 . . . . 0.0 110.623 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . 0.772 ' CB ' HG23 ' A' ' 105' ' ' VAL . 0.4 OUTLIER -156.0 145.16 20.64 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.425 0.631 . . . . 0.0 109.923 179.681 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 1.205 ' HB3' ' CG2' ' A' ' 78' ' ' VAL . . . -145.47 135.96 24.18 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.74 -0.6 . . . . 0.0 109.705 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.572 ' CG1' ' N ' ' A' ' 207' ' ' TRP . 1.5 t -76.57 172.06 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.459 -0.776 . . . . 0.0 110.512 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 1.009 ' CB ' HD11 ' A' ' 57' ' ' ILE . 14.2 p90 -121.91 128.51 51.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.307 -0.871 . . . . 0.0 110.089 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.539 ' N ' ' HG2' ' A' ' 68' ' ' ARG . . . 154.4 -167.12 32.39 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.449 ' C ' ' O ' ' A' ' 208' ' ' GLY . 0.0 OUTLIER -40.21 -28.74 0.06 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.381 -1.07 . . . . 0.0 110.142 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . 0.483 ' C ' ' HG3' ' A' ' 211' ' ' GLN . 9.7 t -64.26 164.29 11.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.321 -0.862 . . . . 0.0 110.219 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.534 ' NE2' ' O ' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -164.24 109.55 1.01 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.358 -0.839 . . . . 0.0 109.655 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.645 ' O ' ' CH2' ' A' ' 48' ' ' TRP . 5.7 p -102.65 143.77 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.437 -0.79 . . . . 0.0 110.308 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . 0.458 ' HB2' ' OG ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -93.93 156.2 16.75 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.364 -0.835 . . . . 0.0 109.41 179.361 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 1.077 HG22 HD11 ' A' ' 64' ' ' LEU . 4.9 tt -139.06 131.54 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.046 -1.034 . . . . 0.0 110.812 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.596 ' HB3' ' HB3' ' A' ' 92' ' ' GLU . 12.6 ttt180 -130.1 108.29 9.96 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . 0.736 ' CZ ' ' CD1' ' A' ' 91' ' ' TRP . 4.2 t80 -118.92 142.94 47.32 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.385 -0.822 . . . . 0.0 111.15 -177.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.58 115.57 12.34 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.558 -0.713 . . . . 0.0 110.102 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 133.85 53.85 0.07 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.265 -1.138 . . . . 0.0 110.114 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.576 ' HG ' ' N ' ' A' ' 30' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.184 0.516 . . . . 0.0 110.285 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.944 ' HA ' HD23 ' A' ' 33' ' ' LEU . 1.3 mt-10 -47.69 -35.12 9.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.101 -0.999 . . . . 0.0 109.192 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -62.27 -24.07 67.07 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.309 -0.87 . . . . 0.0 108.841 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.545 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.7 OUTLIER -83.44 -34.06 25.54 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.102 HD21 ' CG ' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -76.17 -36.06 58.88 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.877 0.846 . . . . 0.0 109.42 179.323 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.606 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -80.46 -7.37 59.13 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.161 179.878 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.982 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -54.87 -66.81 0.82 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.213 -0.929 . . . . 0.0 110.488 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.982 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 48.9 Cg_endo -73.65 143.22 33.62 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.692 1.364 . . . . 0.0 110.316 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 36' ' ' PRO . 53.8 Cg_endo -98.88 56.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 121.898 1.732 . . . . 0.0 112.034 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.726 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 52.8 Cg_endo -75.82 150.91 35.35 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 122.979 0.989 . . . . 0.0 110.118 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.615 ' O ' ' HB3' ' A' ' 43' ' ' GLN . 1.0 OUTLIER -34.26 -33.52 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.313 -0.867 . . . . 0.0 109.457 179.557 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.088 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -57.41 -46.88 83.02 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.242 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.991 HG23 HD13 ' A' ' 40' ' ' LEU . 54.4 t -86.6 -33.7 7.32 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 O-C-N 120.647 -1.283 . . . . 0.0 110.415 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.21 -39.17 12.25 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.401 -0.812 . . . . 0.0 113.058 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.615 ' HB3' ' O ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -86.67 -19.65 28.93 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 120.726 -1.234 . . . . 0.0 109.455 -178.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 1.086 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -79.36 -51.09 9.87 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 122.078 0.942 . . . . 0.0 109.528 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.834 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 59.5 m170 -51.52 -17.57 0.85 Allowed 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.632 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.402 ' CD2' ' C ' ' A' ' 46' ' ' HIS . 4.0 t60 -84.46 -39.21 19.21 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.443 -1.303 . . . . 0.0 110.029 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.942 ' O ' HD12 ' A' ' 214' ' ' ILE . . . -97.98 -68.19 0.93 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 106.597 -2.601 . . . . 0.0 106.597 177.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.838 ' CD1' ' CG2' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -89.26 72.61 8.13 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 177.229 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.834 ' HA ' ' HA ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER -55.22 151.45 18.15 Favored Pre-proline 0 N--CA 1.494 1.754 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.412 -178.514 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.734 ' HD3' ' HA ' ' A' ' 45' ' ' HIS . 45.0 Cg_endo -78.49 -25.86 6.43 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 124.522 1.801 . . . . 0.0 110.563 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.852 ' N ' ' HE3' ' A' ' 51' ' ' LYS . 0.4 OUTLIER -64.48 -14.3 56.4 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.145 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 1.081 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 9.8 m-20 -122.75 2.16 9.45 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.644 178.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.863 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 10.1 t -151.73 132.94 14.45 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.877 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.75 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 0.8 OUTLIER -71.81 118.49 14.73 Favored 'General case' 0 C--N 1.292 -1.926 0 O-C-N 121.548 -0.72 . . . . 0.0 110.34 179.434 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 1.102 ' CG ' HD21 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -40.25 -20.49 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.503 -0.748 . . . . 0.0 111.786 -179.641 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.75 ' ND2' ' HB2' ' A' ' 54' ' ' SER . 0.0 OUTLIER -54.45 -1.9 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.762 -1.211 . . . . 0.0 109.638 179.755 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.706 HG23 ' O ' ' A' ' 67' ' ' GLU . 26.9 mm -111.68 155.35 13.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.923 0.868 . . . . 0.0 111.323 -177.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.582 ' N ' ' O ' ' A' ' 67' ' ' GLU . 1.4 t70 -118.14 95.36 4.86 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.718 0.77 . . . . 0.0 109.266 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.952 HG21 ' CD1' ' A' ' 66' ' ' PHE . 1.1 p -131.56 118.99 41.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 O-C-N 121.808 -0.557 . . . . 0.0 111.397 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.607 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -136.76 157.57 46.44 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.066 -1.021 . . . . 0.0 111.265 179.551 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.771 ' N ' ' CH2' ' A' ' 48' ' ' TRP . 1.0 OUTLIER -39.27 -112.98 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.717 -0.614 . . . . 0.0 112.029 -179.157 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.514 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 42.11 44.57 4.82 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 107.291 -2.324 . . . . 0.0 107.291 -177.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.743 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 84.64 87.08 0.89 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 106.881 -2.488 . . . . 0.0 106.881 -177.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.765 HD13 ' HE1' ' A' ' 48' ' ' TRP . 0.2 OUTLIER 1.48 82.88 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.632 -0.922 . . . . 0.0 109.901 -177.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.703 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -101.57 114.15 27.93 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.879 -0.728 . . . . 0.0 110.48 -178.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.952 ' CD1' HG21 ' A' ' 59' ' ' VAL . 4.5 t80 -114.42 123.39 49.33 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.706 ' O ' HG23 ' A' ' 57' ' ' ILE . 1.3 tm-20 -151.7 163.05 39.96 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.16 -0.963 . . . . 0.0 110.497 -179.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.621 ' CG ' ' HB2' ' A' ' 207' ' ' TRP . 0.2 OUTLIER -111.42 153.37 26.19 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.222 -0.923 . . . . 0.0 109.841 179.223 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.714 ' CB ' ' HD3' ' A' ' 70' ' ' PRO . 34.8 mtp180 -85.2 -73.87 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 120.978 -1.076 . . . . 0.0 109.665 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.714 ' HD3' ' CB ' ' A' ' 69' ' ' ARG . 57.5 Cg_endo -76.23 -124.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 N-CA-C 108.384 -1.429 . . . . 0.0 108.384 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.42 ' H ' ' HB2' ' A' ' 70' ' ' PRO . 2.6 t -140.44 164.51 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.455 -1.403 . . . . 0.0 109.947 179.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.579 ' HB2' ' CD1' ' A' ' 207' ' ' TRP . . . -80.04 33.45 0.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.178 -0.951 . . . . 0.0 110.357 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -45.98 -47.47 16.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.258 -0.901 . . . . 0.0 110.361 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.9 p -172.67 30.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.27 -0.894 . . . . 0.0 110.154 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.565 HG23 ' N ' ' A' ' 76' ' ' ASP . 9.9 t -97.87 -132.06 0.22 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.883 . . . . 0.0 109.992 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.597 ' O ' ' HB2' ' A' ' 54' ' ' SER . 12.5 m-20 -140.41 114.05 8.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.157 -0.964 . . . . 0.0 110.572 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 76' ' ' ASP . . . -55.83 -106.52 0.01 OUTLIER Glycine 0 N--CA 1.486 1.986 0 N-CA-C 107.942 -2.063 . . . . 0.0 107.942 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.03 ' CG2' ' HB3' ' A' ' 205' ' ' ALA . 4.4 m -138.16 123.91 24.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 120.998 -1.295 . . . . 0.0 110.078 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.662 ' NE ' ' O ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -145.42 133.83 21.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.18 -0.95 . . . . 0.0 112.161 -178.616 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 1.081 ' CA ' ' HA ' ' A' ' 52' ' ' ASP . . . -131.79 163.84 23.72 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 178.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.548 ' CB ' ' HB3' ' A' ' 202' ' ' SER . 2.5 ttpm? -171.01 87.28 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.494 -1.003 . . . . 0.0 109.513 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.818 ' HD3' ' H ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -152.31 -91.18 0.05 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.227 -0.92 . . . . 0.0 110.542 -179.366 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.818 ' H ' ' HD3' ' A' ' 82' ' ' ARG . . . 45.75 42.78 11.2 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -97.21 106.2 18.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -1.11 . . . . 0.0 110.217 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.595 ' HB2' ' CE1' ' A' ' 89' ' ' HIS . 75.5 p -138.28 167.17 22.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 0.0 110.071 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.538 ' HA ' ' CB ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -120.14 135.44 54.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.216 -0.927 . . . . 0.0 110.285 -179.824 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 172' ' ' ASP . . . 102.83 -116.64 5.54 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.476 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 2.5 tp -128.36 130.27 47.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.321 -1.105 . . . . 0.0 110.282 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.595 ' CE1' ' HB2' ' A' ' 85' ' ' SER . 33.4 m-70 -146.33 166.2 27.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.099 -1.001 . . . . 0.0 109.997 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.539 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -158.99 153.71 24.63 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.054 -1.029 . . . . 0.0 109.92 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 1.001 ' CZ2' HD22 ' A' ' 171' ' ' LEU . 1.4 m0 -134.81 148.57 50.22 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.298 -0.876 . . . . 0.0 109.911 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.731 ' C ' HD12 ' A' ' 93' ' ' ILE . 7.8 mt-10 -109.56 118.42 36.55 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.52 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.731 HD12 ' C ' ' A' ' 92' ' ' GLU . 1.2 mp -133.69 154.52 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.054 -1.029 . . . . 0.0 110.877 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.589 ' HA ' ' HG ' ' A' ' 167' ' ' LEU . 0.3 OUTLIER -140.88 119.94 12.8 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.16 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 1.134 ' CE3' HG22 ' A' ' 106' ' ' VAL . 3.0 t-105 -117.41 89.5 31.91 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.072 -1.018 . . . . 0.0 110.657 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 94' ' ' SER . 51.0 Cg_endo -89.18 109.53 0.47 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.085 1.571 . . . . 0.0 110.153 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.99 HD23 ' HE1' ' A' ' 95' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.758 0 O-C-N 121.128 -0.982 . . . . 0.0 110.399 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.897 HG23 ' HA ' ' A' ' 134' ' ' ASP . 4.9 p . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 121.244 0.545 . . . . 0.0 112.405 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 1.134 HG22 ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -122.31 115.93 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 177.114 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.591 ' HA3' ' HA3' ' A' ' 132' ' ' GLY . . . -160.54 -164.96 16.43 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 118.648 -1.739 . . . . 0.0 111.227 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.654 ' HB ' HD13 ' A' ' 199' ' ' LEU . 0.7 OUTLIER -120.54 156.23 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.617 -0.931 . . . . 0.0 109.515 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 130' ' ' SER . . . -128.13 143.09 51.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.861 -1.149 . . . . 0.0 110.686 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.886 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.7 OUTLIER -115.38 123.13 47.9 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.196 -0.94 . . . . 0.0 110.455 179.74 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.91 -31.03 14.47 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.465 -0.772 . . . . 0.0 109.712 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.695 ' O ' ' C ' ' A' ' 113' ' ' ALA . 1.7 pp -79.22 -11.87 59.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.507 -0.745 . . . . 0.0 110.115 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.695 ' C ' ' O ' ' A' ' 112' ' ' LEU . . . . . . . . 0 N--CA 1.499 2.01 0 O-C-N 121.872 -0.518 . . . . 0.0 111.128 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.17 0.51 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -149.84 128.91 12.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.268 -0.895 . . . . 0.0 109.964 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 2.9 t -120.41 119.35 32.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.16 -0.963 . . . . 0.0 110.501 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -133.94 136.19 44.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.501 -0.749 . . . . 0.0 109.305 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.591 ' HA3' ' HA3' ' A' ' 107' ' ' GLY . . . -165.39 -111.34 0.24 Allowed Glycine 0 N--CA 1.486 2.001 0 C-N-CA 119.042 -1.552 . . . . 0.0 110.796 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.764 ' CH2' ' HB2' ' A' ' 180' ' ' TYR . 5.3 m-90 -140.3 122.77 16.1 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 121.168 -1.195 . . . . 0.0 111.634 -178.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.897 ' HA ' HG23 ' A' ' 105' ' ' VAL . 0.9 OUTLIER -118.89 148.62 42.72 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.394 -179.638 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.549 HD13 ' N ' ' A' ' 135' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.79 0 O-C-N 121.348 -0.845 . . . . 0.0 110.313 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.88 HG11 ' HB ' ' A' ' 182' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.457 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.686 ' HD3' ' N ' ' A' ' 163' ' ' VAL . 53.7 Cg_endo -79.76 81.91 2.64 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.785 1.413 . . . . 0.0 110.872 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -167.25 -84.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.05 -1.031 . . . . 0.0 110.106 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 1.03 ' O ' HD23 ' A' ' 167' ' ' LEU . 20.3 ttp180 -151.9 155.84 38.9 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.461 -0.775 . . . . 0.0 109.988 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 1.03 HD23 ' O ' ' A' ' 166' ' ' ARG . 9.9 mt -138.15 128.85 26.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.192 -0.943 . . . . 0.0 110.525 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 17.7 tp -103.63 141.34 36.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.259 -0.9 . . . . 0.0 109.167 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.703 HG13 ' CD2' ' A' ' 180' ' ' TYR . 6.8 t -125.55 132.22 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.799 -1.188 . . . . 0.0 111.58 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.743 HG13 ' O ' ' A' ' 170' ' ' VAL . 11.4 p -138.02 104.93 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 1.001 HD22 ' CZ2' ' A' ' 91' ' ' TRP . 0.0 OUTLIER -118.41 141.13 48.85 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.134 -0.979 . . . . 0.0 110.417 -179.083 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 173' ' ' MET . 40.4 t0 -120.2 138.68 53.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.29 -0.881 . . . . 0.0 110.19 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.55 ' CG ' ' O ' ' A' ' 85' ' ' SER . 4.1 tpt -89.97 -39.15 13.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.624 -0.673 . . . . 0.0 109.849 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 173' ' ' MET . 1.4 tt0 -42.09 -27.78 0.15 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.892 . . . . 0.0 109.191 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.515 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 3.0 tt0 -106.99 -27.76 10.46 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.702 0.763 . . . . 0.0 108.97 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 86.11 21.98 50.37 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.98 HG22 ' CD2' ' A' ' 194' ' ' LEU . 0.8 OUTLIER -121.76 150.54 41.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.342 -1.093 . . . . 0.0 110.642 -179.651 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.963 ' HB3' HD12 ' A' ' 171' ' ' LEU . 0.2 OUTLIER -117.44 153.52 32.95 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.439 -0.788 . . . . 0.0 109.895 179.815 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -134.09 122.03 2.88 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.764 ' HB2' ' CH2' ' A' ' 133' ' ' TRP . 2.4 t80 -119.77 124.8 47.06 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.26 -1.141 . . . . 0.0 109.508 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.462 ' HA ' HG23 ' A' ' 185' ' ' THR . 12.5 t -103.66 122.21 44.55 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 122.135 0.969 . . . . 0.0 109.456 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 1.009 HG22 ' CD2' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -129.42 158.54 42.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.819 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.612 ' C ' ' O ' ' A' ' 182' ' ' ILE . . . -33.63 -34.77 0.03 OUTLIER Glycine 0 N--CA 1.493 2.446 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.686 ' O ' ' CD1' ' A' ' 186' ' ' TYR . . . -105.5 32.66 7.2 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.549 -1.82 . . . . 0.0 108.549 178.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . 0.817 ' N ' ' O ' ' A' ' 182' ' ' ILE . 53.3 m -37.77 -26.59 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.494 -1.004 . . . . 0.0 110.871 -179.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.7 ' O ' ' CD2' ' A' ' 186' ' ' TYR . 16.9 p90 -41.38 91.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 122.202 1.001 . . . . 0.0 109.316 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.669 ' C ' ' HD2' ' A' ' 189' ' ' PRO . 0.1 OUTLIER 179.81 31.2 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.542 -0.724 . . . . 0.0 109.221 -178.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.865 ' N ' ' CD ' ' A' ' 189' ' ' PRO . . . -105.67 2.08 39.22 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.403 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.865 ' CD ' ' N ' ' A' ' 188' ' ' GLY . 48.7 Cg_endo -75.79 -27.12 9.06 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 N-CA-C 109.426 -1.028 . . . . 0.0 109.426 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -81.43 21.97 0.73 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.631 -0.668 . . . . 0.0 110.476 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.401 ' HA ' ' HB2' ' A' ' 194' ' ' LEU . 1.8 m-85 -73.2 -48.67 33.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.11 -0.994 . . . . 0.0 109.945 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 9.5 mtm180 -52.87 -19.25 2.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.187 -0.946 . . . . 0.0 109.766 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -107.32 -17.93 10.91 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.166 -1.973 . . . . 0.0 108.166 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.98 ' CD2' HG22 ' A' ' 177' ' ' THR . 6.9 tt -62.2 -31.32 71.83 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.692 -0.887 . . . . 0.0 109.205 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.554 ' HE3' ' N ' ' A' ' 196' ' ' GLY . 0.0 OUTLIER -49.52 -27.83 4.8 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.443 -0.786 . . . . 0.0 109.407 179.534 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.554 ' N ' ' HE3' ' A' ' 195' ' ' LYS . . . -112.29 -21.59 6.17 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.642 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.77 -10.42 42.95 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.65 -0.912 . . . . 0.0 109.749 179.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . 0.623 HG22 ' O ' ' A' ' 194' ' ' LEU . 0.1 OUTLIER -43.83 145.25 0.71 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.907 0.86 . . . . 0.0 111.427 -178.559 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.886 ' CB ' HG23 ' A' ' 110' ' ' THR . 0.0 OUTLIER -140.43 171.45 14.12 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.24 0.543 . . . . 0.0 109.725 179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.421 ' C ' ' CG1' ' A' ' 108' ' ' VAL . 15.8 m-30 -84.33 136.98 39.75 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.178 -0.951 . . . . 0.0 109.218 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.584 ' HG3' ' CH2' ' A' ' 91' ' ' TRP . 40.8 Cg_endo -67.03 109.82 1.81 Allowed 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 123.862 1.454 . . . . 0.0 110.814 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.548 ' HB3' ' CB ' ' A' ' 81' ' ' LYS . 57.4 p -133.47 137.2 45.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.507 -0.746 . . . . 0.0 109.595 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 79' ' ' ARG . 4.9 p -128.9 146.55 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.994 -1.066 . . . . 0.0 111.187 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 26.7 m -128.75 127.19 41.54 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 1.03 ' HB3' ' CG2' ' A' ' 78' ' ' VAL . . . -126.28 166.14 17.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 0.0 110.716 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.583 ' CG1' ' N ' ' A' ' 207' ' ' TRP . 0.9 OUTLIER -101.63 174.66 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 121.363 0.602 . . . . 0.0 110.233 -179.533 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 0.621 ' HB2' ' CG ' ' A' ' 68' ' ' ARG . 63.9 p-90 -99.01 128.43 45.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.89 . . . . 0.0 110.264 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 144.04 -147.48 18.78 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 211' ' ' GLN . 0.0 OUTLIER -66.18 -25.25 66.85 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.345 -1.091 . . . . 0.0 110.239 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . 0.678 ' O ' ' C ' ' A' ' 211' ' ' GLN . 4.9 t -37.12 -30.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.593 -0.692 . . . . 0.0 110.621 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.678 ' C ' ' O ' ' A' ' 210' ' ' CYS . 10.4 mt-30 0.07 114.59 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 121.65 0.738 . . . . 0.0 111.427 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.66 ' O ' HD11 ' A' ' 64' ' ' LEU . 0.8 OUTLIER -115.62 144.09 24.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.642 -0.661 . . . . 0.0 110.668 -179.164 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . 0.554 ' HG3' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -88.54 121.96 31.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.281 -0.887 . . . . 0.0 109.566 179.758 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 1.061 ' O ' HD13 ' A' ' 214' ' ' ILE . 0.0 OUTLIER -123.5 121.59 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 110.896 -179.241 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.653 ' N ' ' O ' ' A' ' 92' ' ' GLU . 0.2 OUTLIER -130.87 139.61 50.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.513 -0.742 . . . . 0.0 109.665 179.495 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . 0.717 ' CE2' ' CD1' ' A' ' 91' ' ' TRP . 0.9 OUTLIER -118.7 150.76 39.21 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.965 -1.085 . . . . 0.0 110.728 -179.439 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . 0.494 ' CB ' ' O ' ' A' ' 90' ' ' ALA . 2.0 ttm -125.08 107.82 11.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.305 -0.872 . . . . 0.0 110.039 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 116.54 21.59 4.67 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.108 -1.23 . . . . 0.0 110.23 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.935 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.052 0.453 . . . . 0.0 109.982 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.54 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 3.0 pt-20 -48.42 -35.71 13.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.052 -1.03 . . . . 0.0 108.691 179.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -59.13 -26.09 64.42 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -77.73 -36.01 51.35 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.457 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.896 HD12 ' C ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -76.3 -38.85 55.49 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.663 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.564 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -45.92 -26.62 0.73 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.454 0.645 . . . . 0.0 109.925 179.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 1.087 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -52.16 -168.47 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.567 -0.708 . . . . 0.0 109.376 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 1.087 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 39.7 Cg_endo -67.07 104.53 0.86 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.448 1.236 . . . . 0.0 109.704 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.846 ' HG2' HG21 ' A' ' 41' ' ' VAL . 51.1 Cg_endo -90.84 115.24 0.46 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.284 1.676 . . . . 0.0 111.49 -178.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.902 ' O ' ' N ' ' A' ' 40' ' ' LEU . 50.6 Cg_endo -86.13 152.59 9.57 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 124.087 1.572 . . . . 0.0 110.493 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.676 ' C ' ' O ' ' A' ' 38' ' ' PRO . 0.4 OUTLIER 4.26 53.68 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 122.313 1.054 . . . . 0.0 110.185 -178.258 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.203 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -129.64 -39.62 1.44 Allowed 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.934 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.846 HG21 ' HG2' ' A' ' 37' ' ' PRO . 1.6 t -78.38 -36.4 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 118.751 -1.179 . . . . 0.0 111.69 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.52 ' HB3' ' OE1' ' A' ' 43' ' ' GLN . . . -74.71 -37.79 62.5 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.585 -1.322 . . . . 0.0 111.681 -178.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.962 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -87.35 -20.27 26.99 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.414 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.822 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 6.6 ttm180 -65.88 -50.6 63.92 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 122.511 1.148 . . . . 0.0 108.085 178.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.78 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 43.2 m-70 -68.68 -17.79 64.14 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.707 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -96.6 -33.19 11.88 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.335 -0.853 . . . . 0.0 109.526 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 43' ' ' GLN . . . -87.3 -113.59 1.0 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.995 ' HE1' HG21 ' A' ' 59' ' ' VAL . 11.9 m95 -86.29 74.31 10.02 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.027 -1.278 . . . . 0.0 108.61 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.633 ' OD1' ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -51.29 127.43 29.96 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.507 -0.746 . . . . 0.0 111.104 -178.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.59 ' C ' ' H ' ' A' ' 52' ' ' ASP . 50.3 Cg_endo -86.64 2.48 7.16 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.339 2.026 . . . . 0.0 111.884 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.958 ' HE2' ' HA ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -57.06 -2.19 0.08 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.651 -1.281 . . . . 0.0 109.365 -179.256 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.668 ' HB3' ' HE ' ' A' ' 79' ' ' ARG . 0.3 OUTLIER -117.83 -9.46 10.66 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.668 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.589 ' CB ' ' HB3' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -155.65 -178.6 7.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.422 -0.799 . . . . 0.0 110.705 -179.474 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.592 ' CB ' HD21 ' A' ' 56' ' ' ASN . 5.0 p -68.51 143.09 55.08 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.235 -0.916 . . . . 0.0 109.767 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.749 ' CG ' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -98.78 7.71 45.76 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.654 -0.654 . . . . 0.0 111.199 -178.796 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 76' ' ' ASP . 0.0 OUTLIER -27.16 -38.12 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 122.031 0.919 . . . . 0.0 109.42 -179.751 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.654 ' N ' ' O ' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -140.0 145.81 25.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.729 ' OD1' ' HA ' ' A' ' 44' ' ' ARG . 0.8 OUTLIER -149.99 158.63 44.36 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 118.789 -1.164 . . . . 0.0 110.867 -179.873 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.995 HG21 ' HE1' ' A' ' 48' ' ' TRP . 1.5 m -114.02 138.45 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.791 0.805 . . . . 0.0 111.92 -177.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.745 ' HA ' ' HB3' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -102.37 152.65 20.84 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.912 179.177 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.459 ' O ' ' O ' ' A' ' 60' ' ' LYS . 1.8 tt0 -60.81 -132.84 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.26 -0.9 . . . . 0.0 110.309 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 44.48 27.71 1.33 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.68 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 131.44 39.73 0.24 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 -179.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.68 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.3 OUTLIER 0.6 87.4 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.897 -0.766 . . . . 0.0 111.026 -179.456 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.967 ' C ' ' HB ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -140.3 134.88 31.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.433 -0.792 . . . . 0.0 110.973 -179.487 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.845 ' CD2' ' CG1' ' A' ' 59' ' ' VAL . 46.1 m-85 -80.14 148.58 30.88 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.599 0.714 . . . . 0.0 110.054 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -128.67 121.63 28.98 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.603 -0.685 . . . . 0.0 109.653 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.866 ' NE ' ' HB2' ' A' ' 72' ' ' ALA . 6.3 ttt-85 -119.06 130.67 55.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.923 . . . . 0.0 110.214 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.706 ' CB ' ' HD3' ' A' ' 70' ' ' PRO . 9.0 mtm-85 -69.81 -74.0 0.17 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.926 . . . . 0.0 110.376 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.706 ' HD3' ' CB ' ' A' ' 69' ' ' ARG . 57.0 Cg_endo -75.82 -112.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.246 1.13 . . . . 0.0 109.544 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.545 ' O ' ' NH1' ' A' ' 68' ' ' ARG . 1.9 t -140.68 158.14 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.551 -1.343 . . . . 0.0 110.087 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.866 ' HB2' ' NE ' ' A' ' 68' ' ' ARG . . . -97.03 109.94 22.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.135 -0.978 . . . . 0.0 109.823 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.88 53.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.141 -0.975 . . . . 0.0 110.712 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 179.81 -61.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.054 -1.029 . . . . 0.0 110.636 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.9 m -81.9 -127.56 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.189 -0.944 . . . . 0.0 110.27 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.613 ' O ' ' O ' ' A' ' 77' ' ' GLY . 0.6 OUTLIER -140.01 116.03 10.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.142 -0.974 . . . . 0.0 109.885 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.613 ' O ' ' O ' ' A' ' 76' ' ' ASP . . . -37.98 -100.03 0.01 OUTLIER Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.455 HG21 ' O ' ' A' ' 48' ' ' TRP . 0.2 OUTLIER -158.87 150.05 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.067 -1.255 . . . . 0.0 110.255 179.379 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.668 ' HE ' ' HB3' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -143.56 171.01 14.76 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.666 -0.646 . . . . 0.0 109.82 179.856 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.53 ' N ' ' CG ' ' A' ' 79' ' ' ARG . . . -150.26 133.12 4.22 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.549 ' CG ' ' O ' ' A' ' 201' ' ' PRO . 0.0 OUTLIER -155.07 55.06 0.65 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.297 -1.12 . . . . 0.0 110.245 179.837 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.473 ' O ' ' C ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -125.43 -88.31 0.59 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.915 . . . . 0.0 110.069 179.88 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.473 ' C ' ' O ' ' A' ' 82' ' ' ARG . . . 40.63 58.42 2.57 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -94.45 95.93 9.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.353 -1.087 . . . . 0.0 110.376 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' A' ' 173' ' ' MET . 38.3 m -136.88 168.07 20.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -0.851 . . . . 0.0 109.948 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.456 ' HA ' ' HB3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -112.47 143.99 42.68 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.22 -0.925 . . . . 0.0 109.835 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.67 -120.34 5.23 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.486 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 13.9 tp -128.36 135.63 49.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.318 -1.107 . . . . 0.0 110.395 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.486 ' CG ' ' C ' ' A' ' 88' ' ' LEU . 8.0 m-70 -147.08 156.34 42.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.207 -0.933 . . . . 0.0 109.569 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.23 138.09 6.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.069 -1.02 . . . . 0.0 110.875 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 1.028 ' CZ2' HG11 ' A' ' 169' ' ' VAL . 3.7 p90 -135.27 171.12 14.89 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.404 -0.81 . . . . 0.0 109.456 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 215' ' ' ARG . 23.7 tt0 -135.63 156.82 48.24 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.474 -0.89 . . . . 0.0 111.352 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.668 HD13 HG13 ' A' ' 214' ' ' ILE . 27.9 mm -143.59 141.89 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.555 -0.716 . . . . 0.0 109.637 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.574 ' HB3' ' HA ' ' A' ' 166' ' ' ARG . 2.9 p -155.84 146.36 21.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.886 -1.134 . . . . 0.0 110.777 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.924 ' CE3' HG22 ' A' ' 212' ' ' VAL . 39.4 m95 -116.81 87.46 21.98 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.321 -0.862 . . . . 0.0 109.269 178.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.532 ' HG2' ' HG3' ' A' ' 213' ' ' ARG . 51.9 Cg_endo -95.72 108.42 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.719 1.378 . . . . 0.0 111.015 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.814 HD22 ' HA ' ' A' ' 211' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 O-C-N 120.973 -1.079 . . . . 0.0 109.586 178.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.779 HG23 ' CB ' ' A' ' 204' ' ' SER . 35.1 m . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 121.587 0.708 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.796 ' HB ' HG23 ' A' ' 203' ' ' VAL . 2.7 p -150.8 149.72 14.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 O-C-N 121.518 -0.739 . . . . 0.0 109.399 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.612 ' HA2' ' HA3' ' A' ' 132' ' ' GLY . . . -162.7 148.89 16.22 Favored Glycine 0 N--CA 1.485 1.952 0 C-N-CA 118.984 -1.579 . . . . 0.0 110.985 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.875 HG12 ' HG ' ' A' ' 199' ' ' LEU . 11.8 t -105.78 156.97 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.707 -0.878 . . . . 0.0 108.947 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.802 ' CA ' HD12 ' A' ' 199' ' ' LEU . . . -150.11 146.69 27.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.728 -1.233 . . . . 0.0 111.501 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 1.0 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -114.18 138.33 50.59 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.561 0.696 . . . . 0.0 109.65 179.268 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.87 -24.45 18.47 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.532 -0.73 . . . . 0.0 109.064 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.672 ' O ' ' C ' ' A' ' 113' ' ' ALA . 0.7 OUTLIER -86.68 -12.21 49.01 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.555 -0.716 . . . . 0.0 109.268 179.08 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.672 ' C ' ' O ' ' A' ' 112' ' ' LEU . . . . . . . . 0 N--CA 1.499 2.021 0 O-C-N 122.04 -0.412 . . . . 0.0 111.192 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.6 m . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.161 0.505 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 14.7 tm-20 -126.41 115.99 20.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.18 -0.95 . . . . 0.0 109.949 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 48.5 t -120.21 119.37 33.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 110.458 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . 0.448 ' HB2' ' OE2' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -133.55 125.34 28.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.468 -0.77 . . . . 0.0 109.764 179.634 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.612 ' HA3' ' HA2' ' A' ' 107' ' ' GLY . . . -170.18 -143.33 3.89 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.948 ' CZ3' HD22 ' A' ' 167' ' ' LEU . 53.7 m0 -115.95 113.48 23.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -1.169 . . . . 0.0 110.317 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.936 ' O ' HG23 ' A' ' 135' ' ' ILE . 3.9 p30 -118.25 131.29 56.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.649 -0.657 . . . . 0.0 110.391 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.936 HG23 ' O ' ' A' ' 134' ' ' ASP . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.278 -0.889 . . . . 0.0 110.248 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.61 HG12 ' N ' ' A' ' 164' ' ' PRO . 1.3 t . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.728 ' CD ' HD11 ' A' ' 135' ' ' ILE . 48.6 Cg_endo -77.28 55.22 4.99 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.714 1.376 . . . . 0.0 110.839 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -64.0 -58.67 6.0 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.629 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 2.1 ttp180 -151.59 115.44 4.92 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.98 HD23 HG23 ' A' ' 182' ' ' ILE . 0.7 OUTLIER -150.25 158.27 43.97 Favored 'General case' 0 C--N 1.287 -2.131 0 O-C-N 121.676 -0.64 . . . . 0.0 110.735 -178.711 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.428 ' HA ' ' HG3' ' A' ' 92' ' ' GLU . 1.7 tp -103.86 139.73 38.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.425 -0.797 . . . . 0.0 109.36 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 1.028 HG11 ' CZ2' ' A' ' 91' ' ' TRP . 1.8 t -105.78 130.25 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.091 -1.006 . . . . 0.0 110.439 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.0 t -100.14 125.76 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.524 -0.735 . . . . 0.0 110.058 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.708 HD22 ' HZ3' ' A' ' 91' ' ' TRP . 13.3 tp -133.27 106.24 7.44 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.141 -0.975 . . . . 0.0 110.127 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 173' ' ' MET . 50.4 t0 -119.71 137.81 53.69 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.188 -0.945 . . . . 0.0 110.095 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.489 ' HB2' ' O ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -93.48 -40.48 10.31 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.654 -0.654 . . . . 0.0 109.857 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 173' ' ' MET . 37.5 tt0 -43.13 -26.34 0.15 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.272 -0.893 . . . . 0.0 109.11 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.736 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.2 OUTLIER -113.88 -25.75 8.47 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.832 0.825 . . . . 0.0 108.894 179.33 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.564 ' O ' HG22 ' A' ' 198' ' ' THR . . . 78.83 27.89 55.73 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 108.139 -1.984 . . . . 0.0 108.139 -178.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 1.123 ' CG2' HD22 ' A' ' 194' ' ' LEU . 0.0 OUTLIER -112.64 143.17 44.29 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.28 -1.129 . . . . 0.0 111.608 -179.182 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.71 HD21 ' O ' ' A' ' 199' ' ' LEU . 0.5 OUTLIER -148.66 154.2 39.33 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.671 -0.643 . . . . 0.0 109.615 179.377 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.976 ' HA3' HD22 ' A' ' 187' ' ' LEU . . . -174.13 166.2 38.15 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.994 ' CD1' HG22 ' A' ' 169' ' ' VAL . 1.7 t80 -118.95 117.52 29.04 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.368 -1.077 . . . . 0.0 109.73 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 186' ' ' TYR . 6.9 t -146.01 165.18 29.8 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.167 -0.958 . . . . 0.0 110.197 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.98 HG23 HD23 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -100.12 116.47 43.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.734 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 71.04 6.92 61.43 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.99 43.1 18.07 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 1.7 m -101.18 -69.52 0.77 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.241 -1.152 . . . . 0.0 110.957 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.539 ' O ' ' N ' ' A' ' 188' ' ' GLY . 6.7 m-30 -45.1 -83.52 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.14 -0.975 . . . . 0.0 110.907 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.976 HD22 ' HA3' ' A' ' 179' ' ' GLY . 0.1 OUTLIER -66.98 43.95 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.87 -1.144 . . . . 0.0 110.202 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 186' ' ' TYR . . . -91.46 -63.4 1.18 Allowed Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.927 -1.13 . . . . 0.0 110.581 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.491 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 46.6 Cg_endo -72.54 -30.25 12.4 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.859 1.452 . . . . 0.0 111.476 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.591 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -74.1 29.4 0.08 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.232 -0.918 . . . . 0.0 111.572 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.544 ' CE1' ' O ' ' A' ' 187' ' ' LEU . 1.2 m-30 -90.53 -14.85 31.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.769 -1.207 . . . . 0.0 110.409 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . 0.505 ' N ' ' HD2' ' A' ' 192' ' ' ARG . 0.0 OUTLIER -90.09 -13.66 35.35 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.328 -0.858 . . . . 0.0 110.283 -179.701 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -110.91 -12.57 15.75 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 107.707 -2.157 . . . . 0.0 107.707 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 1.123 HD22 ' CG2' ' A' ' 177' ' ' THR . 5.4 tt -67.28 -37.62 83.74 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.486 ' CA ' HG23 ' A' ' 198' ' ' THR . 0.0 OUTLIER -44.66 -37.27 3.56 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.561 -0.712 . . . . 0.0 109.787 179.51 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.91 -27.83 30.47 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.715 ' NE ' ' HG ' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -90.26 -3.34 57.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.707 -0.878 . . . . 0.0 109.942 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 194' ' ' LEU . 15.8 p -41.1 114.52 0.5 Allowed 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.996 0.903 . . . . 0.0 110.042 -178.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 1.0 ' CB ' HG23 ' A' ' 110' ' ' THR . 2.6 pt? -139.42 171.63 13.98 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.05 -178.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.437 ' N ' ' CD1' ' A' ' 200' ' ' TYR . 5.9 m-85 -84.46 129.44 57.57 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.911 -1.118 . . . . 0.0 110.189 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.854 ' HA ' HG13 ' A' ' 108' ' ' VAL . 52.8 Cg_endo -84.88 135.98 5.86 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 124.12 1.59 . . . . 0.0 111.164 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.548 ' CB ' ' HB2' ' A' ' 81' ' ' LYS . 3.7 p -133.39 136.99 45.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.292 -0.88 . . . . 0.0 109.993 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.796 HG23 ' HB ' ' A' ' 106' ' ' VAL . 3.9 p -122.44 155.39 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -0.961 . . . . 0.0 109.938 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . 0.779 ' CB ' HG23 ' A' ' 105' ' ' VAL . 2.7 t -130.81 127.5 38.79 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.168 -0.957 . . . . 0.0 110.684 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.695 ' HB1' HG11 ' A' ' 212' ' ' VAL . . . -119.06 154.28 33.4 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.01 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.717 HG12 ' OE1' ' A' ' 211' ' ' GLN . 2.9 p -115.11 -172.49 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 110.284 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 0.743 ' CE3' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -82.77 165.36 19.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.293 -0.879 . . . . 0.0 110.182 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 132.18 131.72 3.25 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.405 ' HG2' ' N ' ' A' ' 210' ' ' CYS . 7.9 tt0 -62.36 -87.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -1.15 . . . . 0.0 110.303 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . 0.527 ' O ' HD22 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -81.18 83.39 6.82 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.323 -0.861 . . . . 0.0 110.541 -179.83 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.814 ' HA ' HD22 ' A' ' 97' ' ' LEU . 2.5 tt0 -155.6 -42.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.187 -0.946 . . . . 0.0 110.659 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.924 HG22 ' CE3' ' A' ' 95' ' ' TRP . 88.3 t -127.27 132.68 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.986 -1.071 . . . . 0.0 111.194 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . 0.532 ' HG3' ' HG2' ' A' ' 96' ' ' PRO . 0.4 OUTLIER -139.86 149.16 43.08 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.42 -0.8 . . . . 0.0 109.811 179.559 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.825 HG22 ' CZ2' ' A' ' 48' ' ' TRP . 5.9 tt -144.31 143.89 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.086 -1.009 . . . . 0.0 111.436 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.564 ' O ' ' N ' ' A' ' 92' ' ' GLU . 15.1 mtt180 -130.21 108.72 10.25 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . 0.721 ' CD2' ' CB ' ' A' ' 91' ' ' TRP . 2.4 t80 -116.29 146.76 42.15 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.031 -1.043 . . . . 0.0 111.435 -177.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . 0.519 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 5.6 tmm? -136.41 107.93 6.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.561 -0.712 . . . . 0.0 109.706 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 149.81 -40.26 0.86 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.165 -1.197 . . . . 0.0 110.205 -179.89 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.947 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.204 0.526 . . . . 0.0 109.822 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.711 ' HA ' HD23 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -48.81 -34.26 12.04 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.16 -0.963 . . . . 0.0 109.279 179.625 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.77 -21.96 66.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.438 -0.789 . . . . 0.0 109.077 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.452 HD22 ' HA ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -83.37 -35.73 24.9 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.783 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.925 HD11 HH21 ' A' ' 44' ' ' ARG . 0.3 OUTLIER -68.56 -37.08 79.62 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 122.071 0.939 . . . . 0.0 109.002 178.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.637 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 3.5 m -76.84 -7.88 56.3 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.387 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 1.025 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -36.63 -59.61 0.86 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.421 -0.8 . . . . 0.0 110.034 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 1.039 ' O ' HD12 ' A' ' 40' ' ' LEU . 48.2 Cg_endo -74.36 108.42 2.67 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.146 1.603 . . . . 0.0 110.337 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.756 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 48.5 Cg_endo -74.36 -25.2 13.51 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.987 1.519 . . . . 0.0 112.7 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.756 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 43.8 Cg_endo -69.18 152.0 72.32 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 122.944 0.971 . . . . 0.0 112.163 -178.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.744 ' HA ' ' HG3' ' A' ' 43' ' ' GLN . 0.0 OUTLIER 3.56 66.83 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 123.121 1.439 . . . . 0.0 111.092 -179.072 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.039 HD12 ' O ' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -156.66 -44.97 0.07 Allowed 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 177.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.66 HG12 ' CE1' ' A' ' 45' ' ' HIS . 2.8 t -87.71 -31.1 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.785 177.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.54 -44.3 10.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.323 -0.861 . . . . 0.0 111.573 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.865 ' HB2' ' HA ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -74.78 -19.32 60.26 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.178 -0.951 . . . . 0.0 110.523 -179.28 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.925 HH21 HD11 ' A' ' 33' ' ' LEU . 2.8 ttp85 -82.29 -41.6 19.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.869 . . . . 0.0 110.066 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.66 ' CE1' HG12 ' A' ' 41' ' ' VAL . 19.7 m170 -68.81 -17.03 63.95 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.717 -0.614 . . . . 0.0 111.353 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.416 ' O ' ' O ' ' A' ' 47' ' ' GLY . 6.0 t60 -95.21 -32.96 12.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.752 -1.218 . . . . 0.0 110.102 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.671 ' HA2' HD22 ' A' ' 64' ' ' LEU . . . -62.45 -99.43 0.01 OUTLIER Glycine 0 N--CA 1.488 2.164 0 N-CA-C 106.447 -2.661 . . . . 0.0 106.447 178.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.906 ' CE2' ' HB ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -100.14 95.44 6.83 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 175.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.822 ' O ' ' HB3' ' A' ' 53' ' ' CYS . 0.0 OUTLIER -42.33 111.36 0.94 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.644 -0.66 . . . . 0.0 111.679 -178.202 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.614 ' HA ' ' CB ' ' A' ' 53' ' ' CYS . 47.7 Cg_endo -73.49 0.69 7.73 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 122.625 2.217 . . . . 0.0 112.172 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.733 ' H ' ' CE ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -65.02 -31.68 73.04 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 177.928 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.727 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 3.2 m-20 -116.12 -12.58 11.23 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 113.46 -1.7 . . . . 0.0 106.668 176.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.822 ' HB3' ' O ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -108.22 157.82 18.0 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.656 0.741 . . . . 0.0 110.913 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.503 ' HB2' ' O ' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -75.78 142.61 42.29 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.552 0.692 . . . . 0.0 110.008 179.345 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.639 ' HG3' HD21 ' A' ' 33' ' ' LEU . 1.1 pm0 -99.33 -4.35 31.92 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.562 -0.711 . . . . 0.0 110.459 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.616 ' H ' ' ND2' ' A' ' 56' ' ' ASN . 9.4 m-80 -50.39 -12.67 0.1 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.629 -0.669 . . . . 0.0 110.805 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.61 HG13 ' CZ3' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -124.7 169.0 16.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.288 -0.882 . . . . 0.0 109.242 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.598 ' O ' ' CB ' ' A' ' 67' ' ' GLU . 49.3 t0 -107.2 133.78 51.27 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.899 -1.126 . . . . 0.0 111.087 -177.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.906 ' HB ' ' CE2' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -130.95 137.15 56.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.675 -179.532 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.865 ' HA ' ' HB2' ' A' ' 43' ' ' GLN . 60.0 mttp -123.86 151.58 43.29 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 118.581 -1.248 . . . . 0.0 111.119 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.461 ' O ' ' C ' ' A' ' 62' ' ' GLY . 0.7 OUTLIER -77.6 -128.72 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.474 -0.766 . . . . 0.0 110.274 -179.787 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 41.3 42.28 3.23 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.556 -1.818 . . . . 0.0 108.556 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.683 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 108.82 67.67 0.61 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.683 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER 0.84 88.09 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.847 -0.796 . . . . 0.0 110.983 -179.076 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 1.2 t -99.88 114.33 27.47 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.45 -0.781 . . . . 0.0 111.049 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.807 ' CD1' ' NE1' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -83.56 128.51 34.57 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.136 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.598 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 1.6 tt0 -138.79 121.82 16.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.567 -1.333 . . . . 0.0 110.502 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.661 ' CZ ' ' CZ3' ' A' ' 207' ' ' TRP . 0.0 OUTLIER -130.85 142.85 50.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.38 -0.825 . . . . 0.0 109.406 179.767 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.683 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -130.96 -70.69 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.055 -1.028 . . . . 0.0 110.954 -179.464 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.683 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 55.5 Cg_endo -69.89 -145.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.552 1.291 . . . . 0.0 109.492 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.745 HG13 ' CZ2' ' A' ' 207' ' ' TRP . 3.9 t -140.02 164.27 23.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 O-C-N 121.417 -0.802 . . . . 0.0 110.175 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.973 ' HB3' ' HB3' ' A' ' 76' ' ' ASP . . . -130.44 94.11 3.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 110.021 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.484 ' O ' ' O ' ' A' ' 72' ' ' ALA . 67.3 mt-30 -48.12 -99.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.281 -0.887 . . . . 0.0 110.106 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.5 p -88.61 39.24 0.91 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.084 -1.01 . . . . 0.0 109.605 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.606 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 3.0 m -144.6 15.73 1.62 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.317 -0.864 . . . . 0.0 110.198 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.973 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 19.1 p-10 -98.47 155.16 17.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.296 -0.878 . . . . 0.0 109.928 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.503 ' O ' ' HB2' ' A' ' 54' ' ' SER . . . 106.78 127.73 5.86 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 106.781 -2.528 . . . . 0.0 106.781 -178.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.641 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 1.2 m -117.51 131.67 69.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 120.814 -1.403 . . . . 0.0 111.131 -178.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.727 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 2.5 ttp180 -104.12 175.08 5.6 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.657 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.63 ' HA2' ' CB ' ' A' ' 52' ' ' ASP . . . -167.4 80.7 0.1 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -125.63 130.48 51.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -1.153 . . . . 0.0 110.311 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.518 ' HG2' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -140.41 -31.21 0.64 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -0.89 . . . . 0.0 110.551 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.518 ' N ' ' HG2' ' A' ' 82' ' ' ARG . . . 37.82 40.6 0.78 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.447 ' H ' ' HG2' ' A' ' 82' ' ' ARG . 1.7 t80 -134.71 95.57 3.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.155 -1.203 . . . . 0.0 110.001 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.809 ' CB ' HD21 ' A' ' 171' ' ' LEU . 0.6 OUTLIER -140.27 163.72 32.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.883 . . . . 0.0 110.415 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.604 ' O ' ' CD2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -131.08 158.82 39.37 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.327 -0.858 . . . . 0.0 110.095 179.661 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.53 ' N ' ' HB3' ' A' ' 173' ' ' MET . . . 51.72 -111.59 1.5 Allowed Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 21.2 tp -128.97 134.39 48.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.516 -0.99 . . . . 0.0 111.134 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.604 ' CD2' ' O ' ' A' ' 86' ' ' ARG . 88.6 m-70 -147.31 173.66 12.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.262 -0.899 . . . . 0.0 109.786 179.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.561 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -163.38 158.96 21.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.179 -0.95 . . . . 0.0 110.586 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.968 ' CE3' HG11 ' A' ' 169' ' ' VAL . 1.0 OUTLIER -134.61 170.63 15.51 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.281 -0.887 . . . . 0.0 109.29 179.557 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 1.0 ' OE2' HD12 ' A' ' 168' ' ' LEU . 6.7 mt-10 -147.82 145.27 28.67 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.178 -0.951 . . . . 0.0 110.748 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.533 ' HB ' HD12 ' A' ' 167' ' ' LEU . 6.3 mt -144.74 153.97 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.283 -0.885 . . . . 0.0 110.879 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.596 ' HB2' ' CB ' ' A' ' 213' ' ' ARG . 2.2 m -135.18 140.95 45.75 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.806 ' HZ2' ' N ' ' A' ' 105' ' ' VAL . 4.9 m95 -99.61 125.58 40.26 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.096 -1.003 . . . . 0.0 111.873 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.714 ' HB3' ' O ' ' A' ' 211' ' ' GLN . 49.4 Cg_endo -79.63 153.24 23.2 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.388 2.059 . . . . 0.0 111.569 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.829 ' C ' HD23 ' A' ' 97' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.481 0.658 . . . . 0.0 110.236 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 1.009 HG12 ' HA ' ' A' ' 134' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.973 HG22 HG23 ' A' ' 203' ' ' VAL . 2.2 t -127.79 170.16 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.929 -1.107 . . . . 0.0 111.368 -176.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.679 ' CA ' ' HA3' ' A' ' 132' ' ' GLY . . . -179.92 156.83 18.99 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 109.986 -1.245 . . . . 0.0 109.986 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.921 ' HB ' HD13 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -108.6 140.72 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.41 -1.053 . . . . 0.0 109.538 179.855 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.504 ' O ' ' HB3' ' A' ' 199' ' ' LEU . . . -109.85 140.39 43.85 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.227 -0.921 . . . . 0.0 110.738 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.833 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -119.46 130.41 55.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.453 -0.78 . . . . 0.0 110.324 179.809 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.73 -27.47 17.22 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.501 -0.749 . . . . 0.0 109.295 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.524 HD11 ' O ' ' A' ' 196' ' ' GLY . 0.9 OUTLIER -81.69 -12.3 58.71 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.535 -0.728 . . . . 0.0 109.587 179.474 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.543 ' CB ' ' HB2' ' A' ' 129' ' ' GLU . . . . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.553 -0.717 . . . . 0.0 110.235 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 110' ' ' THR . 14.7 m . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.26 0.552 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.543 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . 4.9 mm-40 -150.25 133.82 16.58 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.323 -0.861 . . . . 0.0 109.861 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.5 t -120.18 119.73 34.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 110.559 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -133.25 136.32 45.48 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.367 -0.833 . . . . 0.0 109.411 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.679 ' HA3' ' CA ' ' A' ' 107' ' ' GLY . . . -158.83 -163.47 13.04 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.436 -1.364 . . . . 0.0 110.309 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.677 ' CE3' ' CG ' ' A' ' 180' ' ' TYR . 24.6 m0 -115.77 113.12 23.01 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.477 -1.013 . . . . 0.0 110.197 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 1.009 ' HA ' HG12 ' A' ' 105' ' ' VAL . 2.1 p-10 -119.48 142.96 47.81 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.717 -0.614 . . . . 0.0 110.154 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.889 HD13 ' C ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 109.634 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.639 ' CG1' ' HB2' ' A' ' 167' ' ' LEU . 1.5 t . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.935 ' HD2' HG21 ' A' ' 182' ' ' ILE . 43.1 Cg_endo -70.56 178.52 4.98 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.859 1.452 . . . . 0.0 110.913 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.498 ' O ' ' HB3' ' A' ' 94' ' ' SER . 11.1 pt-20 -50.07 -18.34 0.54 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.477 -0.764 . . . . 0.0 110.826 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.475 ' O ' ' HG2' ' A' ' 164' ' ' PRO . 7.9 tpt180 -133.67 154.97 50.53 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.102 -0.999 . . . . 0.0 109.929 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 1.198 HD22 ' N ' ' A' ' 168' ' ' LEU . 0.0 OUTLIER -164.04 146.78 9.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.28 -0.888 . . . . 0.0 109.789 -179.802 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 1.198 ' N ' HD22 ' A' ' 167' ' ' LEU . 1.2 tt -125.77 131.19 52.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.142 -0.974 . . . . 0.0 110.611 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.968 HG11 ' CE3' ' A' ' 91' ' ' TRP . 97.2 t -89.52 156.92 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.395 -0.815 . . . . 0.0 109.805 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.64 HG11 HD21 ' A' ' 187' ' ' LEU . 22.4 t -134.55 112.1 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.165 -0.959 . . . . 0.0 110.155 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.888 HD22 ' CZ2' ' A' ' 91' ' ' TRP . 0.0 OUTLIER -132.39 122.48 25.07 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.287 -0.883 . . . . 0.0 109.791 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -120.15 139.13 53.08 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.244 -0.91 . . . . 0.0 109.942 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.53 ' HB3' ' N ' ' A' ' 87' ' ' GLY . 0.3 OUTLIER -93.05 -38.25 11.73 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.553 -0.717 . . . . 0.0 109.778 179.768 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 173' ' ' MET . 0.8 OUTLIER -43.11 -27.28 0.2 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 108.7 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.609 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.7 OUTLIER -114.59 -27.38 7.52 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.78 0.8 . . . . 0.0 108.876 179.157 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.428 ' O ' HG21 ' A' ' 198' ' ' THR . . . 84.68 22.54 53.15 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 108.706 -1.757 . . . . 0.0 108.706 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.961 HG22 ' CD2' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -115.53 133.72 55.76 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.288 -1.125 . . . . 0.0 111.376 -179.476 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.672 ' O ' HD11 ' A' ' 194' ' ' LEU . 0.1 OUTLIER -143.85 152.63 41.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.569 -0.707 . . . . 0.0 109.423 178.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.414 ' O ' HG13 ' A' ' 169' ' ' VAL . . . -161.67 -156.1 8.21 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 1.019 ' CE1' HD21 ' A' ' 167' ' ' LEU . 0.1 OUTLIER -125.65 138.34 53.9 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.27 -1.135 . . . . 0.0 108.904 -179.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.489 ' HB2' ' HB2' ' A' ' 187' ' ' LEU . 9.2 t -144.0 141.59 30.23 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.143 -0.973 . . . . 0.0 110.624 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.992 HD11 ' CD2' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -127.12 116.76 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.655 -0.653 . . . . 0.0 109.563 179.629 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 65.55 10.09 47.5 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 77.0 41.01 23.71 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . 0.73 HG22 ' CE1' ' A' ' 186' ' ' TYR . 17.4 m -97.31 -47.56 5.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -1.142 . . . . 0.0 110.643 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.992 ' CD2' HD11 ' A' ' 182' ' ' ILE . 8.6 m-85 -112.08 85.55 2.17 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.097 -1.002 . . . . 0.0 110.683 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.64 HD21 HG11 ' A' ' 170' ' ' VAL . 0.9 OUTLIER -179.79 28.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.686 -0.634 . . . . 0.0 109.647 179.54 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -94.88 -89.52 1.72 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.448 ' C ' ' H ' ' A' ' 191' ' ' PHE . 49.6 Cg_endo -74.24 -21.02 18.17 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 124.18 1.621 . . . . 0.0 111.21 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.578 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -66.31 15.2 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.527 -0.733 . . . . 0.0 111.877 -178.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.624 ' CE1' ' HG ' ' A' ' 187' ' ' LEU . 1.1 m-30 -90.51 -28.07 18.78 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.854 -1.154 . . . . 0.0 111.146 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . 0.533 ' HA ' ' NE ' ' A' ' 192' ' ' ARG . 0.1 OUTLIER -86.52 -13.13 46.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.949 -1.094 . . . . 0.0 110.744 -179.5 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -107.48 -13.04 21.77 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.961 ' CD2' HG22 ' A' ' 177' ' ' THR . 9.2 tt -72.17 -40.54 67.89 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.572 -0.958 . . . . 0.0 109.012 179.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.512 ' HD2' ' N ' ' A' ' 196' ' ' GLY . 0.0 OUTLIER -44.12 -40.25 4.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.215 -0.928 . . . . 0.0 109.869 179.583 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.524 ' O ' HD11 ' A' ' 112' ' ' LEU . . . -86.27 -26.82 32.4 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.866 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.62 -4.38 56.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.686 -0.891 . . . . 0.0 109.905 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . 0.8 HG23 HD23 ' A' ' 194' ' ' LEU . 0.8 OUTLIER -43.85 132.08 5.32 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.739 0.78 . . . . 0.0 111.732 -178.441 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.921 HD13 ' HB ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -140.68 171.01 14.7 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.656 -0.652 . . . . 0.0 109.444 179.254 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.486 ' CZ ' ' HA3' ' A' ' 83' ' ' GLY . 0.1 OUTLIER -85.98 128.93 56.12 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 120.909 -1.119 . . . . 0.0 109.84 179.358 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.58 ' CA ' HG13 ' A' ' 108' ' ' VAL . 51.0 Cg_endo -85.91 129.16 3.4 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.995 1.524 . . . . 0.0 111.396 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.459 ' O ' HG13 ' A' ' 106' ' ' VAL . 24.5 t -133.46 142.87 48.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.297 -0.877 . . . . 0.0 109.585 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.973 HG23 HG22 ' A' ' 106' ' ' VAL . 7.4 p -122.35 153.96 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.825 -1.172 . . . . 0.0 111.43 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 15.1 p -149.58 145.39 26.78 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -150.26 167.36 27.19 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.765 -1.209 . . . . 0.0 112.059 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.512 HG13 ' N ' ' A' ' 207' ' ' TRP . 0.3 OUTLIER -69.48 -176.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 121.639 0.733 . . . . 0.0 111.31 -179.02 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 0.745 ' CZ2' HG13 ' A' ' 71' ' ' VAL . 22.7 p-90 -129.78 -5.12 4.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.672 -0.642 . . . . 0.0 109.823 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 207' ' ' TRP . . . -51.72 -168.97 0.01 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.764 ' O ' ' O ' ' A' ' 210' ' ' CYS . 0.5 OUTLIER -79.67 -51.61 9.02 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.467 -1.02 . . . . 0.0 110.864 -179.562 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . 0.764 ' O ' ' O ' ' A' ' 209' ' ' GLN . 26.4 p 0.99 -129.18 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 121.07 0.462 . . . . 0.0 111.422 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.714 ' O ' ' HB3' ' A' ' 96' ' ' PRO . 0.0 OUTLIER 178.64 93.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.766 -1.209 . . . . 0.0 111.054 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.652 ' HB ' ' CZ ' ' A' ' 66' ' ' PHE . 3.1 t -87.05 123.09 39.67 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 O-C-N 121.381 -0.825 . . . . 0.0 108.84 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . 0.596 ' CB ' ' HB2' ' A' ' 94' ' ' SER . 2.0 tpp85 -89.85 147.36 23.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.097 -1.002 . . . . 0.0 110.52 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.604 HD12 ' HB3' ' A' ' 48' ' ' TRP . 1.1 mt -144.33 128.46 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 110.474 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.666 ' O ' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -130.59 108.22 9.77 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.297 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . 0.726 ' CZ ' ' CD1' ' A' ' 91' ' ' TRP . 3.6 t80 -119.02 144.98 46.23 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.249 -0.907 . . . . 0.0 111.233 -178.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . 0.46 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 1.2 ttp -136.59 108.45 7.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.561 -0.712 . . . . 0.0 110.05 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 130.74 70.34 0.11 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.261 -1.141 . . . . 0.0 110.199 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.617 ' HG ' ' N ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.244 0.545 . . . . 0.0 110.026 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.617 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 8.7 mt-10 -52.18 -35.9 50.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.066 -1.021 . . . . 0.0 108.997 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.65 -25.42 60.17 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 0.5 OUTLIER -82.03 -35.74 28.48 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.707 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.886 HD12 ' C ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -77.87 -38.92 44.86 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.91 0.862 . . . . 0.0 108.873 178.884 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.564 ' O ' ' O ' ' A' ' 35' ' ' ALA . 23.2 t -57.58 -14.31 5.1 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.318 0.58 . . . . 0.0 110.25 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 1.067 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -52.61 -161.26 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.402 -0.811 . . . . 0.0 109.942 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 1.067 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 38.6 Cg_endo -65.8 118.37 5.43 Favored 'Trans proline' 0 C--N 1.315 -1.214 0 O-C-N 123.008 1.004 . . . . 0.0 109.647 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.677 ' CB ' HG21 ' A' ' 41' ' ' VAL . 45.7 Cg_endo -71.35 108.44 2.37 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.28 1.674 . . . . 0.0 112.162 -178.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.761 ' O ' ' N ' ' A' ' 40' ' ' LEU . 50.7 Cg_endo -81.98 151.97 16.49 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.23 1.648 . . . . 0.0 108.676 178.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.662 ' C ' ' O ' ' A' ' 38' ' ' PRO . 3.1 t0 -21.49 -41.89 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.311 -0.868 . . . . 0.0 109.806 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.127 HD13 ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -37.84 -50.06 1.24 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 122.012 -0.43 . . . . 0.0 109.875 179.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 1.127 ' N ' HD13 ' A' ' 40' ' ' LEU . 13.8 t -62.03 -26.92 41.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.683 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.611 ' N ' ' O ' ' A' ' 39' ' ' ASP . . . -89.06 -44.79 10.11 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.166 -0.958 . . . . 0.0 111.073 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.658 ' NE2' ' C ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -79.05 -25.28 43.17 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 118.405 -1.318 . . . . 0.0 108.648 179.389 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.741 ' CB ' ' O ' ' A' ' 40' ' ' LEU . 9.1 ttp180 -61.39 -52.87 62.81 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 122.343 1.068 . . . . 0.0 108.198 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.624 ' CE1' HG12 ' A' ' 41' ' ' VAL . 26.0 m170 -60.93 -18.0 54.4 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.989 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -96.87 -30.07 13.35 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 118.207 -1.397 . . . . 0.0 111.648 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.91 ' O ' HD13 ' A' ' 214' ' ' ILE . . . -109.2 -67.12 0.58 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 107.605 -2.198 . . . . 0.0 107.605 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.784 ' CH2' ' N ' ' A' ' 61' ' ' GLU 0.265 0.1 OUTLIER -96.2 71.02 2.81 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.316 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.708 ' OD1' ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -60.26 112.53 5.62 Favored Pre-proline 0 N--CA 1.491 1.616 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.487 -178.809 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.667 ' CD ' ' HE3' ' A' ' 51' ' ' LYS . 44.5 Cg_endo -74.74 0.38 8.84 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 124.535 1.808 . . . . 0.0 112.024 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.913 ' CE ' ' N ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -64.57 -19.72 65.81 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 178.703 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.77 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 8.6 m-20 -133.34 -2.29 3.12 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 114.149 -1.387 . . . . 0.0 107.856 178.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.591 ' HB3' ' HA ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -113.34 152.11 30.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.571 -0.706 . . . . 0.0 110.058 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.52 ' CB ' HD22 ' A' ' 56' ' ' ASN . 0.0 OUTLIER -68.06 104.42 1.76 Allowed 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.13 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.705 ' HG3' HD22 ' A' ' 33' ' ' LEU . 26.1 pt-20 -67.81 -17.01 64.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.105 -0.997 . . . . 0.0 109.064 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.81 ' HB3' HG23 ' A' ' 75' ' ' THR . 11.8 m-80 -33.36 -32.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.678 0.752 . . . . 0.0 110.346 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.706 ' HB ' ' O ' ' A' ' 67' ' ' GLU . 9.0 pt -112.92 166.96 6.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.616 -0.677 . . . . 0.0 110.01 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.577 ' O ' ' N ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -107.13 117.11 33.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.247 -0.908 . . . . 0.0 109.372 -179.362 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.955 HG21 ' CD1' ' A' ' 66' ' ' PHE . 2.6 p -124.52 120.36 58.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 O-C-N 121.445 -0.785 . . . . 0.0 111.463 -178.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.694 ' HG2' ' N ' ' A' ' 61' ' ' GLU . 6.6 tttt -137.4 159.54 41.66 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.534 -0.729 . . . . 0.0 110.27 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.784 ' N ' ' CH2' ' A' ' 48' ' ' TRP . 1.2 tt0 -45.45 -106.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.596 -0.69 . . . . 0.0 110.535 -179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.569 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 35.7 33.76 0.06 OUTLIER Glycine 0 N--CA 1.493 2.487 0 N-CA-C 108.141 -1.984 . . . . 0.0 108.141 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.69 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 107.8 62.83 0.56 Allowed Glycine 0 N--CA 1.485 1.927 0 N-CA-C 108.01 -2.036 . . . . 0.0 108.01 -178.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.712 HD13 ' HE1' ' A' ' 48' ' ' TRP . 0.4 OUTLIER 1.18 80.64 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.899 -0.765 . . . . 0.0 110.724 -179.324 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.429 ' N ' ' O ' ' A' ' 63' ' ' GLY . 17.3 p -141.17 136.92 32.3 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 118.418 -1.313 . . . . 0.0 112.176 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.955 ' CD1' HG21 ' A' ' 59' ' ' VAL . 17.9 m-85 -89.34 165.32 14.45 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.706 ' O ' ' HB ' ' A' ' 57' ' ' ILE . 5.5 tm-20 -136.94 121.01 17.76 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.91 -1.119 . . . . 0.0 109.944 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.561 ' CD ' ' O ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -126.32 148.71 49.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.237 -0.915 . . . . 0.0 109.977 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.75 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 1.7 mtm180 -104.93 -78.93 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.024 -1.048 . . . . 0.0 110.454 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.75 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 57.6 Cg_endo -75.08 -152.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.163 1.086 . . . . 0.0 109.368 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.686 HG13 ' CZ2' ' A' ' 207' ' ' TRP . 2.4 t -140.76 162.55 22.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 1.014 ' HB3' ' CB ' ' A' ' 75' ' ' THR . . . 179.85 175.87 0.75 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.932 -1.105 . . . . 0.0 110.621 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.464 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 2.5 pt20 -66.19 -115.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.385 -0.822 . . . . 0.0 110.31 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 73' ' ' GLN . 11.5 p -41.78 -27.1 0.1 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.195 -0.941 . . . . 0.0 110.225 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 1.014 ' CB ' ' HB3' ' A' ' 72' ' ' ALA . 22.6 m -44.29 -28.51 0.54 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.879 . . . . 0.0 110.028 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.651 ' CB ' ' CD1' ' A' ' 207' ' ' TRP . 12.4 p30 -112.68 155.46 24.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.887 . . . . 0.0 109.992 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.496 ' HA2' ' O ' ' A' ' 205' ' ' ALA . . . 79.86 123.93 0.47 Allowed Glycine 0 N--CA 1.484 1.899 0 N-CA-C 106.886 -2.485 . . . . 0.0 106.886 -178.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.572 ' HB ' ' CB ' ' A' ' 53' ' ' CYS . 1.2 m -117.74 161.85 16.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 120.851 -1.382 . . . . 0.0 110.939 -178.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.77 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -119.5 173.5 6.95 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.015 179.128 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.724 ' HA3' HG12 ' A' ' 203' ' ' VAL . . . -149.47 48.44 0.6 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.508 ' HA ' ' CB ' ' A' ' 202' ' ' SER . 22.7 ttpp -81.95 76.28 8.85 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -1.101 . . . . 0.0 109.985 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.502 ' CG ' ' OD2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -141.47 -91.03 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.381 -0.825 . . . . 0.0 110.064 -179.921 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.421 ' H ' ' CD ' ' A' ' 82' ' ' ARG . . . 49.11 62.69 4.47 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.487 ' CD2' ' O ' ' A' ' 84' ' ' TYR . 52.3 t80 -94.46 96.06 9.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -1.148 . . . . 0.0 109.995 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.572 ' OG ' ' CD2' ' A' ' 89' ' ' HIS . 0.1 OUTLIER -132.13 153.91 50.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.888 . . . . 0.0 110.263 -179.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.614 ' O ' ' CD2' ' A' ' 89' ' ' HIS . 46.5 ttp180 -114.72 176.43 5.05 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.321 -0.862 . . . . 0.0 109.779 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.563 ' N ' ' CG ' ' A' ' 86' ' ' ARG . . . 46.78 -111.22 0.66 Allowed Glycine 0 N--CA 1.485 1.959 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.525 ' O ' ' ND1' ' A' ' 89' ' ' HIS . 5.9 tt -129.08 126.83 40.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.478 -1.013 . . . . 0.0 110.751 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.614 ' CD2' ' O ' ' A' ' 86' ' ' ARG . 52.1 m-70 -147.41 173.69 12.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.792 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.51 155.31 17.29 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.347 -0.846 . . . . 0.0 110.263 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 1.211 ' CZ2' HG11 ' A' ' 169' ' ' VAL . 1.2 p90 -135.05 171.12 14.87 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.199 -0.938 . . . . 0.0 110.064 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.571 ' N ' ' O ' ' A' ' 215' ' ' ARG . 2.9 tp10 -132.93 142.63 48.99 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.538 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.753 HG23 ' OH ' ' A' ' 180' ' ' TYR . 0.3 OUTLIER -144.78 138.36 22.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.215 -0.928 . . . . 0.0 110.961 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.568 ' CB ' ' HB3' ' A' ' 213' ' ' ARG . 0.7 OUTLIER -117.75 137.3 52.8 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.724 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.578 ' HH2' ' O ' ' A' ' 204' ' ' SER . 46.9 t-105 -116.0 87.89 20.21 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.046 -1.034 . . . . 0.0 111.631 -178.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 94' ' ' SER . 52.4 Cg_endo -98.16 109.35 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 121.862 1.708 . . . . 0.0 110.046 178.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.443 HD22 ' HA ' ' A' ' 97' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 O-C-N 120.662 -1.274 . . . . 0.0 110.417 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 1.175 HG22 ' O ' ' A' ' 204' ' ' SER . 1.2 m . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 121.674 0.75 . . . . 0.0 109.27 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.996 HG13 ' O ' ' A' ' 202' ' ' SER . 78.3 t -135.71 152.26 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 120.999 -1.063 . . . . 0.0 109.926 -178.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.536 ' HA2' ' HA2' ' A' ' 132' ' ' GLY . . . -141.52 135.52 6.86 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.06 HG12 HD12 ' A' ' 199' ' ' LEU . 1.3 t -125.79 131.62 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.435 -1.038 . . . . 0.0 108.319 179.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.667 ' HB1' ' HA ' ' A' ' 130' ' ' SER . . . -150.12 149.49 30.33 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.073 -1.017 . . . . 0.0 111.52 -178.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.735 HG23 ' HB3' ' A' ' 199' ' ' LEU . 0.6 OUTLIER -89.47 112.08 23.14 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 122.209 1.004 . . . . 0.0 109.897 178.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 110' ' ' THR 0.294 . . -32.77 -53.42 0.34 Allowed 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.976 179.161 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.768 ' HB2' ' HB3' ' A' ' 128' ' ' SER . 0.0 OUTLIER -43.7 -26.31 0.23 Allowed 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.448 -178.72 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.655 ' N ' ' O ' ' A' ' 110' ' ' THR . . . . . . . . 0 N--CA 1.494 1.769 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.288 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.768 ' HB3' ' HB2' ' A' ' 112' ' ' LEU . 2.4 p . . . . . 0 N--CA 1.501 2.079 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.729 ' N ' ' OG1' ' A' ' 110' ' ' THR . 2.6 tt0 -152.22 160.71 43.32 Favored 'General case' 0 C--N 1.308 -1.229 0 O-C-N 120.323 -1.485 . . . . 0.0 111.213 -178.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.667 ' HA ' ' HB1' ' A' ' 109' ' ' ALA . 2.5 t -134.25 126.39 29.72 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.876 -0.515 . . . . 0.0 109.76 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . 0.479 ' CB ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -133.14 155.16 49.8 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 120.929 -1.107 . . . . 0.0 109.855 -179.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.536 ' HA2' ' HA2' ' A' ' 107' ' ' GLY . . . -141.58 133.67 5.87 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.857 ' CZ3' HG21 ' A' ' 108' ' ' VAL . 3.8 m0 -104.9 113.53 27.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -1.166 . . . . 0.0 109.689 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.615 ' O ' HG23 ' A' ' 135' ' ' ILE . 0.3 OUTLIER -118.48 148.19 42.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.133 -0.979 . . . . 0.0 110.428 -179.843 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.615 HG23 ' O ' ' A' ' 134' ' ' ASP . 3.7 pt . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.316 -0.865 . . . . 0.0 110.11 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.865 HG13 ' HD2' ' A' ' 164' ' ' PRO . 42.4 t . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.865 ' HD2' HG13 ' A' ' 163' ' ' VAL . 40.0 Cg_endo -67.01 125.43 13.61 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.656 1.345 . . . . 0.0 110.495 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 94' ' ' SER . 1.4 tt0 -41.05 -24.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.423 -0.798 . . . . 0.0 110.642 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' ' 164' ' ' PRO . 9.7 ttt85 -111.27 137.58 48.82 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.173 -0.954 . . . . 0.0 109.783 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.836 HD21 ' CG1' ' A' ' 163' ' ' VAL . 3.0 mp -138.47 146.31 41.9 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.463 -0.773 . . . . 0.0 110.411 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.438 HD12 ' OE1' ' A' ' 92' ' ' GLU . 0.7 OUTLIER -116.93 124.51 49.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.495 179.636 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 1.211 HG11 ' CZ2' ' A' ' 91' ' ' TRP . 2.5 t -114.92 139.76 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.073 -1.017 . . . . 0.0 110.683 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 170' ' ' VAL . 9.3 p -118.32 124.93 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.578 -0.701 . . . . 0.0 110.062 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.58 ' CD1' ' HB3' ' A' ' 178' ' ' LEU . 9.3 tp -133.37 111.29 10.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.135 -0.978 . . . . 0.0 110.154 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.524 ' OD2' ' CB ' ' A' ' 88' ' ' LEU . 6.5 t70 -116.27 138.31 51.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.296 -0.877 . . . . 0.0 110.14 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.567 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -94.64 -44.38 7.85 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.71 -0.619 . . . . 0.0 110.041 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.491 ' C ' ' O ' ' A' ' 173' ' ' MET . 2.7 mt-10 -40.19 -28.52 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.115 -0.99 . . . . 0.0 108.791 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.646 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.4 OUTLIER -111.56 -25.15 9.71 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.901 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.597 ' O ' ' CG2' ' A' ' 198' ' ' THR . . . 77.18 24.94 64.97 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 1.081 HG22 ' CD2' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -113.14 134.91 54.33 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.293 -1.122 . . . . 0.0 111.12 -179.429 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 1.092 ' O ' HD11 ' A' ' 194' ' ' LEU . 0.6 OUTLIER -142.54 154.13 44.19 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.655 -0.653 . . . . 0.0 109.815 179.265 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -162.11 162.17 34.0 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 1.031 ' CD1' HG22 ' A' ' 169' ' ' VAL . 1.1 t80 -118.68 121.77 40.92 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.459 -1.024 . . . . 0.0 109.657 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.476 ' OG ' HD23 ' A' ' 187' ' ' LEU . 0.3 OUTLIER -144.26 139.7 28.79 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.267 -0.895 . . . . 0.0 110.349 -179.67 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.637 HG22 ' HA ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -102.78 116.72 47.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.37 -0.831 . . . . 0.0 109.666 179.553 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 88.69 -9.13 77.33 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.535 ' HA2' ' CD2' ' A' ' 187' ' ' LEU . . . 86.21 43.61 6.21 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 70.2 m -114.35 -25.32 8.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.287 -1.125 . . . . 0.0 110.618 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.465 ' CE2' HD11 ' A' ' 182' ' ' ILE . 21.2 m-85 -107.97 69.1 0.72 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.172 -0.955 . . . . 0.0 110.42 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.576 ' HB2' ' CE1' ' A' ' 191' ' ' PHE . 0.9 OUTLIER -173.5 26.21 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.748 0.785 . . . . 0.0 109.497 179.719 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -94.64 -81.62 1.54 Allowed Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.033 -1.08 . . . . 0.0 110.7 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.15 -30.05 16.65 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.997 1.525 . . . . 0.0 111.307 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.584 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -74.06 13.78 0.5 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.312 -0.868 . . . . 0.0 111.234 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.576 ' CE1' ' HB2' ' A' ' 187' ' ' LEU . 1.2 m-30 -90.73 -26.79 19.35 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.018 -1.051 . . . . 0.0 110.416 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.62 -13.27 49.2 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.303 -0.873 . . . . 0.0 110.253 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 197' ' ' ARG . . . -108.17 -6.15 32.05 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.166 -1.974 . . . . 0.0 108.166 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 1.092 HD11 ' O ' ' A' ' 178' ' ' LEU . 7.6 tt -77.64 -41.44 38.38 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.51 ' CA ' HG23 ' A' ' 198' ' ' THR . 1.6 ttmt -43.79 -45.89 7.47 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.761 -0.587 . . . . 0.0 110.163 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -83.54 -24.51 50.19 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.698 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -91.12 -3.8 56.77 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.658 -0.907 . . . . 0.0 110.035 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . 0.75 HG23 ' O ' ' A' ' 194' ' ' LEU . 21.8 p -42.98 112.81 0.4 Allowed 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.641 0.734 . . . . 0.0 111.86 -177.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 1.06 HD12 HG12 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -140.44 171.0 14.76 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.713 -0.617 . . . . 0.0 109.647 178.738 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 11.0 m-85 -84.7 129.23 57.79 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.07 -1.019 . . . . 0.0 110.741 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.814 ' CA ' HG13 ' A' ' 108' ' ' VAL . 51.4 Cg_endo -88.62 146.4 5.9 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 124.179 1.62 . . . . 0.0 110.985 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.996 ' O ' HG13 ' A' ' 106' ' ' VAL . 11.8 p -133.86 157.08 46.86 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.232 -0.918 . . . . 0.0 110.606 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.724 HG12 ' HA3' ' A' ' 80' ' ' GLY . 7.4 p -119.46 157.1 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.076 -1.015 . . . . 0.0 109.693 178.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . 1.175 ' O ' HG22 ' A' ' 105' ' ' VAL . 0.9 OUTLIER -160.3 156.06 25.75 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 120.922 -1.112 . . . . 0.0 110.623 179.47 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.496 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -150.39 164.74 35.08 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.729 0.776 . . . . 0.0 111.02 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.649 HG13 ' N ' ' A' ' 207' ' ' TRP . 1.2 t -60.06 -179.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 121.344 0.592 . . . . 0.0 111.32 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 0.686 ' CZ2' HG13 ' A' ' 71' ' ' VAL . 4.3 t90 -26.19 -55.91 0.07 Allowed 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.288 0.566 . . . . 0.0 110.919 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 209' ' ' GLN . . . 138.73 -1.74 2.64 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' ' 208' ' ' GLY . 1.6 tt0 -42.84 -29.92 0.36 Allowed 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.419 -1.048 . . . . 0.0 109.698 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . 0.506 ' C ' ' CG ' ' A' ' 211' ' ' GLN . 28.9 p -94.91 -131.79 0.16 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.433 -0.792 . . . . 0.0 109.855 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.506 ' CG ' ' C ' ' A' ' 210' ' ' CYS . 0.0 OUTLIER -178.59 112.67 0.06 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.933 . . . . 0.0 110.2 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.69 ' O ' HD11 ' A' ' 64' ' ' LEU . 33.9 m -89.63 139.55 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.277 -0.89 . . . . 0.0 109.765 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . 0.576 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -88.9 135.6 33.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.124 -0.985 . . . . 0.0 109.213 179.676 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.91 HD13 ' O ' ' A' ' 47' ' ' GLY . 0.8 OUTLIER -144.51 112.43 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 120.99 -1.069 . . . . 0.0 111.559 -178.707 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.571 ' O ' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -118.02 108.42 15.22 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.061 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . 0.678 ' CD2' ' CB ' ' A' ' 91' ' ' TRP . 2.1 t80 -106.11 149.14 27.03 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.188 -0.945 . . . . 0.0 111.648 -177.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . 0.425 ' N ' ' HD1' ' A' ' 216' ' ' TYR . 36.1 ttp -129.72 107.63 9.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.72 -0.613 . . . . 0.0 109.56 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . 0.432 ' O ' ' OG ' ' A' ' 85' ' ' SER . . . 108.7 63.73 0.55 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 . . . . . 0 N--CA 1.494 1.759 0 O-C-N 121.195 -1.18 . . . . 0.0 110.012 179.881 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.612 ' O ' ' N ' ' A' ' 32' ' ' LEU . 1.1 pt? . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.182 0.515 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.857 ' HA ' HD23 ' A' ' 33' ' ' LEU . 59.9 mt-10 -46.66 -26.86 1.0 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.053 -1.03 . . . . 0.0 108.704 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -70.99 -22.21 62.2 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.612 ' N ' ' O ' ' A' ' 29' ' ' LEU . 14.7 tp -83.57 -34.86 25.09 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.06 HD22 ' HB2' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -70.41 -36.56 74.1 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.884 0.849 . . . . 0.0 109.057 179.122 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.597 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 2.9 t -70.48 -14.24 62.45 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.423 0.63 . . . . 0.0 109.945 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 1.023 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -54.45 -160.73 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.511 -0.743 . . . . 0.0 109.967 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 1.023 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 38.2 Cg_endo -65.55 -166.55 0.1 OUTLIER 'Trans proline' 0 N--CA 1.489 1.22 0 O-C-N 123.188 1.099 . . . . 0.0 110.022 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.722 ' CD ' ' HB2' ' A' ' 36' ' ' PRO . 51.2 Cg_endo -96.67 54.42 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 121.394 1.396 . . . . 0.0 113.183 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.739 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 51.7 Cg_endo -76.46 151.06 32.75 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 122.93 0.963 . . . . 0.0 109.761 178.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.706 ' OD1' ' N ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -13.89 -54.41 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.53 -0.731 . . . . 0.0 112.072 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.954 ' O ' ' HB3' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -51.86 -46.56 64.49 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.933 -1.104 . . . . 0.0 110.959 -179.502 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.912 HG13 ' CE1' ' A' ' 45' ' ' HIS . 11.9 t -86.11 -19.14 8.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 O-C-N 121.52 -0.738 . . . . 0.0 111.639 -177.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 46' ' ' HIS . . . -88.95 -41.49 12.36 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.667 -1.271 . . . . 0.0 111.197 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.719 ' HB2' ' HA ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -87.65 -19.43 27.72 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 118.848 -1.141 . . . . 0.0 109.426 179.832 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.954 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -77.73 -38.02 48.07 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.113 0.959 . . . . 0.0 108.865 179.276 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.912 ' CE1' HG13 ' A' ' 41' ' ' VAL . 6.5 m170 -80.81 -18.2 48.32 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.429 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.479 ' HB2' ' O ' ' A' ' 42' ' ' ALA . 1.0 OUTLIER -97.42 -34.18 11.13 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.194 -0.941 . . . . 0.0 109.465 178.625 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.617 ' O ' ' CD1' ' A' ' 214' ' ' ILE . . . -68.18 -114.94 0.02 OUTLIER Glycine 0 N--CA 1.489 2.198 0 N-CA-C 107.299 -2.32 . . . . 0.0 107.299 178.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 1.105 ' CZ2' ' HA ' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -85.63 87.86 7.46 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 176.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.57 HD21 ' CA ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -42.72 153.17 0.33 Allowed Pre-proline 0 N--CA 1.492 1.652 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -177.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.657 ' HA ' ' O ' ' A' ' 53' ' ' CYS . 43.7 Cg_endo -70.38 -31.05 18.47 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 O-C-N 124.773 1.933 . . . . 0.0 110.952 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.878 ' N ' ' HE3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -62.37 0.13 0.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.36 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.792 ' HB3' HG11 ' A' ' 203' ' ' VAL . 12.9 m-20 -141.87 2.92 1.59 Allowed 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.112 178.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.874 ' HA ' ' N ' ' A' ' 79' ' ' ARG . 1.6 t -150.69 147.74 27.72 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.377 -0.827 . . . . 0.0 111.545 -179.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.946 ' H ' ' HA ' ' A' ' 78' ' ' VAL . 0.7 OUTLIER -86.92 121.78 29.86 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 120.903 -1.123 . . . . 0.0 109.824 178.648 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 1.06 ' HB2' HD22 ' A' ' 33' ' ' LEU . 1.1 pt-20 -44.77 -35.27 2.63 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.489 -0.757 . . . . 0.0 112.976 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.816 HD21 HG21 ' A' ' 75' ' ' THR . 0.0 OUTLIER -32.48 -20.52 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.54 0 O-C-N 121.29 -0.882 . . . . 0.0 111.379 -179.217 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.04 HD11 ' CB ' ' A' ' 207' ' ' TRP . 1.6 mt -111.18 167.18 5.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.307 -0.87 . . . . 0.0 110.131 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.507 ' N ' ' CG2' ' A' ' 57' ' ' ILE . 36.0 t70 -108.54 128.55 54.91 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.376 -0.828 . . . . 0.0 110.357 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 1.037 ' HB ' ' CE2' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -131.28 132.03 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.577 -0.702 . . . . 0.0 111.099 -179.075 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.719 ' HA ' ' HB2' ' A' ' 43' ' ' GLN . 24.6 tttt -136.58 130.7 32.74 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.804 -1.185 . . . . 0.0 110.101 178.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.589 ' H ' ' HB3' ' A' ' 43' ' ' GLN . 1.6 pt-20 -52.58 -117.25 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.442 -0.786 . . . . 0.0 111.079 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 45.69 41.39 9.72 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 107.998 -2.041 . . . . 0.0 107.998 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.698 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 98.81 74.09 1.13 Allowed Glycine 0 N--CA 1.487 2.07 0 N-CA-C 108.293 -1.923 . . . . 0.0 108.293 -178.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.698 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER 0.84 75.38 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.758 -0.848 . . . . 0.0 110.887 -178.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.546 ' N ' ' O ' ' A' ' 63' ' ' GLY . 53.7 t -101.61 114.64 28.86 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.312 -0.868 . . . . 0.0 110.491 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 1.105 ' HA ' ' CZ2' ' A' ' 48' ' ' TRP . 1.6 m-85 -82.68 138.03 34.26 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.395 -0.816 . . . . 0.0 110.268 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.507 ' O ' HG23 ' A' ' 57' ' ' ILE . 1.8 tt0 -138.2 121.77 17.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.16 -0.962 . . . . 0.0 109.913 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.488 ' HG3' ' HB2' ' A' ' 207' ' ' TRP . 0.6 OUTLIER -131.17 145.74 52.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.181 -0.95 . . . . 0.0 110.343 -179.87 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.628 ' HB3' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -125.1 -67.52 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.361 -0.837 . . . . 0.0 110.317 179.789 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.628 ' CD ' ' HB3' ' A' ' 69' ' ' ARG . 55.9 Cg_endo -69.7 -141.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.385 1.203 . . . . 0.0 109.133 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.447 ' H ' ' HB2' ' A' ' 70' ' ' PRO . 3.5 t -139.74 164.0 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.053 -1.029 . . . . 0.0 110.045 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.6 119.35 6.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.129 -0.982 . . . . 0.0 110.136 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -84.99 -93.62 0.08 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.178 -0.951 . . . . 0.0 110.267 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.9 p -104.19 23.38 13.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.145 -0.972 . . . . 0.0 110.133 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.816 HG21 HD21 ' A' ' 56' ' ' ASN . 3.4 t -141.5 -134.84 0.1 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.307 -0.871 . . . . 0.0 110.088 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.733 ' O ' ' C ' ' A' ' 77' ' ' GLY . 4.9 m-20 -140.55 153.62 46.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 110.868 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.733 ' C ' ' O ' ' A' ' 76' ' ' ASP . . . -26.48 -62.28 0.08 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 106.067 -2.813 . . . . 0.0 106.067 179.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.959 ' CG2' ' HB3' ' A' ' 205' ' ' ALA . 29.0 m -148.92 118.75 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 122.108 -0.643 . . . . 0.0 109.327 176.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.874 ' N ' ' HA ' ' A' ' 53' ' ' CYS . 0.0 OUTLIER -146.6 137.01 23.81 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.687 -0.633 . . . . 0.0 110.681 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.83 ' HA3' ' C ' ' A' ' 51' ' ' LYS . . . -163.38 156.03 27.65 Favored Glycine 0 N--CA 1.481 1.636 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 178.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 201' ' ' PRO . 0.2 OUTLIER -143.66 128.55 18.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.345 -1.091 . . . . 0.0 110.152 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.796 ' HD3' ' H ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -150.35 -95.64 0.07 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.194 -0.941 . . . . 0.0 110.226 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.796 ' H ' ' HD3' ' A' ' 82' ' ' ARG . . . 47.84 63.98 3.22 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -119.16 95.49 4.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.134 -1.216 . . . . 0.0 110.255 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.58 ' HB3' ' CD2' ' A' ' 89' ' ' HIS . 1.0 OUTLIER -140.3 169.37 17.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.249 -0.907 . . . . 0.0 110.098 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.561 ' O ' ' NE2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -117.37 133.48 55.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 110.128 179.792 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 103.76 -117.19 5.63 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.706 ' C ' HD23 ' A' ' 88' ' ' LEU . 7.6 tt -128.64 127.0 41.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.398 -1.06 . . . . 0.0 110.39 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.58 ' CD2' ' HB3' ' A' ' 85' ' ' SER . 8.5 m-70 -147.05 161.43 40.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.165 -0.959 . . . . 0.0 110.215 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.677 ' HB1' ' O ' ' A' ' 169' ' ' VAL . . . -163.52 157.87 20.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.22 -0.925 . . . . 0.0 109.857 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 1.142 ' CZ2' HG11 ' A' ' 169' ' ' VAL . 3.0 p90 -134.79 160.25 38.8 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.065 -1.022 . . . . 0.0 110.403 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.643 ' N ' ' O ' ' A' ' 215' ' ' ARG . 31.3 mt-10 -119.11 121.17 39.18 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.339 0.59 . . . . 0.0 110.648 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.538 HG12 ' HA ' ' A' ' 214' ' ' ILE . 5.3 mt -135.01 149.33 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.215 -0.928 . . . . 0.0 110.168 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.584 ' OG ' ' NH2' ' A' ' 213' ' ' ARG . 0.0 OUTLIER -121.17 135.84 55.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 109.654 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.898 ' HH2' ' O ' ' A' ' 204' ' ' SER . 6.1 t-105 -115.72 87.88 19.01 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.246 -0.909 . . . . 0.0 110.303 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 94' ' ' SER . 51.0 Cg_endo -97.47 114.06 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.156 1.904 . . . . 0.0 110.967 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 O-C-N 120.895 -1.128 . . . . 0.0 109.523 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 1.235 HG13 ' O ' ' A' ' 204' ' ' SER . 0.5 OUTLIER . . . . . 0 N--CA 1.477 0.893 0 CA-C-O 121.482 0.658 . . . . 0.0 109.981 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.679 HG22 ' CZ3' ' A' ' 95' ' ' TRP . 9.7 t -152.49 136.94 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.476 -0.765 . . . . 0.0 109.698 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.519 ' HA3' ' HA3' ' A' ' 132' ' ' GLY . . . 154.07 -146.12 14.04 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 118.895 -1.621 . . . . 0.0 110.559 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.041 HG23 ' C ' ' A' ' 200' ' ' TYR . 2.7 p -149.76 156.93 6.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.689 -0.889 . . . . 0.0 109.597 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.538 ' C ' ' HB3' ' A' ' 199' ' ' LEU . . . -146.41 153.34 40.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.059 -1.025 . . . . 0.0 111.104 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.931 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -110.72 128.61 55.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.468 -0.77 . . . . 0.0 109.738 179.529 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.6 -26.22 17.97 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.31 -0.869 . . . . 0.0 109.726 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.671 ' C ' HD12 ' A' ' 112' ' ' LEU . 4.1 pp -84.88 -11.94 54.55 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.417 -0.802 . . . . 0.0 109.481 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.592 ' HB3' ' HB ' ' A' ' 110' ' ' THR . . . . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.397 -0.814 . . . . 0.0 110.548 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.315 0.578 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -130.45 117.28 19.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 110.147 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.525 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 1.0 OUTLIER -123.96 122.05 36.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -0.914 . . . . 0.0 110.257 -179.876 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 3.2 m0 -125.54 129.53 49.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.245 -0.91 . . . . 0.0 109.958 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.519 ' HA3' ' HA3' ' A' ' 107' ' ' GLY . . . 173.87 -114.8 0.53 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . 0.869 ' CZ2' HD22 ' A' ' 187' ' ' LEU . 34.3 m0 -129.16 122.96 30.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -1.162 . . . . 0.0 110.303 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.474 ' O ' HG12 ' A' ' 135' ' ' ILE . 0.8 OUTLIER -118.03 107.93 14.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.286 -0.883 . . . . 0.0 110.13 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 134' ' ' ASP . 1.3 mt . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.296 -0.878 . . . . 0.0 109.949 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.875 ' HB ' ' HD3' ' A' ' 164' ' ' PRO . 2.4 t . . . . . 0 N--CA 1.497 1.897 0 CA-C-O 119.678 -0.201 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.875 ' HD3' ' HB ' ' A' ' 163' ' ' VAL . 52.9 Cg_endo -95.84 179.21 0.59 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.104 1.055 . . . . 0.0 111.203 -178.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.8 -37.38 5.89 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 1.073 ' O ' HD13 ' A' ' 167' ' ' LEU . 0.3 OUTLIER -142.71 142.19 31.94 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.106 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 1.073 HD13 ' O ' ' A' ' 166' ' ' ARG . 0.3 OUTLIER -126.79 154.75 43.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.003 -1.06 . . . . 0.0 110.971 -179.24 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.7 tt -123.64 135.08 53.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.496 -0.753 . . . . 0.0 109.653 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 1.142 HG11 ' CZ2' ' A' ' 91' ' ' TRP . 42.3 t -106.41 141.71 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.122 -0.986 . . . . 0.0 110.73 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 53.4 t -122.25 114.81 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.357 -0.839 . . . . 0.0 109.742 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.86 HD12 ' N ' ' A' ' 172' ' ' ASP . 0.4 OUTLIER -128.09 124.08 36.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.18 -0.95 . . . . 0.0 110.423 -179.649 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.86 ' N ' HD12 ' A' ' 171' ' ' LEU . 5.5 t70 -116.32 138.36 51.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.312 -0.868 . . . . 0.0 109.914 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.502 ' O ' ' N ' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -93.34 -41.09 10.03 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.05 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.488 ' C ' ' O ' ' A' ' 173' ' ' MET . 0.6 OUTLIER -41.0 -27.84 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.195 -0.94 . . . . 0.0 108.987 179.399 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.566 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 1.8 tp10 -113.45 -27.63 7.84 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.518 ' O ' ' CG2' ' A' ' 198' ' ' THR . . . 83.62 23.74 52.45 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 1.026 HG22 ' CD2' ' A' ' 194' ' ' LEU . 0.7 OUTLIER -116.59 135.52 53.74 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.344 -1.092 . . . . 0.0 111.029 -179.515 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.999 ' O ' HD11 ' A' ' 194' ' ' LEU . 0.2 OUTLIER -136.29 150.65 49.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.45 -0.781 . . . . 0.0 109.594 179.361 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -148.15 -175.17 20.58 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.691 -1.242 . . . . 0.0 110.08 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.692 ' CG ' ' CH2' ' A' ' 133' ' ' TRP . 0.2 OUTLIER -138.98 127.2 22.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.4 -1.059 . . . . 0.0 110.082 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 21.2 t -117.99 124.44 48.19 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.174 -0.954 . . . . 0.0 109.881 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.799 HD12 ' CZ2' ' A' ' 133' ' ' TRP . 0.1 OUTLIER -116.15 116.48 52.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.506 -0.746 . . . . 0.0 109.777 179.814 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.511 ' C ' ' O ' ' A' ' 182' ' ' ILE . . . 38.51 28.94 0.06 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 182' ' ' ILE . . . 62.32 43.2 99.41 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' THR . . . . . 0.881 HG22 ' HD1' ' A' ' 186' ' ' TYR . 25.2 m -72.24 -78.86 0.08 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.201 -1.176 . . . . 0.0 110.468 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.881 ' HD1' HG22 ' A' ' 185' ' ' THR . 8.6 p90 -175.11 104.47 0.09 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.855 -1.153 . . . . 0.0 111.051 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.869 HD22 ' CZ2' ' A' ' 133' ' ' TRP . 4.8 tp 179.6 23.2 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.366 -0.834 . . . . 0.0 110.778 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.835 ' N ' ' CD ' ' A' ' 189' ' ' PRO . . . -109.65 -5.77 29.31 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.752 -1.213 . . . . 0.0 112.088 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.835 ' CD ' ' N ' ' A' ' 188' ' ' GLY . 50.5 Cg_endo -75.59 -33.03 4.31 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 O-C-N 122.718 0.851 . . . . 0.0 110.97 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.585 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -83.04 41.36 0.75 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.221 -0.924 . . . . 0.0 110.976 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -90.53 -46.22 8.45 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.204 -0.935 . . . . 0.0 110.455 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . 0.523 ' HA ' ' NE ' ' A' ' 192' ' ' ARG . 0.5 OUTLIER -68.11 -14.91 63.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.16 -0.963 . . . . 0.0 110.001 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 197' ' ' ARG . . . -103.47 -10.92 34.69 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 1.026 ' CD2' HG22 ' A' ' 177' ' ' THR . 9.2 tt -70.35 -43.36 70.35 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.851 -0.793 . . . . 0.0 109.142 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.555 ' HE3' ' N ' ' A' ' 196' ' ' GLY . 0.1 OUTLIER -43.91 -41.16 5.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.485 -0.759 . . . . 0.0 110.005 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.555 ' N ' ' HE3' ' A' ' 195' ' ' LYS . . . -88.09 -24.87 33.24 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' ARG . . . . . 0.708 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -91.07 -2.84 57.56 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.838 -0.801 . . . . 0.0 109.737 179.659 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . 0.711 HG23 ' O ' ' A' ' 194' ' ' LEU . 13.4 p -41.42 125.94 2.72 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.829 0.823 . . . . 0.0 111.212 -177.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.949 ' CD1' HG13 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -138.11 172.77 12.43 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -179.571 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 1.041 ' C ' HG23 ' A' ' 108' ' ' VAL . 4.2 m-30 -83.76 129.84 57.85 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 120.958 -1.089 . . . . 0.0 109.659 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.521 ' HA ' ' HB ' ' A' ' 108' ' ' VAL . 46.6 Cg_endo -72.49 129.17 14.39 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 124.047 1.551 . . . . 0.0 111.851 -178.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.417 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 1.8 p -133.62 160.27 38.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.486 -0.759 . . . . 0.0 110.101 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.792 HG11 ' HB3' ' A' ' 52' ' ' ASP . 14.9 p -137.1 156.51 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.256 -0.903 . . . . 0.0 110.556 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . 1.235 ' O ' HG13 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -160.11 127.93 4.66 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.442 -0.787 . . . . 0.0 109.217 179.052 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.959 ' HB3' ' CG2' ' A' ' 78' ' ' VAL . . . -127.93 159.95 33.37 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.5 -0.75 . . . . 0.0 110.738 -178.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.568 ' CG1' ' N ' ' A' ' 207' ' ' TRP . 1.0 OUTLIER -60.45 175.61 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 CA-C-O 121.334 0.588 . . . . 0.0 110.655 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 1.04 ' CB ' HD11 ' A' ' 57' ' ' ILE . 39.7 p90 -120.84 57.71 0.97 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.439 -0.788 . . . . 0.0 110.207 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -134.53 -144.37 5.03 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.411 ' O ' ' C ' ' A' ' 210' ' ' CYS . 2.2 tp60 -67.2 -31.67 72.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.353 -1.086 . . . . 0.0 110.481 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . 0.566 ' SG ' HG12 ' A' ' 206' ' ' VAL . 17.2 p -43.58 153.35 0.12 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.289 -0.882 . . . . 0.0 109.917 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.68 ' HA ' ' CD1' ' A' ' 66' ' ' PHE . 8.2 pt20 -156.56 123.67 5.28 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.103 -0.998 . . . . 0.0 110.628 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.424 ' HA ' ' CD ' ' A' ' 96' ' ' PRO . 1.5 m -101.61 140.32 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.336 -0.852 . . . . 0.0 110.114 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . 0.584 ' NH2' ' OG ' ' A' ' 94' ' ' SER . 0.5 OUTLIER -89.43 127.1 35.8 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.237 -0.914 . . . . 0.0 108.999 179.399 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.956 HG21 ' HA ' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -103.59 113.5 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-O 121.939 0.876 . . . . 0.0 111.248 -178.621 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' ARG . . . . . 0.643 ' O ' ' N ' ' A' ' 92' ' ' GLU . 4.0 ttt180 -130.61 126.89 37.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.407 -0.808 . . . . 0.0 108.863 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . 0.616 ' CD2' ' HB3' ' A' ' 91' ' ' TRP . 4.0 t80 -119.27 150.39 40.19 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.921 -1.112 . . . . 0.0 111.017 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' MET . . . . . 0.457 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 6.2 ttp -126.98 107.87 10.45 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.298 -0.876 . . . . 0.0 109.677 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 89.24 59.18 1.58 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.244 -1.15 . . . . 0.0 110.179 179.942 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.16 44.66 1.33 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -1.162 . . . . 0.0 110.18 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.8 m -93.04 -19.76 21.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.204 -0.935 . . . . 0.0 110.257 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.93 -179.64 3.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -0.936 . . . . 0.0 110.154 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -89.67 -71.93 0.58 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.261 -0.899 . . . . 0.0 110.235 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -47.49 116.6 1.49 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.214 -0.929 . . . . 0.0 110.249 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 88.1 p -127.79 -153.39 0.57 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 110.281 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.9 t -147.4 126.11 6.23 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.24 -0.912 . . . . 0.0 110.151 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.16 110.98 3.17 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.957 1.504 . . . . 0.0 110.387 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.48 68.43 0.71 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -0.901 . . . . 0.0 110.17 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -133.31 118.42 18.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.3 -0.875 . . . . 0.0 110.275 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -139.26 75.54 1.52 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 110.15 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.708 ' O ' HD12 ' A' ' 19' ' ' LEU . . . -58.28 101.45 0.08 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.263 -0.898 . . . . 0.0 110.145 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.708 HD12 ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER 179.85 -155.08 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.201 -0.937 . . . . 0.0 110.201 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.46 ' CG ' ' N ' ' A' ' 21' ' ' SER . 25.3 t80 -91.79 -102.38 0.11 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.29 -0.881 . . . . 0.0 110.22 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.46 ' N ' ' CG ' ' A' ' 20' ' ' TYR . 2.0 t -150.21 140.41 22.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.133 -0.979 . . . . 0.0 110.176 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 1.8 p30 -167.72 66.91 0.08 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.207 -0.933 . . . . 0.0 110.267 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.443 ' CG ' ' N ' ' A' ' 24' ' ' SER . 13.7 t80 -76.7 -104.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 110.017 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.443 ' N ' ' CG ' ' A' ' 23' ' ' PHE . 2.8 m -123.4 104.86 34.07 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.552 -0.717 . . . . 0.0 110.111 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -78.11 164.32 27.19 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.018 1.536 . . . . 0.0 110.446 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.97 158.03 50.34 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.002 1.527 . . . . 0.0 110.539 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 179.68 45.11 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.476 -0.765 . . . . 0.0 110.12 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 168.99 -19.94 0.08 OUTLIER Glycine 0 N--CA 1.49 2.299 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.378 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.803 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -71.97 -49.69 35.18 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.064 -1.256 . . . . 0.0 110.025 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.658 ' HA ' HD23 ' A' ' 33' ' ' LEU . 1.7 tt0 -45.02 -34.72 2.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.053 -1.029 . . . . 0.0 108.988 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.37 -24.05 64.78 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.385 -0.822 . . . . 0.0 108.787 178.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.577 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -83.42 -32.3 26.18 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.845 HD12 ' C ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -81.52 -38.19 26.65 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.891 0.853 . . . . 0.0 109.284 179.165 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.57 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 0.9 OUTLIER -46.8 -30.72 2.59 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.625 0.726 . . . . 0.0 109.88 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 1.046 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -72.58 -169.99 0.15 Allowed Pre-proline 0 C--N 1.298 -1.652 0 O-C-N 121.497 -0.752 . . . . 0.0 109.364 179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 1.046 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 42.0 Cg_endo -69.48 106.18 1.57 Allowed 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.6 1.316 . . . . 0.0 109.765 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.651 ' HG3' HG21 ' A' ' 41' ' ' VAL . 50.5 Cg_endo -88.67 108.59 0.51 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.13 1.595 . . . . 0.0 111.166 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.77 ' O ' ' N ' ' A' ' 40' ' ' LEU . 49.4 Cg_endo -76.81 150.55 30.74 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.925 1.487 . . . . 0.0 109.998 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.723 ' O ' ' CG ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER 3.3 61.39 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 122.617 1.199 . . . . 0.0 110.455 -178.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.012 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -149.66 -45.47 0.13 Allowed 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 178.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.8 ' N ' HD13 ' A' ' 40' ' ' LEU . 2.2 t -86.38 -35.64 9.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 46' ' ' HIS . . . -89.21 -43.23 11.15 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.38 0.61 . . . . 0.0 110.089 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.579 ' HG3' ' CD ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -68.66 -25.17 64.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.461 -0.774 . . . . 0.0 110.416 -179.685 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.839 ' HA ' HG12 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -79.05 -50.84 10.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.146 -0.971 . . . . 0.0 108.999 179.475 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.687 ' HA ' ' CB ' ' A' ' 49' ' ' ASN . 9.3 m170 -63.8 -16.16 60.53 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.443 ' HB2' ' O ' ' A' ' 42' ' ' ALA . 3.7 t-160 -96.36 -28.75 14.33 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.44 -119.21 0.05 OUTLIER Glycine 0 N--CA 1.477 1.403 0 N-CA-C 107.838 -2.105 . . . . 0.0 107.838 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 1.086 ' CZ2' HD22 ' A' ' 64' ' ' LEU . 0.8 OUTLIER -103.52 70.56 1.04 Allowed 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.011 -1.287 . . . . 0.0 110.478 179.143 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.687 ' CB ' ' HA ' ' A' ' 45' ' ' HIS . 0.3 OUTLIER -109.24 111.97 59.76 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 121.1 -1.0 . . . . 0.0 111.721 179.578 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.853 ' HG2' ' HB2' ' A' ' 53' ' ' CYS . 48.5 Cg_endo -80.57 -59.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.302 -1.902 0 O-C-N 123.78 1.411 . . . . 0.0 108.847 177.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.694 ' HG2' ' O ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER 179.81 -95.73 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.602 -0.686 . . . . 0.0 110.191 178.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.604 ' N ' ' HA2' ' A' ' 80' ' ' GLY 0.26 54.1 m-20 -68.97 33.97 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.178 0.989 . . . . 0.0 109.175 178.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.853 ' HB2' ' HG2' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -101.07 -176.92 3.3 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.843 -177.38 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.743 ' CA ' HG11 ' A' ' 78' ' ' VAL . 0.3 OUTLIER -50.6 101.73 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.689 -0.804 . . . . 0.0 111.662 -177.17 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.521 ' HG3' ' N ' ' A' ' 56' ' ' ASN . 9.4 pt-20 -102.07 -32.78 9.97 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.826 0.822 . . . . 0.0 109.522 177.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.584 ' HB3' HD21 ' A' ' 29' ' ' LEU . 21.6 m-80 -70.01 -7.98 45.42 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.76 -0.587 . . . . 0.0 111.811 -178.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.98 HG22 HG22 ' A' ' 75' ' ' THR . 1.2 pt -112.69 166.17 6.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 120.844 -1.16 . . . . 0.0 109.988 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.832 ' CB ' HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -108.98 126.86 53.55 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.371 -0.831 . . . . 0.0 110.563 -179.13 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.839 HG12 ' HA ' ' A' ' 44' ' ' ARG . 9.6 p -130.42 130.76 65.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 O-C-N 121.46 -0.775 . . . . 0.0 109.275 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.579 ' CD ' ' HG3' ' A' ' 43' ' ' GLN . 19.7 tttm -135.61 153.25 51.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.069 -1.019 . . . . 0.0 110.689 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.484 ' HA ' ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -66.21 -121.8 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.401 -0.812 . . . . 0.0 110.269 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 44.51 26.54 1.06 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.699 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 124.38 61.01 0.18 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.086 HD22 ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER 0.61 88.76 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.796 -0.826 . . . . 0.0 110.758 -179.658 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 42.4 t -127.64 114.73 17.74 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.289 -0.882 . . . . 0.0 111.396 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.673 ' HA ' HG23 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -84.37 134.31 34.49 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.526 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.637 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 2.4 tt0 -126.66 131.03 51.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.74 -1.225 . . . . 0.0 110.847 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.559 ' HD3' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -136.06 156.07 49.27 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.414 -0.804 . . . . 0.0 109.539 179.602 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.671 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -85.37 -69.92 0.13 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.071 -1.018 . . . . 0.0 111.243 -179.105 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.9 ' HD2' HG21 ' A' ' 75' ' ' THR . 55.8 Cg_endo -72.16 -113.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.55 1.289 . . . . 0.0 110.324 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.48 ' O ' ' N ' ' A' ' 73' ' ' GLN . 4.7 t -140.38 164.83 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.454 -1.404 . . . . 0.0 110.369 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.571 ' HB2' ' NE1' ' A' ' 207' ' ' TRP . . . -41.62 -24.45 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.306 -0.872 . . . . 0.0 110.377 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.495 ' C ' ' O ' ' A' ' 72' ' ' ALA . 1.6 pt20 -36.11 -34.33 0.05 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.263 -0.898 . . . . 0.0 110.577 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 72' ' ' ALA . 69.0 p -149.54 -36.52 0.16 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 110.317 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.98 HG22 HG22 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -72.15 -55.1 7.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.189 -0.945 . . . . 0.0 110.134 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.549 ' OD2' ' HA ' ' A' ' 207' ' ' TRP . 4.7 t0 -99.24 155.36 17.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.225 -0.922 . . . . 0.0 109.741 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.63 74.12 1.26 Allowed Glycine 0 N--CA 1.487 2.068 0 N-CA-C 107.23 -2.348 . . . . 0.0 107.23 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.787 HG22 ' HA ' ' A' ' 53' ' ' CYS . 1.4 p -158.08 162.67 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 O-C-N 121.806 -0.82 . . . . 0.0 109.406 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.667 ' CG ' ' O ' ' A' ' 203' ' ' VAL . 0.0 OUTLIER -145.52 137.35 25.36 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.072 -1.051 . . . . 0.0 113.008 -178.419 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.604 ' HA2' ' N ' ' A' ' 52' ' ' ASP . . . -74.73 154.05 46.51 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 107.729 -2.148 . . . . 0.0 107.729 176.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.505 ' HG2' ' N ' ' A' ' 82' ' ' ARG . 1.3 ttmp? -126.18 -97.55 0.42 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.796 -1.414 . . . . 0.0 112.374 -178.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.888 ' HD3' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -43.33 -87.41 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.208 -0.933 . . . . 0.0 111.666 -178.102 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.888 ' N ' ' HD3' ' A' ' 82' ' ' ARG . . . 60.39 76.9 0.2 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.564 ' CE1' ' SD ' ' A' ' 173' ' ' MET . 10.1 t80 -94.42 132.08 39.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.356 -1.085 . . . . 0.0 110.842 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.468 ' O ' ' SD ' ' A' ' 173' ' ' MET . 7.3 t -140.01 161.34 37.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.39 -0.819 . . . . 0.0 109.911 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.464 ' HA ' ' HG2' ' A' ' 173' ' ' MET . 4.1 mtt180 -111.26 160.22 17.19 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.066 -1.022 . . . . 0.0 109.776 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.77 158.29 34.19 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.603 ' O ' HD23 ' A' ' 88' ' ' LEU . 2.5 tt -87.61 123.52 32.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.306 -1.114 . . . . 0.0 110.163 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.567 ' CD2' ' O ' ' A' ' 171' ' ' LEU . 0.6 OUTLIER -147.36 173.36 12.68 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 110.134 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -149.58 155.4 40.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.351 -0.843 . . . . 0.0 110.037 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.958 ' CZ3' HG11 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -134.72 170.67 15.48 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.116 -0.99 . . . . 0.0 110.352 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.663 ' N ' ' O ' ' A' ' 215' ' ' ARG . 1.0 OUTLIER -129.1 147.89 51.0 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.889 -0.725 . . . . 0.0 110.797 -179.471 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.552 ' CG2' ' OH ' ' A' ' 180' ' ' TYR . 0.6 OUTLIER -144.3 145.48 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.53 -0.731 . . . . 0.0 109.933 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.9 ' O ' HG23 ' A' ' 212' ' ' VAL . 0.0 OUTLIER -145.02 144.32 30.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.173 -0.955 . . . . 0.0 110.204 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.785 ' CZ3' ' HA ' ' A' ' 104' ' ' ALA . 41.7 m95 -117.99 107.6 43.71 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.239 -0.913 . . . . 0.0 110.473 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.571 ' HG3' ' CZ ' ' A' ' 213' ' ' ARG . 49.8 Cg_endo -75.04 109.79 2.99 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.875 1.46 . . . . 0.0 109.899 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.543 HD22 ' OG1' ' A' ' 102' ' ' THR . 0.0 OUTLIER -95.44 -12.03 26.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.114 -0.991 . . . . 0.0 110.225 -179.725 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 97' ' ' LEU . 2.8 tm-20 -40.44 -33.32 0.25 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.239 -0.913 . . . . 0.0 110.577 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 209' ' ' GLN . 1.0 OUTLIER -42.61 -83.71 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.258 -0.901 . . . . 0.0 110.607 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.51 ' HB2' ' NH1' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -167.67 -59.75 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.418 -0.801 . . . . 0.0 110.304 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.614 ' C ' HG23 ' A' ' 102' ' ' THR . . . -149.34 126.0 2.13 Favored Glycine 0 N--CA 1.485 1.903 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.614 HG23 ' C ' ' A' ' 101' ' ' GLY . 75.5 p -156.21 -150.55 0.29 Allowed 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.305 -1.115 . . . . 0.0 110.014 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.597 ' CG ' ' O ' ' A' ' 102' ' ' THR . 0.5 OUTLIER -179.68 113.05 0.05 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.055 -1.028 . . . . 0.0 110.873 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.785 ' HA ' ' CZ3' ' A' ' 95' ' ' TRP . . . -76.19 131.91 39.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.27 -0.894 . . . . 0.0 109.377 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.996 HG23 ' HB2' ' A' ' 204' ' ' SER . 17.4 m -132.2 116.48 29.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 C-N-CA 117.961 -1.496 . . . . 0.0 110.612 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.586 HG22 HG23 ' A' ' 203' ' ' VAL . 89.8 t -150.63 170.09 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.623 -0.673 . . . . 0.0 109.341 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.638 ' CA ' ' HA3' ' A' ' 132' ' ' GLY . . . 165.6 167.3 25.99 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.34 -1.409 . . . . 0.0 110.479 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.75 HG12 ' HB2' ' A' ' 199' ' ' LEU . 1.7 t -112.55 141.73 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.551 -0.97 . . . . 0.0 109.507 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 130' ' ' SER . . . -114.53 142.61 46.19 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.081 -1.012 . . . . 0.0 110.655 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.802 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -118.77 131.99 56.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.277 -0.889 . . . . 0.0 110.357 179.718 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.97 -26.79 17.4 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.399 -0.813 . . . . 0.0 109.286 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.637 ' C ' HD12 ' A' ' 112' ' ' LEU . 4.1 pp -83.83 -12.17 55.97 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.558 -0.714 . . . . 0.0 109.448 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.572 ' CB ' ' CB ' ' A' ' 129' ' ' GLU . . . -36.02 109.99 0.43 Allowed Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.587 -0.695 . . . . 0.0 110.441 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.699 ' C ' HD23 ' A' ' 115' ' ' LEU . 45.5 Cg_endo -72.81 -156.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.024 1.539 . . . . 0.0 110.431 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.945 HD13 ' HA3' ' A' ' 125' ' ' GLY . 0.3 OUTLIER -171.87 59.21 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.176 -0.953 . . . . 0.0 110.306 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -102.07 -70.99 0.73 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.384 -0.822 . . . . 0.0 110.241 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.515 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -114.59 56.61 0.72 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.275 -0.891 . . . . 0.0 110.255 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.515 ' C ' ' O ' ' A' ' 117' ' ' ALA . 8.2 t70 -32.06 146.65 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.512 -0.743 . . . . 0.0 110.66 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -44.96 -37.54 4.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.307 -0.87 . . . . 0.0 110.223 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.632 ' O ' ' HB2' ' A' ' 121' ' ' ALA . 1.6 m-30 -63.86 -56.4 15.63 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.33 -0.856 . . . . 0.0 110.21 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.632 ' HB2' ' O ' ' A' ' 120' ' ' TYR . . . 173.48 -67.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.149 -0.969 . . . . 0.0 110.161 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.534 ' HB2' ' O ' ' A' ' 121' ' ' ALA . . . 178.65 88.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.257 -0.902 . . . . 0.0 110.22 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.561 ' O ' HD12 ' A' ' 124' ' ' LEU . 17.2 mt -98.88 -66.52 0.9 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.239 -0.913 . . . . 0.0 110.191 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.561 HD12 ' O ' ' A' ' 123' ' ' LEU . 0.1 OUTLIER 177.27 -153.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -0.887 . . . . 0.0 110.212 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.945 ' HA3' HD13 ' A' ' 115' ' ' LEU . . . -156.75 158.04 28.46 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.462 ' OG ' ' N ' ' A' ' 127' ' ' ASN . 4.7 t -123.91 -101.04 0.4 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.274 -1.133 . . . . 0.0 110.043 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.462 ' N ' ' OG ' ' A' ' 126' ' ' SER . 0.5 OUTLIER -126.66 -27.55 3.1 Favored 'General case' 0 C--N 1.286 -2.152 0 CA-C-O 121.222 0.534 . . . . 0.0 110.193 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.1 m -160.49 -166.42 1.65 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 110.315 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.572 ' CB ' ' CB ' ' A' ' 113' ' ' ALA . 3.9 tt0 -150.03 129.64 13.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.313 -0.867 . . . . 0.0 109.997 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 32.3 t -120.43 119.68 33.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.189 -0.944 . . . . 0.0 110.409 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.28 131.62 40.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.349 -0.845 . . . . 0.0 109.841 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.638 ' HA3' ' CA ' ' A' ' 107' ' ' GLY . . . -165.05 -144.67 4.13 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.696 ' CE3' ' CD2' ' A' ' 180' ' ' TYR . 31.5 m0 -116.67 114.45 24.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.343 -1.092 . . . . 0.0 110.556 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.492 ' H ' HD23 ' A' ' 161' ' ' LEU . 2.9 p-10 -118.13 143.42 46.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.527 -0.733 . . . . 0.0 110.033 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.704 HD12 ' N ' ' A' ' 136' ' ' GLY . 0.1 OUTLIER -77.64 2.35 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.23 -0.919 . . . . 0.0 110.335 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.704 ' N ' HD12 ' A' ' 135' ' ' ILE . . . -66.01 -9.84 48.91 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.78 4.39 44.5 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.279 -1.13 . . . . 0.0 109.286 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 139' ' ' LYS . . . -125.6 -7.08 5.84 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.497 ' CD ' ' HA2' ' A' ' 136' ' ' GLY . 48.1 mtpt -54.21 -164.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.416 -1.05 . . . . 0.0 110.177 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.5 mt -86.38 4.61 38.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.207 -0.933 . . . . 0.0 110.151 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.574 ' HB3' ' CD2' ' A' ' 142' ' ' HIS . 0.1 OUTLIER -85.04 3.44 38.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 110.243 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.574 ' CD2' ' HB3' ' A' ' 141' ' ' TYR . 91.5 m-70 -150.18 85.81 1.41 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.163 -0.961 . . . . 0.0 110.25 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -142.07 -69.85 0.35 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.228 -0.92 . . . . 0.0 110.212 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 78.9 p -45.14 -41.66 8.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.296 -0.878 . . . . 0.0 110.221 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -99.33 84.61 3.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.259 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -138.5 126.58 3.5 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.05 10.7 7.49 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.233 -1.157 . . . . 0.0 110.209 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.404 ' O ' ' HD3' ' A' ' 150' ' ' PRO . 2.6 mt-10 -63.31 173.72 1.45 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.32 -0.863 . . . . 0.0 110.262 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -56.31 109.83 1.93 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 110.175 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 44.9 Cg_endo -72.87 -10.89 25.32 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.95 1.5 . . . . 0.0 110.487 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -83.31 -62.91 1.46 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.226 -0.921 . . . . 0.0 110.258 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.459 ' HB3' ' HD2' ' A' ' 153' ' ' PRO . 84.7 m-85 -119.27 165.77 16.31 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.337 -0.852 . . . . 0.0 110.136 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.459 ' HD2' ' HB3' ' A' ' 152' ' ' TYR . 45.7 Cg_endo -72.66 110.92 3.12 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.037 1.546 . . . . 0.0 110.453 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -173.13 159.43 3.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 110.215 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 179.31 110.51 0.28 Allowed Glycine 0 N--CA 1.48 1.614 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.86 -43.82 0.75 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.876 1.461 . . . . 0.0 110.374 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 160' ' ' GLN . 27.4 mm-40 -68.94 -2.09 8.94 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.309 -0.87 . . . . 0.0 110.469 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -72.19 -24.06 77.0 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.53 ' HG2' HG13 ' A' ' 163' ' ' VAL . 0.5 OUTLIER -83.18 6.63 18.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.146 -1.208 . . . . 0.0 110.272 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.7 ' C ' HD12 ' A' ' 161' ' ' LEU . 1.0 OUTLIER -68.94 -16.48 63.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.273 -0.892 . . . . 0.0 109.437 179.551 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.746 ' O ' HG23 ' A' ' 162' ' ' VAL . 1.0 OUTLIER -161.24 22.52 0.13 Allowed 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.802 0.811 . . . . 0.0 109.488 179.338 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.786 HG12 ' O ' ' A' ' 162' ' ' VAL . 2.4 t -161.46 88.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.652 -0.655 . . . . 0.0 109.875 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.641 HG21 HD21 ' A' ' 167' ' ' LEU . 0.2 OUTLIER -113.06 83.84 6.52 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 0.0 109.961 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.69 71.8 3.21 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.976 1.514 . . . . 0.0 110.617 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 94' ' ' SER . 1.4 mt-10 -172.29 -81.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.355 -0.841 . . . . 0.0 110.118 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.534 ' HG2' ' N ' ' A' ' 167' ' ' LEU . 0.8 OUTLIER -151.55 154.92 37.42 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.322 -0.861 . . . . 0.0 109.739 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.782 HD22 HG22 ' A' ' 182' ' ' ILE . 0.0 OUTLIER -152.77 139.9 19.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.091 -1.005 . . . . 0.0 110.483 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' A' ' 181' ' ' SER . 17.0 tp -114.3 112.76 23.6 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.226 -0.921 . . . . 0.0 109.748 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.992 HG22 ' CE1' ' A' ' 180' ' ' TYR . 4.2 t -97.1 131.63 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.039 -1.038 . . . . 0.0 110.808 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.6 HG21 HD22 ' A' ' 187' ' ' LEU . 4.3 t -106.65 122.96 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.482 -0.761 . . . . 0.0 109.491 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.643 HD13 HD13 ' A' ' 178' ' ' LEU . 4.6 tp -133.21 115.28 14.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.069 -1.02 . . . . 0.0 110.554 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.539 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 32.1 t0 -120.3 135.15 55.1 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.296 -0.877 . . . . 0.0 110.199 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.587 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -94.58 -39.13 10.53 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.635 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 173' ' ' MET . 5.8 mm-40 -42.65 -27.7 0.19 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.219 -0.926 . . . . 0.0 108.828 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.593 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.1 OUTLIER -112.62 -27.07 8.34 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.235 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 82.57 24.23 54.21 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.955 HG22 ' CD2' ' A' ' 194' ' ' LEU . 0.2 OUTLIER -121.14 128.68 52.76 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.248 -1.148 . . . . 0.0 111.141 -179.458 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 1.061 ' O ' HD11 ' A' ' 194' ' ' LEU . 0.2 OUTLIER -139.99 153.69 46.93 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.459 -0.776 . . . . 0.0 109.588 179.338 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -153.1 174.04 31.89 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.992 ' CE1' HG22 ' A' ' 169' ' ' VAL . 0.7 OUTLIER -118.94 118.67 32.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.351 -1.087 . . . . 0.0 110.119 -179.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.536 ' O ' ' CD1' ' A' ' 167' ' ' LEU . 39.3 t -144.76 165.23 28.67 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.177 -0.952 . . . . 0.0 109.96 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.782 HG22 HD22 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -102.64 116.88 47.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 121.452 -0.78 . . . . 0.0 109.674 179.541 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 66.56 8.31 45.5 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 87.05 35.95 9.4 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . 0.419 ' N ' ' OG ' ' A' ' 181' ' ' SER . 33.0 m -84.89 -74.55 0.39 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.293 -1.122 . . . . 0.0 110.563 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.647 ' CE2' HD11 ' A' ' 182' ' ' ILE . 18.7 m-85 -81.01 88.04 5.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.109 -0.995 . . . . 0.0 110.662 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.602 ' O ' ' CE2' ' A' ' 191' ' ' PHE . 2.3 tp -177.84 28.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.595 -0.691 . . . . 0.0 109.5 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.525 ' H ' ' HD2' ' A' ' 189' ' ' PRO . . . -104.15 -68.27 0.75 Allowed Glycine 0 N--CA 1.491 2.336 0 C-N-CA 120.059 -1.067 . . . . 0.0 110.514 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.525 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 44.4 Cg_endo -71.1 -30.05 16.79 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.843 1.444 . . . . 0.0 111.17 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.565 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -73.12 12.29 0.58 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.175 -0.953 . . . . 0.0 111.17 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.602 ' CE2' ' O ' ' A' ' 187' ' ' LEU . 0.3 OUTLIER -90.13 -13.15 36.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.08 -1.012 . . . . 0.0 109.741 179.255 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.47 -20.37 31.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.436 -0.79 . . . . 0.0 110.718 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -108.97 -24.7 5.92 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.821 -1.711 . . . . 0.0 108.821 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 1.061 HD11 ' O ' ' A' ' 178' ' ' LEU . 6.6 tt -61.99 -32.71 73.2 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.611 -0.935 . . . . 0.0 109.016 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.553 ' HA ' HG23 ' A' ' 177' ' ' THR . 0.1 OUTLIER -47.16 -29.18 2.14 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.434 -0.791 . . . . 0.0 109.409 179.422 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -114.42 -19.38 6.24 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.675 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.91 -8.36 49.59 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.493 -1.004 . . . . 0.0 110.049 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.552 HG22 ' O ' ' A' ' 194' ' ' LEU . 0.1 OUTLIER -43.52 143.16 1.0 Allowed 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.91 0.862 . . . . 0.0 111.587 -178.152 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 1.028 ' O ' HD11 ' A' ' 178' ' ' LEU . 0.0 OUTLIER -140.41 172.26 12.98 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 22.3 m-85 -83.15 129.82 59.52 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.953 -1.092 . . . . 0.0 109.34 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.642 ' HG3' HD22 ' A' ' 171' ' ' LEU . 48.1 Cg_endo -74.18 129.6 13.28 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.054 1.555 . . . . 0.0 111.73 -178.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.511 ' O ' HG13 ' A' ' 106' ' ' VAL . 8.3 m -133.42 151.58 51.82 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.584 -0.697 . . . . 0.0 109.405 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.784 HG13 ' HG3' ' A' ' 50' ' ' PRO . 1.6 p -135.79 139.49 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.033 -1.042 . . . . 0.0 110.431 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 0.996 ' HB2' HG23 ' A' ' 105' ' ' VAL . 74.7 m -119.7 126.88 52.18 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.756 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.614 ' HA ' ' CH2' ' A' ' 95' ' ' TRP . . . -109.79 138.3 46.35 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.772 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.828 HG13 ' N ' ' A' ' 207' ' ' TRP . 0.3 OUTLIER -91.62 -159.68 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.506 -0.746 . . . . 0.0 110.542 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 0.828 ' N ' HG13 ' A' ' 206' ' ' VAL . 0.8 OUTLIER -47.07 176.39 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 110.265 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.422 ' N ' ' OD2' ' A' ' 76' ' ' ASP . . . -82.1 -0.12 89.28 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.474 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 0.5 OUTLIER -72.87 -33.68 66.24 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.616 -0.932 . . . . 0.0 110.155 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . 0.668 ' O ' ' C ' ' A' ' 211' ' ' GLN . 11.4 t -97.08 -0.25 47.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.346 -0.846 . . . . 0.0 110.149 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.668 ' C ' ' O ' ' A' ' 210' ' ' CYS . 0.6 OUTLIER 0.49 106.39 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.787 0.803 . . . . 0.0 111.42 -179.804 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.9 HG23 ' O ' ' A' ' 94' ' ' SER . 1.9 p -87.85 145.02 8.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.708 -0.62 . . . . 0.0 109.545 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.657 ' HA ' HD21 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -87.27 156.45 19.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.17 -0.956 . . . . 0.0 110.466 -178.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 1.0 HD12 ' HB3' ' A' ' 48' ' ' TRP . 0.2 OUTLIER -143.86 130.24 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.453 -0.779 . . . . 0.0 110.657 -179.323 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.663 ' O ' ' N ' ' A' ' 92' ' ' GLU . 6.8 mtt180 -130.81 108.86 10.16 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . 0.79 ' CD2' ' HB3' ' A' ' 91' ' ' TRP . 1.6 t80 -113.84 139.92 48.76 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 120.976 -1.077 . . . . 0.0 111.693 -177.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . 0.45 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 0.3 OUTLIER -136.87 125.85 24.32 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.19 0.519 . . . . 0.0 109.89 179.548 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 120.47 -21.8 8.5 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.608 ' HB2' ' CE1' ' A' ' 216' ' ' TYR . 5.9 tm-20 -95.72 150.21 20.63 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.152 -1.205 . . . . 0.0 110.362 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.408 ' O ' ' OE2' ' A' ' 219' ' ' GLU . 6.4 mtm180 -136.32 -141.09 0.16 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.297 -0.877 . . . . 0.0 110.142 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . 0.521 ' O ' ' C ' ' A' ' 222' ' ' VAL . 8.0 ttp180 -159.13 82.55 0.78 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.248 -0.907 . . . . 0.0 110.087 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.521 ' C ' ' O ' ' A' ' 221' ' ' ARG . 13.6 p -33.67 151.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.642 -0.661 . . . . 0.0 110.673 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 222' ' ' VAL . 5.4 tp10 -179.02 -51.32 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.275 -0.89 . . . . 0.0 110.147 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 223' ' ' GLU . 18.9 tp10 179.2 -29.89 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.217 -0.927 . . . . 0.0 110.304 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.431 ' C ' ' O ' ' A' ' 224' ' ' GLU . 2.5 t -41.72 142.78 0.59 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.254 -0.904 . . . . 0.0 110.307 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.39 109.3 3.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.256 -0.903 . . . . 0.0 110.24 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.57 -170.45 1.86 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.314 -0.866 . . . . 0.0 110.23 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 98.4 mt -77.91 135.02 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.91 . . . . 0.0 110.203 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.424 ' O ' ' CD ' ' A' ' 230' ' ' ARG . 38.6 t-80 -135.45 79.04 1.76 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.226 -0.921 . . . . 0.0 110.258 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . 0.676 ' O ' ' C ' ' A' ' 231' ' ' ASP . 0.9 OUTLIER 179.86 33.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.314 -0.866 . . . . 0.0 110.215 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.676 ' C ' ' O ' ' A' ' 230' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 117.979 -1.01 . . . . 0.0 111.421 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.21 161.21 13.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -1.158 . . . . 0.0 110.235 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 9' ' ' ALA . 0.4 OUTLIER -116.0 132.22 56.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.209 -0.932 . . . . 0.0 110.209 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 8' ' ' SER . . . -177.04 -157.9 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.255 -0.903 . . . . 0.0 110.152 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.84 143.92 48.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.258 -0.901 . . . . 0.0 110.283 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -97.58 28.09 3.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.209 -0.932 . . . . 0.0 110.2 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.8 t -129.73 -1.49 4.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.198 -0.939 . . . . 0.0 110.212 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.8 m -124.33 132.18 24.27 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.245 -0.909 . . . . 0.0 110.129 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.29 75.34 2.9 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.006 1.529 . . . . 0.0 110.342 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.655 HG23 ' O ' ' A' ' 15' ' ' THR . 7.0 t -62.26 105.38 0.6 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.305 -0.872 . . . . 0.0 110.225 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.422 ' O ' ' HG2' ' A' ' 17' ' ' GLN . 1.1 m -103.43 -174.28 2.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.882 . . . . 0.0 110.198 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 16' ' ' SER . 0.5 OUTLIER -161.52 -64.14 0.06 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.904 . . . . 0.0 110.184 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -171.63 165.97 6.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.223 -0.923 . . . . 0.0 110.218 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.44 -160.9 0.11 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.252 -0.905 . . . . 0.0 110.263 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.7 -78.57 0.6 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.282 -0.886 . . . . 0.0 110.301 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.21 -155.24 0.56 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.528 -0.733 . . . . 0.0 110.21 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 2.8 p-10 -121.85 -110.82 0.33 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.249 -0.907 . . . . 0.0 109.912 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.32 -58.45 0.79 Allowed 'General case' 0 C--N 1.284 -2.276 0 CA-C-O 121.433 0.635 . . . . 0.0 110.241 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.8 m -74.34 164.35 61.9 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.463 -0.773 . . . . 0.0 110.306 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.15 143.28 35.53 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.984 1.518 . . . . 0.0 110.559 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.66 ' O ' ' C ' ' A' ' 27' ' ' GLU . 46.1 Cg_endo -73.41 -167.66 0.38 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.999 1.526 . . . . 0.0 110.503 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.66 ' C ' ' O ' ' A' ' 26' ' ' PRO . 3.1 mm-40 1.33 68.43 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.541 0.686 . . . . 0.0 111.183 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 26' ' ' PRO . . . 179.15 -26.41 0.05 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.904 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -76.89 -30.03 56.02 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.276 -1.132 . . . . 0.0 110.048 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.653 ' HA ' HD23 ' A' ' 33' ' ' LEU . 2.1 pp20? -47.54 -43.05 24.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.917 . . . . 0.0 109.745 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.436 ' N ' ' CD ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -57.75 -21.19 39.85 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.201 179.269 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -83.4 -35.2 25.25 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.784 HD12 ' C ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -67.8 -35.63 78.98 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 122.059 0.933 . . . . 0.0 109.087 179.15 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.568 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 1.0 OUTLIER -82.65 -6.8 59.56 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.301 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.999 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -45.82 -67.31 0.39 Allowed Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.226 -0.921 . . . . 0.0 111.068 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.999 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 46.1 Cg_endo -70.42 142.49 45.17 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.674 1.355 . . . . 0.0 110.288 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.692 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 53.3 Cg_endo -96.79 20.62 0.44 Allowed 'Trans proline' 0 CA--C 1.552 1.385 0 C-N-CA 121.724 1.616 . . . . 0.0 113.828 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.701 ' CD ' ' HB2' ' A' ' 36' ' ' PRO . 50.6 Cg_endo -79.58 151.01 22.11 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 122.609 0.794 . . . . 0.0 110.625 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.722 ' CG ' ' OE1' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -15.33 -54.7 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.755 -0.59 . . . . 0.0 111.835 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.1 HD13 HG23 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -44.56 -51.48 8.92 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 120.455 -1.403 . . . . 0.0 109.701 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.1 HG23 HD13 ' A' ' 40' ' ' LEU . 23.4 t -87.26 -30.47 5.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.146 -0.971 . . . . 0.0 110.614 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.67 -36.8 15.04 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.974 -1.079 . . . . 0.0 111.587 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.751 ' CD ' ' HB2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -82.24 -19.53 39.46 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.252 -0.905 . . . . 0.0 110.01 -179.188 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.627 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 2.1 ttt180 -83.23 -42.68 16.95 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.304 -0.872 . . . . 0.0 109.952 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.892 ' CE1' HG13 ' A' ' 41' ' ' VAL . 14.7 m170 -60.4 -18.07 48.17 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.609 -0.682 . . . . 0.0 110.703 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -96.29 -34.71 11.5 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.032 -1.067 . . . . 0.0 109.556 178.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.523 ' HA3' ' HB2' ' A' ' 61' ' ' GLU . . . -92.42 -101.87 1.44 Allowed Glycine 0 N--CA 1.487 2.056 0 N-CA-C 106.929 -2.468 . . . . 0.0 106.929 178.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.771 ' CZ3' HD12 ' A' ' 214' ' ' ILE . 93.8 m95 -81.27 73.81 8.29 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.05 -1.265 . . . . 0.0 108.044 177.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.713 ' HA ' ' HA ' ' A' ' 45' ' ' HIS . 0.1 OUTLIER -43.69 147.02 0.88 Allowed Pre-proline 0 C--N 1.297 -1.714 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.087 -179.362 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.682 ' HD3' ' CD2' ' A' ' 45' ' ' HIS . 40.5 Cg_endo -68.48 -33.04 23.83 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 124.498 1.788 . . . . 0.0 110.142 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.838 ' N ' ' HE3' ' A' ' 51' ' ' LYS . 0.2 OUTLIER -63.58 -16.64 61.4 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.612 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.878 ' O ' ' N ' ' A' ' 79' ' ' ARG . 4.2 m-20 -104.83 0.56 28.2 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 177.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.607 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 21.7 t -167.57 137.31 2.75 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 120.149 -0.621 . . . . 0.0 110.025 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.79 ' CB ' HD21 ' A' ' 56' ' ' ASN . 0.0 OUTLIER -100.77 161.33 13.67 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.209 179.159 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.603 ' HG3' HD21 ' A' ' 29' ' ' LEU . 24.3 pm0 -38.12 -20.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.326 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.79 HD21 ' CB ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -41.81 -29.61 0.21 Allowed 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 118.495 -1.282 . . . . 0.0 108.204 -179.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.999 HD11 ' O ' ' A' ' 207' ' ' TRP . 1.2 mt -131.13 166.11 29.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-O 121.63 0.729 . . . . 0.0 111.056 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.52 ' N ' ' CG2' ' A' ' 57' ' ' ILE . 2.8 t70 -128.11 105.67 8.53 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.72 HG12 ' HA ' ' A' ' 66' ' ' PHE . 10.7 m -128.44 135.52 62.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.327 -0.858 . . . . 0.0 110.955 -178.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.751 ' HB2' ' CD ' ' A' ' 43' ' ' GLN . 2.5 tttm -124.02 155.32 38.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.365 -0.835 . . . . 0.0 110.574 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.523 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . 4.2 tt0 -83.98 -131.25 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.387 -0.821 . . . . 0.0 110.142 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 43.24 52.44 6.0 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 108.389 -1.885 . . . . 0.0 108.389 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.667 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 108.88 61.66 0.54 Allowed Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.669 HD21 ' O ' ' A' ' 214' ' ' ILE . 1.5 mm? 0.49 80.06 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.92 -0.753 . . . . 0.0 111.421 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 63' ' ' GLY . 1.6 m -99.51 114.37 27.31 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.266 -0.896 . . . . 0.0 109.599 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.72 ' HA ' HG12 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -104.89 124.74 49.99 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.311 -0.868 . . . . 0.0 110.079 -179.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.511 ' O ' ' O ' ' A' ' 58' ' ' ASP . 29.2 tt0 -144.62 145.56 31.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 109.862 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.561 ' HG2' ' O ' ' A' ' 207' ' ' TRP . 0.0 OUTLIER -132.68 118.12 18.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 110.207 -179.791 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.688 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 9.9 mmm-85 -84.73 -71.65 0.1 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.284 -0.885 . . . . 0.0 110.302 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.688 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 56.4 Cg_endo -72.18 -145.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.569 1.3 . . . . 0.0 109.155 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.481 ' O ' ' HG2' ' A' ' 73' ' ' GLN . 3.2 t -140.09 163.77 23.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 O-C-N 121.406 -0.809 . . . . 0.0 109.738 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 71' ' ' VAL . . . -43.19 103.3 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.067 -1.021 . . . . 0.0 109.891 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 3.8 pt20 -128.28 -113.27 0.27 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.211 -0.93 . . . . 0.0 110.593 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.589 ' CB ' ' HA ' ' A' ' 26' ' ' PRO . 22.0 p -36.06 -52.08 0.76 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.319 -0.863 . . . . 0.0 110.809 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.493 ' CB ' ' HB3' ' A' ' 54' ' ' SER . 0.2 OUTLIER -118.41 -137.39 0.35 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.131 -0.98 . . . . 0.0 109.993 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.701 ' O ' ' C ' ' A' ' 77' ' ' GLY . 1.3 t0 -140.66 154.84 46.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.893 . . . . 0.0 110.387 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.701 ' C ' ' O ' ' A' ' 76' ' ' ASP . . . -12.23 -98.32 0.0 OUTLIER Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.858 ' CG2' ' HB3' ' A' ' 205' ' ' ALA . 3.7 m -128.06 121.64 56.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.038 -1.272 . . . . 0.0 110.003 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.878 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -145.53 133.76 21.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.415 -0.803 . . . . 0.0 110.907 -179.756 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.709 ' HA3' ' HA ' ' A' ' 52' ' ' ASP . . . -163.7 145.23 10.24 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.813 ' CE ' ' HB3' ' A' ' 109' ' ' ALA . 1.5 tttm -138.73 80.84 1.81 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -1.133 . . . . 0.0 110.04 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.48 -92.79 0.28 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.128 -0.983 . . . . 0.0 110.213 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 53.95 69.59 1.19 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -120.78 111.41 17.55 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.195 -1.179 . . . . 0.0 110.308 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.599 ' HB3' ' CE1' ' A' ' 89' ' ' HIS . 0.8 OUTLIER -140.02 173.65 11.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.936 . . . . 0.0 110.165 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.595 ' N ' ' CD ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -118.47 138.16 52.68 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.225 -0.922 . . . . 0.0 110.119 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.491 ' HA2' ' CG ' ' A' ' 174' ' ' GLU . . . 98.05 -116.52 5.56 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.495 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 0.9 OUTLIER -128.6 135.33 49.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.407 -1.055 . . . . 0.0 110.295 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.813 ' HB2' HD23 ' A' ' 171' ' ' LEU . 9.0 m-70 -147.08 161.14 41.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.154 -0.966 . . . . 0.0 109.811 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.556 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -158.02 147.12 19.45 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.042 -1.036 . . . . 0.0 110.517 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 1.043 ' CZ2' HD22 ' A' ' 171' ' ' LEU . 1.3 m0 -134.75 170.23 16.14 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.374 -0.829 . . . . 0.0 109.097 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 1.003 ' CD ' HD12 ' A' ' 168' ' ' LEU . 3.2 mt-10 -136.47 138.96 41.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.118 -0.989 . . . . 0.0 111.23 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.909 HD13 ' O ' ' A' ' 92' ' ' GLU . 8.3 mm -142.93 126.4 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.58 -0.7 . . . . 0.0 109.361 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.718 ' HA ' HD12 ' A' ' 167' ' ' LEU . 1.4 m -143.62 143.51 31.5 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.166 -0.959 . . . . 0.0 110.325 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.784 ' CG ' ' HB2' ' A' ' 104' ' ' ALA . 47.9 m95 -114.4 88.46 15.64 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.322 -0.861 . . . . 0.0 110.282 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.568 ' O ' ' N ' ' A' ' 101' ' ' GLY . 50.9 Cg_endo -91.92 109.86 0.27 Allowed 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 123.909 1.479 . . . . 0.0 110.255 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.929 HD22 ' O ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -88.86 -12.91 40.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.809 -1.182 . . . . 0.0 110.492 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 97' ' ' LEU . 13.9 tp10 -42.87 -32.58 0.64 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.091 -1.005 . . . . 0.0 109.262 179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.545 ' CB ' ' HD3' ' A' ' 100' ' ' ARG . 4.2 mt-30 -147.81 12.42 1.0 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.589 -0.694 . . . . 0.0 109.47 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.929 ' O ' HD22 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -179.21 -108.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.472 -0.768 . . . . 0.0 109.768 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.638 ' O ' ' CB ' ' A' ' 210' ' ' CYS . . . 47.28 172.29 0.01 OUTLIER Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.532 ' HB ' ' O ' ' A' ' 101' ' ' GLY . 8.9 t 179.59 -177.11 0.32 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.098 -1.236 . . . . 0.0 110.097 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.567 ' HB2' ' CG2' ' A' ' 206' ' ' VAL . 0.0 OUTLIER -42.32 95.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.228 -0.92 . . . . 0.0 109.52 179.609 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.784 ' HB2' ' CG ' ' A' ' 95' ' ' TRP . . . -74.32 119.71 18.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.884 . . . . 0.0 110.971 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.686 HG23 ' C ' ' A' ' 204' ' ' SER . 27.0 m -136.19 115.97 16.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 118.91 -1.116 . . . . 0.0 110.366 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.842 HG13 ' HA ' ' A' ' 203' ' ' VAL . 8.4 t -150.69 170.04 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.464 -0.773 . . . . 0.0 109.631 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.65 ' CA ' ' HA3' ' A' ' 132' ' ' GLY . . . 164.02 164.05 18.33 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.504 -1.331 . . . . 0.0 110.689 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.815 HG12 ' HB2' ' A' ' 199' ' ' LEU . 2.5 t -114.3 155.7 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.639 -0.919 . . . . 0.0 109.072 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.813 ' HB3' ' CE ' ' A' ' 81' ' ' LYS . . . -142.93 144.75 32.52 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.863 -1.148 . . . . 0.0 111.129 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.684 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.8 OUTLIER -103.47 125.12 49.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.397 -0.815 . . . . 0.0 110.0 179.544 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.85 -28.39 16.55 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.459 -0.775 . . . . 0.0 109.9 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.673 ' O ' ' C ' ' A' ' 113' ' ' ALA . 0.5 OUTLIER -81.22 -12.45 59.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.321 -0.862 . . . . 0.0 109.719 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.673 ' C ' ' O ' ' A' ' 112' ' ' LEU . . . -1.58 76.53 0.04 OUTLIER Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.967 -0.458 . . . . 0.0 111.408 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.546 ' N ' ' O ' ' A' ' 112' ' ' LEU . 45.1 Cg_endo -74.41 -61.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.967 1.509 . . . . 0.0 110.385 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.642 ' C ' HD12 ' A' ' 115' ' ' LEU . 1.2 pp 179.9 50.77 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 0.0 110.125 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 118' ' ' ASP . 0.8 OUTLIER -41.68 -68.06 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.217 -0.927 . . . . 0.0 110.294 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.537 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -61.3 75.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.298 -0.876 . . . . 0.0 110.206 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.537 ' C ' ' O ' ' A' ' 117' ' ' ALA . 7.5 t0 -31.64 -68.44 0.09 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.544 -0.723 . . . . 0.0 110.669 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.424 ' O ' ' O ' ' A' ' 117' ' ' ALA . 1.1 p-80 -69.96 -158.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 110.14 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.515 ' CD2' ' O ' ' A' ' 120' ' ' TYR . 34.5 p90 -123.28 59.22 1.09 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.322 -0.861 . . . . 0.0 110.163 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -47.19 -66.47 0.4 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 110.265 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -168.26 -43.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 110.222 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.1 mt -73.31 102.12 3.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.949 . . . . 0.0 110.186 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.26 174.7 10.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.295 -0.878 . . . . 0.0 110.147 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 179.84 138.73 3.46 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.419 ' O ' ' OD1' ' A' ' 127' ' ' ASN . 94.0 p -161.89 28.8 0.12 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.314 -1.109 . . . . 0.0 110.204 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 126' ' ' SER . 1.5 m-20 -163.72 -44.95 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.372 -0.83 . . . . 0.0 110.209 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -167.16 161.74 14.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.33 -0.856 . . . . 0.0 110.193 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -150.11 128.52 12.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 110.083 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 24.0 t -120.43 119.75 33.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 110.276 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -133.35 130.17 38.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -0.902 . . . . 0.0 109.852 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.65 ' HA3' ' CA ' ' A' ' 107' ' ' GLY . . . -169.41 -146.56 5.1 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.705 ' CZ3' ' CG ' ' A' ' 180' ' ' TYR . 47.4 m0 -121.54 113.74 20.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -1.138 . . . . 0.0 110.501 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.59 ' C ' HG23 ' A' ' 135' ' ' ILE . 3.9 t70 -118.14 122.9 44.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.554 -0.716 . . . . 0.0 110.164 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.592 ' CG1' ' HA ' ' A' ' 161' ' ' LEU . 17.6 pt -156.84 36.21 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 110.172 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.562 ' O ' ' CE1' ' A' ' 103' ' ' HIS . . . -87.21 -71.91 1.29 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.459 ' HB3' ' CG ' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -81.35 7.98 10.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -1.164 . . . . 0.0 110.229 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 56.43 43.14 90.28 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.681 ' O ' ' C ' ' A' ' 140' ' ' LEU . 19.6 mtpt -86.38 -178.0 6.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -1.119 . . . . 0.0 110.182 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.681 ' C ' ' O ' ' A' ' 139' ' ' LYS . 3.2 tp 0.29 74.05 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.401 0.62 . . . . 0.0 111.334 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.559 ' N ' ' O ' ' A' ' 139' ' ' LYS . 31.7 p90 -106.07 32.37 4.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.927 . . . . 0.0 110.213 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -98.99 60.04 1.2 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 110.262 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -119.66 -74.5 0.61 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.221 -0.924 . . . . 0.0 110.195 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.28 162.73 0.12 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 110.274 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.507 ' HG3' ' N ' ' A' ' 146' ' ' GLY . 44.3 pttt -167.79 -143.1 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.255 -0.903 . . . . 0.0 110.256 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.507 ' N ' ' HG3' ' A' ' 145' ' ' LYS . . . 78.41 -129.07 9.08 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.45 39.25 3.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.198 -1.178 . . . . 0.0 110.218 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -44.47 164.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.153 -0.967 . . . . 0.0 110.287 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.495 ' HB1' ' HD2' ' A' ' 150' ' ' PRO . . . -174.24 165.26 2.61 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.353 -0.842 . . . . 0.0 110.218 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.506 ' HA ' ' N ' ' A' ' 155' ' ' GLY . 46.9 Cg_endo -74.37 1.82 6.94 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.027 1.54 . . . . 0.0 110.461 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.81 -94.72 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.256 -0.903 . . . . 0.0 110.292 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.542 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 3.0 m-85 -79.68 -58.73 0.62 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.113 -0.992 . . . . 0.0 110.412 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.542 ' CD ' ' CB ' ' A' ' 152' ' ' TYR . 45.2 Cg_endo -72.64 164.89 34.27 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.918 1.483 . . . . 0.0 110.49 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.478 ' O ' ' O ' ' A' ' 155' ' ' GLY . . . -67.78 112.94 5.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.329 -0.857 . . . . 0.0 110.316 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.506 ' N ' ' HA ' ' A' ' 150' ' ' PRO . . . -48.76 178.54 0.01 OUTLIER Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.91 -27.13 14.72 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.988 1.52 . . . . 0.0 110.397 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.32 -6.98 11.32 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.318 -0.864 . . . . 0.0 110.456 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -125.77 -10.9 4.2 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 159' ' ' GLU . 1.2 tm-20 -80.51 7.11 10.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.254 -1.145 . . . . 0.0 110.338 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.471 ' O ' ' HB3' ' A' ' 161' ' ' LEU . 26.3 mm100 -45.88 -25.2 0.49 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.307 -0.871 . . . . 0.0 109.753 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.872 ' O ' HG23 ' A' ' 162' ' ' VAL . 2.4 pt? -178.86 27.1 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.393 0.616 . . . . 0.0 110.307 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.872 HG23 ' O ' ' A' ' 161' ' ' LEU . 2.3 t -166.43 96.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.473 -0.767 . . . . 0.0 110.156 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.699 ' HB ' ' HD3' ' A' ' 164' ' ' PRO . 2.7 t -78.15 -67.92 0.25 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.102 -0.998 . . . . 0.0 109.722 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.699 ' HD3' ' HB ' ' A' ' 163' ' ' VAL . 54.7 Cg_endo -78.89 154.44 26.13 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.457 1.24 . . . . 0.0 109.912 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -58.53 -30.61 67.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.043 -1.036 . . . . 0.0 109.374 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.461 ' HG3' ' OG ' ' A' ' 94' ' ' SER . 1.4 ttt180 -151.82 155.83 38.98 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.631 -0.668 . . . . 0.0 109.321 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 1.011 HD23 HG21 ' A' ' 182' ' ' ILE . 1.2 mp -126.86 138.63 53.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.965 -1.084 . . . . 0.0 110.461 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 1.003 HD12 ' CD ' ' A' ' 92' ' ' GLU . 1.0 OUTLIER -120.76 126.71 50.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.337 -0.852 . . . . 0.0 109.969 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.435 HG11 ' HE3' ' A' ' 91' ' ' TRP . 46.0 t -89.93 136.04 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 109.99 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.503 HG22 ' CD2' ' A' ' 168' ' ' LEU . 3.5 t -124.16 126.47 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.205 -0.934 . . . . 0.0 109.971 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 1.043 HD22 ' CZ2' ' A' ' 91' ' ' TRP . 0.0 OUTLIER -133.04 120.39 21.28 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.116 -0.99 . . . . 0.0 109.843 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 173' ' ' MET . 46.1 t0 -117.92 135.28 54.22 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.33 -0.856 . . . . 0.0 109.928 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.465 ' O ' ' C ' ' A' ' 174' ' ' GLU . 0.0 OUTLIER -98.62 -42.44 7.26 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.796 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.491 ' CG ' ' HA2' ' A' ' 87' ' ' GLY . 1.1 mm-40 -43.62 -26.87 0.26 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.223 -0.923 . . . . 0.0 108.72 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.565 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 2.7 tp10 -112.49 -28.32 7.9 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.717 0.77 . . . . 0.0 108.977 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 85.95 22.53 48.89 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 108.684 -1.766 . . . . 0.0 108.684 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.903 HG22 HD22 ' A' ' 194' ' ' LEU . 0.3 OUTLIER -113.77 123.5 49.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.222 -1.163 . . . . 0.0 111.087 -179.513 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.83 HD13 HD12 ' A' ' 171' ' ' LEU . 0.2 OUTLIER -143.89 154.19 43.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.424 -0.797 . . . . 0.0 109.805 179.458 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -177.86 -161.06 25.43 Favored Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.506 -1.331 . . . . 0.0 110.273 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.83 ' O ' HD13 ' A' ' 187' ' ' LEU . 0.5 OUTLIER -118.7 123.52 45.09 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.493 -1.004 . . . . 0.0 109.724 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.765 ' HB2' HD22 ' A' ' 187' ' ' LEU . 5.7 t -130.15 125.68 35.64 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.417 -0.802 . . . . 0.0 110.356 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 1.011 HG21 HD23 ' A' ' 167' ' ' LEU . 0.1 OUTLIER -110.02 116.9 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.216 -0.928 . . . . 0.0 109.911 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 47.93 23.57 2.64 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 69.14 40.17 82.81 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . 0.925 HG22 ' CD2' ' A' ' 186' ' ' TYR . 92.4 m -71.36 -76.27 0.11 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.277 -1.131 . . . . 0.0 110.642 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.925 ' CD2' HG22 ' A' ' 185' ' ' THR . 25.7 m-85 -126.5 89.28 2.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.172 -0.955 . . . . 0.0 110.641 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.83 HD13 ' O ' ' A' ' 180' ' ' TYR . 0.2 OUTLIER -176.54 26.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.404 -0.81 . . . . 0.0 109.765 179.641 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.575 ' H ' ' HD2' ' A' ' 189' ' ' PRO . . . -95.52 -61.46 1.01 Allowed Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.97 -1.11 . . . . 0.0 110.568 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.575 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 45.0 Cg_endo -71.94 -29.52 15.02 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.951 1.5 . . . . 0.0 111.001 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -74.65 15.78 0.34 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.197 -0.94 . . . . 0.0 111.03 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -90.35 -12.91 36.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.086 -1.009 . . . . 0.0 110.099 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.09 -15.31 34.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.0 110.187 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -109.99 -18.83 8.5 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.903 HD22 HG22 ' A' ' 177' ' ' THR . 6.3 tt -61.82 -32.25 72.55 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.727 -0.867 . . . . 0.0 108.82 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.655 ' HA ' HG23 ' A' ' 177' ' ' THR . 0.0 OUTLIER -47.2 -29.64 2.48 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.576 -0.702 . . . . 0.0 109.422 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -114.19 -19.33 6.35 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.77 ' HD3' HD11 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.88 -4.87 56.22 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.507 -0.996 . . . . 0.0 109.774 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.534 ' O ' ' CG2' ' A' ' 110' ' ' THR . 0.1 OUTLIER -43.38 145.59 0.57 Allowed 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.913 0.863 . . . . 0.0 111.396 -178.269 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.815 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -140.11 172.27 12.99 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.667 ' C ' HG13 ' A' ' 108' ' ' VAL . 1.7 m-85 -82.85 129.62 61.12 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 120.887 -1.133 . . . . 0.0 109.274 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.58 ' HD3' HD12 ' A' ' 178' ' ' LEU . 49.8 Cg_endo -78.07 125.92 7.53 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.079 1.568 . . . . 0.0 111.388 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.55 ' HB3' ' CG ' ' A' ' 81' ' ' LYS . 9.3 p -133.59 138.39 45.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.476 -0.765 . . . . 0.0 109.891 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.842 ' HA ' HG13 ' A' ' 106' ' ' VAL . 7.1 p -119.31 159.54 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.142 -0.974 . . . . 0.0 109.402 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 0.686 ' C ' HG23 ' A' ' 105' ' ' VAL . 22.3 m -160.15 162.67 33.98 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.129 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.858 ' HB3' ' CG2' ' A' ' 78' ' ' VAL . . . -150.14 160.13 43.9 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.424 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.678 HG13 ' N ' ' A' ' 207' ' ' TRP . 0.4 OUTLIER -49.42 -176.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.635 -0.666 . . . . 0.0 110.329 179.618 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 0.999 ' O ' HD11 ' A' ' 57' ' ' ILE . 22.7 p-90 -92.4 -44.44 8.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.929 . . . . 0.0 110.05 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.628 ' N ' ' CG ' ' A' ' 207' ' ' TRP . . . -164.33 128.28 1.79 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -173.89 -39.8 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.239 -1.153 . . . . 0.0 110.432 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . 0.638 ' CB ' ' O ' ' A' ' 101' ' ' GLY . 1.2 m -155.75 -93.48 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.404 -0.81 . . . . 0.0 110.551 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.601 ' CB ' ' HB2' ' A' ' 100' ' ' ARG . 2.1 mt-30 179.53 159.82 0.74 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.067 -1.021 . . . . 0.0 110.161 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.727 ' HB ' ' CH2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -127.5 144.05 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.165 -0.959 . . . . 0.0 110.784 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.65 ' NE ' ' O ' ' A' ' 213' ' ' ARG . 0.0 OUTLIER -101.46 110.79 22.85 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.256 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.771 HD12 ' CZ3' ' A' ' 48' ' ' TRP . 1.4 tt -118.12 132.84 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.906 -1.121 . . . . 0.0 111.319 -178.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.645 ' O ' ' N ' ' A' ' 92' ' ' GLU . 1.6 mtt180 -130.09 109.41 10.82 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . 0.746 ' CZ ' ' CD1' ' A' ' 91' ' ' TRP . 27.3 t80 -113.49 145.49 41.12 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.274 -0.891 . . . . 0.0 111.115 -178.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . 0.477 ' HA ' ' CE ' ' A' ' 217' ' ' MET . 3.8 tpt -136.56 108.59 7.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.536 -0.727 . . . . 0.0 109.877 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 132.97 7.09 2.67 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.577 ' HB2' ' CD1' ' A' ' 216' ' ' TYR . 22.2 tt0 -95.34 157.66 15.8 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.132 -1.216 . . . . 0.0 110.123 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.08 -162.66 0.96 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.931 . . . . 0.0 110.308 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . 0.546 ' O ' ' C ' ' A' ' 222' ' ' VAL . 0.0 OUTLIER -160.88 108.05 1.5 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.283 -0.886 . . . . 0.0 110.075 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.546 ' C ' ' O ' ' A' ' 221' ' ' ARG . 2.0 p -29.77 111.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.52 -0.738 . . . . 0.0 110.854 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.538 ' O ' ' C ' ' A' ' 224' ' ' GLU . 0.8 OUTLIER -74.45 53.18 0.52 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.233 -0.917 . . . . 0.0 110.192 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.538 ' C ' ' O ' ' A' ' 223' ' ' GLU . 11.0 pt-20 -29.46 -41.1 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.561 -0.712 . . . . 0.0 110.818 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.602 HG23 ' O ' ' A' ' 225' ' ' THR . 7.0 t -50.24 115.69 1.54 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -0.961 . . . . 0.0 110.211 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.18 57.51 4.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.27 -0.894 . . . . 0.0 110.275 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -157.5 -168.98 2.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.205 -0.934 . . . . 0.0 110.251 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.433 ' O ' ' C ' ' A' ' 229' ' ' HIS . 25.4 mt -111.67 101.76 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.327 -0.858 . . . . 0.0 110.197 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.53 ' O ' ' N ' ' A' ' 231' ' ' ASP . 26.0 t-80 -42.71 -76.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.284 -0.885 . . . . 0.0 110.228 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . 0.684 ' O ' ' C ' ' A' ' 231' ' ' ASP . 0.9 OUTLIER -56.57 82.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.325 -0.859 . . . . 0.0 110.231 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.684 ' C ' ' O ' ' A' ' 230' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.951 -1.023 . . . . 0.0 111.48 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.8 m -99.74 -56.33 2.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.168 -1.195 . . . . 0.0 110.191 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 t -143.99 -54.18 0.35 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 110.314 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -167.49 -167.04 0.83 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.327 -0.858 . . . . 0.0 110.168 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -83.12 50.4 1.73 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.21 -0.931 . . . . 0.0 110.179 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.25 124.12 9.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.254 -0.904 . . . . 0.0 110.231 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.3 110.1 8.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.915 . . . . 0.0 110.205 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.12 143.85 98.54 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.277 -0.889 . . . . 0.0 110.156 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.94 85.87 1.14 Allowed 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 124.001 1.527 . . . . 0.0 110.453 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.1 t -70.38 171.49 9.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.257 -0.902 . . . . 0.0 110.155 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 18' ' ' ALA . 8.5 t -84.9 -171.96 3.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.198 -0.939 . . . . 0.0 110.058 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -43.5 93.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.921 . . . . 0.0 110.23 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 16' ' ' SER . . . -55.48 -173.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.305 -0.872 . . . . 0.0 110.263 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 19' ' ' LEU . 4.3 mt -55.28 -161.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 110.336 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -63.36 -10.6 17.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 110.35 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.439 ' OG ' ' N ' ' A' ' 22' ' ' ASP . 8.9 t -178.62 -173.42 0.32 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 0.0 110.228 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.439 ' N ' ' OG ' ' A' ' 21' ' ' SER . 0.4 OUTLIER -177.41 30.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 110.219 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -145.6 -71.27 0.26 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.304 -0.873 . . . . 0.0 110.265 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.405 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 1.4 p -131.63 105.46 14.31 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.292 -0.88 . . . . 0.0 110.199 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.492 ' HB2' ' HD2' ' A' ' 26' ' ' PRO . 45.9 Cg_endo -73.26 175.13 10.98 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.069 1.563 . . . . 0.0 110.314 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 25' ' ' PRO . 43.3 Cg_endo -71.9 160.37 47.93 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.872 1.459 . . . . 0.0 110.473 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -83.46 43.03 0.86 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.383 -0.823 . . . . 0.0 109.867 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.65 27.14 69.35 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.636 HD11 ' HB2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -70.78 -51.9 24.05 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.46 -1.023 . . . . 0.0 110.075 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.765 ' HA ' HD23 ' A' ' 33' ' ' LEU . 10.8 pt-20 -44.49 -45.95 9.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.146 -0.971 . . . . 0.0 109.225 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.22 -20.79 7.53 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.639 -0.824 . . . . 0.0 108.777 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.605 ' N ' ' O ' ' A' ' 29' ' ' LEU . 4.1 tp -83.83 -33.62 24.85 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.088 HD21 ' CG ' ' A' ' 55' ' ' GLU . 0.4 OUTLIER -73.66 -36.12 65.33 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 122.012 0.911 . . . . 0.0 109.179 179.367 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.583 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 7.3 m -85.0 -6.76 59.33 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.324 0.583 . . . . 0.0 109.775 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.983 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -49.45 -67.61 0.42 Allowed Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.307 -0.871 . . . . 0.0 110.879 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.983 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 46.5 Cg_endo -72.14 157.68 53.61 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.655 1.345 . . . . 0.0 110.366 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 36' ' ' PRO . 53.9 Cg_endo -99.14 55.3 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 121.94 1.76 . . . . 0.0 112.006 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.695 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 49.4 Cg_endo -73.7 150.7 45.38 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.064 1.034 . . . . 0.0 110.108 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.741 ' O ' ' HB3' ' A' ' 43' ' ' GLN . 0.5 OUTLIER -41.86 -21.87 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.199 -0.938 . . . . 0.0 109.873 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.091 HD13 ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -61.2 -50.45 73.07 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.014 -1.053 . . . . 0.0 109.184 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.091 ' N ' HD13 ' A' ' 40' ' ' LEU . 2.9 t -67.27 -39.84 83.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 C-N-CA 118.481 -1.287 . . . . 0.0 110.845 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.36 -39.9 12.41 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.784 -1.197 . . . . 0.0 112.797 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.849 ' OE1' ' HA ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -82.2 -20.54 37.58 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 118.406 -1.318 . . . . 0.0 109.536 -179.414 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.916 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 5.0 ttp180 -68.68 -52.29 32.64 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.895 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 40.6 m-70 -45.62 -23.57 0.26 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.471 ' N ' ' C ' ' A' ' 44' ' ' ARG . 3.3 t-160 -95.96 -33.01 12.32 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.033 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 49' ' ' ASN . . . -87.72 -115.63 1.16 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 107.065 -2.414 . . . . 0.0 107.065 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.803 ' HH2' HG12 ' A' ' 212' ' ' VAL . 93.7 m95 -67.48 74.47 0.16 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.749 -1.442 . . . . 0.0 108.33 177.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.678 ' OD1' ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -44.11 111.62 1.2 Allowed Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.63 -0.669 . . . . 0.0 110.614 -179.29 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.777 ' O ' ' O ' ' A' ' 53' ' ' CYS . 55.4 Cg_endo -79.49 1.65 9.02 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.166 1.91 . . . . 0.0 111.692 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.752 ' HA ' ' HE3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -50.59 -75.6 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.387 -1.446 . . . . 0.0 108.459 179.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.821 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 0.6 OUTLIER -64.79 3.43 0.54 Allowed 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.777 ' O ' ' O ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -124.67 170.45 10.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.423 -0.798 . . . . 0.0 110.797 -178.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.581 ' N ' ' SG ' ' A' ' 53' ' ' CYS . 4.4 t -100.51 165.8 11.24 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.015 -1.053 . . . . 0.0 108.906 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 1.088 ' CG ' HD21 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -94.32 1.13 55.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.93 -1.106 . . . . 0.0 110.547 -179.045 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.638 ' ND2' ' N ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -22.17 -42.01 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 122.401 1.096 . . . . 0.0 109.937 179.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.695 ' N ' ' O ' ' A' ' 55' ' ' GLU . 11.3 pt -126.03 169.61 17.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.555 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.64 ' O ' ' HB3' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -105.69 118.04 35.57 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.324 -0.86 . . . . 0.0 109.299 -178.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.734 ' CG1' ' CD1' ' A' ' 48' ' ' TRP . 90.1 t -124.44 136.05 61.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.273 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.849 ' HA ' ' OE1' ' A' ' 43' ' ' GLN . 1.7 ttmt -135.21 155.14 51.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.714 -1.241 . . . . 0.0 111.043 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.552 ' N ' ' OE1' ' A' ' 43' ' ' GLN . 23.2 tt0 -67.47 -109.26 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.453 -0.779 . . . . 0.0 110.226 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.546 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 37.26 35.17 0.15 Allowed Glycine 0 N--CA 1.494 2.558 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.68 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 114.56 56.85 0.38 Allowed Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 -178.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.815 HD22 ' H ' ' A' ' 64' ' ' LEU . 2.0 mm? 0.83 84.98 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.962 -0.728 . . . . 0.0 110.92 -178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 63' ' ' GLY . 1.7 m -128.43 130.61 47.86 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.383 -0.823 . . . . 0.0 110.708 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.69 ' CE2' ' HB ' ' A' ' 212' ' ' VAL . 5.3 m-30 -83.61 152.4 24.84 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.64 ' HB3' ' O ' ' A' ' 58' ' ' ASP . 1.1 tp10 -147.65 121.4 9.25 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.228 -0.92 . . . . 0.0 109.755 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.585 ' HG2' ' CD1' ' A' ' 207' ' ' TRP . 1.0 OUTLIER -118.99 156.32 29.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.419 -0.801 . . . . 0.0 109.416 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.574 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -168.15 -56.94 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 120.98 -1.075 . . . . 0.0 111.043 -179.559 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.636 ' HB2' HD11 ' A' ' 29' ' ' LEU . 41.0 Cg_endo -67.29 -47.14 2.4 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.804 1.423 . . . . 0.0 110.729 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.678 HG11 HG22 ' A' ' 57' ' ' ILE . 2.0 p -78.31 165.38 3.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.879 0.847 . . . . 0.0 111.048 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.554 ' N ' HG22 ' A' ' 71' ' ' VAL . . . -156.59 -40.01 0.08 Allowed 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.049 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 75' ' ' THR . 1.8 mt-30 -74.73 151.56 39.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.906 . . . . 0.0 110.125 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.9 91.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.335 -0.853 . . . . 0.0 110.21 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.51 ' N ' ' O ' ' A' ' 73' ' ' GLN . 2.6 m -97.03 -130.38 0.18 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.32 -0.862 . . . . 0.0 110.061 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.513 ' O ' ' O ' ' A' ' 77' ' ' GLY . 0.2 OUTLIER -120.75 113.8 20.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.186 -0.946 . . . . 0.0 110.452 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.577 ' HA2' ' CE3' ' A' ' 207' ' ' TRP . . . -57.14 -114.24 0.01 OUTLIER Glycine 0 N--CA 1.485 1.925 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -148.42 123.17 2.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.944 -1.327 . . . . 0.0 110.979 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.821 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -104.47 175.08 5.61 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.549 -0.72 . . . . 0.0 109.489 179.313 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.576 ' N ' ' CG ' ' A' ' 79' ' ' ARG . . . -157.42 58.29 0.36 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.533 ' HG3' ' CB ' ' A' ' 202' ' ' SER . 0.7 OUTLIER -89.9 75.02 7.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.075 -1.25 . . . . 0.0 110.122 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.779 ' HD3' ' H ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -141.94 -95.29 0.13 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.316 -0.865 . . . . 0.0 110.292 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.779 ' H ' ' HD3' ' A' ' 82' ' ' ARG . . . 56.54 62.23 6.59 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -105.71 95.7 5.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.177 -1.19 . . . . 0.0 110.261 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.584 ' OG ' ' CD2' ' A' ' 89' ' ' HIS . 0.4 OUTLIER -140.01 171.51 14.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 110.018 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.64 ' O ' ' CD2' ' A' ' 89' ' ' HIS . 30.1 mtm180 -123.38 175.79 6.52 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.164 -0.96 . . . . 0.0 110.237 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.519 ' N ' ' HB3' ' A' ' 173' ' ' MET . . . 62.52 -116.45 9.39 Favored Glycine 0 N--CA 1.482 1.722 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.448 HD12 ' HB2' ' A' ' 172' ' ' ASP . 11.6 tp -129.37 127.76 41.69 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.559 -0.966 . . . . 0.0 110.995 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.814 ' HB2' HD23 ' A' ' 171' ' ' LEU . 93.3 m-70 -147.26 173.16 12.82 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.269 -0.895 . . . . 0.0 109.95 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.544 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -163.81 164.11 23.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.261 -0.899 . . . . 0.0 110.133 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.722 ' CD1' ' CZ ' ' A' ' 216' ' ' TYR . 1.1 m0 -134.86 145.89 48.73 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.301 -0.874 . . . . 0.0 109.54 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.644 ' O ' ' N ' ' A' ' 215' ' ' ARG . 2.1 tt0 -109.97 118.9 37.67 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.431 -0.907 . . . . 0.0 109.883 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.533 HD13 ' O ' ' A' ' 92' ' ' GLU . 17.3 mm -118.08 130.05 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.019 -1.051 . . . . 0.0 111.028 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.558 ' CB ' ' HB3' ' A' ' 213' ' ' ARG . 0.0 OUTLIER -118.53 126.38 51.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.404 -0.81 . . . . 0.0 109.428 179.319 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.769 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 7.1 t-105 -117.3 88.19 27.03 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.119 -0.988 . . . . 0.0 110.217 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.535 ' HD2' ' HA ' ' A' ' 212' ' ' VAL . 50.0 Cg_endo -96.21 112.21 0.13 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 121.968 1.779 . . . . 0.0 110.673 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.852 HD22 ' OG1' ' A' ' 102' ' ' THR . 0.5 OUTLIER -95.07 -67.41 0.85 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.824 -1.173 . . . . 0.0 110.184 179.641 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.517 ' CG ' HD23 ' A' ' 97' ' ' LEU . 3.3 mt-10 -98.0 -24.81 15.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 0.0 109.808 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.477 ' OE1' ' CB ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER 179.96 -29.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.643 0.735 . . . . 0.0 109.614 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.435 ' HG2' ' CG ' ' A' ' 99' ' ' GLN . 5.6 mmt180 -119.58 -50.62 2.31 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.529 -0.732 . . . . 0.0 109.649 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.669 ' HA2' ' O ' ' A' ' 95' ' ' TRP . . . 170.15 -164.86 38.21 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.852 ' OG1' HD22 ' A' ' 97' ' ' LEU . 2.8 m -170.62 -55.39 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.235 -1.156 . . . . 0.0 110.523 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.755 ' CE1' HG23 ' A' ' 162' ' ' VAL . 7.1 m-70 -167.32 103.37 0.52 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.094 -1.003 . . . . 0.0 111.103 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.769 ' HA ' ' CE2' ' A' ' 95' ' ' TRP . . . -88.62 146.78 24.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.222 -0.924 . . . . 0.0 109.165 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.905 HG12 ' CD1' ' A' ' 135' ' ' ILE . 0.7 OUTLIER -110.61 114.57 47.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 C-N-CA 117.778 -1.569 . . . . 0.0 109.197 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.806 HG13 ' O ' ' A' ' 202' ' ' SER . 22.2 t -152.04 159.8 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.277 -0.889 . . . . 0.0 109.574 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.613 ' HA2' ' HA3' ' A' ' 132' ' ' GLY . . . -175.57 136.77 3.48 Favored Glycine 0 N--CA 1.487 2.078 0 C-N-CA 118.826 -1.654 . . . . 0.0 110.859 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.862 HG13 ' C ' ' A' ' 200' ' ' TYR . 2.8 t -104.42 141.71 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.601 -0.941 . . . . 0.0 108.999 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.904 ' HB3' ' CZ ' ' A' ' 200' ' ' TYR . . . -130.54 152.39 49.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.883 -1.136 . . . . 0.0 111.126 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.977 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -121.13 130.87 53.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.481 -0.762 . . . . 0.0 110.055 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -89.44 -25.96 21.22 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.291 -0.881 . . . . 0.0 109.343 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.501 ' O ' ' HD3' ' A' ' 114' ' ' PRO . 1.4 pp -83.35 -12.49 56.51 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.489 -0.757 . . . . 0.0 109.398 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.59 ' HB3' ' HB ' ' A' ' 110' ' ' THR . . . -107.65 85.12 2.19 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.47 -0.769 . . . . 0.0 110.246 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 112' ' ' LEU . 46.4 Cg_endo -73.14 104.78 1.84 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.922 1.485 . . . . 0.0 110.5 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.484 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 0.2 OUTLIER 179.95 60.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.277 -0.889 . . . . 0.0 110.162 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 4.5 tt0 -66.92 -40.98 87.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.942 . . . . 0.0 110.33 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.534 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . 179.87 -72.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.246 -0.909 . . . . 0.0 110.181 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.888 ' OD1' ' HB3' ' A' ' 121' ' ' ALA . 11.2 t0 -31.28 126.83 0.19 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.511 -0.743 . . . . 0.0 110.769 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -93.83 -75.55 0.5 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.293 -0.879 . . . . 0.0 110.177 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -118.45 8.65 12.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.929 . . . . 0.0 110.198 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.888 ' HB3' ' OD1' ' A' ' 118' ' ' ASP . . . -70.39 -22.29 62.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.186 -0.946 . . . . 0.0 110.217 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.716 ' HB3' ' OD2' ' A' ' 118' ' ' ASP . . . -152.55 25.97 0.58 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.934 . . . . 0.0 110.224 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.834 ' C ' HD13 ' A' ' 124' ' ' LEU . 25.2 mt 47.52 -147.39 0.2 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.322 -0.861 . . . . 0.0 110.212 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.93 ' N ' HD13 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -160.49 -171.96 3.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.34 -0.85 . . . . 0.0 110.41 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 121.22 -3.84 11.33 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.1 m -152.59 47.97 0.74 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.243 -1.151 . . . . 0.0 110.199 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -157.61 160.08 37.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.365 -0.834 . . . . 0.0 110.117 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.5 p -114.67 -160.37 0.73 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.907 . . . . 0.0 110.131 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.578 ' OE2' ' CG ' ' A' ' 131' ' ' TRP . 4.6 tm-20 -145.03 126.84 15.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.902 . . . . 0.0 109.892 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -122.09 119.45 31.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.946 . . . . 0.0 110.666 -179.727 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . 0.578 ' CG ' ' OE2' ' A' ' 129' ' ' GLU . 16.7 m0 -133.25 133.27 42.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.47 -0.768 . . . . 0.0 109.519 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.613 ' HA3' ' HA2' ' A' ' 107' ' ' GLY . . . -177.23 -140.94 3.84 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.442 -1.361 . . . . 0.0 110.207 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.564 ' CH2' ' O ' ' A' ' 180' ' ' TYR . 52.0 m0 -117.17 112.95 21.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.207 -1.172 . . . . 0.0 110.75 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.537 ' O ' ' CD2' ' A' ' 161' ' ' LEU . 0.3 OUTLIER -119.33 148.27 43.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.761 -0.587 . . . . 0.0 110.269 179.608 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.905 ' CD1' HG12 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -101.86 -11.2 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.204 -0.935 . . . . 0.0 109.955 179.574 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.78 -8.49 52.98 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.636 HH21 HD11 ' A' ' 161' ' ' LEU . 1.1 mtm-85 -83.75 0.49 47.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.401 -1.058 . . . . 0.0 109.312 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.744 ' O ' ' O ' ' A' ' 139' ' ' LYS . . . -116.22 -16.74 6.52 Favored Glycine 0 N--CA 1.485 1.908 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.744 ' O ' ' O ' ' A' ' 138' ' ' GLY . 0.1 OUTLIER 0.98 -131.1 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 CA-C-O 121.771 0.796 . . . . 0.0 112.283 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.454 ' C ' ' O ' ' A' ' 139' ' ' LYS . 38.9 mt -37.66 -67.5 0.19 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.574 -0.704 . . . . 0.0 110.443 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -139.34 -104.8 0.17 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.209 -0.932 . . . . 0.0 110.282 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -148.26 72.75 1.22 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.215 -0.928 . . . . 0.0 110.219 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.488 ' CG ' ' N ' ' A' ' 144' ' ' SER . 10.5 pt20 -45.31 -40.61 7.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.314 -0.866 . . . . 0.0 110.195 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.488 ' N ' ' CG ' ' A' ' 143' ' ' GLN . 58.4 m -68.97 102.88 1.69 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.188 -0.945 . . . . 0.0 110.33 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.04 98.88 11.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.183 -0.948 . . . . 0.0 110.122 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.4 -105.63 0.99 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 148' ' ' GLU . 0.5 OUTLIER -159.02 86.01 0.82 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.291 -1.123 . . . . 0.0 110.187 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 147' ' ' LEU . 0.7 OUTLIER -44.59 115.49 0.87 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.213 -0.929 . . . . 0.0 110.141 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.547 ' N ' ' CD ' ' A' ' 150' ' ' PRO . . . -130.02 49.39 4.66 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.343 -0.848 . . . . 0.0 110.132 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.547 ' CD ' ' N ' ' A' ' 149' ' ' ALA . 46.1 Cg_endo -73.23 -1.02 9.97 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.989 1.52 . . . . 0.0 110.404 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.93 -91.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.159 -0.963 . . . . 0.0 110.265 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.563 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 0.5 OUTLIER -77.5 -59.73 0.81 Allowed Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.191 -0.943 . . . . 0.0 110.247 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.563 ' CD ' ' CB ' ' A' ' 152' ' ' TYR . 45.8 Cg_endo -72.98 152.59 51.82 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.026 1.54 . . . . 0.0 110.397 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 155' ' ' GLY . . . -91.28 127.1 36.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.146 -0.971 . . . . 0.0 110.238 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 154' ' ' ALA . . . -42.1 110.59 0.25 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.42 -20.8 23.55 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.967 1.509 . . . . 0.0 110.369 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.539 ' HA ' ' HB2' ' A' ' 160' ' ' GLN . 0.0 OUTLIER -68.62 -1.51 6.97 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.334 -0.854 . . . . 0.0 110.601 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.439 ' O ' ' HB ' ' A' ' 162' ' ' VAL . . . -61.86 -61.75 6.42 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -92.33 4.84 52.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.209 -1.171 . . . . 0.0 110.213 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.999 ' O ' HD12 ' A' ' 161' ' ' LEU . 15.4 tt0 -73.53 -18.43 61.09 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.329 -0.857 . . . . 0.0 109.222 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.999 HD12 ' O ' ' A' ' 160' ' ' GLN . 0.2 OUTLIER -159.73 21.62 0.17 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.864 0.84 . . . . 0.0 109.444 179.414 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 161' ' ' LEU . 2.5 t -163.14 95.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.716 -0.615 . . . . 0.0 109.937 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.682 HG11 HG21 ' A' ' 182' ' ' ILE . 1.7 t -108.47 76.32 0.65 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.15 -0.969 . . . . 0.0 110.149 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.588 ' HD3' HG12 ' A' ' 162' ' ' VAL . 46.8 Cg_endo -73.18 65.16 4.31 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.903 1.475 . . . . 0.0 110.75 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 27.2 tp10 -167.83 -84.14 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.398 -0.814 . . . . 0.0 110.101 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -152.31 155.86 38.49 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.4 -0.812 . . . . 0.0 110.344 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.668 ' HA ' HG22 ' A' ' 182' ' ' ILE . 2.9 mp -135.74 137.02 41.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 109.793 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.585 HD22 ' HA ' ' A' ' 92' ' ' GLU . 0.2 OUTLIER -130.53 114.21 15.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.066 -1.021 . . . . 0.0 110.571 -179.636 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.878 HG22 ' CE1' ' A' ' 180' ' ' TYR . 18.4 t -89.92 136.04 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.336 -0.852 . . . . 0.0 109.784 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.434 ' HB ' ' CD1' ' A' ' 187' ' ' LEU . 7.5 t -113.06 111.18 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.089 -1.007 . . . . 0.0 110.519 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 1.045 HD12 HD23 ' A' ' 178' ' ' LEU . 0.0 OUTLIER -119.68 105.6 11.33 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.292 -0.88 . . . . 0.0 109.311 179.607 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.448 ' HB2' HD12 ' A' ' 88' ' ' LEU . 5.5 t0 -120.33 135.3 55.06 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.577 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.576 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 0.3 OUTLIER -95.9 -40.68 9.18 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.414 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -44.73 -26.39 0.38 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.299 -0.876 . . . . 0.0 108.99 179.205 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.618 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.0 OUTLIER -110.78 -26.79 9.18 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.282 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.918 ' O ' HG21 ' A' ' 198' ' ' THR . . . 81.53 25.46 53.9 Favored Glycine 0 N--CA 1.482 1.73 0 N-CA-C 108.588 -1.805 . . . . 0.0 108.588 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.925 HG22 ' HB3' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -118.56 112.08 19.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.196 -1.179 . . . . 0.0 111.381 -179.484 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 1.045 HD23 HD12 ' A' ' 171' ' ' LEU . 4.0 mp -118.76 153.85 33.77 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.481 -0.762 . . . . 0.0 109.256 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 177.39 -174.47 46.99 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.07 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.878 ' CE1' HG22 ' A' ' 169' ' ' VAL . 0.3 OUTLIER -123.99 125.62 44.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.341 -1.094 . . . . 0.0 109.949 179.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 35.5 t -136.69 132.77 35.37 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.268 -0.895 . . . . 0.0 110.194 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.682 HG21 HG11 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -103.67 116.81 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.309 -0.87 . . . . 0.0 109.756 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 88.76 -10.41 72.44 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 80.61 46.82 7.1 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 185' ' ' THR . 79.8 m -129.41 -2.5 4.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.255 -1.144 . . . . 0.0 110.441 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.432 ' CE2' HD11 ' A' ' 182' ' ' ILE . 0.2 OUTLIER -99.77 -54.96 2.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.207 -0.933 . . . . 0.0 110.264 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.891 HD21 ' CD1' ' A' ' 194' ' ' LEU . 5.3 mt -77.48 44.54 0.44 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.225 -0.922 . . . . 0.0 109.785 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -80.91 -96.78 0.39 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 191' ' ' PHE . 46.9 Cg_endo -72.9 -25.1 16.97 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 124.229 1.647 . . . . 0.0 111.017 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.55 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -68.62 21.42 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.506 -0.746 . . . . 0.0 111.76 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.829 ' CE1' HD22 ' A' ' 187' ' ' LEU . 0.2 OUTLIER -90.23 -13.83 34.63 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.707 -1.246 . . . . 0.0 110.349 179.467 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.05 -14.72 33.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.105 -0.997 . . . . 0.0 110.597 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -112.63 -11.16 15.3 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.925 ' HB3' HG22 ' A' ' 177' ' ' THR . 7.5 tt -74.69 -28.58 60.88 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.474 -1.015 . . . . 0.0 109.108 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.488 ' O ' ' OG1' ' A' ' 198' ' ' THR . 0.0 OUTLIER -54.08 -33.82 58.54 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.385 -0.822 . . . . 0.0 109.714 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -94.23 -26.88 12.98 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.792 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.46 -6.08 55.29 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.68 -0.894 . . . . 0.0 109.943 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.918 HG21 ' O ' ' A' ' 176' ' ' GLY . 0.2 OUTLIER -44.59 131.86 6.5 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.877 0.846 . . . . 0.0 112.532 -178.114 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.977 ' CB ' HG23 ' A' ' 110' ' ' THR . 0.0 OUTLIER -140.74 170.75 15.18 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.571 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.904 ' CZ ' ' HB3' ' A' ' 109' ' ' ALA . 25.6 p90 -84.6 128.72 60.1 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 120.775 -1.203 . . . . 0.0 109.548 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.766 ' N ' HG13 ' A' ' 108' ' ' VAL . 51.0 Cg_endo -84.49 143.78 9.96 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.138 1.599 . . . . 0.0 111.393 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.806 ' O ' HG13 ' A' ' 106' ' ' VAL . 0.9 OUTLIER -133.54 138.54 46.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.51 -0.744 . . . . 0.0 109.908 179.401 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.54 HG23 HG22 ' A' ' 106' ' ' VAL . 14.6 p -119.64 157.93 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.161 -0.962 . . . . 0.0 110.108 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 0.798 ' O ' HG22 ' A' ' 105' ' ' VAL . 0.4 OUTLIER -160.18 145.87 15.28 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.391 -0.818 . . . . 0.0 110.688 179.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.85 ' CB ' HG11 ' A' ' 212' ' ' VAL . . . -146.21 166.44 26.23 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.56 0.695 . . . . 0.0 110.573 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.581 HG13 ' N ' ' A' ' 207' ' ' TRP . 1.2 t -110.24 176.17 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 CA-C-O 121.456 0.646 . . . . 0.0 110.608 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 0.632 ' CE3' HD13 ' A' ' 57' ' ' ILE . 4.4 p90 -124.97 175.52 7.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.349 -0.844 . . . . 0.0 110.016 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 113.38 -165.57 12.05 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.452 ' O ' ' O ' ' A' ' 210' ' ' CYS . 0.0 OUTLIER -44.52 -29.39 0.71 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.393 -1.063 . . . . 0.0 110.3 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 211' ' ' GLN . 27.0 p -58.03 -154.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.318 -0.864 . . . . 0.0 110.236 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.529 ' O ' ' O ' ' A' ' 96' ' ' PRO . 0.9 OUTLIER 179.59 125.34 0.07 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.248 -0.908 . . . . 0.0 110.377 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.85 HG11 ' CB ' ' A' ' 205' ' ' ALA . 8.3 t -128.6 144.32 38.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 121.671 -0.643 . . . . 0.0 109.941 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.558 ' HB3' ' CB ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -122.41 124.35 43.45 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.247 -0.908 . . . . 0.0 109.996 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.804 HG22 HD12 ' A' ' 64' ' ' LEU . 2.3 tt -119.22 128.06 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.013 -1.054 . . . . 0.0 111.183 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.644 ' N ' ' O ' ' A' ' 92' ' ' GLU . 1.1 mtt180 -130.14 136.9 49.8 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.407 -0.808 . . . . 0.0 109.259 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . 0.722 ' CZ ' ' CD1' ' A' ' 91' ' ' TRP . 14.0 t80 -118.9 150.17 40.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.04 -1.038 . . . . 0.0 110.908 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . 0.505 ' CB ' ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -124.57 107.68 11.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.944 . . . . 0.0 110.05 179.371 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 95.71 74.02 1.2 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.528 ' HB2' ' CD1' ' A' ' 216' ' ' TYR . 3.6 tp10 -135.52 130.58 34.83 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.187 -1.184 . . . . 0.0 110.125 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.492 ' O ' ' CG ' ' A' ' 220' ' ' ARG . 0.0 OUTLIER -126.58 109.52 12.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.122 -0.986 . . . . 0.0 110.341 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . 0.636 ' O ' HG23 ' A' ' 222' ' ' VAL . 2.5 tpm_? -178.78 100.62 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.255 -0.903 . . . . 0.0 110.224 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 221' ' ' ARG . 1.0 OUTLIER -169.22 127.12 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.115 -0.991 . . . . 0.0 110.333 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.531 ' O ' ' C ' ' A' ' 224' ' ' GLU . 0.1 OUTLIER 179.83 -31.1 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.192 -0.943 . . . . 0.0 110.227 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.531 ' C ' ' O ' ' A' ' 223' ' ' GLU . 2.1 mt-10 -32.4 -44.19 0.09 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.349 -0.844 . . . . 0.0 110.725 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.575 HG22 ' H ' ' A' ' 227' ' ' ARG . 27.0 m -47.07 135.73 9.4 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.19 -0.944 . . . . 0.0 110.202 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.43 18.45 7.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.902 . . . . 0.0 110.218 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.575 ' H ' HG22 ' A' ' 225' ' ' THR . 7.3 ptm180 -160.56 -170.54 2.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.277 -0.89 . . . . 0.0 110.174 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.493 ' O ' HG23 ' A' ' 228' ' ' ILE . 3.8 tp -162.91 117.58 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 110.212 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 23.4 p80 -117.44 -0.01 12.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 0.0 110.167 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . 0.682 ' O ' ' C ' ' A' ' 231' ' ' ASP . 0.0 OUTLIER -50.33 110.06 0.36 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.235 -0.915 . . . . 0.0 110.191 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.682 ' C ' ' O ' ' A' ' 230' ' ' ARG . 8.9 t0 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.971 -1.014 . . . . 0.0 111.432 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.3 p -49.14 -24.67 1.76 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.272 -1.134 . . . . 0.0 110.183 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.24 -47.96 0.27 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.296 -0.877 . . . . 0.0 110.185 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.38 166.41 23.9 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.223 -0.923 . . . . 0.0 110.186 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.446 ' O ' ' O ' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -99.81 -28.12 13.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.314 -0.866 . . . . 0.0 110.197 -179.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.446 ' O ' ' O ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -47.22 175.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.199 -0.938 . . . . 0.0 110.186 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.78 74.95 1.68 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.912 . . . . 0.0 110.172 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.546 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -47.24 -55.73 14.86 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 110.241 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 13' ' ' THR . 46.5 Cg_endo -72.75 121.58 7.48 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.124 1.592 . . . . 0.0 110.556 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.445 ' O ' ' HB3' ' A' ' 16' ' ' SER . 0.1 OUTLIER -92.5 64.58 4.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 110.233 -179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.445 ' HB3' ' O ' ' A' ' 15' ' ' THR . 10.6 p -178.3 63.91 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.309 -0.869 . . . . 0.0 110.2 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -104.18 96.21 6.49 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.249 -0.907 . . . . 0.0 110.245 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.75 134.51 41.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.116 -0.99 . . . . 0.0 110.269 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.92 -5.24 58.11 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.328 1.061 . . . . 0.0 110.301 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -170.92 -141.01 0.03 OUTLIER 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.233 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.7 m -103.01 33.77 3.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.0 110.181 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -83.15 44.23 0.93 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.168 -0.958 . . . . 0.0 110.312 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.23 -41.87 16.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 110.159 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.36 105.36 56.51 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.333 -0.854 . . . . 0.0 110.063 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.2 133.89 20.22 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.017 1.535 . . . . 0.0 110.583 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.706 ' O ' ' N ' ' A' ' 28' ' ' GLY . 46.1 Cg_endo -72.79 -161.09 0.1 Allowed 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.052 1.554 . . . . 0.0 110.512 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.674 ' C ' ' O ' ' A' ' 26' ' ' PRO . 28.9 mm-40 1.71 64.78 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.615 0.721 . . . . 0.0 111.125 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.706 ' N ' ' O ' ' A' ' 26' ' ' PRO . . . 160.8 27.9 0.02 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.903 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -60.23 -19.91 56.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.268 -1.137 . . . . 0.0 109.657 179.743 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 1.003 ' HA ' HD23 ' A' ' 33' ' ' LEU . 16.8 pt-20 -49.42 -28.42 5.15 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.255 -0.903 . . . . 0.0 109.167 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.441 ' N ' ' HG3' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -68.24 -23.3 64.78 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.513 -0.875 . . . . 0.0 108.687 179.011 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.539 ' CB ' HD12 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -83.37 -36.84 24.03 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.697 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.003 HD23 ' HA ' ' A' ' 30' ' ' GLU . 0.3 OUTLIER -69.75 -35.79 75.25 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 122.022 0.915 . . . . 0.0 109.365 179.165 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.62 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 1.5 m -78.99 -7.51 58.13 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.804 -0.56 . . . . 0.0 110.346 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 1.059 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -38.63 -66.54 0.31 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.249 -0.907 . . . . 0.0 110.307 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 1.059 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 49.0 Cg_endo -74.5 151.88 42.75 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.645 1.34 . . . . 0.0 109.938 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 36' ' ' PRO . 54.1 Cg_endo -99.06 53.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.856 1.704 . . . . 0.0 112.235 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.743 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 52.7 Cg_endo -76.7 150.12 30.74 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 122.906 0.95 . . . . 0.0 110.384 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.681 ' C ' ' NE2' ' A' ' 43' ' ' GLN . 1.6 t0 -40.78 -30.39 0.12 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 108.624 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.116 HD13 ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -40.95 -44.54 2.36 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.414 0.626 . . . . 0.0 109.449 179.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.116 ' N ' HD13 ' A' ' 40' ' ' LEU . 6.1 t -65.66 -27.25 40.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.797 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.582 ' N ' ' O ' ' A' ' 39' ' ' ASP . . . -88.85 -43.57 11.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.91 -1.119 . . . . 0.0 111.587 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.682 ' CD ' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -81.32 -20.32 41.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.845 -1.16 . . . . 0.0 109.671 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.891 ' HE ' HD21 ' A' ' 40' ' ' LEU . 4.1 ttp85 -71.87 -55.03 8.28 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.709 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 21.1 m-70 -54.26 -27.56 35.77 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.367 0.603 . . . . 0.0 109.573 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.585 ' CE1' ' HG2' ' A' ' 220' ' ' ARG . 0.9 OUTLIER -95.54 -30.62 13.73 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.324 179.083 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 43' ' ' GLN . . . -84.41 -103.73 0.6 Allowed Glycine 0 N--CA 1.487 2.056 0 N-CA-C 107.429 -2.269 . . . . 0.0 107.429 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.814 ' HB2' HG21 ' A' ' 59' ' ' VAL . 91.8 m95 -76.88 74.42 3.49 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.206 -1.173 . . . . 0.0 109.184 178.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.709 ' OD1' ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -44.19 110.9 1.07 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.718 -0.614 . . . . 0.0 110.675 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.64 ' CD ' ' HE2' ' A' ' 51' ' ' LYS . 47.1 Cg_endo -72.08 0.93 6.51 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.202 1.935 . . . . 0.0 112.134 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.719 ' H ' ' CE ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -71.79 -33.1 68.29 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 178.36 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.755 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 8.9 m-20 -117.29 -12.59 10.49 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 113.913 -1.494 . . . . 0.0 107.363 177.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.742 ' HA ' ' HB ' ' A' ' 78' ' ' VAL . 9.0 t -105.81 147.15 28.97 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.175 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.475 ' H ' ' CB ' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -77.6 105.29 8.66 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.244 -0.91 . . . . 0.0 109.426 179.059 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.709 ' O ' HD22 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -70.2 4.04 2.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.448 -0.782 . . . . 0.0 110.4 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.88 ' O ' HG11 ' A' ' 71' ' ' VAL . 1.4 m120 -41.4 -29.52 0.15 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.752 0.787 . . . . 0.0 109.446 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.916 HG21 ' CD1' ' A' ' 207' ' ' TRP . 25.2 pt -112.94 168.88 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.605 ' O ' ' HB3' ' A' ' 67' ' ' GLU . 10.2 t0 -105.85 103.48 12.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.894 -1.129 . . . . 0.0 109.925 -178.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.814 HG21 ' HB2' ' A' ' 48' ' ' TRP . 3.6 m -118.24 135.81 57.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.804 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.682 ' HG3' ' CD ' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -124.92 143.3 50.94 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.011 -1.055 . . . . 0.0 110.844 -179.423 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.535 ' O ' ' C ' ' A' ' 62' ' ' GLY . 46.1 tt0 -63.61 -124.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.452 -0.78 . . . . 0.0 109.954 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.535 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 37.7 50.61 1.93 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.674 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 109.33 46.89 0.9 Allowed Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.106 -1.997 . . . . 0.0 108.106 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.674 ' C ' ' O ' ' A' ' 63' ' ' GLY . 2.2 mm? 0.76 86.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.541 0.686 . . . . 0.0 111.252 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.0 t -120.29 117.55 28.12 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.521 -0.737 . . . . 0.0 110.507 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.738 ' CE1' ' CD2' ' A' ' 48' ' ' TRP . 1.8 m-85 -82.51 130.65 35.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.388 -0.82 . . . . 0.0 109.186 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.605 ' HB3' ' O ' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -132.9 121.81 23.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.902 -1.124 . . . . 0.0 110.528 179.626 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.508 ' O ' ' HD3' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -125.31 156.26 38.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.492 -0.755 . . . . 0.0 109.229 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.544 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 11.5 tpp180 -174.68 -56.92 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 120.773 -1.204 . . . . 0.0 111.183 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 69' ' ' ARG . 41.2 Cg_endo -67.01 -50.39 1.08 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.651 1.343 . . . . 0.0 110.542 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.88 HG11 ' O ' ' A' ' 56' ' ' ASN . 1.3 p -78.57 165.23 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 121.739 0.78 . . . . 0.0 110.852 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.534 ' N ' ' CG2' ' A' ' 71' ' ' VAL . . . -163.83 -43.1 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.257 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 75' ' ' THR . 16.8 mt-30 -56.1 -172.85 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.156 -0.965 . . . . 0.0 110.246 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.74 85.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.916 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.696 HG22 ' CG ' ' A' ' 56' ' ' ASN . 0.1 OUTLIER -136.96 5.36 2.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -0.868 . . . . 0.0 110.312 -179.619 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.585 ' CB ' ' NE1' ' A' ' 207' ' ' TRP . 1.8 p30 -99.16 155.07 17.66 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.217 -0.927 . . . . 0.0 109.962 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 114.65 104.36 2.55 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 106.848 -2.501 . . . . 0.0 106.848 -178.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.806 ' O ' ' HA ' ' A' ' 204' ' ' SER . 2.0 m -116.95 163.0 14.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.161 -1.2 . . . . 0.0 110.322 -178.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.755 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 3.9 ttp180 -120.16 169.34 10.33 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.643 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.559 ' HA2' ' CB ' ' A' ' 52' ' ' ASP . . . -164.22 83.46 0.11 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.496 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 3.7 ttpm? -116.88 16.11 15.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.389 -1.065 . . . . 0.0 110.421 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.456 ' O ' ' C ' ' A' ' 83' ' ' GLY . 1.1 ptt180 -76.16 -101.98 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.106 -0.996 . . . . 0.0 110.228 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 82' ' ' ARG . . . 41.58 46.22 4.62 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.45 ' CE1' ' NH1' ' A' ' 86' ' ' ARG . 0.6 OUTLIER -98.58 103.88 15.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.228 -1.16 . . . . 0.0 110.174 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.561 ' HB3' ' CE1' ' A' ' 89' ' ' HIS . 11.5 t -139.9 173.36 11.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 110.362 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.551 ' N ' ' CD ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -118.53 139.33 51.62 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.372 -0.83 . . . . 0.0 109.827 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 103.36 -112.25 4.17 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.66 ' C ' HD23 ' A' ' 88' ' ' LEU . 7.5 tt -128.18 134.53 49.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -1.128 . . . . 0.0 110.362 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.581 ' CD2' ' O ' ' A' ' 88' ' ' LEU . 7.7 m80 -146.86 161.7 40.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.329 -0.857 . . . . 0.0 109.688 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.06 146.59 10.86 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.082 -1.011 . . . . 0.0 110.508 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 1.122 ' CZ2' HG11 ' A' ' 169' ' ' VAL . 1.7 p90 -135.13 171.3 14.63 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.305 -0.872 . . . . 0.0 109.473 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 215' ' ' ARG . 15.6 tt0 -137.71 140.12 40.55 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.265 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.616 HG13 ' CD1' ' A' ' 91' ' ' TRP . 4.4 mt -140.03 154.22 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.984 ' O ' HG23 ' A' ' 212' ' ' VAL . 0.4 OUTLIER -147.24 122.12 9.98 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.03 -1.068 . . . . 0.0 111.651 -179.005 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 1.023 ' CZ3' ' HB3' ' A' ' 104' ' ' ALA . 37.0 m95 -111.63 88.45 9.45 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 94' ' ' SER . 52.5 Cg_endo -83.61 108.95 1.51 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.695 1.366 . . . . 0.0 111.524 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.669 HD23 ' HB2' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -96.86 -26.69 15.0 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.253 -0.904 . . . . 0.0 109.622 178.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -37.36 -45.39 0.68 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.468 -0.77 . . . . 0.0 110.808 -179.196 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.77 -95.99 0.15 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.077 -1.014 . . . . 0.0 109.682 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.497 ' O ' ' O ' ' A' ' 101' ' ' GLY . 2.2 ptp180 -121.41 -141.63 0.33 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.405 -0.809 . . . . 0.0 109.571 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' A' ' 210' ' ' CYS . . . 37.29 94.07 0.01 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.289 -1.125 . . . . 0.0 110.289 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.663 ' N ' ' HA ' ' A' ' 210' ' ' CYS . 0.0 OUTLIER -54.94 -160.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -1.144 . . . . 0.0 110.294 179.457 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.744 ' CE1' HD11 ' A' ' 135' ' ' ILE . 10.1 t60 -127.44 165.73 19.25 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.305 -0.872 . . . . 0.0 109.742 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 1.023 ' HB3' ' CZ3' ' A' ' 95' ' ' TRP . . . -146.8 -92.77 0.09 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.824 -1.172 . . . . 0.0 111.744 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.975 HG22 ' O ' ' A' ' 204' ' ' SER 0.264 3.6 m -136.9 138.91 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 117.506 -1.678 . . . . 0.0 114.964 -175.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.769 HG22 ' CE2' ' A' ' 95' ' ' TRP . 1.0 OUTLIER -152.27 122.47 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 177.399 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 202' ' ' SER . . . 168.76 -161.64 35.36 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 118.832 -1.651 . . . . 0.0 110.898 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.044 HG23 ' C ' ' A' ' 200' ' ' TYR . 1.4 p -141.49 150.67 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.596 -0.943 . . . . 0.0 109.835 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.514 ' O ' ' N ' ' A' ' 200' ' ' TYR . . . -128.57 152.78 47.92 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.059 -1.026 . . . . 0.0 110.724 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.768 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -101.24 126.35 47.97 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.264 -0.898 . . . . 0.0 110.296 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.528 ' HB3' ' HE2' ' A' ' 200' ' ' TYR . . . -93.58 -30.22 15.09 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 121.591 0.71 . . . . 0.0 109.726 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.609 ' O ' ' N ' ' A' ' 114' ' ' PRO . 0.8 OUTLIER -80.96 -11.83 59.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.458 -0.776 . . . . 0.0 109.926 179.819 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.579 ' C ' ' O ' ' A' ' 112' ' ' LEU . . . -23.59 87.19 0.04 OUTLIER Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 121.829 -0.544 . . . . 0.0 111.222 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.609 ' N ' ' O ' ' A' ' 112' ' ' LEU . 50.1 Cg_endo -77.05 49.89 2.94 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 124.115 1.587 . . . . 0.0 110.493 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 179.87 53.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -0.951 . . . . 0.0 110.273 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.484 ' NE2' ' O ' ' A' ' 128' ' ' SER . 4.1 tp60 -75.6 -90.01 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 110.171 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.511 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . 179.98 -163.2 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 110.29 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.511 ' C ' ' O ' ' A' ' 117' ' ' ALA . 28.8 t0 -31.64 100.77 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.58 -0.7 . . . . 0.0 110.721 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.514 ' CG ' ' O ' ' A' ' 119' ' ' HIS . 18.5 t-80 -89.73 5.86 44.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 110.3 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -55.55 -40.45 71.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.898 . . . . 0.0 110.174 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -51.14 -86.48 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.9 . . . . 0.0 110.212 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 50.96 91.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.0 110.289 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 tt -173.01 -43.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.289 -0.882 . . . . 0.0 110.12 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.666 HD12 ' C ' ' A' ' 124' ' ' LEU . 1.0 OUTLIER -131.1 40.84 3.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 110.261 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 81.72 115.79 0.42 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -172.32 34.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.22 -1.165 . . . . 0.0 110.263 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -144.23 41.19 1.37 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.169 -0.957 . . . . 0.0 110.272 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.484 ' O ' ' NE2' ' A' ' 116' ' ' GLN . 13.4 t -127.18 -176.24 3.67 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.261 -0.899 . . . . 0.0 110.164 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 110' ' ' THR . 1.7 tt0 -150.02 130.06 13.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.298 -0.876 . . . . 0.0 110.087 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.496 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 47.9 t -120.46 119.92 34.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 110.211 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . 0.527 ' O ' ' O ' ' A' ' 108' ' ' VAL . 0.6 OUTLIER -128.1 124.57 37.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.198 -0.939 . . . . 0.0 110.138 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.48 ' HA3' ' HA3' ' A' ' 107' ' ' GLY . . . 170.82 -133.95 2.96 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.709 ' CZ3' HD23 ' A' ' 167' ' ' LEU . 47.3 m0 -121.36 112.84 19.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.09 -1.241 . . . . 0.0 110.404 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.478 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 32.2 t0 -119.22 111.46 18.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.643 -0.661 . . . . 0.0 110.448 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.871 HG21 ' CG2' ' A' ' 162' ' ' VAL . 22.2 pt -139.97 26.74 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.1 -1.0 . . . . 0.0 110.229 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -101.6 -27.95 6.91 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.85 8.27 17.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.29 -1.123 . . . . 0.0 109.986 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.71 51.06 4.7 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -57.57 -18.83 21.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.261 -1.141 . . . . 0.0 110.299 -179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.402 ' HA ' HD13 ' A' ' 140' ' ' LEU . 0.2 OUTLIER -42.86 -40.63 2.98 Favored 'General case' 0 C--N 1.277 -2.561 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.142 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -131.9 36.51 3.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.303 -0.873 . . . . 0.0 110.15 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.431 ' CG ' ' N ' ' A' ' 143' ' ' GLN . 5.2 p80 -51.0 -35.12 32.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.28 -0.888 . . . . 0.0 110.228 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.431 ' N ' ' CG ' ' A' ' 142' ' ' HIS . 3.4 tp-100 -132.49 -85.78 0.47 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.183 -0.948 . . . . 0.0 110.307 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 35.1 m -121.53 141.79 50.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.206 -0.934 . . . . 0.0 110.249 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.26 104.33 16.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.893 . . . . 0.0 110.185 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -67.85 -116.24 0.02 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.23 13.66 2.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.239 -1.154 . . . . 0.0 110.184 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -47.6 161.25 0.09 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.306 -0.871 . . . . 0.0 110.17 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -51.48 126.52 29.84 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 110.213 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.98 -2.69 12.39 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.971 1.511 . . . . 0.0 110.445 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.57 ' O ' ' CD2' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -62.6 -72.72 0.12 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.276 -0.89 . . . . 0.0 110.25 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.584 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 0.3 OUTLIER -176.03 -60.58 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.301 -0.874 . . . . 0.0 110.229 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.584 ' CD ' ' CB ' ' A' ' 152' ' ' TYR . 46.1 Cg_endo -72.79 126.57 11.48 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.912 1.48 . . . . 0.0 110.445 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 155' ' ' GLY . . . -59.71 144.25 48.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.208 -0.932 . . . . 0.0 110.174 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 154' ' ' ALA . . . 42.26 -157.39 0.07 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -73.23 -62.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.016 1.535 . . . . 0.0 110.422 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.417 ' OE1' ' OH ' ' A' ' 186' ' ' TYR . 0.8 OUTLIER -56.42 -60.87 2.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.169 -0.957 . . . . 0.0 110.299 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 68.66 6.23 49.16 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -93.53 6.51 47.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.289 -1.124 . . . . 0.0 110.257 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.442 ' O ' ' HG3' ' A' ' 160' ' ' GLN . 2.8 tp-100 -58.42 -17.48 20.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.265 -0.897 . . . . 0.0 109.338 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.687 ' O ' HG23 ' A' ' 162' ' ' VAL . 0.7 OUTLIER -173.25 26.87 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.647 0.737 . . . . 0.0 109.548 179.511 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.871 ' CG2' HG21 ' A' ' 135' ' ' ILE . 2.4 t -159.34 88.1 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.599 -0.688 . . . . 0.0 109.863 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 1.046 HG11 HG21 ' A' ' 182' ' ' ILE . 0.9 OUTLIER -109.96 90.37 9.32 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.333 -0.854 . . . . 0.0 109.915 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 95' ' ' TRP . 44.3 Cg_endo -71.51 64.42 2.94 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.067 1.562 . . . . 0.0 110.379 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -168.48 -83.85 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.487 -0.758 . . . . 0.0 109.805 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.735 ' C ' HD12 ' A' ' 167' ' ' LEU . 2.2 ttp180 -152.12 150.43 29.88 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.432 -0.793 . . . . 0.0 110.348 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.837 ' N ' HD12 ' A' ' 167' ' ' LEU . 1.7 mp -144.92 131.04 19.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 110.274 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.706 HD13 ' N ' ' A' ' 169' ' ' VAL . 2.6 tm? -103.79 124.54 49.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.351 -0.843 . . . . 0.0 109.595 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 1.122 HG11 ' CZ2' ' A' ' 91' ' ' TRP . 2.4 t -107.18 135.53 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.943 . . . . 0.0 110.63 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.554 ' CG1' HD11 ' A' ' 187' ' ' LEU . 9.7 p -112.48 133.32 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.507 -0.746 . . . . 0.0 109.836 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.822 HD22 ' HG3' ' A' ' 201' ' ' PRO . 11.5 tp -133.03 105.87 7.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.151 -0.968 . . . . 0.0 110.228 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 173' ' ' MET . 49.1 t0 -103.83 136.02 44.28 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.24 -0.912 . . . . 0.0 109.943 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.519 ' HG2' ' HA ' ' A' ' 86' ' ' ARG . 5.5 tpt -96.91 -41.81 8.24 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.747 -0.595 . . . . 0.0 110.231 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.505 ' C ' ' O ' ' A' ' 173' ' ' MET . 2.7 tm-20 -40.26 -28.66 0.06 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.893 . . . . 0.0 108.666 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.678 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.2 OUTLIER -114.84 -26.64 7.72 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.422 ' O ' ' CG2' ' A' ' 198' ' ' THR . . . 81.2 25.35 55.29 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.491 -1.844 . . . . 0.0 108.491 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 1.073 HG22 ' CD2' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -113.42 127.82 56.25 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.335 -1.097 . . . . 0.0 111.436 -179.335 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 1.031 ' O ' HD11 ' A' ' 194' ' ' LEU . 0.1 OUTLIER -134.74 153.71 51.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.473 -0.767 . . . . 0.0 109.378 178.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -155.52 172.74 33.67 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.52 -1.324 . . . . 0.0 109.984 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 1.052 ' CE1' HG22 ' A' ' 169' ' ' VAL . 0.4 OUTLIER -118.77 122.89 43.49 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.47 -1.018 . . . . 0.0 109.895 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' A' ' 186' ' ' TYR . 16.7 t -142.79 139.26 30.91 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.31 -0.869 . . . . 0.0 110.051 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 1.046 HG21 HG11 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -98.56 116.76 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.341 -0.849 . . . . 0.0 109.923 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 81.63 -7.26 62.4 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 86.31 42.35 6.63 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.26 -35.94 8.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.31 -1.112 . . . . 0.0 110.415 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.467 ' O ' ' HB2' ' A' ' 181' ' ' SER . 24.6 m-85 -109.12 90.22 3.23 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.187 -0.946 . . . . 0.0 110.312 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.687 HD22 ' CZ ' ' A' ' 191' ' ' PHE . 0.7 OUTLIER -176.7 28.32 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.471 -0.768 . . . . 0.0 109.671 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.478 ' H ' ' HD2' ' A' ' 189' ' ' PRO . . . -110.51 -71.67 0.66 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.842 -1.171 . . . . 0.0 110.403 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.478 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 44.9 Cg_endo -70.87 -28.84 19.41 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.952 1.501 . . . . 0.0 111.026 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -74.17 15.44 0.32 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.299 -0.876 . . . . 0.0 111.142 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.687 ' CZ ' HD22 ' A' ' 187' ' ' LEU . 0.3 OUTLIER -90.52 -16.3 29.12 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.004 -1.06 . . . . 0.0 110.408 179.652 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.436 ' NE ' ' HA ' ' A' ' 192' ' ' ARG . 0.0 OUTLIER -90.03 -13.97 34.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.319 -0.863 . . . . 0.0 110.75 -179.616 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -112.47 -8.8 20.68 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 108.786 -1.725 . . . . 0.0 108.786 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 1.073 ' CD2' HG22 ' A' ' 177' ' ' THR . 7.7 tt -78.19 -31.66 49.6 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.617 -0.931 . . . . 0.0 109.213 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.453 ' CA ' HG23 ' A' ' 198' ' ' THR . 0.0 OUTLIER -53.56 -39.73 64.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.438 -0.789 . . . . 0.0 109.707 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -86.04 -24.61 40.41 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.836 ' NH1' HD11 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -91.09 -4.59 56.13 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.644 -0.916 . . . . 0.0 110.09 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.873 HG23 ' O ' ' A' ' 194' ' ' LEU . 26.0 p -43.06 116.44 0.9 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.496 -0.753 . . . . 0.0 110.986 -178.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.993 ' HB2' HG22 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -128.69 171.82 11.83 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.564 -0.71 . . . . 0.0 109.955 179.654 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 1.044 ' C ' HG23 ' A' ' 108' ' ' VAL . 14.9 m-30 -83.49 134.72 44.66 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.196 -0.94 . . . . 0.0 109.952 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.822 ' HG3' HD22 ' A' ' 171' ' ' LEU . 43.9 Cg_endo -68.35 118.58 5.73 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.089 1.573 . . . . 0.0 111.614 -178.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -134.01 148.62 51.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.469 -0.769 . . . . 0.0 110.49 179.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.465 HG22 ' N ' ' A' ' 204' ' ' SER . 8.2 p -149.84 159.13 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.125 -0.984 . . . . 0.0 110.311 179.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 0.975 ' O ' HG22 ' A' ' 105' ' ' VAL . 0.3 OUTLIER -144.88 125.67 14.29 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.178 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.721 ' H ' HG22 ' A' ' 78' ' ' VAL . . . -115.72 166.55 11.81 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.438 0.637 . . . . 0.0 110.854 -178.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.578 ' CG1' ' HB3' ' A' ' 210' ' ' CYS . 1.1 p -136.88 165.57 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.343 -0.848 . . . . 0.0 109.952 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 0.916 ' CD1' HG21 ' A' ' 57' ' ' ILE . 40.7 p-90 -132.91 -2.68 3.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.092 -1.005 . . . . 0.0 110.175 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -74.62 -0.83 59.94 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.484 ' O ' ' HA2' ' A' ' 101' ' ' GLY . 4.7 tt0 -175.99 -41.69 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.449 -1.03 . . . . 0.0 110.724 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . 0.663 ' HA ' ' N ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -98.96 146.3 26.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.429 -0.795 . . . . 0.0 110.802 -179.542 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.513 ' HG3' ' CA ' ' A' ' 101' ' ' GLY . 3.6 mt-30 -135.01 102.6 5.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.531 -0.731 . . . . 0.0 109.545 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.984 HG23 ' O ' ' A' ' 94' ' ' SER . 7.2 p -104.42 143.84 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.439 -0.788 . . . . 0.0 110.38 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.559 ' CD ' ' HB2' ' A' ' 94' ' ' SER . 2.9 ptp180 -95.61 131.64 41.61 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.324 -0.86 . . . . 0.0 109.619 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.719 HG22 ' CE2' ' A' ' 48' ' ' TRP . 1.2 tt -118.84 113.95 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.061 -1.024 . . . . 0.0 111.561 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.612 ' O ' ' N ' ' A' ' 92' ' ' GLU . 7.6 ttm180 -112.99 108.81 17.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.073 -1.017 . . . . 0.0 108.896 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . 0.707 ' CD2' ' HB2' ' A' ' 91' ' ' TRP . 1.6 t80 -104.44 149.65 25.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.93 . . . . 0.0 111.179 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.24 107.92 7.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.579 -0.7 . . . . 0.0 109.917 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 141.5 -22.02 2.55 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -95.37 144.89 25.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.172 -1.193 . . . . 0.0 110.194 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.585 ' HG2' ' CE1' ' A' ' 46' ' ' HIS . 0.1 OUTLIER -178.02 132.13 0.15 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.133 -0.98 . . . . 0.0 110.274 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . 0.483 ' O ' ' C ' ' A' ' 222' ' ' VAL . 0.0 OUTLIER -129.54 80.16 1.95 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 110.153 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 222' ' ' VAL . 3.3 p -36.27 115.94 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.6 -0.688 . . . . 0.0 110.577 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.512 ' O ' ' C ' ' A' ' 224' ' ' GLU . 9.6 tm-20 -178.77 -71.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.321 -0.862 . . . . 0.0 110.149 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.512 ' C ' ' O ' ' A' ' 223' ' ' GLU . 6.7 mt-10 -34.06 -46.14 0.23 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.406 -0.809 . . . . 0.0 110.613 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.416 ' C ' ' O ' ' A' ' 224' ' ' GLU . 0.1 OUTLIER -42.61 161.7 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.281 -0.887 . . . . 0.0 110.235 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.23 32.46 0.76 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 0.0 110.23 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.39 120.93 1.87 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 0.0 110.21 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 24.6 pt -77.79 1.69 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.33 -0.856 . . . . 0.0 110.225 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.4 127.71 33.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.243 -0.911 . . . . 0.0 110.149 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . 0.414 ' O ' ' HB3' ' A' ' 231' ' ' ASP . 5.0 tpp180 -46.72 -28.24 1.44 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.126 -0.984 . . . . 0.0 110.162 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.414 ' HB3' ' O ' ' A' ' 230' ' ' ARG . 1.1 p30 . . . . . 0 C--N 1.304 -1.377 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.263 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.0 t -144.86 14.09 1.51 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.16 -1.2 . . . . 0.0 110.213 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.57 63.99 7.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.153 -0.967 . . . . 0.0 110.188 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -162.3 33.8 0.11 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 110.251 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.509 ' O ' ' CG ' ' A' ' 10' ' ' ARG . 0.1 OUTLIER -96.99 66.72 2.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.279 -0.888 . . . . 0.0 110.202 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -156.1 141.12 17.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.162 -0.962 . . . . 0.0 110.204 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.8 t -87.55 110.04 20.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -0.894 . . . . 0.0 110.228 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.3 113.13 19.77 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 110.258 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.89 171.01 18.31 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.979 1.515 . . . . 0.0 110.401 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.3 p -92.11 83.73 5.17 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.316 -0.865 . . . . 0.0 110.211 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.35 -143.03 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -0.922 . . . . 0.0 110.201 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -101.71 -155.29 0.51 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.107 -0.995 . . . . 0.0 110.265 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.43 135.14 45.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 110.188 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.89 -160.61 0.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.255 -0.903 . . . . 0.0 110.203 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.7 -158.21 0.64 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.304 -0.872 . . . . 0.0 110.121 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.63 161.02 28.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.368 -0.832 . . . . 0.0 110.168 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -174.29 32.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.252 -0.905 . . . . 0.0 110.257 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.38 -78.01 0.44 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.888 . . . . 0.0 110.211 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.486 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.9 OUTLIER -102.88 155.03 37.08 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.222 -0.924 . . . . 0.0 110.147 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.36 110.3 3.03 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.971 1.511 . . . . 0.0 110.559 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.671 ' O ' ' N ' ' A' ' 28' ' ' GLY . 48.0 Cg_endo -74.36 -164.64 0.23 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.086 1.572 . . . . 0.0 110.497 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.663 ' C ' ' O ' ' A' ' 26' ' ' PRO . 1.5 tt0 1.46 66.22 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.589 0.709 . . . . 0.0 111.192 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.671 ' N ' ' O ' ' A' ' 26' ' ' PRO . . . -153.61 -34.4 0.03 OUTLIER Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.987 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -73.77 -32.56 63.86 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.449 -1.03 . . . . 0.0 109.888 179.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.708 ' HA ' HD23 ' A' ' 33' ' ' LEU . 0.9 OUTLIER -45.97 -42.8 13.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.307 -0.87 . . . . 0.0 109.783 179.732 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -56.92 -23.27 43.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.4 -0.813 . . . . 0.0 109.302 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.716 ' HB3' HD12 ' A' ' 29' ' ' LEU . 16.7 tp -83.22 -34.5 25.86 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.128 HD21 ' CG ' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -72.92 -36.34 67.23 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.917 0.865 . . . . 0.0 109.116 179.124 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.604 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 1.4 m -69.17 -14.29 62.9 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.252 0.549 . . . . 0.0 110.465 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.954 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -51.72 -61.85 3.75 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.164 -0.96 . . . . 0.0 110.201 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.954 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 43.3 Cg_endo -69.86 110.31 2.54 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.988 1.52 . . . . 0.0 110.77 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.775 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 49.1 Cg_endo -74.92 -24.81 12.64 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 124.146 1.603 . . . . 0.0 112.84 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.775 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 42.3 Cg_endo -68.3 152.4 75.74 Favored 'Trans proline' 0 C--N 1.315 -1.214 0 O-C-N 122.892 0.943 . . . . 0.0 112.38 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.611 ' O ' ' CG ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER 4.79 80.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 123.561 1.648 . . . . 0.0 110.887 -178.694 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.98 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER 179.97 -51.7 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 113.655 -1.611 . . . . 0.0 107.705 178.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.951 HG12 ' CE1' ' A' ' 45' ' ' HIS . 1.8 t -87.36 -20.17 7.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 118.933 -1.107 . . . . 0.0 109.661 178.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.27 -46.49 8.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.154 -0.966 . . . . 0.0 111.954 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.59 ' O ' ' O ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -79.39 -20.89 46.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.662 -1.274 . . . . 0.0 109.411 -179.464 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.833 ' HA ' HG23 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -72.47 -36.22 68.41 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.491 -0.884 . . . . 0.0 108.767 179.283 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.951 ' CE1' HG12 ' A' ' 41' ' ' VAL . 7.2 m170 -81.73 -26.07 34.88 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.866 -0.521 . . . . 0.0 110.272 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -96.38 -28.7 14.34 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.129 -0.982 . . . . 0.0 110.104 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.83 -111.09 1.02 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.961 ' CZ2' HG23 ' A' ' 212' ' ' VAL . 88.6 m95 -91.63 73.97 5.88 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.09 -1.241 . . . . 0.0 109.436 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.781 ' OD1' ' HG3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -52.4 150.09 9.35 Favored Pre-proline 0 N--CA 1.489 1.495 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.151 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.713 ' O ' ' N ' ' A' ' 53' ' ' CYS . 54.2 Cg_endo -91.81 -0.01 4.39 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 122.273 1.982 . . . . 0.0 113.221 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.781 ' HG3' ' OD1' ' A' ' 49' ' ' ASN . 0.0 OUTLIER 0.69 -98.69 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.639 0 CA-C-O 122.646 1.212 . . . . 0.0 111.192 -178.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.819 ' HB3' ' NE ' ' A' ' 79' ' ' ARG 0.259 0.5 OUTLIER -62.19 -28.08 69.42 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.568 -179.707 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.867 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . 0.7 OUTLIER -104.82 -177.02 3.24 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.323 1.059 . . . . 0.0 112.481 -178.096 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.594 ' O ' ' HB3' ' A' ' 50' ' ' PRO . 2.0 m -87.38 165.21 15.76 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.897 0.856 . . . . 0.0 111.257 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 1.128 ' CG ' HD21 ' A' ' 33' ' ' LEU . 2.5 pm0 -94.21 9.71 36.88 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.045 0.926 . . . . 0.0 108.748 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.55 ' C ' ' O ' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -16.27 -38.26 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.263 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.837 ' N ' ' O ' ' A' ' 55' ' ' GLU . 6.6 pt -130.12 167.43 25.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.128 -178.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.933 ' HB2' HD23 ' A' ' 40' ' ' LEU . 6.0 t0 -107.76 141.39 39.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.401 -0.812 . . . . 0.0 110.11 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.833 HG23 ' HA ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -130.42 136.03 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.337 -0.852 . . . . 0.0 110.509 -179.166 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.543 ' NZ ' ' HB2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -135.27 155.05 51.28 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.977 -1.077 . . . . 0.0 110.755 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 62' ' ' GLY . 5.3 mt-10 -78.24 -129.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.515 -0.741 . . . . 0.0 110.115 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 42.15 42.98 4.39 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.666 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 116.11 48.1 0.49 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.807 HD23 ' CZ ' ' A' ' 213' ' ' ARG . 0.5 OUTLIER 0.42 90.5 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.847 -0.796 . . . . 0.0 111.084 -179.438 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -124.96 123.2 39.38 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.493 -0.754 . . . . 0.0 111.194 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.924 ' HE2' HG22 ' A' ' 212' ' ' VAL . 18.2 m-85 -83.39 127.1 33.4 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.61 ' O ' ' HB ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -110.38 121.15 44.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.007 -1.058 . . . . 0.0 110.557 -179.495 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.589 ' HD3' ' N ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -136.11 155.98 49.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.491 -0.755 . . . . 0.0 109.365 179.471 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.589 ' N ' ' HD3' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -173.18 -55.98 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 120.929 -1.107 . . . . 0.0 111.065 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 69' ' ' ARG . 40.9 Cg_endo -67.24 -47.66 2.16 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.756 1.398 . . . . 0.0 110.645 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.547 ' CG2' ' N ' ' A' ' 72' ' ' ALA . 1.6 p -78.49 165.29 3.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-O 121.937 0.875 . . . . 0.0 110.983 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.547 ' N ' ' CG2' ' A' ' 71' ' ' VAL . . . -159.22 -36.52 0.06 Allowed 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.312 0.577 . . . . 0.0 110.026 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -141.99 13.48 2.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.36 -0.838 . . . . 0.0 110.127 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 75' ' ' THR . 0.6 OUTLIER -63.36 -158.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 110.195 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 74' ' ' SER . 0.6 OUTLIER -54.42 -107.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.164 -0.96 . . . . 0.0 110.27 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.529 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 2.4 m-20 -140.32 150.09 43.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.906 -1.121 . . . . 0.0 110.935 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.529 ' O ' ' ND2' ' A' ' 56' ' ' ASN . . . -40.39 -86.49 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.575 ' CG2' ' O ' ' A' ' 49' ' ' ASN . 0.2 OUTLIER -138.05 145.48 28.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.135 -1.214 . . . . 0.0 109.721 178.523 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.867 ' HB3' ' HB2' ' A' ' 53' ' ' CYS . 4.2 tmm_? -148.44 133.83 18.55 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.507 ' HA2' ' HB2' ' A' ' 52' ' ' ASP . . . -126.2 143.34 14.33 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.553 ' HE3' ' CB ' ' A' ' 202' ' ' SER . 0.3 OUTLIER -165.47 9.93 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.067 -1.255 . . . . 0.0 111.451 -179.66 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.74 ' HD2' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -135.27 -9.76 2.23 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.676 -1.265 . . . . 0.0 110.83 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.74 ' N ' ' HD2' ' A' ' 82' ' ' ARG . . . -74.81 38.1 1.07 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.733 ' HE1' HD11 ' A' ' 171' ' ' LEU . 15.8 t80 -94.17 119.37 32.89 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.435 -1.038 . . . . 0.0 110.087 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.7 p -99.92 177.48 5.1 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.302 -0.874 . . . . 0.0 110.395 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.592 ' HA ' ' CB ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -108.04 167.38 10.04 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.307 -0.871 . . . . 0.0 109.933 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.473 ' N ' ' HB3' ' A' ' 173' ' ' MET . . . 100.77 -124.71 8.34 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.497 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 1.3 tp -129.06 130.12 46.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.463 -1.022 . . . . 0.0 110.398 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.552 ' NE2' ' O ' ' A' ' 86' ' ' ARG . 8.4 m-70 -147.29 158.64 44.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.129 -0.982 . . . . 0.0 109.968 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.545 ' O ' ' O ' ' A' ' 217' ' ' MET . . . -161.6 135.22 6.54 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.129 -0.982 . . . . 0.0 109.58 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 1.225 ' CZ3' HG11 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -134.09 156.28 48.54 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.917 -1.114 . . . . 0.0 109.846 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.665 ' O ' ' N ' ' A' ' 215' ' ' ARG . 0.8 OUTLIER -109.53 124.07 50.47 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.705 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 1.067 HG23 ' OH ' ' A' ' 180' ' ' TYR . 0.8 OUTLIER -141.85 154.12 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.953 -1.092 . . . . 0.0 110.62 -179.325 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.503 ' CB ' ' HB3' ' A' ' 213' ' ' ARG . 0.6 OUTLIER -134.17 123.09 23.78 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.5 -0.75 . . . . 0.0 109.093 179.425 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.766 ' HH2' ' O ' ' A' ' 204' ' ' SER . 2.1 t90 -127.6 88.21 54.16 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.067 -1.021 . . . . 0.0 110.817 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -95.43 109.08 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 124.154 1.608 . . . . 0.0 110.166 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.637 HD23 ' HE1' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -96.06 -7.41 36.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.843 -1.16 . . . . 0.0 110.315 179.701 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.463 ' OE2' ' HG3' ' A' ' 99' ' ' GLN . 0.9 OUTLIER -55.55 -15.44 2.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.288 -0.882 . . . . 0.0 110.384 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.503 ' O ' ' HD2' ' A' ' 100' ' ' ARG . 2.7 mt-30 -76.22 -29.41 57.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.111 -0.993 . . . . 0.0 110.426 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.503 ' HD2' ' O ' ' A' ' 99' ' ' GLN . 31.5 mmm180 -150.06 -136.35 0.07 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.444 -0.785 . . . . 0.0 110.206 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.526 ' HA2' ' CD1' ' A' ' 97' ' ' LEU . . . -178.85 127.08 1.11 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.499 ' O ' ' HA3' ' A' ' 136' ' ' GLY . 2.4 m -166.4 -132.25 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.252 -1.146 . . . . 0.0 110.164 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.443 ' H ' HG22 ' A' ' 102' ' ' THR . 0.1 OUTLIER -108.78 23.78 14.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.178 -0.951 . . . . 0.0 110.221 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.744 ' HB1' ' HE1' ' A' ' 95' ' ' TRP . . . -48.07 138.9 8.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.222 -0.924 . . . . 0.0 110.033 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.711 HG13 ' O ' ' A' ' 204' ' ' SER . 0.1 OUTLIER -135.33 136.98 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.961 -1.087 . . . . 0.0 112.015 -178.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.942 HG23 HD11 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -151.24 112.91 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.687 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.571 ' HA3' ' HA3' ' A' ' 132' ' ' GLY . . . 179.55 -147.31 7.51 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 118.621 -1.752 . . . . 0.0 111.223 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.628 ' CG1' ' HB2' ' A' ' 199' ' ' LEU . 1.4 t -139.66 170.27 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.554 -0.968 . . . . 0.0 109.618 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 130' ' ' SER . . . -121.17 139.88 52.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.998 -1.064 . . . . 0.0 110.766 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.865 ' OG1' HD23 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -136.47 133.73 36.88 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.32 -0.862 . . . . 0.0 110.461 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.16 -26.08 17.57 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.308 -0.87 . . . . 0.0 109.266 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.448 ' O ' ' C ' ' A' ' 113' ' ' ALA . 1.0 OUTLIER -85.37 -12.19 52.74 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.545 -0.722 . . . . 0.0 109.445 179.416 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.858 ' HB3' ' HD3' ' A' ' 114' ' ' PRO . . . -39.42 -53.98 3.9 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.552 -0.718 . . . . 0.0 110.646 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.858 ' HD3' ' HB3' ' A' ' 113' ' ' ALA . 46.4 Cg_endo -72.93 102.97 1.51 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.879 1.463 . . . . 0.0 110.497 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.446 ' CD2' ' O ' ' A' ' 114' ' ' PRO . 0.0 OUTLIER 179.89 48.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.338 -0.851 . . . . 0.0 110.221 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 0.5 OUTLIER -128.54 -33.72 2.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.913 . . . . 0.0 110.24 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.523 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -177.14 150.62 0.75 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 110.24 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.523 ' C ' ' O ' ' A' ' 117' ' ' ALA . 22.7 t0 -31.83 109.47 0.06 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.565 -0.709 . . . . 0.0 110.724 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -81.13 157.17 25.42 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.319 -0.863 . . . . 0.0 110.263 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.457 ' O ' ' HB3' ' A' ' 121' ' ' ALA . 8.3 t80 -127.36 138.95 53.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.287 -0.883 . . . . 0.0 110.226 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 120' ' ' TYR . . . 56.64 -88.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.921 . . . . 0.0 110.164 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.477 ' O ' ' CB ' ' A' ' 123' ' ' LEU . . . 47.43 26.17 0.72 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.27 -0.894 . . . . 0.0 110.224 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.477 ' CB ' ' O ' ' A' ' 122' ' ' ALA . 0.2 OUTLIER 66.66 103.13 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.259 -0.901 . . . . 0.0 110.234 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 125' ' ' GLY . 0.4 OUTLIER 55.25 -156.25 0.25 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.243 -0.91 . . . . 0.0 110.31 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 124' ' ' LEU . . . -60.46 -145.64 0.01 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 36.9 p -148.7 20.76 1.02 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -1.121 . . . . 0.0 110.207 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -44.66 -89.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.228 -0.92 . . . . 0.0 110.141 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.65 170.57 14.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.289 -0.882 . . . . 0.0 110.092 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 113' ' ' ALA . 5.9 tp10 -150.21 141.44 23.17 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.271 -0.893 . . . . 0.0 109.692 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.551 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 13.4 t -119.86 120.05 35.33 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.592 -0.692 . . . . 0.0 109.978 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -133.36 136.38 45.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.378 -0.827 . . . . 0.0 109.619 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.606 ' O ' ' CD1' ' A' ' 133' ' ' TRP . . . -178.0 -107.56 0.22 Allowed Glycine 0 N--CA 1.487 2.093 0 C-N-CA 119.545 -1.312 . . . . 0.0 109.924 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.715 ' CH2' ' HB2' ' A' ' 180' ' ' TYR . 5.2 m-90 -141.0 128.91 21.8 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.26 -1.141 . . . . 0.0 111.568 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -118.74 148.04 43.22 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.723 -0.611 . . . . 0.0 109.743 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.942 HD11 HG23 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -131.89 -29.28 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.344 -0.848 . . . . 0.0 109.921 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 102' ' ' THR . . . -63.41 -27.81 71.37 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.441 ' HB3' ' HG2' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -85.35 8.19 19.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -1.12 . . . . 0.0 109.925 179.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 139' ' ' LYS . . . 44.13 41.56 6.32 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.477 ' O ' ' O ' ' A' ' 138' ' ' GLY . 6.6 mmmt -52.8 -169.94 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -1.165 . . . . 0.0 110.151 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.692 ' HA ' HD11 ' A' ' 161' ' ' LEU . 1.4 pp -160.41 104.3 1.43 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.172 -0.955 . . . . 0.0 110.317 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -152.27 24.51 0.62 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.301 -0.874 . . . . 0.0 110.165 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.825 ' CD2' HD12 ' A' ' 161' ' ' LEU . 2.4 p80 -93.83 33.46 1.31 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -0.924 . . . . 0.0 110.263 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -72.43 -41.07 66.59 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.277 -0.889 . . . . 0.0 110.252 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 78.1 p -58.39 -161.64 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.245 -0.91 . . . . 0.0 110.223 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -55.53 167.19 0.54 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.886 . . . . 0.0 110.234 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 147' ' ' LEU . . . 103.58 84.11 1.76 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 146' ' ' GLY . 0.1 OUTLIER -179.88 56.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.2 -1.177 . . . . 0.0 110.144 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.416 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 0.5 OUTLIER 179.81 71.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.885 . . . . 0.0 110.343 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.589 ' N ' ' CD ' ' A' ' 150' ' ' PRO . . . -147.54 47.23 0.54 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.216 -0.928 . . . . 0.0 110.356 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 149' ' ' ALA . 48.0 Cg_endo -74.06 1.78 6.8 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.991 1.522 . . . . 0.0 110.551 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 150' ' ' PRO . 2.9 mp0 -44.6 -96.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 110.44 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.565 ' HB3' ' HD3' ' A' ' 153' ' ' PRO . 0.3 OUTLIER -84.08 -59.26 0.36 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.181 -0.949 . . . . 0.0 110.535 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.565 ' HD3' ' HB3' ' A' ' 152' ' ' TYR . 46.6 Cg_endo -72.56 162.84 40.24 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.873 1.459 . . . . 0.0 110.632 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.643 ' HB1' ' HB2' ' A' ' 157' ' ' GLN . . . -68.58 112.47 5.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 0.0 110.318 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 154' ' ' ALA . . . -54.05 -106.98 0.01 OUTLIER Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.83 -9.36 22.34 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.966 1.508 . . . . 0.0 110.565 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.643 ' HB2' ' HB1' ' A' ' 154' ' ' ALA . 2.4 mm100 -65.85 -4.37 6.66 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.16 -0.962 . . . . 0.0 110.563 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -150.72 -37.09 0.03 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -79.22 7.02 8.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.337 -1.096 . . . . 0.0 110.282 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.495 ' O ' ' HB2' ' A' ' 161' ' ' LEU . 2.7 tt0 -52.37 -18.32 1.56 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.283 -0.886 . . . . 0.0 110.386 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.825 HD12 ' CD2' ' A' ' 142' ' ' HIS . 13.5 tp -179.39 30.34 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.444 -0.785 . . . . 0.0 110.286 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.882 HG13 ' CG2' ' A' ' 135' ' ' ILE . 14.7 t -138.49 -124.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.355 -0.84 . . . . 0.0 110.103 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.969 HG13 ' HD2' ' A' ' 164' ' ' PRO . 15.2 t -130.23 155.05 81.43 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.178 -0.951 . . . . 0.0 109.436 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.969 ' HD2' HG13 ' A' ' 163' ' ' VAL . 38.2 Cg_endo -64.57 -177.89 0.6 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.693 1.365 . . . . 0.0 110.758 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 153' ' ' PRO . 0.3 OUTLIER -48.57 -58.2 5.05 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.43 -0.794 . . . . 0.0 110.389 -179.402 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.469 ' HA ' ' HB3' ' A' ' 94' ' ' SER . 1.3 ttp180 -151.94 155.96 39.1 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.498 -0.751 . . . . 0.0 110.578 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.868 HD23 HG12 ' A' ' 182' ' ' ILE . 0.9 OUTLIER -137.68 157.74 45.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.483 -0.761 . . . . 0.0 109.782 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.416 ' HG ' ' OE1' ' A' ' 92' ' ' GLU . 3.4 tt -103.11 126.72 50.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.93 . . . . 0.0 109.799 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 1.225 HG11 ' CZ3' ' A' ' 91' ' ' TRP . 57.9 t -90.04 138.3 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.349 -0.844 . . . . 0.0 110.829 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 178' ' ' LEU . 85.9 t -116.14 111.51 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.545 -0.722 . . . . 0.0 109.265 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.884 HD12 ' HB3' ' A' ' 178' ' ' LEU . 14.4 tp -118.94 105.51 11.54 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.966 -1.084 . . . . 0.0 110.251 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.438 ' OD2' HD12 ' A' ' 88' ' ' LEU . 4.5 t70 -120.58 133.79 55.34 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.339 -0.851 . . . . 0.0 110.209 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.592 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 1.6 tpt -99.7 -37.96 8.9 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.25 -24.15 1.67 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.474 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.1 OUTLIER -107.04 -26.28 11.22 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.202 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.715 ' O ' HG21 ' A' ' 198' ' ' THR . . . 82.17 24.47 54.62 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 108.604 -1.798 . . . . 0.0 108.604 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.693 ' HA ' HD22 ' A' ' 194' ' ' LEU . 0.6 OUTLIER -130.07 122.91 29.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.093 -1.239 . . . . 0.0 111.486 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.973 HD11 ' O ' ' A' ' 199' ' ' LEU . 0.1 OUTLIER -140.52 153.58 46.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.454 -0.779 . . . . 0.0 109.611 179.168 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.451 ' O ' HG13 ' A' ' 169' ' ' VAL . . . 179.98 -152.2 10.65 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.633 -1.27 . . . . 0.0 110.212 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 1.067 ' OH ' HG23 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -123.0 142.21 51.09 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.331 -1.099 . . . . 0.0 109.332 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.503 ' HA ' ' HB3' ' A' ' 186' ' ' TYR . 15.3 t -140.76 124.78 17.3 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.422 -0.799 . . . . 0.0 110.154 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.868 HG12 HD23 ' A' ' 167' ' ' LEU . 0.1 OUTLIER -107.26 116.64 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.215 -0.928 . . . . 0.0 109.276 179.502 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 79.81 -47.19 3.25 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 137.62 36.39 0.17 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . 0.435 ' O ' ' C ' ' A' ' 186' ' ' TYR . 73.0 m -122.89 -51.47 1.91 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.242 -1.152 . . . . 0.0 110.859 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.573 ' CD2' HD11 ' A' ' 182' ' ' ILE . 0.1 OUTLIER -40.98 -74.34 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.079 -1.013 . . . . 0.0 110.613 -179.415 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.897 HD23 ' CZ ' ' A' ' 191' ' ' PHE . 1.1 mp -71.25 43.85 0.08 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.001 -1.062 . . . . 0.0 109.886 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 186' ' ' TYR . . . -75.67 -99.28 0.13 Allowed Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.472 ' C ' ' H ' ' A' ' 191' ' ' PHE . 49.6 Cg_endo -74.13 -24.17 15.05 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.207 1.635 . . . . 0.0 110.946 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.557 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -65.86 16.81 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.487 -0.758 . . . . 0.0 111.724 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.897 ' CZ ' HD23 ' A' ' 187' ' ' LEU . 0.3 OUTLIER -90.45 -16.68 28.53 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.828 -1.17 . . . . 0.0 110.394 179.56 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.43 ' HA ' ' NE ' ' A' ' 192' ' ' ARG . 0.0 OUTLIER -90.2 -15.12 32.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.282 -0.886 . . . . 0.0 110.902 -179.452 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -110.82 -16.95 9.42 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.693 HD22 ' HA ' ' A' ' 177' ' ' THR . 7.5 tt -67.86 -36.31 80.08 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.617 -0.931 . . . . 0.0 108.87 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.507 ' HA ' HG23 ' A' ' 177' ' ' THR . 0.0 OUTLIER -44.69 -34.88 2.4 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.403 -0.811 . . . . 0.0 109.825 179.562 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.443 ' N ' ' HD2' ' A' ' 195' ' ' LYS . . . -94.11 -27.31 12.43 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.748 ' HD3' HD11 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.94 -4.69 56.3 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.603 -0.94 . . . . 0.0 110.108 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.715 HG21 ' O ' ' A' ' 176' ' ' GLY . 0.7 OUTLIER -44.06 143.49 1.14 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.825 0.821 . . . . 0.0 111.649 -178.327 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.973 ' O ' HD11 ' A' ' 178' ' ' LEU . 0.0 OUTLIER -140.28 171.74 13.73 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.53 ' O ' ' N ' ' A' ' 109' ' ' ALA . 2.8 m-30 -84.18 129.81 56.87 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 120.925 -1.11 . . . . 0.0 109.782 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.499 ' HD3' ' CD1' ' A' ' 178' ' ' LEU . 41.6 Cg_endo -67.51 115.75 3.87 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.888 1.468 . . . . 0.0 111.035 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.553 ' CB ' ' HE3' ' A' ' 81' ' ' LYS . 1.6 p -133.14 154.06 50.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.43 -0.794 . . . . 0.0 110.229 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.687 HG23 ' HA ' ' A' ' 106' ' ' VAL . 2.0 p -158.1 164.11 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.32 -0.863 . . . . 0.0 110.217 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 0.766 ' O ' ' HH2' ' A' ' 95' ' ' TRP . 0.1 OUTLIER -157.94 126.56 5.57 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.397 -0.815 . . . . 0.0 109.981 179.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -119.23 161.63 20.06 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.312 -0.868 . . . . 0.0 110.831 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.559 ' CG1' ' N ' ' A' ' 207' ' ' TRP . 1.1 t -124.33 176.14 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 CA-C-O 121.251 0.548 . . . . 0.0 110.063 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 0.774 ' HB3' HD12 ' A' ' 57' ' ' ILE . 44.2 p90 -103.31 155.0 18.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -0.883 . . . . 0.0 110.056 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 135.18 -152.84 20.95 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.496 ' OE1' ' HG3' ' A' ' 100' ' ' ARG . 5.1 tm0? -66.89 -29.04 68.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.324 -1.103 . . . . 0.0 110.258 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 209' ' ' GLN . 9.2 t -46.74 175.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.304 -0.872 . . . . 0.0 109.985 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.432 ' HG2' ' C ' ' A' ' 210' ' ' CYS . 0.8 OUTLIER -170.11 111.29 0.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 110.588 -179.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.961 HG23 ' CZ2' ' A' ' 48' ' ' TRP . 27.4 m -115.42 145.39 21.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.527 -0.733 . . . . 0.0 109.783 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.89 ' HE ' ' HA ' ' A' ' 213' ' ' ARG . 0.7 OUTLIER -108.48 128.54 54.89 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.204 179.728 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.723 ' HB ' ' CZ3' ' A' ' 48' ' ' TRP . 5.6 tt -123.51 119.62 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.026 -1.047 . . . . 0.0 111.933 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.665 ' N ' ' O ' ' A' ' 92' ' ' GLU . 23.3 ttt180 -130.33 135.07 47.69 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . 0.66 ' HA ' ' HB3' ' A' ' 91' ' ' TRP . 1.8 t80 -119.07 151.02 39.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.651 -1.281 . . . . 0.0 112.265 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . 0.545 ' O ' ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -131.11 107.77 9.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.686 -0.634 . . . . 0.0 109.612 179.061 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 79.23 61.87 2.28 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.578 ' HB2' ' CD1' ' A' ' 216' ' ' TYR . 16.9 tt0 -95.4 150.44 20.28 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.138 -1.213 . . . . 0.0 110.237 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.464 ' N ' ' HG2' ' A' ' 219' ' ' GLU . 0.0 OUTLIER -43.24 136.42 2.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.236 -0.915 . . . . 0.0 110.266 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . 0.504 ' O ' ' C ' ' A' ' 222' ' ' VAL . 4.8 mtt85 -119.28 85.58 2.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 110.316 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.504 ' C ' ' O ' ' A' ' 221' ' ' ARG . 2.6 p -33.54 118.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.504 -0.748 . . . . 0.0 110.582 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.508 ' O ' ' C ' ' A' ' 224' ' ' GLU . 1.9 tt0 179.85 -74.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.254 -0.904 . . . . 0.0 110.251 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.508 ' C ' ' O ' ' A' ' 223' ' ' GLU . 7.7 tt0 -33.89 -89.1 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.466 -0.771 . . . . 0.0 110.638 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.54 111.18 0.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.261 -0.899 . . . . 0.0 110.326 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.78 133.83 53.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.285 -0.885 . . . . 0.0 110.058 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.64 -38.1 5.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.343 -0.848 . . . . 0.0 110.267 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.45 ' O ' HG13 ' A' ' 228' ' ' ILE . 17.1 pt -130.16 133.46 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.217 -0.927 . . . . 0.0 110.295 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.406 ' O ' ' C ' ' A' ' 230' ' ' ARG . 16.8 m170 -97.95 -35.9 10.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.283 -0.886 . . . . 0.0 110.158 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . 0.67 ' O ' ' C ' ' A' ' 231' ' ' ASP . 0.0 OUTLIER -44.12 153.69 0.13 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.209 -0.932 . . . . 0.0 110.178 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.67 ' C ' ' O ' ' A' ' 230' ' ' ARG . 38.9 m-20 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.986 -1.007 . . . . 0.0 111.421 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.98 96.07 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -1.154 . . . . 0.0 110.145 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 51.59 66.66 1.13 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.27 -0.894 . . . . 0.0 110.217 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.63 60.75 6.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.893 . . . . 0.0 110.17 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.89 34.37 0.15 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 110.285 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -77.03 118.52 19.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.212 -0.93 . . . . 0.0 110.198 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.1 m -82.1 96.42 7.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.217 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 37.1 p -137.94 143.57 40.36 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.201 -0.937 . . . . 0.0 110.199 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -73.08 -36.25 4.47 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.001 1.527 . . . . 0.0 110.387 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 90.6 m -97.45 149.81 21.74 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.27 -0.894 . . . . 0.0 110.194 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.2 m -103.91 154.78 19.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -0.88 . . . . 0.0 110.224 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.92 48.67 0.96 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -0.847 . . . . 0.0 110.297 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.38 143.6 57.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.265 -0.897 . . . . 0.0 110.219 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.493 HD23 ' N ' ' A' ' 19' ' ' LEU . 4.3 mt -52.02 173.95 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.922 . . . . 0.0 110.231 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -60.71 -172.38 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.208 -0.932 . . . . 0.0 110.445 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.5 t -94.65 -164.04 1.12 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.285 -0.884 . . . . 0.0 110.347 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -164.55 37.01 0.07 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.906 . . . . 0.0 110.302 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.42 -74.49 0.46 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 0.0 110.209 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.6 109.0 42.27 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.346 -0.847 . . . . 0.0 110.053 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.91 163.89 37.1 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.914 1.481 . . . . 0.0 110.616 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.458 ' O ' ' HB2' ' A' ' 27' ' ' GLU . 47.4 Cg_endo -73.24 165.32 32.93 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.06 1.558 . . . . 0.0 110.443 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 1.2 tt0 -179.28 39.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.328 -0.858 . . . . 0.0 110.156 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.18 22.3 57.35 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.956 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.2 OUTLIER -63.82 -33.23 75.22 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.35 -1.088 . . . . 0.0 110.092 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 1.03 ' HA ' HD23 ' A' ' 33' ' ' LEU . 16.1 pt-20 -45.74 -37.82 6.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 109.719 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.471 ' N ' ' HG3' ' A' ' 30' ' ' GLU . 1.7 tm-20 -72.4 -23.21 61.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.376 -0.828 . . . . 0.0 109.167 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.609 ' O ' ' HD2' ' A' ' 36' ' ' PRO . 15.3 tp -83.81 -30.49 26.5 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.03 HD23 ' HA ' ' A' ' 30' ' ' GLU . 0.3 OUTLIER -71.0 -34.35 71.26 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 122.081 0.943 . . . . 0.0 108.968 179.304 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.608 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -83.81 -6.93 59.54 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.072 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.995 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -71.5 -65.73 0.84 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.313 -0.867 . . . . 0.0 111.11 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.995 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 49.6 Cg_endo -75.45 143.97 28.3 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.607 1.32 . . . . 0.0 110.441 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 36' ' ' PRO . 53.9 Cg_endo -99.02 54.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.947 1.764 . . . . 0.0 112.251 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.722 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 51.8 Cg_endo -75.52 150.91 36.63 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 122.958 0.978 . . . . 0.0 109.845 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.653 ' O ' ' HB3' ' A' ' 43' ' ' GLN . 0.9 OUTLIER -34.04 -34.52 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.187 -0.946 . . . . 0.0 109.662 179.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.245 ' O ' ' HB3' ' A' ' 44' ' ' ARG . 1.8 tp -62.79 -43.91 97.57 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.207 -0.933 . . . . 0.0 110.34 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.688 ' O ' ' CG ' ' A' ' 45' ' ' HIS . 46.6 t -86.68 -36.8 10.65 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 C-N-CA 118.389 -1.324 . . . . 0.0 110.029 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.13 -40.12 11.21 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.436 -0.906 . . . . 0.0 112.696 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.653 ' HB3' ' O ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -87.88 -19.15 27.76 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 120.899 -1.126 . . . . 0.0 110.164 -178.645 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 1.245 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 5.3 ttt180 -84.66 -52.62 5.95 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.795 1.284 . . . . 0.0 109.778 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.693 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 13.7 m170 -52.35 -15.03 0.54 Allowed 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.26 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 20.4 t-160 -82.84 -38.59 22.81 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 118.147 -1.421 . . . . 0.0 110.136 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.736 ' O ' ' N ' ' A' ' 49' ' ' ASN . . . -94.39 -109.93 2.2 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 106.234 -2.746 . . . . 0.0 106.234 177.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.817 ' CZ3' ' HA ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -58.39 71.42 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 177.062 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.736 ' N ' ' O ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -57.66 109.95 2.14 Favored Pre-proline 0 C--N 1.289 -2.052 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.192 -178.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.757 ' HA ' HG23 ' A' ' 78' ' ' VAL . 51.5 Cg_endo -92.54 -0.03 3.92 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.171 1.914 . . . . 0.0 110.448 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.698 ' HA ' ' HE3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -44.97 -77.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.147 -0.97 . . . . 0.0 110.425 -179.518 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.626 ' HB3' ' HE ' ' A' ' 79' ' ' ARG . 0.2 OUTLIER -40.57 -19.29 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.708 0.766 . . . . 0.0 109.192 178.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.638 ' N ' ' O ' ' A' ' 51' ' ' LYS . 3.1 t -114.69 -178.52 3.39 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.653 0.74 . . . . 0.0 110.776 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.579 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 0.3 OUTLIER -89.0 166.6 13.79 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.84 0.828 . . . . 0.0 110.595 -179.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.935 ' CG ' HD22 ' A' ' 33' ' ' LEU . 3.2 pp20? -81.93 8.75 9.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.713 -0.617 . . . . 0.0 110.039 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.579 ' ND2' ' O ' ' A' ' 54' ' ' SER . 0.1 OUTLIER -24.51 -33.1 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.675 0.75 . . . . 0.0 110.134 -179.534 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.797 ' N ' ' O ' ' A' ' 55' ' ' GLU . 6.1 pt -141.73 165.18 18.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.798 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.685 ' CB ' HD13 ' A' ' 40' ' ' LEU . 9.2 t0 -114.91 126.79 55.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.463 -0.773 . . . . 0.0 109.967 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.747 HG11 ' CD1' ' A' ' 48' ' ' TRP . 57.7 t -130.04 127.01 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.115 -0.991 . . . . 0.0 109.907 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.675 ' HA ' ' CH2' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -136.37 157.1 47.6 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.986 -1.071 . . . . 0.0 111.585 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.67 ' N ' ' CH2' ' A' ' 48' ' ' TRP . 1.3 tt0 -52.5 -110.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.694 -0.629 . . . . 0.0 111.076 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 44.54 37.57 5.0 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 107.661 -2.176 . . . . 0.0 107.661 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.73 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 94.35 78.32 1.41 Allowed Glycine 0 N--CA 1.486 1.973 0 N-CA-C 107.809 -2.117 . . . . 0.0 107.809 -178.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.73 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.4 OUTLIER 1.26 88.21 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.661 -0.905 . . . . 0.0 110.126 -178.711 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 46.4 t -122.35 114.64 21.05 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.425 -0.797 . . . . 0.0 111.677 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.658 ' CE2' HG23 ' A' ' 212' ' ' VAL . 0.1 OUTLIER -84.41 135.36 34.3 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.501 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.556 ' O ' ' N ' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -138.39 131.62 30.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.851 -1.156 . . . . 0.0 111.15 -179.535 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.552 ' HG2' ' CA ' ' A' ' 208' ' ' GLY . 0.0 OUTLIER -130.71 141.81 50.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.53 -0.732 . . . . 0.0 109.043 179.133 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.605 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 2.4 ttp180 -110.46 -68.2 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.783 -1.198 . . . . 0.0 111.325 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.605 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 56.3 Cg_endo -71.61 -124.1 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.5 0 O-C-N 123.394 1.207 . . . . 0.0 109.586 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.55 ' O ' ' N ' ' A' ' 73' ' ' GLN . 3.6 t -140.1 164.18 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.441 -1.412 . . . . 0.0 109.874 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.923 ' HB2' ' CE3' ' A' ' 207' ' ' TRP . . . -46.66 91.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.169 -0.957 . . . . 0.0 109.892 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.55 ' N ' ' O ' ' A' ' 71' ' ' VAL . 9.8 mt-30 -50.08 -176.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.932 . . . . 0.0 110.313 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.0 m -51.76 -18.84 1.37 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 0.0 110.127 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' A' ' 54' ' ' SER . 1.3 m -96.87 -131.88 0.2 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.215 -0.928 . . . . 0.0 110.081 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.579 ' O ' ' C ' ' A' ' 77' ' ' GLY . 80.5 m-20 -140.4 154.83 46.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.187 -0.946 . . . . 0.0 110.172 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.579 ' C ' ' O ' ' A' ' 76' ' ' ASP . . . -31.88 -77.78 0.03 OUTLIER Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.757 HG23 ' HA ' ' A' ' 50' ' ' PRO . 0.4 OUTLIER -149.18 153.29 11.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.345 -1.091 . . . . 0.0 109.783 179.024 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.626 ' HE ' ' HB3' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -145.7 174.63 11.03 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.712 -0.617 . . . . 0.0 110.071 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.576 ' N ' ' CG ' ' A' ' 79' ' ' ARG . . . -157.48 152.55 23.83 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.513 ' HB2' ' CB ' ' A' ' 202' ' ' SER . 0.1 OUTLIER 179.85 -27.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.206 -1.173 . . . . 0.0 110.661 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.48 ' HG2' ' OD1' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -72.92 -100.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.137 -0.977 . . . . 0.0 110.334 -179.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 82' ' ' ARG . . . 43.0 59.61 3.28 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.526 ' CD2' ' O ' ' A' ' 84' ' ' TYR . 28.2 t80 -95.33 95.68 8.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.18 -1.188 . . . . 0.0 110.185 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.451 ' O ' ' HG2' ' A' ' 173' ' ' MET . 0.1 OUTLIER -140.11 173.67 11.28 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 110.252 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.541 ' HA ' ' CB ' ' A' ' 173' ' ' MET . 2.3 mmt85 -101.42 -174.36 2.58 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.177 -0.952 . . . . 0.0 109.676 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.96 158.35 15.98 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.774 ' O ' HD23 ' A' ' 88' ' ' LEU . 1.8 tt -87.47 127.41 35.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -1.11 . . . . 0.0 109.98 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.421 ' NE2' ' O ' ' A' ' 86' ' ' ARG . 40.9 m-70 -133.25 173.1 11.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 110.162 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -156.76 151.31 25.56 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.07 -1.019 . . . . 0.0 110.389 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.811 ' CZ2' HG11 ' A' ' 169' ' ' VAL . 4.1 p90 -146.2 171.06 15.5 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.246 -0.909 . . . . 0.0 109.936 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.584 ' N ' ' O ' ' A' ' 215' ' ' ARG . 0.7 OUTLIER -138.28 152.14 48.26 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.351 -0.939 . . . . 0.0 111.45 -178.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 1.037 HG23 HD21 ' A' ' 167' ' ' LEU . 3.7 tt -144.18 151.58 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.545 -0.722 . . . . 0.0 109.674 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.544 ' HG ' ' HG2' ' A' ' 213' ' ' ARG . 0.1 OUTLIER -142.65 135.85 28.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.092 -1.005 . . . . 0.0 110.672 -179.572 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.802 ' CH2' ' HA ' ' A' ' 104' ' ' ALA . 88.3 m95 -104.47 96.25 9.83 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.775 -0.578 . . . . 0.0 110.204 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.621 ' HD2' ' O ' ' A' ' 211' ' ' GLN . 45.9 Cg_endo -72.29 152.37 55.45 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 121.959 1.772 . . . . 0.0 111.214 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 1.216 HD22 ' O ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -32.87 -42.69 0.08 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.533 -0.729 . . . . 0.0 111.158 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 1.161 ' N ' HD13 ' A' ' 97' ' ' LEU . 3.1 mt-10 -35.71 -28.33 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.687 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.769 ' HA ' ' HB3' ' A' ' 210' ' ' CYS . 7.3 pt20 -67.16 50.41 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.247 -0.908 . . . . 0.0 110.304 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.813 ' NH1' HD21 ' A' ' 97' ' ' LEU . 1.9 mtt-85 -56.03 -99.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.173 -0.955 . . . . 0.0 110.233 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.589 ' O ' ' CD2' ' A' ' 103' ' ' HIS . . . -44.88 -93.13 0.01 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.461 ' OG1' HG21 ' A' ' 206' ' ' VAL . 1.2 p -59.45 136.81 58.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.249 -1.148 . . . . 0.0 110.071 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.589 ' CD2' ' O ' ' A' ' 101' ' ' GLY . 8.8 m-70 -98.95 -135.49 0.28 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -0.888 . . . . 0.0 110.212 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.802 ' HA ' ' CH2' ' A' ' 95' ' ' TRP . . . -94.88 131.51 40.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.184 -0.948 . . . . 0.0 110.352 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.924 HG23 ' CB ' ' A' ' 204' ' ' SER . 34.9 m -128.01 114.12 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 118.003 -1.479 . . . . 0.0 110.471 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.861 ' HB ' HG23 ' A' ' 203' ' ' VAL . 9.0 p -152.31 166.91 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.396 -0.815 . . . . 0.0 109.121 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.666 ' CA ' ' HA3' ' A' ' 132' ' ' GLY . . . 176.28 167.99 35.8 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 118.987 -1.578 . . . . 0.0 110.941 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.039 ' CG1' HD13 ' A' ' 199' ' ' LEU . 2.2 t -123.91 155.61 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.712 -0.876 . . . . 0.0 109.017 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.997 ' HB3' ' CZ ' ' A' ' 200' ' ' TYR . . . -142.96 150.78 40.15 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.805 -1.185 . . . . 0.0 111.365 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 1.015 ' OG1' HD23 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -131.45 134.95 46.71 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.513 -0.742 . . . . 0.0 110.087 179.505 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.96 -24.77 18.28 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.343 -0.848 . . . . 0.0 109.337 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.6 pp -86.69 -12.11 49.29 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.583 -0.698 . . . . 0.0 109.255 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.96 ' HB3' ' HD3' ' A' ' 114' ' ' PRO . . . -41.82 -57.61 3.91 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.465 -0.772 . . . . 0.0 110.44 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.96 ' HD3' ' HB3' ' A' ' 113' ' ' ALA . 46.6 Cg_endo -73.84 149.95 43.44 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.956 1.503 . . . . 0.0 110.505 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.609 HD23 ' O ' ' A' ' 113' ' ' ALA . 0.7 OUTLIER -178.39 47.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 110.016 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -91.73 -86.75 0.22 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.329 -0.857 . . . . 0.0 110.257 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.533 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -150.74 67.17 0.94 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.152 -0.968 . . . . 0.0 110.156 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 120' ' ' TYR . 43.0 t0 -30.68 -53.14 0.18 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.464 -0.772 . . . . 0.0 110.778 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.479 ' HB3' ' O ' ' A' ' 118' ' ' ASP . 9.2 t-80 62.42 -71.37 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.357 -0.839 . . . . 0.0 110.239 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.56 ' O ' ' HB2' ' A' ' 121' ' ' ALA . 0.4 OUTLIER -149.32 -51.07 0.15 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 110.165 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 120' ' ' TYR . . . 176.97 -52.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.959 . . . . 0.0 110.172 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 121' ' ' ALA . . . 59.83 167.69 0.07 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.236 -0.915 . . . . 0.0 110.202 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.63 ' O ' HD12 ' A' ' 124' ' ' LEU . 34.0 tp -81.05 -19.22 44.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.16 -0.963 . . . . 0.0 110.237 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.63 HD12 ' O ' ' A' ' 123' ' ' LEU . 1.3 tp -148.25 44.27 1.05 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.254 -0.903 . . . . 0.0 110.193 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -65.61 -119.47 0.01 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.98 58.47 1.54 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.203 -1.175 . . . . 0.0 110.212 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.3 m-20 -47.1 -69.38 0.13 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.256 -0.902 . . . . 0.0 110.166 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.546 ' HA ' ' HG3' ' A' ' 114' ' ' PRO . 32.0 t -156.65 175.8 13.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.252 -0.905 . . . . 0.0 110.211 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.669 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 0.2 OUTLIER -133.5 119.64 19.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 110.051 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 3.1 t -120.58 119.99 34.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 110.334 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -123.68 124.91 43.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.851 . . . . 0.0 109.693 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.666 ' HA3' ' CA ' ' A' ' 107' ' ' GLY . . . -164.53 -164.36 19.64 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.607 ' CH2' ' O ' ' A' ' 180' ' ' TYR . 36.4 m0 -114.64 113.17 24.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -1.103 . . . . 0.0 110.462 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -119.63 107.77 13.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.709 -0.62 . . . . 0.0 109.488 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.699 HG23 ' O ' ' A' ' 135' ' ' ILE . 15.7 tt -144.26 48.15 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.156 -0.965 . . . . 0.0 110.394 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.479 ' HA2' ' HB2' ' A' ' 103' ' ' HIS . . . -91.9 -23.65 27.27 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.94 4.25 23.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -1.175 . . . . 0.0 109.989 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.465 ' O ' ' HG2' ' A' ' 139' ' ' LYS . . . 79.32 -11.67 29.7 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.189 -1.165 . . . . 0.0 110.189 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 7.8 mmtt -145.31 -164.1 1.86 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.047 -1.267 . . . . 0.0 110.459 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 139' ' ' LYS . 0.6 OUTLIER -178.44 61.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.414 -0.804 . . . . 0.0 110.178 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.427 ' CG ' ' O ' ' A' ' 141' ' ' TYR . 40.8 t80 -72.7 68.06 0.82 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.189 -0.944 . . . . 0.0 110.333 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 5.6 m170 -71.67 -71.47 0.27 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 110.311 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.55 -80.89 0.41 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.249 -0.907 . . . . 0.0 110.169 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.31 -162.21 1.48 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.325 -0.859 . . . . 0.0 110.184 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.39 96.17 0.08 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.201 -0.937 . . . . 0.0 110.182 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -146.14 23.16 1.75 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 148' ' ' GLU . 0.5 OUTLIER -172.07 49.65 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.187 -1.184 . . . . 0.0 110.159 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 147' ' ' LEU . 7.3 tp10 179.93 94.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 110.036 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.458 ' HB1' ' NE2' ' A' ' 151' ' ' GLN . . . -122.67 98.59 43.01 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.229 -0.92 . . . . 0.0 110.2 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.98 53.45 2.88 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.973 1.512 . . . . 0.0 110.504 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.5 ' NE2' ' N ' ' A' ' 151' ' ' GLN . 0.2 OUTLIER -77.79 -91.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 0.0 110.184 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.634 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 5.0 m-85 -107.34 -66.44 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.272 -0.893 . . . . 0.0 110.505 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.634 ' CD ' ' CB ' ' A' ' 152' ' ' TYR . 47.3 Cg_endo -73.03 142.91 35.33 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.574 1.302 . . . . 0.0 110.383 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.507 ' O ' ' O ' ' A' ' 155' ' ' GLY . . . -66.48 132.46 48.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 110.117 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.507 ' O ' ' O ' ' A' ' 154' ' ' ALA . . . 58.75 125.53 0.01 OUTLIER Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.07 -49.67 0.29 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.842 1.443 . . . . 0.0 110.494 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -61.96 -10.2 9.06 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.265 -0.897 . . . . 0.0 110.413 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.743 ' O ' HG23 ' A' ' 162' ' ' VAL . . . 59.74 62.1 6.48 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.488 ' O ' ' HG2' ' A' ' 164' ' ' PRO . 3.2 pp20? -69.5 6.47 1.07 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.405 -1.056 . . . . 0.0 110.682 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -76.52 0.13 21.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.891 . . . . 0.0 109.957 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.449 ' HA ' ' OE1' ' A' ' 165' ' ' GLU . 0.6 OUTLIER -167.42 35.43 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.312 -0.868 . . . . 0.0 110.008 179.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 158' ' ' GLY . 24.1 t -106.79 -115.3 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.275 -0.89 . . . . 0.0 110.422 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.858 HG12 ' HD3' ' A' ' 164' ' ' PRO . 8.4 p -87.17 -25.91 0.34 Allowed Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.188 -0.945 . . . . 0.0 111.134 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.858 ' HD3' HG12 ' A' ' 163' ' ' VAL . 48.3 Cg_endo -79.3 52.51 4.31 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 O-C-N 123.068 1.036 . . . . 0.0 109.792 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.506 ' O ' ' CB ' ' A' ' 94' ' ' SER . 0.9 OUTLIER 178.77 -72.4 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.693 0.759 . . . . 0.0 109.371 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.422 ' HA ' ' HB3' ' A' ' 94' ' ' SER . 1.4 tpp180 -140.85 144.0 35.08 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 1.037 HD21 HG23 ' A' ' 93' ' ' ILE . 0.6 OUTLIER -164.36 157.08 17.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.041 -1.037 . . . . 0.0 110.745 -179.604 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.502 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . 7.7 tt -123.31 137.14 54.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.286 -0.884 . . . . 0.0 110.082 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.889 HG21 ' CE1' ' A' ' 180' ' ' TYR . 19.0 t -121.4 147.94 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 110.082 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.604 HG21 HD21 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -127.89 128.87 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.181 -0.95 . . . . 0.0 110.438 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.739 HD13 HD22 ' A' ' 178' ' ' LEU . 4.7 tp -133.14 105.91 7.3 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.225 -0.922 . . . . 0.0 109.678 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.509 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 54.3 t0 -114.88 136.64 52.88 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 110.648 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.541 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -93.26 -39.6 10.9 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.799 -0.563 . . . . 0.0 109.689 179.678 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 173' ' ' MET . 3.5 tt0 -42.51 -28.07 0.2 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.323 -0.861 . . . . 0.0 108.894 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.59 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 3.0 tt0 -111.86 -26.22 9.04 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.521 ' O ' ' HB ' ' A' ' 198' ' ' THR . . . 80.0 25.07 58.58 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 108.703 -1.759 . . . . 0.0 108.703 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 1.097 HG22 HD22 ' A' ' 194' ' ' LEU . 0.2 OUTLIER -121.81 136.7 54.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.191 -1.182 . . . . 0.0 111.252 -179.431 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 1.098 ' O ' HD11 ' A' ' 194' ' ' LEU . 0.3 OUTLIER -144.66 153.76 42.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.56 -0.713 . . . . 0.0 109.514 179.302 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -154.03 167.6 32.28 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.588 -1.292 . . . . 0.0 110.197 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.889 ' CE1' HG21 ' A' ' 169' ' ' VAL . 0.9 OUTLIER -118.74 125.26 49.23 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.594 -0.945 . . . . 0.0 108.906 179.64 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.539 ' CB ' ' HB2' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -144.41 165.07 28.96 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.069 -1.019 . . . . 0.0 110.646 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 1.009 HD11 ' CD2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -120.81 116.65 50.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 O-C-N 121.667 -0.646 . . . . 0.0 109.38 179.402 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 62.78 11.67 37.8 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 86.92 34.52 10.93 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . 0.76 HG22 ' CE1' ' A' ' 186' ' ' TYR . 31.8 m -87.43 -79.41 0.28 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -1.161 . . . . 0.0 110.545 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 1.009 ' CD2' HD11 ' A' ' 182' ' ' ILE . 2.0 m-85 -83.66 89.47 7.13 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.971 -1.081 . . . . 0.0 110.389 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.629 ' HG ' ' CE1' ' A' ' 191' ' ' PHE . 12.3 tp 179.9 29.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.589 -0.694 . . . . 0.0 109.504 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.438 ' H ' ' HD2' ' A' ' 189' ' ' PRO . . . -106.73 -72.06 0.8 Allowed Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.754 -1.212 . . . . 0.0 110.984 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.438 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 44.8 Cg_endo -70.48 -30.84 18.35 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.899 1.473 . . . . 0.0 111.727 -178.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.657 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -72.42 17.21 0.11 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.125 -0.984 . . . . 0.0 111.519 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.629 ' CE1' ' HG ' ' A' ' 187' ' ' LEU . 1.1 m-30 -90.83 -22.14 21.13 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.962 -1.086 . . . . 0.0 110.981 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.476 ' HG2' ' NH1' ' A' ' 192' ' ' ARG . 0.1 OUTLIER -90.02 -14.66 33.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.033 -1.042 . . . . 0.0 110.659 -179.391 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -106.62 -17.36 12.27 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.516 -1.834 . . . . 0.0 108.516 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 1.098 HD11 ' O ' ' A' ' 178' ' ' LEU . 7.2 tt -65.99 -41.44 91.1 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.699 -0.883 . . . . 0.0 109.525 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.559 ' HE3' ' N ' ' A' ' 196' ' ' GLY . 0.0 OUTLIER -47.07 -31.12 3.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.455 -0.778 . . . . 0.0 110.415 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.559 ' N ' ' HE3' ' A' ' 195' ' ' LYS . . . -99.61 -22.91 11.57 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 1.014 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -91.22 -3.66 56.74 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.942 -0.74 . . . . 0.0 110.164 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.789 HG23 ' O ' ' A' ' 194' ' ' LEU . 33.9 p -42.6 123.17 2.53 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.781 0.801 . . . . 0.0 111.785 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 1.039 HD13 ' CG1' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -140.72 172.9 12.05 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.495 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.997 ' CZ ' ' HB3' ' A' ' 109' ' ' ALA . 41.0 p90 -83.13 131.26 54.13 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 120.934 -1.104 . . . . 0.0 109.625 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.51 ' HA ' HG13 ' A' ' 108' ' ' VAL . 52.2 Cg_endo -81.74 132.43 7.65 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 124.01 1.532 . . . . 0.0 111.935 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.513 ' CB ' ' HB2' ' A' ' 81' ' ' LYS . 20.0 p -133.44 127.31 33.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.61 -0.681 . . . . 0.0 109.346 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.861 HG23 ' HB ' ' A' ' 106' ' ' VAL . 11.8 p -119.66 156.33 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.01 -1.056 . . . . 0.0 110.589 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 0.924 ' CB ' HG23 ' A' ' 105' ' ' VAL . 1.4 m -134.18 129.27 35.55 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.527 -0.733 . . . . 0.0 110.726 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 1.001 ' HB1' HG21 ' A' ' 212' ' ' VAL . . . -123.14 131.22 53.6 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.285 0.564 . . . . 0.0 110.202 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.611 HG13 ' N ' ' A' ' 207' ' ' TRP . 1.2 t -47.35 176.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.46 -0.775 . . . . 0.0 110.419 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 0.923 ' CE3' ' HB2' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -101.3 -50.44 3.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.201 -0.937 . . . . 0.0 111.072 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.69 ' N ' ' CG ' ' A' ' 207' ' ' TRP . . . -144.36 -1.19 0.93 Allowed Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.596 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.545 ' OE1' ' CH2' ' A' ' 207' ' ' TRP . 4.0 tp60 -66.9 -23.43 65.99 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.424 -1.045 . . . . 0.0 109.646 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . 0.769 ' HB3' ' HA ' ' A' ' 99' ' ' GLN . 20.7 p -143.98 -121.98 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.625 0.726 . . . . 0.0 110.018 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.621 ' O ' ' HD2' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -173.53 139.55 0.75 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.634 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 1.001 HG21 ' HB1' ' A' ' 205' ' ' ALA . 2.3 t -127.24 140.6 48.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 120.607 -1.308 . . . . 0.0 111.321 -178.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.713 ' HA ' HD12 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -128.39 109.28 11.28 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.153 178.73 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.665 ' O ' HD11 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -123.54 150.79 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.425 -0.797 . . . . 0.0 110.913 -179.024 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.584 ' O ' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -130.0 108.89 10.44 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . 0.714 ' CD2' ' CB ' ' A' ' 91' ' ' TRP . 1.5 t80 -115.8 140.28 49.37 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.187 -0.945 . . . . 0.0 111.048 -178.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . 0.421 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 0.0 OUTLIER -136.71 123.99 21.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.648 -0.657 . . . . 0.0 110.142 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 145.8 -37.54 1.26 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -95.5 142.47 27.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.274 -1.133 . . . . 0.0 110.224 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.471 ' HG3' ' N ' ' A' ' 221' ' ' ARG . 2.8 ptp180 -161.75 -139.48 0.05 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.906 . . . . 0.0 110.221 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . 0.488 ' O ' ' C ' ' A' ' 222' ' ' VAL . 6.0 ttm180 -102.13 79.18 1.84 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.199 -0.938 . . . . 0.0 110.162 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.683 HG13 ' O ' ' A' ' 222' ' ' VAL . 9.3 p -35.03 116.16 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.552 -0.717 . . . . 0.0 110.559 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.505 ' O ' ' C ' ' A' ' 224' ' ' GLU . 49.8 mt-10 -83.81 34.41 0.49 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.176 -0.953 . . . . 0.0 110.53 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.505 ' C ' ' O ' ' A' ' 223' ' ' GLU . 4.7 tp10 -33.73 -70.72 0.07 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.425 -0.797 . . . . 0.0 110.715 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.624 HG23 ' O ' ' A' ' 225' ' ' THR . 5.1 t -42.78 109.83 0.15 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.235 -0.915 . . . . 0.0 110.159 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.51 137.63 23.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.339 -0.851 . . . . 0.0 110.139 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 11.0 ptt85 -103.1 28.85 5.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 110.238 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 228' ' ' ILE . 5.9 tp -131.13 24.99 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.915 . . . . 0.0 110.232 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.427 ' O ' ' CG ' ' A' ' 231' ' ' ASP . 4.2 m170 -88.14 2.59 51.73 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.217 -0.927 . . . . 0.0 110.149 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . 0.448 ' O ' ' HB3' ' A' ' 231' ' ' ASP . 0.0 OUTLIER -51.54 107.78 0.22 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.214 -0.929 . . . . 0.0 110.221 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.448 ' HB3' ' O ' ' A' ' 230' ' ' ARG . 3.6 p30 . . . . . 0 C--N 1.307 -1.279 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.306 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.408 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -55.4 161.56 1.87 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -1.171 . . . . 0.0 110.137 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -159.96 69.25 0.41 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.266 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.74 45.48 1.19 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.288 -0.882 . . . . 0.0 110.115 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.67 75.17 5.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.178 -0.951 . . . . 0.0 110.275 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -48.71 146.36 3.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.218 -0.926 . . . . 0.0 110.219 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.6 m -161.18 -81.8 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.304 -0.873 . . . . 0.0 110.176 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.4 m -160.32 123.73 1.95 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 0.0 110.121 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.17 -170.69 0.67 Allowed 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.921 1.485 . . . . 0.0 110.439 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.38 -163.34 1.58 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.921 . . . . 0.0 110.179 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.407 ' O ' ' OG ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -95.43 14.63 21.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.266 -0.896 . . . . 0.0 110.159 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.406 ' OE1' ' HA ' ' A' ' 17' ' ' GLN . 4.1 mm100 -72.6 141.29 48.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.209 -0.932 . . . . 0.0 110.208 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.62 177.1 0.97 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.281 -0.887 . . . . 0.0 110.269 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.02 -154.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.889 . . . . 0.0 110.258 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.507 ' O ' ' O ' ' A' ' 21' ' ' SER . 1.0 OUTLIER -76.71 -155.83 0.07 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 110.023 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.507 ' O ' ' O ' ' A' ' 20' ' ' TYR . 0.7 OUTLIER -52.05 -167.94 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.234 -0.916 . . . . 0.0 110.404 -179.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.58 40.89 0.25 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.901 . . . . 0.0 110.326 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -56.29 -57.43 12.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 110.152 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.49 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -134.27 130.59 20.25 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.352 -0.843 . . . . 0.0 110.111 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.4 110.09 2.99 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.035 1.545 . . . . 0.0 110.494 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 24' ' ' SER . 47.6 Cg_endo -74.2 164.98 32.98 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.127 1.593 . . . . 0.0 110.304 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 2.3 tt0 -175.94 37.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.883 . . . . 0.0 110.057 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.481 ' O ' ' HG2' ' A' ' 30' ' ' GLU . . . 48.41 25.89 4.68 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.647 HD11 ' HG3' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -41.83 -25.64 0.06 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.429 -1.042 . . . . 0.0 110.218 -179.676 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.705 ' HA ' HD23 ' A' ' 33' ' ' LEU . 10.6 pt-20 -48.57 -29.26 4.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.119 -0.988 . . . . 0.0 108.819 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -66.75 -23.52 66.1 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 29' ' ' LEU . 15.1 tp -83.22 -35.85 25.08 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.833 HD12 ' C ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -73.25 -38.01 66.14 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.903 0.858 . . . . 0.0 109.027 178.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.577 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 23.0 t -58.56 -22.71 56.62 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.444 0.64 . . . . 0.0 110.062 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.985 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -57.95 -173.71 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.454 -0.779 . . . . 0.0 109.555 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.985 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 42.5 Cg_endo -69.16 102.28 0.91 Allowed 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.875 1.461 . . . . 0.0 110.099 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.693 ' HD3' ' O ' ' A' ' 35' ' ' ALA . 49.1 Cg_endo -94.23 121.21 0.35 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.19 1.627 . . . . 0.0 111.215 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.904 ' O ' ' N ' ' A' ' 40' ' ' LEU . 51.6 Cg_endo -83.84 149.58 12.51 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.925 1.487 . . . . 0.0 110.524 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.634 ' C ' ' O ' ' A' ' 38' ' ' PRO . 0.6 OUTLIER 3.02 51.98 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 122.126 0.965 . . . . 0.0 111.358 -179.649 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.068 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -139.63 -48.89 0.47 Allowed 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 178.154 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.068 HG23 ' CD1' ' A' ' 40' ' ' LEU . 2.7 t -88.52 -32.76 6.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 119.327 -0.949 . . . . 0.0 108.554 177.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.46 -43.97 10.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.638 -0.664 . . . . 0.0 112.049 -178.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.738 ' OE1' ' HA ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -81.41 -19.99 41.37 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.056 -1.058 . . . . 0.0 109.972 -178.78 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.696 ' HD2' HG22 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -71.85 -51.63 21.42 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.613 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.628 ' CE1' ' O ' ' A' ' 41' ' ' VAL . 29.6 m170 -56.38 -16.35 5.54 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.638 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -95.04 -33.19 12.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.263 -0.898 . . . . 0.0 109.383 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.645 ' C ' ' CE3' ' A' ' 48' ' ' TRP . . . -83.77 -101.93 0.56 Allowed Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.157 -1.977 . . . . 0.0 108.157 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.786 ' CD2' ' N ' ' A' ' 48' ' ' TRP . 0.3 OUTLIER -86.86 73.06 10.03 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 122.963 1.363 . . . . 0.0 108.479 179.492 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 49' ' ' ASN . 0.1 OUTLIER -46.21 111.67 1.53 Allowed Pre-proline 0 C--N 1.287 -2.148 0 CA-C-N 114.218 -1.356 . . . . 0.0 112.333 -178.295 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.708 ' O ' ' N ' ' A' ' 52' ' ' ASP . 55.4 Cg_endo -91.9 2.09 4.2 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.496 2.131 . . . . 0.0 110.277 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.764 ' HA ' ' CE ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -52.34 71.29 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 122.909 1.338 . . . . 0.0 111.655 -177.783 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.708 ' N ' ' O ' ' A' ' 50' ' ' PRO . 1.6 m-20 178.03 0.16 0.0 OUTLIER 'General case' 0 C--N 1.262 -3.213 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.2 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.85 ' HB2' ' CB ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -166.01 -175.69 3.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.389 -0.819 . . . . 0.0 111.259 -178.187 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.798 ' HB2' HG21 ' A' ' 75' ' ' THR . 0.0 OUTLIER -51.78 124.5 12.63 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.955 0.883 . . . . 0.0 110.709 -179.016 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.745 ' C ' ' H ' ' A' ' 57' ' ' ILE . 1.6 pt-20 -99.67 8.41 44.37 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.591 0.71 . . . . 0.0 110.956 -179.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.732 ' C ' HD13 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -58.84 22.94 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.666 0.746 . . . . 0.0 110.199 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.745 ' H ' ' C ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -112.99 166.13 7.15 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 CA-C-O 121.679 0.752 . . . . 0.0 110.342 -179.7 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.776 ' HA ' HD23 ' A' ' 40' ' ' LEU . 10.1 t0 -134.72 96.32 3.53 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 121.868 0.842 . . . . 0.0 109.737 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.764 ' HA ' ' O ' ' A' ' 65' ' ' CYS . 1.4 m -121.7 121.33 64.11 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 CA-C-O 121.27 0.557 . . . . 0.0 110.186 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.738 ' HA ' ' OE1' ' A' ' 43' ' ' GLN . 7.9 ttmt -135.75 153.42 51.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 110.658 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.554 ' N ' ' HG2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -55.27 -123.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.431 -0.793 . . . . 0.0 110.724 -179.457 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 44.0 32.37 2.34 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.698 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 110.9 65.47 0.53 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.698 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.2 OUTLIER 0.63 90.23 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.835 -0.803 . . . . 0.0 110.832 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.764 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 1.0 OUTLIER -116.88 114.4 23.83 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.528 -0.733 . . . . 0.0 109.786 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.709 ' CE2' HG11 ' A' ' 59' ' ' VAL . 13.4 t80 -116.25 123.56 48.02 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.461 -0.774 . . . . 0.0 109.541 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -151.82 149.03 28.54 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.909 -1.119 . . . . 0.0 110.886 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.627 ' HB2' HG23 ' A' ' 57' ' ' ILE . 17.4 ttt85 -122.51 152.87 39.9 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.253 -0.904 . . . . 0.0 109.71 179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.68 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 2.7 mtt180 -85.8 -69.02 0.13 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.084 -1.01 . . . . 0.0 110.398 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.68 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 56.1 Cg_endo -71.34 -145.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.706 1.371 . . . . 0.0 109.382 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.502 ' O ' ' HG2' ' A' ' 73' ' ' GLN . 4.8 t -140.01 164.45 22.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 O-C-N 121.378 -0.826 . . . . 0.0 109.954 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.781 ' HB2' ' CE3' ' A' ' 207' ' ' TRP . . . -63.06 111.38 2.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.208 -0.932 . . . . 0.0 110.105 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.502 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 0.9 OUTLIER -140.65 -103.81 0.15 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.238 -0.914 . . . . 0.0 110.393 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.482 ' C ' ' O ' ' A' ' 73' ' ' GLN . 8.4 t -38.26 -29.95 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.166 -0.958 . . . . 0.0 110.39 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.798 HG21 ' HB2' ' A' ' 54' ' ' SER . 2.7 t -137.49 -134.69 0.14 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.254 -0.904 . . . . 0.0 110.049 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.627 ' O ' ' C ' ' A' ' 77' ' ' GLY . 2.3 t0 -140.11 154.6 47.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 109.905 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.638 ' O ' ' OG ' ' A' ' 54' ' ' SER . . . -25.01 -94.0 0.01 OUTLIER Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.65 ' CG1' HG13 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -158.24 163.13 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.098 -1.236 . . . . 0.0 109.521 179.728 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.85 ' CB ' ' HB2' ' A' ' 53' ' ' CYS . 3.1 tmm_? -141.08 134.66 30.05 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.4 -0.813 . . . . 0.0 110.776 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.891 ' C ' HG12 ' A' ' 203' ' ' VAL . . . -116.17 -152.34 9.86 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.001 -2.039 . . . . 0.0 108.001 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.845 ' C ' ' HA ' ' A' ' 202' ' ' SER . 0.0 OUTLIER 2.02 123.33 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.414 -1.05 . . . . 0.0 110.986 179.357 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.556 ' HA ' ' CB ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -126.46 -19.83 4.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.267 -0.896 . . . . 0.0 110.549 -179.444 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.552 ' HA3' ' HB3' ' A' ' 200' ' ' TYR . . . 133.53 37.73 0.23 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.544 ' HB2' ' HD3' ' A' ' 82' ' ' ARG . 7.9 t80 -134.8 95.86 3.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.06 -1.259 . . . . 0.0 110.286 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.691 ' CB ' HD11 ' A' ' 171' ' ' LEU . 0.7 OUTLIER -140.16 140.68 35.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.169 -0.957 . . . . 0.0 110.538 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.58 ' HA ' ' CB ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -131.42 145.44 51.81 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -0.902 . . . . 0.0 109.597 179.654 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.452 ' N ' ' HB3' ' A' ' 173' ' ' MET . . . 81.18 165.71 34.79 Favored Glycine 0 N--CA 1.481 1.693 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.466 ' O ' HD23 ' A' ' 88' ' ' LEU . 4.9 tt -87.23 117.86 26.27 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.34 -1.094 . . . . 0.0 110.047 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.454 ' NE2' ' O ' ' A' ' 86' ' ' ARG . 91.4 m-70 -135.39 173.28 11.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -0.882 . . . . 0.0 109.881 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.36 136.58 23.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.14 -0.975 . . . . 0.0 110.107 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 1.152 ' CZ2' HG11 ' A' ' 169' ' ' VAL . 0.5 OUTLIER -135.07 171.0 15.05 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.156 -0.965 . . . . 0.0 110.632 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 215' ' ' ARG . 2.6 mt-10 -133.41 151.19 51.79 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.745 -0.597 . . . . 0.0 110.004 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.584 HG13 ' CD1' ' A' ' 91' ' ' TRP . 11.5 mt -144.6 154.85 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.237 -0.915 . . . . 0.0 110.799 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 1.095 ' O ' HG23 ' A' ' 212' ' ' VAL . 14.5 t -141.3 151.43 43.62 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 109.642 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.764 ' CZ2' HG23 ' A' ' 106' ' ' VAL . 14.4 m95 -137.39 90.92 14.7 Favored Pre-proline 0 C--N 1.296 -1.721 0 O-C-N 121.526 -0.734 . . . . 0.0 110.565 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.535 ' HD2' ' HA ' ' A' ' 212' ' ' VAL . 49.4 Cg_endo -78.93 125.41 6.6 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.977 1.514 . . . . 0.0 110.149 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.586 ' CD2' HD13 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -95.09 -6.44 42.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.184 -0.947 . . . . 0.0 110.229 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.447 ' HG3' ' N ' ' A' ' 99' ' ' GLN . 11.6 pt-20 -43.65 -31.21 0.72 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.891 . . . . 0.0 110.449 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.473 ' O ' ' HD2' ' A' ' 100' ' ' ARG . 0.9 OUTLIER -74.67 -86.79 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.162 -0.961 . . . . 0.0 110.457 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.52 ' O ' HD11 ' A' ' 97' ' ' LEU . 45.3 mmm-85 -139.96 -53.77 0.53 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.377 -0.827 . . . . 0.0 110.244 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.658 ' O ' HG23 ' A' ' 102' ' ' THR . . . 61.26 138.39 0.01 OUTLIER Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.658 HG23 ' O ' ' A' ' 101' ' ' GLY . 0.0 OUTLIER 179.79 -45.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.242 -1.152 . . . . 0.0 110.183 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.709 ' O ' HG22 ' A' ' 105' ' ' VAL . 2.2 m80 -123.43 -91.75 0.54 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.244 -0.91 . . . . 0.0 110.157 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.768 ' HB2' ' HB ' ' A' ' 206' ' ' VAL . . . 0.64 115.59 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 121.38 0.61 . . . . 0.0 112.084 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.751 HG13 ' HA ' ' A' ' 134' ' ' ASP . 1.5 t -139.29 158.71 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.126 -0.984 . . . . 0.0 111.023 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.764 HG23 ' CZ2' ' A' ' 95' ' ' TRP . 5.5 t -132.84 148.58 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.021 -1.049 . . . . 0.0 109.253 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.664 ' HA3' ' HA2' ' A' ' 132' ' ' GLY . . . 175.62 -156.89 22.83 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 118.916 -1.611 . . . . 0.0 111.658 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.783 HG12 ' HB2' ' A' ' 199' ' ' LEU . 2.4 t -135.8 150.48 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.727 -0.866 . . . . 0.0 109.494 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.545 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -120.36 152.94 37.18 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.066 -1.021 . . . . 0.0 110.933 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.979 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -125.76 130.08 50.76 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.277 -0.889 . . . . 0.0 110.491 179.828 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.461 ' O ' ' HD2' ' A' ' 114' ' ' PRO . . . -93.39 -27.79 16.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.53 -0.731 . . . . 0.0 109.539 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.428 HD11 ' O ' ' A' ' 196' ' ' GLY . 2.0 pp -83.4 -12.1 56.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.527 -0.733 . . . . 0.0 109.558 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.819 ' HB3' ' HD3' ' A' ' 114' ' ' PRO . . . -47.12 -51.43 41.15 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.512 -0.742 . . . . 0.0 110.462 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.819 ' HD3' ' HB3' ' A' ' 113' ' ' ALA . 45.3 Cg_endo -72.91 106.84 2.22 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.858 1.452 . . . . 0.0 110.469 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.837 HD21 ' CE1' ' A' ' 120' ' ' TYR . 2.2 tp 179.82 61.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.285 -0.884 . . . . 0.0 110.241 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -105.79 -29.93 9.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.281 -0.887 . . . . 0.0 110.2 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.519 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -65.64 168.27 7.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.357 -0.84 . . . . 0.0 110.227 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.519 ' C ' ' O ' ' A' ' 117' ' ' ALA . 32.3 t70 -33.39 151.76 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.449 -0.782 . . . . 0.0 110.697 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.44 ' C ' ' O ' ' A' ' 118' ' ' ASP . 16.1 m80 -41.85 131.48 3.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.342 -0.849 . . . . 0.0 110.173 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.837 ' CE1' HD21 ' A' ' 115' ' ' LEU . 33.3 p90 -82.13 133.26 35.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.363 -0.836 . . . . 0.0 110.274 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.634 ' O ' ' HB3' ' A' ' 122' ' ' ALA . . . -130.12 103.66 6.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.183 -0.948 . . . . 0.0 110.235 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' A' ' 121' ' ' ALA . . . 64.15 16.33 9.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.252 -0.905 . . . . 0.0 110.187 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 125' ' ' GLY . 13.0 tp -103.1 -19.94 14.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.291 -0.881 . . . . 0.0 110.299 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 7.7 mt 56.89 -84.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.121 -0.987 . . . . 0.0 110.218 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 123' ' ' LEU . . . 132.33 135.62 3.7 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 38.4 p -95.61 27.81 3.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.298 -1.119 . . . . 0.0 110.206 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -129.01 178.67 6.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.924 . . . . 0.0 110.259 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.515 ' HA ' ' HG3' ' A' ' 114' ' ' PRO . 1.1 p -161.5 161.77 30.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.923 . . . . 0.0 110.148 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.748 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -137.98 123.3 19.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.194 -0.941 . . . . 0.0 109.974 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.4 t -142.29 139.52 31.9 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.279 -0.888 . . . . 0.0 110.112 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 8.4 m0 -124.62 128.51 48.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 108.929 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.664 ' HA2' ' HA3' ' A' ' 107' ' ' GLY . . . -127.05 -162.44 11.18 Favored Glycine 0 N--CA 1.484 1.846 0 C-N-CA 118.821 -1.657 . . . . 0.0 111.266 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.716 ' CZ3' ' CD1' ' A' ' 180' ' ' TYR . 6.4 m0 -126.14 118.12 24.58 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.766 -0.843 . . . . 0.0 110.723 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.751 ' HA ' HG13 ' A' ' 105' ' ' VAL . 13.5 t70 -118.68 111.57 18.69 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.599 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.698 HD12 ' N ' ' A' ' 136' ' ' GLY . 0.1 OUTLIER -79.3 4.92 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.156 -0.965 . . . . 0.0 110.315 179.41 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.698 ' N ' HD12 ' A' ' 135' ' ' ILE . . . -41.61 -25.54 0.2 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.501 ' O ' ' N ' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -79.97 4.88 15.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.982 -1.305 . . . . 0.0 110.284 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.544 ' O ' ' CG ' ' A' ' 139' ' ' LYS . . . 40.11 26.39 0.1 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.544 ' CG ' ' O ' ' A' ' 138' ' ' GLY . 12.8 mttp -166.39 -159.03 0.35 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.272 -1.134 . . . . 0.0 110.236 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.787 ' HA ' HG11 ' A' ' 162' ' ' VAL . 1.2 mp -133.87 -51.86 0.85 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.263 -0.898 . . . . 0.0 110.055 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.574 ' O ' ' CD2' ' A' ' 141' ' ' TYR . 33.1 p90 -166.18 107.66 0.72 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.315 -0.866 . . . . 0.0 110.036 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.467 ' H ' ' CD2' ' A' ' 142' ' ' HIS . 0.6 OUTLIER -90.85 38.82 0.96 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.306 -0.871 . . . . 0.0 110.298 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -101.71 -82.12 0.48 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 110.185 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.45 -172.91 3.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -0.89 . . . . 0.0 110.197 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -113.4 -162.05 0.79 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.195 -0.94 . . . . 0.0 110.202 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 113.75 149.18 10.17 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 148' ' ' GLU . 0.7 OUTLIER -96.33 22.38 7.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -1.161 . . . . 0.0 110.253 179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 147' ' ' LEU . 31.5 tp10 179.94 122.8 0.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 110.208 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -50.96 107.92 0.93 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.174 -0.954 . . . . 0.0 110.126 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 46.2 Cg_endo -73.13 -12.92 25.91 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.982 1.517 . . . . 0.0 110.358 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -86.85 -85.55 0.16 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.317 -0.864 . . . . 0.0 110.185 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.591 ' CG ' ' HD2' ' A' ' 153' ' ' PRO . 0.1 OUTLIER -115.78 -178.62 0.53 Allowed Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 0.0 110.065 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.591 ' HD2' ' CG ' ' A' ' 152' ' ' TYR . 45.2 Cg_endo -72.8 111.16 3.19 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.877 1.462 . . . . 0.0 110.476 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 153' ' ' PRO . . . -178.91 111.49 0.05 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.268 -0.895 . . . . 0.0 110.133 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 154' ' ' ALA . . . -42.75 132.28 5.01 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.46 -34.53 5.72 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.957 1.504 . . . . 0.0 110.49 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.511 ' HG2' ' CG ' ' A' ' 159' ' ' GLU . 0.1 OUTLIER -64.91 -6.79 9.15 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.235 -0.916 . . . . 0.0 110.404 -179.73 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 54.99 44.54 82.93 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.653 ' OE2' HD12 ' A' ' 182' ' ' ILE . 8.1 mt-10 -80.9 5.23 16.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.208 -1.172 . . . . 0.0 109.981 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.431 ' HB3' HD23 ' A' ' 161' ' ' LEU . 0.0 OUTLIER -59.89 -16.6 30.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.353 -0.842 . . . . 0.0 109.3 179.477 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.746 ' O ' HG23 ' A' ' 162' ' ' VAL . 0.6 OUTLIER -172.68 26.89 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.706 0.765 . . . . 0.0 109.482 179.579 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.787 HG11 ' HA ' ' A' ' 140' ' ' LEU . 2.4 t -161.23 91.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.585 -0.697 . . . . 0.0 110.141 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 1.003 HG11 ' HG ' ' A' ' 167' ' ' LEU . 1.3 t -85.81 155.9 58.5 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.339 -0.851 . . . . 0.0 109.069 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 1.002 ' HD2' HG12 ' A' ' 163' ' ' VAL . 39.2 Cg_endo -65.12 -177.54 0.63 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.557 1.293 . . . . 0.0 111.481 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.53 ' O ' ' OG ' ' A' ' 94' ' ' SER . 0.3 OUTLIER -40.49 -41.6 1.46 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.737 -0.602 . . . . 0.0 111.068 -179.086 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.846 ' C ' HD13 ' A' ' 167' ' ' LEU . 8.3 ttt-85 -146.83 155.99 42.77 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.231 -0.918 . . . . 0.0 110.767 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 1.003 ' HG ' HG11 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -157.56 158.42 35.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.459 -0.775 . . . . 0.0 110.658 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.548 ' O ' ' O ' ' A' ' 181' ' ' SER . 0.6 OUTLIER -102.99 141.15 36.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.144 -0.972 . . . . 0.0 109.673 -179.758 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 1.152 HG11 ' CZ2' ' A' ' 91' ' ' TRP . 9.3 t -119.25 139.52 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.078 -1.014 . . . . 0.0 111.107 -179.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.695 ' HB ' HD13 ' A' ' 187' ' ' LEU . 12.7 t -114.13 109.27 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.419 -0.8 . . . . 0.0 109.241 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.876 HD12 ' CD2' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -121.56 108.84 14.07 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.134 -0.979 . . . . 0.0 110.476 -179.225 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 88' ' ' LEU . 36.9 t0 -120.21 132.69 55.46 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.799 0.809 . . . . 0.0 110.018 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.58 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 7.0 tpt -94.79 -37.72 11.11 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.847 -0.533 . . . . 0.0 109.642 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 173' ' ' MET . 3.9 mt-10 -43.65 -27.19 0.29 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.522 -0.871 . . . . 0.0 108.805 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.563 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.0 OUTLIER -112.25 -26.53 8.73 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.036 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.489 ' O ' ' CG2' ' A' ' 198' ' ' THR . . . 82.49 23.49 56.29 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.995 HG22 ' CD2' ' A' ' 194' ' ' LEU . 0.1 OUTLIER -120.26 124.14 44.92 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.139 -1.213 . . . . 0.0 111.189 -179.559 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 1.078 ' O ' HD11 ' A' ' 194' ' ' LEU . 2.3 mp -135.24 152.45 51.55 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.55 -0.719 . . . . 0.0 109.568 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.97 ' C ' HD11 ' A' ' 187' ' ' LEU . . . -155.52 177.84 32.46 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.48 -1.343 . . . . 0.0 110.262 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.731 ' CE2' HG21 ' A' ' 163' ' ' VAL . 0.5 OUTLIER -118.77 125.62 50.02 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.499 -1.0 . . . . 0.0 108.836 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.548 ' O ' ' O ' ' A' ' 168' ' ' LEU . 43.5 t -144.18 140.85 29.58 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.084 -1.01 . . . . 0.0 111.135 -179.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.756 HG22 ' HB3' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -95.66 116.33 37.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.478 -0.763 . . . . 0.0 109.319 179.056 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 87.97 -35.07 3.59 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 116.1 39.6 0.87 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 54.9 m -127.28 -5.42 6.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.21 -1.17 . . . . 0.0 110.725 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.494 ' HB3' ' HB2' ' A' ' 181' ' ' SER . 0.3 OUTLIER -85.05 -46.83 10.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.99 -1.069 . . . . 0.0 110.372 -179.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.97 HD11 ' C ' ' A' ' 179' ' ' GLY . 2.4 mt -82.09 41.98 0.7 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.181 -0.95 . . . . 0.0 110.024 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -79.89 -91.17 0.44 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 191' ' ' PHE . 47.6 Cg_endo -73.56 -24.82 15.69 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.012 1.532 . . . . 0.0 110.772 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -69.07 21.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.48 -0.763 . . . . 0.0 111.7 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.66 ' CE1' HD22 ' A' ' 187' ' ' LEU . 0.3 OUTLIER -90.27 -38.0 13.71 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.788 -1.195 . . . . 0.0 110.372 179.57 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.67 -13.57 60.64 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.145 -0.972 . . . . 0.0 110.495 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -107.81 -7.69 31.12 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.791 -1.723 . . . . 0.0 108.791 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 1.078 HD11 ' O ' ' A' ' 178' ' ' LEU . 10.5 tt -78.14 -36.52 47.63 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.498 ' CA ' HG23 ' A' ' 198' ' ' THR . 1.0 OUTLIER -44.07 -44.02 7.22 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.679 -0.638 . . . . 0.0 109.933 179.126 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.428 ' O ' HD11 ' A' ' 112' ' ' LEU . . . -83.29 -26.24 44.62 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.729 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.75 -3.69 57.24 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.699 -0.883 . . . . 0.0 109.934 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.727 HG23 ' O ' ' A' ' 194' ' ' LEU . 11.2 p -42.73 135.12 3.02 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.825 0.821 . . . . 0.0 111.722 -177.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.979 ' CB ' HG23 ' A' ' 110' ' ' THR . 0.0 OUTLIER -140.15 171.0 14.8 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.68 -0.638 . . . . 0.0 109.381 179.454 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.612 ' C ' HG13 ' A' ' 108' ' ' VAL . 25.1 m-85 -84.56 129.29 57.92 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 120.997 -1.064 . . . . 0.0 110.123 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.854 ' HG3' HD12 ' A' ' 171' ' ' LEU . 52.8 Cg_endo -83.38 111.52 1.83 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.954 1.502 . . . . 0.0 110.78 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.845 ' HA ' ' C ' ' A' ' 81' ' ' LYS . 12.2 p -133.94 160.61 37.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 109.864 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.891 HG12 ' C ' ' A' ' 80' ' ' GLY . 14.4 p -122.87 157.11 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.731 -1.23 . . . . 0.0 110.924 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 105' ' ' VAL . 0.3 OUTLIER -138.57 127.2 23.41 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.496 -0.752 . . . . 0.0 109.094 178.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.466 ' HA ' ' HB1' ' A' ' 104' ' ' ALA . . . -128.15 157.85 39.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.954 -1.091 . . . . 0.0 110.481 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.805 HG13 ' N ' ' A' ' 207' ' ' TRP . 5.9 p -90.13 -137.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.193 -0.942 . . . . 0.0 110.103 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 0.805 ' N ' HG13 ' A' ' 206' ' ' VAL . 10.1 p90 -126.21 58.47 1.36 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.975 -1.078 . . . . 0.0 110.493 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 83.27 -1.54 88.54 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.498 ' HB3' HG11 ' A' ' 206' ' ' VAL . 3.0 tp60 -75.47 -33.21 60.81 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.486 -1.008 . . . . 0.0 110.257 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . 0.659 ' O ' ' C ' ' A' ' 211' ' ' GLN . 48.8 t -124.92 17.24 8.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.337 -0.852 . . . . 0.0 110.259 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.659 ' C ' ' O ' ' A' ' 210' ' ' CYS . 3.2 pt20 0.35 114.46 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.592 0.71 . . . . 0.0 111.859 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 1.095 HG23 ' O ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -118.99 145.19 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.441 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.688 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 20.1 mtm180 -88.61 151.51 22.43 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.094 -1.004 . . . . 0.0 110.144 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.752 HD12 ' HB3' ' A' ' 48' ' ' TRP . 0.8 OUTLIER -136.36 123.59 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.315 -0.865 . . . . 0.0 111.231 -179.023 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 92' ' ' GLU . 75.2 ttt180 -131.01 108.63 9.93 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . 0.69 ' CD2' ' CB ' ' A' ' 91' ' ' TRP . 3.2 t80 -118.45 148.94 42.06 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.001 -1.062 . . . . 0.0 111.454 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . 0.551 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 0.0 OUTLIER -125.25 107.78 11.07 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.522 -0.736 . . . . 0.0 109.706 179.315 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 134.85 -1.61 3.9 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.463 ' OE1' ' O ' ' A' ' 220' ' ' ARG . 9.1 tm-20 -95.28 153.58 17.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.062 -1.258 . . . . 0.0 110.116 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.463 ' O ' ' OE1' ' A' ' 219' ' ' GLU . 26.9 mmt180 -42.25 128.4 3.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.241 -0.912 . . . . 0.0 110.416 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . 0.522 ' O ' ' C ' ' A' ' 222' ' ' VAL . 36.7 ttt-85 -172.65 112.32 0.25 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 110.103 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 222' ' ' VAL . 5.2 p -33.89 105.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.441 -0.787 . . . . 0.0 110.588 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.418 ' O ' ' HB3' ' A' ' 224' ' ' GLU . 29.9 tp10 -62.99 -9.94 11.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.307 -0.871 . . . . 0.0 110.344 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.457 ' O ' ' HB ' ' A' ' 225' ' ' THR . 2.6 pt-20 179.29 -30.18 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.185 -0.947 . . . . 0.0 110.296 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' A' ' 224' ' ' GLU . 3.3 t 179.9 136.18 0.11 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.189 -0.944 . . . . 0.0 110.219 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.11 -153.4 0.07 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.277 -0.889 . . . . 0.0 110.2 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.99 -58.61 2.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -0.877 . . . . 0.0 110.258 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.51 ' O ' ' N ' ' A' ' 230' ' ' ARG . 33.1 mm -80.77 -57.74 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.219 -0.926 . . . . 0.0 110.237 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -60.73 77.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.222 -0.924 . . . . 0.0 110.137 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . 0.671 ' O ' ' C ' ' A' ' 231' ' ' ASP . 0.0 OUTLIER -49.74 159.52 0.37 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.342 -0.848 . . . . 0.0 110.262 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.671 ' C ' ' O ' ' A' ' 230' ' ' ARG . 3.3 m-20 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.952 -1.023 . . . . 0.0 111.479 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.43 164.28 12.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.192 -1.181 . . . . 0.0 110.144 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.37 32.02 4.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 0.0 110.198 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.35 132.88 44.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.881 . . . . 0.0 110.202 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.2 99.65 0.95 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.206 -0.933 . . . . 0.0 110.262 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -129.3 118.24 21.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.251 -0.906 . . . . 0.0 110.257 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.612 ' O ' HG23 ' A' ' 13' ' ' THR . 0.1 OUTLIER -78.33 116.23 18.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.314 -0.866 . . . . 0.0 110.23 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -178.06 -60.0 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.315 -0.865 . . . . 0.0 110.189 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.575 ' CD ' ' CB ' ' A' ' 13' ' ' THR . 45.6 Cg_endo -72.5 -44.03 0.84 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.051 1.553 . . . . 0.0 110.393 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 71.8 p -129.67 112.07 13.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.187 -0.946 . . . . 0.0 110.195 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.1 t -147.74 -178.77 6.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.901 . . . . 0.0 110.225 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 1.7 tp60 -77.69 -71.01 0.44 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.352 -0.842 . . . . 0.0 110.246 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 17' ' ' GLN . . . -176.51 105.52 0.07 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.176 -0.953 . . . . 0.0 110.244 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.55 -154.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.179 -0.95 . . . . 0.0 110.271 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.446 ' CG ' ' N ' ' A' ' 21' ' ' SER . 25.1 t80 -108.8 -105.53 0.35 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.301 -0.875 . . . . 0.0 110.243 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.446 ' N ' ' CG ' ' A' ' 20' ' ' TYR . 0.7 OUTLIER -117.81 153.57 33.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.061 -1.025 . . . . 0.0 110.175 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 5.4 p-10 -174.38 40.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.284 -0.885 . . . . 0.0 110.29 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -46.58 -73.1 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.271 -0.893 . . . . 0.0 110.1 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.482 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 50.6 p -103.49 105.07 45.29 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.208 -0.932 . . . . 0.0 109.943 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.03 110.06 3.01 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.031 1.543 . . . . 0.0 110.649 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 24' ' ' SER . 46.0 Cg_endo -74.1 160.19 43.1 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.992 1.522 . . . . 0.0 110.489 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.461 ' O ' ' CG ' ' A' ' 27' ' ' GLU . 0.4 OUTLIER -124.3 35.08 4.89 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.458 -0.776 . . . . 0.0 109.707 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 32' ' ' LEU . . . 63.65 22.25 65.85 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.914 HD13 ' CG ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -80.97 -54.32 5.67 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.428 -1.042 . . . . 0.0 109.852 -179.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.548 ' HG3' ' CB ' ' A' ' 73' ' ' GLN . 26.6 mt-10 -49.06 -47.83 44.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.119 -0.988 . . . . 0.0 109.304 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -61.07 -27.5 68.39 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 29' ' ' LEU . 5.9 tp -83.67 -29.36 27.68 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.975 HD13 ' CD ' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -88.09 -36.52 16.87 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.722 0.772 . . . . 0.0 109.47 179.585 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.531 ' N ' HD12 ' A' ' 33' ' ' LEU . 11.6 p -45.84 -31.17 1.97 Allowed 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.683 0.754 . . . . 0.0 109.748 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.812 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . -91.46 167.21 16.16 Favored Pre-proline 0 C--N 1.298 -1.644 0 O-C-N 121.572 -0.705 . . . . 0.0 109.354 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.555 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 43.5 Cg_endo -70.18 99.01 0.76 Allowed 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.063 1.56 . . . . 0.0 110.431 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.812 ' HD3' ' O ' ' A' ' 35' ' ' ALA . 47.5 Cg_endo -96.6 -175.45 0.28 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 121.999 1.799 . . . . 0.0 110.397 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 1.017 ' O ' ' N ' ' A' ' 40' ' ' LEU . 39.6 Cg_endo -65.54 153.31 78.79 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.041 1.548 . . . . 0.0 110.043 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.67 ' O ' ' N ' ' A' ' 43' ' ' GLN . 1.9 t0 -15.29 -34.14 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.375 0.607 . . . . 0.0 110.143 -178.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.034 HD13 ' N ' ' A' ' 41' ' ' VAL . 0.1 OUTLIER -29.4 -46.78 0.06 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.435 -0.791 . . . . 0.0 109.551 178.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.034 ' N ' HD13 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -85.05 -31.5 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 118.657 -1.217 . . . . 0.0 109.94 179.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.628 ' N ' ' O ' ' A' ' 39' ' ' ASP . . . -89.89 -43.29 10.7 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.078 -1.014 . . . . 0.0 110.784 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.746 ' HG3' ' HB2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -72.23 -21.12 61.44 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.449 -0.782 . . . . 0.0 110.653 -179.13 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.723 ' HG2' ' HA ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -76.47 -55.31 5.65 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.627 ' CE1' ' O ' ' A' ' 41' ' ' VAL . 16.8 m170 -58.89 -18.21 31.06 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -97.82 -25.33 15.08 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.718 0.77 . . . . 0.0 109.259 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.451 ' HA3' HG23 ' A' ' 59' ' ' VAL . . . -63.85 -114.57 0.01 OUTLIER Glycine 0 N--CA 1.479 1.528 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.812 ' CA ' HD13 ' A' ' 214' ' ' ILE . 0.0 OUTLIER -103.26 70.88 1.08 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.492 -1.283 . . . . 0.0 111.052 179.208 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.596 HD22 ' HD2' ' A' ' 50' ' ' PRO . 1.0 OUTLIER -109.23 116.65 54.79 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.025 -1.047 . . . . 0.0 110.152 178.37 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.903 ' HB3' HG12 ' A' ' 203' ' ' VAL . 40.7 Cg_endo -69.07 -64.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 N-CA-C 109.432 -1.026 . . . . 0.0 109.432 178.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 1.124 ' HA ' ' CE ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER 175.49 35.22 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 O-C-N 120.976 -1.077 . . . . 0.0 112.02 177.752 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.888 ' HB2' ' HA2' ' A' ' 80' ' ' GLY 0.25 2.2 m-20 -168.58 20.78 0.02 OUTLIER 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.62 -179.451 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.694 ' SG ' ' NH1' ' A' ' 44' ' ' ARG . 1.7 t -102.23 144.57 30.59 Favored 'General case' 0 C--N 1.289 -2.03 0 C-N-CA 118.866 -1.134 . . . . 0.0 111.657 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.803 ' HB3' HG22 ' A' ' 75' ' ' THR . 0.0 OUTLIER -103.0 167.43 9.84 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.624 0.726 . . . . 0.0 109.954 179.306 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.975 ' CD ' HD13 ' A' ' 33' ' ' LEU . 0.9 OUTLIER -71.35 8.26 1.09 Allowed 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.592 -0.693 . . . . 0.0 111.211 -179.306 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.61 ' ND2' ' O ' ' A' ' 54' ' ' SER . 0.4 OUTLIER -29.02 -32.29 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.923 0.868 . . . . 0.0 109.474 179.414 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.728 ' N ' ' O ' ' A' ' 55' ' ' GLU . 3.7 pt -135.29 167.21 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.797 -0.565 . . . . 0.0 110.107 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.99 ' HB2' HD23 ' A' ' 40' ' ' LEU . 3.4 t0 -109.01 113.04 25.57 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.038 -1.039 . . . . 0.0 110.61 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.752 ' HB ' ' CE2' ' A' ' 48' ' ' TRP . 1.2 m -129.78 135.8 60.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 O-C-N 121.49 -0.756 . . . . 0.0 109.086 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.746 ' HB2' ' HG3' ' A' ' 43' ' ' GLN . 9.0 tttm -128.68 155.31 45.24 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 118.826 -1.15 . . . . 0.0 112.29 -178.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.545 ' O ' ' C ' ' A' ' 62' ' ' GLY . 1.1 tt0 -71.54 -126.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.616 -0.677 . . . . 0.0 110.476 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.545 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 38.85 52.39 2.55 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 107.808 -2.117 . . . . 0.0 107.808 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.662 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 97.86 49.56 1.76 Allowed Glycine 0 N--CA 1.485 1.924 0 N-CA-C 107.113 -2.395 . . . . 0.0 107.113 -177.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.057 HD21 ' CE1' ' A' ' 66' ' ' PHE . 2.8 tt 1.54 93.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.719 0.771 . . . . 0.0 111.232 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 35.0 t -105.32 113.87 27.71 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.602 0.715 . . . . 0.0 110.364 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 1.057 ' CE1' HD21 ' A' ' 64' ' ' LEU . 3.2 m-85 -82.63 130.33 35.1 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.511 -0.743 . . . . 0.0 109.908 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.587 ' HB3' ' O ' ' A' ' 58' ' ' ASP . 2.4 tm-20 -145.75 121.3 10.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.801 -1.187 . . . . 0.0 109.94 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.545 ' CB ' ' HB2' ' A' ' 207' ' ' TRP . 0.5 OUTLIER -126.03 155.3 41.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.371 -0.831 . . . . 0.0 109.404 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.694 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.8 OUTLIER -130.1 -72.52 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 120.89 -1.131 . . . . 0.0 110.875 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.914 ' CG ' HD13 ' A' ' 29' ' ' LEU . 57.1 Cg_endo -72.98 -126.19 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.434 1.228 . . . . 0.0 109.266 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.444 ' O ' ' OE1' ' A' ' 73' ' ' GLN . 2.4 t -140.31 164.24 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.574 -1.329 . . . . 0.0 109.962 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.948 ' HB1' ' HA ' ' A' ' 76' ' ' ASP . . . -59.84 94.24 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.17 -0.956 . . . . 0.0 110.266 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.548 ' CB ' ' HG3' ' A' ' 30' ' ' GLU . 1.2 mp0 -76.08 -90.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 110.18 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.49 ' OG ' ' N ' ' A' ' 75' ' ' THR . 1.5 t -44.04 -94.64 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.144 -0.972 . . . . 0.0 109.623 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.803 HG22 ' HB3' ' A' ' 54' ' ' SER . 7.6 t -88.57 -124.37 0.05 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.148 -0.97 . . . . 0.0 109.189 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.948 ' HA ' ' HB1' ' A' ' 72' ' ' ALA . 13.2 p30 -140.55 154.63 46.59 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.836 -1.165 . . . . 0.0 110.413 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.733 ' C ' ' O ' ' A' ' 76' ' ' ASP . . . 2.95 -78.2 0.0 OUTLIER Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.721 HG23 ' HD2' ' A' ' 50' ' ' PRO . 0.1 OUTLIER -158.16 137.42 3.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.507 -0.996 . . . . 0.0 110.389 179.185 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.88 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 0.7 OUTLIER -144.33 150.68 38.2 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.401 0.62 . . . . 0.0 109.779 179.711 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.888 ' HA2' ' HB2' ' A' ' 52' ' ' ASP . . . -165.32 116.23 0.68 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 108.572 -1.811 . . . . 0.0 108.572 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.597 ' O ' ' C ' ' A' ' 82' ' ' ARG . 4.7 ttpm? -124.59 -75.08 0.6 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.113 -1.227 . . . . 0.0 111.549 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.635 ' HG2' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -25.1 -47.38 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.504 -0.747 . . . . 0.0 111.11 -178.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.635 ' N ' ' HG2' ' A' ' 82' ' ' ARG . . . 34.24 58.95 0.65 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -93.85 108.25 20.05 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.426 -1.043 . . . . 0.0 110.645 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.0 162.87 34.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.432 -0.792 . . . . 0.0 110.002 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -118.67 137.91 52.98 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.233 -0.917 . . . . 0.0 109.931 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 173' ' ' MET . . . 111.2 158.59 15.32 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.521 HD12 ' HA ' ' A' ' 172' ' ' ASP . 18.6 tp -87.6 133.27 33.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.242 -1.152 . . . . 0.0 110.19 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.493 ' ND1' ' O ' ' A' ' 88' ' ' LEU . 66.3 m-70 -147.11 173.08 12.82 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.135 -0.978 . . . . 0.0 110.064 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.553 ' O ' ' CB ' ' A' ' 217' ' ' MET . . . -154.03 139.99 18.26 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.203 -0.936 . . . . 0.0 109.64 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.559 ' HB3' ' HA ' ' A' ' 216' ' ' TYR . 0.0 OUTLIER -134.74 166.43 22.97 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.968 -1.083 . . . . 0.0 110.442 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.629 ' N ' ' O ' ' A' ' 215' ' ' ARG . 22.5 tt0 -115.16 138.63 50.69 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.545 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.535 HG22 HG23 ' A' ' 169' ' ' VAL . 0.2 OUTLIER -144.02 134.99 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 120.625 -1.297 . . . . 0.0 110.765 -179.662 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.678 ' HB3' ' HA ' ' A' ' 166' ' ' ARG . 0.9 OUTLIER -118.68 126.38 51.79 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.477 -0.764 . . . . 0.0 109.537 179.421 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.828 ' HE1' ' HE2' ' A' ' 103' ' ' HIS . 2.8 t90 -129.9 87.62 51.37 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.179 -0.95 . . . . 0.0 109.93 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 164' ' ' PRO . 51.6 Cg_endo -95.7 109.15 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 121.776 1.651 . . . . 0.0 110.742 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.97 HD21 ' C ' ' A' ' 101' ' ' GLY . 5.7 tt -96.15 -22.03 17.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.968 -1.083 . . . . 0.0 110.285 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -44.88 -30.07 0.92 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.348 -0.845 . . . . 0.0 110.686 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.499 ' O ' ' NE ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -94.99 7.06 47.28 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.094 -1.004 . . . . 0.0 110.451 -179.816 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.583 ' CB ' ' HA ' ' A' ' 210' ' ' CYS . 0.9 OUTLIER -134.94 -115.02 0.19 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.145 -0.972 . . . . 0.0 110.322 -179.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.97 ' C ' HD21 ' A' ' 97' ' ' LEU . . . -166.77 156.81 28.93 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.61 HG23 ' CA ' ' A' ' 136' ' ' GLY . 0.7 OUTLIER -38.69 139.94 0.39 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.429 -1.042 . . . . 0.0 110.366 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.828 ' HE2' ' HE1' ' A' ' 95' ' ' TRP . 0.5 OUTLIER -178.28 -146.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.072 -1.018 . . . . 0.0 111.376 179.817 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 1.083 ' HB1' ' O ' ' A' ' 204' ' ' SER . . . -38.85 168.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.797 0.808 . . . . 0.0 112.503 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.873 HG23 ' HA ' ' A' ' 134' ' ' ASP . 0.6 OUTLIER -137.93 159.6 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.665 -0.647 . . . . 0.0 111.912 -178.346 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.983 ' HA ' HG23 ' A' ' 203' ' ' VAL . 1.3 p -132.52 141.71 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.935 -1.103 . . . . 0.0 109.999 177.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.601 ' HA3' ' HA3' ' A' ' 132' ' ' GLY . . . 160.93 -149.1 17.89 Favored Glycine 0 N--CA 1.487 2.061 0 C-N-CA 119.628 -1.273 . . . . 0.0 109.959 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.123 ' CG2' HD13 ' A' ' 199' ' ' LEU . 1.6 p -148.73 161.3 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.385 -1.068 . . . . 0.0 110.157 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.512 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -133.75 152.24 51.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.129 -0.982 . . . . 0.0 110.714 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.8 HG23 ' HB3' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -105.98 128.62 53.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.846 . . . . 0.0 109.862 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.74 -27.2 17.37 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.541 -0.725 . . . . 0.0 109.71 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.692 HD12 ' HD3' ' A' ' 114' ' ' PRO . 3.8 pp -83.95 -12.1 55.87 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.512 -0.742 . . . . 0.0 109.538 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 112' ' ' LEU . . . -35.29 95.34 0.09 OUTLIER Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.72 -0.612 . . . . 0.0 110.625 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.692 ' HD3' HD12 ' A' ' 112' ' ' LEU . 50.9 Cg_endo -77.92 -96.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.077 1.567 . . . . 0.0 110.329 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 114' ' ' PRO . 3.8 tp 179.71 49.3 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.118 -0.989 . . . . 0.0 110.108 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' A' ' 118' ' ' ASP . 6.0 tt0 -64.04 -37.17 86.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.177 -0.952 . . . . 0.0 110.202 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.542 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -60.91 79.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.346 -0.846 . . . . 0.0 110.202 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.542 ' C ' ' O ' ' A' ' 117' ' ' ALA . 13.5 t70 -31.67 -63.01 0.18 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.46 -0.775 . . . . 0.0 110.743 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.469 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 0.0 OUTLIER 60.79 135.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.291 -0.88 . . . . 0.0 110.203 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -81.54 -77.99 0.2 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -0.922 . . . . 0.0 110.19 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.5 84.61 0.1 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.227 -0.92 . . . . 0.0 110.185 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.31 136.04 6.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.193 -0.942 . . . . 0.0 110.19 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.497 HD12 ' H ' ' A' ' 123' ' ' LEU . 1.3 mp -87.39 -154.45 0.25 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -0.894 . . . . 0.0 110.185 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 124' ' ' LEU . 33.3 mt -106.51 158.53 16.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 110.254 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -158.96 156.9 27.95 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.14 23.16 1.35 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.174 -1.192 . . . . 0.0 110.233 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -85.94 -138.07 0.08 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.218 -0.926 . . . . 0.0 110.145 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 57.7 m -116.7 -165.42 1.06 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.113 -0.992 . . . . 0.0 110.218 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 110' ' ' THR . 6.5 tm-20 -150.07 129.42 12.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.916 . . . . 0.0 110.051 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 6.9 t -121.14 120.71 36.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.259 -0.901 . . . . 0.0 110.203 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . 0.493 ' O ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -128.86 124.74 36.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.288 -0.883 . . . . 0.0 109.915 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.601 ' HA3' ' HA3' ' A' ' 107' ' ' GLY . . . -172.35 -160.01 20.01 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.704 ' CZ3' HD11 ' A' ' 167' ' ' LEU . 33.9 m0 -109.27 115.09 29.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.214 -1.168 . . . . 0.0 110.192 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.873 ' HA ' HG23 ' A' ' 105' ' ' VAL . 4.1 t70 -118.31 148.08 42.83 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.416 0.627 . . . . 0.0 110.536 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.554 ' CG2' HG22 ' A' ' 162' ' ' VAL . 0.3 OUTLIER -143.52 17.59 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.504 -0.748 . . . . 0.0 109.404 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.61 ' CA ' HG23 ' A' ' 102' ' ' THR . . . -115.53 -40.54 0.85 Allowed Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.451 ' O ' ' C ' ' A' ' 138' ' ' GLY . 0.0 OUTLIER -90.7 8.03 36.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.076 -1.249 . . . . 0.0 110.02 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.531 ' O ' ' O ' ' A' ' 139' ' ' LYS . . . 41.4 45.87 4.35 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.531 ' O ' ' O ' ' A' ' 138' ' ' GLY . 2.2 mmmp? -52.23 -164.24 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.506 -0.997 . . . . 0.0 110.593 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.98 64.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 110.386 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.537 ' HA ' ' CD2' ' A' ' 161' ' ' LEU . 29.6 p90 -80.2 8.3 7.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.916 . . . . 0.0 110.284 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.558 ' O ' ' CG ' ' A' ' 142' ' ' HIS . 13.9 p80 -137.88 79.16 1.73 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.93 . . . . 0.0 110.151 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -64.32 -57.45 9.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.979 . . . . 0.0 110.297 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.67 165.33 14.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 110.265 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.08 8.52 44.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.163 -0.961 . . . . 0.0 110.205 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.23 -130.72 3.11 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.504 ' O ' ' HD2' ' A' ' 150' ' ' PRO . 0.3 OUTLIER -174.0 80.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.19 -1.183 . . . . 0.0 110.145 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.501 ' O ' ' HB2' ' A' ' 149' ' ' ALA . 3.0 mt-10 -62.62 108.99 1.26 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.301 -0.874 . . . . 0.0 110.369 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 1.009 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . . . 179.91 -60.88 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.218 -0.926 . . . . 0.0 110.327 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 1.009 ' HD3' ' HB3' ' A' ' 149' ' ' ALA . 47.5 Cg_endo -73.04 -10.53 24.66 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 124.016 1.535 . . . . 0.0 110.605 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.431 ' O ' ' CD2' ' A' ' 152' ' ' TYR . 2.8 mp0 -55.03 -62.87 1.38 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.163 -0.961 . . . . 0.0 110.176 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.544 ' HB3' ' HD3' ' A' ' 153' ' ' PRO . 0.2 OUTLIER 179.84 -57.67 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 110.081 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 152' ' ' TYR . 46.8 Cg_endo -73.21 144.62 37.58 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.949 1.5 . . . . 0.0 110.199 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 155' ' ' GLY . . . -41.6 127.03 3.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.221 -0.924 . . . . 0.0 110.081 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.463 ' C ' ' O ' ' A' ' 154' ' ' ALA . . . -40.36 107.5 0.08 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' A' ' 148' ' ' GLU . 45.2 Cg_endo -71.72 -41.36 2.25 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.925 1.487 . . . . 0.0 110.47 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.493 ' HA ' ' HG3' ' A' ' 160' ' ' GLN . 1.2 tp60 -67.27 -3.55 8.25 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.282 -0.886 . . . . 0.0 110.392 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.427 ' O ' ' HB ' ' A' ' 162' ' ' VAL . . . -81.43 -55.3 3.26 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -82.61 6.52 17.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -1.163 . . . . 0.0 110.253 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.493 ' HG3' ' HA ' ' A' ' 157' ' ' GLN . 3.1 mm-40 -68.3 -17.39 64.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.897 . . . . 0.0 109.269 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.672 ' O ' HG23 ' A' ' 162' ' ' VAL . 1.0 OUTLIER -166.78 24.94 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.704 0.764 . . . . 0.0 109.363 179.454 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.801 HG12 ' O ' ' A' ' 162' ' ' VAL . 2.4 t -158.8 85.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.401 0.619 . . . . 0.0 109.825 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.869 HG21 HD21 ' A' ' 167' ' ' LEU . 0.2 OUTLIER -117.97 86.96 26.7 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.429 -0.794 . . . . 0.0 109.671 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.437 ' O ' ' HG3' ' A' ' 165' ' ' GLU . 45.4 Cg_endo -72.26 65.97 3.53 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 124.086 1.571 . . . . 0.0 110.852 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' A' ' 94' ' ' SER . 3.6 mt-10 -167.26 -85.74 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.319 -0.863 . . . . 0.0 109.854 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.678 ' HA ' ' HB3' ' A' ' 94' ' ' SER . 23.6 ttp180 -152.65 156.22 38.82 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.367 -0.833 . . . . 0.0 110.29 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.869 HD21 HG21 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -139.8 133.91 31.03 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.272 -0.892 . . . . 0.0 110.7 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.411 ' O ' ' O ' ' A' ' 181' ' ' SER . 0.4 OUTLIER -103.83 130.78 51.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.329 -0.857 . . . . 0.0 109.228 179.285 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.651 ' CG2' ' CE1' ' A' ' 180' ' ' TYR . 2.7 t -124.57 144.47 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.966 -1.084 . . . . 0.0 111.087 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.451 HG23 HD22 ' A' ' 187' ' ' LEU . 2.3 t -119.84 129.31 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.555 -0.716 . . . . 0.0 109.079 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.987 HD21 ' HE1' ' A' ' 173' ' ' MET . 12.4 tp -133.09 109.82 9.77 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.93 -1.106 . . . . 0.0 110.808 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.521 ' HA ' HD12 ' A' ' 88' ' ' LEU . 5.2 t0 -99.51 139.08 35.7 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.393 -0.817 . . . . 0.0 109.203 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.987 ' HE1' HD21 ' A' ' 171' ' ' LEU . 23.9 mmt -98.95 -44.62 6.26 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.227 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.53 ' HG2' ' N ' ' A' ' 175' ' ' GLU . 3.8 pt-20 -43.48 -24.96 0.12 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.12 -0.987 . . . . 0.0 108.565 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.53 ' N ' ' HG2' ' A' ' 174' ' ' GLU . 3.5 tp10 -115.12 -26.28 7.75 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.06 27.24 58.56 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 -178.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.647 ' HB ' HD22 ' A' ' 194' ' ' LEU . 1.4 p -113.09 139.94 48.29 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.414 -1.051 . . . . 0.0 111.313 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.904 HD21 ' O ' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -146.62 154.05 41.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.533 -0.729 . . . . 0.0 109.73 179.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.735 ' C ' HD11 ' A' ' 187' ' ' LEU . . . -141.52 163.69 26.79 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.848 ' N ' HD11 ' A' ' 187' ' ' LEU . 0.9 OUTLIER -118.63 118.31 31.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -1.146 . . . . 0.0 109.484 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.555 ' CB ' ' HB2' ' A' ' 186' ' ' TYR . 2.7 t -144.64 159.05 43.45 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.33 -0.856 . . . . 0.0 110.085 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.536 ' H ' HD13 ' A' ' 182' ' ' ILE . 0.0 OUTLIER -96.08 116.4 37.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.443 -0.785 . . . . 0.0 109.316 179.191 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 72.76 5.71 65.15 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.86 43.31 18.08 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . 0.494 ' N ' ' OG ' ' A' ' 181' ' ' SER . 95.4 m -116.18 -1.38 12.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.199 -1.177 . . . . 0.0 110.561 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.555 ' HB2' ' CB ' ' A' ' 181' ' ' SER . 0.1 OUTLIER -111.22 -25.08 9.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.153 -0.967 . . . . 0.0 110.359 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.848 HD11 ' N ' ' A' ' 180' ' ' TYR . 4.0 mp -84.46 48.29 1.49 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.252 -0.905 . . . . 0.0 110.105 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.411 ' H ' ' HD2' ' A' ' 189' ' ' PRO . . . -106.86 -73.51 0.85 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.411 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 46.3 Cg_endo -72.6 -29.31 13.29 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.979 1.515 . . . . 0.0 111.167 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.667 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -73.42 12.27 0.63 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.267 -0.896 . . . . 0.0 111.429 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.602 ' CE2' ' O ' ' A' ' 187' ' ' LEU . 0.3 OUTLIER -90.17 -10.68 43.58 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.141 -0.974 . . . . 0.0 109.802 179.132 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.74 -20.22 27.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.381 -0.824 . . . . 0.0 110.908 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.555 ' O ' ' HB3' ' A' ' 197' ' ' ARG . . . -111.15 -13.32 13.67 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.926 HD23 ' O ' ' A' ' 194' ' ' LEU . 3.7 tt -74.56 -19.99 60.12 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.459 ' CE ' ' HA ' ' A' ' 195' ' ' LYS . 0.0 OUTLIER -59.64 -32.08 70.11 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.715 -0.615 . . . . 0.0 109.53 179.119 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -106.83 -25.36 6.24 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.867 ' NH2' HD21 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -82.93 -3.3 56.88 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.855 0.836 . . . . 0.0 109.944 179.653 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.588 ' HB ' ' CG2' ' A' ' 177' ' ' THR . 0.4 OUTLIER -41.0 136.85 1.38 Allowed 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 122.096 0.951 . . . . 0.0 111.24 -178.1 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 1.123 HD13 ' CG2' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -141.85 171.31 14.23 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.372 -179.653 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.808 ' O ' HG23 ' A' ' 108' ' ' VAL . 97.1 m-85 -86.84 129.7 51.39 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.15 -0.969 . . . . 0.0 109.523 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.691 ' HG3' HD22 ' A' ' 171' ' ' LEU . 42.0 Cg_endo -68.24 121.12 8.08 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.863 1.454 . . . . 0.0 111.19 -179.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.572 ' CB ' ' HA ' ' A' ' 81' ' ' LYS . 97.0 p -133.81 142.06 47.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.342 -0.849 . . . . 0.0 110.939 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.983 HG23 ' HA ' ' A' ' 106' ' ' VAL . 1.1 p -146.4 160.51 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.391 -0.818 . . . . 0.0 109.391 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 1.083 ' O ' ' HB1' ' A' ' 104' ' ' ALA . 0.3 OUTLIER -160.35 127.19 4.3 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.415 -0.803 . . . . 0.0 109.645 179.683 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.976 ' HA ' ' CB ' ' A' ' 104' ' ' ALA . . . -114.13 162.1 16.92 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.834 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.67 HG12 ' SG ' ' A' ' 210' ' ' CYS . 1.1 t -105.69 -179.13 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.587 -0.696 . . . . 0.0 110.47 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 0.647 ' N ' HG13 ' A' ' 206' ' ' VAL . 23.0 p90 -94.14 -33.07 13.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.332 -0.855 . . . . 0.0 110.593 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.515 ' H ' HG13 ' A' ' 206' ' ' VAL . . . -44.21 171.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 211' ' ' GLN . 0.0 OUTLIER -40.58 -49.24 2.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.35 -1.088 . . . . 0.0 110.572 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . 0.67 ' SG ' HG12 ' A' ' 206' ' ' VAL . 6.9 p -36.83 93.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.461 -0.774 . . . . 0.0 110.436 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.526 ' N ' ' O ' ' A' ' 209' ' ' GLN . 2.1 pt20 -115.41 123.69 49.29 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.233 -0.917 . . . . 0.0 110.107 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.647 ' O ' ' CZ ' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -101.53 144.52 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.599 -0.688 . . . . 0.0 109.701 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.873 ' HA ' HD22 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -87.64 159.57 18.49 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.194 -0.941 . . . . 0.0 110.279 -179.078 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.894 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -138.33 124.65 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -0.944 . . . . 0.0 111.362 -178.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.629 ' O ' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -130.94 137.49 49.31 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . 0.559 ' HA ' ' HB3' ' A' ' 91' ' ' TRP . 5.5 t80 -119.35 150.64 39.82 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.792 -1.192 . . . . 0.0 111.121 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . 0.553 ' CB ' ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -131.05 107.95 9.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.354 -0.841 . . . . 0.0 110.044 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 72.47 85.18 0.22 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.517 ' HG3' ' CZ ' ' A' ' 216' ' ' TYR . 31.4 tt0 -111.74 157.81 20.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.285 -1.127 . . . . 0.0 110.14 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.498 ' HG3' ' N ' ' A' ' 221' ' ' ARG . 0.1 OUTLIER -114.21 148.94 36.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.915 . . . . 0.0 110.342 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . 0.55 ' O ' ' N ' ' A' ' 223' ' ' GLU . 1.4 mpp_? -136.23 82.84 1.97 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.335 -0.853 . . . . 0.0 110.091 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.605 HG13 ' O ' ' A' ' 222' ' ' VAL . 5.3 p -34.72 92.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.515 -0.741 . . . . 0.0 110.816 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 221' ' ' ARG . 1.5 mm-40 -78.96 -81.54 0.11 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.244 -0.91 . . . . 0.0 110.22 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 223' ' ' GLU . 0.8 OUTLIER 179.36 41.49 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.304 -0.872 . . . . 0.0 110.168 179.549 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.434 ' O ' ' CG ' ' A' ' 226' ' ' ARG . 0.0 OUTLIER -42.74 107.31 0.08 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.322 -0.861 . . . . 0.0 110.332 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.434 ' CG ' ' O ' ' A' ' 225' ' ' THR . 0.0 OUTLIER -179.97 85.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.21 -0.931 . . . . 0.0 110.21 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -165.53 -62.85 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.384 -0.822 . . . . 0.0 110.213 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 27.9 mm -104.1 85.52 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.355 -0.841 . . . . 0.0 110.292 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -110.36 168.48 9.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.328 -0.857 . . . . 0.0 110.105 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . 0.671 ' O ' ' C ' ' A' ' 231' ' ' ASP . 4.3 mtp180 -45.21 -46.07 12.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.363 -0.836 . . . . 0.0 110.236 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.671 ' C ' ' O ' ' A' ' 230' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.974 -1.012 . . . . 0.0 111.494 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.447 ' OG ' ' N ' ' A' ' 8' ' ' SER . 54.3 p -79.82 -59.65 2.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.213 -1.169 . . . . 0.0 110.204 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.447 ' N ' ' OG ' ' A' ' 7' ' ' SER . 23.9 p -77.58 55.46 1.31 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 110.235 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.81 -150.12 0.46 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.173 -0.954 . . . . 0.0 110.215 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -143.14 160.37 40.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.917 . . . . 0.0 110.163 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -103.38 76.57 1.44 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.195 -0.941 . . . . 0.0 110.221 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.75 123.06 18.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 110.211 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.689 ' O ' HG23 ' A' ' 13' ' ' THR . 14.9 t -95.35 116.08 66.0 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.21 -0.931 . . . . 0.0 110.186 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.402 ' C ' HG23 ' A' ' 15' ' ' THR . 46.7 Cg_endo -73.03 147.99 44.18 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.98 1.516 . . . . 0.0 110.47 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.402 HG23 ' C ' ' A' ' 14' ' ' PRO . 20.1 p -151.06 139.96 20.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 110.201 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.85 171.13 13.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.375 -0.828 . . . . 0.0 110.274 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -133.78 126.65 31.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.0 110.206 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.9 152.8 41.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.239 -0.913 . . . . 0.0 110.2 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.8 -159.54 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.257 -0.902 . . . . 0.0 110.197 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.79 -146.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 110.128 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.2 t -119.13 50.07 1.26 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.229 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -82.31 44.37 0.87 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.354 -0.841 . . . . 0.0 110.376 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.482 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -111.62 -66.89 1.04 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.09 -1.006 . . . . 0.0 110.126 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.02 110.06 27.72 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.464 -0.773 . . . . 0.0 110.162 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 23' ' ' PHE . 46.6 Cg_endo -72.97 174.47 11.9 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.957 1.504 . . . . 0.0 110.439 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 25' ' ' PRO . 46.6 Cg_endo -73.32 166.43 29.94 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.019 1.536 . . . . 0.0 110.362 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.7 mp0 -128.67 35.6 4.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.242 -0.911 . . . . 0.0 110.246 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.444 ' O ' ' HG2' ' A' ' 31' ' ' GLU . . . 78.21 19.1 75.21 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.943 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -49.56 -32.54 12.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.284 -1.127 . . . . 0.0 109.771 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.887 ' HA ' HD23 ' A' ' 33' ' ' LEU . 6.4 tm-20 -47.61 -35.47 9.31 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.294 -0.879 . . . . 0.0 109.356 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 28' ' ' GLY . 16.5 pt-20 -60.49 -24.99 65.73 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.277 -0.889 . . . . 0.0 108.856 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -83.35 -33.87 25.74 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.9 HD21 ' HB2' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -78.72 -36.65 43.01 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.861 0.839 . . . . 0.0 109.311 179.274 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.586 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 1.2 t -80.74 -7.39 59.35 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 121.171 0.51 . . . . 0.0 109.937 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.96 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -37.96 -65.32 0.37 Allowed Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.44 -0.787 . . . . 0.0 110.538 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.96 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 47.8 Cg_endo -73.25 143.05 34.78 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.773 1.407 . . . . 0.0 109.928 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 36' ' ' PRO . 54.0 Cg_endo -98.58 53.32 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 121.813 1.675 . . . . 0.0 112.568 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.76 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 52.5 Cg_endo -77.1 150.3 29.35 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 122.89 0.942 . . . . 0.0 109.845 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.664 ' C ' ' NE2' ' A' ' 43' ' ' GLN . 2.1 t0 -39.71 -32.56 0.15 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.056 -1.028 . . . . 0.0 108.81 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.101 HD13 ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -40.95 -45.22 2.52 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.314 0.578 . . . . 0.0 109.628 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.101 ' N ' HD13 ' A' ' 40' ' ' LEU . 10.0 t -68.01 -26.82 35.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 C-N-CA 119.523 -0.871 . . . . 0.0 110.017 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 39' ' ' ASP . . . -89.41 -43.94 10.53 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.018 -1.051 . . . . 0.0 111.703 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.665 ' O ' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -80.59 -24.77 38.93 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.24 -1.384 . . . . 0.0 108.929 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.725 ' CB ' ' O ' ' A' ' 40' ' ' LEU . 21.4 ttt-85 -64.28 -57.71 8.64 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.222 1.011 . . . . 0.0 108.739 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.74 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 54.3 m170 -53.57 -17.26 1.97 Allowed 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.703 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -95.9 -31.75 12.97 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.132 -1.427 . . . . 0.0 111.155 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.61 -60.26 0.51 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 106.845 -2.502 . . . . 0.0 106.845 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.826 ' HD1' ' CE2' ' A' ' 66' ' ' PHE 0.267 0.3 OUTLIER -98.37 71.27 2.04 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.171 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.785 ' O ' ' HB3' ' A' ' 53' ' ' CYS . 0.0 OUTLIER -61.91 168.31 3.77 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.701 -0.624 . . . . 0.0 112.104 -178.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.693 ' O ' ' O ' ' A' ' 53' ' ' CYS . 37.4 Cg_endo -61.38 -61.37 0.17 Allowed 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 121.572 1.515 . . . . 0.0 113.17 -178.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.778 ' HE2' ' OD1' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -67.67 -74.35 0.12 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.045 -1.659 . . . . 0.0 108.323 179.745 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.736 ' N ' ' HA3' ' A' ' 80' ' ' GLY . 0.9 OUTLIER -38.12 -27.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.203 -0.936 . . . . 0.0 109.529 179.15 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.785 ' HB3' ' O ' ' A' ' 49' ' ' ASN . 0.2 OUTLIER -138.48 129.99 27.6 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 118.736 -1.186 . . . . 0.0 111.951 -179.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.96 ' H ' ' HA ' ' A' ' 78' ' ' VAL . 0.9 OUTLIER -58.28 123.5 16.28 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.2 179.278 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.9 ' HB2' HD21 ' A' ' 33' ' ' LEU . 3.6 pt-20 -69.78 -24.48 63.51 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.439 -0.788 . . . . 0.0 109.693 179.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.749 ' ND2' ' HB3' ' A' ' 54' ' ' SER . 3.7 m-80 -28.96 -36.03 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.683 0.754 . . . . 0.0 110.874 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.765 HG22 ' HG2' ' A' ' 68' ' ' ARG . 2.6 pt -116.66 166.69 10.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 O-C-N 121.705 -0.622 . . . . 0.0 110.773 -178.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.521 ' OD1' ' CG ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -107.59 116.16 31.44 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 1.079 HG21 ' CD2' ' A' ' 66' ' ' PHE . 6.3 p -130.01 128.72 65.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 CA-C-O 121.409 0.623 . . . . 0.0 111.55 -178.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.698 ' HG2' ' N ' ' A' ' 61' ' ' GLU . 5.2 tttm -136.96 157.92 45.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.342 -0.849 . . . . 0.0 110.715 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.788 ' N ' ' CH2' ' A' ' 48' ' ' TRP . 19.0 tp10 -42.54 -111.65 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.678 -0.639 . . . . 0.0 111.238 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.56 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 36.67 45.78 1.05 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.669 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 93.14 55.58 1.58 Allowed Glycine 0 N--CA 1.487 2.058 0 N-CA-C 107.369 -2.292 . . . . 0.0 107.369 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.932 HD21 HG22 ' A' ' 214' ' ' ILE . 0.2 OUTLIER 1.11 92.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.792 0.806 . . . . 0.0 111.182 -178.216 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.716 ' C ' HG23 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -140.66 134.88 31.06 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.542 -179.787 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 1.079 ' CD2' HG21 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -102.18 142.79 32.87 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.142 178.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.564 ' O ' ' HB ' ' A' ' 57' ' ' ILE . 67.9 tt0 -114.38 121.32 43.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 110.174 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.765 ' HG2' HG22 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -121.23 149.8 42.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.477 -0.764 . . . . 0.0 109.966 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.678 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -127.89 -71.37 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.063 -1.023 . . . . 0.0 110.797 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.678 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 55.8 Cg_endo -73.86 -108.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.35 1.184 . . . . 0.0 110.177 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.44 HG12 ' HZ2' ' A' ' 207' ' ' TRP . 3.9 t -140.48 164.35 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.638 -1.289 . . . . 0.0 110.27 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.408 ' HA ' ' HB3' ' A' ' 56' ' ' ASN . . . -99.63 87.58 3.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -0.867 . . . . 0.0 109.931 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.551 ' HG3' ' N ' ' A' ' 74' ' ' SER . 2.5 pt20 -70.39 -44.58 67.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.258 -0.901 . . . . 0.0 110.642 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.551 ' N ' ' HG3' ' A' ' 73' ' ' GLN . 0.4 OUTLIER -55.84 -74.8 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.161 -0.962 . . . . 0.0 109.969 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.94 HG23 ' HB3' ' A' ' 54' ' ' SER . 0.3 OUTLIER -129.61 -140.37 0.23 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.308 -0.87 . . . . 0.0 109.405 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.666 ' O ' ' N ' ' A' ' 78' ' ' VAL . 22.7 p-10 -141.1 154.75 46.07 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.976 -1.077 . . . . 0.0 110.788 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.675 ' C ' HG13 ' A' ' 78' ' ' VAL . . . 34.78 -95.16 0.01 OUTLIER Glycine 0 N--CA 1.487 2.055 0 N-CA-C 106.715 -2.554 . . . . 0.0 106.715 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.96 ' HA ' ' H ' ' A' ' 54' ' ' SER . 31.0 m -158.2 119.42 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 O-C-N 121.872 -0.781 . . . . 0.0 109.823 176.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.69 ' O ' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -147.32 133.87 19.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.361 -0.837 . . . . 0.0 110.982 -179.147 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.736 ' HA3' ' N ' ' A' ' 52' ' ' ASP . . . -143.36 166.14 26.88 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 178.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.433 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 0.7 OUTLIER -140.2 75.62 1.52 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.345 -1.091 . . . . 0.0 110.078 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.571 ' CD ' ' HZ2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -145.53 -108.73 0.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.312 -0.867 . . . . 0.0 110.128 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.531 ' N ' ' CZ ' ' A' ' 82' ' ' ARG . . . 70.42 80.78 0.28 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -134.24 104.38 6.15 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.285 -1.127 . . . . 0.0 110.21 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.574 ' HB2' ' CE1' ' A' ' 89' ' ' HIS . 11.4 p -140.03 164.87 28.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.153 -0.967 . . . . 0.0 110.255 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.465 ' HA ' ' CG ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -119.75 135.93 54.65 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.295 -0.878 . . . . 0.0 109.972 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.34 -119.94 5.15 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.488 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 7.8 tp -128.33 138.1 52.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -1.147 . . . . 0.0 110.327 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.969 ' HB2' HD23 ' A' ' 171' ' ' LEU . 43.2 m-70 -147.06 164.81 31.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.273 -0.892 . . . . 0.0 109.992 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.607 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -163.13 152.95 15.55 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.191 -0.943 . . . . 0.0 110.302 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.974 ' CE3' HG11 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -134.62 170.34 15.94 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.079 -1.013 . . . . 0.0 109.891 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.659 ' N ' ' O ' ' A' ' 215' ' ' ARG . 0.6 OUTLIER -140.62 147.54 39.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.368 -0.832 . . . . 0.0 110.672 -179.505 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.861 ' HB ' HD12 ' A' ' 167' ' ' LEU . 2.2 mm -144.68 154.25 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.34 -0.85 . . . . 0.0 110.024 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 1.123 ' O ' HG23 ' A' ' 212' ' ' VAL . 0.0 OUTLIER -151.2 124.38 8.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.338 -0.851 . . . . 0.0 109.614 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 1.069 ' CB ' HD12 ' A' ' 135' ' ' ILE . 34.6 m95 -106.84 89.42 4.32 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.267 -0.896 . . . . 0.0 110.561 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.74 ' HD3' ' O ' ' A' ' 94' ' ' SER . 52.7 Cg_endo -91.92 124.37 0.76 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.496 1.464 . . . . 0.0 111.013 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.593 HD13 ' SG ' ' A' ' 210' ' ' CYS . 0.2 OUTLIER -95.45 -5.98 41.8 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.277 -0.889 . . . . 0.0 109.599 179.198 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 97' ' ' LEU . 2.7 tp10 -37.35 -45.36 0.68 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.347 -0.845 . . . . 0.0 111.963 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.532 ' C ' ' HG2' ' A' ' 100' ' ' ARG . 33.2 tt0 -125.58 -114.1 0.29 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.657 -1.277 . . . . 0.0 110.848 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.554 ' O ' ' N ' ' A' ' 211' ' ' GLN . 13.0 mmt85 -152.11 -134.3 0.05 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.27 -0.894 . . . . 0.0 110.226 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.527 ' HA3' ' HB2' ' A' ' 211' ' ' GLN . . . 95.69 173.82 36.6 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.758 ' HA ' ' HA2' ' A' ' 208' ' ' GLY . 0.2 OUTLIER -60.19 -143.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.017 -1.284 . . . . 0.0 109.907 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.685 ' HA ' HG12 ' A' ' 212' ' ' VAL . 0.2 OUTLIER -154.92 -166.08 2.21 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.768 -1.208 . . . . 0.0 111.575 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 1.026 ' HA ' ' HB2' ' A' ' 205' ' ' ALA . . . -177.1 90.64 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.63 -0.669 . . . . 0.0 110.001 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 1.032 HG23 ' HA ' ' A' ' 205' ' ' ALA . 0.6 OUTLIER -94.01 152.09 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.946 HG11 ' OH ' ' A' ' 180' ' ' TYR . 4.9 p -145.85 167.5 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 120.416 -1.428 . . . . 0.0 111.905 -178.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.687 ' CA ' ' HA3' ' A' ' 132' ' ' GLY . . . 164.57 146.63 4.83 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.075 HG22 ' HB2' ' A' ' 199' ' ' LEU . 7.8 p -94.82 155.19 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.116 -1.226 . . . . 0.0 109.691 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.702 ' C ' ' HB3' ' A' ' 199' ' ' LEU . . . -132.6 149.02 52.37 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.679 -0.809 . . . . 0.0 111.006 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 1.038 ' OG1' HD23 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -106.28 131.05 53.98 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.399 -0.813 . . . . 0.0 109.946 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -84.97 -26.4 27.17 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.444 -0.785 . . . . 0.0 109.418 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.47 -12.14 54.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.419 -0.8 . . . . 0.0 109.352 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.89 ' HB3' ' HD3' ' A' ' 114' ' ' PRO . . . -43.87 -54.06 11.66 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.378 -0.827 . . . . 0.0 110.444 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.89 ' HD3' ' HB3' ' A' ' 113' ' ' ALA . 46.3 Cg_endo -72.54 143.0 37.46 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.875 1.461 . . . . 0.0 110.599 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 114' ' ' PRO . 16.3 tp -178.83 58.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 110.136 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -49.61 -85.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 110.255 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.525 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -125.68 137.46 53.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.287 -0.883 . . . . 0.0 110.293 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.525 ' C ' ' O ' ' A' ' 117' ' ' ALA . 8.0 t70 -32.05 110.03 0.07 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.534 -0.729 . . . . 0.0 110.745 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.466 ' O ' ' O ' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -126.04 -72.02 0.67 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.889 . . . . 0.0 110.142 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.466 ' O ' ' O ' ' A' ' 119' ' ' HIS . 13.1 t80 58.03 116.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.222 -0.923 . . . . 0.0 110.254 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 124' ' ' LEU . . . -170.13 72.27 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.184 -0.948 . . . . 0.0 110.125 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 54.36 -142.99 0.76 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.251 -0.906 . . . . 0.0 110.177 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.34 50.07 1.14 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.258 -0.901 . . . . 0.0 110.237 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 121' ' ' ALA . 0.8 OUTLIER -78.8 78.78 5.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.292 -0.88 . . . . 0.0 110.129 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 105.36 146.77 14.93 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.19 21.05 7.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.187 -1.184 . . . . 0.0 110.183 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' A' ' 127' ' ' ASN . 7.9 m-20 -56.63 132.81 52.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.349 -0.844 . . . . 0.0 110.141 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.485 ' HA ' ' HG3' ' A' ' 114' ' ' PRO . 2.0 p -146.38 -156.34 0.7 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.306 -0.871 . . . . 0.0 110.179 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.517 ' O ' ' CA ' ' A' ' 109' ' ' ALA . 5.5 mt-10 -140.58 123.9 16.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.892 . . . . 0.0 110.111 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.482 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 1.9 t -121.06 121.17 37.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.474 -0.766 . . . . 0.0 110.354 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . 0.437 ' CD1' ' O ' ' A' ' 130' ' ' SER . 33.3 m0 -130.94 131.8 44.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.172 -0.955 . . . . 0.0 110.243 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.687 ' HA3' ' CA ' ' A' ' 107' ' ' GLY . . . -172.73 -152.47 8.68 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.963 ' HB3' HG11 ' A' ' 163' ' ' VAL . 43.5 m0 -112.79 113.27 25.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.161 -1.199 . . . . 0.0 111.11 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.819 ' HA ' ' CG1' ' A' ' 105' ' ' VAL . 18.9 m-20 -120.96 148.12 44.53 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.735 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 1.069 HD12 ' CB ' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -139.96 -26.82 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.049 -1.032 . . . . 0.0 110.454 179.387 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.38 -55.82 6.61 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.531 ' HG3' ' N ' ' A' ' 138' ' ' GLY . 2.1 ptt180 -79.96 -21.12 44.11 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.389 1.09 . . . . 0.0 109.412 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.531 ' N ' ' HG3' ' A' ' 137' ' ' ARG . . . -90.5 3.21 81.58 Favored Glycine 0 C--N 1.288 -2.135 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 141' ' ' TYR . 13.0 tttt -58.53 -140.24 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.379 -1.071 . . . . 0.0 110.449 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.494 ' HA ' HD12 ' A' ' 140' ' ' LEU . 3.9 tp -65.61 64.13 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.636 -0.665 . . . . 0.0 110.282 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.726 ' O ' ' N ' ' A' ' 143' ' ' GLN . 22.8 t80 -149.81 77.74 1.34 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.296 -0.878 . . . . 0.0 110.192 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.652 ' C ' ' O ' ' A' ' 141' ' ' TYR . 68.3 m-70 1.56 63.05 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.635 0.731 . . . . 0.0 111.37 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.726 ' N ' ' O ' ' A' ' 141' ' ' TYR . 0.1 OUTLIER -80.73 -69.91 0.57 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.621 -0.674 . . . . 0.0 110.299 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.9 m -44.96 154.49 0.14 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.191 -0.943 . . . . 0.0 110.28 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -80.25 -56.83 3.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.281 -0.887 . . . . 0.0 110.184 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 136.45 108.94 0.93 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.7 tp -175.07 95.01 0.07 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.198 -1.178 . . . . 0.0 110.29 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -58.22 115.87 3.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.13 -0.981 . . . . 0.0 110.257 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -117.07 70.79 5.49 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.253 -0.905 . . . . 0.0 110.165 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 151' ' ' GLN . 46.8 Cg_endo -72.85 -1.12 9.96 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.066 1.561 . . . . 0.0 110.584 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.454 ' O ' ' O ' ' A' ' 150' ' ' PRO . 2.6 mp0 -47.96 -97.2 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.892 . . . . 0.0 110.202 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.624 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 0.6 OUTLIER -98.62 -65.14 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.243 -0.911 . . . . 0.0 110.423 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.624 ' CD ' ' CB ' ' A' ' 152' ' ' TYR . 46.4 Cg_endo -72.85 155.69 53.3 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.621 1.327 . . . . 0.0 110.444 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 155' ' ' GLY . . . -66.21 149.17 50.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.151 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.504 ' O ' ' O ' ' A' ' 154' ' ' ALA . . . -58.32 -146.79 0.01 OUTLIER Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.71 -31.34 10.68 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.935 1.492 . . . . 0.0 110.411 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.8 -2.23 8.97 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.346 -0.846 . . . . 0.0 110.508 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.861 ' O ' HG23 ' A' ' 162' ' ' VAL . . . -79.31 3.89 65.26 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.59 6.58 5.64 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.25 -1.147 . . . . 0.0 110.429 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -73.89 -2.14 22.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.328 -0.858 . . . . 0.0 110.326 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.721 ' C ' HD12 ' A' ' 161' ' ' LEU . 2.5 pp -172.09 36.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.217 -0.927 . . . . 0.0 110.329 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.861 HG23 ' O ' ' A' ' 158' ' ' GLY . 70.5 t -92.29 -88.56 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.353 -0.842 . . . . 0.0 110.47 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.963 HG11 ' HB3' ' A' ' 133' ' ' TRP . 0.1 OUTLIER -91.98 -19.89 0.24 Allowed Pre-proline 0 C--N 1.29 -1.983 0 O-C-N 121.823 -0.548 . . . . 0.0 111.076 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.785 ' CD ' ' N ' ' A' ' 163' ' ' VAL . 43.4 Cg_endo -72.12 59.3 2.99 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 N-CA-C 109.574 -0.971 . . . . 0.0 109.574 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.523 ' O ' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER 179.91 -76.33 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.361 0.601 . . . . 0.0 109.454 -179.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.544 ' HB2' ' NH1' ' A' ' 166' ' ' ARG . 3.0 ttm105 -152.0 156.17 39.45 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.477 -0.765 . . . . 0.0 110.233 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 1.156 HD22 ' N ' ' A' ' 168' ' ' LEU . 0.0 OUTLIER -159.05 138.63 11.65 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.181 -0.949 . . . . 0.0 110.261 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 1.156 ' N ' HD22 ' A' ' 167' ' ' LEU . 2.9 tt -112.86 121.38 44.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 109.829 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.974 HG11 ' CE3' ' A' ' 91' ' ' TRP . 3.6 t -101.43 146.72 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.956 -1.09 . . . . 0.0 110.759 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.5 t -134.26 108.56 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.502 -0.749 . . . . 0.0 109.667 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.969 HD23 ' HB2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -118.29 121.16 39.74 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.044 -1.035 . . . . 0.0 110.006 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 173' ' ' MET . 46.1 t0 -111.44 137.29 49.42 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.278 -0.889 . . . . 0.0 109.896 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.509 ' N ' ' OD1' ' A' ' 172' ' ' ASP . 2.0 tmt? -95.23 -40.21 9.68 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.6 -0.687 . . . . 0.0 109.931 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.474 ' C ' ' O ' ' A' ' 173' ' ' MET . 0.3 OUTLIER -41.77 -27.81 0.13 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.189 -0.945 . . . . 0.0 108.858 179.209 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.645 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.6 OUTLIER -114.42 -27.32 7.6 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.202 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 83.83 23.88 51.28 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 108.559 -1.816 . . . . 0.0 108.559 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 1.033 HG22 ' CD2' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -113.17 121.71 45.32 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.311 -1.111 . . . . 0.0 111.243 -179.444 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 1.06 ' O ' HD11 ' A' ' 194' ' ' LEU . 0.2 OUTLIER -124.87 151.28 45.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.401 -0.812 . . . . 0.0 109.671 179.03 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -149.31 166.89 29.59 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.946 ' OH ' HG11 ' A' ' 106' ' ' VAL . 0.7 OUTLIER -123.58 117.86 26.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.408 -1.054 . . . . 0.0 108.439 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.563 ' O ' ' CD2' ' A' ' 167' ' ' LEU . 35.2 t -145.66 155.63 43.13 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.971 -1.081 . . . . 0.0 110.724 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.603 HG23 ' CZ3' ' A' ' 133' ' ' TRP . 0.0 OUTLIER -95.7 116.3 37.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.453 -0.779 . . . . 0.0 108.941 178.554 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 64.42 9.65 38.26 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.26 42.97 33.56 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 3.5 m -121.99 -2.43 9.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.17 -1.194 . . . . 0.0 110.705 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.607 ' CD2' ' CZ2' ' A' ' 133' ' ' TRP . 0.1 OUTLIER -101.28 -71.12 0.72 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.193 -0.942 . . . . 0.0 110.413 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.752 HD23 ' O ' ' A' ' 180' ' ' TYR . 3.9 mm? -67.0 47.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 110.258 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 186' ' ' TYR . . . -71.23 -73.4 0.8 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.416 ' C ' ' H ' ' A' ' 191' ' ' PHE . 49.7 Cg_endo -75.29 -25.48 11.39 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.922 1.486 . . . . 0.0 111.145 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.6 ' HB3' HD13 ' A' ' 187' ' ' LEU . . . -68.31 23.79 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.448 -0.783 . . . . 0.0 112.2 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.601 ' CD2' ' O ' ' A' ' 187' ' ' LEU . 2.1 m-85 -90.43 -38.68 13.12 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.66 -1.275 . . . . 0.0 110.536 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -13.61 61.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.198 -0.938 . . . . 0.0 110.162 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -106.43 -8.95 32.22 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.104 -1.999 . . . . 0.0 108.104 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 1.06 HD11 ' O ' ' A' ' 178' ' ' LEU . 8.7 tt -73.1 -42.59 62.8 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.892 -0.77 . . . . 0.0 109.071 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.521 ' HA ' HG23 ' A' ' 177' ' ' THR . 0.0 OUTLIER -45.27 -42.48 9.63 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.472 -0.767 . . . . 0.0 110.012 179.755 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.457 ' N ' ' HD2' ' A' ' 195' ' ' LYS . . . -85.06 -23.75 47.56 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.839 ' HD3' HD11 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -91.04 -4.47 56.33 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.693 -0.886 . . . . 0.0 110.082 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.787 HG23 ' O ' ' A' ' 194' ' ' LEU . 24.5 p -44.56 129.49 6.78 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 121.471 0.653 . . . . 0.0 111.742 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 1.075 ' HB2' HG22 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -140.39 171.82 13.61 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.482 -0.761 . . . . 0.0 109.849 179.49 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 1.014 ' C ' HG23 ' A' ' 108' ' ' VAL . 3.8 m-85 -83.9 129.55 58.6 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.012 -1.055 . . . . 0.0 109.963 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.638 ' HG3' HD13 ' A' ' 171' ' ' LEU . 49.6 Cg_endo -76.18 124.86 8.15 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 124.055 1.555 . . . . 0.0 111.787 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 80' ' ' GLY . 52.1 m -133.68 160.42 37.59 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.443 -0.786 . . . . 0.0 109.282 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.631 HG12 ' O ' ' A' ' 52' ' ' ASP . 1.1 t -119.42 162.41 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.835 -1.166 . . . . 0.0 110.608 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 0.645 ' O ' ' N ' ' A' ' 105' ' ' VAL . 1.6 m -160.68 138.44 9.55 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 1.032 ' HA ' HG23 ' A' ' 105' ' ' VAL . . . -144.77 129.13 17.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.753 -1.217 . . . . 0.0 111.582 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.498 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 1.0 OUTLIER -38.56 160.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-O 121.178 0.514 . . . . 0.0 110.135 178.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 0.44 ' HZ2' HG12 ' A' ' 71' ' ' VAL . 0.9 OUTLIER -50.68 -43.73 57.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.172 -0.955 . . . . 0.0 109.584 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.758 ' HA2' ' HA ' ' A' ' 102' ' ' THR . . . 170.73 134.75 1.8 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.629 ' HB3' ' CD2' ' A' ' 103' ' ' HIS . 0.2 OUTLIER -164.61 -63.28 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -1.133 . . . . 0.0 110.559 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . 0.641 ' CB ' ' CE1' ' A' ' 103' ' ' HIS . 0.5 OUTLIER -136.29 85.55 2.16 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.339 -0.851 . . . . 0.0 110.623 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.554 ' N ' ' O ' ' A' ' 100' ' ' ARG . 1.0 OUTLIER -26.59 126.54 0.06 Allowed 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 122.233 1.016 . . . . 0.0 111.608 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 1.123 HG23 ' O ' ' A' ' 94' ' ' SER . 0.7 OUTLIER -113.16 143.78 22.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.064 179.119 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.928 ' HA ' HD22 ' A' ' 64' ' ' LEU . 40.5 mtm180 -88.65 144.4 26.32 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.024 -1.048 . . . . 0.0 111.104 -178.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.932 HG22 HD21 ' A' ' 64' ' ' LEU . 4.2 tt -144.59 139.51 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.507 -0.745 . . . . 0.0 110.446 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.659 ' O ' ' N ' ' A' ' 92' ' ' GLU . 4.2 mtt180 -130.41 109.18 10.53 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 178.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . 0.715 ' CZ ' ' CD1' ' A' ' 91' ' ' TRP . 4.3 t80 -117.33 140.37 49.65 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.945 -1.097 . . . . 0.0 111.588 -178.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -136.68 114.98 11.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.818 -0.551 . . . . 0.0 109.996 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 123.38 17.98 3.14 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.521 ' HG3' ' NH1' ' A' ' 82' ' ' ARG . 4.9 tt0 -97.0 117.81 31.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.236 -1.155 . . . . 0.0 110.142 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.74 -168.48 1.99 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.253 -0.904 . . . . 0.0 110.154 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . 0.51 ' O ' ' C ' ' A' ' 222' ' ' VAL . 0.0 OUTLIER -158.45 95.06 1.31 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.339 -0.851 . . . . 0.0 110.252 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.51 ' C ' ' O ' ' A' ' 221' ' ' ARG . 2.6 p -34.55 136.89 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.454 -0.778 . . . . 0.0 110.588 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.508 ' O ' ' C ' ' A' ' 224' ' ' GLU . 0.4 OUTLIER 179.91 52.63 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.188 -0.945 . . . . 0.0 110.292 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.508 ' C ' ' O ' ' A' ' 223' ' ' GLU . 0.8 OUTLIER -33.36 -77.04 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.44 -0.787 . . . . 0.0 110.676 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.441 ' O ' ' OE2' ' A' ' 223' ' ' GLU . 7.0 t -52.46 132.15 34.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 110.158 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.484 ' HD2' ' O ' ' A' ' 226' ' ' ARG . 0.0 OUTLIER -111.12 -3.6 15.38 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.386 -0.821 . . . . 0.0 110.221 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -64.59 -30.17 71.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.269 -0.895 . . . . 0.0 110.211 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.443 ' H ' HG22 ' A' ' 228' ' ' ILE . 5.6 tt -86.08 136.48 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.182 -0.949 . . . . 0.0 110.138 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -178.95 -42.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.288 -0.883 . . . . 0.0 110.259 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . 0.671 ' O ' ' C ' ' A' ' 231' ' ' ASP . 0.2 OUTLIER -50.54 167.27 0.07 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.0 110.255 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.671 ' C ' ' O ' ' A' ' 230' ' ' ARG . 17.0 t70 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.008 -0.996 . . . . 0.0 111.489 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.01 -155.98 0.33 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -1.138 . . . . 0.0 110.264 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.7 t -166.85 43.62 0.05 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.262 -0.899 . . . . 0.0 110.278 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -130.44 -38.03 1.37 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.311 -0.868 . . . . 0.0 110.264 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.0 mtm-85 -106.66 130.23 54.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.343 -0.848 . . . . 0.0 110.185 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -159.86 -39.45 0.05 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.306 -0.872 . . . . 0.0 110.153 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.65 177.46 10.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.285 -0.884 . . . . 0.0 110.201 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.401 ' HA ' ' HD2' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -149.46 105.6 3.3 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.299 -0.876 . . . . 0.0 110.189 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 13' ' ' THR . 46.7 Cg_endo -72.98 -40.7 1.65 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.014 1.534 . . . . 0.0 110.495 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.434 ' O ' ' HB3' ' A' ' 16' ' ' SER . 0.1 OUTLIER -126.65 120.31 29.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.341 -0.849 . . . . 0.0 110.134 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.434 ' HB3' ' O ' ' A' ' 15' ' ' THR . 89.0 p -178.32 -65.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.906 . . . . 0.0 110.29 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -77.98 107.13 10.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.323 -0.861 . . . . 0.0 110.283 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.771 ' C ' HD13 ' A' ' 19' ' ' LEU . . . -62.59 -171.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 110.239 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.88 ' N ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -163.21 -171.34 2.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.354 -0.841 . . . . 0.0 110.426 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -166.32 -144.56 0.07 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.159 -0.963 . . . . 0.0 110.301 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.847 ' O ' ' N ' ' A' ' 23' ' ' PHE . 21.3 p -103.77 -145.28 0.37 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.252 -0.905 . . . . 0.0 110.313 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.646 ' C ' ' O ' ' A' ' 21' ' ' SER . 1.1 m-20 2.44 55.88 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.847 0.832 . . . . 0.0 111.114 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.847 ' N ' ' O ' ' A' ' 21' ' ' SER . 0.1 OUTLIER -38.48 -70.85 0.09 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.343 0.592 . . . . 0.0 110.219 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.83 112.71 21.41 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.475 -0.765 . . . . 0.0 110.073 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 23' ' ' PHE . 46.6 Cg_endo -72.66 172.04 16.02 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.01 1.531 . . . . 0.0 110.486 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.559 ' HG3' ' CB ' ' A' ' 30' ' ' GLU . 45.7 Cg_endo -72.51 -179.3 3.97 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.186 1.624 . . . . 0.0 110.347 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -84.28 36.42 0.58 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 110.003 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.93 12.32 60.54 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.487 ' HG ' ' N ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -81.44 -54.64 5.28 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.153 -1.204 . . . . 0.0 109.737 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.559 ' CB ' ' HG3' ' A' ' 26' ' ' PRO . 3.5 tt0 -55.02 -43.86 74.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.223 -0.923 . . . . 0.0 109.117 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -52.35 -24.46 7.64 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.489 HD22 ' HA ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -83.11 -32.23 26.83 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.838 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.03 HD12 ' C ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -85.44 -38.55 18.53 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.759 0.79 . . . . 0.0 109.313 179.211 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.629 ' N ' HD12 ' A' ' 33' ' ' LEU . 37.6 t -45.85 -25.51 0.53 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.449 0.642 . . . . 0.0 109.817 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.903 ' HB1' ' CD ' ' A' ' 36' ' ' PRO . . . -80.68 -164.54 0.05 OUTLIER Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 121.634 -0.666 . . . . 0.0 109.623 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.903 ' CD ' ' HB1' ' A' ' 35' ' ' ALA . 53.2 Cg_endo -95.95 74.61 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.679 1.586 . . . . 0.0 110.96 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.708 ' HD3' ' O ' ' A' ' 35' ' ' ALA . 44.4 Cg_endo -69.29 157.28 61.88 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.458 1.241 . . . . 0.0 110.323 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.735 ' O ' ' N ' ' A' ' 40' ' ' LEU . 50.0 Cg_endo -79.92 152.33 21.88 Favored 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 124.103 1.58 . . . . 0.0 111.716 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.719 ' O ' ' CG ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER 4.13 60.35 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 122.845 1.307 . . . . 0.0 110.792 -179.288 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.92 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -144.63 -45.3 0.24 Allowed 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.144 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.826 ' N ' HD13 ' A' ' 40' ' ' LEU . 2.1 t -86.85 -35.1 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 119.076 -1.049 . . . . 0.0 108.575 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.527 ' O ' ' CB ' ' A' ' 46' ' ' HIS . . . -88.55 -36.53 16.32 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.462 -0.774 . . . . 0.0 110.183 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.679 ' HG3' ' HB2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -76.42 -22.98 53.99 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.414 -0.804 . . . . 0.0 110.469 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.706 ' HA ' HG22 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -84.45 -47.58 10.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.233 -0.917 . . . . 0.0 109.965 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.663 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 40.6 m-70 -73.35 -16.43 61.35 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.535 -0.728 . . . . 0.0 109.424 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.527 ' CB ' ' O ' ' A' ' 42' ' ' ALA . 3.2 t60 -96.7 -31.02 12.89 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.639 0.733 . . . . 0.0 109.085 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 46' ' ' HIS . . . -61.08 -115.47 0.01 OUTLIER Glycine 0 N--CA 1.479 1.534 0 N-CA-C 108.114 -1.995 . . . . 0.0 108.114 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.888 ' CA ' HD13 ' A' ' 214' ' ' ILE . 6.4 p-90 -103.31 71.3 1.1 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.573 -1.251 . . . . 0.0 111.194 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.627 ' ND2' ' HB3' ' A' ' 53' ' ' CYS . 0.9 OUTLIER -108.93 114.57 58.24 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 120.873 -1.142 . . . . 0.0 110.183 178.397 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.618 ' HG2' ' CA ' ' A' ' 80' ' ' GLY . 39.1 Cg_endo -67.35 -63.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.767 0 N-CA-C 109.323 -1.068 . . . . 0.0 109.323 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.964 ' HA ' ' CE ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER 176.02 31.48 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.781 -1.2 . . . . 0.0 112.912 177.423 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.875 ' HB3' ' HG2' ' A' ' 79' ' ' ARG 0.256 0.2 OUTLIER -162.22 19.72 0.1 Allowed 'General case' 0 C--N 1.265 -3.087 0 CA-C-O 122.16 0.981 . . . . 0.0 109.134 -179.207 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.627 ' HB3' ' ND2' ' A' ' 49' ' ' ASN . 18.9 t -102.29 128.64 48.76 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-O 122.336 1.065 . . . . 0.0 111.203 -177.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.623 ' CB ' HD21 ' A' ' 56' ' ' ASN . 0.1 OUTLIER -91.86 166.72 12.59 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.894 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.915 ' OE2' HD13 ' A' ' 33' ' ' LEU . 1.7 pm0 -75.98 6.25 5.46 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.619 -0.675 . . . . 0.0 110.846 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.623 HD21 ' CB ' ' A' ' 54' ' ' SER . 0.1 OUTLIER -28.33 -33.37 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.182 0 CA-C-O 122.065 0.936 . . . . 0.0 109.882 179.256 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.713 ' HB ' ' HG2' ' A' ' 68' ' ' ARG . 0.4 OUTLIER -134.64 169.02 22.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.863 -0.523 . . . . 0.0 109.724 -178.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.548 ' O ' ' HB3' ' A' ' 67' ' ' GLU . 3.4 t70 -107.53 106.93 17.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.821 -1.174 . . . . 0.0 111.034 -178.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.715 HG11 ' CZ2' ' A' ' 48' ' ' TRP . 2.1 m -122.62 135.54 62.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.679 ' HB2' ' HG3' ' A' ' 43' ' ' GLN . 11.1 ttpp -127.42 155.41 43.7 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.632 -1.293 . . . . 0.0 112.09 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.584 ' HA ' HD13 ' A' ' 64' ' ' LEU . 19.0 tt0 -65.17 -128.89 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.741 -0.599 . . . . 0.0 110.397 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 41.05 47.02 4.21 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.679 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 102.76 50.59 1.08 Allowed Glycine 0 N--CA 1.486 2.017 0 N-CA-C 107.904 -2.078 . . . . 0.0 107.904 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.901 HD22 ' H ' ' A' ' 64' ' ' LEU . 2.3 mm? 1.14 81.35 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.763 0.792 . . . . 0.0 110.806 -178.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.413 ' N ' ' O ' ' A' ' 63' ' ' GLY . 6.3 t -99.29 114.96 28.08 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.686 -0.634 . . . . 0.0 109.976 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.864 ' CE1' ' CE2' ' A' ' 48' ' ' TRP . 1.9 m-85 -82.83 129.9 35.06 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.461 -0.774 . . . . 0.0 109.539 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.548 ' HB3' ' O ' ' A' ' 58' ' ' ASP . 1.2 tm-20 -137.37 121.58 18.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.868 -1.145 . . . . 0.0 110.339 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.748 ' HD3' ' HB3' ' A' ' 207' ' ' TRP . 9.2 mtp180 -115.57 154.76 28.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 0.0 109.55 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.681 ' HB3' ' HD3' ' A' ' 70' ' ' PRO . 16.5 ttt85 -95.72 -69.08 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 120.956 -1.09 . . . . 0.0 109.859 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.681 ' HD3' ' HB3' ' A' ' 69' ' ' ARG . 57.6 Cg_endo -77.48 -123.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 N-CA-C 108.713 -1.303 . . . . 0.0 108.713 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 73' ' ' GLN . 2.6 t -140.07 164.33 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.52 -1.363 . . . . 0.0 109.589 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.968 ' HB2' ' CZ3' ' A' ' 207' ' ' TRP . . . -41.66 92.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.176 -0.953 . . . . 0.0 110.314 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.552 ' N ' ' O ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -179.97 -31.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.221 -0.924 . . . . 0.0 110.294 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.463 ' C ' ' O ' ' A' ' 73' ' ' GLN . 10.4 p -40.12 -50.61 2.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.343 -0.848 . . . . 0.0 110.228 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.607 HG22 ' N ' ' A' ' 76' ' ' ASP . 7.5 m -169.03 -84.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.269 -0.894 . . . . 0.0 110.031 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.623 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 66.2 t0 -140.13 113.19 8.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.221 -0.924 . . . . 0.0 110.36 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.533 ' O ' ' O ' ' A' ' 76' ' ' ASP . . . -42.59 -91.41 0.01 OUTLIER Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.046 -2.022 . . . . 0.0 108.046 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.964 HG13 ' O ' ' A' ' 205' ' ' ALA . 0.3 OUTLIER -144.15 139.39 24.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.123 -1.222 . . . . 0.0 109.88 179.302 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.875 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 29.3 ttp180 -145.65 148.08 32.69 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.844 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.709 ' CA ' ' HB2' ' A' ' 52' ' ' ASP . . . -136.99 124.6 3.15 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.511 ' HB3' ' OD1' ' A' ' 52' ' ' ASP . 6.1 ttpm? -134.26 -71.38 0.5 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.855 -1.379 . . . . 0.0 111.74 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.559 ' CZ ' ' NZ ' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -58.32 -93.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.19 -0.944 . . . . 0.0 110.799 -178.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.427 ' HA2' ' HG3' ' A' ' 51' ' ' LYS . . . 51.13 70.04 0.97 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.679 -1.769 . . . . 0.0 108.679 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.575 ' C ' ' CD1' ' A' ' 84' ' ' TYR . 1.0 OUTLIER -94.57 142.16 27.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.341 -1.094 . . . . 0.0 110.495 -179.308 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.58 ' HB3' ' CE1' ' A' ' 89' ' ' HIS . 1.4 m -135.87 174.34 10.73 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.548 -0.72 . . . . 0.0 109.886 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.579 ' O ' ' CE1' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -126.62 138.51 53.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.18 -0.95 . . . . 0.0 110.7 -179.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.486 ' N ' ' HB3' ' A' ' 173' ' ' MET . . . 92.15 -119.46 5.8 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.743 HD12 ' OD2' ' A' ' 172' ' ' ASP . 4.5 tt -128.74 139.63 52.11 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.676 -0.896 . . . . 0.0 110.123 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.58 ' CE1' ' HB3' ' A' ' 85' ' ' SER . 18.3 m-70 -147.23 162.38 39.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.162 -0.961 . . . . 0.0 110.186 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 217' ' ' MET . . . -160.65 138.66 9.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.219 -0.926 . . . . 0.0 109.949 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 1.098 ' CZ2' HG11 ' A' ' 169' ' ' VAL . 1.3 p90 -134.89 170.75 15.39 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.242 -0.911 . . . . 0.0 110.36 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.608 ' N ' ' O ' ' A' ' 215' ' ' ARG . 38.1 mt-10 -141.82 152.58 43.82 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.637 -0.664 . . . . 0.0 110.497 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.755 HG23 ' O ' ' A' ' 213' ' ' ARG . 10.1 mt -144.48 154.2 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.902 . . . . 0.0 110.57 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.564 ' OG ' ' HB2' ' A' ' 213' ' ' ARG . 1.2 m -119.35 133.5 55.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.354 -0.841 . . . . 0.0 109.469 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.936 ' CH2' HG13 ' A' ' 105' ' ' VAL 0.261 2.3 t-105 -136.52 88.12 20.46 Favored Pre-proline 0 C--N 1.297 -1.697 0 O-C-N 121.441 -0.787 . . . . 0.0 110.332 -178.759 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.564 ' HD2' ' O ' ' A' ' 211' ' ' GLN . 51.7 Cg_endo -91.99 107.02 0.24 Allowed 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.095 1.05 . . . . 0.0 110.682 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.648 HD22 ' HG3' ' A' ' 98' ' ' GLU . 5.6 tt -97.84 -68.2 0.81 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.09 -1.006 . . . . 0.0 109.934 178.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.648 ' HG3' HD22 ' A' ' 97' ' ' LEU . 12.9 mt-10 -99.02 -45.43 5.94 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.508 -0.745 . . . . 0.0 110.261 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.504 ' HG2' ' CG ' ' A' ' 100' ' ' ARG . 64.9 tt0 -152.74 -99.31 0.05 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.31 -0.869 . . . . 0.0 110.491 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.554 ' C ' ' HB2' ' A' ' 165' ' ' GLU . 1.4 mmt180 -113.36 -140.75 0.38 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.08 -1.012 . . . . 0.0 110.656 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.734 ' O ' ' HB3' ' A' ' 165' ' ' GLU . . . 103.42 -141.34 15.2 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.619 HG22 ' C ' ' A' ' 101' ' ' GLY . 0.0 OUTLIER 178.47 109.62 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.165 -1.197 . . . . 0.0 110.153 179.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.72 ' N ' ' HA ' ' A' ' 164' ' ' PRO . 0.2 OUTLIER 179.67 -176.22 0.3 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.677 -1.264 . . . . 0.0 112.222 -179.818 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.707 ' N ' HD11 ' A' ' 135' ' ' ILE . . . 179.81 -178.32 0.4 Allowed 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 1.079 HG22 ' O ' ' A' ' 204' ' ' SER . 0.9 OUTLIER -94.56 115.16 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 116.675 -2.01 . . . . 0.0 107.763 178.487 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 1.102 ' CG2' HG23 ' A' ' 203' ' ' VAL . 34.3 t -148.76 169.15 2.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.156 -0.965 . . . . 0.0 110.267 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.709 ' HA2' ' HA3' ' A' ' 132' ' ' GLY . . . -175.35 131.41 1.93 Allowed Glycine 0 N--CA 1.483 1.797 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.136 ' CG1' HD13 ' A' ' 199' ' ' LEU . 0.3 OUTLIER -102.41 143.41 14.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.618 -0.93 . . . . 0.0 109.628 -179.569 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.534 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -109.79 129.76 55.59 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.128 -0.982 . . . . 0.0 110.704 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.913 HG23 ' CG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -110.55 131.74 54.79 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.309 -0.869 . . . . 0.0 110.065 179.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -91.25 -27.13 18.64 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.502 0.668 . . . . 0.0 109.238 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.426 ' CD2' ' O ' ' A' ' 196' ' ' GLY . 1.8 pp -82.15 -12.59 58.08 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.505 -0.747 . . . . 0.0 109.492 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.631 ' HB2' ' HB ' ' A' ' 110' ' ' THR . . . -52.26 143.86 24.29 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.404 -0.81 . . . . 0.0 110.091 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' A' ' 115' ' ' LEU . 46.2 Cg_endo -72.5 165.04 33.83 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.922 1.485 . . . . 0.0 110.411 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.783 HD12 ' O ' ' A' ' 128' ' ' SER . 1.2 tt -179.97 62.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 0.0 110.249 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -85.08 -39.19 18.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.163 -0.96 . . . . 0.0 110.208 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.524 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -131.15 74.84 1.62 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.317 -0.864 . . . . 0.0 110.161 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.524 ' C ' ' O ' ' A' ' 117' ' ' ALA . 12.1 t70 -31.55 146.08 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.413 -0.805 . . . . 0.0 110.771 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -98.32 -44.69 6.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.145 -0.972 . . . . 0.0 110.213 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.453 ' O ' ' OD2' ' A' ' 118' ' ' ASP . 0.3 OUTLIER -128.02 178.08 6.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.251 -0.906 . . . . 0.0 110.152 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 120' ' ' TYR . . . -42.87 130.98 4.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -0.934 . . . . 0.0 110.132 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.13 -167.16 0.83 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.912 . . . . 0.0 110.304 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.453 ' HA ' HD12 ' A' ' 123' ' ' LEU . 1.4 tp -114.27 -170.87 1.81 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.939 . . . . 0.0 110.202 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -50.63 -26.53 5.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.299 -0.876 . . . . 0.0 110.144 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -105.52 132.15 10.98 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 13.5 m -100.0 26.15 6.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.213 -1.169 . . . . 0.0 110.247 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.408 ' O ' ' HB3' ' A' ' 128' ' ' SER . 0.9 OUTLIER -146.06 52.69 1.14 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 110.305 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.783 ' O ' HD12 ' A' ' 115' ' ' LEU . 17.1 p -179.64 -171.32 0.18 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 110.345 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.492 ' HB3' ' CB ' ' A' ' 113' ' ' ALA . 21.6 tt0 -150.11 131.08 14.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.225 -0.922 . . . . 0.0 109.874 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 11.4 t -120.41 119.6 33.54 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.195 -0.941 . . . . 0.0 110.503 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -133.47 141.99 48.06 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.471 -0.768 . . . . 0.0 109.192 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.709 ' HA3' ' HA2' ' A' ' 107' ' ' GLY . . . -173.27 -138.92 2.74 Favored Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.336 -1.411 . . . . 0.0 110.652 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.825 ' CH2' HG23 ' A' ' 182' ' ' ILE . 45.9 m0 -113.11 118.18 34.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.392 -1.063 . . . . 0.0 110.611 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.734 ' O ' HG23 ' A' ' 135' ' ' ILE . 4.2 p30 -118.06 126.5 52.41 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.359 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.734 HG23 ' O ' ' A' ' 134' ' ' ASP . 7.3 pt -160.34 37.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.338 -0.851 . . . . 0.0 110.055 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.46 -58.36 8.72 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.503 ' HB3' ' HG2' ' A' ' 139' ' ' LYS . 3.5 mpt_? -86.46 5.63 34.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.108 -1.23 . . . . 0.0 110.403 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 137' ' ' ARG . . . 38.86 28.74 0.07 OUTLIER Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.686 ' O ' HD13 ' A' ' 161' ' ' LEU . 0.4 OUTLIER -65.45 -162.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.124 -1.221 . . . . 0.0 110.363 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.663 ' O ' ' C ' ' A' ' 141' ' ' TYR . 1.5 pp -160.31 100.89 1.37 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.331 -0.856 . . . . 0.0 110.192 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.663 ' C ' ' O ' ' A' ' 140' ' ' LEU . 1.8 m-85 0.17 75.95 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.694 -0.629 . . . . 0.0 111.308 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.521 ' N ' ' O ' ' A' ' 140' ' ' LEU . 6.3 m170 -55.49 -36.85 67.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.295 -0.878 . . . . 0.0 110.283 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.3 -44.95 96.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.896 . . . . 0.0 110.287 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.404 ' HB3' ' HB3' ' A' ' 141' ' ' TYR . 10.0 p -57.32 -168.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 0.0 110.26 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.6 mmtt -114.68 -55.23 2.51 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.277 -0.889 . . . . 0.0 110.195 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 121.08 170.25 13.98 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -172.24 39.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.198 -1.178 . . . . 0.0 110.336 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 149' ' ' ALA . 16.1 pt-20 -45.87 157.87 0.1 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.282 -0.886 . . . . 0.0 110.231 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.483 ' HB2' ' O ' ' A' ' 148' ' ' GLU . . . -179.99 102.74 0.17 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.181 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.66 53.01 2.62 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.994 1.523 . . . . 0.0 110.406 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.49 -50.24 7.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.916 . . . . 0.0 110.32 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.541 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 0.1 OUTLIER -177.37 -58.77 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.32 -0.862 . . . . 0.0 110.249 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.541 ' CD ' ' CB ' ' A' ' 152' ' ' TYR . 46.1 Cg_endo -72.58 171.08 17.9 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.043 1.549 . . . . 0.0 110.422 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 153' ' ' PRO . . . -40.65 144.23 0.27 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 0.0 110.425 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -179.08 -83.9 0.06 OUTLIER Glycine 0 N--CA 1.481 1.641 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.43 -2.59 12.34 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.065 1.56 . . . . 0.0 110.489 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 158' ' ' GLY . 1.9 mp0 -64.63 -6.75 8.35 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.259 -0.901 . . . . 0.0 110.496 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 157' ' ' GLN . . . 42.18 28.88 0.56 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.893 ' OE2' HG21 ' A' ' 163' ' ' VAL . 22.6 tt0 -79.36 6.43 10.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.237 -1.155 . . . . 0.0 110.184 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.629 ' O ' HD12 ' A' ' 161' ' ' LEU . 0.5 OUTLIER -59.48 -15.92 20.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.344 -0.848 . . . . 0.0 109.516 179.601 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.686 HD13 ' O ' ' A' ' 139' ' ' LYS . 0.2 OUTLIER -174.98 27.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.585 0.707 . . . . 0.0 109.791 179.487 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.812 HG12 ' O ' ' A' ' 162' ' ' VAL . 2.5 t -157.14 81.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-O 121.686 0.755 . . . . 0.0 109.717 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.893 HG21 ' OE2' ' A' ' 159' ' ' GLU . 4.0 p -150.17 41.83 0.23 Allowed Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 121.407 -0.808 . . . . 0.0 110.376 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.868 ' HD3' ' N ' ' A' ' 163' ' ' VAL . 55.2 Cg_endo -93.78 152.08 2.28 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.609 1.32 . . . . 0.0 111.22 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.734 ' HB3' ' O ' ' A' ' 101' ' ' GLY . 5.7 tp10 178.83 -70.33 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.412 -0.805 . . . . 0.0 109.663 178.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.472 ' O ' ' HB ' ' A' ' 102' ' ' THR . 3.0 ttp180 -147.88 141.47 25.49 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.579 -0.7 . . . . 0.0 109.378 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.874 ' O ' HD12 ' A' ' 167' ' ' LEU . 0.5 OUTLIER -162.52 157.14 21.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.128 -0.982 . . . . 0.0 110.455 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.772 ' C ' HD23 ' A' ' 168' ' ' LEU . 6.5 tt -120.68 134.8 55.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.332 -0.855 . . . . 0.0 110.15 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 1.098 HG11 ' CZ2' ' A' ' 91' ' ' TRP . 94.1 t -109.97 128.62 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.272 -0.893 . . . . 0.0 110.412 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 4.7 t -103.75 110.47 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.343 -0.848 . . . . 0.0 109.815 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.754 HD13 HD22 ' A' ' 178' ' ' LEU . 13.7 tp -121.5 106.06 11.05 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.18 -0.95 . . . . 0.0 109.983 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.743 ' OD2' HD12 ' A' ' 88' ' ' LEU . 5.5 t70 -111.43 136.8 50.06 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.283 -0.885 . . . . 0.0 110.477 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.538 ' CE ' ' CE2' ' A' ' 84' ' ' TYR . 12.5 tpp -92.3 -40.07 11.14 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 120.412 -0.515 . . . . 0.0 109.702 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 173' ' ' MET . 15.2 tt0 -41.95 -28.89 0.19 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.279 -0.888 . . . . 0.0 108.91 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.512 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.0 OUTLIER -109.4 -25.83 10.32 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.443 ' O ' ' OG1' ' A' ' 198' ' ' THR . . . 78.96 24.63 61.48 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 -179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.881 ' HB ' HD22 ' A' ' 194' ' ' LEU . 1.1 p -125.38 148.74 48.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.206 -1.173 . . . . 0.0 111.112 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 1.002 HD13 ' HG3' ' A' ' 201' ' ' PRO . 0.4 OUTLIER -148.1 154.33 40.06 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.525 -0.734 . . . . 0.0 109.952 179.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -149.25 164.68 29.34 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.745 ' CD1' HG22 ' A' ' 169' ' ' VAL . 0.4 OUTLIER -118.86 121.88 41.03 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.14 -1.212 . . . . 0.0 109.859 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.695 ' HB2' HD22 ' A' ' 187' ' ' LEU . 11.4 t -113.01 124.5 52.78 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.371 -0.83 . . . . 0.0 110.078 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.825 HG23 ' CH2' ' A' ' 133' ' ' TRP . 0.0 OUTLIER -104.21 116.82 48.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.594 -0.691 . . . . 0.0 109.715 179.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 72.93 4.59 62.84 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.174 -1.571 . . . . 0.0 109.174 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 68.65 47.49 55.97 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . 0.576 HG22 ' CE1' ' A' ' 186' ' ' TYR . 46.3 m -137.07 -27.09 1.0 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.206 -1.173 . . . . 0.0 110.802 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.576 ' CE1' HG22 ' A' ' 185' ' ' THR . 21.8 m-85 -116.8 76.55 1.04 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.949 -1.095 . . . . 0.0 110.676 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.695 HD22 ' HB2' ' A' ' 181' ' ' SER . 0.6 OUTLIER 179.7 29.41 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 121.529 0.68 . . . . 0.0 109.196 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.638 ' H ' ' HD2' ' A' ' 189' ' ' PRO . . . -105.48 -62.01 0.63 Allowed Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.915 -1.136 . . . . 0.0 111.447 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.638 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 43.5 Cg_endo -70.24 -31.6 18.12 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.685 1.361 . . . . 0.0 111.791 -178.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.621 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -71.83 9.2 0.95 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.077 -1.014 . . . . 0.0 111.367 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.568 ' CE1' ' HG ' ' A' ' 187' ' ' LEU . 1.4 m-85 -90.53 -10.78 42.28 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.278 -0.889 . . . . 0.0 110.161 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.474 ' HA ' ' NE ' ' A' ' 192' ' ' ARG . 0.2 OUTLIER -90.12 -15.21 32.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.353 -0.842 . . . . 0.0 110.191 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 197' ' ' ARG . . . -112.07 -17.01 8.62 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.018 -2.033 . . . . 0.0 108.018 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.963 HD23 ' O ' ' A' ' 194' ' ' LEU . 3.8 tt -65.52 -26.31 67.84 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.831 -0.805 . . . . 0.0 109.134 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.582 ' HA ' HG21 ' A' ' 177' ' ' THR . 0.0 OUTLIER -54.51 -26.25 30.51 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.599 -0.688 . . . . 0.0 109.773 179.242 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.426 ' O ' ' CD2' ' A' ' 112' ' ' LEU . . . -118.87 -17.62 5.0 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.762 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.32 -3.96 57.43 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.459 -1.024 . . . . 0.0 110.322 -179.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.812 ' HB ' HG22 ' A' ' 177' ' ' THR . 0.5 OUTLIER -42.1 132.3 3.28 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 122.325 1.059 . . . . 0.0 112.052 -178.094 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 1.136 HD13 ' CG1' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -142.61 171.32 14.21 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.431 178.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.621 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 2.6 m-85 -84.89 128.43 60.6 Favored Pre-proline 0 N--CA 1.498 1.947 0 O-C-N 120.814 -1.179 . . . . 0.0 109.817 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 1.002 ' HG3' HD13 ' A' ' 178' ' ' LEU . 55.7 Cg_endo -87.43 142.33 6.04 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 124.022 1.538 . . . . 0.0 112.4 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 43.1 m -133.91 134.92 43.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.677 -0.639 . . . . 0.0 109.5 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 1.102 HG23 ' CG2' ' A' ' 106' ' ' VAL . 4.0 p -119.5 161.31 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.811 -1.181 . . . . 0.0 110.335 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 1.079 ' O ' HG22 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -160.51 161.48 32.77 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.971 0.891 . . . . 0.0 110.822 179.687 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.964 ' O ' HG13 ' A' ' 78' ' ' VAL . . . -150.65 165.92 31.93 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 121.956 0.884 . . . . 0.0 110.868 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 1.116 HG22 ' CE3' ' A' ' 207' ' ' TRP . 0.3 OUTLIER -98.79 -152.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.037 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 1.116 ' CE3' HG22 ' A' ' 206' ' ' VAL . 48.7 p90 -91.07 -140.66 0.17 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.123 -0.986 . . . . 0.0 110.415 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.526 ' O ' ' NE2' ' A' ' 211' ' ' GLN . . . -65.91 0.29 6.06 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.792 ' HB3' HG11 ' A' ' 206' ' ' VAL . 0.0 OUTLIER -66.09 -28.26 68.69 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.287 -1.125 . . . . 0.0 110.407 -179.818 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . 0.904 ' SG ' HG12 ' A' ' 206' ' ' VAL . 22.9 p -145.52 14.9 1.43 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 110.853 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.671 ' C ' ' O ' ' A' ' 210' ' ' CYS . 0.0 OUTLIER -6.04 117.74 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.655 0.741 . . . . 0.0 111.466 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.67 HG13 ' CZ ' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -121.88 144.77 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.76 -0.588 . . . . 0.0 109.985 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.755 ' O ' HG23 ' A' ' 93' ' ' ILE . 0.8 OUTLIER -88.07 171.8 10.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.217 -0.927 . . . . 0.0 110.229 -179.482 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.888 HD13 ' CA ' ' A' ' 48' ' ' TRP . 0.7 OUTLIER -143.36 118.53 4.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-O 122.013 0.911 . . . . 0.0 111.805 -178.346 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.608 ' O ' ' N ' ' A' ' 92' ' ' GLU . 66.4 mtt-85 -130.62 108.91 10.26 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . 0.651 ' CE2' ' HB3' ' A' ' 91' ' ' TRP . 3.2 t80 -105.82 149.3 26.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.094 -1.004 . . . . 0.0 111.094 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . 0.465 ' O ' ' O ' ' A' ' 90' ' ' ALA . 1.0 OUTLIER -131.5 121.05 23.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.48 -0.762 . . . . 0.0 110.154 179.745 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 132.58 -32.82 2.74 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.472 ' O ' ' HG2' ' A' ' 220' ' ' ARG . 0.9 OUTLIER -95.57 136.36 36.06 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.236 -1.155 . . . . 0.0 110.226 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.69 ' O ' ' C ' ' A' ' 221' ' ' ARG . 18.9 mtm180 -150.41 120.26 7.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 0.0 110.271 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . 0.69 ' C ' ' O ' ' A' ' 220' ' ' ARG . 3.9 mtp180 0.03 78.48 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.431 0.634 . . . . 0.0 111.265 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.49 ' C ' ' O ' ' A' ' 221' ' ' ARG . 2.6 p -35.68 156.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.649 -0.657 . . . . 0.0 110.532 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.518 ' O ' ' C ' ' A' ' 224' ' ' GLU . 11.4 tt0 179.94 70.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.198 -0.939 . . . . 0.0 110.287 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.518 ' C ' ' O ' ' A' ' 223' ' ' GLU . 4.6 mt-10 -33.17 -37.11 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.483 -0.761 . . . . 0.0 110.728 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 223' ' ' GLU . 86.1 m -41.81 112.17 0.3 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.332 -0.855 . . . . 0.0 110.209 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 225' ' ' THR . 13.7 mmm180 -141.7 19.87 2.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 110.272 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.99 -31.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.217 -0.927 . . . . 0.0 110.306 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.455 HG22 ' H ' ' A' ' 229' ' ' HIS . 2.8 mt -95.8 -132.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.32 -0.863 . . . . 0.0 110.016 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.479 ' O ' ' HB2' ' A' ' 230' ' ' ARG . 1.0 OUTLIER -170.34 -146.66 0.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.11 -0.994 . . . . 0.0 110.284 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . 0.682 ' O ' ' C ' ' A' ' 231' ' ' ASP . 1.4 tpt180 -179.57 142.05 0.17 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.392 -0.818 . . . . 0.0 110.056 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.682 ' C ' ' O ' ' A' ' 230' ' ' ARG . 1.2 m-20 . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 117.989 -1.005 . . . . 0.0 111.422 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 8' ' ' SER . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.6 p -59.47 87.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.201 -1.176 . . . . 0.0 110.228 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 6' ' ' GLY . 34.3 t -171.13 143.18 1.89 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.204 -0.935 . . . . 0.0 110.163 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.401 ' O ' ' O ' ' A' ' 10' ' ' ARG . . . -100.09 147.83 25.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.101 -0.999 . . . . 0.0 110.239 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.401 ' O ' ' O ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -46.72 170.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.893 . . . . 0.0 110.243 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.56 131.92 47.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.174 -0.954 . . . . 0.0 110.199 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.4 m -124.87 14.83 8.6 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.905 . . . . 0.0 110.212 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.419 ' HB ' ' HD2' ' A' ' 14' ' ' PRO . 6.3 p -80.39 165.39 46.67 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.336 -0.853 . . . . 0.0 110.131 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.419 ' HD2' ' HB ' ' A' ' 13' ' ' THR . 46.1 Cg_endo -73.15 86.7 1.1 Allowed 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.047 1.551 . . . . 0.0 110.434 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.67 -169.79 0.93 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.264 -0.897 . . . . 0.0 110.278 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.5 p -162.81 -149.47 0.15 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.912 . . . . 0.0 110.192 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.97 4.47 25.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 110.161 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.26 139.02 55.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.136 -0.977 . . . . 0.0 110.266 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.08 -164.43 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.357 -0.84 . . . . 0.0 110.235 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -122.51 -158.23 0.77 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 0.0 110.207 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 52.6 p -148.02 131.12 16.34 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.219 -0.926 . . . . 0.0 110.166 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.41 79.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.203 -0.936 . . . . 0.0 110.259 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.463 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -96.7 -71.36 0.68 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.235 -0.915 . . . . 0.0 110.174 179.926 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.47 105.29 24.8 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.3 -0.875 . . . . 0.0 110.1 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 23' ' ' PHE . 47.0 Cg_endo -73.35 168.65 24.22 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.936 1.493 . . . . 0.0 110.444 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.496 ' HB3' ' HB3' ' A' ' 74' ' ' SER . 45.7 Cg_endo -72.94 165.23 33.36 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.035 1.545 . . . . 0.0 110.364 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.97 37.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.202 -0.936 . . . . 0.0 110.324 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.05 23.19 31.05 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.935 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -51.89 -32.98 34.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.434 -1.039 . . . . 0.0 110.08 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.855 ' HA ' HD23 ' A' ' 33' ' ' LEU . 24.8 pt-20 -47.06 -35.12 6.51 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.304 -0.872 . . . . 0.0 109.579 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.49 ' N ' ' HG3' ' A' ' 30' ' ' GLU . 1.1 tm-20 -63.91 -23.51 67.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.446 -0.784 . . . . 0.0 108.992 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.647 HD13 ' O ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -83.29 -33.88 25.86 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.855 HD23 ' HA ' ' A' ' 30' ' ' GLU . 0.3 OUTLIER -73.55 -35.98 65.59 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 122.058 0.933 . . . . 0.0 108.917 179.293 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.649 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 23.5 t -71.24 -12.57 61.53 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.605 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 1.01 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -45.31 -64.97 0.72 Allowed Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.19 -0.944 . . . . 0.0 110.268 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 1.01 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 50.0 Cg_endo -72.8 147.8 45.15 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.75 1.395 . . . . 0.0 110.15 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.494 ' N ' ' CD ' ' A' ' 38' ' ' PRO . 54.7 Cg_endo -99.3 42.84 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.001 1.801 . . . . 0.0 112.912 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.76 ' HD3' ' HB2' ' A' ' 36' ' ' PRO . 50.8 Cg_endo -76.23 151.13 33.83 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 122.908 0.951 . . . . 0.0 110.303 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.712 ' O ' ' HB3' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -28.62 -36.08 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.587 -0.696 . . . . 0.0 110.659 179.676 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.973 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -49.91 -48.52 51.6 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.786 -1.197 . . . . 0.0 110.501 -179.605 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.953 HG23 ' CD1' ' A' ' 40' ' ' LEU . 41.1 t -83.93 -32.55 8.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 121.161 -0.962 . . . . 0.0 110.296 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 46' ' ' HIS . . . -89.72 -41.13 12.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.092 -1.005 . . . . 0.0 111.731 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.712 ' HB3' ' O ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -78.46 -20.54 50.73 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.095 -1.003 . . . . 0.0 110.39 -179.215 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.718 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 7.6 tpt180 -76.42 -55.02 5.93 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.626 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 38.3 m-70 -65.73 -17.19 64.44 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.544 ' HB2' ' O ' ' A' ' 42' ' ' ALA . 74.1 t60 -96.77 -17.15 20.44 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.697 0.76 . . . . 0.0 109.355 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.97 -112.3 0.12 Allowed Glycine 0 N--CA 1.477 1.367 0 N-CA-C 108.156 -1.977 . . . . 0.0 108.156 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 1.176 ' CZ2' HD22 ' A' ' 64' ' ' LEU . 4.6 m95 -102.97 70.93 1.11 Allowed 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.849 -1.14 . . . . 0.0 110.844 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.674 ' ND2' ' HB3' ' A' ' 53' ' ' CYS . 0.9 OUTLIER -108.41 111.97 61.22 Favored Pre-proline 0 C--N 1.302 -1.491 0 O-C-N 121.139 -0.976 . . . . 0.0 109.694 178.017 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.826 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 40.9 Cg_endo -68.03 -63.68 0.05 OUTLIER 'Trans proline' 0 C--N 1.301 -1.949 0 O-C-N 123.291 1.153 . . . . 0.0 109.764 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 1.123 ' HA ' ' CE ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER 176.07 36.98 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 122.502 1.144 . . . . 0.0 111.561 178.059 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.769 ' HB3' ' HG2' ' A' ' 79' ' ' ARG 0.255 0.7 OUTLIER -169.8 23.23 0.02 OUTLIER 'General case' 0 C--N 1.269 -2.921 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.331 -179.385 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.674 ' HB3' ' ND2' ' A' ' 49' ' ' ASN . 8.3 t -101.27 127.42 47.88 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-O 122.523 1.154 . . . . 0.0 111.337 -177.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.569 ' CB ' HD21 ' A' ' 56' ' ' ASN . 0.6 OUTLIER -90.11 166.23 13.52 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.337 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.814 ' HG3' HD11 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -74.45 1.97 10.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.693 -0.629 . . . . 0.0 110.981 -179.146 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.591 ' ND2' ' O ' ' A' ' 76' ' ' ASP . 0.0 OUTLIER -31.64 -32.63 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.642 0.734 . . . . 0.0 109.833 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.69 HD11 ' NH2' ' A' ' 44' ' ' ARG . 4.6 pt -136.34 166.39 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.562 -0.711 . . . . 0.0 110.41 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.92 ' HB2' HD23 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -109.21 121.59 45.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 110.458 -179.263 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.71 HG11 ' HD1' ' A' ' 48' ' ' TRP . 58.4 t -130.32 132.69 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.287 -0.883 . . . . 0.0 110.21 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.664 ' HB2' ' HG3' ' A' ' 43' ' ' GLN . 3.1 ttpt -135.26 155.07 51.25 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.218 -0.926 . . . . 0.0 110.397 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 63' ' ' GLY . 4.2 tt0 -74.87 -118.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.351 -0.843 . . . . 0.0 110.203 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 42.08 28.81 0.53 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.674 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 129.65 60.55 0.1 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.176 HD22 ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER 0.44 84.83 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.751 -0.852 . . . . 0.0 111.172 -179.716 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 31.5 t -126.65 114.82 18.54 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.162 -0.961 . . . . 0.0 111.005 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.596 ' HA ' HG13 ' A' ' 59' ' ' VAL . 3.6 m-85 -90.23 124.72 35.1 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.576 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 3.4 tt0 -125.37 147.53 49.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.737 -1.227 . . . . 0.0 110.516 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.574 ' HB3' ' CG2' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -136.09 115.68 12.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.434 -0.791 . . . . 0.0 109.777 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.65 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -68.94 -65.99 1.12 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.024 -1.048 . . . . 0.0 110.255 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.65 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 56.1 Cg_endo -70.49 -143.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.924 1.487 . . . . 0.0 109.354 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.556 HG13 ' CH2' ' A' ' 207' ' ' TRP . 3.5 t -139.6 164.11 24.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 O-C-N 121.319 -0.863 . . . . 0.0 109.965 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.839 ' HB2' ' CD1' ' A' ' 207' ' ' TRP . . . -66.92 59.25 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 0.0 110.113 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.484 ' N ' ' O ' ' A' ' 71' ' ' VAL . 4.7 mt-30 -53.38 -92.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.181 -0.949 . . . . 0.0 110.378 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.496 ' HB3' ' HB3' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -143.71 27.86 1.48 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.93 . . . . 0.0 110.367 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.462 ' CG2' ' OE1' ' A' ' 30' ' ' GLU . 1.4 m -103.5 -134.19 0.32 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.19 -0.944 . . . . 0.0 109.761 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.591 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 22.8 t70 -140.67 113.14 8.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 110.363 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.554 ' O ' ' ND2' ' A' ' 56' ' ' ASN . . . -51.44 -90.96 0.01 OUTLIER Glycine 0 N--CA 1.488 2.105 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 178.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.993 ' CG1' ' HB3' ' A' ' 205' ' ' ALA . 0.1 OUTLIER -132.29 134.68 59.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.296 -1.12 . . . . 0.0 109.181 178.405 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.769 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 45.1 ttp180 -146.13 161.99 38.95 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.813 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.742 ' HA2' ' HB2' ' A' ' 52' ' ' ASP . . . -152.94 117.04 0.78 Allowed Glycine 0 N--CA 1.495 2.62 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.505 ' HG3' ' HB3' ' A' ' 202' ' ' SER . 2.5 ttmp? -155.75 -117.26 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.959 -1.318 . . . . 0.0 111.262 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.677 ' HD3' ' H ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -48.53 -17.19 0.14 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.336 -0.853 . . . . 0.0 111.481 -179.131 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.677 ' H ' ' HD3' ' A' ' 82' ' ' ARG . . . -77.5 36.24 1.58 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.45 ' OH ' ' NE1' ' A' ' 91' ' ' TRP . 0.6 OUTLIER -111.49 156.61 21.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.105 -1.233 . . . . 0.0 110.405 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.29 177.83 5.08 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.443 -0.786 . . . . 0.0 110.667 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.557 ' HA ' ' CB ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -99.45 -173.47 2.48 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.394 -0.816 . . . . 0.0 110.024 -179.669 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 100.48 160.65 28.04 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.647 ' O ' HD23 ' A' ' 88' ' ' LEU . 7.8 tt -87.66 114.22 24.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.172 -1.193 . . . . 0.0 110.479 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -147.41 173.22 12.84 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.378 -0.826 . . . . 0.0 109.935 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.562 ' O ' ' O ' ' A' ' 217' ' ' MET . . . -151.63 148.85 28.46 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.149 -0.969 . . . . 0.0 109.79 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.896 ' CZ3' HG11 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -134.75 161.33 35.48 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.846 -1.159 . . . . 0.0 110.216 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.802 ' C ' HD12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -109.47 124.84 51.72 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.515 179.642 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.802 HD12 ' C ' ' A' ' 92' ' ' GLU . 1.6 mp -126.14 154.31 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.14 -0.975 . . . . 0.0 110.385 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.699 ' O ' HG23 ' A' ' 212' ' ' VAL . 0.0 OUTLIER -135.52 119.85 17.89 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.541 -0.724 . . . . 0.0 109.415 179.667 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 1.029 ' CE3' HG21 ' A' ' 212' ' ' VAL . 2.3 t-105 -128.61 89.14 50.21 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.106 -0.997 . . . . 0.0 110.87 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.601 ' HG2' ' HB3' ' A' ' 211' ' ' GLN . 50.5 Cg_endo -88.06 115.09 0.91 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.097 1.578 . . . . 0.0 110.277 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.64 ' HB3' HG22 ' A' ' 162' ' ' VAL . 0.1 OUTLIER -95.08 -6.48 41.93 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.049 -1.032 . . . . 0.0 110.311 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -65.78 -8.75 23.09 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.152 -0.968 . . . . 0.0 110.24 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.429 ' C ' ' HG2' ' A' ' 100' ' ' ARG . 18.5 mm-40 -87.93 -102.7 0.08 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -0.886 . . . . 0.0 110.259 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.429 ' HG2' ' C ' ' A' ' 99' ' ' GLN . 17.7 mmm180 -134.83 -126.76 0.16 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.065 -1.022 . . . . 0.0 110.172 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.498 ' HA3' ' HB3' ' A' ' 210' ' ' CYS . . . 65.24 112.59 0.01 OUTLIER Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.85 -62.7 1.61 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.312 -1.111 . . . . 0.0 110.223 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.533 ' HB2' ' CG2' ' A' ' 206' ' ' VAL . 10.4 m170 -98.32 173.71 6.85 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.308 -0.87 . . . . 0.0 110.439 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.907 ' HB1' ' HE1' ' A' ' 95' ' ' TRP . . . 179.85 133.32 0.1 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.318 -0.864 . . . . 0.0 110.035 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.797 HG13 ' O ' ' A' ' 204' ' ' SER . 0.1 OUTLIER -135.19 134.91 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.962 -1.086 . . . . 0.0 111.88 -179.125 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.674 HG22 ' CD2' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -151.53 118.82 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.555 -0.715 . . . . 0.0 109.521 178.286 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 132' ' ' GLY . . . 161.62 -154.34 25.3 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 118.887 -1.625 . . . . 0.0 110.725 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.88 HG13 ' C ' ' A' ' 200' ' ' TYR . 58.2 t -138.77 157.92 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.687 -0.89 . . . . 0.0 109.785 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.547 ' O ' ' N ' ' A' ' 200' ' ' TYR . . . -133.93 153.38 51.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.043 -1.036 . . . . 0.0 110.436 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 1.073 HG23 ' HB3' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -101.08 128.28 47.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.234 -0.917 . . . . 0.0 109.817 179.618 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.21 -27.76 17.46 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.509 -0.744 . . . . 0.0 109.588 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.444 ' O ' ' C ' ' A' ' 113' ' ' ALA . 0.8 OUTLIER -81.7 -12.54 58.6 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.411 -0.806 . . . . 0.0 109.57 179.312 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.554 ' CB ' ' HB2' ' A' ' 129' ' ' GLU . . . -40.87 150.44 0.29 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.515 -0.741 . . . . 0.0 110.263 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -73.17 -81.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.003 1.528 . . . . 0.0 110.593 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.481 ' HG ' ' HA ' ' A' ' 127' ' ' ASN . 0.4 OUTLIER 179.82 63.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.161 -0.962 . . . . 0.0 110.15 179.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 115' ' ' LEU . 28.3 tp60 -39.14 -39.25 0.57 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.307 -0.87 . . . . 0.0 110.266 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.552 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -41.8 160.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.367 -0.833 . . . . 0.0 110.128 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.552 ' C ' ' O ' ' A' ' 117' ' ' ALA . 21.9 t70 -30.53 -89.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.474 -0.766 . . . . 0.0 110.774 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -168.79 -52.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.212 -0.93 . . . . 0.0 110.169 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.5 93.75 2.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.313 -0.867 . . . . 0.0 110.2 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.428 ' HB1' ' HA3' ' A' ' 125' ' ' GLY . . . -130.85 67.52 1.5 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.155 -0.966 . . . . 0.0 110.197 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 123' ' ' LEU . . . -100.22 135.52 41.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 0.0 110.213 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER 60.87 102.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.25 -0.906 . . . . 0.0 110.216 179.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 124' ' ' LEU . 0.4 OUTLIER 62.66 47.83 4.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.311 -0.868 . . . . 0.0 110.26 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.428 ' HA3' ' HB1' ' A' ' 121' ' ' ALA . . . -100.52 -124.88 5.41 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.1 m -148.38 62.72 1.09 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -1.164 . . . . 0.0 110.193 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.481 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 2.4 t-20 -77.33 -6.52 53.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -0.895 . . . . 0.0 110.169 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 33.3 t -102.72 171.02 7.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.303 -0.873 . . . . 0.0 110.228 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.554 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . 0.3 OUTLIER -150.0 129.9 13.38 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.234 -0.916 . . . . 0.0 110.107 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.54 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 47.8 t -120.36 119.94 34.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.332 -0.855 . . . . 0.0 110.181 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . 0.48 ' O ' ' O ' ' A' ' 108' ' ' VAL . 0.8 OUTLIER -129.69 124.74 34.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.374 -0.829 . . . . 0.0 109.906 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 107' ' ' GLY . . . 174.92 -133.23 2.4 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.701 ' CE3' HG11 ' A' ' 163' ' ' VAL . 54.8 m0 -110.68 113.65 26.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.122 -1.223 . . . . 0.0 110.694 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.469 ' C ' HD13 ' A' ' 135' ' ' ILE . 6.0 t0 -117.97 134.84 54.58 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.741 -0.599 . . . . 0.0 110.263 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.824 HD13 ' N ' ' A' ' 135' ' ' ILE . 0.1 OUTLIER -141.64 7.5 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.275 -0.891 . . . . 0.0 110.308 -179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -101.23 -48.37 1.45 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.74 6.31 36.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.355 -1.085 . . . . 0.0 109.67 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -118.08 -12.98 7.32 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.759 ' HE3' HG23 ' A' ' 162' ' ' VAL . 7.1 tptm -67.29 -140.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -1.103 . . . . 0.0 110.512 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.673 ' C ' ' O ' ' A' ' 139' ' ' LYS . 0.7 OUTLIER 0.39 74.03 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.328 0.585 . . . . 0.0 111.306 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.543 ' N ' ' O ' ' A' ' 139' ' ' LYS . 20.8 t80 -154.64 101.22 2.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.358 -0.838 . . . . 0.0 110.144 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -153.38 86.35 1.22 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.168 -0.957 . . . . 0.0 110.22 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -104.38 -67.4 0.9 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.269 -0.894 . . . . 0.0 110.241 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.97 124.53 49.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.18 -0.95 . . . . 0.0 110.177 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.28 -173.76 4.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.936 . . . . 0.0 110.235 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 75.38 49.86 8.88 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.9 tt -151.76 83.41 1.28 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -1.104 . . . . 0.0 110.22 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 149' ' ' ALA . 36.1 tt0 179.83 140.34 0.13 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.28 -0.887 . . . . 0.0 110.178 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 148' ' ' GLU . . . -177.08 79.29 0.25 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.197 -0.939 . . . . 0.0 110.421 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.415 ' HB3' ' HA3' ' A' ' 155' ' ' GLY . 47.4 Cg_endo -74.57 52.51 2.9 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.027 1.541 . . . . 0.0 110.46 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.48 -90.37 0.08 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.232 -0.917 . . . . 0.0 110.26 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.568 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 3.1 m-85 -76.68 -60.26 0.88 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.247 -0.908 . . . . 0.0 110.259 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.568 ' CD ' ' CB ' ' A' ' 152' ' ' TYR . 46.7 Cg_endo -72.67 169.92 20.75 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.983 1.518 . . . . 0.0 110.41 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 155' ' ' GLY . . . -80.54 104.75 11.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.26 -0.9 . . . . 0.0 110.295 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 154' ' ' ALA . . . -43.61 136.6 4.73 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.423 ' HG2' ' OE1' ' A' ' 157' ' ' GLN . 47.1 Cg_endo -73.54 -17.59 23.4 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.909 1.478 . . . . 0.0 110.344 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.52 ' HA ' ' HB2' ' A' ' 160' ' ' GLN . 3.2 mp0 -68.6 -0.76 5.54 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.256 -0.903 . . . . 0.0 110.685 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -46.06 -43.94 13.64 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -89.34 6.54 40.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -1.15 . . . . 0.0 110.207 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.52 ' HB2' ' HA ' ' A' ' 157' ' ' GLN . 0.0 OUTLIER -89.85 0.56 56.97 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.428 -0.795 . . . . 0.0 110.144 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.692 ' O ' ' C ' ' A' ' 162' ' ' VAL . 1.1 mt -127.31 71.41 1.33 Allowed 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.209 -0.932 . . . . 0.0 110.086 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.759 HG23 ' HE3' ' A' ' 139' ' ' LYS . 2.5 t 1.0 92.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 121.557 0.694 . . . . 0.0 110.926 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.878 HG13 ' HD2' ' A' ' 164' ' ' PRO . 53.8 t -35.52 153.0 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.904 -0.498 . . . . 0.0 110.081 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.878 ' HD2' HG13 ' A' ' 163' ' ' VAL . 38.1 Cg_endo -64.48 134.15 40.25 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.808 1.425 . . . . 0.0 110.771 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.563 ' CB ' ' HB3' ' A' ' 96' ' ' PRO . 24.4 pt-20 -41.23 -25.22 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.604 -0.685 . . . . 0.0 111.317 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 164' ' ' PRO . 0.0 OUTLIER -116.08 138.38 51.29 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.944 -1.097 . . . . 0.0 110.698 -179.388 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.956 HD13 ' CE1' ' A' ' 180' ' ' TYR . 2.5 pp -158.9 154.64 26.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.615 -0.678 . . . . 0.0 109.924 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' A' ' 181' ' ' SER . 18.0 tp -112.78 141.08 47.01 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.116 -0.99 . . . . 0.0 110.128 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.896 HG11 ' CZ3' ' A' ' 91' ' ' TRP . 6.5 t -124.06 136.3 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.147 -0.97 . . . . 0.0 110.486 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.737 HG12 HD23 ' A' ' 187' ' ' LEU . 9.8 p -115.3 121.4 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.449 -0.782 . . . . 0.0 109.377 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.767 HD12 ' HG3' ' A' ' 201' ' ' PRO . 0.0 OUTLIER -127.16 107.82 10.36 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.042 -1.036 . . . . 0.0 110.104 -179.512 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -120.01 129.49 54.28 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.876 0.846 . . . . 0.0 109.903 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.557 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -98.77 -39.46 8.62 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.576 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 173' ' ' MET . 0.1 OUTLIER -46.37 -26.47 0.84 Allowed 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.439 -0.905 . . . . 0.0 108.698 178.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.545 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 3.3 tt0 -110.16 -27.43 9.14 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 198' ' ' THR . . . 84.15 23.36 52.11 Favored Glycine 0 N--CA 1.483 1.77 0 N-CA-C 108.756 -1.738 . . . . 0.0 108.756 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.923 HG22 HD22 ' A' ' 194' ' ' LEU . 0.1 OUTLIER -118.46 116.96 27.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.166 -1.197 . . . . 0.0 111.402 -179.55 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.812 ' N ' HD12 ' A' ' 178' ' ' LEU . 3.3 mp -130.6 153.71 48.62 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.421 -0.799 . . . . 0.0 109.501 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.999 ' C ' HD21 ' A' ' 187' ' ' LEU . . . -161.93 166.96 36.45 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.524 -1.322 . . . . 0.0 110.14 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.956 ' CE1' HD13 ' A' ' 167' ' ' LEU . 1.1 t80 -125.01 118.28 25.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.439 -1.036 . . . . 0.0 109.85 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.704 ' HB2' HD13 ' A' ' 187' ' ' LEU . 0.6 OUTLIER -145.15 165.25 28.86 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.334 -0.854 . . . . 0.0 110.072 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.642 HG21 ' HG2' ' A' ' 164' ' ' PRO . 0.0 OUTLIER -110.18 116.6 52.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 O-C-N 121.501 -0.749 . . . . 0.0 109.543 179.195 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 79.6 -1.72 76.27 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 87.9 39.99 6.82 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . 0.503 HG22 ' N ' ' A' ' 186' ' ' TYR . 32.1 m -94.38 -86.84 0.27 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.214 -1.168 . . . . 0.0 110.65 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.592 ' CE2' HD11 ' A' ' 182' ' ' ILE . 22.5 m-85 -40.15 -40.74 1.15 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.263 -0.898 . . . . 0.0 110.78 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.999 HD21 ' C ' ' A' ' 179' ' ' GLY . 5.8 mp -80.56 47.2 0.92 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.08 -1.013 . . . . 0.0 109.948 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -108.72 -82.15 1.38 Allowed Glycine 0 N--CA 1.491 2.3 0 C-N-CA 119.853 -1.165 . . . . 0.0 110.326 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.98 -28.39 16.28 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.926 1.488 . . . . 0.0 111.081 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.613 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -72.67 20.71 0.07 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.27 -0.894 . . . . 0.0 111.363 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -90.2 -13.55 35.29 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.928 -1.107 . . . . 0.0 110.325 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.489 ' HA ' ' NE ' ' A' ' 192' ' ' ARG . 0.1 OUTLIER -90.28 -14.69 32.74 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.317 -0.865 . . . . 0.0 110.563 -179.76 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 197' ' ' ARG . . . -111.28 -18.91 7.84 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.923 HD22 HG22 ' A' ' 177' ' ' THR . 6.2 tt -61.95 -33.72 74.81 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.799 -0.824 . . . . 0.0 108.818 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.667 ' HA ' HG23 ' A' ' 177' ' ' THR . 0.0 OUTLIER -45.59 -29.84 1.32 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.553 -0.717 . . . . 0.0 109.529 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -115.59 -21.16 5.18 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.783 ' O ' HD23 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.99 -9.24 46.72 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.661 -0.905 . . . . 0.0 109.666 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.683 ' HB ' HD23 ' A' ' 194' ' ' LEU . 0.0 OUTLIER -43.5 148.95 0.29 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.015 0.912 . . . . 0.0 111.961 -177.785 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 1.073 ' HB3' HG23 ' A' ' 110' ' ' THR . 0.1 OUTLIER -140.59 169.81 16.96 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.511 179.519 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.88 ' C ' HG13 ' A' ' 108' ' ' VAL . 19.0 m-85 -84.75 129.92 54.96 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.017 -1.052 . . . . 0.0 109.499 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.844 ' HA ' HG22 ' A' ' 108' ' ' VAL . 41.4 Cg_endo -67.87 125.13 12.71 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.805 1.424 . . . . 0.0 110.407 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.581 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 57.5 p -133.29 152.27 51.92 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.253 -0.904 . . . . 0.0 111.195 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.619 HG23 ' HA ' ' A' ' 106' ' ' VAL . 4.0 p -158.93 160.6 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.648 -0.657 . . . . 0.0 109.532 179.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 0.797 ' O ' HG13 ' A' ' 105' ' ' VAL . 0.3 OUTLIER -160.38 130.32 5.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.307 -0.87 . . . . 0.0 110.319 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.993 ' HB3' ' CG1' ' A' ' 78' ' ' VAL . . . -108.74 150.53 27.46 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.031 -1.043 . . . . 0.0 110.398 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.533 ' CG2' ' HB2' ' A' ' 103' ' ' HIS . 1.2 t -91.19 159.97 2.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.542 0.687 . . . . 0.0 110.712 -179.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 0.839 ' CD1' ' HB2' ' A' ' 72' ' ' ALA . 16.7 p-90 -82.54 46.61 1.08 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.286 -0.884 . . . . 0.0 109.646 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.46 ' H ' HG12 ' A' ' 206' ' ' VAL . . . -108.88 -128.95 5.8 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.791 ' O ' ' O ' ' A' ' 210' ' ' CYS . 1.0 OUTLIER -127.51 -22.59 3.62 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.357 -1.084 . . . . 0.0 110.548 -179.538 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . 0.791 ' O ' ' O ' ' A' ' 209' ' ' GLN . 31.4 p 1.6 -133.42 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.032 0.444 . . . . 0.0 111.875 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.601 ' HB3' ' HG2' ' A' ' 96' ' ' PRO . 0.0 OUTLIER 178.88 33.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.847 -1.158 . . . . 0.0 110.808 -179.595 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 1.029 HG21 ' CE3' ' A' ' 95' ' ' TRP . 2.5 p -86.63 124.96 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.032 -1.042 . . . . 0.0 110.267 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.575 ' HA ' HD21 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -96.97 170.51 9.1 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.624 -0.672 . . . . 0.0 110.868 -179.3 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.829 ' CD1' ' HB3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -132.25 122.37 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.244 -0.91 . . . . 0.0 110.612 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.591 ' HB3' ' CB ' ' A' ' 92' ' ' GLU . 0.5 OUTLIER -130.63 140.15 50.4 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.563 -0.711 . . . . 0.0 109.96 179.464 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . 0.568 ' HA ' ' HB3' ' A' ' 91' ' ' TRP . 8.2 t80 -118.93 150.92 39.08 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.257 -0.902 . . . . 0.0 110.924 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . 0.562 ' O ' ' O ' ' A' ' 90' ' ' ALA . 9.0 tpp -134.99 108.01 7.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.933 . . . . 0.0 110.244 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 128.44 -9.48 6.53 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.485 ' HB2' ' CD1' ' A' ' 216' ' ' TYR . 3.9 mm-40 -95.49 117.76 30.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.203 -1.175 . . . . 0.0 110.044 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -105.04 176.74 5.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.29 -0.881 . . . . 0.0 110.312 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . 0.518 ' O ' ' C ' ' A' ' 222' ' ' VAL . 0.0 OUTLIER -123.85 83.28 2.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 0.0 110.054 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.518 ' C ' ' O ' ' A' ' 221' ' ' ARG . 8.5 p -33.21 144.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.493 -0.755 . . . . 0.0 110.593 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.657 ' O ' ' C ' ' A' ' 224' ' ' GLU . 30.6 mm-40 -73.24 52.42 0.35 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.195 -0.941 . . . . 0.0 110.333 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.657 ' C ' ' O ' ' A' ' 223' ' ' GLU . 1.1 tt0 0.77 70.35 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.329 0.585 . . . . 0.0 111.395 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.929 ' CG2' HD13 ' A' ' 228' ' ' ILE . 15.6 m -170.11 96.94 0.28 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.548 -0.72 . . . . 0.0 110.097 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.734 ' O ' HG23 ' A' ' 228' ' ' ILE . 3.1 tpp180 -43.7 167.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.32 -0.863 . . . . 0.0 110.118 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -43.08 138.09 2.25 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.16 -0.962 . . . . 0.0 110.199 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.929 HD13 ' CG2' ' A' ' 225' ' ' THR . 4.9 pt -142.13 129.34 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 110.166 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.452 ' CD2' ' H ' ' A' ' 229' ' ' HIS . 21.9 p80 -66.35 -25.45 66.81 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.267 -0.896 . . . . 0.0 110.202 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . 0.676 ' O ' ' C ' ' A' ' 231' ' ' ASP . 0.0 OUTLIER 179.8 -35.01 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.161 -0.962 . . . . 0.0 110.184 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.676 ' C ' ' O ' ' A' ' 230' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 117.961 -1.019 . . . . 0.0 111.437 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 50.06 -175.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.254 -1.145 . . . . 0.0 110.207 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.2 m -105.68 -147.29 0.4 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.912 . . . . 0.0 110.163 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -164.58 128.05 2.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.229 -0.919 . . . . 0.0 110.235 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.462 ' O ' ' CG ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -97.54 72.61 2.35 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.904 . . . . 0.0 110.201 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -148.6 -152.43 0.44 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.331 -0.855 . . . . 0.0 110.236 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.49 30.28 1.03 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.372 -0.83 . . . . 0.0 110.179 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.557 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -63.34 -54.87 40.75 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.0 110.27 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 13' ' ' THR . 46.1 Cg_endo -73.04 -158.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.981 1.516 . . . . 0.0 110.452 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.425 ' C ' ' O ' ' A' ' 14' ' ' PRO . 15.0 t -41.03 151.18 0.07 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.292 -0.88 . . . . 0.0 110.292 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.13 170.79 0.06 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -0.922 . . . . 0.0 110.299 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -106.5 -45.84 4.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 0.0 110.324 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -170.83 105.03 0.25 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 0.0 110.383 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.91 -162.58 0.87 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.209 -0.932 . . . . 0.0 110.287 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.1 m-30 -77.29 -160.43 0.17 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.161 -0.962 . . . . 0.0 110.138 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.0 t -149.03 155.4 40.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 0.0 110.252 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -176.14 40.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.89 . . . . 0.0 110.176 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -104.84 -73.38 0.68 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -0.891 . . . . 0.0 110.245 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -125.13 164.53 31.24 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.335 -0.853 . . . . 0.0 110.228 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.99 113.29 3.73 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.01 1.532 . . . . 0.0 110.429 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.681 ' O ' ' C ' ' A' ' 27' ' ' GLU . 46.5 Cg_endo -72.95 -168.95 0.45 Allowed 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 124.01 1.532 . . . . 0.0 110.348 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.681 ' C ' ' O ' ' A' ' 26' ' ' PRO . 27.9 tt0 1.23 68.49 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.585 0.707 . . . . 0.0 111.062 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.642 ' N ' ' O ' ' A' ' 26' ' ' PRO . . . 169.04 -21.26 0.08 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.587 ' HG ' ' N ' ' A' ' 30' ' ' GLU . 0.9 OUTLIER -42.48 -24.86 0.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.16 -1.2 . . . . 0.0 110.122 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.668 ' HA ' HD23 ' A' ' 33' ' ' LEU . 19.1 pt-20 -47.99 -29.78 3.75 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.095 -1.003 . . . . 0.0 108.538 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -64.59 -23.95 67.43 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.543 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -82.68 -37.25 25.07 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.826 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.801 HD12 ' C ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -71.39 -38.28 71.49 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.823 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.672 ' O ' ' O ' ' A' ' 35' ' ' ALA . 1.8 m -78.45 -7.08 57.01 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.252 0.548 . . . . 0.0 110.007 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 1.039 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -49.43 -153.73 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.689 -0.632 . . . . 0.0 110.645 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 1.039 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 38.1 Cg_endo -65.3 -170.74 0.17 Allowed 'Trans proline' 0 N--CA 1.488 1.177 0 O-C-N 122.734 0.86 . . . . 0.0 110.349 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.758 ' O ' ' HB2' ' A' ' 42' ' ' ALA . 52.0 Cg_endo -97.17 50.2 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.525 1.483 . . . . 0.0 113.413 -178.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.781 ' HD2' ' O ' ' A' ' 36' ' ' PRO . 46.7 Cg_endo -73.07 150.67 48.66 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 N-CA-C 108.671 -1.319 . . . . 0.0 108.671 178.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.644 ' C ' ' O ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -21.32 -52.93 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.108 -0.995 . . . . 0.0 111.23 -179.171 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.048 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -54.38 -45.97 72.95 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 120.786 -1.196 . . . . 0.0 110.096 -179.344 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.751 ' CG2' HD13 ' A' ' 40' ' ' LEU . 6.2 t -86.99 -33.6 7.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 O-C-N 121.021 -1.049 . . . . 0.0 110.29 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.758 ' HB2' ' O ' ' A' ' 37' ' ' PRO . . . -90.91 -39.54 12.23 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.003 -1.06 . . . . 0.0 112.435 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.816 ' OE1' ' HA ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -83.0 -20.07 35.79 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.936 -1.102 . . . . 0.0 109.988 -178.832 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.752 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -80.45 -46.67 15.53 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.242 -0.911 . . . . 0.0 109.371 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.719 ' CG ' ' O ' ' A' ' 41' ' ' VAL . 14.7 m170 -54.86 -16.9 2.99 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.645 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.57 ' CG ' ' OE1' ' A' ' 61' ' ' GLU . 6.0 t60 -95.46 -35.06 11.85 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.079 -1.048 . . . . 0.0 109.271 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.48 ' HA2' ' OE2' ' A' ' 61' ' ' GLU . . . -93.53 -107.01 1.85 Allowed Glycine 0 N--CA 1.488 2.128 0 N-CA-C 107.116 -2.394 . . . . 0.0 107.116 178.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.931 ' HH2' HG12 ' A' ' 212' ' ' VAL . 98.9 m95 -79.83 73.57 6.58 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.001 -1.293 . . . . 0.0 108.271 177.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.618 ' HA ' ' HA ' ' A' ' 45' ' ' HIS . 0.1 OUTLIER -46.95 138.81 7.15 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.503 -0.748 . . . . 0.0 111.262 -179.357 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.646 ' HG2' ' HE3' ' A' ' 51' ' ' LYS . 39.8 Cg_endo -69.55 -27.01 27.98 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 124.387 1.73 . . . . 0.0 110.862 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.853 ' CE ' ' N ' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -63.16 -17.9 62.88 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 178.293 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.826 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 7.4 m-20 -121.12 3.25 10.43 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.223 177.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.89 ' SG ' HG12 ' A' ' 78' ' ' VAL . 2.4 t -138.56 128.29 25.01 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.949 0.88 . . . . 0.0 111.045 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.728 ' CB ' ' ND2' ' A' ' 56' ' ' ASN . 0.7 OUTLIER -70.12 118.07 12.49 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.634 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.71 ' HB3' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -51.38 -27.93 11.26 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.079 -1.013 . . . . 0.0 111.211 -179.258 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.729 ' H ' ' ND2' ' A' ' 56' ' ' ASN . 1.4 m-80 -28.29 -34.5 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.747 0.784 . . . . 0.0 110.279 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.661 ' N ' ' O ' ' A' ' 55' ' ' GLU . 15.9 pt -112.29 166.62 6.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.585 -0.697 . . . . 0.0 109.444 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.547 ' N ' ' O ' ' A' ' 67' ' ' GLU . 13.7 t70 -108.51 109.75 21.07 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.13 -0.981 . . . . 0.0 109.788 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.76 ' CG1' ' CD1' ' A' ' 48' ' ' TRP . 95.7 t -130.56 135.16 61.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 O-C-N 121.78 -0.575 . . . . 0.0 110.462 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.816 ' HA ' ' OE1' ' A' ' 43' ' ' GLN . 2.8 tttt -136.3 155.41 50.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.88 -1.138 . . . . 0.0 111.227 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.57 ' OE1' ' CG ' ' A' ' 46' ' ' HIS . 3.1 tt0 -69.07 -120.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.47 -0.769 . . . . 0.0 110.265 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.518 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 38.48 48.99 2.33 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 108.346 -1.901 . . . . 0.0 108.346 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.688 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 102.07 58.65 0.78 Allowed Glycine 0 N--CA 1.487 2.047 0 N-CA-C 107.932 -2.067 . . . . 0.0 107.932 -178.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.824 HD22 ' H ' ' A' ' 64' ' ' LEU . 2.0 mm? 0.91 82.98 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.886 -0.773 . . . . 0.0 111.105 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 3.7 t -99.76 114.65 27.92 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.514 -0.741 . . . . 0.0 109.885 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.61 ' CE1' ' CD2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -97.21 124.89 41.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.414 -0.804 . . . . 0.0 109.538 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 58' ' ' ASP . 8.3 tt0 -145.88 122.01 10.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.826 -1.171 . . . . 0.0 110.23 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.555 ' CD ' ' O ' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -122.81 142.66 50.51 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.332 -0.855 . . . . 0.0 109.674 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.675 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 44.7 mtt180 -112.91 -71.44 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.033 -1.042 . . . . 0.0 110.591 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.675 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 56.6 Cg_endo -73.6 -122.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.502 1.264 . . . . 0.0 109.184 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 t -140.05 164.09 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.5 -1.375 . . . . 0.0 109.96 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.869 ' HB1' ' HA ' ' A' ' 76' ' ' ASP . . . -62.46 88.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.226 -0.921 . . . . 0.0 110.192 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.558 ' N ' ' OD1' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -66.79 -77.5 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.171 -0.956 . . . . 0.0 110.368 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 73' ' ' GLN . 1.9 p -50.86 -101.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.112 -0.992 . . . . 0.0 110.03 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.712 HG23 ' OG ' ' A' ' 54' ' ' SER . 7.1 t -82.93 -129.25 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.929 -1.107 . . . . 0.0 109.203 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.869 ' HA ' ' HB1' ' A' ' 72' ' ' ALA . 0.9 OUTLIER -140.9 154.39 46.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.966 -1.084 . . . . 0.0 110.802 179.555 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.644 ' O ' HG13 ' A' ' 78' ' ' VAL . . . 29.88 -89.87 0.01 OUTLIER Glycine 0 N--CA 1.488 2.133 0 N-CA-C 108.429 -1.868 . . . . 0.0 108.429 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.112 ' CG2' ' HB3' ' A' ' 205' ' ' ALA . 17.1 m -155.26 138.73 7.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 O-C-N 121.736 -0.861 . . . . 0.0 109.999 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.762 ' C ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -144.95 133.22 21.66 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.239 -0.913 . . . . 0.0 112.047 -178.454 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.826 ' CA ' ' HA ' ' A' ' 52' ' ' ASP . . . -115.43 162.68 12.41 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.236 -1.545 . . . . 0.0 109.236 178.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.436 ' HA ' ' HB2' ' A' ' 202' ' ' SER . 13.0 ttpp -160.57 -28.21 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.134 -1.215 . . . . 0.0 110.452 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.552 ' CD ' ' HB3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -82.18 -73.51 0.39 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.978 -1.076 . . . . 0.0 109.872 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.47 ' C ' ' O ' ' A' ' 82' ' ' ARG . . . 36.49 53.15 1.37 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.423 ' CD1' ' C ' ' A' ' 84' ' ' TYR . 2.1 t80 -94.55 125.29 39.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -1.137 . . . . 0.0 110.603 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.592 ' HB3' ' CD2' ' A' ' 89' ' ' HIS . 30.7 m -139.9 166.68 23.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.163 -0.961 . . . . 0.0 110.022 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.505 ' O ' ' NE2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -116.87 133.77 55.6 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.059 -1.026 . . . . 0.0 110.201 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 101.03 -114.92 5.15 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.524 ' O ' ' CD2' ' A' ' 89' ' ' HIS . 17.7 tp -128.49 132.18 48.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.359 -1.083 . . . . 0.0 110.248 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.592 ' CD2' ' HB3' ' A' ' 85' ' ' SER . 2.9 m80 -147.16 156.78 43.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.12 -0.987 . . . . 0.0 109.915 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.546 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -163.04 155.45 18.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.939 . . . . 0.0 110.074 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 1.124 ' CZ3' HG11 ' A' ' 169' ' ' VAL . 0.0 OUTLIER -134.67 158.86 43.0 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.275 -0.891 . . . . 0.0 109.238 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.611 ' HB3' ' HB3' ' A' ' 215' ' ' ARG . 3.0 tt0 -109.81 134.11 52.4 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.876 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.989 HD13 HG13 ' A' ' 214' ' ' ILE . 8.3 mm -129.18 132.25 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.421 -0.8 . . . . 0.0 109.657 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.7 ' HB3' ' HA ' ' A' ' 166' ' ' ARG . 13.3 p -155.22 154.31 32.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.188 -0.945 . . . . 0.0 110.271 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.979 ' CZ2' ' HA ' ' A' ' 104' ' ' ALA . 14.4 m95 -123.32 86.41 51.86 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.09 -1.006 . . . . 0.0 109.8 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.595 ' CD ' ' HB2' ' A' ' 213' ' ' ARG . 52.2 Cg_endo -99.06 109.0 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 121.978 1.785 . . . . 0.0 110.634 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.633 HD11 ' NE2' ' A' ' 211' ' ' GLN . 0.2 OUTLIER -96.03 -66.05 0.93 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.883 -1.136 . . . . 0.0 109.764 179.125 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -97.63 -45.09 6.52 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.24 -0.913 . . . . 0.0 110.001 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.486 ' O ' ' HG2' ' A' ' 100' ' ' ARG . 0.5 OUTLIER 179.93 46.83 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.243 -0.911 . . . . 0.0 110.102 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.486 ' HG2' ' O ' ' A' ' 99' ' ' GLN . 1.8 mtt180 -149.71 -135.1 0.07 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.169 -0.957 . . . . 0.0 110.319 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 95' ' ' TRP . . . -165.36 178.64 40.21 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.572 ' O ' ' CD1' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -164.69 164.42 21.36 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.186 -1.185 . . . . 0.0 110.238 179.782 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.571 ' HA ' ' CG2' ' A' ' 163' ' ' VAL . 3.7 t-80 -66.46 161.08 23.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.311 -0.868 . . . . 0.0 110.426 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.979 ' HA ' ' CZ2' ' A' ' 95' ' ' TRP . . . -111.79 165.44 12.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 110.205 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.793 HG23 ' CB ' ' A' ' 204' ' ' SER . 18.4 m -101.85 116.56 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 118.459 -1.296 . . . . 0.0 107.64 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 1.122 HG13 ' O ' ' A' ' 202' ' ' SER . 36.9 t -149.23 156.26 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.14 -0.975 . . . . 0.0 110.757 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.578 ' HA2' ' HA3' ' A' ' 132' ' ' GLY . . . -149.96 150.23 22.26 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.967 ' CG1' HD13 ' A' ' 199' ' ' LEU . 2.9 t -122.38 141.88 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -1.098 . . . . 0.0 109.666 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.551 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -124.25 156.67 36.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.095 -1.003 . . . . 0.0 110.77 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.866 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -120.52 133.63 55.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.35 -0.844 . . . . 0.0 110.207 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -88.9 -25.03 22.33 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.344 -0.848 . . . . 0.0 109.335 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.6 pp -86.67 -11.96 49.77 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.516 -0.74 . . . . 0.0 109.251 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.654 ' HB2' ' HB ' ' A' ' 110' ' ' THR . . . -48.72 109.03 1.06 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.535 -0.728 . . . . 0.0 110.378 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.653 ' O ' HD12 ' A' ' 115' ' ' LEU . 46.1 Cg_endo -73.45 -155.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.032 1.543 . . . . 0.0 110.196 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.699 HD22 ' H ' ' A' ' 125' ' ' GLY . 0.2 OUTLIER -161.57 54.25 0.26 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.093 -1.004 . . . . 0.0 110.14 179.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.409 ' O ' ' O ' ' A' ' 117' ' ' ALA . 2.4 tt0 -101.66 -28.48 12.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.225 -0.922 . . . . 0.0 110.107 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.529 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -61.17 -148.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -0.915 . . . . 0.0 110.231 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.529 ' C ' ' O ' ' A' ' 117' ' ' ALA . 43.4 t0 -31.53 124.11 0.25 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.502 -0.749 . . . . 0.0 110.772 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.501 ' O ' ' N ' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -112.67 -79.95 0.59 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.885 . . . . 0.0 110.231 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.468 ' CB ' ' O ' ' A' ' 119' ' ' HIS . 0.1 OUTLIER 66.22 -63.95 0.23 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.352 -0.843 . . . . 0.0 110.142 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 119' ' ' HIS . . . -91.18 -158.04 0.53 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.217 -0.927 . . . . 0.0 110.183 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -167.07 29.99 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.274 -0.891 . . . . 0.0 110.184 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.08 -44.4 16.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 0.0 110.297 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.3 mt -89.49 -96.84 0.1 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.328 -0.858 . . . . 0.0 110.186 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.699 ' H ' HD22 ' A' ' 115' ' ' LEU . . . 70.01 4.54 49.19 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.94 43.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.159 -1.2 . . . . 0.0 110.21 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -128.99 -165.4 1.5 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 0.0 110.285 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.4 p -86.84 -174.32 4.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.302 -0.874 . . . . 0.0 110.171 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.435 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 0.6 OUTLIER -149.98 128.97 12.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.355 -0.841 . . . . 0.0 110.076 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 39.1 t -120.55 120.13 34.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.292 -0.88 . . . . 0.0 110.224 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . 0.465 ' O ' ' O ' ' A' ' 108' ' ' VAL . 1.5 m95 -132.82 124.87 28.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.91 . . . . 0.0 109.99 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.578 ' HA3' ' HA2' ' A' ' 107' ' ' GLY . . . -155.18 -172.13 22.52 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.626 ' O ' ' CD1' ' A' ' 133' ' ' TRP . 3.5 p90 -145.26 140.4 27.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.368 -1.077 . . . . 0.0 110.902 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 136' ' ' GLY . 0.7 OUTLIER -120.45 149.05 43.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.778 -0.576 . . . . 0.0 109.709 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.641 ' H ' HD13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -109.7 -6.75 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.966 -1.084 . . . . 0.0 110.361 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.521 ' N ' ' OD1' ' A' ' 134' ' ' ASP . . . -85.76 -40.78 7.51 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.71 4.57 49.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.279 -1.13 . . . . 0.0 109.454 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 139' ' ' LYS . . . -119.61 -5.36 11.19 Favored Glycine 0 N--CA 1.484 1.855 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 141' ' ' TYR . 1.2 tttt -59.02 -140.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.428 -1.042 . . . . 0.0 110.475 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.698 ' O ' HD12 ' A' ' 140' ' ' LEU . 1.0 OUTLIER -65.67 61.54 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.538 -0.726 . . . . 0.0 110.367 -179.872 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.522 ' N ' ' O ' ' A' ' 139' ' ' LYS . 8.1 t80 -128.29 -6.65 5.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.212 -0.93 . . . . 0.0 110.255 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.488 ' CD2' ' O ' ' A' ' 139' ' ' LYS . 12.8 p80 -111.88 43.32 1.58 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.192 -0.942 . . . . 0.0 110.256 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.61 -40.1 50.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.284 -0.885 . . . . 0.0 110.203 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 15.0 m -61.7 -152.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.29 -0.881 . . . . 0.0 110.283 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -102.98 61.59 0.79 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.276 -0.89 . . . . 0.0 110.223 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.46 -95.26 0.07 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -172.26 60.83 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.185 -1.185 . . . . 0.0 110.268 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 149' ' ' ALA . 4.5 mm-40 -56.93 177.04 0.09 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.215 -0.928 . . . . 0.0 110.22 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.469 ' O ' ' HG2' ' A' ' 153' ' ' PRO . . . -176.9 60.1 0.17 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.285 -0.884 . . . . 0.0 110.23 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.493 ' HA ' ' N ' ' A' ' 155' ' ' GLY . 48.1 Cg_endo -73.86 1.44 7.05 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.007 1.53 . . . . 0.0 110.526 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -63.93 -92.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.171 -0.956 . . . . 0.0 110.302 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.517 ' N ' ' HD2' ' A' ' 153' ' ' PRO . 0.4 OUTLIER -78.2 -57.4 0.92 Allowed Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.307 -0.871 . . . . 0.0 110.494 -179.789 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 152' ' ' TYR . 46.3 Cg_endo -72.71 131.65 17.53 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.946 1.498 . . . . 0.0 110.569 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.491 ' O ' ' O ' ' A' ' 155' ' ' GLY . . . -45.2 104.45 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.362 -0.836 . . . . 0.0 110.359 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.493 ' N ' ' HA ' ' A' ' 150' ' ' PRO . . . -59.96 -139.99 0.01 OUTLIER Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.474 ' O ' ' OE2' ' A' ' 159' ' ' GLU . 45.2 Cg_endo -73.14 -6.48 19.02 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.926 1.487 . . . . 0.0 110.312 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.434 ' HA ' ' HB3' ' A' ' 160' ' ' GLN . 0.0 OUTLIER -68.46 -3.09 10.21 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.325 -0.86 . . . . 0.0 110.544 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -61.25 -55.04 31.55 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.589 ' HB3' ' CG2' ' A' ' 135' ' ' ILE . 0.4 OUTLIER -108.24 5.05 25.34 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.238 -1.154 . . . . 0.0 110.098 179.777 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 156' ' ' PRO . 0.0 OUTLIER -67.06 -9.87 43.81 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.444 -0.785 . . . . 0.0 109.154 179.2 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.704 ' O ' ' C ' ' A' ' 162' ' ' VAL . 0.2 OUTLIER -114.83 39.37 2.88 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.579 -0.701 . . . . 0.0 110.162 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.704 ' C ' ' O ' ' A' ' 161' ' ' LEU . 2.3 t 1.2 99.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-O 121.597 0.713 . . . . 0.0 110.402 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.9 HG11 ' HB2' ' A' ' 167' ' ' LEU . 48.0 t -33.72 151.08 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.882 -0.511 . . . . 0.0 109.927 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.854 ' HD2' HG13 ' A' ' 163' ' ' VAL . 38.0 Cg_endo -64.05 176.09 2.74 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.718 1.378 . . . . 0.0 110.572 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 164' ' ' PRO . 12.9 mt-10 -35.75 -32.18 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.503 -0.748 . . . . 0.0 110.681 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.7 ' HA ' ' HB3' ' A' ' 94' ' ' SER . 21.2 ttm180 -152.26 156.71 40.22 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.269 -0.894 . . . . 0.0 111.087 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.9 ' HB2' HG11 ' A' ' 163' ' ' VAL . 7.2 tt -126.21 157.1 39.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.584 -0.697 . . . . 0.0 109.719 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.685 ' N ' HD23 ' A' ' 167' ' ' LEU . 24.9 tp -123.6 116.61 23.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.087 -1.008 . . . . 0.0 110.739 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 1.124 HG11 ' CZ3' ' A' ' 91' ' ' TRP . 10.6 t -91.93 141.91 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.101 -0.999 . . . . 0.0 109.61 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 178' ' ' LEU . 11.4 t -118.93 124.71 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.917 . . . . 0.0 111.133 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.589 HD13 ' HG3' ' A' ' 201' ' ' PRO . 13.0 tp -133.4 105.68 7.07 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.384 -0.822 . . . . 0.0 109.346 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -115.47 139.32 50.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 110.544 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.517 ' O ' ' C ' ' A' ' 174' ' ' GLU . 0.0 OUTLIER -93.43 -41.0 10.05 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 120.174 -0.611 . . . . 0.0 109.996 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.517 ' C ' ' O ' ' A' ' 173' ' ' MET . 15.9 tt0 -39.11 -30.93 0.06 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 0.0 108.497 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.519 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 4.7 tt0 -113.2 -24.97 9.11 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.616 ' O ' ' HB ' ' A' ' 198' ' ' THR . . . 76.81 25.97 63.65 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 -179.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.859 HG22 ' HG ' ' A' ' 194' ' ' LEU . 2.2 p -113.14 144.45 42.64 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.346 -1.091 . . . . 0.0 110.77 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.712 ' H ' HD21 ' A' ' 194' ' ' LEU . 0.1 OUTLIER -153.03 154.04 34.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.405 -0.809 . . . . 0.0 110.169 -179.545 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.602 ' HA3' HD12 ' A' ' 187' ' ' LEU . . . -166.05 -173.17 34.23 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.712 ' CE1' HG22 ' A' ' 169' ' ' VAL . 0.7 OUTLIER -118.05 122.48 43.27 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.363 -1.08 . . . . 0.0 109.431 -179.75 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.633 ' HA ' ' CD2' ' A' ' 186' ' ' TYR . 41.9 t -144.24 142.5 30.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.288 -0.883 . . . . 0.0 110.822 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.774 HG21 ' HD2' ' A' ' 164' ' ' PRO . 0.0 OUTLIER -90.75 116.34 31.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.405 -0.809 . . . . 0.0 109.321 179.046 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 94.96 -26.03 20.83 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.608 ' CA ' HD23 ' A' ' 168' ' ' LEU . . . 102.54 42.18 2.21 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 187' ' ' LEU . 4.7 m -137.53 -54.84 0.68 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.158 -1.201 . . . . 0.0 110.444 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.729 ' HD2' HD13 ' A' ' 182' ' ' ILE . 0.1 OUTLIER -62.0 77.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.129 0.966 . . . . 0.0 109.962 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.828 HD21 ' CZ ' ' A' ' 191' ' ' PHE . 1.7 tt 179.87 24.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.48 0.657 . . . . 0.0 109.793 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.763 ' N ' ' CD ' ' A' ' 189' ' ' PRO . . . -104.94 -21.3 9.11 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.892 -1.147 . . . . 0.0 112.074 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.763 ' CD ' ' N ' ' A' ' 188' ' ' GLY . 47.5 Cg_endo -74.21 -42.76 0.64 Allowed 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 122.812 0.901 . . . . 0.0 111.386 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -90.18 10.43 24.55 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.996 -1.065 . . . . 0.0 111.004 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 1.003 ' CE1' HD23 ' A' ' 194' ' ' LEU . 1.5 m-85 -89.98 -13.3 36.42 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.13 -0.981 . . . . 0.0 109.786 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.465 ' HA ' ' NE ' ' A' ' 192' ' ' ARG . 0.0 OUTLIER -70.19 -29.23 66.05 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.158 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.533 ' O ' ' HB3' ' A' ' 197' ' ' ARG . . . -102.41 -18.76 15.61 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.111 -1.996 . . . . 0.0 108.111 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 1.003 HD23 ' CE1' ' A' ' 191' ' ' PHE . 0.9 OUTLIER -61.61 -20.32 63.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.792 -0.828 . . . . 0.0 109.454 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 195' ' ' LYS . 0.1 OUTLIER -64.32 -22.25 66.89 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.441 -0.787 . . . . 0.0 109.367 179.257 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.45 ' N ' ' HE3' ' A' ' 195' ' ' LYS . . . -125.43 -20.23 2.21 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.728 ' HD2' ' HA ' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -90.45 -4.19 57.15 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.479 -1.012 . . . . 0.0 109.267 179.661 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.616 ' HB ' ' O ' ' A' ' 176' ' ' GLY . 0.1 OUTLIER -43.19 138.54 2.18 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 122.401 1.096 . . . . 0.0 112.43 -177.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.967 HD13 ' CG1' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -141.39 172.93 12.01 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.772 179.399 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.53 ' N ' ' O ' ' A' ' 109' ' ' ALA . 8.5 m-85 -82.3 128.66 66.57 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.619 -1.301 . . . . 0.0 109.502 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.611 ' CG ' HD13 ' A' ' 178' ' ' LEU . 53.2 Cg_endo -78.44 144.79 20.53 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 124.045 1.55 . . . . 0.0 112.556 -178.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 1.122 ' O ' HG13 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -133.58 147.56 51.54 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.247 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 1.002 ' HA ' HG22 ' A' ' 106' ' ' VAL . 8.4 p -119.14 163.5 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.722 -1.236 . . . . 0.0 110.388 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 0.793 ' CB ' HG23 ' A' ' 105' ' ' VAL . 0.4 OUTLIER -155.07 134.65 12.66 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.013 0.911 . . . . 0.0 110.466 179.606 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 1.112 ' HB3' ' CG2' ' A' ' 78' ' ' VAL . . . -138.91 147.42 42.3 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.792 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.505 ' CG1' ' HB3' ' A' ' 211' ' ' GLN . 2.5 p -66.25 173.41 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.405 -0.81 . . . . 0.0 110.54 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 0.585 ' O ' ' CG ' ' A' ' 207' ' ' TRP . 33.0 p-90 -107.02 114.26 28.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.281 -0.887 . . . . 0.0 110.257 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 66' ' ' PHE . . . 172.32 174.18 39.5 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -78.38 -73.53 0.32 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -1.157 . . . . 0.0 110.436 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . 0.463 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 89.1 m -86.29 86.24 7.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.356 -0.84 . . . . 0.0 110.292 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.633 ' NE2' HD11 ' A' ' 97' ' ' LEU . 25.1 mm-40 -154.3 -49.92 0.09 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.211 -0.931 . . . . 0.0 110.365 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.931 HG12 ' HH2' ' A' ' 48' ' ' TRP . 47.9 t -127.81 143.73 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.119 -0.988 . . . . 0.0 112.033 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.595 ' HB2' ' CD ' ' A' ' 96' ' ' PRO . 15.6 tpp85 -128.9 137.79 51.63 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.989 HG13 HD13 ' A' ' 93' ' ' ILE . 3.1 tt -142.36 136.32 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.643 -1.286 . . . . 0.0 112.289 -178.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.611 ' HB3' ' HB3' ' A' ' 92' ' ' GLU . 12.7 tpt180 -130.11 109.43 10.82 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . 0.715 ' CZ ' ' CD1' ' A' ' 91' ' ' TRP . 2.1 t80 -89.0 149.59 23.19 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.055 -1.028 . . . . 0.0 111.531 -178.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 44.2 tpp -132.79 107.92 8.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.671 -0.643 . . . . 0.0 109.632 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 93.39 87.46 1.6 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 221' ' ' ARG . 0.3 OUTLIER -95.33 157.88 15.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.257 -1.143 . . . . 0.0 110.406 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 221' ' ' ARG . 27.6 ttt85 -41.27 96.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.375 -0.828 . . . . 0.0 110.245 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . 0.535 ' O ' ' C ' ' A' ' 222' ' ' VAL . 0.0 OUTLIER -177.74 115.11 0.08 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.247 -0.908 . . . . 0.0 109.985 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.535 ' C ' ' O ' ' A' ' 221' ' ' ARG . 0.5 OUTLIER -30.31 121.47 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.428 -0.795 . . . . 0.0 110.614 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.662 ' O ' ' C ' ' A' ' 224' ' ' GLU . 1.4 mt-10 -57.64 -75.68 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.228 -0.92 . . . . 0.0 110.33 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.662 ' C ' ' O ' ' A' ' 223' ' ' GLU . 19.5 mt-10 0.75 70.26 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.347 0.594 . . . . 0.0 111.317 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.614 ' N ' ' O ' ' A' ' 223' ' ' GLU . 68.6 p -45.25 93.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.52 -0.737 . . . . 0.0 110.15 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 224' ' ' GLU . 0.1 OUTLIER -146.57 -164.72 2.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -0.88 . . . . 0.0 110.331 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.412 ' O ' ' HG3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -155.55 61.03 0.61 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.927 . . . . 0.0 110.2 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.683 ' C ' HD12 ' A' ' 228' ' ' ILE . 2.2 pp -135.02 41.78 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.153 -0.967 . . . . 0.0 110.308 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.427 ' C ' ' O ' ' A' ' 228' ' ' ILE . 94.9 m-70 -42.68 -47.98 5.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.293 -0.88 . . . . 0.0 110.249 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . 0.676 ' O ' ' C ' ' A' ' 231' ' ' ASP . 6.9 ttp180 -47.88 131.57 15.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 110.273 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.676 ' C ' ' O ' ' A' ' 230' ' ' ARG . 5.9 m-20 . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 117.988 -1.006 . . . . 0.0 111.413 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 7' ' ' SER . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 6' ' ' GLY . 8.0 t 59.05 120.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -1.156 . . . . 0.0 110.211 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 9' ' ' ALA . 0.5 OUTLIER -72.39 -42.7 64.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -0.868 . . . . 0.0 110.194 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 8' ' ' SER . . . -177.15 105.94 0.06 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.351 -0.843 . . . . 0.0 110.148 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.59 85.89 2.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.315 -0.866 . . . . 0.0 110.178 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.33 115.4 3.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -0.897 . . . . 0.0 110.223 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.0 t -53.75 -88.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.193 -0.942 . . . . 0.0 110.071 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.477 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 3.0 t -170.27 53.4 0.21 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.93 . . . . 0.0 110.216 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 13' ' ' THR . 45.4 Cg_endo -72.96 149.88 47.9 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.016 1.535 . . . . 0.0 110.38 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 15' ' ' THR . 7.5 t -109.37 48.12 0.89 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.307 -0.871 . . . . 0.0 110.219 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.11 -20.59 60.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.315 -0.866 . . . . 0.0 110.166 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -97.4 -147.75 0.31 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.288 -0.883 . . . . 0.0 110.205 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -44.07 153.11 0.15 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.202 -0.936 . . . . 0.0 110.28 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.442 HD23 ' H ' ' A' ' 20' ' ' TYR . 0.2 OUTLIER -75.46 -149.36 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.257 -0.902 . . . . 0.0 110.164 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.442 ' H ' HD23 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -72.34 -158.78 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.295 -0.878 . . . . 0.0 110.055 179.826 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.8 p -69.59 105.84 2.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.198 -0.939 . . . . 0.0 110.022 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -80.31 43.79 0.65 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 110.394 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.86 -48.16 83.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.892 . . . . 0.0 110.201 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.6 147.24 45.99 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.454 -0.779 . . . . 0.0 110.114 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.0 135.5 23.26 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.007 1.53 . . . . 0.0 110.512 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.694 ' O ' ' N ' ' A' ' 28' ' ' GLY . 45.9 Cg_endo -72.44 -161.01 0.1 OUTLIER 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 124.089 1.573 . . . . 0.0 110.456 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.656 ' C ' ' O ' ' A' ' 26' ' ' PRO . 16.1 mm-40 1.72 65.55 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.586 0.708 . . . . 0.0 110.988 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.694 ' N ' ' O ' ' A' ' 26' ' ' PRO . . . 156.16 31.24 0.03 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.782 ' H ' HD23 ' A' ' 29' ' ' LEU . 1.0 OUTLIER -74.02 -13.85 60.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -1.139 . . . . 0.0 109.796 179.826 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.938 ' HA ' HD23 ' A' ' 33' ' ' LEU . 1.6 tt0 -46.64 -26.86 1.0 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.408 -0.808 . . . . 0.0 109.159 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -74.85 -22.58 58.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.463 -0.773 . . . . 0.0 108.933 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.601 ' N ' ' O ' ' A' ' 29' ' ' LEU . 1.1 mm? -83.84 -32.17 25.4 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.062 HD11 ' HB2' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -71.11 -35.93 71.98 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 122.064 0.935 . . . . 0.0 109.139 179.299 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.65 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 3.7 t -79.71 -7.62 58.72 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.323 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 1.047 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -70.42 -70.96 0.29 Allowed Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.122 -0.986 . . . . 0.0 110.899 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 1.047 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 51.6 Cg_endo -75.39 160.92 38.37 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.495 1.261 . . . . 0.0 110.483 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 36' ' ' PRO . 53.5 Cg_endo -99.81 52.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.123 1.882 . . . . 0.0 112.113 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.685 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 48.6 Cg_endo -72.89 151.04 50.35 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.125 1.066 . . . . 0.0 110.703 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.667 ' OD2' ' HD3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -15.2 -65.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.757 -0.59 . . . . 0.0 111.786 179.282 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.098 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -45.28 -43.71 10.79 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.413 -0.804 . . . . 0.0 110.412 -179.434 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.89 HG12 ' CE1' ' A' ' 45' ' ' HIS . 3.8 t -85.08 -19.33 8.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 O-C-N 121.168 -0.958 . . . . 0.0 111.185 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.52 -44.12 10.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.89 -1.132 . . . . 0.0 112.339 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.683 ' NE2' ' HG2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -85.39 -19.48 31.32 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 118.385 -1.326 . . . . 0.0 109.425 -179.737 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.686 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -69.31 -41.81 76.22 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 122.165 0.983 . . . . 0.0 108.472 179.218 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.89 ' CE1' HG12 ' A' ' 41' ' ' VAL . 20.3 m170 -63.74 -28.82 70.15 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.748 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -96.35 -29.64 13.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.874 -1.141 . . . . 0.0 109.608 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.09 -89.83 1.47 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 107.339 -2.304 . . . . 0.0 107.339 178.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.77 ' HH2' HG12 ' A' ' 212' ' ' VAL . 97.4 m95 -90.77 74.37 6.59 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.58 ' ND2' ' N ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -43.26 137.94 2.74 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.527 -0.733 . . . . 0.0 111.428 -179.045 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.705 ' HA ' ' O ' ' A' ' 53' ' ' CYS . 40.0 Cg_endo -67.67 -23.31 42.65 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 124.435 1.755 . . . . 0.0 111.168 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.835 ' CE ' ' N ' ' A' ' 51' ' ' LYS . 0.6 OUTLIER -65.29 -15.58 62.66 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 178.326 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 1.103 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 11.2 m-20 -121.97 3.15 9.95 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.162 177.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.873 ' SG ' HG12 ' A' ' 78' ' ' VAL . 9.5 t -148.0 138.08 22.7 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.507 0.67 . . . . 0.0 110.292 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.762 ' HB2' ' O ' ' A' ' 76' ' ' ASP . 1.5 m -80.29 130.68 35.37 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.175 -0.953 . . . . 0.0 109.835 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 1.062 ' HB2' HD11 ' A' ' 33' ' ' LEU . 4.3 pm0 -44.63 -24.36 0.19 Allowed 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.669 ' ND2' ' HB2' ' A' ' 54' ' ' SER . 0.1 OUTLIER -55.5 -4.58 0.1 Allowed 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.575 -1.328 . . . . 0.0 109.866 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.576 HG22 HG22 ' A' ' 59' ' ' VAL . 22.8 mm -111.96 157.75 12.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.477 -0.765 . . . . 0.0 110.518 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.654 ' HA ' HD23 ' A' ' 40' ' ' LEU . 35.9 t0 -118.87 105.4 11.46 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.709 0.766 . . . . 0.0 109.534 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.7 ' CG1' ' CD1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -131.08 136.12 58.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 O-C-N 121.628 -0.67 . . . . 0.0 110.919 -178.942 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.683 ' HG2' ' NE2' ' A' ' 43' ' ' GLN . 28.7 mttp -135.53 155.28 50.75 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.282 -0.886 . . . . 0.0 110.535 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.483 ' HG3' ' N ' ' A' ' 62' ' ' GLY . 7.8 pt-20 -75.82 -130.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.227 -0.921 . . . . 0.0 110.408 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.483 ' N ' ' HG3' ' A' ' 61' ' ' GLU . . . 45.73 45.12 12.99 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.661 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 108.9 60.55 0.53 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.953 HD21 ' O ' ' A' ' 214' ' ' ILE . 0.3 OUTLIER -0.32 78.98 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.878 -0.778 . . . . 0.0 111.27 -179.283 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.499 ' O ' ' SG ' ' A' ' 65' ' ' CYS . 31.9 p -99.58 114.33 27.29 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.13 -0.981 . . . . 0.0 109.647 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.7 ' CD1' ' CG1' ' A' ' 59' ' ' VAL . 1.2 t80 -90.55 124.84 35.35 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.479 -0.763 . . . . 0.0 110.211 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 4.9 tt0 -139.99 152.89 46.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.172 -0.955 . . . . 0.0 109.674 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.527 ' HG3' ' HB3' ' A' ' 207' ' ' TRP . 0.1 OUTLIER -135.93 140.25 43.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.022 -1.049 . . . . 0.0 110.83 -179.578 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.629 ' CB ' ' HD2' ' A' ' 70' ' ' PRO . 1.4 mtp85 -61.13 -173.94 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.386 -0.821 . . . . 0.0 109.208 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.629 ' HD2' ' CB ' ' A' ' 69' ' ' ARG . 50.9 Cg_endo -66.28 -138.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.591 1.311 . . . . 0.0 108.958 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.72 152.61 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.966 -1.083 . . . . 0.0 110.015 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.6 -39.95 0.13 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.161 -0.962 . . . . 0.0 110.188 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.549 ' O ' ' N ' ' A' ' 75' ' ' THR . 0.2 OUTLIER -170.14 147.12 3.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.286 -0.884 . . . . 0.0 110.145 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 73' ' ' GLN . 9.2 t -43.74 91.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 110.353 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.647 HG21 ' OD1' ' A' ' 56' ' ' ASN . 1.5 m -99.17 -129.4 0.2 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.296 -0.877 . . . . 0.0 110.053 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.762 ' O ' ' HB2' ' A' ' 54' ' ' SER . 72.5 m-20 -137.73 113.91 10.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.195 -0.94 . . . . 0.0 110.486 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.506 ' O ' ' O ' ' A' ' 76' ' ' ASP . . . -50.73 -96.16 0.01 OUTLIER Glycine 0 N--CA 1.484 1.837 0 N-CA-C 107.759 -2.136 . . . . 0.0 107.759 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.873 HG12 ' SG ' ' A' ' 53' ' ' CYS . 6.9 m -143.05 126.93 14.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.215 -1.168 . . . . 0.0 110.237 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.651 ' C ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -145.57 134.16 22.11 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.131 -0.981 . . . . 0.0 112.536 -178.615 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 1.103 ' CA ' ' HA ' ' A' ' 52' ' ' ASP . . . -133.13 161.56 24.17 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 178.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.505 ' HG3' ' HB3' ' A' ' 202' ' ' SER . 0.4 OUTLIER -169.96 24.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.237 -1.155 . . . . 0.0 110.345 -179.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.469 ' O ' ' CD2' ' A' ' 200' ' ' TYR . 1.1 ptt180 -91.36 -102.44 0.11 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.075 -1.016 . . . . 0.0 110.428 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.452 ' HA3' ' CG ' ' A' ' 201' ' ' PRO . . . 81.03 66.6 1.61 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -121.77 95.8 4.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -1.166 . . . . 0.0 110.361 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 173' ' ' MET . 69.7 m -140.09 155.6 46.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.207 -0.933 . . . . 0.0 110.286 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.518 ' C ' ' NE2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -118.2 135.42 54.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.207 -0.933 . . . . 0.0 109.809 179.832 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 106.45 -118.32 5.64 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.476 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 51.3 tp -128.79 123.09 31.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.408 -1.054 . . . . 0.0 110.904 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.518 ' NE2' ' C ' ' A' ' 86' ' ' ARG . 4.2 m-70 -147.2 153.17 39.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.205 -0.934 . . . . 0.0 109.758 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.54 ' C ' ' CE3' ' A' ' 91' ' ' TRP . . . -163.71 156.85 18.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.025 -1.047 . . . . 0.0 110.201 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.985 ' HB2' HD11 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -134.98 154.69 51.63 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.184 -0.948 . . . . 0.0 110.108 179.484 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.893 ' C ' HD13 ' A' ' 93' ' ' ILE . 0.5 OUTLIER -109.56 118.93 37.89 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.318 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.985 HD11 ' HB2' ' A' ' 91' ' ' TRP . 0.1 OUTLIER -132.95 133.86 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.819 -1.176 . . . . 0.0 111.491 -178.659 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.567 ' O ' ' HD3' ' A' ' 96' ' ' PRO . 0.1 OUTLIER -116.84 120.08 37.39 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.441 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 1.007 ' HZ2' ' HB3' ' A' ' 104' ' ' ALA . 6.3 t-105 -116.13 87.39 19.25 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.106 -0.997 . . . . 0.0 110.332 -178.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.608 ' HA ' ' O ' ' A' ' 101' ' ' GLY . 49.9 Cg_endo -99.24 138.66 0.32 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.257 1.972 . . . . 0.0 110.319 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.766 HD23 ' HB3' ' A' ' 103' ' ' HIS . 1.9 tm? -95.03 -67.05 0.87 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.866 -1.146 . . . . 0.0 109.405 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 99' ' ' GLN . 4.3 mt-10 -96.68 -14.57 21.99 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.437 -0.79 . . . . 0.0 109.203 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.536 ' O ' ' HG2' ' A' ' 100' ' ' ARG . 0.1 OUTLIER 179.99 -32.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.538 0.685 . . . . 0.0 109.893 179.772 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.536 ' HG2' ' O ' ' A' ' 99' ' ' GLN . 3.1 mtt180 -152.23 -43.99 0.1 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.51 -0.744 . . . . 0.0 110.469 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.608 ' O ' ' HA ' ' A' ' 96' ' ' PRO . . . -55.34 -175.04 0.13 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.973 HG23 HG21 ' A' ' 135' ' ' ILE . 0.9 OUTLIER -121.9 -154.9 0.61 Allowed 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.434 -1.039 . . . . 0.0 110.1 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.766 ' HB3' HD23 ' A' ' 97' ' ' LEU . 13.7 t-80 179.74 -50.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.199 -0.938 . . . . 0.0 110.701 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 1.007 ' HB3' ' HZ2' ' A' ' 95' ' ' TRP . . . -85.45 -109.52 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 0.0 110.859 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 204' ' ' SER . 0.1 OUTLIER -136.23 138.59 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.414 -1.429 . . . . 0.0 112.657 -178.286 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.702 HG22 ' CE3' ' A' ' 95' ' ' TRP . 1.0 OUTLIER -152.16 122.82 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.62 -0.675 . . . . 0.0 109.431 177.413 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.529 ' HA3' ' HA3' ' A' ' 132' ' ' GLY . . . 160.44 -158.56 30.0 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 118.711 -1.709 . . . . 0.0 111.097 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.645 HG12 ' HB2' ' A' ' 199' ' ' LEU . 2.3 t -120.78 169.34 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.725 -0.867 . . . . 0.0 109.717 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.539 ' C ' ' HB3' ' A' ' 199' ' ' LEU . . . -146.19 132.66 19.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.996 -1.065 . . . . 0.0 110.263 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.745 HG23 ' CG ' ' A' ' 199' ' ' LEU . 9.7 p -89.43 120.85 31.12 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.146 -0.971 . . . . 0.0 110.304 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.17 -31.55 14.74 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.638 -0.664 . . . . 0.0 109.817 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.492 HD23 ' H ' ' A' ' 112' ' ' LEU . 0.6 OUTLIER -76.91 -12.47 59.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.401 -0.812 . . . . 0.0 110.01 179.807 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.444 ' O ' ' OE1' ' A' ' 129' ' ' GLU . . . -112.83 68.46 1.05 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.376 -0.828 . . . . 0.0 110.261 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.49 ' HD3' ' C ' ' A' ' 112' ' ' LEU . 46.5 Cg_endo -72.7 -44.55 0.66 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.917 1.482 . . . . 0.0 110.362 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.672 ' O ' HD12 ' A' ' 115' ' ' LEU . 1.2 pp -179.88 53.14 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.247 -0.908 . . . . 0.0 110.222 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -56.06 -77.28 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.205 -0.935 . . . . 0.0 110.214 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.524 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -43.58 -45.16 6.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.402 -0.811 . . . . 0.0 110.225 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.524 ' C ' ' O ' ' A' ' 117' ' ' ALA . 2.7 t70 -31.75 142.45 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.454 -0.779 . . . . 0.0 110.823 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.415 ' CD2' ' C ' ' A' ' 119' ' ' HIS . 0.8 OUTLIER -145.21 35.07 1.09 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.395 -0.816 . . . . 0.0 110.177 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.469 ' O ' ' CG ' ' A' ' 120' ' ' TYR . 1.9 p90 -167.28 131.23 1.85 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 110.203 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.638 ' O ' ' HB3' ' A' ' 122' ' ' ALA . . . 42.53 -162.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.884 . . . . 0.0 110.149 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 121' ' ' ALA . . . 64.06 77.62 0.31 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -0.87 . . . . 0.0 110.255 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.525 ' O ' HD12 ' A' ' 123' ' ' LEU . 0.9 OUTLIER -175.53 71.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.0 110.185 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.56 -69.58 0.1 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.158 -0.963 . . . . 0.0 110.276 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -132.56 2.96 5.01 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.95 49.29 0.87 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.105 -1.232 . . . . 0.0 110.27 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.447 ' ND2' ' HB3' ' A' ' 114' ' ' PRO . 6.9 t30 -95.2 78.54 3.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.898 . . . . 0.0 110.251 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -175.74 172.58 2.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 110.218 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.444 ' OE1' ' O ' ' A' ' 113' ' ' ALA . 0.9 OUTLIER -150.4 138.1 19.89 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.224 -0.923 . . . . 0.0 109.766 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 8.9 t -120.06 120.71 37.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.386 -0.821 . . . . 0.0 110.006 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . 0.465 ' O ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -132.2 133.36 44.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.882 . . . . 0.0 110.255 -179.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.529 ' HA3' ' HA3' ' A' ' 107' ' ' GLY . . . 165.72 -120.38 0.92 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.662 ' CZ3' ' CD2' ' A' ' 180' ' ' TYR . 47.0 m0 -119.48 112.81 19.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.043 -1.269 . . . . 0.0 110.025 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.804 ' C ' HD13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -118.92 148.22 43.17 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.397 0.618 . . . . 0.0 110.685 -179.545 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.973 HG21 HG23 ' A' ' 102' ' ' THR . 0.0 OUTLIER -139.34 3.45 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.946 . . . . 0.0 110.116 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.94 -14.79 61.61 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -85.0 3.05 40.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -1.132 . . . . 0.0 109.413 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.786 ' O ' ' O ' ' A' ' 139' ' ' LYS . . . -148.57 13.25 1.19 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.786 ' O ' ' O ' ' A' ' 138' ' ' GLY . 0.4 OUTLIER 1.12 -133.51 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 121.795 0.807 . . . . 0.0 112.196 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.77 -72.12 0.09 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.449 -0.782 . . . . 0.0 110.127 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.584 ' CE2' HD21 ' A' ' 161' ' ' LEU . 0.1 OUTLIER 179.87 106.54 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 110.308 179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -93.58 -2.05 54.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 0.0 110.244 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -100.59 -75.11 0.59 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.36 -0.837 . . . . 0.0 110.323 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.24 156.53 39.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.18 -0.95 . . . . 0.0 110.242 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.437 ' O ' ' HG3' ' A' ' 145' ' ' LYS . 0.1 OUTLIER -77.98 80.93 4.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.892 . . . . 0.0 110.336 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -160.64 142.52 8.2 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 148' ' ' GLU . 1.8 tp -89.88 13.51 14.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.199 -1.177 . . . . 0.0 110.131 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.472 ' O ' ' HD3' ' A' ' 150' ' ' PRO . 0.8 OUTLIER -179.75 100.18 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.233 -0.917 . . . . 0.0 110.09 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.886 ' CB ' ' HB3' ' A' ' 154' ' ' ALA . . . -41.6 101.18 0.24 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.208 -0.933 . . . . 0.0 110.109 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 47.1 Cg_endo -74.71 -14.86 21.77 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.019 1.536 . . . . 0.0 110.42 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -91.61 -99.69 0.12 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.335 -0.853 . . . . 0.0 110.179 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.602 ' CG ' ' HD2' ' A' ' 153' ' ' PRO . 0.1 OUTLIER -73.31 -178.56 0.72 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.156 -0.965 . . . . 0.0 109.991 179.861 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.602 ' HD2' ' CG ' ' A' ' 152' ' ' TYR . 45.5 Cg_endo -72.76 110.98 3.14 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.978 1.515 . . . . 0.0 110.335 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.886 ' HB3' ' CB ' ' A' ' 149' ' ' ALA . . . -174.98 163.48 3.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.189 -0.944 . . . . 0.0 110.228 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.576 ' N ' ' CD ' ' A' ' 156' ' ' PRO . . . 49.03 47.03 32.95 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 155' ' ' GLY . 46.9 Cg_endo -74.08 -63.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.801 1.421 . . . . 0.0 110.565 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.506 ' HB3' ' HG2' ' A' ' 159' ' ' GLU . 3.3 mp0 -75.93 -0.89 23.06 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.216 -0.928 . . . . 0.0 110.425 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.497 ' O ' ' HB ' ' A' ' 162' ' ' VAL . . . 43.89 26.68 0.84 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.624 ' CB ' HG21 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -92.11 4.06 53.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -1.142 . . . . 0.0 110.277 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.19 -16.99 23.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -0.88 . . . . 0.0 108.929 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.62 ' C ' HD12 ' A' ' 161' ' ' LEU . 0.9 OUTLIER -173.96 27.7 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.562 0.696 . . . . 0.0 109.403 179.47 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.821 HG12 ' O ' ' A' ' 162' ' ' VAL . 2.4 t -155.02 84.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.587 -0.696 . . . . 0.0 110.355 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.665 ' H ' ' HD2' ' A' ' 164' ' ' PRO . 1.3 t -154.29 -58.43 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.388 -0.82 . . . . 0.0 110.272 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.665 ' HD2' ' H ' ' A' ' 163' ' ' VAL . 45.6 Cg_endo -73.29 68.6 4.19 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.74 1.389 . . . . 0.0 110.705 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.475 ' HG2' ' CB ' ' A' ' 100' ' ' ARG . 94.5 mt-10 -80.72 -81.27 0.13 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.304 -0.873 . . . . 0.0 109.116 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 1.134 ' O ' HD13 ' A' ' 167' ' ' LEU . 9.7 ttp180 -119.09 115.53 24.48 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.394 -0.816 . . . . 0.0 108.961 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 1.134 HD13 ' O ' ' A' ' 166' ' ' ARG . 0.3 OUTLIER -132.14 157.46 44.2 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 121.424 0.631 . . . . 0.0 110.474 -179.015 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.754 HD12 ' CD ' ' A' ' 92' ' ' GLU . 0.7 OUTLIER -107.42 125.82 51.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.371 -0.831 . . . . 0.0 109.736 179.401 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.716 HG22 ' CE1' ' A' ' 180' ' ' TYR . 19.3 t -89.53 132.37 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.139 -0.975 . . . . 0.0 110.062 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.577 HG13 HD21 ' A' ' 168' ' ' LEU . 0.1 OUTLIER -125.3 111.48 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.398 -0.814 . . . . 0.0 110.186 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.691 ' HB3' ' CZ2' ' A' ' 91' ' ' TRP . 2.0 tp -107.41 114.04 27.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.339 -0.851 . . . . 0.0 110.022 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.496 ' N ' HD12 ' A' ' 171' ' ' LEU . 53.1 t0 -116.22 129.85 56.5 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.268 -0.895 . . . . 0.0 110.067 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.494 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 12.4 tpp -100.85 -42.02 6.62 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 173' ' ' MET . 0.7 OUTLIER -45.87 -25.62 0.56 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.078 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.548 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.0 OUTLIER -111.59 -28.07 8.3 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.751 0.786 . . . . 0.0 108.895 179.29 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.812 ' O ' HG21 ' A' ' 198' ' ' THR . . . 85.37 22.66 50.65 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.649 ' CA ' HD22 ' A' ' 194' ' ' LEU . 0.2 OUTLIER -119.73 111.43 18.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.258 -1.142 . . . . 0.0 111.081 -179.631 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.718 HD11 ' O ' ' A' ' 199' ' ' LEU . 0.3 OUTLIER -136.01 154.34 51.1 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.251 -0.906 . . . . 0.0 110.225 179.345 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.445 ' HA2' HG21 ' A' ' 108' ' ' VAL . . . 172.49 -153.21 18.46 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.886 ' C ' HD22 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -118.79 125.21 49.09 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.192 -1.181 . . . . 0.0 109.768 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.431 ' HA ' ' HB3' ' A' ' 187' ' ' LEU . 17.0 t -116.72 124.88 50.76 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.381 -0.825 . . . . 0.0 110.171 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 1.023 HG22 HD12 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -103.7 116.71 47.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.495 -0.753 . . . . 0.0 109.645 179.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 49.66 22.49 4.12 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 57.26 48.43 80.27 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . 0.863 HG22 ' CD1' ' A' ' 186' ' ' TYR . 69.1 m -110.48 -86.53 0.54 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.326 -1.102 . . . . 0.0 110.892 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.863 ' CD1' HG22 ' A' ' 185' ' ' THR . 8.9 m-30 -59.67 -56.57 20.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.26 -0.9 . . . . 0.0 110.809 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.886 HD22 ' C ' ' A' ' 180' ' ' TYR . 0.6 OUTLIER -76.25 43.94 0.31 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.002 -1.061 . . . . 0.0 110.12 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.489 ' H ' ' HD2' ' A' ' 189' ' ' PRO . . . -105.32 -70.47 0.78 Allowed Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.913 -1.137 . . . . 0.0 110.269 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.489 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 45.3 Cg_endo -71.5 -29.71 16.1 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.899 1.473 . . . . 0.0 111.151 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.539 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -72.74 34.17 0.07 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.339 -0.851 . . . . 0.0 111.267 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.406 ' H ' ' C ' ' A' ' 189' ' ' PRO . 0.4 OUTLIER -90.51 -43.94 9.91 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.982 -1.074 . . . . 0.0 109.884 179.351 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -16.65 61.07 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.32 -0.863 . . . . 0.0 110.107 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -106.23 -13.38 23.16 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.782 HD23 ' O ' ' A' ' 194' ' ' LEU . 7.2 tt -70.94 -29.92 66.08 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.589 -0.948 . . . . 0.0 109.433 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.569 ' HE3' ' N ' ' A' ' 196' ' ' GLY . 0.1 OUTLIER -53.92 -32.61 54.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.224 -0.922 . . . . 0.0 109.493 179.745 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.569 ' N ' ' HE3' ' A' ' 195' ' ' LYS . . . -94.93 -25.97 13.66 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 1.003 ' HD3' HD11 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.67 -4.76 56.53 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.764 -0.845 . . . . 0.0 109.632 179.499 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.812 HG21 ' O ' ' A' ' 176' ' ' GLY . 0.2 OUTLIER -44.01 136.96 3.51 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.76 0.79 . . . . 0.0 111.747 -178.243 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 1.003 HD11 ' HD3' ' A' ' 197' ' ' ARG . 0.0 OUTLIER -140.37 170.81 15.12 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.381 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.542 ' C ' HG13 ' A' ' 108' ' ' VAL . 3.1 m-30 -84.76 139.03 37.54 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.934 . . . . 0.0 109.752 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.452 ' CG ' ' HA3' ' A' ' 83' ' ' GLY . 40.6 Cg_endo -67.8 113.74 3.09 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.871 1.458 . . . . 0.0 110.203 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.505 ' HB3' ' HG3' ' A' ' 81' ' ' LYS . 25.1 p -133.11 152.95 51.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.296 -0.877 . . . . 0.0 110.81 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 79' ' ' ARG . 6.1 p -160.2 149.91 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.524 -0.735 . . . . 0.0 110.049 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 0.904 ' O ' ' HH2' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -139.86 126.53 20.51 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.303 -0.873 . . . . 0.0 109.134 178.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.559 ' HB3' ' CG2' ' A' ' 78' ' ' VAL . . . -127.81 163.5 24.25 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.746 -1.221 . . . . 0.0 111.678 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.57 HG13 ' N ' ' A' ' 207' ' ' TRP . 1.2 t -50.2 174.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.752 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 0.57 ' N ' HG13 ' A' ' 206' ' ' VAL . 79.0 m95 -51.29 -74.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.375 -0.828 . . . . 0.0 109.259 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.631 ' HA2' ' CD2' ' A' ' 66' ' ' PHE . . . 177.03 103.86 0.17 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.487 ' HB2' ' O ' ' A' ' 208' ' ' GLY . 18.6 tt0 179.68 -49.11 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.767 -0.843 . . . . 0.0 110.195 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . 0.521 ' O ' ' CG ' ' A' ' 211' ' ' GLN . 1.7 m -43.0 -96.78 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.62 -0.675 . . . . 0.0 110.658 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.577 ' O ' ' HG2' ' A' ' 96' ' ' PRO . 0.0 OUTLIER 179.53 45.23 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.24 -0.912 . . . . 0.0 109.523 -179.603 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.77 HG12 ' HH2' ' A' ' 48' ' ' TRP . 29.2 t -86.08 138.22 19.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-O 121.558 0.694 . . . . 0.0 110.758 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.454 ' HA ' ' HZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -125.71 143.7 50.93 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.48 -0.763 . . . . 0.0 110.139 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.953 ' O ' HD21 ' A' ' 64' ' ' LEU . 1.5 tt -140.12 127.59 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.086 -1.009 . . . . 0.0 110.488 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -129.96 144.23 51.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.306 -0.871 . . . . 0.0 109.596 179.519 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . 0.731 ' CE2' ' CE3' ' A' ' 91' ' ' TRP . 1.2 t80 -118.62 151.37 38.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.248 -0.908 . . . . 0.0 111.318 -178.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . 0.483 ' HB3' ' O ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -127.79 107.83 10.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.469 -0.77 . . . . 0.0 109.658 179.332 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 71.75 76.51 0.59 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.57 ' HB2' ' CD2' ' A' ' 216' ' ' TYR . 32.1 tt0 -95.39 156.87 16.14 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.22 -1.164 . . . . 0.0 110.296 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.5 ' NE ' ' HA ' ' A' ' 220' ' ' ARG . 0.2 OUTLIER -110.19 -141.15 0.38 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 0.0 110.123 179.781 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . 0.483 ' O ' ' O ' ' A' ' 222' ' ' VAL . 4.1 tpp180 -178.18 97.75 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 110.346 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 221' ' ' ARG . 14.2 p -38.66 161.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.302 -0.874 . . . . 0.0 110.467 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.516 ' O ' ' C ' ' A' ' 224' ' ' GLU . 0.1 OUTLIER -173.4 78.49 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 110.218 179.812 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.516 ' C ' ' O ' ' A' ' 223' ' ' GLU . 1.7 mp0 -32.87 -68.12 0.11 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.49 -0.756 . . . . 0.0 110.683 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 224' ' ' GLU . 22.8 p -42.8 149.28 0.2 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 0.0 110.244 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.422 ' HD2' ' O ' ' A' ' 224' ' ' GLU . 0.0 OUTLIER -162.87 89.83 0.67 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.287 -0.883 . . . . 0.0 110.228 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -47.21 -63.09 1.13 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 110.278 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.5 mt -54.52 141.87 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.282 -0.886 . . . . 0.0 110.337 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.445 ' O ' ' C ' ' A' ' 230' ' ' ARG . 0.2 OUTLIER -115.97 123.76 48.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.227 -0.921 . . . . 0.0 110.016 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 231' ' ' ASP . 11.3 mtp180 -41.44 -80.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 110.223 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 230' ' ' ARG . 6.7 t70 . . . . . 0 C--N 1.306 -1.314 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.314 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.97 -158.62 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.162 -1.199 . . . . 0.0 110.244 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.1 m 53.63 80.24 0.11 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 110.156 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 11' ' ' GLN . . . -119.21 -161.44 0.85 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.88 . . . . 0.0 110.208 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -53.56 89.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 110.307 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -179.86 102.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.337 -0.852 . . . . 0.0 110.256 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.47 101.97 1.7 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 110.179 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 11' ' ' GLN . 20.4 p -136.75 76.19 47.87 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.131 -0.981 . . . . 0.0 110.174 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.453 ' O ' ' N ' ' A' ' 16' ' ' SER . 46.4 Cg_endo -73.14 148.21 44.02 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.942 1.496 . . . . 0.0 110.456 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.56 HG23 ' O ' ' A' ' 15' ' ' THR . 9.1 t -68.64 63.81 0.11 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.201 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -153.02 167.39 29.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.143 -0.973 . . . . 0.0 110.181 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.443 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 6.6 pm0 -55.72 128.77 36.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.135 -0.978 . . . . 0.0 110.234 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 17' ' ' GLN . . . -177.52 156.42 1.17 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.201 -0.937 . . . . 0.0 110.178 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -69.81 -163.67 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 0.0 110.223 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.55 -155.08 0.59 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.353 -0.842 . . . . 0.0 110.109 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 p -83.46 103.66 12.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.251 -0.905 . . . . 0.0 110.054 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -81.8 41.22 0.64 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.912 . . . . 0.0 110.334 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.83 -73.76 0.53 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 109.973 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.8 m -78.98 115.16 50.26 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.455 -0.778 . . . . 0.0 110.133 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.72 118.36 5.54 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.963 1.507 . . . . 0.0 110.495 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.681 ' O ' ' N ' ' A' ' 28' ' ' GLY . 46.3 Cg_endo -73.14 -165.11 0.22 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.998 1.526 . . . . 0.0 110.498 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.668 ' C ' ' O ' ' A' ' 26' ' ' PRO . 10.0 mm-40 1.33 66.09 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.49 0.662 . . . . 0.0 111.059 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.681 ' N ' ' O ' ' A' ' 26' ' ' PRO . . . -153.01 -35.0 0.03 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.897 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -74.43 -40.18 62.13 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.437 -1.037 . . . . 0.0 109.918 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.61 ' HA ' HD23 ' A' ' 33' ' ' LEU . 1.4 pp20? -46.17 -37.37 6.94 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.135 -0.978 . . . . 0.0 109.165 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -57.44 -25.56 59.84 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.381 -0.825 . . . . 0.0 108.823 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 29' ' ' LEU . 5.9 tp -83.12 -32.21 26.82 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.831 HD12 ' C ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -84.94 -38.42 19.36 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 121.82 0.819 . . . . 0.0 109.237 179.164 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.565 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 1.1 t -49.23 -20.63 0.65 Allowed 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.388 0.613 . . . . 0.0 110.189 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 1.051 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -52.34 -161.37 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.516 -0.74 . . . . 0.0 109.692 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 1.051 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 39.2 Cg_endo -66.61 121.85 9.16 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 O-C-N 123.001 1.0 . . . . 0.0 109.754 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.991 ' CB ' HG21 ' A' ' 41' ' ' VAL . 44.0 Cg_endo -70.08 109.27 2.33 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.154 1.607 . . . . 0.0 111.732 -178.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.774 ' O ' ' N ' ' A' ' 40' ' ' LEU . 52.0 Cg_endo -79.74 151.62 22.01 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.238 1.652 . . . . 0.0 109.239 178.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.733 ' C ' HE22 ' A' ' 43' ' ' GLN . 0.9 OUTLIER -12.83 -51.23 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 122.167 0.984 . . . . 0.0 110.062 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.073 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -34.78 -43.23 0.17 Allowed 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.934 -179.346 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.991 HG21 ' CB ' ' A' ' 37' ' ' PRO . 2.9 t -70.87 -24.81 25.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 O-C-N 121.168 -0.957 . . . . 0.0 110.678 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.607 ' N ' ' O ' ' A' ' 39' ' ' ASP . . . -90.69 -41.54 11.24 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 118.981 -1.087 . . . . 0.0 113.104 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.733 HE22 ' C ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -87.37 -19.37 28.24 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.862 -1.149 . . . . 0.0 109.829 -179.1 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 1.034 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 7.5 ttm-85 -72.44 -53.98 10.64 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.756 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 66.3 m170 -55.49 -27.98 51.76 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.556 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -96.07 -30.43 13.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.02 -1.05 . . . . 0.0 109.586 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.87 -74.11 1.27 Allowed Glycine 0 N--CA 1.488 2.131 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.736 ' CD2' ' CE1' ' A' ' 66' ' ' PHE . 99.2 m95 -100.36 74.09 1.71 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.618 ' HA ' ' HA ' ' A' ' 45' ' ' HIS . 0.1 OUTLIER -43.65 145.71 1.11 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.5 -0.75 . . . . 0.0 110.984 -179.419 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.756 ' HD3' ' HA ' ' A' ' 45' ' ' HIS . 42.8 Cg_endo -70.88 -31.07 16.16 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 124.297 1.682 . . . . 0.0 110.681 -178.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.932 ' O ' ' HA2' ' A' ' 80' ' ' GLY . 0.3 OUTLIER -64.17 -16.15 61.32 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.225 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.996 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 4.8 m-20 -118.72 0.28 11.43 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.638 177.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.702 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 16.0 t -150.04 132.9 16.04 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.21 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.649 ' CB ' ' ND2' ' A' ' 56' ' ' ASN . 0.5 OUTLIER -75.23 117.65 17.29 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.593 0.711 . . . . 0.0 109.688 179.186 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.646 ' O ' ' N ' ' A' ' 57' ' ' ILE . 6.7 pt-20 -42.54 -28.67 0.23 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.595 -0.69 . . . . 0.0 112.801 -178.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.834 ' OD1' HG22 ' A' ' 75' ' ' THR . 0.1 OUTLIER -40.34 -16.0 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.298 0 O-C-N 120.96 -1.087 . . . . 0.0 111.04 -179.114 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.747 HG22 HG13 ' A' ' 59' ' ' VAL . 1.2 mt -111.55 165.6 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 120.998 -1.064 . . . . 0.0 110.329 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 67' ' ' GLU . 4.2 t70 -117.54 104.27 10.9 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.76 0.791 . . . . 0.0 110.455 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.782 HG11 ' CE1' ' A' ' 66' ' ' PHE . 34.8 m -130.38 135.42 60.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 121.73 -0.606 . . . . 0.0 110.034 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.755 ' HG2' ' HA ' ' A' ' 40' ' ' LEU . 24.7 mttt -133.04 141.31 48.18 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.763 -1.211 . . . . 0.0 111.377 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.552 ' CG ' ' HB3' ' A' ' 43' ' ' GLN . 0.4 OUTLIER -59.95 -129.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.495 -0.753 . . . . 0.0 110.508 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 44.53 51.11 8.01 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 107.978 -2.049 . . . . 0.0 107.978 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.663 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 103.01 61.58 0.71 Allowed Glycine 0 N--CA 1.486 2.005 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 -178.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.036 HD11 HG22 ' A' ' 214' ' ' ILE . 0.2 OUTLIER 0.83 80.81 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 122.0 -0.706 . . . . 0.0 111.215 -178.737 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.426 ' N ' ' O ' ' A' ' 63' ' ' GLY . 0.5 OUTLIER -99.96 113.89 26.78 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.44 -0.788 . . . . 0.0 110.241 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.782 ' CE1' HG11 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -103.22 124.62 48.96 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.555 -0.716 . . . . 0.0 109.422 179.455 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.621 ' O ' HG23 ' A' ' 57' ' ' ILE . 1.1 tp10 -150.73 149.72 30.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.015 -1.053 . . . . 0.0 110.465 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.598 ' HG2' ' CE2' ' A' ' 207' ' ' TRP . 0.0 OUTLIER -119.54 151.74 38.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.309 -0.87 . . . . 0.0 109.969 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.637 ' CB ' ' HD3' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -94.85 -67.05 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 110.577 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.637 ' HD3' ' CB ' ' A' ' 69' ' ' ARG . 55.9 Cg_endo -73.53 -119.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.584 1.307 . . . . 0.0 109.583 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.408 ' H ' ' HB2' ' A' ' 70' ' ' PRO . 4.0 t -139.97 164.23 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.317 -1.489 . . . . 0.0 110.21 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.912 ' HB2' ' CG ' ' A' ' 207' ' ' TRP . . . -70.48 69.94 0.42 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 0.0 110.108 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -87.29 -160.26 0.58 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.276 -0.89 . . . . 0.0 110.39 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.2 m -73.25 1.22 9.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.928 . . . . 0.0 110.313 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.834 HG22 ' OD1' ' A' ' 56' ' ' ASN . 3.7 m -116.43 0.41 12.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.923 . . . . 0.0 110.104 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.558 ' CB ' ' HA ' ' A' ' 72' ' ' ALA . 0.4 OUTLIER -99.81 154.8 18.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 110.149 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.54 ' O ' ' HB2' ' A' ' 54' ' ' SER . . . 132.47 145.87 5.55 Favored Glycine 0 N--CA 1.483 1.771 0 N-CA-C 108.07 -2.012 . . . . 0.0 108.07 -179.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.105 ' CG2' ' HB3' ' A' ' 205' ' ' ALA . 4.4 m -117.27 128.61 74.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 O-C-N 121.16 -1.2 . . . . 0.0 109.846 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.635 ' C ' ' HA ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -145.11 134.61 23.2 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.966 -0.693 . . . . 0.0 112.521 -177.674 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.996 ' CA ' ' HA ' ' A' ' 52' ' ' ASP . . . -123.09 165.58 15.69 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 178.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 201' ' ' PRO . 0.1 OUTLIER -177.52 68.18 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.409 -1.054 . . . . 0.0 110.23 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.948 ' HD3' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -163.38 -91.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.139 -0.975 . . . . 0.0 110.783 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.948 ' N ' ' HD3' ' A' ' 82' ' ' ARG . . . 83.64 87.5 0.81 Allowed Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -115.59 97.19 6.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.264 -1.139 . . . . 0.0 110.437 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.535 ' O ' ' CG ' ' A' ' 173' ' ' MET . 1.5 m -139.97 160.31 40.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.33 -0.856 . . . . 0.0 110.059 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.515 ' C ' ' NE2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -118.6 134.27 55.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.078 -1.014 . . . . 0.0 110.211 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 101.56 -115.58 5.3 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.506 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 13.2 tp -128.52 130.48 47.52 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.391 -1.064 . . . . 0.0 110.565 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.527 ' CE1' ' HB3' ' A' ' 85' ' ' SER . 4.1 m-70 -147.23 158.5 43.97 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.26 -0.9 . . . . 0.0 109.962 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -162.95 156.43 19.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.134 -0.979 . . . . 0.0 110.354 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 1.026 ' CZ2' HG21 ' A' ' 169' ' ' VAL . 5.4 p90 -143.76 170.82 15.16 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.353 -0.842 . . . . 0.0 110.01 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 215' ' ' ARG . 3.6 tt0 -145.86 157.52 43.9 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.429 -0.794 . . . . 0.0 110.932 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.914 HG22 ' OH ' ' A' ' 180' ' ' TYR . 7.0 tp -143.15 154.37 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.545 -0.722 . . . . 0.0 109.848 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.696 ' O ' ' HD3' ' A' ' 96' ' ' PRO . 0.1 OUTLIER -149.88 137.09 19.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.321 -0.862 . . . . 0.0 110.3 -179.63 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.816 ' CH2' ' HA ' ' A' ' 104' ' ' ALA . 49.7 m95 -108.93 88.3 5.37 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 121.258 -0.901 . . . . 0.0 110.655 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.696 ' HD3' ' O ' ' A' ' 94' ' ' SER . 52.3 Cg_endo -97.26 108.78 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.348 1.365 . . . . 0.0 110.215 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.29 -67.99 0.82 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.781 -1.2 . . . . 0.0 110.187 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.47 -27.79 13.9 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.271 -0.893 . . . . 0.0 109.637 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -179.96 -29.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.625 0.726 . . . . 0.0 109.652 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.451 ' NH1' ' HG3' ' A' ' 100' ' ' ARG . 2.5 mtt85 -115.92 -67.91 0.96 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.464 -0.773 . . . . 0.0 109.787 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.581 ' HA2' ' O ' ' A' ' 95' ' ' TRP . . . 167.52 -162.95 36.74 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 101' ' ' GLY . 8.5 t -178.63 -29.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.201 -1.176 . . . . 0.0 110.721 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.563 ' O ' ' CE3' ' A' ' 95' ' ' TRP . 0.6 OUTLIER -155.56 166.31 33.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.073 -1.017 . . . . 0.0 110.867 -179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.816 ' HA ' ' CH2' ' A' ' 95' ' ' TRP . . . 179.87 137.46 0.11 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.406 -0.809 . . . . 0.0 109.754 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.825 HG23 ' CB ' ' A' ' 204' ' ' SER . 34.2 m -131.95 115.67 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 O-C-N 120.245 -1.534 . . . . 0.0 110.357 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.685 HG22 HG23 ' A' ' 203' ' ' VAL . 76.5 t -151.15 170.21 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.67 ' CA ' ' HA3' ' A' ' 132' ' ' GLY . . . 168.75 169.22 31.89 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 118.798 -1.667 . . . . 0.0 111.251 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.112 ' CG1' HD13 ' A' ' 199' ' ' LEU . 2.2 t -121.74 159.82 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.694 -0.886 . . . . 0.0 109.321 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.557 ' O ' ' CB ' ' A' ' 199' ' ' LEU . . . -140.07 143.8 36.5 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.977 -1.077 . . . . 0.0 111.401 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 1.008 ' OG1' HD23 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -126.07 135.52 51.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.522 -0.736 . . . . 0.0 110.161 179.473 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.15 -25.35 17.9 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.445 -0.784 . . . . 0.0 109.173 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.648 HD12 ' HD3' ' A' ' 114' ' ' PRO . 2.7 pp -85.54 -12.22 52.18 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.581 -0.7 . . . . 0.0 109.356 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.555 ' HB2' ' HB ' ' A' ' 110' ' ' THR . . . -37.4 98.35 0.16 Allowed Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.57 -0.706 . . . . 0.0 110.352 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.648 ' HD3' HD12 ' A' ' 112' ' ' LEU . 46.5 Cg_endo -73.62 -168.64 0.46 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.936 1.493 . . . . 0.0 110.516 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -179.99 48.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.32 -0.862 . . . . 0.0 110.162 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 1.5 tp-100 -129.39 -70.11 0.67 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.893 . . . . 0.0 110.223 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.604 ' HB3' ' HB3' ' A' ' 120' ' ' TYR . . . -179.99 115.48 0.05 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.415 -0.803 . . . . 0.0 110.17 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.525 ' C ' ' O ' ' A' ' 117' ' ' ALA . 19.0 t70 -31.72 -56.94 0.28 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.543 -0.723 . . . . 0.0 110.84 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.86 -57.53 4.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.879 . . . . 0.0 110.196 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.604 ' HB3' ' HB3' ' A' ' 117' ' ' ALA . 0.1 OUTLIER -70.24 96.67 1.13 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.186 -0.946 . . . . 0.0 110.155 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -111.86 87.85 2.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.308 -0.87 . . . . 0.0 110.11 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.475 ' O ' ' CB ' ' A' ' 123' ' ' LEU . . . -80.75 4.93 17.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.242 -0.911 . . . . 0.0 110.216 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.475 ' CB ' ' O ' ' A' ' 122' ' ' ALA . 0.1 OUTLIER 66.75 -68.84 0.13 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.293 -0.879 . . . . 0.0 110.251 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 122' ' ' ALA . 0.6 OUTLIER 51.42 -161.09 0.08 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.299 -0.875 . . . . 0.0 110.267 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -73.63 -161.35 6.97 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.417 ' O ' ' O ' ' A' ' 127' ' ' ASN . 5.1 t -144.89 67.14 1.25 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.273 -1.134 . . . . 0.0 110.237 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.417 ' O ' ' O ' ' A' ' 126' ' ' SER . 0.2 OUTLIER -53.9 -171.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 110.182 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 24.5 p -123.07 160.14 26.98 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 110.234 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.408 ' HB2' ' HB3' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -150.18 134.33 17.08 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.217 -0.927 . . . . 0.0 109.821 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 14.1 t -151.4 118.61 5.94 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.301 -0.874 . . . . 0.0 110.391 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . 0.52 ' CD1' ' N ' ' A' ' 131' ' ' TRP . 2.7 p-90 -135.59 166.23 23.69 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.67 ' HA3' ' CA ' ' A' ' 107' ' ' GLY . . . 177.67 -138.26 3.75 Favored Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.773 -1.203 . . . . 0.0 110.431 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.831 ' HB3' HG11 ' A' ' 163' ' ' VAL . 53.5 m0 -104.8 113.4 26.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.365 -1.08 . . . . 0.0 110.657 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.708 ' O ' HG23 ' A' ' 135' ' ' ILE . 1.9 p30 -118.74 113.31 20.95 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.45 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.954 HD11 ' HB ' ' A' ' 163' ' ' VAL . 3.5 pt -159.74 42.51 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.171 -0.956 . . . . 0.0 110.027 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 103' ' ' HIS . . . -49.88 -59.19 7.64 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 139' ' ' LYS . 0.5 OUTLIER -100.4 5.51 44.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.213 -1.169 . . . . 0.0 110.338 -179.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.492 ' C ' ' O ' ' A' ' 137' ' ' ARG . . . 37.06 30.36 0.04 OUTLIER Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 137' ' ' ARG . 0.1 OUTLIER -177.12 -139.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.121 -1.223 . . . . 0.0 110.553 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.678 ' O ' ' C ' ' A' ' 141' ' ' TYR . 5.9 tp -156.07 95.68 1.64 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.719 -0.613 . . . . 0.0 110.223 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.721 ' O ' ' N ' ' A' ' 143' ' ' GLN . 2.9 t80 0.31 78.0 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.807 -0.558 . . . . 0.0 111.297 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.66 ' C ' ' O ' ' A' ' 141' ' ' TYR . 17.6 p80 1.73 63.3 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.748 0.785 . . . . 0.0 111.36 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.721 ' N ' ' O ' ' A' ' 141' ' ' TYR . 31.6 tp60 -56.5 -54.84 41.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.685 -0.635 . . . . 0.0 110.29 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 143' ' ' GLN . 30.3 t -179.98 -78.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 0.0 110.208 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -134.41 94.13 3.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.275 -0.891 . . . . 0.0 110.295 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 176.08 102.3 0.15 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.436 HD12 ' H ' ' A' ' 147' ' ' LEU . 2.7 mp -109.44 38.62 2.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -1.141 . . . . 0.0 110.124 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.91 134.34 0.1 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.273 -0.892 . . . . 0.0 110.089 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.488 ' O ' ' HD3' ' A' ' 156' ' ' PRO . . . -155.65 89.7 2.91 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.137 -0.977 . . . . 0.0 110.335 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.571 ' HA ' ' CG ' ' A' ' 156' ' ' PRO . 46.2 Cg_endo -72.8 73.63 2.96 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.935 1.492 . . . . 0.0 110.311 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -129.4 -45.44 1.22 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.242 -0.911 . . . . 0.0 110.687 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.506 ' N ' ' HD2' ' A' ' 153' ' ' PRO . 0.1 OUTLIER -175.36 -57.07 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.192 -0.943 . . . . 0.0 110.632 -179.732 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.54 ' O ' ' C ' ' A' ' 154' ' ' ALA . 45.0 Cg_endo -72.22 171.32 17.11 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.917 1.483 . . . . 0.0 110.633 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.54 ' C ' ' O ' ' A' ' 153' ' ' PRO . . . -31.14 115.98 0.15 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.559 -0.713 . . . . 0.0 110.751 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 176.23 -80.63 0.07 OUTLIER Glycine 0 N--CA 1.48 1.571 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.571 ' CG ' ' HA ' ' A' ' 150' ' ' PRO . 49.8 Cg_endo -76.92 -3.45 13.79 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.028 1.541 . . . . 0.0 110.309 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 134' ' ' ASP . 0.3 OUTLIER -48.05 -61.06 2.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.309 -0.869 . . . . 0.0 110.575 -179.699 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 103.8 85.37 1.86 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.91 5.33 1.59 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.284 -1.127 . . . . 0.0 110.771 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.23 -12.3 55.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.163 -0.961 . . . . 0.0 109.507 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.89 HD13 ' CE2' ' A' ' 186' ' ' TYR . 6.3 mt -98.58 49.4 0.98 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.501 -0.75 . . . . 0.0 109.509 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.88 HG13 ' O ' ' A' ' 162' ' ' VAL . 6.3 p 0.65 86.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.645 0.736 . . . . 0.0 111.914 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.954 ' HB ' HD11 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -96.2 -42.38 0.27 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.345 -0.847 . . . . 0.0 109.0 178.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.634 ' HA ' ' HB2' ' A' ' 95' ' ' TRP . 48.8 Cg_endo -82.8 62.41 7.76 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.548 1.288 . . . . 0.0 109.118 178.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.877 ' HB3' HG22 ' A' ' 162' ' ' VAL . 11.0 tp10 -173.75 -78.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.64 -0.662 . . . . 0.0 109.61 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 1.088 ' C ' HD22 ' A' ' 167' ' ' LEU . 7.7 ttt180 -151.6 132.96 14.59 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.537 -0.727 . . . . 0.0 109.645 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 1.088 HD22 ' C ' ' A' ' 166' ' ' ARG . 3.0 mm? -140.33 153.61 46.49 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.366 -0.834 . . . . 0.0 110.8 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.424 ' N ' ' HE1' ' A' ' 180' ' ' TYR . 6.2 tp -129.07 130.24 46.28 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.567 -0.708 . . . . 0.0 109.259 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 1.064 HG12 ' CE1' ' A' ' 180' ' ' TYR . 0.2 OUTLIER -127.25 144.1 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.955 -1.091 . . . . 0.0 110.262 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.584 HG11 ' HZ ' ' A' ' 191' ' ' PHE . 4.3 p -102.53 133.19 46.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.815 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.992 HD13 HD23 ' A' ' 178' ' ' LEU . 2.7 tp -124.76 105.89 9.64 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.433 -0.792 . . . . 0.0 109.824 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.514 ' OD1' ' CG ' ' A' ' 174' ' ' GLU . 5.1 t70 -119.97 134.44 55.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 110.488 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.535 ' CG ' ' O ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -98.8 -42.23 7.29 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.278 0.561 . . . . 0.0 109.63 179.491 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.514 ' CG ' ' OD1' ' A' ' 172' ' ' ASP . 7.9 pt-20 -45.01 -24.91 0.26 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.246 -0.908 . . . . 0.0 108.828 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.622 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.2 OUTLIER -112.25 -27.01 8.5 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.16 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.453 ' O ' ' CG2' ' A' ' 198' ' ' THR . . . 80.88 25.73 55.24 Favored Glycine 0 N--CA 1.483 1.787 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 1.124 HG22 ' CD2' ' A' ' 194' ' ' LEU . 0.1 OUTLIER -112.7 124.05 51.69 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.096 -1.238 . . . . 0.0 111.093 -179.434 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.992 HD23 HD13 ' A' ' 171' ' ' LEU . 2.6 mp -129.08 153.47 47.61 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.51 -0.744 . . . . 0.0 109.434 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.918 ' O ' HG23 ' A' ' 169' ' ' VAL . . . -178.9 163.67 31.5 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.2 -1.476 . . . . 0.0 110.633 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 1.064 ' CE1' HG12 ' A' ' 169' ' ' VAL . 0.1 OUTLIER -118.28 128.17 54.42 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.455 -1.026 . . . . 0.0 109.492 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.597 ' OG ' ' N ' ' A' ' 186' ' ' TYR . 5.7 t -132.34 165.15 24.86 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.662 0.744 . . . . 0.0 110.186 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.813 HG22 ' CD1' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -105.46 116.7 49.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 O-C-N 121.792 -0.568 . . . . 0.0 109.556 179.356 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 64.4 8.86 33.79 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 86.81 35.18 10.31 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . 0.477 ' O ' ' C ' ' A' ' 186' ' ' TYR . 37.3 m -106.77 -65.93 1.05 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.117 -1.225 . . . . 0.0 110.71 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.89 ' CE2' HD13 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -35.98 -74.3 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.315 -0.866 . . . . 0.0 110.761 -179.618 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.84 HD11 HD12 ' A' ' 194' ' ' LEU . 2.7 mm? -67.69 46.19 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.037 -1.039 . . . . 0.0 110.081 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 186' ' ' TYR . . . -73.51 -99.05 0.08 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.536 ' C ' ' H ' ' A' ' 191' ' ' PHE . 49.2 Cg_endo -73.65 -23.99 16.34 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.109 1.583 . . . . 0.0 111.242 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.53 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -62.39 29.39 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.39 -0.819 . . . . 0.0 111.797 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.727 ' HE1' HD12 ' A' ' 187' ' ' LEU . 1.0 OUTLIER -90.54 -22.33 21.35 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.782 -1.199 . . . . 0.0 110.461 179.391 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.496 ' N ' ' HD2' ' A' ' 192' ' ' ARG . 0.0 OUTLIER -87.82 -13.02 43.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.178 -0.951 . . . . 0.0 110.443 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -108.77 -10.46 24.78 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.334 -1.906 . . . . 0.0 108.334 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 1.124 ' CD2' HG22 ' A' ' 177' ' ' THR . 7.8 tt -72.86 -41.56 64.63 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.731 -0.864 . . . . 0.0 108.808 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.503 ' HD2' ' N ' ' A' ' 196' ' ' GLY . 0.0 OUTLIER -43.92 -42.14 5.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.486 -0.759 . . . . 0.0 109.975 179.61 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.503 ' N ' ' HD2' ' A' ' 195' ' ' LYS . . . -85.32 -25.64 39.12 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.881 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.66 -3.74 57.28 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.789 -0.83 . . . . 0.0 109.911 179.835 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.734 HG23 ' O ' ' A' ' 194' ' ' LEU . 15.9 p -42.75 125.59 3.44 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.811 0.815 . . . . 0.0 111.85 -177.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 1.112 HD13 ' CG1' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -140.39 171.44 14.15 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.136 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.417 ' CD2' ' HA ' ' A' ' 82' ' ' ARG . 3.2 m-85 -84.2 129.16 59.36 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.949 -1.094 . . . . 0.0 109.97 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.559 ' HA ' HG13 ' A' ' 108' ' ' VAL . 50.7 Cg_endo -76.92 136.01 16.21 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 124.014 1.534 . . . . 0.0 111.012 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 4.7 t -133.18 140.21 47.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.449 -0.782 . . . . 0.0 109.945 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.685 HG23 HG22 ' A' ' 106' ' ' VAL . 6.0 p -120.3 153.5 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.237 -0.914 . . . . 0.0 110.153 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 0.825 ' CB ' HG23 ' A' ' 105' ' ' VAL . 6.3 t -142.39 127.39 18.41 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.27 -0.894 . . . . 0.0 110.051 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 1.105 ' HB3' ' CG2' ' A' ' 78' ' ' VAL . . . -124.88 140.36 53.0 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.455 0.645 . . . . 0.0 110.415 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.84 HG13 ' N ' ' A' ' 207' ' ' TRP . 0.3 OUTLIER -64.56 -158.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.552 -0.718 . . . . 0.0 110.672 -179.527 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 0.912 ' CG ' ' HB2' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -121.1 154.98 35.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.409 -0.807 . . . . 0.0 109.932 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.458 ' O ' ' OE1' ' A' ' 211' ' ' GLN . . . 134.23 -175.18 20.55 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.533 ' CG ' ' OE1' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -98.21 -30.04 12.86 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.207 -1.172 . . . . 0.0 110.401 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 1.6 t -116.36 81.25 1.59 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.334 -0.854 . . . . 0.0 110.468 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.458 ' OE1' ' O ' ' A' ' 208' ' ' GLY . 0.0 OUTLIER -123.68 -90.49 0.57 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.165 -0.96 . . . . 0.0 110.241 179.683 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.706 HG23 ' CG ' ' A' ' 95' ' ' TRP . 4.2 p -127.5 143.26 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.085 -1.009 . . . . 0.0 111.276 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.564 ' CD ' ' HB3' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -102.18 145.59 29.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.469 -0.769 . . . . 0.0 108.953 178.64 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 1.036 HG22 HD11 ' A' ' 64' ' ' LEU . 4.8 tt -115.97 140.44 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.954 -1.091 . . . . 0.0 111.266 -178.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.606 ' O ' ' N ' ' A' ' 92' ' ' GLU . 7.9 ttm180 -130.6 109.32 10.57 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . 0.65 ' CD2' ' CB ' ' A' ' 91' ' ' TRP . 3.2 t80 -118.13 146.99 43.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.035 -1.041 . . . . 0.0 111.248 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . 0.505 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 2.6 mmt -136.39 115.84 12.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.564 -0.71 . . . . 0.0 110.0 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 126.69 -4.45 7.54 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.59 ' HB2' ' CE1' ' A' ' 216' ' ' TYR . 0.4 OUTLIER -106.44 136.62 45.88 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.248 -1.148 . . . . 0.0 110.229 -179.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.434 ' N ' ' CD ' ' A' ' 219' ' ' GLU . 0.0 OUTLIER 179.95 -81.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 110.168 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . 0.482 ' O ' ' C ' ' A' ' 222' ' ' VAL . 24.0 ttt85 -166.87 81.34 0.23 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.306 -0.871 . . . . 0.0 110.259 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.558 HG13 ' O ' ' A' ' 222' ' ' VAL . 12.7 p -35.96 124.56 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.494 -0.754 . . . . 0.0 110.616 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.529 ' O ' ' C ' ' A' ' 224' ' ' GLU . 1.8 tt0 179.93 -89.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.285 -0.884 . . . . 0.0 110.256 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.529 ' C ' ' O ' ' A' ' 223' ' ' GLU . 20.2 mm-40 -32.14 -64.05 0.18 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.555 -0.716 . . . . 0.0 110.722 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.38 134.91 22.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.296 -0.877 . . . . 0.0 110.197 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -158.34 112.97 2.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 0.0 110.13 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.505 ' O ' ' CG ' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -42.72 107.4 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.329 -0.857 . . . . 0.0 110.276 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.0 tt -113.77 -1.19 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.305 -0.872 . . . . 0.0 110.226 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.491 ' O ' ' CG ' ' A' ' 230' ' ' ARG . 0.7 OUTLIER -106.53 -159.03 0.68 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.162 -0.961 . . . . 0.0 110.242 179.917 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . 0.677 ' O ' ' C ' ' A' ' 231' ' ' ASP . 0.1 OUTLIER 179.78 122.3 0.06 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.273 -0.892 . . . . 0.0 110.21 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.677 ' C ' ' O ' ' A' ' 230' ' ' ARG . 9.3 p-10 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.057 -0.973 . . . . 0.0 111.472 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 37.7 p -49.89 115.0 1.21 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -1.14 . . . . 0.0 110.21 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.64 -31.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.288 -0.882 . . . . 0.0 110.227 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.16 -177.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.222 -0.924 . . . . 0.0 110.25 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.6 mtt180 -113.97 21.29 14.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.241 -0.912 . . . . 0.0 110.225 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -105.44 1.36 27.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 0.0 110.171 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 94.4 p -97.19 59.73 1.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.252 -0.905 . . . . 0.0 110.106 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.2 m -50.85 109.19 1.24 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 0.0 110.267 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.433 ' C ' ' OG1' ' A' ' 15' ' ' THR . 46.0 Cg_endo -73.42 54.2 2.8 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.993 1.523 . . . . 0.0 110.383 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 16' ' ' SER . 0.1 OUTLIER -167.97 25.92 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.199 -0.938 . . . . 0.0 110.144 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 17' ' ' GLN . 34.9 t -177.79 -170.94 0.28 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.279 -0.888 . . . . 0.0 110.184 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 16' ' ' SER . 2.5 tt0 -179.55 -61.05 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.303 -0.873 . . . . 0.0 110.163 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.52 136.86 42.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 110.267 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -72.24 -159.93 0.06 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 110.254 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -108.14 -146.11 0.4 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.189 -0.944 . . . . 0.0 110.272 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.98 152.28 24.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -0.903 . . . . 0.0 110.358 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -83.41 44.66 0.98 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.323 -0.861 . . . . 0.0 110.32 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.19 -57.06 4.05 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.328 -0.857 . . . . 0.0 110.146 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.23 160.23 76.16 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.457 -0.777 . . . . 0.0 110.215 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.46 ' HB3' ' CD ' ' A' ' 30' ' ' GLU . 46.5 Cg_endo -72.83 167.1 28.16 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.991 1.521 . . . . 0.0 110.435 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.739 ' O ' ' N ' ' A' ' 28' ' ' GLY . 43.9 Cg_endo -72.3 157.69 53.04 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.024 1.539 . . . . 0.0 110.709 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.627 ' C ' ' O ' ' A' ' 26' ' ' PRO . 1.8 mp0 0.88 61.11 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 121.131 0.491 . . . . 0.0 111.793 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.739 ' N ' ' O ' ' A' ' 26' ' ' PRO . . . 36.89 30.74 0.04 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.9 HD13 ' HB2' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -73.41 -53.71 10.05 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.455 -1.027 . . . . 0.0 110.459 -179.619 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.78 ' HA ' HD23 ' A' ' 33' ' ' LEU . 42.9 mt-10 -43.87 -35.59 2.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.157 -0.964 . . . . 0.0 108.973 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -58.9 -24.26 62.09 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.631 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -83.46 -32.96 25.74 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.777 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.81 HD12 ' C ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -82.2 -37.18 26.44 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.696 0.76 . . . . 0.0 109.488 179.389 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.549 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 14.9 m -61.61 -11.38 11.18 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.279 0.561 . . . . 0.0 110.264 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 1.088 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -51.95 -168.04 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.431 -0.793 . . . . 0.0 110.272 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 1.088 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 40.7 Cg_endo -67.91 -169.81 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.55 1.289 . . . . 0.0 110.059 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.649 ' CD ' ' HB2' ' A' ' 36' ' ' PRO . 51.6 Cg_endo -96.77 63.55 0.13 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.528 1.486 . . . . 0.0 112.269 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.692 ' CD ' ' O ' ' A' ' 36' ' ' PRO . 51.2 Cg_endo -73.54 151.56 47.47 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.275 1.144 . . . . 0.0 109.583 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.592 ' O ' ' HB3' ' A' ' 43' ' ' GLN . 1.3 t0 -33.67 -30.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.3 -0.875 . . . . 0.0 109.833 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.073 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -57.2 -44.88 84.08 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.279 -0.888 . . . . 0.0 110.72 -179.354 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.697 ' N ' HD13 ' A' ' 40' ' ' LEU . 22.3 t -85.74 -34.4 8.4 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 C-N-CA 118.54 -1.264 . . . . 0.0 110.327 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.62 -39.08 12.07 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.134 -0.979 . . . . 0.0 113.114 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.64 ' NE2' ' HB3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -87.13 -18.75 29.7 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 120.82 -1.175 . . . . 0.0 109.885 -178.741 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.994 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 3.0 ttp85 -76.84 -55.36 5.55 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.28 -0.887 . . . . 0.0 108.918 178.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.635 ' ND1' ' O ' ' A' ' 41' ' ' VAL . 65.9 m170 -45.4 -23.58 0.22 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.407 ' N ' ' O ' ' A' ' 44' ' ' ARG . 7.0 t60 -84.5 -39.67 18.58 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.491 ' CA ' ' HG3' ' A' ' 61' ' ' GLU . . . -83.52 -80.57 1.01 Allowed Glycine 0 N--CA 1.487 2.054 0 N-CA-C 106.679 -2.568 . . . . 0.0 106.679 177.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.701 ' HB2' HG23 ' A' ' 59' ' ' VAL . 99.5 m95 -90.42 73.5 6.95 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.299 -1.118 . . . . 0.0 108.87 177.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.727 ' O ' ' HB3' ' A' ' 53' ' ' CYS . 0.0 OUTLIER -44.88 163.1 0.2 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.721 -0.612 . . . . 0.0 110.997 179.835 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.764 ' O ' ' O ' ' A' ' 53' ' ' CYS . 41.0 Cg_endo -67.66 -60.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.818 1.431 . . . . 0.0 110.887 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.804 ' HA ' ' HE3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -40.17 -84.82 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.661 -1.274 . . . . 0.0 109.121 179.385 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.768 ' HA ' ' N ' ' A' ' 80' ' ' GLY . 2.0 m-20 -47.92 0.89 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.337 -0.852 . . . . 0.0 111.548 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.764 ' O ' ' O ' ' A' ' 50' ' ' PRO . 1.3 t -166.07 129.95 2.16 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.631 -1.293 . . . . 0.0 112.199 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.91 ' H ' ' HA ' ' A' ' 78' ' ' VAL . 1.8 m -81.85 124.1 29.39 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.437 -0.789 . . . . 0.0 109.753 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.673 ' HB3' ' NH2' ' A' ' 44' ' ' ARG . 3.2 pt-20 -51.6 -2.03 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.377 -0.827 . . . . 0.0 110.746 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.822 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -49.46 -21.5 0.95 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.835 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.009 HD11 ' CB ' ' A' ' 207' ' ' TRP . 0.9 OUTLIER -112.04 166.73 6.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.676 -0.64 . . . . 0.0 109.916 -179.705 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.514 ' N ' ' CG2' ' A' ' 57' ' ' ILE . 2.0 t70 -109.12 96.11 6.09 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.006 0.908 . . . . 0.0 110.054 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.971 HG13 HG22 ' A' ' 57' ' ' ILE . 33.3 m -128.35 135.45 62.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.711 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.641 ' HG2' ' HA ' ' A' ' 40' ' ' LEU . 13.1 mtpt -125.62 155.41 40.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.006 -1.058 . . . . 0.0 111.558 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.492 ' O ' ' C ' ' A' ' 62' ' ' GLY . 1.4 tt0 -80.24 -130.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.384 -0.823 . . . . 0.0 110.06 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.492 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 39.92 53.87 3.08 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.676 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 105.84 66.05 0.66 Allowed Glycine 0 N--CA 1.486 2.009 0 N-CA-C 107.785 -2.126 . . . . 0.0 107.785 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.077 HD11 HG22 ' A' ' 214' ' ' ILE . 0.2 OUTLIER 0.77 86.31 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 122.026 -0.691 . . . . 0.0 111.454 -178.522 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -99.66 113.93 26.68 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.703 179.564 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.693 ' CD1' ' CE2' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -114.38 124.67 52.53 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.569 -0.707 . . . . 0.0 109.193 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.631 ' H ' HG12 ' A' ' 59' ' ' VAL . 3.7 tm-20 -150.36 130.32 13.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.982 -1.074 . . . . 0.0 110.921 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.548 ' HD2' ' O ' ' A' ' 68' ' ' ARG . 0.6 OUTLIER -110.85 156.15 21.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.372 -0.83 . . . . 0.0 109.449 179.209 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.608 ' H ' ' HD2' ' A' ' 70' ' ' PRO . 2.3 tpt180 -173.94 -52.95 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 120.982 -1.074 . . . . 0.0 111.687 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.9 ' HB2' HD13 ' A' ' 29' ' ' LEU . 40.0 Cg_endo -66.09 -52.79 0.8 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.508 1.268 . . . . 0.0 111.298 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 56' ' ' ASN . 25.4 t -78.55 164.97 3.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.244 -0.91 . . . . 0.0 110.867 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.471 ' N ' HG12 ' A' ' 71' ' ' VAL . . . -179.47 -30.49 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.445 0.64 . . . . 0.0 109.429 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -73.93 -116.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.373 -0.829 . . . . 0.0 110.202 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.9 t -124.48 50.07 1.74 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.019 -1.051 . . . . 0.0 110.397 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.506 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 4.2 m -83.41 -125.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 0.0 110.054 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.549 ' CB ' ' OD1' ' A' ' 56' ' ' ASN . 0.4 OUTLIER -136.6 112.69 9.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.089 -1.007 . . . . 0.0 110.71 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.642 ' C ' HG13 ' A' ' 78' ' ' VAL . . . -57.23 -92.89 0.01 OUTLIER Glycine 0 N--CA 1.482 1.765 0 N-CA-C 105.359 -3.096 . . . . 0.0 105.359 177.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.205 ' CG2' ' HB3' ' A' ' 205' ' ' ALA . 32.7 m -152.9 119.5 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.229 -1.16 . . . . 0.0 110.047 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.741 ' O ' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -146.87 134.09 20.55 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.602 -0.686 . . . . 0.0 111.224 -179.299 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.768 ' N ' ' HA ' ' A' ' 52' ' ' ASP . . . -132.2 -179.64 16.4 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.587 ' N ' ' HZ3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER 179.98 26.5 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.432 -1.04 . . . . 0.0 110.28 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.73 ' CD ' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -69.77 -18.59 63.5 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.164 -0.96 . . . . 0.0 110.722 -179.674 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.73 ' N ' ' CD ' ' A' ' 82' ' ' ARG . . . 27.8 44.37 0.04 OUTLIER Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.503 ' N ' ' O ' ' A' ' 82' ' ' ARG . 1.2 t80 -103.63 95.56 6.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.218 -1.166 . . . . 0.0 110.482 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 1.034 ' OG ' HD21 ' A' ' 171' ' ' LEU . 3.6 p -140.47 166.58 24.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.311 -0.868 . . . . 0.0 110.172 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.576 ' HA ' ' CB ' ' A' ' 173' ' ' MET . 0.5 OUTLIER -136.31 156.52 48.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 109.928 179.584 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.586 ' N ' ' HB3' ' A' ' 173' ' ' MET . . . 62.31 -114.45 6.83 Favored Glycine 0 N--CA 1.483 1.816 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.19 131.26 47.09 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.513 -0.992 . . . . 0.0 110.968 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.704 ' HB2' HD23 ' A' ' 171' ' ' LEU . 74.1 m-70 -147.25 173.38 12.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.199 -0.938 . . . . 0.0 109.997 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.6 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -163.59 154.36 16.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.362 -0.836 . . . . 0.0 110.583 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.84 ' CE3' HG11 ' A' ' 169' ' ' VAL . 0.1 OUTLIER -134.66 170.79 15.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.171 -0.955 . . . . 0.0 109.3 179.616 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.925 ' O ' HD13 ' A' ' 93' ' ' ILE . 0.9 OUTLIER -146.8 152.66 39.12 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 118.977 -1.089 . . . . 0.0 111.699 -179.511 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.925 HD13 ' O ' ' A' ' 92' ' ' GLU . 7.8 mm -142.71 153.66 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.675 -0.641 . . . . 0.0 109.433 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.561 ' O ' ' HA ' ' A' ' 212' ' ' VAL . 0.0 OUTLIER -155.35 127.56 7.71 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.788 -1.195 . . . . 0.0 111.511 -179.564 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.843 ' CZ2' ' HA ' ' A' ' 104' ' ' ALA . 5.8 m95 -114.21 87.9 14.16 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.221 -0.924 . . . . 0.0 109.922 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.534 ' O ' ' NE2' ' A' ' 211' ' ' GLN . 51.7 Cg_endo -95.14 107.13 0.12 Allowed 'Trans proline' 0 C--N 1.302 -1.891 0 O-C-N 123.399 1.21 . . . . 0.0 110.333 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 23.5 tp -96.94 -69.45 0.76 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.9 -1.125 . . . . 0.0 109.091 178.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 99' ' ' GLN . 10.0 mt-10 -100.31 -45.72 5.5 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.826 0.822 . . . . 0.0 108.996 178.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.514 ' O ' ' O ' ' A' ' 100' ' ' ARG . 1.3 tm0? 178.87 -26.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.226 0.536 . . . . 0.0 110.03 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.514 ' O ' ' O ' ' A' ' 99' ' ' GLN . 10.7 mpt_? -28.97 -99.06 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.822 -0.549 . . . . 0.0 111.548 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 163' ' ' VAL . . . -163.24 -96.97 0.11 Allowed Glycine 0 N--CA 1.487 2.059 0 C-N-CA 119.668 -1.254 . . . . 0.0 110.28 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 1.032 ' CG2' HD11 ' A' ' 167' ' ' LEU . 3.4 t -139.04 -160.05 1.02 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.934 -1.333 . . . . 0.0 111.962 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.815 ' HB2' HG22 ' A' ' 162' ' ' VAL . 3.2 t-80 179.33 29.59 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.764 -0.585 . . . . 0.0 109.88 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.843 ' HA ' ' CZ2' ' A' ' 95' ' ' TRP . . . -54.7 123.53 13.54 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.407 -0.808 . . . . 0.0 111.396 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.772 HG23 ' CB ' ' A' ' 204' ' ' SER . 3.7 m -97.99 114.27 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 118.147 -1.421 . . . . 0.0 108.358 178.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 1.05 HG23 ' O ' ' A' ' 202' ' ' SER . 0.7 OUTLIER -150.33 149.61 14.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.459 -0.776 . . . . 0.0 110.584 -178.302 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.599 ' HA2' ' HA3' ' A' ' 132' ' ' GLY . . . -153.91 142.79 9.44 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.096 ' CG2' HD13 ' A' ' 199' ' ' LEU . 2.8 m -98.46 155.17 3.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.251 -1.146 . . . . 0.0 110.299 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.557 ' C ' ' HB3' ' A' ' 199' ' ' LEU . . . -124.47 141.32 52.17 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.356 -0.84 . . . . 0.0 110.614 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 1.088 ' OG1' HD23 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -121.07 131.62 54.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.397 -0.815 . . . . 0.0 110.127 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.95 -26.4 17.58 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.346 -0.846 . . . . 0.0 109.358 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.454 ' C ' ' HD3' ' A' ' 114' ' ' PRO . 2.0 pp -83.91 -12.31 55.63 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.572 -0.705 . . . . 0.0 109.329 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.691 ' HB3' ' HB ' ' A' ' 110' ' ' THR . . . -111.14 73.05 0.9 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.542 -0.724 . . . . 0.0 110.245 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.778 ' HB2' HD23 ' A' ' 115' ' ' LEU . 46.8 Cg_endo -73.23 -26.54 14.59 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.064 1.56 . . . . 0.0 110.364 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.778 HD23 ' HB2' ' A' ' 114' ' ' PRO . 0.6 OUTLIER 179.93 53.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.304 -0.872 . . . . 0.0 110.102 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -85.45 -70.14 0.61 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.88 . . . . 0.0 110.359 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.519 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -74.42 -39.09 62.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.374 -0.829 . . . . 0.0 110.225 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.519 ' C ' ' O ' ' A' ' 117' ' ' ALA . 17.6 t70 -31.76 97.01 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.47 -0.768 . . . . 0.0 110.74 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.471 ' N ' ' O ' ' A' ' 117' ' ' ALA . 3.8 m-70 -92.33 -21.64 20.16 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.345 -0.847 . . . . 0.0 110.176 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.406 ' O ' ' C ' ' A' ' 121' ' ' ALA . 23.1 m-85 -88.48 116.13 26.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.199 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.604 ' O ' ' HB3' ' A' ' 122' ' ' ALA . . . -43.22 -76.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -0.919 . . . . 0.0 110.141 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 121' ' ' ALA . . . 62.57 -165.09 0.24 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.106 -0.997 . . . . 0.0 110.161 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.47 46.74 1.99 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.189 -0.944 . . . . 0.0 110.176 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.51 71.82 1.47 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.333 -0.854 . . . . 0.0 110.136 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -134.41 4.48 4.45 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 21.5 p -100.88 36.34 1.97 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -1.152 . . . . 0.0 110.204 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.41 ' O ' ' O ' ' A' ' 128' ' ' SER . 3.1 t-20 179.93 -176.12 0.32 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.225 -0.922 . . . . 0.0 110.274 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.41 ' O ' ' O ' ' A' ' 127' ' ' ASN . 66.7 p -60.42 -150.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.943 . . . . 0.0 110.256 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -145.12 125.66 14.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.302 -0.874 . . . . 0.0 109.977 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 108' ' ' VAL . 1.1 t -121.59 119.73 32.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 110.484 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . 0.648 ' O ' HG22 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -133.37 135.16 44.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.288 -0.882 . . . . 0.0 109.781 179.679 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.599 ' HA3' ' HA2' ' A' ' 107' ' ' GLY . . . -175.66 -137.76 2.64 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.028 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.641 ' CD2' ' HG2' ' A' ' 159' ' ' GLU . 42.4 m0 -118.79 113.63 21.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.419 -1.048 . . . . 0.0 110.843 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.44 ' C ' HG12 ' A' ' 135' ' ' ILE . 45.5 t0 -118.63 147.64 43.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.512 -0.742 . . . . 0.0 109.895 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.595 ' CG2' ' NE2' ' A' ' 103' ' ' HIS . 0.1 OUTLIER -149.02 14.17 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.116 -0.99 . . . . 0.0 110.239 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -113.46 -51.56 0.5 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.42 8.18 25.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.326 -1.102 . . . . 0.0 109.577 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 139' ' ' LYS . . . -134.68 8.27 4.57 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -58.16 -147.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.282 -1.128 . . . . 0.0 110.326 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.68 ' O ' ' C ' ' A' ' 141' ' ' TYR . 5.9 tt 179.87 94.63 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.522 -0.737 . . . . 0.0 110.25 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.68 ' C ' ' O ' ' A' ' 140' ' ' LEU . 43.2 m-85 0.13 76.81 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.803 -0.561 . . . . 0.0 111.095 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.523 ' N ' ' O ' ' A' ' 140' ' ' LEU . 9.1 p80 -74.64 51.79 0.48 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.374 -0.829 . . . . 0.0 110.385 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.428 ' O ' ' C ' ' A' ' 144' ' ' SER . 24.1 tp60 -71.07 -50.04 38.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.184 -0.947 . . . . 0.0 110.241 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 143' ' ' GLN . 1.9 p -42.27 162.81 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.28 -0.887 . . . . 0.0 110.222 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.8 -171.31 2.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.336 -0.853 . . . . 0.0 110.219 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.75 -148.5 19.95 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.453 ' HA ' HD22 ' A' ' 147' ' ' LEU . 0.1 OUTLIER -130.56 45.2 2.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -1.163 . . . . 0.0 110.161 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 149' ' ' ALA . 0.2 OUTLIER 179.9 144.04 0.18 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.897 . . . . 0.0 110.122 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.84 ' HB1' ' HD2' ' A' ' 150' ' ' PRO . . . -49.1 176.53 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.282 -0.886 . . . . 0.0 110.225 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.84 ' HD2' ' HB1' ' A' ' 149' ' ' ALA . 45.8 Cg_endo -72.64 -12.78 27.02 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.99 1.521 . . . . 0.0 110.545 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.443 ' NE2' ' HB1' ' A' ' 149' ' ' ALA . 0.0 OUTLIER -99.74 -159.29 0.73 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.291 -0.881 . . . . 0.0 110.198 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.638 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 1.8 m-30 -94.92 -66.17 0.1 OUTLIER Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.229 -0.92 . . . . 0.0 110.326 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.638 ' CD ' ' CB ' ' A' ' 152' ' ' TYR . 49.3 Cg_endo -74.19 110.57 3.12 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.574 1.302 . . . . 0.0 110.299 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.5 ' CB ' ' HB3' ' A' ' 149' ' ' ALA . . . 179.61 161.67 0.87 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.211 -0.931 . . . . 0.0 110.338 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.489 ' N ' ' CD ' ' A' ' 156' ' ' PRO . . . -173.19 53.17 0.16 Allowed Glycine 0 N--CA 1.48 1.585 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.493 ' HB2' ' HB3' ' A' ' 160' ' ' GLN . 48.6 Cg_endo -75.01 -5.39 16.72 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.975 1.513 . . . . 0.0 110.298 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.451 ' HA ' ' HB2' ' A' ' 161' ' ' LEU . 32.7 tp60 -68.85 -0.5 5.56 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.305 -0.872 . . . . 0.0 110.864 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.804 ' O ' HG22 ' A' ' 163' ' ' VAL . . . -86.93 -79.08 1.23 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.641 ' HG2' ' CD2' ' A' ' 133' ' ' TRP . 1.0 OUTLIER -109.76 -2.97 17.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.298 -1.119 . . . . 0.0 110.014 -179.793 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.493 ' HB3' ' HB2' ' A' ' 156' ' ' PRO . 0.1 OUTLIER -97.59 2.18 49.66 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.638 0.732 . . . . 0.0 109.23 179.344 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.667 ' O ' ' C ' ' A' ' 162' ' ' VAL . 1.3 mt -158.34 98.6 1.57 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.831 HG22 ' O ' ' A' ' 102' ' ' THR . 2.2 t 4.47 109.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-O 122.244 1.021 . . . . 0.0 110.568 -178.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 1.08 HG12 ' HD3' ' A' ' 164' ' ' PRO . 0.2 OUTLIER -67.46 -155.4 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.314 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 1.08 ' HD3' HG12 ' A' ' 163' ' ' VAL . 43.8 Cg_endo -72.29 178.76 5.7 Favored 'Trans proline' 0 C--N 1.318 -1.03 0 O-C-N 122.481 0.727 . . . . 0.0 110.999 -178.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.525 ' O ' ' HB3' ' A' ' 94' ' ' SER . 2.2 mt-10 -46.51 -32.2 3.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.428 -0.795 . . . . 0.0 111.232 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.54 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 18.2 ttp180 -151.83 156.17 39.64 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.981 -1.075 . . . . 0.0 111.13 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 1.032 HD11 ' CG2' ' A' ' 102' ' ' THR . 1.7 mp -126.85 157.31 39.65 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.543 -0.723 . . . . 0.0 109.436 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.543 HD21 HG22 ' A' ' 170' ' ' VAL . 1.1 tt -117.44 121.41 40.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.065 -1.022 . . . . 0.0 110.728 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.84 HG11 ' CE3' ' A' ' 91' ' ' TRP . 16.4 t -89.65 128.78 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.3 -0.875 . . . . 0.0 109.494 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.543 HG22 HD21 ' A' ' 168' ' ' LEU . 19.2 t -109.99 115.62 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.004 -1.06 . . . . 0.0 110.675 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 1.034 HD21 ' OG ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -129.27 123.12 31.1 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.285 -0.884 . . . . 0.0 109.491 179.505 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 173' ' ' MET . 47.3 t0 -120.13 137.96 53.86 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.177 -0.952 . . . . 0.0 110.021 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.586 ' HB3' ' N ' ' A' ' 87' ' ' GLY . 0.0 OUTLIER -98.56 -40.68 8.11 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.56 179.676 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -50.85 -22.61 2.27 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.318 -0.864 . . . . 0.0 109.073 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.581 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.3 OUTLIER -109.26 -27.97 9.25 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.803 0.811 . . . . 0.0 108.924 179.473 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.583 ' O ' ' CB ' ' A' ' 198' ' ' THR . . . 86.84 22.34 46.48 Favored Glycine 0 N--CA 1.482 1.709 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.862 HG22 HD22 ' A' ' 194' ' ' LEU . 0.0 OUTLIER -112.52 133.45 54.57 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.099 -1.236 . . . . 0.0 111.466 -179.389 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.997 HD23 HD12 ' A' ' 171' ' ' LEU . 2.6 mp -130.52 153.59 48.68 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.654 -0.654 . . . . 0.0 109.472 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 176.16 -175.29 47.39 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.231 -1.461 . . . . 0.0 110.538 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.729 ' CZ ' HG22 ' A' ' 169' ' ' VAL . 0.2 OUTLIER -127.18 131.51 50.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.67 -0.9 . . . . 0.0 109.173 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 168' ' ' LEU . 3.4 t -136.7 131.22 33.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.122 -0.986 . . . . 0.0 110.536 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.864 HD11 ' CD2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -102.27 116.84 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.372 -0.83 . . . . 0.0 109.393 179.212 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 83.45 -11.87 53.85 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 81.43 47.05 6.59 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 32.4 m -136.13 -36.46 0.74 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.135 -1.215 . . . . 0.0 110.775 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.864 ' CD2' HD11 ' A' ' 182' ' ' ILE . 5.1 m-30 -67.0 -77.23 0.07 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.005 -1.06 . . . . 0.0 110.506 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.602 ' O ' ' CE2' ' A' ' 191' ' ' PHE . 2.4 mm? -68.46 44.28 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.906 -1.121 . . . . 0.0 109.88 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.53 ' H ' ' HD2' ' A' ' 189' ' ' PRO . . . -94.95 -63.89 1.0 Allowed Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.99 -1.1 . . . . 0.0 110.611 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.53 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 45.1 Cg_endo -72.01 -30.99 13.0 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.802 1.422 . . . . 0.0 111.3 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.754 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -74.58 16.59 0.26 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.239 -0.913 . . . . 0.0 111.418 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.602 ' CE2' ' O ' ' A' ' 187' ' ' LEU . 0.3 OUTLIER -89.57 -8.34 52.88 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.063 -1.023 . . . . 0.0 109.982 179.204 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.06 -15.3 32.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.568 -0.707 . . . . 0.0 110.126 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -115.71 -11.17 10.54 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 107.483 -2.247 . . . . 0.0 107.483 179.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.9 ' HA ' ' HD2' ' A' ' 197' ' ' ARG . 0.4 OUTLIER -70.56 -22.17 62.62 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.796 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.588 ' HA ' HG23 ' A' ' 177' ' ' THR . 0.0 OUTLIER -57.29 -26.55 61.04 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.355 -0.84 . . . . 0.0 109.378 179.038 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.539 ' N ' ' HE3' ' A' ' 195' ' ' LYS . . . -106.08 -37.74 2.45 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.9 ' HD2' ' HA ' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -79.62 -4.52 51.98 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.448 -1.031 . . . . 0.0 110.567 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.583 ' CB ' ' O ' ' A' ' 176' ' ' GLY . 0.2 OUTLIER -43.37 133.82 4.08 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-O 122.194 0.997 . . . . 0.0 112.174 -177.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 1.096 HD13 ' CG2' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -141.73 171.06 14.57 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.218 179.19 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.673 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 46.5 m-85 -90.21 126.79 55.68 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.827 -1.171 . . . . 0.0 109.373 178.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.772 ' CA ' HG12 ' A' ' 108' ' ' VAL . 53.2 Cg_endo -82.16 150.36 15.64 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 124.196 1.629 . . . . 0.0 112.489 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 1.05 ' O ' HG23 ' A' ' 106' ' ' VAL . 73.6 p -133.69 149.84 51.52 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.583 HG22 ' N ' ' A' ' 204' ' ' SER . 14.5 p -118.62 168.17 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.406 -1.434 . . . . 0.0 110.623 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 0.772 ' CB ' HG23 ' A' ' 105' ' ' VAL . 0.4 OUTLIER -156.0 145.16 20.64 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.425 0.631 . . . . 0.0 109.923 179.681 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 1.205 ' HB3' ' CG2' ' A' ' 78' ' ' VAL . . . -145.47 135.96 24.18 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.74 -0.6 . . . . 0.0 109.705 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.572 ' CG1' ' N ' ' A' ' 207' ' ' TRP . 1.5 t -76.57 172.06 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.459 -0.776 . . . . 0.0 110.512 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 1.009 ' CB ' HD11 ' A' ' 57' ' ' ILE . 14.2 p90 -121.91 128.51 51.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.307 -0.871 . . . . 0.0 110.089 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.539 ' N ' ' HG2' ' A' ' 68' ' ' ARG . . . 154.4 -167.12 32.39 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.449 ' C ' ' O ' ' A' ' 208' ' ' GLY . 0.0 OUTLIER -40.21 -28.74 0.06 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.381 -1.07 . . . . 0.0 110.142 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . 0.483 ' C ' ' HG3' ' A' ' 211' ' ' GLN . 9.7 t -64.26 164.29 11.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.321 -0.862 . . . . 0.0 110.219 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.534 ' NE2' ' O ' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -164.24 109.55 1.01 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.358 -0.839 . . . . 0.0 109.655 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.645 ' O ' ' CH2' ' A' ' 48' ' ' TRP . 5.7 p -102.65 143.77 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.437 -0.79 . . . . 0.0 110.308 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.458 ' HB2' ' OG ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -93.93 156.2 16.75 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.364 -0.835 . . . . 0.0 109.41 179.361 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 1.077 HG22 HD11 ' A' ' 64' ' ' LEU . 4.9 tt -139.06 131.54 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.046 -1.034 . . . . 0.0 110.812 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.596 ' HB3' ' HB3' ' A' ' 92' ' ' GLU . 12.6 ttt180 -130.1 108.29 9.96 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . 0.736 ' CZ ' ' CD1' ' A' ' 91' ' ' TRP . 4.2 t80 -118.92 142.94 47.32 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.385 -0.822 . . . . 0.0 111.15 -177.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.58 115.57 12.34 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.558 -0.713 . . . . 0.0 110.102 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 133.85 53.85 0.07 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -133.63 138.66 46.05 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.265 -1.138 . . . . 0.0 110.114 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.413 ' C ' ' HG3' ' A' ' 221' ' ' ARG . 5.0 ptm180 -78.22 155.98 30.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.242 -0.911 . . . . 0.0 110.381 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . 0.495 ' O ' ' C ' ' A' ' 222' ' ' VAL . 0.1 OUTLIER -134.62 93.73 3.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.242 -0.911 . . . . 0.0 110.124 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.681 HG13 ' O ' ' A' ' 222' ' ' VAL . 7.3 p -34.57 96.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.368 -0.833 . . . . 0.0 110.742 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.665 ' O ' ' C ' ' A' ' 224' ' ' GLU . 1.0 OUTLIER 179.86 86.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.333 -0.854 . . . . 0.0 110.168 179.856 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.665 ' C ' ' O ' ' A' ' 223' ' ' GLU . 3.4 pt-20 0.73 68.67 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.379 0.609 . . . . 0.0 111.517 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.63 ' N ' ' O ' ' A' ' 223' ' ' GLU . 13.1 t -68.72 161.63 27.89 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.323 -0.86 . . . . 0.0 110.312 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.12 89.31 7.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 110.186 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.494 ' HG2' HG23 ' A' ' 225' ' ' THR . 2.8 ptm180 -124.28 -174.59 3.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.19 -0.944 . . . . 0.0 110.249 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.415 ' O ' ' HB2' ' A' ' 229' ' ' HIS . 1.2 tt -166.28 158.52 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.209 -0.932 . . . . 0.0 110.158 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.43 ' O ' ' C ' ' A' ' 230' ' ' ARG . 58.4 t60 -179.97 -30.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.237 -0.915 . . . . 0.0 110.285 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . 0.68 ' O ' ' C ' ' A' ' 231' ' ' ASP . 36.9 mmm-85 -42.14 126.47 3.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 110.246 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.68 ' C ' ' O ' ' A' ' 230' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 117.984 -1.008 . . . . 0.0 111.541 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 t -110.9 -46.97 3.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.336 -1.097 . . . . 0.0 110.14 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.23 -81.74 0.06 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.261 -0.9 . . . . 0.0 110.129 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -145.55 94.03 2.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.247 -0.908 . . . . 0.0 110.186 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.3 mtp180 -132.92 171.63 13.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.269 -0.895 . . . . 0.0 110.214 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -154.36 80.79 1.11 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.917 . . . . 0.0 110.166 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -79.88 -51.73 8.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 110.336 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.414 ' O ' HG23 ' A' ' 13' ' ' THR . 1.4 t -121.17 117.92 30.38 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 0.0 110.159 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.4 151.48 48.11 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.014 1.534 . . . . 0.0 110.383 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.5 m -105.34 92.19 4.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.309 -0.869 . . . . 0.0 110.219 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.7 t -141.84 25.91 1.93 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.294 -0.879 . . . . 0.0 110.197 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -153.31 -79.14 0.1 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 110.298 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.51 164.93 24.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.296 -0.878 . . . . 0.0 110.198 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.483 HD23 ' H ' ' A' ' 20' ' ' TYR . 0.3 OUTLIER -173.88 -145.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.257 -0.902 . . . . 0.0 110.194 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.483 ' H ' HD23 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -125.51 -5.43 7.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.192 -0.943 . . . . 0.0 110.232 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 22' ' ' ASP . 79.9 p -140.04 -149.63 0.29 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 110.218 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 21' ' ' SER . 25.2 t70 -176.22 89.02 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.193 -0.942 . . . . 0.0 110.146 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.41 -76.52 0.1 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.937 . . . . 0.0 110.15 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.6 m -78.8 116.11 57.25 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.343 -0.848 . . . . 0.0 110.135 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.03 159.07 48.6 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.042 1.549 . . . . 0.0 110.439 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.654 ' O ' ' N ' ' A' ' 28' ' ' GLY . 46.3 Cg_endo -72.79 -171.39 0.75 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.008 1.53 . . . . 0.0 110.505 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.654 ' C ' ' O ' ' A' ' 26' ' ' PRO . 20.1 mt-10 1.25 67.18 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.533 0.683 . . . . 0.0 111.31 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.654 ' N ' ' O ' ' A' ' 26' ' ' PRO . . . -160.74 -32.2 0.02 OUTLIER Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.587 ' H ' HD23 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -76.45 -22.54 54.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -1.147 . . . . 0.0 110.285 -179.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.944 ' HA ' HD23 ' A' ' 33' ' ' LEU . 1.3 mt-10 -47.69 -35.12 9.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.101 -0.999 . . . . 0.0 109.192 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -62.27 -24.07 67.07 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.309 -0.87 . . . . 0.0 108.841 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.545 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.7 OUTLIER -83.44 -34.06 25.54 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.102 HD21 ' CG ' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -76.17 -36.06 58.88 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.877 0.846 . . . . 0.0 109.42 179.323 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.606 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -80.46 -7.37 59.13 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.161 179.878 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.982 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -54.87 -66.81 0.82 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.213 -0.929 . . . . 0.0 110.488 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.982 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 48.9 Cg_endo -73.65 143.22 33.62 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.692 1.364 . . . . 0.0 110.316 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 36' ' ' PRO . 53.8 Cg_endo -98.88 56.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 121.898 1.732 . . . . 0.0 112.034 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.726 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 52.8 Cg_endo -75.82 150.91 35.35 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 122.979 0.989 . . . . 0.0 110.118 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.615 ' O ' ' HB3' ' A' ' 43' ' ' GLN . 1.0 OUTLIER -34.26 -33.52 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.313 -0.867 . . . . 0.0 109.457 179.557 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.088 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -57.41 -46.88 83.02 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.242 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.991 HG23 HD13 ' A' ' 40' ' ' LEU . 54.4 t -86.6 -33.7 7.32 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 O-C-N 120.647 -1.283 . . . . 0.0 110.415 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.21 -39.17 12.25 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.401 -0.812 . . . . 0.0 113.058 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.615 ' HB3' ' O ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -86.67 -19.65 28.93 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 120.726 -1.234 . . . . 0.0 109.455 -178.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 1.086 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -79.36 -51.09 9.87 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 122.078 0.942 . . . . 0.0 109.528 179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.834 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 59.5 m170 -51.52 -17.57 0.85 Allowed 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.632 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.402 ' CD2' ' C ' ' A' ' 46' ' ' HIS . 4.0 t60 -84.46 -39.21 19.21 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.443 -1.303 . . . . 0.0 110.029 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.942 ' O ' HD12 ' A' ' 214' ' ' ILE . . . -97.98 -68.19 0.93 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 106.597 -2.601 . . . . 0.0 106.597 177.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.838 ' CD1' ' CG2' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -89.26 72.61 8.13 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 177.229 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.834 ' HA ' ' HA ' ' A' ' 45' ' ' HIS . 0.0 OUTLIER -55.22 151.45 18.15 Favored Pre-proline 0 N--CA 1.494 1.754 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.412 -178.514 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.734 ' HD3' ' HA ' ' A' ' 45' ' ' HIS . 45.0 Cg_endo -78.49 -25.86 6.43 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 124.522 1.801 . . . . 0.0 110.563 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.852 ' N ' ' HE3' ' A' ' 51' ' ' LYS . 0.4 OUTLIER -64.48 -14.3 56.4 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.145 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 1.081 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 9.8 m-20 -122.75 2.16 9.45 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.644 178.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.863 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 10.1 t -151.73 132.94 14.45 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.877 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.75 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 0.8 OUTLIER -71.81 118.49 14.73 Favored 'General case' 0 C--N 1.292 -1.926 0 O-C-N 121.548 -0.72 . . . . 0.0 110.34 179.434 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 1.102 ' CG ' HD21 ' A' ' 33' ' ' LEU . 0.7 OUTLIER -40.25 -20.49 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.503 -0.748 . . . . 0.0 111.786 -179.641 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.75 ' ND2' ' HB2' ' A' ' 54' ' ' SER . 0.0 OUTLIER -54.45 -1.9 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.762 -1.211 . . . . 0.0 109.638 179.755 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.706 HG23 ' O ' ' A' ' 67' ' ' GLU . 26.9 mm -111.68 155.35 13.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.923 0.868 . . . . 0.0 111.323 -177.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.582 ' N ' ' O ' ' A' ' 67' ' ' GLU . 1.4 t70 -118.14 95.36 4.86 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.718 0.77 . . . . 0.0 109.266 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.952 HG21 ' CD1' ' A' ' 66' ' ' PHE . 1.1 p -131.56 118.99 41.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 O-C-N 121.808 -0.557 . . . . 0.0 111.397 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.607 ' O ' ' O ' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -136.76 157.57 46.44 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.066 -1.021 . . . . 0.0 111.265 179.551 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.771 ' N ' ' CH2' ' A' ' 48' ' ' TRP . 1.0 OUTLIER -39.27 -112.98 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.717 -0.614 . . . . 0.0 112.029 -179.157 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.514 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 42.11 44.57 4.82 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 107.291 -2.324 . . . . 0.0 107.291 -177.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.743 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 84.64 87.08 0.89 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 106.881 -2.488 . . . . 0.0 106.881 -177.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.765 HD13 ' HE1' ' A' ' 48' ' ' TRP . 0.2 OUTLIER 1.48 82.88 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.632 -0.922 . . . . 0.0 109.901 -177.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.703 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -101.57 114.15 27.93 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.879 -0.728 . . . . 0.0 110.48 -178.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.952 ' CD1' HG21 ' A' ' 59' ' ' VAL . 4.5 t80 -114.42 123.39 49.33 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.706 ' O ' HG23 ' A' ' 57' ' ' ILE . 1.3 tm-20 -151.7 163.05 39.96 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.16 -0.963 . . . . 0.0 110.497 -179.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.621 ' CG ' ' HB2' ' A' ' 207' ' ' TRP . 0.2 OUTLIER -111.42 153.37 26.19 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.222 -0.923 . . . . 0.0 109.841 179.223 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.714 ' CB ' ' HD3' ' A' ' 70' ' ' PRO . 34.8 mtp180 -85.2 -73.87 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 120.978 -1.076 . . . . 0.0 109.665 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.714 ' HD3' ' CB ' ' A' ' 69' ' ' ARG . 57.5 Cg_endo -76.23 -124.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 N-CA-C 108.384 -1.429 . . . . 0.0 108.384 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.42 ' H ' ' HB2' ' A' ' 70' ' ' PRO . 2.6 t -140.44 164.51 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.455 -1.403 . . . . 0.0 109.947 179.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.579 ' HB2' ' CD1' ' A' ' 207' ' ' TRP . . . -80.04 33.45 0.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.178 -0.951 . . . . 0.0 110.357 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -45.98 -47.47 16.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.258 -0.901 . . . . 0.0 110.361 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.9 p -172.67 30.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.27 -0.894 . . . . 0.0 110.154 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.565 HG23 ' N ' ' A' ' 76' ' ' ASP . 9.9 t -97.87 -132.06 0.22 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.288 -0.883 . . . . 0.0 109.992 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.597 ' O ' ' HB2' ' A' ' 54' ' ' SER . 12.5 m-20 -140.41 114.05 8.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.157 -0.964 . . . . 0.0 110.572 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 76' ' ' ASP . . . -55.83 -106.52 0.01 OUTLIER Glycine 0 N--CA 1.486 1.986 0 N-CA-C 107.942 -2.063 . . . . 0.0 107.942 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.03 ' CG2' ' HB3' ' A' ' 205' ' ' ALA . 4.4 m -138.16 123.91 24.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 120.998 -1.295 . . . . 0.0 110.078 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.662 ' NE ' ' O ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -145.42 133.83 21.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.18 -0.95 . . . . 0.0 112.161 -178.616 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 1.081 ' CA ' ' HA ' ' A' ' 52' ' ' ASP . . . -131.79 163.84 23.72 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 178.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.548 ' CB ' ' HB3' ' A' ' 202' ' ' SER . 2.5 ttpm? -171.01 87.28 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.494 -1.003 . . . . 0.0 109.513 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.818 ' HD3' ' H ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -152.31 -91.18 0.05 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.227 -0.92 . . . . 0.0 110.542 -179.366 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.818 ' H ' ' HD3' ' A' ' 82' ' ' ARG . . . 45.75 42.78 11.2 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -97.21 106.2 18.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -1.11 . . . . 0.0 110.217 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.595 ' HB2' ' CE1' ' A' ' 89' ' ' HIS . 75.5 p -138.28 167.17 22.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 0.0 110.071 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.538 ' HA ' ' CB ' ' A' ' 173' ' ' MET . 0.0 OUTLIER -120.14 135.44 54.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.216 -0.927 . . . . 0.0 110.285 -179.824 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' ' 172' ' ' ASP . . . 102.83 -116.64 5.54 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.476 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 2.5 tp -128.36 130.27 47.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.321 -1.105 . . . . 0.0 110.282 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.595 ' CE1' ' HB2' ' A' ' 85' ' ' SER . 33.4 m-70 -146.33 166.2 27.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.099 -1.001 . . . . 0.0 109.997 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.539 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -158.99 153.71 24.63 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.054 -1.029 . . . . 0.0 109.92 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 1.001 ' CZ2' HD22 ' A' ' 171' ' ' LEU . 1.4 m0 -134.81 148.57 50.22 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.298 -0.876 . . . . 0.0 109.911 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.731 ' C ' HD12 ' A' ' 93' ' ' ILE . 7.8 mt-10 -109.56 118.42 36.55 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.52 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.731 HD12 ' C ' ' A' ' 92' ' ' GLU . 1.2 mp -133.69 154.52 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.054 -1.029 . . . . 0.0 110.877 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.589 ' HA ' ' HG ' ' A' ' 167' ' ' LEU . 0.3 OUTLIER -140.88 119.94 12.8 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.16 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 1.134 ' CE3' HG22 ' A' ' 106' ' ' VAL . 3.0 t-105 -117.41 89.5 31.91 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.072 -1.018 . . . . 0.0 110.657 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 94' ' ' SER . 51.0 Cg_endo -89.18 109.53 0.47 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.085 1.571 . . . . 0.0 110.153 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.99 HD23 ' HE1' ' A' ' 95' ' ' TRP . 0.3 OUTLIER -95.59 -6.35 40.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.128 -0.982 . . . . 0.0 110.399 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.515 ' HG3' ' N ' ' A' ' 99' ' ' GLN . 0.4 OUTLIER -40.25 -25.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.256 -0.902 . . . . 0.0 110.308 -179.858 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.518 ' N ' ' O ' ' A' ' 97' ' ' LEU . 5.8 mt-30 -73.51 -99.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 110.195 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.769 ' O ' HD11 ' A' ' 97' ' ' LEU . 2.5 mmm180 -136.21 -84.52 0.37 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.109 -0.994 . . . . 0.0 110.261 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.869 ' O ' HG23 ' A' ' 102' ' ' THR . . . 57.81 -157.11 16.57 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.869 HG23 ' O ' ' A' ' 101' ' ' GLY . 0.1 OUTLIER -179.69 -90.87 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -1.144 . . . . 0.0 110.128 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.462 ' O ' ' C ' ' A' ' 104' ' ' ALA . 8.0 t-160 -85.61 -19.72 30.58 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.255 -0.903 . . . . 0.0 110.004 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.692 ' C ' ' CZ2' ' A' ' 95' ' ' TRP . . . -39.43 122.46 1.32 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.372 -0.83 . . . . 0.0 110.147 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.897 HG23 ' HA ' ' A' ' 134' ' ' ASP . 4.9 p -137.72 159.81 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.198 -0.939 . . . . 0.0 112.405 -178.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 1.134 HG22 ' CE3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -122.31 115.93 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 177.114 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.591 ' HA3' ' HA3' ' A' ' 132' ' ' GLY . . . -160.54 -164.96 16.43 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 118.648 -1.739 . . . . 0.0 111.227 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.654 ' HB ' HD13 ' A' ' 199' ' ' LEU . 0.7 OUTLIER -120.54 156.23 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.617 -0.931 . . . . 0.0 109.515 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 130' ' ' SER . . . -128.13 143.09 51.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.861 -1.149 . . . . 0.0 110.686 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.886 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.7 OUTLIER -115.38 123.13 47.9 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.196 -0.94 . . . . 0.0 110.455 179.74 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -93.91 -31.03 14.47 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.465 -0.772 . . . . 0.0 109.712 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.695 ' O ' ' C ' ' A' ' 113' ' ' ALA . 1.7 pp -79.22 -11.87 59.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.507 -0.745 . . . . 0.0 110.115 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.695 ' C ' ' O ' ' A' ' 112' ' ' LEU . . . 0.68 103.06 0.02 OUTLIER Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 121.872 -0.518 . . . . 0.0 111.128 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.72 -156.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.137 1.598 . . . . 0.0 110.654 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.571 ' C ' HD12 ' A' ' 115' ' ' LEU . 0.5 OUTLIER -160.96 55.26 0.3 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.28 -0.888 . . . . 0.0 109.968 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 115' ' ' LEU . 3.6 tt0 -38.3 -39.83 0.47 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.489 -0.757 . . . . 0.0 110.356 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.532 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -71.46 133.97 46.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.347 -0.845 . . . . 0.0 110.125 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.532 ' C ' ' O ' ' A' ' 117' ' ' ALA . 5.6 t70 -30.89 -82.44 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.499 -0.751 . . . . 0.0 110.76 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.438 ' HB3' ' O ' ' A' ' 118' ' ' ASP . 7.0 t60 65.17 -67.18 0.13 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 110.256 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.504 ' N ' ' O ' ' A' ' 118' ' ' ASP . 0.2 OUTLIER 52.72 63.64 2.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.311 -0.868 . . . . 0.0 110.192 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' A' ' 120' ' ' TYR . . . -55.03 -165.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.246 -0.909 . . . . 0.0 110.246 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.35 -43.92 72.66 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.299 -0.876 . . . . 0.0 110.222 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.644 ' O ' HD12 ' A' ' 123' ' ' LEU . 2.0 pp -162.39 107.95 1.22 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.198 -0.939 . . . . 0.0 110.27 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 53.86 -87.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.371 -0.83 . . . . 0.0 110.246 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 123' ' ' LEU . . . 68.11 145.57 0.13 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 128' ' ' SER . 0.3 OUTLIER -137.73 63.72 1.54 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.267 -1.137 . . . . 0.0 110.181 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -44.84 93.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.277 -0.889 . . . . 0.0 110.173 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 126' ' ' SER . 0.5 OUTLIER -47.65 147.36 1.86 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.904 . . . . 0.0 110.227 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -149.84 128.91 12.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.268 -0.895 . . . . 0.0 109.964 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 2.9 t -120.41 119.35 32.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.16 -0.963 . . . . 0.0 110.501 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -133.94 136.19 44.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.501 -0.749 . . . . 0.0 109.305 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.591 ' HA3' ' HA3' ' A' ' 107' ' ' GLY . . . -165.39 -111.34 0.24 Allowed Glycine 0 N--CA 1.486 2.001 0 C-N-CA 119.042 -1.552 . . . . 0.0 110.796 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.764 ' CH2' ' HB2' ' A' ' 180' ' ' TYR . 5.3 m-90 -140.3 122.77 16.1 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 121.168 -1.195 . . . . 0.0 111.634 -178.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.897 ' HA ' HG23 ' A' ' 105' ' ' VAL . 0.9 OUTLIER -118.89 148.62 42.72 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.394 -179.638 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.549 HD13 ' N ' ' A' ' 135' ' ' ILE . 0.2 OUTLIER -69.8 -0.48 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.348 -0.845 . . . . 0.0 110.313 179.561 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.502 ' O ' ' CG ' ' A' ' 139' ' ' LYS . . . -46.16 -20.96 0.58 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.921 ' HB2' HG13 ' A' ' 162' ' ' VAL . 8.0 mpt_? -57.7 -20.04 31.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.266 -1.138 . . . . 0.0 108.989 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.568 ' HA2' ' CG2' ' A' ' 162' ' ' VAL . . . -80.45 -2.17 89.26 Favored Glycine 0 C--N 1.291 -1.942 0 N-CA-C 107.956 -2.057 . . . . 0.0 107.956 178.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.524 ' O ' ' O ' ' A' ' 138' ' ' GLY . 2.2 mmtm -53.69 -161.26 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.669 -0.901 . . . . 0.0 110.174 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.405 ' O ' ' O ' ' A' ' 141' ' ' TYR . 1.9 mp -117.25 82.98 1.9 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -0.924 . . . . 0.0 110.472 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.405 ' O ' ' O ' ' A' ' 140' ' ' LEU . 4.7 m-85 -52.89 -99.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.235 -0.916 . . . . 0.0 110.318 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.584 ' O ' ' CG ' ' A' ' 142' ' ' HIS . 7.2 p80 -159.53 59.39 0.39 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.932 . . . . 0.0 110.376 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -146.4 -55.14 0.26 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.179 -0.951 . . . . 0.0 110.221 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 144' ' ' SER . 0.9 OUTLIER -87.74 20.33 3.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.343 -0.848 . . . . 0.0 110.19 -179.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -52.19 106.38 0.15 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.213 -0.929 . . . . 0.0 110.157 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -152.64 -105.71 0.28 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' A' ' 148' ' ' GLU . 0.5 OUTLIER -140.65 79.04 1.68 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.214 -1.168 . . . . 0.0 110.127 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 147' ' ' LEU . 7.3 tp10 179.94 154.09 0.53 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.898 . . . . 0.0 110.132 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.469 ' O ' ' O ' ' A' ' 154' ' ' ALA . . . -175.64 149.06 1.05 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.165 -0.959 . . . . 0.0 110.328 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.17 1.54 7.14 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.047 1.551 . . . . 0.0 110.613 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -68.0 -94.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.094 -1.004 . . . . 0.0 110.255 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.553 ' HB3' ' HD3' ' A' ' 153' ' ' PRO . 0.1 OUTLIER -82.92 -59.11 0.4 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.208 -0.932 . . . . 0.0 110.618 -179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 152' ' ' TYR . 47.4 Cg_endo -73.89 169.69 21.81 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.861 1.453 . . . . 0.0 110.509 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.469 ' O ' ' O ' ' A' ' 149' ' ' ALA . . . -48.36 166.47 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 0.0 110.176 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.476 ' N ' ' CD ' ' A' ' 156' ' ' PRO . . . -146.73 55.26 0.53 Allowed Glycine 0 N--CA 1.48 1.58 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 155' ' ' GLY . 45.4 Cg_endo -72.13 -47.36 0.43 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.154 1.607 . . . . 0.0 110.211 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -65.47 -6.09 9.6 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.269 -0.894 . . . . 0.0 110.278 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.548 ' O ' HG23 ' A' ' 162' ' ' VAL . . . -77.47 -45.14 11.47 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.563 ' HA ' ' CG2' ' A' ' 162' ' ' VAL . 0.4 OUTLIER -75.89 6.38 5.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -1.135 . . . . 0.0 110.254 179.855 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.57 -6.81 46.6 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.345 -0.847 . . . . 0.0 109.985 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.494 HD23 ' HA ' ' A' ' 161' ' ' LEU . 1.0 OUTLIER -149.82 29.82 0.74 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.386 -0.822 . . . . 0.0 109.806 179.651 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.921 HG13 ' HB2' ' A' ' 137' ' ' ARG . 3.7 t -112.52 -126.61 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.467 -0.771 . . . . 0.0 109.82 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.88 HG11 ' HB ' ' A' ' 182' ' ' ILE . 0.6 OUTLIER -139.87 44.03 0.68 Allowed Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.057 -1.027 . . . . 0.0 110.299 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.686 ' HD3' ' N ' ' A' ' 163' ' ' VAL . 53.7 Cg_endo -79.76 81.91 2.64 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.785 1.413 . . . . 0.0 110.872 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -167.25 -84.44 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.05 -1.031 . . . . 0.0 110.106 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 1.03 ' O ' HD23 ' A' ' 167' ' ' LEU . 20.3 ttp180 -151.9 155.84 38.9 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.461 -0.775 . . . . 0.0 109.988 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 1.03 HD23 ' O ' ' A' ' 166' ' ' ARG . 9.9 mt -138.15 128.85 26.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.192 -0.943 . . . . 0.0 110.525 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 17.7 tp -103.63 141.34 36.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.259 -0.9 . . . . 0.0 109.167 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.703 HG13 ' CD2' ' A' ' 180' ' ' TYR . 6.8 t -125.55 132.22 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.799 -1.188 . . . . 0.0 111.58 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.743 HG13 ' O ' ' A' ' 170' ' ' VAL . 11.4 p -138.02 104.93 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 1.001 HD22 ' CZ2' ' A' ' 91' ' ' TRP . 0.0 OUTLIER -118.41 141.13 48.85 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.134 -0.979 . . . . 0.0 110.417 -179.083 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 173' ' ' MET . 40.4 t0 -120.2 138.68 53.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.29 -0.881 . . . . 0.0 110.19 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.55 ' CG ' ' O ' ' A' ' 85' ' ' SER . 4.1 tpt -89.97 -39.15 13.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.624 -0.673 . . . . 0.0 109.849 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 173' ' ' MET . 1.4 tt0 -42.09 -27.78 0.15 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.892 . . . . 0.0 109.191 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.515 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 3.0 tt0 -106.99 -27.76 10.46 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.702 0.763 . . . . 0.0 108.97 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 86.11 21.98 50.37 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.98 HG22 ' CD2' ' A' ' 194' ' ' LEU . 0.8 OUTLIER -121.76 150.54 41.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.342 -1.093 . . . . 0.0 110.642 -179.651 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.963 ' HB3' HD12 ' A' ' 171' ' ' LEU . 0.2 OUTLIER -117.44 153.52 32.95 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.439 -0.788 . . . . 0.0 109.895 179.815 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -134.09 122.03 2.88 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.764 ' HB2' ' CH2' ' A' ' 133' ' ' TRP . 2.4 t80 -119.77 124.8 47.06 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.26 -1.141 . . . . 0.0 109.508 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.462 ' HA ' HG23 ' A' ' 185' ' ' THR . 12.5 t -103.66 122.21 44.55 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 122.135 0.969 . . . . 0.0 109.456 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 1.009 HG22 ' CD2' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -129.42 158.54 42.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.819 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.612 ' C ' ' O ' ' A' ' 182' ' ' ILE . . . -33.63 -34.77 0.03 OUTLIER Glycine 0 N--CA 1.493 2.446 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.686 ' O ' ' CD1' ' A' ' 186' ' ' TYR . . . -105.5 32.66 7.2 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.549 -1.82 . . . . 0.0 108.549 178.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . 0.817 ' N ' ' O ' ' A' ' 182' ' ' ILE . 53.3 m -37.77 -26.59 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.494 -1.004 . . . . 0.0 110.871 -179.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.7 ' O ' ' CD2' ' A' ' 186' ' ' TYR . 16.9 p90 -41.38 91.08 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 122.202 1.001 . . . . 0.0 109.316 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.669 ' C ' ' HD2' ' A' ' 189' ' ' PRO . 0.1 OUTLIER 179.81 31.2 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.542 -0.724 . . . . 0.0 109.221 -178.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.865 ' N ' ' CD ' ' A' ' 189' ' ' PRO . . . -105.67 2.08 39.22 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.403 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.865 ' CD ' ' N ' ' A' ' 188' ' ' GLY . 48.7 Cg_endo -75.79 -27.12 9.06 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 N-CA-C 109.426 -1.028 . . . . 0.0 109.426 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -81.43 21.97 0.73 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.631 -0.668 . . . . 0.0 110.476 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.401 ' HA ' ' HB2' ' A' ' 194' ' ' LEU . 1.8 m-85 -73.2 -48.67 33.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.11 -0.994 . . . . 0.0 109.945 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 9.5 mtm180 -52.87 -19.25 2.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.187 -0.946 . . . . 0.0 109.766 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -107.32 -17.93 10.91 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.166 -1.973 . . . . 0.0 108.166 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.98 ' CD2' HG22 ' A' ' 177' ' ' THR . 6.9 tt -62.2 -31.32 71.83 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.692 -0.887 . . . . 0.0 109.205 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.554 ' HE3' ' N ' ' A' ' 196' ' ' GLY . 0.0 OUTLIER -49.52 -27.83 4.8 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.443 -0.786 . . . . 0.0 109.407 179.534 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.554 ' N ' ' HE3' ' A' ' 195' ' ' LYS . . . -112.29 -21.59 6.17 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.642 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.77 -10.42 42.95 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.65 -0.912 . . . . 0.0 109.749 179.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.623 HG22 ' O ' ' A' ' 194' ' ' LEU . 0.1 OUTLIER -43.83 145.25 0.71 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.907 0.86 . . . . 0.0 111.427 -178.559 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.886 ' CB ' HG23 ' A' ' 110' ' ' THR . 0.0 OUTLIER -140.43 171.45 14.12 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.24 0.543 . . . . 0.0 109.725 179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.421 ' C ' ' CG1' ' A' ' 108' ' ' VAL . 15.8 m-30 -84.33 136.98 39.75 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.178 -0.951 . . . . 0.0 109.218 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.584 ' HG3' ' CH2' ' A' ' 91' ' ' TRP . 40.8 Cg_endo -67.03 109.82 1.81 Allowed 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 123.862 1.454 . . . . 0.0 110.814 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.548 ' HB3' ' CB ' ' A' ' 81' ' ' LYS . 57.4 p -133.47 137.2 45.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.507 -0.746 . . . . 0.0 109.595 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 79' ' ' ARG . 4.9 p -128.9 146.55 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.994 -1.066 . . . . 0.0 111.187 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 26.7 m -128.75 127.19 41.54 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 1.03 ' HB3' ' CG2' ' A' ' 78' ' ' VAL . . . -126.28 166.14 17.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 0.0 110.716 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.583 ' CG1' ' N ' ' A' ' 207' ' ' TRP . 0.9 OUTLIER -101.63 174.66 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 121.363 0.602 . . . . 0.0 110.233 -179.533 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 0.621 ' HB2' ' CG ' ' A' ' 68' ' ' ARG . 63.9 p-90 -99.01 128.43 45.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.89 . . . . 0.0 110.264 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 144.04 -147.48 18.78 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 211' ' ' GLN . 0.0 OUTLIER -66.18 -25.25 66.85 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.345 -1.091 . . . . 0.0 110.239 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . 0.678 ' O ' ' C ' ' A' ' 211' ' ' GLN . 4.9 t -37.12 -30.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.593 -0.692 . . . . 0.0 110.621 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.678 ' C ' ' O ' ' A' ' 210' ' ' CYS . 10.4 mt-30 0.07 114.59 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 121.65 0.738 . . . . 0.0 111.427 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.66 ' O ' HD11 ' A' ' 64' ' ' LEU . 0.8 OUTLIER -115.62 144.09 24.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.642 -0.661 . . . . 0.0 110.668 -179.164 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.554 ' HG3' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -88.54 121.96 31.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.281 -0.887 . . . . 0.0 109.566 179.758 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 1.061 ' O ' HD13 ' A' ' 214' ' ' ILE . 0.0 OUTLIER -123.5 121.59 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 110.896 -179.241 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.653 ' N ' ' O ' ' A' ' 92' ' ' GLU . 0.2 OUTLIER -130.87 139.61 50.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.513 -0.742 . . . . 0.0 109.665 179.495 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . 0.717 ' CE2' ' CD1' ' A' ' 91' ' ' TRP . 0.9 OUTLIER -118.7 150.76 39.21 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.965 -1.085 . . . . 0.0 110.728 -179.439 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . 0.494 ' CB ' ' O ' ' A' ' 90' ' ' ALA . 2.0 ttm -125.08 107.82 11.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.305 -0.872 . . . . 0.0 110.039 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 116.54 21.59 4.67 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.477 ' OE1' ' N ' ' A' ' 220' ' ' ARG . 0.0 OUTLIER -104.72 117.86 35.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.108 -1.23 . . . . 0.0 110.23 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.477 ' N ' ' OE1' ' A' ' 219' ' ' GLU . 0.9 OUTLIER -126.38 148.26 49.63 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.286 -0.884 . . . . 0.0 110.199 -179.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . 0.516 ' O ' ' C ' ' A' ' 222' ' ' VAL . 0.8 OUTLIER -154.6 94.44 1.68 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.247 -0.908 . . . . 0.0 110.258 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.516 ' C ' ' O ' ' A' ' 221' ' ' ARG . 9.6 p -34.49 135.47 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.485 -0.759 . . . . 0.0 110.476 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.524 ' O ' ' C ' ' A' ' 224' ' ' GLU . 0.8 OUTLIER 179.88 -78.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.934 . . . . 0.0 110.206 179.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.524 ' C ' ' O ' ' A' ' 223' ' ' GLU . 0.0 OUTLIER -32.1 -51.5 0.25 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.456 -0.777 . . . . 0.0 110.669 -179.779 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.503 ' N ' ' OE1' ' A' ' 224' ' ' GLU . 91.5 m -58.71 81.82 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.204 -0.935 . . . . 0.0 110.218 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 224' ' ' GLU . 0.0 OUTLIER -129.32 14.13 6.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 0.0 110.175 -179.858 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.68 -32.18 72.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.304 -0.872 . . . . 0.0 110.132 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 30.5 pt -52.13 139.54 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -0.919 . . . . 0.0 110.167 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -77.57 -44.21 29.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.247 -0.908 . . . . 0.0 110.166 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . 0.418 ' O ' ' OD1' ' A' ' 231' ' ' ASP . 0.3 OUTLIER -47.69 99.83 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.18 -0.95 . . . . 0.0 110.259 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 230' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--N 1.305 -1.351 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.376 179.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.78 172.08 0.79 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.302 -1.117 . . . . 0.0 110.182 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 9' ' ' ALA . 0.1 OUTLIER -163.15 178.92 7.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.332 -0.855 . . . . 0.0 110.165 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.41 ' N ' ' OG ' ' A' ' 8' ' ' SER . . . -124.52 -4.75 7.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.273 -0.892 . . . . 0.0 110.243 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.1 -68.08 0.38 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.177 -0.952 . . . . 0.0 110.208 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -175.45 -35.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.185 -0.947 . . . . 0.0 110.221 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.8 t -70.7 68.47 0.4 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.343 -0.848 . . . . 0.0 110.185 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.572 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -68.13 -54.11 16.94 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.206 -0.934 . . . . 0.0 110.347 179.89 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 13' ' ' THR . 45.7 Cg_endo -73.0 -167.61 0.36 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.867 1.456 . . . . 0.0 110.467 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 16' ' ' SER . 0.3 OUTLIER -78.68 -145.9 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.25 -0.906 . . . . 0.0 110.23 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.435 ' H ' HG22 ' A' ' 15' ' ' THR . 0.1 OUTLIER -176.39 152.63 1.1 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.344 -0.847 . . . . 0.0 110.218 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -115.94 150.92 36.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.302 -0.874 . . . . 0.0 110.15 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.95 101.73 2.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.113 -0.992 . . . . 0.0 110.221 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.8 -5.27 42.53 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 122.245 1.021 . . . . 0.0 110.088 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -55.95 -176.04 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.338 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.101 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.38 -149.03 0.38 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.281 -0.887 . . . . 0.0 110.182 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -120.39 -110.55 0.34 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.298 -0.876 . . . . 0.0 109.896 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.27 -71.41 0.4 Allowed 'General case' 0 C--N 1.284 -2.282 0 CA-C-O 121.384 0.611 . . . . 0.0 110.242 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 t -83.33 125.33 74.52 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.316 -0.865 . . . . 0.0 110.175 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.99 136.5 24.99 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.86 1.453 . . . . 0.0 110.449 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.541 ' HG2' ' CB ' ' A' ' 74' ' ' SER . 44.4 Cg_endo -72.36 160.41 47.02 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.042 1.549 . . . . 0.0 110.631 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -167.54 43.88 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.381 -0.824 . . . . 0.0 109.736 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.418 ' O ' ' HG2' ' A' ' 30' ' ' GLU . . . 134.74 28.42 0.45 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.935 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -42.15 -32.19 0.45 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.324 -1.104 . . . . 0.0 109.982 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.54 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 3.0 pt-20 -48.42 -35.71 13.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.052 -1.03 . . . . 0.0 108.691 179.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -59.13 -26.09 64.42 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -77.73 -36.01 51.35 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.457 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.896 HD12 ' C ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -76.3 -38.85 55.49 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.663 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.564 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -45.92 -26.62 0.73 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.454 0.645 . . . . 0.0 109.925 179.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 1.087 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -52.16 -168.47 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.567 -0.708 . . . . 0.0 109.376 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 1.087 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 39.7 Cg_endo -67.07 104.53 0.86 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.448 1.236 . . . . 0.0 109.704 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.846 ' HG2' HG21 ' A' ' 41' ' ' VAL . 51.1 Cg_endo -90.84 115.24 0.46 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.284 1.676 . . . . 0.0 111.49 -178.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.902 ' O ' ' N ' ' A' ' 40' ' ' LEU . 50.6 Cg_endo -86.13 152.59 9.57 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 124.087 1.572 . . . . 0.0 110.493 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.676 ' C ' ' O ' ' A' ' 38' ' ' PRO . 0.4 OUTLIER 4.26 53.68 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 122.313 1.054 . . . . 0.0 110.185 -178.258 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.203 HD22 ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -129.64 -39.62 1.44 Allowed 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.934 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.846 HG21 ' HG2' ' A' ' 37' ' ' PRO . 1.6 t -78.38 -36.4 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 C-N-CA 118.751 -1.179 . . . . 0.0 111.69 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.52 ' HB3' ' OE1' ' A' ' 43' ' ' GLN . . . -74.71 -37.79 62.5 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.585 -1.322 . . . . 0.0 111.681 -178.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.962 ' H ' ' NE2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -87.35 -20.27 26.99 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.414 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.822 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 6.6 ttm180 -65.88 -50.6 63.92 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 122.511 1.148 . . . . 0.0 108.085 178.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.78 ' CD2' ' O ' ' A' ' 41' ' ' VAL . 43.2 m-70 -68.68 -17.79 64.14 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.707 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -96.6 -33.19 11.88 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.335 -0.853 . . . . 0.0 109.526 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 43' ' ' GLN . . . -87.3 -113.59 1.0 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.995 ' HE1' HG21 ' A' ' 59' ' ' VAL . 11.9 m95 -86.29 74.31 10.02 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.027 -1.278 . . . . 0.0 108.61 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.633 ' OD1' ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -51.29 127.43 29.96 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.507 -0.746 . . . . 0.0 111.104 -178.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.59 ' C ' ' H ' ' A' ' 52' ' ' ASP . 50.3 Cg_endo -86.64 2.48 7.16 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.339 2.026 . . . . 0.0 111.884 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.958 ' HE2' ' HA ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -57.06 -2.19 0.08 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.651 -1.281 . . . . 0.0 109.365 -179.256 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.668 ' HB3' ' HE ' ' A' ' 79' ' ' ARG . 0.3 OUTLIER -117.83 -9.46 10.66 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.668 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.589 ' CB ' ' HB3' ' A' ' 79' ' ' ARG . 0.5 OUTLIER -155.65 -178.6 7.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.422 -0.799 . . . . 0.0 110.705 -179.474 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.592 ' CB ' HD21 ' A' ' 56' ' ' ASN . 5.0 p -68.51 143.09 55.08 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.235 -0.916 . . . . 0.0 109.767 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.749 ' CG ' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -98.78 7.71 45.76 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.654 -0.654 . . . . 0.0 111.199 -178.796 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 76' ' ' ASP . 0.0 OUTLIER -27.16 -38.12 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 122.031 0.919 . . . . 0.0 109.42 -179.751 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.654 ' N ' ' O ' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -140.0 145.81 25.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.729 ' OD1' ' HA ' ' A' ' 44' ' ' ARG . 0.8 OUTLIER -149.99 158.63 44.36 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 118.789 -1.164 . . . . 0.0 110.867 -179.873 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.995 HG21 ' HE1' ' A' ' 48' ' ' TRP . 1.5 m -114.02 138.45 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.791 0.805 . . . . 0.0 111.92 -177.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.745 ' HA ' ' HB3' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -102.37 152.65 20.84 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.912 179.177 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.459 ' O ' ' O ' ' A' ' 60' ' ' LYS . 1.8 tt0 -60.81 -132.84 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.26 -0.9 . . . . 0.0 110.309 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 44.48 27.71 1.33 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.68 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 131.44 39.73 0.24 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 -179.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.68 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.3 OUTLIER 0.6 87.4 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.897 -0.766 . . . . 0.0 111.026 -179.456 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.967 ' C ' ' HB ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -140.3 134.88 31.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.433 -0.792 . . . . 0.0 110.973 -179.487 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.845 ' CD2' ' CG1' ' A' ' 59' ' ' VAL . 46.1 m-85 -80.14 148.58 30.88 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.599 0.714 . . . . 0.0 110.054 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -128.67 121.63 28.98 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.603 -0.685 . . . . 0.0 109.653 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.866 ' NE ' ' HB2' ' A' ' 72' ' ' ALA . 6.3 ttt-85 -119.06 130.67 55.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.923 . . . . 0.0 110.214 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.706 ' CB ' ' HD3' ' A' ' 70' ' ' PRO . 9.0 mtm-85 -69.81 -74.0 0.17 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.926 . . . . 0.0 110.376 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.706 ' HD3' ' CB ' ' A' ' 69' ' ' ARG . 57.0 Cg_endo -75.82 -112.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.246 1.13 . . . . 0.0 109.544 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.545 ' O ' ' NH1' ' A' ' 68' ' ' ARG . 1.9 t -140.68 158.14 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.551 -1.343 . . . . 0.0 110.087 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.866 ' HB2' ' NE ' ' A' ' 68' ' ' ARG . . . -97.03 109.94 22.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.135 -0.978 . . . . 0.0 109.823 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.88 53.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.141 -0.975 . . . . 0.0 110.712 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.541 ' CB ' ' HG2' ' A' ' 26' ' ' PRO . 0.5 OUTLIER 179.81 -61.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.054 -1.029 . . . . 0.0 110.636 179.832 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.9 m -81.9 -127.56 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.189 -0.944 . . . . 0.0 110.27 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.613 ' O ' ' O ' ' A' ' 77' ' ' GLY . 0.6 OUTLIER -140.01 116.03 10.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.142 -0.974 . . . . 0.0 109.885 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.613 ' O ' ' O ' ' A' ' 76' ' ' ASP . . . -37.98 -100.03 0.01 OUTLIER Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.455 HG21 ' O ' ' A' ' 48' ' ' TRP . 0.2 OUTLIER -158.87 150.05 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.067 -1.255 . . . . 0.0 110.255 179.379 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.668 ' HE ' ' HB3' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -143.56 171.01 14.76 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.666 -0.646 . . . . 0.0 109.82 179.856 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.53 ' N ' ' CG ' ' A' ' 79' ' ' ARG . . . -150.26 133.12 4.22 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.549 ' CG ' ' O ' ' A' ' 201' ' ' PRO . 0.0 OUTLIER -155.07 55.06 0.65 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.297 -1.12 . . . . 0.0 110.245 179.837 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.473 ' O ' ' C ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -125.43 -88.31 0.59 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.915 . . . . 0.0 110.069 179.88 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.473 ' C ' ' O ' ' A' ' 82' ' ' ARG . . . 40.63 58.42 2.57 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -94.45 95.93 9.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.353 -1.087 . . . . 0.0 110.376 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' A' ' 173' ' ' MET . 38.3 m -136.88 168.07 20.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -0.851 . . . . 0.0 109.948 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.456 ' HA ' ' HB3' ' A' ' 173' ' ' MET . 0.0 OUTLIER -112.47 143.99 42.68 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.22 -0.925 . . . . 0.0 109.835 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.67 -120.34 5.23 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.486 ' C ' ' CG ' ' A' ' 89' ' ' HIS . 13.9 tp -128.36 135.63 49.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.318 -1.107 . . . . 0.0 110.395 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.486 ' CG ' ' C ' ' A' ' 88' ' ' LEU . 8.0 m-70 -147.08 156.34 42.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.207 -0.933 . . . . 0.0 109.569 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.23 138.09 6.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.069 -1.02 . . . . 0.0 110.875 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 1.028 ' CZ2' HG11 ' A' ' 169' ' ' VAL . 3.7 p90 -135.27 171.12 14.89 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.404 -0.81 . . . . 0.0 109.456 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 215' ' ' ARG . 23.7 tt0 -135.63 156.82 48.24 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.474 -0.89 . . . . 0.0 111.352 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.668 HD13 HG13 ' A' ' 214' ' ' ILE . 27.9 mm -143.59 141.89 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.555 -0.716 . . . . 0.0 109.637 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.574 ' HB3' ' HA ' ' A' ' 166' ' ' ARG . 2.9 p -155.84 146.36 21.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.886 -1.134 . . . . 0.0 110.777 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.924 ' CE3' HG22 ' A' ' 212' ' ' VAL . 39.4 m95 -116.81 87.46 21.98 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.321 -0.862 . . . . 0.0 109.269 178.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.532 ' HG2' ' HG3' ' A' ' 213' ' ' ARG . 51.9 Cg_endo -95.72 108.42 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.719 1.378 . . . . 0.0 111.015 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.814 HD22 ' HA ' ' A' ' 211' ' ' GLN . 0.1 OUTLIER -96.68 -67.77 0.83 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.973 -1.079 . . . . 0.0 109.586 178.572 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -98.71 -40.49 8.14 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.571 -0.706 . . . . 0.0 109.574 179.194 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.454 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 4.4 tp60 179.65 -27.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.708 -0.62 . . . . 0.0 110.1 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.479 ' NH1' ' HG2' ' A' ' 100' ' ' ARG . 4.2 mmp_? -101.74 -79.79 0.51 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.414 -0.804 . . . . 0.0 110.267 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.728 ' O ' HG23 ' A' ' 102' ' ' THR . . . -175.74 -166.5 33.33 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.728 HG23 ' O ' ' A' ' 101' ' ' GLY . 0.0 OUTLIER -179.14 -87.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.097 -1.237 . . . . 0.0 110.6 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.617 ' O ' ' CE3' ' A' ' 95' ' ' TRP . 38.0 m-70 -106.22 157.38 17.62 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.205 -0.934 . . . . 0.0 110.584 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.773 ' HA ' ' CH2' ' A' ' 95' ' ' TRP . . . 179.63 133.01 0.1 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.459 -0.776 . . . . 0.0 109.768 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.779 HG23 ' CB ' ' A' ' 204' ' ' SER . 35.1 m -134.95 115.6 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 O-C-N 120.331 -1.481 . . . . 0.0 110.875 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.796 ' HB ' HG23 ' A' ' 203' ' ' VAL . 2.7 p -150.8 149.72 14.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 O-C-N 121.518 -0.739 . . . . 0.0 109.399 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.612 ' HA2' ' HA3' ' A' ' 132' ' ' GLY . . . -162.7 148.89 16.22 Favored Glycine 0 N--CA 1.485 1.952 0 C-N-CA 118.984 -1.579 . . . . 0.0 110.985 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.875 HG12 ' HG ' ' A' ' 199' ' ' LEU . 11.8 t -105.78 156.97 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.707 -0.878 . . . . 0.0 108.947 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.802 ' CA ' HD12 ' A' ' 199' ' ' LEU . . . -150.11 146.69 27.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.728 -1.233 . . . . 0.0 111.501 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 1.0 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -114.18 138.33 50.59 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.561 0.696 . . . . 0.0 109.65 179.268 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.87 -24.45 18.47 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.532 -0.73 . . . . 0.0 109.064 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.672 ' O ' ' C ' ' A' ' 113' ' ' ALA . 0.7 OUTLIER -86.68 -12.21 49.01 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.555 -0.716 . . . . 0.0 109.268 179.08 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.672 ' C ' ' O ' ' A' ' 112' ' ' LEU . . . 0.12 96.31 0.03 OUTLIER Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 122.04 -0.412 . . . . 0.0 111.192 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.4 -158.3 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.967 1.509 . . . . 0.0 110.363 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.684 HD23 ' O ' ' A' ' 115' ' ' LEU . 1.0 OUTLIER -175.84 49.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.148 -0.97 . . . . 0.0 110.271 179.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -121.08 -30.7 4.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 110.164 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.531 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -110.5 -5.76 15.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.341 -0.849 . . . . 0.0 110.163 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.531 ' C ' ' O ' ' A' ' 117' ' ' ALA . 12.8 t0 -32.14 149.05 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.539 -0.726 . . . . 0.0 110.789 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.466 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 4.4 m-70 -106.23 113.93 27.75 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.173 -0.955 . . . . 0.0 110.34 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.462 ' HB2' ' O ' ' A' ' 119' ' ' HIS . 3.7 m-85 59.77 13.84 3.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 0.0 110.239 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.753 ' O ' ' HB3' ' A' ' 122' ' ' ALA . . . 42.87 -129.02 0.71 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.187 -0.946 . . . . 0.0 110.259 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.753 ' HB3' ' O ' ' A' ' 121' ' ' ALA . . . 70.82 66.54 0.18 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.216 -0.927 . . . . 0.0 110.269 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.474 HD22 ' O ' ' A' ' 122' ' ' ALA . 0.5 OUTLIER -125.73 149.7 48.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.114 -0.991 . . . . 0.0 110.118 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 tp -87.22 125.73 34.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.324 -0.86 . . . . 0.0 110.228 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 62.39 168.78 0.82 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.09 20.45 3.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -1.149 . . . . 0.0 110.273 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 127' ' ' ASN . 2.0 m120 -97.29 -29.66 13.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.251 -0.906 . . . . 0.0 110.141 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.6 m -150.7 155.07 38.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.244 -0.91 . . . . 0.0 110.076 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 109' ' ' ALA . 14.7 tm-20 -126.41 115.99 20.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.18 -0.95 . . . . 0.0 109.949 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 48.5 t -120.21 119.37 33.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 110.458 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . 0.448 ' HB2' ' OE2' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -133.55 125.34 28.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.468 -0.77 . . . . 0.0 109.764 179.634 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.612 ' HA3' ' HA2' ' A' ' 107' ' ' GLY . . . -170.18 -143.33 3.89 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.948 ' CZ3' HD22 ' A' ' 167' ' ' LEU . 53.7 m0 -115.95 113.48 23.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -1.169 . . . . 0.0 110.317 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.936 ' O ' HG23 ' A' ' 135' ' ' ILE . 3.9 p30 -118.25 131.29 56.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.649 -0.657 . . . . 0.0 110.391 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.936 HG23 ' O ' ' A' ' 134' ' ' ASP . 1.0 OUTLIER -171.6 34.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.278 -0.889 . . . . 0.0 110.248 179.837 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.54 ' HA3' ' CG1' ' A' ' 105' ' ' VAL . . . -131.89 -49.35 0.1 Allowed Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.62 8.2 35.21 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.432 -1.04 . . . . 0.0 109.721 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.51 ' O ' ' O ' ' A' ' 139' ' ' LYS . . . 54.59 58.44 13.27 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.675 ' O ' ' C ' ' A' ' 140' ' ' LEU . 1.1 mmtt -57.92 -143.56 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.294 -1.121 . . . . 0.0 110.407 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.675 ' C ' ' O ' ' A' ' 139' ' ' LYS . 0.7 OUTLIER 0.69 75.52 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.76 -0.588 . . . . 0.0 111.257 -179.87 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.674 ' C ' ' O ' ' A' ' 140' ' ' LEU . 0.3 OUTLIER 0.18 75.52 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.277 0.56 . . . . 0.0 111.408 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 140' ' ' LEU . 0.5 OUTLIER -82.91 10.61 7.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.909 . . . . 0.0 110.122 179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 145' ' ' LYS . 9.8 tp-100 -51.91 -49.74 62.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.309 -0.869 . . . . 0.0 110.261 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 143' ' ' GLN . 22.1 t -42.41 94.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.377 -0.827 . . . . 0.0 110.205 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 143' ' ' GLN . 0.1 OUTLIER -71.35 -156.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 110.228 179.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.448 ' C ' HD23 ' A' ' 147' ' ' LEU . . . -165.66 -99.94 0.14 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.448 HD23 ' C ' ' A' ' 146' ' ' GLY . 0.3 OUTLIER -161.64 30.52 0.13 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.35 -1.089 . . . . 0.0 110.058 -179.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -53.43 145.02 15.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.336 -0.853 . . . . 0.0 110.219 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 153' ' ' PRO . . . -156.49 148.16 17.11 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 110.105 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.09 -1.38 10.45 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.005 1.529 . . . . 0.0 110.502 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -76.35 -91.37 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 110.245 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.587 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 2.4 m-85 -78.31 -60.69 0.62 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.186 -0.946 . . . . 0.0 110.293 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.587 ' CD ' ' CB ' ' A' ' 152' ' ' TYR . 45.7 Cg_endo -72.72 171.02 18.16 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.964 1.507 . . . . 0.0 110.463 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 155' ' ' GLY . . . -93.19 114.08 26.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.907 . . . . 0.0 110.169 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 154' ' ' ALA . . . -42.26 163.85 0.02 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.577 ' O ' ' CB ' ' A' ' 160' ' ' GLN . 45.2 Cg_endo -72.44 -9.31 24.0 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.963 1.507 . . . . 0.0 110.322 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -0.34 4.16 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.188 -0.945 . . . . 0.0 110.577 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 162' ' ' VAL . . . -92.31 -80.44 1.44 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.572 ' HA ' HG23 ' A' ' 163' ' ' VAL . 30.9 mt-10 -109.62 3.27 20.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.234 -1.156 . . . . 0.0 111.069 -179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.63 ' O ' HG22 ' A' ' 135' ' ' ILE . 0.0 OUTLIER -73.06 -17.13 61.45 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.172 -0.955 . . . . 0.0 109.223 179.436 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.822 ' O ' HG23 ' A' ' 162' ' ' VAL . 12.1 mt -156.75 21.29 0.33 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.852 0.834 . . . . 0.0 109.208 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 161' ' ' LEU . 2.7 t -163.54 98.2 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.801 -0.562 . . . . 0.0 109.895 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.715 ' H ' ' HD2' ' A' ' 164' ' ' PRO . 1.3 t -134.95 -59.19 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.088 -1.008 . . . . 0.0 110.127 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.728 ' CD ' HD11 ' A' ' 135' ' ' ILE . 48.6 Cg_endo -77.28 55.22 4.99 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.714 1.376 . . . . 0.0 110.839 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 100' ' ' ARG . 24.2 tt0 -64.0 -58.67 6.0 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.629 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 2.1 ttp180 -151.59 115.44 4.92 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.98 HD23 HG23 ' A' ' 182' ' ' ILE . 0.7 OUTLIER -150.25 158.27 43.97 Favored 'General case' 0 C--N 1.287 -2.131 0 O-C-N 121.676 -0.64 . . . . 0.0 110.735 -178.711 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.428 ' HA ' ' HG3' ' A' ' 92' ' ' GLU . 1.7 tp -103.86 139.73 38.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.425 -0.797 . . . . 0.0 109.36 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 1.028 HG11 ' CZ2' ' A' ' 91' ' ' TRP . 1.8 t -105.78 130.25 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.091 -1.006 . . . . 0.0 110.439 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.0 t -100.14 125.76 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.524 -0.735 . . . . 0.0 110.058 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.708 HD22 ' HZ3' ' A' ' 91' ' ' TRP . 13.3 tp -133.27 106.24 7.44 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.141 -0.975 . . . . 0.0 110.127 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 173' ' ' MET . 50.4 t0 -119.71 137.81 53.69 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.188 -0.945 . . . . 0.0 110.095 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.489 ' HB2' ' O ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -93.48 -40.48 10.31 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.654 -0.654 . . . . 0.0 109.857 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 173' ' ' MET . 37.5 tt0 -43.13 -26.34 0.15 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.272 -0.893 . . . . 0.0 109.11 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.736 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.2 OUTLIER -113.88 -25.75 8.47 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.832 0.825 . . . . 0.0 108.894 179.33 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.564 ' O ' HG22 ' A' ' 198' ' ' THR . . . 78.83 27.89 55.73 Favored Glycine 0 N--CA 1.482 1.743 0 N-CA-C 108.139 -1.984 . . . . 0.0 108.139 -178.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 1.123 ' CG2' HD22 ' A' ' 194' ' ' LEU . 0.0 OUTLIER -112.64 143.17 44.29 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.28 -1.129 . . . . 0.0 111.608 -179.182 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.71 HD21 ' O ' ' A' ' 199' ' ' LEU . 0.5 OUTLIER -148.66 154.2 39.33 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.671 -0.643 . . . . 0.0 109.615 179.377 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.976 ' HA3' HD22 ' A' ' 187' ' ' LEU . . . -174.13 166.2 38.15 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.994 ' CD1' HG22 ' A' ' 169' ' ' VAL . 1.7 t80 -118.95 117.52 29.04 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.368 -1.077 . . . . 0.0 109.73 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 186' ' ' TYR . 6.9 t -146.01 165.18 29.8 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.167 -0.958 . . . . 0.0 110.197 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.98 HG23 HD23 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -100.12 116.47 43.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.734 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 71.04 6.92 61.43 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.99 43.1 18.07 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 1.7 m -101.18 -69.52 0.77 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.241 -1.152 . . . . 0.0 110.957 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.539 ' O ' ' N ' ' A' ' 188' ' ' GLY . 6.7 m-30 -45.1 -83.52 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.14 -0.975 . . . . 0.0 110.907 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.976 HD22 ' HA3' ' A' ' 179' ' ' GLY . 0.1 OUTLIER -66.98 43.95 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.87 -1.144 . . . . 0.0 110.202 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 186' ' ' TYR . . . -91.46 -63.4 1.18 Allowed Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.927 -1.13 . . . . 0.0 110.581 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.491 ' HD2' ' H ' ' A' ' 188' ' ' GLY . 46.6 Cg_endo -72.54 -30.25 12.4 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.859 1.452 . . . . 0.0 111.476 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.591 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -74.1 29.4 0.08 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.232 -0.918 . . . . 0.0 111.572 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.544 ' CE1' ' O ' ' A' ' 187' ' ' LEU . 1.2 m-30 -90.53 -14.85 31.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.769 -1.207 . . . . 0.0 110.409 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.505 ' N ' ' HD2' ' A' ' 192' ' ' ARG . 0.0 OUTLIER -90.09 -13.66 35.35 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.328 -0.858 . . . . 0.0 110.283 -179.701 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -110.91 -12.57 15.75 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 107.707 -2.157 . . . . 0.0 107.707 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 1.123 HD22 ' CG2' ' A' ' 177' ' ' THR . 5.4 tt -67.28 -37.62 83.74 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.486 ' CA ' HG23 ' A' ' 198' ' ' THR . 0.0 OUTLIER -44.66 -37.27 3.56 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.561 -0.712 . . . . 0.0 109.787 179.51 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.91 -27.83 30.47 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.715 ' NE ' ' HG ' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -90.26 -3.34 57.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.707 -0.878 . . . . 0.0 109.942 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 194' ' ' LEU . 15.8 p -41.1 114.52 0.5 Allowed 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.996 0.903 . . . . 0.0 110.042 -178.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 1.0 ' CB ' HG23 ' A' ' 110' ' ' THR . 2.6 pt? -139.42 171.63 13.98 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.05 -178.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.437 ' N ' ' CD1' ' A' ' 200' ' ' TYR . 5.9 m-85 -84.46 129.44 57.57 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.911 -1.118 . . . . 0.0 110.189 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.854 ' HA ' HG13 ' A' ' 108' ' ' VAL . 52.8 Cg_endo -84.88 135.98 5.86 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 124.12 1.59 . . . . 0.0 111.164 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.548 ' CB ' ' HB2' ' A' ' 81' ' ' LYS . 3.7 p -133.39 136.99 45.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.292 -0.88 . . . . 0.0 109.993 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.796 HG23 ' HB ' ' A' ' 106' ' ' VAL . 3.9 p -122.44 155.39 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -0.961 . . . . 0.0 109.938 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 0.779 ' CB ' HG23 ' A' ' 105' ' ' VAL . 2.7 t -130.81 127.5 38.79 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.168 -0.957 . . . . 0.0 110.684 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.695 ' HB1' HG11 ' A' ' 212' ' ' VAL . . . -119.06 154.28 33.4 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.01 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.717 HG12 ' OE1' ' A' ' 211' ' ' GLN . 2.9 p -115.11 -172.49 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 110.284 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 0.743 ' CE3' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -82.77 165.36 19.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.293 -0.879 . . . . 0.0 110.182 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 132.18 131.72 3.25 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.405 ' HG2' ' N ' ' A' ' 210' ' ' CYS . 7.9 tt0 -62.36 -87.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -1.15 . . . . 0.0 110.303 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . 0.527 ' O ' HD22 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -81.18 83.39 6.82 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.323 -0.861 . . . . 0.0 110.541 -179.83 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.814 ' HA ' HD22 ' A' ' 97' ' ' LEU . 2.5 tt0 -155.6 -42.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.187 -0.946 . . . . 0.0 110.659 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.924 HG22 ' CE3' ' A' ' 95' ' ' TRP . 88.3 t -127.27 132.68 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.986 -1.071 . . . . 0.0 111.194 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.532 ' HG3' ' HG2' ' A' ' 96' ' ' PRO . 0.4 OUTLIER -139.86 149.16 43.08 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.42 -0.8 . . . . 0.0 109.811 179.559 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.825 HG22 ' CZ2' ' A' ' 48' ' ' TRP . 5.9 tt -144.31 143.89 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.086 -1.009 . . . . 0.0 111.436 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.564 ' O ' ' N ' ' A' ' 92' ' ' GLU . 15.1 mtt180 -130.21 108.72 10.25 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . 0.721 ' CD2' ' CB ' ' A' ' 91' ' ' TRP . 2.4 t80 -116.29 146.76 42.15 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.031 -1.043 . . . . 0.0 111.435 -177.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . 0.519 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 5.6 tmm? -136.41 107.93 6.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.561 -0.712 . . . . 0.0 109.706 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 149.81 -40.26 0.86 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -95.37 117.93 31.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.165 -1.197 . . . . 0.0 110.205 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.449 ' HG2' ' HG2' ' A' ' 221' ' ' ARG . 0.0 OUTLIER -144.32 -75.92 0.23 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.335 -0.853 . . . . 0.0 110.155 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . 0.5 ' CG ' ' O ' ' A' ' 221' ' ' ARG . 0.7 OUTLIER -170.63 98.3 0.24 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.241 -0.912 . . . . 0.0 110.198 179.89 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.495 ' C ' ' O ' ' A' ' 221' ' ' ARG . 9.1 p -34.24 133.56 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.477 -0.764 . . . . 0.0 110.582 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.529 ' O ' ' C ' ' A' ' 224' ' ' GLU . 0.6 OUTLIER -83.22 20.58 1.25 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.217 -0.927 . . . . 0.0 110.566 -179.846 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.529 ' C ' ' O ' ' A' ' 223' ' ' GLU . 0.0 OUTLIER -31.09 -62.4 0.17 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.496 -0.753 . . . . 0.0 110.781 -179.751 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.416 ' O ' ' O ' ' A' ' 223' ' ' GLU . 14.6 t -48.0 155.36 0.45 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.265 -0.897 . . . . 0.0 110.207 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -148.35 70.57 1.14 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.0 110.243 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.55 136.09 33.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.207 -0.933 . . . . 0.0 110.233 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 61.4 mt -104.11 -57.16 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.292 -0.88 . . . . 0.0 110.194 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -165.84 60.4 0.11 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.315 -0.865 . . . . 0.0 110.184 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . 0.683 ' O ' ' C ' ' A' ' 231' ' ' ASP . 0.0 OUTLIER -49.47 -87.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.3 -0.875 . . . . 0.0 110.233 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.683 ' C ' ' O ' ' A' ' 230' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 118.073 -0.965 . . . . 0.0 111.515 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.02 -5.6 11.43 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.224 -1.162 . . . . 0.0 110.112 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.7 t 60.05 159.3 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.235 -0.915 . . . . 0.0 110.231 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -144.88 -41.55 0.24 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.135 -0.978 . . . . 0.0 110.201 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.6 ptt-85 -143.87 39.14 1.35 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.114 -0.991 . . . . 0.0 110.137 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.13 94.33 1.93 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 0.0 110.173 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.5 0.98 55.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.92 . . . . 0.0 110.279 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.749 ' O ' HG23 ' A' ' 13' ' ' THR . 9.7 t -111.48 98.25 39.65 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.22 -0.925 . . . . 0.0 110.215 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.17 -89.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.999 1.526 . . . . 0.0 110.405 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.7 12.65 22.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.911 . . . . 0.0 110.159 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.0 p -59.77 127.91 34.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.223 -0.923 . . . . 0.0 110.217 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -115.25 -20.48 10.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.344 -0.847 . . . . 0.0 110.235 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -171.2 113.4 0.38 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.914 . . . . 0.0 110.166 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.414 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 3.9 mm? -66.2 -169.66 0.07 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.264 -0.897 . . . . 0.0 110.201 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.501 ' C ' ' CD1' ' A' ' 20' ' ' TYR . 0.1 OUTLIER -56.11 -169.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.221 -0.925 . . . . 0.0 110.377 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.473 ' O ' ' NE2' ' A' ' 73' ' ' GLN . 6.0 p -150.26 -151.2 0.38 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 0.0 110.134 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -82.8 45.16 0.97 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.892 . . . . 0.0 110.141 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.76 -40.62 15.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 110.236 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.18 137.68 20.83 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.366 -0.834 . . . . 0.0 110.362 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.511 ' HB2' ' HD2' ' A' ' 26' ' ' PRO . 45.9 Cg_endo -73.24 175.35 10.67 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.038 1.547 . . . . 0.0 110.401 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.511 ' HD2' ' HB2' ' A' ' 25' ' ' PRO . 45.2 Cg_endo -72.09 163.84 37.5 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.973 1.512 . . . . 0.0 110.421 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.436 ' HG3' ' C ' ' A' ' 26' ' ' PRO . 31.8 mt-10 -146.24 36.41 1.01 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 110.278 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.08 20.98 74.82 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.947 ' O ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -45.75 -31.57 2.08 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.476 -1.014 . . . . 0.0 109.822 179.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.711 ' HA ' HD23 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -48.81 -34.26 12.04 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.16 -0.963 . . . . 0.0 109.279 179.625 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.77 -21.96 66.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.438 -0.789 . . . . 0.0 109.077 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.452 HD22 ' HA ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -83.37 -35.73 24.9 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.783 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.925 HD11 HH21 ' A' ' 44' ' ' ARG . 0.3 OUTLIER -68.56 -37.08 79.62 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 122.071 0.939 . . . . 0.0 109.002 178.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.637 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 3.5 m -76.84 -7.88 56.3 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.387 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 1.025 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -36.63 -59.61 0.86 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.421 -0.8 . . . . 0.0 110.034 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 1.039 ' O ' HD12 ' A' ' 40' ' ' LEU . 48.2 Cg_endo -74.36 108.42 2.67 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.146 1.603 . . . . 0.0 110.337 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.756 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 48.5 Cg_endo -74.36 -25.2 13.51 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.987 1.519 . . . . 0.0 112.7 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.756 ' HD2' ' N ' ' A' ' 37' ' ' PRO . 43.8 Cg_endo -69.18 152.0 72.32 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 122.944 0.971 . . . . 0.0 112.163 -178.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.744 ' HA ' ' HG3' ' A' ' 43' ' ' GLN . 0.0 OUTLIER 3.56 66.83 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 123.121 1.439 . . . . 0.0 111.092 -179.072 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.039 HD12 ' O ' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -156.66 -44.97 0.07 Allowed 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 177.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.66 HG12 ' CE1' ' A' ' 45' ' ' HIS . 2.8 t -87.71 -31.1 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.785 177.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.54 -44.3 10.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.323 -0.861 . . . . 0.0 111.573 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.865 ' HB2' ' HA ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -74.78 -19.32 60.26 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.178 -0.951 . . . . 0.0 110.523 -179.28 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.925 HH21 HD11 ' A' ' 33' ' ' LEU . 2.8 ttp85 -82.29 -41.6 19.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.869 . . . . 0.0 110.066 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.66 ' CE1' HG12 ' A' ' 41' ' ' VAL . 19.7 m170 -68.81 -17.03 63.95 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.717 -0.614 . . . . 0.0 111.353 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.416 ' O ' ' O ' ' A' ' 47' ' ' GLY . 6.0 t60 -95.21 -32.96 12.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.752 -1.218 . . . . 0.0 110.102 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.671 ' HA2' HD22 ' A' ' 64' ' ' LEU . . . -62.45 -99.43 0.01 OUTLIER Glycine 0 N--CA 1.488 2.164 0 N-CA-C 106.447 -2.661 . . . . 0.0 106.447 178.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.906 ' CE2' ' HB ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -100.14 95.44 6.83 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 175.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.822 ' O ' ' HB3' ' A' ' 53' ' ' CYS . 0.0 OUTLIER -42.33 111.36 0.94 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.644 -0.66 . . . . 0.0 111.679 -178.202 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.614 ' HA ' ' CB ' ' A' ' 53' ' ' CYS . 47.7 Cg_endo -73.49 0.69 7.73 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 122.625 2.217 . . . . 0.0 112.172 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.733 ' H ' ' CE ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -65.02 -31.68 73.04 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 177.928 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.727 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 3.2 m-20 -116.12 -12.58 11.23 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 113.46 -1.7 . . . . 0.0 106.668 176.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.822 ' HB3' ' O ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -108.22 157.82 18.0 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.656 0.741 . . . . 0.0 110.913 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.503 ' HB2' ' O ' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -75.78 142.61 42.29 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.552 0.692 . . . . 0.0 110.008 179.345 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.639 ' HG3' HD21 ' A' ' 33' ' ' LEU . 1.1 pm0 -99.33 -4.35 31.92 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.562 -0.711 . . . . 0.0 110.459 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.616 ' H ' ' ND2' ' A' ' 56' ' ' ASN . 9.4 m-80 -50.39 -12.67 0.1 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.629 -0.669 . . . . 0.0 110.805 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.61 HG13 ' CZ3' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -124.7 169.0 16.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.288 -0.882 . . . . 0.0 109.242 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.598 ' O ' ' CB ' ' A' ' 67' ' ' GLU . 49.3 t0 -107.2 133.78 51.27 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.899 -1.126 . . . . 0.0 111.087 -177.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.906 ' HB ' ' CE2' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -130.95 137.15 56.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.675 -179.532 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.865 ' HA ' ' HB2' ' A' ' 43' ' ' GLN . 60.0 mttp -123.86 151.58 43.29 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 118.581 -1.248 . . . . 0.0 111.119 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.461 ' O ' ' C ' ' A' ' 62' ' ' GLY . 0.7 OUTLIER -77.6 -128.72 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.474 -0.766 . . . . 0.0 110.274 -179.787 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 41.3 42.28 3.23 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.556 -1.818 . . . . 0.0 108.556 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.683 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 108.82 67.67 0.61 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.683 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER 0.84 88.09 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.847 -0.796 . . . . 0.0 110.983 -179.076 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 1.2 t -99.88 114.33 27.47 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.45 -0.781 . . . . 0.0 111.049 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.807 ' CD1' ' NE1' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -83.56 128.51 34.57 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.136 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.598 ' CB ' ' O ' ' A' ' 58' ' ' ASP . 1.6 tt0 -138.79 121.82 16.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.567 -1.333 . . . . 0.0 110.502 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.661 ' CZ ' ' CZ3' ' A' ' 207' ' ' TRP . 0.0 OUTLIER -130.85 142.85 50.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.38 -0.825 . . . . 0.0 109.406 179.767 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.683 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -130.96 -70.69 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.055 -1.028 . . . . 0.0 110.954 -179.464 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.683 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 55.5 Cg_endo -69.89 -145.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.552 1.291 . . . . 0.0 109.492 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.745 HG13 ' CZ2' ' A' ' 207' ' ' TRP . 3.9 t -140.02 164.27 23.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 O-C-N 121.417 -0.802 . . . . 0.0 110.175 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.973 ' HB3' ' HB3' ' A' ' 76' ' ' ASP . . . -130.44 94.11 3.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 110.021 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.484 ' O ' ' O ' ' A' ' 72' ' ' ALA . 67.3 mt-30 -48.12 -99.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.281 -0.887 . . . . 0.0 110.106 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.5 p -88.61 39.24 0.91 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.084 -1.01 . . . . 0.0 109.605 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.606 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 3.0 m -144.6 15.73 1.62 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.317 -0.864 . . . . 0.0 110.198 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.973 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 19.1 p-10 -98.47 155.16 17.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.296 -0.878 . . . . 0.0 109.928 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.503 ' O ' ' HB2' ' A' ' 54' ' ' SER . . . 106.78 127.73 5.86 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 106.781 -2.528 . . . . 0.0 106.781 -178.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.641 ' HB ' ' SG ' ' A' ' 53' ' ' CYS . 1.2 m -117.51 131.67 69.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 120.814 -1.403 . . . . 0.0 111.131 -178.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.727 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 2.5 ttp180 -104.12 175.08 5.6 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.657 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.63 ' HA2' ' CB ' ' A' ' 52' ' ' ASP . . . -167.4 80.7 0.1 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -125.63 130.48 51.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -1.153 . . . . 0.0 110.311 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.518 ' HG2' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -140.41 -31.21 0.64 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -0.89 . . . . 0.0 110.551 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.518 ' N ' ' HG2' ' A' ' 82' ' ' ARG . . . 37.82 40.6 0.78 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.447 ' H ' ' HG2' ' A' ' 82' ' ' ARG . 1.7 t80 -134.71 95.57 3.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.155 -1.203 . . . . 0.0 110.001 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.809 ' CB ' HD21 ' A' ' 171' ' ' LEU . 0.6 OUTLIER -140.27 163.72 32.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.288 -0.883 . . . . 0.0 110.415 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.604 ' O ' ' CD2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -131.08 158.82 39.37 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.327 -0.858 . . . . 0.0 110.095 179.661 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.53 ' N ' ' HB3' ' A' ' 173' ' ' MET . . . 51.72 -111.59 1.5 Allowed Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 21.2 tp -128.97 134.39 48.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.516 -0.99 . . . . 0.0 111.134 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.604 ' CD2' ' O ' ' A' ' 86' ' ' ARG . 88.6 m-70 -147.31 173.66 12.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.262 -0.899 . . . . 0.0 109.786 179.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.561 ' C ' ' CD1' ' A' ' 91' ' ' TRP . . . -163.38 158.96 21.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.179 -0.95 . . . . 0.0 110.586 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.968 ' CE3' HG11 ' A' ' 169' ' ' VAL . 1.0 OUTLIER -134.61 170.63 15.51 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.281 -0.887 . . . . 0.0 109.29 179.557 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 1.0 ' OE2' HD12 ' A' ' 168' ' ' LEU . 6.7 mt-10 -147.82 145.27 28.67 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.178 -0.951 . . . . 0.0 110.748 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.533 ' HB ' HD12 ' A' ' 167' ' ' LEU . 6.3 mt -144.74 153.97 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.283 -0.885 . . . . 0.0 110.879 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.596 ' HB2' ' CB ' ' A' ' 213' ' ' ARG . 2.2 m -135.18 140.95 45.75 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.837 ' CZ2' ' N ' ' A' ' 104' ' ' ALA . 4.9 m95 -99.61 125.58 40.26 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.096 -1.003 . . . . 0.0 111.873 -178.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.714 ' HB3' ' O ' ' A' ' 211' ' ' GLN . 49.4 Cg_endo -79.63 153.24 23.2 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.388 2.059 . . . . 0.0 111.569 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 1.164 HD23 ' N ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -32.89 -34.79 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.481 0.658 . . . . 0.0 110.236 179.288 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 1.164 ' N ' HD23 ' A' ' 97' ' ' LEU . 0.7 OUTLIER -54.14 -11.08 0.42 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.603 -0.686 . . . . 0.0 110.294 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.594 ' HA ' ' CZ3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -40.85 -23.51 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.187 -0.946 . . . . 0.0 110.742 -179.92 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.558 ' C ' ' O ' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -31.7 -64.73 0.15 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.404 -0.81 . . . . 0.0 110.437 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.515 ' C ' ' NE2' ' A' ' 103' ' ' HIS . . . -87.59 175.27 45.51 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 102' ' ' THR . 13.4 t -90.23 120.48 31.42 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.352 -1.087 . . . . 0.0 110.458 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.976 ' C ' ' HA ' ' A' ' 205' ' ' ALA . 7.7 m-70 -150.8 -96.46 0.06 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.207 -0.933 . . . . 0.0 110.462 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 1.065 ' N ' ' HA ' ' A' ' 205' ' ' ALA . . . -55.93 38.92 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.658 0 O-C-N 120.857 -1.152 . . . . 0.0 110.982 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 1.009 HG12 ' HA ' ' A' ' 134' ' ' ASP . 0.1 OUTLIER -94.25 145.27 8.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -178.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.973 HG22 HG23 ' A' ' 203' ' ' VAL . 2.2 t -127.79 170.16 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.929 -1.107 . . . . 0.0 111.368 -176.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.679 ' CA ' ' HA3' ' A' ' 132' ' ' GLY . . . -179.92 156.83 18.99 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 109.986 -1.245 . . . . 0.0 109.986 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.921 ' HB ' HD13 ' A' ' 199' ' ' LEU . 0.2 OUTLIER -108.6 140.72 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.41 -1.053 . . . . 0.0 109.538 179.855 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.504 ' O ' ' HB3' ' A' ' 199' ' ' LEU . . . -109.85 140.39 43.85 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.227 -0.921 . . . . 0.0 110.738 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.833 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -119.46 130.41 55.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.453 -0.78 . . . . 0.0 110.324 179.809 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.73 -27.47 17.22 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.501 -0.749 . . . . 0.0 109.295 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.524 HD11 ' O ' ' A' ' 196' ' ' GLY . 0.9 OUTLIER -81.69 -12.3 58.71 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.535 -0.728 . . . . 0.0 109.587 179.474 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.543 ' CB ' ' HB2' ' A' ' 129' ' ' GLU . . . -38.25 112.41 0.66 Allowed Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.553 -0.717 . . . . 0.0 110.235 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.477 ' C ' HD23 ' A' ' 115' ' ' LEU . 46.5 Cg_endo -73.29 178.42 6.63 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.941 1.495 . . . . 0.0 110.641 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.477 HD23 ' C ' ' A' ' 114' ' ' PRO . 0.5 OUTLIER -179.91 62.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 110.123 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.463 ' O ' ' C ' ' A' ' 117' ' ' ALA . 0.0 OUTLIER -65.45 -26.62 68.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.287 -0.883 . . . . 0.0 110.262 -179.805 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.54 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -37.87 127.08 1.23 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.409 -0.807 . . . . 0.0 110.286 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.54 ' C ' ' O ' ' A' ' 117' ' ' ALA . 43.5 t0 -31.1 136.78 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.573 -0.704 . . . . 0.0 110.749 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.472 ' CE1' HD12 ' A' ' 115' ' ' LEU . 60.1 m-70 -91.9 137.73 32.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.371 -0.831 . . . . 0.0 110.179 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -116.65 -2.47 11.92 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.171 -0.955 . . . . 0.0 110.205 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -169.44 68.21 0.06 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.213 -0.929 . . . . 0.0 110.239 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -147.21 129.58 15.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 0.0 110.209 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.25 -65.92 0.97 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 0.0 110.242 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -176.68 -153.63 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 110.229 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 90.23 -129.37 9.7 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 127' ' ' ASN . 10.2 t -151.73 64.47 0.86 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -1.149 . . . . 0.0 110.226 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 126' ' ' SER . 7.0 m120 -51.98 -173.42 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.329 -0.857 . . . . 0.0 110.275 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 110' ' ' THR . 14.7 m -161.57 -159.07 0.6 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -0.869 . . . . 0.0 110.211 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.543 ' HB2' ' CB ' ' A' ' 113' ' ' ALA . 4.9 mm-40 -150.25 133.82 16.58 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.323 -0.861 . . . . 0.0 109.861 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.5 t -120.18 119.73 34.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 110.559 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -133.25 136.32 45.48 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.367 -0.833 . . . . 0.0 109.411 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.679 ' HA3' ' CA ' ' A' ' 107' ' ' GLY . . . -158.83 -163.47 13.04 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.436 -1.364 . . . . 0.0 110.309 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.677 ' CE3' ' CG ' ' A' ' 180' ' ' TYR . 24.6 m0 -115.77 113.12 23.01 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.477 -1.013 . . . . 0.0 110.197 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 1.009 ' HA ' HG12 ' A' ' 105' ' ' VAL . 2.1 p-10 -119.48 142.96 47.81 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.717 -0.614 . . . . 0.0 110.154 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.889 HD13 ' C ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -121.41 -12.01 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 109.634 179.46 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.568 ' HA2' ' O ' ' A' ' 99' ' ' GLN . . . -95.61 -25.18 13.99 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.47 ' O ' ' C ' ' A' ' 138' ' ' GLY . 2.5 ttp180 -86.24 4.96 36.54 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.139 -1.213 . . . . 0.0 109.629 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.768 ' O ' ' O ' ' A' ' 139' ' ' LYS . . . 40.47 40.72 2.08 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.768 ' O ' ' O ' ' A' ' 138' ' ' GLY . 0.0 OUTLIER 1.48 -133.14 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 121.694 0.759 . . . . 0.0 112.256 -179.8 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.9 tt -155.71 101.28 2.14 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.458 -0.776 . . . . 0.0 110.352 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.45 ' CE2' ' HG ' ' A' ' 161' ' ' LEU . 0.6 OUTLIER -126.03 29.57 5.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 110.214 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.461 ' CD2' ' N ' ' A' ' 142' ' ' HIS . 7.6 m170 -109.77 65.6 0.62 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.221 -0.924 . . . . 0.0 110.318 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.519 ' CG ' ' N ' ' A' ' 144' ' ' SER . 16.5 pt20 -59.13 -41.99 89.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.898 . . . . 0.0 110.224 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.519 ' N ' ' CG ' ' A' ' 143' ' ' GLN . 21.6 m -100.87 -85.13 0.42 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.261 -0.899 . . . . 0.0 110.145 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -119.54 178.49 4.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.185 -0.947 . . . . 0.0 110.218 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -117.76 174.07 15.09 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.588 HD23 ' O ' ' A' ' 147' ' ' LEU . 0.9 OUTLIER -158.45 44.9 0.3 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -1.156 . . . . 0.0 110.096 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.65 175.2 0.19 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.204 -0.935 . . . . 0.0 110.264 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.407 ' O ' ' O ' ' A' ' 153' ' ' PRO . . . -167.42 58.88 0.44 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.884 . . . . 0.0 110.111 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.15 -3.13 13.11 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.098 1.578 . . . . 0.0 110.507 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.02 -97.05 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.213 -0.93 . . . . 0.0 110.116 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.605 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 0.4 OUTLIER -90.86 -63.52 0.19 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.188 -0.945 . . . . 0.0 110.276 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.605 ' CD ' ' CB ' ' A' ' 152' ' ' TYR . 46.2 Cg_endo -73.43 170.94 18.73 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.673 1.354 . . . . 0.0 110.408 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.423 ' O ' ' C ' ' A' ' 155' ' ' GLY . . . -90.41 130.67 36.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 110.175 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 154' ' ' ALA . . . -43.08 114.79 0.89 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.416 ' O ' ' OE1' ' A' ' 160' ' ' GLN . 47.1 Cg_endo -73.55 -14.07 24.89 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.897 1.472 . . . . 0.0 110.406 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.411 ' OE1' ' NE2' ' A' ' 142' ' ' HIS . 3.3 mm-40 -66.49 -4.21 7.89 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.26 -0.9 . . . . 0.0 110.512 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -85.53 -62.63 1.61 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.989 ' HA ' HG12 ' A' ' 162' ' ' VAL . 3.8 tt0 -73.9 6.69 3.11 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.301 -1.117 . . . . 0.0 110.527 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.509 ' O ' ' CD2' ' A' ' 161' ' ' LEU . 1.2 tp60 -62.03 -11.37 13.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.227 -0.921 . . . . 0.0 110.149 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.509 ' CD2' ' O ' ' A' ' 160' ' ' GLN . 0.1 OUTLIER 179.98 28.81 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.344 -0.848 . . . . 0.0 110.397 179.812 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.989 HG12 ' HA ' ' A' ' 159' ' ' GLU . 4.4 p -113.87 -136.64 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.323 -0.861 . . . . 0.0 109.486 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.863 ' N ' HG13 ' A' ' 162' ' ' VAL . 1.5 t -117.94 133.47 23.38 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 120.873 -1.142 . . . . 0.0 109.678 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.935 ' HD2' HG21 ' A' ' 182' ' ' ILE . 43.1 Cg_endo -70.56 178.52 4.98 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.859 1.452 . . . . 0.0 110.913 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.498 ' O ' ' HB3' ' A' ' 94' ' ' SER . 11.1 pt-20 -50.07 -18.34 0.54 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.477 -0.764 . . . . 0.0 110.826 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.475 ' O ' ' HG2' ' A' ' 164' ' ' PRO . 7.9 tpt180 -133.67 154.97 50.53 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.102 -0.999 . . . . 0.0 109.929 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 1.198 HD22 ' N ' ' A' ' 168' ' ' LEU . 0.0 OUTLIER -164.04 146.78 9.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.28 -0.888 . . . . 0.0 109.789 -179.802 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 1.198 ' N ' HD22 ' A' ' 167' ' ' LEU . 1.2 tt -125.77 131.19 52.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.142 -0.974 . . . . 0.0 110.611 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.968 HG11 ' CE3' ' A' ' 91' ' ' TRP . 97.2 t -89.52 156.92 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.395 -0.815 . . . . 0.0 109.805 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.64 HG11 HD21 ' A' ' 187' ' ' LEU . 22.4 t -134.55 112.1 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.165 -0.959 . . . . 0.0 110.155 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.888 HD22 ' CZ2' ' A' ' 91' ' ' TRP . 0.0 OUTLIER -132.39 122.48 25.07 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.287 -0.883 . . . . 0.0 109.791 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -120.15 139.13 53.08 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.244 -0.91 . . . . 0.0 109.942 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.53 ' HB3' ' N ' ' A' ' 87' ' ' GLY . 0.3 OUTLIER -93.05 -38.25 11.73 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.553 -0.717 . . . . 0.0 109.778 179.768 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 173' ' ' MET . 0.8 OUTLIER -43.11 -27.28 0.2 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 108.7 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.609 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.7 OUTLIER -114.59 -27.38 7.52 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.78 0.8 . . . . 0.0 108.876 179.157 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.428 ' O ' HG21 ' A' ' 198' ' ' THR . . . 84.68 22.54 53.15 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 108.706 -1.757 . . . . 0.0 108.706 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.961 HG22 ' CD2' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -115.53 133.72 55.76 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.288 -1.125 . . . . 0.0 111.376 -179.476 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.672 ' O ' HD11 ' A' ' 194' ' ' LEU . 0.1 OUTLIER -143.85 152.63 41.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.569 -0.707 . . . . 0.0 109.423 178.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.414 ' O ' HG13 ' A' ' 169' ' ' VAL . . . -161.67 -156.1 8.21 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 1.019 ' CE1' HD21 ' A' ' 167' ' ' LEU . 0.1 OUTLIER -125.65 138.34 53.9 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.27 -1.135 . . . . 0.0 108.904 -179.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.489 ' HB2' ' HB2' ' A' ' 187' ' ' LEU . 9.2 t -144.0 141.59 30.23 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.143 -0.973 . . . . 0.0 110.624 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.992 HD11 ' CD2' ' A' ' 186' ' ' TYR . 0.3 OUTLIER -127.12 116.76 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.655 -0.653 . . . . 0.0 109.563 179.629 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 65.55 10.09 47.5 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 77.0 41.01 23.71 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . 0.73 HG22 ' CE1' ' A' ' 186' ' ' TYR . 17.4 m -97.31 -47.56 5.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -1.142 . . . . 0.0 110.643 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.992 ' CD2' HD11 ' A' ' 182' ' ' ILE . 8.6 m-85 -112.08 85.55 2.17 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.097 -1.002 . . . . 0.0 110.683 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.64 HD21 HG11 ' A' ' 170' ' ' VAL . 0.9 OUTLIER -179.79 28.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.686 -0.634 . . . . 0.0 109.647 179.54 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -94.88 -89.52 1.72 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.448 ' C ' ' H ' ' A' ' 191' ' ' PHE . 49.6 Cg_endo -74.24 -21.02 18.17 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 124.18 1.621 . . . . 0.0 111.21 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.578 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -66.31 15.2 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.527 -0.733 . . . . 0.0 111.877 -178.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.624 ' CE1' ' HG ' ' A' ' 187' ' ' LEU . 1.1 m-30 -90.51 -28.07 18.78 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.854 -1.154 . . . . 0.0 111.146 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.533 ' HA ' ' NE ' ' A' ' 192' ' ' ARG . 0.1 OUTLIER -86.52 -13.13 46.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.949 -1.094 . . . . 0.0 110.744 -179.5 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -107.48 -13.04 21.77 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.961 ' CD2' HG22 ' A' ' 177' ' ' THR . 9.2 tt -72.17 -40.54 67.89 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.572 -0.958 . . . . 0.0 109.012 179.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.512 ' HD2' ' N ' ' A' ' 196' ' ' GLY . 0.0 OUTLIER -44.12 -40.25 4.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.215 -0.928 . . . . 0.0 109.869 179.583 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.524 ' O ' HD11 ' A' ' 112' ' ' LEU . . . -86.27 -26.82 32.4 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.866 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -90.62 -4.38 56.86 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.686 -0.891 . . . . 0.0 109.905 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.8 HG23 HD23 ' A' ' 194' ' ' LEU . 0.8 OUTLIER -43.85 132.08 5.32 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.739 0.78 . . . . 0.0 111.732 -178.441 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.921 HD13 ' HB ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -140.68 171.01 14.7 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.656 -0.652 . . . . 0.0 109.444 179.254 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.486 ' CZ ' ' HA3' ' A' ' 83' ' ' GLY . 0.1 OUTLIER -85.98 128.93 56.12 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 120.909 -1.119 . . . . 0.0 109.84 179.358 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.58 ' CA ' HG13 ' A' ' 108' ' ' VAL . 51.0 Cg_endo -85.91 129.16 3.4 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.995 1.524 . . . . 0.0 111.396 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.459 ' O ' HG13 ' A' ' 106' ' ' VAL . 24.5 t -133.46 142.87 48.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.297 -0.877 . . . . 0.0 109.585 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.973 HG23 HG22 ' A' ' 106' ' ' VAL . 7.4 p -122.35 153.96 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.825 -1.172 . . . . 0.0 111.43 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 0.828 ' O ' ' O ' ' A' ' 103' ' ' HIS . 15.1 p -149.58 145.39 26.78 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 1.065 ' HA ' ' N ' ' A' ' 104' ' ' ALA . . . -150.26 167.36 27.19 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.765 -1.209 . . . . 0.0 112.059 -179.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.838 ' N ' ' HB3' ' A' ' 103' ' ' HIS . 0.3 OUTLIER -69.48 -176.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 121.639 0.733 . . . . 0.0 111.31 -179.02 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 0.745 ' CZ2' HG13 ' A' ' 71' ' ' VAL . 22.7 p-90 -129.78 -5.12 4.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.672 -0.642 . . . . 0.0 109.823 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 207' ' ' TRP . . . -51.72 -168.97 0.01 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.764 ' O ' ' O ' ' A' ' 210' ' ' CYS . 0.5 OUTLIER -79.67 -51.61 9.02 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.467 -1.02 . . . . 0.0 110.864 -179.562 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . 0.764 ' O ' ' O ' ' A' ' 209' ' ' GLN . 26.4 p 0.99 -129.18 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 121.07 0.462 . . . . 0.0 111.422 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.714 ' O ' ' HB3' ' A' ' 96' ' ' PRO . 0.0 OUTLIER 178.64 93.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.766 -1.209 . . . . 0.0 111.054 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.652 ' HB ' ' CZ ' ' A' ' 66' ' ' PHE . 3.1 t -87.05 123.09 39.67 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 O-C-N 121.381 -0.825 . . . . 0.0 108.84 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.596 ' CB ' ' HB2' ' A' ' 94' ' ' SER . 2.0 tpp85 -89.85 147.36 23.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.097 -1.002 . . . . 0.0 110.52 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.604 HD12 ' HB3' ' A' ' 48' ' ' TRP . 1.1 mt -144.33 128.46 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 110.474 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.666 ' O ' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -130.59 108.22 9.77 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.297 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . 0.726 ' CZ ' ' CD1' ' A' ' 91' ' ' TRP . 3.6 t80 -119.02 144.98 46.23 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.249 -0.907 . . . . 0.0 111.233 -178.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . 0.46 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 1.2 ttp -136.59 108.45 7.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.561 -0.712 . . . . 0.0 110.05 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 130.74 70.34 0.11 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' A' ' 220' ' ' ARG . 0.2 OUTLIER -103.02 157.97 16.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.261 -1.141 . . . . 0.0 110.199 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.467 ' O ' ' O ' ' A' ' 219' ' ' GLU . 75.4 mtt180 -55.87 -161.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.251 -0.905 . . . . 0.0 110.28 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . 0.504 ' O ' ' C ' ' A' ' 222' ' ' VAL . 8.9 tpm_? -135.24 89.55 2.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.197 -0.939 . . . . 0.0 110.344 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.504 ' C ' ' O ' ' A' ' 221' ' ' ARG . 8.6 p -34.57 132.71 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.493 -0.755 . . . . 0.0 110.69 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.54 ' O ' ' C ' ' A' ' 224' ' ' GLU . 23.1 tt0 -58.14 -34.91 70.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.179 -0.951 . . . . 0.0 110.216 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.54 ' C ' ' O ' ' A' ' 223' ' ' GLU . 5.3 tt0 -31.82 -85.92 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.406 -0.809 . . . . 0.0 110.768 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.7 m -48.7 125.95 10.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.263 -0.898 . . . . 0.0 110.244 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -60.83 140.58 57.6 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.201 -0.937 . . . . 0.0 110.225 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.459 ' NH1' ' HG2' ' A' ' 227' ' ' ARG . 0.4 OUTLIER -96.11 175.84 6.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 110.264 -179.944 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 46.1 mm -129.28 115.31 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.209 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.509 ' O ' ' N ' ' A' ' 231' ' ' ASP . 0.2 OUTLIER -80.01 148.41 31.14 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.257 -0.902 . . . . 0.0 110.263 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . 0.683 ' O ' ' C ' ' A' ' 231' ' ' ASP . 0.0 OUTLIER -49.0 91.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.209 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.683 ' C ' ' O ' ' A' ' 230' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.955 -1.021 . . . . 0.0 111.419 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -115.86 127.42 55.01 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.187 -1.184 . . . . 0.0 110.251 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.04 72.83 0.26 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.295 -0.878 . . . . 0.0 110.152 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.19 126.71 31.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.181 -0.949 . . . . 0.0 110.176 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.89 -16.7 63.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.168 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -130.66 141.7 50.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 0.0 110.316 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.2 m -96.11 -166.88 1.49 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.331 -0.855 . . . . 0.0 110.192 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 48.9 p -112.28 155.92 42.85 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.187 -0.945 . . . . 0.0 110.298 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.91 161.62 43.17 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.047 1.551 . . . . 0.0 110.374 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.6 p -128.81 128.59 44.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 110.267 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.6 m -77.76 -3.96 43.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.332 -0.855 . . . . 0.0 110.157 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.481 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 9.1 pt20 -75.52 62.92 1.45 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.185 -0.947 . . . . 0.0 110.253 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -172.92 121.2 0.38 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.181 -0.949 . . . . 0.0 110.206 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.1 mp -70.07 -161.36 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.192 -0.942 . . . . 0.0 110.223 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -63.52 -94.9 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.203 -0.935 . . . . 0.0 110.174 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.9 179.56 6.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.323 -0.86 . . . . 0.0 110.155 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -175.17 58.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.353 -0.842 . . . . 0.0 110.167 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.93 -42.58 4.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.254 -0.904 . . . . 0.0 110.263 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.09 116.76 53.01 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.345 -0.847 . . . . 0.0 110.386 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.549 ' HB2' ' HD2' ' A' ' 26' ' ' PRO . 46.5 Cg_endo -73.33 176.59 9.01 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.024 1.539 . . . . 0.0 110.456 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.549 ' HD2' ' HB2' ' A' ' 25' ' ' PRO . 42.9 Cg_endo -70.74 161.19 46.93 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.878 1.462 . . . . 0.0 110.542 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -68.69 53.98 0.08 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.374 -0.829 . . . . 0.0 110.014 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 26' ' ' PRO . . . 54.12 19.21 10.88 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.617 ' HG ' ' N ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -43.61 -32.61 0.99 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.225 -1.162 . . . . 0.0 110.026 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.617 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 8.7 mt-10 -52.18 -35.9 50.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.066 -1.021 . . . . 0.0 108.997 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.65 -25.42 60.17 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 29' ' ' LEU . 0.5 OUTLIER -82.03 -35.74 28.48 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.707 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.886 HD12 ' C ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -77.87 -38.92 44.86 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.91 0.862 . . . . 0.0 108.873 178.884 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.564 ' O ' ' O ' ' A' ' 35' ' ' ALA . 23.2 t -57.58 -14.31 5.1 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.318 0.58 . . . . 0.0 110.25 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 1.067 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -52.61 -161.26 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.402 -0.811 . . . . 0.0 109.942 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 1.067 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 38.6 Cg_endo -65.8 118.37 5.43 Favored 'Trans proline' 0 C--N 1.315 -1.214 0 O-C-N 123.008 1.004 . . . . 0.0 109.647 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.677 ' CB ' HG21 ' A' ' 41' ' ' VAL . 45.7 Cg_endo -71.35 108.44 2.37 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.28 1.674 . . . . 0.0 112.162 -178.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.761 ' O ' ' N ' ' A' ' 40' ' ' LEU . 50.7 Cg_endo -81.98 151.97 16.49 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.23 1.648 . . . . 0.0 108.676 178.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.662 ' C ' ' O ' ' A' ' 38' ' ' PRO . 3.1 t0 -21.49 -41.89 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.311 -0.868 . . . . 0.0 109.806 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.127 HD13 ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -37.84 -50.06 1.24 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 122.012 -0.43 . . . . 0.0 109.875 179.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.127 ' N ' HD13 ' A' ' 40' ' ' LEU . 13.8 t -62.03 -26.92 41.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.683 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.611 ' N ' ' O ' ' A' ' 39' ' ' ASP . . . -89.06 -44.79 10.11 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.166 -0.958 . . . . 0.0 111.073 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.658 ' NE2' ' C ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -79.05 -25.28 43.17 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 118.405 -1.318 . . . . 0.0 108.648 179.389 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.741 ' CB ' ' O ' ' A' ' 40' ' ' LEU . 9.1 ttp180 -61.39 -52.87 62.81 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 122.343 1.068 . . . . 0.0 108.198 178.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.624 ' CE1' HG12 ' A' ' 41' ' ' VAL . 26.0 m170 -60.93 -18.0 54.4 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.989 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -96.87 -30.07 13.35 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 118.207 -1.397 . . . . 0.0 111.648 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.91 ' O ' HD13 ' A' ' 214' ' ' ILE . . . -109.2 -67.12 0.58 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 107.605 -2.198 . . . . 0.0 107.605 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.784 ' CH2' ' N ' ' A' ' 61' ' ' GLU 0.265 0.1 OUTLIER -96.2 71.02 2.81 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.316 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.708 ' OD1' ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -60.26 112.53 5.62 Favored Pre-proline 0 N--CA 1.491 1.616 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.487 -178.809 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.667 ' CD ' ' HE3' ' A' ' 51' ' ' LYS . 44.5 Cg_endo -74.74 0.38 8.84 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 124.535 1.808 . . . . 0.0 112.024 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.913 ' CE ' ' N ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -64.57 -19.72 65.81 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 178.703 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.77 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 8.6 m-20 -133.34 -2.29 3.12 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 114.149 -1.387 . . . . 0.0 107.856 178.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.591 ' HB3' ' HA ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -113.34 152.11 30.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.571 -0.706 . . . . 0.0 110.058 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.52 ' CB ' HD22 ' A' ' 56' ' ' ASN . 0.0 OUTLIER -68.06 104.42 1.76 Allowed 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.13 179.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.705 ' HG3' HD22 ' A' ' 33' ' ' LEU . 26.1 pt-20 -67.81 -17.01 64.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.105 -0.997 . . . . 0.0 109.064 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.81 ' HB3' HG23 ' A' ' 75' ' ' THR . 11.8 m-80 -33.36 -32.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.678 0.752 . . . . 0.0 110.346 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.706 ' HB ' ' O ' ' A' ' 67' ' ' GLU . 9.0 pt -112.92 166.96 6.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 121.616 -0.677 . . . . 0.0 110.01 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.577 ' O ' ' N ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -107.13 117.11 33.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.247 -0.908 . . . . 0.0 109.372 -179.362 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.955 HG21 ' CD1' ' A' ' 66' ' ' PHE . 2.6 p -124.52 120.36 58.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 O-C-N 121.445 -0.785 . . . . 0.0 111.463 -178.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.694 ' HG2' ' N ' ' A' ' 61' ' ' GLU . 6.6 tttt -137.4 159.54 41.66 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.534 -0.729 . . . . 0.0 110.27 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.784 ' N ' ' CH2' ' A' ' 48' ' ' TRP . 1.2 tt0 -45.45 -106.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.596 -0.69 . . . . 0.0 110.535 -179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.569 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 35.7 33.76 0.06 OUTLIER Glycine 0 N--CA 1.493 2.487 0 N-CA-C 108.141 -1.984 . . . . 0.0 108.141 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.69 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 107.8 62.83 0.56 Allowed Glycine 0 N--CA 1.485 1.927 0 N-CA-C 108.01 -2.036 . . . . 0.0 108.01 -178.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.712 HD13 ' HE1' ' A' ' 48' ' ' TRP . 0.4 OUTLIER 1.18 80.64 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.899 -0.765 . . . . 0.0 110.724 -179.324 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.429 ' N ' ' O ' ' A' ' 63' ' ' GLY . 17.3 p -141.17 136.92 32.3 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 118.418 -1.313 . . . . 0.0 112.176 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.955 ' CD1' HG21 ' A' ' 59' ' ' VAL . 17.9 m-85 -89.34 165.32 14.45 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.706 ' O ' ' HB ' ' A' ' 57' ' ' ILE . 5.5 tm-20 -136.94 121.01 17.76 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.91 -1.119 . . . . 0.0 109.944 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.561 ' CD ' ' O ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -126.32 148.71 49.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.237 -0.915 . . . . 0.0 109.977 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.75 ' CB ' ' CD ' ' A' ' 70' ' ' PRO . 1.7 mtm180 -104.93 -78.93 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.024 -1.048 . . . . 0.0 110.454 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.75 ' CD ' ' CB ' ' A' ' 69' ' ' ARG . 57.6 Cg_endo -75.08 -152.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.163 1.086 . . . . 0.0 109.368 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.686 HG13 ' CZ2' ' A' ' 207' ' ' TRP . 2.4 t -140.76 162.55 22.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 1.014 ' HB3' ' CB ' ' A' ' 75' ' ' THR . . . 179.85 175.87 0.75 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.932 -1.105 . . . . 0.0 110.621 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.464 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 2.5 pt20 -66.19 -115.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.385 -0.822 . . . . 0.0 110.31 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 73' ' ' GLN . 11.5 p -41.78 -27.1 0.1 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.195 -0.941 . . . . 0.0 110.225 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 1.014 ' CB ' ' HB3' ' A' ' 72' ' ' ALA . 22.6 m -44.29 -28.51 0.54 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.293 -0.879 . . . . 0.0 110.028 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.651 ' CB ' ' CD1' ' A' ' 207' ' ' TRP . 12.4 p30 -112.68 155.46 24.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.887 . . . . 0.0 109.992 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.496 ' HA2' ' O ' ' A' ' 205' ' ' ALA . . . 79.86 123.93 0.47 Allowed Glycine 0 N--CA 1.484 1.899 0 N-CA-C 106.886 -2.485 . . . . 0.0 106.886 -178.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.572 ' HB ' ' CB ' ' A' ' 53' ' ' CYS . 1.2 m -117.74 161.85 16.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 120.851 -1.382 . . . . 0.0 110.939 -178.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.77 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -119.5 173.5 6.95 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.015 179.128 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.724 ' HA3' HG12 ' A' ' 203' ' ' VAL . . . -149.47 48.44 0.6 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.508 ' HA ' ' CB ' ' A' ' 202' ' ' SER . 22.7 ttpp -81.95 76.28 8.85 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -1.101 . . . . 0.0 109.985 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.502 ' CG ' ' OD2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -141.47 -91.03 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.381 -0.825 . . . . 0.0 110.064 -179.921 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.421 ' H ' ' CD ' ' A' ' 82' ' ' ARG . . . 49.11 62.69 4.47 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.487 ' CD2' ' O ' ' A' ' 84' ' ' TYR . 52.3 t80 -94.46 96.06 9.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.248 -1.148 . . . . 0.0 109.995 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.572 ' OG ' ' CD2' ' A' ' 89' ' ' HIS . 0.1 OUTLIER -132.13 153.91 50.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.888 . . . . 0.0 110.263 -179.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.614 ' O ' ' CD2' ' A' ' 89' ' ' HIS . 46.5 ttp180 -114.72 176.43 5.05 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.321 -0.862 . . . . 0.0 109.779 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.563 ' N ' ' CG ' ' A' ' 86' ' ' ARG . . . 46.78 -111.22 0.66 Allowed Glycine 0 N--CA 1.485 1.959 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.525 ' O ' ' ND1' ' A' ' 89' ' ' HIS . 5.9 tt -129.08 126.83 40.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.478 -1.013 . . . . 0.0 110.751 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.614 ' CD2' ' O ' ' A' ' 86' ' ' ARG . 52.1 m-70 -147.41 173.69 12.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.792 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -163.51 155.31 17.29 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.347 -0.846 . . . . 0.0 110.263 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 1.211 ' CZ2' HG11 ' A' ' 169' ' ' VAL . 1.2 p90 -135.05 171.12 14.87 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.199 -0.938 . . . . 0.0 110.064 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.571 ' N ' ' O ' ' A' ' 215' ' ' ARG . 2.9 tp10 -132.93 142.63 48.99 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.538 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.753 HG23 ' OH ' ' A' ' 180' ' ' TYR . 0.3 OUTLIER -144.78 138.36 22.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.215 -0.928 . . . . 0.0 110.961 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.568 ' CB ' ' HB3' ' A' ' 213' ' ' ARG . 0.7 OUTLIER -117.75 137.3 52.8 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.724 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.834 ' CE2' ' HA ' ' A' ' 104' ' ' ALA . 46.9 t-105 -116.0 87.89 20.21 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.046 -1.034 . . . . 0.0 111.631 -178.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 94' ' ' SER . 52.4 Cg_endo -98.16 109.35 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 121.862 1.708 . . . . 0.0 110.046 178.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.443 HD22 ' HA ' ' A' ' 97' ' ' LEU . 0.4 OUTLIER -95.84 -68.48 0.8 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.662 -1.274 . . . . 0.0 110.417 179.806 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 99' ' ' GLN . 0.4 OUTLIER -99.07 -45.53 5.9 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.256 -0.903 . . . . 0.0 110.012 179.412 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 6.6 tt0 179.69 -31.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.723 0.773 . . . . 0.0 109.344 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.592 ' HG3' ' N ' ' A' ' 101' ' ' GLY . 9.3 ptp85 -135.03 -35.6 0.84 Allowed 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.418 0.628 . . . . 0.0 109.594 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.744 ' HA2' HG23 ' A' ' 162' ' ' VAL . . . -46.77 171.43 0.03 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.615 ' HA ' ' HD1' ' A' ' 95' ' ' TRP . 6.0 m -166.4 92.18 0.47 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.156 -1.202 . . . . 0.0 110.618 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.587 ' N ' ' CD1' ' A' ' 95' ' ' TRP . 27.0 m170 -114.32 53.98 0.78 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.191 -0.943 . . . . 0.0 110.959 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.834 ' HA ' ' CE2' ' A' ' 95' ' ' TRP . . . -60.82 129.24 40.47 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.073 -1.017 . . . . 0.0 109.978 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 1.175 HG22 ' O ' ' A' ' 204' ' ' SER . 1.2 m -103.43 116.54 47.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 C-N-CA 118.655 -1.218 . . . . 0.0 109.27 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.996 HG13 ' O ' ' A' ' 202' ' ' SER . 78.3 t -135.71 152.26 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 120.999 -1.063 . . . . 0.0 109.926 -178.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.536 ' HA2' ' HA2' ' A' ' 132' ' ' GLY . . . -141.52 135.52 6.86 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.06 HG12 HD12 ' A' ' 199' ' ' LEU . 1.3 t -125.79 131.62 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.435 -1.038 . . . . 0.0 108.319 179.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.667 ' HB1' ' HA ' ' A' ' 130' ' ' SER . . . -150.12 149.49 30.33 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.073 -1.017 . . . . 0.0 111.52 -178.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.735 HG23 ' HB3' ' A' ' 199' ' ' LEU . 0.6 OUTLIER -89.47 112.08 23.14 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 122.209 1.004 . . . . 0.0 109.897 178.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 110' ' ' THR 0.294 . . -32.77 -53.42 0.34 Allowed 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.976 179.161 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.918 ' HB2' ' O ' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -43.7 -26.31 0.23 Allowed 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.448 -178.72 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.655 ' N ' ' O ' ' A' ' 110' ' ' THR . . . -36.53 156.58 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.769 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.288 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.48 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 45.8 Cg_endo -72.12 101.94 1.29 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.893 1.47 . . . . 0.0 110.599 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.54 ' CG ' ' O ' ' A' ' 115' ' ' LEU . 0.6 OUTLIER -178.81 58.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.309 -0.869 . . . . 0.0 110.199 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.498 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 0.6 OUTLIER -127.35 -34.1 2.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.292 -0.88 . . . . 0.0 110.318 -179.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.543 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . 179.97 114.5 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.407 -0.808 . . . . 0.0 110.172 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.543 ' C ' ' O ' ' A' ' 117' ' ' ALA . 50.3 t0 -30.6 94.07 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.53 -0.731 . . . . 0.0 110.787 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' A' ' 117' ' ' ALA . 1.2 t60 -170.84 165.81 7.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.25 -0.906 . . . . 0.0 110.185 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -107.38 49.72 0.79 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.133 -0.979 . . . . 0.0 110.195 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -95.98 61.19 2.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.363 -0.836 . . . . 0.0 110.26 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -146.91 107.16 4.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.205 -0.934 . . . . 0.0 110.222 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.485 ' O ' ' HB2' ' A' ' 126' ' ' SER . 0.2 OUTLIER -110.29 174.58 5.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.249 -0.907 . . . . 0.0 110.266 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.546 HD12 ' C ' ' A' ' 124' ' ' LEU . 3.6 pp -52.35 163.7 0.38 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 0.0 110.197 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 77.65 8.74 87.17 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -130.68 61.01 1.62 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.327 -1.102 . . . . 0.0 110.175 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.918 ' O ' ' HB2' ' A' ' 112' ' ' LEU . 5.0 p-10 -39.61 161.05 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.378 -0.826 . . . . 0.0 110.279 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.768 ' HB3' ' HB2' ' A' ' 112' ' ' LEU . 2.4 p 178.42 124.63 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.729 ' N ' ' OG1' ' A' ' 110' ' ' THR . 2.6 tt0 -152.22 160.71 43.32 Favored 'General case' 0 C--N 1.308 -1.229 0 O-C-N 120.323 -1.485 . . . . 0.0 111.213 -178.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.667 ' HA ' ' HB1' ' A' ' 109' ' ' ALA . 2.5 t -134.25 126.39 29.72 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.876 -0.515 . . . . 0.0 109.76 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . 0.479 ' CB ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -133.14 155.16 49.8 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 120.929 -1.107 . . . . 0.0 109.855 -179.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.536 ' HA2' ' HA2' ' A' ' 107' ' ' GLY . . . -141.58 133.67 5.87 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.857 ' CZ3' HG21 ' A' ' 108' ' ' VAL . 3.8 m0 -104.9 113.53 27.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -1.166 . . . . 0.0 109.689 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.615 ' O ' HG23 ' A' ' 135' ' ' ILE . 0.3 OUTLIER -118.48 148.19 42.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.133 -0.979 . . . . 0.0 110.428 -179.843 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.648 HD11 ' HB3' ' A' ' 104' ' ' ALA . 3.7 pt -158.1 23.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.316 -0.865 . . . . 0.0 110.11 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.554 ' CA ' ' HB3' ' A' ' 103' ' ' HIS . . . -121.24 -50.84 0.25 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.91 8.12 43.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.171 -1.194 . . . . 0.0 110.119 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.543 ' O ' ' NE2' ' A' ' 157' ' ' GLN . . . 54.64 28.69 46.63 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 9.0 mtpt -58.54 -171.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -1.096 . . . . 0.0 110.176 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 12.8 tp -174.25 109.29 0.14 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.248 -0.908 . . . . 0.0 110.11 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -102.5 -10.62 19.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.218 -0.926 . . . . 0.0 110.262 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.43 ' CE1' ' HE1' ' A' ' 131' ' ' TRP . 84.1 m-70 -105.59 52.06 0.74 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.17 -0.956 . . . . 0.0 110.188 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.471 ' CG ' ' N ' ' A' ' 144' ' ' SER . 5.9 pt20 -51.71 -40.34 59.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.279 -0.888 . . . . 0.0 110.172 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.471 ' N ' ' CG ' ' A' ' 143' ' ' GLN . 0.5 OUTLIER -43.49 -58.46 2.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.272 -0.892 . . . . 0.0 110.122 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.65 29.98 6.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.181 -0.949 . . . . 0.0 110.157 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -132.55 109.23 0.83 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.468 ' O ' ' HG2' ' A' ' 148' ' ' GLU . 3.9 mt -122.49 -111.79 0.32 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.215 -1.168 . . . . 0.0 110.036 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 147' ' ' LEU . 4.9 mt-10 -157.75 131.39 7.89 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.398 -0.814 . . . . 0.0 110.104 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.463 ' O ' ' O ' ' A' ' 153' ' ' PRO . . . -136.51 75.37 51.36 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.892 . . . . 0.0 110.259 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -74.0 -0.52 9.62 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.068 1.562 . . . . 0.0 110.384 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -62.48 -99.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.302 -0.873 . . . . 0.0 110.191 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.537 ' N ' ' HD2' ' A' ' 153' ' ' PRO . 0.1 OUTLIER -76.99 -54.63 1.54 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.115 -0.99 . . . . 0.0 110.188 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 152' ' ' TYR . 45.8 Cg_endo -74.79 142.86 29.11 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.865 1.455 . . . . 0.0 110.24 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.531 ' O ' ' O ' ' A' ' 155' ' ' GLY . . . -100.36 115.41 29.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 110.243 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.531 ' O ' ' O ' ' A' ' 154' ' ' ALA . . . 42.16 98.06 0.01 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.33 -2.43 11.67 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.014 1.533 . . . . 0.0 110.556 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.543 ' NE2' ' O ' ' A' ' 138' ' ' GLY . 4.3 mt-30 -56.64 -13.35 2.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 0.0 110.544 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 93.55 -32.63 5.64 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.531 ' HB3' ' HA ' ' A' ' 135' ' ' ILE . 6.8 pt-20 -88.89 5.27 44.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.185 -1.185 . . . . 0.0 110.114 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.528 ' HB3' ' O ' ' A' ' 154' ' ' ALA . 3.3 tp-100 -91.45 -4.32 55.71 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.381 -0.824 . . . . 0.0 109.787 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.68 ' O ' ' C ' ' A' ' 162' ' ' VAL . 0.1 OUTLIER -128.04 56.43 1.6 Allowed 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.444 -0.785 . . . . 0.0 110.185 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.87 HG13 ' O ' ' A' ' 162' ' ' VAL . 8.3 p 0.69 91.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.69 0.757 . . . . 0.0 111.232 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.865 HG13 ' HD2' ' A' ' 164' ' ' PRO . 42.4 t -44.31 151.52 0.56 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.331 -0.856 . . . . 0.0 109.466 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.865 ' HD2' HG13 ' A' ' 163' ' ' VAL . 40.0 Cg_endo -67.01 125.43 13.61 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.656 1.345 . . . . 0.0 110.495 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 94' ' ' SER . 1.4 tt0 -41.05 -24.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.423 -0.798 . . . . 0.0 110.642 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.483 ' N ' ' O ' ' A' ' 164' ' ' PRO . 9.7 ttt85 -111.27 137.58 48.82 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.173 -0.954 . . . . 0.0 109.783 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.836 HD21 ' CG1' ' A' ' 163' ' ' VAL . 3.0 mp -138.47 146.31 41.9 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.463 -0.773 . . . . 0.0 110.411 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.438 HD12 ' OE1' ' A' ' 92' ' ' GLU . 0.7 OUTLIER -116.93 124.51 49.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.495 179.636 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 1.211 HG11 ' CZ2' ' A' ' 91' ' ' TRP . 2.5 t -114.92 139.76 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.073 -1.017 . . . . 0.0 110.683 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 170' ' ' VAL . 9.3 p -118.32 124.93 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.578 -0.701 . . . . 0.0 110.062 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.58 ' CD1' ' HB3' ' A' ' 178' ' ' LEU . 9.3 tp -133.37 111.29 10.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.135 -0.978 . . . . 0.0 110.154 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.524 ' OD2' ' CB ' ' A' ' 88' ' ' LEU . 6.5 t70 -116.27 138.31 51.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.296 -0.877 . . . . 0.0 110.14 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.567 ' CB ' ' HA ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -94.64 -44.38 7.85 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.71 -0.619 . . . . 0.0 110.041 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.491 ' C ' ' O ' ' A' ' 173' ' ' MET . 2.7 mt-10 -40.19 -28.52 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.115 -0.99 . . . . 0.0 108.791 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.646 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 0.4 OUTLIER -111.56 -25.15 9.71 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.901 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.597 ' O ' ' CG2' ' A' ' 198' ' ' THR . . . 77.18 24.94 64.97 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 1.081 HG22 ' CD2' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -113.14 134.91 54.33 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.293 -1.122 . . . . 0.0 111.12 -179.429 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 1.092 ' O ' HD11 ' A' ' 194' ' ' LEU . 0.6 OUTLIER -142.54 154.13 44.19 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.655 -0.653 . . . . 0.0 109.815 179.265 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -162.11 162.17 34.0 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 1.031 ' CD1' HG22 ' A' ' 169' ' ' VAL . 1.1 t80 -118.68 121.77 40.92 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.459 -1.024 . . . . 0.0 109.657 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.476 ' OG ' HD23 ' A' ' 187' ' ' LEU . 0.3 OUTLIER -144.26 139.7 28.79 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.267 -0.895 . . . . 0.0 110.349 -179.67 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.637 HG22 ' HA ' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -102.78 116.72 47.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.37 -0.831 . . . . 0.0 109.666 179.553 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 88.69 -9.13 77.33 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.535 ' HA2' ' CD2' ' A' ' 187' ' ' LEU . . . 86.21 43.61 6.21 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . . . . . . . . . 70.2 m -114.35 -25.32 8.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.287 -1.125 . . . . 0.0 110.618 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.465 ' CE2' HD11 ' A' ' 182' ' ' ILE . 21.2 m-85 -107.97 69.1 0.72 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.172 -0.955 . . . . 0.0 110.42 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.576 ' HB2' ' CE1' ' A' ' 191' ' ' PHE . 0.9 OUTLIER -173.5 26.21 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.748 0.785 . . . . 0.0 109.497 179.719 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -94.64 -81.62 1.54 Allowed Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.033 -1.08 . . . . 0.0 110.7 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.15 -30.05 16.65 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.997 1.525 . . . . 0.0 111.307 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.584 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -74.06 13.78 0.5 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.312 -0.868 . . . . 0.0 111.234 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.576 ' CE1' ' HB2' ' A' ' 187' ' ' LEU . 1.2 m-30 -90.73 -26.79 19.35 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.018 -1.051 . . . . 0.0 110.416 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.62 -13.27 49.2 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.303 -0.873 . . . . 0.0 110.253 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 197' ' ' ARG . . . -108.17 -6.15 32.05 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.166 -1.974 . . . . 0.0 108.166 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 1.092 HD11 ' O ' ' A' ' 178' ' ' LEU . 7.6 tt -77.64 -41.44 38.38 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.51 ' CA ' HG23 ' A' ' 198' ' ' THR . 1.6 ttmt -43.79 -45.89 7.47 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.761 -0.587 . . . . 0.0 110.163 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -83.54 -24.51 50.19 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.698 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -91.12 -3.8 56.77 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.658 -0.907 . . . . 0.0 110.035 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.75 HG23 ' O ' ' A' ' 194' ' ' LEU . 21.8 p -42.98 112.81 0.4 Allowed 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.641 0.734 . . . . 0.0 111.86 -177.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 1.06 HD12 HG12 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -140.44 171.0 14.76 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.713 -0.617 . . . . 0.0 109.647 178.738 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 11.0 m-85 -84.7 129.23 57.79 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.07 -1.019 . . . . 0.0 110.741 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.814 ' CA ' HG13 ' A' ' 108' ' ' VAL . 51.4 Cg_endo -88.62 146.4 5.9 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 124.179 1.62 . . . . 0.0 110.985 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.996 ' O ' HG13 ' A' ' 106' ' ' VAL . 11.8 p -133.86 157.08 46.86 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.232 -0.918 . . . . 0.0 110.606 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.724 HG12 ' HA3' ' A' ' 80' ' ' GLY . 7.4 p -119.46 157.1 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.076 -1.015 . . . . 0.0 109.693 178.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 1.175 ' O ' HG22 ' A' ' 105' ' ' VAL . 0.9 OUTLIER -160.3 156.06 25.75 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 120.922 -1.112 . . . . 0.0 110.623 179.47 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.496 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . -150.39 164.74 35.08 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.729 0.776 . . . . 0.0 111.02 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.649 HG13 ' N ' ' A' ' 207' ' ' TRP . 1.2 t -60.06 -179.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 121.344 0.592 . . . . 0.0 111.32 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 0.686 ' CZ2' HG13 ' A' ' 71' ' ' VAL . 4.3 t90 -26.19 -55.91 0.07 Allowed 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.288 0.566 . . . . 0.0 110.919 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 209' ' ' GLN . . . 138.73 -1.74 2.64 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' ' 208' ' ' GLY . 1.6 tt0 -42.84 -29.92 0.36 Allowed 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.419 -1.048 . . . . 0.0 109.698 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . 0.506 ' C ' ' CG ' ' A' ' 211' ' ' GLN . 28.9 p -94.91 -131.79 0.16 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.433 -0.792 . . . . 0.0 109.855 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.506 ' CG ' ' C ' ' A' ' 210' ' ' CYS . 0.0 OUTLIER -178.59 112.67 0.06 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.933 . . . . 0.0 110.2 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.69 ' O ' HD11 ' A' ' 64' ' ' LEU . 33.9 m -89.63 139.55 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.277 -0.89 . . . . 0.0 109.765 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.576 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -88.9 135.6 33.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.124 -0.985 . . . . 0.0 109.213 179.676 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.91 HD13 ' O ' ' A' ' 47' ' ' GLY . 0.8 OUTLIER -144.51 112.43 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 120.99 -1.069 . . . . 0.0 111.559 -178.707 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.571 ' O ' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -118.02 108.42 15.22 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.061 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . 0.678 ' CD2' ' CB ' ' A' ' 91' ' ' TRP . 2.1 t80 -106.11 149.14 27.03 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.188 -0.945 . . . . 0.0 111.648 -177.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . 0.425 ' N ' ' HD1' ' A' ' 216' ' ' TYR . 36.1 ttp -129.72 107.63 9.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.72 -0.613 . . . . 0.0 109.56 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . 0.432 ' O ' ' OG ' ' A' ' 85' ' ' SER . . . 108.7 63.73 0.55 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.55 ' HG2' ' N ' ' A' ' 220' ' ' ARG . 1.5 tm-20 -125.55 151.23 46.66 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.195 -1.18 . . . . 0.0 110.012 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.55 ' N ' ' HG2' ' A' ' 219' ' ' GLU . 2.2 ptt85 -40.47 161.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.264 -0.898 . . . . 0.0 110.274 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . 0.498 ' O ' ' C ' ' A' ' 222' ' ' VAL . 8.1 ptm180 -129.73 85.72 2.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.92 . . . . 0.0 110.244 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.562 HG13 ' O ' ' A' ' 222' ' ' VAL . 4.9 p -34.82 112.09 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.407 -0.808 . . . . 0.0 110.638 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.489 ' O ' ' C ' ' A' ' 224' ' ' GLU . 0.2 OUTLIER -79.28 43.47 0.54 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.264 -0.897 . . . . 0.0 110.47 -179.871 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.489 ' C ' ' O ' ' A' ' 223' ' ' GLU . 3.0 tt0 -35.2 -68.43 0.12 Allowed 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.372 -0.83 . . . . 0.0 110.674 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.431 ' C ' ' O ' ' A' ' 224' ' ' GLU . 2.8 t -42.28 155.4 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.273 -0.892 . . . . 0.0 110.262 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -117.16 -173.2 2.36 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.271 -0.893 . . . . 0.0 110.138 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.486 ' NH1' ' HG3' ' A' ' 227' ' ' ARG . 0.0 OUTLIER -145.36 11.92 1.33 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.228 -0.92 . . . . 0.0 110.181 -179.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 1.8 mp -113.56 127.48 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.279 -0.888 . . . . 0.0 110.148 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.478 ' O ' ' HB3' ' A' ' 230' ' ' ARG . 15.2 t-80 -77.99 123.08 26.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.237 -0.915 . . . . 0.0 110.179 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . 0.677 ' O ' ' C ' ' A' ' 231' ' ' ASP . 0.4 OUTLIER 180.0 -176.8 0.35 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.254 -0.903 . . . . 0.0 110.181 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.677 ' C ' ' O ' ' A' ' 230' ' ' ARG . 1.9 m-20 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.955 -1.021 . . . . 0.0 111.404 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.74 21.16 5.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.246 -1.149 . . . . 0.0 110.174 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 9' ' ' ALA . 1.0 OUTLIER -148.2 -176.09 5.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 110.17 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 8' ' ' SER . . . -176.57 170.72 2.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.317 -0.864 . . . . 0.0 110.223 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -146.27 103.42 3.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.279 -0.888 . . . . 0.0 110.238 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -138.72 -63.8 0.53 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 110.173 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.471 ' HB3' ' HD3' ' A' ' 14' ' ' PRO . 0.8 OUTLIER -129.15 143.53 50.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.229 -0.919 . . . . 0.0 110.187 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.2 p -128.47 59.61 42.94 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.25 -0.906 . . . . 0.0 110.196 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' A' ' 12' ' ' SER . 46.6 Cg_endo -73.02 71.64 3.45 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.965 1.508 . . . . 0.0 110.485 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 16' ' ' SER . 14.6 t -136.56 177.99 7.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -0.914 . . . . 0.0 110.168 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 15' ' ' THR . 0.8 OUTLIER -41.89 164.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 110.287 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -116.71 72.63 0.83 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.2 -0.937 . . . . 0.0 110.325 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -172.91 164.3 5.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 110.193 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tp -63.62 -150.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.369 -0.832 . . . . 0.0 110.21 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.7 -169.88 1.55 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 110.186 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.434 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 39.7 t -106.34 172.26 6.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.279 -0.888 . . . . 0.0 110.148 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 21' ' ' SER . 0.1 OUTLIER 179.94 62.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.203 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.29 -43.41 33.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.184 -0.948 . . . . 0.0 110.205 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.479 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 1.1 p -77.54 139.09 63.02 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.427 -0.795 . . . . 0.0 110.162 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.495 ' CB ' ' HB3' ' A' ' 29' ' ' LEU . 46.0 Cg_endo -72.58 110.3 2.96 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.048 1.551 . . . . 0.0 110.53 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.507 ' C ' ' H ' ' A' ' 28' ' ' GLY . 48.1 Cg_endo -73.82 -165.84 0.28 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 124.011 1.532 . . . . 0.0 110.67 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -73.96 26.09 0.07 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.343 -0.848 . . . . 0.0 109.996 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.507 ' H ' ' C ' ' A' ' 26' ' ' PRO . . . -153.51 12.61 0.57 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.612 ' O ' ' N ' ' A' ' 32' ' ' LEU . 1.1 pt? -44.76 -22.81 0.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.157 -1.202 . . . . 0.0 110.2 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.857 ' HA ' HD23 ' A' ' 33' ' ' LEU . 59.9 mt-10 -46.66 -26.86 1.0 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.053 -1.03 . . . . 0.0 108.704 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -70.99 -22.21 62.2 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.612 ' N ' ' O ' ' A' ' 29' ' ' LEU . 14.7 tp -83.57 -34.86 25.09 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.06 HD22 ' HB2' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -70.41 -36.56 74.1 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.884 0.849 . . . . 0.0 109.057 179.122 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.597 ' N ' ' HG ' ' A' ' 33' ' ' LEU . 2.9 t -70.48 -14.24 62.45 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.423 0.63 . . . . 0.0 109.945 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 1.023 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -54.45 -160.73 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.511 -0.743 . . . . 0.0 109.967 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 1.023 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 38.2 Cg_endo -65.55 -166.55 0.1 OUTLIER 'Trans proline' 0 N--CA 1.489 1.22 0 O-C-N 123.188 1.099 . . . . 0.0 110.022 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.722 ' CD ' ' HB2' ' A' ' 36' ' ' PRO . 51.2 Cg_endo -96.67 54.42 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 121.394 1.396 . . . . 0.0 113.183 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.739 ' HD3' ' C ' ' A' ' 36' ' ' PRO . 51.7 Cg_endo -76.46 151.06 32.75 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 122.93 0.963 . . . . 0.0 109.761 178.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.706 ' OD1' ' N ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -13.89 -54.41 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.53 -0.731 . . . . 0.0 112.072 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.954 ' O ' ' HB3' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -51.86 -46.56 64.49 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.933 -1.104 . . . . 0.0 110.959 -179.502 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.912 HG13 ' CE1' ' A' ' 45' ' ' HIS . 11.9 t -86.11 -19.14 8.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 O-C-N 121.52 -0.738 . . . . 0.0 111.639 -177.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 46' ' ' HIS . . . -88.95 -41.49 12.36 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.667 -1.271 . . . . 0.0 111.197 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.719 ' HB2' ' HA ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -87.65 -19.43 27.72 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 118.848 -1.141 . . . . 0.0 109.426 179.832 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.954 ' HB3' ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -77.73 -38.02 48.07 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.113 0.959 . . . . 0.0 108.865 179.276 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.912 ' CE1' HG13 ' A' ' 41' ' ' VAL . 6.5 m170 -80.81 -18.2 48.32 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.429 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.479 ' HB2' ' O ' ' A' ' 42' ' ' ALA . 1.0 OUTLIER -97.42 -34.18 11.13 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.194 -0.941 . . . . 0.0 109.465 178.625 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.617 ' O ' ' CD1' ' A' ' 214' ' ' ILE . . . -68.18 -114.94 0.02 OUTLIER Glycine 0 N--CA 1.489 2.198 0 N-CA-C 107.299 -2.32 . . . . 0.0 107.299 178.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 1.105 ' CZ2' ' HA ' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -85.63 87.86 7.46 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 176.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.57 HD21 ' CA ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -42.72 153.17 0.33 Allowed Pre-proline 0 N--CA 1.492 1.652 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -177.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.657 ' HA ' ' O ' ' A' ' 53' ' ' CYS . 43.7 Cg_endo -70.38 -31.05 18.47 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 O-C-N 124.773 1.933 . . . . 0.0 110.952 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.878 ' N ' ' HE3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -62.37 0.13 0.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.36 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.792 ' HB3' HG11 ' A' ' 203' ' ' VAL . 12.9 m-20 -141.87 2.92 1.59 Allowed 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.112 178.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.874 ' HA ' ' N ' ' A' ' 79' ' ' ARG . 1.6 t -150.69 147.74 27.72 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.377 -0.827 . . . . 0.0 111.545 -179.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.946 ' H ' ' HA ' ' A' ' 78' ' ' VAL . 0.7 OUTLIER -86.92 121.78 29.86 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 120.903 -1.123 . . . . 0.0 109.824 178.648 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 1.06 ' HB2' HD22 ' A' ' 33' ' ' LEU . 1.1 pt-20 -44.77 -35.27 2.63 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.489 -0.757 . . . . 0.0 112.976 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.816 HD21 HG21 ' A' ' 75' ' ' THR . 0.0 OUTLIER -32.48 -20.52 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.54 0 O-C-N 121.29 -0.882 . . . . 0.0 111.379 -179.217 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.04 HD11 ' CB ' ' A' ' 207' ' ' TRP . 1.6 mt -111.18 167.18 5.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.307 -0.87 . . . . 0.0 110.131 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.507 ' N ' ' CG2' ' A' ' 57' ' ' ILE . 36.0 t70 -108.54 128.55 54.91 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.376 -0.828 . . . . 0.0 110.357 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 1.037 ' HB ' ' CE2' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -131.28 132.03 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.577 -0.702 . . . . 0.0 111.099 -179.075 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.719 ' HA ' ' HB2' ' A' ' 43' ' ' GLN . 24.6 tttt -136.58 130.7 32.74 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.804 -1.185 . . . . 0.0 110.101 178.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.589 ' H ' ' HB3' ' A' ' 43' ' ' GLN . 1.6 pt-20 -52.58 -117.25 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.442 -0.786 . . . . 0.0 111.079 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . 45.69 41.39 9.72 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 107.998 -2.041 . . . . 0.0 107.998 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.698 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . 98.81 74.09 1.13 Allowed Glycine 0 N--CA 1.487 2.07 0 N-CA-C 108.293 -1.923 . . . . 0.0 108.293 -178.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.698 ' C ' ' O ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER 0.84 75.38 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.758 -0.848 . . . . 0.0 110.887 -178.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.546 ' N ' ' O ' ' A' ' 63' ' ' GLY . 53.7 t -101.61 114.64 28.86 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.312 -0.868 . . . . 0.0 110.491 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 1.105 ' HA ' ' CZ2' ' A' ' 48' ' ' TRP . 1.6 m-85 -82.68 138.03 34.26 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.395 -0.816 . . . . 0.0 110.268 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.507 ' O ' HG23 ' A' ' 57' ' ' ILE . 1.8 tt0 -138.2 121.77 17.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.16 -0.962 . . . . 0.0 109.913 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.488 ' HG3' ' HB2' ' A' ' 207' ' ' TRP . 0.6 OUTLIER -131.17 145.74 52.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.181 -0.95 . . . . 0.0 110.343 -179.87 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.628 ' HB3' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -125.1 -67.52 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.361 -0.837 . . . . 0.0 110.317 179.789 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.628 ' CD ' ' HB3' ' A' ' 69' ' ' ARG . 55.9 Cg_endo -69.7 -141.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.385 1.203 . . . . 0.0 109.133 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.447 ' H ' ' HB2' ' A' ' 70' ' ' PRO . 3.5 t -139.74 164.0 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.053 -1.029 . . . . 0.0 110.045 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.6 119.35 6.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.129 -0.982 . . . . 0.0 110.136 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -84.99 -93.62 0.08 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.178 -0.951 . . . . 0.0 110.267 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.9 p -104.19 23.38 13.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.145 -0.972 . . . . 0.0 110.133 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.816 HG21 HD21 ' A' ' 56' ' ' ASN . 3.4 t -141.5 -134.84 0.1 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.307 -0.871 . . . . 0.0 110.088 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.733 ' O ' ' C ' ' A' ' 77' ' ' GLY . 4.9 m-20 -140.55 153.62 46.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 110.868 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.733 ' C ' ' O ' ' A' ' 76' ' ' ASP . . . -26.48 -62.28 0.08 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 106.067 -2.813 . . . . 0.0 106.067 179.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.959 ' CG2' ' HB3' ' A' ' 205' ' ' ALA . 29.0 m -148.92 118.75 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 122.108 -0.643 . . . . 0.0 109.327 176.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.874 ' N ' ' HA ' ' A' ' 53' ' ' CYS . 0.0 OUTLIER -146.6 137.01 23.81 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.687 -0.633 . . . . 0.0 110.681 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.83 ' HA3' ' C ' ' A' ' 51' ' ' LYS . . . -163.38 156.03 27.65 Favored Glycine 0 N--CA 1.481 1.636 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 178.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 201' ' ' PRO . 0.2 OUTLIER -143.66 128.55 18.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.345 -1.091 . . . . 0.0 110.152 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.796 ' HD3' ' H ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -150.35 -95.64 0.07 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.194 -0.941 . . . . 0.0 110.226 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.796 ' H ' ' HD3' ' A' ' 82' ' ' ARG . . . 47.84 63.98 3.22 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -119.16 95.49 4.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.134 -1.216 . . . . 0.0 110.255 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.58 ' HB3' ' CD2' ' A' ' 89' ' ' HIS . 1.0 OUTLIER -140.3 169.37 17.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.249 -0.907 . . . . 0.0 110.098 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.561 ' O ' ' NE2' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -117.37 133.48 55.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 110.128 179.792 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 103.76 -117.19 5.63 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.706 ' C ' HD23 ' A' ' 88' ' ' LEU . 7.6 tt -128.64 127.0 41.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.398 -1.06 . . . . 0.0 110.39 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.58 ' CD2' ' HB3' ' A' ' 85' ' ' SER . 8.5 m-70 -147.05 161.43 40.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.165 -0.959 . . . . 0.0 110.215 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.677 ' HB1' ' O ' ' A' ' 169' ' ' VAL . . . -163.52 157.87 20.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.22 -0.925 . . . . 0.0 109.857 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 1.142 ' CZ2' HG11 ' A' ' 169' ' ' VAL . 3.0 p90 -134.79 160.25 38.8 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.065 -1.022 . . . . 0.0 110.403 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.643 ' N ' ' O ' ' A' ' 215' ' ' ARG . 31.3 mt-10 -119.11 121.17 39.18 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.339 0.59 . . . . 0.0 110.648 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.538 HG12 ' HA ' ' A' ' 214' ' ' ILE . 5.3 mt -135.01 149.33 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.215 -0.928 . . . . 0.0 110.168 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.584 ' OG ' ' NH2' ' A' ' 213' ' ' ARG . 0.0 OUTLIER -121.17 135.84 55.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 109.654 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 1.169 ' CZ2' ' HB3' ' A' ' 104' ' ' ALA . 6.1 t-105 -115.72 87.88 19.01 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.246 -0.909 . . . . 0.0 110.303 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.63 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 51.0 Cg_endo -97.47 114.06 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.156 1.904 . . . . 0.0 110.967 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.465 ' H ' ' CA ' ' A' ' 101' ' ' GLY . 0.1 OUTLIER -95.6 -67.65 0.84 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.895 -1.128 . . . . 0.0 109.523 179.126 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.45 -45.23 6.2 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.448 -0.783 . . . . 0.0 109.441 179.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.508 ' HG3' ' HG2' ' A' ' 100' ' ' ARG . 8.2 tp-100 -139.45 -75.36 0.36 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.537 0.684 . . . . 0.0 109.409 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.513 ' HD3' ' CG ' ' A' ' 165' ' ' GLU . 5.7 mmt-85 -87.64 -39.06 15.35 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.596 -0.69 . . . . 0.0 109.144 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.831 ' H ' HG22 ' A' ' 162' ' ' VAL . . . 70.11 115.99 0.04 OUTLIER Glycine 0 N--CA 1.487 2.094 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 179.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.644 HG22 HD12 ' A' ' 135' ' ' ILE . 99.1 m -73.67 -80.49 0.07 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.337 -1.096 . . . . 0.0 109.375 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.721 ' CD2' HG21 ' A' ' 106' ' ' VAL . 0.1 OUTLIER 179.07 79.79 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.349 -0.845 . . . . 0.0 110.393 179.588 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 1.169 ' HB3' ' CZ2' ' A' ' 95' ' ' TRP . . . -36.85 -83.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.946 -1.096 . . . . 0.0 108.488 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 1.235 HG13 ' O ' ' A' ' 204' ' ' SER . 0.5 OUTLIER -126.0 114.31 38.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 C-N-CA 117.774 -1.571 . . . . 0.0 109.981 178.737 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.721 HG21 ' CD2' ' A' ' 103' ' ' HIS . 9.7 t -152.49 136.94 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.476 -0.765 . . . . 0.0 109.698 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.519 ' HA3' ' HA3' ' A' ' 132' ' ' GLY . . . 154.07 -146.12 14.04 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 118.895 -1.621 . . . . 0.0 110.559 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.041 HG23 ' C ' ' A' ' 200' ' ' TYR . 2.7 p -149.76 156.93 6.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.689 -0.889 . . . . 0.0 109.597 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.538 ' C ' ' HB3' ' A' ' 199' ' ' LEU . . . -146.41 153.34 40.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.059 -1.025 . . . . 0.0 111.104 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.931 HG23 ' CB ' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -110.72 128.61 55.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.468 -0.77 . . . . 0.0 109.738 179.529 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -92.6 -26.22 17.97 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.31 -0.869 . . . . 0.0 109.726 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.671 ' C ' HD12 ' A' ' 112' ' ' LEU . 4.1 pp -84.88 -11.94 54.55 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.417 -0.802 . . . . 0.0 109.481 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.592 ' HB3' ' HB ' ' A' ' 110' ' ' THR . . . -117.11 80.98 12.24 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.397 -0.814 . . . . 0.0 110.548 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.403 ' O ' ' CG ' ' A' ' 115' ' ' LEU . 46.2 Cg_endo -74.12 144.91 34.36 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.025 1.539 . . . . 0.0 110.203 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.476 ' HB3' ' OE2' ' A' ' 129' ' ' GLU . 0.2 OUTLIER 179.91 62.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.177 -0.952 . . . . 0.0 110.292 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.82 -72.22 0.6 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.193 -0.942 . . . . 0.0 110.279 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.517 ' O ' ' C ' ' A' ' 118' ' ' ASP . . . -56.65 109.31 0.6 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.25 -0.906 . . . . 0.0 110.282 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.517 ' C ' ' O ' ' A' ' 117' ' ' ALA . 5.9 t0 -33.48 150.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.557 -0.715 . . . . 0.0 110.746 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.508 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 0.1 OUTLIER 41.91 -164.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.315 -0.866 . . . . 0.0 110.237 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -93.45 -13.28 28.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.183 -0.948 . . . . 0.0 110.127 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 50.17 38.29 16.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 110.123 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 47.62 33.58 3.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 0.0 110.156 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -161.46 125.44 3.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.189 -0.944 . . . . 0.0 110.251 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.59 HD13 ' C ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -92.13 105.96 18.08 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.244 -0.91 . . . . 0.0 110.225 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -96.17 -146.76 21.52 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.04 40.09 0.1 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.259 -1.142 . . . . 0.0 110.126 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -81.86 125.92 31.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.274 -0.891 . . . . 0.0 110.219 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.17 174.52 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.225 -0.922 . . . . 0.0 110.16 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.476 ' OE2' ' HB3' ' A' ' 115' ' ' LEU . 2.9 tp10 -130.45 117.28 19.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 110.147 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.525 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 1.0 OUTLIER -123.96 122.05 36.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -0.914 . . . . 0.0 110.257 -179.876 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 3.2 m0 -125.54 129.53 49.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.245 -0.91 . . . . 0.0 109.958 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.519 ' HA3' ' HA3' ' A' ' 107' ' ' GLY . . . 173.87 -114.8 0.53 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . 0.869 ' CZ2' HD22 ' A' ' 187' ' ' LEU . 34.3 m0 -129.16 122.96 30.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -1.162 . . . . 0.0 110.303 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.474 ' O ' HG12 ' A' ' 135' ' ' ILE . 0.8 OUTLIER -118.03 107.93 14.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.286 -0.883 . . . . 0.0 110.13 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.644 HD12 HG22 ' A' ' 102' ' ' THR . 1.3 mt -145.53 11.4 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.296 -0.878 . . . . 0.0 109.949 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -124.23 -38.67 0.51 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.33 1.21 23.61 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.505 -0.997 . . . . 0.0 108.949 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -92.81 -13.12 57.14 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 108.706 -1.758 . . . . 0.0 108.706 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.93 -146.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.503 -0.998 . . . . 0.0 110.154 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.582 ' O ' ' CD2' ' A' ' 141' ' ' TYR . 0.3 OUTLIER -147.37 -97.04 0.09 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.21 -0.931 . . . . 0.0 110.337 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.582 ' CD2' ' O ' ' A' ' 140' ' ' LEU . 1.1 m-85 -167.04 -91.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.181 -0.949 . . . . 0.0 110.155 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -124.29 0.35 8.34 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.407 -0.808 . . . . 0.0 110.325 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.04 -43.86 20.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 110.134 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.96 146.66 41.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.215 -0.928 . . . . 0.0 110.167 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.53 123.11 22.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 110.134 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -173.67 109.26 0.29 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.98 HD21 HD21 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -142.76 67.51 1.31 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -1.166 . . . . 0.0 110.124 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.536 ' CG ' ' HD2' ' A' ' 156' ' ' PRO . 59.2 tt0 -47.98 141.42 5.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.159 -0.963 . . . . 0.0 110.235 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.979 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . . . -179.95 -58.66 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.255 -0.903 . . . . 0.0 110.303 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.979 ' HD3' ' HB3' ' A' ' 149' ' ' ALA . 47.0 Cg_endo -73.51 -8.28 21.46 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.007 1.53 . . . . 0.0 110.597 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.434 ' O ' ' CD2' ' A' ' 152' ' ' TYR . 2.6 mp0 -54.19 -66.94 0.31 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.175 -0.953 . . . . 0.0 110.158 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.56 ' CB ' ' CD ' ' A' ' 153' ' ' PRO . 0.2 OUTLIER -179.87 -59.38 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.267 -0.895 . . . . 0.0 110.16 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.56 ' CD ' ' CB ' ' A' ' 152' ' ' TYR . 45.4 Cg_endo -72.95 160.85 45.04 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.025 1.539 . . . . 0.0 110.36 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 155' ' ' GLY . . . -48.39 116.02 1.43 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.232 -0.918 . . . . 0.0 110.128 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 154' ' ' ALA . . . -42.68 116.24 1.15 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.536 ' HD2' ' CG ' ' A' ' 148' ' ' GLU . 45.1 Cg_endo -73.33 -59.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.986 1.519 . . . . 0.0 110.326 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.493 ' O ' ' HG2' ' A' ' 160' ' ' GLN . 0.0 OUTLIER -69.82 -0.59 7.43 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.176 -0.952 . . . . 0.0 110.475 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.477 ' O ' ' HB ' ' A' ' 162' ' ' VAL . . . -53.35 -17.96 6.48 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.426 ' CD ' HG22 ' A' ' 163' ' ' VAL . 1.6 mm-40 -76.73 3.88 10.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.097 -1.237 . . . . 0.0 110.411 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' A' ' 157' ' ' GLN . 36.2 mm-40 -70.95 -17.85 62.65 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.949 0.88 . . . . 0.0 109.198 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.98 HD21 HD21 ' A' ' 147' ' ' LEU . 1.3 pp -167.87 25.63 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.661 0.743 . . . . 0.0 109.211 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.831 HG22 ' H ' ' A' ' 101' ' ' GLY . 2.2 t -161.22 90.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.805 -0.56 . . . . 0.0 109.714 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.875 ' HB ' ' HD3' ' A' ' 164' ' ' PRO . 2.4 t -111.26 -69.37 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.086 -1.009 . . . . 0.0 111.205 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.875 ' HD3' ' HB ' ' A' ' 163' ' ' VAL . 52.9 Cg_endo -95.84 179.21 0.59 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.104 1.055 . . . . 0.0 111.203 -178.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.513 ' CG ' ' HD3' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -108.8 -37.38 5.89 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.753 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 1.073 ' O ' HD13 ' A' ' 167' ' ' LEU . 0.3 OUTLIER -142.71 142.19 31.94 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.106 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 1.073 HD13 ' O ' ' A' ' 166' ' ' ARG . 0.3 OUTLIER -126.79 154.75 43.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.003 -1.06 . . . . 0.0 110.971 -179.24 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.7 tt -123.64 135.08 53.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.496 -0.753 . . . . 0.0 109.653 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 1.142 HG11 ' CZ2' ' A' ' 91' ' ' TRP . 42.3 t -106.41 141.71 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.122 -0.986 . . . . 0.0 110.73 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 53.4 t -122.25 114.81 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.357 -0.839 . . . . 0.0 109.742 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.86 HD12 ' N ' ' A' ' 172' ' ' ASP . 0.4 OUTLIER -128.09 124.08 36.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.18 -0.95 . . . . 0.0 110.423 -179.649 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.86 ' N ' HD12 ' A' ' 171' ' ' LEU . 5.5 t70 -116.32 138.36 51.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.312 -0.868 . . . . 0.0 109.914 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.502 ' O ' ' N ' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -93.34 -41.09 10.03 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.05 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.488 ' C ' ' O ' ' A' ' 173' ' ' MET . 0.6 OUTLIER -41.0 -27.84 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.195 -0.94 . . . . 0.0 108.987 179.399 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.566 ' HB3' ' OG1' ' A' ' 177' ' ' THR . 1.8 tp10 -113.45 -27.63 7.84 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.518 ' O ' ' CG2' ' A' ' 198' ' ' THR . . . 83.62 23.74 52.45 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 1.026 HG22 ' CD2' ' A' ' 194' ' ' LEU . 0.7 OUTLIER -116.59 135.52 53.74 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.344 -1.092 . . . . 0.0 111.029 -179.515 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.999 ' O ' HD11 ' A' ' 194' ' ' LEU . 0.2 OUTLIER -136.29 150.65 49.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.45 -0.781 . . . . 0.0 109.594 179.361 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -148.15 -175.17 20.58 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.691 -1.242 . . . . 0.0 110.08 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.692 ' CG ' ' CH2' ' A' ' 133' ' ' TRP . 0.2 OUTLIER -138.98 127.2 22.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.4 -1.059 . . . . 0.0 110.082 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 21.2 t -117.99 124.44 48.19 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.174 -0.954 . . . . 0.0 109.881 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.799 HD12 ' CZ2' ' A' ' 133' ' ' TRP . 0.1 OUTLIER -116.15 116.48 52.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.506 -0.746 . . . . 0.0 109.777 179.814 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.511 ' C ' ' O ' ' A' ' 182' ' ' ILE . . . 38.51 28.94 0.06 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 182' ' ' ILE . . . 62.32 43.2 99.41 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' THR . . . . . 0.881 HG22 ' HD1' ' A' ' 186' ' ' TYR . 25.2 m -72.24 -78.86 0.08 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.201 -1.176 . . . . 0.0 110.468 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.881 ' HD1' HG22 ' A' ' 185' ' ' THR . 8.6 p90 -175.11 104.47 0.09 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.855 -1.153 . . . . 0.0 111.051 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.869 HD22 ' CZ2' ' A' ' 133' ' ' TRP . 4.8 tp 179.6 23.2 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.366 -0.834 . . . . 0.0 110.778 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.835 ' N ' ' CD ' ' A' ' 189' ' ' PRO . . . -109.65 -5.77 29.31 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.752 -1.213 . . . . 0.0 112.088 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.835 ' CD ' ' N ' ' A' ' 188' ' ' GLY . 50.5 Cg_endo -75.59 -33.03 4.31 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 O-C-N 122.718 0.851 . . . . 0.0 110.97 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.585 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -83.04 41.36 0.75 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.221 -0.924 . . . . 0.0 110.976 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -90.53 -46.22 8.45 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.204 -0.935 . . . . 0.0 110.455 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.523 ' HA ' ' NE ' ' A' ' 192' ' ' ARG . 0.5 OUTLIER -68.11 -14.91 63.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.16 -0.963 . . . . 0.0 110.001 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 197' ' ' ARG . . . -103.47 -10.92 34.69 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 1.026 ' CD2' HG22 ' A' ' 177' ' ' THR . 9.2 tt -70.35 -43.36 70.35 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.851 -0.793 . . . . 0.0 109.142 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.555 ' HE3' ' N ' ' A' ' 196' ' ' GLY . 0.1 OUTLIER -43.91 -41.16 5.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.485 -0.759 . . . . 0.0 110.005 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.555 ' N ' ' HE3' ' A' ' 195' ' ' LYS . . . -88.09 -24.87 33.24 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.708 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -91.07 -2.84 57.56 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.838 -0.801 . . . . 0.0 109.737 179.659 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.711 HG23 ' O ' ' A' ' 194' ' ' LEU . 13.4 p -41.42 125.94 2.72 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.829 0.823 . . . . 0.0 111.212 -177.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.949 ' CD1' HG13 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -138.11 172.77 12.43 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -179.571 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 1.041 ' C ' HG23 ' A' ' 108' ' ' VAL . 4.2 m-30 -83.76 129.84 57.85 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 120.958 -1.089 . . . . 0.0 109.659 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.521 ' HA ' ' HB ' ' A' ' 108' ' ' VAL . 46.6 Cg_endo -72.49 129.17 14.39 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 124.047 1.551 . . . . 0.0 111.851 -178.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.417 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 1.8 p -133.62 160.27 38.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.486 -0.759 . . . . 0.0 110.101 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.792 HG11 ' HB3' ' A' ' 52' ' ' ASP . 14.9 p -137.1 156.51 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.256 -0.903 . . . . 0.0 110.556 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 1.235 ' O ' HG13 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -160.11 127.93 4.66 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.442 -0.787 . . . . 0.0 109.217 179.052 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.959 ' HB3' ' CG2' ' A' ' 78' ' ' VAL . . . -127.93 159.95 33.37 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.5 -0.75 . . . . 0.0 110.738 -178.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.568 ' CG1' ' N ' ' A' ' 207' ' ' TRP . 1.0 OUTLIER -60.45 175.61 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 CA-C-O 121.334 0.588 . . . . 0.0 110.655 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 1.04 ' CB ' HD11 ' A' ' 57' ' ' ILE . 39.7 p90 -120.84 57.71 0.97 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.439 -0.788 . . . . 0.0 110.207 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -134.53 -144.37 5.03 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.411 ' O ' ' C ' ' A' ' 210' ' ' CYS . 2.2 tp60 -67.2 -31.67 72.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.353 -1.086 . . . . 0.0 110.481 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . 0.566 ' SG ' HG12 ' A' ' 206' ' ' VAL . 17.2 p -43.58 153.35 0.12 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.289 -0.882 . . . . 0.0 109.917 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.68 ' HA ' ' CD1' ' A' ' 66' ' ' PHE . 8.2 pt20 -156.56 123.67 5.28 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.103 -0.998 . . . . 0.0 110.628 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.424 ' HA ' ' CD ' ' A' ' 96' ' ' PRO . 1.5 m -101.61 140.32 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.336 -0.852 . . . . 0.0 110.114 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.584 ' NH2' ' OG ' ' A' ' 94' ' ' SER . 0.5 OUTLIER -89.43 127.1 35.8 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.237 -0.914 . . . . 0.0 108.999 179.399 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.956 HG21 ' HA ' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -103.59 113.5 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-O 121.939 0.876 . . . . 0.0 111.248 -178.621 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.643 ' O ' ' N ' ' A' ' 92' ' ' GLU . 4.0 ttt180 -130.61 126.89 37.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.407 -0.808 . . . . 0.0 108.863 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . 0.616 ' CD2' ' HB3' ' A' ' 91' ' ' TRP . 4.0 t80 -119.27 150.39 40.19 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.921 -1.112 . . . . 0.0 111.017 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . 0.457 ' N ' ' CD1' ' A' ' 216' ' ' TYR . 6.2 ttp -126.98 107.87 10.45 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.298 -0.876 . . . . 0.0 109.677 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 89.24 59.18 1.58 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.501 ' HG2' ' N ' ' A' ' 220' ' ' ARG . 31.0 tt0 -95.41 157.9 15.69 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.244 -1.15 . . . . 0.0 110.179 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.501 ' N ' ' HG2' ' A' ' 219' ' ' GLU . 34.7 ttp85 -41.65 -26.13 0.07 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.208 -0.933 . . . . 0.0 110.621 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . 0.496 ' O ' ' O ' ' A' ' 222' ' ' VAL . 3.8 mtp180 -142.26 85.6 1.92 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.172 -0.955 . . . . 0.0 110.631 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.496 ' O ' ' O ' ' A' ' 221' ' ' ARG . 5.7 p -40.14 164.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.423 -0.798 . . . . 0.0 110.561 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 224' ' ' GLU . 10.7 tt0 -165.71 46.56 0.08 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.313 -0.867 . . . . 0.0 110.344 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 223' ' ' GLU . 0.1 OUTLIER 179.08 -77.68 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.182 -0.949 . . . . 0.0 110.208 179.453 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.584 HG22 ' N ' ' A' ' 226' ' ' ARG . 53.4 m -48.57 171.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.325 -0.859 . . . . 0.0 110.274 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.584 ' N ' HG22 ' A' ' 225' ' ' THR . 1.0 OUTLIER -59.65 156.13 14.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.921 . . . . 0.0 110.307 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -125.53 75.73 1.5 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.908 . . . . 0.0 110.167 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.739 ' O ' HG23 ' A' ' 228' ' ' ILE . 7.3 tt -131.98 106.8 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.204 -0.935 . . . . 0.0 110.164 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -74.16 137.82 43.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.211 -0.931 . . . . 0.0 110.213 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . 0.666 ' O ' ' C ' ' A' ' 231' ' ' ASP . 86.6 mtt-85 -45.12 154.41 0.16 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.238 -0.914 . . . . 0.0 110.182 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.666 ' C ' ' O ' ' A' ' 230' ' ' ARG . 52.6 p30 . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 117.93 -1.033 . . . . 0.0 111.458 -179.681 . . . . . . . . 1 1 . 1 stop_ save_